Citrus Sinensis ID: 048068

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310---
Protein Sequence
MGAAPRSFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFSASNDAFSGNSSATMSTIDSILTVGR
Secondary Structure (PSIPRED)
cccccccccHHHHHHHHHccccccccccEEEEEEcccccHHHHHHHHHHHccccccccccccccccEEEEEEEcccccccHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEccccccccccccccccccccccccEEEccccccccccccccccccHHHHHccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEcccccEEEEEEEccccccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccHHHEEEcccccEEEccHHHcEEccHHccEEEEEEEEccccccHHHHHcccccccccHHHHHEEEEEEHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHHccccHHHHHHHHccccccccccccccEEEcccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
MGAAPRSFYFCVLLCVSFILSALAQDVNQFIyhgfnedpqlqrdglasvhsngllqltntvnsrkgEFLLVydympngsldkilhtnikpslswyQRFRIIRGVASGLLYLHEDWeqvvlhrdikpanvlldadlngklgdfglarlydhdtipqttklvgtfgymapelmrtgkaststdVYAFGVFMLEVasgrrpieqqgsmeMVNLVDWVSDCwkkgaildasdsrlegIYEEEQMELVLKLGlfcshpkpearpnMRQVMQYLdgnatlpdiprdstliapfsasndafsgnssatmsTIDSILTVGR
Flexible Loop (DISEMBL)
MGAAPRSFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFSAsndafsgnssatmstidsiltvgr
Low Complexity Region (SEG)
MGAAPRSFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFSASNDAFSGNSSATMSTIDSILTVGR
Disordered region (IsUnstruct)
******SFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCS**************************************************************
Disordered Region (DISOPRED)
**AAPRSFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE***SMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRD**************************SILTVG*
Disordered Region (DISEMBL)
MGAAPRSFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFSASNDAFSGNSSATMSTIDSILTVGR
Disordered Region (DISPRO)
***APRSFYFCVLLCVSFILSALAQDVN******FNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDS*********************STIDSILT***
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGAAPRSFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFSASNDAFSGNSSATMSTIDSILTVGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	313	2.2.26 [Sep-21-2011]
Q9M345	677	L-type lectin-domain cont	yes	no	0.798	0.369	0.566	6e-79
O81291	669	L-type lectin-domain cont	no	no	0.881	0.412	0.532	3e-78
O80939	675	L-type lectin-domain cont	no	no	0.830	0.385	0.550	7e-78
O81292	674	L-type lectin-domain cont	no	no	0.865	0.402	0.553	3e-77
O04533	656	Putative L-type lectin-do	no	no	0.875	0.417	0.5	7e-74
Q9FIF0	694	Putative L-type lectin-do	no	no	0.849	0.383	0.521	5e-73
Q9M2S4	684	L-type lectin-domain cont	no	no	0.869	0.397	0.512	1e-72
Q9FIF1	674	Probable L-type lectin-do	no	no	0.814	0.378	0.532	2e-72
Q9SZD5	669	L-type lectin-domain cont	no	no	0.750	0.351	0.565	8e-71
Q9M1G4	674	Probable L-type lectin-do	no	no	0.715	0.332	0.577	2e-69

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  294 bits (752), Expect = 6e-79,   Method: Compositional matrix adjust.
 Identities = 150/265 (56%), Positives = 189/265 (71%), Gaps = 15/265 (5%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+GE LLVYDYMPNGSLDK L+ N + +L W QR  II+GVASGL YLHE+WEQVV+HRD
Sbjct: 413 RRGELLLVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRD 472

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +K +NVLLDAD NG+LGDFGLARLYDH + PQTT +VGT GY+APE  RTG+A+T+TDVY
Sbjct: 473 VKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVY 532

Query: 184 AFGVFMLEVASGRRPIE-QQGSMEMVNLVDWVSDCWKKGAILDASDSRL-EGIYEEEQME 241
           AFG F+LEV SGRRPIE    S +   LV+WV   W +G I++A D +L    Y+ E++E
Sbjct: 533 AFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVE 592

Query: 242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI-PRDSTLIAPFS-ASNDAFSGNSS 299
           +VLKLGL CSH  P ARP+MRQV+QYL G+  LP++ P D +  +  +    D FSG + 
Sbjct: 593 MVLKLGLLCSHSDPRARPSMRQVLQYLRGDMALPELTPLDLSAGSVMNLGGRDGFSGIAM 652

Query: 300 ATMSTI-----------DSILTVGR 313
              ST+           DS+L+ GR
Sbjct: 653 TDFSTVFKGFTGGSSIADSLLSGGR 677

Required during pollen development.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  291 bits (746), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 154/289 (53%), Positives = 203/289 (70%), Gaps = 13/289 (4%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
           NE  Q  ++ +A + S G +   N V       R+ E LLVYDYMPNGSLDK L+ + + 
Sbjct: 383 NESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEV 442

Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
           +L W QRF++I GVAS L YLHE+WEQVV+HRD+K +NVLLDA+LNG+LGDFGLA+L DH
Sbjct: 443 TLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDH 502

Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVN 209
            + PQTT++VGT+GY+AP+ +RTG+A+T+TDV+AFGV +LEVA GRRPIE    S E V 
Sbjct: 503 GSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVV 562

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           LVDWV   W +  ILDA D  L   Y+++++E+VLKLGL CSH  P ARP MRQV+QYL 
Sbjct: 563 LVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLR 622

Query: 270 GNATLPDI-PRD----STLIAPFSASNDAFSGNSSATMSTIDSILTVGR 313
           G+A LPD+ P D      ++   + SN+  SG  ++  S   S+L+ GR
Sbjct: 623 GDAMLPDLSPLDLRGSGIMLGTHNGSNE--SGMFTSGSSVAYSLLSSGR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  290 bits (743), Expect = 7e-78,   Method: Compositional matrix adjust.
 Identities = 147/267 (55%), Positives = 188/267 (70%), Gaps = 7/267 (2%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
           +E  Q  ++ +A + S G +   N V       R+GE LLVYDYMPNGSLDK L+   + 
Sbjct: 380 HESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEV 439

Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
           +L+W QR ++I GVASGL YLHE+WEQVV+HRD+K +NVLLD +LNG+LGDFGLARLYDH
Sbjct: 440 TLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 499

Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVN 209
            + PQTT +VGT GY+APE  RTG+A+ +TDV+AFG F+LEVA GRRPIE QQ + E   
Sbjct: 500 GSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFL 559

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           LVDWV   W KG IL A D  +    +E+++E+VLKLGL CSH  P ARP+MRQV+ YL 
Sbjct: 560 LVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLR 619

Query: 270 GNATLPDI-PRDSTLIAPFSASNDAFS 295
           G+A LP++ P D +        +D FS
Sbjct: 620 GDAKLPELSPLDLSGSGMMFGVHDGFS 646

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  288 bits (738), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 155/280 (55%), Positives = 195/280 (69%), Gaps = 9/280 (3%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
           NE  Q  ++ +A + S G +   N V       R+ E LLVYDYMPNGSLDK L+   + 
Sbjct: 388 NESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEV 447

Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
           +L W QRF +I GVASGL YLHE+WEQVV+HRDIK +NVLLDA+ NG+LGDFGLARL DH
Sbjct: 448 TLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDH 507

Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVN 209
            + PQTT++VGT+GY+AP+ +RTG+A+T+TDV+AFGV +LEVA GRRPIE +  S E V 
Sbjct: 508 GSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVL 567

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           LVD V   W +G ILDA+D  L  +Y++ ++E VLKLGL CSH  P+ RP MRQV+QYL 
Sbjct: 568 LVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLR 627

Query: 270 GNATLPDI-PRDSTLIAPFSASNDAFSGNSSATMSTIDSI 308
           G+ATLPD+ P D          N  FS   S T S+  SI
Sbjct: 628 GDATLPDLSPLDFRGSGKMLGMNHRFS--ESCTFSSGSSI 665

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04533|LRK52_ARATH Putative L-type lectin-domain containing receptor kinase V.2 OS=Arabidopsis thaliana GN=LECRK52 PE=3 SV=1

 Score =  277 bits (709), Expect = 7e-74,   Method: Compositional matrix adjust.
 Identities = 143/286 (50%), Positives = 184/286 (64%), Gaps = 12/286 (4%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  R+ LA + + G L+  + V       RKGE  LVYD+MP GSLDK L+      L W
Sbjct: 371 QGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYLVYDFMPKGSLDKFLYNQPNQILDW 430

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            QRF II+ VASGL YLH+ W QV++HRDIKPAN+LLD ++N KLGDFGLA+L DH    
Sbjct: 431 SQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPANILLDENMNAKLGDFGLAKLCDHGIDS 490

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
           QT+ + GTFGY++PEL RTGK+STS+DV+AFGVFMLE+  GRRPI  +GS   + L DWV
Sbjct: 491 QTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVFMLEITCGRRPIGPRGSPSEMVLTDWV 550

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
            DCW  G IL   D +L   Y  EQ+ LVLKLGL CSHP    RP+M  V+Q+LDG ATL
Sbjct: 551 LDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGLLCSHPVAATRPSMSSVIQFLDGVATL 610

Query: 275 P----DIPRDSTLIAPF---SASNDAFSGNSSATMSTIDSILTVGR 313
           P    D+     +   F     + ++   +S+ ++   +S L+ GR
Sbjct: 611 PHNLLDLVNSRIINEGFDTLGVTTESMEASSNVSLVMTESFLSSGR 656

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF0|LRK22_ARATH Putative L-type lectin-domain containing receptor kinase II.2 OS=Arabidopsis thaliana GN=LECRK22 PE=3 SV=3

 Score =  274 bits (701), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 145/278 (52%), Positives = 188/278 (67%), Gaps = 12/278 (4%)

Query: 47  ASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKIL-HTNIKPSLSWYQRFRI 100
           A + S G L+  N V       RKGE LLVYDYMPNGSLD  L + N    L+W QR  I
Sbjct: 418 AEIASMGRLRHKNLVQLLGYCRRKGELLLVYDYMPNGSLDDYLFNKNKLKDLTWSQRVNI 477

Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
           I+GVAS LLYLHE+WEQVVLHRDIK +N+LLDADLNG+LGDFGLAR +D     Q T++V
Sbjct: 478 IKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGRLGDFGLARFHDRGENLQATRVV 537

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKK 220
           GT GYMAPEL   G A+T TD+YAFG F+LEV  GRRP+E     E ++L+ WV+ C K+
Sbjct: 538 GTIGYMAPELTAMGVATTKTDIYAFGSFILEVVCGRRPVEPDRPPEQMHLLKWVATCGKR 597

Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRD 280
             ++D  DS+L G ++ ++ +L+LKLG+ CS   PE+RP+MR ++QYL+GNAT+P I  D
Sbjct: 598 DTLMDVVDSKL-GDFKAKEAKLLLKLGMLCSQSNPESRPSMRHIIQYLEGNATIPSISFD 656

Query: 281 STLIAPFSASNDAFS----GNSSATMSTID-SILTVGR 313
           +      + SN+  +     +SSA  S  D +IL  GR
Sbjct: 657 TAGFGIPNISNETITQMTATSSSANFSFEDVTILFGGR 694

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  273 bits (698), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 143/279 (51%), Positives = 188/279 (67%), Gaps = 7/279 (2%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILH-TNIK 89
           +E  Q  R+ ++ V S G L+  N V       R+ + LLVYD+MPNGSLD  L   N +
Sbjct: 379 HESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPE 438

Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
             L+W QRF+II+GVASGLLYLHE WEQ V+HRDIK ANVLLD+++NG++GDFGLA+LY+
Sbjct: 439 VILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYE 498

Query: 150 HDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
           H + P  T++VGTFGY+APEL ++GK +TSTDVYAFG  +LEVA GRRPIE     E + 
Sbjct: 499 HGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELV 558

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +VDWV   W+ G I D  D RL G ++EE++ +V+KLGL CS+  PE RP MRQV+ YL+
Sbjct: 559 MVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLE 618

Query: 270 GNATLPD-IPRDSTLIAPFSASNDAFSGNSSATMSTIDS 307
                P+ +P    L A  S   D  SG++      +DS
Sbjct: 619 KQFPSPEVVPAPDFLDANDSMCLDERSGSAGEFEDFVDS 657

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1

 Score =  272 bits (696), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 141/265 (53%), Positives = 179/265 (67%), Gaps = 10/265 (3%)

Query: 19  ILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYD 73
           IL +  Q   + +YH   +  Q  +  +A + S G L+  N V+      RKGE LLVYD
Sbjct: 373 ILPSGTQIAVKRVYH---DAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYD 429

Query: 74  YMPNGSLDKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 132
           YMPNGSLD  L H N    L+W QR  II+GVAS LLYLHE+WEQVVLHRDIK +N+LLD
Sbjct: 430 YMPNGSLDDYLFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLD 489

Query: 133 ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
           ADLNGKLGDFGLAR +D     + T++VGT GYMAPEL   G  +T TDVYAFG F+LEV
Sbjct: 490 ADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEV 549

Query: 193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSH 252
             GRRP++     E V LV WV+ C K+ A+ D  DS+L   ++ E+ +L+LKLG+ CS 
Sbjct: 550 VCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLID-FKVEEAKLLLKLGMLCSQ 608

Query: 253 PKPEARPNMRQVMQYLDGNATLPDI 277
             PE RP+MRQ++QYL+GN ++P I
Sbjct: 609 INPENRPSMRQILQYLEGNVSVPAI 633

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  267 bits (682), Expect = 8e-71,   Method: Compositional matrix adjust.
 Identities = 139/246 (56%), Positives = 171/246 (69%), Gaps = 11/246 (4%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  R+ +A + + G L+  N V       RKGE  LVYD MP GSLDK L+   + SL W
Sbjct: 381 QGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLDW 440

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            QRF+II+ VASGL YLH  W QV++HRDIKPANVLLD  +NGKLGDFGLA+L +H   P
Sbjct: 441 SQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDP 500

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS--MEMVNLVD 212
           QT+ + GTFGY++PEL RTGKASTS+DV+AFG+ MLE+  GRRP+  + S   EMV L D
Sbjct: 501 QTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMV-LTD 559

Query: 213 WVSDCWKKGAILDASDSRL--EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG 270
           WV DCW+   IL   D R+  +  Y EEQ+ LVLKLGLFCSHP    RP+M  V+Q+LDG
Sbjct: 560 WVLDCWEDD-ILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDG 618

Query: 271 NATLPD 276
            A LP+
Sbjct: 619 VAQLPN 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M1G4|LRK15_ARATH Probable L-type lectin-domain containing receptor kinase I.5 OS=Arabidopsis thaliana GN=LECRK15 PE=2 SV=2

 Score =  262 bits (670), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/225 (57%), Positives = 162/225 (72%), Gaps = 1/225 (0%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           RKGE LLV +YMPNGSLD+ L  +  P LSW QRF I++G+AS L YLH + EQVVLHRD
Sbjct: 409 RKGELLLVSEYMPNGSLDQHLFDDQSPVLSWSQRFVILKGIASALFYLHTEAEQVVLHRD 468

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           IK +NV+LDA+LNG+LGDFG+AR +DH     TT  VGT GYMAPEL+  G AST TDVY
Sbjct: 469 IKASNVMLDAELNGRLGDFGMARFHDHGGNAATTAAVGTVGYMAPELITMG-ASTITDVY 527

Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
           AFGVF+LEVA GR+P+E    +E   L+ WV +CWKK ++LDA D RL   +  E++ELV
Sbjct: 528 AFGVFLLEVACGRKPVEFGVQVEKRFLIKWVCECWKKDSLLDAKDPRLGEEFVPEEVELV 587

Query: 244 LKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFS 288
           +KLGL C++  PE+RP M QV+ YL GN  LPD    +  I  F+
Sbjct: 588 MKLGLLCTNIVPESRPAMGQVVLYLSGNLPLPDFSPYTLGIGSFT 632

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	313
225434861	675	PREDICTED: L-type lectin-domain containi	0.888	0.411	0.588	7e-92
224106425	674	predicted protein [Populus trichocarpa]	0.811	0.376	0.613	3e-90
224106419	607	predicted protein [Populus trichocarpa]	0.760	0.392	0.629	6e-87
255559006	667	kinase, putative [Ricinus communis] gi|2	0.875	0.410	0.575	8e-86
224106407	675	predicted protein [Populus trichocarpa]	0.875	0.405	0.555	8e-86
224059452	599	predicted protein [Populus trichocarpa]	0.782	0.409	0.612	1e-85
255558978	662	kinase, putative [Ricinus communis] gi|2	0.869	0.410	0.575	2e-85
255559000	670	kinase, putative [Ricinus communis] gi|2	0.904	0.422	0.536	5e-83
38346765	673	OSJNBa0081C01.16 [Oryza sativa Japonica	0.760	0.353	0.629	1e-81
116312038	666	OSIGBa0125M19.6 [Oryza sativa Indica Gro	0.760	0.357	0.629	1e-81

>gi|225434861|ref|XP_002280641.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2 [Vitis vinifera]

 Score =  343 bits (879), Expect = 7e-92,   Method: Compositional matrix adjust.
 Identities = 173/294 (58%), Positives = 214/294 (72%), Gaps = 16/294 (5%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
           ++  Q  R+ +A + S G L+  N V       R+GE LLVYD+MPNGSLDK L ++  P
Sbjct: 382 HDSKQGMREFVAEIASMGRLRHRNLVQLLGYCRRRGELLLVYDHMPNGSLDKFLFSDENP 441

Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
            L+W QR+ I+RGVAS LLYLHE+WEQVVLHRD+K +NVLLDA+LNG+LGDFGLA+LYDH
Sbjct: 442 ILTWPQRYHILRGVASSLLYLHEEWEQVVLHRDVKASNVLLDANLNGRLGDFGLAKLYDH 501

Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
           DT PQTT +VGT GY+APEL RTGKA++STDV+AFG FMLE A GRRP+E QG  E   L
Sbjct: 502 DTNPQTTHVVGTVGYLAPELTRTGKATSSTDVFAFGAFMLETACGRRPVELQGYPEGGVL 561

Query: 211 VDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG 270
           +DWV +CWK+GAIL  SD RLEG Y  E+MELVLKLGL CS P P  RP+MRQVMQYL+G
Sbjct: 562 LDWVLECWKRGAILLTSDPRLEGHYVAEEMELVLKLGLLCSSPIPAVRPSMRQVMQYLNG 621

Query: 271 NATLPDIPRDSTLIAPFSASND-------AFSGNSSAT----MSTIDSILTVGR 313
           +A LP+IPR+ + +  F A+ +       +F  +S  T     S+ DSIL  GR
Sbjct: 622 DAPLPEIPRNFSSMGTFGANGEESAEVITSFPSSSGTTTIRSFSSSDSILNQGR 675

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106425|ref|XP_002314160.1| predicted protein [Populus trichocarpa] gi|222850568|gb|EEE88115.1| predicted protein [Populus trichocarpa]

 Score =  337 bits (865), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 159/259 (61%), Positives = 196/259 (75%), Gaps = 5/259 (1%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  ++ +A + + G L+  N V       RKGE LLVYDYMPNGSLDK L   +KP+L+W
Sbjct: 386 QGMKEFVAEIATMGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKFLFCKVKPNLNW 445

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            QR++IIRGVAS LLYLHE+WEQVVLHRD+K +NVLLDADLNG+LGDFGLA+ +DH + P
Sbjct: 446 AQRYQIIRGVASALLYLHEEWEQVVLHRDVKASNVLLDADLNGRLGDFGLAKFHDHGSTP 505

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
           QTT +VGT GY+APE+ RTGK++T +DV++FG FMLEVA GR+P+E +   E V LVDWV
Sbjct: 506 QTTNVVGTVGYLAPEITRTGKSTTCSDVFSFGTFMLEVACGRKPVESERPPEEVVLVDWV 565

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
            +CWK+GAIL   D R EG + EE+MELVLKLGL C+H  P ARP+MRQ MQYLDGNATL
Sbjct: 566 LECWKRGAILGTVDPRFEGNHVEEEMELVLKLGLLCTHRTPAARPSMRQAMQYLDGNATL 625

Query: 275 PDIPRDSTLIAPFSASNDA 293
           PD+P     I     SN+A
Sbjct: 626 PDLPLHGAGIGLVPVSNEA 644

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106419|ref|XP_002314159.1| predicted protein [Populus trichocarpa] gi|222850567|gb|EEE88114.1| predicted protein [Populus trichocarpa]

 Score =  327 bits (837), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 153/243 (62%), Positives = 191/243 (78%), Gaps = 5/243 (2%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  ++ +A + S G L+  N V       RKGE LLVYDYMPNGSLDK+L  N  PSL+W
Sbjct: 365 QGTKEFVAEIVSMGRLRHRNLVQLFGYCRRKGELLLVYDYMPNGSLDKLLFRNETPSLNW 424

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            +R++IIRGVAS LLYLHE+WEQVVLHRD+K +NVLLDADLNG+LGDFGLA+ +DH + P
Sbjct: 425 GRRYQIIRGVASALLYLHEEWEQVVLHRDVKASNVLLDADLNGRLGDFGLAKFHDHGSTP 484

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
           QTTK+VGT GY+APE+ RTGK++T +DV++FG FMLEVA GR+P+E +   E V LVDWV
Sbjct: 485 QTTKVVGTVGYLAPEITRTGKSTTCSDVFSFGTFMLEVACGRKPVESERPPEEVVLVDWV 544

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
            +CW +GAIL   D R+EG + EE+ME+VLKLGL C+H  P ARP+MRQ +QYLDGNATL
Sbjct: 545 LECWNRGAILGTVDPRIEGNHVEEEMEVVLKLGLLCTHRTPAARPSMRQTVQYLDGNATL 604

Query: 275 PDI 277
           PD+
Sbjct: 605 PDL 607

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255559006|ref|XP_002520526.1| kinase, putative [Ricinus communis] gi|223540368|gb|EEF41939.1| kinase, putative [Ricinus communis]

 Score =  323 bits (827), Expect = 8e-86,   Method: Compositional matrix adjust.
 Identities = 161/280 (57%), Positives = 203/280 (72%), Gaps = 6/280 (2%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  ++ +A + S G L+  N V       RKGE  LVYD+MPNGSLDK L +N KP++ W
Sbjct: 388 QGMKEFVAEIASMGRLRHRNLVQLLGYCRRKGELFLVYDHMPNGSLDKFLFSNEKPNIDW 447

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            +R++II+GVAS L YLHE+WEQVVLHRD+K +NVLLDADLNG+LGDFGLA+LYDH + P
Sbjct: 448 VRRYQIIKGVASALYYLHEEWEQVVLHRDVKASNVLLDADLNGRLGDFGLAKLYDHGSTP 507

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
           QTT +VGT GY+APEL  TGKA+TS+DV+AFG+FMLEVA GR+P++ +   E V LVDWV
Sbjct: 508 QTTHVVGTLGYLAPELTTTGKATTSSDVFAFGIFMLEVACGRKPVKSERPPEEVILVDWV 567

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
            +CW++G IL   D RLE  Y  E+ ELVLKLGL  +   P ARP +RQVMQYLDGNATL
Sbjct: 568 LECWERGNILGTIDPRLEDSYVAEETELVLKLGLLSTQRIPTARPTIRQVMQYLDGNATL 627

Query: 275 PDIPRDSTLIAPFSASNDA-FSGNSSATMSTIDSILTVGR 313
           P I   +  I     +++A    N S ++S  DSILT+GR
Sbjct: 628 PQISLYNAGIGFLPGNHEAPTESNLSYSLSHSDSILTIGR 667

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106407|ref|XP_002314156.1| predicted protein [Populus trichocarpa] gi|222850564|gb|EEE88111.1| predicted protein [Populus trichocarpa]

 Score =  323 bits (827), Expect = 8e-86,   Method: Compositional matrix adjust.
 Identities = 165/297 (55%), Positives = 204/297 (68%), Gaps = 23/297 (7%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
           ++  Q  +  +A + S G L+  N V       RKGE LLVYDYMPNGSLDK+L  N  P
Sbjct: 383 HDSKQGTKQFVAEIASMGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKLLFRNDTP 442

Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
           SL+W QR++++RGVAS LLYLHE+WEQVVLHRD+K +N+LLD D NG+LGDFGLA+ YD 
Sbjct: 443 SLNWVQRYQVLRGVASALLYLHEEWEQVVLHRDVKASNILLDDDFNGRLGDFGLAKFYDR 502

Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
              PQTT +VGT GY+APE+ RTG+A+TS+DV+AFG FMLE+A GR+P+E + S E + L
Sbjct: 503 GANPQTTCVVGTVGYIAPEVTRTGRATTSSDVFAFGTFMLEMACGRKPLEPEQSAEKMIL 562

Query: 211 VDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG 270
           VDWV D WK G IL   D RLEG Y  E+MELVLKLGL C    P ARP+MRQ+ QYLDG
Sbjct: 563 VDWVLDSWKIGDILRTGDPRLEGNYVVEEMELVLKLGLLCCFSTPHARPSMRQIGQYLDG 622

Query: 271 NATLPDIPRDSTLIA--------------PFSASNDAFSGNSSATMSTIDSILTVGR 313
           NA+LP+IP D   I                F  SND     S+ + S+IDSIL+ GR
Sbjct: 623 NASLPEIPLDGASIGLMPVSHEEPGDFNLSFHRSNDY----SAHSFSSIDSILSCGR 675

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224059452|ref|XP_002299853.1| predicted protein [Populus trichocarpa] gi|222847111|gb|EEE84658.1| predicted protein [Populus trichocarpa]

 Score =  322 bits (825), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 155/253 (61%), Positives = 192/253 (75%), Gaps = 8/253 (3%)

Query: 31  IYHGFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILH 85
           I HG N   Q  ++ +A + S G L+  N V       RKGE LLVYDYMPNGSLDK L 
Sbjct: 350 ISHGSN---QGMKEFVAEIASMGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKFLF 406

Query: 86  TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 145
            N KP+L W +R++I+RGV S LLYLHE+W+QVVLHRD+K +NVLLD DLNG+LGDFGLA
Sbjct: 407 CNEKPNLDWPRRYQILRGVGSALLYLHEEWQQVVLHRDVKASNVLLDGDLNGRLGDFGLA 466

Query: 146 RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM 205
           + +DH + PQTT +VGT GY+APE+ RTGKA+TS+DV+AFG FMLEV  GRRP+E +   
Sbjct: 467 KFHDHGSTPQTTNVVGTVGYLAPEITRTGKATTSSDVFAFGTFMLEVVCGRRPVESERPP 526

Query: 206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           E V LVDWV +CWK+GAIL   D RL   YE +++ELVLKLGL C+H  P ARP+MRQV+
Sbjct: 527 EEVVLVDWVLECWKRGAILGTVDPRLNVNYEVKEVELVLKLGLLCTHRTPAARPSMRQVV 586

Query: 266 QYLDGNATLPDIP 278
           Q+L+G+ATLPDIP
Sbjct: 587 QFLEGDATLPDIP 599

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558978|ref|XP_002520512.1| kinase, putative [Ricinus communis] gi|223540354|gb|EEF41925.1| kinase, putative [Ricinus communis]

 Score =  321 bits (823), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 161/280 (57%), Positives = 201/280 (71%), Gaps = 8/280 (2%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  ++ +A + S G L+  N V       RKGE LLVY+YMPNGSLDK L +  +  L+W
Sbjct: 385 QGMKEFIAEIASMGRLRHRNLVQLLGYCRRKGELLLVYEYMPNGSLDKFLFSKKEAKLNW 444

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            QR RIIRGVASGLLYLH DWEQVVLHRD+K +NVLLDA+ N +LGDFGLA+ YDH T P
Sbjct: 445 DQRHRIIRGVASGLLYLHHDWEQVVLHRDVKASNVLLDANFNARLGDFGLAKFYDHGTNP 504

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
           QTT +VGT GY+APEL++TGK +TS+DV+AFG FMLE+A GR+P E +   E   L DWV
Sbjct: 505 QTTCVVGTVGYLAPELIKTGKPTTSSDVFAFGNFMLEIACGRKPFEPKCLPEETILADWV 564

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
            +CWK+G IL +SD RLEG Y  ++MELVLKLGL C+H  P ARP+MRQV+ YLD N +L
Sbjct: 565 LECWKRGDILSSSDPRLEGNYVVQEMELVLKLGLLCAHSTPAARPDMRQVVNYLDHNVSL 624

Query: 275 PDIPRDSTLIAPFSASN-DAFSGNSSATMSTIDSILTVGR 313
           P+I +        + +N D F  NS+ + S+ DSILT GR
Sbjct: 625 PEISQYGGPAGSITVNNHDTF--NSANSWSSTDSILTCGR 662

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255559000|ref|XP_002520523.1| kinase, putative [Ricinus communis] gi|223540365|gb|EEF41936.1| kinase, putative [Ricinus communis]

 Score =  313 bits (803), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 161/300 (53%), Positives = 206/300 (68%), Gaps = 17/300 (5%)

Query: 27  VNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLD 81
           V QF  HG     Q  ++ +A + S G L+  N V       RK E LLVYDYMPNGSLD
Sbjct: 375 VKQF-SHG---SQQGMKEFVAEIASMGRLRHRNLVQLLGYCRRKRELLLVYDYMPNGSLD 430

Query: 82  KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD 141
           + L  N   +L+W QR +I++GVAS LLYLHE+W+QVVLHRD+K +NV+LDA+L G+LGD
Sbjct: 431 RFLFQNDTLNLNWVQRLQILKGVASALLYLHEEWDQVVLHRDVKASNVMLDAELKGRLGD 490

Query: 142 FGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ 201
           FGLA+ YDH ++PQTT++VGT GY+APE+ RTG+ +TS+DV+AFG  +LEVA GR+ IE 
Sbjct: 491 FGLAKFYDHGSLPQTTRVVGTIGYLAPEISRTGRFTTSSDVFAFGTLILEVACGRKTIEP 550

Query: 202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM 261
           +     V LVDWV +CWKKG ILD SD  L+G Y  E+ME VLKLGL C+HP P  RP M
Sbjct: 551 ERPPREVILVDWVLECWKKGVILDTSDPELQGKYMAEEMEFVLKLGLLCAHPAPAVRPTM 610

Query: 262 RQVMQYLDGNATLPDIPRDS-----TLIAPFSASNDAFSGNSS---ATMSTIDSILTVGR 313
           RQVMQYLDG A LPDIP +S      L+    A +   S  +S   +++S   S+L+ GR
Sbjct: 611 RQVMQYLDGKADLPDIPLNSPRTGLVLVNQNEAEDCILSSVASYEYSSLSITASVLSTGR 670

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38346765|emb|CAD41144.2| OSJNBa0081C01.16 [Oryza sativa Japonica Group] gi|218195264|gb|EEC77691.1| hypothetical protein OsI_16754 [Oryza sativa Indica Group] gi|222629261|gb|EEE61393.1| hypothetical protein OsJ_15568 [Oryza sativa Japonica Group]

 Score =  309 bits (792), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 153/243 (62%), Positives = 179/243 (73%), Gaps = 5/243 (2%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  R+ +A V S G L+  N V       RKGE LLVYDYMPNGSLDK L+   K +L W
Sbjct: 389 QGMREFVAEVVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKQLYDQGKITLRW 448

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            QRFRIIRGVASGLLYLHEDWEQVV+HRDIK +NVLLDAD+NG+LGDFGLARLYDH T P
Sbjct: 449 AQRFRIIRGVASGLLYLHEDWEQVVVHRDIKASNVLLDADMNGRLGDFGLARLYDHGTDP 508

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
            TT +VGT GY+APEL  TGKAS ++DV+AFG FMLEVA GR+P+ Q      V LVDWV
Sbjct: 509 HTTHVVGTMGYLAPELGHTGKASKASDVFAFGAFMLEVACGRKPVAQDARDNRVVLVDWV 568

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
            D W+ GAI D  D RL G + E +  LVL+LGL CSHP P ARP  RQ++QYL+G+  L
Sbjct: 569 LDRWRAGAITDTVDPRLHGDFVESEASLVLRLGLLCSHPLPGARPGTRQLVQYLEGDVPL 628

Query: 275 PDI 277
           P++
Sbjct: 629 PEL 631

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116312038|emb|CAJ86403.1| OSIGBa0125M19.6 [Oryza sativa Indica Group]

 Score =  309 bits (791), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 153/243 (62%), Positives = 179/243 (73%), Gaps = 5/243 (2%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           Q  R+ +A V S G L+  N V       RKGE LLVYDYMPNGSLDK L+   K +L W
Sbjct: 382 QGMREFVAEVVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKQLYDQGKITLRW 441

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
            QRFRIIRGVASGLLYLHEDWEQVV+HRDIK +NVLLDAD+NG+LGDFGLARLYDH T P
Sbjct: 442 AQRFRIIRGVASGLLYLHEDWEQVVVHRDIKASNVLLDADMNGRLGDFGLARLYDHGTDP 501

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
            TT +VGT GY+APEL  TGKAS ++DV+AFG FMLEVA GR+P+ Q      V LVDWV
Sbjct: 502 HTTHVVGTMGYLAPELGHTGKASKASDVFAFGAFMLEVACGRKPVAQDARDNRVVLVDWV 561

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
            D W+ GAI D  D RL G + E +  LVL+LGL CSHP P ARP  RQ++QYL+G+  L
Sbjct: 562 LDRWRAGAITDTVDPRLHGDFVESEASLVLRLGLLCSHPLPGARPGTRQLVQYLEGDVPL 621

Query: 275 PDI 277
           P++
Sbjct: 622 PEL 624

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	313
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.884	0.409	0.534	1.5e-81
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.865	0.402	0.553	5.2e-79
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.881	0.412	0.532	5.9e-73
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.869	0.397	0.512	2.9e-72
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.884	0.410	0.528	6.7e-72
TAIR|locus:2020593	656	AT1G70130 [Arabidopsis thalian	0.884	0.422	0.501	3.5e-68
TAIR|locus:2144045	766	LecRK-I.9 "lectin receptor kin	0.677	0.276	0.568	4.7e-68
TAIR|locus:2085587	669	AT3G45440 [Arabidopsis thalian	0.715	0.334	0.528	9.8e-68
TAIR|locus:2144015	668	AT5G60270 [Arabidopsis thalian	0.670	0.314	0.565	5.4e-67
TAIR|locus:2168509	674	AT5G59260 [Arabidopsis thalian	0.929	0.431	0.490	6.5e-67

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 745 (267.3 bits), Expect = 1.5e-81, Sum P(2) = 1.5e-81
 Identities = 153/286 (53%), Positives = 197/286 (68%)

Query:    36 NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
             ++  Q  ++ +A + S G +   N V       R+GE LLVYDYMPNGSLDK L+ N + 
Sbjct:   380 HDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPET 439

Query:    91 SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
             +L W QR  II+GVASGL YLHE+WEQVV+HRD+K +NVLLDAD NG+LGDFGLARLYDH
Sbjct:   440 TLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDH 499

Query:   151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVN 209
              + PQTT +VGT GY+APE  RTG+A+T+TDVYAFG F+LEV SGRRPIE    S +   
Sbjct:   500 GSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFL 559

Query:   210 LVDWVSDCWKKGAILDASDSRLEGI-YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
             LV+WV   W +G I++A D +L    Y+ E++E+VLKLGL CSH  P ARP+MRQV+QYL
Sbjct:   560 LVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYL 619

Query:   269 DGNATLPDI-PRDSTLIAPFS-ASNDAFSGNSSATMSTIDSILTVG 312
              G+  LP++ P D +  +  +    D FSG +    ST+    T G
Sbjct:   620 RGDMALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFSTVFKGFTGG 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 728 (261.3 bits), Expect = 5.2e-79, Sum P(2) = 5.2e-79
 Identities = 155/280 (55%), Positives = 195/280 (69%)

Query:    36 NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
             NE  Q  ++ +A + S G +   N V       R+ E LLVYDYMPNGSLDK L+   + 
Sbjct:   388 NESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEV 447

Query:    91 SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
             +L W QRF +I GVASGL YLHE+WEQVV+HRDIK +NVLLDA+ NG+LGDFGLARL DH
Sbjct:   448 TLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDH 507

Query:   151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ-GSMEMVN 209
              + PQTT++VGT+GY+AP+ +RTG+A+T+TDV+AFGV +LEVA GRRPIE +  S E V 
Sbjct:   508 GSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVL 567

Query:   210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             LVD V   W +G ILDA+D  L  +Y++ ++E VLKLGL CSH  P+ RP MRQV+QYL 
Sbjct:   568 LVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLR 627

Query:   270 GNATLPDI-PRDSTLIAPFSASNDAFSGNSSATMSTIDSI 308
             G+ATLPD+ P D          N  FS   S T S+  SI
Sbjct:   628 GDATLPDLSPLDFRGSGKMLGMNHRFS--ESCTFSSGSSI 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 737 (264.5 bits), Expect = 5.9e-73, P = 5.9e-73
 Identities = 154/289 (53%), Positives = 203/289 (70%)

Query:    36 NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
             NE  Q  ++ +A + S G +   N V       R+ E LLVYDYMPNGSLDK L+ + + 
Sbjct:   383 NESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEV 442

Query:    91 SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
             +L W QRF++I GVAS L YLHE+WEQVV+HRD+K +NVLLDA+LNG+LGDFGLA+L DH
Sbjct:   443 TLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDH 502

Query:   151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVN 209
              + PQTT++VGT+GY+AP+ +RTG+A+T+TDV+AFGV +LEVA GRRPIE    S E V 
Sbjct:   503 GSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVV 562

Query:   210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             LVDWV   W +  ILDA D  L   Y+++++E+VLKLGL CSH  P ARP MRQV+QYL 
Sbjct:   563 LVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLR 622

Query:   270 GNATLPDI-PRD----STLIAPFSASNDAFSGNSSATMSTIDSILTVGR 313
             G+A LPD+ P D      ++   + SN+  SG  ++  S   S+L+ GR
Sbjct:   623 GDAMLPDLSPLDLRGSGIMLGTHNGSNE--SGMFTSGSSVAYSLLSSGR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 689 (247.6 bits), Expect = 2.9e-72, Sum P(2) = 2.9e-72
 Identities = 143/279 (51%), Positives = 188/279 (67%)

Query:    36 NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHT-NIK 89
             +E  Q  R+ ++ V S G L+  N V       R+ + LLVYD+MPNGSLD  L   N +
Sbjct:   379 HESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPE 438

Query:    90 PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
               L+W QRF+II+GVASGLLYLHE WEQ V+HRDIK ANVLLD+++NG++GDFGLA+LY+
Sbjct:   439 VILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYE 498

Query:   150 HDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
             H + P  T++VGTFGY+APEL ++GK +TSTDVYAFG  +LEVA GRRPIE     E + 
Sbjct:   499 HGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELV 558

Query:   210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +VDWV   W+ G I D  D RL G ++EE++ +V+KLGL CS+  PE RP MRQV+ YL+
Sbjct:   559 MVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLE 618

Query:   270 GNATLPDI-PRDSTLIAPFSASNDAFSGNSSATMSTIDS 307
                  P++ P    L A  S   D  SG++      +DS
Sbjct:   619 KQFPSPEVVPAPDFLDANDSMCLDERSGSAGEFEDFVDS 657

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
 Identities = 150/284 (52%), Positives = 194/284 (68%)

Query:    36 NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
             +E  Q  ++ +A + S G +   N V       R+GE LLVYDYMPNGSLDK L+   + 
Sbjct:   380 HESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEV 439

Query:    91 SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
             +L+W QR ++I GVASGL YLHE+WEQVV+HRD+K +NVLLD +LNG+LGDFGLARLYDH
Sbjct:   440 TLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 499

Query:   151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVN 209
              + PQTT +VGT GY+APE  RTG+A+ +TDV+AFG F+LEVA GRRPIE QQ + E   
Sbjct:   500 GSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFL 559

Query:   210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             LVDWV   W KG IL A D  +    +E+++E+VLKLGL CSH  P ARP+MRQV+ YL 
Sbjct:   560 LVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLR 619

Query:   270 GNATLPDI-PRDSTLIAPFSASNDAFSGNSSATMSTIDSILTVG 312
             G+A LP++ P D +        +D FS    +  S++    T G
Sbjct:   620 GDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGG 663

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2020593 AT1G70130 [Arabidopsis thaliana (taxid:3702)]

 Score = 692 (248.7 bits), Expect = 3.5e-68, P = 3.5e-68
 Identities = 146/291 (50%), Positives = 188/291 (64%)

Query:    36 NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
             ++  Q  R+ LA + + G L+  + V       RKGE  LVYD+MP GSLDK L+     
Sbjct:   367 HDSRQGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYLVYDFMPKGSLDKFLYNQPNQ 426

Query:    91 SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
              L W QRF II+ VASGL YLH+ W QV++HRDIKPAN+LLD ++N KLGDFGLA+L DH
Sbjct:   427 ILDWSQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPANILLDENMNAKLGDFGLAKLCDH 486

Query:   151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS-MEMVN 209
                 QT+ + GTFGY++PEL RTGK+STS+DV+AFGVFMLE+  GRRPI  +GS  EMV 
Sbjct:   487 GIDSQTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVFMLEITCGRRPIGPRGSPSEMV- 545

Query:   210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             L DWV DCW  G IL   D +L   Y  EQ+ LVLKLGL CSHP    RP+M  V+Q+LD
Sbjct:   546 LTDWVLDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGLLCSHPVAATRPSMSSVIQFLD 605

Query:   270 GNATLP----DIPRDSTLIAPFSA---SNDAFSGNSSATMSTIDSILTVGR 313
             G ATLP    D+     +   F     + ++   +S+ ++   +S L+ GR
Sbjct:   606 GVATLPHNLLDLVNSRIINEGFDTLGVTTESMEASSNVSLVMTESFLSSGR 656

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2144045 LecRK-I.9 "lectin receptor kinase I.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 636 (228.9 bits), Expect = 4.7e-68, Sum P(2) = 4.7e-68
 Identities = 121/213 (56%), Positives = 158/213 (74%)

Query:    64 RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             RK E LLV +YMPNGSLD+ L  + KP LSW QR  +++G+AS L YLH   +QVVLHRD
Sbjct:   409 RKRELLLVSEYMPNGSLDEHLFDDQKPVLSWSQRLVVVKGIASALWYLHTGADQVVLHRD 468

Query:   124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
             +K +N++LDA+ +G+LGDFG+AR ++H     TT  VGT GYMAPEL+  G AST TDVY
Sbjct:   469 VKASNIMLDAEFHGRLGDFGMARFHEHGGNAATTAAVGTVGYMAPELITMG-ASTGTDVY 527

Query:   184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
             AFGVFMLEV  GRRP+E Q  +E  +++ WV +CWKK ++LDA+D RL G +  E++E+V
Sbjct:   528 AFGVFMLEVTCGRRPVEPQLQVEKRHMIKWVCECWKKDSLLDATDPRLGGKFVAEEVEMV 587

Query:   244 LKLGLFCSHPKPEARPNMRQVMQYLDGNATLPD 276
             +KLGL CS+  PE+RP M QV+ YL+ N  LPD
Sbjct:   588 MKLGLLCSNIVPESRPTMEQVVLYLNKNLPLPD 620

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

GO:0048041 "focal adhesion assembly" evidence=IDA

GO:0002229 "defense response to oomycetes" evidence=IMP

GO:0009694 "jasmonic acid metabolic process" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

TAIR|locus:2085587 AT3G45440 [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 9.8e-68, Sum P(2) = 9.8e-68
 Identities = 119/225 (52%), Positives = 154/225 (68%)

Query:    64 RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             RKGE LLV +YMPNGSLD+ L  + KP  SW +R  II+ +A+ L Y+H    QVVLHRD
Sbjct:   407 RKGELLLVSEYMPNGSLDQYLFNDEKPPFSWRRRLLIIKDIATALNYMHTGAPQVVLHRD 466

Query:   124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
             IK +NV+LD + NG+LGDFG+AR +DH   P TT  VGT GYMAPEL   G A T+TDVY
Sbjct:   467 IKASNVMLDTEFNGRLGDFGMARFHDHGKDPATTAAVGTIGYMAPELATVG-ACTATDVY 525

Query:   184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
              FG F+LEV  GRRP+E   S E   +V WV +CWK  ++L A D R+ G    E++E+V
Sbjct:   526 GFGAFLLEVTCGRRPVEPGLSAERWYIVKWVCECWKMASLLGARDPRMRGEISAEEVEMV 585

Query:   244 LKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFS 288
             LKLGL C++  P+ RP+M  ++QYL+G+  LPDI  +S  I  F+
Sbjct:   586 LKLGLLCTNGVPDLRPSMEDIVQYLNGSLELPDISPNSPGIGSFT 630

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2144015 AT5G60270 [Arabidopsis thaliana (taxid:3702)]

 Score = 615 (221.5 bits), Expect = 5.4e-67, Sum P(2) = 5.4e-67
 Identities = 121/214 (56%), Positives = 155/214 (72%)

Query:    64 RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             RK E LLV +YMPNGSLD  L  + + SL W++R  I+R +AS L YLH + +QVV+HRD
Sbjct:   409 RKHELLLVSEYMPNGSLDHYLFNHDRLSLPWWRRLAILRDIASALSYLHTEADQVVIHRD 468

Query:   124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
             IK ANV+LDA+ NG+LGDFG++RLYD    P TT  VGT GYMAPEL   G AST TDVY
Sbjct:   469 IKAANVMLDAEFNGRLGDFGMSRLYDRGADPSTTAAVGTVGYMAPELTTMG-ASTGTDVY 527

Query:   184 AFGVFMLEVASGRRPIEQQGSMEMVN-LVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
             AFGVF+LEV  GRRP+E  G  E    L+ WVS+CWK+ +++DA D RL   +  +++E 
Sbjct:   528 AFGVFLLEVTCGRRPVEP-GLPEAKRFLIKWVSECWKRSSLIDARDPRLTE-FSSQEVEK 585

Query:   243 VLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPD 276
             VLKLGL C++  P++RP M QV+QYL+GN  LP+
Sbjct:   586 VLKLGLLCANLAPDSRPAMEQVVQYLNGNLALPE 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)]

 Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
 Identities = 150/306 (49%), Positives = 197/306 (64%)

Query:    19 ILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYD 73
             IL +  Q   + +YH   +  Q  +  +A + S G L+  N V+      RKGE LLVYD
Sbjct:   373 ILPSGTQIAVKRVYH---DAEQGMKQYVAEIASMGRLRHKNLVHLLGYCRRKGELLLVYD 429

Query:    74 YMPNGSLDKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 132
             YMPNGSLD  L H N    L+W QR  II+GVAS LLYLHE+WEQVVLHRDIK +N+LLD
Sbjct:   430 YMPNGSLDDYLFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLD 489

Query:   133 ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
             ADLNGKLGDFGLAR +D     + T++VGT GYMAPEL   G  +T TDVYAFG F+LEV
Sbjct:   490 ADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCTDVYAFGAFILEV 549

Query:   193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSH 252
               GRRP++     E V LV WV+ C K+ A+ D  DS+L   ++ E+ +L+LKLG+ CS 
Sbjct:   550 VCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLID-FKVEEAKLLLKLGMLCSQ 608

Query:   253 PKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFSASNDAFSG----NSSATMSTID-S 307
               PE RP+MRQ++QYL+GN ++P I   +  +   + S++  +     +SSA  S  D +
Sbjct:   609 INPENRPSMRQILQYLEGNVSVPAISFGTVALGIPNISHETVTQMTTTSSSANFSFEDVT 668

Query:   308 ILTVGR 313
             +L  GR
Sbjct:   669 VLFGGR 674

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00024271001 SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (675 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	313
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-36
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.001
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  133 bits (336), Expect = 3e-37
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            K    LV +Y   G L   L       LS  +  +I   +  GL YLH +    ++HRD
Sbjct: 69  DKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNG---IIHRD 123

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-ASTSTDV 182
           +KP N+LLD +   K+ DFGLA+     +    T  VGT  YMAPE++  G       DV
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182

Query: 183 YAFGVFMLEVASGRRP---IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ 239
           ++ GV + E+ +G+ P         ++++  +         G  L+  + +     EE +
Sbjct: 183 WSLGVILYELLTGKPPFSGENILDQLQLIRRI--------LGPPLEFDEPKWSSGSEEAK 234

Query: 240 MELVLKLGLFCSHPKPEARPNMRQVMQ 266
            +L+ K    C +  P  RP   +++Q
Sbjct: 235 -DLIKK----CLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  130 bits (329), Expect = 4e-36
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 21/221 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  +    +++L +     + +  LV +Y   G L  +L    + S    +    +R + 
Sbjct: 51  LKKLKHPNIVRLYDVFED-EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQIL 107

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S L YLH      ++HRD+KP N+LLD D + KL DFGLAR  D     + T  VGT  Y
Sbjct: 108 SALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE--KLTTFVGTPEY 162

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MAPE++       + D+++ GV + E+ +G+ P    G  +++ L   +           
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKP-------K 213

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
                 E     E  +L+ KL L      PE R    + +Q
Sbjct: 214 PPFPPPEWDISPEAKDLIRKL-L---VKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  124 bits (313), Expect = 2e-34
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 22/162 (13%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V   +    LV +Y   GSL  +L  N    LS  +  RI+  +  GL YLH      ++
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHS---NGII 114

Query: 121 HRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-TGKAST 178
           HRD+KP N+LLD+D    KL DFGL++L   D       +VGT  YMAPE++   G  S 
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKK 220
            +D+++ GV +                E+  L D +    +K
Sbjct: 174 KSDIWSLGVILY---------------ELPELKDLIRKMLQK 200

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  119 bits (301), Expect = 4e-32
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 22/208 (10%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           ++     +V +YMP G L   L  +    L+     ++   +A G+ YL     +  +HR
Sbjct: 71  TQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLES---KNFVHR 126

Query: 123 DIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           D+   N L+  +L  K+ DFGL+R +Y+ D   +         +MAPE ++ GK ++ +D
Sbjct: 127 DLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSD 186

Query: 182 VYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM 240
           V++FGV + E+ + G +P     + E++ L+       + G  L   ++  + +YE    
Sbjct: 187 VWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-------EDGYRLPRPENCPDELYE---- 235

Query: 241 ELVLKLGLFCSHPKPEARPNMRQVMQYL 268
             ++     C    PE RP   ++++ L
Sbjct: 236 --LMLQ---CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  116 bits (293), Expect = 5e-31
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           +   ++V +YMP G L   L  N    LS          +A G+ YL    +  + HRD+
Sbjct: 73  EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--KNFI-HRDL 129

Query: 125 KPANVLLDADLNGKLGDFGLAR-LYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDV 182
              N L+  +L  K+ DFGL+R LYD D    +  KL     +MAPE ++ GK ++ +DV
Sbjct: 130 AARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDV 187

Query: 183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME 241
           ++FGV + E+ + G  P      M    +++++    KKG  L    +    +Y  + M 
Sbjct: 188 WSFGVLLWEIFTLGEEP---YPGMSNAEVLEYL----KKGYRLPKPPNCPPELY--KLML 238

Query: 242 LVLKLGLFCSHPKPEARPNMRQVMQYL 268
                   C    PE RP   ++++ L
Sbjct: 239 Q-------CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  116 bits (293), Expect = 5e-31
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           +    +V +YM  G L   L  N +P LS          +A G+ YL    +  + HRD+
Sbjct: 73  EEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLES--KNFI-HRDL 128

Query: 125 KPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
              N L+  +L  K+ DFGL+R LYD D   +    +    +MAPE ++ GK ++ +DV+
Sbjct: 129 AARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-WMAPESLKEGKFTSKSDVW 187

Query: 184 AFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           +FGV + E+ + G +P      M    +++++    K G  L    +    +Y  + M  
Sbjct: 188 SFGVLLWEIFTLGEQP---YPGMSNEEVLEYL----KNGYRLPQPPNCPPELY--DLMLQ 238

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQYL 268
                  C    PE RP   ++++ L
Sbjct: 239 -------CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  113 bits (286), Expect = 6e-30
 Identities = 46/138 (33%), Positives = 77/138 (55%), Gaps = 7/138 (5%)

Query: 63  SRKGEFLLVY-DYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
             +   L ++ +Y+  GSL  +L    K      +++   R +  GL YLH      ++H
Sbjct: 70  DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQILEGLAYLHS---NGIVH 124

Query: 122 RDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIK AN+L+D+D   KL DFG A+ L D +T   T  + GT  +MAPE++R  +   + 
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184

Query: 181 DVYAFGVFMLEVASGRRP 198
           D+++ G  ++E+A+G+ P
Sbjct: 185 DIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 5e-29
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 65  KGEFLLVYDYMPNGSLDKIL-------HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ 117
           +    LV +YM  G L   L        +  K +LS          +A G+ YL     +
Sbjct: 68  EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---K 124

Query: 118 VVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
             +HRD+   N L+  DL  K+ DFGL+R +YD D   + T       +MAPE ++ G  
Sbjct: 125 KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF 184

Query: 177 STSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY 235
           ++ +DV++FGV + E+ + G  P     + E++  +       +KG  L   +   + +Y
Sbjct: 185 TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYRLPKPEYCPDELY 237

Query: 236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                EL+L     C    PE RP   ++++ L+
Sbjct: 238 -----ELMLS----CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (268), Expect = 3e-27
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKP--SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           KG+  +V +Y   G L + +    K        Q       +   L YLH    + +LHR
Sbjct: 71  KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHR 127

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           DIKP N+ L ++   KLGDFG++++         T +VGT  Y++PEL +    +  +D+
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKPYNYKSDI 186

Query: 183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           ++ G  + E+ + + P E + ++  +          K   IL      +   Y  E   L
Sbjct: 187 WSLGCVLYELCTLKHPFEGE-NLLEL--------ALK---ILKGQYPPIPSQYSSELRNL 234

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQ 266
           V  L L      PE RP++ Q++Q
Sbjct: 235 VSSL-L---QKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (262), Expect = 7e-26
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 20/229 (8%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H   +++L +     +G   LV +Y+  GSL+ +L     K  LS  +   I+  + S L
Sbjct: 56  HPPNIVKLYDFFQD-EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLN-GKLGDFGLARLYDHDTIPQ-----TTKLVGT 162
            YLH    + ++HRDIKP N+LLD D    KL DFGLA+L              +  VGT
Sbjct: 115 EYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 163 FGYMAPEL---MRTGKASTSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVNLVDWVSDCW 218
            GYMAPE+   +    AS+S+D+++ G+ + E+ +G  P E ++ S      +  + +  
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
                   S S  E I  +   +L+ K         P+ R +    + +
Sbjct: 232 TPSLASPLSPSNPELIS-KAASDLLKK----LLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  100 bits (252), Expect = 5e-25
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 19/171 (11%)

Query: 99  RIIRGVASGLLYLH--EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
           RI+  +   L   H   D    VLHRD+KPAN+ LDA+ N KLGDFGLA++  HD+    
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD 216
           T  VGT  YM+PE +        +D+++ G  + E+ +   P   +  +++ + +     
Sbjct: 169 T-YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI----- 222

Query: 217 CWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
             K+G        R+   Y  E +  V+K      +  P+ RP+  +++Q 
Sbjct: 223 --KEGKF-----RRIPYRYSSE-LNEVIK---SMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  100 bits (251), Expect = 8e-25
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 64  RKGEFLLVYDYMPNGSLDKIL--HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           ++GE  +V +YM  GSL  +L     I   +  Y    I R +  GL YLH     +  H
Sbjct: 70  KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY----IARQILKGLDYLHTKRHII--H 123

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           RDIKP+N+L+++    K+ DFG++++ + +T+ Q    VGT  YM+PE ++    S + D
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNTFVGTVTYMSPERIQGESYSYAAD 182

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME 241
           +++ G+ +LE A G+ P    G      L+          AI D     L       +  
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQ---------AICDGPPPSLPAEEFSPEFR 233

Query: 242 LVLKLGLFCSHPKPEARPNMRQVMQ 266
             +     C    P+ RP+  +++Q
Sbjct: 234 DFISA---CLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 99.3 bits (248), Expect = 2e-24
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 30/210 (14%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKP----SLSWYQRFRIIRGVASGLLYLHEDWEQVV 119
             G+  +  +YM  GSLDKIL           L      +I   V  GL YLHE  +  +
Sbjct: 70  NNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK--I 122

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +HRD+KP+N+L+++    KL DFG++     +++ +T   VGT  YMAPE ++    S  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSLAKT--FVGTSSYMAPERIQGNDYSVK 179

Query: 180 TDVYAFGVFMLEVASGRRPI--EQQGSMEMVNLVDWVSDCWKKGAILDASDSRL-EGIYE 236
           +D+++ G+ ++E+A+GR P   E      +  L+           I++    RL  G + 
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ---------YIVNEPPPRLPSGKFS 230

Query: 237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
            +  + V      C    P  RP+ +++++
Sbjct: 231 PDFQDFVNL----CLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 95.3 bits (237), Expect = 5e-23
 Identities = 50/138 (36%), Positives = 74/138 (53%), Gaps = 4/138 (2%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           KG+  +V +Y  NG L K+L       L   Q +R    +  GL +LH    + +LHRDI
Sbjct: 71  KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDI 127

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           K  N+ LDA  N K+GD G+A+L   +T    T +VGT  Y++PEL      +  +DV+A
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKPYNEKSDVWA 186

Query: 185 FGVFMLEVASGRRPIEQQ 202
            GV + E  +G+ P +  
Sbjct: 187 LGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.8 bits (231), Expect = 4e-22
 Identities = 37/97 (38%), Positives = 51/97 (52%), Gaps = 5/97 (5%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +   L YLH    + ++HRDIKP N+LLD   +  + DF +A     DT   TT   GT 
Sbjct: 109 IVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTP 163

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           GYMAPE++     S + D ++ GV   E   G+RP  
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 92.6 bits (231), Expect = 7e-22
 Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 49/219 (22%)

Query: 50  HSNGLLQLTNTVNSR-KGEFLLVYDYMP---NGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           H N +++L   V S+ KG   +V++YM     G LD      +K + S  Q    ++ + 
Sbjct: 57  HPN-IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVKFTES--QIKCYMKQLL 110

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            GL YLH      +LHRDIK +N+L++ D   KL DFGLAR Y        T  V T  Y
Sbjct: 111 EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167

Query: 166 MAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
             PE L+   +     D+++ G  + E+  G +PI  QGS E+                 
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLG-KPI-FQGSTEL----------------- 208

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ 263
                        EQ+E + +L   C  P  E  P + +
Sbjct: 209 -------------EQLEKIFEL---CGSPTDENWPGVSK 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 1e-21
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 6/142 (4%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y P G L   L    + S    + +     +   L YLH      +++RD+KP N+
Sbjct: 70  LVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLHS---LGIIYRDLKPENI 124

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LLDAD + KL DFGLA+    +   +T    GT  Y+APE++       + D ++ GV +
Sbjct: 125 LLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLL 183

Query: 190 LEVASGRRPIEQQGSMEMVNLV 211
            E+ +G+ P   +   E+   +
Sbjct: 184 YEMLTGKPPFYAEDRKEIYEKI 205

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 90.3 bits (225), Expect = 3e-21
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 14/146 (9%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKP-SLSW--YQRFRIIRGVASGLLYLHEDWEQVVL 120
           +K E  +V ++   GSL  +L +  +  + S   Y    + + +  GL YLH      ++
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY----VCKELLKGLEYLHS---NGII 120

Query: 121 HRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           HRDIK AN+LL +D   KL DFGL+ +L D         +VGT  +MAPE++        
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSD---TKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 180 TDVYAFGVFMLEVASGRRPIEQQGSM 205
            D+++ G+  +E+A G+ P  +   M
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPM 203

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 6e-21
 Identities = 54/156 (34%), Positives = 86/156 (55%), Gaps = 18/156 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +++L   V   +   +++ +YM NGSLDK L  N     +  Q   ++RG+ASG+ 
Sbjct: 64  HPN-IIRLEGVVTKSR-PVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMK 120

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG----- 164
           YL E      +HRD+   N+L++++L  K+ DFGL+R  +      TTK     G     
Sbjct: 121 YLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPI 172

Query: 165 -YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 198
            + APE +   K ++++DV++FG+ M EV S G RP
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 48/135 (35%), Positives = 72/135 (53%), Gaps = 8/135 (5%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
                ++ +Y  NGSL +I+        S    +  +  V  GL YLHE   Q V+HRDI
Sbjct: 71  SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY--VYQVLQGLAYLHE---QGVIHRDI 125

Query: 125 KPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           K AN+L   D   KL DFG+A +L D         +VGT  +MAPE++    AST++D++
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAPEVIEMSGASTASDIW 183

Query: 184 AFGVFMLEVASGRRP 198
           + G  ++E+ +G  P
Sbjct: 184 SLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 32/152 (21%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL----YLHEDWEQVVLHRDIK 125
            V +Y PNG L + +      SL      +  R  A+ +L    YLH    + ++HRD+K
Sbjct: 79  FVLEYAPNGELLQYIRKY--GSLD----EKCTRFYAAEILLALEYLHS---KGIIHRDLK 129

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL-------------------VGTFGYM 166
           P N+LLD D++ K+ DFG A++ D ++ P++ K                    VGT  Y+
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           +PEL+    A  S+D++A G  + ++ +G+ P
Sbjct: 190 SPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 2e-20
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 30/222 (13%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V        +V +YM  GSL   L +  +  ++  Q+      V  G+ 
Sbjct: 59  HPN-LVQLLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMA 167
           YL E   +  +HRD+   NVL+  DL  K+ DFGLA+      D+     K      + A
Sbjct: 117 YLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------WTA 167

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V       +KG  ++A
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-------EKGYRMEA 220

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
            +     +Y         K+   C    P  RP  +Q+ + L
Sbjct: 221 PEGCPPEVY---------KVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.3 bits (220), Expect = 3e-20
 Identities = 44/131 (33%), Positives = 70/131 (53%), Gaps = 13/131 (9%)

Query: 70  LVYDYMPNGSLDKILHTNIKP-SLSWYQR--FRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           LV++Y     L K L     P S +  +   ++++RG+A    Y H      +LHRD+KP
Sbjct: 75  LVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCHSHR---ILHRDLKP 126

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKASTSTDVYAF 185
            N+L++ D   KL DFGLAR +       T ++V T  Y APE L+ +   ST+ D+++ 
Sbjct: 127 QNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTAVDIWSV 185

Query: 186 GVFMLEVASGR 196
           G    E+ +G+
Sbjct: 186 GCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 87.1 bits (216), Expect = 8e-20
 Identities = 48/138 (34%), Positives = 67/138 (48%), Gaps = 16/138 (11%)

Query: 73  DYMPNGSLDKILHTNIKPS--LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 130
           +Y   GSLD I     K    +      +I   V  GL YLH    + ++HRDIKP+N+L
Sbjct: 81  EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNIL 137

Query: 131 LDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG----YMAPELMRTGKASTSTDVYAFG 186
           L      KL DFG++             L GTF     YMAPE ++    S ++DV++ G
Sbjct: 138 LTRKGQVKLCDFGVSG-------ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLG 190

Query: 187 VFMLEVASGRRPIEQQGS 204
           + +LEVA  R P   +G 
Sbjct: 191 LTLLEVAQNRFPFPPEGE 208

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 16/143 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           F+LV +YMP   L ++L    +P L   Q    +R +  G+ Y+H +    ++HRD+KPA
Sbjct: 74  FVLVMEYMP-SDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPA 128

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM---RTGKASTSTDVYA 184
           N+L+ AD   K+ DFGLARL+  +     +  V T  Y APEL+   R  K     D++A
Sbjct: 129 NLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR--KYDPGVDLWA 186

Query: 185 FGVFMLEVA------SGRRPIEQ 201
            G    E+        G   IEQ
Sbjct: 187 VGCIFAELLNGSPLFPGENDIEQ 209

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 17/163 (10%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L ++H    + ++HRDIKPANV + A    KLGD GL R +   T      LVGT 
Sbjct: 115 LCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTP 170

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            YM+PE +     +  +D+++ G  + E+A+ + P      M + +L   +  C      
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEKCDYPPLP 229

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
            D         Y EE  +LV +    C +P PE RP++  V+Q
Sbjct: 230 AD--------HYSEELRDLVSR----CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 82.4 bits (204), Expect = 2e-18
 Identities = 48/146 (32%), Positives = 78/146 (53%), Gaps = 19/146 (13%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLHRDI 124
           +  +  +Y   G+L+++L           + +  +++ G+A    YLH      ++HRDI
Sbjct: 73  KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA----YLHS---HGIVHRDI 125

Query: 125 KPANVLLDADLNG--KLGDFGLA-RLYDHDTIPQTT--KLVGTFGYMAPELMRTGKAS-- 177
           KPAN+ LD   NG  KLGDFG A +L ++ T        L GT  YMAPE++  GK    
Sbjct: 126 KPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 178 -TSTDVYAFGVFMLEVASGRRPIEQQ 202
             + D+++ G  +LE+A+G+RP  + 
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 82.2 bits (204), Expect = 8e-18
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 14/135 (10%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           +V + M    L K++ +    +    Q F  +I+RG    L YLH      V+HRD+KP+
Sbjct: 81  IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG----LKYLHS---ANVIHRDLKPS 132

Query: 128 NVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYA 184
           N+L++++ + K+ DFGLAR  D D       T+ V T  Y APEL+ +    + + D+++
Sbjct: 133 NILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS 192

Query: 185 FGVFMLEVASGRRPI 199
            G    E+   R+P+
Sbjct: 193 VGCIFAELL-TRKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 31/162 (19%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             GE  ++ ++M  GSL+   H   +  L+      + R + SG+ YLH    + ++HRD
Sbjct: 143 HNGEIQVLLEFMDGGSLEGT-HIADEQFLA-----DVARQILSGIAYLHR---RHIVHRD 193

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT--------GK 175
           IKP+N+L+++  N K+ DFG++R+      P  +  VGT  YM+PE + T        G 
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERINTDLNHGAYDGY 252

Query: 176 ASTSTDVYAFGVFMLEVASGRRP--IEQQGSMEMVNLVDWVS 215
           A    D+++ GV +LE   GR P  + +QG        DW S
Sbjct: 253 AG---DIWSLGVSILEFYLGRFPFGVGRQG--------DWAS 283

Length = 353

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 38/212 (17%)

Query: 73  DYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 131
           ++M  GSLD  ++  I +  L      RI   V  GL YL   W   +LHRD+KP+N+L+
Sbjct: 79  EFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLV 128

Query: 132 DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE 191
           +     KL DFG++     ++I +T   VGT  YMAPE +   +    +DV++ G+  +E
Sbjct: 129 NTRGQVKLCDFGVSTQL-VNSIAKT--YVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185

Query: 192 VASGRRPIEQ----QGSMEMVNLVDWVSDCWKKGAILDASDSRL-EGIYEEEQMELVLKL 246
           +A GR P  Q    QGS+  + L+           I+D     L  G + E+ +  + + 
Sbjct: 186 LALGRFPYPQIQKNQGSLMPLQLLQ---------CIVDEDPPVLPVGQFSEKFVHFITQ- 235

Query: 247 GLFCSHPKPEARPNMRQVM------QYLDGNA 272
              C   +P+ RP    +M      QY DGNA
Sbjct: 236 ---CMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 54/166 (32%), Positives = 92/166 (55%), Gaps = 12/166 (7%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +++L   V   K   +++ +YM NG+LDK L  +     S YQ   ++RG+A+G+ 
Sbjct: 65  HHN-IIRLEGVVTKFK-PAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMK 121

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG--YMA 167
           YL +      +HRD+   N+L++++L  K+ DFGL+R+ + D     T   G     + A
Sbjct: 122 YLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRP---IEQQGSMEMVN 209
           PE +   K ++++DV++FG+ M EV S G RP   +     M+ +N
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 80.3 bits (198), Expect = 1e-17
 Identities = 51/174 (29%), Positives = 92/174 (52%), Gaps = 26/174 (14%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +++ ++M NG+LD  L  N     +  Q   ++RG+A+G+ YL E      +HRD+   N
Sbjct: 81  MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARN 136

Query: 129 VLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVG---TFGYMAPELMRTGKASTSTDVYA 184
           +L++++L  K+ DFGL+R  + DT  P  T  +G      + APE +   K ++++DV++
Sbjct: 137 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWS 196

Query: 185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVD-----------------WVSDCWKK 220
           +G+ M EV S G RP     + +++N ++                  + DCW+K
Sbjct: 197 YGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQK 250

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 6/163 (3%)

Query: 41  LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI 100
            ++  L  V S  ++ L     + K +  LV   M  G L   ++   +P     +    
Sbjct: 42  NEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY 100

Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
              +  GL +LH+   + +++RD+KP NVLLD   N ++ D GLA   +     +     
Sbjct: 101 AAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRA 155

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQG 203
           GT GYMAPE+++      S D +A G  + E+ +GR P  Q+ 
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 25/221 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V   + 
Sbjct: 58  HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL  +     +HRD+   NVL+  D   K+ DFGL +  +  +   T KL     + APE
Sbjct: 117 YLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPE 169

Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V+       KG  +DA D
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD 222

Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +Y+      V+K    C H     RP+  Q+ + L+
Sbjct: 223 GCPPVVYD------VMKQ---CWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.6 bits (196), Expect = 3e-17
 Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 24/180 (13%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V ++    ++V +YM NGSLD  L  +     +  Q   ++RG+ASG+ YL +      +
Sbjct: 73  VVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSD---MGYV 128

Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG--YMAPELMRTGKAST 178
           HRD+   N+L++++L  K+ DFGL+R+ + D     T   G     + APE +   K ++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188

Query: 179 STDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD-----------------WVSDCWKK 220
           ++DV+++G+ M EV S G RP  +  + +++  ++                  + DCW+K
Sbjct: 189 ASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQK 248

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 44/136 (32%), Positives = 78/136 (57%), Gaps = 11/136 (8%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLHRD 123
           GE  +  ++M  GSLD++L    K +    +    +I   V  GL YL E  +  ++HRD
Sbjct: 72  GEISICMEHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRD 125

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP+N+L+++    KL DFG++     D++  +   VGT  YM+PE ++    +  +D++
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS--FVGTRSYMSPERLQGTHYTVQSDIW 182

Query: 184 AFGVFMLEVASGRRPI 199
           + G+ ++E+A GR PI
Sbjct: 183 SLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 9e-17
 Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 15/151 (9%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKP---SLSWYQRFRIIRGVAS 106
           H N +++L + V   KG+  LV+++M +  L K++    +    SL     +++++G+A 
Sbjct: 57  HPN-IIKLLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA- 112

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
              + H      +LHRD+KP N+L++ +   KL DFGLAR +     P T   V T  Y 
Sbjct: 113 ---FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY-VVTRWYR 165

Query: 167 APELMRTGKA-STSTDVYAFGVFMLEVASGR 196
           APEL+   K  ST  D+++ G    E+ S R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.9 bits (192), Expect = 1e-16
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 32/203 (15%)

Query: 70  LVYDYMPNGSLDKIL------HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +V +Y P G L K +         I     W    RI   +  GL  LHE   Q +LHRD
Sbjct: 76  IVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALHE---QKILHRD 128

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +K AN+LL A+   K+GD G++++     + +T   +GT  YMAPE+ +    S  +D++
Sbjct: 129 LKSANILLVANDLVKIGDLGISKVLK-KNMAKTQ--IGTPHYMAPEVWKGRPYSYKSDIW 185

Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
           + G  + E+A+   P E + SM+ +              +       +  IY ++    +
Sbjct: 186 SLGCLLYEMATFAPPFEAR-SMQDLRY-----------KVQRGKYPPIPPIYSQDLQNFI 233

Query: 244 LKLGLFCSHPKPEARPNMRQVMQ 266
                     KP+ RPN  +++ 
Sbjct: 234 ----RSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 24/139 (17%)

Query: 70  LVYDYMPNGSLDKILH--------TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV+++M    L+K++          +IK   S+      +RG+     YLH +W   +LH
Sbjct: 79  LVFEFME-TDLEKVIKDKSIVLTPADIK---SYMLM--TLRGLE----YLHSNW---ILH 125

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STST 180
           RD+KP N+L+ +D   KL DFGLAR +       T ++V T  Y APEL+   +      
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHYGVGV 184

Query: 181 DVYAFGVFMLEVASGRRPI 199
           D+++ G    E+   R P 
Sbjct: 185 DMWSVGCIFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.8 bits (192), Expect = 1e-16
 Identities = 47/145 (32%), Positives = 72/145 (49%), Gaps = 8/145 (5%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPS-LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  LV  Y+  GSL  I+ ++     L       +++ V  GL YLH       +HRDIK
Sbjct: 73  ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIK 129

Query: 126 PANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTK--LVGTFGYMAPELMRTGKASTS-TD 181
             N+LL  D + K+ DFG+ A L D     +  +   VGT  +MAPE+M          D
Sbjct: 130 AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKAD 189

Query: 182 VYAFGVFMLEVASGRRPIEQQGSME 206
           +++FG+  +E+A+G  P  +   M+
Sbjct: 190 IWSFGITAIELATGAAPYSKYPPMK 214

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 49/138 (35%), Positives = 69/138 (50%), Gaps = 8/138 (5%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+ +  +V +Y   GSL  I      P LS  Q   + R    GL YLHE      +HRD
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHE---TGKIHRD 126

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM---RTGKASTST 180
           IK AN+LL  D + KL DFG++      TI +    +GT  +MAPE+    R G      
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTA-TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 181 DVYAFGVFMLEVASGRRP 198
           D++A G+  +E+A  + P
Sbjct: 186 DIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 29/148 (19%)

Query: 73  DYMPNGSLDKILHTNIKPSLSWYQRFR------IIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +Y+P GS+   L T        Y RF           V  GL YLH    + +LHRD+K 
Sbjct: 88  EYVPGGSIGSCLRT--------YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKA 136

Query: 127 ANVLLDADLNGKLGDFGLAR----LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS--T 180
            N+L+DAD   K+ DFG+++    +YD+D   Q   + G+  +MAPE++ +     S   
Sbjct: 137 DNLLVDADGICKISDFGISKKSDDIYDND---QNMSMQGSVFWMAPEVIHSYSQGYSAKV 193

Query: 181 DVYAFGVFMLEVASGRRP---IEQQGSM 205
           D+++ G  +LE+ +GRRP    E   +M
Sbjct: 194 DIWSLGCVVLEMFAGRRPWSDEEAIAAM 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 39/101 (38%), Positives = 56/101 (55%), Gaps = 11/101 (10%)

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLL--DADLNG--KLGDFGLARLYDHDTIPQTT--KL 159
           +G+ YLH +W   VLHRD+KPAN+L+  +    G  K+GD GLARL++    P      +
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGRRPI 199
           V T  Y APEL+   +  T   D++A G    E+ +   PI
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 4e-16
 Identities = 42/113 (37%), Positives = 66/113 (58%), Gaps = 5/113 (4%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           IIR V   L Y+H+     V+HRDIK AN+L+    N KL DFG+A L + ++  ++T  
Sbjct: 106 IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-F 161

Query: 160 VGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           VGT  +MAPE++  GK   T  D+++ G+ + E+A+G  P     +   + L+
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 4e-16
 Identities = 66/222 (29%), Positives = 96/222 (43%), Gaps = 27/222 (12%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +++    +V +YM NG L   L    K  L       +   V   + 
Sbjct: 58  HPN-LVQLYG-VCTKQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAME 114

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMA 167
           YL        +HRD+   N L+  D   K+ DFGLAR  L D  T  Q TK      +  
Sbjct: 115 YLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAP 169

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE+    + S+ +DV++FGV M EV S G+ P E+  + E+V  V         G  L  
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-------SAGYRLYR 222

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                  +Y       ++     C H KPE RP  ++++  L
Sbjct: 223 PKLAPTEVYT------IMYS---CWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 7e-16
 Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 27/144 (18%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF---------RIIRGVASGLLYLHEDW 115
           +    +  ++M  GSLD+I           Y++          +I   V  GL YL+   
Sbjct: 75  ENNICMCMEFMDCGSLDRI-----------YKKGGPIPVEILGKIAVAVVEGLTYLYN-- 121

Query: 116 EQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTG 174
              ++HRDIKP+N+L+++    KL DFG++  L +  +I  T   VGT  YM+PE ++ G
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--SIADT--FVGTSTYMSPERIQGG 177

Query: 175 KASTSTDVYAFGVFMLEVASGRRP 198
           K +  +DV++ G+ ++E+A G+ P
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.2 bits (185), Expect = 9e-16
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 24/235 (10%)

Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           +D Q +   L  +    L+ L   V S      ++ + M  GSL   L +     L    
Sbjct: 47  QDFQKEVQALKRLRHKHLISL-FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVAS 105

Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQ 155
              +   VA G+ YL E   Q  +HRD+   N+L+  DL  K+ DFGLARL   D  +  
Sbjct: 106 LIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162

Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWV 214
             K+   + + APE    G  ST +DV++FG+ + E+ + G+ P     + E+ + +   
Sbjct: 163 DKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-- 218

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                 G  +       + IY         K+ L C   +PE RP+ + + + LD
Sbjct: 219 -----AGYRMPCPAKCPQEIY---------KIMLECWAAEPEDRPSFKALREELD 259

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 29/211 (13%)

Query: 69  LLVYDYMPNGSLDKIL--------HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           L+V + M  G L   L        +       +  +  ++   +A G+ YL     +  +
Sbjct: 85  LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFV 141

Query: 121 HRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           HRD+   N ++  DL  K+GDFG+ R +Y+ D   +  K +    +MAPE ++ G  +T 
Sbjct: 142 HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK 201

Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           +DV++FGV + E+A+   +P +   + E++  V         G  LD           E 
Sbjct: 202 SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-------IDGGHLD---------LPEN 245

Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             + +L+L   C    P+ RP   +++  L 
Sbjct: 246 CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 62/241 (25%), Positives = 106/241 (43%), Gaps = 35/241 (14%)

Query: 38  DPQLQRDGLASVHSNGLLQLTNTV---NS--RKGEFLLVYDYMPNGSL-DKILHTNIK-- 89
             + +RD L  +    LLQ  N +   N        L+  +Y   G+L DKI+    +  
Sbjct: 39  SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF 98

Query: 90  --PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 147
               + WY  F+I+  V+    Y+H+     +LHRDIK  N+ L      KLGDFG++++
Sbjct: 99  EEEMVLWYL-FQIVSAVS----YIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKI 150

Query: 148 YDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
              +     T +VGT  YM+PEL +  K +  +D++A G  + E+ + +R  +    + +
Sbjct: 151 LGSEYSMAET-VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209

Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
                      K   I+  + + +  +Y  E + LV           PE RP   +V+  
Sbjct: 210 ---------VVK---IVQGNYTPVVSVYSSELISLVHS----LLQQDPEKRPTADEVLDQ 253

Query: 268 L 268
            
Sbjct: 254 P 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 49/140 (35%), Positives = 76/140 (54%), Gaps = 19/140 (13%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLS----WYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           +  +V + M    L K++ T     LS     Y  ++I+RG    L Y+H      VLHR
Sbjct: 82  DVYIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRG----LKYIHS---ANVLHR 130

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYD--HDTIPQTTKLVGTFGYMAPELMRTGKA-STS 179
           D+KP+N+LL+ + + K+ DFGLAR+ D  HD     T+ V T  Y APE+M   K  + +
Sbjct: 131 DLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKA 190

Query: 180 TDVYAFGVFMLEVASGRRPI 199
            D+++ G  + E+ S  RP+
Sbjct: 191 IDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 76  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGLAYLRE--KHQIMHRDVK 131

Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 37/224 (16%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTN-------IKP-----SLSWYQRFRIIRGVASGL 108
           V +     ++V++YM +G L+K L ++         P      L+  Q  +I   +ASG+
Sbjct: 76  VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY--DHDTIPQTTKLVGTFGY 165
           +YL     Q  +HRD+   N L+  DL  K+GDFG++R +Y  D+  +   T L     +
Sbjct: 136 VYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML--PIRW 190

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
           M PE +   K +T +DV++FGV + E+ + G++P     + E       V +C  +G +L
Sbjct: 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VIECITQGRLL 243

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
               +    +Y+       + LG  C    P+ R N++ + + L
Sbjct: 244 QRPRTCPSEVYD-------IMLG--CWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 74.1 bits (182), Expect = 3e-15
 Identities = 50/155 (32%), Positives = 88/155 (56%), Gaps = 21/155 (13%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN-----IKPSLSWYQRFRIIRGV 104
           H N +++L + +++ + + +LV++YM +  L K + T+     + P+      +++++G+
Sbjct: 57  HEN-IVRLHDVIHT-ENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT--KLVGT 162
           A    + HE+    VLHRD+KP N+L++     KL DFGLAR +    IP  T    V T
Sbjct: 114 A----FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVT 163

Query: 163 FGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
             Y AP+ L+ +   STS D+++ G  M E+ +GR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 73.6 bits (181), Expect = 3e-15
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 23/148 (15%)

Query: 64  RKGEFLLVY-DYMPNGSLDKILHTNIKPSLSWYQRFR------IIRGVASGLLYLHEDWE 116
           R+ + L ++ + +P GSL K+L          Y  F         R +  GL YLH+   
Sbjct: 72  REEDNLYIFLELVPGGSLAKLLKK--------YGSFPEPVIRLYTRQILLGLEYLHD--- 120

Query: 117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGTFGYMAPE-LMRTG 174
           +  +HRDIK AN+L+D +   KL DFG+A+           K   G+  +MAPE + + G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 175 KASTSTDVYAFGVFMLEVASGRRPIEQQ 202
               + D+++ G  +LE+A+G+ P  Q 
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 58/223 (26%), Positives = 108/223 (48%), Gaps = 18/223 (8%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +++L     S KG +L +++Y+   +L ++L      +LSW +R +I  G+A  L 
Sbjct: 742 HPN-IVKLIGLCRSEKGAYL-IHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALR 794

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           +LH      V+  ++ P  +++D      L    L  L   DT     K   +  Y+APE
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDT-----KCFISSAYVAPE 848

Query: 170 LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI---LDA 226
              T   +  +D+Y FG+ ++E+ +G+ P + +  +   ++V+W   C+    +   +D 
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDP 907

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           S      + + E +E V+ L L C+   P ARP    V++ L+
Sbjct: 908 SIRGDVSVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 37/224 (16%)

Query: 68  FLLVYDYMPNGSLDKILHTN--------------IKPSLSWYQRFRIIRGVASGLLYLHE 113
            ++V++YM +G L+K L  +               K  L   Q   I   +ASG++YL  
Sbjct: 82  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 141

Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMR 172
              Q  +HRD+   N L+ A+L  K+GDFG++R +Y  D        +    +M PE + 
Sbjct: 142 ---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 198

Query: 173 TGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
             K +T +DV++FGV + E+ + G++P  Q  + E++       +C  +G +L+      
Sbjct: 199 YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-------ECITQGRVLERPRVCP 251

Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD--GNAT 273
           + +Y+         + L C   +P+ R N++++ + L   G AT
Sbjct: 252 KEVYD---------IMLGCWQREPQQRLNIKEIYKILHALGKAT 286

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 50/141 (35%), Positives = 70/141 (49%), Gaps = 19/141 (13%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
             E  +V +YM  GSL  I+  N    ++  Q   + R V  GL YLH    Q V+HRDI
Sbjct: 87  GDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLHS---QNVIHRDI 142

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-------LVGTFGYMAPELMRTGKAS 177
           K  N+LL  D + KL DFG A         Q TK       +VGT  +MAPE+++     
Sbjct: 143 KSDNILLSKDGSVKLADFGFA--------AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 178 TSTDVYAFGVFMLEVASGRRP 198
              D+++ G+  +E+A G  P
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 7/96 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGT 162
           +  G+L+LH      +++RD+KP NVLLD   N +L D GLA  L D  TI   T+  GT
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGT 157

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            GYMAPE+++    S   D +A G  + E+ +GR P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.0 bits (181), Expect = 4e-15
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 23/198 (11%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +Y+  GS   +L       L   Q   I+R +  GL YLH + +   +HRDIK ANV
Sbjct: 79  IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANV 132

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL      KL DFG+A     DT  +    VGT  +MAPE+++     +  D+++ G+  
Sbjct: 133 LLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191

Query: 190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF 249
           +E+A G  P  +   M+++ L            I   +   LEG Y +   E V      
Sbjct: 192 IELAKGEPPHSELHPMKVLFL------------IPKNNPPTLEGNYSKPLKEFVEA---- 235

Query: 250 CSHPKPEARPNMRQVMQY 267
           C + +P  RP  ++++++
Sbjct: 236 CLNKEPSFRPTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.1 bits (183), Expect = 4e-15
 Identities = 44/132 (33%), Positives = 64/132 (48%), Gaps = 33/132 (25%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSL--------SWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV++YM     +  LH  I+ ++          YQ  + ++       Y+H      V+H
Sbjct: 86  LVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKALK-------YIHS---GNVIH 130

Query: 122 RDIKPANVLLDADLNGKLGDFGLAR----LYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
           RD+KP+N+LL++D   KL DFGLAR    L ++   P  T  V T  Y APE++     S
Sbjct: 131 RDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL---GS 187

Query: 178 TSTDVYAFGVFM 189
           T    Y  GV M
Sbjct: 188 TR---YTKGVDM 196

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 6/158 (3%)

Query: 52  NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYL 111
             L+QL      R     LV+++M +G L   L    +   S      +   V  G+ YL
Sbjct: 59  PKLVQLYGVCTER-SPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYL 116

Query: 112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM 171
                  V+HRD+   N L+  +   K+ DFG+ R    D    +T       + +PE+ 
Sbjct: 117 ESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173

Query: 172 RTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMV 208
              K S+ +DV++FGV M EV S G+ P E + + E+V
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 39/134 (29%), Positives = 70/134 (52%), Gaps = 5/134 (3%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
             +  +V +Y   GS+  I+      +L+  +   I+     GL YLH       +HRDI
Sbjct: 70  NTDLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDI 125

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           K  N+LL+ +   KL DFG++     DT+ +   ++GT  +MAPE+++    +   D+++
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLT-DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184

Query: 185 FGVFMLEVASGRRP 198
            G+  +E+A G+ P
Sbjct: 185 LGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 6e-15
 Identities = 43/133 (32%), Positives = 66/133 (49%), Gaps = 7/133 (5%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
             E   V++YM  G+L +++        S      II  +  GL ++H+       HRD+
Sbjct: 70  NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDL 125

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKASTSTDVY 183
           KP N+L+      K+ DFGLAR  +  + P  T  V T  Y APE L+R+   S+  D++
Sbjct: 126 KPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIW 183

Query: 184 AFGVFMLEVASGR 196
           A G  M E+ + R
Sbjct: 184 ALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 76  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVK 131

Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 188 MGLSLVEMAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 73.2 bits (180), Expect = 7e-15
 Identities = 42/133 (31%), Positives = 68/133 (51%), Gaps = 9/133 (6%)

Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT +       Q   +   V   L +LH    Q V+HRDIK
Sbjct: 90  ELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKALSFLHA---QGVIHRDIK 142

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL +D   KL DFG       + +P+   LVGT  +MAPE++      T  D+++ 
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201

Query: 186 GVFMLEVASGRRP 198
           G+ ++E+  G  P
Sbjct: 202 GIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 73.2 bits (180), Expect = 8e-15
 Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           +  GL +LHE   + +++RD+K  NVLLD++ + K+ DFG+ +  +    T   T+   G
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCG 158

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
           T  Y+APE++       + D +A GV + E+ +G+ P E     E+  
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 55/162 (33%), Positives = 83/162 (51%), Gaps = 11/162 (6%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           LA VHS  ++ L     + K +  LV   M  G L   ++ N+      +   R     A
Sbjct: 47  LAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTA 104

Query: 106 ---SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVG 161
              SGL +LH+   + +++RD+KP NVLLD D N ++ D GLA  L D  +  +T    G
Sbjct: 105 QIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAG 159

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQG 203
           T G+MAPEL++  +   S D +A GV + E+ + R P   +G
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 32/214 (14%)

Query: 68  FLLVYDYMPNGSLDKILHT-----------NIKPSLSWYQRFRIIRGVASGLLYLHEDWE 116
            ++V++YM +G L+K L             N    L+  Q   I + +A+G++YL     
Sbjct: 82  LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--- 138

Query: 117 QVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGK 175
           Q  +HRD+   N L+  +L  K+GDFG++R +Y  D        +    +M PE +   K
Sbjct: 139 QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 198

Query: 176 ASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI 234
            +T +DV++ GV + E+ + G++P  Q  + E++       +C  +G +L    +  + +
Sbjct: 199 FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECITQGRVLQRPRTCPKEV 251

Query: 235 YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           Y+         L L C   +P  R N++++   L
Sbjct: 252 YD---------LMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 20/168 (11%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           I+R +  GL YLH + +   +HRDIK ANVLL    + KL DFG+A       I + T  
Sbjct: 106 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-F 161

Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK 219
           VGT  +MAPE+++        D+++ G+  +E+A G  P      M ++ L         
Sbjct: 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--------- 212

Query: 220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
              I   S   LEG Y +   E V      C +  P  RP  ++++++
Sbjct: 213 ---IPKNSPPTLEGQYSKPFKEFVEA----CLNKDPRFRPTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 24/200 (12%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V + M  G+L   L T  +  +S  Q  +    VA G+ YL     + ++HRD+   N+
Sbjct: 75  IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNI 131

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+  D   K+ DFGLAR+         +KL     + APE ++  K S+ +DV+++GV +
Sbjct: 132 LVSEDGVAKVSDFGLARVGSMGV--DNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLL 187

Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            EV S GR P  +    E       V +C +KG  ++  +     +Y          L  
Sbjct: 188 WEVFSYGRAPYPKMSLKE-------VKECVEKGYRMEPPEGCPADVY---------VLMT 231

Query: 249 FCSHPKPEARPNMRQVMQYL 268
            C   +P+ RP+  ++ + L
Sbjct: 232 SCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 4/99 (4%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           I+R V  GL YLHE   +  +HRDIK AN+LL  + + KL DFG++         + T  
Sbjct: 103 ILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-F 158

Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           VGT  +MAPE+++        D+++ G+  +E+A G  P
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 15/149 (10%)

Query: 61  VNSRKGEFLLVYDYMPNGSLD-KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV 119
           V S   +  +V +Y+ +   D K L   +K      +   ++  + SG+ +LH++W   +
Sbjct: 74  VGSNLDKIYMVMEYVEH---DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---I 127

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKAST 178
           LHRD+K +N+LL+     K+ DFGLAR Y    +   T+LV T  Y APE L+   + ST
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPELLLGAKEYST 186

Query: 179 STDVYAFGVFMLEVAS------GRRPIEQ 201
           + D+++ G    E+ +      G+  I+Q
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQ 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 41/133 (30%), Positives = 71/133 (53%), Gaps = 8/133 (6%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            L+ +Y+P+GSL   L  + +  ++  +       +  G+ YL     Q  +HRD+   N
Sbjct: 84  RLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARN 139

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG---TFGYMAPELMRTGKASTSTDVYAF 185
           +L++++   K+ DFGLA++   D      K  G    F Y APE +RT K S+++DV++F
Sbjct: 140 ILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSF 198

Query: 186 GVFMLEVASGRRP 198
           GV + E+ +   P
Sbjct: 199 GVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 4/126 (3%)

Query: 75  MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD 134
           MP    D   + +    L   Q   I R +   L YLH    + ++HRD+K  N+ LD  
Sbjct: 165 MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEP 221

Query: 135 LNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA 193
            N  LGDFG A +L  H   PQ     GT    +PEL+        TD+++ G+ + E++
Sbjct: 222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Query: 194 SGRRPI 199
                +
Sbjct: 282 VKNVTL 287

Length = 392

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 42/136 (30%), Positives = 73/136 (53%), Gaps = 15/136 (11%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           +V D M +  L  I+H++   +    + F  +++RG    L Y+H      V+HRD+KP+
Sbjct: 85  VVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRG----LKYIHS---ANVIHRDLKPS 136

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQT---TKLVGTFGYMAPELMRT-GKASTSTDVY 183
           N+L++ D   ++GDFG+AR             T+ V T  Y APEL+ +  + +T+ D++
Sbjct: 137 NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMW 196

Query: 184 AFGVFMLEVASGRRPI 199
           + G    E+  GRR +
Sbjct: 197 SVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL   V S +    +V +YM  GSL   L +     L   Q   +   +A G+ YL  
Sbjct: 63  LVQL-YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELM 171
              +  +HRD+   N+L+  +L  K+ DFGLARL   D  T  +  K      + APE  
Sbjct: 122 ---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAA 176

Query: 172 RTGKASTSTDVYAFGVFMLE-VASGRRP 198
             G+ +  +DV++FG+ + E V  GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 39/115 (33%), Positives = 66/115 (57%), Gaps = 8/115 (6%)

Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           ++I+RG    L YLH      +LHRDIKP N+L++++   K+ DFGLAR+ + D     T
Sbjct: 110 YQILRG----LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 158 KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           + V T  Y APE LM +   +++ D+++ G    E+   R   + Q  ++ ++L+
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 30/225 (13%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +++    +V +YM NG L   L  + K      Q   + + V 
Sbjct: 53  MMKLSHEKLVQLYG-VCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVC 110

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--- 162
            G+ YL     +  +HRD+   N L+D     K+ DFGL+R    D   + T  VG+   
Sbjct: 111 EGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD---EYTSSVGSKFP 164

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +  PE++   K S+ +DV+AFGV M EV S G+ P E+  + E V  V          
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV---------- 214

Query: 222 AILDASDSRLEGIYEEEQM-ELVLKLGLFCSHPKPEARPNMRQVM 265
               +   RL   Y      E V  +   C H K E RP  +Q++
Sbjct: 215 ----SQGLRL---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 3e-14
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 19/150 (12%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQ-RFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
            L+  +Y   G L  IL          Y  RF  I  V     YLH    + +++RD+KP
Sbjct: 70  MLM--EYCLGGELWTILRDRGL--FDEYTARF-YIACVVLAFEYLHN---RGIIYRDLKP 121

Query: 127 ANVLLDADLNG--KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
            N+LLD+  NG  KL DFG A+ L       +T    GT  Y+APE++       S D +
Sbjct: 122 ENLLLDS--NGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 184 AFGVFMLEVASGRRP--IEQQGSMEMVNLV 211
           + G+ + E+ +GR P   + +  ME+ N +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDI 206

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.0 bits (174), Expect = 3e-14
 Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 25/146 (17%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQV 118
              F L  ++M  GS+  +L          Y  F           +  GL YLHE+  Q+
Sbjct: 75  DSHFNLFVEWMAGGSVSHLLSK--------YGAFKEAVIINYTEQLLRGLSYLHEN--QI 124

Query: 119 VLHRDIKPANVLLDA---DLNGKLGDFGLA-RLYDHDTIPQTTK--LVGTFGYMAPELMR 172
           + HRD+K AN+L+D+    L  ++ DFG A RL    T     +  L+GT  +MAPE++R
Sbjct: 125 I-HRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRP 198
             +   S DV++ G  ++E+A+ + P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)

Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           N  KG F LV+++  +     + + N+K +LS  ++  +++ + +GL Y+H +    +LH
Sbjct: 88  NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKMLLNGLYYIHRN---KILH 142

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMAPELM----RTG 174
           RD+K AN+L+  D   KL DFGLAR +      +  +    V T  Y  PEL+      G
Sbjct: 143 RDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYG 202

Query: 175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
                 D++  G  M E+ + R PI  QG+ E
Sbjct: 203 PP---IDMWGAGCIMAEMWT-RSPI-MQGNTE 229

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 3e-14
 Identities = 40/131 (30%), Positives = 62/131 (47%), Gaps = 10/131 (7%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+  G    ++ T       W +++  I  V  G+  LH+     ++HRDIKP N+
Sbjct: 74  LVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENL 128

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+D   + KL DFGL+R        +  K VGT  Y+APE +        +D ++ G  +
Sbjct: 129 LIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVI 183

Query: 190 LEVASGRRPIE 200
            E   G  P  
Sbjct: 184 FEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 17/164 (10%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S + ++H    + V+HRDIKPANV + A    KLGD GL R +   T    + LVGT 
Sbjct: 115 LCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTP 170

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            YM+PE +     +  +D+++ G  + E+A+ + P      M + +L   +  C      
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQC------ 223

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
            D      E  Y E+  ELV      C +P P+ RP++  V Q 
Sbjct: 224 -DYPPLPTEH-YSEKLRELV----SMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 4e-14
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 5/160 (3%)

Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL   V + +    +V + M  GSL + L      +L   Q   +   VASG+ YL  
Sbjct: 63  LIQLY-AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
              Q  +HRD+   NVL+  +   K+ DFGLAR+   D             + APE    
Sbjct: 122 ---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY 178

Query: 174 GKASTSTDVYAFGVFMLE-VASGRRPIEQQGSMEMVNLVD 212
            + S  +DV++FG+ + E V  GR P     + E++  VD
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 4e-14
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 28/156 (17%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKP------SLSWYQRFRIIRGVASGLLYLHEDWE 116
           S  G F +  + +P GSL  +L +   P      ++ +Y +      +  GL YLH+   
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLHD--- 126

Query: 117 QVVLHRDIKPANVLLDADLNG--KLGDFG----LARLYDHDTIPQTTKLVGTFGYMAPEL 170
             ++HRDIK  NVL++   +G  K+ DFG    LA +      P T    GT  YMAPE+
Sbjct: 127 NQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGIN-----PCTETFTGTLQYMAPEV 180

Query: 171 MRTGKA--STSTDVYAFGVFMLEVASGRRPIEQQGS 204
           +  G        D+++ G  ++E+A+G+ P  + G 
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 50/137 (36%), Positives = 76/137 (55%), Gaps = 21/137 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPS--LS----WYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +VY+ M     D  LH  I+ S  LS     Y  ++++RG    L Y+H      VLHRD
Sbjct: 86  IVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRG----LKYIHS---ANVLHRD 133

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKASTSTDV 182
           +KP+N+LL+A+ + K+ DFGLAR    +     T+ V T  Y APE L+   + +T+ DV
Sbjct: 134 LKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDV 192

Query: 183 YAFGVFMLEVASGRRPI 199
           ++ G    E+  GR+P+
Sbjct: 193 WSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 50/176 (28%), Positives = 93/176 (52%), Gaps = 15/176 (8%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQ 96
           +++RD LA V+   +++L     + +G+  L+ D++  G L   L   +   +  + +Y 
Sbjct: 46  KMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY- 103

Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQ 155
               +  +A  L +LH      +++RD+KP N+LLD + + KL DFGL++   DH+   +
Sbjct: 104 ----LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 154

Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
                GT  YMAPE++     + S D ++FGV M E+ +G  P + +   E + ++
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.1 bits (172), Expect = 7e-14
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 10/133 (7%)

Query: 79  SLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 136
           SLDK         L+  +    +I   +   L YLH      V+HRD+KP+NVL++ +  
Sbjct: 85  SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQ 142

Query: 137 GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL----MRTGKASTSTDVYAFGVFMLEV 192
            KL DFG++  Y  D++ +T    G   YMAPE     +        +DV++ G+ M+E+
Sbjct: 143 VKLCDFGISG-YLVDSVAKTID-AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Query: 193 ASGRRPIEQQGSM 205
           A+GR P +   + 
Sbjct: 201 ATGRFPYDSWKTP 213

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.1 bits (171), Expect = 8e-14
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L ++H    + V+HRDIKPANV + A    KLGD GL R +   T    + LVGT 
Sbjct: 115 LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTP 170

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            YM+PE +     +  +D+++ G  + E+A+ + P      M + +L   +  C      
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEQCDYPPLP 229

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV 264
            D         Y EE  +LV      C +P PE RP++  V
Sbjct: 230 SDH--------YSEELRQLV----NMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 31/205 (15%)

Query: 73  DYMPNGSLDKI----LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +YM  GSLDK+    + T   P        RI   V  GL +L E+    ++HRD+KP N
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPE---DVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTN 133

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA------STSTDV 182
           VL++ +   KL DFG++      ++ +T   +G   YMAPE +++G        +  +DV
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVA-SLAKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDV 190

Query: 183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           ++ G+ +LE+A GR P   +      N+   +S      AI+D     L   Y ++  + 
Sbjct: 191 WSLGLSILEMALGRYPYPPETY---ANIFAQLS------AIVDGDPPTLPSGYSDDAQDF 241

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQY 267
           V K    C +  P  RP   Q++++
Sbjct: 242 VAK----CLNKIPNRRPTYAQLLEH 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.5 bits (170), Expect = 1e-13
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 26/195 (13%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            ++ +YM NGSL   L T     L+  +   +   +A G+ ++     +  +HRD++ AN
Sbjct: 76  YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAAN 132

Query: 129 VLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
           +L+   L  K+ DFGLARL + +  T  +  K      + APE +  G  +  +DV++FG
Sbjct: 133 ILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFG 190

Query: 187 VFMLEVAS-GRRPIEQQGSMEMV-NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           + + E+ + GR P     + E++ NL        ++G  +   D+  E +YE        
Sbjct: 191 ILLTEIVTYGRIPYPGMTNPEVIQNL--------ERGYRMPRPDNCPEELYE-------- 234

Query: 245 KLGLFCSHPKPEARP 259
            L   C   KPE RP
Sbjct: 235 -LMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 39/100 (39%), Positives = 61/100 (61%), Gaps = 7/100 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGT 162
           +  GL  LH+  E++V +RD+KP N+LLD   + ++ D GLA    H    QT K  VGT
Sbjct: 111 ICCGLEDLHQ--ERIV-YRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGT 164

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ 202
            GYMAPE+++  + + S D +A G  + E+ +G+ P +Q+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           ++V +  P GSL   L  +                +A+G+ YL     +  +HRD+   N
Sbjct: 71  MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARN 127

Query: 129 VLLDADLNGKLGDFGLARLY----DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           +LL +D   K+GDFGL R      DH  + +  K+   F + APE +RT   S ++DV+ 
Sbjct: 128 ILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTRTFSHASDVWM 185

Query: 185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
           FGV + E+ + G  P       +++  +D      K+G  L+  ++  + IY      ++
Sbjct: 186 FGVTLWEMFTYGEEPWAGLSGSQILKKID------KEGERLERPEACPQDIY-----NVM 234

Query: 244 LKLGLFCSHPKPEARPNMRQVMQYL 268
           L+    C    P  RP    + ++L
Sbjct: 235 LQ----CWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 10/100 (10%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGT 162
           +   L YL E  +  V+HRD+KP+N+LLDA  N KL DFG++ RL D       T+  G 
Sbjct: 123 IVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGC 177

Query: 163 FGYMAPELM----RTGKASTSTDVYAFGVFMLEVASGRRP 198
             YMAPE +       K     DV++ G+ ++E+A+G+ P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 4/146 (2%)

Query: 49  VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++S +
Sbjct: 59  IKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAP 168
            YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + AP
Sbjct: 118 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174

Query: 169 ELMRTGKASTSTDVYAFGVFMLEVAS 194
           E +   K S  +DV+AFGV + E+A+
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.0 bits (167), Expect = 3e-13
 Identities = 43/136 (31%), Positives = 71/136 (52%), Gaps = 12/136 (8%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+P G L  +L  N+  SL        I  +   L YLH +    ++HRD+KP N+
Sbjct: 70  LVMEYLPGGDLASLLE-NVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNI 124

Query: 130 LLDADLNGKLGDFGLAR-------LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           L+D++ + KL DFGL++       +  +D   +  ++VGT  Y+APE++     S + D 
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDW 184

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G  + E   G  P
Sbjct: 185 WSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 42/132 (31%), Positives = 67/132 (50%), Gaps = 7/132 (5%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  ++ +++  G+L  I+    +  L+  Q   +   V   L YLH    Q V+HRDIK 
Sbjct: 92  ELWVLMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKS 145

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            ++LL  D   KL DFG       D +P+   LVGT  +MAPE++      T  D+++ G
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204

Query: 187 VFMLEVASGRRP 198
           + ++E+  G  P
Sbjct: 205 IMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.8 bits (165), Expect = 4e-13
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 27/204 (13%)

Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +ASG+ Y+  
Sbjct: 63  LVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELM 171
                 +HRD++ AN+L+  +L  K+ DFGLARL + +  T  Q  K      + APE  
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAA 175

Query: 172 RTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV-----------------DW 213
             G+ +  +DV++FG+ + E+ + GR P     + E+++ V                 D 
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235

Query: 214 VSDCWKKGAILDASDSRLEGIYEE 237
           +  CW+K      +   L+   E+
Sbjct: 236 MCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 22/158 (13%)

Query: 70  LVYDYMPNGSLDKIL--------------HTNIKPSLSWYQRFRIIRGVASGLLYLHEDW 115
           ++++Y+ +G L + L                 +K SL       I   +A+G+ YL    
Sbjct: 85  MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-- 142

Query: 116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVGTFGYMAPELMRTG 174
               +HRD+   N L+   L  K+ DFGL+R  Y  D     +K +    +M PE +  G
Sbjct: 143 -HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG 201

Query: 175 KASTSTDVYAFGVFMLEVAS-GRRP---IEQQGSMEMV 208
           K +T +D+++FGV + E+ S G +P      Q  +EM+
Sbjct: 202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.3 bits (164), Expect = 6e-13
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 27/202 (13%)

Query: 42  QRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           +R  LA   + G    +N V      +R    ++V +YM NG+LD  L  + +  L   Q
Sbjct: 50  RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQ 108

Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
              ++ G+ASG+ YL E      +H+ +    VL+++DL  K+  F   +    + I  T
Sbjct: 109 LMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT 165

Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD--- 212
                   + APE ++    S+++DV++FG+ M EV S G RP       +++  V+   
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF 225

Query: 213 --------------WVSDCWKK 220
                          + DCW+K
Sbjct: 226 RLPAPRNCPNLLHQLMLDCWQK 247

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 8/101 (7%)

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGY 165
           L +LHE   + +++RD+K  NVLLDA+ + KL D+G+ +  +   DT   T+   GT  Y
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNY 162

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
           +APE++R      S D +A GV M E+ +GR P +  G  +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.5 bits (165), Expect = 8e-13
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 14/151 (9%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            KG F LV++YM +  L  +L + +    S       ++ +  GL Y H+   +  LHRD
Sbjct: 87  DKGAFYLVFEYM-DHDLMGLLESGLV-HFSEDHIKSFMKQLLEGLNYCHK---KNFLHRD 141

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM----RTGKASTS 179
           IK +N+LL+     KL DFGLARLY+ +     T  V T  Y  PEL+    R G A   
Sbjct: 142 IKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPA--- 198

Query: 180 TDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
            DV++ G  + E+ + ++PI  Q + E+  L
Sbjct: 199 IDVWSCGCILGELFT-KKPI-FQANQELAQL 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 40/167 (23%), Positives = 79/167 (47%), Gaps = 11/167 (6%)

Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED  ++ D L+      ++ L       + +  ++ ++   G+LD I+    +       
Sbjct: 47  EDFMVEIDILSECKHPNIVGLYEAY-FYENKLWILIEFCDGGALDSIMLELERGLTEPQI 105

Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
           R+ + R +   L +LH      V+HRD+K  N+LL  D + KL DFG++   +  T+ + 
Sbjct: 106 RY-VCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKR 160

Query: 157 TKLVGTFGYMAPELMRTGKASTS-----TDVYAFGVFMLEVASGRRP 198
              +GT  +MAPE++       +      D+++ G+ ++E+A    P
Sbjct: 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 14/169 (8%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N +  L +      G F  +Y Y       L +I+ +    + + +Q F  I  +  G
Sbjct: 61  HKN-ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF--IYQILCG 117

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---TKLVGTFG 164
           L Y+H      VLHRD+KP N+L++AD   K+ DFGLAR +  +        T+ V T  
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 165 YMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPI-EQQGSMEMVNLV 211
           Y APE+M + ++ + + DV++ G  + E+  GR+P+ + +  ++ +N +
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQI 222

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 7/142 (4%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +Y+  GS   +L          +Q   +++ +  GL YLH + +   +HRDIK ANV
Sbjct: 79  IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANV 132

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL    + KL DFG+A       I + T  VGT  +MAPE+++     +  D+++ G+  
Sbjct: 133 LLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191

Query: 190 LEVASGRRPIEQQGSMEMVNLV 211
           +E+A G  P      M ++ L+
Sbjct: 192 IELAKGEPPNSDMHPMRVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 49/225 (21%), Positives = 102/225 (45%), Gaps = 22/225 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++  + L++L   V   K    ++ ++M  GSL   L ++        +       +A
Sbjct: 55  MKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            G+ ++ +   +  +HRD++ AN+L+ A L  K+ DFGLAR+ + +             +
Sbjct: 113 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +  G  +  +DV++FG+ ++E+ + GR P     + E++  ++       +G  +
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRM 222

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
              ++  E +Y          + + C   +PE RP    +   LD
Sbjct: 223 PRPENCPEELYN---------IMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 53/160 (33%), Positives = 73/160 (45%), Gaps = 33/160 (20%)

Query: 64  RKGEFLLVYDYMP---NGSLD----KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE 116
           ++G   +V  YM    +G L+    K+  + IK      Q          G+ YLHE   
Sbjct: 86  KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK--CYMLQLL-------EGINYLHE--- 133

Query: 117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-----------TKLVGTFGY 165
             +LHRDIK AN+L+D     K+ DFGLAR YD    P             T LV T  Y
Sbjct: 134 NHILHRDIKAANILIDNQGILKIADFGLARPYD-GPPPNPKGGGGGGTRKYTNLVVTRWY 192

Query: 166 MAPEL-MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
             PEL +   + +T+ D++  G    E+ + RRPI Q  S
Sbjct: 193 RPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKS 231

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 42/123 (34%), Positives = 65/123 (52%), Gaps = 14/123 (11%)

Query: 80  LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL 139
           +D    T + P L     +++++G+A    Y H      VLHRD+KP N+L+D +   KL
Sbjct: 88  MDSSPLTGLDPPLIKSYLYQLLQGIA----YCHS---HRVLHRDLKPQNLLIDREGALKL 140

Query: 140 GDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGR 196
            DFGLAR +    +P    T  V T  Y APE++   +  ST  D+++ G    E+ + R
Sbjct: 141 ADFGLARAFG---VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-R 196

Query: 197 RPI 199
           RP+
Sbjct: 197 RPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 9/133 (6%)

Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT +       Q   +   V   L YLH    Q V+HRDIK
Sbjct: 93  ELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHN---QGVIHRDIK 145

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL +D   KL DFG       + +P+   LVGT  +MAPE++      T  D+++ 
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 204

Query: 186 GVFMLEVASGRRP 198
           G+ ++E+  G  P
Sbjct: 205 GIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 13/98 (13%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           V   L YLH      +++RD+KP N+LLD+D   K+ DFG A+     T   T  L GT 
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT--LCGTP 162

Query: 164 GYMAPELMRT---GKASTSTDVYAFGVFMLEVASGRRP 198
            Y+APE++ +   GKA    D +A G+ + E+ +G  P
Sbjct: 163 EYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.6 bits (160), Expect = 2e-12
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)

Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL      +K    +V ++M NG L   L    +  LS      + + V  G+ YL  
Sbjct: 61  LVQLYGVCTQQK-PLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLER 118

Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
           +     +HRD+   N L+ +    K+ DFG+ R    D    ++       +  PE+   
Sbjct: 119 N---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF 175

Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE 232
            K S+ +DV++FGV M EV + G+ P E++ + E+V ++                 SR  
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-----------------SRGF 218

Query: 233 GIYEEE-QMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            +Y  +     V ++   C H KPE RP   ++++ + 
Sbjct: 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 42/134 (31%), Positives = 71/134 (52%), Gaps = 15/134 (11%)

Query: 70  LVYDYMPNGSLDKILHTNI----KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           LV++++     D+ L T +    KP L       ++R +  G+ +LH      ++HRD+K
Sbjct: 83  LVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLK 134

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           P N+L+ +D   K+ DFGLAR+Y  +     T +V T  Y APE++     +T  D+++ 
Sbjct: 135 PQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSV 192

Query: 186 GVFMLEVASGRRPI 199
           G    E+   RRP+
Sbjct: 193 GCIFAELFR-RRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 24/161 (14%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR------FR 99
           L  +    +++L + V+S K    LV++Y+    LD   H +  P  +   R      ++
Sbjct: 55  LKEMQHGNIVRLQDVVHSEK-RLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ 110

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIP--QT 156
           I+RG+A    Y H      VLHRD+KP N+L+D   N  KL DFGLAR +    IP    
Sbjct: 111 ILRGIA----YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG---IPVRTF 160

Query: 157 TKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGR 196
           T  V T  Y APE++   +  ST  D+++ G    E+ + +
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 41/119 (34%), Positives = 66/119 (55%), Gaps = 13/119 (10%)

Query: 80  LDKILHTN-IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 138
           L ++L +  ++     Y  ++I+RG    L Y+H      V+HRD+KP+N+L++ + + K
Sbjct: 96  LHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---AGVVHRDLKPSNILINENCDLK 148

Query: 139 LGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGR 196
           + DFGLAR+ D    PQ T  V T  Y APE+M T  K     D+++ G    E+  G+
Sbjct: 149 ICDFGLARIQD----PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 45/143 (31%), Positives = 63/143 (44%), Gaps = 24/143 (16%)

Query: 64  RKGEFLLVYDYMPNGSLDKI------LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ 117
           RKG   LV++Y+    L+ +      L  +   S  W    ++++ +A    Y H     
Sbjct: 71  RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW----QLLQAIA----YCHS---H 119

Query: 118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM----RT 173
            ++HRDIKP N+L+      KL DFG AR          T  V T  Y APEL+      
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 174 GKASTSTDVYAFGVFMLEVASGR 196
           GK     DV+A G  M E+  G 
Sbjct: 180 GKP---VDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 40/105 (38%), Positives = 62/105 (59%), Gaps = 8/105 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L YLHE   + +++RD+K  NVLLD++ + KL D+G+ +  L   DT   T+   G
Sbjct: 105 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 158

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
           T  Y+APE++R      S D +A GV M E+ +GR P +  GS +
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 12/164 (7%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSL-SWYQRF 98
           Q ++       SN  L   ++         LV +Y+  G L  + H   +  L   + RF
Sbjct: 43  QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARF 100

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQT 156
                +   L +LHE   + +++RD+K  NVLLDAD + KL D+G+ +  L   DT   T
Sbjct: 101 YAAE-ICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---T 153

Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           +   GT  Y+APE++R  +   S D +A GV M E+ +GR P +
Sbjct: 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 8/99 (8%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           V   L++LH      V++RD+K  N+LLDA+ + KL DFG+ +  + +  T   TT   G
Sbjct: 105 VTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TTTFCG 158

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           T  Y+APE+++  +   S D +A GV M E+ +G+ P E
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 65.3 bits (159), Expect = 3e-12
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 22/198 (11%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           ++V +Y P G+L + +    K   S      I+      LL LH    +++LHRD+K  N
Sbjct: 75  MIVMEYAPGGTLAEYIQ---KRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQN 131

Query: 129 VLLDADLN-GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           +LLD      K+GDFG++++    +   T  +VGT  Y++PEL      +  +D++A G 
Sbjct: 132 ILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKSDIWALGC 189

Query: 188 FMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLG 247
            + E+AS +R      + E  NL   V        I+  + + +   Y  +  +L+L + 
Sbjct: 190 VLYELASLKR------AFEAANLPALVLK------IMSGTFAPISDRYSPDLRQLILSM- 236

Query: 248 LFCSHPKPEARPNMRQVM 265
               +  P  RP + Q+M
Sbjct: 237 ---LNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.9 bits (158), Expect = 4e-12
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 29/231 (12%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR---FRIIRGVAS 106
           H N L  L   + S    +LLV ++ P G L   L +N        Q+    R+   VAS
Sbjct: 54  HPNVLQCLGQCIESIP--YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGY 165
           GLL+LH+      +H D+   N  L ADL+ K+GD+GLA   Y  D             +
Sbjct: 112 GLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 166 MAPELM-------RTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDC 217
           +APEL+            +  +++++ GV M E+ +   +P       +++  V    D 
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD- 227

Query: 218 WKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                 +     +L+  Y +   E++     FC    PE RP   +V + L
Sbjct: 228 ------IKLPKPQLDLKYSDRWYEVM----QFCWL-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 21/147 (14%)

Query: 65  KGEFL-LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +G+F+ LV D M    L K++   I+ + S  Q   I+  + +GL  LH+ +    +HRD
Sbjct: 91  EGDFINLVMDIM-ASDLKKVVDRKIRLTES--QVKCILLQILNGLNVLHKWY---FMHRD 144

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-------------TKLVGTFGYMAPE- 169
           + PAN+ +++    K+ DFGLAR Y +     T             T  V T  Y APE 
Sbjct: 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL 204

Query: 170 LMRTGKASTSTDVYAFGVFMLEVASGR 196
           LM   K   + D+++ G    E+ +G+
Sbjct: 205 LMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 30/202 (14%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+   MP G L   +  + K ++           +A G+ YL E   + ++HRD+   NV
Sbjct: 85  LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNV 140

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG-----YMAPELMRTGKASTSTDVYA 184
           L+    + K+ DFGLA+L D D      +     G     +MA E +     +  +DV++
Sbjct: 141 LVKTPQHVKITDFGLAKLLDVD----EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWS 196

Query: 185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
           +GV + E+ + G +P E       +  V+ + D  +KG  L         +Y    M LV
Sbjct: 197 YGVTVWELMTFGAKPYEG------IPAVE-IPDLLEKGERLPQPPICTIDVY----MVLV 245

Query: 244 LKLGLFCSHPKPEARPNMRQVM 265
                 C     E+RP  ++++
Sbjct: 246 K-----CWMIDAESRPTFKELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 35/107 (32%), Positives = 63/107 (58%), Gaps = 6/107 (5%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGT 162
           +A GL +LH    + +++RD+K  NV+LDA+ + K+ DFG+ +  ++    +TT+   GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
             Y+APE++       S D +AFGV + E+ +G+ P + +   E+  
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.6 bits (157), Expect = 5e-12
 Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 14/181 (7%)

Query: 35  FNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW 94
           F E+ Q+ +     +  + L+QL   V+       +V +YM  GSL   L      +L  
Sbjct: 48  FLEEAQIMK----KLRHDKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKL 101

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--T 152
                +   VA+G+ Y+        +HRD++ AN+L+   L  K+ DFGLARL + +  T
Sbjct: 102 PNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158

Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE-VASGRRPIEQQGSMEMVNLV 211
             Q  K      + APE    G+ +  +DV++FG+ + E V  GR P     + E++  V
Sbjct: 159 ARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Query: 212 D 212
           +
Sbjct: 217 E 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 2/87 (2%)

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-- 176
           +++RDIK  N+LLD++ +  L DFGL++ +  +   +     GT  YMAPE++R G    
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185

Query: 177 STSTDVYAFGVFMLEVASGRRPIEQQG 203
             + D ++ GV   E+ +G  P    G
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 37/104 (35%), Positives = 59/104 (56%), Gaps = 9/104 (8%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           I+R    GL YLHE+    V+HRDIK  N+LL  +   KL DFG++   D  T+ +    
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGRRNTF 173

Query: 160 VGTFGYMAPELMRTGKASTST-----DVYAFGVFMLEVASGRRP 198
           +GT  +MAPE++   +   ++     DV++ G+  +E+A G+ P
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.7 bits (158), Expect = 7e-12
 Identities = 38/113 (33%), Positives = 65/113 (57%), Gaps = 5/113 (4%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           ++  +  GL YLHE++   ++HRD+K +N+LL      K+ DFGLAR Y     P T K+
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 160 VGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           V T  Y APE L+     +T+ D++A G  + E+ + +  +  +  +E ++L+
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 33/105 (31%), Positives = 60/105 (57%), Gaps = 6/105 (5%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVGT 162
           +  GL +LH+     +++RD+K  NVLLD D + K+ DFG+ +   + +   + +   GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGT 159

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
             Y+APE+++  K + S D ++FGV + E+  G+ P   +   E+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 48/146 (32%), Positives = 65/146 (44%), Gaps = 42/146 (28%)

Query: 79  SLDKILH--TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 136
           SL K L   T++   LS      I   + + + Y+H    + VLHRD+KP N+LL     
Sbjct: 101 SLSKELAEKTSVGAFLS------IFHKICATIEYVHS---KGVLHRDLKPDNILL----- 146

Query: 137 GKLG-----DFGLAR-------------------LYDHDTIPQTTKLVGTFGYMAPELMR 172
           G  G     D+G A                     Y   TIP   K+VGT  YMAPE + 
Sbjct: 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIP--GKIVGTPDYMAPERLL 204

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRP 198
              AS STD+YA GV + ++ +   P
Sbjct: 205 GVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 37/105 (35%), Positives = 62/105 (59%), Gaps = 6/105 (5%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGT 162
           +A GL +LH    + +++RD+K  NV+LD++ + K+ DFG+ +    D +  TTK   GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
             Y+APE++       S D +AFGV + E+ +G+ P E +   E+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 11/174 (6%)

Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD L+  +S  + QL      +   +L V +Y P G L  +L+           +F + 
Sbjct: 51  ERDILSISNSPWIPQLQYAFQDKDNLYL-VMEYQPGGDLLSLLNRYEDQFDEDMAQFYL- 108

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
              A  +L +H   +   +HRDIKP NVL+D   + KL DFG A     + +  +   VG
Sbjct: 109 ---AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVG 165

Query: 162 TFGYMAPELMRT----GKAS--TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
           T  Y+APE++ T    GK +     D ++ GV   E+  GR P  +  S +  N
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 7/94 (7%)

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA 167
           L YL E+ +  ++HRD+KP+N+LLD + N KL DFG++     D+I + T+  G   YMA
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISG-QLVDSIAK-TRDAGCRPYMA 175

Query: 168 PELMRTGKAS---TSTDVYAFGVFMLEVASGRRP 198
           PE +           +DV++ G+ + EVA+G+ P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 9e-12
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 18/149 (12%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYL------HEDWEQVVLHRD 123
           LV DY   G L + + +  K +       R  R   +GLL++      H    + ++HRD
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTN-------RTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDH---DTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           IK AN+LL ++   KLGDFG +++Y     D + +T    GT  Y+APE+ R    S   
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPYYVAPEIWRRKPYSKKA 226

Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
           D+++ GV + E+ + +RP + +   E+++
Sbjct: 227 DMFSLGVLLYELLTLKRPFDGENMEEVMH 255

Length = 496

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 9e-12
 Identities = 48/178 (26%), Positives = 69/178 (38%), Gaps = 46/178 (25%)

Query: 67  EFL-LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVV 119
           E L LV +YMP G L           ++   R  +         +A  +L L    +   
Sbjct: 74  EHLYLVMEYMPGGDL-----------MNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLA------------RLYDHDTIPQTTKL-------- 159
           +HRDIKP N+L+DAD + KL DFGL                 H+ + +   L        
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 160 --------VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
                   VGT  Y+APE++R        D ++ GV + E+  G  P       E  N
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 20/163 (12%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +A  L YLHE   + +LHRD+K  NV L      K+GD G+AR+ ++     +T L+GT 
Sbjct: 111 IAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTP 166

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            YM+PEL      +  +DV+A G  + E+A+ +     +   +M +LV           I
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLV---------YRI 214

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
           ++     +   Y  E  EL+  +       +PE RP+++ +++
Sbjct: 215 IEGKLPPMPKDYSPELGELIATM----LSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 14/134 (10%)

Query: 70  LVYDYMPNGSLDKIL----------HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV 119
           ++ +YM NG L++ L          H N  PS+S      +   +ASG+ YL        
Sbjct: 94  MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNF 150

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +HRD+   N L+      K+ DFG++R LY  D      + V    +MA E +  GK +T
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT 210

Query: 179 STDVYAFGVFMLEV 192
           ++DV+AFGV + E+
Sbjct: 211 ASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 7/100 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGT 162
           +  GL  LH    + +++RD+KP N+LLD   + ++ D GLA  + + +TI      VGT
Sbjct: 111 ITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGT 164

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ 202
            GYMAPE+++  + + S D +  G  + E+  G+ P  Q+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 42/164 (25%), Positives = 85/164 (51%), Gaps = 21/164 (12%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K +  
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + +++  V        +G
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-------MEG 237

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
            +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 238 GLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 7/97 (7%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL ++H    + V++RD+KPAN+LLD   + ++ D GLA  +     P  +  VGT GYM
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYM 162

Query: 167 APELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQ 202
           APE+++ G A  +S D ++ G  + ++  G  P  Q 
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 39/106 (36%), Positives = 54/106 (50%), Gaps = 14/106 (13%)

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
           YQ  R        L Y+H      V HRD+KP N+L +AD   K+ DFGLAR+  +DT  
Sbjct: 110 YQLLR-------ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159

Query: 155 QT--TKLVGTFGYMAPELMRT--GKASTSTDVYAFGVFMLEVASGR 196
               T  V T  Y APEL  +   K + + D+++ G    EV +G+
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 33/104 (31%), Positives = 58/104 (55%), Gaps = 4/104 (3%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L++LH+   + +++RD+K  NVLLD + + KL DFG+ +    +    T+   GT 
Sbjct: 105 ITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCGTP 160

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
            Y+APE+++      S D +A GV + E+  G  P E +   ++
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.2 bits (153), Expect = 1e-11
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 24/203 (11%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V ++M  GSL   L       L   Q   +   +A G+ Y+        +HRD++ AN+
Sbjct: 77  IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANI 133

Query: 130 LLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           L+  +L  K+ DFGLARL + +  T  Q  K      + APE    G+ +  +DV++FG+
Sbjct: 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 188 FMLE-VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
            + E V  GR P     + E++  V+       +G  +       E ++E  ++      
Sbjct: 192 LLTELVTKGRVPYPGMVNREVLEQVE-------RGYRMPCPQGCPESLHELMKL------ 238

Query: 247 GLFCSHPKPEARPNMRQVMQYLD 269
              C    P+ RP    +  +L+
Sbjct: 239 ---CWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 7/99 (7%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL ++H    + V++RD+KPAN+LLD   + ++ D GLA  +     P  +  VGT GYM
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYM 162

Query: 167 APELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGS 204
           APE+++ G A  +S D ++ G  + ++  G  P  Q  +
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 46/131 (35%), Positives = 62/131 (47%), Gaps = 12/131 (9%)

Query: 78  GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 137
           GS   IL  + KP L   +   I  G   GL YLH       +HRDIK  N+LL      
Sbjct: 99  GSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTV 154

Query: 138 KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL---MRTGKASTSTDVYAFGVFMLEVAS 194
           KL DFG A L      P  +  VGT  +MAPE+   M  G+     DV++ G+  +E+A 
Sbjct: 155 KLADFGSASLVS----PANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209

Query: 195 GRRPIEQQGSM 205
            + P+    +M
Sbjct: 210 RKPPLFNMNAM 220

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ YL     Q  +HRD+   NVL+  D   K+ DFGLAR +++ D   +TT     
Sbjct: 143 VARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-------KEG 252

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDS 281
             +D   +    +Y      ++++    C H  P  RP  +Q+++ LD   T+       
Sbjct: 253 HRMDKPANCTHELY------MIMRE---CWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYL 303

Query: 282 TLIAPFSASNDAFSGNSSATMSTIDSILT 310
            L  PF   +     + S+  S  DS+  
Sbjct: 304 DLSVPFEQYSPGCPDSPSSCSSGDDSVFA 332

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 30/200 (15%)

Query: 41  LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI 100
           LQ D L  +++         V +++    ++ +YM  GSL   L ++    +   +    
Sbjct: 58  LQHDKLVRLYA---------VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108

Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
              +A G+ Y+     +  +HRD++ ANVL+   L  K+ DFGLAR+ + +         
Sbjct: 109 SAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIE-----------QQG----S 204
               + APE +  G  +  +DV++FG+ + E+ + G+ P             Q+G     
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR 225

Query: 205 MEM--VNLVDWVSDCWKKGA 222
           ME     L D +  CWK+ A
Sbjct: 226 MENCPDELYDIMKTCWKEKA 245

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 30/163 (18%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            L+ +Y+P GSL   L  +    L+  Q     + +  G+ YLH    Q  +HRD+   N
Sbjct: 84  QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARN 137

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG-----YMAPELMRTGKASTSTD 181
           VLLD D   K+GDFGLA+      +P+  +   V   G     + A E ++  K S ++D
Sbjct: 138 VLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASD 192

Query: 182 VYAFGVFMLEV-------ASGRRPIEQ-----QGSMEMVNLVD 212
           V++FGV + E+        S  +  E+     QG M +V L++
Sbjct: 193 VWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 11/161 (6%)

Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD +A  +S  ++QL       K    +V +YMP G L  ++ +N      W + +   
Sbjct: 93  ERDIMAFANSPWVVQLFCAFQDDK-YLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFY--- 147

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
              A  +L L       ++HRD+KP N+LLD   + KL DFG     D   + +    VG
Sbjct: 148 --TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205

Query: 162 TFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRP 198
           T  Y++PE++++    G      D ++ GVF+ E+  G  P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 11/191 (5%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K     V +++  G L  + H   K     Y+       +  GL +LH      +++RD+
Sbjct: 68  KEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDL 122

Query: 125 KPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           K  NV+LD D + K+ DFG+ +  ++  +   + +   GT  Y+APE+++  K + S D 
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           ++FGV + E+  G+ P       E+   +   +  + +    ++ D  LE ++E +    
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDI-LEKLFERDPTRR 238

Query: 243 VLKLGLFCSHP 253
           +  +G    HP
Sbjct: 239 LGVVGNIRGHP 249

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   NVL+  D   K+ DFGLAR ++  D   +TT     
Sbjct: 141 VARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G
Sbjct: 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-------KEG 250

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             ++   +  + +Y          L   C H  P  RP  +Q+++ LD
Sbjct: 251 YRMEKPQNCTQELY---------HLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 21/158 (13%)

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA 167
           L YLH+  E+ ++HRD+ P N++L  D    + DFGLA+    ++  + T +VGT  Y  
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSC 181

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDAS 227
           PE+++        DV+AFG  + ++ + + P     S  M++L            I++A 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY---STNMLSLAT---------KIVEAV 229

Query: 228 DSRL-EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV 264
              L EG+Y  E +  V+     C  P  EARP++ QV
Sbjct: 230 YEPLPEGMY-SEDVTDVIT---SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)

Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT +       Q   +   V   L  LH    Q V+HRDIK
Sbjct: 91  ELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHA---QGVIHRDIK 143

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL  D   KL DFG       + +P+   LVGT  +MAPEL+         D+++ 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL 202

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G+ ++E+  G  P   +  ++ + ++
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 41/154 (26%), Positives = 83/154 (53%), Gaps = 12/154 (7%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +  L +++++      L  +Y+P GS+  +L+       +  + F  +R +  GL 
Sbjct: 65  HENIVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNF--VRQILKGLN 120

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-----LVGTFG 164
           YLH    + ++HRDIK AN+L+D     K+ DFG+++  + +++   T      L G+  
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 165 YMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE+++    +   D+++ G  ++E+ +G+ P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 9/139 (6%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+ +  +  ++   GSL  I H  +   LS  Q   + R    GL YLH   +   +HRD
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM---RTGKASTST 180
           IK AN+LL  + + KL DFG++      TI +    +GT  +MAPE+    R G  +   
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITA-TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190

Query: 181 DVYAFGVFMLEVASGRRPI 199
           D++A G+  +E+A  + P+
Sbjct: 191 DIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 11/171 (6%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +  LV DYM  G L   L    + S     R +    +A  +L L    +  +++RD+KP
Sbjct: 70  DLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFY--IAELVLALEHLHKYDIVYRDLKP 124

Query: 127 ANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS-TDVY 183
            N+LLDA  +  L DFGL++  L D+ T   T    GT  Y+APE++   K  T   D +
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181

Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI 234
           + GV + E+  G  P   + + +M   + +    + K  + D     ++G+
Sbjct: 182 SLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 63.6 bits (154), Expect = 3e-11
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 10/132 (7%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           ++K +F L Y +M + + D       K      Q   I++ +   + Y+H+   + ++HR
Sbjct: 242 TQKYDFDL-YSFMYDEAFD------WKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHR 291

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           DIK  N+ L+ D    LGDFG A  ++ +        VGT    +PE++        TD+
Sbjct: 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDI 351

Query: 183 YAFGVFMLEVAS 194
           ++ G+ +L++ S
Sbjct: 352 WSCGLILLDMLS 363

Length = 501

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 39/128 (30%), Positives = 68/128 (53%), Gaps = 7/128 (5%)

Query: 73  DYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 132
           +YMP GS+   L      + +  +++   R +  G+ YLH +   +++HRDIK AN+L D
Sbjct: 84  EYMPGGSVKDQLKAYGALTETVTRKY--TRQILEGVEYLHSN---MIVHRDIKGANILRD 138

Query: 133 ADLNGKLGDFGLA-RLYD-HDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML 190
           +  N KLGDFG + RL     +      + GT  +M+PE++         DV++ G  ++
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198

Query: 191 EVASGRRP 198
           E+ + + P
Sbjct: 199 EMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 2/146 (1%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           + LL+ +Y   G L+K +   +K  L  +Q + +       +L L E   + ++HRD+K 
Sbjct: 139 KLLLIMEYGSGGDLNKQIKQRLKEHLP-FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197

Query: 127 ANVLLDADLNGKLGDFGLARLY-DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           AN+ L      KLGDFG ++ Y D  ++   +   GT  Y+APEL    + S   D+++ 
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           GV + E+ +  RP +     E++  V
Sbjct: 258 GVILYELLTLHRPFKGPSQREIMQQV 283

Length = 478

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 36/118 (30%), Positives = 66/118 (55%), Gaps = 11/118 (9%)

Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDH 150
           LSW+ +      ++ GL ++H+   + +LHRDIK  N+ L  + +  KLGDFG+AR  + 
Sbjct: 104 LSWFVQ------ISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN- 153

Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
           D++      VGT  Y++PE+ +    +  TD+++ G  + E+ + + P E     ++V
Sbjct: 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 44/157 (28%), Positives = 68/157 (43%), Gaps = 22/157 (14%)

Query: 56  QLTNTVNSR-----------KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGV 104
           Q+   VNS+           K    LV   M  G L   ++    P     +       +
Sbjct: 52  QILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI 111

Query: 105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VG 161
             GL  LH    +  ++RD+KP N+LLD   + ++ D GLA       IP+   +   VG
Sbjct: 112 LCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAV-----KIPEGESIRGRVG 163

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           T GYMAPE++   + + S D +  G  + E+  G+ P
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 11/150 (7%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDTIPQTTKLVGTF 163
           GL +LH    + +++RD+K  N+LLD D + K+ DFG+ +   L D     +T    GT 
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFCGTP 160

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            Y+APE++   K +TS D ++FGV + E+  G+ P       E+   +   + C+ +   
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLT 220

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHP 253
            +A D  ++    E +  L +K G    HP
Sbjct: 221 REAKDILVKLFVREPERRLGVK-GDIRQHP 249

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 5e-11
 Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 35/161 (21%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR-----------F 98
           H+N ++ L + ++++K    LV++Y+          T++K  +                F
Sbjct: 62  HAN-IVTLHDIIHTKK-TLTLVFEYL---------DTDLKQYMDDCGGGLSMHNVRLFLF 110

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT- 157
           +++RG+A    Y H+   + VLHRD+KP N+L+      KL DFGLAR     ++P  T 
Sbjct: 111 QLLRGLA----YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARA---KSVPSKTY 160

Query: 158 -KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
              V T  Y  P+ L+ + + STS D++  G    E+A+GR
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 5e-11
 Identities = 45/130 (34%), Positives = 67/130 (51%), Gaps = 9/130 (6%)

Query: 73  DYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 132
           +Y   GSL  I H  +   LS  Q   + R    GL YLH   +   +HRDIK AN+LL 
Sbjct: 86  EYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLT 140

Query: 133 ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM---RTGKASTSTDVYAFGVFM 189
            + + KL DFG+A      TI +    +GT  +MAPE+    + G  +   D++A G+  
Sbjct: 141 DNGDVKLADFGVAAKITA-TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199

Query: 190 LEVASGRRPI 199
           +E+A  + P+
Sbjct: 200 IELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           +A G+ YL+    +  +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K +  
Sbjct: 128 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA 222
             +MAPE ++ G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G 
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GG 238

Query: 223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
            LD  D+  E + +  +M         C    P+ RP   +++  L
Sbjct: 239 YLDQPDNCPERVTDLMRM---------CWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 24/162 (14%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPS-------------LSWYQRFRIIRGVASGLLYL--- 111
            L+V++YM +G L++ L ++   +             L+  Q   I   +ASG++YL   
Sbjct: 82  LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL 141

Query: 112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPEL 170
           H       +HRD+   N L+   L  K+GDFG++R +Y  D      + +    +M PE 
Sbjct: 142 H------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES 195

Query: 171 MRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV 211
           +   K +T +D+++FGV + E+ + G++P  Q  + E +  +
Sbjct: 196 ILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 7/136 (5%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ DY+  G L    H + +      +       +   L +LH+     +++RDIK  N+
Sbjct: 82  LILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENI 136

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA--STSTDVYAFGV 187
           LLD++ +  L DFGL++ +  D + +     GT  YMAP+++R G      + D ++ GV
Sbjct: 137 LLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196

Query: 188 FMLEVASGRRPIEQQG 203
            M E+ +G  P    G
Sbjct: 197 LMYELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 61.5 bits (149), Expect = 7e-11
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 9/133 (6%)

Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +Y+  GSL D +  T +       Q   + R     L +LH +    V+HRDIK
Sbjct: 90  ELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSNQ---VIHRDIK 142

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             N+LL  D + KL DFG       +   ++T +VGT  +MAPE++         D+++ 
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 186 GVFMLEVASGRRP 198
           G+  +E+  G  P
Sbjct: 202 GIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)

Query: 65  KGE-FLLVYDYMPNGSLDKIL----HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV 119
           KGE  +LV +  P G L K L       +        +      VA G+ YL     +  
Sbjct: 66  KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES---KHF 116

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKAS 177
           +HRD+   NVLL      K+ DFG++R     +        G +   + APE +  GK S
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE 236
           + +DV+++GV + E  S G +P  +    E++ +++        G  L   +   + IY 
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-------SGERLPRPEECPQEIYS 229

Query: 237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                    + L C   +PE RP   ++    
Sbjct: 230 ---------IMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 5/108 (4%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +A  +L +H   +   +HRDIKP NVLLD + + +L DFG     + D   Q++  VGT 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167

Query: 164 GYMAPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
            Y++PE+++      GK     D ++ GV M E+  G  P   +  +E
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 38/218 (17%)

Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL-----HTNI---- 88
           + Q +   +A +H   ++ L   V +++    ++++Y+  G L + L     H+++    
Sbjct: 53  EFQQEASLMAELHHPNIVCLLGVV-TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS 111

Query: 89  ------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF 142
                 K SL       I   +A+G+ YL   +    +H+D+   N+L+   L+ K+ D 
Sbjct: 112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDL 168

Query: 143 GLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP-- 198
           GL+R +Y  D      K +    +M PE +  GK S+ +D+++FGV + E+ S G +P  
Sbjct: 169 GLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228

Query: 199 -IEQQGSMEMV--------------NLVDWVSDCWKKG 221
               Q  +EMV               +   +++CW++G
Sbjct: 229 GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEG 266

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.9 bits (148), Expect = 9e-11
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 29/210 (13%)

Query: 69  LLVYDYMPNGSLDKIL-----HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L           SL+        R VA G  YL E+     +HRD
Sbjct: 85  FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRD 141

Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+ DFG+AR +Y      +  + +    +M PE    G  ++ 
Sbjct: 142 IAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK 201

Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TDV++FGV + E+ S G  P   + + E++  V         G  LD        +Y   
Sbjct: 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-------TGGGRLDPPKGCPGPVY--- 251

Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                 ++   C    PE RPN   +++ +
Sbjct: 252 ------RIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 44/152 (28%), Positives = 81/152 (53%), Gaps = 16/152 (10%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH----TNIKPSLSWYQRFRIIRGVA 105
           H N +++L + +++   +  LV++++ +  L K +     + I   L     F++++G+A
Sbjct: 58  HPN-IVKLLDVIHTEN-KLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
               + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y
Sbjct: 115 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 166

Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
            APE++   K  ST+ D+++ G    E+ + R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 24/204 (11%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            +V + +P GSL   L    K  L+  +  ++    A+G+ YL     +  +HRD+   N
Sbjct: 68  YIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARN 123

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFG 186
            L+  +   K+ DFG++R  +   I   +  +      + APE +  G+ ++ +DV+++G
Sbjct: 124 CLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYG 182

Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           + + E  S G  P     + +    ++        G  + A     E IY         +
Sbjct: 183 ILLWETFSLGDTPYPGMSNQQTRERIE-------SGYRMPAPQLCPEEIY---------R 226

Query: 246 LGLFCSHPKPEARPNMRQVMQYLD 269
           L L C    PE RP+  ++   L 
Sbjct: 227 LMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.9 bits (147), Expect = 1e-10
 Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 7/138 (5%)

Query: 73  DYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 132
           +YMP GS+   L      + S  +++   R +  G+ YLH +   +++HRDIK AN+L D
Sbjct: 86  EYMPGGSVKDQLKAYGALTESVTRKY--TRQILEGMSYLHSN---MIVHRDIKGANILRD 140

Query: 133 ADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML 190
           +  N KLGDFG ++      +  T    + GT  +M+PE++         DV++ G  ++
Sbjct: 141 SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVV 200

Query: 191 EVASGRRPIEQQGSMEMV 208
           E+ + + P  +  +M  +
Sbjct: 201 EMLTEKPPWAEYEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 28/184 (15%)

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
           +Q  R       GL +LH      V+HRD+KP N+L+ +    KL DFGLAR+Y      
Sbjct: 117 FQLLR-------GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA- 165

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP-------IEQQGSM-E 206
             T +V T  Y APE++     +T  D+++ G    E+   R+P       ++Q G + +
Sbjct: 166 -LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD 223

Query: 207 MVNLV---DWVSDC-WKKGAILDASDSRLEGI---YEEEQMELVLKLGLFCSHPKPEARP 259
           ++ L    DW  D    + A    S   +E      +E   +L+LK   F    +  A  
Sbjct: 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283

Query: 260 NMRQ 263
            +  
Sbjct: 284 ALSH 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 3/108 (2%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH   E+ V++RD+K  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 104 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 160

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q   ++  L+
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 20/109 (18%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-------RLYDHDTIPQT 156
           +  G+L+ H    + VLHRD+KP N+L+D     KL DFGLA       R+Y H+ +   
Sbjct: 110 ILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--- 163

Query: 157 TKLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
                T  Y APE L+ + + ST  D+++ G    E+A+ ++P+    S
Sbjct: 164 -----TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDS 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 42/131 (32%), Positives = 63/131 (48%), Gaps = 12/131 (9%)

Query: 78  GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 137
           GS   +L  + KP L   +   +  G   GL YLH      ++HRD+K  N+LL      
Sbjct: 99  GSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLV 154

Query: 138 KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL---MRTGKASTSTDVYAFGVFMLEVAS 194
           KLGDFG A +     +      VGT  +MAPE+   M  G+     DV++ G+  +E+A 
Sbjct: 155 KLGDFGSASI-----MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209

Query: 195 GRRPIEQQGSM 205
            + P+    +M
Sbjct: 210 RKPPLFNMNAM 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 11/161 (6%)

Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD +A  +S  ++QL       K    +V +YMP G L  ++ +N      W  RF   
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDK-YLYMVMEYMPGGDLVNLM-SNYDIPEKW-ARFYTA 149

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
             V   L  +H       +HRD+KP N+LLD   + KL DFG     D + + +    VG
Sbjct: 150 E-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205

Query: 162 TFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRP 198
           T  Y++PE++++    G      D ++ GVF+ E+  G  P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 38/138 (27%), Positives = 72/138 (52%), Gaps = 7/138 (5%)

Query: 73  DYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD 132
           ++MP GS+   L +    +L+     +  R +  G+ YLH +   +++HRDIK AN+L D
Sbjct: 86  EHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRD 140

Query: 133 ADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML 190
           +  N KLGDFG ++      +  T    + GT  +M+PE++         D+++ G  ++
Sbjct: 141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVV 200

Query: 191 EVASGRRPIEQQGSMEMV 208
           E+ + + P  +  +M  +
Sbjct: 201 EMLTEKPPWAEFEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYD--HDTIPQTTKLV 160
           VA G+ YL     +  +HRD+   N +LD     K+ DFGLAR +YD  + ++   T   
Sbjct: 107 VAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWK 219
               +MA E ++T K +T +DV++FGV + E+ + G  P     S ++   +        
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-------L 216

Query: 220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV 264
           +G  L   +   + +YE         + L C HPKPE RP   ++
Sbjct: 217 QGRRLLQPEYCPDPLYE---------VMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 43/131 (32%), Positives = 61/131 (46%), Gaps = 12/131 (9%)

Query: 78  GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 137
           GS   +L  + KP L   +   I  G   GL YLH      ++HRDIK  N+LL      
Sbjct: 109 GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQV 164

Query: 138 KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL---MRTGKASTSTDVYAFGVFMLEVAS 194
           KL DFG A +            VGT  +MAPE+   M  G+     DV++ G+  +E+A 
Sbjct: 165 KLADFGSASI-----ASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 219

Query: 195 GRRPIEQQGSM 205
            + P+    +M
Sbjct: 220 RKPPLFNMNAM 230

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 44/163 (26%), Positives = 87/163 (53%), Gaps = 14/163 (8%)

Query: 47  ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           A ++   ++ L ++  +  G    V++Y+P  +L ++L  +   +L   +  R++  V  
Sbjct: 33  ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD--GALPAGETGRLMLQVLD 90

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARL------YDHDTIPQTT 157
            L   H    Q ++HRD+KP N+++       + K+ DFG+  L       D  T+ +TT
Sbjct: 91  ALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147

Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           +++GT  Y APE +R    + ++D+YA+G+  LE  +G+R ++
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 6/100 (6%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           ++R    GL +LH +    ++HRD+KP N+L+ +    KL DFGLAR+Y        T +
Sbjct: 113 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPV 167

Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
           V T  Y APE++     +T  D+++ G    E+   R+P+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 32/104 (30%), Positives = 61/104 (58%), Gaps = 4/104 (3%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           ++ GL +LH    + +++RD+K  NV+LD++ + K+ DFG+ + +  D +  T    GT 
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTP 165

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
            Y+APE++       S D +A+GV + E+ +G+ P + +   E+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 30/152 (19%)

Query: 59  NTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--FRIIRGVASGLLYL 111
           N VN      RK    LV++++ +  LD +         S  ++  F+I+RG+     + 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE----FC 116

Query: 112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQT--TKLVGTFGYMA 167
           H      ++HRDIKP N+L+      KL DFG AR     T+  P    T  V T  Y A
Sbjct: 117 HS---HNIIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRA 168

Query: 168 PELM----RTGKASTSTDVYAFGVFMLEVASG 195
           PEL+    + G+A    D++A G  + E+ +G
Sbjct: 169 PELLVGDTKYGRA---VDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 9/100 (9%)

Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           ++I+RG+A    Y H    + VLHRD+KP N+L++     KL DFGLAR     T   + 
Sbjct: 111 YQILRGLA----YCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163

Query: 158 KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
           ++V T  Y  P+ L+ + + ST  D++  G    E+ASGR
Sbjct: 164 EVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 18/160 (11%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT---NIKPSLSWYQRFRIIR 102
           L  +    +++L + ++S K +  LV++Y  +  L K   +   +I P +     F++++
Sbjct: 53  LKELKHKNIVRLYDVLHSDK-KLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLV 160
           G+A    + H      VLHRD+KP N+L++ +   KL DFGLAR +    IP    +  V
Sbjct: 111 GLA----FCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVRCYSAEV 160

Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPI 199
            T  Y  P+++   K  STS D+++ G    E+A+  RP+
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 7/145 (4%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HRDIK 
Sbjct: 90  ELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKS 143

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            NVLL  D + KL DFG       +   ++T +VGT  +MAPE++         D+++ G
Sbjct: 144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 187 VFMLEVASGRRPIEQQGSMEMVNLV 211
           +  +E+  G  P   +  +  + L+
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)

Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD +A  +S  ++QL       +    +V +YMP G L  ++     P   W + +   
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--- 147

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
              A  +L L        +HRD+KP N+LLD   + KL DFG     + + + +    VG
Sbjct: 148 --TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205

Query: 162 TFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRP 198
           T  Y++PE++++    G      D ++ GVF+ E+  G  P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 5/130 (3%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +  P G L   L  N K SL           +++ L YL     +  +HRDI   NV
Sbjct: 83  IVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNV 138

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+ +    KLGDFGL+R  + ++  + +K      +MAPE +   + ++++DV+ FGV M
Sbjct: 139 LVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198

Query: 190 LEVAS-GRRP 198
            E+   G +P
Sbjct: 199 WEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 9/150 (6%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +  LV ++   GS+  ++      +L       I R +  GL +LH+     V+HRDIK 
Sbjct: 83  QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKG 139

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST-----D 181
            NVLL  +   KL DFG++   D  T+ +    +GT  +MAPE++   +   +T     D
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 198

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           +++ G+  +E+A G  P+     M  + L+
Sbjct: 199 LWSLGITAIEMAEGAPPLCDMHPMRALFLI 228

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 45/135 (33%), Positives = 72/135 (53%), Gaps = 16/135 (11%)

Query: 73  DYMPNGSLDKILH---TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +++P GS+  IL+      +P    Y + +I+ GVA    YLH +    V+HRDIK  NV
Sbjct: 82  EFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNN---CVVHRDIKGNNV 133

Query: 130 LLDADLNGKLGDFGLAR----LYDHDTIPQTTKLV-GTFGYMAPELMRTGKASTSTDVYA 184
           +L  +   KL DFG AR    +  H T     K + GT  +MAPE++        +D+++
Sbjct: 134 MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWS 193

Query: 185 FGVFMLEVASGRRPI 199
            G  + E+A+G+ P+
Sbjct: 194 IGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 31/84 (36%), Positives = 45/84 (53%), Gaps = 5/84 (5%)

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TG 174
           +HRDIKP NVLLD + + +L DFG       D   Q+   VGT  Y++PE+++      G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 175 KASTSTDVYAFGVFMLEVASGRRP 198
           +     D ++ GV M E+  G  P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 7/145 (4%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HRDIK 
Sbjct: 90  ELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKS 143

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL  D + KL DFG       +   ++T +VGT  +MAPE++         D+++ G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 187 VFMLEVASGRRPIEQQGSMEMVNLV 211
           +  +E+  G  P   +  +  + L+
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 31/89 (34%), Positives = 52/89 (58%), Gaps = 7/89 (7%)

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT----G 174
           +++RDIK  N+LLD++ +  L DFGL++ +  +   +T    GT  YMAPE++R     G
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185

Query: 175 KASTSTDVYAFGVFMLEVASGRRPIEQQG 203
           KA    D ++ G+ + E+ +G  P   +G
Sbjct: 186 KA---VDWWSLGILIFELLTGASPFTLEG 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 36/242 (14%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH------TNIKPSLSWYQRFR 99
           L  +    +L + +          ++Y YM  G+L   L        N   +LS  Q   
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +   +A G+ YLH+   + V+H+DI   N ++D +L  K+ D  L+R    D  P     
Sbjct: 122 MAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR----DLFPMDYHC 174

Query: 160 VGT-----FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDW 213
           +G        +MA E +   + S+++DV++FGV + E+ + G+ P  +    EM   +  
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL-- 232

Query: 214 VSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL-DGNA 272
                K G  L    +  + ++          +   C    PE RP+  Q++Q L D +A
Sbjct: 233 -----KDGYRLAQPINCPDELFA---------VMACCWALDPEERPSFSQLVQCLTDFHA 278

Query: 273 TL 274
            L
Sbjct: 279 QL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.0 bits (142), Expect = 5e-10
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 13/148 (8%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HRDIK 
Sbjct: 91  ELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKS 144

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTK---LVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL  D + KL DFG          P+ +K   +VGT  +MAPE++         D++
Sbjct: 145 DNILLGMDGSVKLTDFGFCA----QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           + G+  +E+  G  P   +  +  + L+
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 9/150 (6%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +  LV ++   GS+  ++      +L       I R +  GL +LH      V+HRDIK 
Sbjct: 93  QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKG 149

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST-----D 181
            NVLL  +   KL DFG++   D  T+ +    +GT  +MAPE++   +   +T     D
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSD 208

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           +++ G+  +E+A G  P+     M  + L+
Sbjct: 209 IWSLGITAIEMAEGAPPLCDMHPMRALFLI 238

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 27/144 (18%)

Query: 64  RKGEFLLVYDY-----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLH 112
           R+G+  LV++Y           MPNG   + + + I         +++I+ +     + H
Sbjct: 71  RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI---------YQLIKAIH----WCH 117

Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR 172
           ++    ++HRDIKP N+L+  +   KL DFG AR     +    T+ V T  Y +PEL+ 
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 173 TGKASTSTDVYAFGVFMLEVASGR 196
                 + D+++ G  + E++ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.7 bits (142), Expect = 5e-10
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 7/146 (4%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           G   +V DY   G L K ++          Q       +   L ++H+   + +LHRDIK
Sbjct: 72  GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIK 128

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             N+ L  D   KLGDFG+AR+  + T+      +GT  Y++PE+      +  +D++A 
Sbjct: 129 SQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWAL 187

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G  + E+ + +   E  G+M+  NLV
Sbjct: 188 GCVLYEMCTLKHAFE-AGNMK--NLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 8/101 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH      V++RD+K  N++LD D + K+ DFGL +  + D  T        G
Sbjct: 104 IVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCG 157

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ 202
           T  Y+APE++       + D +  GV M E+  GR P   Q
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 4/104 (3%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +AS L YLH      +++RD+KP N+LLD+  +  L DFGL +    +    T+   GT 
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTP 160

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
            Y+APE++R      + D +  G  + E+  G  P   + + EM
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 43/131 (32%), Positives = 60/131 (45%), Gaps = 12/131 (9%)

Query: 78  GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 137
           GS   +L  + KP L   +   I  G   GL YLH      ++HRDIK  N+LL      
Sbjct: 105 GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQV 160

Query: 138 KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL---MRTGKASTSTDVYAFGVFMLEVAS 194
           KL DFG A              VGT  +MAPE+   M  G+     DV++ G+  +E+A 
Sbjct: 161 KLADFGSASK-----SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 215

Query: 195 GRRPIEQQGSM 205
            + P+    +M
Sbjct: 216 RKPPLFNMNAM 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 22/170 (12%)

Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKI-LHTNIKP 90
           +DP +++  L  +     L+  N VN      RK +  LV++Y  +  L+++  +    P
Sbjct: 39  DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVP 98

Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL--- 147
                   +II      + + H+      +HRD+KP N+L+      KL DFG AR+   
Sbjct: 99  EH---LIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152

Query: 148 YDHDTIPQTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVASG 195
              D     T  V T  Y APEL+  G  +     DV+A G    E+ +G
Sbjct: 153 PGDD----YTDYVATRWYRAPELL-VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 17/155 (10%)

Query: 70  LVYDYMPNGSLDKILH-----TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV-VLHRD 123
           ++ + M  G L   L          P L+  +   I   VA G +YL    EQ+  +HRD
Sbjct: 76  IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL----EQMHFIHRD 131

Query: 124 IKPANVLL-----DADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
           +   N L+     DAD   K+GDFGLAR +Y  D   +  + +    +MAPE +  GK +
Sbjct: 132 LAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT 191

Query: 178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV 211
           T +DV++FGV M E+ + G++P     + E++  V
Sbjct: 192 TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.4 bits (141), Expect = 6e-10
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           G+ ++HE   + VLHRDIK  N+ L  +   KLGDFG ARL         T  VGT  Y+
Sbjct: 112 GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYV 167

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
            PE+      +  +D+++ G  + E+ + + P +
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 6e-10
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +   L YLH    + +++RD+KP N+LLD + + KL DFG A+        +T  L GT 
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTP 162

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            Y+APE++++   + + D +A G+ + E+  G  P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 19/144 (13%)

Query: 73  DYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +YMP GS        IK  L  Y         R  R +  G+ YLH +   +++HRDIK 
Sbjct: 86  EYMPGGS--------IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKG 134

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKASTSTDVYA 184
           AN+L D+  N KLGDFG ++      +  T    + GT  +M+PE++         DV++
Sbjct: 135 ANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWS 194

Query: 185 FGVFMLEVASGRRPIEQQGSMEMV 208
               ++E+ + + P  +  +M  +
Sbjct: 195 VACTVVEMLTEKPPWAEYEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 9/90 (10%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMAP 168
           YLH    + +++RD+KP N+LLD   + K+ DFG A+      +P  T  L GT  Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184

Query: 169 ELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           E++++     + D +  GV + E  +G  P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 4/108 (3%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 104 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 6/92 (6%)

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA 167
           L +LH+   Q +++RD+KP N+LLDA  + KL DFGL +   H+    T    GT  YMA
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMA 168

Query: 168 PE-LMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           PE LMR+G    + D ++ G  M ++ +G  P
Sbjct: 169 PEILMRSGHGK-AVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 58.1 bits (140), Expect = 8e-10
 Identities = 46/177 (25%), Positives = 89/177 (50%), Gaps = 11/177 (6%)

Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED  ++ D LAS     +++L +        ++L+ ++   G++D ++   ++  L+  Q
Sbjct: 47  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM-LELERPLTEPQ 104

Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
              + +     L YLHE+    ++HRD+K  N+L   D + KL DFG++   +  TI + 
Sbjct: 105 IRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRR 160

Query: 157 TKLVGTFGYMAPELM--RTGKAST---STDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
              +GT  +MAPE++   T K        DV++ G+ ++E+A    P  +   M ++
Sbjct: 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL 217

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 10/145 (6%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L  +Y+P G    +L  N+      + RF +     + +  LHE      +HRD+KP N 
Sbjct: 78  LAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEA-VDALHE---LGYIHRDLKPENF 132

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+DA  + KL DFGL++      +     +VG+  YMAPE++R      + D ++ G  +
Sbjct: 133 LIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188

Query: 190 LEVASGRRPIEQQGSME-MVNLVDW 213
            E   G  P       E   NL  W
Sbjct: 189 YEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTGK 175
           +++RD+KP N+LLD   + ++ D GLA       IP+   +   VGT GYMAPE++   K
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAV-----QIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 176 ASTSTDVYAFGVFMLEVASGRRPIEQQ 202
            + S D +  G  + E+  G+ P  ++
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 23/202 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            +LV +    G L+K L    K  ++      ++  V+ G+ YL     +  +HRD+   
Sbjct: 69  LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAAR 124

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAF 185
           NVLL      K+ DFGL++    D      +  G +   + APE +   K S+ +DV+++
Sbjct: 125 NVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSY 184

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           G+ M E  S G++P ++    E+++ ++       +G  LD        +Y         
Sbjct: 185 GITMWEAFSYGQKPYKKMKGPEVMSFIE-------QGKRLDCPAECPPEMYA-------- 229

Query: 245 KLGLFCSHPKPEARPNMRQVMQ 266
            L   C   K E RPN  +V +
Sbjct: 230 -LMKDCWIYKWEDRPNFAKVEE 250

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 16/186 (8%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVNSR-----KGE-FLLVYDYMPNGSLDKILHTNIK 89
           N DP L+ + L    +N + QL N    R     + E ++LV +    G L+K L  N  
Sbjct: 34  NNDPALKDELLRE--ANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKN-- 89

Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
             ++      ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 90  KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146

Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      K  G +   + APE M   K S+ +DV++FGV M E  S G++P +     E
Sbjct: 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206

Query: 207 MVNLVD 212
           +  +++
Sbjct: 207 VTQMIE 212

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 21/143 (14%)

Query: 70  LVYDYMPNGSLDKILHTNI-----------------KPSLSWYQRFRIIRGVASGLLYLH 112
           ++ +YM NG L++ L ++                   P++S+     +   +ASG+ YL 
Sbjct: 96  MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155

Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
                  +HRD+   N L+  +L  K+ DFG++R LY  D      + V    +MA E +
Sbjct: 156 S---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212

Query: 172 RTGKASTSTDVYAFGVFMLEVAS 194
             GK +T++DV+AFGV + E+  
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 35/100 (35%), Positives = 59/100 (59%), Gaps = 9/100 (9%)

Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           F+++RG++    Y H+   + +LHRD+KP N+L++     KL DFGLAR     T   + 
Sbjct: 110 FQLLRGLS----YCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162

Query: 158 KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
           ++V T  Y  P+ L+ + + ST  D++  G  + E+A+GR
Sbjct: 163 EVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 15/103 (14%)

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP 154
           YQ   I+RG    L Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D +   
Sbjct: 125 YQ---ILRG----LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--- 171

Query: 155 QTTKLVGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
             T  V T  Y APE+M        T D+++ G  M E+ +G+
Sbjct: 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 4/108 (3%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH      +++RD+K  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTP 159

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q   ++  L+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 10/148 (6%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           G+  ++ ++ P G++D I+   +   L+  Q   I R +   L YLH      ++HRD+K
Sbjct: 82  GKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLK 137

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL-----MRTGKASTST 180
             NVLL  D + KL DFG++   +  T+ +    +GT  +MAPE+     M+        
Sbjct: 138 AGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 196

Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMV 208
           D+++ G+ ++E+A    P  +   M ++
Sbjct: 197 DIWSLGITLIEMAQIEPPHHELNPMRVL 224

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 30/182 (16%)

Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTI 153
           YQ  R       GL Y+H      VLHRD+KPANV ++  DL  K+GDFGLAR+ D    
Sbjct: 121 YQLLR-------GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170

Query: 154 PQ--TTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
            +   ++ + T  Y +P L+ +    T + D++A G    E+ +G+        +E + L
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Query: 211 VDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG 270
                       IL++    +  + EE++ EL+  +  F  +   E R  +R ++  ++ 
Sbjct: 231 ------------ILES----VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274

Query: 271 NA 272
            A
Sbjct: 275 EA 276

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 10/96 (10%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLL--DADLNG--KLGDFGLARLYDHDTIP--QTT 157
           +  G+ YLH +W   VLHRD+KPAN+L+  +    G  K+ D G ARL++    P     
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 158 KLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEV 192
            +V TF Y APEL+   +  T + D++A G    E+
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 8/106 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           +AS L YLH      +++RD+KP N+LLD+  +  L DFGL +  +   DT   TT   G
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCG 158

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           T  Y+APE++R      + D +  G  + E+  G  P   +   EM
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 10/96 (10%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLL--DADLNG--KLGDFGLARLYDHDTIP--QTT 157
           +  G+ YLH +W   VLHRD+KPAN+L+  +    G  K+ D G ARL++    P     
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 158 KLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEV 192
            +V TF Y APEL+   +  T + D++A G    E+
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR     T  + T  
Sbjct: 125 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGY 177

Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 13/102 (12%)

Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           F+++RG+     Y H    + VLHRD+KP N+L++     KL DFGLAR     +IP  T
Sbjct: 111 FQLLRGLN----YCHR---RKVLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKT 160

Query: 158 --KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
               V T  Y  P+ L+ +   ST  D++  G    E+++GR
Sbjct: 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 38/125 (30%), Positives = 68/125 (54%), Gaps = 6/125 (4%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +++P+GSL + L  N K  ++  Q+ +    +  G+ YL     +  +HRD+   NV
Sbjct: 85  LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNV 140

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTK--LVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           L++++   K+GDFGL +  + D    T K  L     + APE +   K   ++DV++FGV
Sbjct: 141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200

Query: 188 FMLEV 192
            + E+
Sbjct: 201 TLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 1/89 (1%)

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           V++RD+KP N+LLD   +  L DFGL +L   D   +T    GT  Y+APEL+     + 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTK 172

Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           + D +  GV + E+ +G  P   +   EM
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEM 201

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 21/168 (12%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGT 162
           VA G+ YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT     
Sbjct: 149 VARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G
Sbjct: 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEG 258

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +D   +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 259 HRMDKPSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 37/161 (22%)

Query: 60  TVNSRKGEFLL--------------VYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG-- 103
           T NS +  FL+              V +Y   G L   +HT+          F   R   
Sbjct: 55  TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD---------VFSEPRAVF 105

Query: 104 ----VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTT 157
               V  GL YLHE+    +++RD+K  N+LLD +   K+ DFGL +  +   D    T+
Sbjct: 106 YAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TS 159

Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
              GT  ++APE++     + + D +  GV + E+  G  P
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.5 bits (133), Expect = 6e-09
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 26/162 (16%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL------DKILHTN--------IKPSLSWY 95
           H   ++ L      R G   L  +Y P+G+L       ++L T+           +LS  
Sbjct: 54  HHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112

Query: 96  QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDT 152
           Q       VA G+ YL +   +  +HRD+   N+L+  +   K+ DFGL+R   +Y   T
Sbjct: 113 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 169

Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
           + +         +MA E +     +T++DV+++GV + E+ S
Sbjct: 170 MGRL-----PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)

Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           L  V+   ++ L N    +K   EF  VY  M   + +L +++H  +      Y  ++++
Sbjct: 74  LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 133

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
                G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR    + +   T  V 
Sbjct: 134 ----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV 184

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ G  M E+  G
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 34/216 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+P GSL   L  + +  L   +       +  G+ YL     +  +HRD+   N+
Sbjct: 84  LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNI 139

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVG---TFGYMAPELMRTGKASTSTDVYAFG 186
           L++++   K+GDFGL ++   D      +  G    F Y APE +   K S ++DV++FG
Sbjct: 140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFG 198

Query: 187 VFMLEVAS----GRRPI---------EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG 233
           V + E+ +       P          ++QG M + +L++ + +  +    L A       
Sbjct: 199 VVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR----LPAPPGCPAE 254

Query: 234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           IY          +   C +  P  RP+  ++   ++
Sbjct: 255 IYA---------IMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 8/106 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VAS + YLH      +++RD+KP N+LLD+  +  L DFGL +  +   +T   T+   G
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCG 158

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           T  Y+APE++R      + D +  G  + E+  G  P   +   +M
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 4/80 (5%)

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+LLD D   K+ DFG A++ D     +T  L GT  Y+APE++       
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGK 207

Query: 179 STDVYAFGVFMLEVASGRRP 198
           + D +  G+F+ E+  G  P
Sbjct: 208 AADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 24/146 (16%)

Query: 70  LVYDYMPNGSLDKILHTNI--------------------KPSLSWYQRFRIIRGVASGLL 109
           L+++YM  G L++ L                           LS  ++  I + VA+G+ 
Sbjct: 85  LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAP 168
           YL E   +  +HRD+   N L+  ++  K+ DFGL+R +Y  D    +        +M P
Sbjct: 145 YLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201

Query: 169 ELMRTGKASTSTDVYAFGVFMLEVAS 194
           E +   + +T +DV+A+GV + E+ S
Sbjct: 202 ESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 17/152 (11%)

Query: 50  HSN--GLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           H N  GLL +  +  S     +F LV  YM    L KI+   +      Y  ++++ G  
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCG-- 129

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             L Y+H      ++HRD+KP N+ ++ D   K+ DFGLAR  D     + T  V T  Y
Sbjct: 130 --LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWY 180

Query: 166 MAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
            APE++        T D+++ G  M E+ +G+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.9 bits (132), Expect = 9e-09
 Identities = 62/260 (23%), Positives = 101/260 (38%), Gaps = 60/260 (23%)

Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHT---- 86
           +   Q Q   L        LQ +N +      +    +LLV ++ P G L   L +    
Sbjct: 33  SASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKA 92

Query: 87  -NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 145
             + P  +  QR      +A GLL+LH++     +H D+   N LL ADL  K+GD+GL+
Sbjct: 93  ELMTPDPTTLQRMAC--EIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147

Query: 146 RL-YDHDTIPQTTKLVGTFGYMAPEL-------MRTGKASTSTDVYAFGVFMLEVAS-GR 196
              Y  D      +L     ++APEL       +     +  ++V++ GV + E+   G 
Sbjct: 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207

Query: 197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL---VLKLGL----- 248
           +P       +++                            E+Q++L    LKL L     
Sbjct: 208 QPYRHLSDEQVLTYT-----------------------VREQQLKLPKPRLKLPLSDRWY 244

Query: 249 ----FCSHPKPEARPNMRQV 264
               FC    PE RP+  +V
Sbjct: 245 EVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 5/101 (4%)

Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 151
           L   Q   I + +  GL YLH    Q ++HRD+K  N+ ++      +GD G A+     
Sbjct: 154 LPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210

Query: 152 TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
             P    L GT    APE++   K ++  D+++ G+ + E+
Sbjct: 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 39/230 (16%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR----------------GVAS 106
           ++ G   ++ +Y   G+L + L     P + +   + I R                 VA 
Sbjct: 91  TQDGPLYVIVEYASKGNLREYLRARRPPGMEY--SYDIARVPDEQMTFKDLVSCTYQVAR 148

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGY 165
           G+ YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +
Sbjct: 149 GMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW 205

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
           MAPE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +
Sbjct: 206 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRM 258

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
           D   +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 259 DKPANCTNELY------MMMR---DCWHAIPSHRPTFKQLVEDLDRILTL 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 27/171 (15%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ YL     +  +HRD+   NVL+  D   K+ DFGLAR ++D D   +T+     
Sbjct: 143 VARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FG+ M E+ + G  P       E+  L+       ++G
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL-------REG 252

Query: 222 AILDASD---SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +D        L  +  E            C H  P  RP  +Q+++ LD
Sbjct: 253 HRMDKPSNCTHELYMLMRE------------CWHAVPTQRPTFKQLVEALD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 30/78 (38%), Positives = 41/78 (52%), Gaps = 6/78 (7%)

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRT-GKA 176
           + HRDIKP N+L+  D+  KL DFG  R +Y     P  T+ + T  Y APE + T G  
Sbjct: 121 IFHRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYISTRWYRAPECLLTDGYY 176

Query: 177 STSTDVYAFGVFMLEVAS 194
               D++A G    E+ S
Sbjct: 177 GPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 22/173 (12%)

Query: 33  HGFNED----PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
             FN       QL +D     + N  ++L  +V + KG  +L+ DY+ +G L  +L    
Sbjct: 52  KNFNAIEPMVHQLMKD-----NPN-FIKLYYSVTTLKG-HVLIMDYIKDGDLFDLLKKEG 104

Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARL 147
           K  LS  +  +IIR +   L  LH+     ++H DIK  NVL D   +   L D+GL + 
Sbjct: 105 K--LSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK- 158

Query: 148 YDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
                I   +   GT  Y +PE ++      S D +A GV   E+ +G+ P +
Sbjct: 159 ----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----G 174
           +HRDIKP N+L+D + + +L DFG       D   Q++  VGT  Y++PE+++      G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
           K     D ++ GV M E+  G  P   +  +E
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 25/147 (17%)

Query: 65  KGEFLLVYDYMPNGSL------DKILHTN--------IKPSLSWYQRFRIIRGVASGLLY 110
           +G   +  +Y P G+L       ++L T+           +L+  Q  +    VA+G+ Y
Sbjct: 75  RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQY 134

Query: 111 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDTIPQTTKLVGTFGYMA 167
           L E   +  +HRD+   NVL+  +L  K+ DFGL+R   +Y   T+ +         +MA
Sbjct: 135 LSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL-----PVRWMA 186

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS 194
            E +     +T +DV++FGV + E+ S
Sbjct: 187 IESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 30/162 (18%)

Query: 70  LVYDYMPNGSLDKIL-----HTNI---------KPSLSWYQRFRIIRGVASGLLYLHEDW 115
           +++ Y  +  L + L     H+++         K +L       I+  +A+G+ +L    
Sbjct: 85  MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-- 142

Query: 116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT----FGYMAPEL 170
              V+H+D+   NVL+   LN K+ D GL R +Y  D      KL+G       +M+PE 
Sbjct: 143 -HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEA 197

Query: 171 MRTGKASTSTDVYAFGVFMLEVAS-GRRP---IEQQGSMEMV 208
           +  GK S  +D++++GV + EV S G +P      Q  +EM+
Sbjct: 198 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 14/132 (10%)

Query: 67  EFLLVYDYMPNGSLDKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           +F LV  +M    L K++ H  +      +  +++++G    L Y+H      ++HRD+K
Sbjct: 94  DFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKG----LKYIHA---AGIIHRDLK 145

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST-DVYA 184
           P N+ ++ D   K+ DFGLAR  D     + T  V T  Y APE++      T T D+++
Sbjct: 146 PGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWS 201

Query: 185 FGVFMLEVASGR 196
            G  M E+ +G+
Sbjct: 202 VGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL Y+H      ++HRD+KP+NV ++ D   ++ DFGLAR  D     + T  V T  Y 
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYR 182

Query: 167 APELMRTGKASTST-DVYAFGVFMLEVASGR 196
           APE+M        T D+++ G  M E+  G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 39/137 (28%), Positives = 71/137 (51%), Gaps = 7/137 (5%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +AS L YLH      +++RD+KP N+LLD+  +  L DFGL +  + +    T+   GT 
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTP 160

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV-NLVDWVSDCWKKGA 222
            Y+APE++       + D +  G  + E+  G  P   + + EM  N+++       K  
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPN 218

Query: 223 ILDASDSRLEGIYEEEQ 239
           I +++   LEG+ ++++
Sbjct: 219 ITNSARHLLEGLLQKDR 235

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 13/133 (9%)

Query: 70  LVYDYMPNGSLDKIL---------HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           ++ +YM NG L++ L               ++S+     +   +ASG+ YL        +
Sbjct: 96  MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFV 152

Query: 121 HRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           HRD+   N L+  +   K+ DFG++R LY  D      + V    +M+ E +  GK +T+
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212

Query: 180 TDVYAFGVFMLEV 192
           +DV+AFGV + E+
Sbjct: 213 SDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 23/160 (14%)

Query: 48  SVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKIL-------HTNIKPSLSWYQRFR 99
           S++   LL + +      K    LV++Y+ +  L K +          +         ++
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIP--QT 156
           +++GVA    + H+     V+HRD+KP N+L+D      K+ D GL R +   +IP    
Sbjct: 119 LLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---SIPVKSY 168

Query: 157 TKLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASG 195
           T  + T  Y APE L+ +   ST  D+++ G    E++  
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 21/173 (12%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTT 157
           R +  +ASG+ YL     +  +HRD+   N +L+ ++   + DFGL++ +Y  D   Q  
Sbjct: 117 RFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSD 216
                  ++A E +     +T +DV+AFGV M E+ + G+ P     + E+ N +     
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL----- 228

Query: 217 CWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
              KG  L      LE +YE         L   C  P+P+ RP+ + +   L+
Sbjct: 229 --IKGNRLKQPPDCLEDVYE---------LMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 13/102 (12%)

Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           F+++RG+A    Y+H    Q +LHRD+KP N+L+      KL DFGLAR     +IP  T
Sbjct: 110 FQLLRGLA----YIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQT 159

Query: 158 --KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
               V T  Y  P+ L+     S++ D++  G   +E+  G+
Sbjct: 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 13/144 (9%)

Query: 59  NTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           N VN     +  G  L++ +Y   G L   L    +  L+          VA G+ +L  
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLVGTFGYMAPEL 170
              +  +HRD+   NVLL      K+ DFGLAR   +D+   +    +L     +MAPE 
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPES 214

Query: 171 MRTGKASTSTDVYAFGVFMLEVAS 194
           +     +  +DV+++G+ + E+ S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 54/202 (26%)

Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSL--SWYQRFR 99
           +RD LA   +  +++L  +    K     V DY+P G +  +L   I+  +      RF 
Sbjct: 51  ERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFY 106

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-------------- 145
           I   +   +  +H+      +HRDIKP N+L+D D + KL DFGL               
Sbjct: 107 IAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162

Query: 146 -------------RLYDHDTIPQTT---------------KLVGTFGYMAPE-LMRTGKA 176
                           + D                      LVGT  Y+APE L+RTG  
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY- 221

Query: 177 STSTDVYAFGVFMLEVASGRRP 198
           +   D ++ GV + E+  G+ P
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 52.1 bits (125), Expect = 9e-08
 Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 28/210 (13%)

Query: 68  FLLVYDYMPNGSLDKILHTNIK-------PSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
             ++ +Y   G L + L            P LS  Q+  +   +A G+ +L        +
Sbjct: 83  HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFV 139

Query: 121 HRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           HRD+   N L+ +    K+    L++ +Y+ +       L+    ++APE ++    ST 
Sbjct: 140 HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAVQEDDFSTK 198

Query: 180 TDVYAFGVFMLEV-ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           +DV++FGV M EV   G  P       E++N +           + +   SRL       
Sbjct: 199 SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP---VPEGCPSRLY------ 249

Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                 KL   C    P+ RP+  +++  L
Sbjct: 250 ------KLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 28/86 (32%), Positives = 50/86 (58%), Gaps = 5/86 (5%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           G+ Y+H+   + +LHRD+K  N+ L  +L  K+GDFG++RL    +    T   GT  YM
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFTGTPYYM 172

Query: 167 APELMRTGKASTSTDVYAFGVFMLEV 192
           +PE ++     + +D+++ G  + E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 46/207 (22%), Positives = 89/207 (42%), Gaps = 25/207 (12%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWY----QRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           +++  +M +G L   L  +    L          + +  +A G+ YL     +  +HRD+
Sbjct: 83  MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDL 139

Query: 125 KPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
              N +L  D+   + DFGL++ +Y  D   Q         ++A E +     ++ +DV+
Sbjct: 140 AARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 199

Query: 184 AFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           AFGV M E+A+ G+ P     + E+ + +       + G  L   +  L+ +Y+      
Sbjct: 200 AFGVTMWEIATRGQTPYPGVENHEIYDYL-------RHGNRLKQPEDCLDELYD------ 246

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQYLD 269
              L   C    P+ RP   ++ + L+
Sbjct: 247 ---LMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 21/168 (12%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           ++ G+ YL E     ++HRD+   NVL+      K+ DFGL+R +Y+ D+  + +K    
Sbjct: 136 ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MA E +     +T +DV++FGV + E+ + G  P        + NL+       K G
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL-------KTG 245

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             ++  ++  E +Y          L L C   +P+ RP    + + L+
Sbjct: 246 YRMERPENCSEEMY---------NLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 20/152 (13%)

Query: 70  LVYDYMPNGSLDKILHT---NIKPSL--SWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           LV   MP+G L   +H    NI   L  +W  +      +A G++YL E   + ++HRD+
Sbjct: 85  LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE---RRLVHRDL 135

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTT---KLVGTFGYMAPELMRTGKASTSTD 181
              NVL+ +  + K+ DFGLARL + D         K+     +MA E +   K +  +D
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYRKFTHQSD 193

Query: 182 VYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD 212
           V+++GV + E+ + G +P +   + E+ +L++
Sbjct: 194 VWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 25/125 (20%)

Query: 100 IIRGVASGLLYLHEDWE----QVVLHRDIKPANVLLDA-------------DLNG----K 138
           I R +   L Y H   +    + VLHRD+KP N+ L               +LNG    K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 139 LGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM--RTGKASTSTDVYAFGVFMLEVASGR 196
           +GDFGL++    +++  +   VGT  Y +PEL+   T      +D++A G  + E+ SG+
Sbjct: 183 IGDFGLSKNIGIESMAHSC--VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 197 RPIEQ 201
            P  +
Sbjct: 241 TPFHK 245

Length = 1021

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 12/145 (8%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV    P GSL   +  + + SL   +       +A G+ YL E     ++HR++   N+
Sbjct: 85  LVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNI 140

Query: 130 LLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVF 188
           LL +D   ++ DFG+A  LY  D     ++      +MA E +  G+ +  +DV+++GV 
Sbjct: 141 LLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVT 200

Query: 189 MLEVAS-------GRRPIEQQGSME 206
           + E+ S       G RP E    +E
Sbjct: 201 VWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 46/225 (20%)

Query: 65  KGEFLLVYDYMPNGSL------DKILHTN--------IKPSLSWYQRFRIIRGVASGLLY 110
           +G   L  +Y P+G+L       ++L T+           +LS  Q       VA G+ Y
Sbjct: 80  RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 139

Query: 111 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG-----Y 165
           L +   +  +HRD+   N+L+  +   K+ DFGL+R        Q   +  T G     +
Sbjct: 140 LSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRW 189

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
           MA E +     +T++DV+++GV + E+ S G  P      M    L + +   ++    L
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---CGMTCAELYEKLPQGYRLEKPL 246

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +  D     +Y+  +          C   KP  RP+  Q++  L+
Sbjct: 247 NCDDE----VYDLMRQ---------CWREKPYERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 13/101 (12%)

Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           F+++RG++    Y+H+ +   +LHRD+KP N+L+      KL DFGLAR     ++P  T
Sbjct: 110 FQLLRGLS----YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA---KSVPSHT 159

Query: 158 --KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASG 195
               V T  Y  P+ L+ + + ST  D++  G   +E+  G
Sbjct: 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 19/145 (13%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR------IIRGVASGLLYLHEDWEQVV 119
           G+  LV +    GS+ ++    +K  L   QR        I+ G   GL +LH +    +
Sbjct: 97  GQLWLVLELCNGGSVTEL----VKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RI 149

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +HRD+K  N+LL  +   KL DFG++       + + T  VGT  +MAPE++   +    
Sbjct: 150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACEQQYDY 208

Query: 180 T-----DVYAFGVFMLEVASGRRPI 199
           +     DV++ G+  +E+  G  P+
Sbjct: 209 SYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 26/211 (12%)

Query: 71  VYDYMPNGSLDKILHTNI---------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           + +YM NG L++ L  ++           SLS+     +   +ASG+ YL        +H
Sbjct: 97  IMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVH 153

Query: 122 RDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RD+   N L+  +   K+ DFG++R LY  D      +      +MA E +  GK +T +
Sbjct: 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS 213

Query: 181 DVYAFGVFMLEVAS--GRRPIEQQGSMEMV-NLVDWVSDCWKKGAILDASDSRLEGIYEE 237
           DV+AFGV + E+ +    +P E     +++ N   +  D   +   L    +  + IYE 
Sbjct: 214 DVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD-DGRQIYLPRPPNCPKDIYE- 271

Query: 238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                   L L C     E RP  R++  +L
Sbjct: 272 --------LMLECWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 37/117 (31%), Positives = 50/117 (42%), Gaps = 39/117 (33%)

Query: 120 LHRDIKPANVLLDADLNGKLGDFGL------------ARLYDHDTI---------PQTTK 158
           +HRDIKP N+LLDA  + KL DFGL             R+  H            P ++K
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 159 ----------------LVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRP 198
                            VGT  Y+APE  ++TG  +   D ++ GV M E+  G  P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V +++    +V + +P G     L    K  L   Q  +     A+G+ YL     +  +
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLES---KNCI 115

Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT-FGYMAPELMRTGKASTS 179
           HRD+   N L+  +   K+ DFG++R  D D I  ++ L      + APE +  G+ S+ 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 180 TDVYAFGVFMLEVAS-GRRP---IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY 235
           +DV+++G+ + E  S G  P   +  Q + E V          +KG  +       + +Y
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQV----------EKGYRMSCPQKCPDDVY 224

Query: 236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                    K+   C   KPE RP   ++ + L
Sbjct: 225 ---------KVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 28/213 (13%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V ++K    +V + +  G     L T   P L   +  +++   A+G+ YL     +  +
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCI 116

Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT-FGYMAPELMRTGKASTS 179
           HRD+   N L+      K+ DFG++R  +      T  +      + APE +  G+ S+ 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 180 TDVYAFGVFMLEVAS-GRRP---IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY 235
           +DV++FG+ + E  S G  P   +  Q + E +          ++G  L   +   + +Y
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI----------EQGVRLPCPELCPDAVY 226

Query: 236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                    +L   C    P  RP+   V Q L
Sbjct: 227 ---------RLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 32/125 (25%), Positives = 60/125 (48%), Gaps = 6/125 (4%)

Query: 72  YDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 131
           Y    +  +  +L  +    L+          VA G+ +L     +  +HRD+   NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270

Query: 132 DADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
                 K+ DFGLAR  ++D + + + +  +    +MAPE +     +T +DV+++G+ +
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PVKWMAPESIFDNLYTTLSDVWSYGILL 329

Query: 190 LEVAS 194
            E+ S
Sbjct: 330 WEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGT 162
           +ASG+ YL     +  +HRD+   N +L+ ++N  + DFGL+ ++Y+ D   Q       
Sbjct: 121 IASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             ++A E +     +T +DV++FGV M E+A+ G+ P     + E       + D  ++G
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQG 230

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             L      L+G+Y          L   C    P+ RP+   +   L+
Sbjct: 231 NRLKQPPDCLDGLYS---------LMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 31/157 (19%)

Query: 67  EFLLVYDYMPNGSLDKILHTN-IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E ++V +Y+  G LD  LH      SL W  +  + + +AS L YL    ++ ++H ++ 
Sbjct: 74  ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVC 128

Query: 126 PANVLL-DADLNG------KLGDFG-----LARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
             N+L+    LN       KL D G     L+R    + IP          ++APE +R 
Sbjct: 129 GKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----------WIAPECIRN 178

Query: 174 GKASTST--DVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           G+AS +   D ++FG  +LE+ S G  P+    S E 
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 32/173 (18%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY-DHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL  +   K+ DFGLAR +Y D D + +    + 
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP-----IEQQGSMEMVNLVDWVS 215
              +MAPE +     +  +DV++FGV + E+ S G  P     I+++    +        
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 295

Query: 216 DCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
              K+G  + A D     +Y+           L C H +P  RP   +++++L
Sbjct: 296 ---KEGTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 18/38 (47%), Positives = 22/38 (57%)

Query: 29 QFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
           F Y+GF+    L   G A+V  NGLLQLTN  N+  G
Sbjct: 4  SFNYNGFSNVSNLTLQGDATVLPNGLLQLTNVTNNSAG 41

Length = 231

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 59/222 (26%)

Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL-HTNIKP-SLSWYQRFR 99
           +RD LA   +  +++L  +    K     V DY+P G +  +L    I P  L+ +    
Sbjct: 51  ERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE 109

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL---------ARLY-- 148
           +   V S    +H+      +HRDIKP N+L+D D + KL DFGL         ++ Y  
Sbjct: 110 LTCAVES----VHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162

Query: 149 -DH---DTI--------PQTTK-----------------------LVGTFGYMAPE-LMR 172
            DH   D++        P   +                       LVGT  Y+APE L+R
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME-MVNLVDW 213
           TG      D ++ GV + E+  G+ P   Q  +E  + +++W
Sbjct: 223 TGYTQL-CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 3/97 (3%)

Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           I R V   + YLHE+    ++HRDIK  N+ ++   +  LGDFG A         +    
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            GT    APEL+       + D+++ G+ + E+A+  
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 16/154 (10%)

Query: 66  GEFLLVYD-YMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           G +L V   +M  GS + +L T     +S      I+ G   GL YLH++     +HR+I
Sbjct: 71  GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNI 127

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG--------YMAPELMRTGKA 176
           K +++L+  D  G +   GL+ LY      Q  K+V  F         +++PEL+R    
Sbjct: 128 KASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185

Query: 177 --STSTDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
             +  +D+Y+ G+   E+A+GR P +     +M+
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.8 bits (113), Expect = 4e-06
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 15/164 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME--LMDANLCQVIQMELDHERMSYLLYQ 127

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 128 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 182

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVAS------GRRPIEQ 201
            Y APE++       + D+++ G  M E+        GR  I+Q
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY-DHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL  +   K+ DFGLAR +Y D D + + +  + 
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKK 220
              +MAPE +     +T +DV++FGV + E+ S G  P         V + +      K 
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG------VQINEEFCQRLKD 292

Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           G  + A ++    IY         ++ L C    P+ RP    +++ L
Sbjct: 293 GTRMRAPENATPEIY---------RIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR      +   T  V T  Y 
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYR 184

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGR 196
           APE++       + D+++ G  M E+  G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 9/104 (8%)

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL +LH +     +HRD+K  N+LL  +   KL DFG++       + + T  VGT  +M
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWM 191

Query: 167 APELMRTGKASTST-----DVYAFGVFMLEVASGRRPIEQQGSM 205
           APE++   +   ST     DV++ G+  +E+  G  P+     M
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 33/181 (18%)

Query: 45  GLASVHSNGLLQ--LTNTVNSRKGEFLLVYDYMPNGSLDKILHTN-----IKPSLSWYQR 97
           G+ S +   LL   LT+TV        LV   MP G L   +  N      +  L+W  +
Sbjct: 65  GVGSPYVCRLLGICLTSTVQ-------LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ 117

Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
                 +A G+ YL E     ++HRD+   NVL+ +  + K+ DFGLARL D D     T
Sbjct: 118 ------IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ET 164

Query: 158 KLVGTFG-----YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV 211
           +     G     +MA E +   + +  +DV+++GV + E+ + G +P +   + E+ +L+
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224

Query: 212 D 212
           +
Sbjct: 225 E 225

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 6/123 (4%)

Query: 72  YDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 131
           Y         +    N  P+LS+         VA+G+ +L     +  +HRD+   NVL+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272

Query: 132 DADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
                 K+ DFGLAR  + D + I + +  +    +MAPE +     +T +DV++FG+ +
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILL 331

Query: 190 LEV 192
            E+
Sbjct: 332 WEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 43/163 (26%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFR--IIRGVAS----GLLYLHEDWEQVVLHRD 123
           LV DY P G L ++L    +P     +     + R  A+     L YLH      +++RD
Sbjct: 78  LVMDYCPGGELFRLLQR--QPG----KCLSEEVARFYAAEVLLALEYLHL---LGIVYRD 128

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIP----------------------------Q 155
           +KP N+LL    +  L DF L++  D +  P                            +
Sbjct: 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188

Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           +   VGT  Y+APE++      ++ D +  G+ + E+  G  P
Sbjct: 189 SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)

Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME--LMDANLCQVIQMELDHERMSYLLYQ 134

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 189

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+  G 
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 18/114 (15%)

Query: 40  QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF- 98
           Q +RD LA   S  ++ L  ++ S    +L V +Y+  G +  +LH         Y  F 
Sbjct: 52  QAERDALALSKSPFIVHLYYSLQSANNVYL-VMEYLIGGDVKSLLHI--------YGYFD 102

Query: 99  -----RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL 147
                + I  VA  L YLH      ++HRD+KP N+L+  + + KL DFGL+++
Sbjct: 103 EEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 54/204 (26%)

Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL-HTNIKPSLSWYQRFRI 100
           +RD LA   +  +++L  +   +   +  V DY+P G +  +L    + P +    RF I
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYF-VMDYIPGGDMMSLLIRMEVFPEV--LARFYI 107

Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL---------------- 144
               A   L +    +   +HRDIKP N+L+D D + KL DFGL                
Sbjct: 108 ----AELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163

Query: 145 ----------ARLYDH----------DTIPQTTK----------LVGTFGYMAPELMRTG 174
                     + L+D            T+ Q             LVGT  Y+APE++   
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223

Query: 175 KASTSTDVYAFGVFMLEVASGRRP 198
             +   D ++ GV + E+  G+ P
Sbjct: 224 GYTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 68  FLLVYDYMPNGSLDKIL--HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           +LLV++Y   G L   L      + +       R+   +A+G+ ++H+      LH D+ 
Sbjct: 70  YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLA 126

Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELM--RTGKASTS--- 179
             N  L +DL  K+GD+G+    Y  D I           ++APEL+    G   T+   
Sbjct: 127 LRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQT 186

Query: 180 --TDVYAFGVFMLEV-ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE 236
             ++V+A GV + E+  +  +P       E++N V        K   +     +LE  Y 
Sbjct: 187 KPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-------IKDQQVKLFKPQLELPYS 239

Query: 237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           E   E VL+   FC    PE R    +V + L
Sbjct: 240 ERWYE-VLQ---FCWLS-PEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY-DHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL  +   K+ DFGLAR +Y D D + +    + 
Sbjct: 182 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKK 220
              +MAPE +     +T +DV++FGV + E+ S G  P         V + +      K+
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG------VQIDEEFCRRLKE 291

Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           G  + A +     IY          + L C H  PE RP   ++++ L
Sbjct: 292 GTRMRAPEYATPEIY---------SIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 4/103 (3%)

Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 151
           L   Q   + R + S + Y+H    + ++HRDIK  NVL++   +  LGDFG A      
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 152 -TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA 193
            + P    + GT    APE++     + S D+++ G+ + E A
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 9/99 (9%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLV 160
           VA G+ +L     +  +HRD+   NVLL      K+ DFGLAR   +D+   +    +L 
Sbjct: 221 VAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 198
               +MAPE +     +  +DV+++G+ + E+ S G+ P
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 17/105 (16%)

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---------LYDHDTIPQTTK 158
           L YLH      ++HRD+KP N+L+ +  + KL DFGL++         LY+      T +
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 159 LV-----GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            +     GT  Y+APE++         D +A G+ + E   G  P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 35/151 (23%), Positives = 68/151 (45%), Gaps = 15/151 (9%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V  +M  GS   ++ T+    +S      I++GV   L Y+H       +HR +K 
Sbjct: 73  ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKA 129

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG--------YMAPELMRTGKA-- 176
           +++L+  D  GK+   GL          Q  ++V  F         +++PE+++      
Sbjct: 130 SHILISVD--GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 187

Query: 177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
              +D+Y+ G+   E+A+G  P +   + +M
Sbjct: 188 DAKSDIYSVGITACELANGHVPFKDMPATQM 218

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 15/26 (57%), Positives = 20/26 (76%)

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLA 145
           +HRDIKP N+L+D   + KL DFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 44/169 (26%), Positives = 67/169 (39%), Gaps = 41/169 (24%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K    L+ +++P G +  +L      S    Q +     +A  +L +    +   +HRDI
Sbjct: 73  KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY-----IAETVLAIDAIHQLGFIHRDI 127

Query: 125 KPANVLLDADLNGKLGDFGL----------------------------------ARLYDH 150
           KP N+LLDA  + KL DFGL                                  A  +  
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187

Query: 151 DTIPQTTKLVGTFGYMAPEL-MRTGKASTSTDVYAFGVFMLEVASGRRP 198
           +        VGT  Y+APE+ M+TG  +   D ++ GV M E+  G  P
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 39/168 (23%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K    L+ +++P G +  +L      +    Q +     +A  +L +    +   +HRDI
Sbjct: 73  KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY-----IAETVLAIDSIHQLGFIHRDI 127

Query: 125 KPANVLLDADLNGKLGDFGLA------------RLYDHDTIPQTT--------------- 157
           KP N+LLD+  + KL DFGL             R  +H      T               
Sbjct: 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKR 187

Query: 158 -------KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
                    VGT  Y+APE+      +   D ++ GV M E+  G  P
Sbjct: 188 NRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 31/119 (26%), Positives = 60/119 (50%), Gaps = 21/119 (17%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD---------TIP 154
           +A G+ YL E   + ++HRD+   NVL+    + K+ DFGLA+L   D          +P
Sbjct: 118 IAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD 212
                     +MA E +     +  +DV+++GV + E+ + G +P +   + E+ ++++
Sbjct: 175 --------IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score = 39.1 bits (92), Expect = 0.001
 Identities = 15/35 (42%), Positives = 21/35 (60%), Gaps = 1/35 (2%)

Query: 29 QFIYHGFNEDPQ-LQRDGLASVHSNGLLQLTNTVN 62
           F ++GF+ D   L   G A++ SNG LQLTN  +
Sbjct: 2  SFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTS 36

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLV 160
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR   +D+   +    +L 
Sbjct: 223 VAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL- 278

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP 198
               +MAPE +     +  +DV+++G+ + E+ S G  P
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 7/103 (6%)

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           L Y+H    + + HRD+KP N+L+D + +  KL DFG A+  +     ++   + +  Y 
Sbjct: 183 LAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRFYR 237

Query: 167 APELMR-TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
           APELM      +T  D+++ G  + E+  G      Q S++ +
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280

Length = 440

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 38.1 bits (89), Expect = 0.004
 Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 25/172 (14%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L  +T+ +     E  +V   M  GS + +L T+    L       I++ V + L 
Sbjct: 58  HPNILPYVTSFIV--DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD 115

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKL-----------GDFGLARLYDHDTIPQTTK 158
           Y+H   +  + HR +K +++LL  D    L                  ++D         
Sbjct: 116 YIHS--KGFI-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF-----PKS 167

Query: 159 LVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
            V    +++PE+++    G    S D+Y+ G+   E+A+G  P +   + +M
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKDMPATQM 218

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	313
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.98
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.98
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.98
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.98
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.98
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.98
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.98
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.98
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.98
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.98
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.98
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.98
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.98
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.98
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.98
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.98
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.98
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.98
PHA03207	392	serine/threonine kinase US3; Provisional	99.98
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.98
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.98
KOG0584	632	consensus Serine/threonine protein kinase [General	99.98
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.98
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.98
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.98
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.98
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.98
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.98
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.98
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.98
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.98
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.98
PHA03209	357	serine/threonine kinase US3; Provisional	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.98
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.98
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.98
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.98
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.98
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.98
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.98
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG3653	534	consensus Transforming growth factor beta/activin	99.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.91
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.87
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.86
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.8
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.74
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.73
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.68
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.62
PRK09188	365	serine/threonine protein kinase; Provisional	99.59
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.55
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.55
PRK12274	218	serine/threonine protein kinase; Provisional	99.54
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.47
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.42
PRK10345	210	hypothetical protein; Provisional	99.4
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.38
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.35
smart00090	237	RIO RIO-like kinase.	99.21
PRK14879	211	serine/threonine protein kinase; Provisional	99.2
KOG1243	690	consensus Protein kinase [General function predict	99.2
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.17
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.16
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.14
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
COG4248	637	Uncharacterized protein with protein kinase and he	98.97
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.89
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.85
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.84
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.81
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.75
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.74
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.7
KOG3087	229	consensus Serine/threonine protein kinase [General	98.63
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.6
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.58
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.51
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.43
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.42
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.04
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.98
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.88
PRK09902	216	hypothetical protein; Provisional	97.85
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.83
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.81
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.32
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.27
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.05
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.84
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.63
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.48
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.33
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.14
PF01636	239	APH: Phosphotransferase enzyme family This family	96.04
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.95
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	95.85
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.84
PLN02876	822	acyl-CoA dehydrogenase	94.79
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.7
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.67
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.42
KOG2270	520	consensus Serine/threonine protein kinase involved	92.74
PRK10593	297	hypothetical protein; Provisional	92.54
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.33
PRK05231	319	homoserine kinase; Provisional	92.18
PHA03111	444	Ser/Thr kinase; Provisional	91.53
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	91.4
PRK10271	188	thiK thiamine kinase; Provisional	90.62
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	90.39
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	90.29
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	89.87
KOG1236	565	consensus Predicted unusual protein kinase [Genera	89.8
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	88.66
PLN02236	344	choline kinase	88.49
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	87.82
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	87.38
COG2334	331	Putative homoserine kinase type II (protein kinase	87.03
COG4499	434	Predicted membrane protein [Function unknown]	86.86
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	86.11
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	85.34
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	85.27
PRK06148	1013	hypothetical protein; Provisional	84.21
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	83.1
PRK11768	325	serine/threonine protein kinase; Provisional	82.32

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=292.53  Aligned_cols=208  Identities=29%  Similarity=0.432  Sum_probs=173.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+++++.++|+++++++.+.+.+...+++||||++|+|.++++..  +.+++..+-+++.+|++||.|||.  ..+|+
T Consensus       126 rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~II  201 (364)
T KOG0581|consen  126 RELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKII  201 (364)
T ss_pred             HHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCee
Confidence            45566677789999999999997444699999999999999999874  569999999999999999999995  48999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||||+..|++||||||.+......   .-.++.||..|+|||.+.+..|+.++||||||..++|+++|+.||.
T Consensus       202 HRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~  278 (364)
T KOG0581|consen  202 HRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYP  278 (364)
T ss_pred             eccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence            9999999999999999999999999765443   3456899999999999999999999999999999999999999997


Q ss_pred             cC--CchhhhhHHHHHHHhhhhccccccccccccCCccH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQ--GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE-EQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..  .......+...+         .    ...+...+. .+++.++.|+..||++||.+|||++|+++|=
T Consensus       279 ~~~~~~~~~~~Ll~~I---------v----~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  279 PPNPPYLDIFELLCAI---------V----DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             CcCCCCCCHHHHHHHH---------h----cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            64  122333333221         1    112222333 4788899999999999999999999999974

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=276.35  Aligned_cols=216  Identities=23%  Similarity=0.355  Sum_probs=175.7

Q ss_pred             hhHHhhhhhccccceeeeee-EEeccCCeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           40 QLQRDGLASVHSNGLLQLTN-TVNSRKGEFLLVYDYMPNGSLDKILHT--NIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~-~~~~~~~~~~lV~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      -.|...+++++|||++++++ .+.+++..++||||+|.+|+|...++.  ..++.+++..+|+++.|++.||..+|+.+.
T Consensus        66 v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~  145 (375)
T KOG0591|consen   66 VKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP  145 (375)
T ss_pred             HHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc
Confidence            35677889999999999999 444545558999999999999999974  336679999999999999999999998554


Q ss_pred             C-CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          117 Q-VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       117 ~-~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      + .++||||||.||+++.+|.+||+|||+++.+.... .......||+.|++||.+.+..|+.++||||+||++|||+..
T Consensus       146 r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL  224 (375)
T KOG0591|consen  146 RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCAL  224 (375)
T ss_pred             ccceeeccCcchheEEcCCCceeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhc
Confidence            3 38899999999999999999999999998776543 234567899999999999999999999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ++||.+.+-   ..+...+.+.          +  .+......++..+..||..|+..||..||+...+++-+.+.
T Consensus       225 ~~PF~g~n~---~~L~~KI~qg----------d--~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  225 QSPFYGDNL---LSLCKKIEQG----------D--YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             CCCcccccH---HHHHHHHHcC----------C--CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence            999998743   3333222111          1  11111256788999999999999999999976666666553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-39  Score=294.07  Aligned_cols=206  Identities=26%  Similarity=0.405  Sum_probs=181.2

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      -...|.++-++++|+|+++.++++++ .+++|+|+|+|+.++|..++++  .+.++|..++.+++||+.|+.|||   +.
T Consensus        64 Kv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH---~~  137 (592)
T KOG0575|consen   64 KVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLH---SL  137 (592)
T ss_pred             HHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHH---hc
Confidence            34466778899999999999999998 6799999999999999999995  457999999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+|||||..|++++++.++||+|||++....... ....+..||+.|+|||++....++..+||||+||+||-|+.|++
T Consensus       138 ~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P  216 (592)
T KOG0575|consen  138 GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP  216 (592)
T ss_pred             CceecccchhheeecCcCcEEecccceeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence            99999999999999999999999999998776543 24456899999999999999999999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||++..-.+.+..+..                 -...+|...+....+||.++|+.||.+|||+++++.|
T Consensus       217 PFetk~vkety~~Ik~-----------------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  217 PFETKTVKETYNKIKL-----------------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             CcccchHHHHHHHHHh-----------------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            9999887777766632                 1222444667778899999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=280.86  Aligned_cols=240  Identities=19%  Similarity=0.308  Sum_probs=193.2

Q ss_pred             hhhhhHHHHHHHHhhccccc---eEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCC
Q 048068            9 YFCVLLCVSFILSALAQDVN---QFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMP   76 (313)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~   76 (313)
                      ...+++.|.|..+|.+++..   .++.|.+...         ...|..++++++|+|+|++.+++.. ++.+|||||||+
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lVMEyC~   92 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLVMEYCN   92 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEEEEeCC
Confidence            34567788888888877754   5666665433         2467789999999999999999998 679999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC------CcEEEeecccccccCC
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD------LNGKLGDFGLARLYDH  150 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~------~~~~l~dfg~~~~~~~  150 (313)
                      ||+|.+++++.  +.+++..++.++.||+.|+++||   +++|+||||||.|||++..      -.+||+|||+++....
T Consensus        93 gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   93 GGDLSDYIRRR--GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            99999999984  46999999999999999999999   6999999999999999865      4589999999987664


Q ss_pred             CCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccccccc
Q 048068          151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSR  230 (313)
Q Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (313)
                      ..  ...+..|++.|+|||++..+.|+.|+|+||+|+++|++++|+.||......+....+++-              ..
T Consensus       168 ~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~--------------~~  231 (429)
T KOG0595|consen  168 GS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG--------------NE  231 (429)
T ss_pred             hh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc--------------cc
Confidence            33  345678999999999999999999999999999999999999999987777665544211              11


Q ss_pred             ccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          231 LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       231 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .....+......+.+++...+..||..|.++.+...+---
T Consensus       232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l  271 (429)
T KOG0595|consen  232 IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFL  271 (429)
T ss_pred             ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhc
Confidence            1222333344456677777888999999888887765433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-40  Score=287.52  Aligned_cols=210  Identities=23%  Similarity=0.333  Sum_probs=174.8

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+.|.+.++.++||++++..+++.. ....|+||||++||.|.+.+-.+  +.+.+..-+.+++|++.|+.|||   +.|
T Consensus       223 v~~EieILkkL~HP~IV~~~d~f~~-~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH---~~G  296 (475)
T KOG0615|consen  223 VQNEIEILKKLSHPNIVRIKDFFEV-PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLH---SQG  296 (475)
T ss_pred             hHHHHHHHHhcCCCCEEEEeeeeec-CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHH---HcC
Confidence            4688899999999999999999987 56789999999999999999875  35888888999999999999999   599


Q ss_pred             ceecCcCCCcEEEcCC---CcEEEeecccccccCCCCCCccccccccccccccccccCCCC---CcchhhHHHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA---STSTDVYAFGVFMLEV  192 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~~l  192 (313)
                      |+||||||+|||+..+   -.+||+|||++...+...  ...++.||+.|.|||++.+.+.   ..+.|+||+||++|-+
T Consensus       297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvc  374 (475)
T KOG0615|consen  297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVC  374 (475)
T ss_pred             cccccCCcceEEeccCCcceEEEecccchhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEE
Confidence            9999999999999876   668999999999876443  5677899999999999976543   4488999999999999


Q ss_pred             HhCCCCCccCCchh-hhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          193 ASGRRPIEQQGSME-MVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       193 l~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++|.+||.+..... ....+-      +..       ...........++...++|.+||..||++|||+.|+|+|-+
T Consensus       375 LsG~pPFS~~~~~~sl~eQI~------~G~-------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  375 LSGYPPFSEEYTDPSLKEQIL------KGR-------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             eccCCCcccccCCccHHHHHh------cCc-------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence            99999998755443 333331      110       01112244567788999999999999999999999999865

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-39  Score=287.01  Aligned_cols=224  Identities=28%  Similarity=0.452  Sum_probs=185.0

Q ss_pred             EEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHH
Q 048068           30 FIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI  100 (313)
Q Consensus        30 ~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i  100 (313)
                      +++|.+..         ....|...+..++|||++++++.+.+....+++||||+++|+|.++++...+..++...+..|
T Consensus        68 vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~  147 (362)
T KOG0192|consen   68 VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRI  147 (362)
T ss_pred             EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHH
Confidence            56666654         456777888889999999999999975557999999999999999998744567999999999


Q ss_pred             HHHHHHHHHHhhhcCCCC-ceecCcCCCcEEEcCCC-cEEEeecccccccCCCCCCcccccccccccccccccc--CCCC
Q 048068          101 IRGVASGLLYLHEDWEQV-VLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR--TGKA  176 (313)
Q Consensus       101 ~~qi~~al~~lhs~~~~~-i~H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~  176 (313)
                      +.+|+.|+.|||   ..+ |+|||||++|||++.++ .+||+|||+++...... .......||..|+|||++.  ...+
T Consensus       148 aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~  223 (362)
T KOG0192|consen  148 ALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPY  223 (362)
T ss_pred             HHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcC
Confidence            999999999999   477 99999999999999997 99999999997654322 2233368899999999999  5689


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      +.++||||||+++||++||+.||.+............               .......+..++..+..+|..||+.||.
T Consensus       224 ~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~---------------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~  288 (362)
T KOG0192|consen  224 TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV---------------GGLRPPIPKECPPHLSSLMERCWLVDPS  288 (362)
T ss_pred             CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------------cCCCCCCCccCCHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998877443332211               1122223444778899999999999999


Q ss_pred             CCCCHHHHHHHHhccC
Q 048068          257 ARPNMRQVMQYLDGNA  272 (313)
Q Consensus       257 ~Rpt~~ell~~L~~~~  272 (313)
                      .||++.+++..|+...
T Consensus       289 ~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  289 RRPSFLEIVSRLESIM  304 (362)
T ss_pred             cCCCHHHHHHHHHHHH
Confidence            9999999999998654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=287.29  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=197.3

Q ss_pred             hhhhHHHHHHHHhhccccc---eEEEcccCC--------ChhhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCC
Q 048068           10 FCVLLCVSFILSALAQDVN---QFIYHGFNE--------DPQLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPN   77 (313)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--------~~~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~   77 (313)
                      .++++.|.|..+++++...   .++.|+.+.        -.-+|...++.++ |+|+|++.+++.+.+..+++||||| .
T Consensus        15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d   93 (538)
T KOG0661|consen   15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-D   93 (538)
T ss_pred             HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-h
Confidence            3455555555555555533   444444422        1224566777787 9999999999998777999999999 5


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      .+|++++++. ...|++..+..|++||++||+|+|   +.|+.|||+||+|||+..+..+||+|||+++......  ...
T Consensus        94 ~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp--PYT  167 (538)
T KOG0661|consen   94 CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP--PYT  167 (538)
T ss_pred             hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC--Ccc
Confidence            6999999988 678999999999999999999999   7999999999999999988999999999998765543  455


Q ss_pred             ccccccccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhc--------cc
Q 048068          158 KLVGTFGYMAPELMR-TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKG--------AI  223 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~--------~~  223 (313)
                      ..+.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++.|.|.++.+.+..+-.+-+.     |.++        ..
T Consensus       168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~  247 (538)
T KOG0661|consen  168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR  247 (538)
T ss_pred             hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence            678899999999876 467899999999999999999999999999998887766444332     2221        11


Q ss_pred             cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+......-+.++..+.++|..|+..||++|||+.|+++|-
T Consensus       248 ~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  248 FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            122222222222334778899999999999999999999999964

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=285.63  Aligned_cols=205  Identities=25%  Similarity=0.397  Sum_probs=176.3

Q ss_pred             hhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..|+..|.++ .||++++++..+++ ...+|+|+||+++|+|.++|++.  +.|++.-++.++.+|+.||+|||   ..|
T Consensus       121 ~~Ek~~l~~L~~hPgivkLy~TFQD-~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH---~~G  194 (604)
T KOG0592|consen  121 TREKEALTQLSGHPGIVKLYFTFQD-EESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH---SNG  194 (604)
T ss_pred             hHHHHHHHHhhCCCCeEEEEEEeec-ccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH---hcC
Confidence            4677778888 99999999999998 66899999999999999999985  46999999999999999999999   599


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCC------------CCccccccccccccccccccCCCCCcchhhHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT------------IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG  186 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  186 (313)
                      |+||||||+|||++.++.++|.|||.+...+...            ......++||..|.+||++.++..+.++|+|+||
T Consensus       195 IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlG  274 (604)
T KOG0592|consen  195 IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALG  274 (604)
T ss_pred             ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHH
Confidence            9999999999999999999999999997664211            1112458999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |++|+|+.|++||.+.++--+.+.+.-                 +...++...++.+.+|+.+.|..||.+|+|++||-+
T Consensus       275 CilyQmlaG~PPFra~NeyliFqkI~~-----------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  275 CILYQMLAGQPPFRAANEYLIFQKIQA-----------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHHhcCCCCCccccHHHHHHHHHH-----------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            999999999999998877665555532                 222344455577888999999999999999999998


Q ss_pred             H
Q 048068          267 Y  267 (313)
Q Consensus       267 ~  267 (313)
                      |
T Consensus       338 H  338 (604)
T KOG0592|consen  338 H  338 (604)
T ss_pred             C
Confidence            6

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=276.84  Aligned_cols=218  Identities=27%  Similarity=0.415  Sum_probs=176.1

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCC-eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKG-EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ...+.+++++++|++||+.++......+ .+++.|||+++|+|.+++.+..+ ++++..+..+..||++||.|||   .+
T Consensus        61 l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~  136 (313)
T KOG0198|consen   61 LEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SK  136 (313)
T ss_pred             HHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            4678899999999999999997554444 79999999999999999998754 7999999999999999999999   59


Q ss_pred             CceecCcCCCcEEEcC-CCcEEEeecccccccCC--CCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHH
Q 048068          118 VVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDH--DTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll  193 (313)
                      ||+|+||||+|||++. ++.+||+|||++.....  ..........||+.|+|||++..+ ....++|||||||++.||+
T Consensus       137 g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~  216 (313)
T KOG0198|consen  137 GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML  216 (313)
T ss_pred             CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc
Confidence            9999999999999999 79999999998876553  111223457899999999999853 3345999999999999999


Q ss_pred             hCCCCCccC-CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          194 SGRRPIEQQ-GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       194 ~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||++||... ........+      ...        ...+ ..+...+...++|+..|+..||++|||++++|+|.-...
T Consensus       217 Tg~~PW~~~~~~~~~~~~i------g~~--------~~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  217 TGKPPWSEFFEEAEALLLI------GRE--------DSLP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             CCCCcchhhcchHHHHHHH------hcc--------CCCC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            999999874 221111111      111        0111 456667788999999999999999999999999987665


Q ss_pred             CCC
Q 048068          273 TLP  275 (313)
Q Consensus       273 ~~~  275 (313)
                      ..+
T Consensus       282 ~~~  284 (313)
T KOG0198|consen  282 NSI  284 (313)
T ss_pred             ccc
Confidence            444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=282.57  Aligned_cols=244  Identities=28%  Similarity=0.393  Sum_probs=196.0

Q ss_pred             hhHHHHHHHHhhccccc--eEEEcccC------CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           12 VLLCVSFILSALAQDVN--QFIYHGFN------EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~--~~~~~~~~------~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      .++.|.|..+++..-..  .++.|.+.      ++...|.+.++.++|++++++++++.. ++.+|||||||+.|+|.++
T Consensus       213 ~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~~piyIVtE~m~~GsLl~y  291 (468)
T KOG0197|consen  213 ELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-QEPIYIVTEYMPKGSLLDY  291 (468)
T ss_pred             HhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-CCceEEEEEecccCcHHHH
Confidence            34555555555554432  22333332      344568899999999999999999987 3489999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF  163 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  163 (313)
                      |+...+..+.....+.++.||++|++||+   .++++||||-..||||+++..+||+|||+++......-.......-..
T Consensus       292 Lr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPI  368 (468)
T KOG0197|consen  292 LRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPI  368 (468)
T ss_pred             hhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCc
Confidence            99865778999999999999999999999   599999999999999999999999999999843322211122222345


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          164 GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       164 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      .|.|||.+..+.++.+|||||||++|||+.| |+.|+.+....+....++       .|       .+++  .|..+++.
T Consensus       369 kWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~G-------yRlp--~P~~CP~~  432 (468)
T KOG0197|consen  369 KWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RG-------YRLP--RPEGCPDE  432 (468)
T ss_pred             eecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------cc-------CcCC--CCCCCCHH
Confidence            7999999999999999999999999999999 999999988887766653       22       1222  46678899


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCC
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYLDGNATLP  275 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~  275 (313)
                      +.+||..||+.+|++|||++.+...|++.....
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            999999999999999999999999999876543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-38  Score=265.99  Aligned_cols=233  Identities=20%  Similarity=0.273  Sum_probs=183.3

Q ss_pred             ceEEEcccCCChh---------hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           28 NQFIYHGFNEDPQ---------LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        28 ~~~~~~~~~~~~~---------~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ..++.|++.++..         +|..++++++|+|++.+..++.. +...+||+|||+. ++-+-+.+. ..+.+...+.
T Consensus        28 qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk  104 (396)
T KOG0593|consen   28 QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVFEYCDH-TVLHELERY-PNGVPSELVK  104 (396)
T ss_pred             cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEeeecch-HHHHHHHhc-cCCCCHHHHH
Confidence            3667777754333         66788899999999988888877 6789999999965 555556555 4579999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKAS  177 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  177 (313)
                      .+++|++.|+.|+|   +.+++||||||+||||+.+|.+||||||+++....+. ........|.+|+|||.+.+ -.|.
T Consensus       105 ~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d~YTDYVATRWYRaPELLvGDtqYG  180 (396)
T KOG0593|consen  105 KYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-DNYTDYVATRWYRAPELLVGDTQYG  180 (396)
T ss_pred             HHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-chhhhhhhhhhccChhhhcccCcCC
Confidence            99999999999999   5899999999999999999999999999998766433 23445678999999999886 6789


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHH--------hhh-hcccccccccccc-----CCccHHHHHHH
Q 048068          178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD--------CWK-KGAILDASDSRLE-----GIYEEEQMELV  243 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~-----~~~~~~~~~~l  243 (313)
                      ...||||+||++.||++|++.|.+..+.+....+...-.        .+. +.......-|.+.     +.-.+..+..+
T Consensus       181 ~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~  260 (396)
T KOG0593|consen  181 KPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVL  260 (396)
T ss_pred             CcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHH
Confidence            999999999999999999999999999998887754321        111 2222222222221     11223445688


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+|+..||+.||.+|++.+|++.|
T Consensus       261 ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  261 LDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHHHHHHhcCCccccccHHHHhcC
Confidence            999999999999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-37  Score=254.91  Aligned_cols=253  Identities=21%  Similarity=0.211  Sum_probs=198.6

Q ss_pred             hhhhHHHHHHHHhhccccc---eEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCC
Q 048068           10 FCVLLCVSFILSALAQDVN---QFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPN   77 (313)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~   77 (313)
                      ..+++.|.+..++++.+..   .++.|++.-         ..-+|...+++++|+|++.+.+++.. .+.+.||+||++ 
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVfEfm~-   84 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVFEFMP-   84 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEEEecc-
Confidence            3455666677777776643   566666632         34478889999999999999999987 668999999995 


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      .+|+.++++. ...++...++.|+.++++|++|||   .+.|+|||+||.|+||+.+|.+||+|||+++.+..+..... 
T Consensus        85 tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~-  159 (318)
T KOG0659|consen   85 TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT-  159 (318)
T ss_pred             ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc-
Confidence            4999999976 457999999999999999999999   58999999999999999999999999999998876654333 


Q ss_pred             cccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccc----------
Q 048068          158 KLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA----------  226 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  226 (313)
                      ...-|.+|+|||.+.| +.|+...|+||.|||+.||+-|.+.|.+..+.++...+-..-.......+.++          
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            2367899999998876 57899999999999999999999999999988877766433322222111111          


Q ss_pred             -ccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          227 -SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       227 -~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                       .........-..++....+|+.+||..||.+|+|++|+++|=.
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y  283 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY  283 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence             1111111122345566799999999999999999999999753

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=272.63  Aligned_cols=246  Identities=37%  Similarity=0.657  Sum_probs=202.9

Q ss_pred             ceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHH
Q 048068           28 NQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI  100 (313)
Q Consensus        28 ~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i  100 (313)
                      ..+++|++...       ...|...+..++|+|++++.+++.+.+.+.+||+||+++|+|.+.+.......++|....+|
T Consensus       100 ~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kI  179 (361)
T KOG1187|consen  100 TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKI  179 (361)
T ss_pred             CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHH
Confidence            45667666432       33455566667899999999999874446999999999999999998763327899999999


Q ss_pred             HHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccc-cccccccccccccCCCCCcc
Q 048068          101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL-VGTFGYMAPELMRTGKASTS  179 (313)
Q Consensus       101 ~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~  179 (313)
                      +.+++.||+|||..+...|+|||||+.|||++.+...||+|||++...+.. ....... .||.+|++||++..+..+.+
T Consensus       180 a~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~K  258 (361)
T KOG1187|consen  180 ALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEK  258 (361)
T ss_pred             HHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcc
Confidence            999999999999866667999999999999999999999999999655431 1122222 78999999999998899999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccccccccc-CCccH-HHHHHHHHHHHHcCCCCCCC
Q 048068          180 TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE-GIYEE-EQMELVLKLGLFCSHPKPEA  257 (313)
Q Consensus       180 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~  257 (313)
                      +||||||+++.|+++|+.+...........+.+|.+..+..+...+..|+.+. ..++. .....+..++..|++.+|.+
T Consensus       259 sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~  338 (361)
T KOG1187|consen  259 SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKE  338 (361)
T ss_pred             cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCc
Confidence            99999999999999999887765444444577888888888889999999877 55554 57778999999999999999


Q ss_pred             CCCHHHHHHHHhccCCC
Q 048068          258 RPNMRQVMQYLDGNATL  274 (313)
Q Consensus       258 Rpt~~ell~~L~~~~~~  274 (313)
                      ||++.|+++.|+.....
T Consensus       339 RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  339 RPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcCHHHHHHHHHhhccc
Confidence            99999999999666544

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=281.59  Aligned_cols=222  Identities=23%  Similarity=0.408  Sum_probs=191.6

Q ss_pred             ceEEEcccCCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHH
Q 048068           28 NQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG  107 (313)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~a  107 (313)
                      .++++|+.++...-....|+.++|+|||.+.++... .-.+|||||||..|.|+.+|+..  .++.......|.++|+.|
T Consensus       148 etVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtq-sPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~G  224 (904)
T KOG4721|consen  148 ETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQ-SPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGG  224 (904)
T ss_pred             ceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecC-CceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhh
Confidence            477888888888888899999999999999999986 56899999999999999999974  469999999999999999


Q ss_pred             HHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHH
Q 048068          108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV  187 (313)
Q Consensus       108 l~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  187 (313)
                      +.|||   ...|+|||||.-||||+.+..+||+|||.+......  ...-.+.||..|+|||++....+++|.||||||+
T Consensus       225 M~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGV  299 (904)
T KOG4721|consen  225 MNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGV  299 (904)
T ss_pred             hHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHH
Confidence            99999   589999999999999999999999999988754432  2234578999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          188 FMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       188 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +||||+||..||.+-+...++         |-.      -...+.-.++..+++.+.-||.+||+..|.+||+++|++.|
T Consensus       300 VLWEmLT~EiPYkdVdssAII---------wGV------GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  300 VLWEMLTGEIPYKDVDSSAII---------WGV------GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHHHhcCCCccccchheeE---------Eec------cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            999999999999875544322         111      12344445777888999999999999999999999999999


Q ss_pred             HhccC
Q 048068          268 LDGNA  272 (313)
Q Consensus       268 L~~~~  272 (313)
                      |+-..
T Consensus       365 ldIa~  369 (904)
T KOG4721|consen  365 LDIAS  369 (904)
T ss_pred             HhhcC
Confidence            98664

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-36  Score=270.90  Aligned_cols=251  Identities=23%  Similarity=0.296  Sum_probs=199.7

Q ss_pred             hhHHHHHHHHhhccccc---eEEEcccCCCh---------hhHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCC
Q 048068           12 VLLCVSFILSALAQDVN---QFIYHGFNEDP---------QLQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNG   78 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g   78 (313)
                      +.+.|-|..+|.+++..   .++.|+..-+.         .+|..+++.++|+|++++.+++.+. .+.+|+|+|||+. 
T Consensus       124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-  202 (560)
T KOG0600|consen  124 KIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-  202 (560)
T ss_pred             HhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-
Confidence            45677788888888764   56777775332         3778899999999999999999976 6799999999965 


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      +|.-++... .-.|++.+++.+++||+.||+|||   .+|++|||||.+||||+.+|.+||+|||+++++..........
T Consensus       203 DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~  278 (560)
T KOG0600|consen  203 DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTS  278 (560)
T ss_pred             hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCccccc
Confidence            898888764 346999999999999999999999   5999999999999999999999999999999887666555667


Q ss_pred             ccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHH-----hhhhcccccccccccc
Q 048068          159 LVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD-----CWKKGAILDASDSRLE  232 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  232 (313)
                      .+-|.+|++||++.| ..|+.+.|+||+|||+.||++|++.|.+..+.++...+-.+-.     .|..............
T Consensus       279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~  358 (560)
T KOG0600|consen  279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ  358 (560)
T ss_pred             ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC
Confidence            788999999999886 4789999999999999999999999999988887766644322     2442111110111111


Q ss_pred             CCc-------cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          233 GIY-------EEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       233 ~~~-------~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+       -...+....+|+..+|..||.+|.|+.++|++
T Consensus       359 ~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  359 QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            111       12234567888999999999999999999873

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=280.15  Aligned_cols=206  Identities=22%  Similarity=0.360  Sum_probs=176.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      -.|...+++.+|+|++.+.+-+.. ++.++.||||++||+|.+++...   .+++.++..+++.+++||+|||   .+||
T Consensus       318 lnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gI  390 (550)
T KOG0578|consen  318 LNEILVMRDLHHPNIVNFLDSYLV-GDELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH---ARGI  390 (550)
T ss_pred             HHHHHHHHhccchHHHHHHHHhcc-cceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcce
Confidence            366778899999999998888877 47899999999999999999864   4999999999999999999999   6999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|||||.+|||++.+|.+||+|||++..+..... ......||+.|+|||++..+.|+++.||||||++++||+.|++||
T Consensus       391 iHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY  469 (550)
T KOG0578|consen  391 IHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY  469 (550)
T ss_pred             eeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc
Confidence            9999999999999999999999999987765442 566778999999999999999999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      -..+.....+++..      +        ..+.-..+...+..+++|+.+||..|+.+|+|+.|||+|
T Consensus       470 lnE~PlrAlyLIa~------n--------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  470 LNENPLRALYLIAT------N--------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCCChHHHHHHHhh------c--------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            76555444444421      1        112223455567889999999999999999999999996

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-37  Score=281.54  Aligned_cols=213  Identities=23%  Similarity=0.336  Sum_probs=180.2

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ....|.-+++-+.|||+++.++++.. +.++|+|.||++||-|.+++.+  ++++++..+.+++.||+.|+.|+|   ..
T Consensus        58 ~IerEIviMkLi~HpnVl~LydVwe~-~~~lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH---~~  131 (786)
T KOG0588|consen   58 GIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCH---AF  131 (786)
T ss_pred             chhhhhHHHHHhcCCCeeeeeeeecc-CceEEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHh---hh
Confidence            34577788999999999999999987 6799999999999999999987  457999999999999999999999   69


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~  196 (313)
                      +|+|||+||+|+|++..+++||+|||++..-..+.  ...+..|.++|.+||++.|..| ..++||||.|+|+|.|++|+
T Consensus       132 ~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~  209 (786)
T KOG0588|consen  132 NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK  209 (786)
T ss_pred             cceeccCCchhhhhhcccCEeeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence            99999999999999999999999999998655444  4566789999999999999887 67999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--hccCCC
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATL  274 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L--~~~~~~  274 (313)
                      .||.+++-.......+       .          -.-++|...+..+++|+.+||..||.+|.|++||++|-  .+...+
T Consensus       210 LPFdDdNir~LLlKV~-------~----------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  210 LPFDDDNIRVLLLKVQ-------R----------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             CCCCCccHHHHHHHHH-------c----------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence            9999665544433221       1          11235556677889999999999999999999999975  444333


Q ss_pred             C
Q 048068          275 P  275 (313)
Q Consensus       275 ~  275 (313)
                      +
T Consensus       273 ~  273 (786)
T KOG0588|consen  273 P  273 (786)
T ss_pred             C
Confidence            3

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-37  Score=274.64  Aligned_cols=220  Identities=21%  Similarity=0.347  Sum_probs=189.2

Q ss_pred             ceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           28 NQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        28 ~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ..+++|++..         ....|...++.+.||+++.+++++..++...||||+||+||+|.+.|.++.+..|++..+.
T Consensus        30 ~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~  109 (426)
T KOG0589|consen   30 KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERIL  109 (426)
T ss_pred             ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHH
Confidence            3556666543         3467788899999999999999999866669999999999999999998867789999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCc
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST  178 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  178 (313)
                      .|+.|++.|+.|||   +..|+|||||+.|||++.++.++|+|||+++..+... .......||+.|+.||.+.+..|..
T Consensus       110 ~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~  185 (426)
T KOG0589|consen  110 KWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNE  185 (426)
T ss_pred             HHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCc
Confidence            99999999999999   6999999999999999999999999999999876654 2345678999999999999999999


Q ss_pred             chhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       179 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      ++|||||||++|||++-+++|...+-......+.                ...-...+..++..++.+|..||..+|..|
T Consensus       186 KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~----------------~~~~~Plp~~ys~el~~lv~~~l~~~P~~R  249 (426)
T KOG0589|consen  186 KSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN----------------RGLYSPLPSMYSSELRSLVKSMLRKNPEHR  249 (426)
T ss_pred             cCcchhhcchHHHHHhcccccCccchHHHHHHHh----------------hccCCCCCccccHHHHHHHHHHhhcCCccC
Confidence            9999999999999999999998877655443331                111223566778899999999999999999


Q ss_pred             CCHHHHHHH
Q 048068          259 PNMRQVMQY  267 (313)
Q Consensus       259 pt~~ell~~  267 (313)
                      |++.++|.+
T Consensus       250 Psa~~LL~~  258 (426)
T KOG0589|consen  250 PSALELLRR  258 (426)
T ss_pred             CCHHHHhhC
Confidence            999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=266.15  Aligned_cols=229  Identities=23%  Similarity=0.343  Sum_probs=179.3

Q ss_pred             ceEEEcccC--------CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           28 NQFIYHGFN--------EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        28 ~~~~~~~~~--------~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ..++.|.+.        +..+.|.+.++.++|||+++++..+.. +..+|+||+||.+|++.++++.....++++..|..
T Consensus        52 e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~  130 (516)
T KOG0582|consen   52 EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIAT  130 (516)
T ss_pred             CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEeehhhcCCcHHHHHHHHccccccHHHHHH
Confidence            355666653        233456667777899999999888887 67899999999999999999987777899999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc--c-ccccccccccccccccC--C
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--T-TKLVGTFGYMAPELMRT--G  174 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~--~-~~~~~~~~y~aPE~~~~--~  174 (313)
                      +++++++||.|||   .+|.+|||||+.||||+.+|.++|+|||.+..........  . ..+.|+++|+|||++..  .
T Consensus       131 iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~  207 (516)
T KOG0582|consen  131 ILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH  207 (516)
T ss_pred             HHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhccc
Confidence            9999999999999   6999999999999999999999999999876554322111  1 45689999999999643  5


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCC
Q 048068          175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPK  254 (313)
Q Consensus       175 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  254 (313)
                      .|+.|+||||||++..|+++|..||..........+.  +    ++ ............+........++.++..||..|
T Consensus       208 GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--L----qn-~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kD  280 (516)
T KOG0582|consen  208 GYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--L----QN-DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKD  280 (516)
T ss_pred             CccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--h----cC-CCCCcccccCChHHhhhhcHHHHHHHHHHhhcC
Confidence            7899999999999999999999999887665433221  1    11 111011112222333345568999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 048068          255 PEARPNMRQVMQY  267 (313)
Q Consensus       255 P~~Rpt~~ell~~  267 (313)
                      |.+|||++++++|
T Consensus       281 P~kRptAskLlkh  293 (516)
T KOG0582|consen  281 PSKRPTASKLLKH  293 (516)
T ss_pred             cccCCCHHHHhcc
Confidence            9999999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-36  Score=270.42  Aligned_cols=210  Identities=21%  Similarity=0.296  Sum_probs=175.2

Q ss_pred             ChhhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           38 DPQLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        38 ~~~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ....|...++.+. |||+++.++++.. ..++++||||+.||+|.+++.+  .+++.+..+..++.|+++|++|||   .
T Consensus        65 ~i~rEi~~~~~~~~HpnI~~l~ev~~t-~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~  138 (370)
T KOG0583|consen   65 LIKREISILRRLRSHPNIIRLLEVFAT-PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---S  138 (370)
T ss_pred             hhHHHHHHHHHhccCCCEeEEEEEEec-CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---h
Confidence            3335667888888 9999999999997 4569999999999999999998  457999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCC-CcEEEeecccccccCCCCCCccccccccccccccccccCCC-C-CcchhhHHHHHHHHHHH
Q 048068          117 QVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A-STSTDVYAFGVFMLEVA  193 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~DiwslG~il~~ll  193 (313)
                      .||+||||||+||+++.+ +.+||+|||++.... ..........|++.|.|||++.+.. | ..++||||+|+++|.|+
T Consensus       139 ~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml  217 (370)
T KOG0583|consen  139 RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL  217 (370)
T ss_pred             CCEeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence            999999999999999999 999999999998764 2223566789999999999999877 7 57999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH-HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ-MELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +|..||...+.......+.                 .....++... +..++.++.+||..||.+|+|+.+++.|=+=.
T Consensus       218 ~G~~PF~d~~~~~l~~ki~-----------------~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~  279 (370)
T KOG0583|consen  218 CGRLPFDDSNVPNLYRKIR-----------------KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ  279 (370)
T ss_pred             hCCCCCCCccHHHHHHHHh-----------------cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence            9999999865554443321                 1111123333 77889999999999999999999999765433

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-36  Score=262.96  Aligned_cols=225  Identities=23%  Similarity=0.359  Sum_probs=186.9

Q ss_pred             cccceEEEcccCCC----------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCH
Q 048068           25 QDVNQFIYHGFNED----------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW   94 (313)
Q Consensus        25 ~~~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~   94 (313)
                      +.+..++.|.++.+          .+.+.+++..++||+||.++.++.. .+.+.|||||..+|.|++++.+.  +.+++
T Consensus        76 ~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvivMEYaS~GeLYDYiSer--~~LsE  152 (668)
T KOG0611|consen   76 KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVIVMEYASGGELYDYISER--GSLSE  152 (668)
T ss_pred             cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEEEEEecCCccHHHHHHHh--ccccH
Confidence            44556666666432          2467788899999999999999987 67899999999999999999874  46999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG  174 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  174 (313)
                      ..+.++++||++|+.|+|   +.+++|||||.+|||++.|+++||+|||++..+....  ...++.|++-|.+||++.+.
T Consensus       153 rEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~  227 (668)
T KOG0611|consen  153 REARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGT  227 (668)
T ss_pred             HHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc--HHHHhcCCcccCCccccCCC
Confidence            999999999999999999   7999999999999999999999999999998876554  46778999999999999988


Q ss_pred             CC-CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCC
Q 048068          175 KA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHP  253 (313)
Q Consensus       175 ~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  253 (313)
                      .| .+..|.||||+++|.++.|..||.+.+-......+.       .+.-           ..+..+...+.||.|||..
T Consensus       228 PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-------~GaY-----------rEP~~PSdA~gLIRwmLmV  289 (668)
T KOG0611|consen  228 PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-------RGAY-----------REPETPSDASGLIRWMLMV  289 (668)
T ss_pred             CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-------cccc-----------cCCCCCchHHHHHHHHHhc
Confidence            77 789999999999999999999999887665443331       1111           1112223467899999999


Q ss_pred             CCCCCCCHHHHHHHHhccCCCC
Q 048068          254 KPEARPNMRQVMQYLDGNATLP  275 (313)
Q Consensus       254 ~P~~Rpt~~ell~~L~~~~~~~  275 (313)
                      ||++|.|+.++..|.+=.+.-.
T Consensus       290 NP~RRATieDiAsHWWvNwgy~  311 (668)
T KOG0611|consen  290 NPERRATIEDIASHWWVNWGYN  311 (668)
T ss_pred             CcccchhHHHHhhhheeecccc
Confidence            9999999999999998766443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-36  Score=257.14  Aligned_cols=206  Identities=23%  Similarity=0.309  Sum_probs=174.0

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...|...+.+++||-+++...-+++ ++++|||+||+.||.|...|+++  +.|++..+.-+++.|+.||.|||   ++|
T Consensus        72 ~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH---~~g  145 (357)
T KOG0598|consen   72 TKAERNILSKIKHPFIVKLIYSFQT-EEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLH---SKG  145 (357)
T ss_pred             HHHHHHHHHhCCCCcEeeeEEeccc-CCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHH---hCC
Confidence            3467788899999999999999987 77999999999999999999875  36999999999999999999999   699


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      |+||||||+|||++..|.++|+|||++...-... ....++.||+.|+|||++.+..++.++|-||||+++|+|++|.+|
T Consensus       146 IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pP  224 (357)
T KOG0598|consen  146 IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPP  224 (357)
T ss_pred             eeeccCCHHHeeecCCCcEEEeccccchhcccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCC
Confidence            9999999999999999999999999998543322 245568999999999999999999999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP----NMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp----t~~ell~~  267 (313)
                      |...+....+..+..-                .....+...+...++++..+|..||.+|.    .+.++-+|
T Consensus       225 F~~~~~~~~~~~I~~~----------------k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  225 FYAEDVKKMYDKILKG----------------KLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             CcCccHHHHHHHHhcC----------------cCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence            9998877766555310                01112333566788888999999999995    66665553

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=270.53  Aligned_cols=233  Identities=25%  Similarity=0.344  Sum_probs=192.5

Q ss_pred             hhHHHHHHHHhhccccc---eEEEccc--------CCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           12 VLLCVSFILSALAQDVN---QFIYHGF--------NEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~---~~~~~~~--------~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      ..+.|+|..+|.+.+..   .++.|.+        .++.+.+..++.+.+++++.++++.+.. +..++++||||.||++
T Consensus        20 ~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   20 LIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHHHhcCcch
Confidence            34556666666666654   3333333        2355678889999999999999988876 6789999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      .+.++..  ..+++..+.-++++++.|+.|||   ..+.+|+|||+.||++...|.++++|||++.+.+..... ..++.
T Consensus        99 ~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r~tfv  172 (467)
T KOG0201|consen   99 LDLLKSG--NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-RKTFV  172 (467)
T ss_pred             hhhhccC--CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc-ccccc
Confidence            9999864  34599999999999999999999   589999999999999999999999999999877665433 37789


Q ss_pred             ccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHH
Q 048068          161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM  240 (313)
Q Consensus       161 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (313)
                      ||+.|+|||++.+..|+.++||||||++.+||++|.+|+..........++                ....+.......+
T Consensus       173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk~~PP~L~~~~S  236 (467)
T KOG0201|consen  173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PKSAPPRLDGDFS  236 (467)
T ss_pred             ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cCCCCCccccccC
Confidence            999999999999889999999999999999999999999988776554444                1222333444677


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          241 ELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+++|+..||+.||+.|||+.++++|
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            889999999999999999999999985

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-35  Score=248.63  Aligned_cols=249  Identities=20%  Similarity=0.237  Sum_probs=196.1

Q ss_pred             HHHHHHHHhhcccc---ceEEEcccCCChh---------hHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCH
Q 048068           14 LCVSFILSALAQDV---NQFIYHGFNEDPQ---------LQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        14 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L   80 (313)
                      ..|.|..+|-+++.   ..++.|+++.+..         +|...+.+.+|+||+....++. .+-+.+|+|||||+ -+|
T Consensus        85 ~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDL  163 (419)
T KOG0663|consen   85 EEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDL  163 (419)
T ss_pred             ccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhH
Confidence            34555555555554   3678888865432         5667778889999999999998 44557999999995 499


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      ..+++.. +++|....++-++.|++.|++|||   ...|+|||||++|+|++..|.+||+|||+++.++.+. .......
T Consensus       164 ksl~d~m-~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~T~lV  238 (419)
T KOG0663|consen  164 KSLMETM-KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPYTPLV  238 (419)
T ss_pred             HHHHHhc-cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc-ccCcceE
Confidence            9999887 467999999999999999999999   6889999999999999999999999999999887764 3445566


Q ss_pred             ccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhccccc---------
Q 048068          161 GTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKGAILD---------  225 (313)
Q Consensus       161 ~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~---------  225 (313)
                      -|.+|+|||.+.+ ..|+.+.|+||+|||+.|++++++.|.+..+.++...+......     |..-....         
T Consensus       239 VTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~  318 (419)
T KOG0663|consen  239 VTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSE  318 (419)
T ss_pred             EEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCC
Confidence            7999999999876 46899999999999999999999999999988888777554333     22211111         


Q ss_pred             cccccccCCccHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          226 ASDSRLEGIYEEE-QMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       226 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+...+... .++.-.+|+..+|..||.+|.|++|.|+|=
T Consensus       319 ~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  319 HPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             CCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence            1111122222222 457788999999999999999999999973

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.2e-34  Score=258.65  Aligned_cols=213  Identities=24%  Similarity=0.353  Sum_probs=164.7

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------------------------
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------------------------   88 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------------------------   88 (313)
                      |...+..+ +|+|++++++.....++.+++||||+++|+|.+++....                                
T Consensus        60 E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (338)
T cd05102          60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEA  139 (338)
T ss_pred             HHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccccc
Confidence            44445555 799999999988766678999999999999999997531                                


Q ss_pred             ----------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEe
Q 048068           89 ----------------------------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG  140 (313)
Q Consensus        89 ----------------------------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~  140 (313)
                                                  ...+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.++|+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~  216 (338)
T cd05102         140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKIC  216 (338)
T ss_pred             ccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEe
Confidence                                        134778889999999999999999   5899999999999999999999999


Q ss_pred             ecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhh
Q 048068          141 DFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCW  218 (313)
Q Consensus       141 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  218 (313)
                      |||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..........      .
T Consensus       217 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~------~  290 (338)
T cd05102         217 DFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR------L  290 (338)
T ss_pred             ecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH------H
Confidence            9999865432211 11222345678999999988889999999999999999997 99999865433211111      0


Q ss_pred             hhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ..+..     ..    .+...+..+.+|+.+||+.||++|||+.++++.|++..
T Consensus       291 ~~~~~-----~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         291 KDGTR-----MR----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             hcCCC-----CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11110     01    12234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.6e-34  Score=251.00  Aligned_cols=209  Identities=18%  Similarity=0.290  Sum_probs=168.4

Q ss_pred             hHHhhhhhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      .|...++.++|+++++.+++..+   ....+++||||+++|+|.+++...  +.+++.....++.|++.|+.|||+  ..
T Consensus        67 ~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~  142 (283)
T PHA02988         67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YT  142 (283)
T ss_pred             HHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cC
Confidence            56678888999999999998764   235789999999999999999864  368899999999999999999995  25


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC--CCCCcchhhHHHHHHHHHHHhC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT--GKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +++||||+|+||+++.++.++|+|||++.......    ....++..|+|||.+.+  ..++.++|||||||++|+|++|
T Consensus       143 ~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g  218 (283)
T PHA02988        143 NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG  218 (283)
T ss_pred             CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence            88999999999999999999999999987543221    23457889999999875  6789999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ..||......+....+.      ..+.         ....+...+..+.+|+.+||+.||++|||++++++.|+...
T Consensus       219 ~~Pf~~~~~~~~~~~i~------~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        219 KIPFENLTTKEIYDLII------NKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCCCHHHHHHHHH------hcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            99998765544332221      0100         01122245667999999999999999999999999998653

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-35  Score=242.96  Aligned_cols=214  Identities=29%  Similarity=0.420  Sum_probs=175.2

Q ss_pred             ccCCChhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           34 GFNEDPQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        34 ~~~~~~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      ++.+....+..+++++ .||+|+++.+.++. +..+++|+|.|+.|-|.+++..  .-.+++.....+++|++.++.|||
T Consensus        64 ~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylH  140 (411)
T KOG0599|consen   64 EMREATRQEISILRQVMGHPYIIDLQDVYES-DAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLH  140 (411)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-cchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHH
Confidence            3344555677777777 69999999999987 7799999999999999999987  446999999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC------CCCCcchhhHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT------GKASTSTDVYAFG  186 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG  186 (313)
                         ..+|+||||||+|||++++.+++|+|||++.....+.  +.....||++|+|||.+..      ..|+...|+|++|
T Consensus       141 ---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~G  215 (411)
T KOG0599|consen  141 ---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACG  215 (411)
T ss_pred             ---HhhhhhcccChhheeeccccceEEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHH
Confidence               7999999999999999999999999999998776554  5667899999999999853      4578899999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      +|||.++.|.+||+.....-+...+.       .|.-      .....--.+.+..+.+||.+||+.||.+|.|++|+|+
T Consensus       216 VImyTLLaGcpPFwHRkQmlMLR~Im-------eGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  216 VIMYTLLAGCPPFWHRKQMLMLRMIM-------EGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHcCCCchhHHHHHHHHHHHH-------hccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            99999999999998654333332221       1110      1111123456677899999999999999999999998


Q ss_pred             HH
Q 048068          267 YL  268 (313)
Q Consensus       267 ~L  268 (313)
                      |-
T Consensus       283 Hp  284 (411)
T KOG0599|consen  283 HP  284 (411)
T ss_pred             Ch
Confidence            63

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-34  Score=255.11  Aligned_cols=222  Identities=20%  Similarity=0.278  Sum_probs=166.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+.+.. ++.+++||||++++.+..+...  ...+++..++.++.|++.||.|||   ..++
T Consensus        48 ~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i  121 (287)
T cd07848          48 LRELKMLRTLKQENIVELKEAFRR-RGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDI  121 (287)
T ss_pred             HHHHHHHHhCCCccccchhhhEec-CCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            356678888999999999988876 6789999999988776655433  346999999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||||+||+++.++.++|+|||++...............++..|+|||++.+..++.++|+|||||++|+|++|++||
T Consensus       122 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf  201 (287)
T cd07848         122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF  201 (287)
T ss_pred             ecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998765433222233456788999999998888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHh---------hhhcccccccccc------ccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDC---------WKKGAILDASDSR------LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      .+....+....+......         ...........+.      .........+..+.+|+.+||+.||++|||++|+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~  281 (287)
T cd07848         202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC  281 (287)
T ss_pred             CCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            876654433322211100         0000000000000      0001112245679999999999999999999999


Q ss_pred             HHH
Q 048068          265 MQY  267 (313)
Q Consensus       265 l~~  267 (313)
                      ++|
T Consensus       282 l~h  284 (287)
T cd07848         282 LNH  284 (287)
T ss_pred             hcC
Confidence            986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-33  Score=245.13  Aligned_cols=225  Identities=24%  Similarity=0.345  Sum_probs=175.5

Q ss_pred             cceEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHH
Q 048068           27 VNQFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI  100 (313)
Q Consensus        27 ~~~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i  100 (313)
                      ...++.|.+....      ..+.+.++.++|+++++..++... ++.+++||||+++++|.+++.......+++..+..+
T Consensus        31 ~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~  109 (263)
T cd05052          31 SLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM  109 (263)
T ss_pred             CceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHH
Confidence            3455666554332      245567778899999999998876 568899999999999999997654556899999999


Q ss_pred             HHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcch
Q 048068          101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST  180 (313)
Q Consensus       101 ~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  180 (313)
                      +.|++.+|.|||   ..+++|+||+|+||+++.++.++|+|||++................+..|++||.+.+..++.++
T Consensus       110 ~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  186 (263)
T cd05052         110 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS  186 (263)
T ss_pred             HHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchh
Confidence            999999999999   58999999999999999999999999999875543322112222335679999999888899999


Q ss_pred             hhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          181 DVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       181 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      |+|||||++|+|++ |..||.+....+......       ..         .....+...+..+.+++.+||+.||++||
T Consensus       187 Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  250 (263)
T cd05052         187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KG---------YRMERPEGCPPKVYELMRACWQWNPSDRP  250 (263)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CC---------CCCCCCCCCCHHHHHHHHHHccCCcccCC
Confidence            99999999999998 999997655443322221       10         01112233456789999999999999999


Q ss_pred             CHHHHHHHHhcc
Q 048068          260 NMRQVMQYLDGN  271 (313)
Q Consensus       260 t~~ell~~L~~~  271 (313)
                      |+.++++.|+..
T Consensus       251 ~~~~l~~~l~~~  262 (263)
T cd05052         251 SFAEIHQAFETM  262 (263)
T ss_pred             CHHHHHHHHHhh
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-34  Score=258.08  Aligned_cols=203  Identities=24%  Similarity=0.286  Sum_probs=165.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|++++++.+.+.. ++..|+||||+++++|.+++...  +.+++..+..++.||+.||.|||   ..+|+
T Consensus        44 ~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iv  117 (323)
T cd05571          44 TESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVV  117 (323)
T ss_pred             HHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeE
Confidence            35567788899999999888876 66899999999999999999764  46899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus       118 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  196 (323)
T cd05571         118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence            99999999999999999999999986432211 12234568999999999998889999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..+.......+.       .+          ....+...+..+.+++.+||+.||++||     ++.++++|
T Consensus       197 ~~~~~~~~~~~~-------~~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         197 NQDHEKLFELIL-------ME----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHH-------cC----------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            655433322221       00          0112233456788999999999999999     89999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=244.31  Aligned_cols=195  Identities=24%  Similarity=0.327  Sum_probs=169.4

Q ss_pred             CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           37 EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        37 ~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      +-...|+..++.+.||-+++......+ .+++++||||.+||-|.+++++.  +.|++..++-++.||+.||+|||   .
T Consensus        89 eH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH---~  162 (355)
T KOG0616|consen   89 EHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLH---S  162 (355)
T ss_pred             HHHhhHHHHHhhccCceeEEEEEeecc-CCeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHH---h
Confidence            344578889999999999999988887 77999999999999999999984  46999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      .+|++|||||+|||++.+|.+||.|||++.....    ...+..||+.|+|||.+..+.+..++|=||||+++|||+.|.
T Consensus       163 ~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~  238 (355)
T KOG0616|consen  163 LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY  238 (355)
T ss_pred             cCeeeccCChHHeeeccCCcEEEEeccceEEecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999999975432    245678999999999999999999999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      +||.......++..+-                 .-...+|...+..+++|+.+.|+.|-.+|
T Consensus       239 pPF~~~~~~~iY~KI~-----------------~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  239 PPFYDDNPIQIYEKIL-----------------EGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CCCcCCChHHHHHHHH-----------------hCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            9999888866665552                 11222555666778888888999999999

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.9e-34  Score=250.95  Aligned_cols=220  Identities=21%  Similarity=0.265  Sum_probs=165.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.++.++|+++++..+++.. ++..++||||++ ++|.+++... ...+++..+..++.||+.||.|||   ..+++
T Consensus        52 ~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~iv  125 (288)
T cd07871          52 REVSLLKNLKHANIVTLHDIIHT-ERCLTLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH---KRKIL  125 (288)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            57778899999999999998876 568999999996 4999988754 345899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      ||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+||++|+|++|++||
T Consensus       126 H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf  204 (288)
T cd07871         126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF  204 (288)
T ss_pred             cCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999865432221 1233467889999998865 46789999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHH-----Hhhhhcc----cccccccccc----CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVS-----DCWKKGA----ILDASDSRLE----GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      .+....+....+....     ..|..-.    ......+...    ............+|+.+||..||.+|||++|+++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         205 PGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            8766555443332211     1111100    0000000000    0001122456789999999999999999999998


Q ss_pred             H
Q 048068          267 Y  267 (313)
Q Consensus       267 ~  267 (313)
                      |
T Consensus       285 h  285 (288)
T cd07871         285 H  285 (288)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=235.80  Aligned_cols=205  Identities=24%  Similarity=0.323  Sum_probs=178.1

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +.++...++||||++.++++-+ ....||++||...|.|...+..+..+.+++...+.+.+|++.|+.|+|   .++++|
T Consensus        72 EiEIqs~L~hpnilrlY~~fhd-~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIh  147 (281)
T KOG0580|consen   72 EIEIQSHLRHPNILRLYGYFHD-SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIH  147 (281)
T ss_pred             eeEeecccCCccHHhhhhheec-cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCccc
Confidence            3344455689999999999887 678999999999999999999776778999999999999999999999   699999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      |||||+|+|++..+.+|++|||.+...+..   ...+..||.-|.+||...+..++...|+|++|++.||++.|.+||+.
T Consensus       148 RdiKpenlLlg~~~~lkiAdfGwsV~~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes  224 (281)
T KOG0580|consen  148 RDIKPENLLLGSAGELKIADFGWSVHAPSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES  224 (281)
T ss_pred             CCCCHHHhccCCCCCeeccCCCceeecCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence            999999999999999999999999866532   35567899999999999999999999999999999999999999998


Q ss_pred             CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ....+.+..+..                 ..-.++...+..+.++|..||..+|.+|.+..|+++|-.-
T Consensus       225 ~~~~etYkrI~k-----------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  225 QSHSETYKRIRK-----------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             hhhHHHHHHHHH-----------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence            887777666532                 2223455667788999999999999999999999998653

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-33  Score=253.87  Aligned_cols=201  Identities=19%  Similarity=0.255  Sum_probs=165.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...+++++|++++++++.+.. ++..++||||+++++|.+++...  ..+++..+..++.||+.||.|||   ..++
T Consensus        66 ~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~i  139 (329)
T PTZ00263         66 AQEKSILMELSHPFIVNMMCSFQD-ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH---SKDI  139 (329)
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            356677888999999999998877 67899999999999999999864  46899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||||+||+++.++.++|+|||++......    .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       140 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  215 (329)
T PTZ00263        140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF  215 (329)
T ss_pred             eecCCCHHHEEECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC
Confidence            99999999999999999999999998754332    22346889999999999888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      .+.........+.       .+.          ...+......+.+|+.+||+.||.+||+     ++++++|
T Consensus       216 ~~~~~~~~~~~i~-------~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        216 FDDTPFRIYEKIL-------AGR----------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCHHHHHHHHh-------cCC----------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            8655433322221       110          0112223456889999999999999996     7999987

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=252.32  Aligned_cols=248  Identities=21%  Similarity=0.268  Sum_probs=190.8

Q ss_pred             ceEEEcccC---------CChhhHHhhhhhccccceeeeeeEEec----cCCeEEEEEecCCCCCHHHHHhhCCCCCCCH
Q 048068           28 NQFIYHGFN---------EDPQLQRDGLASVHSNGLLQLTNTVNS----RKGEFLLVYDYMPNGSLDKILHTNIKPSLSW   94 (313)
Q Consensus        28 ~~~~~~~~~---------~~~~~~~~~l~~~~~~~~l~~~~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~   94 (313)
                      ..++.|++.         ....+|..+++.++|+|++...+++..    .-+.+|+|+|+| +.+|..+++.+  +.+++
T Consensus        48 ~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d  124 (359)
T KOG0660|consen   48 EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTD  124 (359)
T ss_pred             CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcC--ccccH
Confidence            455555554         244467788899999999999999884    456899999999 67999999875  34999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCC-CCCcccccccccccccccccc-
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVGTFGYMAPELMR-  172 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-  172 (313)
                      .-+.-+++||+.||+|+||   .+++||||||.|++++.+..+||+|||+++..... ..........|.+|+|||++. 
T Consensus       125 ~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  125 DHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             HHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence            9999999999999999995   89999999999999999999999999999866432 112234567799999999875 


Q ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccc------------ccc--ccccccCCccHH
Q 048068          173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI------------LDA--SDSRLEGIYEEE  238 (313)
Q Consensus       173 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------~~~--~~~~~~~~~~~~  238 (313)
                      ...|+.+.||||+|||+.||++|++.|.+.+......++..+-+.......            .+.  ..+..-...-+.
T Consensus       202 ~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~  281 (359)
T KOG0660|consen  202 SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPN  281 (359)
T ss_pred             cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCC
Confidence            568999999999999999999999999999888888777544332221111            000  000000111224


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCCCCCCCCCC
Q 048068          239 QMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATLPDIPRDS  281 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~~~~~~~~~  281 (313)
                      ..+...+|+.+||..||.+|+|++|+|+|  |+....+.+.|+..
T Consensus       282 a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~  326 (359)
T KOG0660|consen  282 ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ  326 (359)
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence            55778899999999999999999999996  56666676666433

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-33  Score=245.17  Aligned_cols=210  Identities=25%  Similarity=0.384  Sum_probs=166.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+++++|+++++..+++.. ++..++||||+++++|.+++... ...+++..++.++.||+.|++|||   +.+++
T Consensus        55 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH---~~~ii  129 (266)
T cd05064          55 AEALTLGQFDHSNIVRLEGVITR-GNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYV  129 (266)
T ss_pred             HHHHHHhcCCCCCcCeEEEEEec-CCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            35566677899999999998876 66899999999999999999865 346899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++++|||.................++..|+|||.+.+..++.++|||||||++|++++ |..||
T Consensus       130 H~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~  209 (266)
T cd05064         130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             eccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCc
Confidence            99999999999999999999999875432222111122334568999999988889999999999999999775 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ......+....+.       .+..         ...+...+..+.+++..||+.+|.+|||++++++.|+..
T Consensus       210 ~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         210 WDMSGQDVIKAVE-------DGFR---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CcCCHHHHHHHHH-------CCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            8765544322221       1100         012334556789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=252.34  Aligned_cols=235  Identities=17%  Similarity=0.257  Sum_probs=194.9

Q ss_pred             hhHHHHHHHHhhccccc---eEEEcccC---C------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           12 VLLCVSFILSALAQDVN---QFIYHGFN---E------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~---~~~~~~~~---~------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      .++.|+|..+.+++++-   .+++|.+-   .      ..-.|...++-++|||++++|.++.. ...+|||+|.-++|+
T Consensus        25 TlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyLiLELGD~GD  103 (864)
T KOG4717|consen   25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYLILELGDGGD  103 (864)
T ss_pred             hhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEEEEEecCCch
Confidence            45678888888888853   44444442   1      12256677888899999999999876 578999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCcccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      |.++|-++ ..++.+..+.++++||+.|+.|+|   +..++||||||+|+.+.+ -|.+||.|||++..+..+.  +...
T Consensus       104 l~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--kL~T  177 (864)
T KOG4717|consen  104 LFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--KLTT  177 (864)
T ss_pred             HHHHHHhh-hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--hhhc
Confidence            99999765 457999999999999999999999   699999999999998875 5889999999998776554  5667


Q ss_pred             ccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          159 LVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ..|...|-|||++.+..| .++.||||||+|+|.+++|++||+..++.+....+.                 -.....|.
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-----------------DCKYtvPs  240 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-----------------DCKYTVPS  240 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-----------------cccccCch
Confidence            889999999999998777 579999999999999999999999888877665552                 12334667


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ..+..+++||..||..||++|.|.++|..+-+-
T Consensus       241 hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  241 HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             hhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence            778899999999999999999999999986543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-33  Score=250.53  Aligned_cols=260  Identities=19%  Similarity=0.221  Sum_probs=179.1

Q ss_pred             CCCCCcchhhhhHHHHHHHHhhccc---cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEE
Q 048068            2 GAAPRSFYFCVLLCVSFILSALAQD---VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLL   70 (313)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~l   70 (313)
                      |...+.-...+++.|.+...+..++   ...++.|.+..        ....|...++.++|+++++..+++.. +...++
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l   80 (303)
T cd07869           2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTL   80 (303)
T ss_pred             CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEE
Confidence            4444433344455555555555544   23455555432        22356678889999999999999886 568999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCC
Q 048068           71 VYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH  150 (313)
Q Consensus        71 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~  150 (313)
                      ||||+ .++|.+++... ...+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 v~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          81 VFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99999 46888888764 346899999999999999999999   58999999999999999999999999999864332


Q ss_pred             CCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhh-hhHHHHHHH-----hhhhccc
Q 048068          151 DTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM-VNLVDWVSD-----CWKKGAI  223 (313)
Q Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~-----~~~~~~~  223 (313)
                      .. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+..+... ...+.....     .|.....
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            21 12233467889999998865 4578899999999999999999999987544321 111111100     0110000


Q ss_pred             cccccc-cc----cCCcc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          224 LDASDS-RL----EGIYE-----EEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       224 ~~~~~~-~~----~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+ ..    +....     ......+.+|+.+||+.||++|||++|+++|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~  289 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE  289 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence            000000 00    00000     01235678999999999999999999999853

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-34  Score=251.80  Aligned_cols=203  Identities=23%  Similarity=0.297  Sum_probs=166.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++.++...+ ++.+++||||+++++|.+++...  +.+++..+..++.||+.||.|||   ..++
T Consensus        49 ~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i  122 (291)
T cd05612          49 HNEKRVLKEVSHPFIIRLFWTEHD-QRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH---SKEI  122 (291)
T ss_pred             HHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            346677888999999999888776 56899999999999999999764  36899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++......    .....|++.|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus       123 ~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  198 (291)
T cd05612         123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF  198 (291)
T ss_pred             eecCCCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998754322    22346789999999999888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHh
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQYLD  269 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~L~  269 (313)
                      .+.........+.       .+.          ...+......+.+++.+||+.||.+||+     ++++++|-.
T Consensus       199 ~~~~~~~~~~~i~-------~~~----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  256 (291)
T cd05612         199 FDDNPFGIYEKIL-------AGK----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW  256 (291)
T ss_pred             CCCCHHHHHHHHH-------hCC----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence            8765444332221       000          0122233567889999999999999995     999998853

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=252.59  Aligned_cols=203  Identities=24%  Similarity=0.312  Sum_probs=164.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+.+.. ++..++||||+++++|.+++..+  ..+++..+..++.||+.||.|||   ..+++
T Consensus        42 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~  115 (312)
T cd05585          42 AERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLH---KFNVI  115 (312)
T ss_pred             HHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeE
Confidence            45567788899999999888876 67899999999999999999764  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus       116 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~  194 (312)
T cd05585         116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY  194 (312)
T ss_pred             eCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence            99999999999999999999999986432221 12234568999999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP---NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---t~~ell~~  267 (313)
                      +.........+      ...           ....+...+..+.+++.+||+.||.+||   ++.++++|
T Consensus       195 ~~~~~~~~~~~------~~~-----------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         195 DENVNEMYRKI------LQE-----------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCHHHHHHHH------HcC-----------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            65544322211      110           1112334456788999999999999997   57788776

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-33  Score=247.70  Aligned_cols=208  Identities=25%  Similarity=0.314  Sum_probs=166.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++..++||||+++|+|.+.+.......+++..+..++.|++.||.|||   ..+++
T Consensus        49 ~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ii  124 (285)
T cd05631          49 NEKRILEKVNSRFVVSLAYAYET-KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIV  124 (285)
T ss_pred             HHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEE
Confidence            45677788899999999888776 568999999999999998887544456999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++.......  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus       125 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~  202 (285)
T cd05631         125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR  202 (285)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987543222  1233468899999999998899999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      .............   ...          .....++...+..+.+|+.+||+.||++|||     ++++++|
T Consensus       203 ~~~~~~~~~~~~~---~~~----------~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         203 KRKERVKREEVDR---RVK----------EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CCCcchhHHHHHH---Hhh----------cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            7654332211110   000          0111123344567889999999999999997     8999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.4e-33  Score=241.92  Aligned_cols=210  Identities=22%  Similarity=0.408  Sum_probs=168.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+.... .+..++||||+++++|.++++......++...+..++.|++.||+|||   ..+++
T Consensus        50 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~  125 (261)
T cd05072          50 EEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI  125 (261)
T ss_pred             HHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            46677788899999999988876 567899999999999999998765567899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++...............++..|+|||.+.+..++.++|+||||+++|++++ |..||
T Consensus       126 H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~  205 (261)
T cd05072         126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY  205 (261)
T ss_pred             ccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCC
Confidence            99999999999999999999999997654332222222345667999999988888999999999999999998 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ...........+.       ....     .    ......+..+.+++.+||+.+|++|||++++++.|++
T Consensus       206 ~~~~~~~~~~~~~-------~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         206 PGMSNSDVMSALQ-------RGYR-----M----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCHHHHHHHHH-------cCCC-----C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            8765443322221       1110     0    0112234568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-33  Score=252.05  Aligned_cols=222  Identities=23%  Similarity=0.309  Sum_probs=168.6

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...+.+.+++++|+++++.++++.. ++..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+  ..+
T Consensus        50 ~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~  124 (331)
T cd06649          50 IIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE--KHQ  124 (331)
T ss_pred             HHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCC
Confidence            3355667888999999999998876 56899999999999999999864  358999999999999999999995  346


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||||+||+++.++.++|+|||++......   ......++..|+|||.+.+..++.++|+|||||++|++++|+.|
T Consensus       125 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p  201 (331)
T cd06649         125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP  201 (331)
T ss_pred             EEcCCCChhhEEEcCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998654322   12335688999999999988899999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhh-cc-cc-------------------------------ccccccccCCccHHHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKK-GA-IL-------------------------------DASDSRLEGIYEEEQMELVLK  245 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~-~~-~~-------------------------------~~~~~~~~~~~~~~~~~~l~~  245 (313)
                      |...+..+.......  ..... .. ..                               .......+.......+..+.+
T Consensus       202 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  279 (331)
T cd06649         202 IPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQE  279 (331)
T ss_pred             CCCCCHHHHHHHhcc--cccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHH
Confidence            976554332211100  00000 00 00                               000000011111234567899


Q ss_pred             HHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          246 LGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       246 li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ||.+||+.||++|||++++++|..=
T Consensus       280 li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         280 FVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             HHHHHccCCcccCCCHHHHhcChHH
Confidence            9999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.1e-33  Score=244.98  Aligned_cols=210  Identities=23%  Similarity=0.389  Sum_probs=168.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK--------------PSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~  106 (313)
                      .+.+.++.++|+++++..+.... .+..+++|||+++++|.+++.....              ..+++..++.++.|++.
T Consensus        57 ~ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  135 (283)
T cd05048          57 QEAELMSDLQHPNIVCLLGVCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA  135 (283)
T ss_pred             HHHHHHHhcCCcccceEEEEEcC-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHH
Confidence            45567788899999999998876 5678999999999999999975421              46889999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      ||.|||   ..+++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+|||
T Consensus       136 al~~lH---~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl  212 (283)
T cd05048         136 GMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF  212 (283)
T ss_pred             HHHHHH---hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence            999999   68999999999999999999999999999864322211 11223345778999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       186 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      ||++|+|++ |..||.+....+....+.       .+         .....+...+..+.+|+..||+.||.+|||++++
T Consensus       213 G~il~el~~~g~~p~~~~~~~~~~~~i~-------~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i  276 (283)
T cd05048         213 GVVLWEIFSYGLQPYYGFSNQEVIEMIR-------SR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDI  276 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999998 999998766544332221       11         1111234556889999999999999999999999


Q ss_pred             HHHHhc
Q 048068          265 MQYLDG  270 (313)
Q Consensus       265 l~~L~~  270 (313)
                      +++|++
T Consensus       277 ~~~l~~  282 (283)
T cd05048         277 HTRLRS  282 (283)
T ss_pred             HHHHhc
Confidence            999976

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.3e-35  Score=251.14  Aligned_cols=249  Identities=20%  Similarity=0.219  Sum_probs=189.4

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC---ChhhHHhhhhhccccceeeeeeEEecc-CC---eEEEEEecCCCCCHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE---DPQLQRDGLASVHSNGLLQLTNTVNSR-KG---EFLLVYDYMPNGSLDK   82 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~~~~~~~l~~~~~~~~~-~~---~~~lV~e~~~~g~L~~   82 (313)
                      .++|+|..++-++.   ...++.|+...   -...|-++++.++|||+++....+... ++   +..+||||++. +|.+
T Consensus        32 iG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~  110 (364)
T KOG0658|consen   32 IGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYR  110 (364)
T ss_pred             EeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHH
Confidence            34455544443333   33455555543   345788899999999999988877722 22   45699999964 9999


Q ss_pred             HHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-CcEEEeecccccccCCCCCCccccc
Q 048068           83 ILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        83 ~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      +++..  .+..++.-.++-+..||..||+|||   ..+|+||||||.|+||+.+ |.+||||||.+.......  .....
T Consensus       111 ~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e--pniSY  185 (364)
T KOG0658|consen  111 VIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE--PNISY  185 (364)
T ss_pred             HHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC--CceeE
Confidence            99852  2456999999999999999999999   5999999999999999965 899999999998654433  34567


Q ss_pred             cccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccc---------
Q 048068          160 VGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS---------  229 (313)
Q Consensus       160 ~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  229 (313)
                      ..+..|+|||.+.+ ..|+.+.||||.||++.||+.|++.|.+.+..++...+..+-+....+.+..+...         
T Consensus       186 icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~i  265 (364)
T KOG0658|consen  186 ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQI  265 (364)
T ss_pred             EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccc
Confidence            78999999999876 57899999999999999999999999998888887777555444443332222221         


Q ss_pred             --ccc-CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          230 --RLE-GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       230 --~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                        ... .......++...+|+.++|..+|.+|.|+.|++.|
T Consensus       266 k~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  266 KAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence              111 11334456778899999999999999999999985

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-34  Score=260.90  Aligned_cols=204  Identities=25%  Similarity=0.338  Sum_probs=172.5

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+.+.+++++++|+|++...+.+.. ..++|+|+||+.| +|..++..+  +.++++.+..+++++++||.|||   +.+
T Consensus        48 l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLh---s~r  120 (808)
T KOG0597|consen   48 LRQEVRILRSLKHPNIVEMLESFET-SAHLWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLH---SNR  120 (808)
T ss_pred             HHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hcC
Confidence            4567788899999999999888876 6799999999966 999999884  56999999999999999999999   599


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      |+|+|+||.||++...|.+|+||||+++...... .......||+.|+|||+..++.|+..+|+||+||++||+.+|++|
T Consensus       121 ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PP  199 (808)
T KOG0597|consen  121 ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPP  199 (808)
T ss_pred             cccccCCcceeeecCCCceeechhhhhhhcccCc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999999998766543 234556899999999999999999999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |....--.....+      ..           -+...+...+..+..|+...|..||..|.|-.+++.|
T Consensus       200 F~a~si~~Lv~~I------~~-----------d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  200 FYARSITQLVKSI------LK-----------DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             chHHHHHHHHHHH------hc-----------CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            9754433322222      11           1122344677788899999999999999999999985

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-33  Score=241.59  Aligned_cols=250  Identities=20%  Similarity=0.253  Sum_probs=191.1

Q ss_pred             hHHHHHHHHhhcccc---ceEEEcccCCC---------hhhHHhhhhhccccc-eeeeeeEEeccCC-----eEEEEEec
Q 048068           13 LLCVSFILSALAQDV---NQFIYHGFNED---------PQLQRDGLASVHSNG-LLQLTNTVNSRKG-----EFLLVYDY   74 (313)
Q Consensus        13 ~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~l~~~~~~~-~l~~~~~~~~~~~-----~~~lV~e~   74 (313)
                      ++++.+..++.+...   ..++.|++.-.         .-.|..++++++|++ ++...+++...+.     .+++|+||
T Consensus        19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~   98 (323)
T KOG0594|consen   19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF   98 (323)
T ss_pred             hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence            455555444444432   35666666422         246888999999999 9999999986553     89999999


Q ss_pred             CCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC
Q 048068           75 MPNGSLDKILHTNIK--PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT  152 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~  152 (313)
                      + ..+|..++.....  .+++...++.++.||+.||+|||   ..+|+||||||.||+|+.+|.+||+|||+++.+..+.
T Consensus        99 ~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~  174 (323)
T KOG0594|consen   99 L-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM  174 (323)
T ss_pred             e-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc
Confidence            9 5699999987643  46888999999999999999999   5999999999999999999999999999998766544


Q ss_pred             CCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhcccccc
Q 048068          153 IPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKGAILDA  226 (313)
Q Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  226 (313)
                      .. ......|.+|+|||++.+. .|+...||||+|||+.||++++..|.+..+.++...+......     |........
T Consensus       175 ~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~  253 (323)
T KOG0594|consen  175 RT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPD  253 (323)
T ss_pred             cc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccc
Confidence            32 3455779999999999876 7899999999999999999999999999987777666444333     332211111


Q ss_pred             cccccc-----CCccHHHH---HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          227 SDSRLE-----GIYEEEQM---ELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       227 ~~~~~~-----~~~~~~~~---~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+...+     .......+   ....+++.+||+.+|.+|.|++.+++|
T Consensus       254 ~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  254 YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111     11111111   478899999999999999999999997

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-33  Score=251.48  Aligned_cols=204  Identities=24%  Similarity=0.329  Sum_probs=165.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++.++|+++++..+.+.. ++.+++||||+++++|.+++...  +.+.+..+..++.||+.||.|||   ..+++
T Consensus        49 ~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iv  122 (323)
T cd05584          49 AERNILEAVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH---QQGII  122 (323)
T ss_pred             HHHHHHHhCCCCchhceeeEEec-CCeEEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            46678899999999999988876 56899999999999999999764  35889999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus       123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~  201 (323)
T cd05584         123 YRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT  201 (323)
T ss_pred             cCCCCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCC
Confidence            99999999999999999999999986432221 12233568999999999988888999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      ..........+.      ..           ....+...+..+.++|.+||+.||.+||     +++++++|-
T Consensus       202 ~~~~~~~~~~~~------~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         202 AENRKKTIDKIL------KG-----------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             CCCHHHHHHHHH------cC-----------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence            765443222211      10           0112223456788999999999999999     899998863

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-33  Score=263.26  Aligned_cols=207  Identities=23%  Similarity=0.339  Sum_probs=167.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .|...++.++|++++++++.+.. ++++|+||||+++|+|.+++...  ....+++..+..++.||+.||.|||   ..+
T Consensus       114 ~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~  189 (478)
T PTZ00267        114 SELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRK  189 (478)
T ss_pred             HHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            46677788899999999999886 67999999999999999988643  2346899999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||||||+||+++.++.++|+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       190 ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~  269 (478)
T PTZ00267        190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR  269 (478)
T ss_pred             EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999876543221 12234568999999999998889999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||......+....+.      .. ..         ...+...+..+.++|..||..||++|||+.+++.+
T Consensus       270 Pf~~~~~~~~~~~~~------~~-~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        270 PFKGPSQREIMQQVL------YG-KY---------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCCCHHHHHHHHH------hC-CC---------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            997655443322211      00 00         01222345678999999999999999999998754

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-33  Score=240.37  Aligned_cols=222  Identities=24%  Similarity=0.341  Sum_probs=173.6

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .++.|.+...      ...+.+.++.++|++++++.++... ++..++||||+++++|.+++.......+++..+..++.
T Consensus        32 ~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~  110 (261)
T cd05068          32 PVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA  110 (261)
T ss_pred             EEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHH
Confidence            4555555432      2245567788899999999988776 56789999999999999999875455799999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.|+.+||   ..+++|+||+|+||+++.++.++|+|||++................+..|++||...+..++.++|+
T Consensus       111 ~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  187 (261)
T cd05068         111 QVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV  187 (261)
T ss_pred             HHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhH
Confidence            9999999999   6899999999999999999999999999987654322111111222457999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|++++ |+.||.+.........+.       ...         ....+...+..+.+++.+||+.+|++|||+
T Consensus       188 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~  251 (261)
T cd05068         188 WSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-------QGY---------RMPCPPGCPKELYDIMLDCWKEDPDDRPTF  251 (261)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCC---------CCCCCCcCCHHHHHHHHHHhhcCcccCCCH
Confidence            999999999999 999998765443332221       100         001222345678999999999999999999


Q ss_pred             HHHHHHHhc
Q 048068          262 RQVMQYLDG  270 (313)
Q Consensus       262 ~ell~~L~~  270 (313)
                      +++++.|++
T Consensus       252 ~~l~~~l~~  260 (261)
T cd05068         252 ETLQWKLED  260 (261)
T ss_pred             HHHHHHHhc
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-33  Score=253.77  Aligned_cols=203  Identities=24%  Similarity=0.296  Sum_probs=164.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|++++++...+.. ++.+++||||+++++|...+...  ..+++..+..++.||+.||.|||   ..+++
T Consensus        44 ~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iv  117 (328)
T cd05593          44 TESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIV  117 (328)
T ss_pred             HHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeE
Confidence            34567788899999999888876 67899999999999999988764  36999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.
T Consensus       118 HrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~  196 (328)
T cd05593         118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (328)
T ss_pred             ecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence            99999999999999999999999986432211 12233568999999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..+.......+.      ..           ....+...+..+.+++.+||+.||++|+     ++.++++|
T Consensus       197 ~~~~~~~~~~~~------~~-----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         197 NQDHEKLFELIL------ME-----------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHhc------cC-----------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            755443322210      00           0112233456788999999999999997     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-33  Score=252.97  Aligned_cols=203  Identities=24%  Similarity=0.291  Sum_probs=165.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+.+.. ++.+|+||||+++++|..++...  ..+++..++.++.||+.||.|||   ..+++
T Consensus        44 ~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~iv  117 (323)
T cd05595          44 TESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVV  117 (323)
T ss_pred             HHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            35567788899999999988876 56899999999999999988764  36899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.
T Consensus       118 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  196 (323)
T cd05595         118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             ecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence            99999999999999999999999876432211 12233568899999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..+.......+.      .. .          ...+...+..+.+++.+||+.||++||     ++.++++|
T Consensus       197 ~~~~~~~~~~~~------~~-~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         197 NQDHERLFELIL------ME-E----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHh------cC-C----------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            765443332221      00 0          012223456788999999999999998     89999886

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=233.29  Aligned_cols=212  Identities=21%  Similarity=0.272  Sum_probs=173.8

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..+|..+-+.++||+|+++.+.+.+ .+..|+|+|+++|++|..-|-..  ..+++..+-+.+.||+.||+|+|   .++
T Consensus        57 l~rEarIC~~LqHP~IvrL~~ti~~-~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~  130 (355)
T KOG0033|consen   57 LEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNG  130 (355)
T ss_pred             HHHHHHHHHhcCCCcEeehhhhhcc-cceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcC
Confidence            3456677788999999999988887 67899999999999998877553  46899999999999999999999   599


Q ss_pred             ceecCcCCCcEEEcCC---CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          119 VLHRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      |+|||+||.|+++...   .-+||+|||++...+..  ..-..+.||++|++||++....++..+|||+.|+++|-++.|
T Consensus       131 IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G  208 (355)
T KOG0033|consen  131 IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG  208 (355)
T ss_pred             ceeccCChhheeeeeccCCCceeecccceEEEeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhC
Confidence            9999999999999632   34899999999876632  234457899999999999999999999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+||++.+....+..+..       +.      ...+...-...++..++|+.+||..||.+|.|+.|.|+|-+-+
T Consensus       209 ~~PF~~~~~~rlye~I~~-------g~------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~  271 (355)
T KOG0033|consen  209 YPPFWDEDQHRLYEQIKA-------GA------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC  271 (355)
T ss_pred             CCCCCCccHHHHHHHHhc-------cc------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence            999999887777765531       10      0111212334567788999999999999999999999875543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-33  Score=247.94  Aligned_cols=214  Identities=22%  Similarity=0.357  Sum_probs=162.3

Q ss_pred             hccccceeeeeeEEe----ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecC
Q 048068           48 SVHSNGLLQLTNTVN----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD  123 (313)
Q Consensus        48 ~~~~~~~l~~~~~~~----~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~d  123 (313)
                      .+.|+++++..++..    .....+++||||+. ++|.+++.......+++..++.++.||+.||.|||   ..+++|+|
T Consensus        60 ~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~d  135 (290)
T cd07862          60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRD  135 (290)
T ss_pred             ccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCC
Confidence            346999999998875    33567999999995 69999998755556999999999999999999999   58999999


Q ss_pred             cCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCC
Q 048068          124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQG  203 (313)
Q Consensus       124 l~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  203 (313)
                      |||+||+++.++.++|+|||++......  .......++..|+|||.+.+..++.++|||||||++|+|++|.+||.+..
T Consensus       136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         136 LKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             CCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            9999999999999999999998754432  12334567899999999988888999999999999999999999999876


Q ss_pred             chhhhhHHHHHH-----Hhhhhcc-c----cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          204 SMEMVNLVDWVS-----DCWKKGA-I----LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       204 ~~~~~~~~~~~~-----~~~~~~~-~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +.+....+....     ..|.... .    .............+.....+.+++.+||+.||++|||+.++++|
T Consensus       214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            655443332110     0111000 0    00000000001112345678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=253.42  Aligned_cols=219  Identities=26%  Similarity=0.323  Sum_probs=176.8

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTNIKPS-LSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      ..+.|...++.+.|+|++++..+.. ...+.+|||+|||..|.+...=.   .+. +++.+++.++..++.||.|||+  
T Consensus       154 kv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~--  228 (576)
T KOG0585|consen  154 KVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHY--  228 (576)
T ss_pred             HHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHh--
Confidence            5567888999999999999999999 34668999999998877543322   334 9999999999999999999994  


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC----CCccccccccccccccccccCCC----CCcchhhHHHHH
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT----IPQTTKLVGTFGYMAPELMRTGK----ASTSTDVYAFGV  187 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~  187 (313)
                       +||+||||||+|+|++.+|.+||+|||.+..+....    ........||+.|+|||...++.    .+.+.||||+|+
T Consensus       229 -QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV  307 (576)
T KOG0585|consen  229 -QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV  307 (576)
T ss_pred             -cCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence             899999999999999999999999999998764321    12233468999999999987633    367999999999


Q ss_pred             HHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          188 FMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       188 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +||.++.|+.||.+....+....+..               ..+.-...++..+.+++||.+||.+||+.|.++.++..|
T Consensus       308 TLYCllfG~~PF~~~~~~~l~~KIvn---------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  308 TLYCLLFGQLPFFDDFELELFDKIVN---------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             hHHHhhhccCCcccchHHHHHHHHhc---------------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            99999999999998777666554421               111111223567889999999999999999999999999


Q ss_pred             HhccCCCCCC
Q 048068          268 LDGNATLPDI  277 (313)
Q Consensus       268 L~~~~~~~~~  277 (313)
                      .+-......+
T Consensus       373 pwvt~~g~~~  382 (576)
T KOG0585|consen  373 PWVTRDGDSP  382 (576)
T ss_pred             ceeccCCCCC
Confidence            9877655444

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.2e-33  Score=241.39  Aligned_cols=210  Identities=27%  Similarity=0.424  Sum_probs=170.3

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+.... ...+++||||+++++|.+++.......+++..++.++.||+.|+.|||   +.++
T Consensus        50 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i  125 (261)
T cd05148          50 QKEVQALKRLRHKHLISLFAVCSV-GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNS  125 (261)
T ss_pred             HHHHHHHhcCCCcchhheeeeEec-CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            345567788899999999988876 568999999999999999998765567999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++......... .....++..|++||.+.+..++.++|+||||+++|++++ |+.|
T Consensus       126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p  204 (261)
T cd05148         126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP  204 (261)
T ss_pred             eccccCcceEEEcCCceEEEccccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999998765432211 112344667999999988888999999999999999998 8999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      |......+....+.       .+         .....+...++.+.++|.+||+.||.+|||+.++++.|++
T Consensus       205 ~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         205 YPGMNNHEVYDQIT-------AG---------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCcCCHHHHHHHHH-------hC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            98765444333221       10         0111233445678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-33  Score=253.84  Aligned_cols=200  Identities=22%  Similarity=0.270  Sum_probs=166.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++.+++||||+++|+|.+++...  +.+++..+..++.||+.||.|||   ..+++
T Consensus        80 ~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~iv  153 (340)
T PTZ00426         80 SERKILNYINHPFCVNLYGSFKD-ESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ---SLNIV  153 (340)
T ss_pred             HHHHHHHhCCCCCCcceEEEEEe-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            46678888999999999999876 57899999999999999999874  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++......    .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       154 HrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  229 (340)
T PTZ00426        154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY  229 (340)
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence            9999999999999999999999998754321    234568999999999988888999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..........+.       .+.          ...+...+..+.++|.+||+.||.+|+     |++++++|
T Consensus       230 ~~~~~~~~~~i~-------~~~----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        230 ANEPLLIYQKIL-------EGI----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCHHHHHHHHh-------cCC----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            765443332221       100          012223345678999999999999995     89999987

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-33  Score=265.66  Aligned_cols=225  Identities=26%  Similarity=0.419  Sum_probs=188.1

Q ss_pred             ceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           28 NQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        28 ~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      ..+++|.+++        +.+.|.+.+.+++|+|+|++.+++.+ ++.+|+|+|||..|||.++|+-..           
T Consensus       517 ~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~  595 (774)
T KOG1026|consen  517 QLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQD  595 (774)
T ss_pred             eehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-CCeeEEEEEecccccHHHHHHhhCCccccccCCCC
Confidence            3567777754        34466777788899999999999998 679999999999999999996421           


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc-ccccccccc
Q 048068           89 -KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYM  166 (313)
Q Consensus        89 -~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~  166 (313)
                       +.+++..+.+.++.||+.|+.||.   ...++||||-..|+||+++-.+||+|||+++..-...-.+.. ...-...|+
T Consensus       596 ~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWM  672 (774)
T KOG1026|consen  596 TPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWM  672 (774)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecC
Confidence             123788999999999999999999   589999999999999999999999999999754333222222 334467899


Q ss_pred             ccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHH
Q 048068          167 APELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK  245 (313)
Q Consensus       167 aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  245 (313)
                      +||.+..++++.+|||||+|++|||+.+ |..||.+....+.+..++.               ... -..+..++..++.
T Consensus       673 ppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~---------------g~l-L~~Pe~CP~~vY~  736 (774)
T KOG1026|consen  673 PPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA---------------GQL-LSCPENCPTEVYS  736 (774)
T ss_pred             CHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc---------------CCc-ccCCCCCCHHHHH
Confidence            9999999999999999999999999999 9999999998887776641               112 3367788899999


Q ss_pred             HHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          246 LGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       246 li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||..||+.+|++||+++||-..|+.-.
T Consensus       737 LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  737 LMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            999999999999999999999998764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-32  Score=239.01  Aligned_cols=209  Identities=25%  Similarity=0.408  Sum_probs=165.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++.++.+.. ++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||   ..++
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i  121 (256)
T cd05114          47 IEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSF  121 (256)
T ss_pred             HHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            346678889999999999998876 568999999999999999997642 35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||.+...............++..|+|||.+.+..++.++|+||||+++|++++ |+.|
T Consensus       122 ~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p  201 (256)
T cd05114         122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP  201 (256)
T ss_pred             cccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999886543222111122234567999999988889999999999999999999 8999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      |...+..+....+.       .+..     .    ..+...+..+.+++.+||+.+|++|||++++++.|.
T Consensus       202 ~~~~~~~~~~~~i~-------~~~~-----~----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         202 FEKKSNYEVVEMIS-------RGFR-----L----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCHHHHHHHHH-------CCCC-----C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            97665443332221       0000     0    011123457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=267.51  Aligned_cols=244  Identities=24%  Similarity=0.320  Sum_probs=185.9

Q ss_pred             hhHHHHHHHHhhccccc---eEEEcccC-C------ChhhHHhhhhhcc-ccceeeeee-EEe---ccC--CeEEEEEec
Q 048068           12 VLLCVSFILSALAQDVN---QFIYHGFN-E------DPQLQRDGLASVH-SNGLLQLTN-TVN---SRK--GEFLLVYDY   74 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~---~~~~~~~~-~------~~~~~~~~l~~~~-~~~~l~~~~-~~~---~~~--~~~~lV~e~   74 (313)
                      ++-+|-|..+|++++..   .++.|+.- .      ....|.++++.+. |+|||.+++ ...   .++  -.+.|.|||
T Consensus        44 vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEy  123 (738)
T KOG1989|consen   44 VLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEY  123 (738)
T ss_pred             EEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhh
Confidence            34457777778877754   35555542 2      3346777888887 999999998 332   222  367899999


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~  154 (313)
                      |.||.|-+++.......+++..|++|+++++.|+.+||.. +..|+|||||-+|||++.+|..||||||.+...-.....
T Consensus       124 C~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~  202 (738)
T KOG1989|consen  124 CKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTS  202 (738)
T ss_pred             ccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCcc
Confidence            9999999999876556699999999999999999999964 455999999999999999999999999988643222211


Q ss_pred             cc--------ccccccccccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccc
Q 048068          155 QT--------TKLVGTFGYMAPELM---RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI  223 (313)
Q Consensus       155 ~~--------~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  223 (313)
                      ..        -....|+.|++||.+   .+...++|+|||+|||+||.||....||+......+.               
T Consensus       203 ~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl---------------  267 (738)
T KOG1989|consen  203 AQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL---------------  267 (738)
T ss_pred             HHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---------------
Confidence            00        122468999999987   4567799999999999999999999999875433221               


Q ss_pred             cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCC
Q 048068          224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLP  275 (313)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~  275 (313)
                          .....-...+.++..+.+||..||+.||.+||++-|++.++-..+..+
T Consensus       268 ----ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  268 ----NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ----eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                111111123578899999999999999999999999999886665433

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=266.55  Aligned_cols=230  Identities=26%  Similarity=0.436  Sum_probs=193.5

Q ss_pred             ccccceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHH
Q 048068           24 AQDVNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWY   95 (313)
Q Consensus        24 ~~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~   95 (313)
                      ++....++.|.++.        +.-.|..++.|++|||+|++.+++.. ...+.||+|||++|+|..+|+.+. +.|+.-
T Consensus       654 gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-s~PvMIiTEyMENGsLDsFLR~~D-Gqftvi  731 (996)
T KOG0196|consen  654 GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-SKPVMIITEYMENGSLDSFLRQND-GQFTVI  731 (996)
T ss_pred             CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-CceeEEEhhhhhCCcHHHHHhhcC-CceEee
Confidence            34555677777753        33356667788899999999999986 668999999999999999999874 459999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccc--cccccccccccC
Q 048068           96 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG--TFGYMAPELMRT  173 (313)
Q Consensus        96 ~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~  173 (313)
                      ++..+++.|+.|++||.   +.+++||||...||||+.+-..|++|||+++..............|  ...|.|||.+..
T Consensus       732 QLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~  808 (996)
T KOG0196|consen  732 QLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY  808 (996)
T ss_pred             hHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh
Confidence            99999999999999999   6999999999999999999999999999998765544333333333  357999999999


Q ss_pred             CCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCC
Q 048068          174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSH  252 (313)
Q Consensus       174 ~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  252 (313)
                      .+++.++||||+|++|||.++ |..||++....+.+..++.              +.+++  .|.+++..+.+||.+||+
T Consensus       809 RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~--------------gyRLP--pPmDCP~aL~qLMldCWq  872 (996)
T KOG0196|consen  809 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ--------------GYRLP--PPMDCPAALYQLMLDCWQ  872 (996)
T ss_pred             cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh--------------ccCCC--CCCCCcHHHHHHHHHHHH
Confidence            999999999999999999988 9999999999887776641              12333  567888999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhccCCC
Q 048068          253 PKPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       253 ~~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      +|-.+||++.||+.+|+.....
T Consensus       873 kdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  873 KDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHhhcCCCHHHHHHHHHHHhcC
Confidence            9999999999999999887643

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-33  Score=255.18  Aligned_cols=249  Identities=18%  Similarity=0.185  Sum_probs=174.6

Q ss_pred             HHHHHHHHhhccc---cceEEEcccC-CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFN-EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK   89 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~   89 (313)
                      +.|.+..++...+   ...++.|... .....|.+.+++++|++++++.+.+.. +...++|||++ +++|..++...  
T Consensus       101 g~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~--  176 (391)
T PHA03212        101 TPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPRY-KTDLYCYLAAK--  176 (391)
T ss_pred             cCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEecC-CCCHHHHHHhc--
Confidence            3344444444333   2344555443 344568889999999999999998876 66899999999 57898888763  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccc
Q 048068           90 PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE  169 (313)
Q Consensus        90 ~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  169 (313)
                      ..+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.++|+|||++...............||+.|+|||
T Consensus       177 ~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE  253 (391)
T PHA03212        177 RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPE  253 (391)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChh
Confidence            35899999999999999999999   589999999999999999999999999998643322222233457899999999


Q ss_pred             cccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCch-------hhhhHHHHHHH----------------hhhhcccccc
Q 048068          170 LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM-------EMVNLVDWVSD----------------CWKKGAILDA  226 (313)
Q Consensus       170 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~----------------~~~~~~~~~~  226 (313)
                      ++.+..++.++|||||||++|+|++|..||......       .....+.....                .+........
T Consensus       254 ~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (391)
T PHA03212        254 LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSS  333 (391)
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccC
Confidence            999888999999999999999999999886532211       11111100000                0000000000


Q ss_pred             ccccccC--CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          227 SDSRLEG--IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       227 ~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ..+....  ......+..+.+||.+||+.||.+|||++|+++|-.
T Consensus       334 ~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        334 RKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             CCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence            0000000  001123557889999999999999999999998643

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-33  Score=252.88  Aligned_cols=202  Identities=24%  Similarity=0.318  Sum_probs=162.1

Q ss_pred             Hhhhhh-ccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           43 RDGLAS-VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        43 ~~~l~~-~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      ...+.. .+|++++++++.+.. ++.+|+||||+++++|...+...  ..+++..+..++.||+.||.|||   +.+++|
T Consensus        46 ~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH  119 (321)
T cd05591          46 KRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH---RHGVIY  119 (321)
T ss_pred             HHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence            334443 379999999998886 56899999999999999998764  35899999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      |||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus       120 rDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~  198 (321)
T cd05591         120 RDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             cCCCHHHeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence            9999999999999999999999986432221 122345688999999999988899999999999999999999999987


Q ss_pred             CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHH
Q 048068          202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-------NMRQVMQYL  268 (313)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-------t~~ell~~L  268 (313)
                      .........+.       .+.          ...+...+..+.+++..||+.||++||       +++++++|-
T Consensus       199 ~~~~~~~~~i~-------~~~----------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         199 DNEDDLFESIL-------HDD----------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             CCHHHHHHHHH-------cCC----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence            66544333221       000          011222346688999999999999999       899998873

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=252.26  Aligned_cols=209  Identities=23%  Similarity=0.301  Sum_probs=167.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+.+.. ++..|+||||+++++|.+++...  ..+++..+..++.||+.||.|||   ..+++
T Consensus        50 ~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~iv  123 (333)
T cd05600          50 TERDILTTTKSEWLVKLLYAFQD-DEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH---ELGYI  123 (333)
T ss_pred             HHHHHHHhCCCCCCccEEEEEEc-CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45567778899999999988876 67899999999999999999764  35899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++.....    ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus       124 H~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  199 (333)
T cd05600         124 HRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS  199 (333)
T ss_pred             ccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence            999999999999999999999999865432    2234568899999999998899999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+....+..    |... .   ..+. ........+..+.+++.+||..+|.+|||++++++|-
T Consensus       200 ~~~~~~~~~~i~~----~~~~-~---~~~~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         200 GSTPNETWENLKY----WKET-L---QRPV-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             CCCHHHHHHHHHh----cccc-c---cCCC-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            7655443332211    1100 0   0000 0000123456788999999999999999999999873

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.2e-33  Score=247.02  Aligned_cols=195  Identities=23%  Similarity=0.318  Sum_probs=158.3

Q ss_pred             ccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCc
Q 048068           49 VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN  128 (313)
Q Consensus        49 ~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~n  128 (313)
                      ..|+++++..+.+.. ++.+++||||++|++|.+++...  ..+++..+..++.||+.||.|||   ..+|+||||||+|
T Consensus        53 ~~hp~i~~~~~~~~~-~~~~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~N  126 (316)
T cd05592          53 WEHPFLTHLFCTFQT-KEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDN  126 (316)
T ss_pred             cCCCCccceeeEEEc-CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHH
Confidence            479999999988876 66899999999999999999764  36999999999999999999999   5899999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhh
Q 048068          129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV  208 (313)
Q Consensus       129 Ilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  208 (313)
                      |+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.....
T Consensus       127 ill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~  205 (316)
T cd05592         127 VLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF  205 (316)
T ss_pred             eEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999986543222 2233456899999999999888999999999999999999999999876654433


Q ss_pred             hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 048068          209 NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR-QVMQY  267 (313)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~  267 (313)
                      ..+.       .          .....+...+..+.+++.+||+.||.+||++. ++++|
T Consensus       206 ~~i~-------~----------~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         206 DSIL-------N----------DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             HHHH-------c----------CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            2221       0          00112233456678999999999999999875 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-33  Score=249.67  Aligned_cols=228  Identities=23%  Similarity=0.313  Sum_probs=163.8

Q ss_pred             hHHhhhhhccccceeeeeeEEecc----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      .|...++.++|+++++..++....    ...+|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||   +
T Consensus        48 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~  121 (338)
T cd07859          48 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH---T  121 (338)
T ss_pred             HHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH---H
Confidence            456677888999999998887532    23589999999 56999998764  35999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccC--CCCCcchhhHHHHHHHHHH
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRT--GKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l  192 (313)
                      .+++|+||||+||+++.++.++|+|||++........  .......++..|+|||++.+  ..++.++|||||||++|+|
T Consensus       122 ~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el  201 (338)
T cd07859         122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV  201 (338)
T ss_pred             CCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHH
Confidence            8999999999999999999999999999875432211  11233568899999999865  5788999999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHh--------hhhcc---ccccccccccCC---ccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDC--------WKKGA---ILDASDSRLEGI---YEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      ++|++||.+.........+......        +....   .........+..   ........+.+++.+||+.||++|
T Consensus       202 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  281 (338)
T cd07859         202 LTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDR  281 (338)
T ss_pred             HcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccC
Confidence            9999999876544332221110000        00000   000000000000   001234567899999999999999


Q ss_pred             CCHHHHHHH--HhccCCC
Q 048068          259 PNMRQVMQY--LDGNATL  274 (313)
Q Consensus       259 pt~~ell~~--L~~~~~~  274 (313)
                      ||++++++|  +.+....
T Consensus       282 pt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         282 PTAEEALADPYFKGLAKV  299 (338)
T ss_pred             CCHHHHhcCchhhhcCcc
Confidence            999999987  4444433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.2e-33  Score=254.86  Aligned_cols=209  Identities=24%  Similarity=0.328  Sum_probs=160.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++++.+.+ ++++++||||+++|+|.+++...  ..+++..+..++.||+.||.|||   ..+|+
T Consensus        50 ~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH---~~giv  123 (381)
T cd05626          50 AERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH---KMGFI  123 (381)
T ss_pred             HHHHHHHhcCCCCeeeeEEEEec-CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            46677888999999999999887 66899999999999999999764  35899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCC----------------------------------------------CC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDT----------------------------------------------IP  154 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~----------------------------------------------~~  154 (313)
                      ||||||+||+++.++.++|+|||++.......                                              ..
T Consensus       124 HrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (381)
T cd05626         124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC  203 (381)
T ss_pred             ecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence            99999999999999999999999875321000                                              00


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                      ......||..|+|||.+.+..++.++|||||||++|+|++|..||...........+.    .|...       ...+  
T Consensus       204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~----~~~~~-------~~~~--  270 (381)
T cd05626         204 LAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI----NWENT-------LHIP--  270 (381)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH----ccccc-------cCCC--
Confidence            0123468999999999988889999999999999999999999998765443322111    01100       0000  


Q ss_pred             ccHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Q 048068          235 YEEEQMELVLKLGLF--CSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       235 ~~~~~~~~l~~li~~--cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+..+.++|.+  |+..+|..|||++++++|-
T Consensus       271 ~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp  306 (381)
T cd05626         271 PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP  306 (381)
T ss_pred             CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence            111234556677766  5566777799999999973

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-33  Score=253.48  Aligned_cols=204  Identities=25%  Similarity=0.302  Sum_probs=164.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+.+.. ++.+|+||||+++++|..++...  ..+++..+..++.||+.||.|||+  ..+++
T Consensus        44 ~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~iv  118 (325)
T cd05594          44 TENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVV  118 (325)
T ss_pred             HHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEE
Confidence            34456778899999999888776 66899999999999999988764  369999999999999999999994  37999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       119 HrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~  197 (325)
T cd05594         119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  197 (325)
T ss_pred             ecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence            99999999999999999999999986432211 12234568999999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..........+.      ..           ....+...+..+.+++.+||+.||++|+     ++.++++|
T Consensus       198 ~~~~~~~~~~i~------~~-----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         198 NQDHEKLFELIL------ME-----------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCHHHHHHHHh------cC-----------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            765443332221      00           0012223456688999999999999996     99999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.4e-33  Score=248.10  Aligned_cols=197  Identities=24%  Similarity=0.308  Sum_probs=160.1

Q ss_pred             hhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCC
Q 048068           47 ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP  126 (313)
Q Consensus        47 ~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~  126 (313)
                      +.++|+++++..+.+.. ++..|+||||+++++|...+..   ..+++..+..++.||+.||.|||   +.+++||||||
T Consensus        57 ~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp  129 (324)
T cd05589          57 NSERHPFLVNLFACFQT-EDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKL  129 (324)
T ss_pred             cccCCCChhceeeEEEc-CCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCH
Confidence            45679999999998876 6789999999999999988864   35999999999999999999999   58999999999


Q ss_pred             CcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchh
Q 048068          127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME  206 (313)
Q Consensus       127 ~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  206 (313)
                      +||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+....+
T Consensus       130 ~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~  208 (324)
T cd05589         130 DNLLLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE  208 (324)
T ss_pred             HHeEECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999876432211 12234568999999999998889999999999999999999999998765544


Q ss_pred             hhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          207 MVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      ....+.       .+.          ...+...+..+.++|.+||+.||.+||     ++.++++|-
T Consensus       209 ~~~~i~-------~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         209 VFDSIV-------NDE----------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             HHHHHH-------hCC----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence            332221       000          012223456778999999999999999     688888863

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-32  Score=241.57  Aligned_cols=210  Identities=25%  Similarity=0.402  Sum_probs=166.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI------------KPSLSWYQRFRIIRGVASGL  108 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~al  108 (313)
                      .+.+.++.+.|+++++.+++... +...++||||+++++|.+++....            ...+++..+..++.|++.|+
T Consensus        57 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l  135 (280)
T cd05049          57 REAELLTNFQHENIVKFYGVCTE-GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM  135 (280)
T ss_pred             HHHHHHHhcCCCCchheeeEEec-CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHH
Confidence            35556777899999999999887 578999999999999999997532            24578899999999999999


Q ss_pred             HHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHH
Q 048068          109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV  187 (313)
Q Consensus       109 ~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  187 (313)
                      .+||   ..+++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+
T Consensus       136 ~~lH---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  212 (280)
T cd05049         136 VYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV  212 (280)
T ss_pred             HHHh---hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence            9999   68999999999999999999999999998864322111 1112234467899999999888999999999999


Q ss_pred             HHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          188 FMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       188 il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ++|+|++ |..||......+....+.       .+.         ....+...+..+.+++..||+.||++|||+.|+++
T Consensus       213 il~e~~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         213 VLWEIFTYGKQPWYGLSNEEVIECIT-------QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHH-------cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999998 999997765544332221       110         01112234567899999999999999999999999


Q ss_pred             HHhc
Q 048068          267 YLDG  270 (313)
Q Consensus       267 ~L~~  270 (313)
                      .|++
T Consensus       277 ~l~~  280 (280)
T cd05049         277 RLQK  280 (280)
T ss_pred             HhhC
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.6e-32  Score=237.14  Aligned_cols=209  Identities=24%  Similarity=0.422  Sum_probs=167.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.++++.+.|+++++++++..  .+..++||||+.+++|.+++.......+++..+..++.|++.||.|||   +.+++
T Consensus        50 ~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~  124 (260)
T cd05069          50 QEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI  124 (260)
T ss_pred             HHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence            4667888899999999988875  356889999999999999998754556899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||++++++.++|+|||++...............++..|++||...+..++.++|+||||+++|++++ |..||
T Consensus       125 H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  204 (260)
T cd05069         125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY  204 (260)
T ss_pred             ecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987554322111222345667999999988889999999999999999999 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .+....+....+.       .+.         ....+...+..+.+++.+||+.||++|||++++++.|++
T Consensus       205 ~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         205 PGMVNREVLEQVE-------RGY---------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCHHHHHHHHH-------cCC---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            8765443322210       100         001223445678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-33  Score=248.87  Aligned_cols=199  Identities=24%  Similarity=0.272  Sum_probs=160.4

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCc
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI  124 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl  124 (313)
                      .++.++|+++++..+.+.. ++..++||||+++++|..++..+  +.+++..+..++.||+.||.|||   ..+++||||
T Consensus        49 ~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~di  122 (323)
T cd05575          49 LLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDL  122 (323)
T ss_pred             HHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCC
Confidence            4567899999999988876 67899999999999999999764  46999999999999999999999   589999999


Q ss_pred             CCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCc
Q 048068          125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS  204 (313)
Q Consensus       125 ~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  204 (313)
                      ||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       123 kp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  201 (323)
T cd05575         123 KPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT  201 (323)
T ss_pred             CHHHeEECCCCcEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH
Confidence            9999999999999999999886432211 122345689999999999988899999999999999999999999987654


Q ss_pred             hhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Q 048068          205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM----RQVMQY  267 (313)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~----~ell~~  267 (313)
                      .+....+.       .+          ....+...+..+.+++.+||+.||.+||++    .++++|
T Consensus       202 ~~~~~~i~-------~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         202 AEMYDNIL-------NK----------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             HHHHHHHH-------cC----------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence            43332221       00          001122335678899999999999999987    466654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-32  Score=238.21  Aligned_cols=208  Identities=27%  Similarity=0.402  Sum_probs=165.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++++++... .+..++||||+++++|.+++... ...+++..+..++.|++.|+.|||   ..+++
T Consensus        48 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~  122 (256)
T cd05059          48 EEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLE---SNGFI  122 (256)
T ss_pred             HHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45567888999999999988776 56889999999999999999765 236899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++...............++..|++||.+.+..++.++|+||||+++|++++ |..||
T Consensus       123 H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  202 (256)
T cd05059         123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY  202 (256)
T ss_pred             cccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCC
Confidence            99999999999999999999999886543222111111223457999999988889999999999999999999 89999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ......+....+.       ..         .....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       203 ~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         203 ERFSNSEVVESVS-------AG---------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCHHHHHHHHH-------cC---------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            7665544332221       00         001112234567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-32  Score=237.73  Aligned_cols=223  Identities=25%  Similarity=0.405  Sum_probs=173.8

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .++.|.+...      ...|.+.++.++|+++++++....  ....++||||+++++|.+++.......+++..+..++.
T Consensus        32 ~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~  109 (262)
T cd05071          32 RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA  109 (262)
T ss_pred             eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHH
Confidence            3555555432      234556778889999999988765  35689999999999999999865455689999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+...............++..|++||...+..++.++|+
T Consensus       110 ~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv  186 (262)
T cd05071         110 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV  186 (262)
T ss_pred             HHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhH
Confidence            9999999999   5899999999999999999999999999987554332212222345667999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|++++ |..||...........+.       ..         .....+...+..+.+++.+|++.+|.+|||+
T Consensus       187 wslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~  250 (262)
T cd05071         187 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RG---------YRMPCPPECPESLHDLMCQCWRKEPEERPTF  250 (262)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------cC---------CCCCCccccCHHHHHHHHHHccCCcccCCCH
Confidence            999999999999 888997665443332211       00         0011233455678999999999999999999


Q ss_pred             HHHHHHHhccC
Q 048068          262 RQVMQYLDGNA  272 (313)
Q Consensus       262 ~ell~~L~~~~  272 (313)
                      .++++.|++..
T Consensus       251 ~~~~~~l~~~~  261 (262)
T cd05071         251 EYLQAFLEDYF  261 (262)
T ss_pred             HHHHHHHHHhc
Confidence            99999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.4e-33  Score=248.29  Aligned_cols=220  Identities=25%  Similarity=0.306  Sum_probs=177.9

Q ss_pred             ceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           28 NQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        28 ~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ...+.|.+..          -...|...|.+.+.+.+++.+.-+++ ..++||||||++||++..+|.+  ...+++..+
T Consensus       167 ~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~a  243 (550)
T KOG0605|consen  167 EIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWA  243 (550)
T ss_pred             cEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeEEEEEecCCccHHHHHHh--cCcCchHHH
Confidence            3556666643          23467788889999999999999998 7799999999999999999987  447999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCC-----------------------CCCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-----------------------DTIP  154 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~-----------------------~~~~  154 (313)
                      ..++.+++.|+..+|   +.|++||||||+|+||+..|.+||+|||++.-...                       ....
T Consensus       244 rfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (550)
T KOG0605|consen  244 RFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPK  320 (550)
T ss_pred             HHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccc
Confidence            999999999999999   69999999999999999999999999999842210                       0000


Q ss_pred             ----cc-------------------ccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHH
Q 048068          155 ----QT-------------------TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV  211 (313)
Q Consensus       155 ----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  211 (313)
                          ..                   ....|||-|+|||++.+.+|+..+|-||||||+||||.|.+||...+..+++..+
T Consensus       321 ~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI  400 (550)
T KOG0605|consen  321 FNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKI  400 (550)
T ss_pred             cccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                00                   1236999999999999999999999999999999999999999999988888777


Q ss_pred             HHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Q 048068          212 DWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP---NMRQVMQY  267 (313)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---t~~ell~~  267 (313)
                      ..-+..|..           +  ......+...+||.+||. ||++|.   .++||-+|
T Consensus       401 ~nwr~~l~f-----------P--~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  401 VNWRETLKF-----------P--EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHHhhhccC-----------C--CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            543333331           0  111223677889998998 999996   58888774

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2e-32  Score=241.81  Aligned_cols=213  Identities=26%  Similarity=0.443  Sum_probs=169.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~  106 (313)
                      .+.+.++.++|++++++.+.... +...++||||+++++|.+++....              ...+++..++.++.||+.
T Consensus        56 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~  134 (291)
T cd05094          56 REAELLTNLQHEHIVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIAS  134 (291)
T ss_pred             HHHHHHhcCCCCCcceEEEEEcc-CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHH
Confidence            44566788899999999998876 568999999999999999997532              235899999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      |+.|||   ..+++|+||+|+||+++.++.++|+|||++......... ......++..|++||.+.+..++.++|+|||
T Consensus       135 al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  211 (291)
T cd05094         135 GMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF  211 (291)
T ss_pred             HHHHHH---hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence            999999   699999999999999999999999999998654322211 1122345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       186 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      |+++|+|++ |..||............       ..+...         ..+...+..+.+++.+||+.+|++|||++++
T Consensus       212 G~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v  275 (291)
T cd05094         212 GVILWEIFTYGKQPWFQLSNTEVIECI-------TQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEI  275 (291)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHH-------hCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            999999998 99998765544322211       111110         1122245678999999999999999999999


Q ss_pred             HHHHhccCC
Q 048068          265 MQYLDGNAT  273 (313)
Q Consensus       265 l~~L~~~~~  273 (313)
                      ++.|++...
T Consensus       276 ~~~l~~~~~  284 (291)
T cd05094         276 YKILHALGK  284 (291)
T ss_pred             HHHHHHHHh
Confidence            999998865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-32  Score=237.84  Aligned_cols=209  Identities=28%  Similarity=0.400  Sum_probs=165.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++++++... +...++||||+.+++|.+++.... ..+++..++.++.||+.|+.|||   ..++
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i  121 (256)
T cd05113          47 IEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE---SKQF  121 (256)
T ss_pred             HHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            346677788899999999998876 557899999999999999997642 36899999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||.+...............++..|.+||...+..++.++|+||||+++|++++ |..|
T Consensus       122 ~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p  201 (256)
T cd05113         122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP  201 (256)
T ss_pred             eccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999999886543322111112234567999999988888999999999999999998 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      |...........+.       .+..         ...+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       202 ~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         202 YERFNNSETVEKVS-------QGLR---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             cCcCCHHHHHHHHh-------cCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            97655443322221       0000         0011123567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.2e-33  Score=249.02  Aligned_cols=194  Identities=22%  Similarity=0.334  Sum_probs=158.7

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcE
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV  129 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nI  129 (313)
                      .|++++++++.+.. ++.+|+||||+++++|.+++...  ..+++..+..++.|++.||.|||   ..+++||||||+||
T Consensus        54 ~h~~iv~~~~~~~~-~~~~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NI  127 (320)
T cd05590          54 NHPFLTQLYCCFQT-PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNV  127 (320)
T ss_pred             CCCchhceeeEEEc-CCEEEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHe
Confidence            69999999988876 67899999999999999998764  35999999999999999999999   68999999999999


Q ss_pred             EEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhh
Q 048068          130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN  209 (313)
Q Consensus       130 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  209 (313)
                      +++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~  206 (320)
T cd05590         128 LLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE  206 (320)
T ss_pred             EECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence            99999999999999986432211 12234568999999999998889999999999999999999999998766544333


Q ss_pred             HHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 048068          210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM------RQVMQY  267 (313)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~------~ell~~  267 (313)
                      .+.       .+.          ...+...+..+.+++.+||+.||++||++      +++++|
T Consensus       207 ~i~-------~~~----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         207 AIL-------NDE----------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             HHh-------cCC----------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            221       100          01222345678899999999999999998      777775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.9e-33  Score=248.75  Aligned_cols=199  Identities=23%  Similarity=0.284  Sum_probs=159.3

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCc
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI  124 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl  124 (313)
                      .++.++|+++++..+.+.. ++..++||||+++++|...+...  +.+++..+..++.||+.||.|||   ..+++||||
T Consensus        49 ~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dl  122 (321)
T cd05603          49 LLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDL  122 (321)
T ss_pred             HHHhCCCCCccceeeEEEc-CCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccC
Confidence            5677899999999988776 66899999999999999888763  45899999999999999999999   589999999


Q ss_pred             CCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCc
Q 048068          125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS  204 (313)
Q Consensus       125 ~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  204 (313)
                      ||+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       123 kp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  201 (321)
T cd05603         123 KPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV  201 (321)
T ss_pred             CHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence            9999999999999999999886432211 122345688999999999888899999999999999999999999987654


Q ss_pred             hhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH
Q 048068          205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR----QVMQY  267 (313)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~----ell~~  267 (313)
                      ......+.      ..           +...+......+.+++.+||+.||.+||++.    ++++|
T Consensus       202 ~~~~~~i~------~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         202 SQMYDNIL------HK-----------PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             HHHHHHHh------cC-----------CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence            33322210      00           1112333456788999999999999999753    55543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-32  Score=247.41  Aligned_cols=222  Identities=23%  Similarity=0.321  Sum_probs=165.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+++.. ++++++||||+++++|.+++...  +.+++..+..++.|++.|+.|||+  ..++
T Consensus        51 ~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i  125 (333)
T cd06650          51 IRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKI  125 (333)
T ss_pred             HHHHHHHHHCCCCcccceeEEEEE-CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCE
Confidence            356677888999999999999887 67899999999999999999864  358999999999999999999995  3579


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||||+||+++.++.++|+|||++......   ......++..|+|||.+.+..++.++|+|||||++|++++|+.||
T Consensus       126 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~  202 (333)
T cd06650         126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI  202 (333)
T ss_pred             EecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999998644322   122346788999999999888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHH-HHhhhhcccc---------------------------cc-ccccccCCccHHHHHHHHHHHHHc
Q 048068          200 EQQGSMEMVNLVDWV-SDCWKKGAIL---------------------------DA-SDSRLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~-~~~~~~~~~~---------------------------~~-~~~~~~~~~~~~~~~~l~~li~~c  250 (313)
                      ............... ...+......                           .. .....+..........+.+|+.+|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  282 (333)
T cd06650         203 PPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKC  282 (333)
T ss_pred             CCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHh
Confidence            765443222111000 0000000000                           00 000000000111345689999999


Q ss_pred             CCCCCCCCCCHHHHHHHHh
Q 048068          251 SHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~L~  269 (313)
                      |+.||++|||+.|+++|-.
T Consensus       283 L~~~P~~Rpt~~ell~h~~  301 (333)
T cd06650         283 LIKNPAERADLKQLMVHAF  301 (333)
T ss_pred             ccCCcccCcCHHHHhhCHH
Confidence            9999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.4e-33  Score=242.12  Aligned_cols=221  Identities=26%  Similarity=0.452  Sum_probs=165.4

Q ss_pred             ceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           28 NQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        28 ~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ..+++|.++.        ....+.+.++.++|++++++.++... .+..++||||+++|+|.+++.......+++..++.
T Consensus        29 ~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~  107 (259)
T PF07714_consen   29 QPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLS  107 (259)
T ss_dssp             EEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHH
T ss_pred             EEEEEEEeccccccccceeeeecccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccc
Confidence            3556666643        12233445566799999999999995 55699999999999999999987556799999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCc
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKAST  178 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  178 (313)
                      |+.||+.||.|||+   .+++|++|+++||+++.++.+||+|||+......... ...........|.|||.+.+..++.
T Consensus       108 i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  184 (259)
T PF07714_consen  108 IAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTK  184 (259)
T ss_dssp             HHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESH
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999994   8999999999999999999999999999876532211 1122234567899999998888999


Q ss_pred             chhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC
Q 048068          179 STDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA  257 (313)
Q Consensus       179 ~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~  257 (313)
                      ++||||||+++||+++ |+.||......+....+.       .+         .....+...+..+.++|..||+.||++
T Consensus       185 ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~C~~~~p~~  248 (259)
T PF07714_consen  185 KSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-------QG---------QRLPIPDNCPKDIYSLIQQCWSHDPEK  248 (259)
T ss_dssp             HHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-------TT---------EETTSBTTSBHHHHHHHHHHT-SSGGG
T ss_pred             ccccccccccccccccccccccccccccccccccc-------cc---------ccceeccchhHHHHHHHHHHcCCChhh
Confidence            9999999999999999 789987765544332221       11         111123345667889999999999999


Q ss_pred             CCCHHHHHHHH
Q 048068          258 RPNMRQVMQYL  268 (313)
Q Consensus       258 Rpt~~ell~~L  268 (313)
                      |||++++++.|
T Consensus       249 RPs~~~i~~~L  259 (259)
T PF07714_consen  249 RPSFQEILQEL  259 (259)
T ss_dssp             S--HHHHHHHH
T ss_pred             CcCHHHHHhcC
Confidence            99999999976

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-32  Score=246.75  Aligned_cols=216  Identities=25%  Similarity=0.373  Sum_probs=168.0

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHH
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVA  105 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~  105 (313)
                      .+.+.++.+ .|+++++..+.... ++..++||||+++++|.+++....              ...++...+..++.|++
T Consensus        66 ~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  144 (334)
T cd05100          66 SEMEMMKMIGKHKNIINLLGACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVA  144 (334)
T ss_pred             HHHHHHHhhcCCCCeeeeeEEEcc-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHH
Confidence            455667777 79999999998876 568999999999999999997532              12477888999999999


Q ss_pred             HHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHH
Q 048068          106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYA  184 (313)
Q Consensus       106 ~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws  184 (313)
                      .||.|||   ..+++|+||+|+||+++.++.++|+|||++.......... .....++..|++||.+.+..++.++|+||
T Consensus       145 ~al~~LH---~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  221 (334)
T cd05100         145 RGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  221 (334)
T ss_pred             HHHHHHH---HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHH
Confidence            9999999   6899999999999999999999999999986543221111 11223346799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       185 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      ||+++|+|++ |..||......+....+.       .+.         ....+...+..+.+++..||+.+|++|||+.+
T Consensus       222 lG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e  285 (334)
T cd05100         222 FGVLLWEIFTLGGSPYPGIPVEELFKLLK-------EGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQ  285 (334)
T ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            9999999998 889987665444332221       100         00112234457889999999999999999999


Q ss_pred             HHHHHhccCCCCC
Q 048068          264 VMQYLDGNATLPD  276 (313)
Q Consensus       264 ll~~L~~~~~~~~  276 (313)
                      ++++|+.......
T Consensus       286 ll~~l~~~~~~~~  298 (334)
T cd05100         286 LVEDLDRVLTVTS  298 (334)
T ss_pred             HHHHHHHHhhhcC
Confidence            9999998875443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-32  Score=236.95  Aligned_cols=209  Identities=26%  Similarity=0.436  Sum_probs=167.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++.++...  .+..++||||+++++|.+++.......+++..+..++.|++.||.|||   +.+++
T Consensus        50 ~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~  124 (260)
T cd05070          50 EEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI  124 (260)
T ss_pred             HHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            5667888899999999998875  356889999999999999998754556899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++...............++..|+|||...+..++.++|+||||+++|++++ |..||
T Consensus       125 H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~  204 (260)
T cd05070         125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY  204 (260)
T ss_pred             cCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999987554322111122234567999999888888999999999999999999 89999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .+....+....+.       ...         ....+...+..+.+|+.+||+.+|++|||+.++++.|++
T Consensus       205 ~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         205 PGMNNREVLEQVE-------RGY---------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCHHHHHHHHH-------cCC---------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            7655443222221       100         011223345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-32  Score=237.83  Aligned_cols=209  Identities=28%  Similarity=0.452  Sum_probs=167.2

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...++.++|+++++..+.+.. ++..++||||+++++|.+++... ...+++..+..++.|++.|+.|||   +.+++|
T Consensus        55 e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H  129 (266)
T cd05033          55 EASIMGQFDHPNIIRLEGVVTK-SRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLS---EMNYVH  129 (266)
T ss_pred             HHHHHHhCCCCCcceEeEEEec-CCceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence            5567788899999999998876 56799999999999999999765 346899999999999999999999   689999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      +||+|+||+++.++.++|+|||++........ .......++..|++||.+.+..++.++|+||||+++|++++ |..||
T Consensus       130 ~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~  209 (266)
T cd05033         130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             CCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCC
Confidence            99999999999999999999999876542111 11112234567999999988889999999999999999998 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ...........+.       ....         ...+...+..+.+++.+||+.+|++|||+++++++|+..
T Consensus       210 ~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         210 WDMSNQDVIKAVE-------DGYR---------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCHHHHHHHHH-------cCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            7655443322221       1000         001223456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.8e-32  Score=236.31  Aligned_cols=207  Identities=27%  Similarity=0.388  Sum_probs=166.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.....++..++||||+++++|.+++.......+++..++.++.|++.||.|||   ..+++
T Consensus        48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  124 (256)
T cd05082          48 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV  124 (256)
T ss_pred             HHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence            466778889999999999887766778999999999999999998764556899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++.......    .....+..|++||.+.+..++.++|+|||||++|+|++ |+.||
T Consensus       125 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~  200 (256)
T cd05082         125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY  200 (256)
T ss_pred             ccccchheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886432211    12233567999999988888999999999999999997 99998


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ...........+.       .+.         ....+...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       201 ~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         201 PRIPLKDVVPRVE-------KGY---------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCHHHHHHHHh-------cCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            7554333221110       100         011222345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-32  Score=236.15  Aligned_cols=206  Identities=28%  Similarity=0.421  Sum_probs=166.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+.... ++..++||||+++++|.+++.......+++..++.++.|++.|+.|||   ..+++
T Consensus        48 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~  123 (256)
T cd08529          48 DEARVLAKLDSSYIIRYYESFLD-KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKIL  123 (256)
T ss_pred             HHHHHHHhcCCCCeehheeeecc-CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            34456788899999999988876 568999999999999999998754567999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|++||+..+..++.++|+||||+++|++++|+.||.
T Consensus       124 h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  202 (256)
T cd08529         124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD  202 (256)
T ss_pred             cCCCCcceEEEeCCCCEEEcccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999998875543321 1223457788999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ............       .+         .....+......+.+++.+||+.+|++||++.+++++
T Consensus       203 ~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         203 ANNQGALILKII-------RG---------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCHHHHHHHHH-------cC---------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            665332221110       00         0111222455678999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9e-33  Score=248.66  Aligned_cols=209  Identities=23%  Similarity=0.306  Sum_probs=162.3

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...++.+ +|+++++..+.+.. ++.+++||||+++|+|.+++...  ..+++..+..++.||+.||.|||   +.++
T Consensus        53 ~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i  126 (332)
T cd05614          53 TERNVLEHVRQSPFLVTLHYAFQT-EAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGI  126 (332)
T ss_pred             HHHHHHHhccCCCCcccEEEEEec-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            455666777 58999998887766 66899999999999999999764  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +||||||+||+++.++.++|+|||++...............|+..|+|||.+.+. .++.++|||||||++|+|++|..|
T Consensus       127 vHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  206 (332)
T cd05614         127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP  206 (332)
T ss_pred             EecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence            9999999999999999999999999875433322223345689999999998765 478899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      |.............  .....           .....+...+..+.+++.+||+.||++||     +++++++|-
T Consensus       207 f~~~~~~~~~~~~~--~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  268 (332)
T cd05614         207 FTLEGERNTQSEVS--RRILK-----------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP  268 (332)
T ss_pred             CCCCCCCCCHHHHH--HHHhc-----------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence            97543322211110  00000           01112233456788999999999999999     888999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-32  Score=237.25  Aligned_cols=207  Identities=21%  Similarity=0.324  Sum_probs=165.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++.++++.. +...++||||+++++|.+.+...  +.+++..+..++.|++.|+.|||   +.+++
T Consensus        53 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~  126 (263)
T cd06625          53 CEIQLLKNLQHERIVQYYGCLRD-DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH---SNMIV  126 (263)
T ss_pred             HHHHHHHhCCCCCeeeeEEEEcc-CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            35567788899999999999887 45999999999999999999864  35899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc--ccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      |+||+|+||+++.++.++|+|||++...........  ....++..|+|||.+.+..++.++|+||||+++|++++|+.|
T Consensus       127 H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  206 (263)
T cd06625         127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP  206 (263)
T ss_pred             cCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999865432211111  234567889999999988899999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |.............      ..         ......+......+.+++..||..+|++|||+.++++|.
T Consensus       207 ~~~~~~~~~~~~~~------~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         207 WAEFEAMAAIFKIA------TQ---------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ccccchHHHHHHHh------cc---------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            97654332221110      00         011123334556788999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-32  Score=244.96  Aligned_cols=196  Identities=22%  Similarity=0.333  Sum_probs=157.7

Q ss_pred             hccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCC
Q 048068           48 SVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA  127 (313)
Q Consensus        48 ~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~  127 (313)
                      ...|+++++.++.+.. ++++++||||+++++|..++...  ..+++..+..++.||+.||+|||   ..+++||||||+
T Consensus        52 ~~~~~~i~~~~~~~~~-~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~  125 (316)
T cd05620          52 AWENPFLTHLYCTFQT-KEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLD  125 (316)
T ss_pred             ccCCCCccCeeEEEEe-CCEEEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHH
Confidence            3489999999988876 66999999999999999998764  45899999999999999999999   589999999999


Q ss_pred             cEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhh
Q 048068          128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM  207 (313)
Q Consensus       128 nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  207 (313)
                      ||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus       126 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~  204 (316)
T cd05620         126 NVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL  204 (316)
T ss_pred             HeEECCCCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999886432111 122345689999999999988899999999999999999999999987655433


Q ss_pred             hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 048068          208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR-QVMQY  267 (313)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~  267 (313)
                      ...+.       ..      .+    ..+......+.+++.+||+.||++||++. ++++|
T Consensus       205 ~~~~~-------~~------~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         205 FESIR-------VD------TP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             HHHHH-------hC------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            32221       00      01    11222445688999999999999999984 66644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.9e-33  Score=248.27  Aligned_cols=200  Identities=24%  Similarity=0.347  Sum_probs=159.9

Q ss_pred             hhhhh-ccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           44 DGLAS-VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        44 ~~l~~-~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      ..+.. ..|+++++..+.+.. ++.+++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   ..+++||
T Consensus        47 ~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHr  120 (316)
T cd05619          47 RVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYR  120 (316)
T ss_pred             HHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeC
Confidence            34443 589999999988876 56899999999999999999763  35899999999999999999999   5899999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccC
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ  202 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (313)
                      ||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       121 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         121 DLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             CCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999886432211 1223456889999999999888999999999999999999999999876


Q ss_pred             CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 048068          203 GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR-QVMQY  267 (313)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~  267 (313)
                      +..+....+..       .      .+.    .+......+.+++.+||+.||++||++. ++++|
T Consensus       200 ~~~~~~~~i~~-------~------~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         200 DEEELFQSIRM-------D------NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             CHHHHHHHHHh-------C------CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence            54433322210       0      011    1223445688999999999999999997 77664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-32  Score=235.69  Aligned_cols=211  Identities=26%  Similarity=0.438  Sum_probs=168.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+.... +...++||||+++++|.+++.......+++..+..++.|++.|+.|||   ..++
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i  124 (261)
T cd05034          49 LQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNY  124 (261)
T ss_pred             HHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            356677888999999999988876 567899999999999999998765567999999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++................+..|++||.+.+..++.++|+||||+++|++++ |+.|
T Consensus       125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  204 (261)
T cd05034         125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP  204 (261)
T ss_pred             ccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987554322111222234567999999988889999999999999999998 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      |.+.........+.       .+.         ....+...+..+.+++.+||..+|.+|||++++++.|++
T Consensus       205 ~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         205 YPGMTNREVLEQVE-------RGY---------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCHHHHHHHHH-------cCC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            97655433322221       000         001112235678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-32  Score=240.99  Aligned_cols=210  Identities=26%  Similarity=0.349  Sum_probs=164.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.+++++|++++++.+.+.. +.++++||||++|++|.+++.......+++..+..++.|++.|+.|||   ..+++
T Consensus        42 ~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iv  117 (277)
T cd05607          42 LEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV  117 (277)
T ss_pred             HHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEE
Confidence            46778899999999999888876 678999999999999999987654556999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+|||||++|++++|+.||.
T Consensus       118 H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~  195 (277)
T cd05607         118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK  195 (277)
T ss_pred             EccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987554322  1223467889999999988889999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ........  .......... .        .. ......+..+.+++..||+.||++|||++|+++.+
T Consensus       196 ~~~~~~~~--~~~~~~~~~~-~--------~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         196 DHKEKVAK--EELKRRTLED-E--------VK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCcchhhH--HHHHHHhhcc-c--------cc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            64332211  1111111110 0        00 01113456689999999999999999996655433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-32  Score=240.69  Aligned_cols=211  Identities=25%  Similarity=0.413  Sum_probs=165.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---------------CCCCCHHHHHHHHHHH
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---------------KPSLSWYQRFRIIRGV  104 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~i~~qi  104 (313)
                      ..|...++.++|++++++.+.+.. +...|+||||+++++|.+++....               ...+++..+..++.|+
T Consensus        55 ~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  133 (283)
T cd05090          55 QQEASLMAELHHPNIVCLLGVVTQ-EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI  133 (283)
T ss_pred             HHHHHHHhhCCCCCeeeEEEEEec-CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHH
Confidence            346678889999999999998876 568999999999999999985321               2347888999999999


Q ss_pred             HHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhH
Q 048068          105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVY  183 (313)
Q Consensus       105 ~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  183 (313)
                      +.||.|||   ..+++|+||+|+||+++.++.++|+|||++........ .......++..|++||.+.+..++.++|+|
T Consensus       134 ~~al~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~  210 (283)
T cd05090         134 AAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIW  210 (283)
T ss_pred             HHHHHHHH---hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhH
Confidence            99999999   58999999999999999999999999999865432211 111223345679999999888889999999


Q ss_pred             HHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048068          184 AFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR  262 (313)
Q Consensus       184 slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  262 (313)
                      |||+++|+|++ |..||.+.........+.       ....         ...+...+..+.+++.+||+.||.+||++.
T Consensus       211 slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  274 (283)
T cd05090         211 SFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-------KRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFK  274 (283)
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence            99999999998 999997765433322221       0000         012223456788999999999999999999


Q ss_pred             HHHHHHhc
Q 048068          263 QVMQYLDG  270 (313)
Q Consensus       263 ell~~L~~  270 (313)
                      +++++|..
T Consensus       275 ~i~~~l~~  282 (283)
T cd05090         275 DIHTRLRS  282 (283)
T ss_pred             HHHHHhhc
Confidence            99999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.9e-32  Score=234.74  Aligned_cols=209  Identities=23%  Similarity=0.366  Sum_probs=164.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|++++++.++... ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||   ..++
T Consensus        41 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i  115 (252)
T cd05084          41 LQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHC  115 (252)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            445667788899999999998876 56899999999999999999764 345899999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc-ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||++........... .....+..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus       116 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~  195 (252)
T cd05084         116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAV  195 (252)
T ss_pred             cccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999864322111110 11122456999999988889999999999999999997 889


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ||...........+.       ..         .....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       196 p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         196 PYANLSNQQTREAIE-------QG---------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CccccCHHHHHHHHH-------cC---------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            987655433222221       00         011122334567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.9e-33  Score=260.48  Aligned_cols=248  Identities=21%  Similarity=0.253  Sum_probs=174.5

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC------ChhhHHhhhhhccccc------eeeeeeEEeccCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE------DPQLQRDGLASVHSNG------LLQLTNTVNSRKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~l~~~~~~~------~l~~~~~~~~~~~~~~lV~e~~~   76 (313)
                      +++.|.+..+|.+.+   ...+++|.+..      ....+.++++++.|.+      ++++..++....+++|+||+++ 
T Consensus       136 ~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-  214 (467)
T PTZ00284        136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-  214 (467)
T ss_pred             EEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-
Confidence            345566655555544   23456665532      2234566777776654      6666666666667899999998 


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC----------------cEEEe
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL----------------NGKLG  140 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~----------------~~~l~  140 (313)
                      +++|.+++.+.  ..+++..+..++.||+.||.|||+  ..+|+||||||+||+++..+                .+||+
T Consensus       215 g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~  290 (467)
T PTZ00284        215 GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC  290 (467)
T ss_pred             CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEEC
Confidence            88999988764  369999999999999999999994  25999999999999998665                48999


Q ss_pred             ecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHH----
Q 048068          141 DFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD----  216 (313)
Q Consensus       141 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----  216 (313)
                      |||.+.....    ......||..|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.....    
T Consensus       291 DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~  366 (467)
T PTZ00284        291 DLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS  366 (467)
T ss_pred             CCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Confidence            9998753221    22345789999999999988999999999999999999999999987766554443322111    


Q ss_pred             hhhhc--------------ccccccccc-c------cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          217 CWKKG--------------AILDASDSR-L------EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       217 ~~~~~--------------~~~~~~~~~-~------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .|...              .......+. .      ...........+.+||.+||..||++|||++|+++|-
T Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             HHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            01100              000000000 0      0000011235678999999999999999999999953

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.4e-33  Score=250.49  Aligned_cols=208  Identities=25%  Similarity=0.296  Sum_probs=163.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+.+.+ ++..++||||+++++|.+++... ...+++..+..++.||+.||.|||   ..+++
T Consensus        50 ~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~  124 (330)
T cd05601          50 EERDILSISNSPWIPQLQYAFQD-KDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH---QMGYV  124 (330)
T ss_pred             HHHHHHHhCCCCCCcceeeEEec-CCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            45566777899999999888876 56899999999999999999875 346999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc------CCCCCcchhhHHHHHHHHHHHh
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR------TGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~  194 (313)
                      ||||||+||+++.++.++|+|||++...............+++.|+|||++.      ...++.++|||||||++|+|++
T Consensus       125 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~  204 (330)
T cd05601         125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY  204 (330)
T ss_pred             cccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc
Confidence            9999999999999999999999998765433222223346889999999986      3456789999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |..||...........+.      ....   ..  ..+  .....+..+.+++..||. +|.+|||++++++|
T Consensus       205 g~~Pf~~~~~~~~~~~i~------~~~~---~~--~~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         205 GRSPFHEGTSAKTYNNIM------NFQR---FL--KFP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCCCCCCCCHHHHHHHHH------cCCC---cc--CCC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            999998765544332221      0000   00  000  111244668889999998 99999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.3e-32  Score=239.27  Aligned_cols=209  Identities=27%  Similarity=0.339  Sum_probs=164.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+...++.++|+++++....+.. ++..++||||+++++|...+...  ....+++..+..++.||+.||.|||   +.+
T Consensus        42 ~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~  117 (280)
T cd05608          42 VEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR  117 (280)
T ss_pred             HHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            46667888999999999887776 56899999999999999887532  2456999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|
T Consensus       118 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  196 (280)
T cd05608         118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP  196 (280)
T ss_pred             cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999865443221 22334678999999999988899999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      |............  ......           .....+...+..+.+++..||+.||++||     |++++++|
T Consensus       197 f~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         197 FRARGEKVENKEL--KQRILN-----------DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCCCCcchhHHHH--HHhhcc-----------cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            9765432211111  000000           01112334566788999999999999999     78999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.9e-32  Score=234.82  Aligned_cols=222  Identities=23%  Similarity=0.412  Sum_probs=173.3

Q ss_pred             ceEEEcccCC------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 048068           28 NQFIYHGFNE------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII  101 (313)
Q Consensus        28 ~~~~~~~~~~------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  101 (313)
                      ..++.|.+..      ....|...++.++|+++++..+...  .+.+++||||+++++|.+++.......+++..+..++
T Consensus        31 ~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~  108 (260)
T cd05067          31 TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA  108 (260)
T ss_pred             ceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHH
Confidence            3455555543      2234556778889999999998864  4578999999999999999987655679999999999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchh
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD  181 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  181 (313)
                      .|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...............++..|++||.+.+..++.++|
T Consensus       109 ~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D  185 (260)
T cd05067         109 AQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD  185 (260)
T ss_pred             HHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccc
Confidence            99999999999   689999999999999999999999999998655422222222234467899999998888899999


Q ss_pred             hHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          182 VYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       182 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      +||||+++|++++ |..||.............       .+..         ...+...+..+.+++.+||+.+|++|||
T Consensus       186 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~  249 (260)
T cd05067         186 VWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RGYR---------MPRPDNCPEELYELMRLCWKEKPEERPT  249 (260)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cCCC---------CCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999999998 999998765544332221       1100         0112233467999999999999999999


Q ss_pred             HHHHHHHHhc
Q 048068          261 MRQVMQYLDG  270 (313)
Q Consensus       261 ~~ell~~L~~  270 (313)
                      ++++++.|+.
T Consensus       250 ~~~l~~~l~~  259 (260)
T cd05067         250 FEYLRSVLED  259 (260)
T ss_pred             HHHHHHHhhc
Confidence            9999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-33  Score=250.81  Aligned_cols=203  Identities=25%  Similarity=0.350  Sum_probs=164.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.++.++|+++++..+.+.. ++.+|+||||+++++|.+++.+.  ..+++..++.++.||+.||.|||   ..+++
T Consensus        47 ~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~  120 (318)
T cd05582          47 MERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGII  120 (318)
T ss_pred             HHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            45678889999999999988876 67899999999999999999764  35899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||||+||+++.++.++|+|||++....... .......|+..|++||.+.+..++.++|+|||||++|+|++|+.||.
T Consensus       121 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~  199 (318)
T cd05582         121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ  199 (318)
T ss_pred             cCCCCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCC
Confidence            99999999999999999999999986543221 12234568899999999988888999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      ..........+.      ..           ....+...+..+.+++.+||+.||.+|||     ++++++|
T Consensus       200 ~~~~~~~~~~i~------~~-----------~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         200 GKDRKETMTMIL------KA-----------KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CCCHHHHHHHHH------cC-----------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            765443332221      00           00122234567889999999999999999     5667654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6e-33  Score=251.95  Aligned_cols=231  Identities=22%  Similarity=0.286  Sum_probs=168.8

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      +.|.+...|...+   ...++.|.+..        ....|.+.++.++|++++++.+++.. ++.+++||||+++++|.+
T Consensus        83 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~  161 (353)
T PLN00034         83 GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFMDGGSLEG  161 (353)
T ss_pred             cCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEecCCCCcccc
Confidence            3444444444433   34566665532        22346667788899999999998876 678999999999999864


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ..      ..++..+..++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++....... .......|+
T Consensus       162 ~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt  231 (353)
T PLN00034        162 TH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSVGT  231 (353)
T ss_pred             cc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccccccC
Confidence            32      3567888999999999999999   5899999999999999999999999999987553322 112335688


Q ss_pred             ccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          163 FGYMAPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       163 ~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ..|++||.+..     ...+.++|||||||++|+|++|+.||......+........   ..          ......+.
T Consensus       232 ~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~----------~~~~~~~~  298 (353)
T PLN00034        232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CM----------SQPPEAPA  298 (353)
T ss_pred             ccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hc----------cCCCCCCC
Confidence            99999998743     23356899999999999999999999743332221111100   00          01111233


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+.+||.+||+.||++|||+.|+++|-
T Consensus       299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        299 TASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            4556789999999999999999999999974

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-32  Score=238.36  Aligned_cols=227  Identities=24%  Similarity=0.293  Sum_probs=186.0

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ..+-|+++|+.++||-+..++..++. +...|+|||||+||+|..+++++..+.+++..++.++..++.||+|||   ..
T Consensus       123 Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---ml  198 (459)
T KOG0610|consen  123 RAQTEREILSLLDHPFLPTLYASFET-DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---ML  198 (459)
T ss_pred             HHHHHHHHHHhcCCCccchhhheeec-cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hh
Confidence            45578888999999999999999987 679999999999999999999999899999999999999999999999   69


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCC---------------------------------C-C-----------
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDH---------------------------------D-T-----------  152 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~---------------------------------~-~-----------  152 (313)
                      ||++|||||+||||-++|.+.|+||.++.....                                 . .           
T Consensus       199 GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~  278 (459)
T KOG0610|consen  199 GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASR  278 (459)
T ss_pred             ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccc
Confidence            999999999999999999999999987742210                                 0 0           


Q ss_pred             ----------CCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcc
Q 048068          153 ----------IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA  222 (313)
Q Consensus       153 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  222 (313)
                                ......++||-.|+|||++.+...+.+.|=|+||+.+|||+.|..||.+.+..++...+-..        
T Consensus       279 ~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--------  350 (459)
T KOG0610|consen  279 SLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--------  350 (459)
T ss_pred             cchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--------
Confidence                      00112357889999999999999999999999999999999999999999998877666210        


Q ss_pred             ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH---------HhccCCCCCCCCCCcc
Q 048068          223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN----MRQVMQY---------LDGNATLPDIPRDSTL  283 (313)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt----~~ell~~---------L~~~~~~~~~~~~~~~  283 (313)
                           +...++  .+..+..+++||.+.|.+||.+|.-    +.||-+|         |-.+..+|..|.+...
T Consensus       351 -----~l~Fp~--~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  351 -----PLKFPE--EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             -----CCcCCC--CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence                 011111  1255677899999999999999998    8888875         4445556665644443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.6e-32  Score=241.67  Aligned_cols=216  Identities=22%  Similarity=0.363  Sum_probs=163.1

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------------CCCCCHHHHHHHHHHH
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------------KPSLSWYQRFRIIRGV  104 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~i~~qi  104 (313)
                      |...++.++|++++++.++..+ .+..++||||+++++|.+++....                 ...+++..++.++.||
T Consensus        69 E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  147 (304)
T cd05096          69 EVKILSRLKDPNIIRLLGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQI  147 (304)
T ss_pred             HHHHHhhcCCCCeeEEEEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHH
Confidence            4456677899999999998876 567999999999999999986531                 1246778899999999


Q ss_pred             HHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhH
Q 048068          105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVY  183 (313)
Q Consensus       105 ~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  183 (313)
                      +.||.|||   ..+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+|
T Consensus       148 ~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~  224 (304)
T cd05096         148 ASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW  224 (304)
T ss_pred             HHHHHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhH
Confidence            99999999   589999999999999999999999999998644322111 11223446789999999888899999999


Q ss_pred             HHHHHHHHHHh--CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          184 AFGVFMLEVAS--GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       184 slG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      |||+++|+|++  +..||............   ..........      .....+..++..+.+|+.+||+.||++|||+
T Consensus       225 slG~~l~el~~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         225 AFGVTLWEILMLCKEQPYGELTDEQVIENA---GEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             HHHHHHHHHHHccCCCCCCcCCHHHHHHHH---HHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence            99999999987  56778765544333222   1111111000      0001122345678999999999999999999


Q ss_pred             HHHHHHHhc
Q 048068          262 RQVMQYLDG  270 (313)
Q Consensus       262 ~ell~~L~~  270 (313)
                      .++.+.|++
T Consensus       296 ~~i~~~l~~  304 (304)
T cd05096         296 SDIHAFLTE  304 (304)
T ss_pred             HHHHHHHhC
Confidence            999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.9e-32  Score=236.17  Aligned_cols=210  Identities=25%  Similarity=0.384  Sum_probs=167.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+....  ..+++||||+++++|.+++.......+++..++.++.|++.||.|||   ..+++
T Consensus        45 ~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~  119 (257)
T cd05040          45 KEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFI  119 (257)
T ss_pred             HHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            45567778899999999988876  78999999999999999998753356899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++.........  ......++..|++||.+.+..++.++|+|||||++|+|++ |..
T Consensus       120 H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~  199 (257)
T cd05040         120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE  199 (257)
T ss_pred             ccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998765432111  1112345678999999988889999999999999999998 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ||......+.......      ...         ....+...+..+.+++..||+.+|++|||+.++++.|.+
T Consensus       200 p~~~~~~~~~~~~~~~------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         200 PWAGLSGSQILKKIDK------EGE---------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             CCCCCCHHHHHHHHHh------cCC---------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence            9976554443322211      000         000122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.9e-32  Score=234.63  Aligned_cols=207  Identities=24%  Similarity=0.371  Sum_probs=167.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+.+...+..+++||||+++++|.+++.......+++..++.++.|++.++.+||   +.+++
T Consensus        48 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~  124 (257)
T cd08223          48 QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL  124 (257)
T ss_pred             HHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            455677888999999998887655667899999999999999998754556899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||++++++++|..||.
T Consensus       125 H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~  203 (257)
T cd08223         125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN  203 (257)
T ss_pred             ccCCCchhEEEecCCcEEEecccceEEecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999987553322 12234467889999999998888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+........      . .+..         ...+...+..+.+++.+||+.||++|||+.++++|
T Consensus       204 ~~~~~~~~~~~------~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         204 AKDMNSLVYRI------I-EGKL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCHHHHHHHH------H-hcCC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            55433222111      0 1110         11233455778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-32  Score=248.56  Aligned_cols=212  Identities=22%  Similarity=0.322  Sum_probs=162.8

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-------------------------------
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-------------------------------   88 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-------------------------------   88 (313)
                      .|...++.+ .|+|++++.+.... ++..++||||+++|+|.++++...                               
T Consensus        87 ~Ei~il~~l~~HpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  165 (375)
T cd05104          87 SELKVLSYLGNHINIVNLLGACTV-GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSL  165 (375)
T ss_pred             HHHHHHHHhcCCcceeeeeeeecc-CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhh
Confidence            345556666 79999999998876 568999999999999999996431                               


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCC
Q 048068           89 ------------------------------------------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP  126 (313)
Q Consensus        89 ------------------------------------------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~  126 (313)
                                                                ...+++..+..++.||+.||.|||   ..+++|+||||
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  242 (375)
T cd05104         166 NEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAA  242 (375)
T ss_pred             hhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCch
Confidence                                                      124788889999999999999999   58999999999


Q ss_pred             CcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCc
Q 048068          127 ANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGS  204 (313)
Q Consensus       127 ~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  204 (313)
                      +||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+|||||++|++++ |..||.....
T Consensus       243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         243 RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             hhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence            9999999999999999998754332211 1122234567999999998889999999999999999998 8999876543


Q ss_pred             hhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .....  ...    ..+...         ..+...+..+.+|+.+||+.||++|||+.++++.|+..
T Consensus       323 ~~~~~--~~~----~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         323 DSKFY--KMI----KEGYRM---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             hHHHH--HHH----HhCccC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            32211  111    111100         01112345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-32  Score=246.02  Aligned_cols=200  Identities=24%  Similarity=0.314  Sum_probs=161.3

Q ss_pred             hhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           44 DGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        44 ~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      ..++.+ .|+++++.++++.. ++.+|+||||+++++|..++...  ..+++..+..++.||+.||.|||   ..+++|+
T Consensus        47 ~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~  120 (318)
T cd05570          47 RVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH---ERGIIYR  120 (318)
T ss_pred             HHHHhccCCCCccceeeEEEc-CCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEcc
Confidence            344444 69999999998876 56899999999999999998764  36999999999999999999999   5899999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccC
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ  202 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (313)
                      ||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...
T Consensus       121 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         121 DLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             CCCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence            999999999999999999999886422111 1223346789999999999889999999999999999999999999866


Q ss_pred             CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048068          203 GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM-----RQVMQY  267 (313)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~  267 (313)
                      ........+.       ..          ....+...+..+.+||.+||+.||++|||+     .++++|
T Consensus       200 ~~~~~~~~i~-------~~----------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         200 DEDELFQSIL-------ED----------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CHHHHHHHHH-------cC----------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            5443322221       00          001222345678999999999999999999     999886

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.5e-32  Score=234.90  Aligned_cols=209  Identities=23%  Similarity=0.352  Sum_probs=166.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.++..  ....++||||+++++|.+++... ...+++..++.++.|++.|+.|||   ..+++
T Consensus        44 ~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  117 (257)
T cd05115          44 REAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFV  117 (257)
T ss_pred             HHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hcCee
Confidence            4557788899999999998875  35789999999999999999754 346899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc--ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++...........  ....++..|++||.+.+..++.++|+||||+++|++++ |..
T Consensus       118 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  197 (257)
T cd05115         118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK  197 (257)
T ss_pred             ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999875433221111  11223467999999988888999999999999999996 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ||......+....+.       .+.         ....+...++.+.+++..||..+|++||++.++.+.|+..
T Consensus       198 p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         198 PYKKMKGPEVMSFIE-------QGK---------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CcCcCCHHHHHHHHH-------CCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            998766544332221       110         1112334467888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-32  Score=240.07  Aligned_cols=208  Identities=25%  Similarity=0.314  Sum_probs=167.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++.++|+++++..+.+.. ++..++||||+++++|.+++.......+++..+..++.|++.|+.|||   ..+++
T Consensus        49 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iv  124 (285)
T cd05605          49 NEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIV  124 (285)
T ss_pred             HHHHHHHhcCCCCEeeeeeeecC-CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcE
Confidence            35677888899999999888876 568999999999999999887654556999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||++++++.++|+|||++.......  ......++..|++||.+.+..++.++|+||+|+++|++++|+.||.
T Consensus       125 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~  202 (285)
T cd05605         125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR  202 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEeeCCCceecCCCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999999987543222  1223467899999999988888999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      +.........+.   ....          .....++...+..+.+|+..||+.||++||     +++++++|
T Consensus       203 ~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         203 QRKEKVKREEVE---RRVK----------EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CCchhhHHHHHH---HHhh----------hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            755433221111   0000          011123334567789999999999999999     89999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.4e-32  Score=248.78  Aligned_cols=224  Identities=22%  Similarity=0.310  Sum_probs=168.9

Q ss_pred             eEEEcccCCC--------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           29 QFIYHGFNED--------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        29 ~~~~~~~~~~--------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      .++.|.+...        ...|...++.+ .|+++++..+.... ++.+++||||+++|+|.+++....           
T Consensus        70 ~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~  148 (374)
T cd05106          70 RVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALP  148 (374)
T ss_pred             eeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-CCCeEEeHhhccCCcHHHHHHhhhhhhcccccccc
Confidence            4666666432        12345566666 79999999998776 568999999999999999986421           


Q ss_pred             ---------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHh
Q 048068           89 ---------------------------------------------------------KPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        89 ---------------------------------------------------------~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                                                                               ...+++..++.++.||+.||.||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL  228 (374)
T cd05106         149 EISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL  228 (374)
T ss_pred             ccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHH
Confidence                                                                     12478889999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML  190 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  190 (313)
                      |   ..+++||||||+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|
T Consensus       229 H---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~  305 (374)
T cd05106         229 A---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW  305 (374)
T ss_pred             H---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHH
Confidence            9   589999999999999999999999999998654332211 111223456799999998888999999999999999


Q ss_pred             HHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          191 EVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       191 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +|++ |..||............  .    ..+.         ....+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       306 ellt~G~~Pf~~~~~~~~~~~~--~----~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         306 EIFSLGKSPYPGILVNSKFYKM--V----KRGY---------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ  370 (374)
T ss_pred             HHHhCCCCCCccccccHHHHHH--H----Hccc---------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9997 99999765443221111  0    1100         00011123467899999999999999999999999998


Q ss_pred             cc
Q 048068          270 GN  271 (313)
Q Consensus       270 ~~  271 (313)
                      ..
T Consensus       371 ~~  372 (374)
T cd05106         371 RQ  372 (374)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.7e-32  Score=237.69  Aligned_cols=210  Identities=21%  Similarity=0.400  Sum_probs=163.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------KPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      .+...++.++|++++++.++... ++..++||||+++++|.+++....        ...++...+..++.|++.||.|||
T Consensus        58 ~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH  136 (277)
T cd05062          58 NEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN  136 (277)
T ss_pred             HHHHHHHhCCCCCeeeEEEEEcC-CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            34566778899999999988876 668999999999999999997532        123577889999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                         ..+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus       137 ---~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e  213 (277)
T cd05062         137 ---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE  213 (277)
T ss_pred             ---HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHH
Confidence               589999999999999999999999999988644322211 1112234678999999988889999999999999999


Q ss_pred             HHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          192 VAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       192 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      +++ |..||.+...........       ....         ...+...+..+.+++.+||+.||++|||+.+++++|++
T Consensus       214 l~~~~~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         214 IATLAEQPYQGMSNEQVLRFVM-------EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHH-------cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            999 788997665443332221       1000         01122344678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.4e-32  Score=232.66  Aligned_cols=208  Identities=23%  Similarity=0.362  Sum_probs=165.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.++... .+..++||||+++++|.+++... ...+++..+..++.|++.++.|+|   ..+++
T Consensus        41 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~  115 (250)
T cd05085          41 SEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCI  115 (250)
T ss_pred             HHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            45567788899999999998876 56899999999999999998764 345899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++...............++..|++||+..+..++.++|+||||+++|++++ |..||
T Consensus       116 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~  195 (250)
T cd05085         116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY  195 (250)
T ss_pred             ecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence            99999999999999999999999986443222111222234567999999988888999999999999999998 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ...........+.       .+.         ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       196 ~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         196 PGMTNQQAREQVE-------KGY---------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHH-------cCC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            7654433222111       110         00112234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-31  Score=232.89  Aligned_cols=209  Identities=24%  Similarity=0.381  Sum_probs=165.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.+.|+++++.+++..  ...+++||||+++++|.+++....  .+++..+..++.|++.|+.|||   ..+++
T Consensus        45 ~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~  117 (257)
T cd05060          45 REASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFV  117 (257)
T ss_pred             HHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCee
Confidence            3456778889999999998765  456899999999999999998753  6899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc--ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++...........  ....++..|++||...+..++.++|+||||+++|++++ |..
T Consensus       118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~  197 (257)
T cd05060         118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK  197 (257)
T ss_pred             ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999875533221111  11123457999999988889999999999999999998 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||...+..+....+.   .    ..         ....+...+..+.++|.+||..+|++|||+.++++.|++..
T Consensus       198 p~~~~~~~~~~~~~~---~----~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         198 PYGEMKGAEVIAMLE---S----GE---------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CcccCCHHHHHHHHH---c----CC---------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            997665443322221   1    00         00122234467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.8e-32  Score=239.11  Aligned_cols=214  Identities=25%  Similarity=0.434  Sum_probs=168.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHH
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------KPSLSWYQRFRIIRGVASGL  108 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al  108 (313)
                      ..+.+.++.++|+++++..+.... ++.+++||||+++++|.+++....           ...+++..++.++.|++.||
T Consensus        55 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL  133 (288)
T cd05093          55 HREAELLTNLQHEHIVKFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGM  133 (288)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEec-CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHH
Confidence            345667788899999999998876 568999999999999999997532           13489999999999999999


Q ss_pred             HHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHH
Q 048068          109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV  187 (313)
Q Consensus       109 ~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  187 (313)
                      +|||   ..+++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+
T Consensus       134 ~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~  210 (288)
T cd05093         134 VYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV  210 (288)
T ss_pred             HHHH---hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHH
Confidence            9999   68999999999999999999999999999864432211 1112233467899999998888999999999999


Q ss_pred             HHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          188 FMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       188 il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ++|+|++ |..||......+....+.       .+...     .    .+...+..+.+|+.+||+.||.+|||++++++
T Consensus       211 il~~l~t~g~~p~~~~~~~~~~~~i~-------~~~~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         211 VLWEIFTYGKQPWYQLSNNEVIECIT-------QGRVL-----Q----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCcC-----C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999998 999997665443322221       11100     0    11123456899999999999999999999999


Q ss_pred             HHhccCC
Q 048068          267 YLDGNAT  273 (313)
Q Consensus       267 ~L~~~~~  273 (313)
                      .|++...
T Consensus       275 ~l~~~~~  281 (288)
T cd05093         275 LLQNLAK  281 (288)
T ss_pred             HHHHHHH
Confidence            9988763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=256.22  Aligned_cols=201  Identities=22%  Similarity=0.325  Sum_probs=169.9

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|+.++... +||-++..+..++. +.++|+||||+.||++..+++   ...|++..+.-+++.|+.||.|||   ++||
T Consensus       417 ~EkrI~~la~~HPFL~~L~~~fQT-~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~I  489 (694)
T KOG0694|consen  417 CEKRIFELANRHPFLVNLFSCFQT-KEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGI  489 (694)
T ss_pred             HHHHHHHHhccCCeEeeccccccc-CCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCc
Confidence            444444444 49999988888876 789999999999999544443   346999999999999999999999   6999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      ++||||.+|||++..|.+||+|||+++..-... ....++.||+.|+|||++.+..|+.+.|=||||++||||+.|+.||
T Consensus       490 IYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF  568 (694)
T KOG0694|consen  490 IYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF  568 (694)
T ss_pred             eeeecchhheEEcccCcEEecccccccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999998654222 3567899999999999999999999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQ  266 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~  266 (313)
                      .+.++.+....+.                 .....+|...+.....||..+|..||++|.-     +++|.+
T Consensus       569 ~gddEee~FdsI~-----------------~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~  623 (694)
T KOG0694|consen  569 PGDDEEEVFDSIV-----------------NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK  623 (694)
T ss_pred             CCCCHHHHHHHHh-----------------cCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence            9999988877663                 2333467777788889999999999999974     455554

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-32  Score=237.99  Aligned_cols=224  Identities=21%  Similarity=0.289  Sum_probs=166.0

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.++|++++++.+.+... +..+++||||+++++|.+++...   .+++..++.++.|++.|+.|||   ..++
T Consensus        55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i  128 (283)
T cd05080          55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHY  128 (283)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            456688889999999999887643 45689999999999999999764   4999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc--cccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||||+||+++.++.++|+|||++..........  .....++..|++||.+.+..++.++|+||||+++|+|++|..
T Consensus       129 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~  208 (283)
T cd05080         129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD  208 (283)
T ss_pred             eccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987554322110  112234567999999988888999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ||........ .........+......+..........+...+..+.+++..||+.+|++|||++++++.|++.
T Consensus       209 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         209 SKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             CCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            9865432210 000000000000000000111111112334557899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-32  Score=247.54  Aligned_cols=196  Identities=23%  Similarity=0.275  Sum_probs=158.4

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCc
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI  124 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl  124 (313)
                      .++.+.|+++++..+.+.. ++..++||||+++++|.+++...  ..+.+..+..++.||+.||.|||   ..+++||||
T Consensus        49 ~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDl  122 (325)
T cd05602          49 LLKNVKHPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDL  122 (325)
T ss_pred             HHHhCCCCCCCceeEEEEc-CCeEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCC
Confidence            4567899999999888876 66899999999999999999764  35889999999999999999999   589999999


Q ss_pred             CCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCc
Q 048068          125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS  204 (313)
Q Consensus       125 ~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  204 (313)
                      ||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       123 kp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  201 (325)
T cd05602         123 KPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT  201 (325)
T ss_pred             CHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999999986432211 123345689999999999988899999999999999999999999987655


Q ss_pred             hhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      ......+.      ..           ........+..+.+++.+||+.||.+||++.+.
T Consensus       202 ~~~~~~i~------~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  244 (325)
T cd05602         202 AEMYDNIL------NK-----------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDD  244 (325)
T ss_pred             HHHHHHHH------hC-----------CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence            44332221      00           011222345678899999999999999987743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-32  Score=233.21  Aligned_cols=209  Identities=26%  Similarity=0.418  Sum_probs=169.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-------KPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      .+...++.+.|++++++.+++.. +..+++||||+++++|.+++....       ...+++..++.++.|++.|+.||| 
T Consensus        45 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-  122 (262)
T cd00192          45 KEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-  122 (262)
T ss_pred             HHHHHHhhcCCCChheeeeeecC-CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH-
Confidence            35567788899999999998887 778999999999999999998641       256999999999999999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  192 (313)
                        ..+++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+....++.++|+||||+++|++
T Consensus       123 --~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  200 (262)
T cd00192         123 --SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEI  200 (262)
T ss_pred             --cCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHH
Confidence              69999999999999999999999999999876543321 112334567889999999888899999999999999999


Q ss_pred             Hh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          193 AS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       193 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++ |..||.............       .+         .....+...+..+.+++.+||+.||.+|||+.|++++|+
T Consensus       201 ~~~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         201 FTLGATPYPGLSNEEVLEYLR-------KG---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HhcCCCCCCCCCHHHHHHHHH-------cC---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            99 699998775443332221       00         011123334678899999999999999999999999984

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-32  Score=244.40  Aligned_cols=188  Identities=22%  Similarity=0.312  Sum_probs=142.9

Q ss_pred             hhHHHHHHHHhhccc-----cceEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEec-cCCeEEEEEecCCCCCH
Q 048068           12 VLLCVSFILSALAQD-----VNQFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L   80 (313)
                      +++.|.+..++.+..     ...++.|.+..     ....|...++.++|+++++..+.+.. .+..+++||||+ +++|
T Consensus         8 ~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l   86 (317)
T cd07868           8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDL   86 (317)
T ss_pred             ccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCH
Confidence            444444444444432     23455555432     34567788999999999999888763 355789999999 5688


Q ss_pred             HHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE----cCCCcEEEeecccccccC
Q 048068           81 DKILHTNI-------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARLYD  149 (313)
Q Consensus        81 ~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv----~~~~~~~l~dfg~~~~~~  149 (313)
                      .+++....       ...+++..++.++.||+.||.|||   ..+++||||||+||++    +.++.++|+|||++....
T Consensus        87 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          87 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             HHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            88875321       235899999999999999999999   5899999999999999    456789999999997654


Q ss_pred             CCCC--CccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCC
Q 048068          150 HDTI--PQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQG  203 (313)
Q Consensus       150 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  203 (313)
                      ....  .......+++.|+|||.+.+ ..++.++|+||+||++|+|++|++||....
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            3221  12234567899999999876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2e-32  Score=249.92  Aligned_cols=208  Identities=22%  Similarity=0.299  Sum_probs=164.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++.+++||||++||+|.+++...   .+++..+..++.||+.||.|||   ..+|+
T Consensus        92 ~e~~il~~~~h~~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~iv  164 (370)
T cd05596          92 EERDIMAHANSEWIVQLHYAFQD-DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFI  164 (370)
T ss_pred             HHHHHHHhCCCCCcceEEEEEec-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            45667788899999999988876 67899999999999999999753   4889999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG----KASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~  196 (313)
                      ||||||+||+++.++.++|+|||++...............|++.|+|||.+.+.    .++.++|+|||||++|+|++|.
T Consensus       165 HrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~  244 (370)
T cd05596         165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  244 (370)
T ss_pred             ccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence            999999999999999999999999875543222222345689999999998643    3688999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA--RPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~L  268 (313)
                      .||...........+.      ....  .   ...+  .....+..+.++|..||..+|.+  |+|++++++|-
T Consensus       245 ~Pf~~~~~~~~~~~i~------~~~~--~---~~~~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         245 TPFYADSLVGTYSKIM------DHKN--S---LTFP--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             CCcCCCCHHHHHHHHH------cCCC--c---CCCC--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence            9998766543332221      0000  0   0001  11134567889999999999998  99999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.4e-32  Score=233.88  Aligned_cols=208  Identities=24%  Similarity=0.355  Sum_probs=164.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..++..  +...++||||+++++|.+++...  ..+++..+..++.|++.|+.|||   +.+++
T Consensus        45 ~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~  117 (257)
T cd05116          45 REANVMQQLDNPYIVRMIGICE--AESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFV  117 (257)
T ss_pred             HHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            3455667789999999988765  45679999999999999999764  35899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc--cccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||+|.||+++.++.++|+|||++..........  .....++..|+|||.+....++.++|+||||+++|++++ |..
T Consensus       118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~  197 (257)
T cd05116         118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQK  197 (257)
T ss_pred             ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999987554322111  111223468999999887788899999999999999998 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ||......+....+.       .+.         ....+...+..+.++|.+||+.||.+|||+++|.+.|++.
T Consensus       198 p~~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         198 PYKGMKGNEVTQMIE-------SGE---------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHHHHHHH-------CCC---------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            998665443332221       110         0112223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.2e-32  Score=239.23  Aligned_cols=211  Identities=25%  Similarity=0.389  Sum_probs=165.6

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHH
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--------------IKPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~  106 (313)
                      +.+.++.+ +|+++++..+.+.. ++.+++||||+++++|..+++..              ....+++..+..++.|++.
T Consensus        65 E~~~l~~l~~h~~i~~~~~~~~~-~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  143 (293)
T cd05053          65 EMEMMKMIGKHKNIINLLGVCTQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVAR  143 (293)
T ss_pred             HHHHHHhhcCCCCeeeEEEEEcC-CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence            34455566 79999999998876 56899999999999999999642              2356899999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      ||+|||   ..+++|+||+|+||+++.++.++|+|||++......... ......++..|++||.+.+..++.++|+|||
T Consensus       144 al~~LH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  220 (293)
T cd05053         144 GMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF  220 (293)
T ss_pred             HHHHHH---HCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence            999999   589999999999999999999999999998754332211 1112234567999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       186 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      ||++|++++ |..||......+......       .+.         ....+......+.+|+.+||+.||++|||+.++
T Consensus       221 G~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei  284 (293)
T cd05053         221 GVLLWEIFTLGGSPYPGIPVEELFKLLK-------EGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL  284 (293)
T ss_pred             hhHHHHHhcCCCCCCCCCCHHHHHHHHH-------cCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            999999997 999997665444332221       110         001222345678899999999999999999999


Q ss_pred             HHHHhccC
Q 048068          265 MQYLDGNA  272 (313)
Q Consensus       265 l~~L~~~~  272 (313)
                      ++.|++..
T Consensus       285 l~~l~~~~  292 (293)
T cd05053         285 VEDLDRML  292 (293)
T ss_pred             HHHHHHhh
Confidence            99998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.2e-32  Score=239.12  Aligned_cols=215  Identities=23%  Similarity=0.328  Sum_probs=160.8

Q ss_pred             hhccccceeeeeeEEec----cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           47 ASVHSNGLLQLTNTVNS----RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        47 ~~~~~~~~l~~~~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      +.++|+++++..+++..    ....+++||||+. ++|.+++.......+++..+..++.|++.||.|||   ..+++|+
T Consensus        57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~  132 (288)
T cd07863          57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHR  132 (288)
T ss_pred             hhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            34479999999988763    2456899999996 58999987654556999999999999999999999   5899999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccC
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ  202 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (313)
                      ||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+|||||++|+|++|.+||.+.
T Consensus       133 dikp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         133 DLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             CCCHHHEEECCCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            999999999999999999999987554322  122345788999999998888999999999999999999999999876


Q ss_pred             CchhhhhHHHHHH-----Hhhhhcc-----ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          203 GSMEMVNLVDWVS-----DCWKKGA-----ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       203 ~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...+....+....     ..|....     ....................+.+++.+||+.||++|||+.++++|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            5544332221111     0111100     000000000011112345678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=249.43  Aligned_cols=209  Identities=27%  Similarity=0.370  Sum_probs=167.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.+.|+++++..+.+.+ +++.++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..++
T Consensus        49 ~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~gi  122 (350)
T cd05573          49 RAERDILADADSPWIVKLYYSFQD-EEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGF  122 (350)
T ss_pred             HHHHHHHHhcCCCCccchhhheec-CCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            346677888899999999988876 67899999999999999999875  46999999999999999999999   5999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCC----------------------------CCccccccccccccccccc
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDT----------------------------IPQTTKLVGTFGYMAPELM  171 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~  171 (313)
                      +||||||+||+++.++.++|+|||++.......                            ........|++.|+|||.+
T Consensus       123 iH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  202 (350)
T cd05573         123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL  202 (350)
T ss_pred             eccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            999999999999999999999999987543322                            1122335689999999999


Q ss_pred             cCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcC
Q 048068          172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCS  251 (313)
Q Consensus       172 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  251 (313)
                      .+..++.++|||||||++|+|++|+.||...........+..    |....       ..+  .....+..+.++|..||
T Consensus       203 ~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~-------~~p--~~~~~~~~~~~li~~ll  269 (350)
T cd05573         203 RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN----WKESL-------RFP--PDPPVSPEAIDLICRLL  269 (350)
T ss_pred             cCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhc----cCCcc-------cCC--CCCCCCHHHHHHHHHHc
Confidence            988999999999999999999999999987664433322210    00000       011  01114567889999999


Q ss_pred             CCCCCCCCC-HHHHHHHH
Q 048068          252 HPKPEARPN-MRQVMQYL  268 (313)
Q Consensus       252 ~~~P~~Rpt-~~ell~~L  268 (313)
                      . ||.+||+ ++++++|.
T Consensus       270 ~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         270 C-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             c-ChhhcCCCHHHHhcCC
Confidence            7 9999999 99999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-32  Score=257.74  Aligned_cols=207  Identities=21%  Similarity=0.314  Sum_probs=162.1

Q ss_pred             HHhhhhhccccceeeeeeEEeccC-------CeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRK-------GEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~-------~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      +...+..+.|++++++...+....       ..+++||||+++|+|.++++..  ....+++..+..++.|++.||.|||
T Consensus        81 Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH  160 (496)
T PTZ00283         81 EVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH  160 (496)
T ss_pred             HHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344566778999998776665211       1478999999999999999753  2356999999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                         ..+|+||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+..++.++|||||||++|+
T Consensus       161 ---~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilye  237 (496)
T PTZ00283        161 ---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYE  237 (496)
T ss_pred             ---hCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence               58999999999999999999999999999875433211 12234568999999999998889999999999999999


Q ss_pred             HHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          192 VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       192 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |++|+.||.............       .+.         ....+...+..+.+++..||+.||.+|||+.++++|
T Consensus       238 LltG~~Pf~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        238 LLTLKRPFDGENMEEVMHKTL-------AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHCCCCCCCCCHHHHHHHHh-------cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            999999998655433222110       000         011233445678999999999999999999999986

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-32  Score=249.16  Aligned_cols=221  Identities=22%  Similarity=0.295  Sum_probs=163.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      .+...++.++|+++++..+++...+    ...++||||+. ++|.+.+...  ..+++..+..++.||+.||.|||   .
T Consensus        48 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~  121 (372)
T cd07853          48 RELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---S  121 (372)
T ss_pred             HHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---h
Confidence            4556677889999999999887533    27899999995 6888888653  46999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g  195 (313)
                      .+++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus       122 ~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  201 (372)
T cd07853         122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR  201 (372)
T ss_pred             CCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC
Confidence            8999999999999999999999999999875443322223334578899999998764 478999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHH----------------hhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          196 RRPIEQQGSMEMVNLVDWVSD----------------CWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +.||.+.+..+....+.....                ...... .................+.+.+||.+||+.||++||
T Consensus       202 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~  280 (372)
T cd07853         202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP-HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI  280 (372)
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCC-CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence            999987665544333211100                000000 000000000011122356788999999999999999


Q ss_pred             CHHHHHHHH
Q 048068          260 NMRQVMQYL  268 (313)
Q Consensus       260 t~~ell~~L  268 (313)
                      |+.|+++|-
T Consensus       281 t~~e~l~hp  289 (372)
T cd07853         281 SAADALAHP  289 (372)
T ss_pred             CHHHHhcCH
Confidence            999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.4e-32  Score=238.51  Aligned_cols=210  Identities=22%  Similarity=0.343  Sum_probs=165.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~  106 (313)
                      .+...++.++|+++++..++... .+..++++||+.+++|.+++....              ...+++..+..++.|++.
T Consensus        57 ~e~~~~~~l~h~~iv~~~~~~~~-~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~  135 (283)
T cd05091          57 HEAMMRSRLQHPNIVCLLGVVTK-EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAA  135 (283)
T ss_pred             HHHHHHhcCCCCCcCeEEEEEcC-CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence            34456677899999999998876 457899999999999999985321              234788899999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      ||.|||   +.+++||||||+||++++++.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||
T Consensus       136 aL~~lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  212 (283)
T cd05091         136 GMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY  212 (283)
T ss_pred             HHHHHH---HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence            999999   58999999999999999999999999998764432211 11223345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       186 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      ||++|+|++ |..||.+....+....+.       ..         .....+..++..+.+++..||+.+|.+|||++++
T Consensus       213 G~~l~el~~~g~~p~~~~~~~~~~~~i~-------~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i  276 (283)
T cd05091         213 GVVLWEVFSYGLQPYCGYSNQDVIEMIR-------NR---------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI  276 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cC---------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            999999998 888887655443332221       00         0111233456778999999999999999999999


Q ss_pred             HHHHhc
Q 048068          265 MQYLDG  270 (313)
Q Consensus       265 l~~L~~  270 (313)
                      ++.|+.
T Consensus       277 ~~~l~~  282 (283)
T cd05091         277 HSRLRT  282 (283)
T ss_pred             HHHhhC
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.3e-32  Score=252.31  Aligned_cols=235  Identities=17%  Similarity=0.226  Sum_probs=168.8

Q ss_pred             ceEEEcccCC---ChhhHHhhhhhccccceeeeeeEEe-------ccCCeEEEEEecCCCCCHHHHHhh--CCCCCCCHH
Q 048068           28 NQFIYHGFNE---DPQLQRDGLASVHSNGLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHT--NIKPSLSWY   95 (313)
Q Consensus        28 ~~~~~~~~~~---~~~~~~~~l~~~~~~~~l~~~~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~--~~~~~~~~~   95 (313)
                      ..++.|.+..   ....+...++.++|++++++.+++.       .....+++||||++ ++|.+++..  .....+++.
T Consensus        92 ~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~  170 (440)
T PTZ00036         92 EKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLF  170 (440)
T ss_pred             CEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHH
Confidence            3555655532   2345778899999999999877654       12235779999996 578777753  224569999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC-cEEEeecccccccCCCCCCccccccccccccccccccCC
Q 048068           96 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG  174 (313)
Q Consensus        96 ~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  174 (313)
                      .++.++.||+.||.|||   ..+|+||||||+||+++.++ .++|+|||++.......  ......+++.|+|||++.+.
T Consensus       171 ~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~  245 (440)
T PTZ00036        171 LVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGA  245 (440)
T ss_pred             HHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCC
Confidence            99999999999999999   58999999999999998665 69999999997553322  22235678999999988654


Q ss_pred             -CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhc------------cccccccccccCCccHHHHH
Q 048068          175 -KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKG------------AILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       175 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~  241 (313)
                       .++.++|||||||++|+|++|.+||.+....+....+.........+            .............++...+.
T Consensus       246 ~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~  325 (440)
T PTZ00036        246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPD  325 (440)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCH
Confidence             68999999999999999999999998776554443332211100000            00000001111112223456


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .+.+||.+||..||.+|||+.|+++|-
T Consensus       326 ~~~~li~~~L~~dP~~R~ta~e~l~hp  352 (440)
T PTZ00036        326 DAINFISQFLKYEPLKRLNPIEALADP  352 (440)
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence            789999999999999999999999864

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.7e-32  Score=243.14  Aligned_cols=221  Identities=22%  Similarity=0.287  Sum_probs=164.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+++.. ++..++||||++ ++|.+++... ...+++..+..++.||+.||.|||   +.+++
T Consensus        53 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~iv  126 (309)
T cd07872          53 REVSLLKDLKHANIVTLHDIVHT-DKSLTLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH---RRKVL  126 (309)
T ss_pred             HHHHHHHhCCCCCcceEEEEEee-CCeEEEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            56677888999999999999876 568999999996 4888888764 345899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      ||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||
T Consensus       127 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf  205 (309)
T cd07872         127 HRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF  205 (309)
T ss_pred             cCCCCHHHEEECCCCCEEECccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999865433221 1223456889999998865 45789999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHH-----hhhhcc----cccccccccc----CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSD-----CWKKGA----ILDASDSRLE----GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      .+.+..+....+.....     .|....    ......+...    .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         206 PGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            87665544333321110     111000    0000000000    0011123456789999999999999999999999


Q ss_pred             HH
Q 048068          267 YL  268 (313)
Q Consensus       267 ~L  268 (313)
                      |-
T Consensus       286 h~  287 (309)
T cd07872         286 HA  287 (309)
T ss_pred             Ch
Confidence            54

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-32  Score=232.02  Aligned_cols=209  Identities=22%  Similarity=0.357  Sum_probs=165.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++..+..+ .+..++||||+++++|.+++... ...++...+..++.+++.++.|||   ..+++
T Consensus        41 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~  115 (251)
T cd05041          41 QEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCI  115 (251)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence            45567788899999999988876 56899999999999999999764 336889999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc-ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      |+||+|+||+++.++.++|+|||++........... .....+..|++||.+.++.++.++|+||||+++|++++ |..|
T Consensus       116 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p  195 (251)
T cd05041         116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP  195 (251)
T ss_pred             hhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCC
Confidence            999999999999999999999999865432211111 11223556999999988889999999999999999998 8889


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      |...........+.       ..         .....+...+..+.+++.+||..+|++|||+.++++.|++
T Consensus       196 ~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         196 YPGMSNQQTRERIE-------SG---------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CccCCHHHHHHHHh-------cC---------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            87765443322221       00         0111223345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.2e-32  Score=250.96  Aligned_cols=248  Identities=19%  Similarity=0.210  Sum_probs=183.3

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCChh------hHHhhhhhcc------ccceeeeeeEEeccCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNEDPQ------LQRDGLASVH------SNGLLQLTNTVNSRKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~l~~~~------~~~~l~~~~~~~~~~~~~~lV~e~~~   76 (313)
                      .++.|.|.++.-..+   ...++.|.++....      .|..+|..++      --|+|+.++++.. .+|.|||+|.+ 
T Consensus       193 ~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~HlciVfELL-  270 (586)
T KOG0667|consen  193 VLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLCIVFELL-  270 (586)
T ss_pred             EecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-ccceeeeehhh-
Confidence            344444444332222   34667777665433      4444444443      3467777777766 78999999999 


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC--CcEEEeecccccccCCCCCC
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD--LNGKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~--~~~~l~dfg~~~~~~~~~~~  154 (313)
                      ..+|+++++.+.-.+++...++.++.||+.||.+||   +.+|+|+||||+|||+...  ..+||+|||.+++.....  
T Consensus       271 ~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--  345 (586)
T KOG0667|consen  271 STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV--  345 (586)
T ss_pred             hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccCCcc--
Confidence            679999999987788999999999999999999999   6999999999999999754  469999999998654332  


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh--------hh-------
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC--------WK-------  219 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------~~-------  219 (313)
                        .....+..|+|||++.|..|+.+.|+||||||++||++|.+.|.+.++.++...+.-+-..        +.       
T Consensus       346 --ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~  423 (586)
T KOG0667|consen  346 --YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT  423 (586)
T ss_pred             --eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence              2567789999999999999999999999999999999999999999988877766322111        00       


Q ss_pred             h-cccc------c-----------------ccccccc-------CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          220 K-GAIL------D-----------------ASDSRLE-------GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       220 ~-~~~~------~-----------------~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      . ....      .                 ......+       ..........+.+|+.+||+.||.+|+|..|.++|=
T Consensus       424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp  503 (586)
T KOG0667|consen  424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHP  503 (586)
T ss_pred             ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence            0 0000      0                 0000000       011123446789999999999999999999999964

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-32  Score=235.81  Aligned_cols=210  Identities=24%  Similarity=0.400  Sum_probs=166.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------KPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      .+.+.++.+.|+++++.++++.. +...++||||+++++|.+++....        ...+++..+..++.|++.||.|||
T Consensus        58 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH  136 (277)
T cd05032          58 NEASVMKEFNCHHVVRLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA  136 (277)
T ss_pred             HHHHHHHhCCCCceeEEEEEEcC-CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44566677899999999999887 578999999999999999997532        224788899999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                         ..+++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+
T Consensus       137 ---~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  213 (277)
T cd05032         137 ---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE  213 (277)
T ss_pred             ---hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHH
Confidence               68999999999999999999999999998865433221 12223345678999999988889999999999999999


Q ss_pred             HHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          192 VAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       192 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      +++ |..||.............       .+..         ...+...+..+.+++..||+.+|++|||+.++++.|++
T Consensus       214 l~t~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         214 MATLAEQPYQGLSNEEVLKFVI-------DGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hhccCCCCCccCCHHHHHHHHh-------cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            998 999997655444332221       1100         01122235678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=233.59  Aligned_cols=215  Identities=20%  Similarity=0.283  Sum_probs=170.2

Q ss_pred             cccceeeeeeEEe---ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCC
Q 048068           50 HSNGLLQLTNTVN---SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP  126 (313)
Q Consensus        50 ~~~~~l~~~~~~~---~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~  126 (313)
                      .|+|++++.+++.   .....+.+|||+++||.|.+.++++....|++..+..|+.||..|+.|||   ..+|.||||||
T Consensus       113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKp  189 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKP  189 (400)
T ss_pred             CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCCh
Confidence            6999999998887   44567789999999999999999988888999999999999999999999   59999999999


Q ss_pred             CcEEEcC---CCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCC
Q 048068          127 ANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQG  203 (313)
Q Consensus       127 ~nIlv~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  203 (313)
                      +|+|...   |..+||+|||++.......  ...+...|+.|.|||++...+|+..+|+||+|+++|-|++|.+||....
T Consensus       190 ENLLyt~t~~na~lKLtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h  267 (400)
T KOG0604|consen  190 ENLLYTTTSPNAPLKLTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_pred             hheeeecCCCCcceEecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence            9999974   4558999999998665432  3445567999999999999999999999999999999999999998655


Q ss_pred             chhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--hccCCCCCCC
Q 048068          204 SMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDIP  278 (313)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L--~~~~~~~~~~  278 (313)
                      ...+.--.   +.....+.      ...+..--...++...++|+.+|+.+|.+|.|++++++|-  .....+|..|
T Consensus       268 g~aispgM---k~rI~~gq------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tp  335 (400)
T KOG0604|consen  268 GLAISPGM---KRRIRTGQ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTP  335 (400)
T ss_pred             CccCChhH---HhHhhccC------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCC
Confidence            43221100   00011110      1122222345567889999999999999999999999975  4444566665

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-32  Score=244.55  Aligned_cols=209  Identities=23%  Similarity=0.321  Sum_probs=159.5

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      +...++.+ +|+++++..+.+.. ++.+++||||+++++|..++...  +.+++..++.++.||+.||.|||   ..+++
T Consensus        45 e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~iv  118 (329)
T cd05588          45 EKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGII  118 (329)
T ss_pred             HHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            34445555 79999999988876 66899999999999999988764  46999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+|||||++|++++|+.||.
T Consensus       119 H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ecCCCHHHeEECCCCCEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence            99999999999999999999999886422111 12234568999999999998889999999999999999999999996


Q ss_pred             cCCchh--hhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH
Q 048068          201 QQGSME--MVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN------MRQVMQY  267 (313)
Q Consensus       201 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~ell~~  267 (313)
                      ......  ................      ..    .+...+..+.+++.+||+.||.+|+|      ++++++|
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         198 IVGMSDNPDQNTEDYLFQVILEKQ------IR----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             cccccccccccchHHHHHHHHcCC------CC----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            422111  0000111111111100      01    22234456889999999999999987      7888876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-31  Score=235.42  Aligned_cols=208  Identities=25%  Similarity=0.375  Sum_probs=161.7

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----KPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      +...++.++|+++++..++..+ .+..++||||+++++|.+++....     ...+++..+..++.||+.|+.|||   .
T Consensus        59 e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~  134 (277)
T cd05036          59 EALIMSKFNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---E  134 (277)
T ss_pred             HHHHHHhCCCCCEeeEEEEEcc-CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence            4456677899999999998776 457899999999999999997642     135899999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCC---cEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHH
Q 048068          117 QVVLHRDIKPANVLLDADL---NGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~---~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  192 (313)
                      .+++|+||+|+||+++.++   .++|+|||++......... .......+..|++||.+.+..++.++|||||||++|++
T Consensus       135 ~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el  214 (277)
T cd05036         135 NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI  214 (277)
T ss_pred             CCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHH
Confidence            8999999999999998765   5899999998754222111 11122334679999999888899999999999999999


Q ss_pred             Hh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          193 AS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       193 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++ |..||...........+.       ...         ....+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus       215 ~~~g~~pf~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         215 FSLGYMPYPGRTNQEVMEFVT-------GGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCCCCCCCCCHHHHHHHHH-------cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            97 999998665544332221       000         01122334567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-31  Score=230.50  Aligned_cols=219  Identities=28%  Similarity=0.395  Sum_probs=172.6

Q ss_pred             ceEEEcccCCChh------hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 048068           28 NQFIYHGFNEDPQ------LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII  101 (313)
Q Consensus        28 ~~~~~~~~~~~~~------~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  101 (313)
                      ..++.|.+.....      .+...++.++|+++++..++... .+..++||||+++++|.++++......+++..++.++
T Consensus        30 ~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~  108 (256)
T cd05039          30 QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFA  108 (256)
T ss_pred             cEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence            3455555544332      34567788899999999998877 6789999999999999999987654579999999999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchh
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD  181 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  181 (313)
                      .|++.|+.|||   ..+++|+||+|+||+++.++.++|+|||.+........    ....+..|.+||.+.+..++.++|
T Consensus       109 ~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~D  181 (256)
T cd05039         109 LDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSD  181 (256)
T ss_pred             HHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcCCcCCcHHH
Confidence            99999999999   69999999999999999999999999999875532211    223456799999998888899999


Q ss_pred             hHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          182 VYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       182 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      +||||+++|++++ |..||......+......       .+..         ...+...++.+.+++.+||+.+|++|||
T Consensus       182 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~  245 (256)
T cd05039         182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-------KGYR---------MEAPEGCPPEVYKVMKDCWELDPAKRPT  245 (256)
T ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCC---------CCCccCCCHHHHHHHHHHhccChhhCcC
Confidence            9999999999997 999997655443222111       1100         0112234577889999999999999999


Q ss_pred             HHHHHHHHhc
Q 048068          261 MRQVMQYLDG  270 (313)
Q Consensus       261 ~~ell~~L~~  270 (313)
                      +.++++.|+.
T Consensus       246 ~~~l~~~l~~  255 (256)
T cd05039         246 FKQLREQLAL  255 (256)
T ss_pred             HHHHHHHHhc
Confidence            9999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-32  Score=247.91  Aligned_cols=208  Identities=23%  Similarity=0.291  Sum_probs=163.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++.+|+||||+++|+|.+++...   .+++..+..++.||+.||.|||   ..+|+
T Consensus        92 ~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~Iv  164 (370)
T cd05621          92 EERDIMAFANSPWVVQLFCAFQD-DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLI  164 (370)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            56677788899999999998876 67899999999999999999754   4899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG----KASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~  196 (313)
                      ||||||+||+++.++.++|+|||++...............||+.|+|||.+.+.    .++.++|+|||||++|+|++|.
T Consensus       165 HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~  244 (370)
T cd05621         165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD  244 (370)
T ss_pred             ecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence            999999999999999999999999876543322222345689999999998653    3678999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA--RPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~L  268 (313)
                      .||...........+.      ....       ..........+..+.+++..||..++.+  |+|+.++++|-
T Consensus       245 ~Pf~~~~~~~~~~~i~------~~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         245 TPFYADSLVGTYSKIM------DHKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             CCCCCCCHHHHHHHHH------hCCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence            9998765543332221      0000       0000011234566788899999765544  89999999983

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-31  Score=233.17  Aligned_cols=201  Identities=21%  Similarity=0.344  Sum_probs=156.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+++++|+++++++++... +...++||||+++++|..++... ...+++..++.++.||+.|+.|||   +.+++
T Consensus        53 ~~~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iv  127 (262)
T cd05077          53 ETASMMRQVSHKHIVLLYGVCVR-DVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE---DKDLV  127 (262)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEec-CCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh---hCCeE
Confidence            34467788899999999999876 55789999999999999988764 345899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCc-------EEEeecccccccCCCCCCcccccccccccccccccc-CCCCCcchhhHHHHHHHHHH
Q 048068          121 HRDIKPANVLLDADLN-------GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-TGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l  192 (313)
                      |+||+|+||+++.++.       ++++|||++.....     .....++..|+|||.+. +..++.++||||||+++|++
T Consensus       128 H~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el  202 (262)
T cd05077         128 HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI  202 (262)
T ss_pred             CCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence            9999999999986654       89999998754322     12234677899999886 46688999999999999999


Q ss_pred             H-hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          193 A-SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       193 l-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      + +|..||......+....       +....       .    ......+.+.+||.+||+.||.+||++.+++++|+
T Consensus       203 ~~~~~~p~~~~~~~~~~~~-------~~~~~-------~----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         203 CYNGEIPLKDKTLAEKERF-------YEGQC-------M----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HhCCCCCCCCcchhHHHHH-------HhcCc-------c----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            8 58888865433221111       01100       0    11112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-31  Score=238.19  Aligned_cols=212  Identities=22%  Similarity=0.323  Sum_probs=167.2

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|...++.+ +|+++++..+.... .+..++||||+.+++|.++++......+++..+..++.|++.||.|||   ..++
T Consensus        87 ~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i  162 (302)
T cd05055          87 SELKIMSHLGNHENIVNLLGACTI-GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNC  162 (302)
T ss_pred             HHHHHHHhccCCCCcceEEEEEec-CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            456677788 79999999998876 567999999999999999998654445899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      +|+||+|+||+++.++.++++|||++......... ......++..|++||.+.+..++.++||||+|+++|++++ |..
T Consensus       163 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~  242 (302)
T cd05055         163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN  242 (302)
T ss_pred             ehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999998754332211 1122345678999999988889999999999999999998 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ||............  .    ..+.         ....+...+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       243 p~~~~~~~~~~~~~--~----~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         243 PYPGMPVDSKFYKL--I----KEGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcCCCCchHHHHHH--H----HcCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            98765543322111  0    0110         0001122345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.4e-32  Score=243.42  Aligned_cols=202  Identities=23%  Similarity=0.341  Sum_probs=157.6

Q ss_pred             HHhhhhhccccc-eeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           42 QRDGLASVHSNG-LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        42 ~~~~l~~~~~~~-~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      +...+..+.|++ +++..+.+.. ++.+|+||||+++++|.+++...  ..+++..+..++.||+.||.|||   ..+++
T Consensus        50 e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~iv  123 (324)
T cd05587          50 EKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLH---SKGII  123 (324)
T ss_pred             HHHHHHhcCCCCceeeeEEEEEc-CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            334455566655 5566666655 66899999999999999999764  35899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus       124 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~  202 (324)
T cd05587         124 YRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD  202 (324)
T ss_pred             ecCCCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886432211 12234568999999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM-----RQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~  267 (313)
                      +.........+.       ..          ....+...+..+.+++.+||+.||.+|++.     +++++|
T Consensus       203 ~~~~~~~~~~i~-------~~----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         203 GEDEDELFQSIM-------EH----------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCHHHHHHHHH-------cC----------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            766544332221       00          011222344567899999999999999976     777765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.98  E-value=5.8e-32  Score=242.96  Aligned_cols=237  Identities=17%  Similarity=0.231  Sum_probs=168.6

Q ss_pred             ccceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHH
Q 048068           26 DVNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ   96 (313)
Q Consensus        26 ~~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~   96 (313)
                      ....++.|.+...         ...+...++.++|++++++.+++.. ++..++||||+++++|.+++.......+++..
T Consensus        24 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~  102 (327)
T cd08227          24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFMAYGSAKDLICTHFMDGMSELA  102 (327)
T ss_pred             cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEeccCCCcHHHHHHhhccCCCCHHH
Confidence            3455666665421         2345567778899999999998876 56899999999999999999765445699999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC------Ccccccccccccccccc
Q 048068           97 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMAPEL  170 (313)
Q Consensus        97 ~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~  170 (313)
                      ++.++.|++.||.|||   ..+++|+||||+||+++.++.+++.||+..........      .......++..|+|||+
T Consensus       103 ~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  179 (327)
T cd08227         103 IAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV  179 (327)
T ss_pred             HHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHH
Confidence            9999999999999999   58999999999999999999999999976432211100      00112345677999999


Q ss_pred             ccC--CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhh-------------------hcccccc---
Q 048068          171 MRT--GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK-------------------KGAILDA---  226 (313)
Q Consensus       171 ~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~---  226 (313)
                      +.+  ..++.++|+|||||++|++++|..||............  ......                   .+.....   
T Consensus       180 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T cd08227         180 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGES  257 (327)
T ss_pred             hhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCccccccccchhhhhcccCCcccCCcCCCCcc
Confidence            875  35789999999999999999999999764433221111  000000                   0000000   


Q ss_pred             ---------ccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          227 ---------SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       227 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                               ................+.+|+.+||+.||++|||++++++|-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p  308 (327)
T cd08227         258 TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  308 (327)
T ss_pred             cccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence                     000000012223456789999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.98  E-value=1e-31  Score=242.39  Aligned_cols=213  Identities=25%  Similarity=0.345  Sum_probs=165.5

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------------------------
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------------------------   88 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------------------------   88 (313)
                      +.+.++.+ .|+++++..+.....+..++++|||+++++|.+++....                                
T Consensus        60 E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (337)
T cd05054          60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSS  139 (337)
T ss_pred             HHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcc
Confidence            44556666 799999999988776778999999999999999986421                                


Q ss_pred             ---------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEee
Q 048068           89 ---------------------------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD  141 (313)
Q Consensus        89 ---------------------------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~d  141 (313)
                                                 ...+++..+..++.||+.||.|||   ..+|+||||||.||+++.++.++|+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~D  216 (337)
T cd05054         140 QSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICD  216 (337)
T ss_pred             ccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEec
Confidence                                       125789999999999999999999   58999999999999999999999999


Q ss_pred             cccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhh
Q 048068          142 FGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWK  219 (313)
Q Consensus       142 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~  219 (313)
                      ||++......... ......++..|+|||++.+..++.++|||||||++|++++ |..||.+....+.....      ..
T Consensus       217 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~------~~  290 (337)
T cd05054         217 FGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR------LK  290 (337)
T ss_pred             cccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH------Hh
Confidence            9998754322211 1122344667999999998899999999999999999998 99999764332211100      01


Q ss_pred             hccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .+..         ...+......+.+++.+||+.+|++|||+.+++++|+...
T Consensus       291 ~~~~---------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         291 EGTR---------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             ccCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1100         0112234467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.98  E-value=1.8e-31  Score=231.90  Aligned_cols=209  Identities=23%  Similarity=0.444  Sum_probs=167.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+.+..  ...+++|||+++++|.+++.......++...+..++.|++.||.|||   ..+++
T Consensus        50 ~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~  124 (260)
T cd05073          50 AEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI  124 (260)
T ss_pred             HHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            45667888899999999988876  67899999999999999998755556889999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||.+...............++..|++||.+....++.++|+||||+++|++++ |..||
T Consensus       125 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~  204 (260)
T cd05073         125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY  204 (260)
T ss_pred             ccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999887554322112222334567999999988888999999999999999998 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ...........+       ..+..         ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       205 ~~~~~~~~~~~~-------~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         205 PGMSNPEVIRAL-------ERGYR---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCHHHHHHHH-------hCCCC---------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            876544332221       11110         01122345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.98  E-value=3.1e-32  Score=248.22  Aligned_cols=218  Identities=19%  Similarity=0.207  Sum_probs=161.3

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.++|++++++.+++...     ...+|+||||++ ++|.+.+..    .+++..+..++.|++.||.|||   
T Consensus        72 ~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---  143 (364)
T cd07875          72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---  143 (364)
T ss_pred             HHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---
Confidence            455677888999999999887632     246899999995 578777754    3889999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ..+++||||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++|||||||++|+|++|
T Consensus       144 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  221 (364)
T cd07875         144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG  221 (364)
T ss_pred             hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhC
Confidence            5899999999999999999999999999987543322  22335678999999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHH---------HH---h----hhhcc-c----cccccc----cccCCccHHHHHHHHHHHHHc
Q 048068          196 RRPIEQQGSMEMVNLVDWV---------SD---C----WKKGA-I----LDASDS----RLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~---------~~---~----~~~~~-~----~~~~~~----~~~~~~~~~~~~~l~~li~~c  250 (313)
                      +.||.+.+..+....+...         ..   .    ..... .    .....+    .............+.++|.+|
T Consensus       222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m  301 (364)
T cd07875         222 GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM  301 (364)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHh
Confidence            9999876654433222100         00   0    00000 0    000000    000011112345788999999


Q ss_pred             CCCCCCCCCCHHHHHHHH
Q 048068          251 SHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~L  268 (313)
                      |+.||.+|||+.|+++|-
T Consensus       302 L~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         302 LVIDASKRISVDEALQHP  319 (364)
T ss_pred             cCcCcccCCCHHHHhcCc
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.98  E-value=2.8e-31  Score=229.84  Aligned_cols=207  Identities=22%  Similarity=0.313  Sum_probs=168.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+.+.+ ++..++||||+++++|.+++.......+++..+..++.|++.++.|||   ..+++
T Consensus        48 ~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~  123 (256)
T cd08221          48 NEIVILSLLQHPNIIAYYNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL  123 (256)
T ss_pred             HHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            45667888999999999999987 678999999999999999998764556899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|.+||...+..++.++|+||||+++|+|++|..||.
T Consensus       124 h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~  202 (256)
T cd08221         124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD  202 (256)
T ss_pred             ccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence            999999999999999999999999875543321 2233467889999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+....+.       .+.         ....+...+..+.+++.+||..+|.+|||++++++++
T Consensus       203 ~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         203 ATNPLNLVVKIV-------QGN---------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCHHHHHHHHH-------cCC---------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            654433222211       000         0011234456788999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=253.62  Aligned_cols=230  Identities=24%  Similarity=0.326  Sum_probs=189.0

Q ss_pred             hhHHHHHHHHhhccccc---eEEEccc----------CCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           12 VLLCVSFILSALAQDVN---QFIYHGF----------NEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~---~~~~~~~----------~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      ..+.|+|..+|.+.+..   .++.|+.          ..+.-.+..|++++.|||.|.+.+++.. ....||||||| -|
T Consensus        33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVMEYC-LG  110 (948)
T ss_pred             HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHHHHH-hc
Confidence            34556666666666654   3344433          2344577889999999999999999886 56789999999 66


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      +-.+++.-. ++++.+..|..|+.+.+.||+||||   .+.+|||||..|||+++.|.+||+|||.+...     ++-..
T Consensus       111 SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-----~PAns  181 (948)
T KOG0577|consen  111 SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIM-----APANS  181 (948)
T ss_pred             cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhc-----Cchhc
Confidence            888888766 5689999999999999999999995   89999999999999999999999999988643     34557


Q ss_pred             ccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCc
Q 048068          159 LVGTFGYMAPELMRT---GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY  235 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (313)
                      ++||+.|+|||++..   +.|+-++||||||+++.|+...++|+-..+.....+.+.+.               ..+...
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN---------------esPtLq  246 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------------ESPTLQ  246 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc---------------CCCCCC
Confidence            899999999999863   56899999999999999999999999888887777666321               122234


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .++.++.++.|+..||+.-|.+|||.++++.|
T Consensus       247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            66788999999999999999999999999875

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.98  E-value=4.7e-32  Score=248.14  Aligned_cols=207  Identities=25%  Similarity=0.319  Sum_probs=161.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++++.|++++++++.+.+ ++.+|+||||+++|+|.+++...  +.+++..+..++.||+.||+|||   ..+|+
T Consensus        50 ~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~iv  123 (376)
T cd05598          50 AERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH---KMGFI  123 (376)
T ss_pred             HHHHHHHhCCCCCcceEEEEEEc-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            56678889999999999998887 67999999999999999999764  45899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCC------------------------------------------CCcccc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDT------------------------------------------IPQTTK  158 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~  158 (313)
                      ||||||+||+++.++.++|+|||++..+....                                          ......
T Consensus       124 HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (376)
T cd05598         124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS  203 (376)
T ss_pred             eCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence            99999999999999999999999874221000                                          000112


Q ss_pred             ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.    .|....       ..+  ....
T Consensus       204 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~----~~~~~~-------~~~--~~~~  270 (376)
T cd05598         204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI----NWETTL-------HIP--SQAK  270 (376)
T ss_pred             cCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHh----ccCccc-------cCC--CCCC
Confidence            468999999999998889999999999999999999999998766544322211    111100       000  1112


Q ss_pred             HHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Q 048068          239 QMELVLKLGLFCSHPKPEARP---NMRQVMQY  267 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rp---t~~ell~~  267 (313)
                      .+..+.++|.+|+ .+|.+|+   |+.++++|
T Consensus       271 ~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         271 LSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            3445667777766 5999999   99999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.98  E-value=9.8e-32  Score=232.68  Aligned_cols=206  Identities=21%  Similarity=0.332  Sum_probs=165.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+.+.. ++.+++||||+++++|.+++.......+++..++.++.|++.|+.|||   +.+++
T Consensus        47 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~  122 (255)
T cd08219          47 KEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVL  122 (255)
T ss_pred             HHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcc
Confidence            45567788899999999998876 679999999999999999997655566899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       123 H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~  201 (255)
T cd08219         123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ  201 (255)
T ss_pred             cCCCCcceEEECCCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence            999999999999999999999999865543221 1223467888999999988889999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+........      . .+..         ...+...+..+.+++.+||+.||++|||+.+++..
T Consensus       202 ~~~~~~~~~~~------~-~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         202 ANSWKNLILKV------C-QGSY---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCHHHHHHHH------h-cCCC---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            65433222111      0 1110         01122344568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.98  E-value=1.6e-31  Score=238.78  Aligned_cols=212  Identities=25%  Similarity=0.371  Sum_probs=165.3

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHH
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVA  105 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~  105 (313)
                      .+...++.+ .|++++++.++... ++.+++||||+++++|.+++....              ...+++..+..++.||+
T Consensus        66 ~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  144 (314)
T cd05099          66 SEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVA  144 (314)
T ss_pred             HHHHHHHhccCCCCeeeEEEEEcc-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHH
Confidence            344556666 59999999998876 567999999999999999997531              23588899999999999


Q ss_pred             HHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHH
Q 048068          106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYA  184 (313)
Q Consensus       106 ~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws  184 (313)
                      .||.|||   +.+++|+||+|+||+++.++.++|+|||++.......... .....++..|++||.+.+..++.++|+||
T Consensus       145 ~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  221 (314)
T cd05099         145 RGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS  221 (314)
T ss_pred             HHHHHHH---HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhH
Confidence            9999999   6899999999999999999999999999987543221111 11122345799999998888899999999


Q ss_pred             HHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       185 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      ||+++|++++ |..||......+....+.       .+..         ...+...+..+.+++.+||+.+|++|||+.+
T Consensus       222 lG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~  285 (314)
T cd05099         222 FGILMWEIFTLGGSPYPGIPVEELFKLLR-------EGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQ  285 (314)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            9999999999 889997665444333221       1000         0112234457889999999999999999999


Q ss_pred             HHHHHhccC
Q 048068          264 VMQYLDGNA  272 (313)
Q Consensus       264 ll~~L~~~~  272 (313)
                      +++.|+...
T Consensus       286 ll~~l~~~~  294 (314)
T cd05099         286 LVEALDKVL  294 (314)
T ss_pred             HHHHHHHHH
Confidence            999998775

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.98  E-value=1.5e-31  Score=234.91  Aligned_cols=211  Identities=23%  Similarity=0.375  Sum_probs=165.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHH
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK-------------PSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~  106 (313)
                      ..+.+.++.+.|++++++.+.... +...++||||+++++|.+++.....             ..+++..+..++.||+.
T Consensus        55 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~  133 (280)
T cd05092          55 QREAELLTVLQHQHIVRFYGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIAS  133 (280)
T ss_pred             HHHHHHHhcCCCCCCceEEEEEec-CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHH
Confidence            345567788899999999988776 5678999999999999999975421             34889999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      |+.|||   ..+++|+||+|+||++++++.++|+|||++......... ......++..|++||...+..++.++|+|||
T Consensus       134 al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  210 (280)
T cd05092         134 GMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF  210 (280)
T ss_pred             HHHHHH---HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence            999999   689999999999999999999999999998644322111 1112234578999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       186 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      ||++|++++ |.+||......+......   .   .          .....+...+..+.+++.+||+.||.+||+++++
T Consensus       211 G~il~el~~~g~~p~~~~~~~~~~~~~~---~---~----------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l  274 (280)
T cd05092         211 GVVLWEIFTYGKQPWYQLSNTEAIECIT---Q---G----------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI  274 (280)
T ss_pred             HHHHHHHHcCCCCCCccCCHHHHHHHHH---c---C----------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            999999998 999997655443322211   0   0          0001122345678899999999999999999999


Q ss_pred             HHHHhc
Q 048068          265 MQYLDG  270 (313)
Q Consensus       265 l~~L~~  270 (313)
                      ++.|+.
T Consensus       275 ~~~l~~  280 (280)
T cd05092         275 HSRLQA  280 (280)
T ss_pred             HHHHhC
Confidence            999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=2.1e-32  Score=245.56  Aligned_cols=199  Identities=23%  Similarity=0.279  Sum_probs=158.9

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCc
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI  124 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl  124 (313)
                      .++.++|++++++.+.+.. ++..++||||+++++|..++...  ..+++..+..++.||+.||.|||   ..+++||||
T Consensus        49 ~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dl  122 (325)
T cd05604          49 LLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDL  122 (325)
T ss_pred             HHHhCCCCCCccEEEEEec-CCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCC
Confidence            4667899999999888876 67899999999999999888763  46999999999999999999999   589999999


Q ss_pred             CCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCc
Q 048068          125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS  204 (313)
Q Consensus       125 ~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  204 (313)
                      ||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       123 kp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~  201 (325)
T cd05604         123 KPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV  201 (325)
T ss_pred             CHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence            9999999999999999999986432211 122345688999999999988899999999999999999999999987654


Q ss_pred             hhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH
Q 048068          205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR----QVMQY  267 (313)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~----ell~~  267 (313)
                      .+....+.       ...          .......+..+.+++.+||+.+|.+||++.    ++++|
T Consensus       202 ~~~~~~~~-------~~~----------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         202 AEMYDNIL-------HKP----------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             HHHHHHHH-------cCC----------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence            43322221       000          011223445678899999999999999875    55554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=6.3e-32  Score=241.31  Aligned_cols=235  Identities=22%  Similarity=0.262  Sum_probs=163.2

Q ss_pred             eEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhC-------CCCCCCHH
Q 048068           29 QFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTN-------IKPSLSWY   95 (313)
Q Consensus        29 ~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~-------~~~~~~~~   95 (313)
                      .++.+.+..     ....|...+++++|+++++..+++. ..+..+++||||+. ++|.+++...       ....+++.
T Consensus        30 ~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~  108 (317)
T cd07867          30 EYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRS  108 (317)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHH
Confidence            455554432     3345778889999999999998876 34568899999995 5888887532       12358899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE----cCCCcEEEeecccccccCCCCC--Cccccccccccccccc
Q 048068           96 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPE  169 (313)
Q Consensus        96 ~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv----~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE  169 (313)
                      .++.++.||+.||.|||   ..+++|+||||+||++    +.++.++|+|||++........  .......++..|+|||
T Consensus       109 ~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07867         109 MVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             HHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcH
Confidence            99999999999999999   5899999999999999    4567899999999976543321  1223346788999999


Q ss_pred             cccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhh-------hhHHHHHH-------Hhhhhccc----ccccc--
Q 048068          170 LMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM-------VNLVDWVS-------DCWKKGAI----LDASD--  228 (313)
Q Consensus       170 ~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~-------~~~~~~~~----~~~~~--  228 (313)
                      .+.+ ..++.++|||||||++|+|++|++||........       ........       ..|.....    .....  
T Consensus       186 ~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (317)
T cd07867         186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF  265 (317)
T ss_pred             HhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhh
Confidence            9876 4578999999999999999999999975432110       00000000       00110000    00000  


Q ss_pred             -------ccc---cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          229 -------SRL---EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       229 -------~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                             ...   ...........+.+|+.+||..||.+|||++|+++|
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         266 RRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             cccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence                   000   000111123458889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.98  E-value=2e-31  Score=234.12  Aligned_cols=206  Identities=24%  Similarity=0.335  Sum_probs=162.1

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCc
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI  124 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl  124 (313)
                      .++.+.|+++++++++..  +...++++||+++|+|.+++... ...+++..+..++.||+.|+.|||   ..+++|+||
T Consensus        62 ~l~~l~h~~iv~~~~~~~--~~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dl  135 (279)
T cd05111          62 AMGSLDHAYIVRLLGICP--GASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNL  135 (279)
T ss_pred             HHhcCCCCCcceEEEEEC--CCccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecccc
Confidence            346778999999999875  34678999999999999999765 346899999999999999999999   589999999


Q ss_pred             CCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccC
Q 048068          125 KPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQ  202 (313)
Q Consensus       125 ~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  202 (313)
                      ||+||+++.++.++|+|||++........ .......++..|++||.+.+..++.++|+||||+++|++++ |..||.+.
T Consensus       136 kp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             CcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999875432211 11223345678999999988889999999999999999998 99999876


Q ss_pred             CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          203 GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ........+       ..+...     ..    +......+..++..||..||.+|||+.++++.|....
T Consensus       216 ~~~~~~~~~-------~~~~~~-----~~----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         216 RPHEVPDLL-------EKGERL-----AQ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CHHHHHHHH-------HCCCcC-----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            543322222       111111     01    1112345788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=6.3e-32  Score=242.94  Aligned_cols=202  Identities=24%  Similarity=0.316  Sum_probs=156.4

Q ss_pred             ccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCc
Q 048068           49 VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN  128 (313)
Q Consensus        49 ~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~n  128 (313)
                      .+|++++++.+++.. ++.+++||||+++++|..++...  +.+++..++.++.||+.||.|||   ..+++||||||+|
T Consensus        53 ~~hp~iv~~~~~~~~-~~~~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~N  126 (329)
T cd05618          53 SNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDN  126 (329)
T ss_pred             CCCCcCCceeeEEEe-CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHH
Confidence            379999999998876 67899999999999999888764  46999999999999999999999   5899999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhh-
Q 048068          129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM-  207 (313)
Q Consensus       129 Ilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-  207 (313)
                      |+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||........ 
T Consensus       127 ili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~  205 (329)
T cd05618         127 VLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP  205 (329)
T ss_pred             EEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc
Confidence            999999999999999986432211 122345689999999999988899999999999999999999999963221110 


Q ss_pred             -hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH
Q 048068          208 -VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN------MRQVMQY  267 (313)
Q Consensus       208 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~ell~~  267 (313)
                       ..............          ....+......+.+++.+||+.||++|||      +.++++|
T Consensus       206 ~~~~~~~~~~~i~~~----------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         206 DQNTEDYLFQVILEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ccccHHHHHHHHhcC----------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence             00011111111110          01123344567889999999999999998      5788776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.98  E-value=2.1e-31  Score=230.66  Aligned_cols=209  Identities=26%  Similarity=0.427  Sum_probs=164.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.+.|+++++.++.... ....++||||+++++|.+++... ...+++..++.++.|++.++.+||   ..++
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i  121 (256)
T cd05112          47 IEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLE---SSNV  121 (256)
T ss_pred             HHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            346678888999999999988776 56889999999999999999764 235889999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++...............++..|++||.+.++.++.++|+||||+++|++++ |..|
T Consensus       122 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  201 (256)
T cd05112         122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP  201 (256)
T ss_pred             cccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999886543322111112234568999999988889999999999999999998 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      |.............       .+.         ....+...+..+.+|+.+||+.+|++|||+.+++++|.
T Consensus       202 ~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         202 YENRSNSEVVETIN-------AGF---------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCcCCHHHHHHHHh-------CCC---------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            97655443222210       000         00011123467999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.98  E-value=5.7e-32  Score=240.09  Aligned_cols=222  Identities=21%  Similarity=0.268  Sum_probs=164.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|++++++.+++.. ++.+++||||++ ++|.+++... ...+++..+..++.||+.||.|||   ..++
T Consensus        52 ~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~i  125 (301)
T cd07873          52 IREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKV  125 (301)
T ss_pred             HHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            356788889999999999999886 668999999996 5899888765 346899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+. .++.++|+||||+++|+|++|++|
T Consensus       126 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~  204 (301)
T cd07873         126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL  204 (301)
T ss_pred             eCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999865432221 12233567889999988653 578899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHH-----Hhhhhc----ccccccccccc----CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVS-----DCWKKG----AILDASDSRLE----GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      |...+..+....+....     ..|...    .......+...    .......+..+.+||.+||+.||.+|||++|++
T Consensus       205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil  284 (301)
T cd07873         205 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM  284 (301)
T ss_pred             CCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            98766544332221110     111110    00000000000    001122345688999999999999999999999


Q ss_pred             HHH
Q 048068          266 QYL  268 (313)
Q Consensus       266 ~~L  268 (313)
                      +|-
T Consensus       285 ~h~  287 (301)
T cd07873         285 KHP  287 (301)
T ss_pred             cCc
Confidence            863

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.98  E-value=8.2e-32  Score=242.01  Aligned_cols=209  Identities=23%  Similarity=0.283  Sum_probs=159.4

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      +...+.++ .|++++++.+.+.. .+.+|+||||+++++|..++...  +.+++..++.++.||+.||.|||   ..+++
T Consensus        45 e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~iv  118 (327)
T cd05617          45 EKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGII  118 (327)
T ss_pred             HHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            33444455 69999999988876 56899999999999999988764  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.
T Consensus       119 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             ccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886432211 12234568999999999998889999999999999999999999996


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN------MRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~ell~~  267 (313)
                      .....................          +...+...+..+.+++.+||+.||.+|++      ++++++|
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         198 IITDNPDMNTEDYLFQVILEK----------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             ccCCCcccccHHHHHHHHHhC----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            433222111111111111110          01122234456789999999999999998      5688776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=8.5e-32  Score=233.71  Aligned_cols=203  Identities=21%  Similarity=0.305  Sum_probs=158.8

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...+...++.+.|+++++.++.+.. +...++||||+++|+|.++++.. ...+++..+..++.||+.|+.|||   +.+
T Consensus        46 ~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~  120 (258)
T cd05078          46 FFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLE---DKG  120 (258)
T ss_pred             HHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            3456677888999999999999886 56789999999999999999865 336899999999999999999999   699


Q ss_pred             ceecCcCCCcEEEcCCCc--------EEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADLN--------GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFM  189 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il  189 (313)
                      ++|+||||+||+++.++.        ++++|||++.....     .....++..|++||.+.+ ..++.++|+||||+++
T Consensus       121 iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l  195 (258)
T cd05078         121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTL  195 (258)
T ss_pred             eecCCCccceEEEecccccccCCCceEEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence            999999999999987654        68999998754322     223456788999999876 4578899999999999


Q ss_pred             HHHHhCC-CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          190 LEVASGR-RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       190 ~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |++++|. .||............   .    .           ....+......+.+++..||+.||++|||++++++.|
T Consensus       196 ~~l~~g~~~~~~~~~~~~~~~~~---~----~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         196 WEIFSGGDKPLSALDSQKKLQFY---E----D-----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHcCCCCChhhccHHHHHHHH---H----c-----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            9999984 666543332211111   0    0           0012222335689999999999999999999999987


Q ss_pred             h
Q 048068          269 D  269 (313)
Q Consensus       269 ~  269 (313)
                      +
T Consensus       258 ~  258 (258)
T cd05078         258 N  258 (258)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.98  E-value=1.4e-31  Score=233.17  Aligned_cols=213  Identities=24%  Similarity=0.382  Sum_probs=167.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+...++.+.|++++++...+.. ++..++||||+++++|.+++...  ....+++..++.++.||+.|+.|||   +.+
T Consensus        51 ~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~  126 (267)
T cd08229          51 KEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR  126 (267)
T ss_pred             HHHHHHHHccCCchhhhhheeEe-CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            35567788899999999988876 56899999999999999998742  2346899999999999999999999   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|..|
T Consensus       127 i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p  205 (267)
T cd08229         127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999998865543221 12234578899999999888889999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      |.+..... ........    .     .   ..+.......+..+.+++.+||+.||++|||+.++++.+...
T Consensus       206 ~~~~~~~~-~~~~~~~~----~-----~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         206 FYGDKMNL-YSLCKKIE----Q-----C---DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             cccccchH-HHHhhhhh----c-----C---CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            97543221 11111000    0     0   001111223566799999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.98  E-value=2.4e-31  Score=231.09  Aligned_cols=211  Identities=25%  Similarity=0.359  Sum_probs=161.6

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...++.++|++++++.++....++..++||||+.+++|.+++... ....++..+..++.|++.||.|||   ..+++|
T Consensus        46 e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H  121 (262)
T cd05058          46 EGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLA---SKKFVH  121 (262)
T ss_pred             HHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence            4456677899999999997765566789999999999999999765 234677888999999999999999   689999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCC---CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC-CC
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTI---PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG-RR  197 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~  197 (313)
                      +||+|+||+++.++.++|+|||++........   .......++..|+|||.+.+..++.++||||||+++|++++| .+
T Consensus       122 ~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~  201 (262)
T cd05058         122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  201 (262)
T ss_pred             cccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999864432111   011122346679999999888899999999999999999994 66


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||............      ....      ...    .+...+..+.+++..||+.+|++|||+.++++.|++..
T Consensus       202 ~~~~~~~~~~~~~~------~~~~------~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         202 PYPDVDSFDITVYL------LQGR------RLL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCCHHHHHHHH------hcCC------CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            66654433221111      1110      001    11123457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.98  E-value=3.2e-31  Score=231.16  Aligned_cols=211  Identities=25%  Similarity=0.383  Sum_probs=166.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----KPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      ..+.+.++.++|+++++..+++.. ++..++||||+++++|.+++....     ...+++..+..++.|++.|+.|||  
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--  123 (269)
T cd05044          47 LKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--  123 (269)
T ss_pred             HHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--
Confidence            356677888999999999998876 567999999999999999997532     234788999999999999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCCC-----cEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHH
Q 048068          115 WEQVVLHRDIKPANVLLDADL-----NGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVF  188 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~-----~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i  188 (313)
                       ..+++|+||+|+||+++.++     .++++|||++........ .......++..|++||.+.+..++.++|+||||++
T Consensus       124 -~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i  202 (269)
T cd05044         124 -QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL  202 (269)
T ss_pred             -hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHH
Confidence             58999999999999999877     899999999865432211 11222344678999999998889999999999999


Q ss_pred             HHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          189 MLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       189 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +|+|++ |..||......+....+.       .+.         ....+...+..+.+++.+||..+|.+|||++++++.
T Consensus       203 l~ellt~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  266 (269)
T cd05044         203 MWEILTLGQQPYPALNNQEVLQHVT-------AGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEI  266 (269)
T ss_pred             HHHHHHcCCCCCcccCHHHHHHHHh-------cCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            999998 999997655443322221       000         001223345678999999999999999999999999


Q ss_pred             Hhc
Q 048068          268 LDG  270 (313)
Q Consensus       268 L~~  270 (313)
                      |++
T Consensus       267 l~~  269 (269)
T cd05044         267 LQN  269 (269)
T ss_pred             HhC
Confidence            863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.98  E-value=2e-31  Score=235.25  Aligned_cols=212  Identities=25%  Similarity=0.375  Sum_probs=166.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC----------------------CCCCCHHHHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI----------------------KPSLSWYQRF   98 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~   98 (313)
                      .|.+.++.+.|++++++.+.+.. ++..++||||+.+++|.+++....                      ...+++..++
T Consensus        52 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  130 (290)
T cd05045          52 SEFNLLKQVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLI  130 (290)
T ss_pred             HHHHHHhhCCCCCEeeEEEEEec-CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHH
Confidence            45667888899999999998876 567899999999999999986421                      1347889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKAS  177 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  177 (313)
                      .++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||++......... ......++..|++||.+.+..++
T Consensus       131 ~i~~~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~  207 (290)
T cd05045         131 SFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT  207 (290)
T ss_pred             HHHHHHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc
Confidence            99999999999999   689999999999999999999999999998654322211 11223346689999999888899


Q ss_pred             cchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      .++||||||+++|+|++ |..||.+...........       ...         ....+...+..+.+++..||+.+|+
T Consensus       208 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~  271 (290)
T cd05045         208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK-------TGY---------RMERPENCSEEMYNLMLTCWKQEPD  271 (290)
T ss_pred             hHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCC---------CCCCCCCCCHHHHHHHHHHccCCcc
Confidence            99999999999999998 999997665444332221       100         0011223446788999999999999


Q ss_pred             CCCCHHHHHHHHhccC
Q 048068          257 ARPNMRQVMQYLDGNA  272 (313)
Q Consensus       257 ~Rpt~~ell~~L~~~~  272 (313)
                      +|||+.++++.|++..
T Consensus       272 ~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         272 KRPTFADISKELEKMM  287 (290)
T ss_pred             cCCCHHHHHHHHHHHH
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=2e-31  Score=245.22  Aligned_cols=233  Identities=21%  Similarity=0.258  Sum_probs=170.2

Q ss_pred             eEEEcccCC--ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH
Q 048068           29 QFIYHGFNE--DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        29 ~~~~~~~~~--~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~  106 (313)
                      .+++|.+..  ....|...++.++|+++++..+.+.. +...|+|||++ +++|.+++..  ...+++..++.++.||+.
T Consensus       121 ~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~  196 (392)
T PHA03207        121 KVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLE  196 (392)
T ss_pred             eEEEEeccccccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHH
Confidence            445555443  33467789999999999999988875 56899999999 5688888854  346999999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      ||.|||   ..+|+||||||+||+++.++.++|+|||++........ .......|+..|+|||++.+..++.++|||||
T Consensus       197 aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  273 (392)
T PHA03207        197 ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA  273 (392)
T ss_pred             HHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence            999999   58999999999999999999999999999865433221 11234568999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhc---c---------------ccccccc-cccCC-ccHHHHHHHHH
Q 048068          186 GVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKG---A---------------ILDASDS-RLEGI-YEEEQMELVLK  245 (313)
Q Consensus       186 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~---------------~~~~~~~-~~~~~-~~~~~~~~l~~  245 (313)
                      ||++|+|++|+.||.+.........+..+.......   .               ......+ ..+.. ........+.+
T Consensus       274 Gvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (392)
T PHA03207        274 GLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEY  353 (392)
T ss_pred             HHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHH
Confidence            999999999999997654432211111111100000   0               0000000 00000 00112456788


Q ss_pred             HHHHcCCCCCCCCCCHHHHHHHH
Q 048068          246 LGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       246 li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +|.+||..||++|||+.+++.|-
T Consensus       354 li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        354 LIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             HHHHHhccChhhCCCHHHHhhCc
Confidence            99999999999999999999973

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.1e-32  Score=246.76  Aligned_cols=208  Identities=24%  Similarity=0.314  Sum_probs=163.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+++++|+++++.++.+.+ ++.+++||||+++|+|.+++...  +.+++..+..++.||+.||.|||   ..+++
T Consensus        50 ~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~iv  123 (364)
T cd05599          50 AERDILAEADNPWVVKLYYSFQD-ENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH---KLGYI  123 (364)
T ss_pred             HHHHHHHhCCCCCCcceEEEEEc-CCeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            46778889999999999998887 67899999999999999999764  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-------------------------------------ccccccccc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-------------------------------------QTTKLVGTF  163 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-------------------------------------~~~~~~~~~  163 (313)
                      ||||||+||+++.++.++|+|||++.........                                     ......||+
T Consensus       124 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  203 (364)
T cd05599         124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP  203 (364)
T ss_pred             eccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCc
Confidence            9999999999999999999999988643211100                                     001235899


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       164 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      .|+|||++.+..++.++|+|||||++|+|++|..||...........+.    .|....       ..+  .....++.+
T Consensus       204 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~----~~~~~~-------~~~--~~~~~s~~~  270 (364)
T cd05599         204 DYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII----NWKETL-------QFP--DEVPLSPEA  270 (364)
T ss_pred             cccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHH----cCCCcc-------CCC--CCCCCCHHH
Confidence            9999999988889999999999999999999999998765443322211    011000       000  111234567


Q ss_pred             HHHHHHcCCCCCCCCCC---HHHHHHHH
Q 048068          244 LKLGLFCSHPKPEARPN---MRQVMQYL  268 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt---~~ell~~L  268 (313)
                      .++|.+|+. +|.+|++   ++++++|-
T Consensus       271 ~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         271 KDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             HHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            889999996 9999997   99999863

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.98  E-value=3e-31  Score=231.31  Aligned_cols=209  Identities=28%  Similarity=0.470  Sum_probs=164.7

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +.+.++.++|+++++..+.+.. .+..++||||+++++|.+++... ...+++..+..++.|++.|+.|||   ..+++|
T Consensus        56 e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H  130 (268)
T cd05063          56 EASIMGQFSHHNIIRLEGVVTK-FKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVH  130 (268)
T ss_pred             HHHHHhcCCCCCeeEEEEEEcc-CCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence            4566778899999999998876 56889999999999999999764 346899999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc--cccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT--KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      +||+|+||+++.++.++++|||++............  ....+..|++||.+.+..++.++|+||||+++|++++ |..|
T Consensus       131 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p  210 (268)
T cd05063         131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP  210 (268)
T ss_pred             cccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998654322111111  1122456999999988888999999999999999997 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      |...........+.       ...         ....+...+..+.+++.+||..+|++||++.++++.|++.
T Consensus       211 ~~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         211 YWDMSNHEVMKAIN-------DGF---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCcCCHHHHHHHHh-------cCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            97655433222221       100         0011223456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=2.9e-32  Score=248.48  Aligned_cols=212  Identities=20%  Similarity=0.334  Sum_probs=171.4

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEec-cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ....|...|+.++|+||+++++.+.+ ++..+-+|+|.+..|+|..|+++.  +..+...++.|++||++||.|||+. .
T Consensus        87 R~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~  163 (632)
T KOG0584|consen   87 RLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-D  163 (632)
T ss_pred             HHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-C
Confidence            34467788899999999999999884 345678999999999999999985  4589999999999999999999986 5


Q ss_pred             CCceecCcCCCcEEEcCC-CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          117 QVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ..|+|||||.+||||+.+ |.+||+|+|++...+...   .....|||.|+|||.+. ..|++..||||||++|.||+|+
T Consensus       164 PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~  239 (632)
T KOG0584|consen  164 PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTS  239 (632)
T ss_pred             CCccccccccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhc
Confidence            789999999999999865 899999999998766544   23368999999999998 7899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhcc
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ--YLDGN  271 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~--~L~~~  271 (313)
                      ..||........++..-           .+.   ..+..+..-..+.+++||.+||.. ...|||+.|||+  +|...
T Consensus       240 eYPYsEC~n~AQIYKKV-----------~SG---iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  240 EYPYSECTNPAQIYKKV-----------TSG---IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             cCChhhhCCHHHHHHHH-----------HcC---CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            99998766554433221           001   111111112235789999999999 999999999998  45443

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.98  E-value=1.6e-31  Score=231.07  Aligned_cols=220  Identities=22%  Similarity=0.323  Sum_probs=172.1

Q ss_pred             ceEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           28 NQFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        28 ~~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      ..+++|.+..     ....+.+.++.++|++++++.+.+.. +..+++++||+.+++|.+++... ...+++..++.++.
T Consensus        29 ~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~  106 (256)
T cd06612          29 QVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILY  106 (256)
T ss_pred             cEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHH
Confidence            3455555542     33455667788899999999998887 57899999999999999999754 34689999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.|+.|||   ..+++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+
T Consensus       107 ~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di  182 (256)
T cd06612         107 QTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADI  182 (256)
T ss_pred             HHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhH
Confidence            9999999999   58999999999999999999999999999876543321 2223456788999999988888999999


Q ss_pred             HHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048068          183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR  262 (313)
Q Consensus       183 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  262 (313)
                      ||||+++|++++|+.||.............       .       ........+......+.+++.+||+.||++|||++
T Consensus       183 ~s~G~il~~l~~g~~p~~~~~~~~~~~~~~-------~-------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  248 (256)
T cd06612         183 WSLGITAIEMAEGKPPYSDIHPMRAIFMIP-------N-------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAI  248 (256)
T ss_pred             HHHHHHHHHHHhCCCCCCCcchhhhhhhhc-------c-------CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHH
Confidence            999999999999999997654432211110       0       00011112334456789999999999999999999


Q ss_pred             HHHHH
Q 048068          263 QVMQY  267 (313)
Q Consensus       263 ell~~  267 (313)
                      ++++|
T Consensus       249 ~il~~  253 (256)
T cd06612         249 QLLQH  253 (256)
T ss_pred             HHhcC
Confidence            99975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.98  E-value=2.4e-31  Score=242.34  Aligned_cols=209  Identities=24%  Similarity=0.308  Sum_probs=159.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...+.+++|+++++.++.+.+ +..+|+||||++||+|.+++...  +.+++..+..++.|++.||.|||   +.+|
T Consensus        49 ~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~gi  122 (363)
T cd05628          49 RAERDILVEADSLWVVKMFYSFQD-KLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH---QLGF  122 (363)
T ss_pred             HHHHHHHHhCCCCCcceEEEEEec-CCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            346677888999999999998887 66899999999999999999864  46999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCC----------------------------------Cccccccccccc
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI----------------------------------PQTTKLVGTFGY  165 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~----------------------------------~~~~~~~~~~~y  165 (313)
                      +||||||+||+++.++.++|+|||++........                                  .......||+.|
T Consensus       123 vHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y  202 (363)
T cd05628         123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY  202 (363)
T ss_pred             EecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccc
Confidence            9999999999999999999999999864321100                                  001234689999


Q ss_pred             cccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHH
Q 048068          166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK  245 (313)
Q Consensus       166 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  245 (313)
                      +|||.+.+..++.++|+|||||++|+|++|..||.+.........+..    +....       ..+..  ...++.+.+
T Consensus       203 ~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~----~~~~~-------~~p~~--~~~s~~~~~  269 (363)
T cd05628         203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN----WKETL-------IFPPE--VPISEKAKD  269 (363)
T ss_pred             cCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CcCcc-------cCCCc--CCCCHHHHH
Confidence            999999988899999999999999999999999987655443332210    00000       01110  112345566


Q ss_pred             HHHHcCC--CCCCCCCCHHHHHHH
Q 048068          246 LGLFCSH--PKPEARPNMRQVMQY  267 (313)
Q Consensus       246 li~~cl~--~~P~~Rpt~~ell~~  267 (313)
                      ++..|+.  .++..||+++|+++|
T Consensus       270 li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         270 LILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHHHcCChhhcCCCCCHHHHhCC
Confidence            6665443  344467999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.98  E-value=1.6e-31  Score=238.93  Aligned_cols=211  Identities=23%  Similarity=0.318  Sum_probs=166.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+....  ...++|+||+++|+|.+++... ...+++..++.++.||+.||+|||   +.+++
T Consensus        58 ~e~~~l~~l~h~niv~~~g~~~~--~~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~ii  131 (316)
T cd05108          58 DEAYVMASVDNPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---ERRLV  131 (316)
T ss_pred             HHHHHHHhCCCCCCCeEEEEEcC--CCceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---hcCee
Confidence            34567788899999999998874  3578999999999999999865 345889999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      |+||||+||+++.++.++|+|||++.......... ......+..|++||.+.+..++.++||||||+++|++++ |..|
T Consensus       132 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p  211 (316)
T cd05108         132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  211 (316)
T ss_pred             ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999997654322111 112233567999999988889999999999999999998 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      |.+....+......       .+..       .+  .+..+...+.+++..||..+|.+|||+.+++.+|.....
T Consensus       212 ~~~~~~~~~~~~~~-------~~~~-------~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         212 YDGIPASEISSILE-------KGER-------LP--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCCCHHHHHHHHh-------CCCC-------CC--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            98655443222111       1100       00  112234568899999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.98  E-value=2.8e-31  Score=231.92  Aligned_cols=212  Identities=20%  Similarity=0.323  Sum_probs=163.3

Q ss_pred             hHHhhhhhccccceeeeeeEEec-----cCCeEEEEEecCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNS-----RKGEFLLVYDYMPNGSLDKILHTN----IKPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~-----~~~~~~lV~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      .+...++.++|++++++.++...     .....++||||+++++|.+++...    ....+++..+..++.|++.||.||
T Consensus        49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l  128 (272)
T cd05075          49 SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL  128 (272)
T ss_pred             HHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence            34556778899999999887642     123578999999999999988432    234589999999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML  190 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  190 (313)
                      |   ..+++|+||||+||+++.++.++|+|||++.......... .....++..|++||...+..++.++|+||||+++|
T Consensus       129 H---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~  205 (272)
T cd05075         129 S---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW  205 (272)
T ss_pred             H---HCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence            9   5899999999999999999999999999987553322111 11223466799999999888999999999999999


Q ss_pred             HHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          191 EVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       191 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++++ |+.||...........+       ..+...         ..+......+.++|.+||+.||++|||+.++++.|+
T Consensus       206 el~~~g~~p~~~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         206 EIATRGQTPYPGVENSEIYDYL-------RQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE  269 (272)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHH-------HcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            9999 88999765443322211       111100         012234466899999999999999999999999998


Q ss_pred             cc
Q 048068          270 GN  271 (313)
Q Consensus       270 ~~  271 (313)
                      ..
T Consensus       270 ~~  271 (272)
T cd05075         270 KA  271 (272)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.98  E-value=2.3e-31  Score=236.56  Aligned_cols=217  Identities=24%  Similarity=0.364  Sum_probs=169.1

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHH
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVA  105 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~  105 (313)
                      .+...++.+ .|+++++..+.+.. .+..++||||+++++|.+++....              ...+++..+..++.||+
T Consensus        69 ~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~  147 (304)
T cd05101          69 SEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVA  147 (304)
T ss_pred             HHHHHHHhhccCCCchheeEEEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHH
Confidence            345566667 79999999998876 568899999999999999997632              13478888999999999


Q ss_pred             HHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHH
Q 048068          106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYA  184 (313)
Q Consensus       106 ~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws  184 (313)
                      .||.|||   ..+++|+||||+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++||||
T Consensus       148 ~al~~LH---~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  224 (304)
T cd05101         148 RGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  224 (304)
T ss_pred             HHHHHHH---HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHH
Confidence            9999999   5899999999999999999999999999987554322111 12234456799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       185 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      ||+++|++++ |..||......+....+.       .+..         ...+...+..+.+++..||+.+|++|||+.+
T Consensus       225 lG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e  288 (304)
T cd05101         225 FGVLMWEIFTLGGSPYPGIPVEELFKLLK-------EGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQ  288 (304)
T ss_pred             HHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence            9999999998 788887655444332221       1100         0112234567889999999999999999999


Q ss_pred             HHHHHhccCCCCCC
Q 048068          264 VMQYLDGNATLPDI  277 (313)
Q Consensus       264 ll~~L~~~~~~~~~  277 (313)
                      +++.|+...++..+
T Consensus       289 ~l~~l~~~~~~~~~  302 (304)
T cd05101         289 LVEDLDRILTLTTN  302 (304)
T ss_pred             HHHHHHHHHHhhhc
Confidence            99999887655443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.98  E-value=1.4e-31  Score=238.02  Aligned_cols=209  Identities=25%  Similarity=0.380  Sum_probs=162.6

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHH
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~  106 (313)
                      +...+..+ +|+++++..+++.. ++.+++||||+++++|.++++...              ...+++..++.++.||+.
T Consensus        57 Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~  135 (303)
T cd05088          57 ELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR  135 (303)
T ss_pred             HHHHHHHhcCCCCcceEEEEECC-CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHH
Confidence            44556677 89999999998876 568999999999999999997532              235889999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG  186 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  186 (313)
                      |++|||   +.+++|+||+|+||+++.++.++|+|||++.......  .......+..|++||.+.+..++.++||||||
T Consensus       136 al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  210 (303)
T cd05088         136 GMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG  210 (303)
T ss_pred             HHHHHH---hCCccccccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhh
Confidence            999999   5899999999999999999999999999885322111  11112235679999999888889999999999


Q ss_pred             HHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       187 ~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      +++|++++ |..||......+.....       ..+.         ....+...+..+.+|+.+||+.+|++|||+++++
T Consensus       211 ~il~ellt~g~~p~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  274 (303)
T cd05088         211 VLLWEIVSLGGTPYCGMTCAELYEKL-------PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL  274 (303)
T ss_pred             hHHHHHHhcCCCCcccCChHHHHHHH-------hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            99999998 99999765544322211       0000         0001122345688999999999999999999999


Q ss_pred             HHHhccC
Q 048068          266 QYLDGNA  272 (313)
Q Consensus       266 ~~L~~~~  272 (313)
                      +.|+...
T Consensus       275 ~~l~~~~  281 (303)
T cd05088         275 VSLNRML  281 (303)
T ss_pred             HHHHHHH
Confidence            9987653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.98  E-value=2.4e-31  Score=235.64  Aligned_cols=205  Identities=22%  Similarity=0.350  Sum_probs=163.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|++++++.+.+.. +.+.++||||+++++|.+++...   .+++..+..++.|++.||.|||   ..+++
T Consensus        66 ~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~  138 (296)
T cd06654          66 NEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVI  138 (296)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            35567788899999999998876 56899999999999999999753   4899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+|||||++|++++|+.||.
T Consensus       139 H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~  217 (296)
T cd06654         139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (296)
T ss_pred             cCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999998865432221 1223467889999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...........      +...        ......+......+.+++.+||..+|++|||+.+++++
T Consensus       218 ~~~~~~~~~~~------~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         218 NENPLRALYLI------ATNG--------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCHHHhHHHH------hcCC--------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            65432221111      0000        00111223445678899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.98  E-value=3.7e-31  Score=231.01  Aligned_cols=212  Identities=20%  Similarity=0.349  Sum_probs=165.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC-----CeEEEEEecCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHTN----IKPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      .+...++.++|+++++..++.....     ...++||||+++++|..++...    ....+++..+..++.|++.||.||
T Consensus        50 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l  129 (273)
T cd05035          50 SEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL  129 (273)
T ss_pred             HHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence            3556778889999999998876422     2479999999999999998543    134689999999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML  190 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  190 (313)
                      |   ..+++|+||+|+||++++++.++|+|||++.......... ......+..|++||.+.+..++.++|+|||||++|
T Consensus       130 H---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~  206 (273)
T cd05035         130 S---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW  206 (273)
T ss_pred             H---hCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHH
Confidence            9   5899999999999999999999999999987543322111 11123456799999998888999999999999999


Q ss_pred             HHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          191 EVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       191 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++++ |..||.+....+......       .+.         ....+......+.+++.+||+.||++|||+.+++++|+
T Consensus       207 el~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         207 EIATRGQTPYPGVENHEIYDYLR-------HGN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE  270 (273)
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHH-------cCC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999 899997655433222111       110         00122334567899999999999999999999999998


Q ss_pred             cc
Q 048068          270 GN  271 (313)
Q Consensus       270 ~~  271 (313)
                      ..
T Consensus       271 ~~  272 (273)
T cd05035         271 NI  272 (273)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.98  E-value=1.1e-31  Score=245.04  Aligned_cols=208  Identities=22%  Similarity=0.295  Sum_probs=162.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++.+++||||+++|+|.+++...   .+++..+..++.||+.||.|||   ..+|+
T Consensus        92 ~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~iv  164 (371)
T cd05622          92 EERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFI  164 (371)
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEE
Confidence            45667788899999999988876 67899999999999999999754   4899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG----KASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~  196 (313)
                      ||||||+||+++.++.++|+|||++...............||+.|+|||++.+.    .++.++|+|||||++|+|++|.
T Consensus       165 HrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~  244 (371)
T cd05622         165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  244 (371)
T ss_pred             eCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence            999999999999999999999999876543322223345689999999998653    3788999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA--RPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~L  268 (313)
                      .||...+.......+.      ....       ..........+..+.++|..||..++.+  |++++++++|.
T Consensus       245 ~Pf~~~~~~~~~~~i~------~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         245 TPFYADSLVGTYSKIM------NHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCCCCCCHHHHHHHHH------cCCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            9998765443332221      0000       0000112234567889999999844443  78999999985

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.6e-32  Score=250.62  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=194.6

Q ss_pred             hhHHHHHHHHhhccccc---eEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           12 VLLCVSFILSALAQDVN---QFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      +++.|.|..+|.+.+..   ..+.|++.+       -.++|...-+.+.|.||+++.+.+.+ ++++-+.||-.+||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcHH
Confidence            45666777777777754   556666643       23355666688899999999999766 67888999999999999


Q ss_pred             HHHhhCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCcccc
Q 048068           82 KILHTNIKPSL--SWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        82 ~~l~~~~~~~~--~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      ++++.. =+++  .+..+..+.+||++||.|||   +..|+|||||-+|++|+. .|.+||+|||.++....-. ....+
T Consensus       661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TET  735 (1226)
T KOG4279|consen  661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTET  735 (1226)
T ss_pred             HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccc
Confidence            999864 2344  88899999999999999999   799999999999999984 6889999999987654322 24567


Q ss_pred             ccccccccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCcc
Q 048068          159 LVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE  236 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (313)
                      +.||..|+|||++..+  .|..++|||||||++.||.||++||............              .--......+|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--------------VGmyKvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--------------VGMYKVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--------------hcceecCCCCc
Confidence            8999999999999754  6889999999999999999999999876665432211              11122344578


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhccCCCCCCC
Q 048068          237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQ--YLDGNATLPDIP  278 (313)
Q Consensus       237 ~~~~~~l~~li~~cl~~~P~~Rpt~~ell~--~L~~~~~~~~~~  278 (313)
                      .+.+...+.||.+|+.++|.+||+++++|+  +|.....-+.|+
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~  845 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPK  845 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCC
Confidence            888999999999999999999999999997  665553333333

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=4.7e-31  Score=239.89  Aligned_cols=231  Identities=18%  Similarity=0.196  Sum_probs=163.4

Q ss_pred             eEEEcccC-CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHH
Q 048068           29 QFIYHGFN-EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG  107 (313)
Q Consensus        29 ~~~~~~~~-~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~a  107 (313)
                      .++.|... .....|...++.++|++++++++.+.. ++..++|||++ .++|.+++... ...+++..+..++.||+.|
T Consensus        93 ~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~a  169 (357)
T PHA03209         93 PVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEG  169 (357)
T ss_pred             eEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHH
Confidence            44444432 344567888999999999999998886 56889999999 56888888764 4569999999999999999


Q ss_pred             HHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHH
Q 048068          108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV  187 (313)
Q Consensus       108 l~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  187 (313)
                      |.|||   ..+|+||||||+||+++.++.++|+|||++.......  ......|+..|+|||++.+..++.++|+|||||
T Consensus       170 L~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  244 (357)
T PHA03209        170 LRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGI  244 (357)
T ss_pred             HHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHH
Confidence            99999   5899999999999999999999999999986432211  122346889999999999888999999999999


Q ss_pred             HHHHHHhCCCC-CccCCchhhhhHH---HHHHHhhhhcccc-cccc-----------------cccc-CC----ccHHHH
Q 048068          188 FMLEVASGRRP-IEQQGSMEMVNLV---DWVSDCWKKGAIL-DASD-----------------SRLE-GI----YEEEQM  240 (313)
Q Consensus       188 il~~ll~g~~p-f~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~-----------------~~~~-~~----~~~~~~  240 (313)
                      ++|+|+++..+ |............   ............. ....                 ...+ ..    .....+
T Consensus       245 vl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (357)
T PHA03209        245 VLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLP  324 (357)
T ss_pred             HHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCC
Confidence            99999985554 4432221110000   0000000000000 0000                 0000 00    001123


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          241 ELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+.++|.+||+.||.+|||+.|+++|
T Consensus       325 ~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        325 IDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             chHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            455679999999999999999999987

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=3.2e-31  Score=231.15  Aligned_cols=210  Identities=27%  Similarity=0.459  Sum_probs=166.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.. ++..++||||+++++|.+++... ...+++..+..++.|++.|+.+||   +.+++
T Consensus        54 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~  128 (267)
T cd05066          54 SEASIMGQFDHPNIIHLEGVVTK-SKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLS---DMGYV  128 (267)
T ss_pred             HHHHHHHhCCCCCcceEEEEEec-CCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            34566777899999999998876 56899999999999999999865 346899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc--ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||+|+||+++.++.++++|||++...........  ....++..|++||.+.+..++.++|+||||+++|++++ |..
T Consensus       129 h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~  208 (267)
T cd05066         129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER  208 (267)
T ss_pred             ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999876543221111  11223457999999988889999999999999999886 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ||......+....+.       .+..       .  ..+...+..+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       209 p~~~~~~~~~~~~~~-------~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         209 PYWEMSNQDVIKAIE-------EGYR-------L--PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CcccCCHHHHHHHHh-------CCCc-------C--CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            998765543322221       1100       0  11223456788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.98  E-value=2.6e-31  Score=235.49  Aligned_cols=210  Identities=26%  Similarity=0.392  Sum_probs=162.9

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHH
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~  106 (313)
                      +.+.+.++ +|++++++.+.... .+.+++||||+++++|.+++....              ...+++..++.++.|++.
T Consensus        52 E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  130 (297)
T cd05089          52 ELEVLCKLGHHPNIINLLGACEN-RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVAT  130 (297)
T ss_pred             HHHHHHhhcCCCchhheEEEEcc-CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHH
Confidence            44555566 79999999998876 567999999999999999997532              135889999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG  186 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  186 (313)
                      ||+|||   +.+++|+||||+||+++.++.++|+|||++.......  .......+..|++||.+.+..++.++||||||
T Consensus       131 al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG  205 (297)
T cd05089         131 GMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFG  205 (297)
T ss_pred             HHHHHH---HCCcccCcCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHH
Confidence            999999   5899999999999999999999999999885322111  11112234569999999888889999999999


Q ss_pred             HHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       187 ~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      |++|+|++ |..||......+......       .+         .....+...+..+.+|+..||+.+|.+|||+++++
T Consensus       206 ~il~el~t~g~~pf~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  269 (297)
T cd05089         206 VLLWEIVSLGGTPYCGMTCAELYEKLP-------QG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQIS  269 (297)
T ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHh-------cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            99999997 999997665443322110       00         00111223456788999999999999999999999


Q ss_pred             HHHhccCC
Q 048068          266 QYLDGNAT  273 (313)
Q Consensus       266 ~~L~~~~~  273 (313)
                      +.|++...
T Consensus       270 ~~l~~~~~  277 (297)
T cd05089         270 VQLSRMLE  277 (297)
T ss_pred             HHHHHHHH
Confidence            99877653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.98  E-value=9e-32  Score=246.78  Aligned_cols=208  Identities=25%  Similarity=0.334  Sum_probs=159.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...+++++|+++++.++.+.+ ++.+++||||+++|+|.+++.+.  +.+++..+..++.||+.||.|||   ..+|
T Consensus        49 ~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~i  122 (382)
T cd05625          49 KAERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGF  122 (382)
T ss_pred             HHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            346677888999999999999887 66899999999999999999764  35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCC----------------------------------------------C
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDT----------------------------------------------I  153 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~----------------------------------------------~  153 (313)
                      +||||||+||+++.++.++|+|||++..+....                                              .
T Consensus       123 vHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (382)
T cd05625         123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQR  202 (382)
T ss_pred             ecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence            999999999999999999999999864221000                                              0


Q ss_pred             CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccC
Q 048068          154 PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG  233 (313)
Q Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (313)
                      .......||+.|+|||++.+..++.++|+|||||++|+|++|++||......+....+.    .|..         ....
T Consensus       203 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~---------~~~~  269 (382)
T cd05625         203 CLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI----NWQT---------SLHI  269 (382)
T ss_pred             ccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH----ccCC---------CcCC
Confidence            00112468899999999998889999999999999999999999998765443222111    0000         0000


Q ss_pred             CccHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Q 048068          234 IYEEEQMELVLKLGLFCSHPKPEARPN---MRQVMQY  267 (313)
Q Consensus       234 ~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ell~~  267 (313)
                      ......++.+.+++.+|+ .+|.+|++   ++++++|
T Consensus       270 p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         270 PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            011123445667776665 49999997   9999886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.98  E-value=1.7e-31  Score=232.60  Aligned_cols=206  Identities=19%  Similarity=0.361  Sum_probs=164.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|++++++.+.... ++..++||||+++++|.+++...  +.+++..+..++.|++.|+.|||   ..++
T Consensus        54 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~i  127 (267)
T cd06628          54 AREIALLKELQHENIVQYLGSSLD-ADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGI  127 (267)
T ss_pred             HHHHHHHHhcCCCCeeeEEEEEEe-CCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCc
Confidence            345677888999999999998876 56889999999999999999764  45899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCC-----CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-----PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  194 (313)
                      +|+||+|+||+++.++.++|+|||.+........     .......++..|++||.+.+..++.++|+||||+++|++++
T Consensus       128 vH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~  207 (267)
T cd06628         128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT  207 (267)
T ss_pred             ccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh
Confidence            9999999999999999999999998865542111     11122356788999999988888999999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |+.||.............       .     .    .....+...+..+.++|.+||+.||.+|||+.++++|
T Consensus       208 g~~p~~~~~~~~~~~~~~-------~-----~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         208 GKHPFPDCTQLQAIFKIG-------E-----N----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CCCCCCCccHHHHHHHHh-------c-----c----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            999998654332221110       0     0    1111223445678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-32  Score=247.40  Aligned_cols=241  Identities=24%  Similarity=0.325  Sum_probs=179.2

Q ss_pred             HHHHHHHhhccccceEEEcccCC---ChhhHHhhh------hhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHh
Q 048068           15 CVSFILSALAQDVNQFIYHGFNE---DPQLQRDGL------ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH   85 (313)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l------~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~   85 (313)
                      -|+|..++-+.---.+++|.|+.   .....+.|.      ++.+|.|++-..+++-. + .+.||+.+|+|.+|+.+++
T Consensus       402 sGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-p-~~AIiTqwCeGsSLY~hlH  479 (678)
T KOG0193|consen  402 SGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-P-PLAIITQWCEGSSLYTHLH  479 (678)
T ss_pred             cccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-C-ceeeeehhccCchhhhhcc
Confidence            34444444444444667777753   222334444      45567777777766664 3 3499999999999999998


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCC-CCCcccccccccc
Q 048068           86 TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVGTFG  164 (313)
Q Consensus        86 ~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~  164 (313)
                      .. ..+|+-...+.|+.||++|+.|||   .++|+|+|||..||++.+++.+||+|||++...... .........+...
T Consensus       480 v~-etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsil  555 (678)
T KOG0193|consen  480 VQ-ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLL  555 (678)
T ss_pred             ch-hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchh
Confidence            76 356999999999999999999999   799999999999999999999999999998643322 2223334567888


Q ss_pred             ccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          165 YMAPELMRT---GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       165 y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      |+|||++..   ..|++.+|||||||++|||++|..||.......++...         +.-.-..+..   .....++.
T Consensus       556 wmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV---------GrG~l~pd~s---~~~s~~pk  623 (678)
T KOG0193|consen  556 WMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV---------GRGYLMPDLS---KIRSNCPK  623 (678)
T ss_pred             hhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---------cccccCccch---hhhccCHH
Confidence            999999863   46799999999999999999999999955544433222         1110011111   12345667


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      .+.+|+..||+.++++||++.+|+..|+....
T Consensus       624 ~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  624 AMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             HHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            89999999999999999999999999988864

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.98  E-value=3.5e-31  Score=231.21  Aligned_cols=210  Identities=24%  Similarity=0.364  Sum_probs=166.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.++..+  ...++||||+++++|.+++... ...+++..+..++.|++.||.|||   ..+++
T Consensus        56 ~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~  129 (270)
T cd05056          56 QEAYIMRQFDHPHIVKLIGVITE--NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---SKRFV  129 (270)
T ss_pred             HHHHHHHhCCCCchhceeEEEcC--CCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            35567788899999999988764  4578999999999999999764 335899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++...............++..|++||.+....++.++|+||||+++|++++ |..||
T Consensus       130 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf  209 (270)
T cd05056         130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF  209 (270)
T ss_pred             ccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999886543332211222233467999999988888999999999999999986 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ......+....+.       .+...         ..+...+..+.+++.+|+..+|.+|||+.++++.|++..
T Consensus       210 ~~~~~~~~~~~~~-------~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         210 QGVKNNDVIGRIE-------NGERL---------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             CCCCHHHHHHHHH-------cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            7765543322211       11100         122334567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.98  E-value=2.2e-31  Score=242.26  Aligned_cols=219  Identities=21%  Similarity=0.253  Sum_probs=160.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC-----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.++|++++++.+++...+     ..+|+||||++ ++|.+.+..    .+++..+..++.||+.||.|||   
T Consensus        69 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---  140 (359)
T cd07876          69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---  140 (359)
T ss_pred             HHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---
Confidence            4556778889999999999886432     35799999995 467776643    3889999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ..+++||||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++|||||||++|+|++|
T Consensus       141 ~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg  218 (359)
T cd07876         141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG  218 (359)
T ss_pred             hCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhC
Confidence            5899999999999999999999999999986432211  22335678899999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHH----------------HHHhhhhcccccccc-----c----cccCCccHHHHHHHHHHHHHc
Q 048068          196 RRPIEQQGSMEMVNLVDW----------------VSDCWKKGAILDASD-----S----RLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~-----~----~~~~~~~~~~~~~l~~li~~c  250 (313)
                      +.||.+.+..+.......                +..............     +    .............+.+|+.+|
T Consensus       219 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m  298 (359)
T cd07876         219 SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKM  298 (359)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHH
Confidence            999987654432221100                000000000000000     0    000001112345689999999


Q ss_pred             CCCCCCCCCCHHHHHHHHh
Q 048068          251 SHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~L~  269 (313)
                      |..||++|||+.|+++|-.
T Consensus       299 L~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         299 LVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             hccCcccCCCHHHHhcCch
Confidence            9999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=2.2e-31  Score=234.18  Aligned_cols=240  Identities=18%  Similarity=0.258  Sum_probs=168.2

Q ss_pred             cceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           27 VNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        27 ~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ...++.|.+...       ...+.+.++.++|++++++.++.. .....+++||||+++++|.+++... ...+++..++
T Consensus        33 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~  111 (284)
T cd05081          33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLL  111 (284)
T ss_pred             CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHH
Confidence            345555555422       234556778889999999988765 3345789999999999999999764 3458999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc--cccccccccccccccccCCCC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--TTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      .++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++..........  .....++..|++||.+.+..+
T Consensus       112 ~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  188 (284)
T cd05081         112 LYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF  188 (284)
T ss_pred             HHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc
Confidence            99999999999999   6899999999999999999999999999987554322111  111223446999999988889


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-hhhccccccccccccCCccHHHHHHHHHHHHHcCCCCC
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-WKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP  255 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P  255 (313)
                      +.++|+||||+++|++++|..++........ ......... .......+..........+...+..+.+|+.+||+.+|
T Consensus       189 ~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  267 (284)
T cd05081         189 SVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDP  267 (284)
T ss_pred             ChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999999999998777543321110 000000000 00000000000000001122345679999999999999


Q ss_pred             CCCCCHHHHHHHHhcc
Q 048068          256 EARPNMRQVMQYLDGN  271 (313)
Q Consensus       256 ~~Rpt~~ell~~L~~~  271 (313)
                      ++|||++++++.|+..
T Consensus       268 ~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         268 SQRPSFSELALQVEAI  283 (284)
T ss_pred             hhCCCHHHHHHHHHhc
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.98  E-value=2.5e-31  Score=236.64  Aligned_cols=210  Identities=25%  Similarity=0.386  Sum_probs=163.2

Q ss_pred             Hhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHH
Q 048068           43 RDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVASG  107 (313)
Q Consensus        43 ~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~a  107 (313)
                      ...++.+ +|++++++.+.... ++..++||||+.+++|.+++....              ...+++..+..++.|++.|
T Consensus        74 ~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a  152 (307)
T cd05098          74 MEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARG  152 (307)
T ss_pred             HHHHHHhcCCCCEeeEEEEEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHH
Confidence            3444455 79999999998876 568899999999999999997642              1348889999999999999


Q ss_pred             HHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHHHH
Q 048068          108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYAFG  186 (313)
Q Consensus       108 l~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  186 (313)
                      |.|||   +.+++|+||+|+||+++.++.++|+|||.+.......... .....++..|+|||.+.+..++.++|+||||
T Consensus       153 L~~lH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG  229 (307)
T cd05098         153 MEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG  229 (307)
T ss_pred             HHHHH---HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHH
Confidence            99999   5899999999999999999999999999886543221111 1112234679999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       187 ~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      |++|+|++ |..||......+....+.       ...         ....+...+..+.+++..||+.+|++|||+.+++
T Consensus       230 ~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl  293 (307)
T cd05098         230 VLLWEIFTLGGSPYPGVPVEELFKLLK-------EGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV  293 (307)
T ss_pred             HHHHHHHcCCCCCCCcCCHHHHHHHHH-------cCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence            99999998 889987655433322221       100         0112233456788999999999999999999999


Q ss_pred             HHHhccC
Q 048068          266 QYLDGNA  272 (313)
Q Consensus       266 ~~L~~~~  272 (313)
                      +.|+...
T Consensus       294 ~~l~~~~  300 (307)
T cd05098         294 EDLDRIL  300 (307)
T ss_pred             HHHHHHH
Confidence            9998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=4.1e-31  Score=231.24  Aligned_cols=205  Identities=26%  Similarity=0.421  Sum_probs=165.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.+++++|+++++..+.+.+ +..+++|+||+++++|.+++...   .+++..++.++.|++.|+.|||   ..++
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i  119 (274)
T cd06609          47 QQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGK  119 (274)
T ss_pred             HHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            345567788899999999998876 57899999999999999999864   6899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+..++.++|+||||+++|++++|..||
T Consensus       120 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~  198 (274)
T cd06609         120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL  198 (274)
T ss_pred             ccCCCCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999999999999999999999999987655432 1223346778899999998888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...........+.      ..      ..+...   ....+..+.+++..||..+|++|||++++++|
T Consensus       199 ~~~~~~~~~~~~~------~~------~~~~~~---~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         199 SDLHPMRVLFLIP------KN------NPPSLE---GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ccCchHHHHHHhh------hc------CCCCCc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            7655332221110      00      001111   11145678899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.98  E-value=1.2e-31  Score=240.60  Aligned_cols=194  Identities=24%  Similarity=0.355  Sum_probs=155.5

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcE
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV  129 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nI  129 (313)
                      .|+++++....+.. ++.+++||||+++|+|.+.+...  ..+++..+..++.||+.||.|||   ..+++||||||+||
T Consensus        59 ~~~~i~~~~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Ni  132 (323)
T cd05616          59 KPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNV  132 (323)
T ss_pred             CCCeEeeEEEEEec-CCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHe
Confidence            46777777777766 66899999999999999998764  35899999999999999999999   58999999999999


Q ss_pred             EEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhh
Q 048068          130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN  209 (313)
Q Consensus       130 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  209 (313)
                      +++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........
T Consensus       133 ll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~  211 (323)
T cd05616         133 MLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ  211 (323)
T ss_pred             EECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999986432211 12234568999999999998889999999999999999999999998765544332


Q ss_pred             HHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048068          210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM-----RQVMQY  267 (313)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~  267 (313)
                      .+.       ..          ....+...+..+.+++.+||+.||.+|++.     .++++|
T Consensus       212 ~i~-------~~----------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         212 SIM-------EH----------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHH-------hC----------CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            221       00          011223345678899999999999999984     677664

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=3.9e-31  Score=233.90  Aligned_cols=216  Identities=23%  Similarity=0.369  Sum_probs=166.6

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---------KPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      +.+.++++.|+++++..+.+.. ++..++|||++++++|.+++....         ...+++..++.++.|++.||.|||
T Consensus        69 e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH  147 (296)
T cd05051          69 EVKILSRLSDPNIARLLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE  147 (296)
T ss_pred             HHHHHHhcCCCCEeEEEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            5567788899999999998876 578999999999999999997642         126899999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                         ..+++|+||||+||+++.++.++|+|||++......... ......++..|++||.+.+..++.++|||||||++|+
T Consensus       148 ---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  224 (296)
T cd05051         148 ---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE  224 (296)
T ss_pred             ---HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHH
Confidence               589999999999999999999999999998654322211 1223345678999999988889999999999999999


Q ss_pred             HHh--CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          192 VAS--GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       192 ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +++  +..||............   ...+.....      ......+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       225 l~~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         225 ILTLCREQPYEHLTDQQVIENA---GHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHhcCCCCCCCCcChHHHHHHH---Hhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            998  77888765544332222   111111000      0001112234467999999999999999999999999986


Q ss_pred             c
Q 048068          270 G  270 (313)
Q Consensus       270 ~  270 (313)
                      .
T Consensus       296 ~  296 (296)
T cd05051         296 R  296 (296)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=5.2e-31  Score=230.67  Aligned_cols=213  Identities=22%  Similarity=0.329  Sum_probs=167.0

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHh
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK-------PSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      ...+.+.++.++|+++++..++..+ .+..++||||+++++|.+++.....       ..+++..+..++.|++.||.||
T Consensus        55 ~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L  133 (275)
T cd05046          55 FRRELDMFRKLSHKNVVRLLGLCRE-AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL  133 (275)
T ss_pred             HHHHHHHHHhcCCcceeeeEEEECC-CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh
Confidence            3456678888999999999998776 5688999999999999999976431       1589999999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                      |   +.+++|+||+|+||+++.++.++++|||++...............++..|++||.+.+..++.++|+||||+++|+
T Consensus       134 H---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  210 (275)
T cd05046         134 S---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE  210 (275)
T ss_pred             h---hcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHH
Confidence            9   5899999999999999999999999999876433222222223345677999999988888999999999999999


Q ss_pred             HHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          192 VAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       192 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      +++ |..||.............       .+..        ....+...+..+.+++.+||+.+|.+|||+.+++++|..
T Consensus       211 l~~~~~~p~~~~~~~~~~~~~~-------~~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         211 VFTQGELPFYGLSDEEVLNRLQ-------AGKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHhCCCCCccccchHHHHHHHH-------cCCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            998 888997654433222111       1000        001122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.5e-31  Score=247.69  Aligned_cols=248  Identities=17%  Similarity=0.130  Sum_probs=172.1

Q ss_pred             HHHHHHHHhhcccc---ceEEEccc-CCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC
Q 048068           14 LCVSFILSALAQDV---NQFIYHGF-NEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK   89 (313)
Q Consensus        14 ~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~   89 (313)
                      +.|.+..++...+.   ..++.|.. ......|.+.++.++|+|++++.++... ++..++|||++ .++|.+++... .
T Consensus       178 g~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~-~  254 (461)
T PHA03211        178 TPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLPKY-RSDLYTYLGAR-L  254 (461)
T ss_pred             ccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEEcc-CCCHHHHHHhc-C
Confidence            34444444444432   23444432 2345578889999999999999998776 67899999999 56888888754 3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-cccccccccccccc
Q 048068           90 PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAP  168 (313)
Q Consensus        90 ~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  168 (313)
                      ..+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.++|+|||++......... ......||..|++|
T Consensus       255 ~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~AP  331 (461)
T PHA03211        255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP  331 (461)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCH
Confidence            46999999999999999999999   589999999999999999999999999998754332211 12234689999999


Q ss_pred             ccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCch-----hhhhHHHHHHHhhhh-ccccc-----------------
Q 048068          169 ELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM-----EMVNLVDWVSDCWKK-GAILD-----------------  225 (313)
Q Consensus       169 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-~~~~~-----------------  225 (313)
                      |++.+..++.++|||||||++|||++|..++......     ........+...... .....                 
T Consensus       332 E~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  411 (461)
T PHA03211        332 EVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN  411 (461)
T ss_pred             HHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcc
Confidence            9999888999999999999999999987664322111     001111111110000 00000                 


Q ss_pred             cccccccCCc--cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          226 ASDSRLEGIY--EEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       226 ~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..........  .......+.+||.+||..||.+|||+.|+|+|
T Consensus       412 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        412 RRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000000000  00123468899999999999999999999997

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=246.80  Aligned_cols=218  Identities=25%  Similarity=0.357  Sum_probs=179.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+++++++|+|+++++++... ...+++|||+|+||+|.+++++.. +.++......++.+.+.||+|||   .++++
T Consensus       210 ~EArvMr~l~H~NVVr~yGVa~~-~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh---~k~~I  284 (474)
T KOG0194|consen  210 KEARVMRQLNHPNVVRFYGVAVL-EEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLH---SKNCI  284 (474)
T ss_pred             HHHHHHHhCCCCCEEEEEEEEcC-CCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHH---HCCCc
Confidence            56778889999999999998887 678999999999999999999863 36999999999999999999999   59999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      ||||-..|+|+..++.+||+|||+++......... ..-.-...|+|||.+....++.++||||||+++||+.+ |..||
T Consensus       285 HRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py  363 (474)
T KOG0194|consen  285 HRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY  363 (474)
T ss_pred             chhHhHHHheecCCCeEEeCccccccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence            99999999999999999999999987543111111 01123568999999999999999999999999999999 88899


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPR  279 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~~~~~  279 (313)
                      .+....+....+.      ..+         .+-..+...+..+..++..|+..+|++|||+.++.+.|+.......++.
T Consensus       364 ~g~~~~~v~~kI~------~~~---------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~  428 (474)
T KOG0194|consen  364 PGMKNYEVKAKIV------KNG---------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD  428 (474)
T ss_pred             CCCCHHHHHHHHH------hcC---------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence            9887765544331      111         1112333566788899999999999999999999999999887766653

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=224.54  Aligned_cols=216  Identities=25%  Similarity=0.276  Sum_probs=162.6

Q ss_pred             hHHhhhhhccccceeeeeeEEe----ccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVN----SRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~----~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      +|.+.-+.++|+++++..+...    +.....|++++|+..|+|.+.+....  +..+++..+..|+.+|..||.+||. 
T Consensus        67 rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-  145 (302)
T KOG2345|consen   67 REIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-  145 (302)
T ss_pred             HHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-
Confidence            4445556678888888776655    34557899999999999999997642  4479999999999999999999994 


Q ss_pred             CCCC--ceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--------CccccccccccccccccccC---CCCCcchh
Q 048068          115 WEQV--VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--------PQTTKLVGTFGYMAPELMRT---GKASTSTD  181 (313)
Q Consensus       115 ~~~~--i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~---~~~~~~~D  181 (313)
                        ..  +.|+||||.||++.+.+.+++.|||.+....-...        ........|..|+|||.+.-   ...++++|
T Consensus       146 --~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertD  223 (302)
T KOG2345|consen  146 --KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTD  223 (302)
T ss_pred             --cCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccc
Confidence              55  99999999999999999999999998865432111        11123357889999999853   45689999


Q ss_pred             hHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       182 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||||++|.|+.|..||+...........          ++.. ..-..+.  ...+++.+.++|.+||+.||.+||++
T Consensus       224 IWSLGCtLYa~mf~~sPfe~~~~~GgSlaL----------Av~n-~q~s~P~--~~~yse~l~~lik~mlqvdP~qRP~i  290 (302)
T KOG2345|consen  224 IWSLGCTLYAMMFGESPFERIYQQGGSLAL----------AVQN-AQISIPN--SSRYSEALHQLIKSMLQVDPNQRPTI  290 (302)
T ss_pred             hhhhhHHHHHHHHcCCcchHHhhcCCeEEE----------eeec-cccccCC--CCCccHHHHHHHHHHhcCCcccCCCH
Confidence            999999999999999999743221100000          0000 0001111  12277889999999999999999999


Q ss_pred             HHHHHHHhccC
Q 048068          262 RQVMQYLDGNA  272 (313)
Q Consensus       262 ~ell~~L~~~~  272 (313)
                      .+++.++++..
T Consensus       291 ~~ll~~~d~Li  301 (302)
T KOG2345|consen  291 PELLSKLDDLI  301 (302)
T ss_pred             HHHHHHHHhhc
Confidence            99999998753

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=4.6e-31  Score=231.66  Aligned_cols=213  Identities=26%  Similarity=0.328  Sum_probs=166.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..++...  ...+++|+|+++|+|.+++... ...+++..+..++.|++.||.|||   +.+++
T Consensus        58 ~e~~~l~~~~~~~i~~~~~~~~~--~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ii  131 (279)
T cd05109          58 DEAYVMAGVGSPYVCRLLGICLT--STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE---EVRLV  131 (279)
T ss_pred             HHHHHHHhcCCCCCceEEEEEcC--CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            34455677789999999888764  4578999999999999999764 346899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      |+||||+||+++.++.++|+|||++......... ......++..|++||...+..++.++|||||||++|++++ |..|
T Consensus       132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999998755432211 1112234567999999988889999999999999999998 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCC
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLP  275 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~  275 (313)
                      |...........+.       .+..         ...+...+..+.+++..||+.||++|||+.++++.|+....-+
T Consensus       212 ~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         212 YDGIPAREIPDLLE-------KGER---------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCCCCHHHHHHHHH-------CCCc---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            87655433322221       1110         0112234567889999999999999999999999998876544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=3.1e-31  Score=236.26  Aligned_cols=221  Identities=22%  Similarity=0.333  Sum_probs=165.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.+++++|+++++..+.+.. ++.+++||||+++++|.++++..  ..+++..+..++.|++.||.|||+  ..+++
T Consensus        48 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~  122 (308)
T cd06615          48 RELKVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIM  122 (308)
T ss_pred             HHHHHHHhCCCCCCCeEEEEEee-CCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEE
Confidence            46667888899999999999877 67999999999999999999864  458999999999999999999995  35899


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++......   ......++..|++||.+.+..++.++|+||||+++|++++|..||.
T Consensus       123 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             ECCCChHHEEEecCCcEEEccCCCccccccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999988643221   1233467889999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccc------c-----------c----cccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAI------L-----------D----ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~------~-----------~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      ..+....................      .           .    ......+.......+..+.+++.+||..+|++||
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  279 (308)
T cd06615         200 PPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA  279 (308)
T ss_pred             CcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc
Confidence            55433222111100000000000      0           0    0000000000112455689999999999999999


Q ss_pred             CHHHHHHHHh
Q 048068          260 NMRQVMQYLD  269 (313)
Q Consensus       260 t~~ell~~L~  269 (313)
                      |+.++++|..
T Consensus       280 t~~~ll~~~~  289 (308)
T cd06615         280 DLKELTKHPF  289 (308)
T ss_pred             CHHHHhcChh
Confidence            9999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=3.2e-32  Score=247.31  Aligned_cols=218  Identities=20%  Similarity=0.227  Sum_probs=160.5

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.++|++++++.+++...     ....++||||++ ++|.+.+..    .+++..+..++.|++.||.|||   
T Consensus        65 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---  136 (355)
T cd07874          65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---  136 (355)
T ss_pred             HHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---
Confidence            355667888999999999987632     246799999995 477777754    3889999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +.+++||||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus       137 ~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  214 (355)
T cd07874         137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH  214 (355)
T ss_pred             hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence            6899999999999999999999999999987543322  22335678999999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHH----------------HHhhhhccc-cccc------cc--cccCCccHHHHHHHHHHHHHc
Q 048068          196 RRPIEQQGSMEMVNLVDWV----------------SDCWKKGAI-LDAS------DS--RLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~----------------~~~~~~~~~-~~~~------~~--~~~~~~~~~~~~~l~~li~~c  250 (313)
                      +.||.+.+..+........                ......... ....      +.  .............+.+||.+|
T Consensus       215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m  294 (355)
T cd07874         215 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM  294 (355)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHH
Confidence            9999876543332211000                000000000 0000      00  000011122345789999999


Q ss_pred             CCCCCCCCCCHHHHHHHH
Q 048068          251 SHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~L  268 (313)
                      |+.||.+|||+.|+++|-
T Consensus       295 L~~dP~~Rps~~ell~hp  312 (355)
T cd07874         295 LVIDPAKRISVDEALQHP  312 (355)
T ss_pred             hcCCchhcCCHHHHhcCc
Confidence            999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=3.7e-31  Score=231.23  Aligned_cols=209  Identities=26%  Similarity=0.384  Sum_probs=161.8

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHH
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVA  105 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~  105 (313)
                      .+.+.+..+ .|++++++.+.+.. .+.+++||||+++++|.+++....              ...+++..+..++.|++
T Consensus        44 ~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~  122 (270)
T cd05047          44 GELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA  122 (270)
T ss_pred             HHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHH
Confidence            355566677 79999999998876 567899999999999999997532              13478999999999999


Q ss_pred             HHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHH
Q 048068          106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       106 ~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      .|++|||   ..+++|+||+|+||+++.++.++++|||++.......  .......+..|.+||.+....++.++|+|||
T Consensus       123 ~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  197 (270)
T cd05047         123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY  197 (270)
T ss_pred             HHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHH
Confidence            9999999   5899999999999999999999999999875322111  1111223457999999988888999999999


Q ss_pred             HHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       186 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      |+++|++++ |..||.+.+..+......       .+..       .  ..+......+.+++.+||+.||.+|||+.++
T Consensus       198 G~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  261 (270)
T cd05047         198 GVLLWEIVSLGGTPYCGMTCAELYEKLP-------QGYR-------L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQI  261 (270)
T ss_pred             HHHHHHHHcCCCCCccccCHHHHHHHHh-------CCCC-------C--CCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            999999997 999997654433222110       0000       0  0112234568899999999999999999999


Q ss_pred             HHHHhcc
Q 048068          265 MQYLDGN  271 (313)
Q Consensus       265 l~~L~~~  271 (313)
                      ++.|...
T Consensus       262 l~~l~~~  268 (270)
T cd05047         262 LVSLNRM  268 (270)
T ss_pred             HHHHHHh
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=239.73  Aligned_cols=210  Identities=25%  Similarity=0.294  Sum_probs=179.1

Q ss_pred             ChhhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           38 DPQLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        38 ~~~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ....|.++++++. |++++.+++.+.. ...+++|||+++||.|.+.+...   .+++..+..++.|++.++.|||   .
T Consensus        81 ~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~  153 (382)
T KOG0032|consen   81 DVRREVAILQQLSGHPNIVQLKDAFED-PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---S  153 (382)
T ss_pred             HHHHHHHHHHhccCCCCEEEEEEEEEc-CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---h
Confidence            5567889999998 9999999999998 56999999999999999999876   3999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCC----CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHH
Q 048068          117 QVVLHRDIKPANVLLDAD----LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  192 (313)
                      .|++|||+||+|+|+...    +.++++|||++.....  ........||+.|+|||++....++..+|+||+|+++|.|
T Consensus       154 ~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL  231 (382)
T KOG0032|consen  154 LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL  231 (382)
T ss_pred             CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH
Confidence            999999999999999643    4799999999987766  3345667899999999999999999999999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++|.+||.+.........+.       .+.      .......-...+..+.++|..||..||.+|+|+.++|+|-+
T Consensus       232 L~G~~PF~~~~~~~~~~~i~-------~~~------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  232 LSGVPPFWGETEFEIFLAIL-------RGD------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             hhCCCCCcCCChhHHHHHHH-------cCC------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            99999999887666554331       110      01222334456778899999999999999999999999854

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=2.6e-31  Score=234.21  Aligned_cols=209  Identities=25%  Similarity=0.328  Sum_probs=165.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++.+.+...+ ++..++||||+++++|.+++.......+++..+..++.|++.||.|||   ..+++
T Consensus        49 ~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ii  124 (285)
T cd05630          49 NEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIV  124 (285)
T ss_pred             HHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEE
Confidence            35567788899999999888876 568999999999999999987654456999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.
T Consensus       125 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~  202 (285)
T cd05630         125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ  202 (285)
T ss_pred             eCCCCHHHEEECCCCCEEEeeccceeecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886543222  1123467899999999988889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~L  268 (313)
                      .............   ....          .....+......+.+|+..||+.||.+|||     ++|+++|-
T Consensus       203 ~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~  262 (285)
T cd05630         203 QRKKKIKREEVER---LVKE----------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP  262 (285)
T ss_pred             CCCccchHHHHHh---hhhh----------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence            6543221111110   0000          001122234566889999999999999999     89999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.3e-31  Score=237.73  Aligned_cols=210  Identities=23%  Similarity=0.278  Sum_probs=159.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++++|+||||+++++|.+++.+. ...+++..+..++.||+.||.|||   ..+++
T Consensus        50 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iv  124 (331)
T cd05597          50 EERDVLVNGDRRWITNLHYAFQD-ENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYV  124 (331)
T ss_pred             HHHHHHHhCCCCCCCceEEEEec-CCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeE
Confidence            45566677899999999988876 67899999999999999999753 346999999999999999999999   69999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----GKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ||||||+||+++.++.++|+|||++...............|++.|+|||++..     ..++.++|+|||||++|+|++|
T Consensus       125 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g  204 (331)
T cd05597         125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG  204 (331)
T ss_pred             ECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhC
Confidence            99999999999999999999999986544322222223468999999999863     3567899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCC--CCCCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP--EARPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P--~~Rpt~~ell~~  267 (313)
                      +.||......+....+      .......     ..+. .....++.+.+++.+||..++  ..|++++++++|
T Consensus       205 ~~Pf~~~~~~~~~~~i------~~~~~~~-----~~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         205 ETPFYAESLVETYGKI------MNHKEHF-----QFPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCCCCCCHHHHHHHH------HcCCCcc-----cCCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999765543332222      1111000     0111 111245567788888775444  348899999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.6e-31  Score=228.49  Aligned_cols=210  Identities=26%  Similarity=0.360  Sum_probs=165.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|++++++++.... ++.++++|||+.+++|.+++... ..++++..++.++.|++.|+.|||   ..++
T Consensus        48 ~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i  122 (262)
T cd06613          48 QQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGK  122 (262)
T ss_pred             HHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            455567788899999999988876 66899999999999999998764 346999999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC---CCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG---KASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+.   .++.++|+||||+++|+|++|.
T Consensus       123 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~  201 (262)
T cd06613         123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ  201 (262)
T ss_pred             eecCCChhhEEECCCCCEEECccccchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC
Confidence            9999999999999999999999998865433211 12234577889999998766   7889999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .||.............      ....    .  ..........+..+.+++.+||..+|.+|||+.+++.|
T Consensus       202 ~p~~~~~~~~~~~~~~------~~~~----~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         202 PPMFDLHPMRALFLIS------KSNF----P--PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CCCCCCCHHHHHHHHH------hccC----C--CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9997655433222111      0000    0  00011233455678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-31  Score=243.54  Aligned_cols=208  Identities=23%  Similarity=0.287  Sum_probs=160.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.++.++|++++++++.+.+ ++++|+||||+++|+|.+++...  +.+++..+..++.|++.||.|||   ..+|+
T Consensus        50 ~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~giv  123 (377)
T cd05629          50 AERDVLAESDSPWVVSLYYSFQD-AQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFI  123 (377)
T ss_pred             HHHHHHHhCCCCCcceEEEEEEc-CCeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            45667788899999999998886 66899999999999999999763  46899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC------------C----------------------------------
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI------------P----------------------------------  154 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~------------~----------------------------------  154 (313)
                      ||||||+||+++.++.++|+|||++..+.....            .                                  
T Consensus       124 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (377)
T cd05629         124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL  203 (377)
T ss_pred             ccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence            999999999999999999999998853211000            0                                  


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                      ......||+.|+|||++.+..++.++|+|||||++|+|++|..||......+....+.    .|...       ...+. 
T Consensus       204 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~~-------~~~p~-  271 (377)
T cd05629         204 MAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKII----NWRET-------LYFPD-  271 (377)
T ss_pred             cccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHH----ccCCc-------cCCCC-
Confidence            0012358899999999998889999999999999999999999998765443332221    01100       00010 


Q ss_pred             ccHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHH
Q 048068          235 YEEEQMELVLKLGLFCSHPKPEAR---PNMRQVMQYL  268 (313)
Q Consensus       235 ~~~~~~~~l~~li~~cl~~~P~~R---pt~~ell~~L  268 (313)
                       ....+..+.++|.+||. +|.+|   +|+.++++|-
T Consensus       272 -~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp  306 (377)
T cd05629         272 -DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP  306 (377)
T ss_pred             -CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence             11234568889999997 66665   6999999984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=8.8e-31  Score=227.89  Aligned_cols=214  Identities=25%  Similarity=0.380  Sum_probs=168.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+.+.++.++|++++++++.+.. ++..++||||+++++|.+++...  ....+++..++.++.|++.|+.|||   ..+
T Consensus        51 ~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~  126 (267)
T cd08224          51 KEIDLLKQLDHPNVIKYLASFIE-NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR  126 (267)
T ss_pred             HHHHHHHhCCCCCeeeeeeeeec-CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            45567788899999999999887 56899999999999999998652  2345899999999999999999999   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++.++.++|+|||++........ ......++..|.+||.+.+..++.++|+||||+++|++++|+.|
T Consensus       127 i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p  205 (267)
T cd08224         127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             EecCCcChhhEEECCCCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999999998865433221 12234577889999999888899999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      |...... .....+.    ...+.        .........+..+.++|.+||+.+|++|||+.++++.|++..
T Consensus       206 ~~~~~~~-~~~~~~~----~~~~~--------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         206 FYGDKMN-LYSLCKK----IEKCD--------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cccCCcc-HHHHHhh----hhcCC--------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            8654321 1111111    00100        011111245567899999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=5.4e-31  Score=227.84  Aligned_cols=208  Identities=26%  Similarity=0.420  Sum_probs=165.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++.++.+.. .+..+++|||+++++|.+++.......+++..++.++.|++.|+.+||   ..+++
T Consensus        50 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~  125 (258)
T smart00219       50 REARIMRKLDHPNIVKLLGVCTE-EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFI  125 (258)
T ss_pred             HHHHHHHhcCCCchheEEEEEcC-CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCee
Confidence            35567778899999999998887 478999999999999999998653333999999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++...............++..|++||.+.+..++.++|+||+|++++++++ |..||
T Consensus       126 h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~  205 (258)
T smart00219      126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPY  205 (258)
T ss_pred             ecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987655432222212335678999999988888999999999999999998 88888


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .............       .+..         ...+...+..+.+++.+||..||.+|||+.|+++.|
T Consensus       206 ~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      206 PGMSNEEVLEYLK-------KGYR---------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCHHHHHHHHh-------cCCC---------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            7654433332221       1000         011222456788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=4.2e-31  Score=230.75  Aligned_cols=208  Identities=23%  Similarity=0.344  Sum_probs=160.4

Q ss_pred             hHHhhhhhc-cccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      .+...++.+ +|+++++..+.+...     ...+++||||+.+++|.+++.......+++..+..++.|++.|++|||  
T Consensus        51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--  128 (272)
T cd06637          51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--  128 (272)
T ss_pred             HHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            344455566 699999999887632     346899999999999999998754556899999999999999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHH
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFM  189 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il  189 (313)
                       ..+++|+||+|+||+++.++.++|+|||++....... .......++..|++||++.     +..++.++|+|||||++
T Consensus       129 -~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l  206 (272)
T cd06637         129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA  206 (272)
T ss_pred             -HCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHH
Confidence             5899999999999999999999999999986543221 1233456788999999885     23577899999999999


Q ss_pred             HHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       190 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |+|++|..||............      +...         .........+..+.+|+.+||..||.+|||+.++++|
T Consensus       207 ~el~~g~~p~~~~~~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         207 IEMAEGAPPLCDMHPMRALFLI------PRNP---------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HHHHhCCCCccccCHHHHHHHH------hcCC---------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            9999999999754433222111      1100         0001112234568999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=5.3e-31  Score=230.89  Aligned_cols=201  Identities=23%  Similarity=0.330  Sum_probs=156.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+++++|+|+++.+++... +...++||||+++++|..++... .+.+++..+..++.||+.||.|||   .++++
T Consensus        65 ~~~~~~~~l~h~niv~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ii  139 (274)
T cd05076          65 ETASLMSQVSHIHLAFVHGVCVR-GSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLV  139 (274)
T ss_pred             HHHHHHhcCCCCCeeeEEEEEEe-CCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCcc
Confidence            34566788899999999998876 56889999999999999998764 346899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCC-------cEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHH
Q 048068          121 HRDIKPANVLLDADL-------NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       121 H~dl~~~nIlv~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l  192 (313)
                      |+||||+||+++..+       .++++|||++......     ....++..|++||.+.+ ..++.++|+||||+++|++
T Consensus       140 H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el  214 (274)
T cd05076         140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI  214 (274)
T ss_pred             CCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence            999999999997643       3799999987533211     12345678999998865 4678999999999999998


Q ss_pred             H-hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          193 A-SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       193 l-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      + +|+.||............   .    ..       ...+    ......+.++|..||+.+|++|||+.++++.|+
T Consensus       215 ~~~g~~p~~~~~~~~~~~~~---~----~~-------~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         215 CFDGEVPLKERTPSEKERFY---E----KK-------HRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HhCCCCCccccChHHHHHHH---H----hc-------cCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            5 699999765443321111   0    00       0011    112245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=8.5e-31  Score=229.78  Aligned_cols=204  Identities=24%  Similarity=0.389  Sum_probs=166.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..+.+.+ ++..++||||+++++|.+++..+   .+++..+..++.|++.|+.|||   ..+++
T Consensus        51 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~iv  123 (277)
T cd06640          51 QEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH---SEKKI  123 (277)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            45566677899999999998877 67899999999999999998753   5899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++++|||++........ ......++..|.+||.+.+..++.++|+||||+++|++++|..||.
T Consensus       124 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06640         124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             CcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence            999999999999999999999999865433221 1223456788999999988889999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..........+.                ...........+..+.+++..||+.+|++|||+.++++|-
T Consensus       203 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         203 DMHPMRVLFLIP----------------KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             CcChHhHhhhhh----------------cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            655433221110                0111223445677899999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=2.4e-31  Score=231.77  Aligned_cols=209  Identities=25%  Similarity=0.353  Sum_probs=162.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+++++|++++++.+.... ++..++||||+++++|.+++...  .++++..+..++.|++.|+.|||   ..+++
T Consensus        55 ~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~  128 (267)
T cd06646          55 QEIFMVKECKHCNIVAYFGSYLS-REKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKM  128 (267)
T ss_pred             HHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            46677888899999999988876 56899999999999999999764  36899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|++||.+.   ...++.++|+||+|+++|+|++|+.
T Consensus       129 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~  207 (267)
T cd06646         129 HRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP  207 (267)
T ss_pred             ccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999875532221 122345778899999874   3446789999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ||.............       ...   ...+...  .....+..+.+++..||..+|++|||++++++||
T Consensus       208 p~~~~~~~~~~~~~~-------~~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         208 PMFDLHPMRALFLMS-------KSN---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             Cccccchhhhheeee-------cCC---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            986543222111110       000   0000010  1123456789999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=3.5e-31  Score=230.65  Aligned_cols=213  Identities=24%  Similarity=0.382  Sum_probs=167.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+...++.++|+++++..+.... .+..++||||+++++|.+++...  ....+++..++.++.|++.|+.|||   ..+
T Consensus        51 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~  126 (267)
T cd08228          51 KEIDLLKQLNHPNVIKYLDSFIE-DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR  126 (267)
T ss_pred             HHHHHHHhCCCcceeeeeeeEEE-CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCC
Confidence            46677788899999999998876 56889999999999999988642  2345899999999999999999999   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus       127 i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p  205 (267)
T cd08228         127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             eeCCCCCHHHEEEcCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999998875443221 11234577889999999888889999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      |...... .......+..   .         ..+.......+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus       206 ~~~~~~~-~~~~~~~~~~---~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         206 FYGDKMN-LFSLCQKIEQ---C---------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             Ccccccc-HHHHHHHHhc---C---------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            8654321 1111111100   0         011112234557799999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=6e-31  Score=231.25  Aligned_cols=208  Identities=22%  Similarity=0.309  Sum_probs=162.5

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +.+.++.++|+++++..+.+.. ++..++||||+++++|..++.+. ...+++..+..++.|++.||.|||   ..+++|
T Consensus        52 e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H  126 (282)
T cd06643          52 EIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH  126 (282)
T ss_pred             HHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeee
Confidence            4456677899999999998876 56899999999999999988653 346999999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCC
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +||+|+||+++.++.++|+|||++....... .......++..|++||.+.     +..++.++|+|||||++|++++|+
T Consensus       127 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~  205 (282)
T cd06643         127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE  205 (282)
T ss_pred             cCCCcccEEEccCCCEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence            9999999999999999999999986543221 1223346788999999873     345678999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +||...........+.       ...     .+  ....+...+..+.++|.+||+.||.+|||+.++++|-.
T Consensus       206 ~p~~~~~~~~~~~~~~-------~~~-----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         206 PPHHELNPMRVLLKIA-------KSE-----PP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             CCccccCHHHHHHHHh-------hcC-----CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            9997655433221111       000     00  00112234567899999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=5.8e-31  Score=229.72  Aligned_cols=210  Identities=27%  Similarity=0.478  Sum_probs=164.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++..++||||+++++|.+++... .+.+++..++.++.|++.|+.|||   ..+++
T Consensus        54 ~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~g~~  128 (269)
T cd05065          54 SEASIMGQFDHPNIIHLEGVVTK-SRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS---EMNYV  128 (269)
T ss_pred             HHHHHHHhCCCcCcceEEEEECC-CCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            35567788899999999998875 66889999999999999999765 345899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc--cccc--ccccccccccccCCCCCcchhhHHHHHHHHHHHh-C
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLV--GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-G  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g  195 (313)
                      |+||+|+||+++.++.++|+|||++...........  ....  .+..|++||.+.+..++.++|+||||+++|++++ |
T Consensus       129 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g  208 (269)
T cd05065         129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG  208 (269)
T ss_pred             ecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCC
Confidence            999999999999999999999998865433221111  1111  1346999999988888999999999999999886 9


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ..||......+....+.   ..+         ...    .+...+..+.+++..||+.+|.+|||++++++.|+..
T Consensus       209 ~~p~~~~~~~~~~~~i~---~~~---------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         209 ERPYWDMSNQDVINAIE---QDY---------RLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCCCCCCCHHHHHHHHH---cCC---------cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99997665443322221   000         000    1123345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=3.1e-31  Score=233.18  Aligned_cols=222  Identities=22%  Similarity=0.275  Sum_probs=163.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..+...++.++|++++++.+.+.+ ++..++||||++ ++|.+++.... ...+++..++.++.||+.||.|||   ..+
T Consensus        47 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~  121 (285)
T cd07861          47 IREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRR  121 (285)
T ss_pred             HHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            456678888999999999999886 678999999996 68988886543 356999999999999999999999   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|++++|++
T Consensus       122 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~  200 (285)
T cd07861         122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP  200 (285)
T ss_pred             eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence            99999999999999999999999999875433221 12233567889999988654 46889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHH-----HHhhhhccccc-------cccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWV-----SDCWKKGAILD-------ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      ||.+.............     ...|.......       ..............++.+.++|.+||+.||.+|||+.+++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll  280 (285)
T cd07861         201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL  280 (285)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            99865543322211000     00111000000       0000000001112356678999999999999999999998


Q ss_pred             HH
Q 048068          266 QY  267 (313)
Q Consensus       266 ~~  267 (313)
                      +|
T Consensus       281 ~~  282 (285)
T cd07861         281 NH  282 (285)
T ss_pred             cC
Confidence            76

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=2.7e-31  Score=230.13  Aligned_cols=209  Identities=26%  Similarity=0.421  Sum_probs=165.1

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...+++++|+++++..++... +...++|||++++++|.+++..  ...+++..++.++.||+.||.+||   ..+++|
T Consensus        48 e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H  121 (260)
T PF00069_consen   48 EIKILRRLRHPNIVQILDVFQD-DNYLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLH---SKGIVH  121 (260)
T ss_dssp             HHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             hhhccccccccccccccccccc-cccccccccccccccccccccc--cccccccccccccccccccccccc---cccccc
Confidence            4568888899999999999987 6789999999998899999984  235999999999999999999999   489999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-TGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      +||+|+||+++.++.++|+|||.+..... .........++..|.|||.+. +..++.++|+||||+++|+|++|..||.
T Consensus       122 ~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~  200 (260)
T PF00069_consen  122 RDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE  200 (260)
T ss_dssp             SSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999875311 112334456788999999998 7888999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .....+..............          ............+.+++..||+.||++|||+.++++|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  201 ESNSDDQLEIIEKILKRPLP----------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSSHHHHHHHHHHHHHTHHH----------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccchhhhhhhhhccccccc----------ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            76333322222111110000          0000011112789999999999999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=8.8e-31  Score=232.07  Aligned_cols=206  Identities=23%  Similarity=0.370  Sum_probs=164.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. +..+++|+||+++++|..++...   .+++..+..++.|++.|+.|||   ..+++
T Consensus        65 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~  137 (296)
T cd06655          65 NEILVMKELKNPNIVNFLDSFLV-GDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVI  137 (296)
T ss_pred             HHHHHHHhcCCCceeeeeeeEec-CceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            35566788899999999998876 66899999999999999998753   4899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|..||.
T Consensus       138 H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~  216 (296)
T cd06655         138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (296)
T ss_pred             cCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999998865433221 1223457889999999988889999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ............      ...        ......+...+..+.++|.+||..||.+|||+.++++|=
T Consensus       217 ~~~~~~~~~~~~------~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~  270 (296)
T cd06655         217 NENPLRALYLIA------TNG--------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (296)
T ss_pred             CCCHHHHHHHHH------hcC--------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence            655433221110      000        000112223455788999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=5.6e-31  Score=242.20  Aligned_cols=212  Identities=23%  Similarity=0.329  Sum_probs=164.0

Q ss_pred             HHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------------------------
Q 048068           42 QRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------------------------   88 (313)
Q Consensus        42 ~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------------------------   88 (313)
                      |...++.+. |+|++++.+.... .+..++||||+++|+|.+++..+.                                
T Consensus        90 Ei~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (400)
T cd05105          90 ELKIMTHLGPHLNIVNLLGACTK-SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVI  168 (400)
T ss_pred             HHHHHHhcCCCCCeeeEEEEEcc-CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhh
Confidence            445556665 9999999998876 668999999999999999986431                                


Q ss_pred             --------------------------------------------------------------CCCCCHHHHHHHHHHHHH
Q 048068           89 --------------------------------------------------------------KPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        89 --------------------------------------------------------------~~~~~~~~~~~i~~qi~~  106 (313)
                                                                                    ...+++..+..++.||+.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~  248 (400)
T cd05105         169 LSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVAR  248 (400)
T ss_pred             hhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHH
Confidence                                                                          124778888999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHH
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAF  185 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  185 (313)
                      ||.|||   ..+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||
T Consensus       249 aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl  325 (400)
T cd05105         249 GMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY  325 (400)
T ss_pred             HHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence            999999   589999999999999999999999999998754322211 1222345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       186 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      |+++|+|++ |..||............  +    ..+.         ....+...+..+.+++.+||+.||++|||+.++
T Consensus       326 Gvil~ellt~g~~P~~~~~~~~~~~~~--~----~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  390 (400)
T cd05105         326 GILLWEIFSLGGTPYPGMIVDSTFYNK--I----KSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL  390 (400)
T ss_pred             HHHHHHHHHCCCCCCcccchhHHHHHH--H----hcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence            999999997 99998764332221111  0    0110         001223445678999999999999999999999


Q ss_pred             HHHHhccC
Q 048068          265 MQYLDGNA  272 (313)
Q Consensus       265 l~~L~~~~  272 (313)
                      .+.|+...
T Consensus       391 ~~~l~~l~  398 (400)
T cd05105         391 SDIVESLL  398 (400)
T ss_pred             HHHHHHHc
Confidence            99998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=1e-30  Score=230.56  Aligned_cols=211  Identities=23%  Similarity=0.409  Sum_probs=164.2

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------KPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      +...++.+.|++++++.+++.. ++..++||||+++|+|.+++....        ....+...+..++.|++.||.||| 
T Consensus        59 e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-  136 (288)
T cd05061          59 EASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN-  136 (288)
T ss_pred             HHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            4557788899999999998876 568999999999999999997531        123567788999999999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  192 (313)
                        +.+++|+||||+||+++.++.++|+|||++......... ......++..|++||.+.++.++.++|+|||||++|++
T Consensus       137 --~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el  214 (288)
T cd05061         137 --AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI  214 (288)
T ss_pred             --hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence              689999999999999999999999999988644322111 11122345679999999888899999999999999999


Q ss_pred             Hh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          193 AS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       193 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ++ |..||......+....+.      ..+.      .    ..+...+..+.+++.+||+.||++|||+.++++.|.+.
T Consensus       215 ~~~~~~p~~~~~~~~~~~~~~------~~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         215 TSLAEQPYQGLSNEQVLKFVM------DGGY------L----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HhCCCCCCCCCCHHHHHHHHH------cCCC------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            98 788987655443222110      0000      0    01122346799999999999999999999999999886


Q ss_pred             C
Q 048068          272 A  272 (313)
Q Consensus       272 ~  272 (313)
                      .
T Consensus       279 ~  279 (288)
T cd05061         279 L  279 (288)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=3e-31  Score=233.47  Aligned_cols=218  Identities=21%  Similarity=0.322  Sum_probs=164.1

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.+.|++++++.++.... +...++||||++|++|.+++... ...+++..+..++.|++.||.|||   +.++
T Consensus        55 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH---~~gi  130 (284)
T cd05079          55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQY  130 (284)
T ss_pred             HHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            456678889999999999988754 46789999999999999999765 235899999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||++.........  ......++..|.|||.+.+..++.++|+||||+++|+++++..
T Consensus       131 ~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~  210 (284)
T cd05079         131 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCD  210 (284)
T ss_pred             eecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCC
Confidence            99999999999999999999999998754332211  1123445667999999988888999999999999999999877


Q ss_pred             CCccCCchhhh--------hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          198 PIEQQGSMEMV--------NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       198 pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      |+.........        ............+.         ....+...+..+.+|+.+||+.||++|||++++++.|+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  281 (284)
T cd05079         211 SESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE  281 (284)
T ss_pred             CCccccchhhhhcccccccccHHHHHHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            64322110000        00000000000000         01112234568999999999999999999999999998


Q ss_pred             cc
Q 048068          270 GN  271 (313)
Q Consensus       270 ~~  271 (313)
                      ..
T Consensus       282 ~~  283 (284)
T cd05079         282 AI  283 (284)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=4.2e-31  Score=237.80  Aligned_cols=210  Identities=23%  Similarity=0.295  Sum_probs=161.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+..+.|++++++.+.+.. ++..|+||||++||+|.+++... ...+++..+..++.|++.||.|||   ..+|+
T Consensus        50 ~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~~ii  124 (331)
T cd05624          50 EERNVLVNGDCQWITTLHYAFQD-ENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH---QLHYV  124 (331)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            44566677789999999988876 67899999999999999999864 246899999999999999999999   69999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----GKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ||||||+||+++.++.++|+|||++...............|++.|+|||++.+     +.++.++|+||||+++|+|++|
T Consensus       125 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g  204 (331)
T cd05624         125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG  204 (331)
T ss_pred             eccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhC
Confidence            99999999999999999999999987654433222334568999999999865     4578899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA--RPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~  267 (313)
                      +.||......+....+.      ......     ..+. .....+..+.+++.+||..++.+  |++++++++|
T Consensus       205 ~~Pf~~~~~~~~~~~i~------~~~~~~-----~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         205 ETPFYAESLVETYGKIM------NHEERF-----QFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCccCCCHHHHHHHHH------cCCCcc-----cCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            99998655443322221      000000     0111 11123567888999999866554  5689999987

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=9.1e-31  Score=226.58  Aligned_cols=206  Identities=27%  Similarity=0.410  Sum_probs=164.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+....  +..++||||+.+++|.+++.......+++..++.++.|++.|+.|||   +.++
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~  121 (254)
T cd05083          47 LEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKL  121 (254)
T ss_pred             HHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            346677888899999999998865  34799999999999999998765556899999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++.......    .....+..|.+||.+.+..++.++|+||||+++|++++ |..|
T Consensus       122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  197 (254)
T cd05083         122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP  197 (254)
T ss_pred             eccccCcceEEEcCCCcEEECCCccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999886432211    12233567999999988888999999999999999997 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      |......+....+.       .+..       +  ..+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus       198 ~~~~~~~~~~~~~~-------~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         198 YPKMSLKEVKECVE-------KGYR-------M--EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CccCCHHHHHHHHh-------CCCC-------C--CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            97665443222111       1110       0  1122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=260.22  Aligned_cols=224  Identities=25%  Similarity=0.357  Sum_probs=180.4

Q ss_pred             eEEEcccCCC--hhh------HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----CCCCCHH
Q 048068           29 QFIYHGFNED--PQL------QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----KPSLSWY   95 (313)
Q Consensus        29 ~~~~~~~~~~--~~~------~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----~~~~~~~   95 (313)
                      .++.|.+...  .+.      |...++.++|||+++..++..+ .+..++++|||+||+|..+|++..     ...++..
T Consensus       724 ~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~  802 (1025)
T KOG1095|consen  724 QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMR  802 (1025)
T ss_pred             EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHH
Confidence            4667776543  333      4444566799999999999998 788999999999999999998751     3458889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCC
Q 048068           96 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTG  174 (313)
Q Consensus        96 ~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~  174 (313)
                      .++.++.+|++|.+||+   ++.++||||...|+|++....+||+|||+++..-...-.. ...-.....|+|||.+.++
T Consensus       803 dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~  879 (1025)
T KOG1095|consen  803 DLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG  879 (1025)
T ss_pred             HHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc
Confidence            99999999999999999   6999999999999999999999999999998332211111 1112345689999999999


Q ss_pred             CCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCC
Q 048068          175 KASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHP  253 (313)
Q Consensus       175 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  253 (313)
                      .++.++||||||+++||+++ |..||...+..+.....       .++       .  +-..|..+++.+.++|..||+.
T Consensus       880 iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~-------~~g-------g--RL~~P~~CP~~ly~lM~~CW~~  943 (1025)
T KOG1095|consen  880 IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV-------LEG-------G--RLDPPSYCPEKLYQLMLQCWKH  943 (1025)
T ss_pred             ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH-------HhC-------C--ccCCCCCCChHHHHHHHHHccC
Confidence            99999999999999999999 99999887766544322       111       1  2225667888999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccC
Q 048068          254 KPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       254 ~P~~Rpt~~ell~~L~~~~  272 (313)
                      +|++||++..|++.++...
T Consensus       944 ~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  944 DPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             ChhhCccHHHHHhhhhhhh
Confidence            9999999999999876654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=245.54  Aligned_cols=229  Identities=23%  Similarity=0.337  Sum_probs=189.5

Q ss_pred             ccccceEEEcccCCChhhHHhh------hhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           24 AQDVNQFIYHGFNEDPQLQRDG------LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~------l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      +++.-++++|.++++.-...+|      +++++|+|++++.+++.. ...+|||+|||.+|+|-+++++.+....+...+
T Consensus       289 KkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvL  367 (1157)
T KOG4278|consen  289 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVL  367 (1157)
T ss_pred             eccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CCCeEEEEecccCccHHHHHHHhchhhcchhHH
Confidence            4555677888888766555555      567789999999988886 568999999999999999999877777888899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS  177 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  177 (313)
                      +.++.||.+|+.||.   +++++||||-..|+||.++..+|++|||+++++....-.....-.-...|.|||-+..+.++
T Consensus       368 lyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFS  444 (1157)
T KOG4278|consen  368 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS  444 (1157)
T ss_pred             HHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccc
Confidence            999999999999999   79999999999999999999999999999998765543222222235679999999999999


Q ss_pred             cchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      .++|||+||++|||+.| |-.||.+.+-.+.+.+++       ++.       ++.  -+..+++.+.+||..||+.+|.
T Consensus       445 iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------kgy-------RM~--~PeGCPpkVYeLMraCW~WsPs  508 (1157)
T KOG4278|consen  445 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------KGY-------RMD--GPEGCPPKVYELMRACWNWSPS  508 (1157)
T ss_pred             cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------ccc-------ccc--CCCCCCHHHHHHHHHHhcCCcc
Confidence            99999999999999999 889999887776666553       222       122  3556788899999999999999


Q ss_pred             CCCCHHHHHHHHhccC
Q 048068          257 ARPNMRQVMQYLDGNA  272 (313)
Q Consensus       257 ~Rpt~~ell~~L~~~~  272 (313)
                      +||++.++-+.+|...
T Consensus       509 DRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  509 DRPSFAEIHQAFETMF  524 (1157)
T ss_pred             cCccHHHHHHHHHHHh
Confidence            9999999988887543

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=6.1e-31  Score=227.50  Aligned_cols=206  Identities=23%  Similarity=0.374  Sum_probs=164.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+.+.. ++..++||||+++++|.+++.......+++..+..++.|++.++.|||   ..++
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i  122 (256)
T cd08220          47 QNECQVLKLLSHPNIIEYYENFLE-DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLI  122 (256)
T ss_pred             HHHHHHHhhCCCCchhheeeeEec-CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            345667888899999999988775 678999999999999999998754556899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCC-CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.+ +.++++|||++.......  ......++..|++||.+.+..++.++|+||||+++|++++|..|
T Consensus       123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  200 (256)
T cd08220         123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA  200 (256)
T ss_pred             ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCC
Confidence            999999999999855 468999999987654332  12234578899999999888889999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |...+.......+.      ..          .....+...+..+.+++.+||+.+|++|||++|+++|
T Consensus       201 ~~~~~~~~~~~~~~------~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         201 FEAANLPALVLKIM------SG----------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             cccCchHHHHHHHH------hc----------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            97655433221110      00          0111222345678899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=7.3e-31  Score=231.32  Aligned_cols=208  Identities=24%  Similarity=0.322  Sum_probs=165.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++.+...+.. ++..++||||+++++|.+.+.......+++..+..++.|++.||.|||   ..+|+
T Consensus        49 ~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~ii  124 (285)
T cd05632          49 NEKQILEKVNSQFVVNLAYAYET-KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTV  124 (285)
T ss_pred             HHHHHHHHcCCcCceeEEEEEec-CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            46678888999999998888776 568999999999999999887654457999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......++..|++||.+.+..++.++|+||||+++|++++|..||.
T Consensus       125 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~  202 (285)
T cd05632         125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR  202 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEecCCcceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886543221  1223467899999999988889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      ............   .....          ....++...+..+.+|+..||+.||++|||     +.++++|
T Consensus       203 ~~~~~~~~~~~~---~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         203 GRKEKVKREEVD---RRVLE----------TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CCCHHHHHHHHH---Hhhhc----------cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            654432222111   00000          011122334556789999999999999999     7888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-31  Score=233.91  Aligned_cols=220  Identities=23%  Similarity=0.322  Sum_probs=159.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.++.++|+++++..+++.. ++..++||||+. ++|.+++.+. ...+++..++.++.|++.||.|||   ..+++
T Consensus        52 ~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~  125 (291)
T cd07844          52 REASLLKDLKHANIVTLHDIIHT-KKTLTLVFEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCH---QRRVL  125 (291)
T ss_pred             HHHHHHhhCCCcceeeEEEEEec-CCeEEEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            47788899999999999999876 678999999996 5999988765 346899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||
T Consensus       126 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~  204 (291)
T cd07844         126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF  204 (291)
T ss_pred             cccCCHHHEEEcCCCCEEECccccccccCCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999988643322111 112345778999998865 45788999999999999999999999


Q ss_pred             ccCCch-hhhhHHHHH-----HHhhhhcc----ccc----cccccccCCc--cHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          200 EQQGSM-EMVNLVDWV-----SDCWKKGA----ILD----ASDSRLEGIY--EEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       200 ~~~~~~-~~~~~~~~~-----~~~~~~~~----~~~----~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      .+.... +....+...     ...|....    ...    ..........  .......+.+++.+||+.+|.+|||+.+
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e  284 (291)
T cd07844         205 PGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE  284 (291)
T ss_pred             CCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence            765422 111111100     00010000    000    0000000000  0111256789999999999999999999


Q ss_pred             HHHH
Q 048068          264 VMQY  267 (313)
Q Consensus       264 ll~~  267 (313)
                      +++|
T Consensus       285 ~l~~  288 (291)
T cd07844         285 AMKH  288 (291)
T ss_pred             HhcC
Confidence            9875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=3.3e-31  Score=237.64  Aligned_cols=201  Identities=23%  Similarity=0.341  Sum_probs=155.4

Q ss_pred             Hhhhhhccc-cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           43 RDGLASVHS-NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        43 ~~~l~~~~~-~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      ...++.+.| ++++++...+.. ++.+++||||+++++|.+++...  ..+++..+..++.||+.||.|||   ..+++|
T Consensus        51 ~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivH  124 (323)
T cd05615          51 KRVLALQDKPPFLTQLHSCFQT-VDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH---RRGIIY  124 (323)
T ss_pred             HHHHHhccCCCchhheeeEEec-CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence            334444544 455566666655 56899999999999999999764  35999999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      |||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+
T Consensus       125 rDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (323)
T cd05615         125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             cCCCHHHeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986432221 122335688999999999888899999999999999999999999987


Q ss_pred             CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048068          202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM-----RQVMQY  267 (313)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~  267 (313)
                      .........+.      ..           ....+...+..+.+++.+||+.+|.+|++.     +++.+|
T Consensus       204 ~~~~~~~~~i~------~~-----------~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         204 EDEDELFQSIM------EH-----------NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             CCHHHHHHHHH------hC-----------CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            65443332221      00           011222344567899999999999999974     566665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=6.9e-31  Score=228.88  Aligned_cols=208  Identities=24%  Similarity=0.344  Sum_probs=161.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.... ++.+++||||+++++|.+++...  +.+++..+..++.|++.|+.|||   ..+++
T Consensus        55 ~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  128 (267)
T cd06645          55 QEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH---SKGKM  128 (267)
T ss_pred             HHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            35567788899999999998876 67899999999999999999764  36999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.   ...++.++|+|||||++|++++|..
T Consensus       129 H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~  207 (267)
T cd06645         129 HRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP  207 (267)
T ss_pred             cCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCC
Confidence            99999999999999999999999986543221 1223446788999999874   3457889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||.............      .....    .+...  .....+..+.+++.+||+.+|++|||++++++|
T Consensus       208 p~~~~~~~~~~~~~~------~~~~~----~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         208 PMFDLHPMRALFLMT------KSNFQ----PPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CcccccchhhHHhhh------ccCCC----CCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            986544322211110      00000    00000  011234568899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=1.2e-30  Score=231.09  Aligned_cols=225  Identities=22%  Similarity=0.288  Sum_probs=168.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+++.. ++..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||   ..+++
T Consensus        51 ~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~  124 (298)
T cd07841          51 REIKLLQELKHPNIIGLLDVFGH-KSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWIL  124 (298)
T ss_pred             HHHHHHhhcCCCCChhhhheeec-CCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            35667888999999999999987 67899999999 899999998653 36999999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+|||||++|++++|.+||
T Consensus       125 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~  203 (298)
T cd07841         125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL  203 (298)
T ss_pred             ecCCChhhEEEcCCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc
Confidence            999999999999999999999999876544321 1223345778999998854 45688999999999999999998888


Q ss_pred             ccCCchhhhhHHHHH-----HHhhhhc-ccccccc-----ccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Q 048068          200 EQQGSMEMVNLVDWV-----SDCWKKG-AILDASD-----SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY-  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~-  267 (313)
                      ......+....+...     ...|... .......     ...........+..+.++|.+||+.+|++|||+.++++| 
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~  283 (298)
T cd07841         204 PGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP  283 (298)
T ss_pred             cCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence            765554333222100     0001000 0000000     000011122345778999999999999999999999997 


Q ss_pred             -HhccC
Q 048068          268 -LDGNA  272 (313)
Q Consensus       268 -L~~~~  272 (313)
                       +.+..
T Consensus       284 ~~~~~~  289 (298)
T cd07841         284 YFSNDP  289 (298)
T ss_pred             cccCCC
Confidence             55554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=2.2e-30  Score=228.90  Aligned_cols=208  Identities=23%  Similarity=0.327  Sum_probs=160.3

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...++.++|++++++.+.+.. ++.+++||||+++++|..++.+. ...+++..+..++.|++.++.|||   ..+++|
T Consensus        59 e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H  133 (292)
T cd06644          59 EIEILATCNHPYIVKLLGAFYW-DGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH---SMKIIH  133 (292)
T ss_pred             HHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeee
Confidence            4455677899999999998876 56899999999999999888654 346899999999999999999999   689999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCC
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +||+|+||+++.++.++|+|||++....... .......++..|++||.+.     ...++.++|+||||+++|+|++|.
T Consensus       134 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~  212 (292)
T cd06644         134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE  212 (292)
T ss_pred             cCCCcceEEEcCCCCEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCC
Confidence            9999999999999999999999876432221 1122345778899999884     344678999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      .||............  .     ...     .+  ....+...+..+.+++.+||+.||++||+++++++|-.
T Consensus       213 ~p~~~~~~~~~~~~~--~-----~~~-----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  271 (292)
T cd06644         213 PPHHELNPMRVLLKI--A-----KSE-----PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF  271 (292)
T ss_pred             CCCccccHHHHHHHH--h-----cCC-----Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            999765432221111  0     000     00  00112234456889999999999999999999998643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=8.5e-31  Score=229.99  Aligned_cols=213  Identities=24%  Similarity=0.334  Sum_probs=166.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK------PSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      .+...++.+.|+++++..++....+...+++++|+.+++|.+++.....      ..+++..++.++.|++.||.|||  
T Consensus        57 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--  134 (280)
T cd05043          57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--  134 (280)
T ss_pred             HHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--
Confidence            3445567779999999999877667789999999999999999975321      45899999999999999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                       +.+++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+++
T Consensus       135 -~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~  213 (280)
T cd05043         135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM  213 (280)
T ss_pred             -HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHh
Confidence             689999999999999999999999999998644322111 111233466799999998888999999999999999999


Q ss_pred             h-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          194 S-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       194 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      + |..||......+.....       ..+..       .  ..+...++.+.+++.+||..+|++|||+.++++.|++..
T Consensus       214 ~~g~~p~~~~~~~~~~~~~-------~~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         214 TLGQTPYVEIDPFEMAAYL-------KDGYR-------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             cCCCCCcCcCCHHHHHHHH-------HcCCC-------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            9 99999765443322111       11110       0  012234567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=5.5e-31  Score=229.26  Aligned_cols=208  Identities=24%  Similarity=0.342  Sum_probs=164.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|++++++.+...+ ++..++||||+++++|.+++.+.  ..+++..+..++.|++.|+.|||   ..++
T Consensus        50 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i  123 (265)
T cd06631          50 QEEVDLLKSLKHVNIVQYLGTCLD-DNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH---NNCV  123 (265)
T ss_pred             HHHHHHHHhcCCCCEeeEeeEeec-CCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            346677888899999999999887 57899999999999999999764  35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCC-----CCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-----IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  194 (313)
                      +|+||+|+||+++.++.++|+|||++.......     ........++..|++||.+.+..++.++|+||||+++|++++
T Consensus       124 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  203 (265)
T cd06631         124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT  203 (265)
T ss_pred             ccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999886542111     111223457889999999988888999999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |..||...........+.       ..   ..    .....+......+.++|.+||+.+|.+|||+.++++|
T Consensus       204 g~~p~~~~~~~~~~~~~~-------~~---~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         204 GKPPLASMDRLAAMFYIG-------AH---RG----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCccccCChHHHHHHhh-------hc---cC----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            999997654332221110       00   00    0011223345678999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-31  Score=241.69  Aligned_cols=195  Identities=25%  Similarity=0.329  Sum_probs=155.2

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcE
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV  129 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nI  129 (313)
                      .|+++++....+.. ++.+++||||+++++|.+++...  +.+++..++.++.||+.||.|||   ..+|+||||||+||
T Consensus        54 ~~p~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Ni  127 (330)
T cd05586          54 ESPFIVGLKFSFQT-DSDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENI  127 (330)
T ss_pred             CCCcCcceEEEEec-CCeEEEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHe
Confidence            69999999888876 67899999999999999998763  46999999999999999999999   58999999999999


Q ss_pred             EEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhh
Q 048068          130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV  208 (313)
Q Consensus       130 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  208 (313)
                      +++.++.++|+|||++....... .......|+..|+|||.+.+. .++.++|||||||++|+|++|..||......+..
T Consensus       128 li~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~  206 (330)
T cd05586         128 LLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY  206 (330)
T ss_pred             EECCCCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH
Confidence            99999999999999986432221 122345689999999998754 4789999999999999999999999876544333


Q ss_pred             hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHH
Q 048068          209 NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP----NMRQVMQY  267 (313)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp----t~~ell~~  267 (313)
                      ..+.       .+.      ...+   .......+.+++.+||+.||.+||    ++.++++|
T Consensus       207 ~~i~-------~~~------~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         207 RNIA-------FGK------VRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             HHHH-------cCC------CCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            2221       000      0011   112345678999999999999998    68888885

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=1.2e-30  Score=235.03  Aligned_cols=210  Identities=22%  Similarity=0.288  Sum_probs=160.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+..+.|++++++...+.+ ++.+++||||+++|+|.+++.+. ...+++..+..++.||+.|+.|||   ..+++
T Consensus        50 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~ii  124 (332)
T cd05623          50 EERDVLVNGDNQWITTLHYAFQD-ENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH---QLHYV  124 (332)
T ss_pred             HHHHHHhhCCCCCEeeEEEEEec-CCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            45556677899999999888876 67899999999999999999864 345899999999999999999999   59999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ||||||+||+++.++.++|+|||++...............|++.|+|||++.     ...++.++|+|||||++|+|++|
T Consensus       125 HrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g  204 (332)
T cd05623         125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG  204 (332)
T ss_pred             ecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcC
Confidence            9999999999999999999999998654322222223356899999999986     34578899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA--RPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~  267 (313)
                      +.||...........+.      ......     ..+. .....+..+.+++.+||..++++  |++++++++|
T Consensus       205 ~~Pf~~~~~~~~~~~i~------~~~~~~-----~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         205 ETPFYAESLVETYGKIM------NHKERF-----QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCCCCCCHHHHHHHHh------CCCccc-----cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            99998665444332221      100000     0010 11233566788888888655544  6899999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=7.8e-31  Score=227.05  Aligned_cols=207  Identities=22%  Similarity=0.346  Sum_probs=166.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+.+.. +++.++||||+++++|.+.+.......+++..+..++.|++.|+.|||   ..++
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i  122 (256)
T cd08218          47 RKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKI  122 (256)
T ss_pred             HHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence            345667888999999999998876 678999999999999999998654456899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++++|||++........ ......++..|++||...+..++.++|+||||++++++++|..||
T Consensus       123 ~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08218         123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF  201 (256)
T ss_pred             ecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCc
Confidence            9999999999999999999999998865433221 112335678899999998888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ......+....+      . .+.         ....+......+.++|.+||+.+|++||++.++++|
T Consensus       202 ~~~~~~~~~~~~------~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         202 EAGNMKNLVLKI------I-RGS---------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCCHHHHHHHH------h-cCC---------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            754433322111      0 000         001223445678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=2.1e-31  Score=234.27  Aligned_cols=222  Identities=25%  Similarity=0.340  Sum_probs=166.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..++... +..+++||||+ +++|.+++... ...+++..++.++.||+.||.|||   ..++
T Consensus        47 ~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i  120 (286)
T cd07832          47 LREIKALQACQHPYVVKLLDVFPH-GSGFVLVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMH---ANGI  120 (286)
T ss_pred             HHHHHHHHhCCCCCCcceeeEEec-CCeeEEEeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            355677788899999999998877 67899999999 99999999765 356999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++...............++..|++||.+.+. .++.++||||+|+++|++++|.++
T Consensus       121 ~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~  200 (286)
T cd07832         121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL  200 (286)
T ss_pred             ecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcC
Confidence            9999999999999999999999999876544332223345678899999988654 468899999999999999999888


Q ss_pred             CccCCchhhhhHHHHH-----HHhhhhcc-------c-cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          199 IEQQGSMEMVNLVDWV-----SDCWKKGA-------I-LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~-----~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      |.+..+..........     ...|....       . ...................+.+++.+||..||.+|||+++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l  280 (286)
T cd07832         201 FPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL  280 (286)
T ss_pred             cCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence            8766554333222110     00111100       0 000000000011123347889999999999999999999999


Q ss_pred             HH
Q 048068          266 QY  267 (313)
Q Consensus       266 ~~  267 (313)
                      +|
T Consensus       281 ~h  282 (286)
T cd07832         281 RH  282 (286)
T ss_pred             hC
Confidence            87

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.5e-31  Score=229.97  Aligned_cols=207  Identities=21%  Similarity=0.325  Sum_probs=162.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. +...++||||+++++|.+++... ...+++..+..++.|++.|+.|||   ..+++
T Consensus        51 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~  125 (280)
T cd06611          51 VEIDILSECKHPNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH---SHKVI  125 (280)
T ss_pred             HHHHHHHhCCCCceeEEEEEEec-CCeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            35567788899999999999886 66899999999999999998764 346999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|++||.+.     +..++.++|+||||+++|++++|
T Consensus       126 h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g  204 (280)
T cd06611         126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM  204 (280)
T ss_pred             cCCCChhhEEECCCCCEEEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999998764432221 223345788899999874     34467899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..||............       .....       .....+...+..+.+++..||+.+|.+|||+.++++|
T Consensus       205 ~~p~~~~~~~~~~~~~-------~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         205 EPPHHELNPMRVLLKI-------LKSEP-------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCcccCCHHHHHHHH-------hcCCC-------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            9999765443322111       01000       0111222345678899999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-31  Score=234.02  Aligned_cols=208  Identities=24%  Similarity=0.284  Sum_probs=165.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+.... +...++||||+.+++|.+++.......+++..+..++.|++.||.|||   ..+++
T Consensus        50 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~  125 (316)
T cd05574          50 TEQEILATLDHPFLPTLYASFQT-ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIV  125 (316)
T ss_pred             HHHHHHHhCCCCCchhheeeeec-CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            45567788899999999988876 678999999999999999998755567999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC----------------------------Ccccccccccccccccccc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI----------------------------PQTTKLVGTFGYMAPELMR  172 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~  172 (313)
                      |+||||+||+++.++.++|+|||++........                            .......|+..|++||.+.
T Consensus       126 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  205 (316)
T cd05574         126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS  205 (316)
T ss_pred             ccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc
Confidence            999999999999999999999998764422110                            0111235788899999999


Q ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCC
Q 048068          173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSH  252 (313)
Q Consensus       173 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  252 (313)
                      +..++.++||||||+++|++++|..||...+.......+.      ...       ...+  .....+..+.+++.+||+
T Consensus       206 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~------~~~-------~~~~--~~~~~~~~~~~li~~~l~  270 (316)
T cd05574         206 GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL------KKE-------VTFP--GSPPVSSSARDLIRKLLV  270 (316)
T ss_pred             CCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHh------cCC-------ccCC--CccccCHHHHHHHHHHcc
Confidence            8888999999999999999999999997665443322111      000       0011  111256789999999999


Q ss_pred             CCCCCCCC----HHHHHHH
Q 048068          253 PKPEARPN----MRQVMQY  267 (313)
Q Consensus       253 ~~P~~Rpt----~~ell~~  267 (313)
                      .||++|||    ++++++|
T Consensus       271 ~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         271 KDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCHhHCCCchhhHHHHHcC
Confidence            99999999    8888886

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=8.4e-31  Score=230.41  Aligned_cols=221  Identities=21%  Similarity=0.269  Sum_probs=164.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|++++++.+++.. +..+++||||+++++|..++...  ..+++..+..++.|++.+|.|||   ..++
T Consensus        48 ~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH---~~~i  121 (286)
T cd07847          48 LREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH---KHNC  121 (286)
T ss_pred             HHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            346678889999999999998876 66899999999998888777653  35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus       122 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p  200 (286)
T cd07847         122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL  200 (286)
T ss_pred             eecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999876543321 1223456788999999875 4578899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHH--------hhhhccc-cccccccccCC-----ccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSD--------CWKKGAI-LDASDSRLEGI-----YEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      |.+....+....+.....        .+..... .....+.....     .....+..+.+|+.+||+.+|++|||+.|+
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  280 (286)
T cd07847         201 WPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL  280 (286)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence            987665443322211100        0000000 00000000000     011235678899999999999999999999


Q ss_pred             HHH
Q 048068          265 MQY  267 (313)
Q Consensus       265 l~~  267 (313)
                      ++|
T Consensus       281 l~~  283 (286)
T cd07847         281 LEH  283 (286)
T ss_pred             hcC
Confidence            876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=1.3e-30  Score=227.66  Aligned_cols=212  Identities=25%  Similarity=0.373  Sum_probs=157.6

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      +...++.++|+++++..+...+ ....++||||+++++|.+++....   ....+...+..++.|++.|+.|||   ..+
T Consensus        45 E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~  120 (269)
T cd05087          45 EAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNN  120 (269)
T ss_pred             HHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCC
Confidence            5566788899999999988776 567899999999999999997532   234677788899999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCC-------CCCcchhhHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTG-------KASTSTDVYAFGVFML  190 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~  190 (313)
                      ++|+||||+||+++.++.++|+|||++......... ......++..|+|||++.+.       .++.++|+||||+++|
T Consensus       121 i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~  200 (269)
T cd05087         121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIW  200 (269)
T ss_pred             EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHH
Confidence            999999999999999999999999988643322111 11223456789999988532       3578999999999999


Q ss_pred             HHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          191 EVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       191 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++++ |..||......+......      . +.......+.    ......+.+.+++..|+ .+|++|||+++|++.|+
T Consensus       201 el~~~g~~p~~~~~~~~~~~~~~------~-~~~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         201 ELFELGSQPYRHLSDEQVLTYTV------R-EQQLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHhCCCCCCCCCChHHHHHHHh------h-cccCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            9996 999997655443322110      0 0111111111    11223456788999998 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=1.3e-30  Score=229.83  Aligned_cols=210  Identities=24%  Similarity=0.397  Sum_probs=162.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------------CCCCCHHHHHHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------------KPSLSWYQRFRI  100 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~i  100 (313)
                      .+...++.+.|+++++..++... +...++||||+++++|.+++....                    ...+++..++.+
T Consensus        57 ~ei~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  135 (288)
T cd05050          57 REAALMAEFDHPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCI  135 (288)
T ss_pred             HHHHHHHhcCCCchheEEEEEcC-CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHH
Confidence            34566677899999999998776 568899999999999999997431                    124788899999


Q ss_pred             HHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcc
Q 048068          101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTS  179 (313)
Q Consensus       101 ~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~  179 (313)
                      +.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++......... .......+..|++||.+.+..++.+
T Consensus       136 ~~~i~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (288)
T cd05050         136 AKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE  212 (288)
T ss_pred             HHHHHHHHHHHH---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch
Confidence            999999999999   589999999999999999999999999988644322111 1112234567999999988889999


Q ss_pred             hhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       180 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      +|+|||||++|+|++ |..||.+....+....+.       .+...         ..+...+..+.+++.+||+.+|.+|
T Consensus       213 ~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~-------~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~R  276 (288)
T cd05050         213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR-------DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDR  276 (288)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCCCC---------CCCCCCCHHHHHHHHHHcccCcccC
Confidence            999999999999997 888887655443222111       11100         0122345678999999999999999


Q ss_pred             CCHHHHHHHHhc
Q 048068          259 PNMRQVMQYLDG  270 (313)
Q Consensus       259 pt~~ell~~L~~  270 (313)
                      ||+.|+++.|+.
T Consensus       277 pt~~el~~~l~~  288 (288)
T cd05050         277 PSFASINRILQR  288 (288)
T ss_pred             CCHHHHHHHhhC
Confidence            999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=1.2e-30  Score=229.27  Aligned_cols=206  Identities=23%  Similarity=0.345  Sum_probs=158.7

Q ss_pred             Hhhhhhc-cccceeeeeeEEec-----cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           43 RDGLASV-HSNGLLQLTNTVNS-----RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        43 ~~~l~~~-~~~~~l~~~~~~~~-----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ...++.+ +|++++++.+....     .+..++++|||+.+++|.+++.......+++..+..++.||+.|+.|||   .
T Consensus        63 ~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~  139 (282)
T cd06636          63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---A  139 (282)
T ss_pred             HHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence            3344445 69999999888752     3568899999999999999998755556899999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHHHH
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~  191 (313)
                      .+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.     +..++.++|+||||+++|+
T Consensus       140 ~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e  218 (282)
T cd06636         140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE  218 (282)
T ss_pred             CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence            899999999999999999999999999986543221 1123346788999999875     3456789999999999999


Q ss_pred             HHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          192 VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       192 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +++|..||...........+.      .         ...........+..+.++|.+||..||.+|||+.|+++|
T Consensus       219 l~~g~~p~~~~~~~~~~~~~~------~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         219 MAEGAPPLCDMHPMRALFLIP------R---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             HHhCCCCccccCHHhhhhhHh------h---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            999999997654322221110      0         001111122345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=1.8e-30  Score=226.31  Aligned_cols=206  Identities=22%  Similarity=0.368  Sum_probs=160.9

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.++|+++++..+++... +..++++|||+++++|.+++...  ..+++..++.++.|++.|+.|||   ..++
T Consensus        53 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~i  127 (266)
T cd06651          53 CEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLH---SNMI  127 (266)
T ss_pred             HHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            355678889999999999988743 46789999999999999999764  35899999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||++........  .......++..|+|||.+.+..++.++|+|||||++|++++|+.
T Consensus       128 ~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~  207 (266)
T cd06651         128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP  207 (266)
T ss_pred             eeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999864432111  11123457888999999988888999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||.............      .         .......+....+.+.+++ .||..+|++|||++++++|
T Consensus       208 pf~~~~~~~~~~~~~------~---------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         208 PWAEYEAMAAIFKIA------T---------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CccccchHHHHHHHh------c---------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            997654332221110      0         0011122334456677777 6777899999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.7e-30  Score=225.04  Aligned_cols=200  Identities=24%  Similarity=0.369  Sum_probs=158.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..+....  ...++||||+++++|.+++.... ..++...+..++.||+.||.|||   ..+++
T Consensus        50 ~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~  123 (259)
T cd05037          50 ETASLMSQLSHKHLVKLYGVCVR--DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLE---DKKLV  123 (259)
T ss_pred             HHHHHHHcCCCcchhheeeEEec--CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCee
Confidence            45567888899999999998876  56799999999999999998753 26899999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCC-------cEEEeecccccccCCCCCCccccccccccccccccccCC--CCCcchhhHHHHHHHHH
Q 048068          121 HRDIKPANVLLDADL-------NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLE  191 (313)
Q Consensus       121 H~dl~~~nIlv~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~  191 (313)
                      |+||||+||+++.++       .++|+|||++.....     .....++..|++||.+.+.  .++.++|+||||+++|+
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~  198 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLE  198 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence            999999999999887       799999998865432     1223456779999998766  67899999999999999


Q ss_pred             HHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          192 VAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       192 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +++ |..||............       ....       ..    +......+.+++.+||..+|.+|||+.++++.|+
T Consensus       199 l~~~~~~p~~~~~~~~~~~~~-------~~~~-------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         199 ICSNGEEPLSTLSSSEKERFY-------QDQH-------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHhCCCCCcccCCchhHHHHH-------hcCC-------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            999 57777665432211111       0000       00    0111167899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=7e-31  Score=230.88  Aligned_cols=221  Identities=21%  Similarity=0.260  Sum_probs=160.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...+++++|++++++.+.+.+ .+..++|+||++ ++|.+++... ...+++..++.++.||+.||.|||   ..++
T Consensus        47 ~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i  120 (284)
T cd07839          47 LREICLLKELKHKNIVRLYDVLHS-DKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH---SHNV  120 (284)
T ss_pred             hHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCE
Confidence            356678889999999999998876 568999999995 5888887654 346999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+|||||++|+|++|..|
T Consensus       121 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p  199 (284)
T cd07839         121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  199 (284)
T ss_pred             ecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999875443221 12234567889999988764 468899999999999999999888


Q ss_pred             CccCCc-hhhhhHHHHH-----HHhhhhcc-cccc-cccccc-----CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          199 IEQQGS-MEMVNLVDWV-----SDCWKKGA-ILDA-SDSRLE-----GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       199 f~~~~~-~~~~~~~~~~-----~~~~~~~~-~~~~-~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      +....+ ......+...     ...|.... .... ..+...     .......+..+.+++.+||+.||.+|||+++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il  279 (284)
T cd07839         200 LFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL  279 (284)
T ss_pred             CcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence            643332 2221111000     00010000 0000 000000     111223456788999999999999999999999


Q ss_pred             HH
Q 048068          266 QY  267 (313)
Q Consensus       266 ~~  267 (313)
                      +|
T Consensus       280 ~h  281 (284)
T cd07839         280 QH  281 (284)
T ss_pred             cC
Confidence            86

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=9.9e-31  Score=229.29  Aligned_cols=205  Identities=25%  Similarity=0.378  Sum_probs=164.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+.+.. ++..++||||+++++|.+++..   ..+++..+..++.|++.|+.|||   ..++
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i  122 (277)
T cd06642          50 QQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERK  122 (277)
T ss_pred             HHHHHHHHcCCCCccHhhhccccc-CCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCe
Confidence            455667778899999999998876 6689999999999999999864   35899999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++++|||++....... .......++..|++||.+.+..++.++|+||||+++|++++|..||
T Consensus       123 vH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06642         123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             eccCCChheEEEeCCCCEEEccccccccccCcc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999986543221 1122345678899999998888899999999999999999999998


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ...........+       ...         .........+..+.+++.+||+.+|++|||+.++++|-
T Consensus       202 ~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         202 SDLHPMRVLFLI-------PKN---------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             cccchhhHHhhh-------hcC---------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            754433222111       000         01112223456788999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=1.8e-30  Score=229.87  Aligned_cols=217  Identities=21%  Similarity=0.337  Sum_probs=163.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK---------PSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      .+...++.++|+++++..+.... ++..++||||+++++|.+++.....         ..+++..+..++.|++.|++||
T Consensus        68 ~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l  146 (296)
T cd05095          68 KEIKIMSRLKDPNIIRLLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL  146 (296)
T ss_pred             HHHHHHHhCCCCCcceEEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            35567788899999999998876 5678999999999999999976321         2467789999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML  190 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  190 (313)
                      |   ..+++|+||||+||+++.++.++|+|||++........ ........+..|++||...++.++.++|+|||||++|
T Consensus       147 H---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~  223 (296)
T cd05095         147 S---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW  223 (296)
T ss_pred             H---HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHH
Confidence            9   58999999999999999999999999999865432211 1112223356799999888788999999999999999


Q ss_pred             HHHh--CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          191 EVAS--GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       191 ~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ++++  |..||......+.....   ...........    ..  ..+..++..+.+|+.+||+.||++|||+.++++.|
T Consensus       224 el~~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~----~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  294 (296)
T cd05095         224 EILTLCKEQPYSQLSDEQVIENT---GEFFRDQGRQV----YL--PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL  294 (296)
T ss_pred             HHHHhCCCCCccccChHHHHHHH---HHHHhhccccc----cC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            9998  77888765544332211   11111100000    00  01223446789999999999999999999999988


Q ss_pred             hc
Q 048068          269 DG  270 (313)
Q Consensus       269 ~~  270 (313)
                      +.
T Consensus       295 ~~  296 (296)
T cd05095         295 LE  296 (296)
T ss_pred             hC
Confidence            63

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=1.3e-30  Score=239.74  Aligned_cols=224  Identities=22%  Similarity=0.327  Sum_probs=169.3

Q ss_pred             eEEEcccCCCh--------hhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           29 QFIYHGFNEDP--------QLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        29 ~~~~~~~~~~~--------~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      .+++|.+....        ..+...+..+. |+|+++..+.+.. ++..++||||+++|+|.++++.+.           
T Consensus        69 ~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~  147 (401)
T cd05107          69 KVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKN  147 (401)
T ss_pred             EEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-CCCcEEEEeccCCCcHHHHHHhccccchhhhcccc
Confidence            56667665321        12445556666 9999999988876 568999999999999999997531           


Q ss_pred             --------------------------------------------------------------------------------
Q 048068           89 --------------------------------------------------------------------------------   88 (313)
Q Consensus        89 --------------------------------------------------------------------------------   88 (313)
                                                                                                      
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (401)
T cd05107         148 RDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRD  227 (401)
T ss_pred             cccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchh
Confidence                                                                                            


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccc
Q 048068           89 -----KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT  162 (313)
Q Consensus        89 -----~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~  162 (313)
                           ...+++..+..++.||+.||.|||   ..+++|+||+|.||+++.++.++|+|||++........ .......++
T Consensus       228 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~  304 (401)
T cd05107         228 TLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP  304 (401)
T ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCC
Confidence                 123667788899999999999999   68999999999999999999999999999875432211 112223456


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      ..|++||.+.+..++.++|+||||+++|++++ |..||......+.....  +    ..+.         ....+...+.
T Consensus       305 ~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~--~----~~~~---------~~~~p~~~~~  369 (401)
T cd05107         305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA--I----KRGY---------RMAKPAHASD  369 (401)
T ss_pred             CceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH--H----HcCC---------CCCCCCCCCH
Confidence            78999999988888999999999999999998 88998765433321111  0    0110         0012223456


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+.+|+..||+.+|.+||+++++++.|+..
T Consensus       370 ~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         370 EIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.2e-30  Score=227.39  Aligned_cols=211  Identities=25%  Similarity=0.328  Sum_probs=167.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..++...  ...++||||+++++|.+++..+ ...+++..+..++.|++.|+.|||   ..+++
T Consensus        58 ~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~  131 (279)
T cd05057          58 DEAYVMASVDHPHVVRLLGICLS--SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLE---EKRLV  131 (279)
T ss_pred             HHHHHHHhCCCCCcceEEEEEec--CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEE
Confidence            45567788899999999998875  6889999999999999999875 335899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      |+||+|+||+++.++.++|+|||++.......... .....++..|++||.+....++.++|+||||+++|++++ |..|
T Consensus       132 H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  211 (279)
T cd05057         132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999987554322111 111223467999999988888999999999999999998 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      |.+....+....+.       .+.         ....+......+.+++..||..||++|||+.++++.|.+...
T Consensus       212 ~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         212 YEGIPAVEIPDLLE-------KGE---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCHHHHHHHHh-------CCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            98765544332221       100         001122234568899999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=9.1e-31  Score=232.06  Aligned_cols=204  Identities=22%  Similarity=0.341  Sum_probs=163.2

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...++.++|+++++..+.+.. ++..++||||+++++|.+++...   .+++..+..++.|++.+|.|||   ..+++|
T Consensus        66 e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH---~~~i~H  138 (297)
T cd06656          66 EILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH---SNQVIH  138 (297)
T ss_pred             HHHHHHhCCCCCEeeEEEEEec-CCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            4456778899999999998876 66899999999999999999753   4899999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      +||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|..||..
T Consensus       139 ~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             CCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998865433221 12234678889999999888889999999999999999999999976


Q ss_pred             CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..........      +..        .......+...+..+.+++.+||+.+|++|||++++++|
T Consensus       218 ~~~~~~~~~~------~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         218 ENPLRALYLI------ATN--------GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCcchheeee------ccC--------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            5432211110      000        011111233445678899999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=9e-31  Score=236.78  Aligned_cols=213  Identities=24%  Similarity=0.340  Sum_probs=161.1

Q ss_pred             HHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------------------------
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------------------------   88 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------------------------   88 (313)
                      +...+..+ +|++++++.+.....+...++||||+++|+|.+++....                                
T Consensus        60 E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (343)
T cd05103          60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLD  139 (343)
T ss_pred             HHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcc
Confidence            44555666 679999999887766778899999999999999986421                                


Q ss_pred             ---------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC
Q 048068           89 ---------------------------------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL  135 (313)
Q Consensus        89 ---------------------------------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~  135 (313)
                                                       ...++...+..++.|++.||.|||   ..+++|+||||.||+++.++
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~  216 (343)
T cd05103         140 SITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENN  216 (343)
T ss_pred             ccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCC
Confidence                                             123677888999999999999999   58999999999999999999


Q ss_pred             cEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHH
Q 048068          136 NGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDW  213 (313)
Q Consensus       136 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~  213 (313)
                      .++|+|||++........ .......++..|++||.+.+..++.++|+||||+++|++++ |..||.........  ...
T Consensus       217 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~  294 (343)
T cd05103         217 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR  294 (343)
T ss_pred             cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHH
Confidence            999999999865422211 11122234567999999988889999999999999999997 99998764332211  110


Q ss_pred             HHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          214 VSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                          ...+..     ..    .+......+.+++..||+.||++|||+.+++++|+...
T Consensus       295 ----~~~~~~-----~~----~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         295 ----LKEGTR-----MR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             ----HhccCC-----CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                011110     00    11112346889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=1.8e-30  Score=225.84  Aligned_cols=211  Identities=25%  Similarity=0.390  Sum_probs=165.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK-PSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...++.++|+++++..+.... ++..++|||++++++|.++++.... ..+++..+..++.|++.|+.+||   ..++
T Consensus        48 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i  123 (267)
T cd06610          48 KEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQ  123 (267)
T ss_pred             HHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            34456778899999999988776 6789999999999999999986432 56899999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g  195 (313)
                      +|+||+|+||++++++.++|+|||++.........   ......++..|++||.+... .++.++|+||||+++|+|++|
T Consensus       124 ~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g  203 (267)
T cd06610         124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG  203 (267)
T ss_pred             ecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence            99999999999999999999999998755433221   12334578899999998766 788999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC-ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI-YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +.||............      ....      .+..... .....+..+.+++..||+.||.+|||++++++|
T Consensus       204 ~~p~~~~~~~~~~~~~------~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         204 AAPYSKYPPMKVLMLT------LQND------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCCccccChhhhHHHH------hcCC------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            9999765443222111      0000      0011110 112445778999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=4.1e-31  Score=235.83  Aligned_cols=223  Identities=19%  Similarity=0.295  Sum_probs=165.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+.+.. ++..+++|||+++++|.+++.......+++..+..++.|++.||.|||   ..+|+
T Consensus        48 ~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~iv  123 (314)
T cd08216          48 QEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFI  123 (314)
T ss_pred             HHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            45566788899999999988876 568899999999999999998765556999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC------CccccccccccccccccccC--CCCCcchhhHHHHHHHHHH
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMAPELMRT--GKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l  192 (313)
                      |+||+|+||+++.++.++++||+.+........      .......++..|++||.+..  ..++.++|+|||||++|++
T Consensus       124 H~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el  203 (314)
T cd08216         124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL  203 (314)
T ss_pred             cCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHH
Confidence            999999999999999999999998754322111      11122346678999999865  3578899999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHhhh----h-------cccc--------ccccccccCCccHHHHHHHHHHHHHcCCC
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDCWK----K-------GAIL--------DASDSRLEGIYEEEQMELVLKLGLFCSHP  253 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~~~----~-------~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~  253 (313)
                      ++|..||.........  .+.......    .       ....        ..................+.+|+..||..
T Consensus       204 ~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  281 (314)
T cd08216         204 ANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR  281 (314)
T ss_pred             HhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhc
Confidence            9999999865433221  111110000    0       0000        00000111123334557889999999999


Q ss_pred             CCCCCCCHHHHHHHHh
Q 048068          254 KPEARPNMRQVMQYLD  269 (313)
Q Consensus       254 ~P~~Rpt~~ell~~L~  269 (313)
                      ||++|||++++++|-.
T Consensus       282 ~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         282 DPESRPSASQLLNHSF  297 (314)
T ss_pred             CCCcCcCHHHHhcCch
Confidence            9999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=2.9e-30  Score=225.18  Aligned_cols=203  Identities=23%  Similarity=0.403  Sum_probs=161.6

Q ss_pred             hccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcC
Q 048068           48 SVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        48 ~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~  125 (313)
                      .++|+++++..+.+.. ++..++||||+++++|.+++...  ....+++..++.++.|++.++.|||+  ..+++|+||+
T Consensus        65 ~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~  141 (269)
T cd08528          65 QLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLT  141 (269)
T ss_pred             cCCCCCeeeEEeeEcc-CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCC
Confidence            4789999999998876 67899999999999999988542  24569999999999999999999994  3689999999


Q ss_pred             CCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCch
Q 048068          126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM  205 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  205 (313)
                      |+||+++.++.++|+|||.+.......  ......++..|.+||...+..++.++|+||||+++|++++|+.||......
T Consensus       142 ~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~  219 (269)
T cd08528         142 PNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML  219 (269)
T ss_pred             HHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence            999999999999999999987554332  223445788899999998888899999999999999999999999765433


Q ss_pred             hhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .......       ....    .+.    ........+.++|.+||+.||++|||+.|+..++++
T Consensus       220 ~~~~~~~-------~~~~----~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         220 SLATKIV-------EAVY----EPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HHHHHHh-------hccC----CcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            3221110       0000    000    111234678899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=2.6e-31  Score=235.56  Aligned_cols=205  Identities=22%  Similarity=0.351  Sum_probs=162.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|++++++.+.+.. ++..++||||+++++|..++..   ..+++..++.++.|++.||.|||   ..+++
T Consensus        67 ~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~iv  139 (297)
T cd06659          67 NEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVI  139 (297)
T ss_pred             HHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            34556777899999999988876 6789999999999999998865   35899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|++++|+.||.
T Consensus       140 H~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             cCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886543322 11223467889999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...........   ...+.           ............+.+++..||+.+|++|||++++++|
T Consensus       219 ~~~~~~~~~~~---~~~~~-----------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         219 SDSPVQAMKRL---RDSPP-----------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHH---hccCC-----------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            65433322111   10000           0000112234568899999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=3.4e-31  Score=241.04  Aligned_cols=207  Identities=26%  Similarity=0.332  Sum_probs=160.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+.+++|+++++++..+.. ++.+++||||++||+|.+++.+.  ..+++..+..++.|++.||.|||   ..+++
T Consensus        50 ~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~giv  123 (360)
T cd05627          50 AERDILVEADGAWVVKMFYSFQD-KRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH---QLGFI  123 (360)
T ss_pred             HHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            45667788899999999988876 67899999999999999999764  35999999999999999999999   59999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC----------------------------------Ccccccccccccc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI----------------------------------PQTTKLVGTFGYM  166 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~----------------------------------~~~~~~~~~~~y~  166 (313)
                      ||||||+||+++.++.++|+|||++........                                  .......||+.|+
T Consensus       124 HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  203 (360)
T cd05627         124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI  203 (360)
T ss_pred             ccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcccc
Confidence            999999999999999999999998764321100                                  0011346899999


Q ss_pred             ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHH
Q 048068          167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL  246 (313)
Q Consensus       167 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (313)
                      |||++.+..++.++|+|||||++|+|++|..||...........+.    .|...     .  ..+.  ....+..+.++
T Consensus       204 APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~----~~~~~-----~--~~p~--~~~~s~~~~~l  270 (360)
T cd05627         204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVM----NWKET-----L--VFPP--EVPISEKAKDL  270 (360)
T ss_pred             CHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHH----cCCCc-----e--ecCC--CCCCCHHHHHH
Confidence            9999998899999999999999999999999998765544332221    00000     0  0111  11134567778


Q ss_pred             HHHcCCCCCCCCC---CHHHHHHH
Q 048068          247 GLFCSHPKPEARP---NMRQVMQY  267 (313)
Q Consensus       247 i~~cl~~~P~~Rp---t~~ell~~  267 (313)
                      |.+|+ .||.+|+   +++++++|
T Consensus       271 i~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         271 ILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             HHHhc-cChhhcCCCCCHHHHhcC
Confidence            87776 4999998   47888887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=1.6e-30  Score=226.85  Aligned_cols=212  Identities=24%  Similarity=0.355  Sum_probs=156.2

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      +...++.++|+++++..+.+.. ...+++||||+++++|.+++....   ....++..+..++.||+.|+.|||   +.+
T Consensus        45 e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~  120 (269)
T cd05042          45 EVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QAD  120 (269)
T ss_pred             HHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcC
Confidence            4445667789999999988776 568999999999999999997642   233567888999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-cccccccccccccccccc-------CCCCCcchhhHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMR-------TGKASTSTDVYAFGVFML  190 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~  190 (313)
                      ++|+||||+||+++.++.++|+|||++......... ......++..|+|||++.       ...++.++|+|||||++|
T Consensus       121 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~  200 (269)
T cd05042         121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMW  200 (269)
T ss_pred             EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHH
Confidence            999999999999999999999999988543221110 112223456799999864       235678999999999999


Q ss_pred             HHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          191 EVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       191 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++++ |..||......+.....      .... ......+    ..+...+..+..++..|+ .||++|||++++++.|.
T Consensus       201 el~~~~~~p~~~~~~~~~~~~~------~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         201 ELFTAADQPYPDLSDEQVLKQV------VREQ-DIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHhCCCCCCCcCCHHHHHHHH------hhcc-CccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            9999 78888765544322111      1111 1111111    122344566778888898 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=1.5e-30  Score=228.56  Aligned_cols=208  Identities=25%  Similarity=0.315  Sum_probs=159.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.+++++|++++++.+.+.. ++..++||||+++++|..+.      .+++..+..++.|++.|+.|||   +.+++
T Consensus        48 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~  117 (279)
T cd06619          48 SELEILYKCDSPYIIGFYGAFFV-ENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKIL  117 (279)
T ss_pred             HHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            35556777899999999998887 56889999999999986542      3788999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++......   ......++..|+|||.+.+..++.++|+||||+++|++++|..||.
T Consensus       118 H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~  194 (279)
T cd06619         118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP  194 (279)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence            9999999999999999999999998654322   1233567889999999998889999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ......................        .........+..+.+++.+||+.+|++||+++++++|..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         195 QIQKNQGSLMPLQLLQCIVDED--------PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             hhcccccccchHHHHHHHhccC--------CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence            5332221110000000000000        000011223456889999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=254.44  Aligned_cols=209  Identities=21%  Similarity=0.363  Sum_probs=159.8

Q ss_pred             hHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhcC--
Q 048068           41 LQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQRFRIIRGVASGLLYLHEDW--  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lhs~~--  115 (313)
                      .+...++++.|++++++++.+. ..+..+|+||||+++++|.++|....  ...+++..++.|+.||+.||.|||+..  
T Consensus        61 ~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~  140 (1021)
T PTZ00266         61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG  140 (1021)
T ss_pred             HHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccc
Confidence            4667788899999999998876 33567999999999999999997532  346999999999999999999999521  


Q ss_pred             --CCCceecCcCCCcEEEcC-----------------CCcEEEeecccccccCCCCCCccccccccccccccccccC--C
Q 048068          116 --EQVVLHRDIKPANVLLDA-----------------DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT--G  174 (313)
Q Consensus       116 --~~~i~H~dl~~~nIlv~~-----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~  174 (313)
                        ..+|+|+||||+|||++.                 .+.++|+|||++.......  ......+++.|+|||++.+  .
T Consensus       141 ~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~  218 (1021)
T PTZ00266        141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETK  218 (1021)
T ss_pred             cccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCC
Confidence              145999999999999964                 2348999999987543322  1233468999999999864  4


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCC
Q 048068          175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPK  254 (313)
Q Consensus       175 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  254 (313)
                      .++.++|||||||++|+|++|..||.........  +..+    ...       +..   .....+..+.+||..||..+
T Consensus       219 ~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql--i~~l----k~~-------p~l---pi~~~S~eL~dLI~~~L~~d  282 (1021)
T PTZ00266        219 SYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL--ISEL----KRG-------PDL---PIKGKSKELNILIKNLLNLS  282 (1021)
T ss_pred             CCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH--HHHH----hcC-------CCC---CcCCCCHHHHHHHHHHhcCC
Confidence            5788999999999999999999999765443221  1110    110       000   11123467889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 048068          255 PEARPNMRQVMQY  267 (313)
Q Consensus       255 P~~Rpt~~ell~~  267 (313)
                      |.+|||+.|++++
T Consensus       283 PeeRPSa~QlL~h  295 (1021)
T PTZ00266        283 AKERPSALQCLGY  295 (1021)
T ss_pred             hhHCcCHHHHhcc
Confidence            9999999999964

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=1.5e-30  Score=229.72  Aligned_cols=201  Identities=23%  Similarity=0.300  Sum_probs=164.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.+.|+++++..+.... ++.+++||||+++++|.+++...  ..+++..+..++.|++.||.|||   ..+++
T Consensus        50 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~  123 (290)
T cd05580          50 NEKRILQSIRHPFLVNLYGSFQD-DSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIV  123 (290)
T ss_pred             HHHHHHHhCCCCCccceeeEEEc-CCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            45567888899999999998877 66899999999999999999874  46999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|.||+++.++.++|+|||++......    .....+++.|++||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       124 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  199 (290)
T cd05580         124 YRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF  199 (290)
T ss_pred             cCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998765433    223457889999999988888899999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      ..........+.       .+.          ...+......+.+++.+||..||.+|+     +++++++|-
T Consensus       200 ~~~~~~~~~~~~-------~~~----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~  255 (290)
T cd05580         200 DDNPIQIYEKIL-------EGK----------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP  255 (290)
T ss_pred             CCCHHHHHHHHh-------cCC----------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence            655332222110       000          012223356788999999999999999     888888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=4.1e-31  Score=232.40  Aligned_cols=221  Identities=21%  Similarity=0.285  Sum_probs=163.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+.+.+ ++..++||||+. ++|.+++.......+++..++.++.|++.|++|||   ..++
T Consensus        47 ~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i  121 (284)
T cd07860          47 IREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRV  121 (284)
T ss_pred             HHHHHHHHhcCCCCCcchhhhccc-CCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            356778899999999999999876 668999999995 68999987655567999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+.. ++.++|+||||+++|++++|+.|
T Consensus       122 ~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p  200 (284)
T cd07860         122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL  200 (284)
T ss_pred             ecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999999865433221 122334578899999886544 58899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHH-----hhhh--------ccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSD-----CWKK--------GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~-----~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      |......+..........     .|..        ........ .............+.++|.+||+.||.+|||+++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l  279 (284)
T cd07860         201 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR-QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL  279 (284)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccc-cCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence            986654432221110000     0000        00000000 000001112345678999999999999999999999


Q ss_pred             HH
Q 048068          266 QY  267 (313)
Q Consensus       266 ~~  267 (313)
                      +|
T Consensus       280 ~~  281 (284)
T cd07860         280 AH  281 (284)
T ss_pred             cC
Confidence            76

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=1.6e-30  Score=226.04  Aligned_cols=207  Identities=23%  Similarity=0.327  Sum_probs=164.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+.+.+ +..+++||||+++++|.+++.+.  ..+++..+..++.||+.||.|||   +.++
T Consensus        41 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~~  114 (262)
T cd05572          41 FSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLH---NRGI  114 (262)
T ss_pred             HHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hCCc
Confidence            345667788899999999998776 67899999999999999999864  35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++.......  ......++..|++||.+.+..++.++|+||||+++|++++|..||
T Consensus       115 ~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  192 (262)
T cd05572         115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF  192 (262)
T ss_pred             ccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCc
Confidence            999999999999999999999999987654332  122345788899999988888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      ....... .......   ..         .......+...+..+.++|.+||..||++|||     ++|+++|
T Consensus       193 ~~~~~~~-~~~~~~~---~~---------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         193 GEDDEDP-MEIYNDI---LK---------GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCCCCH-HHHHHHH---hc---------cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            8765311 1111100   00         00111123333678999999999999999999     8898885

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.3e-30  Score=229.16  Aligned_cols=216  Identities=22%  Similarity=0.339  Sum_probs=164.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI----------KPSLSWYQRFRIIRGVASGLLY  110 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~al~~  110 (313)
                      .+.+.++.++|+++++..+.... ++..++||||+++++|.+++....          ...+++..++.++.|++.|+.|
T Consensus        66 ~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  144 (295)
T cd05097          66 KEIKIMSRLKNPNIIRLLGVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKY  144 (295)
T ss_pred             HHHHHHHhCCCCCcCeEEEEEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHH
Confidence            35667788999999999998876 568899999999999999996431          1236888999999999999999


Q ss_pred             hhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHH
Q 048068          111 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM  189 (313)
Q Consensus       111 lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il  189 (313)
                      ||   ..+++|+||+|+||+++.++.++|+|||++........ .......++..|+|||...++.++.++|+||||+++
T Consensus       145 lH---~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l  221 (295)
T cd05097         145 LA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL  221 (295)
T ss_pred             HH---hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHH
Confidence            99   58999999999999999999999999999865432211 112223446689999999888899999999999999


Q ss_pred             HHHHh--CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          190 LEVAS--GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       190 ~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |++++  +..||.............   ..+......      .....+...+..+.+|+.+||+.||++|||++++++.
T Consensus       222 ~el~~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~  292 (295)
T cd05097         222 WEMFTLCKEQPYSLLSDEQVIENTG---EFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF  292 (295)
T ss_pred             HHHHHcCCCCCCcccChHHHHHHHH---Hhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            99988  667887655444322211   111110000      0000112234679999999999999999999999999


Q ss_pred             Hh
Q 048068          268 LD  269 (313)
Q Consensus       268 L~  269 (313)
                      |.
T Consensus       293 l~  294 (295)
T cd05097         293 LR  294 (295)
T ss_pred             Hh
Confidence            86

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=1.2e-30  Score=230.89  Aligned_cols=205  Identities=23%  Similarity=0.377  Sum_probs=162.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.... ++..++||||+++++|.+++...   .+++..+..++.||+.|+.|||   ..+++
T Consensus        68 ~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~iv  140 (292)
T cd06658          68 NEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVI  140 (292)
T ss_pred             HHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            45566777889999998888776 67899999999999999988643   4899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++....... .......++..|+|||...+..++.++|+||||+++|++++|+.||.
T Consensus       141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  219 (292)
T cd06658         141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF  219 (292)
T ss_pred             ecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886543222 12223457889999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ............       ..     ......  ........+.+++..||..||.+|||++++++|
T Consensus       220 ~~~~~~~~~~~~-------~~-----~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         220 NEPPLQAMRRIR-------DN-----LPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCCHHHHHHHHH-------hc-----CCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            654433221110       00     000011  112345578899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=2.3e-30  Score=227.98  Aligned_cols=209  Identities=25%  Similarity=0.388  Sum_probs=163.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.++|+++++..+.+.. ++.+++||||+++++|..++.... ...+++..+..++.|++.|+.|||+  ..++
T Consensus        48 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i  124 (286)
T cd06622          48 MELDILHKAVSPYIVDFYGAFFI-EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI  124 (286)
T ss_pred             HHHHHHHhcCCCcHHhhhhheec-CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCE
Confidence            35567788899999999988776 678999999999999999987632 3469999999999999999999995  3599


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC------CCcchhhHHHHHHHHHHH
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK------ASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll  193 (313)
                      +|+||+|+||+++.++.++|+|||++.......   .....++..|++||.+.+..      ++.++|+|||||++|+++
T Consensus       125 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~  201 (286)
T cd06622         125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA  201 (286)
T ss_pred             eeCCCCHHHEEECCCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence            999999999999999999999999886543221   22345678899999985433      478999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +|+.||...............   .          .......+......+.++|.+||+.+|.+||+++++++|-
T Consensus       202 ~g~~pf~~~~~~~~~~~~~~~---~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         202 LGRYPYPPETYANIFAQLSAI---V----------DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             hCCCCCCCcchhhHHHHHHHH---h----------hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence            999999754433322211100   0          0011123344667789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=2.9e-30  Score=223.97  Aligned_cols=209  Identities=23%  Similarity=0.394  Sum_probs=166.2

Q ss_pred             HHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcC--C
Q 048068           42 QRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDW--E  116 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~--~  116 (313)
                      +.+.++.++|++++++.+... ..+...+++|||+++++|.+++...  ....+++..++.++.||+.||.|||..+  .
T Consensus        49 e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~  128 (265)
T cd08217          49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG  128 (265)
T ss_pred             HHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            456677889999999988765 3456789999999999999999753  2456899999999999999999999321  3


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      .+++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|+
T Consensus       129 ~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~  207 (265)
T cd08217         129 NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS  207 (265)
T ss_pred             CcceecCCCHHHEEEecCCCEEEecccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence            7899999999999999999999999999876544332 122346788999999998888899999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .||...........+       ..+         .....+...+..+.+++..||+.+|++|||++++++|
T Consensus       208 ~p~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         208 PPFTARNQLQLASKI-------KEG---------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CcccCcCHHHHHHHH-------hcC---------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            999876533222111       111         1112333456788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3e-30  Score=225.30  Aligned_cols=209  Identities=23%  Similarity=0.320  Sum_probs=160.4

Q ss_pred             hHHhhhhhc-cccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      .+...++.+ .|+++++..+.+...     +..+++||||+++++|.+++....  +..+++..+..++.|++.||.|||
T Consensus        51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH  130 (275)
T cd06608          51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH  130 (275)
T ss_pred             HHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            344555666 699999999988642     346899999999999999987532  457999999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-----CCCCcchhhHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----GKASTSTDVYAFGV  187 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~  187 (313)
                         ..+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+..     ..++.++|+||||+
T Consensus       131 ---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~  206 (275)
T cd06608         131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI  206 (275)
T ss_pred             ---cCCcccCCCCHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHH
Confidence               5899999999999999999999999999886543222 12233457889999998753     34678999999999


Q ss_pred             HHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          188 FMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       188 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ++|++++|+.||...........+      . ..       .......+......+.+++.+||..||++|||+.++++|
T Consensus       207 il~~l~~g~~p~~~~~~~~~~~~~------~-~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         207 TAIELADGKPPLCDMHPMRALFKI------P-RN-------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HHHHHHhCCCCccccchHHHHHHh------h-cc-------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            999999999999754333222111      0 00       001111223356788999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=2e-30  Score=225.86  Aligned_cols=209  Identities=23%  Similarity=0.388  Sum_probs=164.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.+ ++.+++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||   ..+++
T Consensus        52 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~  125 (268)
T cd06630          52 KEIRLMARLNHPHIIRMLGATCE-DSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQII  125 (268)
T ss_pred             HHHHHHHHcCCCceehhhceecc-CCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            45567777899999999999876 66899999999999999999764  36899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCC-cEEEeecccccccCCCCC---CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          121 HRDIKPANVLLDADL-NGKLGDFGLARLYDHDTI---PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       121 H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      |+||+|+||+++.++ .++|+|||.+........   .......++..|++||.+.+..++.++|+||+|++++++++|.
T Consensus       126 H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~  205 (268)
T cd06630         126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK  205 (268)
T ss_pred             cCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCC
Confidence            999999999998776 599999999865543211   1122345778999999998888899999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .||...........+...   .         ........+......+.+++.+||..+|++|||+.++++|
T Consensus       206 ~p~~~~~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         206 PPWNAEKHSNHLALIFKI---A---------SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CCCCCCCCcchHHHHHHH---h---------ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            999754433222211100   0         0011122444566788999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=2.7e-30  Score=225.54  Aligned_cols=209  Identities=23%  Similarity=0.361  Sum_probs=154.3

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      .++.++|+++++..+.... ....++||||+++++|.+++....  ....+...++.++.||+.||.|||   +.+++|+
T Consensus        48 ~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~  123 (268)
T cd05086          48 PYRILQHPNILQCLGQCVE-AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHS  123 (268)
T ss_pred             HHhccCCcchhheEEEecC-CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence            3455789999999988876 568899999999999999997642  234677888999999999999999   5899999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCC-CCCccccccccccccccccccC-------CCCCcchhhHHHHHHHHHHHh
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVGTFGYMAPELMRT-------GKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~  194 (313)
                      ||||+||+++.++.++|+|||++...... .........++..|++||++..       ..++.++|+||||+++|+|++
T Consensus       124 dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~  203 (268)
T cd05086         124 DLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE  203 (268)
T ss_pred             CCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence            99999999999999999999987532111 1111223456788999998743       235779999999999999997


Q ss_pred             -CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          195 -GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       195 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                       +..||......+.....      ... .......+..    .....+.+.+++..|| .+|++|||++++++.|.
T Consensus       204 ~~~~p~~~~~~~~~~~~~------~~~-~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         204 NAAQPYSHLSDREVLNHV------IKD-QQVKLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCCCCCCCCHHHHHHHH------Hhh-cccccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             57788655443322211      111 1111111221    2224466788999999 68999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=2.1e-30  Score=228.15  Aligned_cols=211  Identities=23%  Similarity=0.361  Sum_probs=164.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+.... .+.+++||||+++++|.+++...  +.+++..+..++.+++.++.|||+  ..+++
T Consensus        52 ~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~  126 (284)
T cd06620          52 RELQIMHECRSPYIVSFYGAFLN-ENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIM  126 (284)
T ss_pred             HHHHHHHHcCCCCcceEeeeEec-CCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCee
Confidence            45567788899999999999887 47899999999999999998763  468999999999999999999995  36899


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++.......   .....++..|++||.+.+..++.++|+|||||++|++++|..||.
T Consensus       127 H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~  203 (284)
T cd06620         127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA  203 (284)
T ss_pred             ccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence            99999999999999999999999875432211   223467889999999988888999999999999999999999998


Q ss_pred             cCCchhh-----hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQGSMEM-----VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .......     .............         ..+.......+..+.+|+.+||+.||++|||+.|++++.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         204 FSNIDDDGQDDPMGILDLLQQIVQE---------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ccchhhhhhhhhhHHHHHHHHHhhc---------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            6554211     1111111111111         001111112456788999999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=2.3e-30  Score=227.00  Aligned_cols=208  Identities=25%  Similarity=0.329  Sum_probs=164.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. ++.+|+||||+++++|.+++.......+++..+..++.|++.|+.|||   ..+++
T Consensus        42 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~  117 (277)
T cd05577          42 NEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV  117 (277)
T ss_pred             HHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            46677889999999999988876 568999999999999999998754456999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||.+.......  ......++..|++||.+.+..++.++|+||||+++|++++|+.||.
T Consensus       118 H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  195 (277)
T cd05577         118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR  195 (277)
T ss_pred             cCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence            99999999999999999999999886543321  1223456778999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..........+.  ..      ..     ......+...++.+.+++.+||+.||.+||     ++.++++|
T Consensus       196 ~~~~~~~~~~~~--~~------~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         196 QRKEKVEKEELK--RR------TL-----EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CCcccccHHHHH--hc------cc-----cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            654422111110  00      00     011112333467789999999999999999     77778764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=228.30  Aligned_cols=222  Identities=23%  Similarity=0.341  Sum_probs=165.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.+.|+++++..+++.. ++..++||||++++.+..+...  ...+++..++.++.||+.|+.|||   ..++
T Consensus        48 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i  121 (288)
T cd07833          48 LREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCH---SHNI  121 (288)
T ss_pred             HHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            456677888899999999999876 6789999999988766665544  345899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++...............++..|++||.+.+. .++.++|+||||+++|++++|++|
T Consensus       122 ~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  201 (288)
T cd07833         122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL  201 (288)
T ss_pred             ecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999876544332122335667889999999877 788999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHh--------hhhcc------ccccccc-cccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDC--------WKKGA------ILDASDS-RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~--------~~~~~------~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      |.+....+...........        +....      ..+.... .....++...+..+.+||..||..+|++|||+++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  281 (288)
T cd07833         202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE  281 (288)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence            9765544322222111000        00000      0000000 0001122233678999999999999999999999


Q ss_pred             HHHH
Q 048068          264 VMQY  267 (313)
Q Consensus       264 ll~~  267 (313)
                      +++|
T Consensus       282 il~~  285 (288)
T cd07833         282 LLQH  285 (288)
T ss_pred             HhcC
Confidence            9875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.2e-31  Score=237.35  Aligned_cols=217  Identities=22%  Similarity=0.256  Sum_probs=159.4

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.++|++++++.+++...     ....+++|+++ +++|.++++..   .+++..+..++.||+.||.|||   
T Consensus        63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---  135 (343)
T cd07878          63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIH---  135 (343)
T ss_pred             HHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---
Confidence            466788889999999998877521     24679999998 88999888643   5999999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHh
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~  194 (313)
                      ..+|+|+||||+||+++.++.++|+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus       136 ~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  211 (343)
T cd07878         136 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK  211 (343)
T ss_pred             HCCeecccCChhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH
Confidence            589999999999999999999999999998754322    223467899999999876 467899999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhh--------ccccccc--cccccCC----ccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKK--------GAILDAS--DSRLEGI----YEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      |+.||.+....+....+.........        .......  .+..+..    ......+.+.+|+.+||..||++|||
T Consensus       212 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s  291 (343)
T cd07878         212 GKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS  291 (343)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC
Confidence            99999765544332222110000000        0000000  0000000    00112345789999999999999999


Q ss_pred             HHHHHHHH
Q 048068          261 MRQVMQYL  268 (313)
Q Consensus       261 ~~ell~~L  268 (313)
                      +.|+++|-
T Consensus       292 ~~ell~hp  299 (343)
T cd07878         292 ASEALAHP  299 (343)
T ss_pred             HHHHhcCc
Confidence            99999873

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=2.8e-30  Score=227.25  Aligned_cols=210  Identities=20%  Similarity=0.273  Sum_probs=160.2

Q ss_pred             hHHhhhhhc-cccceeeeeeEEe----ccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVN----SRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~----~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      .+...++.+ +|+++++..+...    ..++.+++||||+++++|.+++...  ....+++..++.++.|++.|+.||| 
T Consensus        63 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-  141 (286)
T cd06638          63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-  141 (286)
T ss_pred             HHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH-
Confidence            345566777 6999999998764    2356799999999999999988642  2356899999999999999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVF  188 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~i  188 (313)
                        ..+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.     +..++.++|+||+||+
T Consensus       142 --~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi  218 (286)
T cd06638         142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT  218 (286)
T ss_pred             --hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence              58999999999999999999999999999865433221 222346788999999875     2457889999999999


Q ss_pred             HHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          189 MLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       189 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +|++++|+.||............       ....       ......+......+.++|.+||+.||++|||+.++++|+
T Consensus       219 ~~el~~g~~p~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         219 AIELGDGDPPLADLHPMRALFKI-------PRNP-------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             HHHHhcCCCCCCCCchhHHHhhc-------cccC-------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            99999999999765432221110       0000       000001112345688999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=240.98  Aligned_cols=202  Identities=20%  Similarity=0.230  Sum_probs=164.0

Q ss_pred             hhhHH-hhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           39 PQLQR-DGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        39 ~~~~~-~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      .+.+. ..+..-.|+++++..+...+ +.+.++|||.++|+-|.+.+....   .....+..|+++|+.|+.|||   .+
T Consensus       362 ~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH---~~  434 (612)
T KOG0603|consen  362 NQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLH---EQ  434 (612)
T ss_pred             cccccchhhhhcCCCcceeecceecC-CceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHH---hc
Confidence            33444 44556689999999988877 679999999999988888887642   333777889999999999999   69


Q ss_pred             CceecCcCCCcEEE-cCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          118 VVLHRDIKPANVLL-DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       118 ~i~H~dl~~~nIlv-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      |++||||||+|||+ +..++++|+|||.+...+..    .....-|..|.|||+.....+++++|+||||+++|+|++|+
T Consensus       435 gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~  510 (612)
T KOG0603|consen  435 GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGR  510 (612)
T ss_pred             CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCC
Confidence            99999999999999 68899999999998765433    22334578899999999999999999999999999999999


Q ss_pred             CCCccCCch-hhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          197 RPIEQQGSM-EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       197 ~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .||...... ++...+                   ....+....++..++|+.+||+.||.+|+++.++..|=.-
T Consensus       511 tp~~~~P~~~ei~~~i-------------------~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  511 TLFAAHPAGIEIHTRI-------------------QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             CccccCCchHHHHHhh-------------------cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            999877665 222222                   1111235667889999999999999999999999997655

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=228.73  Aligned_cols=237  Identities=23%  Similarity=0.296  Sum_probs=187.2

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      +++.|+|..++.+.+   +..++.|...-     ..-.+..++++.+.++++++++.+.. +..+++|||||-.|+..++
T Consensus        40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEYCGAGSiSDI  118 (502)
T KOG0574|consen   40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEYCGAGSISDI  118 (502)
T ss_pred             HhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhhcCCCcHHHH
Confidence            344444444443333   34555555431     22245677888899999999998876 5689999999988999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF  163 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  163 (313)
                      ++-. .++++++.+..++...++||.|||   ...-+|||||..|||++.+|..||+|||++-...... .+..+..||+
T Consensus       119 ~R~R-~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIGTP  193 (502)
T KOG0574|consen  119 MRAR-RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIGTP  193 (502)
T ss_pred             HHHh-cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccccCc
Confidence            9866 568999999999999999999999   4677999999999999999999999999987655433 3455678999


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       164 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      .|+|||++..-.|+.++||||||++..||..|++||.+......+..+-              -.+.+.-..+...+..+
T Consensus       194 FWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--------------T~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  194 FWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--------------TKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             ccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--------------CCCCCCCCChHhhhhHH
Confidence            9999999998899999999999999999999999998765544333220              11112222455667899


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .+|+..||-.+|++|-|+.++++|-
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            9999999999999999999999974

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=2.2e-30  Score=228.72  Aligned_cols=258  Identities=19%  Similarity=0.214  Sum_probs=174.9

Q ss_pred             CCCCCCcchhhhhHHHHHHHHhhcc---ccceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEE
Q 048068            1 MGAAPRSFYFCVLLCVSFILSALAQ---DVNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFL   69 (313)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~   69 (313)
                      ||+..+.-..+.++.+.+...+...   ....++.|.+..        ....+...++.++|+++++..+.+.. ++..+
T Consensus         1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~   79 (291)
T cd07870           1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLT   79 (291)
T ss_pred             CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEE
Confidence            3444444444445555444444432   233555555431        12346677889999999999999876 56899


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccC
Q 048068           70 LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD  149 (313)
Q Consensus        70 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~  149 (313)
                      +||||+. ++|.+.+... ...+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            9999995 6777777654 345788899999999999999999   5899999999999999999999999999886433


Q ss_pred             CCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh--------hhh
Q 048068          150 HDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC--------WKK  220 (313)
Q Consensus       150 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------~~~  220 (313)
                      .... ......++..|++||.+.+. .++.++|+||||+++|++++|..||......... ... ....        +..
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~~-~~~~~~~~~~~~~~~  231 (291)
T cd07870         155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LEK-IWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HHH-HHHHcCCCChhhhhh
Confidence            2211 11233468899999998753 5788999999999999999999999765442111 110 0000        000


Q ss_pred             -----ccccccccccccCCc-----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          221 -----GAILDASDSRLEGIY-----EEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       221 -----~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                           ...............     .......+.+++.+||..||.+|||++|++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                 000000000000000     00124578899999999999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=2.6e-30  Score=227.10  Aligned_cols=197  Identities=21%  Similarity=0.299  Sum_probs=156.7

Q ss_pred             ccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCc
Q 048068           49 VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN  128 (313)
Q Consensus        49 ~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~n  128 (313)
                      ..|+++++....+.. ++..++||||+++++|.+++..+  +.+++..+..++.|++.||.|||   ..+++|+||+|+|
T Consensus        54 ~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~N  127 (279)
T cd05633          54 GDCPFIVCMTYAFHT-PDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPAN  127 (279)
T ss_pred             CCCCcEeEEEEEEec-CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHH
Confidence            368899988888776 56899999999999999998764  35999999999999999999999   5899999999999


Q ss_pred             EEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhh
Q 048068          129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM  207 (313)
Q Consensus       129 Ilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  207 (313)
                      |+++.++.++|+|||++.......   .....++..|++||.+.+ ..++.++|+||+||++|++++|..||........
T Consensus       128 il~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  204 (279)
T cd05633         128 ILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  204 (279)
T ss_pred             EEECCCCCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH
Confidence            999999999999999986443221   223467899999998863 5578999999999999999999999976544332


Q ss_pred             hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      .......              .......+...+..+.++|..||+.||.+||     |++++++|.
T Consensus       205 ~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         205 HEIDRMT--------------LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             HHHHHHh--------------hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            2111100              0111123344567889999999999999999     699999973

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=1.8e-30  Score=225.76  Aligned_cols=209  Identities=25%  Similarity=0.399  Sum_probs=162.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.+.|++++++.+.+.. ++.+++|+||+++++|.+++.... ..+++..+..++.|++.|+.|||+  ..+++
T Consensus        48 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~  123 (265)
T cd06605          48 RELDILHKCNSPYIVGFYGAFYN-NGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKII  123 (265)
T ss_pred             HHHHHHHHCCCCchhhhheeeec-CCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCee
Confidence            34456677889999999988877 578999999999999999998652 579999999999999999999993  28999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||.+.......   .....++..|++||.+.+..++.++|+||||+++|++++|..||.
T Consensus       124 H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  200 (265)
T cd06605         124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP  200 (265)
T ss_pred             cCCCCHHHEEECCCCCEEEeecccchhhHHHH---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999886443221   112567788999999988889999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE-QMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ........ ..+........         . ....+.. .+..+.++|..||..||++|||+.+++.|
T Consensus       201 ~~~~~~~~-~~~~~~~~~~~---------~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         201 PENDPPDG-IFELLQYIVNE---------P-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             cccccccc-HHHHHHHHhcC---------C-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            54321110 01111111000         0 0111112 56678999999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=4.6e-30  Score=223.94  Aligned_cols=207  Identities=24%  Similarity=0.395  Sum_probs=159.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSL--SWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+...++.++|+++++..+.... ++..++|+||+++++|.+++.... ..+  ++..+..++.||+.|+.|||   ..+
T Consensus        54 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~  128 (268)
T cd06624          54 EEIALHSYLKHRNIVQYLGSDSE-NGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQ  128 (268)
T ss_pred             HHHHHHHhcCCCCeeeeeeeecc-CCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCC
Confidence            45567788899999999988776 578999999999999999998642 234  88889999999999999999   589


Q ss_pred             ceecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCccccccccccccccccccCC--CCCcchhhHHHHHHHHHHHhC
Q 048068          119 VLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       119 i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g  195 (313)
                      ++|+||+|+||+++. ++.++|+|||++........ ......++..|++||.+.+.  .++.++|+||||+++|++++|
T Consensus       129 i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g  207 (268)
T cd06624         129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG  207 (268)
T ss_pred             EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC
Confidence            999999999999976 67899999998865432211 12234568899999998654  378899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..||............        ..      ........+....+.+.+++.+||+.+|++|||+.++++|
T Consensus       208 ~~p~~~~~~~~~~~~~--------~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         208 KPPFIELGEPQAAMFK--------VG------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CCCCccccChhhhHhh--------hh------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            9999754332211100        00      0001112334456778999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.9e-31  Score=236.52  Aligned_cols=207  Identities=22%  Similarity=0.292  Sum_probs=153.2

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|..+|..+ .|..+|+++++-.. ++.+|+||||= ..+|..+|+.... ..+.-.++.++.||+.|+.++|   ..||
T Consensus       408 nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH---~~gI  481 (677)
T KOG0596|consen  408 NEIALLNKLKGHDKIIQLYDYEVT-DGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIH---QHGI  481 (677)
T ss_pred             HHHHHHHHhcCCceEEEEeeeecc-CceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHH---Hhce
Confidence            444455555 47888888888766 78999999987 5699999987532 3443488999999999999999   6999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCC-----------CCcchhhHHHHH
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGK-----------ASTSTDVYAFGV  187 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DiwslG~  187 (313)
                      +|.||||.|+++ -.|.+||+|||.+...+..... ....+.||+.|++||.+....           .+.++|||||||
T Consensus       482 VHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC  560 (677)
T KOG0596|consen  482 VHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC  560 (677)
T ss_pred             eecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence            999999999887 4579999999999877655433 234578999999999885322           467999999999


Q ss_pred             HHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          188 FMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE-EQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       188 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |+|+|+.|++||............              ..++...-+++. .....+.++|..||+.||++|||+.+||+
T Consensus       561 ILYqMvYgktPf~~~~n~~aKl~a--------------I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  561 ILYQMVYGKTPFGQIINQIAKLHA--------------ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHHHhcCCchHHHHHHHHHHHh--------------hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            999999999999743221110000              011100000111 11223899999999999999999999999


Q ss_pred             HH
Q 048068          267 YL  268 (313)
Q Consensus       267 ~L  268 (313)
                      |-
T Consensus       627 hp  628 (677)
T KOG0596|consen  627 HP  628 (677)
T ss_pred             Cc
Confidence            73

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=5.2e-30  Score=226.01  Aligned_cols=214  Identities=25%  Similarity=0.333  Sum_probs=163.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEec-cCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ..+.+.++.++|++++++.+++.. .++.+++||||+++++|.+++...  ....+++..+..++.||+.||.|||   .
T Consensus        47 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~  123 (287)
T cd06621          47 LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---S  123 (287)
T ss_pred             HHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence            345567778899999999988763 355789999999999999987642  2456899999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      .+++|+||+|+||+++.++.++|+|||++.......   .....++..|++||.+.+..++.++|+||||+++|+|++|.
T Consensus       124 ~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~  200 (287)
T cd06621         124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR  200 (287)
T ss_pred             CCcccCCCCHHHEEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            899999999999999999999999999976443222   12345678899999998888999999999999999999999


Q ss_pred             CCCccCCch--hhhhHHHHHHHhhhhccccccccccccCCc--cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          197 RPIEQQGSM--EMVNLVDWVSDCWKKGAILDASDSRLEGIY--EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .||......  .......+...    ...     +.+....  .....+.+.+++.+||+.||.+|||+.|+++|-
T Consensus       201 ~p~~~~~~~~~~~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         201 FPFPPEGEPPLGPIELLSYIVN----MPN-----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             CCCCcccCCCCChHHHHHHHhc----CCc-----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            999765321  11111111110    000     0111101  112456789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=3.5e-31  Score=232.92  Aligned_cols=221  Identities=23%  Similarity=0.316  Sum_probs=163.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+++.. ++..++||||+++++|..+....  ..+++..+..++.||+.|+.|||   ..++
T Consensus        48 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i  121 (286)
T cd07846          48 MREIRMLKQLRHENLVNLIEVFRR-KKRLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNI  121 (286)
T ss_pred             HHHHHHHHhcCCcchhhHHHhccc-CCeEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            346677888899999999998876 67899999999998888877653  34899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+ ..++.++|+||||+++|++++|.+|
T Consensus       122 ~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~  200 (286)
T cd07846         122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL  200 (286)
T ss_pred             cccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999875433221 2223456888999998865 3467899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhh--------hhccc-cccccccc-----cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCW--------KKGAI-LDASDSRL-----EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      |......+....+.......        ....+ .....+..     .....+..+..+.+++.+||+.+|++|||+.++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  280 (286)
T cd07846         201 FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL  280 (286)
T ss_pred             CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence            97655433222211100000        00000 00000000     001122345779999999999999999999999


Q ss_pred             HHH
Q 048068          265 MQY  267 (313)
Q Consensus       265 l~~  267 (313)
                      ++|
T Consensus       281 l~~  283 (286)
T cd07846         281 LHH  283 (286)
T ss_pred             hcC
Confidence            986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=8.1e-30  Score=225.09  Aligned_cols=208  Identities=22%  Similarity=0.316  Sum_probs=158.9

Q ss_pred             HHhhhhhc-cccceeeeeeEEecc----CCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSR----KGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      +...++.+ +|+++++..+++...    .+.+++||||+++++|.++++..  ....+++..++.++.|++.||.|||  
T Consensus        68 e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--  145 (291)
T cd06639          68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--  145 (291)
T ss_pred             HHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            44455666 799999999887632    35789999999999999998642  2456899999999999999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-----CCCcchhhHHHHHHH
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-----KASTSTDVYAFGVFM  189 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il  189 (313)
                       ..+++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+...     .++.++|+||||+++
T Consensus       146 -~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~  223 (291)
T cd06639         146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA  223 (291)
T ss_pred             -hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence             58999999999999999999999999999875433221 11234577889999987543     367899999999999


Q ss_pred             HHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       190 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |++++|+.||............       ......       ....+......+.++|.+||+.+|++||++.++++|
T Consensus       224 ~el~~g~~p~~~~~~~~~~~~~-------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         224 IELGDGDPPLFDMHPVKTLFKI-------PRNPPP-------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHhhCCCCCCCCcHHHHHHHH-------hcCCCC-------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            9999999999765443322111       010000       001122334568999999999999999999999987

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=3.2e-30  Score=225.26  Aligned_cols=211  Identities=25%  Similarity=0.379  Sum_probs=163.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+.... ++..++||||+++++|.++++..  ..+++..+..++.|++.|+.|||   ..++
T Consensus        56 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i  129 (272)
T cd06629          56 RSEIETLKDLDHLNIVQYLGFETT-EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGI  129 (272)
T ss_pred             HHHHHHHHhcCCCCcceEEEEecc-CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCe
Confidence            345677888999999999988776 67899999999999999999875  46899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGK--ASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~  196 (313)
                      +|+||+|+||+++.++.++++|||++........ .......++..|++||.+....  ++.++|+||||+++|++++|.
T Consensus       130 ~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  209 (272)
T cd06629         130 LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR  209 (272)
T ss_pred             eecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCC
Confidence            9999999999999999999999999865432111 1122345678899999987644  788999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .||............      ..     .......+.......+..+.+++..||+.+|.+|||++++++|
T Consensus       210 ~p~~~~~~~~~~~~~------~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         210 RPWSDEEAIAAMFKL------GN-----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCCcCcchHHHHHHh------hc-----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            999643332211110      00     0001111122223456788999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=239.87  Aligned_cols=208  Identities=21%  Similarity=0.309  Sum_probs=170.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+++.+.+||+++++++-+.- .+.++++.|||.||....++-.- ..++.+..|.-+++|++.||.|||   .++|+
T Consensus        78 VEIeILa~CdHP~ivkLl~ayy~-enkLwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LH---s~~iI  152 (1187)
T KOG0579|consen   78 VEIEILAECDHPVIVKLLSAYYF-ENKLWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLH---SQNII  152 (1187)
T ss_pred             hhhhhhhcCCChHHHHHHHHHhc-cCceEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHh---hcchh
Confidence            45567778899999998877765 67899999999999988887654 557999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccc-----cCCCCCcchhhHHHHHHHHHHHhC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-----RTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      |||||..|||+.-+|.++|+|||++..... .......+.||++|+|||+.     ++..|+.++||||||+++.+|..+
T Consensus       153 HRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi  231 (1187)
T KOG0579|consen  153 HRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI  231 (1187)
T ss_pred             hhhccccceEEEecCcEeeecccccccchh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence            999999999999999999999999865332 23456678999999999986     457889999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .+|....+.......+..      .       . .+.-..|...+..+.+|+..||..||..||++.|+++|-
T Consensus       232 EPPHhelnpMRVllKiaK------S-------e-PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  232 EPPHHELNPMRVLLKIAK------S-------E-PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             CCCccccchHHHHHHHhh------c-------C-CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence            999877666554433311      0       0 111123445677899999999999999999999999974

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=6.5e-30  Score=222.60  Aligned_cols=206  Identities=20%  Similarity=0.314  Sum_probs=162.0

Q ss_pred             HHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      +.+.++.+.|+++++..+.+.+. ...+++||||+++++|.+++...  ..+++..+..++.|++.||.|||   ..+++
T Consensus        54 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~  128 (265)
T cd06652          54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH---SNMIV  128 (265)
T ss_pred             HHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence            56778888999999999987643 45788999999999999999764  35889999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      |+||+|+||+++.++.++|+|||++........  .......++..|++||.+.+..++.++|+||||+++|++++|+.|
T Consensus       129 H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  208 (265)
T cd06652         129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP  208 (265)
T ss_pred             cCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence            999999999999999999999998864432111  112224577889999999888889999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |.............       .        .......+......+.+++..|+. +|++|||++++++|-
T Consensus       209 ~~~~~~~~~~~~~~-------~--------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         209 WAEFEAMAAIFKIA-------T--------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             CCccchHHHHHHHh-------c--------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence            97654332221110       0        001112344556778889999984 999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=4e-30  Score=222.51  Aligned_cols=204  Identities=25%  Similarity=0.362  Sum_probs=162.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+.... +..+++||||+++++|.+++.+.  +.+++..+..++.||+.|+.|||   ..+++
T Consensus        51 ~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  124 (258)
T cd06632          51 QEIALLSKLQHPNIVQYLGTERE-EDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTV  124 (258)
T ss_pred             HHHHHHHhcCCCCchheeeeEec-CCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45567788899999999998876 56899999999999999999864  35899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......++..|++||.+.... ++.++|+||||+++|++++|+.||
T Consensus       125 H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf  202 (258)
T cd06632         125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW  202 (258)
T ss_pred             cCCCCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence            99999999999999999999999886543322  223456788899999987666 889999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .............      ...         .....+......+.+++.+||+.+|.+|||+.++++|
T Consensus       203 ~~~~~~~~~~~~~------~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         203 SQLEGVAAVFKIG------RSK---------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ccCcHHHHHHHHH------hcc---------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            7654322111110      000         0011223345678899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2.2e-30  Score=227.40  Aligned_cols=218  Identities=22%  Similarity=0.353  Sum_probs=164.3

Q ss_pred             hHHhhhhhccccceeeeeeEEec-cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.+.|++++++.++... .+...++||||+++++|.+++... ...+++..+..++.|++.||.|||   ..++
T Consensus        55 ~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i  130 (284)
T cd05038          55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG---SQRY  130 (284)
T ss_pred             HHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            44456778899999999887764 345789999999999999999865 335999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc--cccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||.+..........  .....++..|.+||.+.+..++.++|+||||+++|+|++|..
T Consensus       131 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~  210 (284)
T cd05038         131 IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD  210 (284)
T ss_pred             ecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence            999999999999999999999999987654221111  111234556999999988888999999999999999999999


Q ss_pred             CCccCCchhhh--------hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          198 PIEQQGSMEMV--------NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       198 pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      |+.........        .............         .....+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05038         211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD  281 (284)
T ss_pred             CcccccchhccccccccccccHHHHHHHHHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence            98654322211        0000000000110         011112234467999999999999999999999999998


Q ss_pred             cc
Q 048068          270 GN  271 (313)
Q Consensus       270 ~~  271 (313)
                      ..
T Consensus       282 ~i  283 (284)
T cd05038         282 RL  283 (284)
T ss_pred             hc
Confidence            64

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=3.8e-30  Score=226.08  Aligned_cols=222  Identities=23%  Similarity=0.288  Sum_probs=164.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|.+.++.++|+++++..++..+ ++..++||||+ +++|.+++.......+++..+..++.|++.||.|||   ..++
T Consensus        46 ~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~  120 (283)
T cd07835          46 IREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRV  120 (283)
T ss_pred             HHHHHHHHhcCCCCccCHhheecc-CCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            346678889999999999999876 57899999999 569999998754456999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|++++|++|
T Consensus       121 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  199 (283)
T cd07835         121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPL  199 (283)
T ss_pred             eCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999865433221 11223457889999988654 468899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHH-----Hhhhh-----ccc--cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVS-----DCWKK-----GAI--LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~-----~~~~~-----~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |...........+....     ..|..     +..  ................+..+.+++.+||+.+|.+|||++++++
T Consensus       200 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         200 FPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            98765433222111000     00000     000  0000000001112234467889999999999999999999997


Q ss_pred             H
Q 048068          267 Y  267 (313)
Q Consensus       267 ~  267 (313)
                      |
T Consensus       280 ~  280 (283)
T cd07835         280 H  280 (283)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=5.1e-30  Score=225.94  Aligned_cols=205  Identities=20%  Similarity=0.324  Sum_probs=162.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..+.+.. ++..++|+||+++++|.+++..   ..+++..+..++.|++.|+.+||   ..+++
T Consensus        65 ~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~  137 (285)
T cd06648          65 NEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVI  137 (285)
T ss_pred             HHHHHHHHcCCCChheEEEEEEc-CCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            34566777899999999998776 6789999999999999999986   35899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||.+........ ......++..|++||.+.+..++.++|+||||+++|++++|+.||.
T Consensus       138 H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~  216 (285)
T cd06648         138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF  216 (285)
T ss_pred             cCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence            999999999999999999999998764433221 1223457889999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ............      .. .     .+...  .....+..+.+++.+||+.+|++|||+.++++|
T Consensus       217 ~~~~~~~~~~~~------~~-~-----~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         217 NEPPLQAMKRIR------DN-L-----PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCCHHHHHHHHH------hc-C-----CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            644322221110      00 0     00000  111245678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=8e-31  Score=221.11  Aligned_cols=230  Identities=23%  Similarity=0.249  Sum_probs=169.1

Q ss_pred             cCCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHh
Q 048068           35 FNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        35 ~~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      +..+.-+|...++|++|+|++.+..++...+..+++++||.+. +|..+|+-+.   .+-++...++.++.||+.|+.||
T Consensus        70 iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL  148 (438)
T KOG0666|consen   70 ISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL  148 (438)
T ss_pred             cCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH
Confidence            3445567888999999999999999999878899999999965 9999997432   35689999999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCC----CcEEEeecccccccCCCCC--CccccccccccccccccccC-CCCCcchhhHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRT-GKASTSTDVYA  184 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~----~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws  184 (313)
                      |++   =++||||||.||+|..+    |.+||+|+|+++.+..+-.  .......-|.+|+|||.+.+ ..|+.+.|+|+
T Consensus       149 H~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWA  225 (438)
T KOG0666|consen  149 HSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWA  225 (438)
T ss_pred             hhh---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHH
Confidence            964   48999999999999876    8999999999998865432  23344567999999999876 46899999999


Q ss_pred             HHHHHHHHHhCCCCCccCCchhh---hhHHHHHHHhhh------hcccccccc----------ccccCCccH--------
Q 048068          185 FGVFMLEVASGRRPIEQQGSMEM---VNLVDWVSDCWK------KGAILDASD----------SRLEGIYEE--------  237 (313)
Q Consensus       185 lG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~----------~~~~~~~~~--------  237 (313)
                      +|||+.||++.++.|.+....-.   -+..+++...+.      ...+..+..          .......+.        
T Consensus       226 iGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~  305 (438)
T KOG0666|consen  226 IGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHK  305 (438)
T ss_pred             HHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHH
Confidence            99999999999999875322211   011111111111      111100000          000000000        


Q ss_pred             --HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          238 --EQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       238 --~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                        .-.+...+|+.+||..||.+|.|++|.++|.
T Consensus       306 ~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  306 HKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             hcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence              0112367899999999999999999999964

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=5.8e-30  Score=226.21  Aligned_cols=221  Identities=21%  Similarity=0.277  Sum_probs=164.3

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...++++.|+++++..+++... .+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||   ..++
T Consensus        53 ~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i  127 (293)
T cd07843          53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWI  127 (293)
T ss_pred             HHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            466778889999999999887642 378999999996 59999987642 36999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+. .++.++|+||||+++|+|++|.+|
T Consensus       128 ~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~  206 (293)
T cd07843         128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL  206 (293)
T ss_pred             eeccCCHHHEEECCCCcEEEeecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998876544321 12234567889999988754 458899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHH-----Hhhhh---------ccccccccccccCCccHH-HHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          199 IEQQGSMEMVNLVDWVS-----DCWKK---------GAILDASDSRLEGIYEEE-QMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      |...........+....     ..|..         ..............++.. ..+.+.++|.+||+.+|++|||+.|
T Consensus       207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e  286 (293)
T cd07843         207 FPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED  286 (293)
T ss_pred             CCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence            98766544333221100     00110         000000001111112222 3667889999999999999999999


Q ss_pred             HHHH
Q 048068          264 VMQY  267 (313)
Q Consensus       264 ll~~  267 (313)
                      +++|
T Consensus       287 ll~~  290 (293)
T cd07843         287 ALKH  290 (293)
T ss_pred             HhcC
Confidence            9976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-30  Score=225.31  Aligned_cols=220  Identities=24%  Similarity=0.311  Sum_probs=165.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+++.. ++.+++||||+++ +|.+++.... ..+++..+..++.|++.||.|||   ..+++
T Consensus        47 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~  120 (283)
T cd05118          47 REIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGIL  120 (283)
T ss_pred             HHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            45567888899999999998876 5789999999964 8888887642 46999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||.+....... .......++..|++||.+.+. .++.++|+||||+++|++++|+.||
T Consensus       121 H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~  199 (283)
T cd05118         121 HRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF  199 (283)
T ss_pred             ecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999887654433 112234567789999998766 7889999999999999999999999


Q ss_pred             ccCCchhhhhHHHHH-----HHhhhhc--------cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          200 EQQGSMEMVNLVDWV-----SDCWKKG--------AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~-----~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ...+..+....+...     ...|...        ..................+..+.++|..||+.||.+||++++++.
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         200 PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            776554433222100     0000000        000000000001122345678999999999999999999999997


Q ss_pred             H
Q 048068          267 Y  267 (313)
Q Consensus       267 ~  267 (313)
                      |
T Consensus       280 ~  280 (283)
T cd05118         280 H  280 (283)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=8.5e-30  Score=220.04  Aligned_cols=206  Identities=23%  Similarity=0.392  Sum_probs=166.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+.+.+++++|+++++..+.... +...++|+|++++++|.+++....  ...+++..+..++.+++.|+.+||   ..+
T Consensus        48 ~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~  123 (258)
T cd08215          48 NEVKILKKLNHPNIIKYYESFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK  123 (258)
T ss_pred             HHHHHHHhcCCCChhheEEEEec-CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            45667788899999999998887 478999999999999999998653  367999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++.++.++|+|||++....... .......+++.|++||...+..++.++|+||+|++++++++|..|
T Consensus       124 ~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p  202 (258)
T cd08215         124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP  202 (258)
T ss_pred             EecccCChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999987654432 122334678889999998888889999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |............      ... .         ....+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       203 ~~~~~~~~~~~~~------~~~-~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         203 FEGENLLELALKI------LKG-Q---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCcHHHHHHHH------hcC-C---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            9765433222111      000 0         111222445678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=5.2e-30  Score=227.98  Aligned_cols=210  Identities=21%  Similarity=0.244  Sum_probs=160.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++.++.... ++++++||||++|++|.+++...  +.+++..+..++.|++.|+.|||   ..+++
T Consensus        50 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  123 (305)
T cd05609          50 VERDILTFAENPFVVSMFCSFET-KRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH---NYGIV  123 (305)
T ss_pred             HHHHHHHhCCCCCeeeeEEEEec-CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            44556778899999999988876 66899999999999999999764  46899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCC--------------CCccccccccccccccccccCCCCCcchhhHHHH
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDT--------------IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG  186 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  186 (313)
                      |+||+|.||+++.++.++++|||++.......              ........++..|++||.+.+..++.++|+||||
T Consensus       124 H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  203 (305)
T cd05609         124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG  203 (305)
T ss_pred             ccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHH
Confidence            99999999999999999999999875321000              0001123467789999999888889999999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      +++|++++|..||.+....+......       .+...   .+.    .....+..+.++|.+||+.||++|||+.++++
T Consensus       204 ~vl~el~~g~~pf~~~~~~~~~~~~~-------~~~~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  269 (305)
T cd05609         204 IILYEFLVGCVPFFGDTPEELFGQVI-------SDDIE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFE  269 (305)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHH-------hcccC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHH
Confidence            99999999999997654433222111       10000   000    11134567899999999999999998544444


Q ss_pred             HHhc
Q 048068          267 YLDG  270 (313)
Q Consensus       267 ~L~~  270 (313)
                      .|+.
T Consensus       270 ll~~  273 (305)
T cd05609         270 VKQH  273 (305)
T ss_pred             HHhC
Confidence            4444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4.7e-30  Score=242.76  Aligned_cols=224  Identities=18%  Similarity=0.214  Sum_probs=158.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ..|...++.++|+|+++.++++.. .+..++|++++ +++|.+++....   ........+..++.||+.||.|||   .
T Consensus       211 ~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~  285 (501)
T PHA03210        211 ENEILALGRLNHENILKIEEILRS-EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---D  285 (501)
T ss_pred             HHHHHHHHhCCCCCcCcEeEEEEE-CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---h
Confidence            456677888999999999999886 56789999999 567777775431   223446678889999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      .+|+||||||+|||++.++.++|+|||++...............|+..|++||++.+..++.++|||||||++|+|++|.
T Consensus       286 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             CCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            89999999999999999999999999999765443322333457899999999999888999999999999999999987


Q ss_pred             CC-CccCCchhhhhHHHHHHHh--hhhccc------ccccc----ccccCCc-----cHHHHHHHHHHHHHcCCCCCCCC
Q 048068          197 RP-IEQQGSMEMVNLVDWVSDC--WKKGAI------LDASD----SRLEGIY-----EEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       197 ~p-f~~~~~~~~~~~~~~~~~~--~~~~~~------~~~~~----~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      .+ +..................  ......      .+.+.    .......     .......+.+++.+||+.||++|
T Consensus       366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R  445 (501)
T PHA03210        366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR  445 (501)
T ss_pred             CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence            64 4332222111111111100  000000      00000    0000000     00123456788999999999999


Q ss_pred             CCHHHHHHHH
Q 048068          259 PNMRQVMQYL  268 (313)
Q Consensus       259 pt~~ell~~L  268 (313)
                      ||+.|+++|-
T Consensus       446 psa~elL~hp  455 (501)
T PHA03210        446 PGAAELLALP  455 (501)
T ss_pred             cCHHHHhhCh
Confidence            9999999863

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.3e-29  Score=221.32  Aligned_cols=194  Identities=23%  Similarity=0.331  Sum_probs=156.5

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcE
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV  129 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nI  129 (313)
                      +|+++++..+.+.. ++.+++||||+++++|.+++..+.  .+++..+..++.|++.|+.|||   ..+++|+||+|+||
T Consensus        67 ~h~~iv~~~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~ni  140 (267)
T PHA03390         67 DNPNFIKLYYSVTT-LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENV  140 (267)
T ss_pred             cCCCEEEEEEEEec-CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHE
Confidence            69999999999887 568999999999999999998753  6999999999999999999999   58999999999999


Q ss_pred             EEcCCC-cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhh
Q 048068          130 LLDADL-NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV  208 (313)
Q Consensus       130 lv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  208 (313)
                      +++.++ .++|+|||++......     ....++..|+|||.+.+..++.++|+||+|+++|++++|..||........ 
T Consensus       141 l~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-  214 (267)
T PHA03390        141 LYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-  214 (267)
T ss_pred             EEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-
Confidence            999988 9999999988654322     224578899999999888889999999999999999999999985543321 


Q ss_pred             hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 048068          209 NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-MRQVMQY  267 (313)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ell~~  267 (313)
                      ....+. ....           .........+..+.++|..||+.+|.+||+ ++++++|
T Consensus       215 ~~~~~~-~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        215 DLESLL-KRQQ-----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             hHHHHH-Hhhc-----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            111110 0000           001122245677899999999999999996 6999975

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=6.6e-30  Score=227.16  Aligned_cols=210  Identities=26%  Similarity=0.361  Sum_probs=164.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|++++++.++...  ...++++||+++|+|.+++... ...+++..++.++.|++.||.|||   ..+++
T Consensus        58 ~e~~~~~~l~h~niv~~~~~~~~--~~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~iv  131 (303)
T cd05110          58 DEALIMASMDHPHLVRLLGVCLS--PTIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE---ERRLV  131 (303)
T ss_pred             HHHHHHHhCCCCCcccEEEEEcC--CCceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh---hcCee
Confidence            45567788899999999998864  3467999999999999999765 335899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      |+||+|+||+++.++.++|+|||++......... ......++..|++||.+.+..++.++||||||+++|++++ |..|
T Consensus       132 H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p  211 (303)
T cd05110         132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP  211 (303)
T ss_pred             ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998754322211 1112234668999999988889999999999999999997 8999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      |.+.........+.       .+..       .+  .+......+.+++..||..+|++|||++++++.|+...
T Consensus       212 ~~~~~~~~~~~~~~-------~~~~-------~~--~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         212 YDGIPTREIPDLLE-------KGER-------LP--QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             CCCCCHHHHHHHHH-------CCCC-------CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            97655433222221       1110       00  11123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=9.1e-30  Score=228.78  Aligned_cols=224  Identities=19%  Similarity=0.230  Sum_probs=160.8

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...++.++|+++++.++++.. ++..++||||+.+++|.+++.......+++..+..++.|++.||+|||   +.+++|
T Consensus        49 e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH  124 (328)
T cd08226          49 EVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIH  124 (328)
T ss_pred             HHHHHHhCCCCCcceEeeeEec-CCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence            3344455799999999999987 568999999999999999998765556999999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCC------ccccccccccccccccccCC--CCCcchhhHHHHHHHHHHH
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIP------QTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll  193 (313)
                      +||||+||+++.++.++++||+...........      ......++..|++||++.+.  .++.++|+|||||++|+++
T Consensus       125 rDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~  204 (328)
T cd08226         125 RNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA  204 (328)
T ss_pred             CCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999998754322111000      00111235569999998763  4688999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHH---------------------hhhh---------ccccccccccccCCccHHHHHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSD---------------------CWKK---------GAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~---------------------~~~~---------~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      +|..||.................                     .+..         ......................+
T Consensus       205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (328)
T cd08226         205 TGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF  284 (328)
T ss_pred             hCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence            99999976554322211100000                     0000         00000011111112234466789


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      .+|+.+||..||++|||+.++++|-.
T Consensus       285 ~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         285 QNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhCHH
Confidence            99999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=222.10  Aligned_cols=205  Identities=24%  Similarity=0.416  Sum_probs=160.3

Q ss_pred             hHHhhhhhcc---ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           41 LQRDGLASVH---SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        41 ~~~~~l~~~~---~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      .+...++.+.   |+++++..+.+.. +..+++||||+++++|.++++..   .+++..++.++.|++.++.|||   ..
T Consensus        48 ~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~  120 (277)
T cd06917          48 REVALLSQLRQSQPPNITKYYGSYLK-GPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KV  120 (277)
T ss_pred             HHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            3445566665   9999999988765 67899999999999999998753   5899999999999999999999   68


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+ ..++.++|+||||+++|+|++|.
T Consensus       121 ~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~  199 (277)
T cd06917         121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN  199 (277)
T ss_pred             CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999987654332 12233467888999998864 45688999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .||............            .....+...   .......+.+++..||+.||++|||+.+++++-
T Consensus       200 ~p~~~~~~~~~~~~~------------~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~  256 (277)
T cd06917         200 PPYSDVDAFRAMMLI------------PKSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKSK  256 (277)
T ss_pred             CCCCCCChhhhhhcc------------ccCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence            999765432221111            000001111   111456788999999999999999999999854

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.3e-29  Score=220.27  Aligned_cols=208  Identities=26%  Similarity=0.392  Sum_probs=161.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+.... .+.+++|+||+++++|.+++...  ..+++..+..++.|++.|+.|||   +.+++
T Consensus        48 ~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~  121 (264)
T cd06626          48 DEMKVLELLKHPNLVKYYGVEVH-REKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH---SHGIV  121 (264)
T ss_pred             HHHHHHHhCCCCChhheeeeEec-CCEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45567778899999999988765 67899999999999999999864  35889999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc---ccccccccccccccccCCC---CCcchhhHHHHHHHHHHHh
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---TKLVGTFGYMAPELMRTGK---ASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~  194 (313)
                      |+||+|+||+++.++.++|+|||++...........   ....++..|++||.+.+..   ++.++|+||||+++|++++
T Consensus       122 H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~  201 (264)
T cd06626         122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT  201 (264)
T ss_pred             cCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence            999999999999999999999999876543322111   1245678899999987665   7889999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |+.||.............  .    .+     ..+..+  ........+.+++.+||+.+|.+|||+.++++|
T Consensus       202 g~~pf~~~~~~~~~~~~~--~----~~-----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         202 GKRPWSELDNEFQIMFHV--G----AG-----HKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCCccCCcchHHHHHHH--h----cC-----CCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            999997554322111110  0    00     001111  111235667899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=260.84  Aligned_cols=217  Identities=24%  Similarity=0.317  Sum_probs=174.4

Q ss_pred             cccCCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           33 HGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        33 ~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      ++.-....+|...+.-++|||+++++++-.+ +..++|-||||++|+|.+.++..  .-.++.....+..|++.|++|||
T Consensus      1275 ~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH 1351 (1509)
T KOG4645|consen 1275 HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLH 1351 (1509)
T ss_pred             cccCcchHHHHHHHHhccCccccccCceeec-HHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHH
Confidence            4444555678889999999999999998876 66889999999999999999863  34777777888999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC---CCccccccccccccccccccC---CCCCcchhhHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLVGTFGYMAPELMRT---GKASTSTDVYAFG  186 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG  186 (313)
                         +.||+||||||.||+++.+|.+|++|||.+.......   ........||+.|+|||++.+   .+...+.||||||
T Consensus      1352 ---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslG 1428 (1509)
T KOG4645|consen 1352 ---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLG 1428 (1509)
T ss_pred             ---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhccc
Confidence               6999999999999999999999999999997664332   123345689999999999964   4467789999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |++.||+||+.||...+..-.+..-        .+.       .-....|...+..-++|+..||..||++|.++.|+++
T Consensus      1429 CVVlEM~tGkrPW~~~dne~aIMy~--------V~~-------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1429 CVVLEMATGKRPWAELDNEWAIMYH--------VAA-------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ceEEEeecCCCchhhccchhHHHhH--------Hhc-------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            9999999999999876654322111        000       1112245557888899999999999999999999998


Q ss_pred             HHhc
Q 048068          267 YLDG  270 (313)
Q Consensus       267 ~L~~  270 (313)
                      |-=+
T Consensus      1494 ~~f~ 1497 (1509)
T KOG4645|consen 1494 HAFG 1497 (1509)
T ss_pred             hhcc
Confidence            7533

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=240.28  Aligned_cols=232  Identities=23%  Similarity=0.326  Sum_probs=181.4

Q ss_pred             ceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           28 NQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        28 ~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ..+++|.+..        +...|...+.+++|||++++.++... ++.+|+||||+++|+|.+++..+......-.....
T Consensus       563 lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vs  641 (807)
T KOG1094|consen  563 LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVS  641 (807)
T ss_pred             eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHHHHHHhcCcHHHHHHhccCcccccchhHH
Confidence            3567777754        22345556666789999999888876 56899999999999999999876444455566677


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCc
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKAST  178 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  178 (313)
                      ++.||++|++||.+   .+++|||+.+.|+|++.++.+||+|||+++..-...-. ..+.......|+|+|.+.-++++.
T Consensus       642 i~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFtt  718 (807)
T KOG1094|consen  642 ICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTT  718 (807)
T ss_pred             HHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccc
Confidence            99999999999995   89999999999999999999999999999744332222 233445678899999999999999


Q ss_pred             chhhHHHHHHHHHHHh--CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          179 STDVYAFGVFMLEVAS--GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       179 ~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      ++|+|+||+++||+++  .+.||....+++......         ..........-...|..++..+.++|..||..+-.
T Consensus       719 aSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~---------~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~  789 (807)
T KOG1094|consen  719 ASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG---------EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESE  789 (807)
T ss_pred             hhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh---------hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhh
Confidence            9999999999999977  778998877776554332         11111222222335667788899999999999999


Q ss_pred             CCCCHHHHHHHHhccC
Q 048068          257 ARPNMRQVMQYLDGNA  272 (313)
Q Consensus       257 ~Rpt~~ell~~L~~~~  272 (313)
                      +|||++++..+|.+..
T Consensus       790 ~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  790 QRPSFEQLHLFLQEDA  805 (807)
T ss_pred             cCCCHHHHHHHHHHhc
Confidence            9999999999998753

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=1.3e-29  Score=217.97  Aligned_cols=220  Identities=24%  Similarity=0.351  Sum_probs=171.4

Q ss_pred             cceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           27 VNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        27 ~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ...++++.+...       ...+...++.+.|+++++..+.+.. ++..++++||+++++|.+++... ...+++..+..
T Consensus        25 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~  102 (253)
T cd05122          25 GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFCSGGSLKDLLKST-NQTLTESQIAY  102 (253)
T ss_pred             CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecCCCCcHHHHHhhc-CCCCCHHHHHH
Confidence            344555555332       3345567778899999999998876 57899999999999999999875 25699999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcc
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS  179 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  179 (313)
                      ++.|++.++.+||   ..+++|+||+|+||+++.++.++|+|||.+........  .....++..|++||.+.+..++.+
T Consensus       103 i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~  177 (253)
T cd05122         103 VCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYK  177 (253)
T ss_pred             HHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCcc
Confidence            9999999999999   69999999999999999999999999998876544321  334567889999999988888999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          180 TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       180 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +|+||||+++|++++|..||.............   .   . .       ..........+..+.+++..||+.||++||
T Consensus       178 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~---~-~-------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  243 (253)
T cd05122         178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T---N-G-------PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP  243 (253)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h---c-C-------CCCcCcccccCHHHHHHHHHHccCChhhCC
Confidence            999999999999999999997654322221110   0   0 0       000001111256789999999999999999


Q ss_pred             CHHHHHHH
Q 048068          260 NMRQVMQY  267 (313)
Q Consensus       260 t~~ell~~  267 (313)
                      |+.++++|
T Consensus       244 t~~~~l~~  251 (253)
T cd05122         244 TAEQLLKH  251 (253)
T ss_pred             CHHHHhcC
Confidence            99999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=1.2e-29  Score=220.18  Aligned_cols=207  Identities=27%  Similarity=0.424  Sum_probs=165.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE-QVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~-~~i  119 (313)
                      .+...+..++|+++++..+.... ++.+++||||+++++|.+++...  ..+++..++.++.|++.|+.|||   . .++
T Consensus        48 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~  121 (264)
T cd06623          48 RELKTLRSCESPYVVKCYGAFYK-EGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHI  121 (264)
T ss_pred             HHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCC
Confidence            34455667789999999998876 57899999999999999999864  46999999999999999999999   6 899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|..||
T Consensus       122 ~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~  200 (264)
T cd06623         122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF  200 (264)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCccceecccCCC-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999876543332 122345788899999998888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE-QMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...............   ...          .....+.. .+..+.+++..||+.+|++|||+.+++++
T Consensus       201 ~~~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         201 LPPGQPSFFELMQAI---CDG----------PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ccccccCHHHHHHHH---hcC----------CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            876532222212111   110          00112222 56789999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=8.1e-30  Score=227.12  Aligned_cols=224  Identities=25%  Similarity=0.295  Sum_probs=165.0

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...+++++|+++++..+++... .+.+++||||+. ++|.+++... ...+++..++.++.||+.|+.|||   ..++
T Consensus        55 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i  129 (309)
T cd07845          55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH---ENFI  129 (309)
T ss_pred             HHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            466788999999999999988743 357899999995 5898888764 356999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|++++|++|
T Consensus       130 ~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~  208 (309)
T cd07845         130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL  208 (309)
T ss_pred             ecCCCCHHHEEECCCCCEEECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999876543321 1122234678999998865 4578999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHH-----hhhhcccccc-ccccccC-------CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSD-----CWKKGAILDA-SDSRLEG-------IYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      |...+..+....+.....     .|........ .......       ......+..+.++|.+||+.||++|||+++++
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il  288 (309)
T cd07845         209 LPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL  288 (309)
T ss_pred             CCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            987665544433321110     1100000000 0000000       00011356678999999999999999999999


Q ss_pred             HHHhc
Q 048068          266 QYLDG  270 (313)
Q Consensus       266 ~~L~~  270 (313)
                      +|-.=
T Consensus       289 ~h~~f  293 (309)
T cd07845         289 ESSYF  293 (309)
T ss_pred             cChhh
Confidence            97543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-30  Score=221.08  Aligned_cols=197  Identities=25%  Similarity=0.281  Sum_probs=156.3

Q ss_pred             hhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCC
Q 048068           47 ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP  126 (313)
Q Consensus        47 ~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~  126 (313)
                      ....|+++++.++.+.. ++.+++||||+++++|.+++...  ..+++..+..++.|++.||.|||   ..+++|+||+|
T Consensus        52 ~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p  125 (260)
T cd05611          52 IQGESPYVAKLYYSFQS-KDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKP  125 (260)
T ss_pred             hcCCCCCeeeeeeeEEc-CCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence            44589999999998876 67899999999999999999764  35899999999999999999999   58999999999


Q ss_pred             CcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchh
Q 048068          127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME  206 (313)
Q Consensus       127 ~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  206 (313)
                      +||+++.++.++|+|||++.....     .....++..|++||...+..++.++|+||||+++|++++|..||.......
T Consensus       126 ~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  200 (260)
T cd05611         126 ENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA  200 (260)
T ss_pred             HHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            999999999999999998864332     223456788999999988778999999999999999999999997655443


Q ss_pred             hhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Q 048068          207 MVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR---QVMQY  267 (313)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~---ell~~  267 (313)
                      ......       ....      ..+.......+..+.+++.+||+.||++|||+.   |++.|
T Consensus       201 ~~~~~~-------~~~~------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         201 VFDNIL-------SRRI------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             HHHHHH-------hccc------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            322221       0000      011112223457789999999999999999664   55544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=4.7e-30  Score=222.08  Aligned_cols=206  Identities=22%  Similarity=0.335  Sum_probs=164.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.++.++|+++++..+.+.. ++..++|+||+++++|.+++.......+++..+..++.|++.|+.|||   ..+++
T Consensus        48 ~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~  123 (257)
T cd08225          48 KEVILLAKMKHPNIVTFFASFQE-NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKIL  123 (257)
T ss_pred             HHHHHHHhCCCCChhhhhheecc-CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45667788899999999998876 678999999999999999998754556899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCC-cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++ .++++|||.+........ ......++..|.+||...+..++.++|+||||++++++++|..||
T Consensus       124 H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  202 (257)
T cd08225         124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF  202 (257)
T ss_pred             cccCCHHHEEEcCCCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999998875 469999998865543221 122345788899999998888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ............      ... .         ........+..+.+++.+||..+|++|||+.++++|
T Consensus       203 ~~~~~~~~~~~~------~~~-~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         203 EGNNLHQLVLKI------CQG-Y---------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCccHHHHHHHH------hcc-c---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            755433221111      110 0         011122345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=4.5e-30  Score=250.83  Aligned_cols=213  Identities=23%  Similarity=0.297  Sum_probs=161.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---------KPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      .+.+.++.++|+++++.+++..+ ++..++||||++|++|.+++....         ....+...+..++.||+.||.||
T Consensus        51 rEi~ILs~L~HPNIVkl~~v~~d-~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL  129 (932)
T PRK13184         51 REAKIAADLIHPGIVPVYSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV  129 (932)
T ss_pred             HHHHHHHhCCCcCcCeEEEEEee-CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH
Confidence            45567778899999999988876 678999999999999999986421         22356677899999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-----------------CCccccccccccccccccccCC
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-----------------IPQTTKLVGTFGYMAPELMRTG  174 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~~~y~aPE~~~~~  174 (313)
                      |   ..+++||||||+||+++.++.++|+|||++.......                 ........||+.|+|||.+.+.
T Consensus       130 H---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~  206 (932)
T PRK13184        130 H---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV  206 (932)
T ss_pred             H---HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC
Confidence            9   5899999999999999999999999999987552110                 0011234689999999999988


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCC
Q 048068          175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPK  254 (313)
Q Consensus       175 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  254 (313)
                      .++.++|+|||||++|+|++|..||............          .........    .....+..+.+++.+||+.|
T Consensus       207 ~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~----------~i~~P~~~~----p~~~iP~~L~~LI~rcL~~D  272 (932)
T PRK13184        207 PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD----------VILSPIEVA----PYREIPPFLSQIAMKALAVD  272 (932)
T ss_pred             CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhh----------hccChhhcc----ccccCCHHHHHHHHHHccCC
Confidence            8999999999999999999999999764432221110          000000000    01234466889999999999


Q ss_pred             CCCCC-CHHHHHHHHhcc
Q 048068          255 PEARP-NMRQVMQYLDGN  271 (313)
Q Consensus       255 P~~Rp-t~~ell~~L~~~  271 (313)
                      |++|| +++++++.|+..
T Consensus       273 P~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        273 PAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hhhCcCHHHHHHHHHHHH
Confidence            99996 667777777655

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=2.6e-29  Score=219.61  Aligned_cols=212  Identities=23%  Similarity=0.354  Sum_probs=162.2

Q ss_pred             hHHhhhhhccccceeeeeeEEecc--C---CeEEEEEecCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR--K---GEFLLVYDYMPNGSLDKILHTNI----KPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~--~---~~~~lV~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      .+.+.+++++|+++++.+++....  .   ...+++++|+.+++|.+++....    ...++...+..++.|++.|+.||
T Consensus        50 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l  129 (273)
T cd05074          50 REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL  129 (273)
T ss_pred             HHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            456778889999999999977632  1   13478999999999998875321    12478899999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML  190 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  190 (313)
                      |   ..+++|+||+|+||+++.++.++++|||++......... ......++..|++||.+....++.++|+||||+++|
T Consensus       130 H---~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~  206 (273)
T cd05074         130 S---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW  206 (273)
T ss_pred             H---hCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHH
Confidence            9   589999999999999999999999999988754322111 111223456799999998888899999999999999


Q ss_pred             HHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          191 EVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       191 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ++++ |.+||...+..+......       ...     ...    .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       207 el~~~g~~p~~~~~~~~~~~~~~-------~~~-----~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~  270 (273)
T cd05074         207 EIMTRGQTPYAGVENSEIYNYLI-------KGN-----RLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE  270 (273)
T ss_pred             HHhhCCCCCCCCCCHHHHHHHHH-------cCC-----cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999 889987655433222211       000     000    11234567999999999999999999999999998


Q ss_pred             cc
Q 048068          270 GN  271 (313)
Q Consensus       270 ~~  271 (313)
                      +.
T Consensus       271 ~~  272 (273)
T cd05074         271 LI  272 (273)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=1.4e-29  Score=229.79  Aligned_cols=218  Identities=20%  Similarity=0.211  Sum_probs=161.9

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.++|++++++.+++...     ..+.|+||||+. ++|.+.+...    ++...+..++.|++.||.|||   
T Consensus        64 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---  135 (353)
T cd07850          64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---  135 (353)
T ss_pred             HHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---
Confidence            356677888999999999887632     246799999995 5888888653    889999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ..+++|+||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus       136 ~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g  213 (353)
T cd07850         136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG  213 (353)
T ss_pred             hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHC
Confidence            5899999999999999999999999999987544322  12234568889999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHH------------HHhhh----hccc----------cccccccccCCccHHHHHHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWV------------SDCWK----KGAI----------LDASDSRLEGIYEEEQMELVLKLGLF  249 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~------------~~~~~----~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~  249 (313)
                      +.||...+.......+...            .....    ....          .....+.............+.++|.+
T Consensus       214 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  293 (353)
T cd07850         214 TVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK  293 (353)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHH
Confidence            9999766543332221100            00000    0000          00000000001122345678999999


Q ss_pred             cCCCCCCCCCCHHHHHHHH
Q 048068          250 CSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       250 cl~~~P~~Rpt~~ell~~L  268 (313)
                      ||+.||.+|||+.|+++|-
T Consensus       294 ~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         294 MLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HcCCChhhCcCHHHHhcCh
Confidence            9999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-29  Score=222.32  Aligned_cols=222  Identities=25%  Similarity=0.355  Sum_probs=163.8

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.+.|++++++.+++... ++..++||||++ ++|.+++... ...+++..++.++.||+.|++|||   ..++
T Consensus        47 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~~  121 (287)
T cd07840          47 REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLH---SNGI  121 (287)
T ss_pred             HHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            455678888999999999998864 378999999996 5898888764 246999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++...............++..|++||.+.+ ..++.++|+||||+++|++++|+.|
T Consensus       122 ~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p  201 (287)
T cd07840         122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI  201 (287)
T ss_pred             eeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987554432212223355778999997764 4578999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHH-----Hhhhhcc---------ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          199 IEQQGSMEMVNLVDWVS-----DCWKKGA---------ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      |...........+....     ..|....         ................++..+.+++.+||..+|.+|||++++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  281 (287)
T cd07840         202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA  281 (287)
T ss_pred             CCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            98766543332221110     0010000         000000000001111125678999999999999999999999


Q ss_pred             HHH
Q 048068          265 MQY  267 (313)
Q Consensus       265 l~~  267 (313)
                      +++
T Consensus       282 l~~  284 (287)
T cd07840         282 LQH  284 (287)
T ss_pred             hhC
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-31  Score=226.24  Aligned_cols=226  Identities=19%  Similarity=0.301  Sum_probs=169.3

Q ss_pred             EcccCCChhhHHhhhhhcccc---ceee---eeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHH
Q 048068           32 YHGFNEDPQLQRDGLASVHSN---GLLQ---LTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA  105 (313)
Q Consensus        32 ~~~~~~~~~~~~~~l~~~~~~---~~l~---~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~  105 (313)
                      +.++.+....|.+.++.+...   +..+   ..+++ +..++.|+|+|.+ |.++.++++.++-.+++...+..+.+|++
T Consensus       125 V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~  202 (415)
T KOG0671|consen  125 VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLL  202 (415)
T ss_pred             HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHH
Confidence            334556666677777776322   2222   22223 5588999999999 88999999998777899999999999999


Q ss_pred             HHHHHhhhcCCCCceecCcCCCcEEEcC--------------------CCcEEEeecccccccCCCCCCccccccccccc
Q 048068          106 SGLLYLHEDWEQVVLHRDIKPANVLLDA--------------------DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY  165 (313)
Q Consensus       106 ~al~~lhs~~~~~i~H~dl~~~nIlv~~--------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y  165 (313)
                      .++++||   +.+++|.||||+||++-.                    +..++++|||.+.+.....    .....|..|
T Consensus       203 ~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHY  275 (415)
T KOG0671|consen  203 ESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHY  275 (415)
T ss_pred             HHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeecccc
Confidence            9999999   699999999999999932                    3347899999987654433    445779999


Q ss_pred             cccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhh--------------hhccccccccccc
Q 048068          166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCW--------------KKGAILDASDSRL  231 (313)
Q Consensus       166 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~  231 (313)
                      +|||++.+-+|+..+||||+||||+|+.+|...|.++++.+.....+.+.+-.              ..+ ..+......
T Consensus       276 RAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~  354 (415)
T KOG0671|consen  276 RAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSS  354 (415)
T ss_pred             CCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccc
Confidence            99999999999999999999999999999999999998777554443322110              011 000000000


Q ss_pred             cC----------------CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          232 EG----------------IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       232 ~~----------------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+                .....+...+.+|+.+||..||.+|+|+.|+++|
T Consensus       355 ~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  355 KGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             cccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence            00                1122345679999999999999999999999987

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.8e-29  Score=222.29  Aligned_cols=209  Identities=27%  Similarity=0.387  Sum_probs=165.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+.+.. ++..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||   ..++
T Consensus        63 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi  137 (286)
T cd06614          63 INEILIMKDCKHPNIVDYYDSYLV-GDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNV  137 (286)
T ss_pred             HHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            345567788899999999988876 578999999999999999998752 36999999999999999999999   5999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|..||
T Consensus       138 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~  216 (286)
T cd06614         138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY  216 (286)
T ss_pred             eeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764432211 122335678899999998888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ...........+.       ....       .........+..+.++|.+||+.+|.+|||+.+++++.
T Consensus       217 ~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         217 LREPPLRALFLIT-------TKGI-------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             CCCCHHHHHHHHH-------hcCC-------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            7654432221110       0000       00111222456789999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=2.2e-29  Score=220.80  Aligned_cols=203  Identities=26%  Similarity=0.411  Sum_probs=163.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+.+.. +...++||||+++++|.+++...   .+++..+..++.|++.++.+||   ..+++
T Consensus        51 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~  123 (277)
T cd06641          51 QEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKI  123 (277)
T ss_pred             HHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCee
Confidence            45567778899999999998876 66899999999999999998743   5899999999999999999999   69999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|..||.
T Consensus       124 h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  202 (277)
T cd06641         124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS  202 (277)
T ss_pred             cCCCCHHhEEECCCCCEEEeecccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999998865433221 1223456788999999988888999999999999999999999997


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..........+.       ..         .........+..+.+++..||+.+|.+||++.++++|
T Consensus       203 ~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         203 ELHPMKVLFLIP-------KN---------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccchHHHHHHHh-------cC---------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            654332221110       00         0111222345678899999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=1.3e-29  Score=219.04  Aligned_cols=204  Identities=25%  Similarity=0.375  Sum_probs=165.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+.+.++.++|++++++.+++.. +...++||||+++++|.+++.+..  ...+++..++.++.|++.|+.|||   ..+
T Consensus        48 ~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~  123 (256)
T cd08530          48 NEIRILASVNHPNIISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK  123 (256)
T ss_pred             HHHHHHHhCCCCCchhhhhhhcc-CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCC
Confidence            34466788899999999888876 578999999999999999987621  346899999999999999999999   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++.++.++++|||++......   ......++..|++||.+.+..++.++|+||||+++|++++|+.|
T Consensus       124 i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p  200 (256)
T cd08530         124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP  200 (256)
T ss_pred             cccCCCCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765443   12234567889999999888889999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |...+........       ..         ......+......+.+++..||..+|++|||+.++++|
T Consensus       201 ~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         201 FEARSMQDLRYKV-------QR---------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCCHHHHHHHH-------hc---------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            9766543322111       01         11111233566779999999999999999999999987

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.9e-30  Score=234.04  Aligned_cols=231  Identities=22%  Similarity=0.305  Sum_probs=167.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      .+...++.++|++++++.+++....    ...++||||+ +++|.+++...  ..+++..++.++.|++.||.|||   .
T Consensus        53 ~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~  126 (337)
T cd07858          53 REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---S  126 (337)
T ss_pred             HHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---h
Confidence            3556778889999999988776322    4689999999 57899888763  46999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g  195 (313)
                      .+++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.. ..++.++|+|||||++|++++|
T Consensus       127 ~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  205 (337)
T cd07858         127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR  205 (337)
T ss_pred             CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcC
Confidence            899999999999999999999999999987554322 12223456888999998764 4688999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHh-----hh---hcc-------ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDC-----WK---KGA-------ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~-----~~---~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      ++||.+.+.......+......     +.   ...       ......... .......+..+.++|.+||+.+|++|||
T Consensus       206 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps  284 (337)
T cd07858         206 KPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRIT  284 (337)
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccC
Confidence            9999765443322222111000     00   000       000000000 0111234567899999999999999999


Q ss_pred             HHHHHHH--HhccCCCCCCCC
Q 048068          261 MRQVMQY--LDGNATLPDIPR  279 (313)
Q Consensus       261 ~~ell~~--L~~~~~~~~~~~  279 (313)
                      ++++++|  +.........|.
T Consensus       285 ~~ell~h~~~~~~~~~~~~~~  305 (337)
T cd07858         285 VEEALAHPYLASLHDPSDEPV  305 (337)
T ss_pred             HHHHHcCcchhhhcCcccCcc
Confidence            9999998  666554444443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=4.3e-30  Score=222.75  Aligned_cols=205  Identities=26%  Similarity=0.300  Sum_probs=163.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++....+.. +...++|+||+++++|.+++...  ..+++..+..++.|++.||.|||   ..+++
T Consensus        49 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~  122 (258)
T cd05578          49 NERRILQELNHPFLVNLWYSFQD-EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGII  122 (258)
T ss_pred             HHHHHHHhCCCCChHHHHHhhcC-CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            44566778899999998888765 67899999999999999999864  46999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......++..|++||.+.+..++.++|+||||+++|++++|..||.
T Consensus       123 h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  200 (258)
T cd05578         123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR  200 (258)
T ss_pred             ccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCC
Confidence            99999999999999999999999887554332  2233457788999999988888999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM--RQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~--~ell~~  267 (313)
                      ..............    ..          .....+...+..+.++|.+||+.||.+||++  +++++|
T Consensus       201 ~~~~~~~~~~~~~~----~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         201 GHSRTIRDQIRAKQ----ET----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             CCCccHHHHHHHHh----cc----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            66543111111100    00          1111333445788999999999999999999  777653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=235.46  Aligned_cols=211  Identities=23%  Similarity=0.346  Sum_probs=180.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++.++||+|+++.+++.+  ...++|||.++.|-|..+++.+ +..++......+++||..||.||||   +.++
T Consensus       440 qEa~iMrnfdHphIikLIGv~~e--~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeS---krfV  513 (974)
T KOG4257|consen  440 QEASIMRNFDHPHIIKLIGVCVE--QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLES---KRFV  513 (974)
T ss_pred             HHHHHHHhCCCcchhheeeeeec--cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHh---hchh
Confidence            44566788899999999999985  5799999999999999999987 4569999999999999999999995   8999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      ||||-..||||.....+||+|||+++......-...........|++||-+.-..++.++|||-||+++||++. |.-||
T Consensus       514 HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPf  593 (974)
T KOG4257|consen  514 HRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPF  593 (974)
T ss_pred             hhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcc
Confidence            99999999999999999999999998776655444444445678999999998999999999999999999998 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      .+-...+.+..++       +         .-+...|+.+++.+..|+.+||+.+|.+||++.++...|++...
T Consensus       594 qgvkNsDVI~~iE-------n---------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  594 QGVKNSDVIGHIE-------N---------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ccccccceEEEec-------C---------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            9877776654442       1         12223677888999999999999999999999999988776543

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=2.8e-29  Score=223.47  Aligned_cols=203  Identities=25%  Similarity=0.367  Sum_probs=160.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.. ++..++||||+. |+|.+.+... ...+++..+..++.|++.||.|||   ..+++
T Consensus        64 ~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~  137 (307)
T cd06607          64 KEVRFLQQLRHPNTIEYKGCYLR-EHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH---SHERI  137 (307)
T ss_pred             HHHHHHHhCCCCCEEEEEEEEEe-CCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCce
Confidence            45567788899999999999886 567899999995 5777777643 346999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++......     ....++..|++||.+.   ...++.++|+||||+++|++++|+.
T Consensus       138 H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~  212 (307)
T cd06607         138 HRDIKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  212 (307)
T ss_pred             ecCCCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCC
Confidence            9999999999999999999999988643322     2345678899999874   3567889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ||...........+.      ..         ..+.......+..+.+++..||..+|++|||+.++++|..
T Consensus       213 p~~~~~~~~~~~~~~------~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         213 PLFNMNAMSALYHIA------QN---------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             CCCCccHHHHHHHHh------cC---------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            997655433222111      00         0011112235567999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=2.5e-29  Score=222.23  Aligned_cols=222  Identities=22%  Similarity=0.288  Sum_probs=162.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+.... +..+++||||++ ++|.+.+.......+++..++.++.||+.||.|||   ..++
T Consensus        49 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i  123 (294)
T PLN00009         49 IREISLLKEMQHGNIVRLQDVVHS-EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRV  123 (294)
T ss_pred             HHHHHHHHhccCCCEeeEEEEEec-CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            356678889999999999999886 568999999995 58888886654445789999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++. ++.++|+|||++........ ......++..|++||.+.+ ..++.++|+||||+++|++++|..
T Consensus       124 ~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~  202 (294)
T PLN00009        124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP  202 (294)
T ss_pred             eCCCCCcceEEEECCCCEEEEcccccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999985 45799999999875443221 1223456788999998865 357889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHH-----HHhhhhcc-ccccc------cccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWV-----SDCWKKGA-ILDAS------DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      ||......+........     ...|.... .....      ............++.+.+++.+||+.+|++||++.+++
T Consensus       203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l  282 (294)
T PLN00009        203 LFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL  282 (294)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence            99876554333222110     00111000 00000      00000001123346688999999999999999999999


Q ss_pred             HH
Q 048068          266 QY  267 (313)
Q Consensus       266 ~~  267 (313)
                      +|
T Consensus       283 ~~  284 (294)
T PLN00009        283 EH  284 (294)
T ss_pred             cC
Confidence            85

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=9.8e-30  Score=218.17  Aligned_cols=210  Identities=18%  Similarity=0.156  Sum_probs=160.4

Q ss_pred             cceEEEcccCCCh--hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHH
Q 048068           27 VNQFIYHGFNEDP--QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGV  104 (313)
Q Consensus        27 ~~~~~~~~~~~~~--~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi  104 (313)
                      ...++.|.+....  ..+...+....|++++++.+.... +...++||||+++++|.+++...  ..+++..+..++.|+
T Consensus        18 ~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql   94 (237)
T cd05576          18 QQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEM   94 (237)
T ss_pred             CcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHH
Confidence            3456666665422  223333344568999999998876 57899999999999999998764  358999999999999


Q ss_pred             HHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHH
Q 048068          105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA  184 (313)
Q Consensus       105 ~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  184 (313)
                      +.||.|||   +.+++|+||||+||+++.++.++++|||.+.......    ....++..|++||.+.+..++.++|+||
T Consensus        95 ~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dvws  167 (237)
T cd05576          95 VVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGISEETEACDWWS  167 (237)
T ss_pred             HHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCcccCCCCCCchhhHHH
Confidence            99999999   6899999999999999999999999999875443221    1234466799999998888899999999


Q ss_pred             HHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH---
Q 048068          185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM---  261 (313)
Q Consensus       185 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~---  261 (313)
                      +|+++|++++|..|+.........                     ......+...+..+.+++.+||+.||++|||+   
T Consensus       168 lG~il~el~~g~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         168 LGAILFELLTGKTLVECHPSGINT---------------------HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHHHHHHHHHCcchhhcCchhccc---------------------ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence            999999999999887543211000                     00001223345678899999999999999986   


Q ss_pred             --HHHHHH
Q 048068          262 --RQVMQY  267 (313)
Q Consensus       262 --~ell~~  267 (313)
                        +++++|
T Consensus       227 ~~~~~~~h  234 (237)
T cd05576         227 GVEDIKSH  234 (237)
T ss_pred             chHHHHcC
Confidence              666654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=2.1e-29  Score=221.11  Aligned_cols=218  Identities=22%  Similarity=0.231  Sum_probs=158.3

Q ss_pred             HHhhhhhc-cccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           42 QRDGLASV-HSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      +...+..+ .|+++++..+++.+. .+.+++||||++ ++|.+.+... ...+++..++.++.|++.||.|||   ..++
T Consensus        47 e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~i  121 (282)
T cd07831          47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMH---RNGI  121 (282)
T ss_pred             HHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            33445555 499999999998863 268999999996 5888888754 346899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++. +.++|+|||++........  .....++..|++||.+.. ..++.++|+|||||++|+|++|..|
T Consensus       122 ~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p  198 (282)
T cd07831         122 FHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL  198 (282)
T ss_pred             eecccCHHHEEEcC-CCeEEEecccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence            99999999999999 9999999999875533221  122456789999997654 4568899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHH----Hhhhhc-cccccccccccC-------CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVS----DCWKKG-AILDASDSRLEG-------IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |.+.+..+....+....    ..+... ..........+.       ......+..+.++|.+||+.+|++|||++++++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            98765443322221100    000000 000000000000       011234688999999999999999999999998


Q ss_pred             H
Q 048068          267 Y  267 (313)
Q Consensus       267 ~  267 (313)
                      |
T Consensus       279 ~  279 (282)
T cd07831         279 H  279 (282)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=3.1e-29  Score=255.13  Aligned_cols=234  Identities=24%  Similarity=0.466  Sum_probs=174.5

Q ss_pred             cceEEEcccCC---ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Q 048068           27 VNQFIYHGFNE---DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG  103 (313)
Q Consensus        27 ~~~~~~~~~~~---~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~q  103 (313)
                      ...+++|.+..   ....+.+.+++++|+++++.+++..+ ++..++||||+++|+|.++++.     +++..+..++.|
T Consensus       715 ~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~  788 (968)
T PLN00113        715 GMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIG  788 (968)
T ss_pred             CcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHH
Confidence            44666666643   22345677889999999999999986 5678999999999999999963     889999999999


Q ss_pred             HHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhH
Q 048068          104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY  183 (313)
Q Consensus       104 i~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  183 (313)
                      ++.|++|||+.+..+++|||+||+||+++.++..++. ++......     ......++..|+|||++.+..++.++|||
T Consensus       789 ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~  862 (968)
T PLN00113        789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----TDTKCFISSAYVAPETRETKDITEKSDIY  862 (968)
T ss_pred             HHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----cCCCccccccccCcccccCCCCCcccchh
Confidence            9999999996555799999999999999988887765 44432211     11223568899999999988899999999


Q ss_pred             HHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccC--CccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG--IYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       184 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||++|||++|+.||...... ......+..............++....  ..+......+.+++.+||+.||++|||+
T Consensus       863 S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~  941 (968)
T PLN00113        863 GFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA  941 (968)
T ss_pred             hHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence            9999999999999998532221 112222332222222222222222221  2344566678999999999999999999


Q ss_pred             HHHHHHHhccCC
Q 048068          262 RQVMQYLDGNAT  273 (313)
Q Consensus       262 ~ell~~L~~~~~  273 (313)
                      +|+++.|+....
T Consensus       942 ~evl~~L~~~~~  953 (968)
T PLN00113        942 NDVLKTLESASR  953 (968)
T ss_pred             HHHHHHHHHhhc
Confidence            999999998753

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=1.8e-29  Score=223.41  Aligned_cols=204  Identities=22%  Similarity=0.346  Sum_probs=162.1

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...++.++|+++++..+.+.. ++..++|+||+++++|.+++.+.   .+++..+..++.|++.|+.|||   +.+++|
T Consensus        66 e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H  138 (293)
T cd06647          66 EILVMRENKHPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIH  138 (293)
T ss_pred             HHHHHhhcCCCCeeehhheeee-CCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEee
Confidence            4456778899999999988876 56889999999999999999753   4889999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      +||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||||+++|++++|+.||..
T Consensus       139 ~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~  217 (293)
T cd06647         139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (293)
T ss_pred             ccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998865433221 12234577889999999888889999999999999999999999976


Q ss_pred             CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..........      ...        .......+......+.+++..||..+|.+||++.+++.|
T Consensus       218 ~~~~~~~~~~------~~~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         218 ENPLRALYLI------ATN--------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CChhhheeeh------hcC--------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            5433211111      000        001111222345678899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=4.7e-29  Score=223.09  Aligned_cols=212  Identities=24%  Similarity=0.361  Sum_probs=165.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+++.. +...++||||+. |+|.+.+... ..++++..+..++.|++.|+.|||   ..+++
T Consensus        74 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~  147 (317)
T cd06635          74 KEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMI  147 (317)
T ss_pred             HHHHHHHhCCCCCEEEEEEEEee-CCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            34566777899999999998876 567899999996 5888877654 446899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++.....     .....++..|++||.+.   .+.++.++|+||||+++|+|++|..
T Consensus       148 H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~  222 (317)
T cd06635         148 HRDIKAGNILLTEPGQVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  222 (317)
T ss_pred             cCCCCcccEEECCCCCEEEecCCCccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999998764332     22345778899999874   3567889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCCCC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI  277 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~~~  277 (313)
                      ||...........+.      ...         .........+..+.+++.+||+.+|.+|||+.++++|+.-....+.+
T Consensus       223 p~~~~~~~~~~~~~~------~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         223 PLFNMNAMSALYHIA------QNE---------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             CCCCccHHHHHHHHH------hcc---------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            987654333322221      000         01111223456789999999999999999999999998776655555


Q ss_pred             C
Q 048068          278 P  278 (313)
Q Consensus       278 ~  278 (313)
                      +
T Consensus       288 ~  288 (317)
T cd06635         288 V  288 (317)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=216.99  Aligned_cols=198  Identities=24%  Similarity=0.336  Sum_probs=158.1

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcE
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV  129 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nI  129 (313)
                      +.|.|++.++++.. +..+++.||.| +.++..++++. ++++++..+-++...+++||.||-.  +.+|+|||+||+||
T Consensus       149 dcpyIV~c~GyFi~-n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNI  223 (391)
T KOG0983|consen  149 DCPYIVQCFGYFIT-NTDVFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNI  223 (391)
T ss_pred             CCCeeeeeeeEEee-CchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccce
Confidence            57899999999886 45688899999 65777777665 6679999999999999999999987  78999999999999


Q ss_pred             EEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchh
Q 048068          130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME  206 (313)
Q Consensus       130 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  206 (313)
                      |+++.|++|+||||.+-......  ......|.+.|+|||.+.   ...|+.++||||||++++|++||+.||.+.+..-
T Consensus       224 LlDe~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF  301 (391)
T KOG0983|consen  224 LLDERGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF  301 (391)
T ss_pred             EEccCCCEEeecccccceeeccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH
Confidence            99999999999999986554332  234457889999999985   3468999999999999999999999999866543


Q ss_pred             hhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          207 MVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .....  +         .....+.+++.  ...++.+++|+..||..|+.+||...++++|
T Consensus       302 e~ltk--v---------ln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  302 EVLTK--V---------LNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHHHH--H---------HhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            22111  1         00111223322  2267889999999999999999999999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.7e-29  Score=221.86  Aligned_cols=200  Identities=21%  Similarity=0.305  Sum_probs=157.0

Q ss_pred             hhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcC
Q 048068           46 LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~  125 (313)
                      ++...|+++++....+.. ++..++||||+.|++|.+++...  +.+++..+..++.|++.|+.|||   ..+++|+||+
T Consensus        51 ~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~  124 (278)
T cd05606          51 VSTGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLK  124 (278)
T ss_pred             HHhCCCCcEeeeeeeeec-CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCC
Confidence            334578999998888876 56899999999999999988753  46999999999999999999999   5899999999


Q ss_pred             CCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCc
Q 048068          126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGS  204 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  204 (313)
                      |+||+++.++.++|+|||++.......   .....++..|++||.+.++ .++.++|+||+|+++|+|++|+.||.....
T Consensus       125 p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~  201 (278)
T cd05606         125 PANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  201 (278)
T ss_pred             HHHEEECCCCCEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999999999986443221   2234678899999998744 578999999999999999999999976533


Q ss_pred             hhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      ..........    .          ......+...+..+.+++.+||..+|.+||     ++.++++|-
T Consensus       202 ~~~~~~~~~~----~----------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~  256 (278)
T cd05606         202 KDKHEIDRMT----L----------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP  256 (278)
T ss_pred             cchHHHHHHh----h----------ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence            2221111000    0          001112223456789999999999999999     999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-29  Score=225.33  Aligned_cols=224  Identities=22%  Similarity=0.269  Sum_probs=160.3

Q ss_pred             hhHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      ..+...++.++|+++++..+.+... +..+++||||++ ++|.+.+....   ...+++..++.++.||+.|+.|||   
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---  125 (316)
T cd07842          50 CREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---  125 (316)
T ss_pred             HHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---
Confidence            4466788999999999999998863 368999999995 47777775321   236899999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcC----CCcEEEeecccccccCCCCC--CccccccccccccccccccC-CCCCcchhhHHHHHH
Q 048068          116 EQVVLHRDIKPANVLLDA----DLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVF  188 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~----~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i  188 (313)
                      ..+++|+||+|+||+++.    ++.++|+|||++........  .......++..|+|||.+.+ ..++.++|+||||++
T Consensus       126 ~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~  205 (316)
T cd07842         126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCI  205 (316)
T ss_pred             hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHH
Confidence            589999999999999999    89999999999875533221  11223456788999998765 457889999999999


Q ss_pred             HHHHHhCCCCCccCCchhhh-------hHHHHHHH-------hhhh---c-ccc----ccccc-----cccCCccH--HH
Q 048068          189 MLEVASGRRPIEQQGSMEMV-------NLVDWVSD-------CWKK---G-AIL----DASDS-----RLEGIYEE--EQ  239 (313)
Q Consensus       189 l~~ll~g~~pf~~~~~~~~~-------~~~~~~~~-------~~~~---~-~~~----~~~~~-----~~~~~~~~--~~  239 (313)
                      +|++++|++||.+.......       ........       .|..   . ...    .....     ........  ..
T Consensus       206 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (316)
T cd07842         206 FAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP  285 (316)
T ss_pred             HHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCC
Confidence            99999999999865543200       00000000       0000   0 000    00000     00000001  23


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...+.+++.+||+.||++|||+.|+++|
T Consensus       286 ~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         286 DSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            4568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-29  Score=215.53  Aligned_cols=205  Identities=26%  Similarity=0.401  Sum_probs=164.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.+.|+++++..++... ++..++||||+++++|.+++...  ..+++..++.++.|++.++.+||   ..++
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i  120 (254)
T cd06627          47 MQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGV  120 (254)
T ss_pred             HHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCc
Confidence            345566778899999999988876 57899999999999999999864  46999999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++......... .....++..|++||...+..++.++|+|++|+++|++++|..||
T Consensus       121 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~  199 (254)
T cd06627         121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY  199 (254)
T ss_pred             ccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998765443321 23345788899999998777899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .............      ..          .....+......+.+++.+||..+|++|||+.+++.+
T Consensus       200 ~~~~~~~~~~~~~------~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         200 YDLNPMAALFRIV------QD----------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCccHHHHHHHHh------cc----------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            7654322111110      00          0011222345678899999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=7.7e-30  Score=221.34  Aligned_cols=208  Identities=27%  Similarity=0.402  Sum_probs=160.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.+.|+++++....+.. +...|+||||+++++|.+++....  .+++..+..++.||+.||.|||   ..+++
T Consensus        42 ~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~  115 (265)
T cd05579          42 TERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGII  115 (265)
T ss_pred             HHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCee
Confidence            34456777889999998887765 678999999999999999998743  6999999999999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC-------CccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-------PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                      |+||+|+||+++.++.++|+|||++........       .......++..|++||.......+.++|+||||+++|+++
T Consensus       116 H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~  195 (265)
T cd05579         116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL  195 (265)
T ss_pred             cCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence            999999999999999999999998864432211       0122345677899999998878899999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +|..||.............       .+..      ..+.  ....+..+.+++..||+.+|++|||+..+.+.|+
T Consensus       196 ~g~~p~~~~~~~~~~~~~~-------~~~~------~~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         196 VGIPPFHGETPEEIFQNIL-------NGKI------EWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             hCCCCCCCCCHHHHHHHHh-------cCCc------CCCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            9999997655433222111       0000      0000  1113577899999999999999999955544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1e-29  Score=229.05  Aligned_cols=224  Identities=23%  Similarity=0.292  Sum_probs=163.6

Q ss_pred             hHHhhhhhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      .+...++.++|++++++.+++..   .....++||||+ +++|.+++...  +.+++..++.++.||+.||.|||   ..
T Consensus        53 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~  126 (334)
T cd07855          53 RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH---SA  126 (334)
T ss_pred             HHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence            45677888899999998887652   345789999999 46899988753  35999999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccccccccC-CCCCcchhhHHHHHHHHHHH
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  193 (313)
                      +++|+||+|+||+++.++.++|+|||++.........   ......++..|++||.+.+ ..++.++|+||||+++|+|+
T Consensus       127 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~  206 (334)
T cd07855         127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML  206 (334)
T ss_pred             CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence            9999999999999999999999999998654322211   1123467889999998765 45789999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHh---------hhh---ccc--cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDC---------WKK---GAI--LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~---------~~~---~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +|+.||...+.......+......         +..   ...  ................+..+.++|..||+.+|.+||
T Consensus       207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  286 (334)
T cd07855         207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI  286 (334)
T ss_pred             cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence            999999765544332222111000         000   000  000000000111123467899999999999999999


Q ss_pred             CHHHHHHHHhc
Q 048068          260 NMRQVMQYLDG  270 (313)
Q Consensus       260 t~~ell~~L~~  270 (313)
                      |+.++++|-.-
T Consensus       287 t~~~~l~~~~~  297 (334)
T cd07855         287 TVEQALQHPFL  297 (334)
T ss_pred             CHHHHHhChhh
Confidence            99999997644

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=1e-29  Score=224.72  Aligned_cols=222  Identities=19%  Similarity=0.233  Sum_probs=158.4

Q ss_pred             hHHhhhhhcc-ccceeeeeeEEeccCC----eEEEEEecCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           41 LQRDGLASVH-SNGLLQLTNTVNSRKG----EFLLVYDYMPNGSLDKILHTNI---KPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        41 ~~~~~l~~~~-~~~~l~~~~~~~~~~~----~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      .|...++.+. |+++++..++....+.    ..++||||+++ +|.+++....   ...+++..++.++.||+.||.|||
T Consensus        49 ~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH  127 (295)
T cd07837          49 REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH  127 (295)
T ss_pred             HHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4556677774 5999999988874332    47999999975 8888886532   246899999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFML  190 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~  190 (313)
                         ..+++|+||+|+||+++. ++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|
T Consensus       128 ---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~  203 (295)
T cd07837         128 ---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFA  203 (295)
T ss_pred             ---HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHH
Confidence               589999999999999998 88999999998875432221 1122345778999998865 45689999999999999


Q ss_pred             HHHhCCCCCccCCchhhhhHHHHHHH-----hhhhc-cc-----cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          191 EVASGRRPIEQQGSMEMVNLVDWVSD-----CWKKG-AI-----LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~-~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +|++|..||.+.........+.....     .|... ..     .....+..........+..+.++|.+||..||.+||
T Consensus       204 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~  283 (295)
T cd07837         204 EMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI  283 (295)
T ss_pred             HHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC
Confidence            99999999987654433222111000     00000 00     000000000011123456789999999999999999


Q ss_pred             CHHHHHHH
Q 048068          260 NMRQVMQY  267 (313)
Q Consensus       260 t~~ell~~  267 (313)
                      |+.++++|
T Consensus       284 ~~~eil~~  291 (295)
T cd07837         284 SAKAALTH  291 (295)
T ss_pred             CHHHHhcC
Confidence            99999976

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4e-29  Score=217.60  Aligned_cols=207  Identities=21%  Similarity=0.326  Sum_probs=163.7

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.++|++++++.+.+.+. .+.+++||||+++++|.+++...  ..+++..+..++.|++.|+.|||   ..++
T Consensus        53 ~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH---~~~i  127 (264)
T cd06653          53 CEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLH---SNMI  127 (264)
T ss_pred             HHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence            355678888999999999988753 45789999999999999999764  34889999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||++........  .......++..|++||.+.+..++.++|+||||+++|++++|+.
T Consensus       128 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  207 (264)
T cd06653         128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP  207 (264)
T ss_pred             ecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999875432111  11123457888999999988888999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ||.............               ........+....+.+.+++..||. +|.+|||+.+++.|.
T Consensus       208 p~~~~~~~~~~~~~~---------------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         208 PWAEYEAMAAIFKIA---------------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             CCCccCHHHHHHHHH---------------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence            997654332221110               0011122455566789999999999 579999999998863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.2e-29  Score=228.04  Aligned_cols=227  Identities=21%  Similarity=0.262  Sum_probs=169.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccC----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRK----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      ..+...++.++|+++++..+++...+    +.+|+||||+. ++|.+++...  ..+++..++.++.||+.||.+||   
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH---  120 (330)
T cd07834          47 LREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLH---  120 (330)
T ss_pred             HHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---
Confidence            34667788889999999999887643    47899999996 5899988764  36999999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCC-CCCcchhhHHHHHHHHHH
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l  192 (313)
                      ..+++|+||+|+||+++.++.++|+|||++........  .......++..|++||.+.+. .++.++|+||||+++|++
T Consensus       121 ~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l  200 (330)
T cd07834         121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL  200 (330)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence            58999999999999999999999999999876544321  112334568889999999877 789999999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHhhhhccc--------ccc------ccccccCCccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI--------LDA------SDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      ++|.+||.+....+....+......+.....        ...      .............+..+.+++..||+.+|.+|
T Consensus       201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  280 (330)
T cd07834         201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR  280 (330)
T ss_pred             HcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence            9999999877655433322111111000000        000      00000001112245678999999999999999


Q ss_pred             CCHHHHHHH--HhccC
Q 048068          259 PNMRQVMQY--LDGNA  272 (313)
Q Consensus       259 pt~~ell~~--L~~~~  272 (313)
                      ||++++++|  +++..
T Consensus       281 pt~~~ll~~~~~~~~~  296 (330)
T cd07834         281 ITADEALAHPYLAQLH  296 (330)
T ss_pred             CCHHHHHhCccHHhhc
Confidence            999999996  55544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=2.9e-29  Score=221.92  Aligned_cols=204  Identities=22%  Similarity=0.333  Sum_probs=160.7

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...++.++|+++++..+.+.. ++..++||||+++++|.+++...   .+++..+..++.|++.+++|||   ..+++|
T Consensus        67 e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH  139 (292)
T cd06657          67 EVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIH  139 (292)
T ss_pred             HHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence            4456777899999999998876 67899999999999999988643   4899999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      +||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||+|+++|++++|..||..
T Consensus       140 ~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             CCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998764433221 12234578889999999888889999999999999999999999976


Q ss_pred             CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...........   ....         ....  .....+..+.+++.+||+.+|.+||++.++++|
T Consensus       219 ~~~~~~~~~~~---~~~~---------~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         219 EPPLKAMKMIR---DNLP---------PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCHHHHHHHHH---hhCC---------cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            54433221111   0000         0000  112234567889999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=5.5e-29  Score=214.91  Aligned_cols=209  Identities=25%  Similarity=0.354  Sum_probs=167.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccC-CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRK-GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..+...++.++|+++++..+...... ..+++|+||+++++|.+++....  .+++..++.++.|++.++.|||   +.+
T Consensus        47 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~  121 (260)
T cd06606          47 EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNG  121 (260)
T ss_pred             HHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            34556778889999999998888632 68999999999999999998753  7999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      ++|+||+|+||+++.++.++|+|||.+......... ......++..|.+||...+..++.++|+||||++++++++|..
T Consensus       122 ~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~  201 (260)
T cd06606         122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP  201 (260)
T ss_pred             ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999998765443210 1233467888999999988889999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||........  ..   ....         ........+...+..+.+++.+||+.||.+|||+.++++|
T Consensus       202 p~~~~~~~~~--~~---~~~~---------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         202 PWSELGNPMA--AL---YKIG---------SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCCCCchHH--HH---Hhcc---------ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            9986652111  11   0000         0011112333446789999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=8.5e-29  Score=217.65  Aligned_cols=214  Identities=24%  Similarity=0.350  Sum_probs=159.4

Q ss_pred             hccccceeeeeeEEeccCC----eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecC
Q 048068           48 SVHSNGLLQLTNTVNSRKG----EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD  123 (313)
Q Consensus        48 ~~~~~~~l~~~~~~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~d  123 (313)
                      .++|+++++..++....+.    ..+++|||+. ++|.+++.......+++..++.++.|++.||.|||   ..+++|+|
T Consensus        57 ~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~  132 (287)
T cd07838          57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRD  132 (287)
T ss_pred             ccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecc
Confidence            3469999999999885332    4899999995 58999887754446999999999999999999999   58999999


Q ss_pred             cCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCC
Q 048068          124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQG  203 (313)
Q Consensus       124 l~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  203 (313)
                      |+|+||+++.++.++|+|||++.......  ......++..|++||.+.+..++.++|+|||||++|+|++|.+||....
T Consensus       133 l~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         133 LKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             CChhhEEEccCCCEEEeccCcceeccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            99999999999999999999886653322  1223346788999999988888999999999999999999999998765


Q ss_pred             chhhhhHHHHHH-----Hhhhhcc-----ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          204 SMEMVNLVDWVS-----DCWKKGA-----ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       204 ~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+....+....     ..|....     ....................+.+++..||+.||.+||+++++++|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            544332221100     0000000     000000001111222445778899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=3.5e-29  Score=220.64  Aligned_cols=207  Identities=25%  Similarity=0.371  Sum_probs=153.9

Q ss_pred             hhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHh---hCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           44 DGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH---TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        44 ~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~---~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+..+ .|+++++.++.... ++..+++|||+. ++|.++..   ......+++..+..++.|++.|++|||+  ..++
T Consensus        54 ~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i  129 (288)
T cd06616          54 DVVMRSSDCPYIVKFYGALFR-EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKI  129 (288)
T ss_pred             HHHHHhcCCCCEeeeeeEEec-CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCe
Confidence            334444 49999999998876 567899999984 56655442   2224569999999999999999999995  3599


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC---CCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG---KASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +|+||+|+||+++.++.++|+|||++.......  ......++..|++||.+.+.   .++.++|+||||+++|++++|+
T Consensus       130 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  207 (288)
T cd06616         130 IHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK  207 (288)
T ss_pred             eccCCCHHHEEEccCCcEEEeecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCC
Confidence            999999999999999999999999986543222  11223567889999998765   6789999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .||.....  .....   .....      ...+..........+..+.+|+.+||+.+|++|||++++++|
T Consensus       208 ~p~~~~~~--~~~~~---~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         208 FPYPKWNS--VFDQL---TQVVK------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCchhcch--HHHHH---hhhcC------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            99975441  11111   00000      001111111223356678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=7.6e-30  Score=226.99  Aligned_cols=223  Identities=25%  Similarity=0.296  Sum_probs=160.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEecc-------CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSR-------KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~-------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      ..+.+.++.++|+++++..++....       ...+++||||+. ++|...+... ...+++..+..++.|+++||.|||
T Consensus        55 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH  132 (311)
T cd07866          55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH  132 (311)
T ss_pred             HHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567788999999999998877632       235899999995 5777777654 346999999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc----------cccccccccccccccccCC-CCCcchh
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ----------TTKLVGTFGYMAPELMRTG-KASTSTD  181 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~-~~~~~~D  181 (313)
                         ..+++|+||+|+||+++.++.++|+|||++..........          .....++..|+|||.+.+. .++.++|
T Consensus       133 ---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  209 (311)
T cd07866         133 ---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVD  209 (311)
T ss_pred             ---hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhH
Confidence               5899999999999999999999999999986543221111          1123457789999987653 5788999


Q ss_pred             hHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHH--------hhhhccccc--cccccccCC---ccHHHHHHHHHHHH
Q 048068          182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD--------CWKKGAILD--ASDSRLEGI---YEEEQMELVLKLGL  248 (313)
Q Consensus       182 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~  248 (313)
                      +||||+++|+|++|++||.+.........+.....        .|.......  ......+..   ........+.+++.
T Consensus       210 v~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  289 (311)
T cd07866         210 IWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLS  289 (311)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHH
Confidence            99999999999999999987665543332221100        000000000  000000000   00122356889999


Q ss_pred             HcCCCCCCCCCCHHHHHHH
Q 048068          249 FCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       249 ~cl~~~P~~Rpt~~ell~~  267 (313)
                      +||+.||.+|||+.+++.|
T Consensus       290 ~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         290 KLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHcccCcccCcCHHHHhcC
Confidence            9999999999999999876

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=2.1e-29  Score=227.15  Aligned_cols=225  Identities=23%  Similarity=0.300  Sum_probs=161.1

Q ss_pred             hHHhhhhhccccceeeeeeEEecc----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      .+...++.++|++++++.++....    ....++||||+. ++|.+.+...   .+++..++.++.|++.||.|||   .
T Consensus        52 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH---~  124 (336)
T cd07849          52 REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIH---S  124 (336)
T ss_pred             HHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---h
Confidence            356677888999999998876632    246899999995 5888887643   5999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccC-CCCCcchhhHHHHHHHHHHH
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  193 (313)
                      .+++|+||+|+||+++.++.++|+|||++.........  ......++..|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus       125 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~  204 (336)
T cd07849         125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML  204 (336)
T ss_pred             CCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence            89999999999999999999999999998654322111  1123457888999998754 46789999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHH-----hhh-------hccccccc-ccccc-CCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSD-----CWK-------KGAILDAS-DSRLE-GIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~-----~~~-------~~~~~~~~-~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +|+.||.+.+.............     .+.       ........ ..... .......+..+.++|.+||+.+|++||
T Consensus       205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  284 (336)
T cd07849         205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI  284 (336)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence            99999976543332221110000     000       00000000 00000 001112356789999999999999999


Q ss_pred             CHHHHHHH--HhccC
Q 048068          260 NMRQVMQY--LDGNA  272 (313)
Q Consensus       260 t~~ell~~--L~~~~  272 (313)
                      |+.++++|  ++...
T Consensus       285 t~~e~l~hp~~~~~~  299 (336)
T cd07849         285 TVEEALAHPYLEQYH  299 (336)
T ss_pred             CHHHHhcCccccccC
Confidence            99999998  55544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.7e-29  Score=214.93  Aligned_cols=205  Identities=25%  Similarity=0.339  Sum_probs=163.9

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...+...++.+.|+++++..+.+.. +..+++||||+++++|.+++...  ..+++..++.++.|++.|+.|||   ..+
T Consensus        40 ~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh---~~~  113 (250)
T cd05123          40 TLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLH---SLG  113 (250)
T ss_pred             HHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            3455577888999999999888776 67899999999999999999864  35899999999999999999999   599


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++.++.++|+|||++....... .......++..|++||...+..++.++|+||||+++|++++|..|
T Consensus       114 ~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p  192 (250)
T cd05123         114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP  192 (250)
T ss_pred             ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999999987554322 122334567889999999888889999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM---RQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~---~ell~~  267 (313)
                      |...+.........      ..           ....+...+..+.+++.+||..||++|||+   +++++|
T Consensus       193 ~~~~~~~~~~~~~~------~~-----------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         193 FYAEDRKEIYEKIL------KD-----------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCCCCHHHHHHHHh------cC-----------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            97655422221111      00           011222335678899999999999999999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=5e-29  Score=218.89  Aligned_cols=202  Identities=25%  Similarity=0.343  Sum_probs=153.8

Q ss_pred             hhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecC
Q 048068           46 LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD  123 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~d  123 (313)
                      ++..+|+++++..+.+.. ++..++||||++ ++|.+++...  ....+++..++.++.||+.|+.|||+  ..+++|+|
T Consensus        54 ~~~~~~~~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~d  129 (283)
T cd06617          54 MRSVDCPYTVTFYGALFR-EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRD  129 (283)
T ss_pred             HHHcCCCCeeeeeEEEec-CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCC
Confidence            456689999999998876 567999999995 6888888642  23569999999999999999999994  23999999


Q ss_pred             cCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC----CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       124 l~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+|+||+++.++.++|+|||++.......  ......++..|++||.+.+    ..++.++|+|||||++|+|++|+.||
T Consensus       130 lkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  207 (283)
T cd06617         130 VKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY  207 (283)
T ss_pred             CCHHHEEECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence            99999999999999999999987543221  1122456788999998864    34678999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ........  ..   ...... .     .+..   .....+..+.++|.+||..+|++|||+.++++|
T Consensus       208 ~~~~~~~~--~~---~~~~~~-~-----~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         208 DSWKTPFQ--QL---KQVVEE-P-----SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CccccCHH--HH---HHHHhc-C-----CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            65332211  11   000000 0     0001   111245678999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=5e-29  Score=221.61  Aligned_cols=222  Identities=22%  Similarity=0.298  Sum_probs=159.8

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-------CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-------KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      .+.+.++.++|+++++..++....       ....++||||+. ++|.+.+... ...+++..++.++.||+.||.||| 
T Consensus        60 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH-  136 (310)
T cd07865          60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH-  136 (310)
T ss_pred             HHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH-
Confidence            356778899999999999887632       346799999995 5888888754 346899999999999999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccccccccCC-CCCcchhhHHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFM  189 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il  189 (313)
                        ..+++|+||+|+||+++.++.++|+|||++.........   ......++..|+|||.+.+. .++.++|+||||+++
T Consensus       137 --~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l  214 (310)
T cd07865         137 --RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM  214 (310)
T ss_pred             --HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHH
Confidence              589999999999999999999999999998755332211   11233567789999987654 468899999999999


Q ss_pred             HHHHhCCCCCccCCchhhhhHHHHHHHhhhhccc-----ccccc-ccccCCc---------cHHHHHHHHHHHHHcCCCC
Q 048068          190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI-----LDASD-SRLEGIY---------EEEQMELVLKLGLFCSHPK  254 (313)
Q Consensus       190 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~---------~~~~~~~l~~li~~cl~~~  254 (313)
                      |++++|..||...........+............     ..... ...+...         +......+.+||.+||..|
T Consensus       215 ~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~  294 (310)
T cd07865         215 AEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD  294 (310)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC
Confidence            9999999999876554333333222110000000     00000 0000000         0012345679999999999


Q ss_pred             CCCCCCHHHHHHH
Q 048068          255 PEARPNMRQVMQY  267 (313)
Q Consensus       255 P~~Rpt~~ell~~  267 (313)
                      |.+|||++++++|
T Consensus       295 P~~R~t~~e~l~h  307 (310)
T cd07865         295 PAKRIDADTALNH  307 (310)
T ss_pred             hhhccCHHHHhcC
Confidence            9999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=6.1e-29  Score=218.44  Aligned_cols=221  Identities=23%  Similarity=0.322  Sum_probs=163.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|...+++++|++++++.+...+ .+..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||   ..++
T Consensus        47 ~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i  121 (284)
T cd07836          47 REISLMKELKHENIVRLHDVIHT-ENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV  121 (284)
T ss_pred             HHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            45678888999999999999887 5688999999964 8888887543 346899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++++|||++........ ......++..|++||.+.+. .++.++|+||||+++|++++|+.|
T Consensus       122 ~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  200 (284)
T cd07836         122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL  200 (284)
T ss_pred             eeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999865433221 11223457889999988653 568899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHH-----Hhhhhcccccccccc-------ccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVS-----DCWKKGAILDASDSR-------LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |.+.+..+....+....     ..|+...........       ......+..+..+.+++.+||+.||.+|||+.++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         201 FPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            98766544333221110     001100000000000       001112234567899999999999999999999987


Q ss_pred             H
Q 048068          267 Y  267 (313)
Q Consensus       267 ~  267 (313)
                      |
T Consensus       281 ~  281 (284)
T cd07836         281 H  281 (284)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=5.7e-29  Score=224.39  Aligned_cols=220  Identities=24%  Similarity=0.325  Sum_probs=161.8

Q ss_pred             hHHhhhhhc-cccceeeeeeEEec-cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+...++++ +|++++++.+++.. ++..+++||||+. ++|.+++...   .+++..+..++.||+.||.|||   ..+
T Consensus        55 ~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~  127 (337)
T cd07852          55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGN  127 (337)
T ss_pred             HHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            356677888 99999999998764 3457899999996 5999988764   5889999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCC----CccccccccccccccccccC-CCCCcchhhHHHHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI----PQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  193 (313)
                      ++|+||+|+||+++.++.++|+|||++........    .......++..|++||.+.+ ..++.++|+||||+++|+++
T Consensus       128 i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~  207 (337)
T cd07852         128 VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML  207 (337)
T ss_pred             eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHH
Confidence            99999999999999999999999998875433221    12223457889999998764 45688999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHh--------hhhcc---cccc---ccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDC--------WKKGA---ILDA---SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +|+.||..................        +....   ....   .............+..+.++|.+||+.||.+||
T Consensus       208 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp  287 (337)
T cd07852         208 LGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL  287 (337)
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc
Confidence            999999765544332221111000        00000   0000   000000111112457789999999999999999


Q ss_pred             CHHHHHHH
Q 048068          260 NMRQVMQY  267 (313)
Q Consensus       260 t~~ell~~  267 (313)
                      |+.+++++
T Consensus       288 s~~~il~~  295 (337)
T cd07852         288 TAEEALEH  295 (337)
T ss_pred             CHHHHhhC
Confidence            99999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=2.2e-29  Score=220.45  Aligned_cols=205  Identities=25%  Similarity=0.410  Sum_probs=163.8

Q ss_pred             hhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..+...++.+. |+++++..+.... ++..++|||++++++|.+++...  ..+++..++.++.|++.||.+||   ..+
T Consensus        49 ~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh---~~~  122 (280)
T cd05581          49 KIEKEVLTRLNGHPGIIKLYYTFQD-EENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLH---SKG  122 (280)
T ss_pred             HHHHHHHHhcccCCCchhHHHHhcC-CceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            34456667777 9999998887765 66899999999999999999874  36999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-------------------CccccccccccccccccccCCCCCcc
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-------------------PQTTKLVGTFGYMAPELMRTGKASTS  179 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~  179 (313)
                      ++|+||+|+||+++.++.++++|||++........                   .......++..|++||...+..++.+
T Consensus       123 ~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~  202 (280)
T cd05581         123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS  202 (280)
T ss_pred             eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh
Confidence            99999999999999999999999999875543221                   12223456788999999988888999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          180 TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       180 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +|+||||++++++++|..||.............      .           .....+...+..+.+++..||+.+|.+||
T Consensus       203 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~  265 (280)
T cd05581         203 SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL------K-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRL  265 (280)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------h-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCC
Confidence            999999999999999999998765332221110      0           01112233366789999999999999999


Q ss_pred             CH----HHHHHH
Q 048068          260 NM----RQVMQY  267 (313)
Q Consensus       260 t~----~ell~~  267 (313)
                      |+    +++++|
T Consensus       266 ~~~~~~~~ll~~  277 (280)
T cd05581         266 GVNEGYDELKAH  277 (280)
T ss_pred             CcccCHHHHhcC
Confidence            99    888876

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=7e-29  Score=220.08  Aligned_cols=221  Identities=25%  Similarity=0.329  Sum_probs=159.9

Q ss_pred             hHHhhhhhccccceeeeeeEEecc---------CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR---------KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~---------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      .+.+.++.++|+++++..+++.+.         ++.+++|+||+++ +|...+... ...+++..+..++.|++.||.||
T Consensus        55 ~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~L  132 (302)
T cd07864          55 REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYC  132 (302)
T ss_pred             HHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHH
Confidence            456778888999999998887643         2489999999965 777777654 34699999999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFML  190 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~  190 (313)
                      |   ..+++|+||+|+||+++.++.++|+|||++...............++..|++||.+.+ ..++.++|+|||||++|
T Consensus       133 H---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~  209 (302)
T cd07864         133 H---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG  209 (302)
T ss_pred             H---hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHH
Confidence            9   6899999999999999999999999999987554332111222345678999998764 35688999999999999


Q ss_pred             HHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccccc--------------ccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          191 EVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD--------------SRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      ++++|++||...........+.................              ..... .....+..+.+++..||+.||.
T Consensus       210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~  288 (302)
T cd07864         210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPS  288 (302)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChh
Confidence            99999999976544333222211100000000000000              00000 0112356789999999999999


Q ss_pred             CCCCHHHHHHH
Q 048068          257 ARPNMRQVMQY  267 (313)
Q Consensus       257 ~Rpt~~ell~~  267 (313)
                      +|||+.++++|
T Consensus       289 ~Rp~~~~il~~  299 (302)
T cd07864         289 KRCTAEEALNS  299 (302)
T ss_pred             hCCCHHHHhcC
Confidence            99999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=6.6e-29  Score=215.58  Aligned_cols=205  Identities=21%  Similarity=0.347  Sum_probs=162.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT--NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+...++.++|+++++..+.+.+ ....++||||+++++|.+++..  .....+++..++.++.|++.|+.|||   +.+
T Consensus        51 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~  126 (260)
T cd08222          51 QEAQLLSKLDHPAIVKFHASFLE-RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRR  126 (260)
T ss_pred             HHHHHHHhCCCCcHHHHHHHHhc-CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcC
Confidence            45567888899999999988876 5578999999999999999864  22456999999999999999999999   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ++|+||+|+||+++. +.++|+|||++....... .......++..|++||...+..++.++|+||||+++|++++|..|
T Consensus       127 i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~  204 (260)
T cd08222         127 ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA  204 (260)
T ss_pred             ccccCCChhheEeec-CCEeecccCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999975 569999999886543221 122234567889999998888888999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |............      . .+         .....+...+..+.++|.+||..||++||++.++++|
T Consensus       205 ~~~~~~~~~~~~~------~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         205 FEGQNFLSVVLRI------V-EG---------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCccHHHHHHHH------H-cC---------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            9654332211111      0 00         1111234556788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=1.8e-28  Score=218.92  Aligned_cols=201  Identities=25%  Similarity=0.378  Sum_probs=158.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..++..+ +...++||||+. ++|.+++... ...+++..+..++.||+.++.|||   ..+++
T Consensus        70 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH---~~gi~  143 (313)
T cd06633          70 KEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMI  143 (313)
T ss_pred             HHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            45567788899999999998887 568899999995 5888887654 346899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++.....     .....++..|++||.+.   ...++.++|+||||+++|++++|..
T Consensus       144 H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~  218 (313)
T cd06633         144 HRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  218 (313)
T ss_pred             cCCCChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999998753221     22346788899999974   3557889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||..............      . .        .+.......+..+.+++.+||+.+|.+|||+.++++|
T Consensus       219 p~~~~~~~~~~~~~~~------~-~--------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         219 PLFNMNAMSALYHIAQ------N-D--------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCCCChHHHHHHHHh------c-C--------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9876554332222110      0 0        1111122334568899999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=1.6e-28  Score=221.30  Aligned_cols=222  Identities=21%  Similarity=0.273  Sum_probs=163.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+++.. ++..++||||+. ++|.+++...  ..+++..+..++.|++.||.|||   ..+++
T Consensus        69 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~  141 (335)
T PTZ00024         69 RELKIMNEIKHENIMGLVDVYVE-GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFM  141 (335)
T ss_pred             HHHHHHHhCCCcceeeeeEEEec-CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            46677889999999999998876 568999999995 6999998763  35899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCC-------------CCccccccccccccccccccCC-CCCcchhhHHHH
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDT-------------IPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFG  186 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG  186 (313)
                      |+||+|+||+++.++.++|+|||++.......             ........++..|++||.+.+. .++.++|+||||
T Consensus       142 H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  221 (335)
T PTZ00024        142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG  221 (335)
T ss_pred             cccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence            99999999999999999999999987554111             0111223457789999988754 468899999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhccc---ccccccccc---CCccHHHHHHHHHHHHHcCCCCC
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKGAI---LDASDSRLE---GIYEEEQMELVLKLGLFCSHPKP  255 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P  255 (313)
                      |++|++++|..||.+.+..+....+......     |.....   ........+   .......++.+.+++.+||+.+|
T Consensus       222 ~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  301 (335)
T PTZ00024        222 CIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP  301 (335)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence            9999999999999877655433322111000     110000   000000000   00112235678899999999999


Q ss_pred             CCCCCHHHHHHHHh
Q 048068          256 EARPNMRQVMQYLD  269 (313)
Q Consensus       256 ~~Rpt~~ell~~L~  269 (313)
                      .+|||+++++.|-.
T Consensus       302 ~~R~s~~~~l~~~~  315 (335)
T PTZ00024        302 LERISAKEALKHEY  315 (335)
T ss_pred             hhccCHHHHhcCcc
Confidence            99999999999653

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=1.1e-28  Score=221.89  Aligned_cols=218  Identities=20%  Similarity=0.263  Sum_probs=162.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...+++++|+++++..+.+...+..+++||||+ +++|..+++..   .+++..+..++.|++.||.|||   ..++
T Consensus        57 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~i  129 (328)
T cd07856          57 YRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGV  129 (328)
T ss_pred             HHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            346678889999999999998876567899999999 67999888743   4888999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||.+......    .....++..|++||.+.+ ..++.++|+||||+++|++++|+.|
T Consensus       130 iH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~  205 (328)
T cd07856         130 VHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL  205 (328)
T ss_pred             ccCCCCHHHEeECCCCCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999988643321    123456778999998765 5678999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHH----hhhh----c----cccccc--cccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSD----CWKK----G----AILDAS--DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~----~~~~----~----~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      |...........+.....    .+..    .    ......  .+...........+.+.++|.+||+.+|++|||+.++
T Consensus       206 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el  285 (328)
T cd07856         206 FPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA  285 (328)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            976554332222111000    0000    0    000000  0000000111235788999999999999999999999


Q ss_pred             HHHH
Q 048068          265 MQYL  268 (313)
Q Consensus       265 l~~L  268 (313)
                      +.|-
T Consensus       286 l~~~  289 (328)
T cd07856         286 LAHP  289 (328)
T ss_pred             hcCC
Confidence            9984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=8e-29  Score=217.27  Aligned_cols=220  Identities=22%  Similarity=0.298  Sum_probs=164.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+++.+ .+..++||||++ ++|.+++.... ..+++..+..++.|++.||.+||   ..+++
T Consensus        47 ~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~  120 (282)
T cd07829          47 REISLLKELKHPNIVKLLDVIHT-ERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRIL  120 (282)
T ss_pred             HHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45567888899999999999887 478999999996 59999998752 46999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||.+........ .......+..|+|||.+.+. .++.++|+||||+++|++++|..||
T Consensus       121 H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~  199 (282)
T cd07829         121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF  199 (282)
T ss_pred             cCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876543321 12223456789999998766 7889999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHH-----Hhhhhc-c------ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVS-----DCWKKG-A------ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~-----~~~~~~-~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...........+....     ..|... .      ..............+.....+.+++..||..||++|||+++++.|
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         200 PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             CCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            8765443332221100     011100 0      000000000001111235679999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-29  Score=219.67  Aligned_cols=208  Identities=25%  Similarity=0.318  Sum_probs=172.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      -.+++.+..++.+-++..-.-+.. ++.+|+||..|+||+|.-.|.+.....|++..+..++.+|+-||.+||   ..+|
T Consensus       233 LnEk~iL~kV~s~FiVslaYAfeT-kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~i  308 (591)
T KOG0986|consen  233 LNEKQILEKVSSPFIVSLAYAFET-KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRI  308 (591)
T ss_pred             hHHHHHHHHhccCcEEEEeeeecC-CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcce
Confidence            467888999998877765555544 789999999999999999998776678999999999999999999999   7999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +.||+||+|||+++.|.++|+|+|++..+....  ......||.+|+|||++....|+...|=|||||++|+|+.|+.||
T Consensus       309 VYRDLKPeNILLDd~GhvRISDLGLAvei~~g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF  386 (591)
T KOG0986|consen  309 VYRDLKPENILLDDHGHVRISDLGLAVEIPEGK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF  386 (591)
T ss_pred             eeccCChhheeeccCCCeEeeccceEEecCCCC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence            999999999999999999999999998776554  344558999999999999989999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQ  266 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~  266 (313)
                      .......-..-++.             .....+..++...++..++|....|..||++|.     .++++-+
T Consensus       387 r~~KeKvk~eEvdr-------------r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~  445 (591)
T KOG0986|consen  387 RQRKEKVKREEVDR-------------RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE  445 (591)
T ss_pred             hhhhhhhhHHHHHH-------------HHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence            87766554322211             011233456677788888998889999999996     3445544

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=1.4e-28  Score=216.86  Aligned_cols=211  Identities=22%  Similarity=0.309  Sum_probs=160.1

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.+..+ +|+++++..+.+.. +...++||||+++++|.+++...  ..+++..+..++.|++.+|.|||   ..++
T Consensus        53 ~E~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~  126 (288)
T cd05583          53 TERQVLEAVRRCPFLVTLHYAFQT-DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGI  126 (288)
T ss_pred             HHHHHHHhccCCcchhhhheeeec-CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            455566677 58999998888776 56899999999999999998763  35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC--CCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK--ASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||++...............++..|++||...+..  .+.++|+||||+++|+|++|..
T Consensus       127 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~  206 (288)
T cd05583         127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS  206 (288)
T ss_pred             eccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999999988654333222222345788999999987654  6889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ||............  .......           ....+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       207 p~~~~~~~~~~~~~--~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         207 PFTVDGEQNSQSEI--SRRILKS-----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CcccCcccchHHHH--HHHHHcc-----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            99644322111111  0111110           011222344678899999999999999998777665544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=1.7e-28  Score=218.61  Aligned_cols=206  Identities=24%  Similarity=0.348  Sum_probs=161.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|++++++.+++.. +...++||||+. ++|.+.+... ...+++..+..++.|++.|+.|||   ..+++
T Consensus        64 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~  137 (308)
T cd06634          64 KEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMI  137 (308)
T ss_pred             HHHHHHHhCCCCCcccEEEEEEc-CCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            35567788899999999998876 568899999995 6888877654 345899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++.....     .....++..|+|||.+.   ...++.++|+|||||++|++++|..
T Consensus       138 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  212 (308)
T cd06634         138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  212 (308)
T ss_pred             cCCCCHHhEEECCCCcEEECCcccceeecC-----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCC
Confidence            999999999999999999999998865432     22345678899999874   3457889999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||.............       ...        .+.......+..+.++|.+||..+|++|||++++++|..-..
T Consensus       213 p~~~~~~~~~~~~~~-------~~~--------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         213 PLFNMNAMSALYHIA-------QNE--------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             CCccccHHHHHHHHh-------hcC--------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            987654332221110       000        011112245567889999999999999999999999865544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=2.6e-28  Score=216.03  Aligned_cols=205  Identities=17%  Similarity=0.243  Sum_probs=152.1

Q ss_pred             hhccccceeeeeeEEeccC---CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecC
Q 048068           47 ASVHSNGLLQLTNTVNSRK---GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD  123 (313)
Q Consensus        47 ~~~~~~~~l~~~~~~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~d  123 (313)
                      ..+.|++++++++......   ...+++++++ ..++.+.+...  ...++..+..++.|++.|+.|||   ..+++|||
T Consensus        78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrD  151 (294)
T PHA02882         78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGD  151 (294)
T ss_pred             ccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            4567888888887654322   2447888887 45777777653  23678889999999999999999   58999999


Q ss_pred             cCCCcEEEcCCCcEEEeecccccccCCCCC------CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          124 IKPANVLLDADLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       124 l~~~nIlv~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |||+||+++.++.++|+|||++........      .......||+.|+|||.+.+..++.++|||||||++|+|++|+.
T Consensus       152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~  231 (294)
T PHA02882        152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL  231 (294)
T ss_pred             CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999875532111      11123468999999999998889999999999999999999999


Q ss_pred             CCccCCchhhhhHH---HHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          198 PIEQQGSMEMVNLV---DWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       198 pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ||............   ++..+.. .+.        .   .....+..+.+++..|++.+|++||+++++++.|+
T Consensus       232 P~~~~~~~~~~~~~~~~~~~~~~~-~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        232 PWKGFGHNGNLIHAAKCDFIKRLH-EGK--------I---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             CCCccccchHHHHHhHHHHHHHhh-hhh--------h---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            99876432221111   1111111 100        0   11123567889999999999999999999998763

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-28  Score=214.66  Aligned_cols=219  Identities=23%  Similarity=0.321  Sum_probs=162.6

Q ss_pred             HHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           42 QRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        42 ~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      +...++.+. |+++++..+++.+ ++..++||||+ +++|.+.+.......+++..+..++.|++.+|.|||   ..+++
T Consensus        47 e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~  121 (283)
T cd07830          47 EVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFF  121 (283)
T ss_pred             HHHHHHhccCCCCchhHHHHhhc-CCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            445566777 9999999998877 77899999999 889999998764457899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-TGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......++..|++||.+. ...++.++|+||||++++++++|++||
T Consensus       122 H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~  199 (283)
T cd07830         122 HRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF  199 (283)
T ss_pred             cCCCChhhEEEcCCCCEEEeecccceeccCCC--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence            99999999999999999999999987543322  122345678899999875 345788999999999999999999999


Q ss_pred             ccCCchhhhhHHHHH-----HHhhhhc-----ccccccccccc---CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          200 EQQGSMEMVNLVDWV-----SDCWKKG-----AILDASDSRLE---GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ......+........     ...|...     ...........   ..........+.+++.+||+.+|.+|||++|++.
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         200 PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            776554433222110     0001110     00000000000   0011112467899999999999999999999987


Q ss_pred             H
Q 048068          267 Y  267 (313)
Q Consensus       267 ~  267 (313)
                      |
T Consensus       280 ~  280 (283)
T cd07830         280 H  280 (283)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=1.9e-28  Score=216.28  Aligned_cols=208  Identities=25%  Similarity=0.366  Sum_probs=159.8

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+.+.++.+ +|++++++...+.. +...++||||+++++|.+++...  ..+++..+..++.|++.||.|||   ..++
T Consensus        53 ~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i  126 (290)
T cd05613          53 TERQVLEHIRQSPFLVTLHYAFQT-DTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGI  126 (290)
T ss_pred             HHHHHHHhcccCCChhceeeEeec-CCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            455667777 58999998888776 56889999999999999999764  35889999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC--CCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||++...............++..|++||.+.+.  .++.++|+||||+++|++++|..
T Consensus       127 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~  206 (290)
T cd05613         127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS  206 (290)
T ss_pred             eccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999875543322222334578899999998753  46789999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ||............  .......           ....+......+.+++.+||..||++||     ++++++.|
T Consensus       207 p~~~~~~~~~~~~~--~~~~~~~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         207 PFTVDGEKNSQAEI--SRRILKS-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCCcCCccccHHHH--HHHhhcc-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            99754332211111  1111000           0112333456788999999999999997     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=3.9e-29  Score=227.77  Aligned_cols=240  Identities=22%  Similarity=0.290  Sum_probs=188.8

Q ss_pred             hhHHHHHHHHhhccccc---eEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           12 VLLCVSFILSALAQDVN---QFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      +++.+.+..+.++.+..   .++.|.+-+         ....+.+.++.++|||+++.+.+... ...+|+||||..+|.
T Consensus        63 tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV~eya~~ge  141 (596)
T KOG0586|consen   63 TIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLVMEYASGGE  141 (596)
T ss_pred             eeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEEEEeccCch
Confidence            33445555555555543   555554422         12456677888899999999999986 568999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      +.+++.++.  .+.+..+..++.|+++|++|||   .+.|+|||||.+||+++.+..+||+|||++.++....  ....+
T Consensus       142 ~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--~lqt~  214 (596)
T KOG0586|consen  142 LFDYLVKHG--RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--MLQTF  214 (596)
T ss_pred             hHHHHHhcc--cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc--ccccc
Confidence            999999853  4777999999999999999999   6999999999999999999999999999998877443  56678


Q ss_pred             cccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          160 VGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      .|++.|.|||+..+..+ .+++|+|++|+++|-++.|..||.+.+-.......               +.....  ++..
T Consensus       215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l~gk~r--Ip~~  277 (596)
T KOG0586|consen  215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------LRGKYR--IPFY  277 (596)
T ss_pred             CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------eeeeec--ccce
Confidence            99999999999988766 78999999999999999999999977654432211               001111  2223


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCCC
Q 048068          239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPD  276 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~~  276 (313)
                      .+..+.++|+++|-.+|.+|++++++.++-+-......
T Consensus       278 ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  278 MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             eechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            34456778888899999999999999998776655555

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=9.1e-29  Score=193.94  Aligned_cols=223  Identities=22%  Similarity=0.253  Sum_probs=176.4

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      +.-.|...++|++|.|+++.++++-+ +..+-+|+||| ..+|..+...- ++.++...++.++.|++.++.++|   ..
T Consensus        47 salreicllkelkhknivrl~dvlhs-dkkltlvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fch---sh  120 (292)
T KOG0662|consen   47 SALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCH---SH  120 (292)
T ss_pred             HHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhh---hh
Confidence            34467889999999999999999887 66899999999 56888887654 456999999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHh-C
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVAS-G  195 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~-g  195 (313)
                      +++|||+||.|.+|+.+|.+|++|||+++.++-+..+... ..-|.+|++|.++.+. .|+.+.|+||.|||+.|+.. |
T Consensus       121 nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanag  199 (292)
T KOG0662|consen  121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_pred             hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence            9999999999999999999999999999988876654433 3458999999998764 57999999999999999988 7


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhcccccc---ccccccCCcc---------HHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDA---SDSRLEGIYE---------EEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      .+.|.+.+..+....+-++.....++.+..+   .+...-..++         +.....-++++.+.|.-+|..|.+++.
T Consensus       200 rplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea  279 (292)
T KOG0662|consen  200 RPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA  279 (292)
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence            7778888877777666555444333332221   2222212222         122334588899999999999999999


Q ss_pred             HHHH
Q 048068          264 VMQY  267 (313)
Q Consensus       264 ll~~  267 (313)
                      .++|
T Consensus       280 alqh  283 (292)
T KOG0662|consen  280 ALQH  283 (292)
T ss_pred             HhcC
Confidence            9986

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.5e-30  Score=216.91  Aligned_cols=203  Identities=23%  Similarity=0.277  Sum_probs=169.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      -+.+.++..+||-+..+...++. ++++|+||||.+||.|.-.+.+  ...+++...+.+-..|++||.|||   .++|+
T Consensus       217 TE~RVL~~~~HPFLt~LKYsFQt-~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLH---s~~iv  290 (516)
T KOG0690|consen  217 TENRVLQNCRHPFLTSLKYSFQT-QDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLH---SRNIV  290 (516)
T ss_pred             hHHHHHHhccCcHHHHhhhhhcc-CceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhh---hCCee
Confidence            45667788889988887777766 6799999999999999888876  446999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      .||+|.+|++++.+|.+||.|||++..--.. ......+.||+.|+|||++.+..|..+.|-|.+|++||||++|+.||.
T Consensus       291 YRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  291 YRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             eeechhhhheeccCCceEeeecccchhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence            9999999999999999999999999743222 234567899999999999999999999999999999999999999999


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..+......++..                 ..-.+|...++....|+...|..||++|.     .+.|+.+|
T Consensus       370 n~dh~kLFeLIl~-----------------ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  370 NKDHEKLFELILM-----------------EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ccchhHHHHHHHh-----------------hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            8887777666631                 11124555566777888888999999995     57777664

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.7e-28  Score=220.50  Aligned_cols=227  Identities=22%  Similarity=0.280  Sum_probs=162.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC-----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+.+.++.+.|+++++..+++....     ..+++|+||+. .+|..++.    ..+++..+..++.|++.|+.|||   
T Consensus        63 ~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---  134 (342)
T cd07879          63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---  134 (342)
T ss_pred             HHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---
Confidence            4667888899999999998876322     35799999995 47776653    24899999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHh
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~  194 (313)
                      ..+++|+||+|+||+++.++.++|+|||++......    .....++..|+|||.+.+ ..++.++|+||||+++|++++
T Consensus       135 ~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~  210 (342)
T cd07879         135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT  210 (342)
T ss_pred             HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh
Confidence            589999999999999999999999999998643221    223456788999999875 457889999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHH--------Hhhhhcccc---ccccccccCCc---cHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          195 GRRPIEQQGSMEMVNLVDWVS--------DCWKKGAIL---DASDSRLEGIY---EEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      |+.||.+.+.......+....        +.+......   ...........   .+.....+.++|..||+.||++|||
T Consensus       211 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~  290 (342)
T cd07879         211 GKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT  290 (342)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC
Confidence            999998654333222111100        000000000   00000000000   1123456889999999999999999


Q ss_pred             HHHHHHH--HhccCCCCCCCC
Q 048068          261 MRQVMQY--LDGNATLPDIPR  279 (313)
Q Consensus       261 ~~ell~~--L~~~~~~~~~~~  279 (313)
                      +.+++.|  +++....++.+.
T Consensus       291 ~~e~l~h~~f~~~~~~~~~~~  311 (342)
T cd07879         291 ATEALEHPYFDSFRDADEETE  311 (342)
T ss_pred             HHHHhcCcchhhcccccccCC
Confidence            9999976  888765444443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=1.1e-28  Score=222.96  Aligned_cols=221  Identities=22%  Similarity=0.276  Sum_probs=156.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccC-------------CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRK-------------GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS  106 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~-------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~  106 (313)
                      ..+.+.++.++|++++++.+.+....             ...++||||++ ++|.+++...   .+++..++.++.||+.
T Consensus        50 ~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~  125 (342)
T cd07854          50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLR  125 (342)
T ss_pred             HHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHH
Confidence            34667788899999999887665322             36789999996 5898888643   5899999999999999


Q ss_pred             HHHHhhhcCCCCceecCcCCCcEEEc-CCCcEEEeecccccccCCCCCC--ccccccccccccccccccC-CCCCcchhh
Q 048068          107 GLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRT-GKASTSTDV  182 (313)
Q Consensus       107 al~~lhs~~~~~i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  182 (313)
                      |+.|||   ..+++|+||+|+||+++ .++.++++|||++.........  ......++..|+|||.+.+ ..++.++|+
T Consensus       126 aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  202 (342)
T cd07854         126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM  202 (342)
T ss_pred             HHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhH
Confidence            999999   68999999999999997 4567899999998654322111  1122356788999998754 457889999


Q ss_pred             HHHHHHHHHHHhCCCCCccCCchhhhhHHHHHH---------Hhhh---hccccccccc-cccCCccHHHHHHHHHHHHH
Q 048068          183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS---------DCWK---KGAILDASDS-RLEGIYEEEQMELVLKLGLF  249 (313)
Q Consensus       183 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~  249 (313)
                      |||||++|++++|+.||................         ....   .......... .............+.+++.+
T Consensus       203 wSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  282 (342)
T cd07854         203 WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ  282 (342)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHH
Confidence            999999999999999997665433322111000         0000   0000000000 00000111234668899999


Q ss_pred             cCCCCCCCCCCHHHHHHH
Q 048068          250 CSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       250 cl~~~P~~Rpt~~ell~~  267 (313)
                      ||..||++|||+.++++|
T Consensus       283 ~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         283 ILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhCCCchhccCHHHHhCC
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-28  Score=226.47  Aligned_cols=218  Identities=22%  Similarity=0.309  Sum_probs=178.1

Q ss_pred             ceEEEcccCCCh--------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           28 NQFIYHGFNEDP--------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        28 ~~~~~~~~~~~~--------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ..+++|-+..+.        ..|...+-.++|+++|++++++.+  ....+|||.++.|+|.+.|++..+..+-...+-.
T Consensus       139 V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcd  216 (1039)
T KOG0199|consen  139 VNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCD  216 (1039)
T ss_pred             EeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHhhhcccchHHHHHhhccccceeHHHHHH
Confidence            366777775433        234455555689999999999986  5688999999999999999986667799999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Cc-cccccccccccccccccCCCCC
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQ-TTKLVGTFGYMAPELMRTGKAS  177 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~-~~~~~~~~~y~aPE~~~~~~~~  177 (313)
                      ++.||+.|+.||.   .++++||||-..|+++.....+||+|||+.+..+.... .. .....-...|+|||.+....++
T Consensus       217 ya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS  293 (1039)
T KOG0199|consen  217 YAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS  293 (1039)
T ss_pred             HHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc
Confidence            9999999999999   58999999999999999999999999999976543321 11 1112235579999999999999


Q ss_pred             cchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      .++|+|++|+++|||.+ |+.||.+.....+...++                ....-.-+..+++.+++++..||..+|.
T Consensus       294 haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----------------~~erLpRPk~csedIY~imk~cWah~pa  357 (1039)
T KOG0199|consen  294 HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----------------AGERLPRPKYCSEDIYQIMKNCWAHNPA  357 (1039)
T ss_pred             ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----------------ccccCCCCCCChHHHHHHHHHhccCCcc
Confidence            99999999999999999 999999988777665553                1112224667889999999999999999


Q ss_pred             CCCCHHHHHH
Q 048068          257 ARPNMRQVMQ  266 (313)
Q Consensus       257 ~Rpt~~ell~  266 (313)
                      +|||+..|.+
T Consensus       358 DRptFsair~  367 (1039)
T KOG0199|consen  358 DRPTFSAIRE  367 (1039)
T ss_pred             ccccHHHHHH
Confidence            9999999973

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=212.08  Aligned_cols=234  Identities=21%  Similarity=0.216  Sum_probs=178.8

Q ss_pred             CChhhHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHh
Q 048068           37 EDPQLQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        37 ~~~~~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      ...+.+...+..+.|+|+++..+++...     -...|+|||+| ..+|.+++...    ++-..+..+++|++.|++||
T Consensus        60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~l  134 (369)
T KOG0665|consen   60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHL  134 (369)
T ss_pred             hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHH
Confidence            4556777888999999999999999832     34689999999 66999999843    78889999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                      |   ..+|+||||||+||++..+..+||.|||++..-...  ........+..|+|||++.+..+.+.+||||+||++.|
T Consensus       135 h---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gE  209 (369)
T KOG0665|consen  135 H---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  209 (369)
T ss_pred             H---hcceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHH
Confidence            9   599999999999999999999999999999754433  24555677889999999999889999999999999999


Q ss_pred             HHhCCCCCccCCchhhhhHHHHHHHh---------hhh-----------cc--ccccc---cccccCCccHHHHHHHHHH
Q 048068          192 VASGRRPIEQQGSMEMVNLVDWVSDC---------WKK-----------GA--ILDAS---DSRLEGIYEEEQMELVLKL  246 (313)
Q Consensus       192 ll~g~~pf~~~~~~~~~~~~~~~~~~---------~~~-----------~~--~~~~~---~~~~~~~~~~~~~~~l~~l  246 (313)
                      |++|+..|.+.+..+.+..+....+.         ...           ..  ..+..   .-...-+.+.-.....+++
T Consensus       210 li~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardl  289 (369)
T KOG0665|consen  210 LILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDL  289 (369)
T ss_pred             HhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHH
Confidence            99999999988777776555221111         000           00  00000   0000011122345678999


Q ss_pred             HHHcCCCCCCCCCCHHHHHHHH--h---ccCCCCCCCCC
Q 048068          247 GLFCSHPKPEARPNMRQVMQYL--D---GNATLPDIPRD  280 (313)
Q Consensus       247 i~~cl~~~P~~Rpt~~ell~~L--~---~~~~~~~~~~~  280 (313)
                      +.+||-.||++|.+++++|+|-  .   +...++.|+..
T Consensus       290 l~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe  328 (369)
T KOG0665|consen  290 LSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE  328 (369)
T ss_pred             HHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence            9999999999999999999974  3   33444444444

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.4e-28  Score=222.44  Aligned_cols=216  Identities=21%  Similarity=0.277  Sum_probs=159.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC-----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.+.|++++++.+++...+     ...++|+||+ +++|.+++..   ..+++..++.++.|++.|+.|||   
T Consensus        63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---  135 (343)
T cd07851          63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---  135 (343)
T ss_pred             HHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---
Confidence            3567778889999999887766422     3589999999 7799999875   35999999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHh
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~  194 (313)
                      ..+++|+||+|+||+++.++.++|+|||++......    .....++..|++||.+.+ ..++.++|+||||+++|++++
T Consensus       136 ~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt  211 (343)
T cd07851         136 SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT  211 (343)
T ss_pred             HCCeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh
Confidence            589999999999999999999999999998754332    223456788999998865 367889999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHh--------hhhcccc---ccccccccCC---ccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDC--------WKKGAIL---DASDSRLEGI---YEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      |+.||...........+......        +......   ..........   .....+..+.++|.+||+.||++|||
T Consensus       212 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt  291 (343)
T cd07851         212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT  291 (343)
T ss_pred             CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC
Confidence            99999866544332222111000        0000000   0000000000   01123567899999999999999999


Q ss_pred             HHHHHHH
Q 048068          261 MRQVMQY  267 (313)
Q Consensus       261 ~~ell~~  267 (313)
                      +.++++|
T Consensus       292 ~~ell~h  298 (343)
T cd07851         292 AAEALAH  298 (343)
T ss_pred             HHHHhcC
Confidence            9999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=7.7e-28  Score=213.09  Aligned_cols=200  Identities=24%  Similarity=0.346  Sum_probs=151.6

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcE
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV  129 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nI  129 (313)
                      .|+++++.++.+.. +...++||||+ +++|.+++... ...+++..+..++.|++.|+.|||+  ..+++|+||+|+||
T Consensus        72 ~~~~i~~~~~~~~~-~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~ni  146 (296)
T cd06618          72 DCPYIVKCYGYFIT-DSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNI  146 (296)
T ss_pred             CCCchHhhheeeec-CCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHE
Confidence            59999999999876 56899999998 55888877654 3469999999999999999999995  35999999999999


Q ss_pred             EEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC----CCcchhhHHHHHHHHHHHhCCCCCccCCch
Q 048068          130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK----ASTSTDVYAFGVFMLEVASGRRPIEQQGSM  205 (313)
Q Consensus       130 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~  205 (313)
                      +++.++.++|+|||++........  .....++..|++||.+.+..    ++.++|+||||+++|+|++|+.||......
T Consensus       147 ll~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  224 (296)
T cd06618         147 LLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE  224 (296)
T ss_pred             EEcCCCCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH
Confidence            999999999999999865433221  12234677899999987543    688999999999999999999999653221


Q ss_pred             hhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      .  ....   ...... .     +..+  ........+.+++.+||+.||.+|||++++++|-.
T Consensus       225 ~--~~~~---~~~~~~-~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         225 F--EVLT---KILQEE-P-----PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             H--HHHH---HHhcCC-C-----CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            1  1111   001110 0     0000  11123467899999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=1.9e-28  Score=220.58  Aligned_cols=219  Identities=23%  Similarity=0.290  Sum_probs=156.4

Q ss_pred             HHhhhhhc-cccceeeeeeEEe---ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           42 QRDGLASV-HSNGLLQLTNTVN---SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        42 ~~~~l~~~-~~~~~l~~~~~~~---~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      +...++.+ .|+++++..+...   .....++++++++ +++|.+++..  ...+++..++.++.||+.||.|||   ..
T Consensus        51 E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~  124 (332)
T cd07857          51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIH---SA  124 (332)
T ss_pred             HHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            44556666 5999999887643   2235678999998 5689998865  346999999999999999999999   68


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCC---CccccccccccccccccccC-CCCCcchhhHHHHHHHHHHH
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI---PQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  193 (313)
                      +++|+||+|+||+++.++.++|+|||++........   .......++..|++||...+ ..++.++|+||+|+++|+++
T Consensus       125 givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~  204 (332)
T cd07857         125 NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL  204 (332)
T ss_pred             CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999875432211   11223467889999998765 46789999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHh-----hh---hcc-------ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDC-----WK---KGA-------ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~-----~~---~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      +|.+||...+.......+......     +.   ...       .......... .........+.+++.+||+.||.+|
T Consensus       205 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R  283 (332)
T cd07857         205 GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKR  283 (332)
T ss_pred             hCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccC
Confidence            999999865543322211100000     00   000       0000000000 0111234678999999999999999


Q ss_pred             CCHHHHHHH
Q 048068          259 PNMRQVMQY  267 (313)
Q Consensus       259 pt~~ell~~  267 (313)
                      ||+.+++++
T Consensus       284 ~t~~~ll~~  292 (332)
T cd07857         284 ISVEEALEH  292 (332)
T ss_pred             CCHHHHhcC
Confidence            999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.4e-28  Score=218.31  Aligned_cols=216  Identities=22%  Similarity=0.271  Sum_probs=157.3

Q ss_pred             HHhhhhhccccceeeeeeEEec-----cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           42 QRDGLASVHSNGLLQLTNTVNS-----RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~-----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      +...++.++|++++++.+++..     .....+++++++ +++|.+++...   .+++..++.++.|++.|+.|||   .
T Consensus        66 Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~  138 (345)
T cd07877          66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---S  138 (345)
T ss_pred             HHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---H
Confidence            5567788899999999988763     224578899987 88999888643   4899999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g  195 (313)
                      .+++|+||+|+||+++.++.++|+|||++.....    ......++..|+|||.+.+ ..++.++|+|||||++|++++|
T Consensus       139 ~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  214 (345)
T cd07877         139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG  214 (345)
T ss_pred             CCeeecCCChHHEEEcCCCCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhC
Confidence            8999999999999999999999999999864322    1223456888999998865 4678899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhcc---cc--------ccccccccC---CccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGA---IL--------DASDSRLEG---IYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~--------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      +.||...........+...........   ..        .........   .........+.++|..||+.||.+|||+
T Consensus       215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  294 (345)
T cd07877         215 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  294 (345)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence            999976544332221111000000000   00        000000000   0001134567899999999999999999


Q ss_pred             HHHHHHH
Q 048068          262 RQVMQYL  268 (313)
Q Consensus       262 ~ell~~L  268 (313)
                      .++++|-
T Consensus       295 ~e~l~h~  301 (345)
T cd07877         295 AQALAHA  301 (345)
T ss_pred             HHHhcCh
Confidence            9999975

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=226.88  Aligned_cols=229  Identities=25%  Similarity=0.316  Sum_probs=169.8

Q ss_pred             CChhhHHhhhhhccccceeeeeeEEeccC-----CeEEEEEecCCCCCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHH
Q 048068           37 EDPQLQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHT-NIKPSLSWYQRFRIIRGVASGLLY  110 (313)
Q Consensus        37 ~~~~~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~  110 (313)
                      +.--.|.+++++++|+|||+..++-....     ....+|||||.||+|..++.+ .+..++++..++.++..+..|+.|
T Consensus        56 e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~  135 (732)
T KOG4250|consen   56 ERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRH  135 (732)
T ss_pred             HHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHH
Confidence            34447788999999999999999887433     467899999999999999985 346789999999999999999999


Q ss_pred             hhhcCCCCceecCcCCCcEEEcCC--C--cEEEeecccccccCCCCCCcccccccccccccccccc-CCCCCcchhhHHH
Q 048068          111 LHEDWEQVVLHRDIKPANVLLDAD--L--NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-TGKASTSTDVYAF  185 (313)
Q Consensus       111 lhs~~~~~i~H~dl~~~nIlv~~~--~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diwsl  185 (313)
                      ||   +.+|+||||||.||++...  |  ..||+|||.++......  ......||..|.+||.+. .+.|+..+|.|||
T Consensus       136 Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~  210 (732)
T KOG4250|consen  136 LR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSF  210 (732)
T ss_pred             HH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence            99   7999999999999999532  3  36999999998665544  455689999999999998 4788999999999


Q ss_pred             HHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhh------------hccccccccccccCCccHHHHHHHHHHHHHcCCC
Q 048068          186 GVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK------------KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHP  253 (313)
Q Consensus       186 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  253 (313)
                      ||++|+++||..||.......-...+.+.....+            ++.+.-...-..+-.........+...+..+|..
T Consensus       211 GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~  290 (732)
T KOG4250|consen  211 GVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEW  290 (732)
T ss_pred             hhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhh
Confidence            9999999999999975443321111111111111            1111100111112233444556778888889999


Q ss_pred             CCCCCC--CHHHHHHHHhc
Q 048068          254 KPEARP--NMRQVMQYLDG  270 (313)
Q Consensus       254 ~P~~Rp--t~~ell~~L~~  270 (313)
                      +|.+|.  .+.+....+.+
T Consensus       291 ~~~~~~~~~~~~~Fa~~~d  309 (732)
T KOG4250|consen  291 NPRKRGHEGFDRFFAEVDD  309 (732)
T ss_pred             hHHHhCCCCcchHHHHHHH
Confidence            999998  55555544443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.4e-28  Score=220.98  Aligned_cols=221  Identities=21%  Similarity=0.274  Sum_probs=160.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC-----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.++|++++++.+++....     ..+++||||+ +++|.+++...   .+++..+..++.|++.|+.|||   
T Consensus        63 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH---  135 (343)
T cd07880          63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIH---  135 (343)
T ss_pred             HHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---
Confidence            4667788999999999998887432     2569999999 78999888743   5899999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHh
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~  194 (313)
                      ..+++|+||+|+||+++.++.++|+|||++......    .....++..|++||.+.+ ..++.++|+||||+++|++++
T Consensus       136 ~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  211 (343)
T cd07880         136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT  211 (343)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            689999999999999999999999999998654322    223456788999998875 457889999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHh--------hhhccccc----ccccc--ccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDC--------WKKGAILD----ASDSR--LEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~----~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      |..||.+.........+......        +.......    .....  ............+.+++.+||+.||.+|||
T Consensus       212 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t  291 (343)
T cd07880         212 GKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT  291 (343)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC
Confidence            99999866543322211100000        00000000    00000  000011223456889999999999999999


Q ss_pred             HHHHHHH--HhccC
Q 048068          261 MRQVMQY--LDGNA  272 (313)
Q Consensus       261 ~~ell~~--L~~~~  272 (313)
                      +.+++.|  ++...
T Consensus       292 ~~~~l~~~~~~~~~  305 (343)
T cd07880         292 AAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHhcCccHhhhc
Confidence            9999964  44443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.8e-29  Score=220.53  Aligned_cols=210  Identities=23%  Similarity=0.296  Sum_probs=178.1

Q ss_pred             CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           37 EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        37 ~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      +-...|+.++-+...+-|++.+-.+.+ +.++|++||.|-||.|+.++++.  +.|++.....++..+++|+.|||   .
T Consensus       465 eHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH---~  538 (732)
T KOG0614|consen  465 EHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLH---R  538 (732)
T ss_pred             HHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHH---h
Confidence            445578888999999999999998887 66899999999999999999884  46999999999999999999999   6


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      ++|+.|||||+|++++.+|-+||.|||++.......  +..++.||+.|.|||++..+..+.+.|.||||+++||+++|.
T Consensus       539 k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~  616 (732)
T KOG0614|consen  539 KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS  616 (732)
T ss_pred             cCceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence            999999999999999999999999999999877665  566789999999999999999999999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHh
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQYLD  269 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~L~  269 (313)
                      +||.+.+....+.++-.--+.|               .+|........++|.+.-..+|.+|.-     +.++-+|.+
T Consensus       617 pPFs~~dpmktYn~ILkGid~i---------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  617 PPFSGVDPMKTYNLILKGIDKI---------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             CCCCCCchHHHHHHHHhhhhhh---------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            9999999888777662111111               133344455667777778899999975     778877753

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3e-28  Score=206.29  Aligned_cols=217  Identities=21%  Similarity=0.290  Sum_probs=164.1

Q ss_pred             hhhHHhhhhhc-------cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHh
Q 048068           39 PQLQRDGLASV-------HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        39 ~~~~~~~l~~~-------~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      -+.....++++       .|+|++++.+++.+ +..+|||||-|.||+|-..|.++  +.|++..+..+.+.|+.||.+|
T Consensus       116 gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFl  192 (463)
T KOG0607|consen  116 GHSRSRVFREVETFYQCQGHKNILQLIEFFED-DTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFL  192 (463)
T ss_pred             chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHH
Confidence            34455566666       59999999999887 67999999999999999999875  3599999999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCc---EEEeecccccccCCCC------CCcccccccccccccccccc-----CCCCC
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGLARLYDHDT------IPQTTKLVGTFGYMAPELMR-----TGKAS  177 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~---~~l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~-----~~~~~  177 (313)
                      |   .+||.|||+||+|||-.....   +||+||.+........      .....+..|+..|+|||+..     ...|+
T Consensus       193 H---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YD  269 (463)
T KOG0607|consen  193 H---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYD  269 (463)
T ss_pred             h---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccc
Confidence            9   799999999999999976544   7999998875332111      11233457888899999863     23578


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCccCCchhhh-------hHHH-HHHHhhhhccccccccccccCCccHHHHHHHHHHHHH
Q 048068          178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMV-------NLVD-WVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF  249 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  249 (313)
                      .++|.||||+|+|-|+.|.+||.++-..+..       ..++ .+-...+++.      ...++..-...+....+++..
T Consensus       270 KrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk------YeFPdkdWahIS~eakdlisn  343 (463)
T KOG0607|consen  270 KRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK------YEFPDKDWAHISSEAKDLISN  343 (463)
T ss_pred             ccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC------CcCChhhhHHhhHHHHHHHHH
Confidence            9999999999999999999999876554332       1111 0111111111      123333445566778899999


Q ss_pred             cCCCCCCCCCCHHHHHHH
Q 048068          250 CSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       250 cl~~~P~~Rpt~~ell~~  267 (313)
                      .|..++..|.++.++++|
T Consensus       344 Llvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  344 LLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHhccHHhhhhhhhccCC
Confidence            999999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=3.3e-27  Score=201.50  Aligned_cols=206  Identities=28%  Similarity=0.365  Sum_probs=162.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+.+.++.++|+++++..+.... ....++++|++.+++|.+++....  .++...++.++.+++.++.+||   ..++
T Consensus        35 ~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i  108 (244)
T smart00220       35 LREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLH---SNGI  108 (244)
T ss_pred             HHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HcCe
Confidence            355566777899999998888876 578999999999889999998643  3899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|.||+++.++.++++|||.+.......  ......++..|++||...+..++.++|+|+||++++++++|..||
T Consensus       109 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~  186 (244)
T smart00220      109 IHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPF  186 (244)
T ss_pred             ecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987654432  223445678899999998888889999999999999999999999


Q ss_pred             ccCCchhh-hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEM-VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ........ ....       .....      ... .........+.+++.+||..+|++||++.+++++
T Consensus       187 ~~~~~~~~~~~~~-------~~~~~------~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      187 PGDDQLLELFKKI-------GKPKP------PFP-PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             CCCCcHHHHHHHH-------hccCC------CCc-cccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            76332221 1111       00000      000 0000044678899999999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.6e-28  Score=199.82  Aligned_cols=232  Identities=24%  Similarity=0.349  Sum_probs=172.6

Q ss_pred             EcccCCChhhHHhhhhhccccceeeeeeEEe-------ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHH
Q 048068           32 YHGFNEDPQLQRDGLASVHSNGLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGV  104 (313)
Q Consensus        32 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi  104 (313)
                      ...+-...-.+...+..++|++++.+..++.       .....+|+|+.+|+. +|..++.+. ...++...+.+++.++
T Consensus        56 KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~L  133 (376)
T KOG0669|consen   56 KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGL  133 (376)
T ss_pred             ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHH
Confidence            3444445556777888888998888777766       224568999999954 888888765 4569999999999999


Q ss_pred             HHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccccccccC-CCCCcch
Q 048068          105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPELMRT-GKASTST  180 (313)
Q Consensus       105 ~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~  180 (313)
                      ..||.|+|   ...|+|||+|+.|++|+.+|.++|+|||+++.+......   ......-|.+|++||.+.+ ..++++.
T Consensus       134 m~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~i  210 (376)
T KOG0669|consen  134 MNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPI  210 (376)
T ss_pred             HHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcc
Confidence            99999999   689999999999999999999999999999655322211   1223455899999998876 5789999


Q ss_pred             hhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHH-----Hhhhhcccccccc----ccccC-Ccc--HH------HHHH
Q 048068          181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS-----DCWKKGAILDASD----SRLEG-IYE--EE------QMEL  242 (313)
Q Consensus       181 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~-~~~--~~------~~~~  242 (313)
                      |+|+.||++.+|.++.+-+.+..+.....++...-     +.|.+-.-.+...    +.+++ .+.  .+      -.+.
T Consensus       211 DiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~  290 (376)
T KOG0669|consen  211 DIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDE  290 (376)
T ss_pred             hhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChh
Confidence            99999999999999999999988887776664432     2233211100000    00000 000  00      1235


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..+|+..+|..||.+|+++++++.|-
T Consensus       291 a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  291 ALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             HHHHHHHHhccCcccCcchHhhhchh
Confidence            67899999999999999999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-27  Score=207.97  Aligned_cols=125  Identities=26%  Similarity=0.257  Sum_probs=100.8

Q ss_pred             CCCcchhhhhHHHHHHHHhhccccc---eEEEcccC------CChhhHHhhhhhcc--------ccceeeeeeEEe---c
Q 048068            4 APRSFYFCVLLCVSFILSALAQDVN---QFIYHGFN------EDPQLQRDGLASVH--------SNGLLQLTNTVN---S   63 (313)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------~~~~~~~~~l~~~~--------~~~~l~~~~~~~---~   63 (313)
                      +.|....++++=|.|+.+|+.-+.-   .+++|..+      +..-.|..++++++        -..+|++.+.+.   .
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            4678888999999999999998864   33444333      23335556666662        334666555555   6


Q ss_pred             cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE
Q 048068           64 RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL  131 (313)
Q Consensus        64 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv  131 (313)
                      ++.|+|+|+|++ |.+|-.+|+...-++++...++.|++||+.||.|||.  +.||+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            788999999999 8899999988777889999999999999999999999  7899999999999999

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=2.2e-27  Score=231.40  Aligned_cols=101  Identities=34%  Similarity=0.514  Sum_probs=89.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++++..+.. .+++|+||||+.+++|.+++...  +.+++..++.++.||+.||.|||   ..+|
T Consensus        52 ~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH---~~gI  125 (669)
T cd05610          52 QAERDALALSKSPFIVHLYYSLQS-ANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLH---RHGI  125 (669)
T ss_pred             HHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence            345566778899999999887765 66899999999999999999763  35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      +|+||||+|||++.++.++|+|||++.
T Consensus       126 iHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         126 IHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=209.30  Aligned_cols=195  Identities=24%  Similarity=0.337  Sum_probs=154.1

Q ss_pred             hHHhhhhhcccccee-eeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLL-QLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l-~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|++.+....-|..+ +....++ .-+++|+||||++||+|-..+++-  +++.+..+.-++..|+-||-+||   .+||
T Consensus       398 ~EKrvLAL~~kppFL~qlHScFQ-TmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh---~kgI  471 (683)
T KOG0696|consen  398 VEKRVLALPGKPPFLVQLHSCFQ-TMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLH---SKGI  471 (683)
T ss_pred             hhhhheecCCCCchHHHHHHHhh-hhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhh---cCCe
Confidence            344444444333333 3333333 356899999999999998888763  46999999999999999999999   6999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +.||||.+||+++..|.+||+|||++...-... ....++.||+-|+|||++..+.|..+.|-||+|+++|||+.|++||
T Consensus       472 iYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPF  550 (683)
T KOG0696|consen  472 IYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF  550 (683)
T ss_pred             eeeeccccceEeccCCceEeeecccccccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999997543332 2356789999999999999999999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      .+.++.+....+.-                 -...++...+.....+....|..+|.+|.
T Consensus       551 dGeDE~elF~aI~e-----------------hnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  551 DGEDEDELFQAIME-----------------HNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             CCCCHHHHHHHHHH-----------------ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            99998887766631                 12224555555566666667888999884

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-27  Score=222.22  Aligned_cols=200  Identities=23%  Similarity=0.347  Sum_probs=170.0

Q ss_pred             cccceeeeeeEEe----ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcC
Q 048068           50 HSNGLLQLTNTVN----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        50 ~~~~~l~~~~~~~----~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~  125 (313)
                      .|+|+...++++.    -.++.++||||||.||+..++++.-.+..+.|..+.-|++.++.|+.+||   ...++|||+|
T Consensus        74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDik  150 (953)
T KOG0587|consen   74 HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIK  150 (953)
T ss_pred             CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeeccc
Confidence            7999999999888    34679999999999999999999766778999999999999999999999   7899999999


Q ss_pred             CCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      -.|||++.++.+|++|||++....... ....+..||++|+|||++..     ..|+.++|+||||++..||..|.+|+.
T Consensus       151 G~NiLLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~  229 (953)
T KOG0587|consen  151 GQNVLLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC  229 (953)
T ss_pred             CceEEEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence            999999999999999999998665433 34566789999999999853     356789999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +.........+              .+.|.+.-.-+......+.++|..||..|..+||++.++++|
T Consensus       230 DmHPmraLF~I--------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  230 DMHPMRALFLI--------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             CcchhhhhccC--------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            87665544333              122333333466778899999999999999999999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-29  Score=205.79  Aligned_cols=227  Identities=23%  Similarity=0.276  Sum_probs=170.4

Q ss_pred             ccccceEEEcccCC--ChhhHHhhhhhc-------cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh---CCCCC
Q 048068           24 AQDVNQFIYHGFNE--DPQLQRDGLASV-------HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT---NIKPS   91 (313)
Q Consensus        24 ~~~~~~~~~~~~~~--~~~~~~~~l~~~-------~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~---~~~~~   91 (313)
                      +..+...++|++..  .....++++.++       +.++|+++++.... ++..++.||.| ..+|.-+.+.   -.+..
T Consensus        86 k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCMELM-d~SlDklYk~vy~vq~~~  163 (361)
T KOG1006|consen   86 KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICMELM-DISLDKLYKRVYSVQKSR  163 (361)
T ss_pred             CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHHHH-hhhHHHHHHHHHHHHhcc
Confidence            44455677777753  334445555544       68999999999887 67899999999 5577666542   12456


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccc
Q 048068           92 LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM  171 (313)
Q Consensus        92 ~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  171 (313)
                      ++++.+-++..-.+.||.||-.  ...|+|||+||+|||++..|.+||||||.+-......  ......|...|+|||.+
T Consensus       164 ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi  239 (361)
T KOG1006|consen  164 IPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERI  239 (361)
T ss_pred             CcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH--HhhhccCCccccChhcc
Confidence            9999999999999999999987  6889999999999999999999999999886543322  22335678889999998


Q ss_pred             c--CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccccccccc-CCccHHHHHHHHHHHH
Q 048068          172 R--TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE-GIYEEEQMELVLKLGL  248 (313)
Q Consensus       172 ~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  248 (313)
                      .  +..|+.++|+||||++|||++||..|+.+++.. ..++.+.+....+          .+. ..-..+.+..+.++|.
T Consensus       240 ~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-feql~~Vv~gdpp----------~l~~~~~~~~~s~~~~~fin  308 (361)
T KOG1006|consen  240 DPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FEQLCQVVIGDPP----------ILLFDKECVHYSFSMVRFIN  308 (361)
T ss_pred             CCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HHHHHHHHcCCCC----------eecCcccccccCHHHHHHHH
Confidence            5  346899999999999999999999999988762 2222222211111          111 1112346678999999


Q ss_pred             HcCCCCCCCCCCHHHHHHH
Q 048068          249 FCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       249 ~cl~~~P~~Rpt~~ell~~  267 (313)
                      -||-.|-..||.+.++.++
T Consensus       309 tCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  309 TCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHhhcccccCcchhhhhcC
Confidence            9999999999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-27  Score=226.39  Aligned_cols=224  Identities=21%  Similarity=0.368  Sum_probs=172.6

Q ss_pred             ceEEEcccCCChh--hHHhhh------hhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC------C---
Q 048068           28 NQFIYHGFNEDPQ--LQRDGL------ASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI------K---   89 (313)
Q Consensus        28 ~~~~~~~~~~~~~--~~~~~l------~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~------~---   89 (313)
                      ..+++|.+.+...  ....+.      +.+ .|+|++...+.+.. ++..++|+||++.|+|..+++...      .   
T Consensus       329 ~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~  407 (609)
T KOG0200|consen  329 VTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV  407 (609)
T ss_pred             EEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence            3556666653222  233333      333 59999999998887 789999999999999999998653      0   


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccc--cc
Q 048068           90 -----PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV--GT  162 (313)
Q Consensus        90 -----~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~--~~  162 (313)
                           ..+....++.++.||+.|++||+   ...++||||-..|||+..+..+||+|||+++..............  -.
T Consensus       408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP  484 (609)
T KOG0200|consen  408 FPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP  484 (609)
T ss_pred             CccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence                 13888999999999999999999   589999999999999999999999999999854433322212112  34


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCC-chhhhhHHHHHHHhhhhccccccccccccCCccHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQG-SMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM  240 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (313)
                      ..|+|||.+....++.++||||+|+++||+.+ |..||.+.. ..+...   +    .+.|.+         -..|..+.
T Consensus       485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~---~----l~~G~r---------~~~P~~c~  548 (609)
T KOG0200|consen  485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE---F----LKEGNR---------MEQPEHCS  548 (609)
T ss_pred             eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH---H----HhcCCC---------CCCCCCCC
Confidence            56999999999999999999999999999999 889998743 222221   1    112211         12345567


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          241 ELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +.+.++|..||+.+|++||++.++.+.++..
T Consensus       549 ~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  549 DEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            8889999999999999999999999999984

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=2.7e-27  Score=225.83  Aligned_cols=197  Identities=18%  Similarity=0.192  Sum_probs=132.1

Q ss_pred             ccCCeEEEEEecCCCCCHHHHHhhCCC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCc
Q 048068           63 SRKGEFLLVYDYMPNGSLDKILHTNIK------------------PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI  124 (313)
Q Consensus        63 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl  124 (313)
                      ..+...++||||+.+++|.+++.....                  .......+..++.||+.||.|||   ..+|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence            346689999999999999999875321                  01223456789999999999999   589999999


Q ss_pred             CCCcEEEcC-CCcEEEeecccccccCCCCCCccccccccccccccccccCC----------------------CCCcchh
Q 048068          125 KPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG----------------------KASTSTD  181 (313)
Q Consensus       125 ~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  181 (313)
                      ||+|||++. ++.+||+|||++...............+++.|+|||.+...                      ++..++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 57899999999975543333333456778999999965321                      2345679


Q ss_pred             hHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHH------HhhhhccccccccccccC--CccHHHHHHHHHHHHHcCCC
Q 048068          182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS------DCWKKGAILDASDSRLEG--IYEEEQMELVLKLGLFCSHP  253 (313)
Q Consensus       182 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~  253 (313)
                      ||||||++|||+++..++...    .........      ..|....... ..+....  ...........+|+.+||+.
T Consensus       362 VwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccC
Confidence            999999999999876654321    111111000      1111100000 0000000  00011123455899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 048068          254 KPEARPNMRQVMQY  267 (313)
Q Consensus       254 ~P~~Rpt~~ell~~  267 (313)
                      ||.+|||++|+++|
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999997

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-27  Score=227.50  Aligned_cols=206  Identities=28%  Similarity=0.315  Sum_probs=159.1

Q ss_pred             HhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           43 RDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        43 ~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      ...+.--+..=++....-+++ +.++|+|||||+||+|-.++.+..  .+++.-++.++..|+.||..+|   ..|++||
T Consensus       126 RDimv~~ns~Wiv~LhyAFQD-~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHR  199 (1317)
T KOG0612|consen  126 RDIMVFGNSEWIVQLHYAFQD-ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHR  199 (1317)
T ss_pred             hHHHHcCCcHHHHHHHHHhcC-ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceec
Confidence            333333344455555555555 779999999999999999998753  6999999999999999999999   6999999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc----C-CCCCcchhhHHHHHHHHHHHhCCC
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR----T-GKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      ||||+|||++..|.++|+|||.+-.......-.....+|||-|++||++.    + +.|+..+|-||+|+++|||+.|..
T Consensus       200 DiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T  279 (1317)
T KOG0612|consen  200 DIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET  279 (1317)
T ss_pred             cCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence            99999999999999999999999877655544455678999999999985    2 568899999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN---MRQVMQYL  268 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ell~~L  268 (313)
                      ||....-.+++..|......+.           .|  .....+...++||+..+ -+|+.|..   ++++-.|.
T Consensus       280 PFYadslveTY~KIm~hk~~l~-----------FP--~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  280 PFYADSLVETYGKIMNHKESLS-----------FP--DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             cchHHHHHHHHHHHhchhhhcC-----------CC--cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence            9998777777766643211111           11  11224445556665555 47788887   99988863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=9.7e-27  Score=212.29  Aligned_cols=164  Identities=27%  Similarity=0.394  Sum_probs=141.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|..+|.|.+..=+++++..+++ ++.+|+||+|++||++-.+|-+.  +-|++..++.++..+..|+++.|   +.|+
T Consensus       677 KAERDILAEADn~WVVrLyySFQD-kdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVH---kmGF  750 (1034)
T KOG0608|consen  677 KAERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVH---KMGF  750 (1034)
T ss_pred             hhhhhhHhhcCCcceEEEEEEecc-CCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHH---hccc
Confidence            367789999999999999999998 67899999999999999998773  46999999999999999999999   7999


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCC-----------------------------------------CCcccc
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-----------------------------------------IPQTTK  158 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-----------------------------------------~~~~~~  158 (313)
                      +||||||+||||+.+|.+||.|||++.-+....                                         ......
T Consensus       751 IHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahs  830 (1034)
T KOG0608|consen  751 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHS  830 (1034)
T ss_pred             eecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhh
Confidence            999999999999999999999999996442110                                         000012


Q ss_pred             ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhh
Q 048068          159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN  209 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  209 (313)
                      ..||+.|+|||++....++..+|-||.|+|||||+.|++||......+...
T Consensus       831 lvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  831 LVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             hcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCccee
Confidence            368999999999999999999999999999999999999998776665443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=3.6e-26  Score=186.92  Aligned_cols=167  Identities=19%  Similarity=0.200  Sum_probs=125.6

Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      |+|.++++.. +..+++..++.++.|++.||.|||+   .+      ||+||+++.++.+++  ||++.......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            6899999864 4469999999999999999999994   44      999999999999998  99886543321     


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                       ..+++.|+|||++.+..++.++|||||||++|+|++|+.||........... ..... ....      .+. ......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~-~~~~------~~~-~~~~~~  133 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE-ILLNG-MPAD------DPR-DRSNLE  133 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH-HHHHH-hccC------Ccc-ccccHH
Confidence             2578999999999988999999999999999999999999975433221110 11100 0000      000 001122


Q ss_pred             HHHH--HHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          238 EQME--LVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       238 ~~~~--~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ....  .+.+++..||+.||.+|||+.++++|+...
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            2333  689999999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-28  Score=215.78  Aligned_cols=210  Identities=23%  Similarity=0.299  Sum_probs=166.7

Q ss_pred             CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           37 EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        37 ~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      +..+.|..+++++.||+++.+...+.. .+.++.|||-+.|.-|.-++... ++.+++..-+.++.||+.||+|||   -
T Consensus       608 sqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~GDMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH---~  682 (888)
T KOG4236|consen  608 SQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKLHGDMLEMILSSE-KGRLPERITKFLVTQILVALRYLH---F  682 (888)
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhhcchHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhh---h
Confidence            345577788999999999988888775 77999999999664455445443 678999999999999999999999   6


Q ss_pred             CCceecCcCCCcEEEcCC---CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          117 QVVLHRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                      ++|+|.||||+|||+...   -++||||||+++..++..  ......||+.|+|||++..+.|...-|+||+|+|+|--+
T Consensus       683 knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL  760 (888)
T KOG4236|consen  683 KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL  760 (888)
T ss_pred             cceeeccCCchheeeccCCCCCceeeccccceeecchhh--hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe
Confidence            999999999999999754   468999999999887654  456689999999999999999999999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .|..||....+.  -..++..         .-+..+.+.    .+.+....+||...|+..-.+|.|.++.+.|-
T Consensus       761 SGTFPFNEdEdI--ndQIQNA---------aFMyPp~PW----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  761 SGTFPFNEDEDI--NDQIQNA---------AFMYPPNPW----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             cccccCCCccch--hHHhhcc---------ccccCCCch----hhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            999999754433  2222210         111122222    23445566777778999999999999988764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-26  Score=202.98  Aligned_cols=247  Identities=23%  Similarity=0.284  Sum_probs=179.5

Q ss_pred             CcchhhhhHHHHHHHHhhccccc---eEEEcccC--C------------ChhhHHhhhhhccccceeeeeeEEeccCCeE
Q 048068            6 RSFYFCVLLCVSFILSALAQDVN---QFIYHGFN--E------------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEF   68 (313)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~------------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~   68 (313)
                      |.+..-.++.|-|+.+|.+-+..   .++.|.-+  .            -.-.+..+-++++||.|++.++++.-+.+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            34444556677777777777654   22333221  1            1113455668999999999999999778899


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc---CCCcEEEeecccc
Q 048068           69 LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLA  145 (313)
Q Consensus        69 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~---~~~~~~l~dfg~~  145 (313)
                      |-|+|||+|-+|.-+++.+  +.+++..+..|+.||+.||.||..- +..|+|-||||.|||+-   ..|.+||.|||++
T Consensus       544 CTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             eeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            9999999999999999874  4699999999999999999999854 46799999999999984   3478999999999


Q ss_pred             cccCCCC------CCccccccccccccccccccCC----CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHH
Q 048068          146 RLYDHDT------IPQTTKLVGTFGYMAPELMRTG----KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS  215 (313)
Q Consensus       146 ~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  215 (313)
                      ..+....      ........||.+|++||.+.-+    +.+.+.||||+|+|+|.++.|+-||...-....+...   +
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe---N  697 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE---N  697 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh---h
Confidence            8775432      1223456799999999977533    3578999999999999999999999765443322111   1


Q ss_pred             HhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          216 DCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ...+...+   .-+.     -+..+.....||..||+..-++|....++..
T Consensus       698 TIlkAtEV---qFP~-----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  698 TILKATEV---QFPP-----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             chhcceec---cCCC-----CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            11111111   1111     1123345778999999999999999888765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=2.4e-27  Score=211.94  Aligned_cols=232  Identities=19%  Similarity=0.208  Sum_probs=169.1

Q ss_pred             ceEEEcccCCChhhHHhhhhhccc------------cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-CCCCCH
Q 048068           28 NQFIYHGFNEDPQLQRDGLASVHS------------NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSW   94 (313)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~l~~~~~------------~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~   94 (313)
                      .++++|.+......-+..++++..            -+.++++-.+ .+.+|+|||+|.+ ..+|.+++++-. +-++..
T Consensus       458 ~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-~hknHLClVFE~L-slNLRevLKKyG~nvGL~i  535 (752)
T KOG0670|consen  458 QEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHI  535 (752)
T ss_pred             CeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-hhcceeEEEehhh-hchHHHHHHHhCcccceee
Confidence            478888887766655555555432            1223333333 3378999999999 779999998743 456999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-CcEEEeecccccccCCCCCCccccccccccccccccccC
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT  173 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  173 (313)
                      ..+..++.|+..||..|-   .+|++|.||||+||||++. ..+||||||.+.......   ...+.-+..|+|||++.|
T Consensus       536 kaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG  609 (752)
T KOG0670|consen  536 KAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILG  609 (752)
T ss_pred             hHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeec
Confidence            999999999999999999   7999999999999999976 458999999987654432   222334567999999999


Q ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHH---------------hhhh--------------cc--
Q 048068          174 GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD---------------CWKK--------------GA--  222 (313)
Q Consensus       174 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------~~~~--------------~~--  222 (313)
                      -.|+...|+||+||+|||+.||+..|.+.....+..+..-+..               .+..              ..  
T Consensus       610 ~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~  689 (752)
T KOG0670|consen  610 LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKR  689 (752)
T ss_pred             CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeE
Confidence            9999999999999999999999999998877776655422211               1110              00  


Q ss_pred             -cccccccc------c-----cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          223 -ILDASDSR------L-----EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       223 -~~~~~~~~------~-----~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                       +.....|.      +     -..........+.+|+.+||..||.+|.|..|+|+|
T Consensus       690 ~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  690 TVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             EEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence             00000000      0     001122345688999999999999999999999987

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=8.5e-27  Score=232.04  Aligned_cols=180  Identities=17%  Similarity=0.245  Sum_probs=128.6

Q ss_pred             CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc---------
Q 048068           66 GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---------  136 (313)
Q Consensus        66 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~---------  136 (313)
                      ..++++||++ +++|.+++... ...+++..++.++.||+.||.|||   .++|+||||||+|||++..+.         
T Consensus        53 ~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~  127 (793)
T PLN00181         53 DSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASC  127 (793)
T ss_pred             chhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeecccc
Confidence            4678889988 67999999754 346999999999999999999999   699999999999999965444         


Q ss_pred             ----------EEEeecccccccCCCC---------------CCccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          137 ----------GKLGDFGLARLYDHDT---------------IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       137 ----------~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                                ++++|||++.......               ........+|+.|+|||++.+..++.++|||||||++||
T Consensus       128 ~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~E  207 (793)
T PLN00181        128 SDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFE  207 (793)
T ss_pred             CcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHH
Confidence                      4555555543211000               000011347888999999998889999999999999999


Q ss_pred             HHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          192 VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       192 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |++|.+|+.....  ......       ...    ..+.     ..........++.+||+.+|.+|||+.|+++|-
T Consensus       208 Ll~~~~~~~~~~~--~~~~~~-------~~~----~~~~-----~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        208 LFCPVSSREEKSR--TMSSLR-------HRV----LPPQ-----ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HhhCCCchhhHHH--HHHHHH-------Hhh----cChh-----hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999888653211  110000       000    0000     011123456788899999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1e-25  Score=199.60  Aligned_cols=260  Identities=25%  Similarity=0.304  Sum_probs=177.8

Q ss_pred             hHHHHHHHHhhccccc-eEEEcccCCChh----hHHhhhh--hccccceeeeeeEEe---ccCCeEEEEEecCCCCCHHH
Q 048068           13 LLCVSFILSALAQDVN-QFIYHGFNEDPQ----LQRDGLA--SVHSNGLLQLTNTVN---SRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        13 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~l~--~~~~~~~l~~~~~~~---~~~~~~~lV~e~~~~g~L~~   82 (313)
                      .+.|+|..+|.++-.+ .+++|.+.....    .|+.+.+  -++|+||+++...-.   .....++||++|.+.|+|.+
T Consensus       218 i~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~d  297 (534)
T KOG3653|consen  218 IGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCD  297 (534)
T ss_pred             hhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHH
Confidence            3457777777777654 778888864332    2332222  236777776555443   12448999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh------cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Cc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHE------DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQ  155 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs------~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~  155 (313)
                      +++.+   .+++....+++..++.||+|||.      ..+..|+|||||..||||..++..-|+|||++..+..... ..
T Consensus       298 yL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d  374 (534)
T KOG3653|consen  298 YLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGD  374 (534)
T ss_pred             HHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcc
Confidence            99976   49999999999999999999996      2367899999999999999999999999999976653322 22


Q ss_pred             cccccccccccccccccCC-CCC-----cchhhHHHHHHHHHHHhCCCCCc-cCCchhhhhHHHHHHHhhhhcccc----
Q 048068          156 TTKLVGTFGYMAPELMRTG-KAS-----TSTDVYAFGVFMLEVASGRRPIE-QQGSMEMVNLVDWVSDCWKKGAIL----  224 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~~-~~~-----~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~----  224 (313)
                      .....||..|+|||++.+. +..     .+.||||+|.++||++++...+. +...+...-...-+......+.+.    
T Consensus       375 ~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV  454 (534)
T KOG3653|consen  375 THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVV  454 (534)
T ss_pred             hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHH
Confidence            3347899999999999753 222     37999999999999999765543 222211111111111111110000    


Q ss_pred             -ccccccccC-CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCC
Q 048068          225 -DASDSRLEG-IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLP  275 (313)
Q Consensus       225 -~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~  275 (313)
                       +...|..+. ..-......+++.+..||+.||+.|.|+.=+.+.+.....+.
T Consensus       455 ~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  455 RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence             000011110 011134567899999999999999999999988888876554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.93  E-value=6.4e-26  Score=219.81  Aligned_cols=185  Identities=26%  Similarity=0.451  Sum_probs=137.4

Q ss_pred             ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeec
Q 048068           63 SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF  142 (313)
Q Consensus        63 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~df  142 (313)
                      .+...+||=||||+..+|.++++++.. .-..+..|+++.+|+.||.|+|   +.|++||||||.||+++.++.+||+||
T Consensus       666 q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDF  741 (1351)
T KOG1035|consen  666 QKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDF  741 (1351)
T ss_pred             ccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeeccc
Confidence            345678999999999888888887631 1258899999999999999999   689999999999999999999999999


Q ss_pred             ccccccC----------------CCC-CCccccccccccccccccccCC---CCCcchhhHHHHHHHHHHHhCCCCCccC
Q 048068          143 GLARLYD----------------HDT-IPQTTKLVGTFGYMAPELMRTG---KASTSTDVYAFGVFMLEVASGRRPIEQQ  202 (313)
Q Consensus       143 g~~~~~~----------------~~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (313)
                      |++....                ... ........||.-|.|||++.+.   .|+.|+|+||||++++||+.   ||.+.
T Consensus       742 GLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts  818 (1351)
T KOG1035|consen  742 GLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS  818 (1351)
T ss_pred             ccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch
Confidence            9997611                001 1123456899999999998754   59999999999999999985   46543


Q ss_pred             CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          203 GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      -+.  ...+.   . .+.+.+...      ..+..+....-.++|.+|++.||.+|||+.|+|+
T Consensus       819 MER--a~iL~---~-LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  819 MER--ASILT---N-LRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHH--HHHHH---h-cccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            221  11111   1 112222211      1122333344568999999999999999999986

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-25  Score=193.26  Aligned_cols=208  Identities=22%  Similarity=0.295  Sum_probs=171.0

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHh-----h-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH-----T-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~-----~-~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+....|+|++...++.......++.++.++.-|+|..++.     + +....++...+..++.|++.|++|||   +.+
T Consensus       340 lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~  416 (563)
T KOG1024|consen  340 LLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHG  416 (563)
T ss_pred             HHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcC
Confidence            44556899999999988877889999999999999999997     2 22456888889999999999999999   699


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccc-cCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GR  196 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  196 (313)
                      ++|.||-..|.+|++.-++||+|-.+++. ++..-.+.....-....|++||.+....|+.++|+||||+++||++| |+
T Consensus       417 ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~  496 (563)
T KOG1024|consen  417 VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGK  496 (563)
T ss_pred             cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCC
Confidence            99999999999999999999999998863 33333333333344668999999999999999999999999999999 99


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .|+..-+..+....+.       .|.         +-..|.++++++..+|..||...|++||+++|++.-|.+.
T Consensus       497 ~PyaeIDPfEm~~ylk-------dGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  497 LPYAEIDPFEMEHYLK-------DGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             CCccccCHHHHHHHHh-------ccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            9998877766554331       111         1124667889999999999999999999999999988654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=5.6e-26  Score=213.03  Aligned_cols=218  Identities=21%  Similarity=0.313  Sum_probs=159.4

Q ss_pred             eEEEcccCC----ChhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-C-CCCCHHHHHHHH
Q 048068           29 QFIYHGFNE----DPQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-K-PSLSWYQRFRII  101 (313)
Q Consensus        29 ~~~~~~~~~----~~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~-~~~~~~~~~~i~  101 (313)
                      .+++|++..    -.++|.+.+++- +|+|+|++++.-.+ ....|++.|.| ..+|.++++... . .....-..+.++
T Consensus       535 ~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l  612 (903)
T KOG1027|consen  535 EVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVL  612 (903)
T ss_pred             eehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHH
Confidence            445555532    334555555555 69999999988776 77999999999 679999998741 1 111114457789


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---CC--cEEEeecccccccCCCCCC--ccccccccccccccccccCC
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DL--NGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTG  174 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~--~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~  174 (313)
                      .|+++||++||   ..+|+||||||.||||..   ++  .++|+|||++.........  ......||.+|+|||++...
T Consensus       613 ~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~  689 (903)
T KOG1027|consen  613 SQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED  689 (903)
T ss_pred             HHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcc
Confidence            99999999999   599999999999999976   33  5789999999876544322  23456799999999999887


Q ss_pred             CCCcchhhHHHHHHHHHHHhC-CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCC
Q 048068          175 KASTSTDVYAFGVFMLEVASG-RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHP  253 (313)
Q Consensus       175 ~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  253 (313)
                      ....+.||||+||++|+.++| .+||......+.-  +  +    ....  .  ...+..  ..++  ...+||..|++.
T Consensus       690 ~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--I--l----~~~~--~--L~~L~~--~~d~--eA~dLI~~ml~~  753 (903)
T KOG1027|consen  690 RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--I--L----TGNY--T--LVHLEP--LPDC--EAKDLISRMLNP  753 (903)
T ss_pred             ccCcccchhhcCceEEEEecCCccCCCchHHhhhh--h--h----cCcc--c--eeeecc--CchH--HHHHHHHHhcCC
Confidence            778899999999999999995 9999876554311  1  0    0000  0  001111  1111  788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 048068          254 KPEARPNMRQVMQY  267 (313)
Q Consensus       254 ~P~~Rpt~~ell~~  267 (313)
                      +|..||++.+++.|
T Consensus       754 dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  754 DPQLRPSATDVLNH  767 (903)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-26  Score=213.20  Aligned_cols=210  Identities=25%  Similarity=0.342  Sum_probs=174.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.-.+..++|+|++++.++...  ..+.||++|+++|+|.++++.+ +..+..+..+.|++||++|+.|||   ++..+
T Consensus       747 deAl~masldHpnl~RLLgvc~~--s~~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe---~qrlV  820 (1177)
T KOG1025|consen  747 DEALRMASLDHPNLLRLLGVCML--STLQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE---EQRLV  820 (1177)
T ss_pred             HHHHHHhcCCCchHHHHhhhccc--chHHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hcchh
Confidence            34456678899999999999884  3488999999999999999876 557999999999999999999999   79999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  198 (313)
                      ||||-..||||..-..+||.|||++.........- .....-.+.|+|-|.+....++.++||||||+++||++| |..|
T Consensus       821 HrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~P  900 (1177)
T KOG1025|consen  821 HRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKP  900 (1177)
T ss_pred             hhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCc
Confidence            99999999999999999999999998665433221 112223456888898888999999999999999999999 9999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +.+....++-.+.+       .+         .+-..|+.++..+..++.+||..|++.||+++++...+.+-+
T Consensus       901 y~gi~~~eI~dlle-------~g---------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  901 YDGIPAEEIPDLLE-------KG---------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             cCCCCHHHhhHHHh-------cc---------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            99988877665553       11         112356677888999999999999999999999998776544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-24  Score=190.88  Aligned_cols=249  Identities=23%  Similarity=0.242  Sum_probs=174.9

Q ss_pred             HHHHHHHhhccc-cceEEEcccCCChhhHHhhhhhc--------cccceeeeeeEEe-c--cCCeEEEEEecCCCCCHHH
Q 048068           15 CVSFILSALAQD-VNQFIYHGFNEDPQLQRDGLASV--------HSNGLLQLTNTVN-S--RKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        15 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~--------~~~~~l~~~~~~~-~--~~~~~~lV~e~~~~g~L~~   82 (313)
                      .|+|..+|-+.- +..+++|.+...  .|..+.+|.        +|.||+.+..--. +  ....++||++|-+.|+|+|
T Consensus       221 kGRyGEVwrG~wrGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~D  298 (513)
T KOG2052|consen  221 KGRFGEVWRGRWRGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYD  298 (513)
T ss_pred             CccccceeeccccCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHH
Confidence            455555555554 346677776532  344444433        5666665432222 1  1337899999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC---C
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHE-----DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI---P  154 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs-----~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~---~  154 (313)
                      +|.++   .++.....+++..++.||++||.     +.+..|.|||||+.||+|..++..-|+|+|++........   -
T Consensus       299 yL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi  375 (513)
T KOG2052|consen  299 YLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDI  375 (513)
T ss_pred             HHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccC
Confidence            99985   49999999999999999999995     4567899999999999999999999999999976654421   1


Q ss_pred             ccccccccccccccccccCCC----C--CcchhhHHHHHHHHHHHhC----------CCCCccCCchhhhhHHHHHHHhh
Q 048068          155 QTTKLVGTFGYMAPELMRTGK----A--STSTDVYAFGVFMLEVASG----------RRPIEQQGSMEMVNLVDWVSDCW  218 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~----~--~~~~DiwslG~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~  218 (313)
                      ......||-.|+|||++....    +  -..+||||||.++||++-.          ++||.+....+...-.     ..
T Consensus       376 ~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee-----Mr  450 (513)
T KOG2052|consen  376 PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE-----MR  450 (513)
T ss_pred             CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH-----Hh
Confidence            233467999999999986421    2  2479999999999999763          3677654333221110     00


Q ss_pred             hhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      +.--+...+...+....+.+....+.++|..||..||..|-|+--+-+.|.+...
T Consensus       451 kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  451 KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            0001122222223334456677889999999999999999999999888877664

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.92  E-value=6.7e-25  Score=175.66  Aligned_cols=178  Identities=26%  Similarity=0.342  Sum_probs=138.6

Q ss_pred             hccccceEEEcccCC--ChhhHHhhhhhcc-------ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh--CCCCC
Q 048068           23 LAQDVNQFIYHGFNE--DPQLQRDGLASVH-------SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT--NIKPS   91 (313)
Q Consensus        23 ~~~~~~~~~~~~~~~--~~~~~~~~l~~~~-------~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~--~~~~~   91 (313)
                      ..+.+...++|++..  ..++.++.+.+++       -|..+.+++-... .+.+++.||.| ..+|..+.++  ..++.
T Consensus        67 h~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egdvwIcME~M-~tSldkfy~~v~~~g~~  144 (282)
T KOG0984|consen   67 HIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGDVWICMELM-DTSLDKFYRKVLKKGGT  144 (282)
T ss_pred             eccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-cccEEEeHHHh-hhhHHHHHHHHHhcCCc
Confidence            344555677777753  3445556666664       5666666665545 67899999999 5688887764  23567


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccc
Q 048068           92 LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM  171 (313)
Q Consensus        92 ~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  171 (313)
                      +++..+-+++..++.|+.|||+  +..++|||+||+|||++..|++|+||||.+-.......  .....|.-.|+|||.+
T Consensus       145 ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--kt~daGCkpYmaPEri  220 (282)
T KOG0984|consen  145 IPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--KTMDAGCKPYMAPERI  220 (282)
T ss_pred             CchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--HHHhcCCCccCChhhc
Confidence            9999999999999999999999  78999999999999999999999999998865443221  1224566779999988


Q ss_pred             c----CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchh
Q 048068          172 R----TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME  206 (313)
Q Consensus       172 ~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  206 (313)
                      .    ...|+.++||||||+++.||++++.||..+..+-
T Consensus       221 ~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF  259 (282)
T KOG0984|consen  221 NPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF  259 (282)
T ss_pred             CcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence            4    3478999999999999999999999998776553

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.5e-26  Score=191.01  Aligned_cols=224  Identities=23%  Similarity=0.310  Sum_probs=162.5

Q ss_pred             hHHhhhhhccccceeeeeeEEecc----CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR----KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      .+...+.-++|.|++...++.+..    -..+|.|+|.+. .+|..+|-.  ...++.+.++-+++||+.||+|||   .
T Consensus       101 re~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---s  174 (449)
T KOG0664|consen  101 REIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---T  174 (449)
T ss_pred             HHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---h
Confidence            344455556777777777777732    124578888884 477777654  456999999999999999999999   4


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g  195 (313)
                      .+|+||||||.|++++.|-.+||||||+++..............-|-.|+|||.+.+ ..|+.+.||||+|||+.|++..
T Consensus       175 A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR  254 (449)
T KOG0664|consen  175 ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQR  254 (449)
T ss_pred             cchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence            899999999999999999999999999998654443333334455788999999876 4689999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhh--------hccccccc-----cccccCC----ccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWK--------KGAILDAS-----DSRLEGI----YEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-----~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      +..|......+...++.-......        ++....+.     .+.....    .+....-....+...+|..+|++|
T Consensus       255 rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkr  334 (449)
T KOG0664|consen  255 KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKR  334 (449)
T ss_pred             hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccc
Confidence            999998888777776643322211        11111111     1111110    111223345667778999999999


Q ss_pred             CCHHHHHHHHhc
Q 048068          259 PNMRQVMQYLDG  270 (313)
Q Consensus       259 pt~~ell~~L~~  270 (313)
                      .+..+.++|+..
T Consensus       335 is~~~A~~~~~~  346 (449)
T KOG0664|consen  335 ISVEEALQHRYL  346 (449)
T ss_pred             ccHhhhcccccc
Confidence            999999998753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.9e-24  Score=182.67  Aligned_cols=151  Identities=28%  Similarity=0.393  Sum_probs=132.3

Q ss_pred             HhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           43 RDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        43 ~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      .-|.+.-++|-++-+...++. ...+++|.||.+||+|--.++++  .++++..+..+...|..||.|||   .+||+.|
T Consensus       302 ~vfe~asn~pflvglhscfqt-esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh---~rgiiyr  375 (593)
T KOG0695|consen  302 HVFEQASNNPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH---ERGIIYR  375 (593)
T ss_pred             HHHHhccCCCeEEehhhhhcc-cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh---hcCeeee
Confidence            345556678888887777775 67999999999999997777664  46999999999999999999999   6999999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |||.+|++++..|.+|+.|+|++...-.+ .....++.||+.|+|||.+.+..|..+.|-|+||++|+||+.|+.||.
T Consensus       376 dlkldnvlldaeghikltdygmcke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             eccccceEEccCCceeecccchhhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence            99999999999999999999999754322 234567899999999999999999999999999999999999999995

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.91  E-value=3.4e-23  Score=172.38  Aligned_cols=188  Identities=29%  Similarity=0.477  Sum_probs=155.5

Q ss_pred             cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           27 VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        27 ~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ....++|.+...        ...+.+.++.+.|+++++..++... ....+++||++.+++|.+++.... ..++...++
T Consensus        18 ~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~   95 (215)
T cd00180          18 GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEIL   95 (215)
T ss_pred             CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHH
Confidence            344555555433        3456677788889999999998886 478999999999899999998642 358999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCccccccccccccccccccCC-CC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KA  176 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~  176 (313)
                      .++.+++.++.+||   ..+++|+||+|.||+++. .+.++|+||+.+........ ......+...|.+||..... .+
T Consensus        96 ~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~  171 (215)
T cd00180          96 RILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYY  171 (215)
T ss_pred             HHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCC
Confidence            99999999999999   589999999999999999 89999999999875543321 12234567789999998876 77


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      +.+.|+|++|++++++                                                ..+.+++..|++.||+
T Consensus       172 ~~~~D~~~lg~~~~~l------------------------------------------------~~~~~~l~~~l~~~p~  203 (215)
T cd00180         172 SEKSDIWSLGVILYEL------------------------------------------------PELKDLIRKMLQKDPE  203 (215)
T ss_pred             CchhhhHHHHHHHHHH------------------------------------------------HHHHHHHHHHhhCCcc
Confidence            8999999999999998                                                4467899999999999


Q ss_pred             CCCCHHHHHHHH
Q 048068          257 ARPNMRQVMQYL  268 (313)
Q Consensus       257 ~Rpt~~ell~~L  268 (313)
                      +||++.++++++
T Consensus       204 ~R~~~~~l~~~~  215 (215)
T cd00180         204 KRPSAKEILEHL  215 (215)
T ss_pred             cCcCHHHHhhCC
Confidence            999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.91  E-value=7.6e-24  Score=172.15  Aligned_cols=247  Identities=16%  Similarity=0.193  Sum_probs=173.7

Q ss_pred             hhhHHHHHHHHhhccccc---eEEEcccCC----ChhhHHhhhhhcc-ccceeeeeeEEecc-CCeEEEEEecCCCCCHH
Q 048068           11 CVLLCVSFILSALAQDVN---QFIYHGFNE----DPQLQRDGLASVH-SNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~l~~~~-~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~   81 (313)
                      ++.+.||++.++-+....   ..+.|.++.    -...|..++.-+. ++|++++.+++.+. ...+.||+||+++.+..
T Consensus        44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk  123 (338)
T KOG0668|consen   44 RKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFK  123 (338)
T ss_pred             HHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHH
Confidence            466778888777666432   344555543    2334555666665 99999999999943 44678999999998877


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-CcEEEeecccccccCCCCCCcccccc
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      .+..     .++...+..++.++++||.|+||   .||.|||+||.|++|+.. -.++|+|+|++.++-......  ...
T Consensus       124 ~ly~-----tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn--VRV  193 (338)
T KOG0668|consen  124 QLYP-----TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--VRV  193 (338)
T ss_pred             HHhh-----hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCceee--eee
Confidence            7654     38888999999999999999995   999999999999999954 569999999998765544322  234


Q ss_pred             ccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC-ccCCchhhhhHHHHHHHhh------hhcccc--------
Q 048068          161 GTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI-EQQGSMEMVNLVDWVSDCW------KKGAIL--------  224 (313)
Q Consensus       161 ~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~------~~~~~~--------  224 (313)
                      .+..|.-||.+.+ +.++-+-|+|||||++..|+..+.|| .+.+..++...+..+...-      ....+.        
T Consensus       194 ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i  273 (338)
T KOG0668|consen  194 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI  273 (338)
T ss_pred             ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH
Confidence            5677889998865 46788999999999999999988886 5666665554442221110      000000        


Q ss_pred             ------ccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          225 ------DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       225 ------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                            ..........-..-.++...+|+.+.|..|-.+|+|++|.+.|
T Consensus       274 ~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  274 LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                  0000000000001123567788888999999999999999886

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2e-23  Score=195.13  Aligned_cols=197  Identities=20%  Similarity=0.208  Sum_probs=134.7

Q ss_pred             CCeEEEEEecCCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           65 KGEFLLVYDYMPNGSLDKILHTNI----------------------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        65 ~~~~~lV~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      ++..++||||+++++|.++++...                      ...+++..++.++.|++.+|.|||   ..+++|+
T Consensus       257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHr  333 (507)
T PLN03224        257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHR  333 (507)
T ss_pred             CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence            456899999999999999987421                      113466788999999999999999   5899999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC----------------------CCcch
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK----------------------ASTST  180 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~  180 (313)
                      ||||+||+++.++.++|+|||++...............+++.|++||.+....                      ...+.
T Consensus       334 DLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~  413 (507)
T PLN03224        334 DIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF  413 (507)
T ss_pred             CCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCcc
Confidence            99999999999999999999998654332211122233478999999875321                      12347


Q ss_pred             hhHHHHHHHHHHHhCCC-CCccCCchhhh-hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCC---
Q 048068          181 DVYAFGVFMLEVASGRR-PIEQQGSMEMV-NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP---  255 (313)
Q Consensus       181 DiwslG~il~~ll~g~~-pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---  255 (313)
                      |+||+||++++|+++.. ||......... .........|......     ...........+...+|+.+||..+|   
T Consensus       414 DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~-----~~~~~~~d~~s~~~~dLi~~LL~~~~~~~  488 (507)
T PLN03224        414 DSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ-----KYDFSLLDRNKEAGWDLACKLITKRDQAN  488 (507)
T ss_pred             chhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc-----CCCcccccccChHHHHHHHHHhccCCCCc
Confidence            99999999999999875 66532211111 0011111222211100     01111122345678888999998766   


Q ss_pred             CCCCCHHHHHHHHh
Q 048068          256 EARPNMRQVMQYLD  269 (313)
Q Consensus       256 ~~Rpt~~ell~~L~  269 (313)
                      .+|+|++|+|+|-.
T Consensus       489 ~~RlSa~eaL~Hp~  502 (507)
T PLN03224        489 RGRLSVGQALSHRF  502 (507)
T ss_pred             ccCCCHHHHhCCCC
Confidence            68999999999843

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.2e-24  Score=177.02  Aligned_cols=223  Identities=21%  Similarity=0.330  Sum_probs=160.6

Q ss_pred             hccccceEEEcccCCChhhHHhhhhhcc-------ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHH
Q 048068           23 LAQDVNQFIYHGFNEDPQLQRDGLASVH-------SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWY   95 (313)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~   95 (313)
                      .++....++.|..........+|.+|++       |.+|+..+++..+..+.++++|||++.|+|.+-+..+   ++.+.
T Consensus        45 Hr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~---GigE~  121 (378)
T KOG1345|consen   45 HRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEA  121 (378)
T ss_pred             ccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc---cccHH
Confidence            3444556777777777777888999985       6666666666666677999999999999999988764   59999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC--CCcEEEeecccccccCCCCCCccccccccccccccccccC
Q 048068           96 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT  173 (313)
Q Consensus        96 ~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  173 (313)
                      .-+.++.|+++|+.|+|   .++++|||||.+||||..  ...+|+||||+....+...    .....+..|.+||....
T Consensus       122 ~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~  194 (378)
T KOG1345|consen  122 NTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDT  194 (378)
T ss_pred             HHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCcee----hhhhhhcccCCcHHHhh
Confidence            99999999999999999   599999999999999964  3579999999986543322    22234567889997642


Q ss_pred             ---C--CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHH
Q 048068          174 ---G--KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL  248 (313)
Q Consensus       174 ---~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (313)
                         .  ...+.+|+|.||+++|.+++|..||......+..+   +....|..+...     ..+..+ ...++.+.++..
T Consensus       195 ~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y---~~~~~w~~rk~~-----~~P~~F-~~fs~~a~r~Fk  265 (378)
T KOG1345|consen  195 VVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY---WEWEQWLKRKNP-----ALPKKF-NPFSEKALRLFK  265 (378)
T ss_pred             ccccceEecccccchheeeeeeeeecCCCcchhhhccCchH---HHHHHHhcccCc-----cCchhh-cccCHHHHHHHH
Confidence               2  34788999999999999999999998433222211   222334433322     222211 123455667777


Q ss_pred             HcCCCCCCCCCCHHHH
Q 048068          249 FCSHPKPEARPNMRQV  264 (313)
Q Consensus       249 ~cl~~~P~~Rpt~~el  264 (313)
                      +-|..+|++|--..+.
T Consensus       266 k~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  266 KSLTPRFKDRCKIWTA  281 (378)
T ss_pred             HhcCCcccccchhHHH
Confidence            7899999999444333

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=7.4e-24  Score=194.55  Aligned_cols=209  Identities=25%  Similarity=0.342  Sum_probs=168.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      +.+.-.+++-+|+|++.+++-+.. +...+++||||.||+|.+..+-  .+++++.++...++..+.+++|||   ..|-
T Consensus        60 qqei~~~~dc~h~nivay~gsylr-~dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylh---s~gk  133 (829)
T KOG0576|consen   60 QQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLH---SQGK  133 (829)
T ss_pred             ccceeeeecCCCcChHHHHhhhhh-hcCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhh---cCCc
Confidence            345556788899999999988876 5689999999999999998876  457999999999999999999999   5888


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +|||||-.||++++.|.++++|||.+..++... .+...+.||+.|+|||+..   .+.|...+|+|++|++..|+...+
T Consensus       134 ~hRdiKGanilltd~gDvklaDfgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLq  212 (829)
T KOG0576|consen  134 IHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQ  212 (829)
T ss_pred             ccccccccceeecccCceeecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcC
Confidence            999999999999999999999999997765432 3566789999999999873   467899999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +|..........++...      .+     .++ +.........+.+..|++.||-.||++|||++.+|+|
T Consensus       213 pplfdlhpmr~l~LmTk------S~-----~qp-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  213 PPLFDLHPMRALFLMTK------SG-----FQP-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CcccccchHHHHHHhhc------cC-----CCC-CcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            98655444443333321      00     111 1112344567789999999999999999999987763

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-22  Score=182.07  Aligned_cols=153  Identities=25%  Similarity=0.381  Sum_probs=133.5

Q ss_pred             hhHHhhhhhcc---ccceeeeeeEEeccCCeEEEEEecC-CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           40 QLQRDGLASVH---SNGLLQLTNTVNSRKGEFLLVYDYM-PNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        40 ~~~~~~l~~~~---~~~~l~~~~~~~~~~~~~~lV~e~~-~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      ..|.+++.-++   |+||++..+++.+ ++++||+||.- +|.+|.++|...  ..+++..+..|++|++.|+++||   
T Consensus       614 p~EIqIla~l~~~sH~NIlKlLdfFEd-dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh---  687 (772)
T KOG1152|consen  614 PSEIQILATLNKHSHENILKLLDFFED-DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH---  687 (772)
T ss_pred             chhHHHHHHhhhcCccchhhhhheeec-CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc---
Confidence            45666666666   9999999999988 67999999976 678999999874  46999999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHh
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  194 (313)
                      ..||+|||||-+|+.++.+|-+||+|||.+.....+.   -..+.||..|.|||++.+..| ...-|||++|+++|.++.
T Consensus       688 ~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy  764 (772)
T KOG1152|consen  688 DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY  764 (772)
T ss_pred             ccCceecccccccEEEecCCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence            6999999999999999999999999999987554332   345789999999999998877 667899999999999999


Q ss_pred             CCCCCcc
Q 048068          195 GRRPIEQ  201 (313)
Q Consensus       195 g~~pf~~  201 (313)
                      ...||..
T Consensus       765 kenpyyn  771 (772)
T KOG1152|consen  765 KENPYYN  771 (772)
T ss_pred             ccCCCcC
Confidence            9988853

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.86  E-value=1.2e-21  Score=171.77  Aligned_cols=247  Identities=22%  Similarity=0.340  Sum_probs=165.5

Q ss_pred             hhHHHHHHHHhhccccc------eEEEcccC-----CChhhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           12 VLLCVSFILSALAQDVN------QFIYHGFN-----EDPQLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~------~~~~~~~~-----~~~~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      +++.|.+..++.+.+..      .++.|.+.     .....|-+++..+. +.+++++.+.+.. ++..++||||++...
T Consensus        43 kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-nd~v~ivlp~~~H~~  121 (418)
T KOG1167|consen   43 KIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN-NDQVAIVLPYFEHDR  121 (418)
T ss_pred             cccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc-CCeeEEEecccCccC
Confidence            34445555544444333      44454442     34445666666664 5666666666655 779999999999988


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-CcEEEeecccccccC---------
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYD---------  149 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~---------  149 (313)
                      ..+++..     ++...+..++..++.||.++|   ..||+||||||.|++.+.. +.-.|.|||++....         
T Consensus       122 f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~  193 (418)
T KOG1167|consen  122 FRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSR  193 (418)
T ss_pred             HHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhh
Confidence            8888764     779999999999999999999   6999999999999999854 567899999986110         


Q ss_pred             C-------C---------------------------CCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHh
Q 048068          150 H-------D---------------------------TIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       150 ~-------~---------------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~  194 (313)
                      .       .                           .........||++|+|||++.. ...+.++||||.|+|+.-+++
T Consensus       194 ~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls  273 (418)
T KOG1167|consen  194 SYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLS  273 (418)
T ss_pred             hhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhc
Confidence            0       0                           0011123469999999998864 567889999999999999999


Q ss_pred             CCCCCccCC-chhhhhHHHHH------HH---------hhhhcc-------------c-cccccc-----cccCCccHHH
Q 048068          195 GRRPIEQQG-SMEMVNLVDWV------SD---------CWKKGA-------------I-LDASDS-----RLEGIYEEEQ  239 (313)
Q Consensus       195 g~~pf~~~~-~~~~~~~~~~~------~~---------~~~~~~-------------~-~~~~~~-----~~~~~~~~~~  239 (313)
                      +..||-... +.+....+..+      ++         .|+...             . .....+     -.........
T Consensus       274 ~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~  353 (418)
T KOG1167|consen  274 RRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVF  353 (418)
T ss_pred             cccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccc
Confidence            999985432 22222111100      00         111000             0 000000     0011111223


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +..+.+++.+||+.||.+|.|+++.|+|
T Consensus       354 ~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  354 PALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            3478999999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.85  E-value=1.6e-20  Score=158.58  Aligned_cols=155  Identities=29%  Similarity=0.429  Sum_probs=130.4

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +.+.++.++|+++++..+.... ....++++|++++++|.+++..... .+++..++.++.+++.++.+||   ..+++|
T Consensus        47 e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h  121 (225)
T smart00221       47 EIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVH  121 (225)
T ss_pred             HHHHHHhCCCCChhhheeeeec-CCceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence            4456677789999998888776 5688999999999999999987532 2899999999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      +|+++.||+++.++.++|+|||.+...............++..|++||.. ....++.++|+|+||++++++++|+.||.
T Consensus       122 ~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      122 RDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             CCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            99999999999999999999998876544321122344567789999998 66677889999999999999999999996


Q ss_pred             c
Q 048068          201 Q  201 (313)
Q Consensus       201 ~  201 (313)
                      .
T Consensus       202 ~  202 (225)
T smart00221      202 G  202 (225)
T ss_pred             c
Confidence            5

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=6.2e-22  Score=188.91  Aligned_cols=205  Identities=19%  Similarity=0.219  Sum_probs=158.5

Q ss_pred             hhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCC
Q 048068           47 ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP  126 (313)
Q Consensus        47 ~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~  126 (313)
                      ..+.|++++....++.+.....+. ||||++ +|..++...  ..+....+.-++.|++.|++|+|   ..|+.|+|+|+
T Consensus       376 ~~l~h~~~~e~l~~~~~~~~~~~~-mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~  448 (601)
T KOG0590|consen  376 SSLSHPNIIETLDIVQEIDGILQS-MEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKL  448 (601)
T ss_pred             ccccCCchhhhHHHHhhcccchhh-hhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCcc
Confidence            456788887777777765555554 999999 999999874  35899999999999999999999   59999999999


Q ss_pred             CcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCccC
Q 048068          127 ANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPELMRTGKAS-TSTDVYAFGVFMLEVASGRRPIEQQ  202 (313)
Q Consensus       127 ~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~  202 (313)
                      +|+++..+|.+||+|||.+..+..+...   ......|...|+|||.+.+..|+ ...||||.|+++..|.+|+.||...
T Consensus       449 enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a  528 (601)
T KOG0590|consen  449 ENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA  528 (601)
T ss_pred             ccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence            9999999999999999999877655442   34556789999999999988774 4799999999999999999999765


Q ss_pred             CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          203 GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ...+..+.. ..       ..........+.......+...+.+|..||+.||.+|.|++++++
T Consensus       529 ~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  529 KKSDNSFKT-NN-------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccchhh-hc-------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            544432100 00       000001111112233445667889999999999999999999987

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-19  Score=151.66  Aligned_cols=211  Identities=20%  Similarity=0.326  Sum_probs=165.1

Q ss_pred             CCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           36 NEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        36 ~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      ..+.+.|.--++-+.|||++...+-.++ .-++.++..||+.|+|+.+++.+..-..+..++.+++..++.+++|||+- 
T Consensus       231 srdfneefp~lrifshpnilpvlgacns-ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-  308 (448)
T KOG0195|consen  231 SRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-  308 (448)
T ss_pred             cchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-
Confidence            3445556666777889999888887776 56789999999999999999988777788889999999999999999973 


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEe--ecccccccCCCCCCccccccccccccccccccCCCC---CcchhhHHHHHHHH
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLG--DFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA---STSTDVYAFGVFML  190 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~  190 (313)
                      +.-|.--.|+...++|+++-..+|.  |--++.        ........+.|++||.+....-   -.++|+|||++++|
T Consensus       309 ep~ipr~~lns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillw  380 (448)
T KOG0195|consen  309 EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLW  380 (448)
T ss_pred             chhhhhhhcccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHH
Confidence            2334455788999999988766553  332221        1112344788999999875432   45899999999999


Q ss_pred             HHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          191 EVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      |+.|...||......++...+.               ...+...+++..+..+.++|.-|++.||.+||.+++++-.||.
T Consensus       381 el~trevpfadlspmecgmkia---------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  381 ELNTREVPFADLSPMECGMKIA---------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             HhhccccccccCCchhhhhhhh---------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            9999999999988877654442               1234556778888899999999999999999999999999886


Q ss_pred             c
Q 048068          271 N  271 (313)
Q Consensus       271 ~  271 (313)
                      -
T Consensus       446 m  446 (448)
T KOG0195|consen  446 M  446 (448)
T ss_pred             h
Confidence            3

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.1e-17  Score=149.84  Aligned_cols=221  Identities=20%  Similarity=0.221  Sum_probs=159.5

Q ss_pred             hhhHHhhhhhccc----cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           39 PQLQRDGLASVHS----NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        39 ~~~~~~~l~~~~~----~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      ...|...+..+..    .++..........+...++||+.+ |.+|.++......+.++...+..++.|++.+|.++|  
T Consensus        63 l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--  139 (322)
T KOG1164|consen   63 LKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--  139 (322)
T ss_pred             chhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--
Confidence            3455566666652    344444444433466889999998 999999987765678999999999999999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCC-----CcEEEeecccccccC--CCC----CC--c-cccccccccccccccccCCCCCcch
Q 048068          115 WEQVVLHRDIKPANVLLDAD-----LNGKLGDFGLARLYD--HDT----IP--Q-TTKLVGTFGYMAPELMRTGKASTST  180 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~-----~~~~l~dfg~~~~~~--~~~----~~--~-~~~~~~~~~y~aPE~~~~~~~~~~~  180 (313)
                       +.|++||||||.|+++...     ..+.+.|||+++.+.  ...    ..  . ...+.||..|.++....+...+.+.
T Consensus       140 -~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~D  218 (322)
T KOG1164|consen  140 -SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRD  218 (322)
T ss_pred             -hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCch
Confidence             6999999999999999865     358999999998332  111    11  1 2235699999999999999999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       181 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      |+||++.++.++..|..||...............   ........         .....+..+.++...+-..+...+|.
T Consensus       219 Dles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pd  286 (322)
T KOG1164|consen  219 DLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD---PRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPD  286 (322)
T ss_pred             hhhhHHHHHHHHhcCCCCCccccccchHHHHHHH---hhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCC
Confidence            9999999999999999999766544332211110   00000000         11222344556666666789999999


Q ss_pred             HHHHHHHHhccCCCC
Q 048068          261 MRQVMQYLDGNATLP  275 (313)
Q Consensus       261 ~~ell~~L~~~~~~~  275 (313)
                      ...+...|.+.....
T Consensus       287 y~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  287 YEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHHHHHHHHHHhc
Confidence            999999987775443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=8e-18  Score=147.20  Aligned_cols=182  Identities=22%  Similarity=0.249  Sum_probs=130.3

Q ss_pred             CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc--CCC--cEEEe
Q 048068           65 KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD--ADL--NGKLG  140 (313)
Q Consensus        65 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~--~~~--~~~l~  140 (313)
                      +..+|+||.-+ ..+|..++-.+.   .+.....-++.|+++|+.|||   +.|+.|||+|.+||++-  +++  ++.++
T Consensus       315 ~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVva  387 (598)
T KOG4158|consen  315 PKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVA  387 (598)
T ss_pred             CceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEc
Confidence            56789999999 459999997653   777888889999999999999   79999999999999994  443  46899


Q ss_pred             ecccccccCC-----CCCCccccccccccccccccccCCC------CCcchhhHHHHHHHHHHHhCCCCCccCCchhhhh
Q 048068          141 DFGLARLYDH-----DTIPQTTKLVGTFGYMAPELMRTGK------ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN  209 (313)
Q Consensus       141 dfg~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  209 (313)
                      |||.+-....     +.....-...|..+.+|||+.....      .-.++|.|+.|.+.||+++...||.+..+.-.. 
T Consensus       388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-  466 (598)
T KOG4158|consen  388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-  466 (598)
T ss_pred             ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-
Confidence            9998754322     1112222345777899999875321      245899999999999999999999874332111 


Q ss_pred             HHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ...          -.+..-+.+    +...+..+++++...|+.||.+|++..=....|
T Consensus       467 ~r~----------Yqe~qLPal----p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  467 TRT----------YQESQLPAL----PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hhh----------hhhhhCCCC----cccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            110          011112233    334455677788888999999999876555443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=1e-17  Score=153.79  Aligned_cols=218  Identities=25%  Similarity=0.381  Sum_probs=160.9

Q ss_pred             hhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcC
Q 048068           46 LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~  125 (313)
                      ++++.|.|+.+..+...+ +...+.|.+||..|+|.+.+... ...++......+++.|+.|+.|+|.+  ...+|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            467889999999999988 47899999999999999999875 44688889999999999999999973  344999999


Q ss_pred             CCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCC-------CCCcchhhHHHHHHHHHHHhCCC
Q 048068          126 PANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTG-------KASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +.|.+++.+..+|+.|||+......... ...........|.|||.+...       ..+.+.|+||+|++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999999999999999999875532100 011112234568999998653       14667999999999999999999


Q ss_pred             CCccCCchhh-hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCC
Q 048068          198 PIEQQGSMEM-VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       198 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      ||........ ...+..+...+..     ...|....  ..+..+.+..++..||..+|.+||+++++-..++...+.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~-----~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSN-----PFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCC-----CcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9976333222 2222222221111     11111111  113444788999999999999999999999988877643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.74  E-value=2.3e-16  Score=139.53  Aligned_cols=216  Identities=29%  Similarity=0.399  Sum_probs=160.2

Q ss_pred             hhHHhhhhhcccc-ceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           40 QLQRDGLASVHSN-GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK-PSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        40 ~~~~~~l~~~~~~-~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ..+...+..+.++ ++++..+.... ....+++++++.++++.+++..... ..+....+..++.|++.++.++|   ..
T Consensus        45 ~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~  120 (384)
T COG0515          45 LREIQILASLNHPPNIVKLYDFFQD-EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK  120 (384)
T ss_pred             HHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            3445567777888 69988888854 5558999999999999977765421 26999999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCC-cEEEeecccccccCCCCCC-----ccccccccccccccccccC---CCCCcchhhHHHHHH
Q 048068          118 VVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIP-----QTTKLVGTFGYMAPELMRT---GKASTSTDVYAFGVF  188 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~i  188 (313)
                      +++|||+||+||+++..+ .++++|||.+.........     ......++..|++||.+.+   .......|+|++|++
T Consensus       121 ~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~  200 (384)
T COG0515         121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT  200 (384)
T ss_pred             CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHH
Confidence            899999999999999988 7999999998754433221     2355678999999999987   577889999999999


Q ss_pred             HHHHHhCCCCCccCCch----hhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          189 MLEVASGRRPIEQQGSM----EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       189 l~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      ++++++|..||......    .....+   ..   ....  .................+.+++..|+..+|..|.+..+.
T Consensus       201 ~~~~~~~~~p~~~~~~~~~~~~~~~~~---~~---~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~  272 (384)
T COG0515         201 LYELLTGLPPFEGEKNSSATSQTLKII---LE---LPTP--SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD  272 (384)
T ss_pred             HHHHHhCCCCCCCCCccccHHHHHHHH---Hh---cCCc--ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHH
Confidence            99999999997665531    111111   11   1000  000000000112334578889999999999999999988


Q ss_pred             HHH
Q 048068          265 MQY  267 (313)
Q Consensus       265 l~~  267 (313)
                      ..+
T Consensus       273 ~~~  275 (384)
T COG0515         273 LSH  275 (384)
T ss_pred             hhc
Confidence            875

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.73  E-value=1.3e-18  Score=168.13  Aligned_cols=199  Identities=22%  Similarity=0.233  Sum_probs=138.2

Q ss_pred             hhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcC
Q 048068           46 LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~  125 (313)
                      ...+++||.+.+...... +...|+|-+|. .-+|+|.+...  ..+..-+.+.|+.|++.|+..+|   +.||+|||||
T Consensus        75 ~~l~~~pn~lPfqk~~~t-~kAAylvRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIK  147 (1431)
T KOG1240|consen   75 FALMKAPNCLPFQKVLVT-DKAAYLVRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIK  147 (1431)
T ss_pred             HHhhcCCcccchHHHHHh-hHHHHHHHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccc
Confidence            455577877766655443 45678888998 55999999864  35777888889999999999999   7999999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccc--CCCCCC----ccccccccccccccccccCC-----------CCCcchhhHHHHHH
Q 048068          126 PANVLLDADLNGKLGDFGLARLY--DHDTIP----QTTKLVGTFGYMAPELMRTG-----------KASTSTDVYAFGVF  188 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~--~~~~~~----~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~i  188 (313)
                      .+||||..=+.+.|+||...+-.  ++....    .-.+...-.+|+|||.+...           .-.++.||||+||+
T Consensus       148 sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCV  227 (1431)
T KOG1240|consen  148 SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCV  227 (1431)
T ss_pred             cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHH
Confidence            99999999999999999876422  111100    00112234589999987421           14679999999999


Q ss_pred             HHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          189 MLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       189 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +.|+++ |+++|.-.      ++..+     +.+. .......+.+ +   ....++.++..|++.||.+|.++++.|+.
T Consensus       228 iaELf~Eg~PlF~LS------QL~aY-----r~~~-~~~~e~~Le~-I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  228 IAELFLEGRPLFTLS------QLLAY-----RSGN-ADDPEQLLEK-I---EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhcCCCcccHH------HHHhH-----hccC-ccCHHHHHHh-C---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            999988 68887521      11110     0110 0000000000 1   11268899999999999999999999986

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.70  E-value=1.1e-16  Score=137.01  Aligned_cols=248  Identities=18%  Similarity=0.172  Sum_probs=170.0

Q ss_pred             hhhHHHHHHHHhhccccc--eEEEccc----CCChh--hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           11 CVLLCVSFILSALAQDVN--QFIYHGF----NEDPQ--LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~--~~~~~~~----~~~~~--~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      .+.+||+|..-.+++..-  ..+.=++    .+..+  .|-.+-+.+.+..-|....++...+.+-.||||.+ |.+|++
T Consensus        34 kKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLED  112 (449)
T KOG1165|consen   34 KKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLED  112 (449)
T ss_pred             cccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHH
Confidence            355666665544444421  1111112    23333  44455577766555555566666577889999999 999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-----CcEEEeecccccccCCCCCC---
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-----LNGKLGDFGLARLYDHDTIP---  154 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-----~~~~l~dfg~~~~~~~~~~~---  154 (313)
                      +.... +..|+..++..++.|++.-+.|+|   .+..+.|||||+|.||...     ..+.++|||++..+..+...   
T Consensus       113 LFD~C-gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI  188 (449)
T KOG1165|consen  113 LFDLC-GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI  188 (449)
T ss_pred             HHHHh-cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence            99876 456999999999999999999999   6999999999999999743     34789999999887654322   


Q ss_pred             ---ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccc
Q 048068          155 ---QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL  231 (313)
Q Consensus       155 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (313)
                         ......||..|++-....+...+.+.|+=|||-++++++-|..||.+..........+.+.+.-+...+.       
T Consensus       189 PYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~-------  261 (449)
T KOG1165|consen  189 PYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE-------  261 (449)
T ss_pred             ccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH-------
Confidence               2234578999999999999999999999999999999999999999987765444333222211111111       


Q ss_pred             cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       232 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                        ......+..+..-+.-.-..+-.+-|..+-+..-+.++.
T Consensus       262 --~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  262 --VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             --HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence              111223344444444444556666677776666655554

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=5.4e-18  Score=153.26  Aligned_cols=175  Identities=27%  Similarity=0.410  Sum_probs=129.7

Q ss_pred             CCeEEEEEecCCCCCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecc
Q 048068           65 KGEFLLVYDYMPNGSLDKILHT-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG  143 (313)
Q Consensus        65 ~~~~~lV~e~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg  143 (313)
                      ..++++.|++|+..+|.+++.+ ......+......++.|+..++.|      ++.+|+|+||.||++..+.+++|.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence            4468999999999999999974 345678888999999999999998      578999999999999999999999999


Q ss_pred             cccccCCCC-----CCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHh
Q 048068          144 LARLYDHDT-----IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDC  217 (313)
Q Consensus       144 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  217 (313)
                      +........     ........||..|++||.+.++.|+.++||||||++++|++. -..+++.....            
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~------------  469 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL------------  469 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh------------
Confidence            986543322     223455689999999999999999999999999999999987 22222211111            


Q ss_pred             hhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          218 WKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                            .+..+..+++.+- ...+.-..|+.+++...|.+||++.+.
T Consensus       470 ------~d~r~g~ip~~~~-~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 ------TDIRDGIIPPEFL-QDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ------hhhhcCCCChHHh-hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence                  0111111111110 111223578888999999999955443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.68  E-value=3.7e-17  Score=150.61  Aligned_cols=190  Identities=26%  Similarity=0.315  Sum_probs=154.3

Q ss_pred             ChhhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           38 DPQLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        38 ~~~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      -...+..++..++ ++.+++....++. ++..++++++..||.|...+...  ..+.+.....+...++.+++++|   +
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh---~  115 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLH---K  115 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcc---h
Confidence            3445667777887 8888887777765 67899999999999998888764  35888889999999999999999   6


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      .+++++|+|++||+++.+|.+++.|||+++..-....     ..|+..|+|||++.  ....+.|-||||++++++++|.
T Consensus       116 l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~  188 (612)
T KOG0603|consen  116 LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGT  188 (612)
T ss_pred             hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCC
Confidence            9999999999999999999999999999976543321     17799999999998  5567899999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      .||.+    +....+-                 .....++........+++..++..+|.+|--.
T Consensus       189 ~pf~~----~~~~~Il-----------------~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  189 LPFGG----DTMKRIL-----------------KAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCCch----HHHHHHh-----------------hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            99987    2222220                 12233677778888899999999999999644

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.66  E-value=8.5e-17  Score=139.18  Aligned_cols=162  Identities=22%  Similarity=0.224  Sum_probs=106.4

Q ss_pred             EEEEEecCCCCCHHHHHhh----CCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeec
Q 048068           68 FLLVYDYMPNGSLDKILHT----NIK-PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDF  142 (313)
Q Consensus        68 ~~lV~e~~~~g~L~~~l~~----~~~-~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~df  142 (313)
                      .+++|+-+ -++|.+++.-    ... ..........+..|++..+++||   ..|++|+||+|+|++++.+|.++|+||
T Consensus       114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F  189 (288)
T PF14531_consen  114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDF  189 (288)
T ss_dssp             EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--G
T ss_pred             hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcCh
Confidence            37788888 5699888752    111 12233344556689999999999   599999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCC--------CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHH
Q 048068          143 GLARLYDHDTIPQTTKLVGTFGYMAPELMRTG--------KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV  214 (313)
Q Consensus       143 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  214 (313)
                      +.....+.....    ...+..|.+||.....        .++.+.|.|+||+++|.+.++..||...........    
T Consensus       190 ~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----  261 (288)
T PF14531_consen  190 SSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----  261 (288)
T ss_dssp             GGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred             HHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence            877654432211    2334678899876431        468899999999999999999999986543321110    


Q ss_pred             HHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                                      .-..+. +.++.++.||..+|+.||.+|
T Consensus       262 ----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 ----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                            112244 778899999999999999988

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=5.5e-16  Score=132.81  Aligned_cols=202  Identities=19%  Similarity=0.268  Sum_probs=144.5

Q ss_pred             hhhccccceeeeeeEEec----cCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           46 LASVHSNGLLQLTNTVNS----RKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      +-++.|.++++...++.+    +.....+++||+..|+|..+|++.  ..+.+......+|+.||++||.|||++ ..-|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            445678999998888884    344788999999999999999863  245688999999999999999999987 6889


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccC---CCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYD---HDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +|+++..+.|++..+|.+|+.-..-.....   ...........+.++|.+||.-...+-+..+|||+||....+|..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999999885432221111   11111222334577899999887777788999999999999998876


Q ss_pred             CCCc-cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          197 RPIE-QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .--. ..........+..+        +..            -....-++++.+|++-.|..||+++.++-|.
T Consensus       280 iq~tnseS~~~~ee~ia~~--------i~~------------len~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANV--------IIG------------LENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eccCCCcceeehhhhhhhh--------eee------------ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            6422 11111111111000        000            0112234678889999999999999998764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.59  E-value=3.1e-15  Score=134.70  Aligned_cols=118  Identities=21%  Similarity=0.241  Sum_probs=88.1

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...|.+.++++.|++++.....    .+..++||||++|++|... ..     ..   ...++.|++.+|.|||   ..|
T Consensus        68 ~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH---~~g  131 (365)
T PRK09188         68 AAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLH---RAG  131 (365)
T ss_pred             HHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHH---HCC
Confidence            3567777888888888753221    2457999999999999732 11     11   1467899999999999   589


Q ss_pred             ceecCc-CCCcEEEcCCCcEEEeecccccccCCCCCC-------cccccccccccccccccc
Q 048068          119 VLHRDI-KPANVLLDADLNGKLGDFGLARLYDHDTIP-------QTTKLVGTFGYMAPELMR  172 (313)
Q Consensus       119 i~H~dl-~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~  172 (313)
                      |+|||| ||+||+++.++.++|+|||++.........       ......+++.|.+||.+.
T Consensus       132 IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        132 ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            999999 999999998899999999999866433211       112445677789999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.55  E-value=1.5e-14  Score=119.11  Aligned_cols=166  Identities=20%  Similarity=0.237  Sum_probs=126.4

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      |...-+.+.+-.-+.+.-.+...+.+-.+||+.+ |.+|+++..-. ...++-.+++.++-|++.-++|+|   .++++|
T Consensus        60 EskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH---~r~fiH  134 (341)
T KOG1163|consen   60 ESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVH---LRNFIH  134 (341)
T ss_pred             HHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHH---hhcccc
Confidence            3444445544443444334444466778999999 99999998754 235999999999999999999999   699999


Q ss_pred             cCcCCCcEEEcC---CCcEEEeecccccccCCCCC------CccccccccccccccccccCCCCCcchhhHHHHHHHHHH
Q 048068          122 RDIKPANVLLDA---DLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       122 ~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  192 (313)
                      |||||+|.|..-   ...+.++|||++..+.....      .......||..|.+-....+-..+.+.|+-|+|.++..+
T Consensus       135 RDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYf  214 (341)
T KOG1163|consen  135 RDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYF  214 (341)
T ss_pred             ccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeee
Confidence            999999999964   35689999999986643221      122345788889888777777778899999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHH
Q 048068          193 ASGRRPIEQQGSMEMVNLVD  212 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~  212 (313)
                      .-|..||.+.......+..+
T Consensus       215 nrG~LPWQglka~tk~QKyE  234 (341)
T KOG1163|consen  215 NRGSLPWQGLKAATKKQKYE  234 (341)
T ss_pred             ecCCCcccccchhhHHHHHH
Confidence            99999999887665444443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.55  E-value=1.4e-14  Score=119.72  Aligned_cols=98  Identities=15%  Similarity=0.133  Sum_probs=75.4

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCce
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYL-HEDWEQVVL  120 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l-hs~~~~~i~  120 (313)
                      |.+.+..+.++++.. +..+.. . ..++||||++|+++...+..  ...++...+..++.|++.+|.++ |   ..|++
T Consensus        69 E~~~l~~l~~~~v~~-p~~~~~-~-~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H---~~gii  140 (190)
T cd05147          69 EMRNLKRLVTAGIPC-PEPILL-K-SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ---DCRLV  140 (190)
T ss_pred             HHHHHHHHHHCCCCC-CcEEEe-c-CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            556677777766633 333332 2 23899999988777655332  23689999999999999999999 6   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeeccccccc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLY  148 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~  148 (313)
                      ||||||+||+++ ++.++|+|||++...
T Consensus       141 HrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         141 HADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            999999999998 478999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.54  E-value=5e-14  Score=116.25  Aligned_cols=149  Identities=18%  Similarity=0.078  Sum_probs=106.5

Q ss_pred             hhHHhhhhhccc-cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASVHS-NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~~~-~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..|.+.++++.| +++.+..++     +..+++|||+.|.+|...+..         ....++.|++.++.++|   ..|
T Consensus        49 ~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~G  111 (218)
T PRK12274         49 RREALALRQLDGLPRTPRLLHW-----DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCG  111 (218)
T ss_pred             HHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCc
Confidence            457777888854 445555443     346999999999998754321         11357789999999999   699


Q ss_pred             ceecCc-CCCcEEEcCCCcEEEeecccccccCCCCCC----c--------cccccccccccccccccCC-CCC-cchhhH
Q 048068          119 VLHRDI-KPANVLLDADLNGKLGDFGLARLYDHDTIP----Q--------TTKLVGTFGYMAPELMRTG-KAS-TSTDVY  183 (313)
Q Consensus       119 i~H~dl-~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Diw  183 (313)
                      ++|+|| ||.||+++.++.++|+|||++.........    .        ......++.+++|+...-- ..+ .+.+-+
T Consensus       112 IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~  191 (218)
T PRK12274        112 VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF  191 (218)
T ss_pred             CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence            999999 799999999999999999999755433210    0        0112346677777654321 223 566778


Q ss_pred             HHHHHHHHHHhCCCCCccCCch
Q 048068          184 AFGVFMLEVASGRRPIEQQGSM  205 (313)
Q Consensus       184 slG~il~~ll~g~~pf~~~~~~  205 (313)
                      +.|+-+|.++|+..++.++.+.
T Consensus       192 ~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        192 ATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             HhcchHHHHHhccCCccccCCC
Confidence            9999999999999998876543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.53  E-value=1.1e-14  Score=122.54  Aligned_cols=125  Identities=13%  Similarity=0.176  Sum_probs=92.2

Q ss_pred             HHhhhhhccccceeeeeeEEecc-------CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSR-------KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~-------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      +...+..+.|+++.....+....       .+..++||||++|.+|.++..      +++.    ...+++.++..+|  
T Consensus        85 Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH--  152 (232)
T PRK10359         85 LIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLH--  152 (232)
T ss_pred             HHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHH--
Confidence            33356777899999887775522       346899999999999988732      3332    4568999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                       ..|++|+|++|.||+++.+| ++++|||...........             ..+.....+..++|+|+||+++..+.
T Consensus       153 -~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        153 -QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence             69999999999999999888 999999987644221110             01223344567899999999887664

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.47  E-value=2.7e-14  Score=138.35  Aligned_cols=138  Identities=26%  Similarity=0.310  Sum_probs=106.7

Q ss_pred             HHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCC--------------CCCcccccccccccccccc
Q 048068          105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--------------TIPQTTKLVGTFGYMAPEL  170 (313)
Q Consensus       105 ~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~--------------~~~~~~~~~~~~~y~aPE~  170 (313)
                      +.+++|+|   ..+|+|+|+||+|.+|..-|.+|+.|||++...-..              .........||+.|+|||+
T Consensus       153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            78899999   599999999999999999999999999998643211              1111223478999999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHc
Q 048068          171 MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       171 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  250 (313)
                      +..+.|....|=|++|+|+|+++.|+.||.+...++......-..-.|.++              ........++++...
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--------------dea~p~Ea~dli~~L  295 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--------------DEALPPEAQDLIEQL  295 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc--------------CcCCCHHHHHHHHHH
Confidence            999999999999999999999999999999987777654432111122221              222334567788888


Q ss_pred             CCCCCCCCC
Q 048068          251 SHPKPEARP  259 (313)
Q Consensus       251 l~~~P~~Rp  259 (313)
                      |+.+|..|-
T Consensus       296 L~qnp~~Rl  304 (1205)
T KOG0606|consen  296 LRQNPLCRL  304 (1205)
T ss_pred             HHhChHhhc
Confidence            999999995

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.42  E-value=8.9e-13  Score=109.16  Aligned_cols=99  Identities=17%  Similarity=0.153  Sum_probs=75.0

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI-LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      |.+.+..+.++++.....+...   ..++||||++|+++... +..   ..++...+..++.|++.++.++|+  ..|++
T Consensus        69 E~~~l~~l~~~~i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~giv  140 (190)
T cd05145          69 EFRNLKRLYEAGVPVPEPILLK---KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQ--EAGLV  140 (190)
T ss_pred             HHHHHHHHHhCCCCCceEEEec---CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            4456667777765433333222   24899999988755433 332   357888999999999999999994  28999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYD  149 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~  149 (313)
                      |+||||+||+++ ++.++|+|||++....
T Consensus       141 HrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         141 HGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            999999999998 7899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.40  E-value=9.5e-13  Score=110.12  Aligned_cols=100  Identities=17%  Similarity=0.194  Sum_probs=78.0

Q ss_pred             ChhhHHhhhhhc-----cccceeeeeeEEeccC--Ce-EEEEEec--CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHH
Q 048068           38 DPQLQRDGLASV-----HSNGLLQLTNTVNSRK--GE-FLLVYDY--MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG  107 (313)
Q Consensus        38 ~~~~~~~~l~~~-----~~~~~l~~~~~~~~~~--~~-~~lV~e~--~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~a  107 (313)
                      ....|..+++++     .|+++++.++++..+.  +. +.+||||  +.+++|.+++++.   .+++.  ..++.|++.+
T Consensus        42 ~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~  116 (210)
T PRK10345         42 EIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKK  116 (210)
T ss_pred             HHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHH
Confidence            456677788888     5799999999999653  34 3378999  5579999999753   36666  3568888877


Q ss_pred             H-HHhhhcCCCCceecCcCCCcEEEcCC----CcEEEeecccc
Q 048068          108 L-LYLHEDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLA  145 (313)
Q Consensus       108 l-~~lhs~~~~~i~H~dl~~~nIlv~~~----~~~~l~dfg~~  145 (313)
                      + +|||   ..+|+|+||||+||+++..    +.++|+|++.+
T Consensus       117 l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        117 LKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            7 8999   6999999999999999743    37999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=1.8e-12  Score=127.59  Aligned_cols=128  Identities=20%  Similarity=0.182  Sum_probs=106.9

Q ss_pred             CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc-------CCCcE
Q 048068           65 KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-------ADLNG  137 (313)
Q Consensus        65 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~-------~~~~~  137 (313)
                      .+..++|+||.+.|+|-+++..  .+.+++..+..+.+|++..+..||   ..+|+||||||+|.++.       ++..+
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccce
Confidence            4567899999999999999984  567999999999999999999999   79999999999999993       23458


Q ss_pred             EEeecccccccCCC-CCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          138 KLGDFGLARLYDHD-TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       138 ~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+|||.+--+... ....-....+|-.+--+|...+..|+.+.|.|.|+.+++-|+.|+.
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999988533211 1112334567778889999999999999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=9.7e-14  Score=132.96  Aligned_cols=200  Identities=26%  Similarity=0.361  Sum_probs=151.6

Q ss_pred             ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHH-hhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcE
Q 048068           51 SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV  129 (313)
Q Consensus        51 ~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l-~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nI  129 (313)
                      |.++++..+...+ ....++++++.+|+++.+.+ ... ....+...+-.++.|+..++.|+|.  ..++.|+|++|+|.
T Consensus        80 h~n~~~~~~~~~~-~~~~~~~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~  155 (601)
T KOG0590|consen   80 HSNTVHMIEPSSS-PRSYLLSLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNS  155 (601)
T ss_pred             cccccccCCccCC-CcccccccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccc
Confidence            7777776666655 67889999999999999998 433 2257888888999999999999995  48999999999999


Q ss_pred             EEcCCC-cEEEeecccccccCC--CCCCccccccc-cccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCc
Q 048068          130 LLDADL-NGKLGDFGLARLYDH--DTIPQTTKLVG-TFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGS  204 (313)
Q Consensus       130 lv~~~~-~~~l~dfg~~~~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  204 (313)
                      +++.++ .++++|||++..+..  ..........| ++.|.+||...+. ...+..|+||.|+++.-+++|..|+.....
T Consensus       156 ~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  156 LLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             hhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            999999 999999999986655  33333444567 9999999999874 557889999999999999999999887655


Q ss_pred             hhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      .......      |....      ................+++.+++..+|..|.+.+++-.
T Consensus       236 ~~~~~~~------~~~~~------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  236 KDGRYSS------WKSNK------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccee------ecccc------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            5422111      11110      01011122233455677888889999999999988765

>smart00090 RIO RIO-like kinase

Probab=99.21  E-value=4.2e-11  Score=102.42  Aligned_cols=98  Identities=12%  Similarity=0.116  Sum_probs=72.9

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-c
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV-V  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~-i  119 (313)
                      .|...++.+.+. .+..+..+..  ...++||||++|.+|......  ....+...+..++.|++.++.+||   ..+ +
T Consensus        99 ~E~~~L~~L~~~-~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~g~i  170 (237)
T smart00090       99 KEFRNLQRLYEA-GVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLY---KEGEL  170 (237)
T ss_pred             HHHHHHHHHHhc-CCCCCeeeEe--cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHH---hcCCE
Confidence            355555666542 3333333332  235899999988887765433  224666777899999999999999   588 9


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccc
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARL  147 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~  147 (313)
                      +|+||||+||+++ ++.++|+|||.+..
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            9999999999999 78899999998764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.20  E-value=8e-11  Score=98.90  Aligned_cols=96  Identities=20%  Similarity=0.326  Sum_probs=76.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+..+.++++.....+... .+..++||||++|++|.+++....     . ....++.+++.++.++|   ..+++
T Consensus        48 ~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~  117 (211)
T PRK14879         48 REARIMSRARKAGVNVPAVYFVD-PENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGII  117 (211)
T ss_pred             HHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcc
Confidence            34456666777766554444333 456789999999999999987531     2 78899999999999999   68999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARL  147 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~  147 (313)
                      |+|++|.||+++ ++.++++|||.+..
T Consensus       118 H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        118 HGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             cCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999 78899999998754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.20  E-value=3.1e-10  Score=106.24  Aligned_cols=143  Identities=17%  Similarity=0.244  Sum_probs=110.3

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ......++-++||+|+++...... .+..|+|+|-+.  .|..++++.     ....+..-+.||+.||.+||.  ++++
T Consensus        57 ~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~--d~~l  126 (690)
T KOG1243|consen   57 KRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKEL-----GKEEVCLGLFQILAALSFLND--DCNL  126 (690)
T ss_pred             HHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhc--cCCe
Confidence            345577888999999999988887 569999999884  899999873     366777779999999999987  6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +|++|..+.|+|+..|..+|++|.++........ ........-.|..|+.+....  ...|.|.|||++++++.|
T Consensus       127 vHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  127 VHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            9999999999999999999999988754322211 111122223456666544322  356999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.17  E-value=9.3e-11  Score=112.23  Aligned_cols=93  Identities=22%  Similarity=0.293  Sum_probs=76.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|.+.++.+.++++.....+... ....++||||++|++|.+++.          ....++.+++.++.+||   ..++
T Consensus       384 ~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~gi  449 (535)
T PRK09605        384 RAEARLLSEARRAGVPTPVIYDVD-PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGI  449 (535)
T ss_pred             HHHHHHHHhhcccCCCeeEEEEEe-CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCC
Confidence            356667788888887665444333 456789999999999999886          24678999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccc
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARL  147 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~  147 (313)
                      +|||+||+||++ .++.++|+|||++..
T Consensus       450 iHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        450 VHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999999 677899999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.16  E-value=1.2e-10  Score=96.92  Aligned_cols=93  Identities=18%  Similarity=0.297  Sum_probs=71.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.++.+.+.++.... +........++||||++|++|.+.+....   .      .++.+++.++.++|   ..+++
T Consensus        46 ~E~~~l~~l~~~~i~~p~-~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH---~~gi~  112 (199)
T TIGR03724        46 NEARLLSRARKAGVNTPV-VYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLH---KAGIV  112 (199)
T ss_pred             HHHHHHHHHHHCCCCCCE-EEEEECCCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHH---HCCee
Confidence            355556666666543222 22222456789999999999999886531   1      78999999999999   69999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARL  147 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~  147 (313)
                      |+|++|.||+++ ++.++++|||++..
T Consensus       113 H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       113 HGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             cCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999 78999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.14  E-value=1.8e-10  Score=98.67  Aligned_cols=99  Identities=24%  Similarity=0.234  Sum_probs=73.6

Q ss_pred             hhHHhhhhhccccce--eeeeeEEeccCC---eEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           40 QLQRDGLASVHSNGL--LQLTNTVNSRKG---EFLLVYDYMPN-GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~--l~~~~~~~~~~~---~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      ..+...+..+.++++  .+.........+   ..++|||+++| .+|.+++...   .+++..    +.+|+.++.+|| 
T Consensus        88 ~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH-  159 (239)
T PRK01723         88 FAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFH-  159 (239)
T ss_pred             HHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHH-
Confidence            346667777777664  344433222222   23599999997 6999988653   355543    578999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeeccccccc
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY  148 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~  148 (313)
                        ..||+|+||||.||+++.++.++|+|||.+...
T Consensus       160 --~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        160 --DAGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             --HCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence              699999999999999998889999999988653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.06  E-value=5.3e-10  Score=93.13  Aligned_cols=93  Identities=13%  Similarity=0.204  Sum_probs=69.1

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...+..+.+.++ ..+..+.  ....++||||++|++|......        .....++.+++.++.++|   ..+++|
T Consensus        83 E~~~l~~l~~~~i-~v~~~~~--~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H  148 (198)
T cd05144          83 EFAALKALYEEGF-PVPKPID--WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIH  148 (198)
T ss_pred             HHHHHHHHHHcCC-CCCceee--cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCc
Confidence            4444555555532 1222222  2355899999999998765431        335678899999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeeccccccc
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLY  148 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~  148 (313)
                      +||+|.||+++.++.++|+|||.+...
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccccC
Confidence            999999999999999999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=9.9e-10  Score=101.71  Aligned_cols=195  Identities=20%  Similarity=0.244  Sum_probs=140.1

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCceecCcC
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS----GLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~----al~~lhs~~~~~i~H~dl~  125 (313)
                      .|++.++....+ ..++..++-+|.+ +.+|..+.+.- ...++...++..+.+...    |+.++|   ..+++|.|++
T Consensus       176 ~~~~~v~~~~~~-e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~k  249 (524)
T KOG0601|consen  176 SHENPVRDSPAW-EGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLK  249 (524)
T ss_pred             ccccccccCccc-ccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccC---CCcccccccc
Confidence            355555533333 3367888999988 67888888754 335899999999999999    999999   5899999999


Q ss_pred             CCcEEEcCC-CcEEEeecccccccCCCCCCc----cccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          126 PANVLLDAD-LNGKLGDFGLARLYDHDTIPQ----TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       126 ~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |.||+...+ ...++.|||+...+.......    .....+...|.+||... +.++...|++++|.+..+...+..+..
T Consensus       250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence            999999999 788999999987665443211    11225677899999987 577889999999999999988877654


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...... +               .+....-++.++.......+...+..|++.+|..|++.+.+..+
T Consensus       329 ~g~~~~-W---------------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  329 VGKNSS-W---------------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             CCCCCC-c---------------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            331111 0               00011112222333334455668899999999999999888763

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.97  E-value=2.8e-08  Score=88.89  Aligned_cols=200  Identities=17%  Similarity=0.157  Sum_probs=130.9

Q ss_pred             eEEEEEecCCCC-CHHHHH----hhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEee
Q 048068           67 EFLLVYDYMPNG-SLDKIL----HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD  141 (313)
Q Consensus        67 ~~~lV~e~~~~g-~L~~~l----~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~d  141 (313)
                      ...++|+.+.|. ....++    ++++...+.++.+...++.++.+.+.||   ..|.+-+|++++|+||++++.+.|.|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEc
Confidence            478999998764 333333    2344556899999999999999999999   78999999999999999999999987


Q ss_pred             cccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHHHHHHhC-CCCCccCCchh----hhh-H
Q 048068          142 FGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVASG-RRPIEQQGSME----MVN-L  210 (313)
Q Consensus       142 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~----~~~-~  210 (313)
                      -........+.  ......|...|.+||.-.     +...+..+|.|.||+++++++.| ++||.+-....    ... .
T Consensus       161 sDsfqi~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         161 SDSFQINANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             ccceeeccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            55443322211  223457788999999753     34567889999999999999986 99997632221    111 1


Q ss_pred             HHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCC--CCCCCCCHHHHHHHHhccC
Q 048068          211 VDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHP--KPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~P~~Rpt~~ell~~L~~~~  272 (313)
                      +.--........ .....+.+....-...+..+..+..+|+..  ++.-|||++-.+..|....
T Consensus       239 Ia~g~f~ya~~~-~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         239 IAHGRFAYASDQ-RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hhcceeeechhc-cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            100000000000 000111111111123345677777788743  4678999999988776543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.89  E-value=7.6e-09  Score=81.30  Aligned_cols=98  Identities=21%  Similarity=0.213  Sum_probs=75.3

Q ss_pred             hhhHHhhhhhcccc--ceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           39 PQLQRDGLASVHSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        39 ~~~~~~~l~~~~~~--~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ...+...++.+.+.  .+.+....... .+..+++|||+++..+..+         +......++.+++.++..+|....
T Consensus        38 ~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~  107 (155)
T cd05120          38 REREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPL  107 (155)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence            45666777777664  55555554443 4678999999988776543         456667788999999999995322


Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      .+++|+|++|.||+++..+.+++.||+.+.
T Consensus       108 ~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120         108 LVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             eEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            479999999999999998899999999775

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.85  E-value=1.9e-07  Score=85.65  Aligned_cols=205  Identities=11%  Similarity=0.220  Sum_probs=141.0

Q ss_pred             hhccccceEEEccc---CCC----hhhHHhhhhhccccceeeeeeEEe---ccCCeEEEEEecCCC-CCHHHHHhhC---
Q 048068           22 ALAQDVNQFIYHGF---NED----PQLQRDGLASVHSNGLLQLTNTVN---SRKGEFLLVYDYMPN-GSLDKILHTN---   87 (313)
Q Consensus        22 ~~~~~~~~~~~~~~---~~~----~~~~~~~l~~~~~~~~l~~~~~~~---~~~~~~~lV~e~~~~-g~L~~~l~~~---   87 (313)
                      +...+++.++.+++   +..    .....+.++++.|.|+|...+++.   -.+..+++|++|+++ ++|.+..-..   
T Consensus       296 ~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~  375 (655)
T KOG3741|consen  296 TSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPF  375 (655)
T ss_pred             eeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcc
Confidence            44556777788887   211    123456788999999999999888   235688999999976 5777765321   


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc
Q 048068           88 ----------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        88 ----------~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                                .+.+.++..+|.++.|+..||.++|+   .|...+-|.+.+|++..+..++|..+|..........    
T Consensus       376 t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----  448 (655)
T KOG3741|consen  376 TKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----  448 (655)
T ss_pred             ccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCCCC----
Confidence                      13458889999999999999999995   8999999999999999888888887776654332220    


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                                 +.+.   -..+-|.=.||.++..+.+|..--+..+... ...++                     ....
T Consensus       449 -----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~-~s~~~---------------------~I~~  492 (655)
T KOG3741|consen  449 -----------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQ-SSHLT---------------------RITT  492 (655)
T ss_pred             -----------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchH-HHHHH---------------------Hhhh
Confidence                       1111   1235688899999999999865422111111 11111                     1334


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .++..+++++......++.+ -++.+++.++-+
T Consensus       493 ~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~  524 (655)
T KOG3741|consen  493 TYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS  524 (655)
T ss_pred             hhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence            55666777777777777776 677787776543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.84  E-value=7.3e-09  Score=85.24  Aligned_cols=75  Identities=19%  Similarity=0.193  Sum_probs=58.2

Q ss_pred             eEEEEEecCCCCCHHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccc
Q 048068           67 EFLLVYDYMPNGSLDKI-LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA  145 (313)
Q Consensus        67 ~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~  145 (313)
                      ..++||||++++.+... +... .  . ...+..++.+++.++.++|.  ..+++|+||+|+||+++ ++.++++|||.+
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~-~--~-~~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~~~liDfg~a  161 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDV-R--L-LEDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGKVYIIDVPQA  161 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhh-h--h-cccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCcEEEEECccc
Confidence            45899999988543221 2111 0  1 16678899999999999993  28999999999999999 889999999988


Q ss_pred             ccc
Q 048068          146 RLY  148 (313)
Q Consensus       146 ~~~  148 (313)
                      ...
T Consensus       162 ~~~  164 (187)
T cd05119         162 VEI  164 (187)
T ss_pred             ccc
Confidence            643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.81  E-value=1.1e-08  Score=95.27  Aligned_cols=96  Identities=17%  Similarity=0.189  Sum_probs=70.8

Q ss_pred             hhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHhhhcCCCCceecCcC
Q 048068           47 ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS-GLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        47 ~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~-al~~lhs~~~~~i~H~dl~  125 (313)
                      +.+.+.+.+..+.++.+..+..++||||++|++|.++...... ..+.   ..++.+++. .+..+|   ..|++|+|++
T Consensus       212 ~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~~---~~ia~~~~~~~l~ql~---~~g~~H~D~h  284 (437)
T TIGR01982       212 ENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLDR---KALAENLARSFLNQVL---RDGFFHADLH  284 (437)
T ss_pred             HhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCCH---HHHHHHHHHHHHHHHH---hCCceeCCCC
Confidence            3344556677777776656678999999999999988754211 2222   334455544 356778   5899999999


Q ss_pred             CCcEEEcCCCcEEEeecccccccC
Q 048068          126 PANVLLDADLNGKLGDFGLARLYD  149 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~~  149 (313)
                      |.||++..++.++++|||++....
T Consensus       285 PgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       285 PGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             cccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999986543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=8.9e-10  Score=103.63  Aligned_cols=183  Identities=18%  Similarity=0.239  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc--c------cccccccccccc
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--T------KLVGTFGYMAPE  169 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~--~------~~~~~~~y~aPE  169 (313)
                      ..=+.+++.|+.++|.  ..+++|++|.|++|.++.++..||+.|+++..........-  .      .......|.+||
T Consensus       102 f~nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE  179 (700)
T KOG2137|consen  102 FANLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE  179 (700)
T ss_pred             hhhhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence            3345566689999998  68999999999999999999999999998865443221111  0      012344699999


Q ss_pred             cccCCCCCcchhhHHHHHHHHHHH-hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHH
Q 048068          170 LMRTGKASTSTDVYAFGVFMLEVA-SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL  248 (313)
Q Consensus       170 ~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (313)
                      ++.....+.++|++|+|+++|.+. .|+.-+........+....             ..+......++...+..+++-+.
T Consensus       180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             hhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHH
Confidence            999878889999999999999998 5665555433222221111             11111222244556677788888


Q ss_pred             HcCCCCCCCCCCHHHHHHHH-hccCCCCCCCCCCcccccCCCCCCccC
Q 048068          249 FCSHPKPEARPNMRQVMQYL-DGNATLPDIPRDSTLIAPFSASNDAFS  295 (313)
Q Consensus       249 ~cl~~~P~~Rpt~~ell~~L-~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (313)
                      +++..++..||++.++.... -+...+.....=..+....+.++++|.
T Consensus       247 k~l~~~~~~rp~~~~l~~~~ff~D~~~~aLrfLD~l~~kdn~qKs~Fl  294 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLSIPFFSDPGLKALRFLDDLPQKDNSQKSSFL  294 (700)
T ss_pred             HHhcCCcccCcchhhhhcccccCCchhhhhhhcccccccCcHHHHHHH
Confidence            89999999999877766532 222234444444445555666666665

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.75  E-value=4.2e-09  Score=103.08  Aligned_cols=180  Identities=24%  Similarity=0.260  Sum_probs=134.2

Q ss_pred             cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecc
Q 048068           64 RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG  143 (313)
Q Consensus        64 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg  143 (313)
                      .....++|++|+.+++|...++...  ..+..-....+..+..++++||+   ..+.|+|++|.|+++..++..++.+|+
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~  949 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFG  949 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccc
Confidence            3567899999999999999998753  46666667777888899999994   558999999999999999999999987


Q ss_pred             cccccC-------C------------------CCC-----CccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          144 LARLYD-------H------------------DTI-----PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       144 ~~~~~~-------~------------------~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                      ......       .                  ...     .......+|+.|.+||...+......+|.|++|+++++.+
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence            322110       0                  000     0112346788999999999999899999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR  262 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  262 (313)
                      +|.+||...........+-...              ......+........+++...+..+|.+|..+.
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~--------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRD--------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCC--------------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999998776665553331100              111223344455677788888999999998776

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.74  E-value=5.2e-08  Score=80.34  Aligned_cols=99  Identities=17%  Similarity=0.130  Sum_probs=67.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH-HHHhhCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD-KILHTNIKPSLSWYQRFRIIRGVASGLLYL-HEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~l-hs~~~~~  118 (313)
                      .|...++.+...+ +..+..+..  ..-+|||||+.+..+. ..+++.   .++...+..+..+++.++..+ |   ..+
T Consensus        75 kE~r~L~rl~~~G-v~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H---~~g  145 (197)
T cd05146          75 KEMHNLKRMQKAG-IPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYK---ECN  145 (197)
T ss_pred             HHHHHHHHHHHcC-CCCCeEEEe--cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHH---hCC
Confidence            4445555554433 223333332  3468899999654332 223321   355566778889999999988 7   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYD  149 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~  149 (313)
                      ++|+||++.||++. ++.+.++||+.+....
T Consensus       146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999999999997 4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.70  E-value=9e-08  Score=76.90  Aligned_cols=96  Identities=21%  Similarity=0.299  Sum_probs=71.4

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ....|...+..+.-.++. .+.++.-+.....|+|||++|..|.+.+...     .    ..++..+-.-+.-||   ..
T Consensus        45 Rt~~Earil~~a~~~GV~-~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH---~~  111 (204)
T COG3642          45 RTRREARILAKAREAGVP-VPIVYDVDPDNGLIVMEYIEGELLKDALEEA-----R----PDLLREVGRLVGKLH---KA  111 (204)
T ss_pred             HHHHHHHHHHHHHHcCCC-CCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHH---hc
Confidence            334556666666555433 4444444466778999999999999888764     1    455666667778899   79


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccc
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARL  147 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~  147 (313)
                      ||+|+||+++||++...+ +.++|||++..
T Consensus       112 givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999999999997664 89999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.63  E-value=2.5e-07  Score=74.15  Aligned_cols=104  Identities=17%  Similarity=0.213  Sum_probs=74.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPN-GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|...+....-.++....-++.+ ...-+|+|||++| .++.+++...-...........++.+|-..+.-||   ..++
T Consensus        59 ~Ear~l~k~~~~GI~~P~l~~~D-~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndi  134 (229)
T KOG3087|consen   59 QEARLLAKCRALGIPAPRLIFID-TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDI  134 (229)
T ss_pred             HHHHHHHHHHHhCCCCceEEEEe-cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCe
Confidence            34445555555555444434433 4456789999976 48888887653333444555788999999999999   6999


Q ss_pred             eecCcCCCcEEEcCCCc---EEEeeccccccc
Q 048068          120 LHRDIKPANVLLDADLN---GKLGDFGLARLY  148 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~---~~l~dfg~~~~~  148 (313)
                      +||||+.+||++...+.   +.++|||++...
T Consensus       135 iHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  135 IHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99999999999976554   479999998644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.60  E-value=1.8e-07  Score=75.47  Aligned_cols=91  Identities=20%  Similarity=0.173  Sum_probs=62.3

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV-  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~-  118 (313)
                      ..|...++.+...+++.  .++.......++||||++|.++... .      .   ....++.+++.++..||.   .+ 
T Consensus        40 ~~E~~~l~~l~~~~~~P--~~~~~~~~~~~lv~e~i~G~~l~~~-~------~---~~~~~~~~l~~~l~~LH~---~~~  104 (170)
T cd05151          40 ENEAENSKLAAEAGIGP--KLYYFDPETGVLITEFIEGSELLTE-D------F---SDPENLEKIAKLLKKLHS---SPL  104 (170)
T ss_pred             HHHHHHHHHHHHhCCCC--ceEEEeCCCCeEEEEecCCCccccc-c------c---cCHHHHHHHHHHHHHHhC---CCC
Confidence            45556666665444332  1122112345799999999887543 0      1   113456789999999994   55 


Q ss_pred             ----ceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          119 ----VLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       119 ----i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                          ++|+|++|.||+++ ++.++++||+.+.
T Consensus       105 ~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151         105 PDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence                59999999999998 6689999999774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.58  E-value=9.2e-08  Score=90.51  Aligned_cols=91  Identities=15%  Similarity=0.148  Sum_probs=66.7

Q ss_pred             ccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHH--hhCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCc
Q 048068           49 VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL--HTNI--KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI  124 (313)
Q Consensus        49 ~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l--~~~~--~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl  124 (313)
                      +.+...+..+.++.+..+..++||||++|+++.++-  ....  .+.+.+..+..++.|++          ..|++|+|+
T Consensus       217 f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----------~~GffHaDp  286 (537)
T PRK04750        217 FEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----------RDGFFHADM  286 (537)
T ss_pred             ccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH----------hCCeeeCCC
Confidence            346667777888877777889999999999998753  2211  01244444455555543          369999999


Q ss_pred             CCCcEEEcCCC----cEEEeecccccccC
Q 048068          125 KPANVLLDADL----NGKLGDFGLARLYD  149 (313)
Q Consensus       125 ~~~nIlv~~~~----~~~l~dfg~~~~~~  149 (313)
                      +|.||+++.++    .++++|||+.....
T Consensus       287 HPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        287 HPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            99999999887    89999999986553

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.53  E-value=3.9e-07  Score=79.16  Aligned_cols=77  Identities=19%  Similarity=0.157  Sum_probs=64.4

Q ss_pred             eEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-------CCcEE
Q 048068           67 EFLLVYDYMPNG-SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------DLNGK  138 (313)
Q Consensus        67 ~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-------~~~~~  138 (313)
                      ..++|||++++. +|.+++........+......++.+++..+.-||   ..|++|+|+++.||+++.       ...+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEE
Confidence            578999999875 8999986422334667788899999999999999   699999999999999975       45789


Q ss_pred             Eeeccccc
Q 048068          139 LGDFGLAR  146 (313)
Q Consensus       139 l~dfg~~~  146 (313)
                      ++||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999775

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.51  E-value=5.8e-08  Score=90.13  Aligned_cols=190  Identities=17%  Similarity=0.169  Sum_probs=128.9

Q ss_pred             ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEE
Q 048068           51 SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL  130 (313)
Q Consensus        51 ~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIl  130 (313)
                      |.+.+....-+.. ..+.++=-|||+++++...+.-  ...+++...+.+..|++.++.++|   ...++|+|++|+||+
T Consensus       325 ~~~~~g~~~~W~~-~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~  398 (524)
T KOG0601|consen  325 HLPSVGKNSSWSQ-LRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNIL  398 (524)
T ss_pred             ccccCCCCCCccc-cccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhccccccccee
Confidence            4444444333333 3455688999999988777633  345899999999999999999999   599999999999999


Q ss_pred             EcCC-CcEEEeecccccccCCCCCCcccccccccccc--ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhh
Q 048068          131 LDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM--APELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM  207 (313)
Q Consensus       131 v~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  207 (313)
                      +..+ +.-++.||+.......    .........++.  ++.......+..+.|+++||..+.+.+++.+.-+....-..
T Consensus       399 i~~~~~~~~~~~~~~~t~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~  474 (524)
T KOG0601|consen  399 ISNDGFFSKLGDFGCWTRLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT  474 (524)
T ss_pred             eccchhhhhccccccccccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccccee
Confidence            9886 5667888887753111    111122222333  45455566778899999999999999998765432211100


Q ss_pred             hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                         +            .....+     ......+.+..+...++..++..||.+.++..+.+-
T Consensus       475 ---i------------~~~~~p-----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  475 ---I------------RSGDTP-----NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ---e------------eccccc-----CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence               0            000011     111222666777788999999999999998877653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.43  E-value=1.6e-06  Score=72.55  Aligned_cols=76  Identities=28%  Similarity=0.398  Sum_probs=65.0

Q ss_pred             eEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC---cEEEeec
Q 048068           67 EFLLVYDYMPNG-SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLGDF  142 (313)
Q Consensus        67 ~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~---~~~l~df  142 (313)
                      ..++|+|++++. +|.+++.....  .+......++.+++..+.-||   ..|++|+|+++.|||+..++   .+.++||
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDl  165 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDL  165 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcc
Confidence            458999999874 89999986322  667778889999999999999   69999999999999999887   7899999


Q ss_pred             ccccc
Q 048068          143 GLARL  147 (313)
Q Consensus       143 g~~~~  147 (313)
                      +.+..
T Consensus       166 d~~~~  170 (206)
T PF06293_consen  166 DRMRF  170 (206)
T ss_pred             hhcee
Confidence            97754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.42  E-value=7e-07  Score=73.31  Aligned_cols=101  Identities=18%  Similarity=0.263  Sum_probs=60.8

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCC--CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-hhhc
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLY-LHED  114 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~-lhs~  114 (313)
                      ....|.+.|..+...++. .+..+.-  +.-++||||++  |..+..+....    ++......++.+++..+.. +|  
T Consensus        54 ~~~~E~~~L~~l~~~Gv~-vP~p~~~--~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~--  124 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVP-VPKPYDY--NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH--  124 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-S-S--EEEE--ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHHHHHCCcc-CCcEEEE--eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH--
Confidence            445566667777655421 2222221  12369999997  65555544322    2244456667777775554 57  


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeecccccccC
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD  149 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~  149 (313)
                       ..|++|||+++.||+++++ .+.++|||.+....
T Consensus       125 -~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  125 -KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             -CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             -hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence             6899999999999999887 89999999876443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.04  E-value=2.2e-05  Score=66.03  Aligned_cols=106  Identities=23%  Similarity=0.224  Sum_probs=72.0

Q ss_pred             ChhhHHhhhhhccccc--eeeeeeEEecc--CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           38 DPQLQRDGLASVHSNG--LLQLTNTVNSR--KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~--~l~~~~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      ....|.+.++.+...+  +.++.......  .+..++||||++|.++.+.+..   ..+++.....++.+++.++..||+
T Consensus        41 ~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          41 DVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             cHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            3455666677766533  23333333221  1366899999999888776532   236677777777788888877774


Q ss_pred             c-----------------------------------------------------CCCCceecCcCCCcEEEcC--CCcEE
Q 048068          114 D-----------------------------------------------------WEQVVLHRDIKPANVLLDA--DLNGK  138 (313)
Q Consensus       114 ~-----------------------------------------------------~~~~i~H~dl~~~nIlv~~--~~~~~  138 (313)
                      .                                                     ....++|+|+.+.||+++.  ++.+.
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~  197 (223)
T cd05154         118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVA  197 (223)
T ss_pred             CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEE
Confidence            1                                                     0255799999999999998  56688


Q ss_pred             Eeeccccc
Q 048068          139 LGDFGLAR  146 (313)
Q Consensus       139 l~dfg~~~  146 (313)
                      |+||+.+.
T Consensus       198 iID~e~~~  205 (223)
T cd05154         198 VLDWELAT  205 (223)
T ss_pred             EEeccccc
Confidence            99998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.98  E-value=1.6e-05  Score=66.28  Aligned_cols=67  Identities=19%  Similarity=0.335  Sum_probs=51.4

Q ss_pred             CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccc
Q 048068           66 GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA  145 (313)
Q Consensus        66 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~  145 (313)
                      ...++||||++|..|.+...      +++.    +.-.+.+++.-+|   ..|++|+|.+|.|+++.++ .++++|++.-
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~iID~~~k  181 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRIIDTQGK  181 (229)
T ss_pred             eEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEEEECccc
Confidence            35568999999988876542      2322    3455667889999   6999999999999999865 4889999755


Q ss_pred             c
Q 048068          146 R  146 (313)
Q Consensus       146 ~  146 (313)
                      .
T Consensus       182 ~  182 (229)
T PF06176_consen  182 R  182 (229)
T ss_pred             c
Confidence            3

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.88  E-value=4.2e-05  Score=72.23  Aligned_cols=103  Identities=14%  Similarity=0.117  Sum_probs=74.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      ...+|.+-++...-++.+.++.+..+.-.|+|||++|-.+.++..... .+.+...+...+.++.-  ..+-   ..|++
T Consensus       214 n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~---~dgff  287 (517)
T COG0661         214 NAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLL---RDGFF  287 (517)
T ss_pred             HHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHH---hcCcc
Confidence            334455556778888899999887788899999999999998854321 23554444333333221  1111   26999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYD  149 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~  149 (313)
                      |.|.+|.||+++.+|.+.+.|||+.....
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCC
Confidence            99999999999999999999999886554

>PRK09902 hypothetical protein; Provisional

Probab=97.85  E-value=9.2e-05  Score=61.54  Aligned_cols=77  Identities=17%  Similarity=0.113  Sum_probs=63.9

Q ss_pred             eEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc--EEEeecc
Q 048068           67 EFLLVYDYMPN-GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--GKLGDFG  143 (313)
Q Consensus        67 ~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~--~~l~dfg  143 (313)
                      .-+||+|-+.| .+|.+++.+..-...+......++.+++..+.-||   ..|+.|+|+.+.||+++..+.  +.++||.
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            46799998743 68998887643345678888899999999999999   699999999999999986667  8899998


Q ss_pred             ccc
Q 048068          144 LAR  146 (313)
Q Consensus       144 ~~~  146 (313)
                      .+.
T Consensus       176 k~r  178 (216)
T PRK09902        176 KSR  178 (216)
T ss_pred             ccc
Confidence            664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.83  E-value=3.3e-05  Score=66.03  Aligned_cols=95  Identities=13%  Similarity=0.145  Sum_probs=58.6

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+.|-++|..+... -.+.+..+.  .+..++|||+++|-.|...--       +...+..++..|+.-+..+-   ..|
T Consensus       156 A~rEf~~L~~L~~~-G~~VP~P~~--~nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~---~~G  222 (304)
T COG0478         156 AEREFEALQRLYPE-GVKVPKPIA--WNRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY---RRG  222 (304)
T ss_pred             HHHHHHHHHHhhhc-CCCCCCccc--cccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH---HcC
Confidence            34455555555433 112222222  456789999999876654431       22223333444444444333   389


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ++|+|+++-||+++++|.++++||--+.
T Consensus       223 iVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         223 IVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             ccccCCchheEEEecCCCEEEEeCcccc
Confidence            9999999999999999999999986553

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.81  E-value=6.5e-05  Score=70.88  Aligned_cols=105  Identities=13%  Similarity=0.135  Sum_probs=73.3

Q ss_pred             hhhHHhhhhhccccc---eeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           39 PQLQRDGLASVHSNG---LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~---~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .++...+.+.+.+.+   -+..+.++.+......|+|||++|..+.+.-.-. ..+++...+..-+.+...-.-+     
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~qIf-----  318 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQIF-----  318 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHHHH-----
Confidence            334445556666777   5668888888778899999999998777664322 2347777555444443322222     


Q ss_pred             CCCceecCcCCCcEEEcC----CCcEEEeecccccccC
Q 048068          116 EQVVLHRDIKPANVLLDA----DLNGKLGDFGLARLYD  149 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~----~~~~~l~dfg~~~~~~  149 (313)
                      ..|++|+|-+|.||++..    ++.+.+.|+|+.....
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            258999999999999984    5678999999886443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.32  E-value=0.00063  Score=57.67  Aligned_cols=75  Identities=20%  Similarity=0.202  Sum_probs=53.5

Q ss_pred             EEEEEecCCCCC--HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccc
Q 048068           68 FLLVYDYMPNGS--LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA  145 (313)
Q Consensus        68 ~~lV~e~~~~g~--L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~  145 (313)
                      -.|||||+ |..  -.-.|++   -..+...+..+..+++..+.-|-.  ..+++|+||+.-|||+. .+.+.|+|++-+
T Consensus       141 nVLvMEfI-g~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~Qa  213 (268)
T COG1718         141 NVLVMEFI-GDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQA  213 (268)
T ss_pred             CeEEEEec-cCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECccc
Confidence            36999999 433  1111221   123343677778888888887774  48999999999999999 788999999977


Q ss_pred             cccC
Q 048068          146 RLYD  149 (313)
Q Consensus       146 ~~~~  149 (313)
                      ....
T Consensus       214 V~~~  217 (268)
T COG1718         214 VTID  217 (268)
T ss_pred             cccC
Confidence            6443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.27  E-value=0.0014  Score=66.26  Aligned_cols=199  Identities=16%  Similarity=0.149  Sum_probs=124.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC--C-eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK--G-EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~--~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      -+...+....|+++..++.+.....  + ...+..+++..-++...+..  -...+...++.+..+.+.++.++|+   .
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~---~  305 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHS---L  305 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHH---h
Confidence            4455666778888888777766321  1 22345677777788777765  3468999999999999999999995   4


Q ss_pred             CceecCcCCC---cEEEcCCCcEEEe--ecccccccCCCCCCccccccccccccccccccCCCC--CcchhhHHHHHHHH
Q 048068          118 VVLHRDIKPA---NVLLDADLNGKLG--DFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA--STSTDVYAFGVFML  190 (313)
Q Consensus       118 ~i~H~dl~~~---nIlv~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslG~il~  190 (313)
                      ...|.-+...   +..++..+.+.+.  ||+.........  ..........+.++|....+..  ....|+|.+|....
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            3334333333   2222333445544  666655433222  2222334555677877765544  44579999999999


Q ss_pred             HHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          191 EVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .+..|..+-........                       .   .+........+....|+..++++|+++.+++.+.--
T Consensus       384 ~~~~~~~i~~~~~~~~~-----------------------~---l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~  437 (1351)
T KOG1035|consen  384 QLSQGEDISEKSAVPVS-----------------------L---LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFL  437 (1351)
T ss_pred             hhhhcCcccccccchhh-----------------------h---hccccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence            99887665322111100                       0   011111145677788999999999999999998754


Q ss_pred             cC
Q 048068          271 NA  272 (313)
Q Consensus       271 ~~  272 (313)
                      ..
T Consensus       438 ~~  439 (1351)
T KOG1035|consen  438 RF  439 (1351)
T ss_pred             cc
Confidence            44

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.05  E-value=0.0063  Score=51.66  Aligned_cols=30  Identities=20%  Similarity=0.180  Sum_probs=25.8

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ....+|+|+.|.||++++.+ +.++||+.+.
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            35678999999999999887 8999998664

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.97  E-value=0.0013  Score=61.23  Aligned_cols=162  Identities=19%  Similarity=0.178  Sum_probs=95.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      ...++++.+.|.+...+..+.........+|||++ +.+|++.+.....  ..+.    +.         -     .++.
T Consensus        31 gr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l--~~~s----~~---------~-----~~~~   89 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL--KDES----LL---------A-----HGVL   89 (725)
T ss_pred             hhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc--chhh----hc---------c-----cccc
Confidence            45678899999999999999887677899999999 7899999986521  1111    00         1     2232


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |-+            ..+++| .+..        ..           |-.+     .+++|||++|.++.++.-|...+.
T Consensus        90 ~~~------------~~~~td-~~~t--------~~-----------~~~~-----~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   90 HLN------------IIYITD-HFLT--------KY-----------PSPI-----GPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             eeh------------hhhccc-cccc--------cC-----------CCCC-----CcchhhhhHHHHHHHHHHhhHHHH
Confidence            211            122222 0000        00           1000     149999999999999998877665


Q ss_pred             cCCchhhhhHHHHHHHhhhhccc-cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAI-LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      .....+....+.      +-... .......+.......+...+.++...|+-..|..||...++.+
T Consensus       133 ~~~~s~~l~~i~------k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  133 ELTESEYLEILL------KYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHHH------HhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            443333222221      11100 0111111222344456677889999999999999986655543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.84  E-value=0.00045  Score=65.56  Aligned_cols=153  Identities=20%  Similarity=0.239  Sum_probs=105.2

Q ss_pred             CCChhhHHhhhhhccccc-eeeeeeEEeccCCeEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           36 NEDPQLQRDGLASVHSNG-LLQLTNTVNSRKGEFLLVYDYMPNG-SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        36 ~~~~~~~~~~l~~~~~~~-~l~~~~~~~~~~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      ....+.+.+.|.+++||+ .+...+-. +-+...+++|+++.++ +-....... ...+.+.....++..=..+++++|+
T Consensus       277 ~l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~  354 (829)
T KOG0576|consen  277 TLSRRLAIELLDKVNNPNPVVRYLEDY-DGEDYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHS  354 (829)
T ss_pred             chhhHHHHHHHHHccCCCCcccccccC-CcccccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhccccccccc
Confidence            367778899999999999 33322222 3356788999999766 221111110 1224455555666666788899995


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                         ..-+|+|    ||+... +..+..+|+.........  ......+++.+++||+...+.+...-|.|++|.-..++.
T Consensus       355 ---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a  424 (829)
T KOG0576|consen  355 ---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA  424 (829)
T ss_pred             ---ccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence               3346776    666544 678888998876554432  345678899999999999888999999999998777887


Q ss_pred             hCCCCCc
Q 048068          194 SGRRPIE  200 (313)
Q Consensus       194 ~g~~pf~  200 (313)
                      -|-+|-.
T Consensus       425 p~~pPr~  431 (829)
T KOG0576|consen  425 PGLPPRS  431 (829)
T ss_pred             CCCCCCC
Confidence            7777644

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.63  E-value=0.012  Score=48.51  Aligned_cols=97  Identities=22%  Similarity=0.161  Sum_probs=68.5

Q ss_pred             hhhhccc-cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           45 GLASVHS-NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        45 ~l~~~~~-~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      .++.+.+ .++.++.+...     .++|+||...+++...... ..--..++....+++.+++..+.+++..-...+...
T Consensus        12 ll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc   86 (188)
T PF12260_consen   12 LLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC   86 (188)
T ss_pred             HHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            3444443 36666666653     2578999976655422100 001137899999999999999999985333457888


Q ss_pred             CcCCCcEEEcCCCcEEEeeccccc
Q 048068          123 DIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      |++++|+-++.++.++++|.....
T Consensus        87 Dv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   87 DVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             ecchHHeEEeCCCcEEEEechhcc
Confidence            999999999999999999988664

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.48  E-value=0.033  Score=47.64  Aligned_cols=31  Identities=26%  Similarity=0.301  Sum_probs=26.4

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...++|+|+.+.||+++.++...|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3568999999999999987777899998663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.33  E-value=0.02  Score=51.45  Aligned_cols=76  Identities=22%  Similarity=0.200  Sum_probs=59.3

Q ss_pred             eccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEee
Q 048068           62 NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD  141 (313)
Q Consensus        62 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~d  141 (313)
                      .+...+.|++|++- |++|..+-      .....++..++.+-+..+.-+..  +-.+-||++..+||+|+ +|++.|+|
T Consensus       295 ~de~~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         295 LDETLYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             cCCceEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEE
Confidence            34456778889875 76764332      25577788888888887777775  56788999999999999 99999999


Q ss_pred             cccccc
Q 048068          142 FGLARL  147 (313)
Q Consensus       142 fg~~~~  147 (313)
                      |-+++.
T Consensus       365 fklsRl  370 (488)
T COG5072         365 FKLSRL  370 (488)
T ss_pred             eeeeec
Confidence            999874

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.14  E-value=0.0062  Score=53.85  Aligned_cols=94  Identities=13%  Similarity=0.188  Sum_probs=62.3

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ....+-.|++.+...+.- .+..+ + .+..|+|||++.|.+|..+-+-     .+...+..-+..+   +.-|.   ..
T Consensus       156 aa~kEfafmkaL~e~gfp-VPkpi-D-~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~---Iv~la---~~  221 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFP-VPKPI-D-HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGL---IVRLA---NH  221 (465)
T ss_pred             HHHHHHHHHHHHHHcCCC-CCCcc-c-ccceeeHHHhhcccceeeeeec-----CChHHHHHHHHHH---HHHHH---Hc
Confidence            445666677766542211 12222 2 3567899999999998877543     3344444333333   33444   68


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccc
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLA  145 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~  145 (313)
                      |++|+|++-=||+|.+++.++++||--.
T Consensus       222 GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  222 GLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             CceecccchheeEEecCCCEEEeechHh
Confidence            9999999999999999999999999644

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.04  E-value=0.032  Score=46.85  Aligned_cols=31  Identities=35%  Similarity=0.523  Sum_probs=21.4

Q ss_pred             CCCceecCcCCCcEEEc-CCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLD-ADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~-~~~~~~l~dfg~~~  146 (313)
                      ...++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccce
Confidence            57799999999999999 55666799998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.95  E-value=0.0012  Score=68.56  Aligned_cols=154  Identities=13%  Similarity=0.043  Sum_probs=107.6

Q ss_pred             hhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhCCCCC--CCHHHHHHHHHHHHHHHHHhhh--cCCCCce
Q 048068           46 LASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTNIKPS--LSWYQRFRIIRGVASGLLYLHE--DWEQVVL  120 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~~~~~--~~~~~~~~i~~qi~~al~~lhs--~~~~~i~  120 (313)
                      .++..|++....+.-+. ..+..-+.+++++.+|.+.+.|-+...+.  ....-+.-.-.+.+.+..-+|+  ..+...+
T Consensus      1283 ~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v 1362 (2724)
T KOG1826|consen 1283 LREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNV 1362 (2724)
T ss_pred             hhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccch
Confidence            34456777766655555 33456789999999999999997653222  2222222222332555555554  2234468


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+++++.|.+|..+..+++.++|+.+.-+ +.....+...+++.|+.|+....-.++.++|+|..|+-+|....|..+|.
T Consensus      1363 ~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1363 SKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             hhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            99999999999999999999999997322 22234455667778888888877778888999999999999988877764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=95.85  E-value=0.11  Score=43.15  Aligned_cols=85  Identities=18%  Similarity=0.240  Sum_probs=57.6

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCC------CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecC
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPN------GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD  123 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~------g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~d  123 (313)
                      .+.++-+.++++.. +....+|+|.+.+      .+|.+++.+.   .++. .+...+.++   ..||-   +..|+.+|
T Consensus        75 ~~~~i~r~~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~---~~~Iv~~d  143 (199)
T PF10707_consen   75 DWSHIPRFYGFVET-NLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLL---DHHIVIRD  143 (199)
T ss_pred             cccccccEeEEEec-CCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHH---HcCCeecC
Confidence            47788888888886 4567888888733      3788888653   3555 444444443   34555   47799999


Q ss_pred             cCCCcEEEcCCC----cEEEee-cccc
Q 048068          124 IKPANVLLDADL----NGKLGD-FGLA  145 (313)
Q Consensus       124 l~~~nIlv~~~~----~~~l~d-fg~~  145 (313)
                      ++|.||++..+.    .+.|+| ||..
T Consensus       144 l~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  144 LNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCcccEEEEecCCCceEEEEEeCCCCc
Confidence            999999996432    366666 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.84  E-value=0.035  Score=47.29  Aligned_cols=31  Identities=29%  Similarity=0.443  Sum_probs=25.7

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.||+++..+..-|+||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            4568999999999999876656799999763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=94.79  E-value=0.16  Score=51.69  Aligned_cols=30  Identities=17%  Similarity=0.295  Sum_probs=23.7

Q ss_pred             CCceecCcCCCcEEEcC-CCc-EEEeeccccc
Q 048068          117 QVVLHRDIKPANVLLDA-DLN-GKLGDFGLAR  146 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~-~~~-~~l~dfg~~~  146 (313)
                      ..++|+|+++.||+++. ++. .-|.||.++.
T Consensus       225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~  256 (822)
T PLN02876        225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELST  256 (822)
T ss_pred             cceEecCcccccEEEcCCCCeEEEEEeeeccc
Confidence            46999999999999975 333 5688998765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.70  E-value=0.089  Score=44.22  Aligned_cols=75  Identities=23%  Similarity=0.220  Sum_probs=49.7

Q ss_pred             ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEE
Q 048068           51 SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL  130 (313)
Q Consensus        51 ~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIl  130 (313)
                      .-++++..+   +++-.+.++.|.|-.              ......-.+.. -+++|...|+. ..+.+|||.+|+||+
T Consensus       115 mhGilrL~N---Dn~~~yGvIlE~Cy~--------------~~i~~~N~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM  175 (308)
T PF07387_consen  115 MHGILRLKN---DNNYKYGVILERCYK--------------IKINFSNFITA-GIKDLMDFHSE-NQHCLHGDCNPDNIM  175 (308)
T ss_pred             hhheeEeec---CCCceeEEEEeeccC--------------cccchhHHHHH-hHHHHHHhhcc-CCCeecCCCChhhee
Confidence            344555543   345577899998832              11111111111 24667788865 578999999999999


Q ss_pred             EcCCCcEEEeeccc
Q 048068          131 LDADLNGKLGDFGL  144 (313)
Q Consensus       131 v~~~~~~~l~dfg~  144 (313)
                      -+..|.+||.|-+.
T Consensus       176 ~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  176 CDKFGYLKLVDPVC  189 (308)
T ss_pred             ecCCCCEEecChhh
Confidence            99999999998653

The function of this family is unknown.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.77  E-value=0.14  Score=44.75  Aligned_cols=51  Identities=22%  Similarity=0.190  Sum_probs=38.4

Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCC-CCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068           94 WYQRFRIIRGVASGLLYLHEDWE-QVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus        94 ~~~~~~i~~qi~~al~~lhs~~~-~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...+...+..+-.++.-.+.  . ..++|+|+.++|++.++.+.++|+||..+.
T Consensus       131 ~~~~~~~~~~l~~~l~~~~~--~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         131 NHLLRKKLKELRRALEEVPK--DDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             hHHHHHHHHHHHHHhhhcCC--CceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            33444455556666666663  2 469999999999999998999999998764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.67  E-value=0.16  Score=44.85  Aligned_cols=31  Identities=32%  Similarity=0.328  Sum_probs=27.2

Q ss_pred             CCCceecCcCCCcEEEcCC----CcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDAD----LNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~----~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            5688999999999999875    789999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.42  E-value=0.15  Score=43.24  Aligned_cols=31  Identities=23%  Similarity=0.327  Sum_probs=26.6

Q ss_pred             CCCceecCcCCCcEEEcC-CCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDA-DLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.||+++. ++.+.++||..+.
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            357999999999999997 5779999998664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=92.74  E-value=0.42  Score=43.38  Aligned_cols=76  Identities=20%  Similarity=0.178  Sum_probs=55.5

Q ss_pred             EEEEEecCCCCCH--HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccc
Q 048068           68 FLLVYDYMPNGSL--DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA  145 (313)
Q Consensus        68 ~~lV~e~~~~g~L--~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~  145 (313)
                      ..|||+++ |.+=  .-.|++   -.++...+..+-.|++.-+.-|..  .+..+|.||+--|+|+. .|.+.|+|.+-+
T Consensus       239 hVLVM~Fl-Grdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG~lyiIDVSQS  311 (520)
T KOG2270|consen  239 HVLVMEFL-GRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DGKLYIIDVSQS  311 (520)
T ss_pred             ceEeeeec-cCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CCEEEEEEcccc
Confidence            46899999 4331  122232   247777788888888888887776  57899999999999984 578999999877


Q ss_pred             cccCC
Q 048068          146 RLYDH  150 (313)
Q Consensus       146 ~~~~~  150 (313)
                      ....+
T Consensus       312 VE~DH  316 (520)
T KOG2270|consen  312 VEHDH  316 (520)
T ss_pred             ccCCC
Confidence            64433

>PRK10593 hypothetical protein; Provisional

Probab=92.54  E-value=1  Score=39.82  Aligned_cols=28  Identities=18%  Similarity=0.184  Sum_probs=21.6

Q ss_pred             CCCceecCcCCCcEEEcCC-Cc-EEEeecc
Q 048068          116 EQVVLHRDIKPANVLLDAD-LN-GKLGDFG  143 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~-~~-~~l~dfg  143 (313)
                      ...++|||+.+.||+++.+ +. +.+.|..
T Consensus       192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa  221 (297)
T PRK10593        192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG  221 (297)
T ss_pred             CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence            3578999999999999855 43 5677755

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.33  E-value=0.16  Score=42.37  Aligned_cols=31  Identities=39%  Similarity=0.549  Sum_probs=21.9

Q ss_pred             CCCceecCcCCCcEEE-cCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLL-DADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv-~~~~~~~l~dfg~~~  146 (313)
                      ...++|+|+.+.||++ ..++.++++||..+.
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            3678999999999999 788999999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK05231 homoserine kinase; Provisional

Probab=92.18  E-value=0.25  Score=44.11  Aligned_cols=31  Identities=32%  Similarity=0.376  Sum_probs=26.3

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.||+++.+...-++||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4689999999999999866556799999774

>PHA03111 Ser/Thr kinase; Provisional

Probab=91.53  E-value=0.45  Score=42.46  Aligned_cols=44  Identities=20%  Similarity=0.080  Sum_probs=31.9

Q ss_pred             CHHHHHHHHHHHHHHHHHh-hhcCCCCceecCcCCCcEEEcCCCc
Q 048068           93 SWYQRFRIIRGVASGLLYL-HEDWEQVVLHRDIKPANVLLDADLN  136 (313)
Q Consensus        93 ~~~~~~~i~~qi~~al~~l-hs~~~~~i~H~dl~~~nIlv~~~~~  136 (313)
                      -...++.++.||+.-.-.+ ...|-..++|.||||+||||.+...
T Consensus       277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~  321 (444)
T PHA03111        277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDE  321 (444)
T ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCC
Confidence            3456777888887655333 3343478999999999999987653

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=91.40  E-value=0.52  Score=41.85  Aligned_cols=31  Identities=39%  Similarity=0.480  Sum_probs=27.4

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+++.||+++.++...++||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4789999999999999988777899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10271 thiK thiamine kinase; Provisional

Probab=90.62  E-value=0.24  Score=40.54  Aligned_cols=29  Identities=28%  Similarity=0.294  Sum_probs=25.3

Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...+|+|+.|.|+++.+++ ++++||+.+.
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            4679999999999998877 8899999774

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=90.39  E-value=0.22  Score=43.88  Aligned_cols=31  Identities=35%  Similarity=0.389  Sum_probs=26.9

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.|.||+++.++...|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3679999999999999987777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=90.29  E-value=0.65  Score=41.10  Aligned_cols=30  Identities=23%  Similarity=0.205  Sum_probs=25.5

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368899999999999987 678899998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=89.87  E-value=0.27  Score=42.41  Aligned_cols=29  Identities=28%  Similarity=0.295  Sum_probs=25.1

Q ss_pred             CCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          117 QVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..++|+|+.+.||+++.++ +.++||..+.
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            4689999999999999876 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=89.80  E-value=1.9  Score=39.83  Aligned_cols=77  Identities=17%  Similarity=0.183  Sum_probs=53.3

Q ss_pred             cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE
Q 048068           52 NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL  131 (313)
Q Consensus        52 ~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv  131 (313)
                      ..-+.++.-+.+.-....+|=+|..|.++..+++..   ..++.....++.-.+.|+.-+--  -.+++|.|++|.||++
T Consensus       304 s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVli  378 (565)
T KOG1236|consen  304 SKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLI  378 (565)
T ss_pred             ceeecCCcccccccccceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEE
Confidence            333444444444344567788888999999999864   35666777777766677654332  3789999999999999


Q ss_pred             cC
Q 048068          132 DA  133 (313)
Q Consensus       132 ~~  133 (313)
                      -.
T Consensus       379 rf  380 (565)
T KOG1236|consen  379 RF  380 (565)
T ss_pred             Ee
Confidence            54

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=88.66  E-value=0.4  Score=38.89  Aligned_cols=90  Identities=17%  Similarity=0.154  Sum_probs=54.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|.+++..+...++..-...+.    .-++.|||++|..|......     .+...    +..++.+.--|.   ..||
T Consensus        63 ~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD---~~GI  126 (201)
T COG2112          63 EKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLD---RLGI  126 (201)
T ss_pred             HHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHH---Hhcc
Confidence            34555555555444443222222    23466999999888766542     12222    334455534444   6899


Q ss_pred             eecCcCC--CcEEEcCCCcEEEeeccccc
Q 048068          120 LHRDIKP--ANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       120 ~H~dl~~--~nIlv~~~~~~~l~dfg~~~  146 (313)
                      -|+.++-  .||+++++ .+.|+||..+.
T Consensus       127 ~H~El~~~~k~vlv~~~-~~~iIDFd~At  154 (201)
T COG2112         127 EHGELSRPWKNVLVNDR-DVYIIDFDSAT  154 (201)
T ss_pred             chhhhcCCceeEEecCC-cEEEEEccchh
Confidence            9999986  56776654 89999999775

>PLN02236 choline kinase

Probab=88.49  E-value=0.83  Score=41.40  Aligned_cols=31  Identities=23%  Similarity=0.319  Sum_probs=26.4

Q ss_pred             CCCceecCcCCCcEEEcC-CCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDA-DLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~  146 (313)
                      ...++|+|+++.||++++ ++.+.++||..+.
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            457899999999999986 4679999998774

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=87.82  E-value=0.9  Score=40.84  Aligned_cols=43  Identities=21%  Similarity=0.109  Sum_probs=28.1

Q ss_pred             HHHHHHHHHHHHHHHHHh-hhcCCCCceecCcCCCcEEEcCCCc
Q 048068           94 WYQRFRIIRGVASGLLYL-HEDWEQVVLHRDIKPANVLLDADLN  136 (313)
Q Consensus        94 ~~~~~~i~~qi~~al~~l-hs~~~~~i~H~dl~~~nIlv~~~~~  136 (313)
                      ...++.++.||+.-.--+ ...+-..++|.||||+|||+.+...
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~  317 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKE  317 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCC
Confidence            445666777775433112 2232468999999999999976543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=87.38  E-value=1.1  Score=39.83  Aligned_cols=31  Identities=23%  Similarity=0.359  Sum_probs=27.8

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.|++++.++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            5689999999999999998889999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=87.03  E-value=1.6  Score=39.24  Aligned_cols=28  Identities=39%  Similarity=0.661  Sum_probs=24.5

Q ss_pred             ceecCcCCCcEEEcCCCc-EEEeeccccc
Q 048068          119 VLHRDIKPANVLLDADLN-GKLGDFGLAR  146 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~-~~l~dfg~~~  146 (313)
                      ++|+|+.++||+++.... ..+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998874 7888998664

>COG4499 Predicted membrane protein [Function unknown]

Probab=86.86  E-value=7.3  Score=35.27  Aligned_cols=105  Identities=15%  Similarity=0.137  Sum_probs=67.4

Q ss_pred             CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeeccc
Q 048068           65 KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGL  144 (313)
Q Consensus        65 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~  144 (313)
                      ++.+.|-++......-...++     .+.....++++.|.+..|.-+.    ..-.|--|.|+||+++.++.+.+..+|+
T Consensus        60 ~Ds~vIsy~i~~~~~~F~~~k-----~~~k~~Klr~a~~~I~~l~e~~----~tr~~~~laPeNilf~~~l~p~~vH~Gl  130 (434)
T COG4499          60 NDSFVISYPIPEAAKSFASAK-----RKEKTRKLRLALQNIATLSELN----NTRYTFFLAPENILFDGGLTPFFVHRGL  130 (434)
T ss_pred             CceeEEEecCccccchHHHHH-----HHHHHHHHHHHHHHHHHHHHhh----ccceeEEecchheEEcCCCceEEEecch
Confidence            555666666543322222222     2667777888888888888765    5667888999999999999999988887


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          145 ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      -...+.             .=+.||.+.          =.+-+++..++.|..+|..
T Consensus       131 k~~lpP-------------ye~tee~f~----------~~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         131 KNSLPP-------------YEMTEERFL----------KEYKALAIYAFNGKFSFES  164 (434)
T ss_pred             hccCCC-------------CCCCHHHHH----------HHHHHHHHHHHcCCccHHH
Confidence            643221             112333322          1345666677777777753

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=86.11  E-value=0.66  Score=38.32  Aligned_cols=31  Identities=29%  Similarity=0.357  Sum_probs=25.2

Q ss_pred             CCCceecCcCCCcEEEcCCC-----cEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADL-----NGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~-----~~~l~dfg~~~  146 (313)
                      ...++|||+.+.|+++..++     .+.+.||..+.
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            46789999999999997543     57889998664

subfamily of choline kinases

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=85.34  E-value=3.1  Score=35.43  Aligned_cols=41  Identities=24%  Similarity=0.553  Sum_probs=27.3

Q ss_pred             hHHhhhhhccccceeeeeeEEe--ccCCeEEEEEecCCCCCHH
Q 048068           41 LQRDGLASVHSNGLLQLTNTVN--SRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~--~~~~~~~lV~e~~~~g~L~   81 (313)
                      .|..-++.+.-.+-+..+.++.  ..+++.|+||||++-+.+.
T Consensus        57 AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          57 AEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             HHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3444555555556555555555  4477999999999886554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=85.27  E-value=1.5  Score=39.51  Aligned_cols=30  Identities=23%  Similarity=0.327  Sum_probs=25.7

Q ss_pred             CCceecCcCCCcEEEcC-CCcEEEeeccccc
Q 048068          117 QVVLHRDIKPANVLLDA-DLNGKLGDFGLAR  146 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~  146 (313)
                      ..++|+|+.+.||++++ ++.++++||..+.
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            45899999999999975 4689999998774

>PRK06148 hypothetical protein; Provisional

Probab=84.21  E-value=1.7  Score=45.37  Aligned_cols=31  Identities=42%  Similarity=0.460  Sum_probs=25.9

Q ss_pred             CCCceecCcCCCcEEEcCCC--cEE-Eeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADL--NGK-LGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~--~~~-l~dfg~~~  146 (313)
                      ..+++|+|+++.||+++.++  .+. |+|||-+.
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            46899999999999999775  454 89999775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=83.10  E-value=1.1  Score=39.29  Aligned_cols=31  Identities=32%  Similarity=0.592  Sum_probs=24.9

Q ss_pred             CCCceecCcCCCcEEEcCCCc-EEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLN-GKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~-~~l~dfg~~~  146 (313)
                      ...++|+|+++.||+++.++. .-|+||+.+.
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            346899999999999987554 4689999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK11768 serine/threonine protein kinase; Provisional

Probab=82.32  E-value=2.6  Score=37.78  Aligned_cols=29  Identities=34%  Similarity=0.489  Sum_probs=24.2

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+.+|+|+.+.||++. + .+.++||+-+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            46789999999999995 3 57789999764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	313
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-28
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-25
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 87/229 (37%), Positives = 136/229 (59%), Gaps = 6/229 (2%)
Query: 48  SVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT--NIKPSLSWYQRFRIIRGVA 105
           +VH N LL+L     +   E LLVY YM NGS+   L      +P L W +R RI  G A
Sbjct: 92  AVHRN-LLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 149
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            GL YLH+  +  ++HRD+K AN+LLD +    +GDFGLA+L D+        + GT G+
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE--QQGSMEMVNLVDWVSDCWKKGAI 223
           +APE + TGK+S  TDV+ +GV +LE+ +G+R  +  +  + + V L+DWV    K+  +
Sbjct: 210 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 269
Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA 272
               D  L+G Y++E++E ++++ L C+   P  RP M +V++ L+G+ 
Sbjct: 270 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 86/229 (37%), Positives = 135/229 (58%), Gaps = 6/229 (2%)
Query: 48  SVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT--NIKPSLSWYQRFRIIRGVA 105
           +VH N LL+L     +   E LLVY YM NGS+   L      +P L W +R RI  G A
Sbjct: 84  AVHRN-LLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            GL YLH+  +  ++HRD+K AN+LLD +    +GDFGLA+L D+        + G  G+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE--QQGSMEMVNLVDWVSDCWKKGAI 223
           +APE + TGK+S  TDV+ +GV +LE+ +G+R  +  +  + + V L+DWV    K+  +
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA 272
               D  L+G Y++E++E ++++ L C+   P  RP M +V++ L+G+ 
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/253 (31%), Positives = 138/253 (54%), Gaps = 17/253 (6%)
Query: 20  LSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS 79
           L+A+     + +   F+++ ++    +A      L++L    +S   +  LVY YMPNGS
Sbjct: 62  LAAMVDITTEELKQQFDQEIKV----MAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGS 116
Query: 80  L-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 138
           L D++   +  P LSW+ R +I +G A+G+ +LHE+     +HRDIK AN+LLD     K
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAK 173
Query: 139 LGDFGLARLYDHDTIPQT---TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           + DFGLAR    +   QT   +++VGT  YMAPE +R G+ +  +D+Y+FGV +LE+ +G
Sbjct: 174 ISDFGLARA--SEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230
Query: 196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP 255
              +++    +++ L        ++  I D  D ++    +   +E +  +   C H K 
Sbjct: 231 LPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKK 288
Query: 256 EARPNMRQVMQYL 268
             RP++++V Q L
Sbjct: 289 NKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 80/253 (31%), Positives = 137/253 (54%), Gaps = 17/253 (6%)
Query: 20  LSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS 79
           L+A+     + +   F+++ ++    +A      L++L    +S   +  LVY YMPNGS
Sbjct: 62  LAAMVDITTEELKQQFDQEIKV----MAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGS 116
Query: 80  L-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 138
           L D++   +  P LSW+ R +I +G A+G+ +LHE+     +HRDIK AN+LLD     K
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAK 173
Query: 139 LGDFGLARLYDHDTIPQTT---KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           + DFGLAR    +   QT    ++VGT  YMAPE +R G+ +  +D+Y+FGV +LE+ +G
Sbjct: 174 ISDFGLARA--SEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230
Query: 196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP 255
              +++    +++ L        ++  I D  D ++    +   +E +  +   C H K 
Sbjct: 231 LPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKK 288
Query: 256 EARPNMRQVMQYL 268
             RP++++V Q L
Sbjct: 289 NKRPDIKKVQQLL 301

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKP--SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           + E +L+Y YM NG+L + L+ +  P  S+SW QR  I  G A GL YLH    + ++HR
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHR 163
Query: 123 DIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           D+K  N+LLD +   K+ DFG+++   + D       + GT GY+ PE    G+ +  +D
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSD 223
Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME 241
           VY+FGV + EV   R  I Q    EMVNL +W  +    G +    D  L      E + 
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283
Query: 242 LVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                 + C     E RP+M  V+  L+
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 135/251 (53%), Gaps = 13/251 (5%)
Query: 20  LSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS 79
           L+A+     + +   F+++ ++    +A      L++L    +S   +  LVY YMPNGS
Sbjct: 56  LAAMVDITTEELKQQFDQEIKV----MAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGS 110
Query: 80  L-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK 138
           L D++   +  P LSW+ R +I +G A+G+ +LHE+     +HRDIK AN+LLD     K
Sbjct: 111 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAK 167
Query: 139 LGDFGLARLYDH-DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR 197
           + DFGLAR  +         ++VGT  YMAPE +R G+ +  +D+Y+FGV +LE+ +G  
Sbjct: 168 ISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLP 226
Query: 198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA 257
            +++    +++ L        ++  I D  D ++    +   +E +  +   C H K   
Sbjct: 227 AVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNK 284
Query: 258 RPNMRQVMQYL 268
           RP++++V Q L
Sbjct: 285 RPDIKKVQQLL 295

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 104/208 (50%), Gaps = 6/208 (2%)
Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKP--SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           + E +L+Y YM NG+L + L+ +  P  S+SW QR  I  G A GL YLH    + ++HR
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHR 163
Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV-GTFGYMAPELMRTGKASTSTD 181
           D+K  N+LLD +   K+ DFG+++            +V GT GY+ PE    G+ +  +D
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSD 223
Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME 241
           VY+FGV + EV   R  I Q    EMVNL +W  +    G +    D  L      E + 
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283
Query: 242 LVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                 + C     E RP+M  V+  L+
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 8/204 (3%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           +  LVY Y PNGSL D++   +  P LSW+ R +I +G A+G+ +LHE+     +HRDIK
Sbjct: 95  DLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIK 151
Query: 126 PANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
            AN+LLD     K+ DFGLAR  +        +++VGT  Y APE +R G+ +  +D+Y+
Sbjct: 152 SANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYS 210
Query: 185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           FGV +LE+ +G   +++    +++ L        ++  I D  D +     +   +E   
Sbjct: 211 FGVVLLEIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKXNDA-DSTSVEAXY 268
Query: 245 KLGLFCSHPKPEARPNMRQVMQYL 268
            +   C H K   RP++++V Q L
Sbjct: 269 SVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 96  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK--IMHRDVK 151
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 152 PSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWS 207
Query: 185 FGVFMLEVASGRRPI-EQQGSMEMVNLVDWVSDCWKKGAILDASDSRL-EGIYEEEQMEL 242
            G+ ++E+A GR PI    GSM +  L+D+         I++    +L  G++  E  + 
Sbjct: 208 MGLSLVEMAVGRYPIGSGSGSMAIFELLDY---------IVNEPPPKLPSGVFSLEFQDF 258
Query: 243 VLKLGLFCSHPKPEARPNMRQVM 265
           V K    C    P  R +++Q+M
Sbjct: 259 VNK----CLIKNPAERADLKQLM 277

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 33/214 (15%)
Query: 34  GFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  + +RD L+     G     N ++     ++    +++ ++M NGSLD  L  N 
Sbjct: 72  GYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN- 128
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+A+G+ YL +      +HRD+   N+L++++L  K+ DFGL+R  
Sbjct: 129 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 149 DHDTI-PQTTKLVG---TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQG 203
           + DT  P  T  +G      + APE ++  K ++++DV+++G+ M EV S G RP     
Sbjct: 186 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 245
Query: 204 SMEMVNLVD-----------------WVSDCWKK 220
           + +++N ++                  + DCW+K
Sbjct: 246 NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQK 279

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGLAR+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           ++V +YM NGSLD  L T+     +  Q   ++RGV +G+ YL +      +HRD+   N
Sbjct: 126 MIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARN 181
Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFG 186
           VL+D++L  K+ DFGL+R+ + D     T   G     + APE +     S+++DV++FG
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 187 VFMLEV-ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           V M EV A G RP     + ++++ V+       +G  L A       +++         
Sbjct: 242 VVMWEVLAYGERPYWNMTNRDVISSVE-------EGYRLPAPMGCPHALHQ--------- 285
Query: 246 LGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIA 285
           L L C H     RP   Q++  LD     P+  R +  ++
Sbjct: 286 LMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 55  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 111
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 112 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 168
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 169 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 229 DVIKAVD 235

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 72  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 128
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 129 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 185
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 186 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 245
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 246 DVIKAVD 252

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           ++V +YM NGSLD  L T+     +  Q   ++RGV +G+ YL +      +HRD+   N
Sbjct: 126 MIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARN 181
Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFG 186
           VL+D++L  K+ DFGL+R+ + D     T   G     + APE +     S+++DV++FG
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 187 VFMLEV-ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           V M EV A G RP     + ++++ V+       +G  L A       +++         
Sbjct: 242 VVMWEVLAYGERPYWNMTNRDVISSVE-------EGYRLPAPMGCPHALHQ--------- 285
Query: 246 LGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIA 285
           L L C H     RP   Q++  LD     P+  R +  ++
Sbjct: 286 LMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 21/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASG 107
           H N +      ++       +V +Y   G L  ++    K      + F  R++  +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 108 LLYLHE--DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           L   H   D    VLHRD+KPANV LD   N KLGDFGLAR+ +HDT    T  VGT  Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYY 182
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           M+PE M     +  +D+++ G  + E+ +   P       E+             G I +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GKIRE 230
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
               R+   Y +E  E++ ++     + K   RP++ ++++
Sbjct: 231 GKFRRIPYRYSDELNEIITRM----LNLKDYHRPSVEEILE 267

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 82  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 138
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 139 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 196 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 255
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 256 DVIKAVD 262

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 99/187 (52%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V +YM NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 31/212 (14%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N ++ L   V   K   ++V +YM NGSLD  L  N 
Sbjct: 61  GYTEKQRRDFLGEASIMGQFDHPN-IIHLEGVVTKSK-PVMIVTEYMENGSLDTFLKKN- 117
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+++G+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 118 DGQFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 174
Query: 149 DHDTIPQTTKLVGTFG--YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + APE +   K ++++DV+++G+ M EV S G RP  +  + 
Sbjct: 175 EDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQ 234
Query: 206 EMVNLVD-----------------WVSDCWKK 220
           +++  V+                  + DCW+K
Sbjct: 235 DVIKAVEEGYRLPSPMDCPAALYQLMLDCWQK 266

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 76/130 (58%), Gaps = 3/130 (2%)
Query: 70  LVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V +Y+  GSL ++LH +  +  L   +R  +   VA G+ YLH      ++HR++K  N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPN 169
Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVF 188
           +L+D     K+ DFGL+RL    T   +    GT  +MAPE++R   ++  +DVY+FGV 
Sbjct: 170 LLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 189 MLEVASGRRP 198
           + E+A+ ++P
Sbjct: 229 LWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 76/130 (58%), Gaps = 3/130 (2%)
Query: 70  LVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V +Y+  GSL ++LH +  +  L   +R  +   VA G+ YLH      ++HRD+K  N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPN 169
Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVF 188
           +L+D     K+ DFGL+RL     +  +    GT  +MAPE++R   ++  +DVY+FGV 
Sbjct: 170 LLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 189 MLEVASGRRP 198
           + E+A+ ++P
Sbjct: 229 LWELATLQQP 238

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASG 107
           H N +      ++       +V +Y   G L  ++    K      + F  R++  +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 108 LLYLHE--DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           L   H   D    VLHRD+KPANV LD   N KLGDFGLAR+ +HDT       VGT  Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYY 182
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           M+PE M     +  +D+++ G  + E+ +   P       E+             G I +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GKIRE 230
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
               R+   Y +E  E++ ++     + K   RP++ ++++
Sbjct: 231 GKFRRIPYRYSDELNEIITRM----LNLKDYHRPSVEEILE 267

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 30/251 (11%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  ++   G A +     H N +++L   ++  K   +++ +YM NG+LDK L    
Sbjct: 84  GYTEKQRVDFLGEAGIMGQFSHHN-IIRLEGVISKYK-PMMIITEYMENGALDKFLREK- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               S  Q   ++RG+A+G+ YL        +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGTFG--YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + APE +   K ++++DV++FG+ M EV + G RP  +  + 
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
Query: 206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           E++  ++   D ++    +D   +             + +L + C   +   RP    ++
Sbjct: 258 EVMKAIN---DGFRLPTPMDCPSA-------------IYQLMMQCWQQERARRPKFADIV 301
Query: 266 QYLDGNATLPD 276
             LD     PD
Sbjct: 302 SILDKLIRAPD 312

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 33/214 (15%)
Query: 34  GFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  + +RD L+     G     N ++     ++    +++ ++M NGSLD  L  N 
Sbjct: 46  GYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN- 102
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+A+G+ YL +      +HR +   N+L++++L  K+ DFGL+R  
Sbjct: 103 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFL 159
Query: 149 DHDTI-PQTTKLVG---TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQG 203
           + DT  P  T  +G      + APE ++  K ++++DV+++G+ M EV S G RP     
Sbjct: 160 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 219
Query: 204 SMEMVNLVD-----------------WVSDCWKK 220
           + +++N ++                  + DCW+K
Sbjct: 220 NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQK 253

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 99/187 (52%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V + M NGSLD  L  + 
Sbjct: 55  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEXMENGSLDSFLRKH- 111
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 112 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 168
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 169 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 229 DVIKAVD 235

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 30/244 (12%)
Query: 34  GFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  + +RD L      G     N V+     +R    ++V ++M NG+LD  L  + 
Sbjct: 82  GYTE--KQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKH- 138
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+A+G+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 139 DGQFTVIQLVGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVI 195
Query: 149 DHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + APE ++  K ++++DV+++G+ M EV S G RP     + 
Sbjct: 196 EDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 255
Query: 206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +++  ++       +G  L A      G+++         L L C   +   RP   Q++
Sbjct: 256 DVIKAIE-------EGYRLPAPMDCPAGLHQ---------LMLDCWQKERAERPKFEQIV 299
Query: 266 QYLD 269
             LD
Sbjct: 300 GILD 303

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 99/187 (52%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V + M NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEXMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 92/174 (52%), Gaps = 26/174 (14%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +++ ++M NG+LD  L  N     +  Q   ++RG+ASG+ YL E      +HRD+   N
Sbjct: 93  MILTEFMENGALDSFLRLN-DGQFTVIQLVGMLRGIASGMRYLAE---MSYVHRDLAARN 148
Query: 129 VLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVG---TFGYMAPELMRTGKASTSTDVYA 184
           +L++++L  K+ DFGL+R L ++ + P  T  +G      + APE +   K ++++D ++
Sbjct: 149 ILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWS 208
Query: 185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVD-----------------WVSDCWKK 220
           +G+ M EV S G RP     + +++N ++                  + DCW+K
Sbjct: 209 YGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQK 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVK 132
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 185 FGVFMLEVASGRRPI-------EQQGSMEMVNLVDWVSDCWKKGAILDASDSRL-EGIYE 236
            G+ ++E+A GR PI       + +  M +  L+D+         I++    +L  G++ 
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDY---------IVNEPPPKLPSGVFS 239
Query: 237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
            E  + V K    C    P  R +++Q+M +
Sbjct: 240 LEFQDFVNK----CLIKNPAERADLKQLMVH 266

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N ++ L   V   K   +++ +YM NGSLD  L  N     +  Q   ++RG+ SG+ 
Sbjct: 89  HPN-IIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKN-DGRFTVIQLVGMLRGIGSGMK 145
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMA 167
           YL +      +HRD+   N+L++++L  K+ DFG++R+ + D     T   G     + A
Sbjct: 146 YLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 202
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD 212
           PE +   K ++++DV+++G+ M EV S G RP     + +++  ++
Sbjct: 203 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 248

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASG 107
           H N +      ++       +V +Y   G L  ++    K      + F  R++  +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 108 LLYLHE--DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           L   H   D    VLHRD+KPANV LD   N KLGDFGLAR+ +HD      + VGT  Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE-DFAKEFVGTPYY 182
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           M+PE M     +  +D+++ G  + E+ +   P       E+             G I +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GKIRE 230
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
               R+   Y +E  E++ ++     + K   RP++ ++++
Sbjct: 231 GKFRRIPYRYSDELNEIITRM----LNLKDYHRPSVEEILE 267

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 92/174 (52%), Gaps = 26/174 (14%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +++ ++M NG+LD  L  N     +  Q   ++RG+ASG+ YL E      +HRD+   N
Sbjct: 91  MILTEFMENGALDSFLRLN-DGQFTVIQLVGMLRGIASGMRYLAE---MSYVHRDLAARN 146
Query: 129 VLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVG---TFGYMAPELMRTGKASTSTDVYA 184
           +L++++L  K+ DFGL+R L ++ + P  T  +G      + APE +   K ++++D ++
Sbjct: 147 ILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWS 206
Query: 185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVD-----------------WVSDCWKK 220
           +G+ M EV S G RP     + +++N ++                  + DCW+K
Sbjct: 207 YGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQK 260

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N ++ L   V   K   +++ +YM NGSLD  L  N     +  Q   ++RG+ SG+ 
Sbjct: 68  HPN-IIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKN-DGRFTVIQLVGMLRGIGSGMK 124
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMA 167
           YL +      +HRD+   N+L++++L  K+ DFG++R+ + D     T   G     + A
Sbjct: 125 YLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD 212
           PE +   K ++++DV+++G+ M EV S G RP     + +++  ++
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 227

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 99/187 (52%), Gaps = 14/187 (7%)
Query: 34  GFNEDPQLQRDGLASV-----HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI 88
           G+ E  +    G AS+     H N +++L   V   K   ++V + M NGSLD  L  + 
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPN-IIRLEGVVTKSK-PVMIVTEXMENGSLDSFLRKH- 140
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
               +  Q   ++RG+ASG+ YL +      +HRD+   N+L++++L  K+ DFGL+R+ 
Sbjct: 141 DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 149 DHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSM 205
           + D     T   G     + +PE +   K ++++DV+++G+ + EV S G RP  +  + 
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 206 EMVNLVD 212
           +++  VD
Sbjct: 258 DVIKAVD 264

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N ++ L   V   K   +++ +YM NGSLD  L  N     +  Q   ++RG+ SG+ 
Sbjct: 74  HPN-IIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKN-DGRFTVIQLVGMLRGIGSGMK 130
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMA 167
           YL +      +HRD+   N+L++++L  K+ DFG++R+ + D     T   G     + A
Sbjct: 131 YLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD 212
           PE +   K ++++DV+++G+ M EV S G RP     + +++  ++
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 233

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 87  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGLAYLREKHQ--IMHRDVK 142
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YMAPE ++    S  +D+++
Sbjct: 143 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERLQGTHYSVQSDIWS 198
Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 199 MGLSLVELAVGRYPIPPPDAKEL 221

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 37/224 (16%)
Query: 68  FLLVYDYMPNGSLDKILHTN--------------IKPSLSWYQRFRIIRGVASGLLYLHE 113
            ++V++YM +G L+K L  +               K  L   Q   I   +ASG++YL  
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMR 172
              Q  +HRD+   N L+ A+L  K+GDFG++R +Y  D        +    +M PE + 
Sbjct: 152 ---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 208
Query: 173 TGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
             K +T +DV++FGV + E+ + G++P  Q  + E++       +C  +G +L+      
Sbjct: 209 YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-------ECITQGRVLERPRVCP 261
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD--GNAT 273
           + +Y+         + L C   +P+ R N++++ + L   G AT
Sbjct: 262 KEVYD---------VMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 83/150 (55%), Gaps = 12/150 (8%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 80  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVK 135
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D        + VGT  YM+PE ++    S  +D+++
Sbjct: 136 PSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQGTHYSVQSDIWS 191
Query: 185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWV 214
            G+ ++E+A GR P   +  M +  L+D++
Sbjct: 192 MGLSLVEMAVGRYP---RPPMAIFELLDYI 218

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 139 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK--IMHRDVK 194
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 195 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 250
Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 251 MGLSLVEMAVGRYPIPPPDAKEL 273

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V   + 
Sbjct: 73  HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL  +     +HRD+   NVL+  D   K+ DFGL +  +  +   T KL     + APE
Sbjct: 132 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPE 184
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V+       KG  +DA D
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD 237
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +YE      V+K    C H     RP+  Q+ + L+
Sbjct: 238 GCPPAVYE------VMK---NCWHLDAAMRPSFLQLREQLE 269

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V   + 
Sbjct: 58  HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL  +     +HRD+   NVL+  D   K+ DFGL +  +  +   T KL     + APE
Sbjct: 117 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPE 169
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V+       KG  +DA D
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD 222
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +YE      V+K    C H     RP+  Q+ + L+
Sbjct: 223 GCPPAVYE------VMK---NCWHLDAAMRPSFLQLREQLE 254

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVK 132
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK--IMHRDVK 159
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 160 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 215
Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKEL 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVK 132
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVK 132
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 9/143 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           GE  +  ++M  GSLD++L    +       +  I   V  GL YL E  +  ++HRD+K
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLRE--KHKIMHRDVK 132
Query: 126 PANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           P+N+L+++    KL DFG++ +L D          VGT  YM+PE ++    S  +D+++
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            G+ ++E+A GR PI    + E+
Sbjct: 189 MGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 119
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA +        Q  +L G+  
Sbjct: 120 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 119
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA +        Q  +L G+  
Sbjct: 120 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 56  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 114
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA +        Q  +L G+  
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 58  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 116
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA +        Q  +L G+  
Sbjct: 117 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 83  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 141
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA +        Q  +L G+  
Sbjct: 142 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 84  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 142
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA +        Q  +L G+  
Sbjct: 143 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +Y+  GS   +L       L   Q   I+R +  GL YLH + +   +HRDIK ANV
Sbjct: 102 IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANV 155
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL      KL DFG+A       I + T  VGT  +MAPE+++     +  D+++ G+  
Sbjct: 156 LLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITA 214
Query: 190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF 249
           +E+A G  P  +   M+++ L+               +   LEG Y +   E V      
Sbjct: 215 IELARGEPPHSELHPMKVLFLIP------------KNNPPTLEGNYSKPLKEFVEA---- 258
Query: 250 CSHPKPEARPNMRQVMQY 267
           C + +P  RP  ++++++
Sbjct: 259 CLNKEPSFRPTAKELLKH 276

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V   + 
Sbjct: 245 HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL  +     +HRD+   NVL+  D   K+ DFGL +  +  +   T KL     + APE
Sbjct: 304 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPE 356
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V+       KG  +DA D
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD 409
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +Y+      V+K    C H     RP   Q+ + L+
Sbjct: 410 GCPPAVYD------VMK---NCWHLDAATRPTFLQLREQLE 441

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V   + 
Sbjct: 64  HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL  +     +HRD+   NVL+  D   K+ DFGL +  +  +   T KL     + APE
Sbjct: 123 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPE 175
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +R    ST +DV++FG+ + E+ S GR P  +    ++V  V+       KG  +DA D
Sbjct: 176 ALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD 228
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +YE      V+K    C H     RP+  Q+ + L+
Sbjct: 229 GCPPAVYE------VMK---NCWHLDAAMRPSFLQLREQLE 260

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 94/176 (53%), Gaps = 15/176 (8%)
Query: 40  QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQ 96
           +++RD LA V+   +++L     + +G+  L+ D++  G L   L   +   +  + +Y 
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY- 135
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQ 155
               +  +A GL +LH      +++RD+KP N+LLD + + KL DFGL++   DH+   +
Sbjct: 136 ----LAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEK--K 186
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
                GT  YMAPE++     S S D +++GV M E+ +G  P + +   E + L+
Sbjct: 187 AYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +Y+  GS   +L       L   Q   I+R +  GL YLH + +   +HRDIK ANV
Sbjct: 82  IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANV 135
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL      KL DFG+A       I + T  VGT  +MAPE+++     +  D+++ G+  
Sbjct: 136 LLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITA 194
Query: 190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF 249
           +E+A G  P  +   M+++ L+               +   LEG Y +   E V      
Sbjct: 195 IELARGEPPHSELHPMKVLFLIP------------KNNPPTLEGNYSKPLKEFVEA---- 238
Query: 250 CSHPKPEARPNMRQVMQY 267
           C + +P  RP  ++++++
Sbjct: 239 CLNKEPSFRPTAKELLKH 256

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 56  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 114
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA          Q  +L G+  
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 76  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 134
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA          Q  +L G+  
Sbjct: 135 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +Y+  GS   +L       L   Q   I+R +  GL YLH + +   +HRDIK ANV
Sbjct: 97  IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANV 150
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL      KL DFG+A     DT  +    VGT  +MAPE+++     +  D+++ G+  
Sbjct: 151 LLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 209
Query: 190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF 249
           +E+A G  P  +   M+++ L            I   +   LEG Y +   E V      
Sbjct: 210 IELARGEPPHSELHPMKVLFL------------IPKNNPPTLEGNYSKPLKEFVEA---- 253
Query: 250 CSHPKPEARPNMRQVMQY 267
           C + +P  RP  ++++++
Sbjct: 254 CLNKEPSFRPTAKELLKH 271

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 68  FLLVYDYMPNGSLDKILHT-----------NIKPSLSWYQRFRIIRGVASGLLYLHEDWE 116
            ++V++YM +G L+K L             N    L+  Q   I + +A+G++YL     
Sbjct: 90  LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--- 146
Query: 117 QVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGK 175
           Q  +HRD+   N L+  +L  K+GDFG++R +Y  D        +    +M PE +   K
Sbjct: 147 QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 206
Query: 176 ASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI 234
            +T +DV++ GV + E+ + G++P  Q  + E++       +C  +G +L    +  + +
Sbjct: 207 FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECITQGRVLQRPRTCPQEV 259
Query: 235 YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA 272
           YE         L L C   +P  R N++ +   L   A
Sbjct: 260 YE---------LMLGCWQREPHMRKNIKGIHTLLQNLA 288

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 41  LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI 100
           +++  LA VHS  ++ L     + K +  LV   M  G +   ++ N+      +Q  R 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 101 I---RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQT 156
           I     + SGL +LH+   + +++RD+KP NVLLD D N ++ D GLA  L    T  +T
Sbjct: 292 IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KT 346
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
               GT G+MAPEL+   +   S D +A GV + E+ + R P   +G 
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 84  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 142
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA          Q  +L G+  
Sbjct: 143 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +Y+  GS   +L       L   Q   I+R +  GL YLH + +   +HRDIK ANV
Sbjct: 82  IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANV 135
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL      KL DFG+A     DT  +    VGT  +MAPE+++     +  D+++ G+  
Sbjct: 136 LLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 194
Query: 190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF 249
           +E+A G  P  +   M+++ L+               +   LEG Y +   E V      
Sbjct: 195 IELARGEPPHSELHPMKVLFLIP------------KNNPPTLEGNYSKPLKEFVEA---- 238
Query: 250 CSHPKPEARPNMRQVMQY 267
           C + +P  RP  ++++++
Sbjct: 239 CLNKEPSFRPTAKELLKH 256

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 41  LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI 100
           +++  LA VHS  ++ L     + K +  LV   M  G +   ++ N+      +Q  R 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 101 I---RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQT 156
           I     + SGL +LH+   + +++RD+KP NVLLD D N ++ D GLA  L    T  +T
Sbjct: 292 IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KT 346
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
               GT G+MAPEL+   +   S D +A GV + E+ + R P   +G 
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 140
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 244
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 41  LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI 100
           +++  LA VHS  ++ L     + K +  LV   M  G +   ++ N+      +Q  R 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 101 I---RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQT 156
           I     + SGL +LH+   + +++RD+KP NVLLD D N ++ D GLA  L    T  +T
Sbjct: 292 IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KT 346
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
               GT G+MAPEL+   +   S D +A GV + E+ + R P   +G 
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 85  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 141
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 142 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 201
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 202 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 245
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 246 LCWKERPEDRPTFDYLRSVLE 266

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 86  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 142
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 143 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 202
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 203 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 246
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 247 LCWKERPEDRPTFDYLRSVLE 267

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 41  LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI 100
           +++  LA VHS  ++ L     + K +  LV   M  G +   ++ N+      +Q  R 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 101 I---RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQT 156
           I     + SGL +LH+   + +++RD+KP NVLLD D N ++ D GLA  L    T  +T
Sbjct: 292 IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KT 346
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
               GT G+MAPEL+   +   S D +A GV + E+ + R P   +G 
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 140
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 244
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 89  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 145
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 146 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 205
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 206 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 249
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 250 LCWKERPEDRPTFDYLRSVLE 270

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S   +  +V  +    SL   LH  I+      +   I R  A
Sbjct: 56  GVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTA 114
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  DL  K+GDFGLA +        Q  +L G+  
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R       S  +DVYAFG+ + E+ +G+ P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 146
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 206
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 207 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 250
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 251 LCWKERPEDRPTFDYLRSVLE 271

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 93  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 149
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 150 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 209
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 210 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 253
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 254 LCWKERPEDRPTFDYLRSVLE 274

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 140
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 244
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   +L  I+HT  +  ++  +   +I      L + H++    ++HRD+KPAN+
Sbjct: 93  IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           L+ A    K+ DFG+AR      +++ QT  ++GT  Y++PE  R       +DVY+ G 
Sbjct: 148 LISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 188 FMLEVASGRRP 198
            + EV +G  P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 79  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 135
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 136 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 195
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 196 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 239
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 240 LCWKERPEDRPTFDYLRSVLE 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 92  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 148
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 149 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 208
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 209 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 252
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 253 LCWKERPEDRPTFDYLRSVLE 273

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 146
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 206
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 207 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 250
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 251 LCWKERPEDRPTFDYLRSVLE 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 94  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 150
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 151 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 210
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 211 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 254
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 255 LCWKERPEDRPTFDYLRSVLE 275

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 27/237 (11%)
Query: 32  YHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPS 91
           + GF+ DP+   D L S   +      N+  S+     +  ++   G+L++ +       
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPE-NSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 132
Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 151
           L       +   +  G+ Y+H    + ++HRD+KP+N+ L      K+GDFGL     +D
Sbjct: 133 LDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 189
Query: 152 TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
              + T+  GT  YM+PE + +       D+YA G+ +                E++++ 
Sbjct: 190 --GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL---------------AELLHVC 232
Query: 212 DWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           D   +  K     D  D  +  I+++++  L+ KL       KPE RPN  ++++ L
Sbjct: 233 DTAFETSK--FFTDLRDGIISDIFDKKEKTLLQKL----LSKKPEDRPNTSEILRTL 283

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   +L  I+HT  +  ++  +   +I      L + H++    ++HRD+KPAN+
Sbjct: 93  IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           ++ A    K+ DFG+AR      +++ QT  ++GT  Y++PE  R       +DVY+ G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 188 FMLEVASGRRP 198
            + EV +G  P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   +L  I+HT  +  ++  +   +I      L + H++    ++HRD+KPAN+
Sbjct: 93  IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           ++ A    K+ DFG+AR      +++ QT  ++GT  Y++PE  R       +DVY+ G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 188 FMLEVASGRRP 198
            + EV +G  P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   +L  I+HT  +  ++  +   +I      L + H++    ++HRD+KPAN+
Sbjct: 93  IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           ++ A    K+ DFG+AR      +++ QT  ++GT  Y++PE  R       +DVY+ G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 188 FMLEVASGRRP 198
            + EV +G  P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   +L  I+HT  +  ++  +   +I      L + H++    ++HRD+KPAN+
Sbjct: 93  IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           ++ A    K+ DFG+AR      +++ QT  ++GT  Y++PE  R       +DVY+ G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 188 FMLEVASGRRP 198
            + EV +G  P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   +L  I+HT  +  ++  +   +I      L + H++    ++HRD+KPAN+
Sbjct: 110 IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           ++ A    K+ DFG+AR      +++ QT  ++GT  Y++PE  R       +DVY+ G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 188 FMLEVASGRRP 198
            + EV +G  P
Sbjct: 225 VLYEVLTGEPP 235

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ AN+
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 140
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL +               + APE +  G  +  +DV++FG+ +
Sbjct: 141 LVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 244
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH + +      +   I R  A
Sbjct: 60  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTA 118
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  D   K+GDFGLA +        Q  +L G+  
Sbjct: 119 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R   +   S  +DVYAFG+ + E+ +G+ P
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 69/142 (48%), Gaps = 17/142 (11%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED--W------EQV 118
           E  L+  +   GSL   L  NI   ++W +   +   ++ GL YLHED  W      +  
Sbjct: 87  ELWLITAFHDKGSLTDYLKGNI---ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPS 143
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTG--- 174
           + HRD K  NVLL +DL   L DFGLA  ++    P  T   VGT  YMAPE++      
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 203
Query: 175 --KASTSTDVYAFGVFMLEVAS 194
              A    D+YA G+ + E+ S
Sbjct: 204 QRDAFLRIDMYAMGLVLWELVS 225

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L ++H    + V+HRDIKPANV + A    KLGD GL R +   T    + LVGT 
Sbjct: 145 LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTP 200
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            YM+PE +     +  +D+++ G  + E+A+ + P      M + +L   +  C      
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDYPPLP 259
Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV 264
            D         Y EE  +LV      C +P PE RP++  V
Sbjct: 260 SDH--------YSEELRQLV----NMCINPDPEKRPDVTYV 288

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/141 (34%), Positives = 69/141 (48%), Gaps = 16/141 (11%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED-------WEQVV 119
           +  L+  +   GSL   L  N+   +SW +   I   +A GL YLHED        +  +
Sbjct: 96  DLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMAPELMRTG---- 174
            HRDIK  NVLL  +L   + DFGLA  ++   +   T   VGT  YMAPE++       
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212
Query: 175 -KASTSTDVYAFGVFMLEVAS 194
             A    D+YA G+ + E+AS
Sbjct: 213 RDAFLRIDMYAMGLVLWELAS 233

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 47  ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
            S H N ++QL +T  +    F LV+D M  G L   L   +  +LS  +  +I+R +  
Sbjct: 67  VSGHPN-IIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 122
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
            +  LH+     ++HRD+KP N+LLD D+N KL DFG +   D     +  ++ GT  Y+
Sbjct: 123 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYL 177
Query: 167 APELMRTGKAST------STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           APE++               D+++ GV M  + +G  P   +  M M+ ++
Sbjct: 178 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQRFRIIRGVASGLLYLHEDWEQ 117
           V S++    +V +Y+ NG L   L ++   ++PS    Q   +   V  G+ +L      
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS----QLLEMCYDVCEGMAFLES---H 123
Query: 118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
             +HRD+   N L+D DL  K+ DFG+ R    D    +        + APE+    K S
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE 236
           + +DV+AFG+ M EV S G+ P +   + E+V  V      ++      ASD+  + +Y 
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL---ASDTIYQIMYS 240
Query: 237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                        C H  PE RP  +Q++  ++
Sbjct: 241 -------------CWHELPEKRPTFQQLLSSIE 260

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 86/155 (55%), Gaps = 14/155 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQRFRIIR 102
           L  +H   ++ L + ++S +    LV+++M    L K+L  N   ++ S      ++++R
Sbjct: 73  LKELHHPNIVSLIDVIHSERC-LTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 162
           GVA    + H+     +LHRD+KP N+L+++D   KL DFGLAR +       T ++V T
Sbjct: 131 GVA----HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-T 182
Query: 163 FGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
             Y AP+ LM + K STS D+++ G    E+ +G+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 86/155 (55%), Gaps = 14/155 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQRFRIIR 102
           L  +H   ++ L + ++S +    LV+++M    L K+L  N   ++ S      ++++R
Sbjct: 73  LKELHHPNIVSLIDVIHSERC-LTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 162
           GVA    + H+     +LHRD+KP N+L+++D   KL DFGLAR +       T ++V T
Sbjct: 131 GVA----HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-T 182
Query: 163 FGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
             Y AP+ LM + K STS D+++ G    E+ +G+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HR+++ AN+
Sbjct: 80  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNLRAANI 136
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+   L+ K+ DFGLARL + +             + APE +  G  +  +DV++FG+ +
Sbjct: 137 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 196
Query: 190 LEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
            E+ + GR P     + E++  ++       +G  +   D+  E +Y+         L  
Sbjct: 197 TEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ---------LMR 240
Query: 249 FCSHPKPEARPN---MRQVMQ 266
            C   +PE RP    +R V++
Sbjct: 241 LCWKERPEDRPTFDYLRSVLE 261

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 15/171 (8%)
Query: 47  ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
            S H N ++QL +T  +    F LV+D M  G L   L   +  +LS  +  +I+R +  
Sbjct: 80  VSGHPN-IIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 135
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
            +  LH+     ++HRD+KP N+LLD D+N KL DFG +   D     +  ++ GT  Y+
Sbjct: 136 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYL 190
Query: 167 APELMRTGKAST------STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           APE++               D+++ GV M  + +G  P   +  M M+ ++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 24/148 (16%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPS---LSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           ++    LV ++   G L+++L     P    ++W  +      +A G+ YLH++    ++
Sbjct: 77  KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIVPII 130
Query: 121 HRDIKPANVLL-----DADLNGKL---GDFGLARLYDHDTIPQTTKL--VGTFGYMAPEL 170
           HRD+K +N+L+     + DL+ K+    DFGLAR +      +TTK+   G + +MAPE+
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-----RTTKMSAAGAYAWMAPEV 185
Query: 171 MRTGKASTSTDVYAFGVFMLEVASGRRP 198
           +R    S  +DV+++GV + E+ +G  P
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 92/176 (52%), Gaps = 15/176 (8%)
Query: 40  QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQ 96
           +++RD L  V+   +++L     + +G+  L+ D++  G L   L   +   +  + +Y 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY- 131
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQ 155
               +  +A  L +LH      +++RD+KP N+LLD + + KL DFGL++   DH+   +
Sbjct: 132 ----LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 182
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
                GT  YMAPE++     + S D ++FGV M E+ +G  P + +   E + ++
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 15/171 (8%)
Query: 47  ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
            S H N ++QL +T  +    F LV+D M  G L   L   +  +LS  +  +I+R +  
Sbjct: 80  VSGHPN-IIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 135
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
            +  LH+     ++HRD+KP N+LLD D+N KL DFG +   D     +   + GT  Y+
Sbjct: 136 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLRSVCGTPSYL 190
Query: 167 APELMRTGKAST------STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           APE++               D+++ GV M  + +G  P   +  M M+ ++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S K +  +V  +    SL   LH + +      +   I R  A
Sbjct: 72  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTA 130
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  D   K+GDFGLA          Q  +L G+  
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R   +   S  +DVYAFG+ + E+ +G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 5/131 (3%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           + LV +Y+   +L + + ++    LS          +  G+ + H+     ++HRDIKP 
Sbjct: 86  YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQ 140
Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           N+L+D++   K+ DFG+A+     ++ QT  ++GT  Y +PE  +       TD+Y+ G+
Sbjct: 141 NILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGI 200
Query: 188 FMLEVASGRRP 198
            + E+  G  P
Sbjct: 201 VLYEMLVGEPP 211

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 92/176 (52%), Gaps = 15/176 (8%)
Query: 40  QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQ 96
           +++RD L  V+   +++L     + +G+  L+ D++  G L   L   +   +  + +Y 
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY- 132
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQ 155
               +  +A  L +LH      +++RD+KP N+LLD + + KL DFGL++   DH+   +
Sbjct: 133 ----LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 183
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
                GT  YMAPE++     + S D ++FGV M E+ +G  P + +   E + ++
Sbjct: 184 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 92/176 (52%), Gaps = 15/176 (8%)
Query: 40  QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---KPSLSWYQ 96
           +++RD L  V+   +++L     + +G+  L+ D++  G L   L   +   +  + +Y 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY- 131
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQ 155
               +  +A  L +LH      +++RD+KP N+LLD + + KL DFGL++   DH+   +
Sbjct: 132 ----LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 182
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
                GT  YMAPE++     + S D ++FGV M E+ +G  P + +   E + ++
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           I+R +  GL YLH + +   +HRDIK ANVLL    + KL DFG+A     DT  +    
Sbjct: 121 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNXF 176
Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK 219
           VGT  +MAPE+++        D+++ G+  +E+A G  P      M ++ L+        
Sbjct: 177 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP------- 229
Query: 220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
                  S   LEG + +   E V      C +  P  RP  ++++++
Sbjct: 230 -----KNSPPTLEGQHSKPFKEFVEA----CLNKDPRFRPTAKELLKH 268

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLARLYDHDTIPQT 156
           ++  ++S L YLHE+    ++HRD+KP N++L      L  K+ D G A+  D   +   
Sbjct: 127 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--C 181
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           T+ VGT  Y+APEL+   K + + D ++FG    E  +G RP
Sbjct: 182 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLARLYDHDTIPQT 156
           ++  ++S L YLHE+    ++HRD+KP N++L      L  K+ D G A+  D   +   
Sbjct: 126 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--C 180
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           T+ VGT  Y+APEL+   K + + D ++FG    E  +G RP
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 20/148 (13%)
Query: 60  TVNSRKGEFLLVYDYMPNGSLDKILHT-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV 118
           T   +K    +  +Y  NG+L  ++H+ N+      Y  +R+ R +   L Y+H    Q 
Sbjct: 82  TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY--WRLFRQILEALSYIHS---QG 136
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLAR---------LYDHDTIPQT----TKLVGTFGY 165
           ++HRD+KP N+ +D   N K+GDFGLA+           D   +P +    T  +GT  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 166 MAPELMR-TGKASTSTDVYAFGVFMLEV 192
           +A E++  TG  +   D+Y+ G+   E+
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 9/112 (8%)
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
           +P   +Y     +R +  G  YLH +    V+HRD+K  N+ L+ DL  K+GDFGLA   
Sbjct: 116 EPEARYY-----LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 167
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           ++D   + T L GT  Y+APE++     S   DV++ G  M  +  G+ P E
Sbjct: 168 EYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 9/112 (8%)
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
           +P   +Y     +R +  G  YLH +    V+HRD+K  N+ L+ DL  K+GDFGLA   
Sbjct: 116 EPEARYY-----LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 167
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           ++D   + T L GT  Y+APE++     S   DV++ G  M  +  G+ P E
Sbjct: 168 EYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 60/112 (53%), Gaps = 9/112 (8%)
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
           +P   +Y     +R +  G  YLH +    V+HRD+K  N+ L+ DL  K+GDFGLA   
Sbjct: 120 EPEARYY-----LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 171
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           ++D   + T L GT  Y+APE++     S   DV++ G  M  +  G+ P E
Sbjct: 172 EYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 67  MKKIRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 57  MKKLRHEKLVQLYAVVSEEP--IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 114
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 115 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 224
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 225 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++  + L++L   V   K    ++ ++M  GSL   L ++        +       +A
Sbjct: 64  MKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 121
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            G+ ++ +   +  +HRD++ AN+L+ A L  K+ DFGLAR+ + +             +
Sbjct: 122 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 178
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +  G  +  +DV++FG+ ++E+ + GR P     + E++  ++       +G  +
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRM 231
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
              ++  E +Y          + + C   +PE RP    +   LD
Sbjct: 232 PRPENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 68  FLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           F +V +    G L D+I+    +   S +   RII+ V SG+ Y+H+     ++HRD+KP
Sbjct: 96  FYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKP 149
Query: 127 ANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL++   D + K+ DFGL+  +  +T  +    +GT  Y+APE++R G      DV+
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYDEKCDVW 206
Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           + GV +  + SG  P   +   +++  V+
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVE 235

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 68  FLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           F +V +    G L D+I+    +   S +   RII+ V SG+ Y+H+     ++HRD+KP
Sbjct: 96  FYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKP 149
Query: 127 ANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL++   D + K+ DFGL+  +  +T  +    +GT  Y+APE++R G      DV+
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYDEKCDVW 206
Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           + GV +  + SG  P   +   +++  V+
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVE 235

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 68  FLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           F +V +    G L D+I+    +   S +   RII+ V SG+ Y+H+     ++HRD+KP
Sbjct: 96  FYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKP 149
Query: 127 ANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL++   D + K+ DFGL+  +  +T  +    +GT  Y+APE++R G      DV+
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYDEKCDVW 206
Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           + GV +  + SG  P   +   +++  V+
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVE 235

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 58  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 115
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 116 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 225
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 226 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 60  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 117
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 118 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 227
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 228 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 7/132 (5%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  ++ +++  G+L  I+    +  L+  Q   +   V   L YLH    Q V+HRDIK 
Sbjct: 116 ELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKS 169
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            ++LL  D   KL DFG       D +P+   LVGT  +MAPE++     +T  D+++ G
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKD-VPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 187 VFMLEVASGRRP 198
           + ++E+  G  P
Sbjct: 229 IMVIEMVDGEPP 240

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 128 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 130 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 132 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           ++ +Y+  GS   +L          +Q   +++ +  GL YLH + +   +HRDIK ANV
Sbjct: 98  IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANV 151
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL    + KL DFG+A       I + T  VGT  +MAPE+++     +  D+++ G+  
Sbjct: 152 LLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAYDSKADIWSLGITA 210
Query: 190 LEVASGRRPIEQQGSMEMVNLV 211
           +E+A G  P      M ++ L+
Sbjct: 211 IELAKGEPPNSDMHPMRVLFLI 232

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 133 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 186 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 56  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 113
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 114 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 223
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 224 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 134 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 186
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 187 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 125 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 177
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 178 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 132 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 130 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 136 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 188
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 189 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 128 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 126 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 132 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP--IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 126 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 291 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 400
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 401 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++  + L++L   V   K    ++ ++M  GSL   L ++        +       +A
Sbjct: 237 MKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            G+ ++ +   +  +HRD++ AN+L+ A L  K+ DFGLAR+ + +             +
Sbjct: 295 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 351
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +  G  +  +DV++FG+ ++E+ + GR P     + E++  ++       +G  +
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRM 404
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
              ++  E +Y          + + C   +PE RP    +   LD
Sbjct: 405 PRPENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 148 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 200
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 291 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 400
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 401 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 128 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 128 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDH 180
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 128 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 132 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
           +P   +Y     +R +  G  YLH +    V+HRD+K  N+ L+ DL  K+GDFGLA   
Sbjct: 114 EPEARYY-----LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           ++D   +   L GT  Y+APE++     S   DV++ G  M  +  G+ P E
Sbjct: 166 EYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 8/138 (5%)
Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K    +V  +    SL K LH   +     +Q   I R  A G+ YLH    + ++HRD+
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDM 158
Query: 125 KPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMAPELMR---TGKASTST 180
           K  N+ L   L  K+GDFGLA +        Q  +  G+  +MAPE++R       S  +
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 181 DVYAFGVFMLEVASGRRP 198
           DVY++G+ + E+ +G  P
Sbjct: 219 DVYSYGIVLYELMTGELP 236

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 132 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 148 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 200
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
           +P   +Y     +R +  G  YLH +    V+HRD+K  N+ L+ DL  K+GDFGLA   
Sbjct: 138 EPEARYY-----LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 189
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           ++D   +   L GT  Y+APE++     S   DV++ G  M  +  G+ P E
Sbjct: 190 EYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY 148
           +P   +Y     +R +  G  YLH +    V+HRD+K  N+ L+ DL  K+GDFGLA   
Sbjct: 140 EPEARYY-----LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           ++D   +   L GT  Y+APE++     S   DV++ G  M  +  G+ P E
Sbjct: 192 EYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 53  GLLQLTNTVN-------SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           G+L+ T  VN       S   +  +V  +    SL   LH + +      +   I R  A
Sbjct: 72  GVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTA 130
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG 164
            G+ YLH    + ++HRD+K  N+ L  D   K+GDFGLA          Q  +L G+  
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 165 YMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRP 198
           +MAPE++R   +   S  +DVYAFG+ + E+ +G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP--IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 291 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 400
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 401 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 64  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIA 121
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 122 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 231
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 232 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 130 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDH 182
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 64  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIA 121
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 122 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 231
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 232 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD--HDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+L++   + K+ DFGLAR+ D  HD 
Sbjct: 148 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDH 200
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
               T+ V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 201 TGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L       L   Q   +   +A
Sbjct: 316 MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 374 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 483
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C   +PE RP    +  +L+
Sbjct: 484 PCPPECPESLHD---------LMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD+  AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKPSL 92
           D + QR  L  V     L+  N +       +      + +Y+  G+L  I+ + +    
Sbjct: 47  DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQY 105
Query: 93  SWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHD 151
            W QR    + +ASG+ YLH      ++HRD+   N L+  + N  + DFGLARL  D  
Sbjct: 106 PWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162
Query: 152 TIPQTTK------------LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
           T P+  +            +VG   +MAPE++         DV++FG+ + E+
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  G L   L   +   L   Q   +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP--IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 74/144 (51%), Gaps = 17/144 (11%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIK---PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +  ++ DY+  G L  +L  + +   P   +Y        V   L YLH    + +++RD
Sbjct: 80  QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-----EVCLALEYLHS---KDIIYRD 131
Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMAPELMRTGKASTSTDV 182
           +KP N+LLD + + K+ DFG A+      +P  T  L GT  Y+APE++ T   + S D 
Sbjct: 132 LKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVSTKPYNKSIDW 186
Query: 183 YAFGVFMLEVASGRRPIEQQGSME 206
           ++FG+ + E+ +G  P     +M+
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNTMK 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  G L   L   +   L   Q   +   +A
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 125 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 234
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 235 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +   NG +++ L   +KP  S  +    +  + +G+LYLH      +LHRD+  +N+
Sbjct: 88  LVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNL 143
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           LL  ++N K+ DFGLA           T L GT  Y++PE+         +DV++ G   
Sbjct: 144 LLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESDVWSLGCMF 202
Query: 190 LEVASGRRPIEQ---QGSMEMVNLVDW 213
             +  GR P +    + ++  V L D+
Sbjct: 203 YTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 6/136 (4%)
Query: 70  LVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV +Y   GSL  +LH     P  +           + G+ YLH    + ++HRD+KP N
Sbjct: 77  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 136
Query: 129 VLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           +LL A     K+ DFG A     D     T   G+  +MAPE+      S   DV+++G+
Sbjct: 137 LLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 192
Query: 188 FMLEVASGRRPIEQQG 203
            + EV + R+P ++ G
Sbjct: 193 ILWEVITRRKPFDEIG 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 59/97 (60%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    AS S+D++A G  + ++ +G  P 
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           +++L + + S K E ++V +Y  N   D I+  +    +S  +  R  + + S + Y H 
Sbjct: 76  IIKLYDVIKS-KDEIIMVIEYAGNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR 131
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                ++HRD+KP N+LLD  LN K+ DFGL+ +       +T+   G+  Y APE++ +
Sbjct: 132 ---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-S 185
Query: 174 GK--ASTSTDVYAFGVFMLEVASGRRPIEQQ 202
           GK  A    DV++ GV +  +   R P + +
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 6/136 (4%)
Query: 70  LVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV +Y   GSL  +LH     P  +           + G+ YLH    + ++HRD+KP N
Sbjct: 76  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 129 VLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           +LL A     K+ DFG A     D     T   G+  +MAPE+      S   DV+++G+
Sbjct: 136 LLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 188 FMLEVASGRRPIEQQG 203
            + EV + R+P ++ G
Sbjct: 192 ILWEVITRRKPFDEIG 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           +++L + + S K E ++V +Y  N   D I+  +    +S  +  R  + + S + Y H 
Sbjct: 75  IIKLYDVIKS-KDEIIMVIEYAGNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR 130
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                ++HRD+KP N+LLD  LN K+ DFGL+ +       +T+   G+  Y APE++ +
Sbjct: 131 ---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-S 184
Query: 174 GK--ASTSTDVYAFGVFMLEVASGRRPIEQQ 202
           GK  A    DV++ GV +  +   R P + +
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 22/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+       +V +YM  GSL   L   +   L   Q   +   +A
Sbjct: 234 MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 291
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGL RL + +             +
Sbjct: 292 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE    G+ +  +DV++FG+ + E+ + GR P     + E+++ V+       +G  +
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM 401
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E +++         L   C    PE RP    +  +L+
Sbjct: 402 PCPPECPESLHD---------LMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 20/148 (13%)
Query: 60  TVNSRKGEFLLVYDYMPNGSLDKILHT-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV 118
           T   +K    +  +Y  N +L  ++H+ N+      Y  +R+ R +   L Y+H    Q 
Sbjct: 82  TAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY--WRLFRQILEALSYIHS---QG 136
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLAR---------LYDHDTIPQT----TKLVGTFGY 165
           ++HRD+KP N+ +D   N K+GDFGLA+           D   +P +    T  +GT  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 166 MAPELMR-TGKASTSTDVYAFGVFMLEV 192
           +A E++  TG  +   D+Y+ G+   E+
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 89/166 (53%), Gaps = 13/166 (7%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +++L +    ++  +L++  Y      D+I+H   +   +      II+ V SG+ 
Sbjct: 95  HPN-IMKLYDFFEDKRNYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVT 150
Query: 110 YLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           YLH+     ++HRD+KP N+LL++   D   K+ DFGL+ ++++    +  + +GT  Y+
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYI 205
Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           APE++R  K     DV++ GV +  + +G  P   Q   E++  V+
Sbjct: 206 APEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           +++L + + S K E ++V +Y  N   D I+  +    +S  +  R  + + S + Y H 
Sbjct: 66  IIKLYDVIKS-KDEIIMVIEYAGNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR 121
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                ++HRD+KP N+LLD  LN K+ DFGL+ +       +T+   G+  Y APE++ +
Sbjct: 122 ---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-S 175
Query: 174 GK--ASTSTDVYAFGVFMLEVASGRRPIEQQ 202
           GK  A    DV++ GV +  +   R P + +
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           +++L + + S K E ++V +Y  N   D I+  +    +S  +  R  + + S + Y H 
Sbjct: 70  IIKLYDVIKS-KDEIIMVIEYAGNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR 125
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                ++HRD+KP N+LLD  LN K+ DFGL+ +       +T+   G+  Y APE++ +
Sbjct: 126 ---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-S 179
Query: 174 GK--ASTSTDVYAFGVFMLEVASGRRPIEQQ 202
           GK  A    DV++ GV +  +   R P + +
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 13/149 (8%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            LV+D M  G L   L   +  +LS  +   I+R +   + +LH +    ++HRD+KP N
Sbjct: 176 FLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPEN 230
Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST------STDV 182
           +LLD ++  +L DFG +   +     +  +L GT GY+APE+++     T        D+
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288
Query: 183 YAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           +A GV +  + +G  P   +  + M+ ++
Sbjct: 289 WACGVILFTLLAGSPPFWHRRQILMLRMI 317

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 60/105 (57%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 132 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
                + V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 185 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 60/105 (57%), Gaps = 10/105 (9%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDT 152
           Y  ++I+RG    L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD 
Sbjct: 133 YFLYQILRG----LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185
Query: 153 IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASGR 196
                + V T  Y APE+M   K  T S D+++ G  + E+ S R
Sbjct: 186 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 9/133 (6%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT +       Q   +   V   L YLH    Q V+HRDIK
Sbjct: 116 ELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHN---QGVIHRDIK 168
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL +D   KL DFG       + +P+   LVGT  +MAPE++      T  D+++ 
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSL 227
Query: 186 GVFMLEVASGRRP 198
           G+ ++E+  G  P
Sbjct: 228 GIMVIEMIDGEPP 240

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 8/103 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L YLHE   + +++RD+K  NVLLD++ + KL D+G+ +  L   DT   T+   G
Sbjct: 130 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCG 183
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
           T  Y+APE++R      S D +A GV M E+ +GR P +  GS
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 226

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 8/103 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L YLHE   + +++RD+K  NVLLD++ + KL D+G+ +  L   DT   T+   G
Sbjct: 115 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCG 168
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
           T  Y+APE++R      S D +A GV M E+ +GR P +  GS
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 211

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 8/103 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L YLHE   + +++RD+K  NVLLD++ + KL D+G+ +  L   DT   T+   G
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 215
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
           T  Y+APE++R      S D +A GV M E+ +GR P +  GS
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 27/148 (18%)
Query: 67  EFLLVYDYMPNGSLDKI--LHTNIKPSLSWYQRFRIIRGVASGLLYLHED------WEQV 118
           E+LLV +Y PNGSL K   LHT+      W    R+   V  GL YLH +      ++  
Sbjct: 86  EYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIP------QTTKLVGTFGYMAPELM 171
           + HRD+   NVL+  D    + DFGL+ RL  +  +            VGT  YMAPE++
Sbjct: 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200
Query: 172 RTG-------KASTSTDVYAFGVFMLEV 192
                      A    D+YA G+   E+
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 88  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 147
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K +    +MAPE +
Sbjct: 148 A---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 204
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 205 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 258
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P+ RP   +++  L  D + + P++
Sbjct: 259 ERVTDLMRM---------CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 8/103 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L YLHE   + +++RD+K  NVLLD++ + KL D+G+ +  L   DT   T+   G
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCG 172
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
           T  Y+APE++R      S D +A GV M E+ +GR P +  GS
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 14/171 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGV 104
           L S+    +++L +    +K  F LV ++   G L ++I++   +          I++ +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQI 155
Query: 105 ASGLLYLHEDWEQVVLHRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQTTKLVG 161
            SG+ YLH+     ++HRDIKP N+LL+     LN K+ DFGL+  +  D   +    +G
Sbjct: 156 LSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLG 210
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           T  Y+APE+++  K +   DV++ GV M  +  G  P   Q   +++  V+
Sbjct: 211 TAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 114
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 26/238 (10%)
Query: 33  HGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSL 92
             F E+ Q+    +  +  + L+QL   V+       +V +YM  GSL   L      +L
Sbjct: 49  ESFLEEAQI----MKKLKHDKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKDGEGRAL 102
Query: 93  SWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT 152
                  +   VA+G+ Y+        +HRD++ AN+L+   L  K+ DFGLARL + + 
Sbjct: 103 KLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNE 159
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE-VASGRRPIEQQGSMEMVNLV 211
                       + APE    G+ +  +DV++FG+ + E V  GR P     + E++  V
Sbjct: 160 XTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 219
Query: 212 DWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +       +G  +         ++E         L + C    PE RP    +  +L+
Sbjct: 220 E-------RGYRMPCPQDCPISLHE---------LMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 74/135 (54%), Gaps = 5/135 (3%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +  +  +V +Y   GS+  I+    K +L+  +   I++    GL YLH   +   +HRD
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHFMRK---IHRD 150
Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           IK  N+LL+ + + KL DFG+A     D + +   ++GT  +MAPE+++    +   D++
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 184 AFGVFMLEVASGRRP 198
           + G+  +E+A G+ P
Sbjct: 210 SLGITAIEMAEGKPP 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL   V   +    LV+++M +G L   L T  +   +      +   V  G+ YL E
Sbjct: 64  LVQLYG-VCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                V+HRD+   N L+  +   K+ DFG+ R    D    +T       + +PE+   
Sbjct: 122 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 178
Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
            + S+ +DV++FGV M EV S G+ P E + + E+V 
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 215

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 87  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 146
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K +    +MAPE +
Sbjct: 147 A---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 203
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 204 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 257
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P+ RP   +++  L  D + + P++
Sbjct: 258 ERVTDLMRM---------CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 296

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 5/141 (3%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV+++M +G L   L T  +   +      +   V  G+ YL E     V+HRD+   N 
Sbjct: 82  LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNC 137
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+  +   K+ DFG+ R    D    +T       + +PE+    + S+ +DV++FGV M
Sbjct: 138 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 197
Query: 190 LEVAS-GRRPIEQQGSMEMVN 209
            EV S G+ P E + + E+V 
Sbjct: 198 WEVFSEGKIPYENRSNSEVVE 218

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL   V   +    LV+++M +G L   L T  +   +      +   V  G+ YL E
Sbjct: 62  LVQLYG-VCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                V+HRD+   N L+  +   K+ DFG+ R    D    +T       + +PE+   
Sbjct: 120 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
            + S+ +DV++FGV M EV S G+ P E + + E+V 
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 19  ILSALAQDVNQFIYHGFN---------EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFL 69
           IL    +D  Q++    N         E+ + +   LA++    ++Q   +     G   
Sbjct: 41  ILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLY 99
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V DY   G L K ++         +Q  +I+       L L    ++ +LHRDIK  N+
Sbjct: 100 IVMDYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
            L  D   +LGDFG+AR+ +  T+      +GT  Y++PE+      +  +D++A G  +
Sbjct: 157 FLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVL 215
Query: 190 LEVASGRRPIEQQGSMEMVNLV 211
            E+ + +   E  GSM+  NLV
Sbjct: 216 YELCTLKHAFE-AGSMK--NLV 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 13/152 (8%)
Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           KG F LV +    G L D+I+    +   S     RIIR V SG+ Y+H++    ++HRD
Sbjct: 121 KGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRD 174
Query: 124 IKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           +KP N+LL++   D N ++ DFGL+  +  +   +    +GT  Y+APE++  G      
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLH-GTYDEKC 231
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           DV++ GV +  + SG  P       +++  V+
Sbjct: 232 DVWSTGVILYILLSGCPPFNGANEYDILKKVE 263

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 13/152 (8%)
Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           KG F LV +    G L D+I+    +   S     RIIR V SG+ Y+H++    ++HRD
Sbjct: 98  KGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRD 151
Query: 124 IKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           +KP N+LL++   D N ++ DFGL+  +  +   +    +GT  Y+APE++  G      
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLH-GTYDEKC 208
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           DV++ GV +  + SG  P       +++  V+
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKVE 240

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 119 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPSL---------SWYQRFRIIRGVASGLLYLHEDWEQVV 119
           L++ + M  G L   L + ++P++         S  +  ++   +A G+ YL+ +     
Sbjct: 104 LVIMELMTRGDLKSYLRS-LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KF 159
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K +    +M+PE ++ G  +T
Sbjct: 160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 219
Query: 179 STDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE 237
            +DV++FGV + E+A+   +P +   + +++  V        +G +LD  D+  + ++E 
Sbjct: 220 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-------MEGGLLDKPDNCPDMLFEL 272
Query: 238 EQM------ELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPD 276
            +M      ++        S  K E  P  R+V  Y      LP+
Sbjct: 273 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPE 317

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 7/100 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGT 162
           +  GL  LH +    +++RD+KP N+LLD   + ++ D GLA    H    QT K  VGT
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGT 348
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ 202
            GYMAPE+++  + + S D +A G  + E+ +G+ P +Q+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 13/152 (8%)
Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           KG F LV +    G L D+I+    +   S     RIIR V SG+ Y+H++    ++HRD
Sbjct: 122 KGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRD 175
Query: 124 IKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           +KP N+LL++   D N ++ DFGL+  +  +   +    +GT  Y+APE++  G      
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLH-GTYDEKC 232
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           DV++ GV +  + SG  P       +++  V+
Sbjct: 233 DVWSTGVILYILLSGCPPFNGANEYDILKKVE 264

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 118 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 117 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 20/195 (10%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y
Sbjct: 135 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM------ELVLKLGLFCSHPKPEARPNM 261
           +  V        +G +LD  D+  + ++E  +M      ++        S  K E  P  
Sbjct: 250 LRFV-------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 262 RQVMQYLDGNATLPD 276
           R+V  Y      LP+
Sbjct: 303 REVSFYYSEENKLPE 317

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 146 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y
Sbjct: 129 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 184 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 243
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 244 LRFV-------MEGGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 285

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 116 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 123 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 142 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL   V   +    LV+++M +G L   L T  +   +      +   V  G+ YL E
Sbjct: 84  LVQLYG-VCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE 141
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                V+HRD+   N L+  +   K+ DFG+ R    D    +T       + +PE+   
Sbjct: 142 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 198
Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
            + S+ +DV++FGV M EV S G+ P E + + E+V 
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 235

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 116
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPSL---------SWYQRFRIIRGVASGLLYLHEDWEQVV 119
           L++ + M  G L   L + ++P++         S  +  ++   +A G+ YL+ +     
Sbjct: 94  LVIMELMTRGDLKSYLRS-LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KF 149
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K +    +M+PE ++ G  +T
Sbjct: 150 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 209
Query: 179 STDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE 237
            +DV++FGV + E+A+   +P +   + +++  V        +G +LD  D+  + ++E 
Sbjct: 210 YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-------MEGGLLDKPDNCPDMLFEL 262
Query: 238 EQMELVLKLGLFCSHPKPEARPNMRQVM 265
            +M         C    P+ RP+  +++
Sbjct: 263 MRM---------CWQYNPKMRPSFLEII 281

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 7/100 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGT 162
           +  GL  LH +    +++RD+KP N+LLD   + ++ D GLA    H    QT K  VGT
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGT 348
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ 202
            GYMAPE+++  + + S D +A G  + E+ +G+ P +Q+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y
Sbjct: 157 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 211
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 212 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 271
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 272 LRFV-------MEGGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 313

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 13/152 (8%)
Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           KG F LV +    G L D+I+    +   S     RIIR V SG+ Y+H++    ++HRD
Sbjct: 104 KGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRD 157
Query: 124 IKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           +KP N+LL++   D N ++ DFGL+  ++     +    +GT  Y+APE++  G      
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVLH-GTYDEKC 214
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           DV++ GV +  + SG  P       +++  V+
Sbjct: 215 DVWSTGVILYILLSGCPPFNGANEYDILKKVE 246

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y
Sbjct: 128 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 242
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 243 LRFV-------MEGGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 284

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 52  NGLLQLTNTV----NSRKGEF-LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           N +L   N V    + R+G    L  +Y   G L   +  +I       QRF     + +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMA 115
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGY 165
           G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 166 MAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQ 201
           +APEL++  +  +   DV++ G+ +  + +G  P +Q
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 142 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y
Sbjct: 126 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 240
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 241 LRFV-------MEGGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 282

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 65  KGEFLLVYDYMPNGS-LDKILHTNIKPS-----LSWYQRFRIIRGVASGLLYLHEDWEQV 118
           K E  LV   +  GS LD I H   K       L       I+R V  GL YLH++ +  
Sbjct: 80  KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ-- 137
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARL------YDHDTIPQTTKLVGTFGYMAPELMR 172
            +HRD+K  N+LL  D + ++ DFG++           + + +T   VGT  +MAPE+M 
Sbjct: 138 -IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGTPCWMAPEVME 194
Query: 173 TGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
             +      D+++FG+  +E+A+G  P  +   M+++ L             L      L
Sbjct: 195 QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------------LQNDPPSL 242
Query: 232 E-GIYEEEQMEL----VLKLGLFCSHPKPEARPNMRQVMQY 267
           E G+ ++E ++       K+   C    PE RP   +++++
Sbjct: 243 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 283

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y
Sbjct: 122 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 176
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 236
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 237 LRFV-------MEGGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 278

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R +Y
Sbjct: 128 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 242
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 243 LRFV-------MEGGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 284

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 144 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 65  KGEFLLVYDYMPNGS-LDKILHTNIKPS-----LSWYQRFRIIRGVASGLLYLHEDWEQV 118
           K E  LV   +  GS LD I H   K       L       I+R V  GL YLH++ +  
Sbjct: 85  KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ-- 142
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARL------YDHDTIPQTTKLVGTFGYMAPELMR 172
            +HRD+K  N+LL  D + ++ DFG++           + + +T   VGT  +MAPE+M 
Sbjct: 143 -IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGTPCWMAPEVME 199
Query: 173 TGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
             +      D+++FG+  +E+A+G  P  +   M+++ L             L      L
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------------LQNDPPSL 247
Query: 232 E-GIYEEEQMEL----VLKLGLFCSHPKPEARPNMRQVMQY 267
           E G+ ++E ++       K+   C    PE RP   +++++
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 74/142 (52%), Gaps = 10/142 (7%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V S   +  +V +Y+  G L   +  N +  L   +  R+ + + SG+ Y H     +V+
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHR---HMVV 138
Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK--AST 178
           HRD+KP NVLLDA +N K+ DFGL+ +       + +   G+  Y APE++ +G+  A  
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPNYAAPEVI-SGRLYAGP 195
Query: 179 STDVYAFGVFMLEVASGRRPIE 200
             D+++ GV +  +  G  P +
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 58/97 (59%), Gaps = 4/97 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT 162
           + S L YLH    + ++HRD+KP N+LL+ D++ ++ DFG A++   ++   +    VGT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
             Y++PEL+    A  S+D++A G  + ++ +G  P 
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 20/147 (13%)
Query: 60  TVNSRKGEFLLVYDYMPNGSLDKILHT-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV 118
           T   +K    +  +Y  N +L  ++H+ N+      Y  +R+ R +   L Y+H    Q 
Sbjct: 82  TAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY--WRLFRQILEALSYIHS---QG 136
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLAR---------LYDHDTIPQT----TKLVGTFGY 165
           ++HR++KP N+ +D   N K+GDFGLA+           D   +P +    T  +GT  Y
Sbjct: 137 IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXY 196
Query: 166 MAPELMR-TGKASTSTDVYAFGVFMLE 191
           +A E++  TG  +   D Y+ G+   E
Sbjct: 197 VATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 13/152 (8%)
Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           KG F LV +    G L D+I+    +   S     RIIR V SG+ Y H++    ++HRD
Sbjct: 98  KGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYXHKN---KIVHRD 151
Query: 124 IKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           +KP N+LL++   D N ++ DFGL+  +  +   +    +GT  Y+APE++  G      
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAPEVLH-GTYDEKC 208
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           DV++ GV +  + SG  P       +++  V+
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKVE 240

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 5/141 (3%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV+++M +G L   L T  +   +      +   V  G+ YL E     V+HRD+   N 
Sbjct: 79  LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDLAARNC 134
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+  +   K+ DFG+ R    D    +T       + +PE+    + S+ +DV++FGV M
Sbjct: 135 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 194
Query: 190 LEVAS-GRRPIEQQGSMEMVN 209
            EV S G+ P E + + E+V 
Sbjct: 195 WEVFSEGKIPYENRSNSEVVE 215

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD +A  +S  ++QL       K    +V +YMP G L  ++ +N      W + +   
Sbjct: 125 ERDIMAFANSPWVVQLFCAFQDDK-YLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFY--- 179
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
              A  +L L       ++HRD+KP N+LLD   + KL DFG     D   +      VG
Sbjct: 180 --TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVG 237
Query: 162 TFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRPI 199
           T  Y++PE++++    G      D ++ GVF+ E+  G  P 
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 91/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N  +  D   K+GDFG+ R +Y
Sbjct: 122 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 236
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+           +++L+L   C    P+ RP+  +++
Sbjct: 237 LRFV-------MEGGLLDKPDN---------CPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++  + L++L   V   K    ++ ++M  GSL   L ++        +       +A
Sbjct: 231 MKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 288
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            G+ ++ +   +  +HRD++ AN+L+ A L  K+ DFGLAR+     I  T         
Sbjct: 289 EGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT--------- 336
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +  G  +  +DV++FG+ ++E+ + GR P     + E++  ++       +G  +
Sbjct: 337 -APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRM 388
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
              ++  E +Y          + + C   +PE RP    +   LD
Sbjct: 389 PRPENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 5/117 (4%)
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           LH   K       R+  +R    G+ YLH +    V+HRD+K  N+ L+ D++ K+GDFG
Sbjct: 132 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 144 LARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           LA   + D   + T L GT  Y+APE++     S   D+++ G  +  +  G+ P E
Sbjct: 188 LATKIEFDGERKKT-LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G + K L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 90  LILEYAPRGEVYKELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 141
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 142 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 245
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 246 ---LKH-NPSQRPMLREVLEHPWITANSSKP 272

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V S   +F +V +Y+  G L   +  + +  +   +  R+ + + S + Y H     +V+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHR---HMVV 133
Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK--AST 178
           HRD+KP NVLLDA +N K+ DFGL+ +       +T+   G+  Y APE++ +G+  A  
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI-SGRLYAGP 190
Query: 179 STDVYAFGVFMLEVASGRRPIEQQ 202
             D+++ GV +  +  G  P + +
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 89  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 148
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HR++   N ++  D   K+GDFG+ R +Y+ D   +  K +    +MAPE +
Sbjct: 149 A---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 205
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 206 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 259
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P  RP   +++  L  D + + P++
Sbjct: 260 ERVTDLMRM---------CWQFNPNMRPTFLEIVNLLKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 88  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 147
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HR++   N ++  D   K+GDFG+ R +Y+ D   +  K +    +MAPE +
Sbjct: 148 A---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 204
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 205 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 258
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P  RP   +++  L  D + + P++
Sbjct: 259 ERVTDLMRM---------CWQFNPNMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++  + L++L   V +R+    ++ +YM  GSL   L ++    +   +       +A
Sbjct: 62  MKTLQHDKLVRLYAVV-TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 120
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            G+ Y+     +  +HRD++ ANVL+   L  K+ DFGLAR+ + +             +
Sbjct: 121 EGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 177
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN--------------- 209
            APE +  G  +  +DV++FG+ + E+ + G+ P   + + +++                
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCP 237
Query: 210 --LVDWVSDCWKKGA-----------ILDASDSRLEGIYEEE 238
             L D +  CWK+ A           +LD   +  EG Y+++
Sbjct: 238 DELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQ 279

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 88  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 147
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HRD+   N ++  D   K+GDFG+ R + + D   +  K +    +MAPE +
Sbjct: 148 A---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESL 204
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 205 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 258
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P+ RP   +++  L  D + + P++
Sbjct: 259 ERVTDLMRM---------CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 6/157 (3%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL   V   +    LV ++M +G L   L T  +   +      +   V  G+ YL E
Sbjct: 65  LVQLYG-VCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
                V+HRD+   N L+  +   K+ DFG+ R    D    +T       + +PE+   
Sbjct: 123 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 179
Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
            + S+ +DV++FGV M EV S G+ P E + + E+V 
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 3   AAPRSFYFCVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVN 62
           A  +  +F V L V F     +Q   + + H    + ++Q    A +H   +L+L N   
Sbjct: 42  AREKKSHFIVALKVLF----KSQIEKEGVEHQLRREIEIQ----AHLHHPNILRLYNYFY 93
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
            R+  +L++ +Y P G L K L  +   +    +   I+  +A  L+Y H    + V+HR
Sbjct: 94  DRRRIYLIL-EYAPRGELYKELQKSC--TFDEQRTATIMEELADALMYCHG---KKVIHR 147
Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           DIKP N+LL      K+ DFG +    H    +   + GT  Y+ PE++     +   D+
Sbjct: 148 DIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDL 204
Query: 183 YAFGVFMLEVASGRRPIEQQGSME 206
           +  GV   E+  G  P E     E
Sbjct: 205 WCIGVLCYELLVGNPPFESASHNE 228

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 68  FLLVYDYMPNGSLDKILHT------------NIKPS-LSWYQRFRIIRGVASGLLYL--- 111
            L+V++YM +G L++ L +            ++ P  L   Q   +   VA+G++YL   
Sbjct: 95  LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 154
Query: 112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPEL 170
           H       +HRD+   N L+   L  K+GDFG++R +Y  D      + +    +M PE 
Sbjct: 155 H------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES 208
Query: 171 MRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
           +   K +T +DV++FGV + E+ + G++P  Q  + E +       DC  +G  L+   +
Sbjct: 209 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------DCITQGRELERPRA 261
Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
               +Y          +   C   +P+ R +++ V   L   A  P +
Sbjct: 262 CPPEVY---------AIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 300

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 68  FLLVYDYMPNGSLDKILHT------------NIKPS-LSWYQRFRIIRGVASGLLYL--- 111
            L+V++YM +G L++ L +            ++ P  L   Q   +   VA+G++YL   
Sbjct: 89  LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 148
Query: 112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPEL 170
           H       +HRD+   N L+   L  K+GDFG++R +Y  D      + +    +M PE 
Sbjct: 149 H------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES 202
Query: 171 MRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
           +   K +T +DV++FGV + E+ + G++P  Q  + E +       DC  +G  L+   +
Sbjct: 203 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------DCITQGRELERPRA 255
Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
               +Y          +   C   +P+ R +++ V   L   A  P +
Sbjct: 256 CPPEVY---------AIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 85  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 144
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HRD+   N ++  D   K+GDFG+ R + + D   +  K +    +MAPE +
Sbjct: 145 A---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESL 201
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 202 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 255
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P+ RP   +++  L  D + + P++
Sbjct: 256 ERVTDLMRM---------CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 294

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 40/228 (17%)
Query: 68  FLLVYDYMPNGSLDKILHT------------NIKPS-LSWYQRFRIIRGVASGLLYL--- 111
            L+V++YM +G L++ L +            ++ P  L   Q   +   VA+G++YL   
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPEL 170
           H       +HRD+   N L+   L  K+GDFG++R +Y  D      + +    +M PE 
Sbjct: 178 H------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES 231
Query: 171 MRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
           +   K +T +DV++FGV + E+ + G++P  Q  + E +       DC  +G  L+   +
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------DCITQGRELERPRA 284
Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
               +Y        +  G  C   +P+ R +++ V   L   A  P +
Sbjct: 285 CPPEVY-------AIMRG--CWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 165
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 225
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 226 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 275
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 276 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 101 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 157
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 158 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 217
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 218 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 267
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 268 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 300

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 110 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 166
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 167 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 226
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 227 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 276
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 277 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 124 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 180
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 181 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 240
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 241 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 290
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 291 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 88  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 147
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HRD+   N ++  D   K+GDFG+ R +Y+     +  K +    +MAPE +
Sbjct: 148 A---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESL 204
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 205 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 258
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P+ RP   +++  L  D + + P++
Sbjct: 259 ERVTDLMRM---------CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 5/117 (4%)
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           LH   K       R+  +R    G+ YLH +    V+HRD+K  N+ L+ D++ K+GDFG
Sbjct: 132 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 144 LARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           LA   + D   +   L GT  Y+APE++     S   D+++ G  +  +  G+ P E
Sbjct: 188 LATKIEFDG-ERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 109 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 165
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 225
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 226 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 275
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 276 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +  +V D +  G L   L  N+       + F  I  +   L YL     Q ++HRD+KP
Sbjct: 89  DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--ICELVMALDYLQN---QRIIHRDMKP 143
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA---STSTDVY 183
            N+LLD   +  + DF +A +   +T  Q T + GT  YMAPE+  + K    S + D +
Sbjct: 144 DNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWW 201
Query: 184 AFGVFMLEVASGRRPIEQQGS 204
           + GV   E+  GRRP   + S
Sbjct: 202 SLGVTAYELLRGRRPYHIRSS 222

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 59  NTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV 118
           N+  S+     +  ++   G+L++ +       L       +   +  G+ Y+H    + 
Sbjct: 86  NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KK 142
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP+N+ L      K+GDFGL     +D     +K  GT  YM+PE + +     
Sbjct: 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK--GTLRYMSPEQISSQDYGK 200
Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
             D+YA G+ +                E++++ D   +  K     D  D  +  I++++
Sbjct: 201 EVDLYALGLIL---------------AELLHVCDTAFETSK--FFTDLRDGIISDIFDKK 243
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           +  L+ KL       KPE RPN  ++++ L
Sbjct: 244 EKTLLQKL----LSKKPEDRPNTSEILRTL 269

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+ +  LV++++ +  L   L     P L       ++R    GL +LH +    ++HRD
Sbjct: 90  REIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRD 145
Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP N+L+ +    KL DFGLAR+Y +      T +V T  Y APE++     +T  D++
Sbjct: 146 LKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMW 203
Query: 184 AFGVFMLEVASGRRPI-------EQQGSM-EMVNLV---DWVSDC-WKKGAILDASDSRL 231
           + G    E+   R+P+       +Q G + +++ L    DW  D    +GA        +
Sbjct: 204 SVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPV 262
Query: 232 EGIY---EEEQMELVLKLGLFCSHPK 254
           + +    EE   +L+L++  F  H +
Sbjct: 263 QSVVPEMEESGAQLLLEMLTFNPHKR 288

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 5/117 (4%)
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           LH   K       R+  +R    G+ YLH +    V+HRD+K  N+ L+ D++ K+GDFG
Sbjct: 116 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFG 171
Query: 144 LARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           LA   + D   +   L GT  Y+APE++     S   D+++ G  +  +  G+ P E
Sbjct: 172 LATKIEFDG-ERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLH 112
           V S+    L+V + M +G L   L +          +P  +  +  ++   +A G+ YL+
Sbjct: 88  VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 147
Query: 113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELM 171
               +  +HRD+   N ++  D   K+GDFG+ R + + D   +  K +    +MAPE +
Sbjct: 148 A---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESL 204
Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
           + G  +TS+D+++FGV + E+ S      Q  S E V  + +V D    G  LD  D+  
Sbjct: 205 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--LKFVMD----GGYLDQPDNCP 258
Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL--DGNATLPDI 277
           E + +  +M         C    P  RP   +++  L  D + + P++
Sbjct: 259 ERVTDLMRM---------CWQFNPNMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 5/117 (4%)
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           LH   K       R+  +R    G+ YLH +    V+HRD+K  N+ L+ D++ K+GDFG
Sbjct: 132 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 144 LARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           LA   + D   +   L GT  Y+APE++     S   D+++ G  +  +  G+ P E
Sbjct: 188 LATKIEFDG-ERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 110 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 166
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 167 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 226
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 227 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 276
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 277 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 124 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 180
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 181 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 240
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 241 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 290
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 291 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 124 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 180
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 181 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 240
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 241 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 290
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 291 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 323

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 126 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 182
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 183 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 242
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 243 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 292
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 293 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 325

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 116 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 172
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 173 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 232
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 233 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 282
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 283 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 315

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT     ++  Q   +   V   L  LH    Q V+HRDIK
Sbjct: 222 ELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIK 274
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL  D   KL DFG       + +P+   LVGT  +MAPEL+         D+++ 
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSL 333
Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G+ ++E+  G  P   +  ++ + ++
Sbjct: 334 GIMVIEMVDGEPPYFNEPPLKAMKMI 359

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T+L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 240
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 241 ---LKH-NPSQRPMLREVLEHPWITANSSKP 267

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 149 HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 205
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH--DTIPQTTKLVGTFGY 165
            +L     +  +HRD+   N +LD     K+ DFGLAR +YD   D++   T       +
Sbjct: 206 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFD-ITVYLLQGRRLL 316
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 317 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 347

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT     ++  Q   +   V   L  LH    Q V+HRDIK
Sbjct: 100 ELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIK 152
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL  D   KL DFG       + +P+   LVGT  +MAPEL+         D+++ 
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSL 211
Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G+ ++E+  G  P   +  ++ + ++
Sbjct: 212 GIMVIEMVDGEPPYFNEPPLKAMKMI 237

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 136 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 192
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 193 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 252
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 253 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 302
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 303 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 335

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 127 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 183
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 184 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK 243
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 244 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 293
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 294 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 326

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT     ++  Q   +   V   L  LH    Q V+HRDIK
Sbjct: 102 ELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIK 154
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL  D   KL DFG       + +P+   LVGT  +MAPEL+         D+++ 
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSL 213
Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G+ ++E+  G  P   +  ++ + ++
Sbjct: 214 GIMVIEMVDGEPPYFNEPPLKAMKMI 239

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 63/104 (60%), Gaps = 4/104 (3%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           ++ GL +LH+   + +++RD+K  NV+LD++ + K+ DFG+ + +  D +  T +  GT 
Sbjct: 129 ISIGLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCGTP 184
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
            Y+APE++       S D +A+GV + E+ +G+ P + +   E+
Sbjct: 185 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT +       Q   +   V   L  LH    Q V+HRDIK
Sbjct: 91  ELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHA---QGVIHRDIK 143
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL  D   KL DFG       + +P+   LVGT  +MAPEL+         D+++ 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSL 202
Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G+ ++E+  G  P   +  ++ + ++
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMI 228

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL ++H    + V++RD+KPAN+LLD   + ++ D GLA  +     P  +  VGT GYM
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYM 357
Query: 167 APELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGS 204
           APE+++ G A  +S D ++ G  + ++  G  P  Q  +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL ++H    + V++RD+KPAN+LLD   + ++ D GLA  +     P  +  VGT GYM
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYM 357
Query: 167 APELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGS 204
           APE+++ G A  +S D ++ G  + ++  G  P  Q  +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 206
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+AR +Y      +    +    +M PE    G  ++ 
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK 266
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 267 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 316
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 317 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL ++H    + V++RD+KPAN+LLD   + ++ D GLA  +     P  +  VGT GYM
Sbjct: 303 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYM 356
Query: 167 APELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGS 204
           APE+++ G A  +S D ++ G  + ++  G  P  Q  +
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL ++H    + V++RD+KPAN+LLD   + ++ D GLA  +     P  +  VGT GYM
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYM 357
Query: 167 APELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGS 204
           APE+++ G A  +S D ++ G  + ++  G  P  Q  +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT +       Q   +   V   L  LH    Q V+HRDIK
Sbjct: 95  ELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHA---QGVIHRDIK 147
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL  D   KL DFG       + +P+   LVGT  +MAPEL+         D+++ 
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSL 206
Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G+ ++E+  G  P   +  ++ + ++
Sbjct: 207 GIMVIEMVDGEPPYFNEPPLKAMKMI 232

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 72/141 (51%), Gaps = 8/141 (5%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V     E +L+ +Y   G +  +    +   +S     R+I+ +  G+ YLH++    ++
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIV 153
Query: 121 HRDIKPANVLLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
           H D+KP N+LL +     + K+ DFG++R   H    +  +++GT  Y+APE++     +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPIT 211
Query: 178 TSTDVYAFGVFMLEVASGRRP 198
           T+TD++  G+    + +   P
Sbjct: 212 TATDMWNIGIIAYMLLTHTSP 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 82  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 138
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 139 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFD-ITVYLLQGRRLL 249
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 250 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 280

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 89  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 145
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 146 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 256
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 257 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 287

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 91  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 147
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH--DTIPQTTKLVGTFGY 165
            +L     +  +HRD+   N +LD     K+ DFGLAR +YD   D++   T       +
Sbjct: 148 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 258
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 259 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 289

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 3/108 (2%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH   E+ V++RD+K  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 260 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 316
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q   ++  L+
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 91/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R + 
Sbjct: 120 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 174
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 175 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 234
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+           +++L+L   C    P+ RP+  +++
Sbjct: 235 LRFV-------MEGGLLDKPDN---------CPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 90  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 146
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 147 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 257
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 258 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 288

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 108 HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 164
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 165 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFD-ITVYLLQGRRLL 275
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 276 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 306

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E  +V +++  G+L D + HT     ++  Q   +   V   L  LH    Q V+HRDIK
Sbjct: 145 ELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIK 197
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
             ++LL  D   KL DFG       + +P+   LVGT  +MAPEL+         D+++ 
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSL 256
Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV 211
           G+ ++E+  G  P   +  ++ + ++
Sbjct: 257 GIMVIEMVDGEPPYFNEPPLKAMKMI 282

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 3/108 (2%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH   E+ V++RD+K  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 313
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q   ++  L+
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 91/178 (51%), Gaps = 23/178 (12%)
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LY 148
           PSLS  +  ++   +A G+ YL+ +     +HRD+   N ++  D   K+GDFG+ R + 
Sbjct: 129 PSLS--KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 183
Query: 149 DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEM 207
           + D   +  K +    +M+PE ++ G  +T +DV++FGV + E+A+   +P +   + ++
Sbjct: 184 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 243
Query: 208 VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           +  V        +G +LD  D+  + ++E  +M         C    P+ RP+  +++
Sbjct: 244 LRFV-------MEGGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 285

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 109 HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 165
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 166 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFD-ITVYLLQGRRLL 276
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 277 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 307

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 87  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 143
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 144 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFD-ITVYLLQGRRLL 254
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 255 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 285

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 111 LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 162
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 163 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 266
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 267 ---LKH-NPSQRPMLREVLEHPWITANSSKP 293

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 66  HPN-LVQLLG-VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-----------KDYRM 229
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 230 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 95  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 151
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH--DTIPQTTKLVGTFGY 165
            +L     +  +HRD+   N +LD     K+ DFGLAR +YD   D++   T       +
Sbjct: 152 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFD-ITVYLLQGRRLL 262
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 263 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 293

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
            R + S + Y H+ +   ++HRD+K  N+LLDAD+N K+ DFG +  +      +  +  
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDEFC 173
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           G+  Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 88  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 144
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 145 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 255
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 256 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 286

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 102 LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 153
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 154 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 210
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 211 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 257
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 258 ---LKH-NPSQRPMLREVLEHPWITANSSKP 284

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 90  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 146
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH--DTIPQTTKLVGTFGY 165
            +L     +  +HRD+   N +LD     K+ DFGLAR +YD   D++   T       +
Sbjct: 147 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 257
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 258 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 288

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 89  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 145
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 146 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 256
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 257 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 287

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 90  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 146
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH--DTIPQTTKLVGTFGY 165
            +L     +  +HRD+   N +LD     K+ DFGLAR +YD   D++   T       +
Sbjct: 147 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 257
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 258 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 288

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 90  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 146
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 147 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 257
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 258 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 288

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 90  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 141
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 142 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 245
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 246 ---LKH-NPSQRPMLREVLEHPWITANSSKP 272

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 85  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 141
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLVGTFGY 165
            YL     +  +HRD+   N +LD     K+ DFGLAR +YD +  ++   T       +
Sbjct: 142 KYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 252
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 253 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 283

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 7/171 (4%)
Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWY 95
            E  + +R  L  +  +  L   +     + +  L+ DY+  G L    H + +   + +
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEH 159
Query: 96  QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 155
           +    +  +   L +LH+     +++RDIK  N+LLD++ +  L DFGL++ +  D   +
Sbjct: 160 EVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 156 TTKLVGTFGYMAPELMRTGKAS--TSTDVYAFGVFMLEVASGRRPIEQQGS 204
                GT  YMAP+++R G +    + D ++ GV M E+ +G  P    G 
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 66  HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-----------KDYRM 229
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 230 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 88  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 144
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH--DTIPQTTKLVGTFGY 165
            +L     +  +HRD+   N +LD     K+ DFGLAR +YD   D++   T       +
Sbjct: 145 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLL 255
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 256 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 286

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 90  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 141
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE +         D+++ G
Sbjct: 142 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLG 198
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 245
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 246 ---LKH-NPSQRPXLREVLEHPWITANSSKP 272

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 240
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 241 ---LKH-NPSQRPMLREVLEHPWITANSSKP 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
            R + S + Y H+ +   ++HRD+K  N+LLDAD+N K+ DFG +  +       T    
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 173
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           G+  Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
            R + S + Y H+ +   ++HRD+K  N+LLDAD+N K+ DFG +  +       T    
Sbjct: 112 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 166
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           G+  Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +A GL +L     + +++RD+K  NV+LD++ + K+ DFG+ +    D +  T    GT 
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTP 506
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       S D +AFGV + E+ +G+ P E +   E+   +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 88  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 139
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 140 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 243
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 244 ---LKH-NPSQRPMLREVLEHPWITANSSKP 270

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 86  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 137
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 138 ENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 241
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 242 ---LKH-NPSQRPMLREVLEHPWITANSSKP 268

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
            R + S + Y H+ +   ++HRD+K  N+LLDAD+N K+ DFG +  +       T    
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 173
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           G+  Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
            R + S + Y H+ +   ++HRD+K  N+LLDAD+N K+ DFG +  +       T    
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FC 173
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           G+  Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 240
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 241 ---LKH-NPSQRPMLREVLEHPWITANSSKP 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 66  HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-----------KDYRM 229
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 230 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HRDIK 
Sbjct: 91  ELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKS 144
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL  D + KL DFG       +   ++T +VGT  +MAPE++         D+++ G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLV 211
           +  +E+  G  P   +  +  + L+
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLI 228

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 240
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 241 ---LKH-NPSQRPMLREVLEHPWITANSSKP 267

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI-IRGVASGLLYLHEDWEQVVLH 121
           S  G   +  + +P GSL  +L +   P     Q      + +  GL YLH++    ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 122 RDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA--S 177
           RDIK  NVL++   +G  K+ DFG ++       P T    GT  YMAPE++  G     
Sbjct: 146 RDIKGDNVLINT-YSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGS 204
            + D+++ G  ++E+A+G+ P  + G 
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGE 230

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 84  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 135
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 136 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 192
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 193 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 239
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 240 ---LKH-NPSQRPMLREVLEHPWITANSSKP 266

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 240
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 241 ---LKH-NPSQRPMLREVLEHPWITANSSKP 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 89  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 140
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 141 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 198 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 244
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 245 ---LKH-NPSQRPMLREVLEHPWITANSSKP 271

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +A GL +L     + +++RD+K  NV+LD++ + K+ DFG+ +    D +  T    GT 
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTP 185
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       S D +AFGV + E+ +G+ P E +   E+   +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 90  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 141
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 142 ENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 245
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 246 ---LKH-NPSQRPMLREVLEHPWITANSSKP 272

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 13/149 (8%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN +++L + ++++K   +LV++++ +  L K+L    +  L        +  + +G+ 
Sbjct: 59  HSN-IVKLYDVIHTKK-RLVLVFEHL-DQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIA 114
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMA 167
           Y H+   + VLHRD+KP N+L++ +   K+ DFGLAR +    IP  + T  V T  Y A
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEVVTLWYRA 168
Query: 168 PE-LMRTGKASTSTDVYAFGVFMLEVASG 195
           P+ LM + K ST+ D+++ G    E+ +G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 85/149 (57%), Gaps = 13/149 (8%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN +++L + ++++K   +LV++++ +  L K+L    +  L        +  + +G+ 
Sbjct: 59  HSN-IVKLYDVIHTKK-RLVLVFEHL-DQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIA 114
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMA 167
           Y H+   + VLHRD+KP N+L++ +   K+ DFGLAR +    IP  + T  V T  Y A
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEVVTLWYRA 168
Query: 168 PE-LMRTGKASTSTDVYAFGVFMLEVASG 195
           P+ LM + K ST+ D+++ G    E+ +G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G + K L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 90  LILEYAPRGEVYKELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 141
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 142 ENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 245
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 246 ---LKH-NPSQRPMLREVLEHPWITANSSKP 272

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 35/176 (19%)
Query: 48  SVHSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGV 104
           S H N   LL +    N R  +  LV+DYM    L  ++  NI +P    Y  +++I+ +
Sbjct: 66  SGHENIVNLLNVLRADNDR--DVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-------------- 150
                YLH      +LHRD+KP+N+LL+A+ + K+ DFGL+R + +              
Sbjct: 123 K----YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 151 ------DTIPQTTKLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
                 D  P  T  V T  Y APE L+ + K +   D+++ G  + E+  G +PI
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 86  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 137
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 138 ENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 241
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 242 ---LKH-NPSQRPMLREVLEHPWITANSSKP 268

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 84/147 (57%), Gaps = 9/147 (6%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN +++L + ++++K   +LV++++ +  L K+L    +  L        +  + +G+ 
Sbjct: 59  HSN-IVKLYDVIHTKK-RLVLVFEHL-DQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIA 114
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           Y H+   + VLHRD+KP N+L++ +   K+ DFGLAR +       T ++V T  Y AP+
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
Query: 170 -LMRTGKASTSTDVYAFGVFMLEVASG 195
            LM + K ST+ D+++ G    E+ +G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 30/161 (18%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPN-----------GSLDKILHTNIKPSLSWYQRF 98
           H N +++L + +++ + +  LV+++M N           G+  + L  N+     W    
Sbjct: 62  HEN-IVRLYDVIHT-ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ--- 116
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT- 157
                +  GL + HE+    +LHRD+KP N+L++     KLGDFGLAR +    IP  T 
Sbjct: 117 -----LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTF 165
Query: 158 -KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
              V T  Y AP+ LM +   STS D+++ G  + E+ +G+
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 75/144 (52%), Gaps = 10/144 (6%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V S   +F +V +Y+  G L   +  + +  +   +  R+ + + S + Y H     +V+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHR---HMVV 133
Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK--AST 178
           HRD+KP NVLLDA +N K+ DFGL+ +       + +   G+  Y APE++ +G+  A  
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPEVI-SGRLYAGP 190
Query: 179 STDVYAFGVFMLEVASGRRPIEQQ 202
             D+++ GV +  +  G  P + +
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI-IRGVASGLLYLHEDWEQVVLH 121
           S  G   +  + +P GSL  +L +   P     Q      + +  GL YLH++    ++H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 131
Query: 122 RDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA--S 177
           RDIK  NVL++   +G  K+ DFG ++       P T    GT  YMAPE++  G     
Sbjct: 132 RDIKGDNVLINT-YSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGS 204
            + D+++ G  ++E+A+G+ P  + G 
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGE 216

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 69  LLVYDYMPNGSLDKIL-HTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
            ++ + M  G L   L  T  +PS    L+      + R +A G  YL E+     +HRD
Sbjct: 110 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRD 166
Query: 124 IKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I   N LL     G   K+GDFG+A+ +Y      +    +    +M PE    G  ++ 
Sbjct: 167 IAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 226
Query: 180 TDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           TD ++FGV + E+ S G  P   + + E++  V         G  +D   +    +Y   
Sbjct: 227 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPKNCPGPVY--- 276
Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
                 ++   C   +PE RPN   +++ ++     PD+
Sbjct: 277 ------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 309

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 62/111 (55%), Gaps = 10/111 (9%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDTIPQTTKLV 160
           +  GL +LH    + +++RD+K  N+LLD D + K+ DFG+ +   L D     +T +  
Sbjct: 128 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNEFC 180
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           GT  Y+APE++   K + S D ++FGV + E+  G+ P   Q   E+ + +
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 68  HPN-LVQLLG-VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 231
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 232 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HRDIK 
Sbjct: 91  ELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKS 144
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTK---LVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL  D + KL DFG          P+ +K   +VGT  +MAPE++         D++
Sbjct: 145 DNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 184 AFGVFMLEVASGRRP 198
           + G+  +E+  G  P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HRDIK 
Sbjct: 91  ELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKS 144
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTK---LVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL  D + KL DFG          P+ +K   +VGT  +MAPE++         D++
Sbjct: 145 DNILLGMDGSVKLTDFGFC----AQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 184 AFGVFMLEVASGRRP 198
           + G+  +E+  G  P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 27/166 (16%)
Query: 70  LVYDYMPNGSLDKIL------------HTNIK----------PSLSWYQRFRIIRGVASG 107
           L+++YM  G L++ L            H+++           P LS  ++  I R VA+G
Sbjct: 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186
Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYM 166
           + YL E   +  +HRD+   N L+  ++  K+ DFGL+R +Y  D             +M
Sbjct: 187 MAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM 243
Query: 167 APELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV 211
            PE +   + +T +DV+A+GV + E+ S G +P       E++  V
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 9/150 (6%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +  LV ++   GS+  ++      +L       I R +  GL +LH+     V+HRDIK 
Sbjct: 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKG 157
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST-----D 181
            NVLL  +   KL DFG++   D  T+ +    +GT  +MAPE++   +   +T     D
Sbjct: 158 QNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 216
Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           +++ G+  +E+A G  P+     M  + L+
Sbjct: 217 LWSLGITAIEMAEGAPPLCDMHPMRALFLI 246

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+ +  LV++++ +  L   L     P L       ++R    GL +LH +    ++HRD
Sbjct: 82  REIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRD 137
Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP N+L+ +    KL DFGLAR+Y +        +V T  Y APE++     +T  D++
Sbjct: 138 LKPENILVTSGGTVKLADFGLARIYSYQM--ALAPVVVTLWYRAPEVLLQSTYATPVDMW 195
Query: 184 AFGVFMLEVASGRRPI-------EQQGSM-EMVNLV---DWVSDC-WKKGAILDASDSRL 231
           + G    E+   R+P+       +Q G + +++ L    DW  D    +GA        +
Sbjct: 196 SVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPV 254
Query: 232 EGIY---EEEQMELVLKLGLFCSHPK 254
           + +    EE   +L+L++  F  H +
Sbjct: 255 QSVVPEMEESGAQLLLEMLTFNPHKR 280

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
            R + S + Y H+ +   ++HRD+K  N+LLDAD+N K+ DFG +  +      +     
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDAFC 173
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           G   Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HRDIK 
Sbjct: 92  ELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKS 145
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTK---LVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL  D + KL DFG          P+ +K   +VGT  +MAPE++         D++
Sbjct: 146 DNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 184 AFGVFMLEVASGRRP 198
           + G+  +E+  G  P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 68  HPN-LVQLLG-VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 231
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 232 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 68  HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 231
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 232 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 68  HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 231
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 232 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 73  HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 130
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 236
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 237 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 58  TNTVNSRKGEFLLVYDYMPNG---SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED 114
           T +   R+ +  LV++++       LDK+    +         F+++RG    L +LH  
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG----LDFLHS- 138
Query: 115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG 174
               V+HRD+KP N+L+ +    KL DFGLAR+Y        T +V T  Y APE++   
Sbjct: 139 --HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQS 194
Query: 175 KASTSTDVYAFGVFMLEVASGRRPI 199
             +T  D+++ G    E+   R+P+
Sbjct: 195 SYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 58  TNTVNSRKGEFLLVYDYMPNG---SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED 114
           T +   R+ +  LV++++       LDK+    +         F+++RG    L +LH  
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG----LDFLHS- 138
Query: 115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG 174
               V+HRD+KP N+L+ +    KL DFGLAR+Y        T +V T  Y APE++   
Sbjct: 139 --HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQS 194
Query: 175 KASTSTDVYAFGVFMLEVASGRRPI 199
             +T  D+++ G    E+   R+P+
Sbjct: 195 SYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 58  TNTVNSRKGEFLLVYDYMPNG---SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED 114
           T +   R+ +  LV++++       LDK+    +         F+++RG    L +LH  
Sbjct: 84  TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG----LDFLHS- 138
Query: 115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG 174
               V+HRD+KP N+L+ +    KL DFGLAR+Y        T +V T  Y APE++   
Sbjct: 139 --HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQS 194
Query: 175 KASTSTDVYAFGVFMLEVASGRRPI 199
             +T  D+++ G    E+   R+P+
Sbjct: 195 SYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD +A  +S  ++QL       +    +V +YMP G L  ++ +N      W + +   
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLM-SNYDVPEKWARFY--- 178
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
              A  +L L        +HRD+KP N+LLD   + KL DFG     + + + +    VG
Sbjct: 179 --TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 162 TFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRPI 199
           T  Y++PE++++    G      D ++ GVF+ E+  G  P 
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 61/111 (54%), Gaps = 10/111 (9%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR---LYDHDTIPQTTKLV 160
           +  GL +LH    + +++RD+K  N+LLD D + K+ DFG+ +   L D     +T    
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNXFC 179
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           GT  Y+APE++   K + S D ++FGV + E+  G+ P   Q   E+ + +
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD +A  +S  ++QL       +    +V +YMP G L  ++ +N      W + +   
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLM-SNYDVPEKWARFY--- 178
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
              A  +L L        +HRD+KP N+LLD   + KL DFG     + + + +    VG
Sbjct: 179 --TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 162 TFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRPI 199
           T  Y++PE++++    G      D ++ GVF+ E+  G  P 
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 31/201 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 82  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 133
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 134 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 190
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 191 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 237
Query: 247 GLFCSHPKPEARPNMRQVMQY 267
                H  P  RP +R+V+++
Sbjct: 238 ---LKH-NPSQRPMLREVLEH 254

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+ +  LV++++ +  L   L     P L       ++R    GL +LH +    ++HRD
Sbjct: 82  REIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRD 137
Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP N+L+ +    KL DFGLAR+Y +        +V T  Y APE++     +T  D++
Sbjct: 138 LKPENILVTSGGTVKLADFGLARIYSYQM--ALDPVVVTLWYRAPEVLLQSTYATPVDMW 195
Query: 184 AFGVFMLEVASGRRPI-------EQQGSM-EMVNLV---DWVSDC-WKKGAILDASDSRL 231
           + G    E+   R+P+       +Q G + +++ L    DW  D    +GA        +
Sbjct: 196 SVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPV 254
Query: 232 EGIY---EEEQMELVLKLGLFCSHPK 254
           + +    EE   +L+L++  F  H +
Sbjct: 255 QSVVPEMEESGAQLLLEMLTFNPHKR 280

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 31/201 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 88  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 139
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 140 ENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 243
Query: 247 GLFCSHPKPEARPNMRQVMQY 267
                H  P  RP +R+V+++
Sbjct: 244 ---LKH-NPSQRPMLREVLEH 260

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 42  QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII 101
           +RD +A  +S  ++QL       +    +V +YMP G L  ++ +N      W + +   
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLM-SNYDVPEKWARFY--- 173
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
              A  +L L        +HRD+KP N+LLD   + KL DFG     + + + +    VG
Sbjct: 174 --TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 162 TFGYMAPELMRT----GKASTSTDVYAFGVFMLEVASGRRPI 199
           T  Y++PE++++    G      D ++ GVF+ E+  G  P 
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 86/188 (45%), Gaps = 21/188 (11%)
Query: 27  VNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFL------LVYDYMPNGSL 80
           + +  Y G   + + Q D +  V     L+  NT+  R G +L      LV +Y   GS 
Sbjct: 84  IKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHPNTIQYR-GCYLREHTAWLVMEYC-LGSA 140
Query: 81  DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 140
             +L  + KP L   +   +  G   GL YLH      ++HRD+K  N+LL      KLG
Sbjct: 141 SDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLG 196
Query: 141 DFGLARLYDHDTIPQTTKLVGTFGYMAPEL---MRTGKASTSTDVYAFGVFMLEVASGRR 197
           DFG A +     +      VGT  +MAPE+   M  G+     DV++ G+  +E+A  + 
Sbjct: 197 DFGSASI-----MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
Query: 198 PIEQQGSM 205
           P+    +M
Sbjct: 252 PLFNMNAM 259

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 6/157 (3%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++    L+QL      ++  F++  +YM NG L   L   ++      Q   + + V 
Sbjct: 57  MMNLSHEKLVQLYGVCTKQRPIFIIT-EYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVC 114
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             + YL     +  LHRD+   N L++     K+ DFGL+R    D    +        +
Sbjct: 115 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 171
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQ 201
             PE++   K S+ +D++AFGV M E+ S G+ P E+
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 86/188 (45%), Gaps = 21/188 (11%)
Query: 27  VNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFL------LVYDYMPNGSL 80
           + +  Y G   + + Q D +  V     L+  NT+  R G +L      LV +Y   GS 
Sbjct: 45  IKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHPNTIQYR-GCYLREHTAWLVMEYCL-GSA 101
Query: 81  DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG 140
             +L  + KP L   +   +  G   GL YLH      ++HRD+K  N+LL      KLG
Sbjct: 102 SDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLG 157
Query: 141 DFGLARLYDHDTIPQTTKLVGTFGYMAPEL---MRTGKASTSTDVYAFGVFMLEVASGRR 197
           DFG A +     +      VGT  +MAPE+   M  G+     DV++ G+  +E+A  + 
Sbjct: 158 DFGSASI-----MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 198 PIEQQGSM 205
           P+    +M
Sbjct: 213 PLFNMNAM 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 6/157 (3%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++    L+QL      ++  F++  +YM NG L   L   ++      Q   + + V 
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIIT-EYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVC 110
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             + YL     +  LHRD+   N L++     K+ DFGL+R    D    +        +
Sbjct: 111 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQ 201
             PE++   K S+ +D++AFGV M E+ S G+ P E+
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 87  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 138
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ +FG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 139 ENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 242
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 243 ---LKH-NPSQRPMLREVLEHPWITANSSKP 269

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGV 104
           +  +H   L+ L +     K E +L+ +++  G L D+I   + K  +S  +    +R  
Sbjct: 102 MNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQA 158
Query: 105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGT 162
             GL ++HE     ++H DIKP N++ +       K+ DFGLA   + D I + T     
Sbjct: 159 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM---VNLVDWVSD 216
           F   APE++        TD++A GV    + SG  P   +  +E    V   DW  D
Sbjct: 216 FA--APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH   E+ V++RD+K  N++LD D + K+ DFGL +  + D  T+       G
Sbjct: 119 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFCG 173
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T  Y+APE++       + D +  GV M E+  GR P   Q   ++  L+
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH   E+ V++RD+K  N++LD D + K+ DFGL +  + D  T+       G
Sbjct: 117 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFCG 171
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T  Y+APE++       + D +  GV M E+  GR P   Q   ++  L+
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL      ++  F++  +YM NG L   L   ++      Q   + + V   + YL  
Sbjct: 72  LVQLYGVCTKQRPIFIIT-EYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES 129
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
              +  LHRD+   N L++     K+ DFGL+R    D    +        +  PE++  
Sbjct: 130 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 186
Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQ 201
            K S+ +D++AFGV M E+ S G+ P E+
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYER 215

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 6/157 (3%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++    L+QL      ++  F++  +YM NG L   L   ++      Q   + + V 
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIIT-EYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVC 115
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             + YL     +  LHRD+   N L++     K+ DFGL+R    D    +        +
Sbjct: 116 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 172
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQ 201
             PE++   K S+ +D++AFGV M E+ S G+ P E+
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH   E+ V++RD+K  N++LD D + K+ DFGL +  + D  T+       G
Sbjct: 118 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFCG 172
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T  Y+APE++       + D +  GV M E+  GR P   Q   ++  L+
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL      ++  F++  +YM NG L   L   ++      Q   + + V   + YL  
Sbjct: 81  LVQLYGVCTKQRPIFIIT-EYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
              +  LHRD+   N L++     K+ DFGL+R    D    +        +  PE++  
Sbjct: 139 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQ 201
            K S+ +D++AFGV M E+ S G+ P E+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 68  MKEIKHPNLVQLLG-VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 127 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 232
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 233 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+ +  LV++++ +  L   L     P L       ++R    GL +LH +    ++HRD
Sbjct: 82  REIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRD 137
Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP N+L+ +    KL DFGLAR+Y +        +V T  Y APE++     +T  D++
Sbjct: 138 LKPENILVTSGGTVKLADFGLARIYSYQM--ALFPVVVTLWYRAPEVLLQSTYATPVDMW 195
Query: 184 AFGVFMLEVASGRRPI-------EQQGSM-EMVNLV---DWVSDC-WKKGAILDASDSRL 231
           + G    E+   R+P+       +Q G + +++ L    DW  D    +GA        +
Sbjct: 196 SVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPV 254
Query: 232 EGIY---EEEQMELVLKLGLFCSHPK 254
           + +    EE   +L+L++  F  H +
Sbjct: 255 QSVVPEMEESGAQLLLEMLTFNPHKR 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----G 174
           +HRDIKP NVLLD + + +L DFG     + D   Q++  VGT  Y++PE+++      G
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
           K     D ++ GV M E+  G  P   +  +E
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVE 304

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +    D     T   GT 
Sbjct: 117 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 172
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 68  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 127 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 232
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 233 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 88  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 139
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ +FG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 140 ENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 243
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 244 ---LKH-NPSQRPMLREVLEHPWITANSSKP 270

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 88  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 139
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 140 ENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 243
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 244 ---LKH-NPSQRPMLREVLEHPWITANSSKP 270

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 68  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 127 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 183
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 232
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 233 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL      ++  F++  +YM NG L   L   ++      Q   + + V   + YL  
Sbjct: 66  LVQLYGVCTKQRPIFIIT-EYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
              +  LHRD+   N L++     K+ DFGL+R    D    +        +  PE++  
Sbjct: 124 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMY 180
Query: 174 GKASTSTDVYAFGVFMLEVAS-GRRPIEQ 201
            K S+ +D++AFGV M E+ S G+ P E+
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
           R + S + Y H+ +   ++HRD+K  N+LLD D+N K+ DFG +  +       T    G
Sbjct: 121 RQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCG 175
Query: 162 TFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           +  Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 176 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 6/108 (5%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
            R + S + Y H+ +   ++HRD+K  N+LLDAD N K+ DFG +  +      +     
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN--KLDAFC 173
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           G   Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----G 174
           +HRDIKP NVLLD + + +L DFG     + D   Q++  VGT  Y++PE+++      G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
           K     D ++ GV M E+  G  P   +  +E
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 63  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 122 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 227
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 228 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 52/272 (19%)
Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLD--KILHTNI 88
           ++D  +++  +  +     L+  N VN      +K  + LV++++ +  LD  ++    +
Sbjct: 62  DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGL 121
Query: 89  KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-- 146
              +     F+II G+  G  + H      ++HRDIKP N+L+      KL DFG AR  
Sbjct: 122 DYQVVQKYLFQIINGI--GFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTL 174
Query: 147 -----LYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGR---- 196
                +YD +        V T  Y APEL+    K   + DV+A G  + E+  G     
Sbjct: 175 AAPGEVYDDE--------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226
Query: 197 --RPIEQQGSMEMV--NLVDWVSDCWKKGAILDASDSRLEGIYEEEQM--------ELVL 244
               I+Q   + M   NL+    + + K  +   +  RL  I E E +        E+V+
Sbjct: 227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF--AGVRLPEIKEREPLERRYPKLSEVVI 284
Query: 245 KLGLFCSHPKPEARPNMRQVMQY----LDGNA 272
            L   C H  P+ RP   +++ +    +DG A
Sbjct: 285 DLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 5/145 (3%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V + +  F +V +YMP G+L   L    +  ++      +   ++S + 
Sbjct: 87  HPN-LVQLLG-VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAME 144
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 145 YLEK---KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 201
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS 194
            +     S  +DV+AFGV + E+A+
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 61/112 (54%), Gaps = 10/112 (8%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTT 157
           +I       L +L E+ +  ++HRDIKP+N+LLD   N KL DFG++ +L D       T
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KT 183
Query: 158 KLVGTFGYMAPELMRTGKA----STSTDVYAFGVFMLEVASGRRPIEQQGSM 205
           +  G   YMAPE +    +       +DV++ G+ + E+A+GR P  +  S+
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 67/149 (44%), Gaps = 14/149 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 89  LILEYAPLGTVYRELQ-----KLSRFDEQRTATYITELANALSYCHS---KRVIHRDIKP 140
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL ++   K+ DFG +    H    + T L GT  Y+ PE++         D+++ G
Sbjct: 141 ENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           V   E   G  P E     E    +  V 
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVE 226

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 87  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 138
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 139 ENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 242
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 243 ---LKH-NPSQRPMLREVLEHPWITANSSKP 269

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           L+QL      ++  F++  +YM NG L   L   ++      Q   + + V   + YL  
Sbjct: 81  LVQLYGVCTKQRPIFIIT-EYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELM 171
              +  LHRD+   N L++     K+ DFGL+R  L D +T    +K      +  PE++
Sbjct: 139 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVL 193
Query: 172 RTGKASTSTDVYAFGVFMLEVAS-GRRPIEQ 201
              K S+ +D++AFGV M E+ S G+ P E+
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 64  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 123 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 179
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 228
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 229 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 50  HSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVAS 106
           H N L  + + + SR    +  L+  Y  +GSL D +    ++P L+     R+    A 
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAAC 116
Query: 107 GLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTT 157
           GL +LH +      +  + HRD K  NVL+ ++L   + D GLA ++    D+  I    
Sbjct: 117 GLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNP 176
Query: 158 KLVGTFGYMAPELM----RTG--KASTSTDVYAFGVFMLEVASGRRPI 199
           + VGT  YMAPE++    RT   ++   TD++AFG+ + E+A  RR I
Sbjct: 177 R-VGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTI 221

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 65  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 124 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 180
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 229
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 230 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 67  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 125
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 231
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 232 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 63  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 122 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 227
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 228 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQT 156
           I+R + S + ++H+     V+HRD+KP N+L    + +L  K+ DFG ARL   D  P  
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
           T    T  Y APEL+       S D+++ GV +  + SG+ P +
Sbjct: 168 TPCF-TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 64  MKEIKHPNLVQLLG-VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 123 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 179
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 228
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 229 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++S + 
Sbjct: 73  HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 236
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 237 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 63/121 (52%), Gaps = 11/121 (9%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 158
           R  + +   + Y H      ++HRD+KP N+LLD +LN K+ DFGL+ +       +T+ 
Sbjct: 112 RFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS- 167
Query: 159 LVGTFGYMAPELMRTGK--ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD 216
             G+  Y APE++  GK  A    DV++ G+ +  +  GR P + +    + NL   V+ 
Sbjct: 168 -CGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF---IPNLFKKVNS 222
Query: 217 C 217
           C
Sbjct: 223 C 223

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 111 LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 162
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 163 ENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 266
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 267 ---LKH-NPSQRPMLREVLEHPWITANSSKP 293

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 7/132 (5%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH +    V+HR+IK 
Sbjct: 92  ELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRNIKS 145
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL  D + KL DFG       +   ++T +VGT  +MAPE++         D+++ G
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 187 VFMLEVASGRRP 198
           +  +E+  G  P
Sbjct: 205 IMAIEMIEGEPP 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 12/103 (11%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQ 155
           ++ +   + YLHE+    ++HRD+KP N+L      DA L  K+ DFGL+++ +H  + +
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVLMK 208
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           T  + GT GY APE++R        D+++ G+    +  G  P
Sbjct: 209 T--VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           N  KG   LV+D+  +     + +  +K +LS  +R  +++ + +GL Y+H +    +LH
Sbjct: 94  NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIHRN---KILH 148
Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTGK-AS 177
           RD+K ANVL+  D   KL DFGLAR +      Q  +    V T  Y  PEL+   +   
Sbjct: 149 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYG 208
Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
              D++  G  M E+ + R PI  QG+ E   L
Sbjct: 209 PPIDLWGAGCIMAEMWT-RSPI-MQGNTEQHQL 239

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 240
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 241 ---LKH-NPSQRPMLREVLEHPWITANSSKP 267

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           N  KG   LV+D+  +     + +  +K +LS  +R  +++ + +GL Y+H +    +LH
Sbjct: 93  NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIHRN---KILH 147
Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTGK-AS 177
           RD+K ANVL+  D   KL DFGLAR +      Q  +    V T  Y  PEL+   +   
Sbjct: 148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYG 207
Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
              D++  G  M E+ + R PI  QG+ E   L
Sbjct: 208 PPIDLWGAGCIMAEMWT-RSPI-MQGNTEQHQL 238

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 64/126 (50%), Gaps = 10/126 (7%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+P GSL   L  +   S+   Q     + +  G+ YLH    Q  +HRD+   NV
Sbjct: 112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNV 165
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVG---TFGYMAPELMRTGKASTSTDVYAFG 186
           LLD D   K+GDFGLA+           +  G    F Y APE ++  K   ++DV++FG
Sbjct: 166 LLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFG 224
Query: 187 VFMLEV 192
           V + E+
Sbjct: 225 VTLYEL 230

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 65  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 124 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 229
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 230 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 86  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 137
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 138 ENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 241
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 242 ---LKH-NPSQRPMLREVLEHPWITANSSKP 268

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/222 (21%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++  + L++L   V +++    ++ ++M  GSL   L ++    +   +       +A
Sbjct: 61  MKTLQHDKLVRLYAVV-TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 119
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            G+ Y+     +  +HRD++ ANVL+   L  K+ DFGLAR+ + +             +
Sbjct: 120 EGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 176
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN--------------- 209
            APE +  G  +  ++V++FG+ + E+ + G+ P   + + ++++               
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCP 236
Query: 210 --LVDWVSDCWKKGA-----------ILDASDSRLEGIYEEE 238
             L D +  CWK+ A           +LD   +  EG Y+++
Sbjct: 237 DELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQ 278

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 76  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 134
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 135 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 191
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 192 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 240
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 241 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++
Sbjct: 65  MKEIKHPNLVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 124 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +   K S  +DV+AFGV + E+A+ G  P       ++  L++            
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------K 229
Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D    R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 230 DYRMERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           N  KG   LV+D+  +     + +  +K +LS  +R  +++ + +GL Y+H +    +LH
Sbjct: 94  NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIHRN---KILH 148
Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTGK-AS 177
           RD+K ANVL+  D   KL DFGLAR +      Q  +    V T  Y  PEL+   +   
Sbjct: 149 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYG 208
Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
              D++  G  M E+ + R PI  QG+ E   L
Sbjct: 209 PPIDLWGAGCIMAEMWT-RSPI-MQGNTEQHQL 239

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 11/91 (12%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---------TKLVGTFGYMAPE 169
           V+HRD+KP+N+L++++ + K+ DFGLAR+ D      +         T+ V T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 170 LMRT-GKASTSTDVYAFGVFMLEVASGRRPI 199
           +M T  K S + DV++ G  + E+   RRPI
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 11/91 (12%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---------TKLVGTFGYMAPE 169
           V+HRD+KP+N+L++++ + K+ DFGLAR+ D      +         T+ V T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 170 LMRT-GKASTSTDVYAFGVFMLEVASGRRPI 199
           +M T  K S + DV++ G  + E+   RRPI
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 67/125 (53%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +++P+GSL + L  N K  ++  Q+ +    +  G+ YL     +  +HRD+   NV
Sbjct: 102 LIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNV 157
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTK--LVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           L++++   K+GDFGL +  + D    T K        + APE +   K   ++DV++FGV
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGV 217
Query: 188 FMLEV 192
            + E+
Sbjct: 218 TLHEL 222

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 240
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 241 ---LKH-NPSQRPMLREVLEHPWITANSSKP 267

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +++P+GSL + L  N K  ++  Q+ +    +  G+ YL     +  +HRD+   NV
Sbjct: 90  LIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNV 145
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTK--LVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           L++++   K+GDFGL +  + D    T K        + APE +   K   ++DV++FGV
Sbjct: 146 LVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGV 205
Query: 188 FMLEVAS 194
            + E+ +
Sbjct: 206 TLHELLT 212

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
           R + S + Y H+   + ++HRD+K  N+LLDAD+N K+ DFG +  +       T    G
Sbjct: 118 RQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCG 172
Query: 162 TFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           +  Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 219

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR     T  + T  
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGY 189
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 27  VNQFIYHGFNEDPQLQRDG--LASVHSNGLLQLTN-TVNSRKGEFLLVYDYMPNGSLDKI 83
           V Q  + G ++    QR+   L ++HS+ +++    +    + E  LV +Y+P+G L   
Sbjct: 41  VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDF 100
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           L  + +  L   +       +  G+ YL     +  +HRD+   N+L++++ + K+ DFG
Sbjct: 101 LQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFG 156
Query: 144 LARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
           LA+L   D      +  G     + APE +     S  +DV++FGV + E+
Sbjct: 157 LAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR     T  + T  
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGY 189
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED  ++ D LAS     +++L +        ++L+ ++   G++D ++    +P L+  Q
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERP-LTESQ 136
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
              + +     L YLH++    ++HRD+K  N+L   D + KL DFG++   +  TI + 
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRR 192
Query: 157 TKLVGTFGYMAPELMRTGKAST-----STDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
              +GT  +MAPE++    +         DV++ G+ ++E+A    P  +   M ++
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR     T  + T  
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGY 189
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGL 108
           H N +L L       +G  L+V  YM +G L   +      P++     F +   VA G+
Sbjct: 91  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGM 147
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY---DHDTIPQTTKLVGTFGY 165
            +L     +  +HRD+   N +LD     K+ DFGLAR     + D++   T       +
Sbjct: 148 KFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           MA E ++T K +T +DV++FGV + E+ +   P         VN  D ++    +G  L 
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFD-ITVYLLQGRRLL 258
Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
             +   + +Y     E++LK    C HPK E RP+  +++
Sbjct: 259 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELV 289

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 88  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 139
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 140 ENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E     E    +  V   +       A D             L+ +L
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-------------LISRL 243
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                H  P  RP +R+V++  ++  N++ P
Sbjct: 244 ---LKH-NPSQRPMLREVLEHPWITANSSKP 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           H+N L+QL +   S K + +LV +Y+  G L D+I+  +   +L+       ++ +  G+
Sbjct: 145 HAN-LIQLYDAFES-KNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEGI 200
Query: 109 LYLHEDWEQVVLHRDIKPANVL-LDADLNG-KLGDFGLARLYDHDTIPQTTKLV--GTFG 164
            ++H+ +   +LH D+KP N+L ++ D    K+ DFGLAR Y     P+    V  GT  
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK----PREKLKVNFGTPE 253
Query: 165 YMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
           ++APE++     S  TD+++ GV    + SG  P       E +N +  ++  W      
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI--LACRW------ 305
Query: 225 DASDSRLEGIYEEEQMELVLKL 246
           D  D   + I EE + E + KL
Sbjct: 306 DLEDEEFQDISEEAK-EFISKL 326

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +  + D  T+       G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCG 167
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T  Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 85  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KKVIHRDIKP 136
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 137 ENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
           V   E   G+ P E           +   D +K+        SR+E  + +   E    L
Sbjct: 194 VLCYEFLVGKPPFE----------ANTYQDTYKR-------ISRVEFTFPDFVTEGARDL 236
Query: 247 GLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
                   P  RP +R+V++  ++  N++ P
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGY 188
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
           R + S + Y H+   + ++HRD+K  N+LLDAD+N K+ DFG +   +     +     G
Sbjct: 121 RQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCG 175
Query: 162 TFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
              Y APEL +  K      DV++ GV +  + SG  P + Q   E+
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGY 188
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 187
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 129 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 181
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 182 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGX 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 184
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 159 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 211
Query: 160 VGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGR 196
           V T  Y APE+M      + + D+++ G  M E+ +GR
Sbjct: 212 VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 137 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 189
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 275 HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HR++   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 333 YLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 438
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 439 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 188
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +  + D  T+       G
Sbjct: 119 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCG 172
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T  Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 140 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 192
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 193 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 184
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 187
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 184
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGY 187
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +  + D  T+       G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCG 167
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T  Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 135 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGY 187
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 127 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 179
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           + S L YLH    + V++RDIK  N++LD D + K+ DFGL +  + D  T+       G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCG 167
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T  Y+APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 120 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI 176
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           + S L++LH+   + +++RD+K  NVLLD + + KL DFG+ +    + +  T    GT 
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-TTATFCGTP 188
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            Y+APE+++      + D +A GV + E+  G  P E +   ++   +
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 141 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 193
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 178
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 142 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 194
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/102 (39%), Positives = 56/102 (54%), Gaps = 13/102 (12%)
Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           F+++RG+A    Y H    Q VLHRD+KP N+L++     KL DFGLAR     +IP  T
Sbjct: 107 FQLLRGLA----YCHR---QKVLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKT 156
Query: 158 --KLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
               V T  Y  P+ L+ +   ST  D++  G    E+A+GR
Sbjct: 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 142 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 194
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 202
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 142 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 194
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 195 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 127 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 179
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 178
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 178
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 153 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 205
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 128 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 180
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 141 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGY 193
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 149 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 201
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 202
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 52  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 109
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 110 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 163 ADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 207 MVNLVD 212
           +  +++
Sbjct: 223 VTAMLE 228

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 149 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGY 201
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 9/140 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL-YDHDTIPQTTKLVGT 162
           +AS L YLH      +++RD+KP N+LLD+  +  L DFGL +   +H++   T+   GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGT 202
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV-NLVDWVSDCWKKG 221
             Y+APE++       + D +  G  + E+  G  P   + + EM  N+++       K 
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKP 260
Query: 222 AILDASDSRLEGIYEEEQME 241
            I +++   LEG+ ++++ +
Sbjct: 261 NITNSARHLLEGLLQKDRTK 280

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 40  QLQRDGLASVH--SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR 97
           QL+R+     H     +L++ N  + RK  +L++ ++ P G L K L  + +        
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML-EFAPRGELYKELQKHGRFDEQRSAT 119
Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           F  +  +A  L Y HE   + V+HRDIKP N+L+      K+ DFG +    H    +  
Sbjct: 120 F--MEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRR 171
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
            + GT  Y+ PE++         D++  GV   E   G  P +     E
Sbjct: 172 XMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 48  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 105
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 106 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 207 MVNLVD 212
           +  +++
Sbjct: 219 VTAMLE 224

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 11/169 (6%)
Query: 40  QLQRDGLASVH--SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR 97
           QL+R+     H     +L++ N  + RK  +L++ ++ P G L K L  + +        
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML-EFAPRGELYKELQKHGRFDEQRSAT 118
Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
           F  +  +A  L Y HE   + V+HRDIKP N+L+      K+ DFG +    H    +  
Sbjct: 119 F--MEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRR 170
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
            + GT  Y+ PE++         D++  GV   E   G  P +     E
Sbjct: 171 XMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 14/149 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 88  LILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKP 139
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL +    K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 140 ENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           V   E   G+ P E     E    +  V 
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVE 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 11/91 (12%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---------TKLVGTFGYMAPE 169
           V+HRD+KP+N+L++++ + K+ DFGLAR+ D      +          + V T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 170 LMRT-GKASTSTDVYAFGVFMLEVASGRRPI 199
           +M T  K S + DV++ G  + E+   RRPI
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 58  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 115
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 116 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
Query: 207 MVNLVD 212
           +  +++
Sbjct: 229 VTAMLE 234

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 16/151 (10%)
Query: 66  GEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           G+  L+ +Y+  G L   L      ++ +  +Y     +  ++  L +LH+   + +++R
Sbjct: 94  GKLYLILEYLSGGELFMQLEREGIFMEDTACFY-----LAEISMALGHLHQ---KGIIYR 145
Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVGTFGYMAPE-LMRTGKASTST 180
           D+KP N++L+   + KL DFGL +   HD T+  T    GT  YMAPE LMR+G  + + 
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRSGH-NRAV 202
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           D ++ G  M ++ +G  P   +   + ++ +
Sbjct: 203 DWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ A    KLGDFGL+R  +  T  + +K     
Sbjct: 120 LSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 52  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 109
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 110 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 163 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 207 MVNLVD 212
           +  +++
Sbjct: 223 VTAMLE 228

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 46  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 103
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 104 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 156
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 157 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216
Query: 207 MVNLVD 212
           +  +++
Sbjct: 217 VTAMLE 222

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 68  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 125
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 126 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 178
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 179 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 207 MVNLVD 212
           +  +++
Sbjct: 239 VTAMLE 244

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 97  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 152
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 153 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 212
Query: 188 FMLEV 192
            + E+
Sbjct: 213 VLYEL 217

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 68  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 125
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 126 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 178
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 179 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 207 MVNLVD 212
           +  +++
Sbjct: 239 VTAMLE 244

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 32/185 (17%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLH 121
           R+G+  +  + M + SLDK     I    +  +    +I   +   L +LH      V+H
Sbjct: 121 REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIH 177
Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA-----PELMRTGKA 176
           RD+KP+NVL++A    K+ DFG++  Y  D++ +T    G   YMA     PEL + G  
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISG-YLVDSVAKTID-AGCKPYMAPERINPELNQKG-Y 234
Query: 177 STSTDVYAFGVFMLEVASGRRPIEQQGS----MEMV---------------NLVDWVSDC 217
           S  +D+++ G+ M+E+A  R P +  G+    ++ V                 VD+ S C
Sbjct: 235 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQC 294
Query: 218 WKKGA 222
            KK +
Sbjct: 295 LKKNS 299

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 93  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 148
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 149 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 208
Query: 188 FMLEV 192
            + E+
Sbjct: 209 VLYEL 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTN--IK 89
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N  +K
Sbjct: 66  DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVK 123
Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
                     ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++   
Sbjct: 124 DK----NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 176
Query: 150 HDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSME 206
            D      +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E
Sbjct: 177 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 236
Query: 207 MVNLVD 212
           +  +++
Sbjct: 237 VTAMLE 242

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 136 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD----EMTGY 188
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 96  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 151
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 152 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 211
Query: 188 FMLEV 192
            + E+
Sbjct: 212 VLYEL 216

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 95  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 150
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 151 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 210
Query: 188 FMLEV 192
            + E+
Sbjct: 211 VLYEL 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 90  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 145
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 146 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205
Query: 188 FMLEV 192
            + E+
Sbjct: 206 VLYEL 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 121 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 176
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 177 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 188 FMLEV 192
            + E+
Sbjct: 237 VLYEL 241

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 88  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 143
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 144 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 203
Query: 188 FMLEV 192
            + E+
Sbjct: 204 VLYEL 208

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 89  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 144
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 145 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 204
Query: 188 FMLEV 192
            + E+
Sbjct: 205 VLYEL 209

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 90  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 145
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 146 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205
Query: 188 FMLEV 192
            + E+
Sbjct: 206 VLYEL 210

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 13/166 (7%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +++L      ++  +L++  Y      D+I+   ++   S      I++ V SG  
Sbjct: 80  HPN-IMKLYEFFEDKRNYYLVMEVYRGGELFDEII---LRQKFSEVDAAVIMKQVLSGTT 135
Query: 110 YLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           YLH+     ++HRD+KP N+LL++   D   K+ DFGL+  +  +   +  + +GT  Y+
Sbjct: 136 YLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYI 190
Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           APE++R  K     DV++ GV +  +  G  P   Q   E++  V+
Sbjct: 191 APEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 235

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 120 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 19/142 (13%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW-----EQVVLH 121
           +  L+ DY  NGSL   L +    +L      ++     SGL +LH +      +  + H
Sbjct: 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDT----IPQTTKLVGTFGYMAPELMRTG--- 174
           RD+K  N+L+  +    + D GLA  +  DT    IP  T+ VGT  YM PE++      
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRYMPPEVLDESLNR 224
Query: 175 ---KASTSTDVYAFGVFMLEVA 193
              ++    D+Y+FG+ + EVA
Sbjct: 225 NHFQSYIMADMYSFGLILWEVA 246

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 108 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 163
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 164 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 223
Query: 188 FMLEV 192
            + E+
Sbjct: 224 VLYEL 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 132 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD----EMTGY 184
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 120 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 13/166 (7%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +++L      ++  +L++  Y      D+I+   ++   S      I++ V SG  
Sbjct: 63  HPN-IMKLYEFFEDKRNYYLVMEVYRGGELFDEII---LRQKFSEVDAAVIMKQVLSGTT 118
Query: 110 YLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           YLH+     ++HRD+KP N+LL++   D   K+ DFGL+  +  +   +  + +GT  Y+
Sbjct: 119 YLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYI 173
Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
           APE++R  K     DV++ GV +  +  G  P   Q   E++  V+
Sbjct: 174 APEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 94  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 149
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 150 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 209
Query: 188 FMLEV 192
            + E+
Sbjct: 210 VLYEL 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 122 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 178
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 179 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 125 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 123 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 179
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 180 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 18/132 (13%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+P GSL   L  +   S+   Q     + +  G+ YLH    Q  +HR++   NV
Sbjct: 95  LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNV 148
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLV-------GTFGYMAPELMRTGKASTSTDV 182
           LLD D   K+GDFGLA+      +P+  +             + APE ++  K   ++DV
Sbjct: 149 LLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 183 YAFGVFMLEVAS 194
           ++FGV + E+ +
Sbjct: 204 WSFGVTLYELLT 215

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 21/168 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGT 162
           VA G+ YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT     
Sbjct: 159 VARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLP 215
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEG 268
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +D   +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 269 HRMDKPSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 307

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 89  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGM 148
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 149 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 258
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 259 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 292

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 108 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 163
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 164 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 223
Query: 188 FMLEV 192
            + E+
Sbjct: 224 VLYEL 228

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 148 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 204
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 205 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ A    KLGDFGL+R  +  T  + +K     
Sbjct: 500 LSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 66  GEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           G+  L+ +Y+  G L   L      ++ +  +Y     +  ++  L +LH+   + +++R
Sbjct: 94  GKLYLILEYLSGGELFMQLEREGIFMEDTACFY-----LAEISMALGHLHQ---KGIIYR 145
Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKASTSTD 181
           D+KP N++L+   + KL DFGL +   HD    T    GT  YMAPE LMR+G  + + D
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILMRSGH-NRAVD 203
Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            ++ G  M ++ +G  P   +   + ++ +
Sbjct: 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 75/141 (53%), Gaps = 17/141 (12%)
Query: 66  GEFLLVY---DYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           GEF  VY   D M    L +I+H++   +L   + F  +  +  GL Y+H      V+HR
Sbjct: 130 GEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYF--LYQLLRGLKYMHSAQ---VIHR 183
Query: 123 DIKPANVLLDADLNGKLGDFGLAR-----LYDHDTIPQTTKLVGTFGYMAPELMRT-GKA 176
           D+KP+N+L++ +   K+GDFG+AR       +H      T+ V T  Y APELM +  + 
Sbjct: 184 DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF--MTEYVATRWYRAPELMLSLHEY 241
Query: 177 STSTDVYAFGVFMLEVASGRR 197
           + + D+++ G    E+ + R+
Sbjct: 242 TQAIDLWSVGCIFGEMLARRQ 262

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           N  K    LV+D+  +     + +  +K +LS  +R  +++ + +GL Y+H +    +LH
Sbjct: 94  NRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIHRN---KILH 148
Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTGK-AS 177
           RD+K ANVL+  D   KL DFGLAR +      Q  +    V T  Y  PEL+   +   
Sbjct: 149 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYG 208
Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
              D++  G  M E+ + R PI  QG+ E   L
Sbjct: 209 PPIDLWGAGCIMAEMWT-RSPI-MQGNTEQHQL 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 104 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGM 163
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 164 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 220
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 221 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 273
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 274 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 307

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 14/149 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRI---IRGVASGLLYLHEDWEQVVLHRDIKP 126
           L+ +Y P G++ + L       LS +   R    I  +A+ L Y H    + V+HRDIKP
Sbjct: 89  LILEYAPLGTVYRELQ-----KLSRFDEQRTATYITELANALSYCHS---KRVIHRDIKP 140
Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
            N+LL ++   K+ DFG +    H    +   L GT  Y+ PE++         D+++ G
Sbjct: 141 ENLLLGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           V   E   G  P E     E    +  V 
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVE 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 18/132 (13%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+P GSL   L  +   S+   Q     + +  G+ YLH    Q  +HR++   NV
Sbjct: 95  LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNV 148
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLV-------GTFGYMAPELMRTGKASTSTDV 182
           LLD D   K+GDFGLA+      +P+  +             + APE ++  K   ++DV
Sbjct: 149 LLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 183 YAFGVFMLEVAS 194
           ++FGV + E+ +
Sbjct: 204 WSFGVTLYELLT 215

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 205 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 261
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 262 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 314
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 315 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 348

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 93  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 152
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 153 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 209
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 210 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 262
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 263 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 296

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ D+GLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     +    
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGF 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     +    
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGF 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLL--DADLNG--KLGDFGLARLYDHDTIP- 154
           ++  +  G+ YLH +W   VLHRD+KPAN+L+  +    G  K+ D G ARL++    P 
Sbjct: 133 LLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 155 -QTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEVASG 195
                +V TF Y APEL+   +  T + D++A G    E+ + 
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 97  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 156
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 157 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 213
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 214 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 266
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 267 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 300

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 96  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 155
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 156 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 212
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 213 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 265
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 266 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 104 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 163
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 164 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 220
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 221 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 273
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 274 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 307

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 19/195 (9%)
Query: 11  CVLLCVSFILSALAQDVNQFIYHGFNEDPQLQRDGLAS---VHSNGLLQLTNTVNSRKGE 67
           CV LC     +A   +  +       +  +L+R+        HSN +++L +++ S +G 
Sbjct: 23  CVKLCTGHEYAAKIINTKKL---SARDHQKLEREARICRLLKHSN-IVRLHDSI-SEEGF 77
Query: 68  FLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
             LV+D +  G L + I+    +   S       I+ +   +L+ H+     V+HRD+KP
Sbjct: 78  HYLVFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQ---MGVVHRDLKP 131
Query: 127 ANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
            N+LL +   G   KL DFGLA     D         GT GY++PE++R        D++
Sbjct: 132 ENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVLRKEAYGKPVDIW 190
Query: 184 AFGVFMLEVASGRRP 198
           A GV +  +  G  P
Sbjct: 191 ACGVILYILLVGYPP 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRIIR-------------GVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMA 227
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 280
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 281 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +++ L YL     +  +HRDI   NVL+ ++   KLGDFGL+R  +  T  + +K     
Sbjct: 500 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEV-ASGRRPIE 200
            +MAPE +   + ++++DV+ FGV M E+   G +P +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR--------------FRIIRGVASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 104 TQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 163
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMA 167
            YL     +  +HRD+   NVL+  D   K+ DFGLAR   H D   +TT       +MA
Sbjct: 164 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 220
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G  +D 
Sbjct: 221 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHRMDK 273
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    +Y      ++++    C H  P  RP  +Q+++ LD
Sbjct: 274 PSNCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLD 307

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 66  GEFLLVY---DYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           GEF  VY   D M    L +I+H++   +L   + F  +  +  GL Y+H      V+HR
Sbjct: 129 GEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYF--LYQLLRGLKYMHSAQ---VIHR 182
Query: 123 DIKPANVLLDADLNGKLGDFGLAR-----LYDHDTIPQTTKLVGTFGYMAPELMRT-GKA 176
           D+KP+N+L++ +   K+GDFG+AR       +H      T+ V T  Y APELM +  + 
Sbjct: 183 DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF--MTEYVATRWYRAPELMLSLHEY 240
Query: 177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           + + D+++ G    E+ + R+    +  +  + L+
Sbjct: 241 TQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 275

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 64/125 (51%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +++P GSL + L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 93  LIMEFLPYGSLREYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 148
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 149 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 208
Query: 188 FMLEV 192
            + E+
Sbjct: 209 VLYEL 213

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVL---LDADLNGKLGDFGLARLYDHDTIPQ 155
           R+I  V   + YLH+     ++HRD+KP N+L   LD D    + DFGL+++ D  ++  
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T    GT GY+APE++     S + D ++ GV    +  G  P   +   ++   +
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     +    
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGF 178
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVL---LDADLNGKLGDFGLARLYDHDTIPQ 155
           R+I  V   + YLH+     ++HRD+KP N+L   LD D    + DFGL+++ D  ++  
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T    GT GY+APE++     S + D ++ GV    +  G  P   +   ++   +
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVL---LDADLNGKLGDFGLARLYDHDTIPQ 155
           R+I  V   + YLH+     ++HRD+KP N+L   LD D    + DFGL+++ D  ++  
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T    GT GY+APE++     S + D ++ GV    +  G  P   +   ++   +
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 87/177 (49%), Gaps = 11/177 (6%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED  ++ D LAS     +++L +        ++L+ ++   G++D ++    +P L+  Q
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERP-LTESQ 136
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
              + +     L YLH++    ++HRD+K  N+L   D + KL DFG++   +   I + 
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRR 192
Query: 157 TKLVGTFGYMAPELMRTGKAST-----STDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
              +GT  +MAPE++    +         DV++ G+ ++E+A    P  +   M ++
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           L  V+   ++ L N    +K   EF  VY  M   + +L +++H  +      Y  ++++
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR    + +   T  V 
Sbjct: 137 CGIK----HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++     + + D+++ G  M E+  G
Sbjct: 188 TRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--- 156
           I   +A  + +LH    + ++HRD+KP+N+    D   K+GDFGL    D D   QT   
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 157 --------TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
                   T  VGT  YM+PE +     S   D+++ G+ + E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRI-------------IRGVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 100 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 159
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 160 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 216
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 217 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 269
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 270 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 308

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRI-------------IRGVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 103 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 162
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 163 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 219
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 220 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 272
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 273 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 311

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 87/177 (49%), Gaps = 11/177 (6%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED  ++ D LAS     +++L +        ++L+ ++   G++D ++    +P L+  Q
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERP-LTESQ 136
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
              + +     L YLH++    ++HRD+K  N+L   D + KL DFG++   +   I + 
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRR 192
Query: 157 TKLVGTFGYMAPELMRTGKAST-----STDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
              +GT  +MAPE++    +         DV++ G+ ++E+A    P  +   M ++
Sbjct: 193 DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRI-------------IRGVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 98  TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 157
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 158 EYLAS---QKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 214
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 215 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 267
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 268 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 306

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVL---LDADLNGKLGDFGLARLYDHDTIPQ 155
           R+I  V   + YLH+     ++HRD+KP N+L   LD D    + DFGL+++ D  ++  
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           T    GT GY+APE++     S + D ++ GV    +  G  P   +   ++   +
Sbjct: 177 TA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRI-------------IRGVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 280
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 281 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRI-------------IRGVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 280
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 281 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 23/139 (16%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           ++  V+ G+ YL E   +  +HRD+   NVLL      K+ DFGL++    D    T + 
Sbjct: 115 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171
Query: 160 VGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP------------IEQQGS 204
            G +   + APE +   K S+ +DV+++GV M E  S G++P            IEQ   
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 231
Query: 205 MEM-----VNLVDWVSDCW 218
           ME        L   +SDCW
Sbjct: 232 MECPPECPPELYALMSDCW 250

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL   V +R+  F ++ ++M  G+L   L    +  ++      +   ++S + 
Sbjct: 314 HPN-LVQLLG-VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 371
Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HR++   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 372 YLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++            D   
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------KDYRM 477
Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            R EG  E+     V +L   C    P  RP+  ++ Q  +
Sbjct: 478 ERPEGCPEK-----VYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           L  V+   ++ L N    +K   EF  VY  M   + +L +++H  +      Y  ++++
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 134
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR    + +   T  V 
Sbjct: 135 CGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFM--MTPYVV 185
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ G  M E+  G
Sbjct: 186 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRIIR-------------GVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 280
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 281 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH 150
           SL   Q +  +R     L +LH    Q ++H D+KPAN+ L      KLGDFGL  L + 
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL--LVEL 207
Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA 193
            T        G   YMAPEL++ G   T+ DV++ G+ +LEVA
Sbjct: 208 GTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVA 249

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 60/106 (56%), Gaps = 9/106 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVL-LDADLNGKL--GDFGLARLYDHDTIPQT 156
           +I+ V S + YLHE+    ++HRD+KP N+L L  + N K+   DFGL+++ + + I  T
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMST 166
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQ 202
               GT GY+APE++     S + D ++ GV    +  G  P  ++
Sbjct: 167 A--CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     +    
Sbjct: 153 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMXGY 205
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 40/80 (50%)
Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           HRD+KP N+L+ AD    L DFG+A     + + Q    VGT  Y APE      A+   
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 181 DVYAFGVFMLEVASGRRPIE 200
           D+YA    + E  +G  P +
Sbjct: 217 DIYALTCVLYECLTGSPPYQ 236

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTNIKPS 91
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N    
Sbjct: 410 DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNR--H 465
Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 151
           +       ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++    D
Sbjct: 466 VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522
Query: 152 TIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMV 208
                 +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E+ 
Sbjct: 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582
Query: 209 NLVD 212
            +++
Sbjct: 583 AMLE 586

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRIIR-------------GVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT       +MA
Sbjct: 217 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 326
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 327 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 365

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G +   N  N    +  LV DY  +GSL   L+   + +++     ++    ASG
Sbjct: 62  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASG 118
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--- 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA    HD+   T  +   
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 176
Query: 160 --VGTFGYMAPEL------MRTGKASTSTDVYAFGVFMLEVA 193
             VGT  YMAPE+      M+  ++    D+YA G+   E+A
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G +   N  N    +  LV DY  +GSL   L+   + +++     ++    ASG
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASG 112
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--- 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA    HD+   T  +   
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 170
Query: 160 --VGTFGYMAPEL------MRTGKASTSTDVYAFGVFMLEVA 193
             VGT  YMAPE+      M+  ++    D+YA G+   E+A
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 35/189 (18%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           F LV++ +  GS+  + H   +   +  +  R++R VA+ L +LH    + + HRD+KP 
Sbjct: 86  FYLVFEKLQGGSI--LAHIQKQKHFNEREASRVVRDVAAALDFLHT---KGIAHRDLKPE 140
Query: 128 NVLLDADLN---GKLGDFGLARLYDHD------TIPQTTKLVGTFGYMAPELMR--TGKA 176
           N+L ++       K+ DF L      +      T P+ T   G+  YMAPE++   T +A
Sbjct: 141 NILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQA 200
Query: 177 S---TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-WKKGAILDASDSRL- 231
           +      D+++ GV +  + SG  P                +DC W +G +     ++L 
Sbjct: 201 TFYDKRCDLWSLGVVLYIMLSGYPPFVGHCG----------ADCGWDRGEVCRVCQNKLF 250
Query: 232 ----EGIYE 236
               EG YE
Sbjct: 251 ESIQEGKYE 259

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G +   N  N    +  LV DY  +GSL   L+   + +++     ++    ASG
Sbjct: 57  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASG 113
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--- 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA    HD+   T  +   
Sbjct: 114 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 171
Query: 160 --VGTFGYMAPEL------MRTGKASTSTDVYAFGVFMLEVA 193
             VGT  YMAPE+      M+  ++    D+YA G+   E+A
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 38  DPQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMPNGSLDKILHTNIKPS 91
           DP L+ + LA   +N + QL N    R         ++LV +    G L+K L  N    
Sbjct: 411 DPALKDELLAE--ANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNR--H 466
Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 151
           +       ++  V+ G+ YL E      +HRD+   NVLL      K+ DFGL++    D
Sbjct: 467 VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 523
Query: 152 TIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMV 208
                 +  G +   + APE +   K S+ +DV++FGV M E  S G++P       E+ 
Sbjct: 524 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583
Query: 209 NLVD 212
            +++
Sbjct: 584 AMLE 587

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGLAR  D     +    
Sbjct: 150 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMXGX 202
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + +  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 93  LIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 148
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 149 LVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 208
Query: 188 FMLEV 192
            + E+
Sbjct: 209 VLYEL 213

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL Y+H      ++HRD+KP+NV ++ D   ++ DFGLAR  D +     T  V T  Y 
Sbjct: 135 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----MTGYVATRWYR 187
Query: 167 APELMRTGKASTST-DVYAFGVFMLEVASGR 196
           APE+M        T D+++ G  M E+  G+
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G +   N  N    +  LV DY  +GSL   L+   + +++     ++    ASG
Sbjct: 59  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASG 115
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--- 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA    HD+   T  +   
Sbjct: 116 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 173
Query: 160 --VGTFGYMAPEL------MRTGKASTSTDVYAFGVFMLEVA 193
             VGT  YMAPE+      M+  ++    D+YA G+   E+A
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DFGL R  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G +   N  N    +  LV DY  +GSL   L+   + +++     ++    ASG
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASG 151
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--- 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA    HD+   T  +   
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 209
Query: 160 --VGTFGYMAPEL------MRTGKASTSTDVYAFGVFMLEVA 193
             VGT  YMAPE+      M+  ++    D+YA G+   E+A
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRI-------------IRGVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D    TT       +MA
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMA 227
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 280
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 281 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G +   N  N    +  LV DY  +GSL   L+   + +++     ++    ASG
Sbjct: 82  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASG 138
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--- 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA    HD+   T  +   
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 196
Query: 160 --VGTFGYMAPEL------MRTGKASTSTDVYAFGVFMLEVA 193
             VGT  YMAPE+      M+  ++    D+YA G+   E+A
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           G+  ++ ++ P G++D I+   +   L+  Q   + R +   L +LH    + ++HRD+K
Sbjct: 81  GKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLK 136
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL-----MRTGKASTST 180
             NVL+  + + +L DFG++   +  T+ +    +GT  +MAPE+     M+        
Sbjct: 137 AGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 195
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMV 208
           D+++ G+ ++E+A    P  +   M ++
Sbjct: 196 DIWSLGITLIEMAQIEPPHHELNPMRVL 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           G+  ++ ++ P G++D I+   +   L+  Q   + R +   L +LH    + ++HRD+K
Sbjct: 89  GKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLK 144
Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL-----MRTGKASTST 180
             NVL+  + + +L DFG++   +  T+ +    +GT  +MAPE+     M+        
Sbjct: 145 AGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMV 208
           D+++ G+ ++E+A    P  +   M ++
Sbjct: 204 DIWSLGITLIEMAQIEPPHHELNPMRVL 231

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 11/101 (10%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQTTKLVGT 162
           +   L YL E  +  V+HRD+KP+N+LLD     KL DFG++ RL D     ++    G 
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGC 187
Query: 163 FGYMAPELMRTGKAST-----STDVYAFGVFMLEVASGRRP 198
             YMAPE +     +        DV++ G+ ++E+A+G+ P
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 50  HSN--GLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           H N  GLL +    +S +   +F LV  +M    L KI+          Y  +++++G  
Sbjct: 100 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGMEFSEEKIQYLVYQMLKG-- 156
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             L Y+H      V+HRD+KP N+ ++ D   K+ DFGLAR  D     + T  V T  Y
Sbjct: 157 --LKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWY 207
Query: 166 MAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
            APE++ +      T D+++ G  M E+ +G+
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-----G 174
           +HRDIKP N+L+D + + +L DFG       D   Q++  VGT  Y++PE+++      G
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
           +     D ++ GV M E+  G  P   +  +E
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   N+
Sbjct: 90  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNI 145
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 146 LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205
Query: 188 FMLEV-----ASGRRPIE--------QQGSMEMVNLVDWVSD 216
            + E+      S   P E        +QG M + +L++ + +
Sbjct: 206 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 67/133 (50%), Gaps = 15/133 (11%)
Query: 65  KGEFLLVYDYMPNGSLDKILHTN---IKPS-LSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           K    LV+D+M    L+ I+  N   + PS +  Y    +      GL YLH+ W   +L
Sbjct: 84  KSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL-----QGLEYLHQHW---IL 134
Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STS 179
           HRD+KP N+LLD +   KL DFGLA+ +         ++V T  Y APEL+   +     
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGARMYGVG 193
Query: 180 TDVYAFGVFMLEV 192
            D++A G  + E+
Sbjct: 194 VDMWAVGCILAEL 206

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 50  HSN--GLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           H N  GLL +    +S +   +F LV  +M    L KI+          Y  +++++G  
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQMLKG-- 138
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             L Y+H      V+HRD+KP N+ ++ D   K+ DFGLAR  D     + T  V T  Y
Sbjct: 139 --LKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWY 189
Query: 166 MAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
            APE++ +      T D+++ G  M E+ +G+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           +A G+ YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT     
Sbjct: 166 LARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEG 275
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +D   +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 276 HRMDKPANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 84/158 (53%), Gaps = 14/158 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT---NIKPSLSWYQRFRIIR 102
           L  +    +++L + ++S K +  LV+++  +  L K   +   ++ P +     F++++
Sbjct: 55  LKELKHKNIVRLHDVLHSDK-KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 162
           G+     + H    + VLHRD+KP N+L++ +   KL DFGLAR +       + ++V T
Sbjct: 113 GLG----FCHS---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-T 164
Query: 163 FGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPI 199
             Y  P+++   K  STS D+++ G    E+A+  RP+
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW-YQRFRI-------------IRGVASGL 108
           ++ G   ++ +Y   G+L + L     P + + Y   R+                +A G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            YL     Q  +HRD+   NVL+  +   ++ DFGLAR + + D   +TT       +MA
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMA 227
Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G  +D 
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEGHRMDK 280
Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 281 PANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+  FGLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           +A G+ YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT     
Sbjct: 166 LARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEG 275
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +D   +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 276 HRMDKPANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           +A G+ YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT     
Sbjct: 166 LARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEG 275
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL 274
             +D   +    +Y      ++++    C H  P  RP  +Q+++ LD   TL
Sbjct: 276 HRMDKPANCTNELY------MMMR---DCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           I   +A  + +LH    + ++HRD+KP+N+    D   K+GDFGL    D D   QT   
Sbjct: 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 160 -----------VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
                      VGT  YM+PE +     S   D+++ G+ + E+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 67  EFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           ++ +V + M  G L DK++ +  +K +      ++++  V     YLHE+    ++HRD+
Sbjct: 87  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----YLHENG---IIHRDL 139
Query: 125 KPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKA--ST 178
           KP NVLL   + D   K+ DFG +++    ++ +T  L GT  Y+APE L+  G A  + 
Sbjct: 140 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNR 197
Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           + D ++ GV +    SG  P  +  +   V+L D ++
Sbjct: 198 AVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 67  EFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           ++ +V + M  G L DK++ +  +K +      ++++  V     YLHE+    ++HRD+
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----YLHENG---IIHRDL 140
Query: 125 KPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKA--ST 178
           KP NVLL   + D   K+ DFG +++    ++ +T  L GT  Y+APE L+  G A  + 
Sbjct: 141 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNR 198
Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           + D ++ GV +    SG  P  +  +   V+L D ++
Sbjct: 199 AVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 233

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ DF LAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           H N +++L +++ S +G   L++D +  G L + I+    +   S       I+ +   +
Sbjct: 80  HPN-IVRLHDSI-SEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAV 134
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           L+ H+     V+HRD+KP N+LL + L G   KL DFGLA   + +         GT GY
Sbjct: 135 LHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGY 190
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           ++PE++R        D++A GV +  +  G  P
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 169
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 116 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 171
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 169
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 169
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 67  EFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           ++ +V + M  G L DK++ +  +K +      ++++  V     YLHE+    ++HRD+
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----YLHENG---IIHRDL 140
Query: 125 KPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKA--ST 178
           KP NVLL   + D   K+ DFG +++    ++ +T  L GT  Y+APE L+  G A  + 
Sbjct: 141 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNR 198
Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           + D ++ GV +    SG  P  +  +   V+L D ++
Sbjct: 199 AVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 233

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 67  EFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           ++ +V + M  G L DK++ +  +K +      ++++  V     YLHE+    ++HRD+
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----YLHENG---IIHRDL 140
Query: 125 KPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKA--ST 178
           KP NVLL   + D   K+ DFG +++    ++ +T  L GT  Y+APE L+  G A  + 
Sbjct: 141 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNR 198
Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           + D ++ GV +    SG  P  +  +   V+L D ++
Sbjct: 199 AVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 233

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 169
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +YMP G +   L    + S   + RF   + V +   YLH      +++RD+KP N+
Sbjct: 118 MVMEYMPGGDMFSHLRRIGRFSEP-HARFYAAQIVLT-FEYLHS---LDLIYRDLKPENL 172
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+D     K+ DFG A+        +T  L GT  Y+APE++ +   + + D +A GV +
Sbjct: 173 LIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 190 LEVASGRRPI 199
            E+A+G  P 
Sbjct: 229 YEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +YMP G +   L    + S   + RF   + V +   YLH      +++RD+KP N+
Sbjct: 118 MVMEYMPGGDMFSHLRRIGRFSEP-HARFYAAQIVLT-FEYLHS---LDLIYRDLKPENL 172
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+D     K+ DFG A+        +T  L GT  Y+APE++ +   + + D +A GV +
Sbjct: 173 LIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 190 LEVASGRRPI 199
            E+A+G  P 
Sbjct: 229 YEMAAGYPPF 238

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 122 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 177
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 62/127 (48%), Gaps = 8/127 (6%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+P GSL   L    +  +   Q     + +  G+ YLH    Q  +HR +   NV
Sbjct: 90  LVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNV 143
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           LLD D   K+GDFGLA+     H+             + APE ++  K   ++DV++FGV
Sbjct: 144 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGV 203
Query: 188 FMLEVAS 194
            + E+ +
Sbjct: 204 TLYELLT 210

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL Y+H      ++HRD+KP+NV ++ D   ++ DFGLAR  D +     T  V T  Y 
Sbjct: 143 GLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWYR 195
Query: 167 APELMRTGKASTST-DVYAFGVFMLEVASGR 196
           APE+M        T D+++ G  M E+  G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 19/160 (11%)
Query: 50  HSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N L  + + + SR    +  L+  Y   GSL   L      ++S     RI+  +ASG
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASG 146
Query: 108 LLYLH-----EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKL 159
           L +LH        +  + HRD+K  N+L+  +    + D GLA ++   T          
Sbjct: 147 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 206
Query: 160 VGTFGYMAPELMRTG------KASTSTDVYAFGVFMLEVA 193
           VGT  YMAPE++          +    D++AFG+ + EVA
Sbjct: 207 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 67  EFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           ++ +V + M  G L DK++ +  +K +      ++++  V     YLHE+    ++HRD+
Sbjct: 94  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----YLHENG---IIHRDL 146
Query: 125 KPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKA--ST 178
           KP NVLL   + D   K+ DFG +++    ++ +T  L GT  Y+APE L+  G A  + 
Sbjct: 147 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNR 204
Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           + D ++ GV +    SG  P  +  +   V+L D ++
Sbjct: 205 AVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 239

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 83/156 (53%), Gaps = 15/156 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH----TNIKPSLSWYQRFRII 101
           L  ++   +++L + +++ + +  LV++++ +  L K +     T I   L     F+++
Sbjct: 60  LKELNHPNIVKLLDVIHT-ENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
           +G+A    + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V 
Sbjct: 118 QGLA----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 169
Query: 162 TFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           T  Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 83/156 (53%), Gaps = 15/156 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH----TNIKPSLSWYQRFRII 101
           L  ++   +++L + +++ + +  LV++++ +  L K +     T I   L     F+++
Sbjct: 63  LKELNHPNIVKLLDVIHT-ENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
           +G+A    + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V 
Sbjct: 121 QGLA----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 172
Query: 162 TFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           T  Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 173 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 27  VNQFIYHGFNEDPQLQRDG--LASVHSNGLLQLTN-TVNSRKGEFLLVYDYMPNGSLDKI 83
           V Q  + G ++    QR+   L ++HS+ +++    +    +    LV +Y+P+G L   
Sbjct: 45  VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 104
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           L  + +  L   +       +  G+ YL     +  +HRD+   N+L++++ + K+ DFG
Sbjct: 105 LQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFG 160
Query: 144 LARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
           LA+L   D      +  G     + APE +     S  +DV++FGV + E+
Sbjct: 161 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 27  VNQFIYHGFNEDPQLQRDG--LASVHSNGLLQLTN-TVNSRKGEFLLVYDYMPNGSLDKI 83
           V Q  + G ++    QR+   L ++HS+ +++    +    +    LV +Y+P+G L   
Sbjct: 44  VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 103
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           L  + +  L   +       +  G+ YL     +  +HRD+   N+L++++ + K+ DFG
Sbjct: 104 LQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFG 159
Query: 144 LARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
           LA+L   D      +  G     + APE +     S  +DV++FGV + E+
Sbjct: 160 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL Y+H      ++HRD+KP+NV ++ D   ++ DFGLAR  D +     T  V T  Y 
Sbjct: 143 GLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWYR 195
Query: 167 APELMRTGKASTST-DVYAFGVFMLEVASGR 196
           APE+M        T D+++ G  M E+  G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 27  VNQFIYHGFNEDPQLQRDG--LASVHSNGLLQLTN-TVNSRKGEFLLVYDYMPNGSLDKI 83
           V Q  + G ++    QR+   L ++HS+ +++    +    +    LV +Y+P+G L   
Sbjct: 57  VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 116
Query: 84  LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
           L  + +  L   +       +  G+ YL     +  +HRD+   N+L++++ + K+ DFG
Sbjct: 117 LQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFG 172
Query: 144 LARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGVFMLEV 192
           LA+L   D      +  G     + APE +     S  +DV++FGV + E+
Sbjct: 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 62/127 (48%), Gaps = 8/127 (6%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+P GSL   L    +  +   Q     + +  G+ YLH    Q  +HR +   NV
Sbjct: 89  LVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNV 142
Query: 130 LLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           LLD D   K+GDFGLA+     H+             + APE ++  K   ++DV++FGV
Sbjct: 143 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGV 202
Query: 188 FMLEVAS 194
            + E+ +
Sbjct: 203 TLYELLT 209

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 50  HSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N L  + + + SR    +  L+  Y   GSL   L      ++S     RI+  +ASG
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASG 117
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKL 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA ++   T          
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 160 VGTFGYMAPELMRTG------KASTSTDVYAFGVFMLEVA 193
           VGT  YMAPE++          +    D++AFG+ + EVA
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ D GLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 13/129 (10%)
Query: 67  EFLLVYDYMPNGSLDK------ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           E  ++Y+YM N S+ K      +L  N    +       II+ V +   Y+H   E+ + 
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNIC 174
Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM--RTGKAST 178
           HRD+KP+N+L+D +   KL DFG +       I  +    GT+ +M PE     +     
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR---GTYEFMPPEFFSNESSYNGA 231
Query: 179 STDVYAFGV 187
             D+++ G+
Sbjct: 232 KVDIWSLGI 240

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 50  HSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N L  + + + SR    +  L+  Y   GSL   L      ++S     RI+  +ASG
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASG 117
Query: 108 LLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKL 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA ++   T          
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 160 VGTFGYMAPELMRTG------KASTSTDVYAFGVFMLEVA 193
           VGT  YMAPE++          +    D++AFG+ + EVA
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ D GLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HR++   N+
Sbjct: 91  LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNI 146
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT--FGYMAPELMRTGKASTSTDVYAFGV 187
           L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++FGV
Sbjct: 147 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 206
Query: 188 FMLEV-----ASGRRPIE--------QQGSMEMVNLVDWVSD 216
            + E+      S   P E        +QG M + +L++ + +
Sbjct: 207 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 248

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 7/102 (6%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTT 157
           +R +   L Y H++    ++HRD+KP NVLL +  N    KLGDFG+A       +    
Sbjct: 136 MRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
           + VGT  +MAPE+++        DV+  GV +  + SG  P 
Sbjct: 193 R-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +       T ++V T  Y 
Sbjct: 115 GLSFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 167 APELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 23/139 (16%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           ++  V+ G+ YL E   +  +HR++   NVLL      K+ DFGL++    D    T + 
Sbjct: 441 LLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 160 VGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRP------------IEQQGS 204
            G +   + APE +   K S+ +DV+++GV M E  S G++P            IEQ   
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 557
Query: 205 MEM-----VNLVDWVSDCW 218
           ME        L   +SDCW
Sbjct: 558 MECPPECPPELYALMSDCW 576

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           +I  +  GL Y+H      ++HRD+KP+N+ ++ D   K+ D GLAR  D     + T  
Sbjct: 130 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD----EMTGY 182
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE+M        T D+++ G  M E+ +GR
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLH 121
           R+G+  +  + M + SLDK     I    +  +    +I   +   L +LH      V+H
Sbjct: 77  REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIH 133
Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL----MRTGKAS 177
           RD+KP+NVL++A    K+ DFG++     D         G   YMAPE     +     S
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPERINPELNQKGYS 191
Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGS 204
             +D+++ G+ M+E+A  R P +  G+
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGT 218

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 25/161 (15%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLL-------VYDYMPNGSLDKILHTNIKPSLSWYQRF 98
           L  ++   +++L + +++    +L+       + D+M   +L  I    IK  L     F
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL-----F 112
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 158
           ++++G+A    + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T 
Sbjct: 113 QLLQGLA----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTY 162
Query: 159 L--VGTFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
              V T  Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 163 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 35/207 (16%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E +++Y++M  G L +K+   + K  +S  +    +R V  GL ++HE+     +H D+K
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLK 282
Query: 126 PANVLLDADLNG--KLGDFGL-ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           P N++     +   KL DFGL A L    ++  TT   GT  + APE+         TD+
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDM 339
Query: 183 YAFGVFMLEVASGRRPIEQQGSMEM---VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ 239
           ++ GV    + SG  P   +   E    V   DW  D           DS   GI E+ +
Sbjct: 340 WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-----------DSAFSGISEDGK 388
Query: 240 MELVLKLGLFCSHPKPEARPNMRQVMQ 266
            + + KL L        A PN R  + 
Sbjct: 389 -DFIRKLLL--------ADPNTRMTIH 406

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 25/161 (15%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLL-------VYDYMPNGSLDKILHTNIKPSLSWYQRF 98
           L  ++   +++L + +++    +L+       + D+M   +L  I    IK  L     F
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL-----F 113
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 158
           ++++G+A    + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T 
Sbjct: 114 QLLQGLA----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTY 163
Query: 159 L--VGTFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
              V T  Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 164 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 168
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 25/161 (15%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLL-------VYDYMPNGSLDKILHTNIKPSLSWYQRF 98
           L  ++   +++L + +++    +L+       + D+M   +L  I    IK  L     F
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYL-----F 110
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 158
           ++++G+A    + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T 
Sbjct: 111 QLLQGLA----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTY 160
Query: 159 L--VGTFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
              V T  Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 161 XHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 93/178 (52%), Gaps = 21/178 (11%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRG 103
           L  ++   ++++ N  ++   ++ +V + M  G L DK++ +  +K +      ++++  
Sbjct: 208 LKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 265
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLV 160
           V     YLHE+    ++HRD+KP NVLL   + D   K+ DFG +++    ++ +T  L 
Sbjct: 266 VQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LC 316
Query: 161 GTFGYMAPE-LMRTGKA--STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           GT  Y+APE L+  G A  + + D ++ GV +    SG  P  +  +   V+L D ++
Sbjct: 317 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 372

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 169
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 168
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 93/178 (52%), Gaps = 21/178 (11%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRG 103
           L  ++   ++++ N  ++   ++ +V + M  G L DK++ +  +K +      ++++  
Sbjct: 194 LKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLV 160
           V     YLHE+    ++HRD+KP NVLL   + D   K+ DFG +++    ++ +T  L 
Sbjct: 252 VQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LC 302
Query: 161 GTFGYMAPE-LMRTGKA--STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           GT  Y+APE L+  G A  + + D ++ GV +    SG  P  +  +   V+L D ++
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT 358

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 171
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 168
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 168
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 169
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 167
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTF 163
            GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T 
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTL 166
Query: 164 GYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
            Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 171
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 117 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 170
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 169
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 117 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 170
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 117 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 170
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 169
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 119 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 172
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 171
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 171
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 35/207 (16%)
Query: 67  EFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           E +++Y++M  G L +K+   + K  +S  +    +R V  GL ++HE+     +H D+K
Sbjct: 122 EMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLK 176
Query: 126 PANVLLDADLNG--KLGDFGL-ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           P N++     +   KL DFGL A L    ++  TT   GT  + APE+         TD+
Sbjct: 177 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDM 233
Query: 183 YAFGVFMLEVASGRRPIEQQGSMEM---VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ 239
           ++ GV    + SG  P   +   E    V   DW  D           DS   GI E+ +
Sbjct: 234 WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-----------DSAFSGISEDGK 282
Query: 240 MELVLKLGLFCSHPKPEARPNMRQVMQ 266
            + + KL L        A PN R  + 
Sbjct: 283 -DFIRKLLL--------ADPNTRMTIH 300

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL--VGTFG 164
           GL + H      VLHRD+KP N+L++ +   KL DFGLAR +    +P  T    V T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLW 171
Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGR 196
           Y APE++   K  ST+ D+++ G    E+ + R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 48/81 (59%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     K+ DFGLA+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 70  LVYDYMPNGSLDKIL-----HTNI---------KPSLSWYQRFRIIRGVASGLLYLHEDW 115
           +++ Y  +G L + L     H+++         K +L       ++  +A+G+ YL    
Sbjct: 89  MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-- 146
Query: 116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTG 174
              V+H+D+   NVL+   LN K+ D GL R +Y  D        +    +MAPE +  G
Sbjct: 147 -HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG 205
Query: 175 KASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV 211
           K S  +D++++GV + EV S G +P     + ++V ++
Sbjct: 206 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           H N +++L +++ S +G   L++D +  G L + I+    +   S       I+ +   +
Sbjct: 69  HPN-IVRLHDSI-SEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAV 123
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           L+ H+     V+HR++KP N+LL + L G   KL DFGLA   + +         GT GY
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGY 179
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           ++PE++R        D++A GV +  +  G  P
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 70  LVYDYMPNGSLDKIL-----HTNI---------KPSLSWYQRFRIIRGVASGLLYLHEDW 115
           +++ Y  +G L + L     H+++         K +L       ++  +A+G+ YL    
Sbjct: 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-- 163
Query: 116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTG 174
              V+H+D+   NVL+   LN K+ D GL R +Y  D        +    +MAPE +  G
Sbjct: 164 -HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG 222
Query: 175 KASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV 211
           K S  +D++++GV + EV S G +P     + ++V ++
Sbjct: 223 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V++ +  G + ++    +KP LS  Q     + +  G+ YLH    Q ++HRDIKP+N+
Sbjct: 115 MVFELVNQGPVMEV--PTLKP-LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNL 168
Query: 130 LLDADLNGKLGDFGLARLYD-HDTIPQTTKLVGTFGYMAPE-LMRTGK--ASTSTDVYAF 185
           L+  D + K+ DFG++  +   D +   T  VGT  +MAPE L  T K  +  + DV+A 
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAM 226
Query: 186 GVFMLEVASGRRP 198
           GV +     G+ P
Sbjct: 227 GVTLYCFVFGQCP 239

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV   MP+G L + +H + K ++           +A G++YL E   + ++HRD+   NV
Sbjct: 93  LVTQLMPHGCLLEYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNV 148
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTT---KLVGTFGYMAPELMRTGKASTSTDVYAFG 186
           L+ +  + K+ DFGLARL + D         K+     +MA E +   K +  +DV+++G
Sbjct: 149 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYRKFTHQSDVWSYG 206
Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVD 212
           V + E+ + G +P +   + E+ +L++
Sbjct: 207 VTIWELMTFGGKPYDGIPTREIPDLLE 233

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 84/158 (53%), Gaps = 14/158 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT---NIKPSLSWYQRFRIIR 102
           L  +    +++L + ++S K +  LV+++  +  L K   +   ++ P +     F++++
Sbjct: 55  LKELKHKNIVRLHDVLHSDK-KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT 162
           G+     + H    + VLHRD+KP N+L++ +   KL +FGLAR +       + ++V T
Sbjct: 113 GLG----FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-T 164
Query: 163 FGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPI 199
             Y  P+++   K  STS D+++ G    E+A+  RP+
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 47/271 (17%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL------DKILHTN--------IKPSLSWY 95
           H   ++ L      R G   L  +Y P+G+L       ++L T+           +LS  
Sbjct: 74  HHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 96  QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 155
           Q       VA G+ YL +   +  +HRD+   N+L+  +   K+ DFGL+R        Q
Sbjct: 133 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQ 182
Query: 156 TTKLVGTFG-----YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
              +  T G     +MA E +     +T++DV+++GV + E+ S G  P      M    
Sbjct: 183 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---CGMTCAE 239
Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           L + +   ++    L+  D              V  L   C   KP  RP+  Q++  L+
Sbjct: 240 LYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLN 286
Query: 270 GNATLPDIPRDSTLIAPFSASNDAFSGNSSA 300
                     ++TL   F+ +    S   +A
Sbjct: 287 RMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 317

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 47/271 (17%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL------DKILHTN--------IKPSLSWY 95
           H   ++ L      R G   L  +Y P+G+L       ++L T+           +LS  
Sbjct: 84  HHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 96  QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 155
           Q       VA G+ YL +   +  +HRD+   N+L+  +   K+ DFGL+R        Q
Sbjct: 143 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQ 192
Query: 156 TTKLVGTFG-----YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
              +  T G     +MA E +     +T++DV+++GV + E+ S G  P      M    
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---CGMTCAE 249
Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           L + +   ++    L+  D              V  L   C   KP  RP+  Q++  L+
Sbjct: 250 LYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLN 296
Query: 270 GNATLPDIPRDSTLIAPFSASNDAFSGNSSA 300
                     ++TL   F+ +    S   +A
Sbjct: 297 RMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 327

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV   MP+G L + +H + K ++           +A G++YL E   + ++HRD+   NV
Sbjct: 116 LVTQLMPHGCLLEYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNV 171
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTT---KLVGTFGYMAPELMRTGKASTSTDVYAFG 186
           L+ +  + K+ DFGLARL + D         K+     +MA E +   K +  +DV+++G
Sbjct: 172 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYRKFTHQSDVWSYG 229
Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVD 212
           V + E+ + G +P +   + E+ +L++
Sbjct: 230 VTIWELMTFGGKPYDGIPTREIPDLLE 256

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 VGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ GV M E+  G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 VGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ GV M E+  G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     K+ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTTKL 159
           VA G+ YL     +  +HRD+   N+LL      K+GDFGL R      DH  + +  K+
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCW 218
              F + APE ++T   S ++D + FGV + E+ + G+ P       ++++ +D      
Sbjct: 177 --PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 228
Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           K+G  L   +   + IY          + + C   KPE RP    +  +L
Sbjct: 229 KEGERLPRPEDCPQDIY---------NVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     ++ DFGLA+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQT 156
           +IR V   + YLH      ++HRD+KP N+L    D +    + DFGL+++     +  T
Sbjct: 125 LIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST 181
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
               GT GY+APE++     S + D ++ GV    +  G  P
Sbjct: 182 A--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V +  P GSL D++        L    R+ +   VA G+ YL     +  +HRD+   N
Sbjct: 97  MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---KRFIHRDLAARN 151
Query: 129 VLLDADLNGKLGDFGLARLY----DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           +LL      K+GDFGL R      DH  + +  K+   F + APE ++T   S ++D + 
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV--PFAWCAPESLKTRTFSHASDTWM 209
Query: 185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
           FGV + E+ + G+ P       ++++ +D      K+G  L   +   + IY        
Sbjct: 210 FGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERLPRPEDCPQDIY-------- 255
Query: 244 LKLGLFCSHPKPEARPNMRQVMQYL 268
             + + C   KPE RP    +  +L
Sbjct: 256 -NVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTTKL 159
           VA G+ YL     +  +HRD+   N+LL      K+GDFGL R      DH  + +  K+
Sbjct: 124 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCW 218
              F + APE ++T   S ++D + FGV + E+ + G+ P       ++++ +D      
Sbjct: 181 --PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 232
Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           K+G  L   +   + IY          + + C   KPE RP    +  +L
Sbjct: 233 KEGERLPRPEDCPQDIY---------NVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H   +L +   ++  K   L++ + M  G L   +      + +  +   I+R + + + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 110 YLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           +LH      + HRD+KP N+L    + D   KL DFG A+    + + QT     T  Y+
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTP--CYTPYYV 196
Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
           APE++   K   S D+++ GV M  +  G  P 
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 CGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ G  M E+  G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 47/80 (58%), Gaps = 1/80 (1%)
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +HRDI   N+L+ +    KLGDFGL+R  + +   + +       +M+PE +   + +T+
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 190
Query: 180 TDVYAFGVFMLEVAS-GRRP 198
           +DV+ F V M E+ S G++P
Sbjct: 191 SDVWMFAVCMWEILSFGKQP 210

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H   +L +   ++  K   L++ + M  G L   +      + +  +   I+R + + + 
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 110 YLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYM 166
           +LH      + HRD+KP N+L    + D   KL DFG A+    + + QT     T  Y+
Sbjct: 124 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTP--CYTPYYV 177
Query: 167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
           APE++   K   S D+++ GV M  +  G  P 
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 211 AVDWWALGVLIYEMAAGYPPF 231

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 211 AVDWWALGVLIYEMAAGYPPF 231

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 35/189 (18%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           F LV++ M  GS+  + H + +   +  +   +++ VAS L +LH    + + HRD+KP 
Sbjct: 86  FYLVFEKMRGGSI--LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPE 140
Query: 128 NVLLDADLN---GKLGDFGLARLYDHD------TIPQTTKLVGTFGYMAPELMRTGKAST 178
           N+L +        K+ DFGL      +      + P+     G+  YMAPE++       
Sbjct: 141 NILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 179 S-----TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-WKKGAILDASDSRL- 231
           S      D+++ GV +  + SG  P   +            SDC W +G    A  + L 
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCG----------SDCGWDRGEACPACQNMLF 250
Query: 232 ----EGIYE 236
               EG YE
Sbjct: 251 ESIQEGKYE 259

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 204
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 205 AVDWWALGVLIYEMAAGYPPF 225

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 64/145 (44%), Gaps = 17/145 (11%)
Query: 59  NTVNSRKGEFLLVYDYMPNGSLDKILH----TNIKPSLSWYQRFRIIRGVASGLLYLHED 114
           +TV  +K   +LV +   +G+L   L       IK   SW       R +  GL +LH  
Sbjct: 96  STVKGKKC-IVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQFLHTR 148
Query: 115 WEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
              ++ HRD+K  N+ +       K+GD GLA L           ++GT  + APE    
Sbjct: 149 TPPII-HRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXYEE 204
Query: 174 GKASTSTDVYAFGVFMLEVASGRRP 198
            K   S DVYAFG   LE A+   P
Sbjct: 205 -KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 9/103 (8%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-DADLNG--KLGDFGLARLYDHDTIPQ 155
            +++ + + L Y H    Q V+H+D+KP N+L  D   +   K+ DFGLA L+  D    
Sbjct: 128 ELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--H 182
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           +T   GT  YMAPE+ +    +   D+++ GV M  + +G  P
Sbjct: 183 STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 47/80 (58%), Gaps = 1/80 (1%)
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +HRDI   N+L+ +    KLGDFGL+R  + +   + +       +M+PE +   + +T+
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 206
Query: 180 TDVYAFGVFMLEVAS-GRRP 198
           +DV+ F V M E+ S G++P
Sbjct: 207 SDVWMFAVCMWEILSFGKQP 226

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEIILSKGYNK 203
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 204 AVDWWALGVLIYEMAAGYPPF 224

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
            Y APE++       + D+++ G  M E+  G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLAGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 212
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 213 AVDWWALGVLIYEMAAGYPPF 233

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 47/80 (58%), Gaps = 1/80 (1%)
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +HRDI   N+L+ +    KLGDFGL+R  + +   + +       +M+PE +   + +T+
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 180 TDVYAFGVFMLEVAS-GRRP 198
           +DV+ F V M E+ S G++P
Sbjct: 195 SDVWMFAVCMWEILSFGKQP 214

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME--LMDANLCQVIQMELDHERMSYLLYQ 135
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 136 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 190
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
            Y APE++       + D+++ G  M E+  G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 24/146 (16%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           +L+ ++ P GSL  +L    +PS    L   +   ++R V  G+ +L E+    ++HR+I
Sbjct: 85  VLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNI 138
Query: 125 KPANVLLDADLNG----KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG------ 174
           KP N++     +G    KL DFG AR  + D   Q   L GT  Y+ P++          
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 175 --KASTSTDVYAFGVFMLEVASGRRP 198
             K   + D+++ GV     A+G  P
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTTKL 159
           VA G+ YL     +  +HRD+   N+LL      K+GDFGL R      DH  + +  K+
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCW 218
              F + APE ++T   S ++D + FGV + E+ + G+ P       ++++ +D      
Sbjct: 177 --PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 228
Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           K+G  L   +   + IY          + + C   KPE RP    +  +L
Sbjct: 229 KEGERLPRPEDCPQDIY---------NVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           ++ G+ YL E     ++HRD+   N+L+      K+ DFGL+R +Y+ D+  + ++    
Sbjct: 159 ISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIP 215
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MA E +     +T +DV++FGV + E+ + G  P        + NL+       K G
Sbjct: 216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-------KTG 268
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP 259
             ++  D+  E +Y         +L L C   +P+ RP
Sbjct: 269 HRMERPDNCSEEMY---------RLMLQCWKQEPDKRP 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEIILSKGYNK 218
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           ++ G+ YL E     ++HRD+   N+L+      K+ DFGL+R +Y+ D+  + ++    
Sbjct: 159 ISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP 215
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MA E +     +T +DV++FGV + E+ + G  P        + NL+       K G
Sbjct: 216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-------KTG 268
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP 259
             ++  D+  E +Y         +L L C   +P+ RP
Sbjct: 269 HRMERPDNCSEEMY---------RLMLQCWKQEPDKRP 297

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           ++ G+ YL E     ++HRD+   N+L+      K+ DFGL+R +Y+ D+  + ++    
Sbjct: 159 ISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIP 215
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MA E +     +T +DV++FGV + E+ + G  P        + NL+       K G
Sbjct: 216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-------KTG 268
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP 259
             ++  D+  E +Y         +L L C   +P+ RP
Sbjct: 269 HRMERPDNCSEEMY---------RLMLQCWKQEPDKRP 297

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTTKL 159
           VA G+ YL     +  +HRD+   N+LL      K+GDFGL R      DH  + +  K+
Sbjct: 124 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCW 218
              F + APE ++T   S ++D + FGV + E+ + G+ P       ++++ +D      
Sbjct: 181 --PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 232
Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           K+G  L   +   + IY          + + C   KPE RP    +  +L
Sbjct: 233 KEGERLPRPEDCPQDIY---------NVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 24/147 (16%)
Query: 69  LLVYDYMPNGSLDKILHTNIKPS----LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           +L+ ++ P GSL  +L    +PS    L   +   ++R V  G+ +L E+    ++HR+I
Sbjct: 85  VLIMEFCPCGSLYTVLE---EPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNI 138
Query: 125 KPANVLLDADLNG----KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG------ 174
           KP N++     +G    KL DFG AR  + D   Q   L GT  Y+ P++          
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVXLYGTEEYLHPDMYERAVLRKDH 196
Query: 175 --KASTSTDVYAFGVFMLEVASGRRPI 199
             K   + D+++ GV     A+G  P 
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF 259

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF 259

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 56  QLTNTVNS--RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           QLT+ V S        +V +YM    L  +L     P L  + R  + + +  GL Y+H 
Sbjct: 83  QLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQG--PLLEEHARLFMYQ-LLRGLKYIHS 138
Query: 114 DWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYD--HDTIPQTTKLVGTFGYMAPEL 170
                VLHRD+KPAN+ ++  DL  K+GDFGLAR+ D  +      ++ + T  Y +P L
Sbjct: 139 ---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 171 MRTGKAST-STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           + +    T + D++A G    E+ +G+        +E + L+
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
            Y APE++       + D+++ G  M E+  G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTTKL 159
           VA G+ YL     +  +HRD+   N+LL      K+GDFGL R      DH  + +  K+
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCW 218
              F + APE ++T   S ++D + FGV + E+ + G+ P       ++++ +D      
Sbjct: 177 --PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 228
Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           K+G  L   +   + IY          + + C   KPE RP    +  +L
Sbjct: 229 KEGERLPRPEDCPQDIY---------NVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 CGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ G  M E+  G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLXGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY----DHDTIPQTTKL 159
           VA G+ YL     +  +HRD+   N+LL      K+GDFGL R      DH  + +  K+
Sbjct: 130 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCW 218
              F + APE ++T   S ++D + FGV + E+ + G+ P       ++++ +D      
Sbjct: 187 --PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 238
Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
           K+G  L   +   + IY          + + C   KPE RP    +  +L
Sbjct: 239 KEGERLPRPEDCPQDIY---------NVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHD--TIPQTTKLV 160
           VA G+ YL E   Q  +HRD+   N +LD     K+ DFGLAR + D +  ++ Q     
Sbjct: 133 VARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
               + A E ++T + +T +DV++FGV + E+ +   P
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL 159
           ++  +  GL Y+H      ++HRD+KP N+ ++ D   K+ DFGLAR  D     +    
Sbjct: 133 LVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMXGX 185
Query: 160 VGTFGYMAPELMRTGKASTST-DVYAFGVFMLEVASGR 196
           V T  Y APE++      T T D+++ G  M E+ +G+
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 47/271 (17%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL------DKILHTN--------IKPSLSWY 95
           H   ++ L      R G   L  +Y P+G+L       ++L T+           +LS  
Sbjct: 81  HHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 96  QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ 155
           Q       VA G+ YL +   +  +HR++   N+L+  +   K+ DFGL+R        Q
Sbjct: 140 QLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR-------GQ 189
Query: 156 TTKLVGTFG-----YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
              +  T G     +MA E +     +T++DV+++GV + E+ S G  P      M    
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---CGMTCAE 246
Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           L + +   ++    L+  D              V  L   C   KP  RP+  Q++  L+
Sbjct: 247 LYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLN 293
Query: 270 GNATLPDIPRDSTLIAPFSASNDAFSGNSSA 300
                     ++TL   F+ +    S   +A
Sbjct: 294 RMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 324

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 VGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ G  M E+  G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
            Y APE++       + D+++ G  M E+  G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 10/102 (9%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLA-RLYDHDTIPQT 156
           I+ +   + Y H +    ++HR++KP N+LL +   G   KL DFGLA  + D +     
Sbjct: 111 IQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---W 164
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
               GT GY++PE+++    S   D++A GV +  +  G  P
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTT 157
           I+ +   + Y H +    ++HR++KP N+LL +   G   KL DFGLA   + +      
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 165
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
              GT GY++PE+++    S   D++A GV +  +  G  P
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 13/154 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 CGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
           T  Y APE++       + D+++ G  M E+  G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTT 157
           I+ +   + Y H +    ++HR++KP N+LL +   G   KL DFGLA   + +      
Sbjct: 110 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 164
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
              GT GY++PE+++    S   D++A GV +  +  G  P
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 46/81 (56%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+         T  L GT  Y+APE++ +   + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWTLCGTPEYLAPEIILSKGYNK 238
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF 259

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+++D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIIISKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 10/102 (9%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLA-RLYDHDTIPQT 156
           I+ +   + Y H +    ++HR++KP N+LL +   G   KL DFGLA  + D +     
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--- 187
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
               GT GY++PE+++    S   D++A GV +  +  G  P
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 61/122 (50%), Gaps = 16/122 (13%)
Query: 89  KPSLSWYQRFRII----RGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD--LNGKLGDF 142
           + SL + QR ++I    R + S L YLH    Q + HRDIKP N L   +     KL DF
Sbjct: 158 RESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 143 GLA----RLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS--TSTDVYAFGVFMLEVASGR 196
           GL+    +L + +    TTK  GT  ++APE++ T   S     D ++ GV +  +  G 
Sbjct: 215 GLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 197 RP 198
            P
Sbjct: 274 VP 275

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 136
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T       V T 
Sbjct: 137 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFVVTR 191
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASG 195
            Y APE++       + D+++ G  M E+  G
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 130 XGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVV 180
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
           T  Y APE++       + D+++ G  M E+   +
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 47/81 (58%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + ++A+G  P 
Sbjct: 218 AVDWWALGVLIYQMAAGYPPF 238

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 XGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
           T  Y APE++       + D+++ G  M E+   +
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 172
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTR 227
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           H N +++L +++ S +G   LV+D +  G L + I+    +   S       I  +   +
Sbjct: 89  HPN-IVRLHDSI-SEEGFHYLVFDLVTGGELFEDIV---AREYYSEADASHCIHQILESV 143
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            ++H+     ++HRD+KP N+LL +   G   KL DFGLA +             GT GY
Sbjct: 144 NHIHQ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGY 199
Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           ++PE++R        D++A GV +  +  G  P
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMP--NGSLDKILHTNIKPSLSWYQRFRII 101
           +  V+   ++ L N    +K   EF  VY  M   + +L +++   +      Y  ++++
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG 161
            G+     +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V 
Sbjct: 137 XGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVV 187
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
           T  Y APE++       + D+++ G  M E+   +
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 172
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 227
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 135
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 136 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 190
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 128 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 182
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 129 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 183
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 129 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 183
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 135
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 136 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 190
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLCQVIQMELDHERMSYLLYQ 133
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 134 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 188
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 189 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 119 VLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK 175
           ++HRD+KP N+LL +   G   KL DFGLA     D         GT GY++PE++R   
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVLRKDP 182
Query: 176 ASTSTDVYAFGVFMLEVASGRRP 198
                D++A GV +  +  G  P
Sbjct: 183 YGKPVDMWACGVILYILLVGYPP 205

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 27/136 (19%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------------DLNGKLGD 141
           Y    ++R +ASG+ +LH      ++HRD+KP N+L+               +L   + D
Sbjct: 115 YNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 142 FGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTG-------KASTSTDVYAFG-VFML 190
           FGL +  D       T L    GT G+ APEL+          + + S D+++ G VF  
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 191 EVASGRRPIEQQGSME 206
            ++ G+ P   + S E
Sbjct: 232 ILSKGKHPFGDKYSRE 247

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 31/234 (13%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQRFRIIRG--- 103
           H   ++ L        G  +++ ++   G+L   L +      P    Y+ F  +     
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 104 ----VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTK 158
               VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +   
Sbjct: 149 YSFQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 205
Query: 159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDC 217
                 +MAPE +     +  +DV++FGV + E+ S G  P         V + +     
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRR 259
Query: 218 WKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
            K+G  + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 303

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 129 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 183
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 184 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVM--ELMDANLXQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 119 VLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK 175
           ++HRD+KP N+LL +   G   KL DFGLA     D         GT GY++PE++R   
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVLRKDP 182
Query: 176 ASTSTDVYAFGVFMLEVASGRRP 198
                D++A GV +  +  G  P
Sbjct: 183 YGKPVDMWACGVILYILLVGYPP 205

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 139
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 140 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 194
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 195 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------------DLNGKLGD 141
           Y    ++R +ASG+ +LH      ++HRD+KP N+L+               +L   + D
Sbjct: 133 YNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 189
Query: 142 FGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTG---KASTSTDVYAFG-VFMLEVAS 194
           FGL +  D         L    GT G+ APEL+      + + S D+++ G VF   ++ 
Sbjct: 190 FGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249
Query: 195 GRRPIEQQGSME 206
           G+ P   + S E
Sbjct: 250 GKHPFGDKYSRE 261

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------------DLNGKLGD 141
           Y    ++R +ASG+ +LH      ++HRD+KP N+L+               +L   + D
Sbjct: 133 YNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 189
Query: 142 FGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTG---KASTSTDVYAFG-VFMLEVAS 194
           FGL +  D         L    GT G+ APEL+      + + S D+++ G VF   ++ 
Sbjct: 190 FGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249
Query: 195 GRRPIEQQGSME 206
           G+ P   + S E
Sbjct: 250 GKHPFGDKYSRE 261

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 46/81 (56%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT  Y+AP ++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPAIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 52/113 (46%), Gaps = 30/113 (26%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--------------- 151
           G+ Y+H      +LHRD+KPAN L++ D + K+ DFGLAR  D+                
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 152 ----TIPQTTKL-------VGTFGYMAPELMRTGKAST-STDVYAFGVFMLEV 192
               T P T  L       V T  Y APEL+   +  T + DV++ G    E+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 35/189 (18%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           F LV++ M  GS+  + H + +   +  +   +++ VAS L +LH    + + HRD+KP 
Sbjct: 86  FYLVFEKMRGGSI--LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPE 140
Query: 128 NVLLDADLN---GKLGDFGLARLYDHD------TIPQTTKLVGTFGYMAPELMRTGKAST 178
           N+L +        K+ DF L      +      + P+     G+  YMAPE++       
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 179 S-----TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-WKKGAILDASDSRL- 231
           S      D+++ GV +  + SG  P   +            SDC W +G    A  + L 
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCG----------SDCGWDRGEACPACQNMLF 250
Query: 232 ----EGIYE 236
               EG YE
Sbjct: 251 ESIQEGKYE 259

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME--LMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR     T    T  V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 31/234 (13%)
Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQRFRIIRG--- 103
           H   ++ L        G  +++ ++   G+L   L +      P    Y+ F  +     
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 104 ----VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTK 158
               VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +   
Sbjct: 149 YSFQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDC 217
                 +MAPE +     +  +DV++FGV + E+ S G  P         V + +     
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFXRR 259
Query: 218 WKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
            K+G  + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 303

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 7/102 (6%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTT 157
           +R +   L Y H++    ++HRD+KP  VLL +  N    KLG FG+A       +    
Sbjct: 138 MRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
           + VGT  +MAPE+++        DV+  GV +  + SG  P 
Sbjct: 195 R-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT------ 173
           +HRDIKP N+LLD   + +L DFG       D   ++   VGT  Y++PE+++       
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 174 -GKASTSTDVYAFGVFMLEVASGRRPIEQQGSME 206
            G      D +A GVF  E+  G+ P     + E
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 7/102 (6%)
Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTT 157
           +R +   L Y H++    ++HRD+KP  VLL +  N    KLG FG+A       +    
Sbjct: 136 MRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI 199
           + VGT  +MAPE+++        DV+  GV +  + SG  P 
Sbjct: 193 R-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL  +   K+ DFGLAR +Y +    +       
Sbjct: 208 VARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     ST +DV+++GV + E+ S G  P         V + +      ++G
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG------VQMDEDFCSRLREG 318
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
             + A +     IY+         + L C H  P+ RP   ++++ L
Sbjct: 319 MRMRAPEYSTPEIYQ---------IMLDCWHRDPKERPRFAELVEKL 356

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 157 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 267
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 268 TRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 148 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 258
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 259 TRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 298

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 157 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 267
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 268 TRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 307

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 148 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 258
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 259 TRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 298

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 200 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 310
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 311 TRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL-GN 350

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 159 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 216 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 269
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 270 TRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 309

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR    D D + +    + 
Sbjct: 157 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL- 212
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKK 220
              +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKE 266
Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
           G  + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 267 GTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 307

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 194 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 304
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 305 TRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 344

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR      + +    V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE--VVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR    D D + +    + 
Sbjct: 157 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL- 212
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKK 220
              +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKE 266
Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
           G  + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 267 GTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 307

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 63/135 (46%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I++ +   + YLH      + HRD+KP 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++   T+   T  Y+APE++   K   S D++
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNSL---TEPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 184 AFGVFMLEVASGRRP 198
           + GV M  +  G  P
Sbjct: 202 SLGVIMYILLCGYPP 216

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR    D D + +    + 
Sbjct: 148 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL- 203
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKK 220
              +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKE 257
Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
           G  + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 258 GTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 298

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 312
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 313 TRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL-GN 352

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR    D D + +    + 
Sbjct: 148 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL- 203
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKK 220
              +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKE 257
Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
           G  + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 258 GTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 298

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 207 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 317
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 318 TRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL-GN 357

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 46/81 (56%), Gaps = 4/81 (4%)
Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +++RD+KP N+L+D     ++ DFG A+        +T  L GT   +APE++ +   + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEALAPEIILSKGYNK 217
Query: 179 STDVYAFGVFMLEVASGRRPI 199
           + D +A GV + E+A+G  P 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 209 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+G
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKEG 319
Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
             + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 320 TRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL-GN 359

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 27/136 (19%)
Query: 95  YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------------DLNGKLGD 141
           Y    ++R +ASG+ +LH      ++HRD+KP N+L+               +L   + D
Sbjct: 115 YNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 142 FGLARLYDHDTIPQTTKL---VGTFGYMAPELMRTG-------KASTSTDVYAFG-VFML 190
           FGL +  D         L    GT G+ APEL+          + + S D+++ G VF  
Sbjct: 172 FGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 191 EVASGRRPIEQQGSME 206
            ++ G+ P   + S E
Sbjct: 232 ILSKGKHPFGDKYSRE 247

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     DT        VGT  YM 
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 40/180 (22%)
Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIKP 90
            +DP +++  L  +     L+  N VN      RK    LV++Y  +     +LH     
Sbjct: 40  EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT----VLH----- 90
Query: 91  SLSWYQR---FRIIRGVASGLL----YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG 143
            L  YQR     +++ +    L    + H+      +HRD+KP N+L+      KL DFG
Sbjct: 91  ELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFG 147
Query: 144 LARL-------YDHDTIPQTTKLVGTFGYMAPELMR-TGKASTSTDVYAFGVFMLEVASG 195
            ARL       YD +        V T  Y +PEL+    +     DV+A G    E+ SG
Sbjct: 148 FARLLTGPSDYYDDE--------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 81  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     DT        VGT  YM 
Sbjct: 141 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 65  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 124
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     DT        VGT  YM 
Sbjct: 125 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 180
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQ 155
           I++ +   + YLH      + HRD+KP N+L  +       KL DFG A+    H+++  
Sbjct: 127 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 181
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            T    T  Y+APE++   K   S D+++ GV M  +  G  P
Sbjct: 182 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR    D D + +    + 
Sbjct: 157 VAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL- 212
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKK 220
              +MAPE +     +  +DV++FGV + E+ S G  P         V + +      K+
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFCRRLKE 266
Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN 271
           G  + A D     +Y+           L C H +P  RP   +++++L GN
Sbjct: 267 GTRMRAPDYTTPEMYQTM---------LDCWHGEPSQRPTFSELVEHL-GN 307

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQ 155
           I++ +   + YLH      + HRD+KP N+L  +       KL DFG A+    H+++  
Sbjct: 126 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 180
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            T    T  Y+APE++   K   S D+++ GV M  +  G  P
Sbjct: 181 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I++ +   + YLH      + HRD+KP 
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 152
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++   T    T  Y+APE++   K   S D++
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMW 209
Query: 184 AFGVFMLEVASGRRP 198
           + GV M  +  G  P
Sbjct: 210 SLGVIMYILLCGYPP 224

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  +    +++L + ++       L+++Y  N  L K +  N   S+   + F  +  + 
Sbjct: 87  LKELQHRNIIELKSVIH-HNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLI 142
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLL---DADLNG--KLGDFGLARLYDHDTIPQTTKLV 160
           +G+ + H    +  LHRD+KP N+LL   DA      K+GDFGLAR +    I Q T  +
Sbjct: 143 NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEI 198
Query: 161 GTFGYMAPELMRTGKA-STSTDVYAFGVFMLEV 192
            T  Y  PE++   +  STS D+++      E+
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEM 231

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 61  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 120
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     DT        VGT  YM 
Sbjct: 121 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 176
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 221

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 63/135 (46%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I++ +   + YLH      + HRD+KP 
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 160
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++  TT     + Y+APE++   K   S D++
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPY-YVAPEVLGPEKYDKSCDMW 217
Query: 184 AFGVFMLEVASGRRP 198
           + GV M  +  G  P
Sbjct: 218 SLGVIMYILLCGYPP 232

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I++ +   + YLH      + HRD+KP 
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 190
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++   T    T  Y+APE++   K   S D++
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMW 247
Query: 184 AFGVFMLEVASGRRP 198
           + GV M  +  G  P
Sbjct: 248 SLGVIMYILLCGYPP 262

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I++ +   + YLH      + HRD+KP 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++   T    T  Y+APE++   K   S D++
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 184 AFGVFMLEVASGRRP 198
           + GV M  +  G  P
Sbjct: 202 SLGVIMYILLCGYPP 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQ 155
           I++ +   + YLH      + HRD+KP N+L  +       KL DFG A+    H+++  
Sbjct: 122 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 176
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            T    T  Y+APE++   K   S D+++ GV M  +  G  P
Sbjct: 177 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 53/118 (44%), Gaps = 28/118 (23%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT------- 152
           I+  +  G  ++HE     ++HRD+KPAN LL+ D + K+ DFGLAR  + D        
Sbjct: 136 ILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVND 192
Query: 153 -----------------IPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEV 192
                              Q T  V T  Y APEL+   +  T S D+++ G    E+
Sbjct: 193 LEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 58  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 114
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 115 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 172 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229
Query: 210 LVDW 213
            V++
Sbjct: 230 AVNY 233

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 46  LASVHSNGLLQLTNTVNSRKG--EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG 103
           +  V+   ++ L N    +K   EF  VY  M    +D  L   I+  L   +   ++  
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR      + +    V T 
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE--VVTR 189
Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
            Y APE++       + D+++ G  M E+   +
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     DT        VGT  YM 
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 58  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 114
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 115 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 172 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229
Query: 210 LVDW 213
            V++
Sbjct: 230 AVNY 233

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     DT        VGT  YM 
Sbjct: 122 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I++ +   + YLH      + HRD+KP 
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 196
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++   T    T  Y+APE++   K   S D++
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMW 253
Query: 184 AFGVFMLEVASGRRP 198
           + GV M  +  G  P
Sbjct: 254 SLGVIMYILLCGYPP 268

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQ 155
           I++ +   + YLH      + HRD+KP N+L  +       KL DFG A+    H+++  
Sbjct: 121 IMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 175
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            T    T  Y+APE++   K   S D+++ GV M  +  G  P
Sbjct: 176 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I++ +   + YLH      + HRD+KP 
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 146
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++   T    T  Y+APE++   K   S D++
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMW 203
Query: 184 AFGVFMLEVASGRRP 198
           + GV M  +  G  P
Sbjct: 204 SLGVIMYILLCGYPP 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   NVLL      K+GDFGLAR  + D + I +    + 
Sbjct: 175 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 230
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
              +MAPE +     +  +DV+++G+ + E+ S
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 54/115 (46%), Gaps = 25/115 (21%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL------------ 147
           I+  +  G  ++HE     ++HRD+KPAN LL+ D + K+ DFGLAR             
Sbjct: 134 ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 148 ---------YDHDTIPQTTKLVGTFGYMAPELMRTGKAST-STDVYAFGVFMLEV 192
                    ++ +   Q T  V T  Y APEL+   +  T S D+++ G    E+
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   NVLL      K+GDFGLAR  + D + I +    + 
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
              +MAPE +     +  +DV+++G+ + E+ S
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   NVLL      K+GDFGLAR  + D + I +    + 
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
              +MAPE +     +  +DV+++G+ + E+ S
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   NVLL      K+GDFGLAR  + D + I +    + 
Sbjct: 161 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 216
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
              +MAPE +     +  +DV+++G+ + E+ S
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   NVLL      K+GDFGLAR  + D + I +    + 
Sbjct: 169 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 224
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
              +MAPE +     +  +DV+++G+ + E+ S
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 63/147 (42%), Gaps = 27/147 (18%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 158
           +I   +   L +LH      V+HRD+KP+NVL++A    K  DFG++     D       
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID- 196
Query: 159 LVGTFGYMAPEL----MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS----MEMV-- 208
             G   Y APE     +     S  +D+++ G+  +E+A  R P +  G+    ++ V  
Sbjct: 197 -AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE 255
Query: 209 -------------NLVDWVSDCWKKGA 222
                          VD+ S C KK +
Sbjct: 256 EPSPQLPADKFSAEFVDFTSQCLKKNS 282

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V   + + +L+ + +  G L   L    K SLS  +    I+ +  G+ YLH    + + 
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIA 137
Query: 121 HRDIKPANV-LLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
           H D+KP N+ LLD ++   + KL DFGLA  ++ +   +   + GT  ++APE++     
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 177 STSTDVYAFGVFMLEVASGRRP 198
               D+++ GV    + SG  P
Sbjct: 196 GLEADMWSIGVITYILLSGASP 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   NVLL      K+GDFGLAR  + D + I +    + 
Sbjct: 167 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 222
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
              +MAPE +     +  +DV+++G+ + E+ S
Sbjct: 223 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V   + + +L+ + +  G L   L    K SLS  +    I+ +  G+ YLH    + + 
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIA 137
Query: 121 HRDIKPANV-LLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
           H D+KP N+ LLD ++   + KL DFGLA  ++ +   +   + GT  ++APE++     
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 177 STSTDVYAFGVFMLEVASGRRP 198
               D+++ GV    + SG  P
Sbjct: 196 GLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V   + + +L+ + +  G L   L    K SLS  +    I+ +  G+ YLH    + + 
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIA 137
Query: 121 HRDIKPANV-LLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
           H D+KP N+ LLD ++   + KL DFGLA  ++ +   +   + GT  ++APE++     
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 177 STSTDVYAFGVFMLEVASGRRP 198
               D+++ GV    + SG  P
Sbjct: 196 GLEADMWSIGVITYILLSGASP 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V   + + +L+ + +  G L   L    K SLS  +    I+ +  G+ YLH    + + 
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIA 137
Query: 121 HRDIKPANV-LLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
           H D+KP N+ LLD ++   + KL DFGLA  ++ +   +   + GT  ++APE++     
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 177 STSTDVYAFGVFMLEVASGRRP 198
               D+++ GV    + SG  P
Sbjct: 196 GLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V   + + +L+ + +  G L   L    K SLS  +    I+ +  G+ YLH    + + 
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIA 137
Query: 121 HRDIKPANV-LLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
           H D+KP N+ LLD ++   + KL DFGLA  ++ +   +   + GT  ++APE++     
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 177 STSTDVYAFGVFMLEVASGRRP 198
               D+++ GV    + SG  P
Sbjct: 196 GLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V   + + +L+ + +  G L   L    K SLS  +    I+ +  G+ YLH    + + 
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIA 137
Query: 121 HRDIKPANV-LLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
           H D+KP N+ LLD ++   + KL DFGLA  ++ +   +   + GT  ++APE++     
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 177 STSTDVYAFGVFMLEVASGRRP 198
               D+++ GV    + SG  P
Sbjct: 196 GLEADMWSIGVITYILLSGASP 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 37  EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ 96
           ED + +   L  +    ++ L + V   K + +L+ + +  G L   L    K SL+  +
Sbjct: 59  EDIEREVSILKEIQHPNVITL-HEVYENKTDVILIGELVAGGELFDFLAE--KESLTEEE 115
Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV-LLDADLNG---KLGDFGLARLYDHDT 152
               ++ + +G+ YLH      + H D+KP N+ LLD ++     K+ DFGLA   D   
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI---EQQGSMEMVN 209
             +   + GT  ++APE++         D+++ GV    + SG  P     +Q ++  V+
Sbjct: 173 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
Query: 210 LVDW 213
            V++
Sbjct: 231 AVNY 234

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 5/113 (4%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTT 157
           R +  +A G+ YL     +  +HRD+   N +L  D+   + DFGL+R +Y  D   Q  
Sbjct: 141 RFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVN 209
                  ++A E +     +  +DV+AFGV M E+ + G+ P     + E+ N
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 179
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 237
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 238 IDVWSAGCVLAELLLGQ 254

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 145
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 203
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 115 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 164
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 165 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 222
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 223 IDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 108 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 157
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 158 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 215
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 216 IDVWSAGCVLAELLLGQ 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 108 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 157
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 158 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 215
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 216 IDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 97  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 146
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 147 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 204
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 205 IDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 145
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 203
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 104 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 153
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 154 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 211
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 212 IDVWSAGCVLAELLLGQ 228

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 145
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 203
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 100 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 149
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 150 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 207
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 208 IDVWSAGCVLAELLLGQ 224

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     DT        VG   YM 
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 37/181 (20%)
Query: 36  NEDPQLQRDGLASVHSNGLLQLTNTV-----NSRKGEFL-LVYDYMPNGSLDKILHTNIK 89
           N + Q+ +D LA +H   ++QL +         R+  +L +V +Y+P+      LH   +
Sbjct: 64  NRELQIMQD-LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-----TLHRCCR 117
Query: 90  PSLSWYQR-------------FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-DADL 135
              ++Y+R             F++IR +  G L+L       V HRDIKP NVL+ +AD 
Sbjct: 118 ---NYYRRQVAPPPILIKVFLFQLIRSI--GCLHLPS---VNVCHRDIKPHNVLVNEADG 169
Query: 136 NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVAS 194
             KL DFG A+     + P    +   + Y APEL+   +  +T+ D+++ G    E+  
Sbjct: 170 TLKLCDFGSAKKLS-PSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 195 G 195
           G
Sbjct: 228 G 228

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV + M  G L DKIL        S  +   ++  +   + YLH    Q V+HRD+KP+N
Sbjct: 98  LVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSN 151
Query: 129 VLLDADLNG-----KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +L   D +G     ++ DFG A+    +     T    T  ++APE+++        D++
Sbjct: 152 ILY-VDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIW 209
Query: 184 AFGVFMLEVASGRRP 198
           + G+ +  + +G  P
Sbjct: 210 SLGILLYTMLAGYTP 224

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 31/110 (28%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLV----------------- 160
           ++HRD+KP+N L +  L    L DFGLA+   HDT  +  K V                 
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQ-GTHDTKIELLKFVQSEAQQERCSQNKCSIC 196
Query: 161 -----------GTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRP 198
                      GT G+ APE L +    +T+ D+++ GV  L + SGR P
Sbjct: 197 LSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 145
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 203
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 26/165 (15%)
Query: 59  NTVNSRKGEFLLVYDY----------MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
           N +     + + +YDY          M  G++D       K S+  ++R    + +   +
Sbjct: 81  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT-KLVGTFGYMA 167
             +H+     ++H D+KPAN L+  D   KL DFG+A     D         VGT  YM 
Sbjct: 141 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMP 196
Query: 168 PELMRTGKASTST-----------DVYAFGVFMLEVASGRRPIEQ 201
           PE ++   +S              DV++ G  +  +  G+ P +Q
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLV 160
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR   +D+   +    +L 
Sbjct: 177 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL- 232
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
               +MAPE +     +  +DV+++G+F+ E+ S
Sbjct: 233 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 124 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 173
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 174 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 231
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 232 IDVWSAGCVLAELLLGQ 248

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 96  LVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 145
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY-YRAPELIFGATDYTSS 203
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 179
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 237
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 238 IDVWSAGCVLAELLLGQ 254

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 145
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 203
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 101 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 150
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 151 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 208
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 209 IDVWSAGCVLAELLLGQ 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 175 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 224
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 225 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 282
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 283 IDVWSAGCVLAELLLGQ 299

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV + M  G L DKIL        S  +   ++  +   + YLH    Q V+HRD+KP+N
Sbjct: 98  LVTELMRGGELLDKILRQKF---FSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSN 151
Query: 129 VLLDADLNG-----KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +L   D +G     ++ DFG A+    +     T    T  ++APE+++        D++
Sbjct: 152 ILY-VDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIW 209
Query: 184 AFGVFMLEVASGRRP 198
           + G+ +  + +G  P
Sbjct: 210 SLGILLYTMLAGYTP 224

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 15/172 (8%)
Query: 45  GLASVHSNGLLQ--LTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR 102
           G+ S + + LL   LT+TV        LV   MP G L   +  N +  L          
Sbjct: 75  GVGSPYVSRLLGICLTSTVQ-------LVTQLMPYGCLLDHVREN-RGRLGSQDLLNWCM 126
Query: 103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVG 161
            +A G+ YL +     ++HRD+   NVL+ +  + K+ DFGLARL D D T         
Sbjct: 127 QIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 183
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVD 212
              +MA E +   + +  +DV+++GV + E+ + G +P +   + E+ +L++
Sbjct: 184 PIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 96  LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 145
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 203
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 132 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 181
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 182 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 239
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 240 IDVWSAGCVLAELLLGQ 256

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 109 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 158
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 159 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 216
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 217 IDVWSAGCVLAELLLGQ 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 9/113 (7%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQ 155
           RI++ V S + Y H+     V HRD+KP N L      D   KL DFGLA  +    + +
Sbjct: 110 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
           T   VGT  Y++P+++  G      D ++ GV M  +  G  P       E++
Sbjct: 167 TK--VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 216

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLV 160
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR   +D+   +    +L 
Sbjct: 170 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL- 225
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
               +MAPE +     +  +DV+++G+F+ E+ S
Sbjct: 226 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 70  LVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           LV DY+P        H +        I   L  YQ FR        L Y+H      + H
Sbjct: 134 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICH 183
Query: 122 RDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           RDIKP N+LLD D    KL DFG A+       P  + +   + Y APEL+      TS+
Sbjct: 184 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-YRAPELIFGATDYTSS 241
Query: 181 -DVYAFGVFMLEVASGR 196
            DV++ G  + E+  G+
Sbjct: 242 IDVWSAGCVLAELLLGQ 258

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 9/113 (7%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQ 155
           RI++ V S + Y H+     V HRD+KP N L      D   KL DFGLA  +    + +
Sbjct: 127 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
           T   VGT  Y++P+++  G      D ++ GV M  +  G  P       E++
Sbjct: 184 TK--VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 233

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLV 160
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR   +D+   +    +L 
Sbjct: 172 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL- 227
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
               +MAPE +     +  +DV+++G+F+ E+ S
Sbjct: 228 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-----ADLNGKLGDFGLAR--LYDHDT 152
           +++   SGL +LH      ++HRD+KP N+L+        +   + DFGL +       +
Sbjct: 123 LLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTST---DVYAFG-VFMLEVASGRRPIEQQGSMEMV 208
             + + + GT G++APE++        T   D+++ G VF   ++ G  P  +    +  
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239
Query: 209 NLVDWVS-DCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
            L+   S DC            + E +   E +E ++ +        P+ RP+ + V+++
Sbjct: 240 ILLGACSLDCLHP--------EKHEDVIARELIEKMIAMD-------PQKRPSAKHVLKH 284

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 25/148 (16%)
Query: 61  VNSRKGEFL-LVYDYMPNGSLDKILHTNIKP---------SLSWYQRFRIIRGVASGLLY 110
           VN  + ++L ++ +Y+P+ +L K+L + I+          S+  YQ FR     A G ++
Sbjct: 105 VNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-----AVGFIH 158
Query: 111 LHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
                   + HRDIKP N+L+++  N  KL DFG A+     + P    +   F Y APE
Sbjct: 159 -----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI-PSEPSVAXICSRF-YRAPE 211
Query: 170 LMRTGKAST-STDVYAFGVFMLEVASGR 196
           LM      T S D+++ G    E+  G+
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGK 239

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQT----TKLVG 161
           GL YLH    + +LH D+K  NVLL +D  +  L DFG A     D + ++      + G
Sbjct: 197 GLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ 201
           T  +MAPE++         DV++    ML + +G  P  Q
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 293

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLV 160
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR   +D+   +    +L 
Sbjct: 177 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL- 232
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
               +MAPE +     +  +DV+++G+F+ E+ S
Sbjct: 233 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLV 160
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR   +D+   +    +L 
Sbjct: 154 VAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL- 209
Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
               +MAPE +     +  +DV+++G+F+ E+ S
Sbjct: 210 -PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K + +L+ + +  G L   L    K SL+  +  + ++ +  G+ YLH    + + H D+
Sbjct: 87  KTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDL 141
Query: 125 KPANV-LLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           KP N+ LLD ++     KL DFG+A   +     +   + GT  ++APE++         
Sbjct: 142 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           D+++ GV    + SG  P   +   E +  +  V+
Sbjct: 200 DMWSIGVITYILLSGASPFLGETKQETLTNISAVN 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTF 163
           SG+ Y H      + HRD+K  N LLD       K+ DFG ++     + P++T  VGT 
Sbjct: 127 SGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTP 181
Query: 164 GYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
            Y+APE L+R        DV++ GV +  +  G  P E
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K + +L+ + +  G L   L    K SL+  +  + ++ +  G+ YLH    + + H D+
Sbjct: 80  KTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDL 134
Query: 125 KPANV-LLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           KP N+ LLD ++     KL DFG+A   +     +   + GT  ++APE++         
Sbjct: 135 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEA 192
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           D+++ GV    + SG  P   +   E +  +  V+
Sbjct: 193 DMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K + +L+ + +  G L   L    K SL+  +  + ++ +  G+ YLH    + + H D+
Sbjct: 101 KTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDL 155
Query: 125 KPANV-LLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           KP N+ LLD ++     KL DFG+A   +     +   + GT  ++APE++         
Sbjct: 156 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEA 213
Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS 215
           D+++ GV    + SG  P   +   E +  +  V+
Sbjct: 214 DMWSIGVITYILLSGASPFLGETKQETLTNISAVN 248

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 48/98 (48%), Gaps = 4/98 (4%)
Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
            +++   A+G+ YL     +  +HRD+   N L+      K+ DFG++R         + 
Sbjct: 216 LQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASG 272
Query: 158 KLVGT-FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
            L      + APE +  G+ S+ +DV++FG+ + E  S
Sbjct: 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTT----KLVG 161
           GL YLH    + +LH D+K  NVLL +D     L DFG A     D + ++      + G
Sbjct: 162 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ 201
           T  +MAPE++         D+++    ML + +G  P  Q
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTT----KLVG 161
           GL YLH    + +LH D+K  NVLL +D     L DFG A     D + ++      + G
Sbjct: 178 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ 201
           T  +MAPE++         D+++    ML + +G  P  Q
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 15/140 (10%)
Query: 66  GEFLLVYDYMPNGS--LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           G+++ V   +  G   LDKIL        S  +   ++  +   + YLH    Q V+HRD
Sbjct: 88  GKYVYVVTELXKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA---QGVVHRD 141
Query: 124 IKPANVLLDADLNG-----KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +KP+N+L   D +G     ++ DFG A+    +     T    T  ++APE++       
Sbjct: 142 LKPSNILY-VDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLERQGYDA 199
Query: 179 STDVYAFGVFMLEVASGRRP 198
           + D+++ GV +    +G  P
Sbjct: 200 ACDIWSLGVLLYTXLTGYTP 219

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 48/98 (48%), Gaps = 4/98 (4%)
Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT 157
            +++   A+G+ YL     +  +HRD+   N L+      K+ DFG++R         + 
Sbjct: 216 LQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272
Query: 158 KLVGT-FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
            L      + APE +  G+ S+ +DV++FG+ + E  S
Sbjct: 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 17/141 (12%)
Query: 66  GEFLLVYDYMPNGS--LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           G+++ V   +  G   LDKIL        S  +   ++  +   + YLH    Q V+HRD
Sbjct: 88  GKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA---QGVVHRD 141
Query: 124 IKPANVLLDADLNG-----KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
           +KP+N+L   D +G     ++ DFG A+ L   + +  T      F  +APE++      
Sbjct: 142 LKPSNILY-VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLERQGYD 198
Query: 178 TSTDVYAFGVFMLEVASGRRP 198
            + D+++ GV +  + +G  P
Sbjct: 199 AACDIWSLGVLLYTMLTGYTP 219

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLN-GKLGDFGLARLYDHDTIPQTT----KLVG 161
           GL YLH    + +LH D+K  NVLL +D +   L DFG A     D + ++      + G
Sbjct: 176 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 232
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ 201
           T  +MAPE++         D+++    ML + +G  P  Q
Sbjct: 233 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 98  FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA-RLYDHDTIPQT 156
            + +  +A G+ YL     +  LHRD+   N +L  D+   + DFGL+ ++Y  D   Q 
Sbjct: 150 LKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
                   ++A E +     ++ +DV+AFGV M E+A+
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 46/191 (24%)
Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGK--LGDFGL---------ARL 147
           +I + +  G+ YLH    + +LH+D+K  NV  D   NGK  + DFGL          R 
Sbjct: 134 QIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRR 187
Query: 148 YDHDTIPQTTKLVGTFGYMAPELMRTGKASTS---------TDVYAFGVFMLEVASGRRP 198
            D   I       G   ++APE++R     T          +DV+A G    E+ +   P
Sbjct: 188 EDKLRIQN-----GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR 258
            + Q +  ++         W+ G  +  + S++ G+ +E     +  + LFC   + E R
Sbjct: 243 FKTQPAEAII---------WQMGTGMKPNLSQI-GMGKE-----ISDILLFCWAFEQEER 287
Query: 259 PNMRQVMQYLD 269
           P   ++M  L+
Sbjct: 288 PTFTKLMDMLE 298

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 59/135 (43%), Gaps = 10/135 (7%)
Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            L+V + +  G L   +      + +  +   I + +   + YLH      + HRD+KP 
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI---NIAHRDVKPE 190
Query: 128 NVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           N+L  +       KL DFG A+    H+++   T    T  Y+APE++   K   S D +
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDXW 247
Query: 184 AFGVFMLEVASGRRP 198
           + GV    +  G  P
Sbjct: 248 SLGVIXYILLCGYPP 262

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQ----TTKLVG 161
           GL YLH    + +LH D+K  NVLL +D  +  L DFG A     D + +       + G
Sbjct: 178 GLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ 201
           T  +MAPE++         DV++    ML + +G  P  Q
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 274

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 220
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRW 270

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 239
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 240 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 289

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 219
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRW 269

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 220
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRW 270

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 234
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 284

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 206
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 256

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 234
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 284

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 207
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDWV 214
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W 
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 258

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG--DFGLARLYDHDTIPQTTKLVGTF 163
           SG+ Y H      V HRD+K  N LLD     +L   DFG ++     + P++T  VGT 
Sbjct: 125 SGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTP 179
Query: 164 GYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
            Y+APE L++        DV++ GV +  +  G  P E
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLG--DFGLARLYDHDTIPQTTKLVGTF 163
           SG+ Y H      V HRD+K  N LLD     +L   DFG ++     + P++T  VGT 
Sbjct: 126 SGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTP 180
Query: 164 GYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
            Y+APE L++        DV++ GV +  +  G  P E
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           VA G+ +L     +  +HRD+   NVL+      K+ DFGLAR  + D + + +    + 
Sbjct: 181 VAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS 194
              +MAPE +  G  +  +DV+++G+ + E+ S
Sbjct: 238 V-KWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 207
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 257

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 187
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 237

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 214
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 215 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 264

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 220
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRW 270

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 190
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 191 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 240

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 107 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 158
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 159 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 216
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 217 MFAGMIFRKEPF 228

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 234
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDWV 214
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W 
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 285

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 219
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 269

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 105 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 156
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 157 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 214
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 215 MFAGMIFRKEPF 226

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 106 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 157
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 158 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 215
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 216 MFAGMIFRKEPF 227

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 192
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 219
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRW 269

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 191
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 241

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 187
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 206
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDWV 214
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W 
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 257

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 13/168 (7%)
Query: 37  EDPQLQRDGL-----ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPS 91
           EDP+L +  L     + V    ++++ + +   +G F LV +   +G LD     +  P 
Sbjct: 69  EDPKLGKVTLEIAILSRVEHANIIKVLD-IFENQGFFQLVMEKHGSG-LDLFAFIDRHPR 126
Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD 151
           L       I R + S + YL     + ++HRDIK  N+++  D   KL DFG A   +  
Sbjct: 127 LDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 152 TIPQTTKLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRP 198
            +  T    GT  Y APE LM         ++++ GV +  +     P
Sbjct: 184 KLFYT--FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 220
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRW 270

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 105 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 156
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 157 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 214
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 215 MFAGMIFRKEPF 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 192
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 242

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 219
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRW 269

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 191
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 241

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 192
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 242

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 187
Query: 177 STSTDVYAFGVFMLEVASGRRPIEQ 201
             S  V++ G+ + ++  G  P E 
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEH 212

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 51/111 (45%), Gaps = 18/111 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 207
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDWV 214
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W 
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 258

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 105 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 156
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 157 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 214
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 215 MFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 105 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 156
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 157 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 214
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 215 MFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 105 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 156
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 157 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 214
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 215 MFAGMIFRKEPF 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 119 VLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A 176
           VLHRDIK  N+L+D +    KL DFG   L   DT+   T   GT  Y  PE +R  +  
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYH 226
Query: 177 STSTDVYAFGVFMLEVASGRRPIE-------------QQGSMEMVNLVDW 213
             S  V++ G+ + ++  G  P E             Q+ S E  +L+ W
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 105 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 156
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 157 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 214
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 215 MFAGMIFRKEPF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 106 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 157
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGV 187
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+        S D+++ G 
Sbjct: 158 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELLVDLQDYDYSLDMWSLGC 215
Query: 188 FMLEVASGRRPI 199
               +   + P 
Sbjct: 216 MFAGMIFRKEPF 227

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           E +LV +++  GSLD  L  N K  ++   +  + + +A+ + +L E+    ++H ++  
Sbjct: 86  ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCA 141
Query: 127 ANVLLDADLNGKLGDFGLARLYDHD---TIPQTTKLVGTFGYMAPELMRTGKA-STSTDV 182
            N+LL  + + K G+    +L D     T+     L     ++ PE +   K  + +TD 
Sbjct: 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDK 201
Query: 183 YAFGVFMLEVASG-RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME 241
           ++FG  + E+ SG  +P                         L A DS+ +  + E++ +
Sbjct: 202 WSFGTTLWEICSGGDKP-------------------------LSALDSQRKLQFYEDRHQ 236
Query: 242 L-------VLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDS 281
           L       +  L   C   +P+ RP+ R +++ L+   T   +PR S
Sbjct: 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+++Y+ N    K+L+    P+L+ Y     I  +   L Y H    Q ++HRD+KP NV
Sbjct: 126 LIFEYVNNTDF-KVLY----PTLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNV 177
Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM 171
           ++D +L   +L D+GLA  Y H       ++   + +  PEL+
Sbjct: 178 MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRY-FKGPELL 218

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA 167
           LL LH   E  V+HRD+ P N+LL  + +  + DF LAR    D     T  V    Y A
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRA 201
Query: 168 PELMRTGKASTS-TDVYAFGVFMLEV 192
           PEL+   K  T   D+++ G  M E+
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA 167
           LL LH   E  V+HRD+ P N+LL  + +  + DF LAR    D     T  V    Y A
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRA 201
Query: 168 PELMRTGKASTS-TDVYAFGVFMLEV 192
           PEL+   K  T   D+++ G  M E+
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 15/131 (11%)
Query: 70  LVYDYMPNGSL-DKILHTN--IKPSL--SWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           LV  Y+P GSL D +      + P L  +W  +      +A G+ YL E     ++HR++
Sbjct: 109 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE---HGMVHRNL 159
Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT-FGYMAPELMRTGKASTSTDVY 183
              NVLL +    ++ DFG+A L   D          T   +MA E +  GK +  +DV+
Sbjct: 160 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVW 219
Query: 184 AFGVFMLEVAS 194
           ++GV + E+ +
Sbjct: 220 SYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 15/131 (11%)
Query: 70  LVYDYMPNGSL-DKILHTN--IKPSL--SWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           LV  Y+P GSL D +      + P L  +W  +      +A G+ YL E     ++HR++
Sbjct: 91  LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE---HGMVHRNL 141
Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT-FGYMAPELMRTGKASTSTDVY 183
              NVLL +    ++ DFG+A L   D          T   +MA E +  GK +  +DV+
Sbjct: 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVW 201
Query: 184 AFGVFMLEVAS 194
           ++GV + E+ +
Sbjct: 202 SYGVTVWELMT 212

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTF 163
           SG+ Y H      V HRD+K  N LLD       K+ DFG ++     + P++   VGT 
Sbjct: 126 SGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGTP 180
Query: 164 GYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIE 200
            Y+APE L++        DV++ GV +  +  G  P E
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/141 (21%), Positives = 63/141 (44%), Gaps = 10/141 (7%)
Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+  +MP GSL  +LH      +   Q  +    +A G+ +LH   E ++    +   +V
Sbjct: 86  LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSV 144
Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST---STDVYAFG 186
           ++D D+  ++       + D     Q+   +    ++APE ++     T   S D+++F 
Sbjct: 145 MIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198
Query: 187 VFMLEVASGRRPIEQQGSMEM 207
           V + E+ +   P     +ME+
Sbjct: 199 VLLWELVTREVPFADLSNMEI 219
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	313
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-86
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-78
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-43
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-25
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-24
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-22
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-22
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-19
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-19
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-17
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-14
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-06
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	5e-06
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	8e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-05
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	5e-05
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	5e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-05
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	9e-05
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	1e-04
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	1e-04
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-04
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	1e-04
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	1e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	2e-04
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	2e-04
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	2e-04
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	3e-04
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	3e-04
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	5e-04
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  259 bits (665), Expect = 8e-86
 Identities = 82/208 (39%), Positives = 128/208 (61%), Gaps = 4/208 (1%)

Query: 69  LLVYDYMPNGSLDKILH--TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           LLVY YM NGS+   L      +P L W +R RI  G A GL YLH+  +  ++HRD+K 
Sbjct: 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
           AN+LLD +    +GDFGLA+L D+     TT + GT G++APE + TGK+S  TDV+ +G
Sbjct: 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 222

Query: 187 VFMLEVASGRRPIE--QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           V +LE+ +G+R  +  +  + + V L+DWV    K+  +    D  L+G Y++E++E ++
Sbjct: 223 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI 282

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLDGNA 272
           ++ L C+   P  RP M +V++ L+G+ 
Sbjct: 283 QVALLCTQSSPMERPKMSEVVRMLEGDG 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  239 bits (612), Expect = 4e-78
 Identities = 73/207 (35%), Positives = 114/207 (55%), Gaps = 10/207 (4%)

Query: 67  EFLLVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           +  LVY YMPNGSL   L   +  P LSW+ R +I +G A+G+ +LHE+    + HRDIK
Sbjct: 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHI-HRDIK 160

Query: 126 PANVLLDADLNGKLGDFGLARLYDH-DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
            AN+LLD     K+ DFGLAR  +       T+++VGT  YMAPE +  G+ +  +D+Y+
Sbjct: 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYS 219

Query: 185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK-KGAILDASDSRLEGIYEEEQMELV 243
           FGV +LE+ +G   +++    E   L+D   +    +  I D  D ++    +   +E +
Sbjct: 220 FGVVLLEIITGLPAVDE--HREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAM 276

Query: 244 LKLGLFCSHPKPEARPNMRQVMQYLDG 270
             +   C H K   RP++++V Q L  
Sbjct: 277 YSVASQCLHEKKNKRPDIKKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  229 bits (586), Expect = 7e-74
 Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 6/215 (2%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPS--LSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           + E +L+Y YM NG+L + L+ +  P+  +SW QR  I  G A GL YLH      ++HR
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHR 163

Query: 123 DIKPANVLLDADLNGKLGDFGLARLY-DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           D+K  N+LLD +   K+ DFG+++   + D    +T + GT GY+ PE    G+ +  +D
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSD 223

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME 241
           VY+FGV + EV   R  I Q    EMVNL +W  +    G +    D  L      E + 
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283

Query: 242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPD 276
                 + C     E RP+M  V+  L+    L +
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  193 bits (491), Expect = 1e-59
 Identities = 61/241 (25%), Positives = 95/241 (39%), Gaps = 26/241 (10%)

Query: 50  HSNGLLQL---TNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           H N +LQ         S   +  L+  +   GSL   L  N    +SW +   I   +A 
Sbjct: 77  HEN-ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMAR 132

Query: 107 GLLYLHED-------WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTK 158
           GL YLHED        +  + HRDIK  NVLL  +L   + DFGLA  ++       T  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192

Query: 159 LVGTFGYMAPELMRTG-----KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDW 213
            VGT  YMAPE++         A    D+YA G+ + E+AS     +      M+   + 
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252

Query: 214 VSDCWKKGAILDASDSRL------EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
           +        + +    +       +   +   M ++ +    C     EAR +   V + 
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312

Query: 268 L 268
           +
Sbjct: 313 I 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  154 bits (391), Expect = 9e-45
 Identities = 55/255 (21%), Positives = 90/255 (35%), Gaps = 41/255 (16%)

Query: 50  HSNGLLQL----TNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           H N + +            + E+LLV +Y PNGSL K L      +  W    R+   V 
Sbjct: 66  HDN-IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLAHSVT 121

Query: 106 SGLLYLHEDWEQ------VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ---- 155
            GL YLH +  +       + HRD+   NVL+  D    + DFGL+     + + +    
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 156 ---TTKLVGTFGYMAPELMR-------TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM 205
                  VGT  YMAPE++           A    D+YA G+   E+      +    S+
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

Query: 206 EMVNLVDWVSDCWKKGAILDASDS------RLEGIYE-----EEQMELVLKLGLFCSHPK 254
               +  + ++        D          R +   E        +  + +    C    
Sbjct: 242 PEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPK-FPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 255 PEARPNMRQVMQYLD 269
            EAR   +   + + 
Sbjct: 300 AEARLTAQXAEERMA 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  153 bits (389), Expect = 1e-44
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 20/220 (9%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           ++     +V +Y+  GSL ++LH +  +  L   +R  +   VA G+ YLH      ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           R++K  N+L+D     K+ DFGL+RL    T   +    GT  +MAPE++R   ++  +D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME 241
           VY+FGV + E+A+ ++P       ++V  V +      K   L+   +    +       
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQVVAAVGF------KCKRLEIPRNLNPQVA-----A 270

Query: 242 LVLKLGLFCSHPKPEARPNMRQVMQYLDG--NATLPDIPR 279
           ++      C   +P  RP+   +M  L     + +P   R
Sbjct: 271 IIEG----CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  150 bits (381), Expect = 1e-43
 Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 26/207 (12%)

Query: 68  FLLVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
             LV +Y   GSL  +LH     P  +           + G+ YLH    + ++HRD+KP
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133

Query: 127 ANVLLDADLN-GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
            N+LL A     K+ DFG A           T   G+  +MAPE+      S   DV+++
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSW 189

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA---ILDASDSRLEGIYEEEQMEL 242
           G+ + EV + R+P +     E+      +      G    ++      +E +        
Sbjct: 190 GIILWEVITRRKPFD-----EIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR----- 239

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  C    P  RP+M ++++ + 
Sbjct: 240 -------CWSKDPSQRPSMEEIVKIMT 259

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  143 bits (363), Expect = 4e-41
 Identities = 56/255 (21%), Positives = 90/255 (35%), Gaps = 52/255 (20%)

Query: 50  HSNGLLQL---TNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVAS 106
           H N +L       T      +  L+  Y   GSL   L      +L      RI+  +AS
Sbjct: 61  HEN-ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIAS 116

Query: 107 GLLYLHEDWEQ-----VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ---TTK 158
           GL +LH +         + HRD+K  N+L+  +    + D GLA ++   T         
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 159 LVGTFGYMAPELMR------TGKASTSTDVYAFGVFMLEVASGRRPIE------------ 200
            VGT  YMAPE++          +    D++AFG+ + EVA                   
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

Query: 201 ---QQGSMEMVNLVDWVSDCWKKGAILDASDSRLE---GIYEEEQMELVLKLGLFCSHPK 254
                   +M  +V     C  +         R       + +  +  + KL   C +  
Sbjct: 237 VPNDPSFEDMRKVV-----CVDQ--------QRPNIPNRWFSDPTLTSLAKLMKECWYQN 283

Query: 255 PEARPNMRQVMQYLD 269
           P AR    ++ + L 
Sbjct: 284 PSARLTALRIKKTLT 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  142 bits (360), Expect = 6e-41
 Identities = 37/206 (17%), Positives = 79/206 (38%), Gaps = 31/206 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+  +MP GSL  +LH      +   Q  +    +A G+ +LH   E ++    +   +V
Sbjct: 86  LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSV 144

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST---DVYAFG 186
           ++D D+  ++    +   +      Q+   +    ++APE ++     T+    D+++F 
Sbjct: 145 MIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198

Query: 187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKG---AILDASDSRLEGIYEEEQMELV 243
           V + E+ +   P     +ME+   V        +G    I       +  + +       
Sbjct: 199 VLLWELVTREVPFADLSNMEIGMKVAL------EGLRPTIPPGISPHVSKLMKI------ 246

Query: 244 LKLGLFCSHPKPEARPNMRQVMQYLD 269
                 C +  P  RP    ++  L+
Sbjct: 247 ------CMNEDPAKRPKFDMIVPILE 266

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  142 bits (361), Expect = 2e-40
 Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 22/222 (9%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED-----WEQVVLH 121
           +  L+ DY  NGSL   L +    +L      ++     SGL +LH +      +  + H
Sbjct: 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ---TTKLVGTFGYMAPEL------MR 172
           RD+K  N+L+  +    + D GLA  +  DT          VGT  YM PE+        
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN 225

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM--VNLVDWVSDCWKKGAILDASDSR 230
             ++    D+Y+FG+ + EVA            ++   +LV           I+     R
Sbjct: 226 HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285

Query: 231 LE---GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                    +E +  + KL   C    P +R    +V + L 
Sbjct: 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  141 bits (357), Expect = 3e-40
 Identities = 45/210 (21%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +++P G L   L     P + W  + R++  +A G+ Y+  +    ++HRD++  N+
Sbjct: 98  MVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNI 155

Query: 130 LLD-----ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM--RTGKASTSTDV 182
            L      A +  K+ DFGL++   H      + L+G F +MAPE +       +   D 
Sbjct: 156 FLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADT 211

Query: 183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA---ILDASDSRLEGIYEEEQ 239
           Y+F + +  + +G  P ++    ++     +++   ++G    I +    RL  + E   
Sbjct: 212 YSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGLRPTIPEDCPPRLRNVIEL-- 265

Query: 240 MELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                     C    P+ RP+   +++ L 
Sbjct: 266 ----------CWSGDPKKRPHFSYIVKELS 285

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  142 bits (360), Expect = 4e-40
 Identities = 49/223 (21%), Positives = 84/223 (37%), Gaps = 24/223 (10%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ-----VVLH 121
           +  LV DY  +GSL   L+     +++     ++    ASGL +LH +         + H
Sbjct: 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT---TKLVGTFGYMAPELMR------ 172
           RD+K  N+L+  +    + D GLA  +D  T          VGT  YMAPE++       
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA---SDS 229
             ++    D+YA G+   E+A            ++    D V        +         
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSVEEMRKVVCEQKL 289

Query: 230 RLE---GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           R          E + ++ K+   C +    AR    ++ + L 
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  140 bits (355), Expect = 4e-40
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 29/210 (13%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             LV ++   G L+++L       +           +A G+ YLH++    ++HRD+K +
Sbjct: 81  LCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137

Query: 128 NVLLDADLNG--------KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           N+L+   +          K+ DFGLAR +   T        G + +MAPE++R    S  
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKG 194

Query: 180 TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ 239
           +DV+++GV + E+ +G  P      + +   V            L    +  E       
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM------NKLALPIPSTCPEPFA---- 244

Query: 240 MELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            +L+      C +P P +RP+   ++  L 
Sbjct: 245 -KLMED----CWNPDPHSRPSFTNILDQLT 269

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  140 bits (355), Expect = 1e-39
 Identities = 44/220 (20%), Positives = 84/220 (38%), Gaps = 31/220 (14%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
            +      + +Y+  G+L  I+ +       W QR    + +ASG+ YLH      ++HR
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTI-------------PQTTKLVGTFGYMAPE 169
           D+   N L+  + N  + DFGLARL   +                +   +VG   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 170 LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
           ++         DV++FG+ + E+              M   ++      +         +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----VRGFLDRYCPPN 247

Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +      + ++    C    PE RP+  ++  +L+
Sbjct: 248 CPPSFF-----PITVR----CCDLDPEKRPSFVKLEHWLE 278

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  138 bits (350), Expect = 4e-39
 Identities = 49/221 (22%), Positives = 97/221 (43%), Gaps = 25/221 (11%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
              +  +V  +    SL   LH + +      +   I R  A G+ YLH    + ++HRD
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLVGTFGYMAPELMRTGKASTST-- 180
           +K  N+ L  D   K+GDFGLA      +      +L G+  +MAPE++R   ++  +  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 181 -DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ 239
            DVYAFG+ + E+ +G+ P     + + +  ++ V        +     +  + +     
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGRGSLSPDLSKVRSNCPKRMK---- 259

Query: 240 MELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRD 280
             L+ +    C   K + RP+  +++  ++      ++ R+
Sbjct: 260 -RLMAE----CLKKKRDERPSFPRILAEIE------ELARE 289

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  131 bits (332), Expect = 2e-36
 Identities = 44/229 (19%), Positives = 84/229 (36%), Gaps = 36/229 (15%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
                 ++       +L  ++  + K  L   +  +I + +  G+ YLH    + +LH+D
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKD 155

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIP----QTTKLVGTFGYMAPELMRTGKA--- 176
           +K  NV  D +    + DFGL  +           +     G   ++APE++R       
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214

Query: 177 ------STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSR 230
                 S  +DV+A G    E+ +   P + Q +  ++  +               +  +
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--------------GTGMK 260

Query: 231 LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPR 279
                     E+   + LFC   + E RP   ++M  L+    LP   R
Sbjct: 261 PNLSQIGMGKEIS-DILLFCWAFEQEERPTFTKLMDMLE---KLPKRNR 305

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  118 bits (299), Expect = 9e-32
 Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 26/209 (12%)

Query: 58  TNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ 117
            N+  S+     +  ++   G+L++ +       L       +   +  G+ Y+H    +
Sbjct: 85  KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---K 141

Query: 118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
            +++RD+KP+N+ L      K+GDFGL     +D   + T+  GT  YM+PE + +    
Sbjct: 142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYG 199

Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE 237
              D+YA G+ + E+           + E                  D  D  +  I+++
Sbjct: 200 KEVDLYALGLILAELLHVCDT-----AFETSKF------------FTDLRDGIISDIFDK 242

Query: 238 EQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
           ++  L+ KL L     KPE RPN  ++++
Sbjct: 243 KEKTLLQKL-L---SKKPEDRPNTSEILR 267

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  117 bits (296), Expect = 8e-31
 Identities = 44/203 (21%), Positives = 81/203 (39%), Gaps = 20/203 (9%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
            G   +V DY   G L K ++          Q       +   L ++H+   + +LHRDI
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDI 151

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           K  N+ L  D   +LGDFG+AR+ +          +GT  Y++PE+      +  +D++A
Sbjct: 152 KSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKPYNNKSDIWA 210

Query: 185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
            G  + E+ + +   E      +V  +         G+        +   Y  +   LV 
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKI-------ISGSF-----PPVSLHYSYDLRSLVS 258

Query: 245 KLGLFCSHPKPEARPNMRQVMQY 267
           +         P  RP++  +++ 
Sbjct: 259 Q----LFKRNPRDRPSVNSILEK 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  116 bits (292), Expect = 2e-30
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 29/209 (13%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQV 118
             E  +V +    G L ++    IK      +        +    + S L ++H    + 
Sbjct: 104 DNELNIVLELADAGDLSRM----IKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RR 156

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           V+HRDIKPANV + A    KLGD GL R +   T    + LVGT  YM+PE +     + 
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYNF 215

Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL-EGIYEE 237
            +D+++ G  + E+A+ + P      M + +L        KK  I       L    Y E
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLC-------KK--IEQCDYPPLPSDHYSE 265

Query: 238 EQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
           E  +LV      C +P PE RP++  V  
Sbjct: 266 ELRQLVNM----CINPDPEKRPDVTYVYD 290

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  113 bits (285), Expect = 4e-29
 Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 24/212 (11%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V ++K    +V + +  G     L T     L      +++   A+G+ YL     +  +
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MAPELMRTGKAST 178
           HRD+   N L+      K+ DFG++R         +  L         APE +  G+ S+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL-RQVPVKWTAPEALNYGRYSS 294

Query: 179 STDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE 237
            +DV++FG+ + E  S G  P     + +    V+       KG  L   +   + ++  
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGRLPCPELCPDAVF-- 345

Query: 238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
               L+ +    C   +P  RP+   + Q L 
Sbjct: 346 ---RLMEQ----CWAYEPGQRPSFSTIYQELQ 370

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  111 bits (279), Expect = 6e-29
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHE- 113
           ++       +V +Y   G L  +    I       Q        R++  +   L   H  
Sbjct: 75  IDRTNTTLYIVMEYCEGGDLASV----ITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 114 -DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR 172
            D    VLHRD+KPANV LD   N KLGDFGLAR+ +HDT       VGT  YM+PE M 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMN 189

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE 232
               +  +D+++ G  + E+ +   P       E+   +       ++G        R+ 
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGKF-----RRIP 237

Query: 233 GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
             Y +E  E++ +      + K   RP++ ++++ 
Sbjct: 238 YRYSDELNEIITR----MLNLKDYHRPSVEEILEN 268

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (278), Expect = 2e-28
 Identities = 47/218 (21%), Positives = 79/218 (36%), Gaps = 33/218 (15%)

Query: 62  NSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           +S K    +        +L D +                I   +A  + +LH    + ++
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLM 186

Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-----------TKLVGTFGYMAPE 169
           HRD+KP+N+    D   K+GDFGL    D D   QT           T  VGT  YM+PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 170 LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
            +     S   D+++ G+ + E+            ME V ++  V    +          
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRIITDV----RNLKFPLLFTQ 297

Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY 267
                   ++  +V  + L    P P  RP    +++ 
Sbjct: 298 -----KYPQEHMMVQDM-L---SPSPTERPEATDIIEN 326

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  113 bits (284), Expect = 2e-28
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 22/221 (9%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL     +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 275 HPN-LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL +   +  +HR++   N L+  +   K+ DFGL+RL   DT            + APE
Sbjct: 333 YLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389

Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +   K S  +DV+AFGV + E+A+ G  P       ++  L++       K   ++  +
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERPE 442

Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
              E +YE         L   C    P  RP+  ++ Q  +
Sbjct: 443 GCPEKVYE---------LMRACWQWNPSDRPSFAEIHQAFE 474

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  112 bits (283), Expect = 2e-28
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             +V +YM  GSL   L       L   Q   +   +ASG+ Y+        +HRD++ A
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAA 309

Query: 128 NVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           N+L+  +L  K+ DFGLARL + +  T  Q  K      + APE    G+ +  +DV++F
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSF 367

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           G+ + E+ + GR P     + E+++ V+       +G  +       E +++        
Sbjct: 368 GILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMPCPPECPESLHD-------- 412

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLD 269
            L   C   +PE RP    +  +L+
Sbjct: 413 -LMCQCWRKEPEERPTFEYLQAFLE 436

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  113 bits (283), Expect = 3e-28
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             +V +YM  GSL   L       L   Q   +   +ASG+ Y+        +HRD++ A
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAA 392

Query: 128 NVLLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           N+L+  +L  K+ DFGLARL + +  T  Q  K      + APE    G+ +  +DV++F
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSF 450

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           G+ + E+ + GR P     + E+++ V+       +G  +       E +++        
Sbjct: 451 GILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMPCPPECPESLHD-------- 495

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLD 269
            L   C   +PE RP    +  +L+
Sbjct: 496 -LMCQCWRKEPEERPTFEYLQAFLE 519

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  109 bits (275), Expect = 3e-28
 Identities = 45/209 (21%), Positives = 73/209 (34%), Gaps = 33/209 (15%)

Query: 71  VYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
                   +L D +                I   +A  + +LH    + ++HRD+KP+N+
Sbjct: 93  QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNI 149

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTT-----------KLVGTFGYMAPELMRTGKAST 178
               D   K+GDFGL    D D   QT              VGT  YM+PE +     S 
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209

Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
             D+++ G+ + E+     P      ME V              + +     L       
Sbjct: 210 KVDIFSLGLILFELL---YPFS--TQMERVRT-------LTD--VRNLKFPPLFTQKYPC 255

Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQY 267
           +  +V  + L    P P  RP    +++ 
Sbjct: 256 EYVMVQDM-L---SPSPMERPEAINIIEN 280

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  108 bits (271), Expect = 1e-27
 Identities = 36/129 (27%), Positives = 67/129 (51%), Gaps = 5/129 (3%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y+   +L + + ++    LS          +  G+ + H+     ++HRDIKP N+
Sbjct: 88  LVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNI 142

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+D++   K+ DFG+A+     ++ QT  ++GT  Y +PE  +       TD+Y+ G+ +
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVL 202

Query: 190 LEVASGRRP 198
            E+  G  P
Sbjct: 203 YEMLVGEPP 211

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  108 bits (271), Expect = 1e-27
 Identities = 38/129 (29%), Positives = 55/129 (42%), Gaps = 5/129 (3%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +    +    L  +L       L+  +   I+R + S L   H        HRD+KP N+
Sbjct: 111 VDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENI 165

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           L+ AD    L DFG+A     + + Q    VGT  YMAPE      A+   D+YA    +
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVL 225

Query: 190 LEVASGRRP 198
            E  +G  P
Sbjct: 226 YECLTGSPP 234

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  105 bits (264), Expect = 1e-26
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 25/224 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +L L       +G  L+V  YM +G L   +      + +          VA G+ 
Sbjct: 85  HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMK 142

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GYM 166
           YL     +  +HRD+   N +LD     K+ DFGLAR +YD +      K        +M
Sbjct: 143 YLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           A E ++T K +T +DV++FGV + E+ + G  P     + ++   +        +G  L 
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGRRLL 252

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +   + +YE         + L C HPK E RP+  +++  + 
Sbjct: 253 QPEYCPDPLYE---------VMLKCWHPKAEMRPSFSELVSRIS 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  105 bits (263), Expect = 2e-26
 Identities = 43/190 (22%), Positives = 67/190 (35%), Gaps = 27/190 (14%)

Query: 78  GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG 137
            SL +         L   Q +  +R     L +LH    Q ++H D+KPAN+ L      
Sbjct: 141 PSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRC 196

Query: 138 KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR 197
           KLGDFGL          +     G   YMAPEL++ G   T+ DV++ G+ +LEVA    
Sbjct: 197 KLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNME 253

Query: 198 PIEQQGSM-EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE 256
                    ++                              E   +++        P P+
Sbjct: 254 LPHGGEGWQQLRQGYL---------------PPEFTAGLSSELRSVLVM----MLEPDPK 294

Query: 257 ARPNMRQVMQ 266
            R     ++ 
Sbjct: 295 LRATAEALLA 304

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (264), Expect = 2e-26
 Identities = 69/239 (28%), Positives = 115/239 (48%), Gaps = 25/239 (10%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +++L   V +R    ++V +YM NGSLD  L T+     +  Q   ++RGV +G+ 
Sbjct: 109 HPN-IIRLEGVV-TRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMR 165

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MA 167
           YL +      +HRD+   NVL+D++L  K+ DFGL+R+ + D     T   G       A
Sbjct: 166 YLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +     S+++DV++FGV M EV + G RP     + ++++ V+       +G  L A
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-------EGYRLPA 275

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIA 285
                  +++         L L C H     RP   Q++  LD     P+  R +  ++
Sbjct: 276 PMGCPHALHQ---------LMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  106 bits (266), Expect = 4e-26
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 25/221 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V   + 
Sbjct: 245 HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL        +HRD+   NVL+  D   K+ DFGL +  +  +   T KL     + APE
Sbjct: 304 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPE 356

Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V+       KG  +DA D
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD 409

Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +Y     +++      C H     RP   Q+ + L+
Sbjct: 410 GCPPAVY-----DVMKN----CWHLDAATRPTFLQLREQLE 441

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  102 bits (257), Expect = 7e-26
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 27/223 (12%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H   L++      S++    +V +Y+ NG L   L ++    L   Q   +   V  G+ 
Sbjct: 62  HPK-LVKFYGVC-SKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMA 118

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MA 167
           +L        +HRD+   N L+D DL  K+ DFG+ R    D     + +   F     A
Sbjct: 119 FLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSA 173

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE+    K S+ +DV+AFG+ M EV S G+ P +   + E+V  V        +G  L  
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------QGHRLYR 226

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                + IY+         +   C H  PE RP  +Q++  ++
Sbjct: 227 PHLASDTIYQ---------IMYSCWHELPEKRPTFQQLLSSIE 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  104 bits (261), Expect = 8e-26
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            ++V +YM NGSLD  L  +     +  Q   ++RG+ASG+ YL +      +HRD+   
Sbjct: 121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAAR 176

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MAPELMRTGKASTSTDVYAF 185
           N+L++++L  K+ DFGL R+ + D     T   G       +PE +   K ++++DV+++
Sbjct: 177 NILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           G+ + EV S G RP  +  + +++  VD       +G  L         +Y+        
Sbjct: 237 GIVLWEVMSYGERPYWEMSNQDVIKAVD-------EGYRLPPPMDCPAALYQ-------- 281

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLD 269
            L L C       RP   Q++  LD
Sbjct: 282 -LMLDCWQKDRNNRPKFEQIVSILD 305

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  103 bits (258), Expect = 1e-25
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 45/217 (20%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPS--LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +  +Y  NG+L D I   N+       W    R+ R +   L Y+H    Q ++HRD+KP
Sbjct: 92  IQMEYCENGTLYDLIHSENLNQQRDEYW----RLFRQILEALSYIHS---QGIIHRDLKP 144

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQT-------------TKLVGTFGYMAPELMR- 172
            N+ +D   N K+GDFGLA+                       T  +GT  Y+A E++  
Sbjct: 145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDAS---DS 229
           TG  +   D+Y+ G+   E+            ME VN+        KK  +   S     
Sbjct: 205 TGHYNEKIDMYSLGIIFFEMIYPFST-----GMERVNI-------LKK--LRSVSIEFPP 250

Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
             +    + + +++  L +      P  RP  R ++ 
Sbjct: 251 DFDDNKMKVEKKIIRLL-I---DHDPNKRPGARTLLN 283

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  102 bits (257), Expect = 1e-25
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 26/223 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N L+QL     +R+  F ++ ++M  G+L   L    +  +S      +   ++S + 
Sbjct: 68  HPN-LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MA 167
           YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT          F     A
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTA 180

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE +   K S  +DV+AFGV + E+A+ G  P       ++  L++       K   ++ 
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMER 233

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            +   E +YE         L   C    P  RP+  ++ Q  +
Sbjct: 234 PEGCPEKVYE---------LMRACWQWNPSDRPSFAEIHQAFE 267

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  103 bits (259), Expect = 1e-25
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 23/216 (10%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            +++ +YM NG+LDK L        S  Q   ++RG+A+G+ YL        +HRD+   
Sbjct: 121 MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAAR 176

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MAPELMRTGKASTSTDVYAF 185
           N+L++++L  K+ DFGL+R+ + D     T   G       APE +   K ++++DV++F
Sbjct: 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           G+ M EV + G RP  +  + E++  ++        G  L         IY+        
Sbjct: 237 GIVMWEVMTYGERPYWELSNHEVMKAIN-------DGFRLPTPMDCPSAIYQ-------- 281

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRD 280
            L + C   +   RP    ++  LD     PD  + 
Sbjct: 282 -LMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (258), Expect = 1e-25
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 7/131 (5%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   +L  I+HT     ++  +   +I      L + H+     ++HRD+KPAN+
Sbjct: 93  IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANI 147

Query: 130 LLDADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           ++ A    K+ DFG+AR       ++ QT  ++GT  Y++PE  R       +DVY+ G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207

Query: 188 FMLEVASGRRP 198
            + EV +G  P
Sbjct: 208 VLYEVLTGEPP 218

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  101 bits (254), Expect = 2e-25
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 27/223 (12%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H   L+QL   V   +    LV ++M +G L   L T  +   +      +   V  G+ 
Sbjct: 62  HPK-LVQLYG-VCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMA 118

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MA 167
           YL E     V+HRD+   N L+  +   K+ DFG+ R    D    T+     F     +
Sbjct: 119 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWAS 173

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE+    + S+ +DV++FGV M EV S G+ P E + + E+V  +         G  L  
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TGFRLYK 226

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  +Y+         +   C   +PE RP   ++++ L 
Sbjct: 227 PRLASTHVYQ---------IMNHCWRERPEDRPAFSRLLRQLA 260

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  101 bits (254), Expect = 2e-25
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 25/221 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V   + 
Sbjct: 73  HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
           YL        +HRD+   NVL+  D   K+ DFGL +  +  +   T KL     + APE
Sbjct: 132 YLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPE 184

Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
            +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V+       KG  +DA D
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD 237

Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                +YE         +   C H     RP+  Q+ + L+
Sbjct: 238 GCPPAVYE---------VMKNCWHLDAAMRPSFLQLREQLE 269

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  102 bits (257), Expect = 3e-25
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 25/224 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +L L       +G  L+V  YM +G L   +      + +          VA G+ 
Sbjct: 149 HPN-VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMK 206

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GYM 166
           +L     +  +HRD+   N +LD     K+ DFGLAR +YD +      K        +M
Sbjct: 207 FLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           A E ++T K +T +DV++FGV + E+ + G  P     + ++   +        +G  L 
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGRRLL 316

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +   + +Y     E++LK    C HPK E RP+  +++  + 
Sbjct: 317 QPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELVSRIS 351

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  101 bits (253), Expect = 3e-25
 Identities = 44/195 (22%), Positives = 79/195 (40%), Gaps = 24/195 (12%)

Query: 74  YMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 133
            M +G+L   L       +         R +  GL +LH      ++HRD+K  N+ +  
Sbjct: 110 LMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITG 166

Query: 134 DLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE 191
              G  K+GD GLA L           ++GT  +MAPE+        S DVYAFG+ MLE
Sbjct: 167 P-TGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLE 221

Query: 192 VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCS 251
           +A+   P  +  +   +         +++        +  + +   E  E++      C 
Sbjct: 222 MATSEYPYSECQNAAQI---------YRR-VTSGVKPASFDKVAIPEVKEIIEG----CI 267

Query: 252 HPKPEARPNMRQVMQ 266
               + R +++ ++ 
Sbjct: 268 RQNKDERYSIKDLLN 282

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (253), Expect = 3e-25
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 24/205 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             ++ +YM NGSL   L T     L+  +   +   +A G+ ++ E   +  +HRD++ A
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAA 138

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MAPELMRTGKASTSTDVYAF 185
           N+L+   L+ K+ DFGLARL + +    T +    F     APE +  G  +  +DV++F
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           G+ + E+ + GR P     + E++  ++       +G  +   D+  E +Y+        
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCPEELYQ-------- 241

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLD 269
            L   C   +PE RP    +   L+
Sbjct: 242 -LMRLCWKERPEDRPTFDYLRSVLE 265

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  102 bits (255), Expect = 4e-25
 Identities = 42/254 (16%), Positives = 83/254 (32%), Gaps = 35/254 (13%)

Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           ++ + EFLL+ +      ++ +     +  LS     +I       + ++H   +  ++H
Sbjct: 103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIH 161

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL-----------VGTFGYMAPEL 170
           RD+K  N+LL      KL DFG A    H      +               T  Y  PE+
Sbjct: 162 RDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI 221

Query: 171 ---MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDAS 227
                        D++A G  +  +   + P E    +                 I++  
Sbjct: 222 IDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----------------RIVNGK 265

Query: 228 DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPF 287
            S      +      +++         PE R ++ +V+  L   A   ++   S  I   
Sbjct: 266 YSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS-PITEL 321

Query: 288 SASNDAFSGNSSAT 301
              N  +   + + 
Sbjct: 322 LEQNGGYGSATLSR 335

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (257), Expect = 4e-25
 Identities = 20/151 (13%), Positives = 48/151 (31%), Gaps = 10/151 (6%)

Query: 68  FLLVYDYMPNGSLDKILHTNIK--PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
           FL         +  ++L ++     SL  + R ++   V   L  LH      ++H  ++
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 238

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTST 180
           P +++LD      L  F          +    +        A  ++          + + 
Sbjct: 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298

Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           D +  G+ +  +     P     ++     +
Sbjct: 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  103 bits (258), Expect = 5e-25
 Identities = 47/205 (22%), Positives = 94/205 (45%), Gaps = 24/205 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             ++ ++M  GSL   L ++        +       +A G+ ++ +   +  +HRD++ A
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAA 313

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MAPELMRTGKASTSTDVYAF 185
           N+L+ A L  K+ DFGLAR+ + +    T +    F     APE +  G  +  +DV++F
Sbjct: 314 NILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           G+ ++E+ + GR P     + E++  ++       +G  +   ++  E +Y         
Sbjct: 372 GILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRMPRPENCPEELYN-------- 416

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLD 269
            + + C   +PE RP    +   LD
Sbjct: 417 -IMMRCWKNRPEERPTFEYIQSVLD 440

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  100 bits (251), Expect = 6e-25
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 23/205 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
            +LV +    G L K L    +  +       ++  V+ G+ YL E   +  +HRD+   
Sbjct: 84  LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAAR 139

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAF 185
           NVLL      K+ DFGL++    D    T +  G +   + APE +   K S+ +DV+++
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 199

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           GV M E  S G++P ++    E++  ++       +G  ++        +Y      L+ 
Sbjct: 200 GVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRMECPPECPPELY-----ALMS 247

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLD 269
                C   K E RP+   V Q + 
Sbjct: 248 D----CWIYKWEDRPDFLTVEQRMR 268

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  100 bits (251), Expect = 7e-25
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 25/204 (12%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            ++ +  P G L   L  N K SL           +   + YL        +HRDI   N
Sbjct: 88  WIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRN 143

Query: 129 VLLDADLNGKLGDFGLAR-LYDHDTIPQT-TKLVGTFGYMAPELMRTGKASTSTDVYAFG 186
           +L+ +    KLGDFGL+R + D D    + T+L     +M+PE +   + +T++DV+ F 
Sbjct: 144 ILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFTTASDVWMFA 201

Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           V M E+ S G++P     + +++ +++       KG  L   D     +Y          
Sbjct: 202 VCMWEILSFGKQPFFWLENKDVIGVLE-------KGDRLPKPDLCPPVLYT--------- 245

Query: 246 LGLFCSHPKPEARPNMRQVMQYLD 269
           L   C    P  RP   +++  L 
Sbjct: 246 LMTRCWDYDPSDRPRFTELVCSLS 269

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  100 bits (251), Expect = 7e-25
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 27/223 (12%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H   L+QL   V +++    ++ +YM NG L   L    +      Q   + + V   + 
Sbjct: 78  HEK-LVQLYG-VCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAME 134

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MA 167
           YL     +  LHRD+   N L++     K+ DFGL+R    D    T+ +   F      
Sbjct: 135 YLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 189

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA 226
           PE++   K S+ +D++AFGV M E+ S G+ P E+  + E    +        +G  L  
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYR 242

Query: 227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                E +Y          +   C H K + RP  + ++  + 
Sbjct: 243 PHLASEKVYT---------IMYSCWHEKADERPTFKILLSNIL 276

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (251), Expect = 8e-25
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 25/224 (11%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           H N +L L   +   +G   ++  YM +G L + + +  + + +          VA G+ 
Sbjct: 81  HPN-VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGME 138

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GYM 166
           YL E   Q  +HRD+   N +LD     K+ DFGLAR + D +               + 
Sbjct: 139 YLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           A E ++T + +T +DV++FGV + E+ + G  P       ++ + +        +G  L 
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------AQGRRLP 248

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +   + +Y+         +   C    P  RP  R ++  ++
Sbjct: 249 QPEYCPDSLYQ---------VMQQCWEADPAVRPTFRVLVGEVE 283

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  100 bits (252), Expect = 1e-24
 Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 26/204 (12%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+   MP G L   +  + K ++           +A G+ YL +   + ++HRD+   NV
Sbjct: 93  LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNV 148

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT---FGYMAPELMRTGKASTSTDVYAFG 186
           L+    + K+ DFGLA+L   +   +     G      +MA E +     +  +DV+++G
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206

Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           V + E+ + G +P +   + E+ ++++       KG  L         +Y      ++ K
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSILE-------KGERLPQPPICTIDVY-----MIMRK 254

Query: 246 LGLFCSHPKPEARPNMRQVMQYLD 269
               C     ++RP  R+++    
Sbjct: 255 ----CWMIDADSRPKFRELIIEFS 274

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 25/205 (12%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             ++ +    G L   L    K SL           +++ L YL     +  +HRDI   
Sbjct: 90  VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAAR 145

Query: 128 NVLLDADLNGKLGDFGLAR-LYDHDTIPQT-TKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           NVL+ ++   KLGDFGL+R + D      +  KL     +MAPE +   + ++++DV+ F
Sbjct: 146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMF 203

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           GV M E+   G +P +   + +++  ++        G  L    +    +Y         
Sbjct: 204 GVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLPMPPNCPPTLYS-------- 248

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLD 269
            L   C    P  RP   ++   L 
Sbjct: 249 -LMTKCWAYDPSRRPRFTELKAQLS 272

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  103 bits (257), Expect = 1e-24
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 23/203 (11%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            ++ +    G L   L    K SL           +++ L YL     +  +HRDI   N
Sbjct: 466 WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARN 521

Query: 129 VLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           VL+ ++   KLGDFGL+R + D      +   +    +MAPE +   + ++++DV+ FGV
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGV 580

Query: 188 FMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
            M E+   G +P +   + +++  ++        G  L    +    +Y          L
Sbjct: 581 CMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLPMPPNCPPTLYS---------L 624

Query: 247 GLFCSHPKPEARPNMRQVMQYLD 269
              C    P  RP   ++   L 
Sbjct: 625 MTKCWAYDPSRRPRFTELKAQLS 647

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 99.7 bits (249), Expect = 2e-24
 Identities = 48/255 (18%), Positives = 81/255 (31%), Gaps = 43/255 (16%)

Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF------RII 101
           H N   L+         K E  L+  +   G+L       I+                ++
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE----IERLKDKGNFLTEDQILWLL 140

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL-- 159
            G+  GL  +H    +   HRD+KP N+LL  +    L D G               L  
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 160 ------VGTFGYMAPELMRT---GKASTSTDVYAFGVFMLEVASGRRPIEQQG-SMEMVN 209
                   T  Y APEL            TDV++ G  +  +  G  P +      + V 
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           L           A+ +         +     +L+  + +      P  RP++  ++  L+
Sbjct: 258 L-----------AVQNQLSIPQSPRHSSALWQLLNSM-M---TVDPHQRPHIPLLLSQLE 302

Query: 270 GNATLPDIPRDSTLI 284
                P   + +T I
Sbjct: 303 ALQP-PAPGQHTTQI 316

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  100 bits (250), Expect = 3e-24
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 40/223 (17%)

Query: 74  YMPNGSLDKILHTNIK---PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 130
           +M  GSLD++L    +     L      ++   V  GL YL E  +  ++HRD+KP+N+L
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 164

Query: 131 LDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML 190
           +++    KL DFG++     D++  +   VGT  YM+PE ++    S  +D+++ G+ ++
Sbjct: 165 VNSRGEIKLCDFGVSGQLI-DSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221

Query: 191 EVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE----------EQM 240
           E+A GR PI    + E+  +     +                               E +
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281

Query: 241 ELV-------LKLGLF----------CSHPKPEARPNMRQVMQ 266
           + +       L  G+F          C    P  R +++Q+M 
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 98.5 bits (246), Expect = 3e-24
 Identities = 43/143 (30%), Positives = 74/143 (51%), Gaps = 13/143 (9%)

Query: 63  SRKGEFLLVY-DYMPNGSLDKILHTNIKPSLSWYQRFRII-RGVASGLLYLHEDWEQVVL 120
             +  F+ ++ + +P GSL  +L +   P     Q      + +  GL YLH+     ++
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIV 144

Query: 121 HRDIKPANVLLDADLNG--KLGDFGLA-RLYDHDTIPQTTKLVGTFGYMAPELMRTGK-- 175
           HRDIK  NVL++   +G  K+ DFG + RL   +   +T    GT  YMAPE++  G   
Sbjct: 145 HRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG 201

Query: 176 ASTSTDVYAFGVFMLEVASGRRP 198
              + D+++ G  ++E+A+G+ P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (251), Expect = 8e-24
 Identities = 31/129 (24%), Positives = 53/129 (41%), Gaps = 14/129 (10%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +Y+   SL +         L   +    +  +   L YLH      +++ D+KP N+
Sbjct: 161 IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENI 213

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           +L  +   KL D G         I     L GT G+ APE++R    + +TD+Y  G  +
Sbjct: 214 MLTEE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTL 266

Query: 190 LEVASGRRP 198
             +      
Sbjct: 267 AALTLDLPT 275

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  100 bits (249), Expect = 1e-23
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +LV +    G L K L    +  +       ++  V+ G+ YL E   +  +HR++   N
Sbjct: 411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARN 466

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MAPELMRTGKASTSTDVYAFG 186
           VLL      K+ DFGL++    D    T +  G +     APE +   K S+ +DV+++G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526

Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           V M E  S G++P ++    E++  ++       +G  ++        +Y      L+  
Sbjct: 527 VTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRMECPPECPPELY-----ALMSD 574

Query: 246 LGLFCSHPKPEARPNMRQVMQYLD 269
               C   K E RP+   V Q + 
Sbjct: 575 ----CWIYKWEDRPDFLTVEQRMR 594

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 51/252 (20%), Positives = 103/252 (40%), Gaps = 32/252 (12%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           L+   MP G L   +  + K ++           +A G+ YL +   + ++HRD+   NV
Sbjct: 93  LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNV 148

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT---FGYMAPELMRTGKASTSTDVYAFG 186
           L+    + K+ DFGLA+L   +   +     G      +MA E +     +  +DV+++G
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206

Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           V + E+ + G +P +   + E+ ++++       KG  L         +Y      +++K
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSILE-------KGERLPQPPICTIDVY-----MIMVK 254

Query: 246 LGLFCSHPKPEARPNMRQVMQYLDGNATLP----DIPRDSTLIAPFSASNDAFSGNSSAT 301
               C     ++RP  R+++      A  P     I  D  +  P  +  D+    +   
Sbjct: 255 ----CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP--SPTDSNFYRALMD 308

Query: 302 MSTIDSILTVGR 313
              +D ++    
Sbjct: 309 EEDMDDVVDADE 320

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 95.8 bits (239), Expect = 4e-23
 Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 24/204 (11%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +LV +    G L+K L  N    +       ++  V+ G+ YL E  E   +HRD+   N
Sbjct: 93  MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYL-E--ESNFVHRDLAARN 147

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAFG 186
           VLL      K+ DFGL++    D      +  G +   + APE +   K S+ +DV++FG
Sbjct: 148 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 207

Query: 187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK 245
           V M E  S G++P       E+  +++       KG  +         +Y+         
Sbjct: 208 VLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGCPREMYD--------- 251

Query: 246 LGLFCSHPKPEARPNMRQVMQYLD 269
           L   C     E RP    V   L 
Sbjct: 252 LMNLCWTYDVENRPGFAAVELRLR 275

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 95.8 bits (239), Expect = 4e-23
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 22/203 (10%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +  P GSL   L  + +         R    VA G+ YL     +  +HRD+   N+
Sbjct: 97  MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNL 152

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY--MAPELMRTGKASTSTDVYAFGV 187
           LL      K+GDFGL R    +      +      +   APE ++T   S ++D + FGV
Sbjct: 153 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 212

Query: 188 FMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL 246
            + E+ + G+ P       ++++ +D      K+G  L   +   + IY      ++++ 
Sbjct: 213 TLWEMFTYGQEPWIGLNGSQILHKID------KEGERLPRPEDCPQDIY-----NVMVQ- 260

Query: 247 GLFCSHPKPEARPNMRQVMQYLD 269
              C   KPE RP    +  +L 
Sbjct: 261 ---CWAHKPEDRPTFVALRDFLL 280

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 94.7 bits (236), Expect = 9e-23
 Identities = 42/215 (19%), Positives = 76/215 (35%), Gaps = 49/215 (22%)

Query: 74  YMPNGSLDKIL--HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 131
           Y   GSL   +  +  I       +   ++  V  GL Y+H      ++H DIKP+N+ +
Sbjct: 92  YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFI 148

Query: 132 DAD-------------------LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR 172
                                 +  K+GD G          PQ     G   ++A E+++
Sbjct: 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQV--EEGDSRFLANEVLQ 203

Query: 173 TGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL 231
                    D++A  + ++  A    P+ + G              W +  I      R+
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQ------------WHE--IRQGRLPRI 248

Query: 232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
             +  +E  EL+        HP PE RP+   +++
Sbjct: 249 PQVLSQEFTELLKV----MIHPDPERRPSAMALVK 279

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 9/154 (5%)

Query: 58  TNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPS-LSWYQRFRIIRGVASGLLYLHEDWE 116
                +     LL  +Y   G L K L+       L       ++  ++S L YLHE   
Sbjct: 83  GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--- 139

Query: 117 QVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT 173
             ++HRD+KP N++L         K+ D G A+  D   +      VGT  Y+APEL+  
Sbjct: 140 NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPELLEQ 197

Query: 174 GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
            K + + D ++FG    E  +G RP         
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 23/147 (15%)

Query: 64  RKGEFLLVY-DYMPNGSLDKILHTNIKPSLSWYQRFR------IIRGVASGLLYLHEDWE 116
           R+G ++ ++ + +  GSL +++                      +     GL YLH    
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQ--------MGCLPEDRALYYLGQALEGLEYLHT--- 168

Query: 117 QVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTK----LVGTFGYMAPELM 171
           + +LH D+K  NVLL +D +   L DFG A     D + ++      + GT  +MAPE++
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 172 RTGKASTSTDVYAFGVFMLEVASGRRP 198
                    D+++    ML + +G  P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 26/212 (12%)

Query: 69  LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
            LV  Y+P GSL   +  + + +L           +A G+ YL E     ++HR++   N
Sbjct: 90  QLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARN 145

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT---FGYMAPELMRTGKASTSTDVYAF 185
           VLL +    ++ DFG+A L   D   +            +MA E +  GK +  +DV+++
Sbjct: 146 VLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           GV + E+ + G  P       E+ +L++       KG  L         +Y      +++
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGERLAQPQICTIDVY-----MVMV 251

Query: 245 KLGLFCSHPKPEARPNMRQVMQYLDGNATLPD 276
           K    C       RP  +++       A  P 
Sbjct: 252 K----CWMIDENIRPTFKELANEFTRMARDPP 279

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 53/244 (21%), Positives = 96/244 (39%), Gaps = 41/244 (16%)

Query: 50  HSNGLLQL----TNTVNSRKGEFLLVYDYMPNGSLDKIL----HTNIKPSLSWYQRFRII 101
           H N +++L        +    + +++  +M  G L   L           +      + +
Sbjct: 95  HPN-VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLV 160
             +A G+ YL     +  LHRD+   N +L  D+   + DFGL++ +Y  D   Q     
Sbjct: 154 VDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI-- 208

Query: 161 GTFG-----YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWV 214
                    ++A E +     ++ +DV+AFGV M E+A+ G  P     + EM + +   
Sbjct: 209 ---AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL--- 262

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG-NAT 273
                 G  L   +  L+ +Y     E++      C    P  RP    +   L+    +
Sbjct: 263 ----LHGHRLKQPEDCLDELY-----EIMYS----CWRTDPLDRPTFSVLRLQLEKLLES 309

Query: 274 LPDI 277
           LPD+
Sbjct: 310 LPDV 313

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 20/153 (13%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQ 117
           R+G+  +  + M + S DK                      +I       L +L E    
Sbjct: 92  REGDCWICMELM-STSFDKFYKYVYSVLD---DVIPEEILGKITLATVKALNHLKE--NL 145

Query: 118 VVLHRDIKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA 176
            ++HRDIKP+N+LLD   N KL DFG+  +L   D+I +T    G   YMAPE +    +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRD-AGCRPYMAPERIDPSAS 202

Query: 177 ----STSTDVYAFGVFMLEVASGRRPIEQQGSM 205
                  +DV++ G+ + E+A+GR P  +  S+
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 93.4 bits (233), Expect = 2e-22
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 40/206 (19%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +   NG +++ L   +KP  S  +    +  + +G+LYLH      +LHRD+  +N+
Sbjct: 88  LVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNL 143

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVF 188
           LL  ++N K+ DFGLA           T L GT  Y++PE + T  A    +DV++ G  
Sbjct: 144 LLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATRSAHGLESDVWSLGCM 201

Query: 189 MLEVASGRRPIEQQGSMEMVNLV--------DWVSDCWKKGAILDASDSRLEGIYEEEQM 240
              +  GR P +       +N V         ++S         +A D            
Sbjct: 202 FYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI--------EAKD------------ 241

Query: 241 ELVLKLGLFCSHPKPEARPNMRQVMQ 266
            L+ +L L      P  R ++  V+ 
Sbjct: 242 -LIHQL-L---RRNPADRLSLSSVLD 262

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 14/145 (9%)

Query: 74  YMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA 133
            M     +K+      P +      ++   +   L YL E  +  V+HRD+KP+N+LLD 
Sbjct: 105 LM-GTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDE 160

Query: 134 DLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST-----DVYAFGV 187
               KL DFG+  RL   D   +     G   YMAPE +     +        DV++ G+
Sbjct: 161 RGQIKLCDFGISGRL--VDDKAKDR-SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217

Query: 188 FMLEVASGRRPIEQQGS-MEMVNLV 211
            ++E+A+G+ P +   +  E++  V
Sbjct: 218 SLVELATGQFPYKNCKTDFEVLTKV 242

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 34/235 (14%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKIL-------------HTNIKPSLSWYQRFRIIRGVASG 107
           V +     L+V++YM +G L++ L                    L   Q   +   VA+G
Sbjct: 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYM 166
           ++YL        +HRD+   N L+   L  K+GDFG++R +Y  D      + +    +M
Sbjct: 171 MVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 227

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
            PE +   K +T +DV++FGV + E+ + G++P  Q  + E ++ +        +G  L+
Sbjct: 228 PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-------TQGRELE 280

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRD 280
              +    +Y      ++      C   +P+ R +++ V   L   A  P +  D
Sbjct: 281 RPRACPPEVY-----AIMRG----CWQREPQQRHSIKDVHARLQALAQAPPVYLD 326

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.1 bits (234), Expect = 2e-22
 Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 18/147 (12%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
               +L+ ++ P GSL   +   +    L   +   ++R V  G+ +L E     ++HR+
Sbjct: 81  TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRN 137

Query: 124 IKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           IKP N++     D     KL DFG AR  + D    +  L GT  Y+ P++         
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAVLRKD 195

Query: 180 T--------DVYAFGVFMLEVASGRRP 198
                    D+++ GV     A+G  P
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGSLP 222

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 93.5 bits (233), Expect = 3e-22
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 20/159 (12%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQ 117
           R+G+  +  + M + SLDK      K  +   Q        +I   +   L +LH   + 
Sbjct: 77  REGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KL 129

Query: 118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA- 176
            V+HRD+KP+NVL++A    K+ DFG++     D + +     G   YMAPE +      
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDI-DAGCKPYMAPERINPELNQ 187

Query: 177 ---STSTDVYAFGVFMLEVASGRRPIEQQGS-MEMVNLV 211
              S  +D+++ G+ M+E+A  R P +  G+  + +  V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 33/229 (14%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKIL-----HTNIKPSLSWYQRFRIIRGVASGLLYLHEDW 115
           V+ +     ++ + M  G L   L       +   SL+      + R +A G  YL E  
Sbjct: 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-- 158

Query: 116 EQVVLHRDIKPANVLLDA---DLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG--YMAPE 169
               +HRDI   N LL         K+GDFG+AR +Y      +           +M PE
Sbjct: 159 -NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC--AMLPVKWMPPE 215

Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
               G  ++ TD ++FGV + E+ S G  P   + + E++  V         G  +D   
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPK 268

Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
           +    +Y          +   C   +PE RPN   +++ ++     PD+
Sbjct: 269 NCPGPVYR---------IMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 94.3 bits (234), Expect = 4e-22
 Identities = 23/207 (11%), Positives = 53/207 (25%), Gaps = 23/207 (11%)

Query: 67  EFLLVYDYMPNGSLDKIL-----HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
            +LL+     +  L+ +          +          +   +      L       ++H
Sbjct: 162 NYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA--STS 179
               P N+ +  D    LGD             +         Y   E +    A  + +
Sbjct: 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHA 273

Query: 180 TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ 239
            + +  G+ +  V     P          +            ++   S + L     +  
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL----PDFV 329

Query: 240 MELVLKLGLFCSHPKPEARPNMRQVMQ 266
             L+ +  L   +     R    + M+
Sbjct: 330 KTLIGRF-L---NFDRRRRLLPLEAME 352

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 94.0 bits (234), Expect = 5e-22
 Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 33/229 (14%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKIL-----HTNIKPSLSWYQRFRIIRGVASGLLYLHEDW 115
           V+ +     ++ + M  G L   L       +   SL+      + R +A G  YL E  
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-- 199

Query: 116 EQVVLHRDIKPANVLLDADLNG---KLGDFGLAR-LYDHDTIPQTTKLVGTFG--YMAPE 169
               +HRDI   N LL     G   K+GDFG+AR +Y      +           +M PE
Sbjct: 200 -NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC--AMLPVKWMPPE 256

Query: 170 LMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD 228
               G  ++ TD ++FGV + E+ S G  P   + + E++  V         G  +D   
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRMDPPK 309

Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI 277
           +    +Y          +   C   +PE RPN   +++ ++     PD+
Sbjct: 310 NCPGPVYR---------IMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 94.5 bits (235), Expect = 6e-22
 Identities = 36/211 (17%), Positives = 81/211 (38%), Gaps = 36/211 (17%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +  +     +L + +      +    +   +++   SGL +LH      ++HRD+KP N+
Sbjct: 95  IAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNI 149

Query: 130 LL-----DADLNGKLGDFGLARLYDHD--TIPQTTKLVGTFGYMAPELMR---TGKASTS 179
           L+        +   + DFGL +       +  + + + GT G++APE++        + +
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209

Query: 180 TDVYAFGVFMLEVASGRRP----IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY 235
            D+++ G     V S          Q+ +  ++          +K   + A +       
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE------- 262

Query: 236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
                 L+ K         P+ RP+ + V++
Sbjct: 263 ------LIEK----MIAMDPQKRPSAKHVLK 283

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.4 bits (230), Expect = 9e-22
 Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 39/222 (17%)

Query: 63  SRKGEFLLVYDYMPNGSLDKIL--------HTNIKPSLSWYQRFRIIRGVASGLLYLHED 114
           S+    L++ + M  G L   L        +  +    S  +  ++   +A G+ YL+  
Sbjct: 98  SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA- 156

Query: 115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGY-----MAP 168
                +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K     G      M+P
Sbjct: 157 --NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-----GLLPVRWMSP 209

Query: 169 ELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDAS 227
           E ++ G  +T +DV++FGV + E+A+   +P +   + +++  V        +G +LD  
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-------MEGGLLDKP 262

Query: 228 DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           D+  + ++     EL+      C    P+ RP+  +++  + 
Sbjct: 263 DNCPDMLF-----ELMRM----CWQYNPKMRPSFLEIISSIK 295

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 18/147 (12%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
               +L+ ++ P GSL   +   +    L   +   ++R V  G+ +L E     ++HR+
Sbjct: 81  TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRN 137

Query: 124 IKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           IKP N++     D     KL DFG AR  + D    +  L GT  Y+ P++         
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAVLRKD 195

Query: 180 T--------DVYAFGVFMLEVASGRRP 198
                    D+++ GV     A+G  P
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGSLP 222

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 91.6 bits (228), Expect = 1e-21
 Identities = 48/239 (20%), Positives = 93/239 (38%), Gaps = 51/239 (21%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           V     E +LV +++  GSLD  L  N K  ++   +  + + +A+ + +L E     ++
Sbjct: 80  VCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEE---NTLI 135

Query: 121 HRDIKPANVLLDADLNG--------KLGDFGLAR-LYDHDTIPQTTKLVGTFGY------ 165
           H ++   N+LL  + +         KL D G++  +   D                    
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------ILQERIPW 183

Query: 166 MAPELMRTGKA-STSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
           + PE +   K  + +TD ++FG  + E+ S G +P+    S   +   +           
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-------DRHQ 236

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDST 282
           L A  +    +           L   C   +P+ RP+ R +++ L+   T   +PR S 
Sbjct: 237 LPAPKA--AELAN---------LINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSH 284

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 91.5 bits (228), Expect = 1e-21
 Identities = 50/225 (22%), Positives = 91/225 (40%), Gaps = 39/225 (17%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTN--------------IKPSLSWYQRFRIIRGVASGL 108
           ++     +++ Y  +G L + L                 +K +L       ++  +A+G+
Sbjct: 82  TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GY 165
            YL       V+H+D+   NVL+   LN K+ D GL R +Y  D               +
Sbjct: 142 EYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN--SLLPIRW 196

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
           MAPE +  GK S  +D++++GV + EV S G +P     + ++V ++       +   +L
Sbjct: 197 MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-------RNRQVL 249

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
              D     +Y          L + C +  P  RP  + +   L 
Sbjct: 250 PCPDDCPAWVYA---------LMIECWNEFPSRRPRFKDIHSRLR 285

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 91.7 bits (228), Expect = 2e-21
 Identities = 34/146 (23%), Positives = 62/146 (42%), Gaps = 13/146 (8%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQVVLHRD 123
           ++Y+YM N S+ K          ++           II+ V +   Y+H   E+ + HRD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRD 177

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM--RTGKASTSTD 181
           +KP+N+L+D +   KL DFG +               GT+ +M PE     +       D
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDKK---IKGSRGTYEFMPPEFFSNESSYNGAKVD 234

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEM 207
           +++ G+ +  +     P   + S+  
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVE 260

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 91.7 bits (228), Expect = 2e-21
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 22/136 (16%)

Query: 77  NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 136
           N  L+  L    K S+  ++R    + +   +  +H+     ++H D+KPAN L+    +
Sbjct: 92  NIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV---D 143

Query: 137 G--KLGDFGLARLYDHDTIPQTTK-LVGTFGYMAPELMR-----------TGKASTSTDV 182
           G  KL DFG+A     DT        VGT  YM PE ++             K S  +DV
Sbjct: 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G  +  +  G+ P
Sbjct: 204 WSLGCILYYMTYGKTP 219

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 57/258 (22%), Positives = 102/258 (39%), Gaps = 46/258 (17%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTN--------------IKPSLSWYQRFRIIRGVASGL 108
             +G   L  +Y P+G+L   L  +                 +LS  Q       VA G+
Sbjct: 96  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG---- 164
            YL +   +  +HRD+   N+L+  +   K+ DFGL+R    +   + T      G    
Sbjct: 156 DYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM-----GRLPV 205

Query: 165 -YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGA 222
            +MA E +     +T++DV+++GV + E+ S G  P       E+   +        +G 
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGY 258

Query: 223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDST 282
            L+   +  + +Y+         L   C   KP  RP+  Q++  L+          ++T
Sbjct: 259 RLEKPLNCDDEVYD---------LMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 309

Query: 283 LIAPFSASNDAFSGNSSA 300
           L   F+ +    S   +A
Sbjct: 310 LYEKFTYAGIDCSAEEAA 327

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 33/243 (13%), Positives = 66/243 (27%), Gaps = 53/243 (21%)

Query: 44  DGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL-----HTNIKPSLSWYQRF 98
           D +       ++++                     +L         H++   SL  + R 
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 158
           ++   V   L  LH      ++H  ++P +++LD      L  F          +     
Sbjct: 210 QLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVS---- 262

Query: 159 LVGTFGYMAPELM-----------RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
              + G+  PEL            R    + S D +A G+ +  +     PI +  ++  
Sbjct: 263 -SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321

Query: 208 VNLV----DWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ 263
              +      +                           L+    L       E R    Q
Sbjct: 322 SEWIFRSCKNIPQ--------PVRA-------------LLEGF-L---RYPKEDRLLPLQ 356

Query: 264 VMQ 266
            M+
Sbjct: 357 AME 359

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 36/136 (26%), Positives = 59/136 (43%), Gaps = 22/136 (16%)

Query: 77  NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 136
           N  L+  L    K S+  ++R    + +   +  +H+     ++H D+KPAN L+    +
Sbjct: 139 NIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV---D 190

Query: 137 G--KLGDFGLARLYDHDTIPQTTK-LVGTFGYMAPELMR-----------TGKASTSTDV 182
           G  KL DFG+A     DT        VG   YM PE ++             K S  +DV
Sbjct: 191 GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G  +  +  G+ P
Sbjct: 251 WSLGCILYYMTYGKTP 266

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 90.8 bits (226), Expect = 4e-21
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 22/136 (16%)

Query: 77  NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN 136
           N  L+  L    K S+  ++R    + +   +  +H+     ++H D+KPAN L+    +
Sbjct: 111 NIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV---D 162

Query: 137 G--KLGDFGLARLYDHDTIPQTTK-LVGTFGYMAPELMR-----------TGKASTSTDV 182
           G  KL DFG+A     DT        VGT  YM PE ++             K S  +DV
Sbjct: 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G  +  +  G+ P
Sbjct: 223 WSLGCILYYMTYGKTP 238

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.9 bits (226), Expect = 4e-21
 Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 29/216 (13%)

Query: 62  NSRKGEFLLVYDYMPNGSLDKIL----HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ 117
             R    +++  +M +G L   L          +L      R +  +A G+ YL     +
Sbjct: 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---R 156

Query: 118 VVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GYMAPELMRTG 174
             +HRD+   N +L  D+   + DFGL+R +Y  D   Q           ++A E +   
Sbjct: 157 NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA--SKLPVKWLALESLADN 214

Query: 175 KASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG 233
             +  +DV+AFGV M E+ + G+ P     + E+ N +         G  L      +E 
Sbjct: 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-------IGGNRLKQPPECMEE 267

Query: 234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +Y     +L+ +    C    P+ RP+   +   L+
Sbjct: 268 VY-----DLMYQ----CWSADPKQRPSFTCLRMELE 294

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 89.7 bits (223), Expect = 6e-21
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             L+ +++P+GSL + L  N K  ++  Q+ +    +  G+ YL     +  +HRD+   
Sbjct: 100 IKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAAR 155

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAF 185
           NVL++++   K+GDFGL +  + D    T K        + APE +   K   ++DV++F
Sbjct: 156 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215

Query: 186 GVFMLEVAS-GRRPIEQ-----------QGSMEMVNLVDWVSDCWKKGAILDASDSRLEG 233
           GV + E+ +                    G M +  LV+ +    K+G  L    +  + 
Sbjct: 216 GVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL----KEGKRLPCPPNCPDE 271

Query: 234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +Y+         L   C   +P  R + + +++  +
Sbjct: 272 VYQ---------LMRKCWEFQPSNRTSFQNLIEGFE 298

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 89.7 bits (223), Expect = 1e-20
 Identities = 48/235 (20%), Positives = 95/235 (40%), Gaps = 33/235 (14%)

Query: 50  HSNGLLQLTNTVNSRKGE-FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGL 108
               +++          +   LV +Y+P+G L   L  + +  L   +       +  G+
Sbjct: 83  SDF-IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGM 140

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYM 166
            YL     +  +HRD+   N+L++++ + K+ DFGLA+L   D      +  G     + 
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197

Query: 167 APELMRTGKASTSTDVYAFGVFMLEVAS-GRRP-----------IEQQGSMEMVNLVDWV 214
           APE +     S  +DV++FGV + E+ +   +              ++    +  L++ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
               ++G  L A  +    ++E         L   C  P P+ RP+   +   LD
Sbjct: 258 ----EEGQRLPAPPACPAEVHE---------LMKLCWAPSPQDRPSFSALGPQLD 299

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 39/225 (17%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTN--------------IKPSLSWYQRFRIIRGVASGL 108
                 ++V++YM +G L+K L  +               K  L   Q   I   +ASG+
Sbjct: 87  GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 146

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF--GY 165
           +YL     Q  +HRD+   N L+ A+L  K+GDFG++R +Y  D               +
Sbjct: 147 VYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH--TMLPIRW 201

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
           M PE +   K +T +DV++FGV + E+ + G++P  Q  + E++  +        +G +L
Sbjct: 202 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-------TQGRVL 254

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +      + +Y+         + L C   +P+ R N++++ + L 
Sbjct: 255 ERPRVCPKEVYD---------VMLGCWQREPQQRLNIKEIYKILH 290

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 38/220 (17%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   
Sbjct: 88  LKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATR 143

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAF 185
           N+L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++F
Sbjct: 144 NILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203

Query: 186 GVFMLEVAS----------------GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
           GV + E+ +                G     Q     ++ L+       K    L   D 
Sbjct: 204 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-------KNNGRLPRPDG 256

Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             + IY          +   C +     RP+ R +   +D
Sbjct: 257 CPDEIYM---------IMTECWNNNVNQRPSFRDLALRVD 287

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 51/211 (24%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQVVLHRD 123
           +V +     SL ++            +          +R +  G  YLH      V+HRD
Sbjct: 92  VVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRD 140

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +K  N+ L+ DL  K+GDFGLA   ++D   +   L GT  Y+APE++     S   DV+
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDVW 199

Query: 184 AFGVFMLEVASGRRPIEQQGSMEM--------VNLVDWVSDCWKKGAILDASDSRLEGIY 235
           + G  M  +  G+ P E     E          ++   ++          A+        
Sbjct: 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP--------VAAS------- 244

Query: 236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
                 L+ K+ L      P ARP + +++ 
Sbjct: 245 ------LIQKM-L---QTDPTARPTINELLN 265

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 88.2 bits (219), Expect = 2e-20
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 14/140 (10%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFR------IIRGVASGLLYLHEDWEQVVLHRD 123
           LV   +  GS+  I+   +                 I+R V  GL YLH+      +HRD
Sbjct: 90  LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRD 146

Query: 124 IKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTK---LVGTFGYMAPELMRTGKA-ST 178
           +K  N+LL  D + ++ DFG+ A L     I +       VGT  +MAPE+M   +    
Sbjct: 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF 206

Query: 179 STDVYAFGVFMLEVASGRRP 198
             D+++FG+  +E+A+G  P
Sbjct: 207 KADIWSFGITAIELATGAAP 226

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 87.7 bits (218), Expect = 3e-20
 Identities = 40/144 (27%), Positives = 62/144 (43%), Gaps = 20/144 (13%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQVVLHRD 123
           L+ +Y P G++ + L            +F        I  +A+ L Y H    + V+HRD
Sbjct: 86  LILEYAPLGTVYRELQKL--------SKFDEQRTATYITELANALSYCHS---KRVIHRD 134

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           IKP N+LL +    K+ DFG +         +T  L GT  Y+ PE++         D++
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPEMIEGRMHDEKVDLW 191

Query: 184 AFGVFMLEVASGRRPIEQQGSMEM 207
           + GV   E   G+ P E     E 
Sbjct: 192 SLGVLCYEFLVGKPPFEANTYQET 215

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 51/211 (24%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQVVLHRD 123
           +V +     SL ++            +          +R +  G  YLH      V+HRD
Sbjct: 118 VVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRD 166

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +K  N+ L+ DL  K+GDFGLA   ++D   +   L GT  Y+APE++     S   DV+
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDVW 225

Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLV--------DWVSDCWKKGAILDASDSRLEGIY 235
           + G  M  +  G+ P E     E    +          ++          A+        
Sbjct: 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP--------VAAS------- 270

Query: 236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
                 L+ K+ L      P ARP + +++ 
Sbjct: 271 ------LIQKM-L---QTDPTARPTINELLN 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 88.2 bits (219), Expect = 3e-20
 Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 38/220 (17%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             L+ +Y+P GSL   L  + K  +   +  +    +  G+ YL     +  +HRD+   
Sbjct: 119 LKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATR 174

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAF 185
           N+L++ +   K+GDFGL ++   D      K  G     + APE +   K S ++DV++F
Sbjct: 175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234

Query: 186 GVFMLEVAS----------------GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
           GV + E+ +                G     Q     ++ L+       K    L   D 
Sbjct: 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-------KNNGRLPRPDG 287

Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             + IY          +   C +     RP+ R +   +D
Sbjct: 288 CPDEIYM---------IMTECWNNNVNQRPSFRDLALRVD 318

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 88.8 bits (220), Expect = 4e-20
 Identities = 28/137 (20%), Positives = 58/137 (42%), Gaps = 11/137 (8%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V  +M  GS   ++ T+    ++      I++GV   L Y+H       +HR +K +++
Sbjct: 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHI 159

Query: 130 LLDADLNGKLGDFG-LARLYDHDTIPQTTKL-----VGTFGYMAPELMRTGKA--STSTD 181
           L+  D    L        +  H    +         V    +++PE+++         +D
Sbjct: 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219

Query: 182 VYAFGVFMLEVASGRRP 198
           +Y+ G+   E+A+G  P
Sbjct: 220 IYSVGITACELANGHVP 236

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 87.8 bits (218), Expect = 5e-20
 Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 25/212 (11%)

Query: 68  FLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
             LV +Y+P GSL   L  +   S+   Q     + +  G+ YLH    Q  +HRD+   
Sbjct: 110 LQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAAR 163

Query: 128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF--GYMAPELMRTGKASTSTDVYAF 185
           NVLLD D   K+GDFGLA+           +  G     + APE ++  K   ++DV++F
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223

Query: 186 GVFMLEVAS-GRRPIEQQGSMEMVNLVDW-------VSDCWKKGAILDASDSRLEGIYEE 237
           GV + E+ +              +  +         +++  ++G  L   D     +Y  
Sbjct: 224 GVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYH- 282

Query: 238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                   L   C   +   RP    ++  L 
Sbjct: 283 --------LMKNCWETEASFRPTFENLIPILK 306

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 9/139 (6%)

Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
             R+ +  LV++++    L   L     P L       ++R    GL +LH +    ++H
Sbjct: 88  TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVH 143

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLVGTFGYMAPELMRTGKASTST 180
           RD+KP N+L+ +    KL DFGLAR+Y         T +V T  Y APE++     +T  
Sbjct: 144 RDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYATPV 200

Query: 181 DVYAFGVFMLEVASGRRPI 199
           D+++ G    E+   R+P+
Sbjct: 201 DMWSVGCIFAEMFR-RKPL 218

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 43/138 (31%), Positives = 63/138 (45%), Gaps = 22/138 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
           +V D +  G L    H      L     F+          +   L YL     Q ++HRD
Sbjct: 92  MVVDLLLGGDL--RYH------LQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRD 140

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA---STST 180
           +KP N+LLD   +  + DF +A +   +T  Q T + GT  YMAPE+  + K    S + 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAV 198

Query: 181 DVYAFGVFMLEVASGRRP 198
           D ++ GV   E+  GRRP
Sbjct: 199 DWWSLGVTAYELLRGRRP 216

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 85.1 bits (211), Expect = 3e-19
 Identities = 46/135 (34%), Positives = 68/135 (50%), Gaps = 8/135 (5%)

Query: 65  KGEFL-LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           K   L ++ +Y+  GS   +L       L   Q   I+R +  GL YLH    +  +HRD
Sbjct: 91  KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS---EKKIHRD 144

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           IK ANVLL      KL DFG+A     DT  +    VGT  +MAPE+++     +  D++
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 203

Query: 184 AFGVFMLEVASGRRP 198
           + G+  +E+A G  P
Sbjct: 204 SLGITAIELARGEPP 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 85.1 bits (211), Expect = 4e-19
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 9/134 (6%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV ++   GS+  ++      +L       I R +  GL +LH+     V+HRDIK  NV
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNV 160

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST-----DVYA 184
           LL  +   KL DFG++   D  T+ +    +GT  +MAPE++   +   +T     D+++
Sbjct: 161 LLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 219

Query: 185 FGVFMLEVASGRRP 198
            G+  +E+A G  P
Sbjct: 220 LGITAIEMAEGAPP 233

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 41/136 (30%), Positives = 65/136 (47%), Gaps = 21/136 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
            + D M  G L    H      LS +  F           +  GL ++H    + V++RD
Sbjct: 269 FILDLMNGGDL--HYH------LSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRD 317

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDV 182
           +KPAN+LLD   + ++ D GLA  +      +    VGT GYMAPE+++ G A  +S D 
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADW 374

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G  + ++  G  P
Sbjct: 375 FSLGCMLFKLLRGHSP 390

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.0 bits (211), Expect = 4e-19
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 18/136 (13%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
               Y  NG L  + +      +     F           + S L YLH    + ++HRD
Sbjct: 107 FGLSYAKNGEL--LKY------IRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRD 155

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK-LVGTFGYMAPELMRTGKASTSTDV 182
           +KP N+LL+ D++ ++ DFG A++   ++        VGT  Y++PEL+    A  S+D+
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 215

Query: 183 YAFGVFMLEVASGRRP 198
           +A G  + ++ +G  P
Sbjct: 216 WALGCIIYQLVAGLPP 231

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.0 bits (211), Expect = 4e-19
 Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 45/228 (19%)

Query: 63  SRKGEFLLVYDYMPNGSL--------------DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           ++ G   ++ +Y   G+L                 ++   +  +++         +A G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG--- 164
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT      G   
Sbjct: 171 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN-----GRLP 222

Query: 165 --YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEG 275

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +D   +    +Y          +   C H  P  RP  +Q+++ LD
Sbjct: 276 HRMDKPANCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLD 314

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 84.7 bits (210), Expect = 5e-19
 Identities = 41/136 (30%), Positives = 74/136 (54%), Gaps = 7/136 (5%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +  +  +V +Y   GS+  I+    K  L+  +   I++    GL YLH       +HRD
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHF---MRKIHRD 150

Query: 124 IKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           IK  N+LL+ + + KL DFG+  +L   DT+ +   ++GT  +MAPE+++    +   D+
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADI 208

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G+  +E+A G+ P
Sbjct: 209 WSLGITAIEMAEGKPP 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 84.7 bits (210), Expect = 5e-19
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 9/136 (6%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
              E  ++ +++  G+L  I+       L+  Q   +   V   L YLH    Q V+HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHA---QGVIHRD 166

Query: 124 IKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           IK  ++LL  D   KL DFG  A++     +P+   LVGT  +MAPE++     +T  D+
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G+ ++E+  G  P
Sbjct: 225 WSLGIMVIEMVDGEPP 240

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.6 bits (210), Expect = 6e-19
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 9/144 (6%)

Query: 57  LTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE 116
            T +   R+ +  LV++++    L   L    +P +       ++  +  GL +LH    
Sbjct: 83  CTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR- 140

Query: 117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT-TKLVGTFGYMAPELMRTGK 175
             V+HRD+KP N+L+ +    KL DFGLAR+Y         T +V T  Y APE++    
Sbjct: 141 --VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSS 195

Query: 176 ASTSTDVYAFGVFMLEVASGRRPI 199
            +T  D+++ G    E+   R+P+
Sbjct: 196 YATPVDLWSVGCIFAEMFR-RKPL 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 83.9 bits (208), Expect = 7e-19
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 9/136 (6%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
              E  +V +Y+  GSL  ++       +   Q   + R     L +LH      V+HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHS---NQVIHRD 141

Query: 124 IKPANVLLDADLNGKLGDFGL-ARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           IK  N+LL  D + KL DFG  A++       + + +VGT  +MAPE++         D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 183 YAFGVFMLEVASGRRP 198
           ++ G+  +E+  G  P
Sbjct: 200 WSLGIMAIEMIEGEPP 215

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 85.2 bits (211), Expect = 9e-19
 Identities = 44/198 (22%), Positives = 79/198 (39%), Gaps = 51/198 (25%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-------------ADLNGKLGDFGLA 145
            ++R +ASG+ +LH      ++HRD+KP N+L+               +L   + DFGL 
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 146 RLYDHDTIPQTTKL---VGTFGYMAPELMR-------TGKASTSTDVYAFGVFMLEVAS- 194
           +  D       T L    GT G+ APEL+          + + S D+++ G     + S 
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 195 GRRP------IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL 248
           G+ P       E      + +L +      +   I +A+D             L+ ++ +
Sbjct: 236 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRS-LIAEATD-------------LISQM-I 280

Query: 249 FCSHPKPEARPNMRQVMQ 266
                 P  RP   +V++
Sbjct: 281 ---DHDPLKRPTAMKVLR 295

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 44/135 (32%), Positives = 65/135 (48%), Gaps = 14/135 (10%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
           LV   M  G +      +I         F+  R       + SGL +LH+   + +++RD
Sbjct: 262 LVMTIMNGGDI----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRD 314

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP NVLLD D N ++ D GLA         +T    GT G+MAPEL+   +   S D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373

Query: 184 AFGVFMLEVASGRRP 198
           A GV + E+ + R P
Sbjct: 374 ALGVTLYEMIAARGP 388

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 45/228 (19%)

Query: 63  SRKGEFLLVYDYMPNGSL--------------DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           ++ G   ++ +Y   G+L                 ++   +  +++         +A G+
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG--- 164
            YL     Q  +HRD+   NVL+  +   K+ DFGLAR + + D   +TT      G   
Sbjct: 217 EYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN-----GRLP 268

Query: 165 --YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV M E+ + G  P       E+  L+       K+G
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-------KEG 321

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +D   +    +Y      ++      C H  P  RP  +Q+++ LD
Sbjct: 322 HRMDKPANCTNELY-----MMMRD----CWHAVPSQRPTFKQLVEDLD 360

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 38/144 (26%), Positives = 58/144 (40%), Gaps = 20/144 (13%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQVVLHRD 123
           L+ ++ P G L K L  +         RF        +  +A  L Y HE   + V+HRD
Sbjct: 91  LMLEFAPRGELYKELQKH--------GRFDEQRSATFMEELADALHYCHE---RKVIHRD 139

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           IKP N+L+      K+ DFG +         +   + GT  Y+ PE++         D++
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLW 196

Query: 184 AFGVFMLEVASGRRPIEQQGSMEM 207
             GV   E   G  P +     E 
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTET 220

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 44/239 (18%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV ++   G L ++I++   +          I++ + SG+ YLH+     ++HRDIKP N
Sbjct: 123 LVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPEN 176

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           +LL   ++ LN K+ DFGL+  +  D        +GT  Y+APE+++  K +   DV++ 
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSC 233

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV-----DWVSDCWKKGAILDASDSRLEGIYEEEQM 240
           GV M  +  G  P   Q   +++  V      +  + WK                 +E  
Sbjct: 234 GVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN--------------ISDEAK 279

Query: 241 ELVLKLGLFCSHPKPEARPNMRQV-----MQYLDGNATLPDIPRDSTLIA---PFSASN 291
           EL+  + L         R    +      ++    N    D       ++    F  S 
Sbjct: 280 ELIKLM-L---TYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQ 334

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 40/125 (32%), Positives = 63/125 (50%), Gaps = 15/125 (12%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV+D M  G L D +     K +LS  +  +I+R +   +  LH+     ++HRD+KP N
Sbjct: 101 LVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPEN 154

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST------DV 182
           +LLD D+N KL DFG +   D     +   + GT  Y+APE++               D+
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212

Query: 183 YAFGV 187
           ++ GV
Sbjct: 213 WSTGV 217

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 15/134 (11%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQT 156
            I+R + S L YLH    Q + HRDIKP N L   + +   KL DFGL++ +      + 
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228

Query: 157 TKL---VGTFGYMAPELMRTGKAS--TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
             +    GT  ++APE++ T   S     D ++ GV +  +  G  P       + ++ V
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV 288

Query: 212 -----DWVSDCWKK 220
                 + +  +  
Sbjct: 289 LNKKLCFENPNYNV 302

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 45/228 (19%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG--------------VASGL 108
           ++ G   ++ +Y   G+L + L     P L +                       VA G+
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG--- 164
            YL     +  +HRD+   NVL+  D   K+ DFGLAR ++  D   +TT      G   
Sbjct: 205 EYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN-----GRLP 256

Query: 165 --YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +     +  +DV++FGV + E+ + G  P       E+  L+       K+G
Sbjct: 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEG 309

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +D   +    +Y          +   C H  P  RP  +Q+++ LD
Sbjct: 310 HRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLD 348

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 51/230 (22%), Positives = 82/230 (35%), Gaps = 37/230 (16%)

Query: 59  NTVN-----SRKGEFLLVYDYMPNGSL------------DKILHTNIKPSLSWYQRFRII 101
           N VN     +  G  L++ +Y   G L                      + S        
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLV 160
             VA G+ +L     +  +HRD+   NVLL      K+GDFGLAR + +           
Sbjct: 171 SQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWK 219
               +MAPE +     +  +DV+++G+ + E+ S G  P    G +        V    K
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--PGILVNSKFYKLV----K 281

Query: 220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            G  +       + IY          +   C   +P  RP  +Q+  +L 
Sbjct: 282 DGYQMAQPAFAPKNIYS---------IMQACWALEPTHRPTFQQICSFLQ 322

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.4 bits (204), Expect = 5e-18
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 53/236 (22%)

Query: 63  SRKGEFLLVYDYMPNGSLDKIL----------------------HTNIKPSLSWYQRFRI 100
           +      L+++YM  G L++ L                       +   P LS  ++  I
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179

Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKL 159
            R VA+G+ YL E   +  +HRD+   N L+  ++  K+ DFGL+R +Y  D        
Sbjct: 180 ARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN- 235

Query: 160 VGTFGY-----MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDW 213
                      M PE +   + +T +DV+A+GV + E+ S G +P       E++  V  
Sbjct: 236 ----DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-- 289

Query: 214 VSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                + G IL   ++    +Y      L+      C    P  RP+   + + L 
Sbjct: 290 -----RDGNILACPENCPLELY-----NLMRL----CWSKLPADRPSFCSIHRILQ 331

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 44/239 (18%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV +    G L D+I+    +   S     RIIR V SG+ Y+H+     ++HRD+KP N
Sbjct: 103 LVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPEN 156

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           +LL     D N ++ DFGL+  ++     +    +GT  Y+APE++  G      DV++ 
Sbjct: 157 LLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWST 213

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV-----DWVSDCWKKGAILDASDSRLEGIYEEEQM 240
           GV +  + SG  P       +++  V      +    WKK                E   
Sbjct: 214 GVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK--------------VSESAK 259

Query: 241 ELVLKLGLFCSHPKPEARPNMRQV-----MQYLDGNATLPDIPRDSTLIA---PFSASN 291
           +L+ K+ L      P  R + R       +Q         D+P     I     F  + 
Sbjct: 260 DLIRKM-L---TYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQ 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.4 bits (202), Expect = 5e-18
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 23/144 (15%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTN---IKPSL--SW-YQRFRIIRGVASGLLYLHEDWEQV 118
             +  LV+++     L K   +    + P +  S+ +Q   +++G+     + H      
Sbjct: 73  DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ---LLKGLG----FCHSRN--- 121

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPE-LMRTGK 175
           VLHRD+KP N+L++ +   KL +FGLAR +    IP    +  V T  Y  P+ L     
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 176 ASTSTDVYAFGVFMLEVASGRRPI 199
            STS D+++ G    E+A+  RP+
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPL 202

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 49/160 (30%), Positives = 82/160 (51%), Gaps = 18/160 (11%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV +    G L D+I+H   +   +      II+ V SG+ YLH+     ++HRD+KP N
Sbjct: 113 LVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPEN 166

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           +LL   + D   K+ DFGL+ ++++    +  + +GT  Y+APE++R  K     DV++ 
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSI 223

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV-----DWVSDCWKK 220
           GV +  + +G  P   Q   E++  V      + S  WK 
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 82.1 bits (203), Expect = 6e-18
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 21/139 (15%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV+D M  G L D +     K +LS  +   I+R +   + +LH      ++HRD+KP N
Sbjct: 177 LVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPEN 230

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST------DV 182
           +LLD ++  +L DFG +   +     +   L GT GY+APE+++     T        D+
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDL 288

Query: 183 YAFGV---FMLEVASGRRP 198
           +A GV    +L   +G  P
Sbjct: 289 WACGVILFTLL---AGSPP 304

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 82.3 bits (204), Expect = 7e-18
 Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 49/246 (19%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +G   L++D +  G L + I+    +   S       I+ +   +L+ H+     V+HR+
Sbjct: 82  EGHHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRN 135

Query: 124 IKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +KP N+LL      A +  KL DFGLA   + +         GT GY++PE++R      
Sbjct: 136 LKPENLLLASKLKGAAV--KLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGK 192

Query: 179 STDVYAFGV---FMLEVASGRRPI---EQQGSMEMVNL--VDWVSDCWKKGAILDASDSR 230
             D++A GV    +L    G  P    +Q    + +     D+ S  W        +   
Sbjct: 193 PVDLWACGVILYILL---VGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD-----TVTP-- 242

Query: 231 LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ--YLDGNATLPDIPRDSTLIA--- 285
                  E  +L+ K+ L      P  R    + ++  ++   +T+         +    
Sbjct: 243 -------EAKDLINKM-L---TINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLK 291

Query: 286 PFSASN 291
            F+A  
Sbjct: 292 KFNARR 297

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.1 bits (201), Expect = 8e-18
 Identities = 46/227 (20%), Positives = 84/227 (37%), Gaps = 40/227 (17%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG----------------VAS 106
           +  G  L++ +Y   G L   L       +       I+                  VA 
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 107 GLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTF-- 163
           G+ +L     +  +HRD+   N+LL      K+ DFGLAR + +                
Sbjct: 157 GMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN--ARLPV 211

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGA 222
            +MAPE +     +  +DV+++G+F+ E+ S G  P    G          +    K+G 
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMI----KEGF 265

Query: 223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            + + +     +Y+         +   C    P  RP  +Q++Q ++
Sbjct: 266 RMLSPEHAPAEMYD---------IMKTCWDADPLKRPTFKQIVQLIE 303

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 81.2 bits (201), Expect = 8e-18
 Identities = 33/140 (23%), Positives = 70/140 (50%), Gaps = 10/140 (7%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             G+  ++ ++ P G++D I+    +  L+  Q   + R +   L +LH    + ++HRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS---KRIIHRD 142

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST--- 180
           +K  NVL+  + + +L DFG++         + +  +GT  +MAPE++       +    
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMKDTPYDY 201

Query: 181 --DVYAFGVFMLEVASGRRP 198
             D+++ G+ ++E+A    P
Sbjct: 202 KADIWSLGITLIEMAQIEPP 221

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.8 bits (200), Expect = 9e-18
 Identities = 37/143 (25%), Positives = 68/143 (47%), Gaps = 14/143 (9%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V++ +  G + +      +    +        + +  G+ YLH    Q ++HRDIKP+N
Sbjct: 115 MVFELVNQGPVMEVPTLKPLSEDQAR----FYFQDLIKGIEYLHY---QKIIHRDIKPSN 167

Query: 129 VLLDADLNGKLGDFGLARLY-DHDTIPQTTKLVGTFGYMAPELMRTGKAS---TSTDVYA 184
           +L+  D + K+ DFG++  +   D +   T  VGT  +MAPE +   +      + DV+A
Sbjct: 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWA 225

Query: 185 FGVFMLEVASGRRPIEQQGSMEM 207
            GV +     G+ P   +  M +
Sbjct: 226 MGVTLYCFVFGQCPFMDERIMCL 248

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 53/236 (22%)

Query: 63  SRKGEFLLVYDYMPNGSL----------------------DKILHTNIKPSLSWYQRFRI 100
           S+ G  LL+ +Y   GSL                         L    + +L+       
Sbjct: 96  SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155

Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKL 159
              ++ G+ YL E     ++HRD+   N+L+      K+ DFGL+R +Y+ D+  + ++ 
Sbjct: 156 AWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ- 211

Query: 160 VGTFG-----YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDW 213
               G     +MA E +     +T +DV++FGV + E+ + G  P        + NL+  
Sbjct: 212 ----GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-- 265

Query: 214 VSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                K G  ++  D+  E +Y          L L C   +P+ RP    + + L+
Sbjct: 266 -----KTGHRMERPDNCSEEMYR---------LMLQCWKQEPDKRPVFADISKDLE 307

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 11/101 (10%)

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNG----KLGDFGLARLYD--HDTIPQTTKL 159
            G+ YLH +W   VLHRD+KPAN+L+  +       K+ D G ARL++     +     +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 160 VGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPI 199
           V TF Y APEL+   +  + + D++A G    E+ +   PI
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 80.8 bits (200), Expect = 1e-17
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +    LV + +  G L ++I     K   S  +   I+R + S + ++H+     V+HRD
Sbjct: 78  QLHTFLVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRD 131

Query: 124 IKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +KP N+L      + ++  K+ DFG ARL   D  P  T    T  Y APEL+       
Sbjct: 132 LKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNGYDE 188

Query: 179 STDVYAFGV---FMLEVASGRRP 198
           S D+++ GV    ML   SG+ P
Sbjct: 189 SCDLWSLGVILYTML---SGQVP 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 80.8 bits (200), Expect = 1e-17
 Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 16/129 (12%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             E  LV + +  G L D+I+    K   S       ++ +   + YLHE     ++HRD
Sbjct: 120 PTEISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRD 173

Query: 124 IKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST 178
           +KP N+L      DA L  K+ DFGL+++ +H  +     + GT GY APE++R      
Sbjct: 174 LKPENLLYATPAPDAPL--KIADFGLSKIVEHQVL--MKTVCGTPGYCAPEILRGCAYGP 229

Query: 179 STDVYAFGV 187
             D+++ G+
Sbjct: 230 EVDMWSVGI 238

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 55/248 (22%), Positives = 93/248 (37%), Gaps = 62/248 (25%)

Query: 60  TVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRF------RIIRGVASGLLYLH 112
            ++  K   L++ + M  G L  +I            Q F       I+R + + + +LH
Sbjct: 93  NMHHGKRCLLIIMECMEGGELFSRIQERG-------DQAFTEREAAEIMRDIGTAIQFLH 145

Query: 113 EDWEQVVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA 167
                 + HRD+KP N+L      DA L  KL DFG A+    + +        T  Y+A
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVL--KLTDFGFAKETTQNAL---QTPCYTPYYVA 197

Query: 168 PELMRTGKASTSTDVYAFGV---FMLEVASGRRP----IEQQGSMEMVNLV-----DWVS 215
           PE++   K   S D+++ GV    +L    G  P      Q  S  M   +      + +
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILL---CGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254

Query: 216 DCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNAT 273
             W      + S+            +L+  L L      P  R  + Q M +  ++ +  
Sbjct: 255 PEWS-----EVSEDAK---------QLIRLL-L---KTDPTERLTITQFMNHPWINQSMV 296

Query: 274 LPDIPRDS 281
           +P  P  +
Sbjct: 297 VPQTPLHT 304

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 31/178 (17%), Positives = 56/178 (31%), Gaps = 28/178 (15%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPS--LSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           +   +LV +    G+L + I      P   +           +   +  +H+     ++H
Sbjct: 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIH 195

Query: 122 RDIKPANVLL-----------DADLNGKLGDFGLARLYDHDTIPQTTKLV---GTFGYMA 167
            DIKP N +L           D      L D G +   D    P+ T       T G+  
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI--DMKLFPKGTIFTAKCETSGFQC 253

Query: 168 PELMRTGKAST-STDVYAFGVFMLEVASGRRP-IEQQGSMEMVNLV---DWVSDCWKK 220
            E M + K      D +     +  +  G    ++ +G       +       D W +
Sbjct: 254 VE-MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNE 310

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 25/169 (14%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           K E +L+ +++  G L D+I   +    +S  +    +R    GL ++HE     ++H D
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVHLD 174

Query: 124 IKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           IKP N++      + +  K+ DFGLA   + D I +      T  + APE++        
Sbjct: 175 IKPENIMCETKKASSV--KIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFY 230

Query: 180 TDVYAFGV---FMLEVASGRRPIE---QQGSMEMVNLVDW--VSDCWKK 220
           TD++A GV    +L   SG  P        +++ V   DW    D +  
Sbjct: 231 TDMWAIGVLGYVLL---SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 19/145 (13%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           H N ++ L +   +R  + +L+ + +  G L D +     K SLS  +    I+ +  G+
Sbjct: 74  HHN-VITLHDVYENRT-DVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGV 128

Query: 109 LYLHEDWEQVVLHRDIKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGT 162
            YLH    + + H D+KP N++L         +  KL DFGLA   +         + GT
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVE--FKNIFGT 181

Query: 163 FGYMAPELMRTGKASTSTDVYAFGV 187
             ++APE++         D+++ GV
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGV 206

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.6 bits (197), Expect = 3e-17
 Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 39/238 (16%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL--------------DKILHTNIKPSLSWY 95
           H N ++ L        G  +++ ++   G+L                      K  L+  
Sbjct: 90  HLN-VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 96  QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIP 154
                   VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      
Sbjct: 149 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 155 QTTKLVGTF--GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLV 211
           +           +MAPE +     +  +DV++FGV + E+ S G  P    G        
Sbjct: 206 RKGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFC 261

Query: 212 DWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +    K+G  + A D     +Y     + +L     C H +P  RP   +++++L 
Sbjct: 262 RRL----KEGTRMRAPDYTTPEMY-----QTMLD----CWHGEPSQRPTFSELVEHLG 306

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 79.5 bits (197), Expect = 3e-17
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 9/92 (9%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQ 155
            +I+ V S + YLHE     ++HRD+KP N+L    + +    + DFGL+++  +  +  
Sbjct: 110 LVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM-- 164

Query: 156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
            +   GT GY+APE++     S + D ++ GV
Sbjct: 165 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 12/143 (8%)

Query: 62  NSRKGEFLLVYDYMPNGSLD-KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           N  KG   LV+D+      D   L +N+    +  +  R+++ + +GL Y+H +    +L
Sbjct: 93  NRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---IL 146

Query: 121 HRDIKPANVLLDADLNGKLGDFGLARLYD---HDTIPQTTKLVGTFGYMAPE-LMRTGKA 176
           HRD+K ANVL+  D   KL DFGLAR +    +    + T  V T  Y  PE L+     
Sbjct: 147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 206

Query: 177 STSTDVYAFGVFMLEVASGRRPI 199
               D++  G  M E+ + R PI
Sbjct: 207 GPPIDLWGAGCIMAEMWT-RSPI 228

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 78.8 bits (195), Expect = 4e-17
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 17/137 (12%)

Query: 70  LVYDYMPNGSL-DKILHTNIKP-SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           +V +    G L ++I+    +  +LS      +++ + + L Y H    Q V+H+D+KP 
Sbjct: 97  IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPE 153

Query: 128 NVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           N+L          K+ DFGLA L+  D         GT  YMAPE+ +    +   D+++
Sbjct: 154 NILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK-RDVTFKCDIWS 210

Query: 185 FGV---FMLEVASGRRP 198
            GV   F+L   +G  P
Sbjct: 211 AGVVMYFLL---TGCLP 224

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQ-RFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV   M  G L   ++   +      +  F     +  GL  LH    + +++RD+KP N
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPEN 316

Query: 129 VLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV 187
           +LLD   + ++ D GLA  + +  T       VGT GYMAPE+++  + + S D +A G 
Sbjct: 317 ILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373

Query: 188 FMLEVASGRRP 198
            + E+ +G+ P
Sbjct: 374 LLYEMIAGQSP 384

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 34/169 (20%), Positives = 72/169 (42%), Gaps = 25/169 (14%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             E +++++++    + ++I  +     L+  +    +  V   L +LH      + H D
Sbjct: 73  MEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127

Query: 124 IKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           I+P N++      + +  K+ +FG AR        +   L     Y APE+ +    ST+
Sbjct: 128 IRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVSTA 183

Query: 180 TDVYAFGV---FMLEVASGRRPIE---QQGSMEMVNLVDW--VSDCWKK 220
           TD+++ G     +L   SG  P      Q  +E +   ++    + +K+
Sbjct: 184 TDMWSLGTLVYVLL---SGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 27/167 (16%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V + M  G L DK++       L           +   + YLHE     ++HRD+KP N
Sbjct: 216 IVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPEN 269

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKA--STSTDV 182
           VLL   + D   K+ DFG +++    ++ +T  L GT  Y+APE L+  G A  + + D 
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDC 327

Query: 183 YAFGV---FMLEVASGRRP-IEQQGSMEMVNLV-----DWVSDCWKK 220
           ++ GV     L   SG  P  E +  + + + +     +++ + W +
Sbjct: 328 WSLGVILFICL---SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 26/150 (17%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA--------SGLLYLHEDWEQVVLH 121
           +V +YMP G L           ++    + +    A          L  +H       +H
Sbjct: 146 MVMEYMPGGDL-----------VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIH 191

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKAST-- 178
           RD+KP N+LLD   + KL DFG     + + + +    VGT  Y++PE L   G      
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251

Query: 179 -STDVYAFGVFMLEVASGRRPIEQQGSMEM 207
              D ++ GVF+ E+  G  P      +  
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGT 281

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.1 bits (196), Expect = 5e-17
 Identities = 39/141 (27%), Positives = 59/141 (41%), Gaps = 15/141 (10%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQV 118
           V  RK    LV++Y  +  L ++            +    + ++ V     + H+     
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN----FCHKHN--- 122

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPE-LMRTGK 175
            +HRD+KP N+L+      KL DFG ARL    T P       V T  Y +PE L+   +
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVATRWYRSPELLVGDTQ 179

Query: 176 ASTSTDVYAFGVFMLEVASGR 196
                DV+A G    E+ SG 
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV 200

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.4 bits (194), Expect = 6e-17
 Identities = 38/171 (22%), Positives = 79/171 (46%), Gaps = 28/171 (16%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           K + +L+ + +  G L D +     K SL+  +  + ++ +  G+ YLH    + + H D
Sbjct: 80  KTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFD 133

Query: 124 IKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
           +KP N++L      +  +  KL DFG+A   +     +   + GT  ++APE++      
Sbjct: 134 LKPENIMLLDKNVPNPRI--KLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLG 189

Query: 178 TSTDVYAFGV---FMLEVASGRRPI---EQQGSMEMVNLVDW--VSDCWKK 220
              D+++ GV    +L   SG  P     +Q ++  ++ V++    + +  
Sbjct: 190 LEADMWSIGVITYILL---SGASPFLGETKQETLTNISAVNYDFDEEYFSN 237

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 10/127 (7%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V + M   +L +++   +      Y  ++++ G    + +LH      ++HRD+KP+N+
Sbjct: 107 IVMELMDA-NLCQVIQMELDHERMSYLLYQMLCG----IKHLHS---AGIIHRDLKPSNI 158

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
           ++ +D   K+ DFGLAR          T  V T  Y APE++       + D+++ G  M
Sbjct: 159 VVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216

Query: 190 LEVASGR 196
            E+  G 
Sbjct: 217 GEMIKGG 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.8 bits (195), Expect = 7e-17
 Identities = 39/168 (23%), Positives = 78/168 (46%), Gaps = 21/168 (12%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
             E +L+ +Y   G +    L    +  +S     R+I+ +  G+ YLH+     ++H D
Sbjct: 101 TSEIILILEYAAGGEIFSLCLPELAE-MVSENDVIRLIKQILEGVYYLHQ---NNIVHLD 156

Query: 124 IKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           +KP N+LL       + K+ DFG++R   H    +   ++GT  Y+APE++     +T+T
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNYDPITTAT 214

Query: 181 DVYAFGV---FMLEVASGRRPI---EQQGSMEMVNLVDW--VSDCWKK 220
           D++  G+    +L   +   P    + Q +   ++ V+     + +  
Sbjct: 215 DMWNIGIIAYMLL---THTSPFVGEDNQETYLNISQVNVDYSEETFSS 259

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.9 bits (195), Expect = 8e-17
 Identities = 34/130 (26%), Positives = 60/130 (46%), Gaps = 17/130 (13%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           + + +L+ + +  G L D +     K SLS  +    I+ +  G+ YLH    + + H D
Sbjct: 87  RTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFD 140

Query: 124 IKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
           +KP N++L         +  KL DFGLA   +         + GT  ++APE++      
Sbjct: 141 LKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLG 196

Query: 178 TSTDVYAFGV 187
              D+++ GV
Sbjct: 197 LEADMWSIGV 206

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.9 bits (195), Expect = 8e-17
 Identities = 46/235 (19%), Positives = 79/235 (33%), Gaps = 51/235 (21%)

Query: 63  SRKGEFLLVYDYMPNGSL---------------------DKILHTNIKPSLSWYQRFRII 101
           +  G   L+++Y   G L                      ++        L++       
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178

Query: 102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLV 160
             VA G+ +L     +  +HRD+   NVL+      K+ DFGLAR +             
Sbjct: 179 YQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN-- 233

Query: 161 GTFG-----YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWV 214
                    +MAPE +  G  +  +DV+++G+ + E+ S G  P    G     N    +
Sbjct: 234 ---ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY--PGIPVDANFYKLI 288

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
               + G  +D      E IY          +   C       RP+   +  +L 
Sbjct: 289 ----QNGFKMDQPFYATEEIYI---------IMQSCWAFDSRKRPSFPNLTSFLG 330

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 78.5 bits (194), Expect = 9e-17
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 15/125 (12%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V + M  G L DK++       L           +   + YLHE     ++HRD+KP N
Sbjct: 91  IVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPEN 144

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKASTST--DV 182
           VLL   + D   K+ DFG +++    ++     L GT  Y+APE L+  G A  +   D 
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202

Query: 183 YAFGV 187
           ++ GV
Sbjct: 203 WSLGV 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.5 bits (196), Expect = 9e-17
 Identities = 45/184 (24%), Positives = 73/184 (39%), Gaps = 27/184 (14%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGL 108
           H   L+ L +       E +++Y++M  G L +K+        +S  +    +R V  GL
Sbjct: 213 HPT-LVNLHDAFEDDN-EMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGL 268

Query: 109 LYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG 164
            ++HE      +H D+KP N++       +L  KL DFGL    D           GT  
Sbjct: 269 CHMHE---NNYVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQ--SVKVTTGTAE 321

Query: 165 YMAPELMRTGKASTSTDVYAFGV---FMLEVASGRRP---IEQQGSMEMVNLVDW--VSD 216
           + APE+         TD+++ GV    +L   SG  P        ++  V   DW     
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILL---SGLSPFGGENDDETLRNVKSCDWNMDDS 378

Query: 217 CWKK 220
            +  
Sbjct: 379 AFSG 382

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.4 bits (194), Expect = 9e-17
 Identities = 37/136 (27%), Positives = 62/136 (45%), Gaps = 11/136 (8%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +K  + LV++++ + ++   L       L +    + +  + +G+ + H      ++HRD
Sbjct: 95  KKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSHN---IIHRD 149

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPE-LMRTGKASTST 180
           IKP N+L+      KL DFG AR       P       V T  Y APE L+   K   + 
Sbjct: 150 IKPENILVSQSGVVKLCDFGFARTL---AAPGEVYDDEVATRWYRAPELLVGDVKYGKAV 206

Query: 181 DVYAFGVFMLEVASGR 196
           DV+A G  + E+  G 
Sbjct: 207 DVWAIGCLVTEMFMGE 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 37/137 (27%), Positives = 59/137 (43%), Gaps = 24/137 (17%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLS-------WYQRFRIIRGVASGLLYLHEDWEQVV 119
           +  LV + M     D  L   I+  L         YQ          G+ +LH      +
Sbjct: 141 DVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLC-------GIKHLHS---AGI 185

Query: 120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +HRD+KP+N+++ +D   K+ DFGLAR          T  V T  Y APE++       +
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKEN 243

Query: 180 TDVYAFGVFMLEVASGR 196
            D+++ G  M E+   +
Sbjct: 244 VDIWSVGCIMGEMVRHK 260

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 50/141 (35%), Positives = 77/141 (54%), Gaps = 23/141 (16%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTN---IKPSL--SW-YQRFRIIRGVASGLLYLHEDWEQV 118
           +    LV+++M    L K+L  N   ++ S    + YQ   ++RGVA    + H+     
Sbjct: 91  ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ---LLRGVA----HCHQHR--- 139

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPE-LMRTGK 175
           +LHRD+KP N+L+++D   KL DFGLAR +    IP    T  V T  Y AP+ LM + K
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAPDVLMGSKK 196

Query: 176 ASTSTDVYAFGVFMLEVASGR 196
            STS D+++ G    E+ +G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 17/140 (12%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
                L+++Y  N  L K +  N   S+   + F  +  + +G+ + H       LHRD+
Sbjct: 105 NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLINGVNFCHSRR---CLHRDL 158

Query: 125 KPANVLLDADLNG-----KLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPE-LMRTGKA 176
           KP N+LL           K+GDFGLAR +    IP    T  + T  Y  PE L+ +   
Sbjct: 159 KPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIRQFTHEIITLWYRPPEILLGSRHY 215

Query: 177 STSTDVYAFGVFMLEVASGR 196
           STS D+++      E+    
Sbjct: 216 STSVDIWSIACIWAEMLMKT 235

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 27/143 (18%)

Query: 65  KGEFLLVYDYMPNGSLDKILHT--------NIKPSLSWYQRFRIIRGVASGLLYLHEDWE 116
           +    LV++Y+    L + L          N+K  L  +Q  R       GL Y H    
Sbjct: 72  EKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL--FQLLR-------GLAYCHRQK- 120

Query: 117 QVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPE-LMRT 173
             VLHRD+KP N+L++     KL DFGLAR     +IP       V T  Y  P+ L+ +
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTYDNEVVTLWYRPPDILLGS 175

Query: 174 GKASTSTDVYAFGVFMLEVASGR 196
              ST  D++  G    E+A+GR
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 45/240 (18%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V +    G L D+I+    +   S +   RII+ V SG+ Y+H+     ++HRD+KP N
Sbjct: 98  IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPEN 151

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           +LL   + D + K+ DFGL+  +  +T  +    +GT  Y+APE++R G      DV++ 
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSA 208

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV-----DWVSDCWKKGAILDASDSRLEGIYEEEQM 240
           GV +  + SG  P   +   +++  V      +    W+                 ++  
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT--------------ISDDAK 254

Query: 241 ELVLKLGLFCSHPKPEARPNMRQVMQ------YLDGNATLPDIPRDSTLIA---PFSASN 291
           +L+ K+ L      P  R    Q ++      Y     T+ D+P   + +     F A  
Sbjct: 255 DLIRKM-L---TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEK 310

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 22/135 (16%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS-------WYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           LV + M    L +++H   +  +S        Y           GL  LHE     V+HR
Sbjct: 111 LVTELMRT-DLAQVIHDQ-RIVISPQHIQYFMYHILL-------GLHVLHE---AGVVHR 158

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTD 181
           D+ P N+LL  + +  + DF LAR    D     T  V    Y APEL+   K  +   D
Sbjct: 159 DLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVD 216

Query: 182 VYAFGVFMLEVASGR 196
           +++ G  M E+ + +
Sbjct: 217 MWSAGCVMAEMFNRK 231

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 41/168 (24%), Positives = 67/168 (39%), Gaps = 19/168 (11%)

Query: 65  KGEFLLVYDYMPNGSL-DKIL-HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
            G   +V+++M    L  +I+   +     S       +R +   L Y H+     ++HR
Sbjct: 98  DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHR 154

Query: 123 DIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           D+KP  VLL   +     KLG FG+A       +    + VGT  +MAPE+++       
Sbjct: 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVVKREPYGKP 213

Query: 180 TDVYAFGV---FMLEVASGRRPI--EQQGSMEMV--NLVDWVSDCWKK 220
            DV+  GV    +L   SG  P    ++   E +           W  
Sbjct: 214 VDVWGCGVILFILL---SGCLPFYGTKERLFEGIIKGKYKMNPRQWSH 258

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 54/254 (21%), Positives = 94/254 (37%), Gaps = 55/254 (21%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
                +V + M  G L DKIL    +   S  +   ++  +   + YLH    Q V+HRD
Sbjct: 88  GKYVYVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRD 141

Query: 124 IKPANVLLDADLNG----KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +KP+N+L   +       ++ DFG A+    +     T    T  ++APE++       +
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPEVLERQGYDAA 200

Query: 180 TDVYAFGV---FMLEVASG-----RRPIE-QQGSMEMVNL--VDWVSDCWKKGAILDASD 228
            D+++ GV    ML   +G       P +  +  +  +           W        SD
Sbjct: 201 CDIWSLGVLLYTML---TGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN-----SVSD 252

Query: 229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATLPDIPRDST---- 282
           +           +LV K+ L   H  P  R     V+++  +     LP    +      
Sbjct: 253 TAK---------DLVSKM-L---HVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPH 299

Query: 283 -----LIAPFSASN 291
                + A +SA N
Sbjct: 300 LVKGAMAATYSALN 313

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 12/127 (9%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +    LV+D +  G L + I+    +   S       I+ +   + Y H      ++HR+
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRN 153

Query: 124 IKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST 180
           +KP N+LL +   G   KL DFGLA   +           GT GY++PE+++    S   
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPV 211

Query: 181 DVYAFGV 187
           D++A GV
Sbjct: 212 DIWACGV 218

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 23/168 (13%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           K + +LV +Y+  G L D+I+  +   +L+       ++ +  G+ ++H+     +LH D
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEGIRHMHQ---MYILHLD 212

Query: 124 IKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS 179
           +KP N+L        +  K+ DFGLAR Y      +     GT  ++APE++     S  
Sbjct: 213 LKPENILCVNRDAKQI--KIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFP 268

Query: 180 TDVYAFGV--FMLEVASGRRPIE---QQGSMEMVNLVDW--VSDCWKK 220
           TD+++ GV  +ML   SG  P        ++  +    W    + ++ 
Sbjct: 269 TDMWSVGVIAYML--LSGLSPFLGDNDAETLNNILACRWDLEDEEFQD 314

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 44/138 (31%), Positives = 69/138 (50%), Gaps = 12/138 (8%)

Query: 65  KGEFLLVYDYMPN---GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           + +  LV+++M N     +D     N    L           +  GL + HE+    +LH
Sbjct: 75  ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILH 131

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPE-LMRTGKAST 178
           RD+KP N+L++     KLGDFGLAR +    IP    +  V T  Y AP+ LM +   ST
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLARAF---GIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188

Query: 179 STDVYAFGVFMLEVASGR 196
           S D+++ G  + E+ +G+
Sbjct: 189 SIDIWSCGCILAEMITGK 206

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 8/109 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +   +  +H+      +HRDIKP N+L+D + + +L DFG       D   Q++  VGT 
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 164 GYMAPELMRTGKASTST-----DVYAFGVFMLEVASGRRPIEQQGSMEM 207
            Y++PE+++  +          D ++ GV M E+  G  P   +  +E 
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 28/171 (16%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           K + +L+ + +  G L D +     K SL+  +    ++ + +G+ YLH      + H D
Sbjct: 86  KTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139

Query: 124 IKPANVLL------DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS 177
           +KP N++L         +  K+ DFGLA   D         + GT  ++APE++      
Sbjct: 140 LKPENIMLLDRNVPKPRI--KIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLG 195

Query: 178 TSTDVYAFGV---FMLEVASGRRPI---EQQGSMEMVNLVDW--VSDCWKK 220
              D+++ GV    +L   SG  P     +Q ++  V+ V++    + +  
Sbjct: 196 LEADMWSIGVITYILL---SGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.8 bits (190), Expect = 2e-16
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 12/122 (9%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV+D +  G L + I+    +   S       I+ +   + Y H      ++HR++KP N
Sbjct: 82  LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPEN 135

Query: 129 VLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           +LL +   G   KL DFGLA   +           GT GY++PE+++    S   D++A 
Sbjct: 136 LLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 193

Query: 186 GV 187
           GV
Sbjct: 194 GV 195

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 76.5 bits (189), Expect = 2e-16
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 19/136 (13%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           LV +    G L ++++H   K         RI++ V S + Y H+     V HRD+KP N
Sbjct: 83  LVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPEN 136

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
            L      D   KL DFGLA  +    + +T   VGT  Y++P+++  G      D ++ 
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE-GLYGPECDEWSA 193

Query: 186 GV---FMLEVASGRRP 198
           GV    +L    G  P
Sbjct: 194 GVMMYVLL---CGYPP 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 45/136 (33%), Positives = 73/136 (53%), Gaps = 19/136 (13%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V +    G L D+I+    +   S +   RII+ V SG+ Y+H+     ++HRD+KP N
Sbjct: 98  IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPEN 151

Query: 129 VLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           +LL   + D + K+ DFGL+  +  +T  +    +GT  Y+APE++R G      DV++ 
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSA 208

Query: 186 GV---FMLEVASGRRP 198
           GV    +L   SG  P
Sbjct: 209 GVILYILL---SGTPP 221

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.4 bits (189), Expect = 3e-16
 Identities = 46/150 (30%), Positives = 81/150 (54%), Gaps = 13/150 (8%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
           HSN +++L + +++ K   +LV++++    L K+L    +  L        +  + +G+ 
Sbjct: 59  HSN-IVKLYDVIHT-KKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIA 114

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMA 167
           Y H+     VLHRD+KP N+L++ +   K+ DFGLAR +    IP    T  + T  Y A
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRA 168

Query: 168 PE-LMRTGKASTSTDVYAFGVFMLEVASGR 196
           P+ LM + K ST+ D+++ G    E+ +G 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 22/169 (13%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y      +       
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQ-QGSMEMVNLVDWVSDCWKK 220
             +MAPE +     +  +DV++FGV + E+ S G  P    +   E    +       K+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------KE 311

Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           G  + A D     +Y  + M       L C H +P  RP   +++++L 
Sbjct: 312 GTRMRAPDYTTPEMY--QTM-------LDCWHGEPSQRPTFSELVEHLG 351

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 39/128 (30%), Positives = 65/128 (50%), Gaps = 13/128 (10%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV  +M    L KI+          Y  +++++G    L Y+H      V+HRD+KP N+
Sbjct: 106 LVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKG----LKYIHS---AGVVHRDLKPGNL 157

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVF 188
            ++ D   K+ DFGLAR  D     + T  V T  Y APE++ +    + + D+++ G  
Sbjct: 158 AVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCI 213

Query: 189 MLEVASGR 196
           M E+ +G+
Sbjct: 214 MAEMLTGK 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 52/248 (20%), Positives = 91/248 (36%), Gaps = 61/248 (24%)

Query: 60  TVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRF------RIIRGVASGLLYLH 112
            + + +   L+V + +  G L  +I            Q F       I++ +   + YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRG-------DQAFTEREASEIMKSIGEAIQYLH 178

Query: 113 EDWEQVVLHRDIKPANVLL-----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA 167
                 + HRD+KP N+L      +A L  KL DFG A+         T     T  Y+A
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSHNSLTTP--CYTPYYVA 231

Query: 168 PELMRTGKASTSTDVYAFGV---FMLEVASGRRP-------IEQQGSMEMVNL--VDWVS 215
           PE++   K   S D+++ GV    +L    G  P           G    + +   ++ +
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILL---CGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288

Query: 216 DCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNAT 273
             W      + S+         E   L+  L L     +P  R  + + M +  +  +  
Sbjct: 289 PEWS-----EVSE---------EVKMLIRNL-L---KTEPTQRMTITEFMNHPWIMQSTK 330

Query: 274 LPDIPRDS 281
           +P  P  +
Sbjct: 331 VPQTPLHT 338

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 51/137 (37%), Positives = 69/137 (50%), Gaps = 24/137 (17%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS-------WYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           +V D M    L K+L T     LS        YQ  R       GL Y+H      VLHR
Sbjct: 107 IVQDLMET-DLYKLLKTQH---LSNDHICYFLYQILR-------GLKYIHS---ANVLHR 152

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYD--HDTIPQTTKLVGTFGYMAPELMRTGKA-STS 179
           D+KP+N+LL+   + K+ DFGLAR+ D  HD     T+ V T  Y APE+M   K  + S
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212

Query: 180 TDVYAFGVFMLEVASGR 196
            D+++ G  + E+ S R
Sbjct: 213 IDIWSVGCILAEMLSNR 229

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 13/132 (9%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV +Y    + D +L  + KP L   +   +  G   GL YLH      ++HRD+K  N+
Sbjct: 131 LVMEYCLGSASD-LLEVHKKP-LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNI 185

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST---STDVYAFG 186
           LL      KLGDFG A       +      VGT  +MAPE++            DV++ G
Sbjct: 186 LLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240

Query: 187 VFMLEVASGRRP 198
           +  +E+A  + P
Sbjct: 241 ITCIELAERKPP 252

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 75.5 bits (186), Expect = 9e-16
 Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 8/91 (8%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK 158
            I R + S + YL     + ++HRDIK  N+++  D   KL DFG A   +   +  T  
Sbjct: 134 YIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF- 189

Query: 159 LVGTFGYMAPELMRTGK--ASTSTDVYAFGV 187
             GT  Y APE++  G        ++++ GV
Sbjct: 190 -CGTIEYCAPEVLM-GNPYRGPELEMWSLGV 218

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 25/141 (17%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS---------WYQRFRIIRGVASGLLYLHEDWEQVVL 120
           LV DY+P  ++ ++     +   +          YQ FR        L Y+H      + 
Sbjct: 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFG---IC 178

Query: 121 HRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-RTGKAST 178
           HRDIKP N+LLD D    KL DFG A+             + +  Y APEL+      ++
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTS 236

Query: 179 STDVYAFGVFMLEVASGRRPI 199
           S DV++ G  + E+  G +PI
Sbjct: 237 SIDVWSAGCVLAELLLG-QPI 256

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 45/146 (30%), Positives = 66/146 (45%), Gaps = 21/146 (14%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
            V +Y   G L    H      LS  + F   R       + S L YLH   E+ V++RD
Sbjct: 225 FVMEYANGGEL--FFH------LSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRD 274

Query: 124 IKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           +K  N++LD D + K+ DFGL +  + D  T        GT  Y+APE++       + D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVD 331

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEM 207
            +  GV M E+  GR P   Q   ++
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKL 357

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 10/111 (9%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +   +  +H       +HRDIKP N+LLD   + +L DFG       D   ++   VGT 
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 164 GYMAPELMRTGKASTSTDVY-------AFGVFMLEVASGRRPIEQQGSMEM 207
            Y++PE+++       T  Y       A GVF  E+  G+ P     + E 
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 24/144 (16%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTN---IKPSL--SW-YQRFRIIRGVASGLLYLHEDWEQV 118
           K    LV+D+M    L+ I+  N   + PS   ++       ++G+     YLH+ W   
Sbjct: 84  KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM---TLQGLE----YLHQHW--- 132

Query: 119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT--TKLVGTFGYMAPELMRTGKA 176
           +LHRD+KP N+LLD +   KL DFGLA+ +     P    T  V T  Y APEL+   + 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRAPELLFGARM 189

Query: 177 -STSTDVYAFGVFMLEVASGRRPI 199
                D++A G  + E+   R P 
Sbjct: 190 YGVGVDMWAVGCILAELLL-RVPF 212

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 12/141 (8%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           L+ +Y   G + D ++       +   +     R + S + Y H+   + ++HRD+K  N
Sbjct: 91  LIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAEN 144

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK--ASTSTDVYAFG 186
           +LLDAD+N K+ DFG +  +            G   Y APEL + GK       DV++ G
Sbjct: 145 LLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKYDGPEVDVWSLG 201

Query: 187 VFMLEVASGRRPIEQQGSMEM 207
           V +  + SG  P + Q   E+
Sbjct: 202 VILYTLVSGSLPFDGQNLKEL 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 26/135 (19%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSW-------YQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           LV  +M    L K++       L         YQ  +       GL Y+H      ++HR
Sbjct: 107 LVMPFMGT-DLGKLMKHEK---LGEDRIQFLVYQMLK-------GLRYIHA---AGIIHR 152

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTD 181
           D+KP N+ ++ D   K+ DFGLAR  D     + T  V T  Y APE++    + + + D
Sbjct: 153 DLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVILNWMRYTQTVD 208

Query: 182 VYAFGVFMLEVASGR 196
           +++ G  M E+ +G+
Sbjct: 209 IWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 41/135 (30%), Positives = 62/135 (45%), Gaps = 26/135 (19%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS-------WYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           LV   M    L+ I+       L+        YQ  R       GL Y+H      ++HR
Sbjct: 111 LVTHLMGA-DLNNIVKCQK---LTDDHVQFLIYQILR-------GLKYIHS---ADIIHR 156

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTD 181
           D+KP+N+ ++ D   K+ DFGLAR        + T  V T  Y APE+M      + + D
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYRAPEIMLNWMHYNQTVD 212

Query: 182 VYAFGVFMLEVASGR 196
           +++ G  M E+ +GR
Sbjct: 213 IWSVGCIMAELLTGR 227

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 45/146 (30%), Positives = 64/146 (43%), Gaps = 22/146 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
            V +Y   G L    H      LS  + F   R       + S L YLH    + V++RD
Sbjct: 82  FVMEYANGGEL--FFH------LSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRD 130

Query: 124 IKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           IK  N++LD D + K+ DFGL +  + D  T        GT  Y+APE++       + D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVD 187

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEM 207
            +  GV M E+  GR P   Q    +
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERL 213

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 19/137 (13%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
           L+ DY+  G L    H      LS  +RF           +   L +LH+     +++RD
Sbjct: 136 LILDYINGGEL--FTH------LSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRD 184

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA--STSTD 181
           IK  N+LLD++ +  L DFGL++ +  D   +     GT  YMAP+++R G +    + D
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 244

Query: 182 VYAFGVFMLEVASGRRP 198
            ++ GV M E+ +G  P
Sbjct: 245 WWSLGVLMYELLTGASP 261

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 37/141 (26%), Positives = 66/141 (46%), Gaps = 25/141 (17%)

Query: 70  LVYDYMPNGSLDKILHTNIKPS---------LSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
           ++ +Y+P+ +L K+L + I+           +  YQ FR        + ++H      + 
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHS---LGIC 163

Query: 121 HRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-ST 178
           HRDIKP N+L+++  N  KL DFG A+         +   + +  Y APELM      + 
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTP 221

Query: 179 STDVYAFGVFMLEVASGRRPI 199
           S D+++ G    E+    +P+
Sbjct: 222 SIDLWSIGCVFGELI-LGKPL 241

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 25/142 (17%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS---------WYQRFRIIRGVASGLLYLHEDWEQVVL 120
           +V +Y+P+ +L +      +  ++          +Q  R        +  LH     V  
Sbjct: 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR-------SIGCLHLPSVNV-C 153

Query: 121 HRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-S 177
           HRDIKP NVL++   +G  KL DFG A+             + +  Y APEL+   +  +
Sbjct: 154 HRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYT 210

Query: 178 TSTDVYAFGVFMLEVASGRRPI 199
           T+ D+++ G    E+  G  PI
Sbjct: 211 TAVDIWSVGCIFAEMMLG-EPI 231

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 28/162 (17%)

Query: 50  HSN--GLLQLTNTVNSRKGE-FL-LVYDYMPNGSLDKILHTNIKPSLS---------WYQ 96
           H N   L     +   +K E FL LV +Y+P  ++ +      K   +          YQ
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 97  RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQ 155
             R        L Y+H      + HRDIKP N+LLD      KL DFG A++        
Sbjct: 150 LLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EP 197

Query: 156 TTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGR 196
               + +  Y APEL+      +T+ D+++ G  M E+  G+
Sbjct: 198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 73.1 bits (180), Expect = 7e-15
 Identities = 30/132 (22%), Positives = 60/132 (45%), Gaps = 12/132 (9%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           LV++++ N    ++  T +      +  + I++     L Y H      ++HRD+KP NV
Sbjct: 110 LVFEHVNNTDFKQLYQT-LTDYDIRFYMYEILKA----LDYCHSMG---IMHRDVKPHNV 161

Query: 130 LLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGV 187
           ++D +    +L D+GLA  Y      +    V +  +  PEL+   +    S D+++ G 
Sbjct: 162 MIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 219

Query: 188 FMLEVASGRRPI 199
            +  +   + P 
Sbjct: 220 MLASMIFRKEPF 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.1 bits (180), Expect = 7e-15
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 25/138 (18%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS-------WYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           +V +YM    L  +L       L         YQ  R       GL Y+H      VLHR
Sbjct: 99  IVQEYMET-DLANVLEQGP---LLEEHARLFMYQLLR-------GLKYIHS---ANVLHR 144

Query: 123 DIKPANVLLDA-DLNGKLGDFGLARLYD--HDTIPQTTKLVGTFGYMAPELMRTGKA-ST 178
           D+KPAN+ ++  DL  K+GDFGLAR+ D  +      ++ + T  Y +P L+ +    + 
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK 204

Query: 179 STDVYAFGVFMLEVASGR 196
           + D++A G    E+ +G+
Sbjct: 205 AIDMWAAGCIFAEMLTGK 222

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 9e-15
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 22/146 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
            V +Y+  G L  + H      +    +F + R       +  GL +LH    + +++RD
Sbjct: 95  FVMEYLNGGDL--MYH------IQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRD 143

Query: 124 IKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           +K  N+LLD D + K+ DFG+ +  +        T    GT  Y+APE++   K + S D
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVD 200

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEM 207
            ++FGV + E+  G+ P   Q   E+
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQDEEEL 226

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 32/147 (21%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS-------WYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           ++ + M    L +++ T +   LS        YQ  R        +  LH      V+HR
Sbjct: 91  IIQELMQT-DLHRVISTQM---LSDDHIQYFIYQTLR-------AVKVLHG---SNVIHR 136

Query: 123 DIKPANVLLDADLNGKLGDFGLARLYD---------HDTIPQTTKLVGTFGYMAPELMRT 173
           D+KP+N+L++++ + K+ DFGLAR+ D                 + V T  Y APE+M T
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196

Query: 174 GKA-STSTDVYAFGVFMLEVASGRRPI 199
               S + DV++ G  + E+   RRPI
Sbjct: 197 SAKYSRAMDVWSCGCILAELF-LRRPI 222

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 22/146 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
            V +++  G L  + H      +   +RF   R       + S L++LH+   + +++RD
Sbjct: 101 FVMEFVNGGDL--MFH------IQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRD 149

Query: 124 IKPANVLLDADLNGKLGDFGLA--RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           +K  NVLLD + + KL DFG+    + +  T   T    GT  Y+APE+++      + D
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEILQEMLYGPAVD 206

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEM 207
            +A GV + E+  G  P E +   ++
Sbjct: 207 WWAMGVLLYEMLCGHAPFEAENEDDL 232

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 31/154 (20%)

Query: 65  KGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           +  F LV++ M  GS+   I     +   +  +   +++ VAS L +LH    + + HRD
Sbjct: 83  EDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRD 136

Query: 124 IKPANVLL-----DADLNGKLGDFGLARLYDHD------TIPQTTKLVGTFGYMAPELMR 172
           +KP N+L       + +  K+ DF L      +      + P+     G+  YMAPE++ 
Sbjct: 137 LKPENILCEHPNQVSPV--KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 173 TGKASTST-----DVYAFGV---FMLEVASGRRP 198
                 S      D+++ GV    +L   SG  P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILL---SGYPP 225

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 35/106 (33%), Positives = 61/106 (57%), Gaps = 8/106 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           +A GL +L     + +++RD+K  NV+LD++ + K+ DFG+ +  ++D  T   T    G
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCG 504

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           T  Y+APE++       S D +AFGV + E+ +G+ P E +   E+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 29/104 (27%), Positives = 53/104 (50%), Gaps = 7/104 (6%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF 163
           +     YLH      +++RD+KP N+L+D     ++ DFG A+        +T  L GT 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTP 202

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
             +APE++ +   + + D +A GV + E+A+G  P      +++
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 8/97 (8%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L YLHE   + +++RD+K  NVLLD++ + KL D+G+ +  L   DT   T+   G
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 172

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           T  Y+APE++R      S D +A GV M E+ +GR P
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.4 bits (176), Expect = 2e-14
 Identities = 29/106 (27%), Positives = 56/106 (52%), Gaps = 8/106 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L +LH+   + +++RD+KP N++L+   + KL DFGL +  ++D      T    G
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCG 183

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           T  YMAPE++     + + D ++ G  M ++ +G  P   +   + 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 35/106 (33%), Positives = 61/106 (57%), Gaps = 8/106 (7%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           +A GL +L     + +++RD+K  NV+LD++ + K+ DFG+ +  ++D  T   T    G
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCG 183

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           T  Y+APE++       S D +AFGV + E+ +G+ P E +   E+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.4 bits (176), Expect = 2e-14
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 21/144 (14%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
           ++ DY+  G L           L   QRF           V   L YLH    + +++RD
Sbjct: 83  MIMDYIEGGEL--FSL------LRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRD 131

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP N+LLD + + K+ DFG A+ Y  D    T  L GT  Y+APE++ T   + S D +
Sbjct: 132 LKPENILLDKNGHIKITDFGFAK-YVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWW 187

Query: 184 AFGVFMLEVASGRRPIEQQGSMEM 207
           +FG+ + E+ +G  P     +M+ 
Sbjct: 188 SFGILIYEMLAGYTPFYDSNTMKT 211

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 8/97 (8%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           +AS L YLH      +++RD+KP N+LLD+  +  L DFGL +  +  + T   T+   G
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCG 201

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           T  Y+APE++       + D +  G  + E+  G  P
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 8/97 (8%)

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVG 161
           ++  L YLHE   + +++RD+K  NVLLD++ + KL D+G+ +  L   DT   T+   G
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 215

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP 198
           T  Y+APE++R      S D +A GV M E+ +GR P
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.0 bits (175), Expect = 3e-14
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 22/146 (15%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG------VASGLLYLHEDWEQVVLHRD 123
           L+ D++  G L           LS    F           +A  L +LH      +++RD
Sbjct: 103 LILDFLRGGDL--FTR------LSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRD 151

Query: 124 IKPANVLLDADLNGKLGDFGLAR--LYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD 181
           +KP N+LLD + + KL DFGL++  +             GT  YMAPE++     + S D
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSAD 208

Query: 182 VYAFGVFMLEVASGRRPIEQQGSMEM 207
            ++FGV M E+ +G  P + +   E 
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKET 234

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 33/132 (25%), Positives = 50/132 (37%), Gaps = 15/132 (11%)

Query: 61  VNSRKGEFLLVYDYMPNGS--LDKI-LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ 117
               +  F+LV +         D I     +    S   R      V + + + H    +
Sbjct: 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---R-CFFGQVVAAIQHCHS---R 158

Query: 118 VVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK- 175
            V+HRDIK  N+L+D      KL DFG   L  HD         GT  Y  PE +   + 
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF--DGTRVYSPPEWISRHQY 215

Query: 176 ASTSTDVYAFGV 187
            +    V++ G+
Sbjct: 216 HALPATVWSLGI 227

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 69.9 bits (172), Expect = 5e-14
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 12/141 (8%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V +Y+  G L D I        +   +  R+ + + S + Y H     +V+HRD+KP N
Sbjct: 88  MVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPEN 141

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK--ASTSTDVYAFG 186
           VLLDA +N K+ DFGL+ +       +T+   G+  Y APE++  G+  A    D+++ G
Sbjct: 142 VLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYAGPEVDIWSCG 198

Query: 187 VFMLEVASGRRPIEQQGSMEM 207
           V +  +  G  P + +    +
Sbjct: 199 VILYALLCGTLPFDDEHVPTL 219

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 38/132 (28%), Positives = 55/132 (41%), Gaps = 15/132 (11%)

Query: 61  VNSRKGEFLLVYDY-MPNGSL-DKI-LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ 117
              R   F+L+ +   P   L D I     ++  L+   R      V   + + H     
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELA---R-SFFWQVLEAVRHCHN---C 168

Query: 118 VVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK- 175
            VLHRDIK  N+L+D +    KL DFG   L   DT+       GT  Y  PE +R  + 
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDF--DGTRVYSPPEWIRYHRY 225

Query: 176 ASTSTDVYAFGV 187
              S  V++ G+
Sbjct: 226 HGRSAAVWSLGI 237

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 43/158 (27%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLS-------WYQRFRIIRGVASGLLYLHEDWEQVVLHR 122
           LV+DYM    L  ++  NI   L         YQ  +        + YLH      +LHR
Sbjct: 88  LVFDYMET-DLHAVIRANI---LEPVHKQYVVYQLIK-------VIKYLHS---GGLLHR 133

Query: 123 DIKPANVLLDADLNGKLGDFGLARLY--------------------DHDTIPQTTKLVGT 162
           D+KP+N+LL+A+ + K+ DFGL+R +                      D  P  T  V T
Sbjct: 134 DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT 193

Query: 163 FGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPI 199
             Y APE++      +   D+++ G  + E+    +PI
Sbjct: 194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 68.1 bits (167), Expect = 3e-13
 Identities = 33/145 (22%), Positives = 58/145 (40%), Gaps = 15/145 (10%)

Query: 70  LVYDYMPNGS---LDKILHTNIKPSLSWYQRFR-IIRGVASGLLYLHEDWEQVVLHRDIK 125
           +V +Y   G    LD +         +    F  +I G+     YLH    Q ++H+DIK
Sbjct: 85  MVMEYCVCGMQEMLDSVPEKRFPVCQAH-GYFCQLIDGLE----YLHS---QGIVHKDIK 136

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV-GTFGYMAPELMRTGK--ASTSTDV 182
           P N+LL      K+   G+A          T +   G+  +  PE+       +    D+
Sbjct: 137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDI 196

Query: 183 YAFGVFMLEVASGRRPIEQQGSMEM 207
           ++ GV +  + +G  P E     ++
Sbjct: 197 WSAGVTLYNITTGLYPFEGDNIYKL 221

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 67.2 bits (165), Expect = 5e-13
 Identities = 39/123 (31%), Positives = 57/123 (46%), Gaps = 15/123 (12%)

Query: 98  FR-IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-- 154
           F  ++ GV     YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++     
Sbjct: 111 FHQLMAGVV----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 155 -QTTKLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
                  GT  Y+APE L R    +   DV++ G+ +  + +G  P +Q          D
Sbjct: 164 LNKM--CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSD 220

Query: 213 WVS 215
           W  
Sbjct: 221 WKE 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 37/146 (25%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           +V +   +    K+  T +  +    +     ++ G    + Y+H      +LHRD+KPA
Sbjct: 134 VVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVG----VKYVHS---AGILHRDLKPA 185

Query: 128 NVLLDADLNGKLGDFGLARLYDHD--------------------------TIPQTTKLVG 161
           N L++ D + K+ DFGLAR  D+                              Q T  V 
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245

Query: 162 TFGYMAPELMRTGKA-STSTDVYAFG 186
           T  Y APEL+   +  + + DV++ G
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIG 271

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 39/164 (23%), Positives = 66/164 (40%), Gaps = 42/164 (25%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWEQVVLHRDIKPA 127
           +V +   +  L K+  T I  +    +     ++ G      ++HE     ++HRD+KPA
Sbjct: 107 IVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLG----ENFIHE---SGIIHRDLKPA 158

Query: 128 NVLLDADLNGKLGDFGLARLYDHDT---------------------IPQTTKLVGTFGYM 166
           N LL+ D + K+ DFGLAR  + +                        Q T  V T  Y 
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218

Query: 167 APELMRTGKA-STSTDVYAFG----------VFMLEVASGRRPI 199
           APEL+   +  + S D+++ G             +   + R P+
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 67.0 bits (164), Expect = 8e-13
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 8/105 (7%)

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTF 163
           SG+ Y H      + HRD+K  N LLD       K+ DFG ++     + P++T  VGT 
Sbjct: 127 SGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTP 181

Query: 164 GYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
            Y+APE L+R        DV++ GV +  +  G  P E       
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 66.6 bits (163), Expect = 9e-13
 Identities = 39/123 (31%), Positives = 58/123 (47%), Gaps = 15/123 (12%)

Query: 98  FR-IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH---DTI 153
           F  ++ GV     YLH      + HRDIKP N+LLD   N K+ DFGLA ++ +   + +
Sbjct: 111 FHQLMAGVV----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 154 PQTTKLVGTFGYMAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD 212
                  GT  Y+APE L R    +   DV++ G+ +  + +G  P +Q          D
Sbjct: 164 LNKM--CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSD 220

Query: 213 WVS 215
           W  
Sbjct: 221 WKE 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 13/113 (11%)

Query: 98  FR-IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT 156
           F+ II  +     Y H      ++HRD+KP N+LLD +LN K+ DFGL+ +       +T
Sbjct: 114 FQQIICAIE----YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166

Query: 157 TKLVGTFGYMAPELMRTGK--ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM 207
           +   G+  Y APE++  GK  A    DV++ G+ +  +  GR P + +    +
Sbjct: 167 S--CGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 41/121 (33%), Positives = 65/121 (53%), Gaps = 12/121 (9%)

Query: 70  LVYDYMPNGSL-DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN 128
           +V +Y+  G L D I        L   +  R+ + + SG+ Y H     +V+HRD+KP N
Sbjct: 93  MVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPEN 146

Query: 129 VLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK--ASTSTDVYAFG 186
           VLLDA +N K+ DFGL+ +       +T+   G+  Y APE++  G+  A    D+++ G
Sbjct: 147 VLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYAGPEVDIWSSG 203

Query: 187 V 187
           V
Sbjct: 204 V 204

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 65.9 bits (161), Expect = 1e-12
 Identities = 22/142 (15%), Positives = 42/142 (29%), Gaps = 35/142 (24%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V +++  GSL ++  T+  P        R ++ +A+     H      V      P+ V
Sbjct: 108 VVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHR---AGVALSIDHPSRV 160

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFM 189
            +  D        G   L                  M         A+   D+   G  +
Sbjct: 161 RVSID--------GDVVL-------------AYPATMPD-------ANPQDDIRGIGASL 192

Query: 190 LEVASGRRPIEQQGSMEMVNLV 211
             +   R P+ + G    +   
Sbjct: 193 YALLVNRWPLPEAGVRSGLAPA 214

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 52.3 bits (126), Expect = 6e-08
 Identities = 23/92 (25%), Positives = 42/92 (45%), Gaps = 12/92 (13%)

Query: 60  TVNSRKGEFLLVYDYMPNGSL-DKILHTNIKPSLSWYQRF--RIIRGVASGLLYLHEDWE 116
            + + +   L+V + +  G L  +I     +   ++ +R    I++ +   + YLH    
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS--- 135

Query: 117 QVVLHRDIKPANVLL---DADLNGKLGDFGLA 145
             + HRD+KP N+L      +   KL DFG A
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.1 bits (116), Expect = 6e-07
 Identities = 23/106 (21%), Positives = 31/106 (29%), Gaps = 8/106 (7%)

Query: 70  LVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANV 129
           +V ++   G     L        S      I+  + + L            HRD+   NV
Sbjct: 139 IVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 130 LLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK 175
           LL      KL      +     TIP     V    Y    L R G 
Sbjct: 194 LLKKTSLKKLHYTLNGKSS---TIPSCGLQVSIIDYTLSRLERDGI 236

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 11/65 (16%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGK--LGDFGLARLY----DHDTIPQTTK--LVG 161
           Y+HE      +H DIK AN+LL      +  L D+GL+  Y    +H    +  +    G
Sbjct: 166 YIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222

Query: 162 TFGYM 166
           T  + 
Sbjct: 223 TIEFT 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 20/65 (30%), Positives = 28/65 (43%), Gaps = 11/65 (16%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGK--LGDFGLARLY----DHDTIPQTTK--LVG 161
           Y+HE      +H DIK +N+LL+     +  L D+GLA  Y     H       K    G
Sbjct: 167 YIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223

Query: 162 TFGYM 166
           T  + 
Sbjct: 224 TIEFT 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 12/104 (11%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD------ADLNGKLGDFGLARLYDHDT 152
           +I + +  GL Y+H      ++H DIKP NVL++        +  K+ D G A  +  + 
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEH 191

Query: 153 IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
               T  + T  Y +PE++         D+++    + E+ +G 
Sbjct: 192 Y---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 4e-06
 Identities = 49/284 (17%), Positives = 86/284 (30%), Gaps = 101/284 (35%)

Query: 70  LVYDYMPNG-SLDKILHTNIKPSLSWYQRF------RIIRGVASGLLYLHEDWEQVVLHR 122
           +V++ +  G  L K +  +       YQ        +II+ V  GL YLH      ++H 
Sbjct: 122 MVFEVL--GHHLLKWIIKS------NYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHT 171

Query: 123 DIKPANVLLDAD------------------------------------------------ 134
           DIKP N+LL  +                                                
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231

Query: 135 -LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA 193
            L  K+ D G A           T+ + T  Y + E++     +T  D+++      E+A
Sbjct: 232 KLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287

Query: 194 SGRRPIEQQGSM----------EMVNLV-----------DWVSDCW-KKGAILDASD--- 228
           +G    E                ++ L+            +  + + KKG +   +    
Sbjct: 288 TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347

Query: 229 ----SRLEGIYE--EEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
                 L   YE  +E+        L      PE R    + ++
Sbjct: 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score = 46.0 bits (108), Expect = 5e-06
 Identities = 13/43 (30%), Positives = 21/43 (48%), Gaps = 1/43 (2%)

Query: 24 AQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          A +   F +  F+ D +L   G A++ S G LQLT   ++   
Sbjct: 1  ATET-SFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELP 42

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score = 45.1 bits (106), Expect = 8e-06
 Identities = 15/43 (34%), Positives = 19/43 (44%), Gaps = 2/43 (4%)

Query: 24 AQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          A +   FI   FN+   L   G A+V SNG LQL+        
Sbjct: 1  ATET-SFIIDAFNKT-NLILQGDATVSSNGNLQLSYNSYDSMS 41

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 23/68 (33%), Positives = 33/68 (48%), Gaps = 14/68 (20%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGK-----LGDFGLARLY-DHDT---IPQTTK-- 158
           Y+H    + +++RD+KP N L+    N       + DF LA+ Y D +T   IP      
Sbjct: 120 YVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176

Query: 159 LVGTFGYM 166
           L GT  YM
Sbjct: 177 LTGTARYM 184

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 9/100 (9%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-DADLNG-KLGDFGLARLYDHDTIPQT 156
           +    +   L  LH+     ++H D+KP N+LL     +G K+ DFG +  Y+H  +   
Sbjct: 204 KFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRV--Y 257

Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
           T +   F Y APE++   +     D+++ G  + E+ +G 
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 11/65 (16%), Positives = 24/65 (36%), Gaps = 11/65 (16%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGK--LGDFGLARLY--DHDTIP----QTTKLVG 161
           +LHE      +H ++   N+ +D +   +  L  +G A  Y      +       +   G
Sbjct: 174 FLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEG 230

Query: 162 TFGYM 166
              ++
Sbjct: 231 DLEFI 235

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score = 42.8 bits (100), Expect = 5e-05
 Identities = 9/31 (29%), Positives = 14/31 (45%)

Query: 30 FIYHGFNEDPQLQRDGLASVHSNGLLQLTNT 60
          F Y  F +D  L   G A + ++G L +   
Sbjct: 3  FNYTRFKDDGSLIFQGDAKIWTDGRLAMPTD 33

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score = 42.9 bits (100), Expect = 5e-05
 Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 1/50 (2%)

Query: 18 FILSALAQDVNQFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
           +  A + D   F +  F+ D   L   G A    N +LQLT T ++   
Sbjct: 2  LLNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAP 51

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 23/68 (33%), Positives = 33/68 (48%), Gaps = 14/68 (20%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGK-----LGDFGLARLY-DHDT---IPQTTK-- 158
            +HE   + +++RDIKP N L+    +       + DFG+ + Y D  T   IP   K  
Sbjct: 121 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177

Query: 159 LVGTFGYM 166
           L GT  YM
Sbjct: 178 LSGTARYM 185

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score = 42.1 bits (98), Expect = 9e-05
 Identities = 14/44 (31%), Positives = 20/44 (45%), Gaps = 2/44 (4%)

Query: 24 AQDVNQFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          A++   F++  F    P L   G A V   G+LQLTN   +   
Sbjct: 1  AEET-SFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVP 43

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score = 42.1 bits (98), Expect = 1e-04
 Identities = 14/46 (30%), Positives = 23/46 (50%), Gaps = 2/46 (4%)

Query: 24 AQDVNQFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKGEF 68
          + ++  F  + F  +   L   G ASV S G+LQLT   N +  ++
Sbjct: 1  SDEL-SFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKY 45

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 15/43 (34%), Positives = 23/43 (53%), Gaps = 2/43 (4%)

Query: 24 AQDVNQFIYHGFNE-DPQLQRDGLASVHSNGLLQLTNTVNSRK 65
          A+ V  F ++ F+E +P +   G  +V SNG +QLTN      
Sbjct: 1  AETV-SFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNS 42

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score = 42.1 bits (98), Expect = 1e-04
 Identities = 12/42 (28%), Positives = 20/42 (47%), Gaps = 1/42 (2%)

Query: 26 DVNQFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          +   F +  F E+  +L     AS+ SNG+L+LT    +   
Sbjct: 1  ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVP 42

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 24/66 (36%), Positives = 30/66 (45%), Gaps = 12/66 (18%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGK---LGDFGLARLY-DHDT---IPQTTK--LV 160
           ++H    +  LHRDIKP N L+          + DFGLA+ Y D  T   IP      L 
Sbjct: 118 FVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174

Query: 161 GTFGYM 166
           GT  Y 
Sbjct: 175 GTARYA 180

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score = 41.7 bits (97), Expect = 1e-04
 Identities = 16/41 (39%), Positives = 19/41 (46%), Gaps = 1/41 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKGEF 68
           F +  F  + P L   G A V S G+LQLTN VN      
Sbjct: 5  SFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSK 45

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score = 41.7 bits (97), Expect = 1e-04
 Identities = 14/38 (36%), Positives = 19/38 (50%), Gaps = 1/38 (2%)

Query: 29 QFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
           F +  FNE   L     ASV S+G L+LTN   + + 
Sbjct: 5  YFNFQRFNET-NLILQRDASVSSSGQLRLTNLNGNGEP 41

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 23/100 (23%), Positives = 46/100 (46%), Gaps = 7/100 (7%)

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQT 156
           +  + + + LL+L      ++ H D+KP N+LL        K+ DFG +       I   
Sbjct: 161 KFAQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI--Y 216

Query: 157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR 196
             +   F Y +PE++       + D+++ G  ++E+ +G 
Sbjct: 217 QYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 23/66 (34%), Positives = 30/66 (45%), Gaps = 12/66 (18%)

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGK---LGDFGLARLY----DHDTIPQTTK--LV 160
           Y+H    +  +HRD+KP N L+     G    + DFGLA+ Y     H  IP      L 
Sbjct: 120 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176

Query: 161 GTFGYM 166
           GT  Y 
Sbjct: 177 GTARYA 182

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score = 40.9 bits (95), Expect = 2e-04
 Identities = 11/38 (28%), Positives = 15/38 (39%), Gaps = 1/38 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRK 65
           F +  FN +   L     A V+S G L+LT       
Sbjct: 5  SFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAP 42

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score = 40.9 bits (95), Expect = 2e-04
 Identities = 12/35 (34%), Positives = 17/35 (48%), Gaps = 1/35 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVN 62
           F +  F+++   L   G ASV   G+LQL    N
Sbjct: 5  SFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGN 39

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score = 40.9 bits (95), Expect = 2e-04
 Identities = 13/37 (35%), Positives = 17/37 (45%), Gaps = 1/37 (2%)

Query: 29 QFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRK 65
           F    FN+   L   G A+V S G L LTN   + +
Sbjct: 5  SFNVETFNKT-NLILQGDATVSSEGHLLLTNVKGNEE 40

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score = 40.5 bits (94), Expect = 3e-04
 Identities = 10/39 (25%), Positives = 15/39 (38%), Gaps = 1/39 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
           F +  F      L   G A +  +G+LQLT    +   
Sbjct: 5  SFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMP 43

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score = 40.5 bits (94), Expect = 3e-04
 Identities = 13/44 (29%), Positives = 19/44 (43%), Gaps = 2/44 (4%)

Query: 24 AQDVNQFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          A+ V  F ++ F    P +   G A V S+G LQL     +   
Sbjct: 1  AETV-SFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTP 43

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score = 39.8 bits (92), Expect = 5e-04
 Identities = 13/39 (33%), Positives = 15/39 (38%), Gaps = 1/39 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
           F +  F      L   G ASV SN  LQLT   +    
Sbjct: 5  CFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNP 43

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score = 39.8 bits (92), Expect = 5e-04
 Identities = 12/35 (34%), Positives = 21/35 (60%), Gaps = 1/35 (2%)

Query: 30 FIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNS 63
          F ++ F+++  QL+    A + SN +L+LT  VN 
Sbjct: 6  FNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNG 40

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	313
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.98
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.98
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.98
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.98
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.77
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.52
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.23
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.9
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.39
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.26
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.18
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.94
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.49
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.36
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.13
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.48
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.72
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	94.31
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	93.21
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	92.55
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.23
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	89.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.01
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	87.98
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	86.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	85.06
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	84.98
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.43
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	84.35
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	83.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	83.79
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.01

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-46  Score=335.01  Aligned_cols=241  Identities=20%  Similarity=0.153  Sum_probs=191.8

Q ss_pred             hhHHHHHHHHhhcccc---ceEEEcccCC--ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh
Q 048068           12 VLLCVSFILSALAQDV---NQFIYHGFNE--DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT   86 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~   86 (313)
                      +++.|.+..++...+.   ..+++|.+..  ....|...++.++|||++++++++.+ ++.+|||||||+||+|.+++++
T Consensus        65 ~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy~~gg~L~~~l~~  143 (336)
T 4g3f_A           65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLIKQ  143 (336)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEECCCTTCBHHHHHHH
T ss_pred             EeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeccCCCcHHHHHHH
Confidence            3556666666666543   4677777653  23468889999999999999999887 6789999999999999999987


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC-cEEEeecccccccCCCCCC----ccccccc
Q 048068           87 NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIP----QTTKLVG  161 (313)
Q Consensus        87 ~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~----~~~~~~~  161 (313)
                      .  +.+++..+..++.||+.||.|||   .++|+||||||+|||++.+| .+||+|||++.........    ......|
T Consensus       144 ~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~G  218 (336)
T 4g3f_A          144 M--GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG  218 (336)
T ss_dssp             H--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCC
T ss_pred             c--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCcccc
Confidence            4  36999999999999999999999   69999999999999999887 5999999999865432211    1233579


Q ss_pred             cccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       162 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      |+.|+|||++.+..++.++|||||||++|+|++|++||.+.........+..       +       +......+...++
T Consensus       219 T~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~-------~~~~~~~~~~~s~  284 (336)
T 4g3f_A          219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-------E-------PPPIREIPPSCAP  284 (336)
T ss_dssp             CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-------S-------CCGGGGSCTTSCH
T ss_pred             CccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-------C-------CCCchhcCccCCH
Confidence            9999999999999999999999999999999999999987766555443321       0       0011123445567


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .+.+||.+||+.||++|||+.|++++|....
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            8899999999999999999999999986653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.2e-47  Score=338.26  Aligned_cols=236  Identities=21%  Similarity=0.317  Sum_probs=187.2

Q ss_pred             hhhHHHHHHHHhhcccc---ceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           11 CVLLCVSFILSALAQDV---NQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      .+++.|.+..+++..+.   ..+++|.+..         ....|.+.++.++|||++++++++.+ ++.+|||||||+||
T Consensus        30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVmEy~~gg  108 (350)
T 4b9d_A           30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVMDYCEGG  108 (350)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTC
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEeCCCCC
Confidence            45678888888887653   4677776632         22356677888999999999999987 67899999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      +|.+++..+....+++..++.++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||++....... .....
T Consensus       109 ~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~  184 (350)
T 4b9d_A          109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARA  184 (350)
T ss_dssp             BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHHHH
T ss_pred             cHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccccc
Confidence            9999998765667899999999999999999999   5899999999999999999999999999997543211 11234


Q ss_pred             ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.       .+..     +    ..+..
T Consensus       185 ~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------~~~~-----~----~~~~~  248 (350)
T 4b9d_A          185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-------SGSF-----P----PVSLH  248 (350)
T ss_dssp             HHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCC-----C----CCCTT
T ss_pred             cCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cCCC-----C----CCCcc
Confidence            579999999999999999999999999999999999999998876655443331       1110     0    12233


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          239 QMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+..+.+||.+||+.||++|||++|+++|
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            45678999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=329.28  Aligned_cols=244  Identities=22%  Similarity=0.319  Sum_probs=184.3

Q ss_pred             hhHHHHHHHHhhccccceEEEcccCC---C------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           12 VLLCVSFILSALAQDVNQFIYHGFNE---D------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      +++.|.+..++.+.....+++|.++.   .      ...|.+.++.++|||+++++++..+  +.++||||||+||+|.+
T Consensus        43 ~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVmEy~~gGsL~~  120 (307)
T 3omv_A           43 RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVTQWCEGSSLYK  120 (307)
T ss_dssp             ECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCSSCBHHH
T ss_pred             EEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEEEcCCCCCHHH
Confidence            34555555566666555667766642   1      2346677788899999999998753  56899999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-CCccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVG  161 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~  161 (313)
                      +++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....... ........|
T Consensus       121 ~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~G  196 (307)
T 3omv_A          121 HLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTG  196 (307)
T ss_dssp             HHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCC
T ss_pred             HHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeeccccc
Confidence            99765 3469999999999999999999994   899999999999999999999999999997554322 122345679


Q ss_pred             cccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          162 TFGYMAPELMRT---GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       162 ~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      |+.|+|||++.+   ..++.++|||||||++|||+||+.||.+...........      ..+..    .+. ....+..
T Consensus       197 T~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~------~~~~~----~p~-~~~~~~~  265 (307)
T 3omv_A          197 SVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV------GRGYA----SPD-LSKLYKN  265 (307)
T ss_dssp             CTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH------HTTCC----CCC-STTSCTT
T ss_pred             CCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH------hcCCC----CCC-ccccccc
Confidence            999999999864   358999999999999999999999998766544332221      11111    111 1123345


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +++.+.+||.+||+.||++|||+.|++++|+...
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            5678899999999999999999999999998654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-46  Score=332.41  Aligned_cols=234  Identities=20%  Similarity=0.247  Sum_probs=188.3

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccC-------CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFN-------EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      ++.|.+..++++.+   +..++.|.+.       +....|.+.++.++|||++++++++.+ ++.+|||||||+||+|.+
T Consensus        82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy~~gg~L~~  160 (346)
T 4fih_A           82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGALTD  160 (346)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEECCCTTEEHHH
T ss_pred             eecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeCCCCCcHHH
Confidence            45555555555554   3456666652       234467888999999999999999987 678999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ++.+.   .+++..++.++.||+.||.|||   .++|+||||||+|||++.+|.+||+|||++....... .......||
T Consensus       161 ~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT  233 (346)
T 4fih_A          161 IVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGT  233 (346)
T ss_dssp             HHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSC
T ss_pred             HHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-CcccccccC
Confidence            99864   5999999999999999999999   5899999999999999999999999999998654332 234457899


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      +.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+.       ...       ..........++.
T Consensus       234 p~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~~-------~~~~~~~~~~s~~  299 (346)
T 4fih_A          234 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------DNL-------PPRLKNLHKVSPS  299 (346)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HSS-------CCCCSCGGGSCHH
T ss_pred             cCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cCC-------CCCCCccccCCHH
Confidence            99999999999999999999999999999999999998776555443331       100       0011122345567


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +.+||.+||+.||++|||++|+++|=
T Consensus       300 ~~dli~~~L~~dP~~R~ta~e~l~Hp  325 (346)
T 4fih_A          300 LKGFLDRLLVRDPAQRATAAELLKHP  325 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            89999999999999999999999973

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=326.86  Aligned_cols=242  Identities=24%  Similarity=0.342  Sum_probs=184.4

Q ss_pred             hhHHHHHHHHhhcc--------ccceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQ--------DVNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~   76 (313)
                      +++.|.|..+|.++        ....+++|.+...       ...|.+.++.++|||++++++++.+ ++.++||||||+
T Consensus        48 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~lV~Ey~~  126 (329)
T 4aoj_A           48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLLMVFEYMR  126 (329)
T ss_dssp             EEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEEEEEECCT
T ss_pred             EEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCC
Confidence            34555555555553        2345677777532       2345667778899999999999886 568999999999


Q ss_pred             CCCHHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecc
Q 048068           77 NGSLDKILHTNI-------------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFG  143 (313)
Q Consensus        77 ~g~L~~~l~~~~-------------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg  143 (313)
                      +|+|.++++...             ..++++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||
T Consensus       127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~DFG  203 (329)
T 4aoj_A          127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFG  203 (329)
T ss_dssp             TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcccc
Confidence            999999997542             246999999999999999999999   4899999999999999999999999999


Q ss_pred             cccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhc
Q 048068          144 LARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG  221 (313)
Q Consensus       144 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  221 (313)
                      +++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+....+.       .+
T Consensus       204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-------~g  276 (329)
T 4aoj_A          204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-------QG  276 (329)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH-------HT
T ss_pred             cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cC
Confidence            9975533221 12234578999999999999999999999999999999999 899998876655443331       11


Q ss_pred             cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      .         ....+..+++.+.+||.+||+.||++|||++|++++|+....
T Consensus       277 ~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          277 R---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             C---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            1         011233455678999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-45  Score=324.34  Aligned_cols=241  Identities=23%  Similarity=0.351  Sum_probs=189.9

Q ss_pred             hhHHHHHHHHhhccc--------cceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQD--------VNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~   76 (313)
                      +++.|.|..++.++.        ...+++|.+...       ...|.+.+++++|||++++++++.+ ++.+++|||||+
T Consensus        20 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~lV~Ey~~   98 (299)
T 4asz_A           20 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIMVFEYMK   98 (299)
T ss_dssp             EEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEEEEEECCT
T ss_pred             EEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEEEEcCC
Confidence            455666666665542        345677777542       2345667778899999999999987 668999999999


Q ss_pred             CCCHHHHHhhC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccc
Q 048068           77 NGSLDKILHTN-----------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA  145 (313)
Q Consensus        77 ~g~L~~~l~~~-----------~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~  145 (313)
                      +|+|.++++..           ....+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++
T Consensus        99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DFGla  175 (299)
T 4asz_A           99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMS  175 (299)
T ss_dssp             TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred             CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCcccc
Confidence            99999999753           2356999999999999999999999   489999999999999999999999999999


Q ss_pred             cccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccc
Q 048068          146 RLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAI  223 (313)
Q Consensus       146 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  223 (313)
                      +........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+....+.       .+..
T Consensus       176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-------~~~~  248 (299)
T 4asz_A          176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-------QGRV  248 (299)
T ss_dssp             HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------HTCC
T ss_pred             eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cCCC
Confidence            754332211 1223468999999999999999999999999999999998 899998876655443331       1111


Q ss_pred             cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                               ...+..+++.+.+||.+||+.||++|||++|+++.|++..
T Consensus       249 ---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          249 ---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     1123345567899999999999999999999999998764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.3e-46  Score=327.52  Aligned_cols=232  Identities=22%  Similarity=0.306  Sum_probs=186.7

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      +++.|.+..+++..+   ...++.|.+..          ....|.+.++.++|||+++.++.+.+ ++++|+||||++||
T Consensus        39 ~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yivmEy~~gG  117 (311)
T 4aw0_A           39 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNG  117 (311)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCTTE
T ss_pred             EEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecCCCC
Confidence            345566666666554   34566666531          23467788899999999999999987 67899999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCC-CCCccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTT  157 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~-~~~~~~  157 (313)
                      +|.+++++.  +.+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...... ......
T Consensus       118 ~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~  192 (311)
T 4aw0_A          118 ELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN  192 (311)
T ss_dssp             EHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBC
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccccc
Confidence            999999874  46999999999999999999999   589999999999999999999999999999865432 222345


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ...||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+....+.       .+.      ..    ++.
T Consensus       193 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~~------~~----~p~  255 (311)
T 4aw0_A          193 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII-------KLE------YD----FPE  255 (311)
T ss_dssp             CCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTC------CC----CCT
T ss_pred             CcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCC------CC----CCc
Confidence            6789999999999999999999999999999999999999998876655444332       111      01    222


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ..++.+.+||.+||+.||++|||++|++.
T Consensus       256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          256 KFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            34567889999999999999999998643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=334.10  Aligned_cols=234  Identities=20%  Similarity=0.250  Sum_probs=188.1

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccC-------CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFN-------EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      +++.|.+..++++.+   +..+++|.+.       +....|...++.++|+|++++++++.+ ++.+|||||||+||+|.
T Consensus       158 ~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmEy~~gG~L~  236 (423)
T 4fie_A          158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGALT  236 (423)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEHH
T ss_pred             EeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEeCCCCCcHH
Confidence            345555555565554   3456666652       223467788999999999999999987 67899999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccc
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG  161 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  161 (313)
                      ++++..   .+++..+..++.||+.||.|||   .++|+||||||+|||++.+|.+||+|||++....... .......|
T Consensus       237 ~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~G  309 (423)
T 4fie_A          237 DIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG  309 (423)
T ss_dssp             HHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCCCEE
T ss_pred             HHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cccccccc
Confidence            999864   4999999999999999999999   5899999999999999999999999999998654332 23445789


Q ss_pred             cccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       162 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      |+.|+|||++.+..|+.++|||||||++|||++|++||.+....+....+.       ....     +  ........++
T Consensus       310 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~~~-----~--~~~~~~~~s~  375 (423)
T 4fie_A          310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------DNLP-----P--RLKNLHKVSP  375 (423)
T ss_dssp             CTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HSCC-----C--CCSCTTSSCH
T ss_pred             CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cCCC-----C--CCcccccCCH
Confidence            999999999999999999999999999999999999998776655443331       1100     0  0111223456


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+.+||.+||..||++|||++|+++|
T Consensus       376 ~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          376 SLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            78899999999999999999999997

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.2e-45  Score=323.14  Aligned_cols=225  Identities=22%  Similarity=0.342  Sum_probs=182.5

Q ss_pred             ceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           28 NQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        28 ~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      ..+++|.+..        ....|...++.++|||++++++++.+ ++.+++|||||++|+|.++|....           
T Consensus        57 ~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~  135 (308)
T 4gt4_A           57 QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD  135 (308)
T ss_dssp             EEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----
T ss_pred             eEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEEEEEEEcCCCCcHHHHHHhhCccccccccccc
Confidence            4567777643        23356677788899999999999886 568999999999999999996532           


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-CCcccccccccc
Q 048068           89 ---KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGTFG  164 (313)
Q Consensus        89 ---~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~  164 (313)
                         ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ........||+.
T Consensus       136 ~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~  212 (308)
T 4gt4_A          136 RTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR  212 (308)
T ss_dssp             CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGG
T ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCc
Confidence               2458999999999999999999994   899999999999999999999999999987543221 122344578999


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          165 YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       165 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      |+|||++.++.++.++|||||||++|||+| |..||.+....+....+.       .+..         ...+..++..+
T Consensus       213 ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-------~~~~---------~~~p~~~~~~~  276 (308)
T 4gt4_A          213 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-------NRQV---------LPCPDDCPAWV  276 (308)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-------TTCC---------CCCCTTCCHHH
T ss_pred             ccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC---------CCCcccchHHH
Confidence            999999999999999999999999999998 899998877655443331       1111         11234456778


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .+||..||+.||++|||++||+++|+.-.
T Consensus       277 ~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          277 YALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            99999999999999999999999998653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.6e-45  Score=318.64  Aligned_cols=233  Identities=23%  Similarity=0.344  Sum_probs=179.1

Q ss_pred             hhHHHHHHHHhhcccc---ceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEec---cCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQDV---NQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNS---RKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~   76 (313)
                      +++.|.+..++.+.+.   ..++.|.+..         ....|.+.++.++|||++++++++..   .++.+|||||||+
T Consensus        33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~  112 (290)
T 3fpq_A           33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT  112 (290)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCC
Confidence            3556666666665443   3566665532         12356777888999999999998763   3457899999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--ceecCcCCCcEEEc-CCCcEEEeecccccccCCCCC
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTI  153 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~--i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~~~~~~~  153 (313)
                      ||+|.+++++.  +.+++..+..++.||+.||.|||   .++  |+||||||+|||++ .++.+||+|||++......  
T Consensus       113 gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--  185 (290)
T 3fpq_A          113 SGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--  185 (290)
T ss_dssp             SCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence            99999999874  46999999999999999999999   466  99999999999997 4789999999999754322  


Q ss_pred             CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccC
Q 048068          154 PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG  233 (313)
Q Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (313)
                       ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........  +    ..+.        .+.
T Consensus       186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~--i----~~~~--------~~~  249 (290)
T 3fpq_A          186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--V----TSGV--------KPA  249 (290)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--H----TTTC--------CCG
T ss_pred             -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH--H----HcCC--------CCC
Confidence             2445689999999998875 6999999999999999999999999765543322111  1    1110        011


Q ss_pred             CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       234 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+...++.+.+||.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1222234568899999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-45  Score=322.56  Aligned_cols=232  Identities=24%  Similarity=0.313  Sum_probs=180.0

Q ss_pred             hhHHHHHHHHhhccc------cceEEEcccC---------CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQD------VNQFIYHGFN---------EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~   76 (313)
                      .++.|.+..++++++      ...++.|.+.         .....|.+.++.++|||++++++++.+ ++.+|+|||||+
T Consensus        31 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ivmEy~~  109 (304)
T 3ubd_A           31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLYLILDFLR  109 (304)
T ss_dssp             EEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEEEEECCCT
T ss_pred             EEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEEEcCC
Confidence            345555555555433      2244555442         234457788899999999999999987 679999999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT  156 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~  156 (313)
                      ||+|.+++.+.  +.+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||++....... ...
T Consensus       110 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~  183 (304)
T 3ubd_A          110 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA  183 (304)
T ss_dssp             TCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------CCC
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-ccc
Confidence            99999999874  36999999999999999999999   5899999999999999999999999999997543322 223


Q ss_pred             ccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCcc
Q 048068          157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE  236 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (313)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.       .+.          ...+
T Consensus       184 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------~~~----------~~~p  246 (304)
T 3ubd_A          184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL-------KAK----------LGMP  246 (304)
T ss_dssp             CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC----------CCCC
T ss_pred             cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH-------cCC----------CCCC
Confidence            45689999999999999999999999999999999999999998876665544332       110          0122


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          237 EEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       237 ~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      ...++.+.+||.+||+.||++|||     ++|+++|
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            334567889999999999999998     5788876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-44  Score=314.19  Aligned_cols=231  Identities=23%  Similarity=0.292  Sum_probs=174.1

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      .++.|.+..++...+   ...++.|.+..          ....|.+.++.++|||+++.++++.+ ++.+|+||||+ +|
T Consensus        20 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy~-~g   97 (275)
T 3hyh_A           20 TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMVIEYA-GN   97 (275)
T ss_dssp             EEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECC-CE
T ss_pred             EEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEEeCC-CC
Confidence            455666666666654   34666666531          12356778889999999999999987 67899999999 78


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      +|.+++.++  +.+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        98 ~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~~  170 (275)
T 3hyh_A           98 ELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKT  170 (275)
T ss_dssp             EHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------------
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--ccCC
Confidence            999999874  46999999999999999999999   5899999999999999999999999999997654332  2345


Q ss_pred             ccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          159 LVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ..||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.       .+.      ..    .+.
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~-------~~~------~~----~p~  233 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS-------NGV------YT----LPK  233 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTC------CC----CCT
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCC------CC----CCC
Confidence            689999999999998776 579999999999999999999998765544333221       111      01    222


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..++.+.+||.+||+.||++|||++|+++|=
T Consensus       234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  264 (275)
T 3hyh_A          234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQDD  264 (275)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence            3456788999999999999999999999964

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.3e-43  Score=314.06  Aligned_cols=225  Identities=22%  Similarity=0.282  Sum_probs=177.0

Q ss_pred             eEEEcccCCC--------hhhHHhhhhhccc-cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           29 QFIYHGFNED--------PQLQRDGLASVHS-NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        29 ~~~~~~~~~~--------~~~~~~~l~~~~~-~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      .+++|.+...        ...|...+.++.| +|++++++++...++.+++|||||++|+|.++|+...           
T Consensus        96 ~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~  175 (353)
T 4ase_A           96 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE  175 (353)
T ss_dssp             EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----
T ss_pred             EEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccch
Confidence            4666666432        1234455566655 8999999998766778999999999999999997531           


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccccc
Q 048068           89 ---KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFG  164 (313)
Q Consensus        89 ---~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~  164 (313)
                         ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus       176 ~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~  252 (353)
T 4ase_A          176 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  252 (353)
T ss_dssp             --CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGG
T ss_pred             hhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeecccccccc
Confidence               2458999999999999999999994   8999999999999999999999999999976543322 22344578999


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          165 YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       165 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      |+|||++.+..++.++|||||||++|||+| |+.||.+....+.....      ...+..         ...+..+++.+
T Consensus       253 ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~------i~~g~~---------~~~p~~~~~~~  317 (353)
T 4ase_A          253 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------LKEGTR---------MRAPDYTTPEM  317 (353)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH------HHHTCC---------CCCCTTCCHHH
T ss_pred             ccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH------HHcCCC---------CCCCccCCHHH
Confidence            999999999999999999999999999998 99999876543322111      111111         11233445678


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .++|..||+.||++|||+.|+++||++.
T Consensus       318 ~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          318 YQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            8999999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.2e-42  Score=302.90  Aligned_cols=238  Identities=21%  Similarity=0.257  Sum_probs=171.0

Q ss_pred             ceEEEcccCCChhh------HHhhhhhccccceeeeeeEEeccC---CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           28 NQFIYHGFNEDPQL------QRDGLASVHSNGLLQLTNTVNSRK---GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        28 ~~~~~~~~~~~~~~------~~~~l~~~~~~~~l~~~~~~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ..+++|.+......      +...+..++|||+++++++..+.+   ..+||||||+++|+|.++++..   ++++..+.
T Consensus        27 ~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~  103 (303)
T 3hmm_A           27 EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMI  103 (303)
T ss_dssp             EEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHH
T ss_pred             EEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHH
Confidence            46677777543322      222334678999999999988533   2689999999999999999864   49999999


Q ss_pred             HHHHHHHHHHHHhhhcC-----CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---cccccccccccccccc
Q 048068           99 RIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPEL  170 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~-----~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~  170 (313)
                      .++.|++.||.|||+.+     ..+|+||||||+|||++.++.+||+|||++.........   ......||+.|+|||+
T Consensus       104 ~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~  183 (303)
T 3hmm_A          104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHH
Confidence            99999999999999521     238999999999999999999999999998765433211   2234579999999999


Q ss_pred             ccCC------CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhh--------HHHHHHHhhhhccccccccccccC-Cc
Q 048068          171 MRTG------KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN--------LVDWVSDCWKKGAILDASDSRLEG-IY  235 (313)
Q Consensus       171 ~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (313)
                      +.+.      .++.++|||||||++|||+||.+||..........        ..........    .....+..+. ..
T Consensus       184 l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~rp~~p~~~~  259 (303)
T 3hmm_A          184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC----EQKLRPNIPNRWQ  259 (303)
T ss_dssp             HTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGG
T ss_pred             hcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHh----cccCCCCCCcccc
Confidence            8754      35779999999999999999988775433221100        0000111100    1111111111 12


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +.+....+.+||.+||+.||++|||+.|+++.|+...
T Consensus       260 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            3456778999999999999999999999999998653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-41  Score=300.47  Aligned_cols=233  Identities=20%  Similarity=0.273  Sum_probs=165.0

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccC-----------CeEEEE
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRK-----------GEFLLV   71 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~-----------~~~~lV   71 (313)
                      +.|.+..++.+.+   ...++.|.+..        ....|.+.++.++|||++++++.+.+.+           .++|+|
T Consensus        14 G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~iv   93 (299)
T 4g31_A           14 GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQ   93 (299)
T ss_dssp             EECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEE
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEE
Confidence            3444444444433   34666666531        1234667888899999999999887432           257999


Q ss_pred             EecCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCC
Q 048068           72 YDYMPNGSLDKILHTNIK-PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDH  150 (313)
Q Consensus        72 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~  150 (313)
                      ||||+||+|.+++..... ...+...++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.....
T Consensus        94 mE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~  170 (299)
T 4g31_A           94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ  170 (299)
T ss_dssp             EECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCCC-----
T ss_pred             EecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCccceecCC
Confidence            999999999999986532 34567788999999999999999   48999999999999999999999999999976543


Q ss_pred             CCC-----------CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhh
Q 048068          151 DTI-----------PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK  219 (313)
Q Consensus       151 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  219 (313)
                      ...           .......||+.|+|||++.+..++.++|||||||++|||++   ||.+..+  ....+..+    .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~~~~~----~  241 (299)
T 4g31_A          171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRTLTDV----R  241 (299)
T ss_dssp             ---------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHHHHHH----H
T ss_pred             CccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHHHHHH----h
Confidence            221           11233579999999999999999999999999999999996   7754221  11111111    0


Q ss_pred             hccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...        .+ .......+.+.+||.+||+.||++|||+.|+++|
T Consensus       242 ~~~--------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          242 NLK--------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             TTC--------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cCC--------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000        00 1122334556789999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=309.28  Aligned_cols=252  Identities=20%  Similarity=0.228  Sum_probs=187.3

Q ss_pred             hhhHHHHHHHHhhccc---cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEec-----cCCeEEEEEe
Q 048068           11 CVLLCVSFILSALAQD---VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNS-----RKGEFLLVYD   73 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~-----~~~~~~lV~e   73 (313)
                      .+++.|.+..++.+.+   +..+++|.+...         ...|.+.++.++|+|++++++++..     ..+++|||||
T Consensus        60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE  139 (398)
T 4b99_A           60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD  139 (398)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred             EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence            3456666666666654   346777776421         1246778889999999999998763     3468999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCC--
Q 048068           74 YMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD--  151 (313)
Q Consensus        74 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~--  151 (313)
                      ||+ |+|.+++...  +.+++..+..+++||+.||.|||   ..+|+||||||+|||++.++.+||+|||++......  
T Consensus       140 ~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~  213 (398)
T 4b99_A          140 LME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA  213 (398)
T ss_dssp             CCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred             CCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence            995 6899999764  46999999999999999999999   589999999999999999999999999999755322  


Q ss_pred             -CCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccc----
Q 048068          152 -TIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD----  225 (313)
Q Consensus       152 -~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----  225 (313)
                       .........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+..............    
T Consensus       214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~  293 (398)
T 4b99_A          214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE  293 (398)
T ss_dssp             --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----
T ss_pred             ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhh
Confidence             12233456899999999998865 568999999999999999999999998877766655533221111100000    


Q ss_pred             ----------cccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          226 ----------ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       226 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                                ...+..........++.+.+||.+||..||++|||++|+|+|=
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  346 (398)
T 4b99_A          294 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP  346 (398)
T ss_dssp             CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             hhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence                      0000000001112346788999999999999999999999973

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-40  Score=299.21  Aligned_cols=247  Identities=20%  Similarity=0.249  Sum_probs=173.7

Q ss_pred             hhHHHHHHHHhhccc------cceEEEcccCCC-----hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           12 VLLCVSFILSALAQD------VNQFIYHGFNED-----PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~-----~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      +++.|.+..++++.+      ...++.|.+...     ...|.+.++.+ .|+|+++.++++.+ ++++|+||||++||+
T Consensus        28 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~~lvmE~~~g~~  106 (361)
T 4f9c_A           28 KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHVVIAMPYLEHES  106 (361)
T ss_dssp             EEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEEEEEEECCCCCC
T ss_pred             EEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEEEEEEeCCCccc
Confidence            345555555555543      235666665432     22455566666 69999999999887 679999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-CcEEEeecccccccCCCCC-----
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTI-----  153 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~-----  153 (313)
                      |.++++     .+++..++.++.||+.||.|||   +.||+||||||+|||++.+ +.+||+|||++........     
T Consensus       107 L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~  178 (361)
T 4f9c_A          107 FLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKF  178 (361)
T ss_dssp             HHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGG
T ss_pred             HHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccc
Confidence            999984     3999999999999999999999   5899999999999999876 7999999999975432210     


Q ss_pred             ----------------------CccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCC-chhhhh
Q 048068          154 ----------------------PQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQG-SMEMVN  209 (313)
Q Consensus       154 ----------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~  209 (313)
                                            .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.... +.+...
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~  258 (361)
T 4f9c_A          179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALA  258 (361)
T ss_dssp             C--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence                                  112235699999999999765 58999999999999999999999996443 333333


Q ss_pred             HHHHHHHhhh-----hcc---------cc--------------cccccc---------ccCCccHHHHHHHHHHHHHcCC
Q 048068          210 LVDWVSDCWK-----KGA---------IL--------------DASDSR---------LEGIYEEEQMELVLKLGLFCSH  252 (313)
Q Consensus       210 ~~~~~~~~~~-----~~~---------~~--------------~~~~~~---------~~~~~~~~~~~~l~~li~~cl~  252 (313)
                      .+..+.....     ...         ..              ....+.         .........++.+.+||.+||.
T Consensus       259 ~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~  338 (361)
T 4f9c_A          259 QIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLD  338 (361)
T ss_dssp             HHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTC
T ss_pred             HHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCc
Confidence            2221111000     000         00              000000         0000111234567899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048068          253 PKPEARPNMRQVMQY  267 (313)
Q Consensus       253 ~~P~~Rpt~~ell~~  267 (313)
                      .||++|||++|+++|
T Consensus       339 ~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          339 LNPASRITAEEALLH  353 (361)
T ss_dssp             SCTTTSCCHHHHHTS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.6e-39  Score=307.97  Aligned_cols=202  Identities=20%  Similarity=0.281  Sum_probs=166.7

Q ss_pred             hhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecC
Q 048068           44 DGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD  123 (313)
Q Consensus        44 ~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~d  123 (313)
                      ..++.++||+++++++.+.+ ++++||||||++||+|.+++.+.  +.+++..++.++.||+.||.|||   ..+|+|||
T Consensus       244 ~ll~~~~HP~IV~l~~~f~~-~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRD  317 (689)
T 3v5w_A          244 SLVSTGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRD  317 (689)
T ss_dssp             HHHSSSCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCC
T ss_pred             HHHhhCCCCCEeEEEEEEEE-CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccC
Confidence            44566789999999999987 67999999999999999999874  46999999999999999999999   69999999


Q ss_pred             cCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccC
Q 048068          124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQ  202 (313)
Q Consensus       124 l~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (313)
                      |||+|||++.+|.+||+|||++.......   .....||+.|+|||++.. ..|+.++|+|||||++|+|++|.+||.+.
T Consensus       318 LKPeNILld~~G~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          318 LKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CchHHeEEeCCCCEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998654332   345689999999999964 57899999999999999999999999876


Q ss_pred             CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048068          203 GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQYL  268 (313)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~L  268 (313)
                      ...+........   ..           ....++...++.+.+||.+||..||.+|++     ++|+++|-
T Consensus       395 ~~~~~~~i~~~i---~~-----------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          395 KTKDKHEIDRMT---LT-----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             GCCCHHHHHHHH---HH-----------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             ChHHHHHHHHhh---cC-----------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence            544433222111   11           111133345567899999999999999998     79998863

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-39  Score=307.47  Aligned_cols=222  Identities=21%  Similarity=0.273  Sum_probs=179.3

Q ss_pred             cceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           27 VNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        27 ~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      +..++.|.+..       ....|.+.++.++|||++++++++.+ ++.+|+|||||+||+|.+++... ...+++..+..
T Consensus       182 g~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~  259 (573)
T 3uto_A          182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVE  259 (573)
T ss_dssp             CCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHH
T ss_pred             CCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHH
Confidence            34556665532       22346677889999999999999987 67999999999999999999754 34699999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC--CcEEEeecccccccCCCCCCccccccccccccccccccCCCCC
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD--LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAS  177 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  177 (313)
                      ++.||+.||.|||   .++|+||||||+|||++.+  +.+||+|||++.......  ......||+.|+|||++.+..++
T Consensus       260 ~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~  334 (573)
T 3uto_A          260 YMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVG  334 (573)
T ss_dssp             HHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCC
Confidence            9999999999999   5899999999999999854  889999999998664432  33456799999999999999999


Q ss_pred             cchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC
Q 048068          178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA  257 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~  257 (313)
                      .++|||||||++|+|++|.+||.+.+..+....+..       ..      ...+.......++.+.+||.+||..||.+
T Consensus       335 ~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~-------~~------~~~~~~~~~~~s~~~~dli~~~L~~dp~~  401 (573)
T 3uto_A          335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-------CD------WNMDDSAFSGISEDGKDFIRKLLLADPNT  401 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT-------TC------CCCCSGGGTTSCHHHHHHHHTTSCSSGGG
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh-------CC------CCCCcccccCCCHHHHHHHHHHccCChhH
Confidence            999999999999999999999998776655443321       00      01111122334567889999999999999


Q ss_pred             CCCHHHHHHHH
Q 048068          258 RPNMRQVMQYL  268 (313)
Q Consensus       258 Rpt~~ell~~L  268 (313)
                      |||+.|+++|=
T Consensus       402 R~t~~e~l~Hp  412 (573)
T 3uto_A          402 RMTIHQALEHP  412 (573)
T ss_dssp             SCCHHHHHHST
T ss_pred             CcCHHHHhcCc
Confidence            99999999973

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.4e-38  Score=281.52  Aligned_cols=245  Identities=36%  Similarity=0.637  Sum_probs=196.9

Q ss_pred             cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHH
Q 048068           27 VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQ   96 (313)
Q Consensus        27 ~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~   96 (313)
                      ...+++|.+..        ....+...++.+.|+++++..+++.. ++..++||||+++++|.+++....  ...+++..
T Consensus        54 ~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  132 (326)
T 3uim_A           54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPK  132 (326)
T ss_dssp             SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHH
T ss_pred             CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-CCceEEEEEeccCCCHHHHHHhccccCCCCCHHH
Confidence            34566666543        22456778889999999999999876 567899999999999999998653  34599999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC
Q 048068           97 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus        97 ~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      ++.++.|++.||.|||+.+..+++|+||||+||+++.++.++|+|||++...............|++.|+|||.+.+..+
T Consensus       133 ~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  212 (326)
T 3uim_A          133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS  212 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE
T ss_pred             HHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCC
Confidence            99999999999999995222299999999999999999999999999998665444334445568999999999988889


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCC--chhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCC
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQG--SMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPK  254 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  254 (313)
                      +.++||||||+++|+|++|..||....  .........+..............+.......+......+.+++.+||+.|
T Consensus       213 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  292 (326)
T 3uim_A          213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS  292 (326)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSC
T ss_pred             CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcC
Confidence            999999999999999999999996321  112222334444444555555556666666778889999999999999999


Q ss_pred             CCCCCCHHHHHHHHhccC
Q 048068          255 PEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       255 P~~Rpt~~ell~~L~~~~  272 (313)
                      |.+|||+++++++|++..
T Consensus       293 P~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          293 PMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             GGGSCCHHHHHHHHHTSS
T ss_pred             CccCCCHHHHHHHhcCcc
Confidence            999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-37  Score=276.59  Aligned_cols=244  Identities=30%  Similarity=0.503  Sum_probs=197.6

Q ss_pred             cceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHH
Q 048068           27 VNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQR   97 (313)
Q Consensus        27 ~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~   97 (313)
                      ...+++|.+...       ...+...++.++|+++++..+++.. ++..++||||+++++|.+++....  ...+++..+
T Consensus        63 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  141 (321)
T 2qkw_B           63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR  141 (321)
T ss_dssp             CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHH
T ss_pred             CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHH
Confidence            345666655422       2356677888899999999998876 668999999999999999997543  245999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      +.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+..+
T Consensus       142 ~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  218 (321)
T 2qkw_B          142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL  218 (321)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC
T ss_pred             HHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCC
Confidence            999999999999999   58999999999999999999999999999875433221 12233457899999999988889


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      +.++||||||+++|+|++|+.||......+......+.......+......++..........+..+.+++.+||+.||+
T Consensus       219 ~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  298 (321)
T 2qkw_B          219 TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE  298 (321)
T ss_dssp             CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGG
T ss_pred             CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcc
Confidence            99999999999999999999999876665555555444444444455555556666667788999999999999999999


Q ss_pred             CCCCHHHHHHHHhccCCC
Q 048068          257 ARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       257 ~Rpt~~ell~~L~~~~~~  274 (313)
                      +|||+.|++++|+.....
T Consensus       299 ~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          299 DRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             GSCCHHHHHHHHHHHHHS
T ss_pred             cCcCHHHHHHHHHHHhhc
Confidence            999999999999987544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-36  Score=271.34  Aligned_cols=230  Identities=22%  Similarity=0.291  Sum_probs=180.9

Q ss_pred             HHHHHHHhhccc---cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           15 CVSFILSALAQD---VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        15 ~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      .|.+..++++.+   ...++.|.+...         ...|...++.++|+|+++.++++.. ++..++||||+++++|.+
T Consensus        25 ~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~~~~L~~  103 (328)
T 3fe3_A           25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLIMEYASGGEVFD  103 (328)
T ss_dssp             ECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTTCBHHH
T ss_pred             eCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEECCCCCcHHH
Confidence            344444444433   345666655321         2246677888899999999999876 678999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ++...  +.+++..++.++.||+.||.|||   ..+++||||||+||+++.++.++|+|||++.......  ......|+
T Consensus       104 ~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt  176 (328)
T 3fe3_A          104 YLVAH--GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGA  176 (328)
T ss_dssp             HHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGTTSSS
T ss_pred             HHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--ccccccCC
Confidence            99764  35999999999999999999999   5899999999999999999999999999997654332  33456789


Q ss_pred             ccccccccccCCCCC-cchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          163 FGYMAPELMRTGKAS-TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      +.|+|||.+.+..+. .++|||||||++|+|++|+.||.+.+.......+.       .+.          ...+...+.
T Consensus       177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~~----------~~~p~~~s~  239 (328)
T 3fe3_A          177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL-------RGK----------YRIPFYMST  239 (328)
T ss_dssp             GGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC----------CCCCTTSCH
T ss_pred             cceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCC----------CCCCCCCCH
Confidence            999999999887764 89999999999999999999998776554433221       110          012223456


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      .+.+|+.+||..||.+|||++|+++|-.
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence            6889999999999999999999999854

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-36  Score=268.63  Aligned_cols=235  Identities=21%  Similarity=0.274  Sum_probs=183.5

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      ++.|.+..+|...+   ...++.|.+..       ....+...++.++|+++++.++++.. ++.+++||||+++++|.+
T Consensus        28 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~  106 (297)
T 3fxz_A           28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTD  106 (297)
T ss_dssp             EEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTCBHHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEEECCCCCCHHH
Confidence            34455555555533   34556665421       12356677888999999999998886 668999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ++...   .+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++....... .......|+
T Consensus       107 ~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt  179 (297)
T 3fxz_A          107 VVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGT  179 (297)
T ss_dssp             HHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSC
T ss_pred             HHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccCCccCC
Confidence            99875   4999999999999999999999   5899999999999999999999999999987654332 223445789


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      +.|+|||.+.+..++.++|||||||++|+|++|..||...........+.      ...        ......+...+..
T Consensus       180 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~~--------~~~~~~~~~~~~~  245 (297)
T 3fxz_A          180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNG--------TPELQNPEKLSAI  245 (297)
T ss_dssp             GGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HHC--------SCCCSCGGGSCHH
T ss_pred             cCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC--------CCCCCCccccCHH
Confidence            99999999998899999999999999999999999998765544332221      010        0111123345567


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +.+||.+||+.||++|||++|+++|-.
T Consensus       246 ~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          246 FRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChh
Confidence            899999999999999999999999754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.5e-37  Score=277.27  Aligned_cols=224  Identities=23%  Similarity=0.358  Sum_probs=178.8

Q ss_pred             eEEEcccCCC--------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           29 QFIYHGFNED--------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        29 ~~~~~~~~~~--------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      .+++|.+...        ...|...++.+ +|++++++++++.. ++.+++||||+++|+|.+++....           
T Consensus       115 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  193 (370)
T 2psq_A          115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN  193 (370)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHTCCC---------
T ss_pred             eEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-CCCEEEEEEcCCCCCHHHHHHhhCCcccccccccc
Confidence            4677766532        22455666777 89999999999876 668999999999999999998643           


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccccc
Q 048068           89 ---KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFG  164 (313)
Q Consensus        89 ---~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~  164 (313)
                         ...+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||++........ .......+++.
T Consensus       194 ~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~  270 (370)
T 2psq_A          194 RVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK  270 (370)
T ss_dssp             --CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGG
T ss_pred             ccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccc
Confidence               135899999999999999999999   58999999999999999999999999999975543221 12233456788


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          165 YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       165 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      |+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.       .+.         ....+...+..+
T Consensus       271 y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l  334 (370)
T 2psq_A          271 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-------EGH---------RMDKPANCTNEL  334 (370)
T ss_dssp             GCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TTC---------CCCCCTTSCHHH
T ss_pred             eECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------cCC---------CCCCCCCCCHHH
Confidence            999999998899999999999999999999 999998766554433221       111         111233455678


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .++|.+||+.||.+|||+.|++++|+...
T Consensus       335 ~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          335 YMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-37  Score=271.74  Aligned_cols=218  Identities=26%  Similarity=0.400  Sum_probs=166.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQV-  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~-  118 (313)
                      .|...++.++|+++++..+++.. ++..++||||+++++|.+++.... ...+++..++.++.||+.||.|||   ..+ 
T Consensus        83 ~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~  158 (309)
T 3p86_A           83 REVAIMKRLRHPNIVLFMGAVTQ-PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNP  158 (309)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEECS-TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSS
T ss_pred             HHHHHHHhCCCCCEeeEEEEEEE-CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCC
Confidence            46677888899999999999876 567899999999999999998642 124999999999999999999999   588 


Q ss_pred             -ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          119 -VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       119 -i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                       ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.
T Consensus       159 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  237 (309)
T 3p86_A          159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ  237 (309)
T ss_dssp             CCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCC
T ss_pred             CEECCCCChhhEEEeCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999987543322 12334578999999999998889999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCCCC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDI  277 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~~~  277 (313)
                      ||......+.......      .         ......+...+..+.+||.+||+.||.+|||++++++.|+.......|
T Consensus       238 Pf~~~~~~~~~~~~~~------~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          238 PWGNLNPAQVVAAVGF------K---------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             TTTTSCHHHHHHHHHH------S---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             CCCCCCHHHHHHHHHh------c---------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            9987665543322210      0         011112334456789999999999999999999999999988755444


Q ss_pred             C
Q 048068          278 P  278 (313)
Q Consensus       278 ~  278 (313)
                      |
T Consensus       303 ~  303 (309)
T 3p86_A          303 P  303 (309)
T ss_dssp             -
T ss_pred             C
Confidence            4

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-36  Score=264.35  Aligned_cols=223  Identities=25%  Similarity=0.393  Sum_probs=178.6

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .++.|.+...      ...|...++.++|+++++.+++..+ ++..++||||+++++|.+++... ...+++..++.++.
T Consensus        36 ~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~  113 (269)
T 4hcu_A           36 KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCL  113 (269)
T ss_dssp             EEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHH
T ss_pred             eEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHH
Confidence            4566665432      2356778888999999999999876 56799999999999999999765 44699999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.||.|||   ..+++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+..++.++|+
T Consensus       114 ~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  190 (269)
T 4hcu_A          114 DVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV  190 (269)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhh
Confidence            9999999999   5899999999999999999999999999997554332222233456778999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|+|++ |..||......+....+.       .+         .....+...+..+.+++..||+.||.+|||+
T Consensus       191 ~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  254 (269)
T 4hcu_A          191 WSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TG---------FRLYKPRLASTHVYQIMNHCWRERPEDRPAF  254 (269)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------cC---------ccCCCCCcCCHHHHHHHHHHccCCcccCcCH
Confidence            999999999999 999998766554332221       10         0111222335678999999999999999999


Q ss_pred             HHHHHHHhccC
Q 048068          262 RQVMQYLDGNA  272 (313)
Q Consensus       262 ~ell~~L~~~~  272 (313)
                      .+++++|++..
T Consensus       255 ~~ll~~l~~l~  265 (269)
T 4hcu_A          255 SRLLRQLAEIA  265 (269)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-36  Score=263.25  Aligned_cols=224  Identities=24%  Similarity=0.363  Sum_probs=179.0

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .+++|.+...      ...+.+.++.++|++++++.++... ++..++||||+++++|.+++... ...+++..++.++.
T Consensus        34 ~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~  111 (268)
T 3sxs_A           34 DVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCY  111 (268)
T ss_dssp             EEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHH
T ss_pred             eEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHH
Confidence            4566665432      2356677888899999999998876 66899999999999999999865 34599999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.||.|||   ..+++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+..++.++|+
T Consensus       112 qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  188 (268)
T 3sxs_A          112 DVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV  188 (268)
T ss_dssp             HHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHH
T ss_pred             HHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhh
Confidence            9999999999   5899999999999999999999999999997655443223333455678999999988888999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|++++ |..||.............       .+.         ....+...++.+.+++..||+.||.+|||+
T Consensus       189 ~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  252 (268)
T 3sxs_A          189 WAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------QGH---------RLYRPHLASDTIYQIMYSCWHELPEKRPTF  252 (268)
T ss_dssp             HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TTC---------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHcCCCCCccccChHHHHHHHH-------cCC---------CCCCCCcChHHHHHHHHHHcCCChhhCcCH
Confidence            999999999999 999998766554332221       100         011122234578899999999999999999


Q ss_pred             HHHHHHHhccCC
Q 048068          262 RQVMQYLDGNAT  273 (313)
Q Consensus       262 ~ell~~L~~~~~  273 (313)
                      .+++++|+....
T Consensus       253 ~~ll~~L~~l~~  264 (268)
T 3sxs_A          253 QQLLSSIEPLRE  264 (268)
T ss_dssp             HHHHHHHGGGCC
T ss_pred             HHHHHHHHHhhh
Confidence            999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.7e-36  Score=265.76  Aligned_cols=219  Identities=18%  Similarity=0.337  Sum_probs=170.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..++... ++.+++||||++|++|.+++...  ..+++..++.++.|++.||.|||   ..+++
T Consensus        60 ~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~  133 (294)
T 4eqm_A           60 REVHNSSQLSHQNIVSMIDVDEE-DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH---DMRIV  133 (294)
T ss_dssp             HHHHHHTTCCBTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHhcCCCCCCceEEEeeee-CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45566778899999999999876 67899999999999999999874  36999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||||+||+++.++.++|+|||++...............|++.|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus       134 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  213 (294)
T 4eqm_A          134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN  213 (294)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999997654443333444578999999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhccCCCCCC
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-NMRQVMQYLDGNATLPDI  277 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ell~~L~~~~~~~~~  277 (313)
                      +..........      ... .     .+..........++.+.++|.+||+.||.+|| +++++.+.|+....-...
T Consensus       214 ~~~~~~~~~~~------~~~-~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          214 GETAVSIAIKH------IQD-S-----VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             SSCHHHHHHHH------HSS-C-----CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             CCChHHHHHHH------hhc-c-----CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            76554322111      000 0     01111112333457789999999999999998 999999999987644433

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.4e-37  Score=280.55  Aligned_cols=237  Identities=17%  Similarity=0.215  Sum_probs=173.1

Q ss_pred             cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           27 VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        27 ~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ...+++|.+..         ....|...++.++|+|++++.+++.. ++.+++||||+++++|.+++.......+++..+
T Consensus        52 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  130 (389)
T 3gni_B           52 GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFMAYGSAKDLICTHFMDGMNELAI  130 (389)
T ss_dssp             CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHH
T ss_pred             CCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHH
Confidence            34566666542         12236677888999999999999886 678999999999999999998765567999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC------CCccccccccccccccccc
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT------IPQTTKLVGTFGYMAPELM  171 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~  171 (313)
                      +.++.||+.||.|||   ..+|+||||||+||+++.++.++|+|||.+.......      ........++..|+|||++
T Consensus       131 ~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (389)
T 3gni_B          131 AYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL  207 (389)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHH
Confidence            999999999999999   5899999999999999999999999999875432111      1112234678899999999


Q ss_pred             cC--CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHH--HHHhhhhcc------------------ccc----
Q 048068          172 RT--GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDW--VSDCWKKGA------------------ILD----  225 (313)
Q Consensus       172 ~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~------------------~~~----  225 (313)
                      .+  ..++.++|||||||++|+|++|+.||.+............  .........                  ...    
T Consensus       208 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (389)
T 3gni_B          208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT  287 (389)
T ss_dssp             STTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------
T ss_pred             hccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccccc
Confidence            87  5789999999999999999999999987655443321100  000000000                  000    


Q ss_pred             -----cccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          226 -----ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       226 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                           ..........+...+..+.+||.+||+.||++|||++|+++|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                 000000111233445679999999999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-35  Score=262.33  Aligned_cols=247  Identities=21%  Similarity=0.252  Sum_probs=182.8

Q ss_pred             cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCC-CCCCCHHH
Q 048068           27 VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQ   96 (313)
Q Consensus        27 ~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~   96 (313)
                      ...+++|.+..        ....|.+.++.++|+++++..++.... ....++||||+++++|.+++.... ...+++..
T Consensus        34 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  113 (319)
T 4euu_A           34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE  113 (319)
T ss_dssp             CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHH
T ss_pred             CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHH
Confidence            34566666542        122566788999999999999988753 347899999999999999998643 33499999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE----cCCCcEEEeecccccccCCCCCCcccccccccccccccccc
Q 048068           97 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR  172 (313)
Q Consensus        97 ~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  172 (313)
                      ++.++.||+.||.|||   ..+++|+||||+||++    +.++.++|+|||++.......  ......++..|+|||.+.
T Consensus       114 ~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          114 FLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC--ceeecccCCCccCHHHhh
Confidence            9999999999999999   5899999999999999    777889999999997654432  223456899999999885


Q ss_pred             --------CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhh-HHHHHHHhhhhcccc-----------cccccccc
Q 048068          173 --------TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN-LVDWVSDCWKKGAIL-----------DASDSRLE  232 (313)
Q Consensus       173 --------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~-----------~~~~~~~~  232 (313)
                              +..++.++|||||||++|+|++|+.||.......... ....+..........           -.......
T Consensus       189 ~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (319)
T 4euu_A          189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS  268 (319)
T ss_dssp             HHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred             hccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcc
Confidence                    4678999999999999999999999997544432221 111111110000000           00011122


Q ss_pred             CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCCCCC
Q 048068          233 GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIP  278 (313)
Q Consensus       233 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~~~~  278 (313)
                      ...+......+.+++.+||+.||++|||++|+++|..+....-..+
T Consensus       269 ~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~~  314 (319)
T 4euu_A          269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSH  314 (319)
T ss_dssp             CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-----
T ss_pred             cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCcc
Confidence            2456788889999999999999999999999999999887554433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.2e-36  Score=271.37  Aligned_cols=208  Identities=21%  Similarity=0.313  Sum_probs=170.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.+.|++++++++++.. ++.+++||||++|++|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        63 ~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~gi  136 (361)
T 2yab_A           63 EREVSILRQVLHPNIITLHDVYEN-RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKI  136 (361)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCcCCCcEEEEEEe-CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            467778899999999999999876 67899999999999999999763  46999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCC----cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          120 LHRDIKPANVLLDADL----NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +|+||||+||+++.++    .++|+|||++.......  ......||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus       137 vHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g  214 (361)
T 2yab_A          137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  214 (361)
T ss_dssp             ECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhC
Confidence            9999999999998776    79999999997654432  23345789999999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..||.+....+....+.       ....      ..+.......+..+.+||.+||..||.+|||+.|+++|-
T Consensus       215 ~~Pf~~~~~~~~~~~i~-------~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          215 ASPFLGDTKQETLANIT-------AVSY------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             CCSSCCSSHHHHHHHHH-------TTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             CCCCCCCCHHHHHHHHH-------hcCC------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            99998876555443331       0000      000011123346788999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-36  Score=271.35  Aligned_cols=239  Identities=25%  Similarity=0.356  Sum_probs=175.8

Q ss_pred             ceEEEcccCCChh------hHHhhhhhccccceeeeeeEEecc---CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           28 NQFIYHGFNEDPQ------LQRDGLASVHSNGLLQLTNTVNSR---KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        28 ~~~~~~~~~~~~~------~~~~~l~~~~~~~~l~~~~~~~~~---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ..+++|.+.....      .+...++.++|+|++++++++...   ...+++||||+++|+|.++++..   .+++..++
T Consensus        48 ~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~  124 (322)
T 3soc_A           48 EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELC  124 (322)
T ss_dssp             EEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHH
T ss_pred             CEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHH
Confidence            3566676643222      244557788999999999998853   33589999999999999999864   49999999


Q ss_pred             HHHHHHHHHHHHhhhcCCC----------CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccc
Q 048068           99 RIIRGVASGLLYLHEDWEQ----------VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMA  167 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~----------~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~a  167 (313)
                      .++.|++.||.|||   ..          +++|+||||+||+++.++.+||+|||++......... ......+|+.|+|
T Consensus       125 ~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~a  201 (322)
T 3soc_A          125 HIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA  201 (322)
T ss_dssp             HHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCC
T ss_pred             HHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccC
Confidence            99999999999999   57          9999999999999999999999999999765433221 2333578999999


Q ss_pred             cccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhccccccccccccC-Ccc
Q 048068          168 PELMRTG-----KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKGAILDASDSRLEG-IYE  236 (313)
Q Consensus       168 PE~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-~~~  236 (313)
                      ||.+.+.     .++.++|||||||++|+|++|+.||.+..+.............     +..........+.... ...
T Consensus       202 PE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (322)
T 3soc_A          202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK  281 (322)
T ss_dssp             HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             HhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccc
Confidence            9998763     4567889999999999999999999875543322211110000     0000000011111111 112


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       237 ~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ......+.+||.+||+.||++|||+.++++.|+...
T Consensus       282 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          282 HAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             SHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            345677999999999999999999999999998653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-36  Score=265.82  Aligned_cols=227  Identities=20%  Similarity=0.358  Sum_probs=175.6

Q ss_pred             cceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           27 VNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        27 ~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ...++.|.+..       ....|...++.++|+++++.++++.+ ++..++||||+++++|.++++.. ...+++..++.
T Consensus        35 ~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~  112 (310)
T 3s95_A           35 GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVS  112 (310)
T ss_dssp             CCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHH
T ss_pred             CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHH
Confidence            44566665532       22356677788899999999999886 67899999999999999999875 34699999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-------------ccccccccccc
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-------------TTKLVGTFGYM  166 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-------------~~~~~~~~~y~  166 (313)
                      ++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++..........             .....||+.|+
T Consensus       113 i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  189 (310)
T 3s95_A          113 FAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM  189 (310)
T ss_dssp             HHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGC
T ss_pred             HHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCccee
Confidence            9999999999999   5899999999999999999999999999997654322111             11456899999


Q ss_pred             ccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHH
Q 048068          167 APELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL  246 (313)
Q Consensus       167 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (313)
                      |||.+.+..++.++||||||+++|++++|..||.............. .             .......+...+..+.++
T Consensus       190 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~-------------~~~~~~~~~~~~~~l~~l  255 (310)
T 3s95_A          190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-R-------------GFLDRYCPPNCPPSFFPI  255 (310)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-H-------------HHHHHTCCTTCCTTHHHH
T ss_pred             CHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-h-------------ccccccCCCCCCHHHHHH
Confidence            99999999999999999999999999999999875433221110000 0             000011223334568899


Q ss_pred             HHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          247 GLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       247 i~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +..||+.||.+|||+.++++.|+...
T Consensus       256 i~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          256 TVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-36  Score=285.63  Aligned_cols=241  Identities=22%  Similarity=0.284  Sum_probs=190.3

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      +++.|.+..++.+..   ...+++|.+....      ..|...++.++|++++++++++.. ++.+++||||+++|+|.+
T Consensus       227 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~E~~~~g~L~~  305 (495)
T 1opk_A          227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLD  305 (495)
T ss_dssp             ESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHH
T ss_pred             EecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEEEccCCCCHHH
Confidence            345555555555443   3467777775432      245677788899999999999876 568999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      +++......+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||++...............++
T Consensus       306 ~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~  382 (495)
T 1opk_A          306 YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP  382 (495)
T ss_dssp             HHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCC
T ss_pred             HHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCC
Confidence            998765567999999999999999999999   58999999999999999999999999999976543322222233456


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      ..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.       .+         .....+..++.
T Consensus       383 ~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~  446 (495)
T 1opk_A          383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KD---------YRMERPEGCPE  446 (495)
T ss_dssp             GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TT---------CCCCCCTTCCH
T ss_pred             cceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cC---------CCCCCCCCCCH
Confidence            78999999988889999999999999999999 999998776554433221       11         11112334557


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .+.+||.+||+.||.+|||+.++++.|++..
T Consensus       447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          447 KVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            7899999999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-36  Score=265.54  Aligned_cols=239  Identities=23%  Similarity=0.295  Sum_probs=188.3

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..++...+   ...++.|.+....      ..+...++.++|+++++..+++.. ++..++||||+++++|.++
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~   99 (288)
T 3kfa_A           21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDY   99 (288)
T ss_dssp             SGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTEEHHHH
T ss_pred             cCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEEEEcCCCCcHHHH
Confidence            34444444444433   3356666665432      255677788899999999998876 6689999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF  163 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  163 (313)
                      +.......+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++...............+++
T Consensus       100 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~  176 (288)
T 3kfa_A          100 LRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI  176 (288)
T ss_dssp             HHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECG
T ss_pred             HHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCcccc
Confidence            98866667999999999999999999999   589999999999999999999999999999766544333334445678


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          164 GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       164 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      .|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.       ..         .....+...++.
T Consensus       177 ~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~  240 (288)
T 3kfa_A          177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KD---------YRMERPEGCPEK  240 (288)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TT---------CCCCCCTTCCHH
T ss_pred             CcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cc---------CCCCCCCCCCHH
Confidence            8999999998889999999999999999999 999998766554433221       10         111122334567


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +.+++..||+.||.+|||+.++++.|+..
T Consensus       241 l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          241 VYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            89999999999999999999999999865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.9e-36  Score=267.77  Aligned_cols=204  Identities=24%  Similarity=0.284  Sum_probs=169.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+.+.. .+.+++||||++||+|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        53 ~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~i  126 (337)
T 1o6l_A           53 VTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV  126 (337)
T ss_dssp             HHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhCCCCcCcceEEEEEe-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            346677888899999999999887 56899999999999999999864  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.+|.++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       127 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  205 (337)
T 1o6l_A          127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCcCCHHHEEECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCC
Confidence            999999999999999999999999987533221 1234567899999999999889999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      .+.+.......+.       .+.          ...+...+..+.+||.+||+.||.+||     +++|+++|
T Consensus       206 ~~~~~~~~~~~i~-------~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          206 YNQDHERLFELIL-------MEE----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCSSHHHHHHHHH-------HCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCHHHHHHHHH-------cCC----------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            8766544433321       000          012233456788999999999999999     99999987

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.5e-36  Score=268.09  Aligned_cols=239  Identities=26%  Similarity=0.361  Sum_probs=184.0

Q ss_pred             hHHHHHHHHhhccc------cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           13 LLCVSFILSALAQD------VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        13 ~~~~~~~~~~~~~~------~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      ++.|.+..++.+..      ...+++|.+...        ...|...++.++|++++++.+++.. ++..++||||++++
T Consensus        57 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~  135 (325)
T 3kul_A           57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAMIVTEYMENG  135 (325)
T ss_dssp             EEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCEEEEECCTTC
T ss_pred             EEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccEEEeeCCCCC
Confidence            34455544454443      223666666532        2346677788899999999999876 56889999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--cc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QT  156 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~  156 (313)
                      +|.++++.. ...+++..++.++.||+.||.|||   ..+|+|+||||+||+++.++.++|+|||++.........  ..
T Consensus       136 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (325)
T 3kul_A          136 SLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT  211 (325)
T ss_dssp             BHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEEC
T ss_pred             cHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeec
Confidence            999999765 346999999999999999999999   589999999999999999999999999999765433211  12


Q ss_pred             ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCc
Q 048068          157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY  235 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (313)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.       .+         .....
T Consensus       212 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~  275 (325)
T 3kul_A          212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-------EG---------YRLPA  275 (325)
T ss_dssp             C---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TT---------CCCCC
T ss_pred             cCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cC---------CCCCC
Confidence            22345678999999988889999999999999999999 999998776655433321       11         01112


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +...+..+.+||..||+.||.+|||+.++++.|+...
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3345567899999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.8e-36  Score=262.87  Aligned_cols=209  Identities=22%  Similarity=0.350  Sum_probs=160.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++.++++.  ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||   ..+++
T Consensus        65 ~e~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~  138 (281)
T 1mp8_A           65 QEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV  138 (281)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCccceEEEEEc--cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            4556678889999999999875  45789999999999999999865 346999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      |+||||+||+++.++.++|+|||++...............+++.|+|||.+.+..++.++||||||+++|++++ |..||
T Consensus       139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf  218 (281)
T 1mp8_A          139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  218 (281)
T ss_dssp             CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999997654433222333456778999999988889999999999999999996 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+....+....+.       .+.         ....+...+..+.+++.+||+.||++|||+.+++++|+..
T Consensus       219 ~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          219 QGVKNNDVIGRIE-------NGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             TTCCGGGHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHH-------cCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            8776655433221       110         0112334456788999999999999999999999999865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-35  Score=265.28  Aligned_cols=243  Identities=16%  Similarity=0.152  Sum_probs=184.9

Q ss_pred             HHHHHHHHhhcc---ccceEEEcccC-----CChhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHH
Q 048068           14 LCVSFILSALAQ---DVNQFIYHGFN-----EDPQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL   84 (313)
Q Consensus        14 ~~~~~~~~~~~~---~~~~~~~~~~~-----~~~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l   84 (313)
                      +.|.+..++...   ....+++|.+.     .....|..+++.+ .|++++++.++... ++..++||||+ +++|.+++
T Consensus        18 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~~   95 (330)
T 2izr_A           18 GCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVLELL-GPSLEDLF   95 (330)
T ss_dssp             CC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEEECC-CCBHHHHH
T ss_pred             eccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEEEeC-CCCHHHHH
Confidence            344444444443   23355555442     3455778888999 99999999998877 67899999999 99999999


Q ss_pred             hhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc-----EEEeecccccccCCCCCC-----
Q 048068           85 HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN-----GKLGDFGLARLYDHDTIP-----  154 (313)
Q Consensus        85 ~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~-----~~l~dfg~~~~~~~~~~~-----  154 (313)
                      ... ...+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.     ++|+|||++.........     
T Consensus        96 ~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~  171 (330)
T 2izr_A           96 DLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPY  171 (330)
T ss_dssp             HHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCC
T ss_pred             HHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccc
Confidence            875 456999999999999999999999   589999999999999998887     999999999765433211     


Q ss_pred             -ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccC
Q 048068          155 -QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG  233 (313)
Q Consensus       155 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (313)
                       ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+............+.......         ...
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---------~~~  242 (330)
T 2izr_A          172 REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT---------PIE  242 (330)
T ss_dssp             CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS---------CHH
T ss_pred             cccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC---------CHH
Confidence             1235678999999999999899999999999999999999999998865554433332221111100         000


Q ss_pred             CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       234 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ......+ .+.+++..||+.||.+|||++++++.|++..
T Consensus       243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            0011123 7899999999999999999999999997654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-37  Score=272.20  Aligned_cols=233  Identities=19%  Similarity=0.299  Sum_probs=173.5

Q ss_pred             ccceEEEcccCCCh-------hhHHhhhhhccccceeeeeeEEec-cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           26 DVNQFIYHGFNEDP-------QLQRDGLASVHSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        26 ~~~~~~~~~~~~~~-------~~~~~~l~~~~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ....+++|.+....       ..|...++.++|+++++..+++.. ....+++||||+++++|.+++... ...+++..+
T Consensus        38 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~  116 (295)
T 3ugc_A           38 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKL  116 (295)
T ss_dssp             CCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHH
T ss_pred             CCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHH
Confidence            34466777665322       346677788899999999998763 345789999999999999999875 345999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTGK  175 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~  175 (313)
                      +.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++........  .......++..|+|||.+.+..
T Consensus       117 ~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  193 (295)
T 3ugc_A          117 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK  193 (295)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence            999999999999999   58999999999999999999999999999976543221  1122334677799999999889


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCCCccCCchhhh---------hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHH
Q 048068          176 ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV---------NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL  246 (313)
Q Consensus       176 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (313)
                      ++.++||||||+++|++++|..|+.........         ............+         .....+...++.+.+|
T Consensus       194 ~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~l  264 (295)
T 3ugc_A          194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN---------GRLPRPDGCPDEIYMI  264 (295)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT---------CCCCCCTTCCHHHHHH
T ss_pred             CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc---------CcCCCCcCcCHHHHHH
Confidence            999999999999999999999998654321100         0000001111111         1111233455778999


Q ss_pred             HHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          247 GLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       247 i~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      |..||+.||++|||++|+++.|+..
T Consensus       265 i~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          265 MTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-36  Score=272.18  Aligned_cols=226  Identities=25%  Similarity=0.378  Sum_probs=178.8

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      ..+++|.+...        ...|...++.++|++++++.+++.. ++..++||||+++++|.+++....           
T Consensus        78 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  156 (343)
T 1luf_A           78 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD  156 (343)
T ss_dssp             EEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHTCC----------
T ss_pred             eeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-CCceEEEEecCCCCcHHHHHHHhCccccccccccc
Confidence            45666666432        2346677888899999999999876 668999999999999999998642           


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccc
Q 048068           89 -----------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQT  156 (313)
Q Consensus        89 -----------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~  156 (313)
                                 ...+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........ ...
T Consensus       157 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  233 (343)
T 1luf_A          157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD  233 (343)
T ss_dssp             ------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC--
T ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCcccccc
Confidence                       156999999999999999999999   58999999999999999999999999999875432211 122


Q ss_pred             ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCc
Q 048068          157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY  235 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (313)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.       .+..         ...
T Consensus       234 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~  297 (343)
T 1luf_A          234 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-------DGNI---------LAC  297 (343)
T ss_dssp             --CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TTCC---------CCC
T ss_pred             CCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHh-------CCCc---------CCC
Confidence            34467889999999988889999999999999999999 999998766544332221       1111         012


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      +...+..+.+++..||+.||.+|||+.+++++|++...
T Consensus       298 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          298 PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            23345678999999999999999999999999998753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-36  Score=279.77  Aligned_cols=229  Identities=25%  Similarity=0.386  Sum_probs=178.0

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .+++|.+...      ...|.+.++.++|+++++.++++.+  +..++||||+++|+|.++++......+++..++.++.
T Consensus       210 ~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~  287 (452)
T 1fmk_A          210 RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA  287 (452)
T ss_dssp             EEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred             eEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence            4677766532      2456778888999999999998865  5789999999999999999764345699999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      ||+.||.|||   ..+++||||||+||+++.++.+||+|||++...............++..|+|||.+.+..++.++||
T Consensus       288 qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv  364 (452)
T 1fmk_A          288 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV  364 (452)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccH
Confidence            9999999999   5899999999999999999999999999997654322222223456778999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|+|++ |..||.+....+....+.       .+.         ....+...++.+.+||.+||+.||++|||+
T Consensus       365 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  428 (452)
T 1fmk_A          365 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGY---------RMPCPPECPESLHDLMCQCWRKEPEERPTF  428 (452)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            999999999999 999998766554332221       111         011233455678999999999999999999


Q ss_pred             HHHHHHHhccCCCCCCC
Q 048068          262 RQVMQYLDGNATLPDIP  278 (313)
Q Consensus       262 ~ell~~L~~~~~~~~~~  278 (313)
                      +++++.|++......+.
T Consensus       429 ~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          429 EYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             HHHHHHHHTTTSCSCCC
T ss_pred             HHHHHHHHHHhccCCcc
Confidence            99999999987554443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-36  Score=267.88  Aligned_cols=210  Identities=18%  Similarity=0.240  Sum_probs=170.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|+|++++++++.+ .+.+++||||++|++|.+++... ...+++..++.++.||+.||.|||   ..++
T Consensus        49 ~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gi  123 (321)
T 1tki_A           49 KKEISILNIARHRNILHLHESFES-MEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNI  123 (321)
T ss_dssp             HHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence            356677888899999999999876 67899999999999999999764 346999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcC--CCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||||+||+++.  ++.++|+|||++.......  ......+++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       124 vH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  201 (321)
T 1tki_A          124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN  201 (321)
T ss_dssp             ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             CcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999987  7899999999997654332  2334568999999999998888999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ||.+.........+..      . ..      ..........+..+.+|+.+||..||.+|||+.|+++|-.
T Consensus       202 pf~~~~~~~~~~~i~~------~-~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          202 PFLAETNQQIIENIMN------A-EY------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             TTCCSSHHHHHHHHHH------T-CC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CCcCCCHHHHHHHHHc------C-CC------CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            9987665544333211      0 00      0000011123567889999999999999999999999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-36  Score=263.93  Aligned_cols=222  Identities=22%  Similarity=0.260  Sum_probs=169.3

Q ss_pred             hHHhhhhhcc---ccceeeeeeEEeccCC----eEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           41 LQRDGLASVH---SNGLLQLTNTVNSRKG----EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        41 ~~~~~l~~~~---~~~~l~~~~~~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      .+...++.+.   |+|+++..+++.....    .+++||||+. ++|.+++.......+++..++.++.||+.||.||| 
T Consensus        60 ~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-  137 (308)
T 3g33_A           60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-  137 (308)
T ss_dssp             HHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            4455555554   9999999999875332    6899999995 69999998875566999999999999999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                        ..+++|+||||+||+++.++.++|+|||++.......  ......+|+.|+|||.+.+..++.++|||||||++|+|+
T Consensus       138 --~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~  213 (308)
T 3g33_A          138 --ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF  213 (308)
T ss_dssp             --HTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTT
T ss_pred             --HCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHH
Confidence              5899999999999999999999999999997654332  234467899999999999888999999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhcccccc----------ccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA----------SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      +|.+||.+....+....+...............          ..+..........++.+.+||.+||+.||++|||+.|
T Consensus       214 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  293 (308)
T 3g33_A          214 RRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR  293 (308)
T ss_dssp             TSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH
Confidence            999999887766554433221111110000000          0000000111234567889999999999999999999


Q ss_pred             HHHHH
Q 048068          264 VMQYL  268 (313)
Q Consensus       264 ll~~L  268 (313)
                      +++|-
T Consensus       294 ~l~h~  298 (308)
T 3g33_A          294 ALQHS  298 (308)
T ss_dssp             HHTST
T ss_pred             HhcCc
Confidence            99874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-36  Score=266.47  Aligned_cols=243  Identities=23%  Similarity=0.330  Sum_probs=175.2

Q ss_pred             hHHHHHHHHhhccccceEEEcccCC---C------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQDVNQFIYHGFNE---D------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..+|.......+++|.+..   .      ...+...+++++|++++++.++..  ....++||||+++++|.++
T Consensus        32 lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~~~~~~L~~~  109 (289)
T 3og7_A           32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEGSSLYHH  109 (289)
T ss_dssp             EEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEECCCEEEHHHH
T ss_pred             ecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEEEEEecCCCcHHHH
Confidence            3445555555556555666666542   1      235667788889999999998654  4568999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-CCcccccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGT  162 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~  162 (313)
                      +... ...+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++....... ........++
T Consensus       110 l~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  185 (289)
T 3og7_A          110 LHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS  185 (289)
T ss_dssp             HTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------------------CC
T ss_pred             Hhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCC
Confidence            9765 456999999999999999999999   5899999999999999999999999999987543211 1122345689


Q ss_pred             cccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          163 FGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       163 ~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      +.|+|||.+.   +..++.++||||||+++|+|++|+.||......+.....  .    ..+...     ..........
T Consensus       186 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~----~~~~~~-----~~~~~~~~~~  254 (289)
T 3og7_A          186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM--V----GRGSLS-----PDLSKVRSNC  254 (289)
T ss_dssp             CTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH--H----HHTSCC-----CCTTSSCTTS
T ss_pred             ccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH--h----cccccC-----cchhhccccC
Confidence            9999999986   566788999999999999999999999876554432211  1    111110     0111122344


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +..+.+|+..||+.||.+|||+.++++.|++..
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            577899999999999999999999999998865

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=273.39  Aligned_cols=209  Identities=21%  Similarity=0.294  Sum_probs=170.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|||++++++++.+ ++..++||||++||+|.+.+...  ..+++..+..++.||+.||.|||   ..+|
T Consensus        58 ~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH---~~gi  131 (444)
T 3soa_A           58 EREARICRLLKHPNIVRLHDSISE-EGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH---QMGV  131 (444)
T ss_dssp             HHHHHHHHHCCBTTBCCEEEEEEC-SSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhCCCcCCCeEEEEEEE-CCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            356778888999999999999886 67899999999999999999874  45999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEc---CCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLD---ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +||||||+||+++   .++.++|+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       132 vHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~  210 (444)
T 3soa_A          132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY  210 (444)
T ss_dssp             BCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence            9999999999998   457899999999976543321 223457899999999999888999999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +||.+.+.......+.       .+..      ..+.......++.+.+||.+||+.||++|||+.|+++|-
T Consensus       211 ~Pf~~~~~~~~~~~i~-------~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          211 PPFWDEDQHRLYQQIK-------AGAY------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             CSCCCSSHHHHHHHHH-------HTCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             CCCCCccHHHHHHHHH-------hCCC------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            9998776555443331       1110      001111123456788999999999999999999999973

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4e-36  Score=262.77  Aligned_cols=237  Identities=22%  Similarity=0.317  Sum_probs=182.1

Q ss_pred             HHHHHHHHhhcccc--ceEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHh
Q 048068           14 LCVSFILSALAQDV--NQFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH   85 (313)
Q Consensus        14 ~~~~~~~~~~~~~~--~~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~   85 (313)
                      +.|.+..++.....  ..++.|.+...      ...+...++.++|+++++.++++.. ++..++||||+++++|.+++.
T Consensus        33 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~  111 (283)
T 3gen_A           33 GTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLR  111 (283)
T ss_dssp             C---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECCCTTCBHHHHHH
T ss_pred             CCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEeccCCCcHHHHHH
Confidence            34444444444332  24566666432      2356677888899999999999876 668999999999999999997


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccc
Q 048068           86 TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY  165 (313)
Q Consensus        86 ~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y  165 (313)
                      .. ...+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++...............+++.|
T Consensus       112 ~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y  187 (283)
T 3gen_A          112 EM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW  187 (283)
T ss_dssp             CG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGG
T ss_pred             Hh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCccc
Confidence            64 345999999999999999999999   58999999999999999999999999999976543222222234557789


Q ss_pred             cccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHH
Q 048068          166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL  244 (313)
Q Consensus       166 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (313)
                      +|||.+.+..++.++|+||||+++|+|++ |..||...........+.       .+         .....+...++.+.
T Consensus       188 ~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~l~  251 (283)
T 3gen_A          188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QG---------LRLYRPHLASEKVY  251 (283)
T ss_dssp             CCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TT---------CCCCCCTTCCHHHH
T ss_pred             CCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-------cc---------cCCCCCCcCCHHHH
Confidence            99999998889999999999999999998 999998776554433221       10         01111222346788


Q ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          245 KLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       245 ~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +++.+||+.||.+|||+++++++|++.
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=274.99  Aligned_cols=232  Identities=22%  Similarity=0.277  Sum_probs=177.1

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCC----------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNED----------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~----------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      ++.|.+..+++.++   ...+++|.+...          ...+...++.+ .|+++++.++++.. ++.+|+||||++||
T Consensus        31 lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~lv~E~~~gg  109 (353)
T 3txo_A           31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRLFFVMEFVNGG  109 (353)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECCCSC
T ss_pred             EeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEEEEEEeCCCCC
Confidence            34444444554433   345666665421          22445556665 79999999999887 66899999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      +|.+++...  ..+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.++|+|||++....... .....
T Consensus       110 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~  183 (353)
T 3txo_A          110 DLMFHIQKS--RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTAT  183 (353)
T ss_dssp             BHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--------
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-ccccc
Confidence            999999874  35999999999999999999999   5899999999999999999999999999987533221 22345


Q ss_pred             ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      ..||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.       .+          ...++..
T Consensus       184 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~-------~~----------~~~~p~~  246 (353)
T 3txo_A          184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------ND----------EVVYPTW  246 (353)
T ss_dssp             --CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HC----------CCCCCTT
T ss_pred             cCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH-------cC----------CCCCCCC
Confidence            678999999999988889999999999999999999999998876655444332       11          0112233


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Q 048068          239 QMELVLKLGLFCSHPKPEARPNM------RQVMQYL  268 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~------~ell~~L  268 (313)
                      .+..+.+||.+||+.||.+||++      +++++|-
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp  282 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP  282 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence            45678899999999999999998      8888753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.4e-36  Score=270.62  Aligned_cols=227  Identities=22%  Similarity=0.285  Sum_probs=176.3

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC---------
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK---------   89 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------   89 (313)
                      ..+++|.+...        ...+.+.++.+ .|++++++++++.+.+..+++||||+++|+|.+++.....         
T Consensus        53 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~  132 (359)
T 3vhe_A           53 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG  132 (359)
T ss_dssp             EEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---
T ss_pred             eEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccccccccc
Confidence            35666666432        22345555666 7899999999988767779999999999999999976421         


Q ss_pred             -------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           90 -------------------------------------------------------PSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        90 -------------------------------------------------------~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                                                                             ..+++..++.++.||+.||.|||  
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--  210 (359)
T 3vhe_A          133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--  210 (359)
T ss_dssp             ---------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--
T ss_pred             chhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--
Confidence                                                                   12899999999999999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                       ..+++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus       211 -~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  289 (359)
T 3vhe_A          211 -SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  289 (359)
T ss_dssp             -HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             -HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHH
Confidence             58999999999999999999999999999975533221 1233456788999999998888999999999999999999


Q ss_pred             h-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          194 S-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       194 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      + |..||.+...........      ..+.         ....+...++.+.+++..||+.||.+|||+.|+++||+...
T Consensus       290 t~g~~p~~~~~~~~~~~~~~------~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          290 SLGASPYPGVKIDEEFCRRL------KEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             TTSCCSSTTCCCSHHHHHHH------HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCCCCCccchhHHHHHHH------HcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            8 999998765443221111      1110         11122234567889999999999999999999999998753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=270.76  Aligned_cols=230  Identities=24%  Similarity=0.352  Sum_probs=181.0

Q ss_pred             eEEEcccCCC--------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           29 QFIYHGFNED--------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        29 ~~~~~~~~~~--------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      .+++|.+...        ...|.+.++.+ +|+++++..+++.. ++..++||||+++++|.+++....           
T Consensus       103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  181 (382)
T 3tt0_A          103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS  181 (382)
T ss_dssp             EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCC
T ss_pred             EEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-CCceEEEEEecCCCcHHHHHHHhcccccccccccc
Confidence            4666666432        22455566677 89999999999876 667999999999999999998653           


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccccc
Q 048068           89 ---KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFG  164 (313)
Q Consensus        89 ---~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~  164 (313)
                         ...+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++........ .......++..
T Consensus       182 ~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~  258 (382)
T 3tt0_A          182 HNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK  258 (382)
T ss_dssp             SSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGG
T ss_pred             cccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcc
Confidence               245999999999999999999999   58999999999999999999999999999976543321 12233456788


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          165 YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       165 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      |+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.       .+.         ....+...+..+
T Consensus       259 y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l  322 (382)
T 3tt0_A          259 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-------EGH---------RMDKPSNCTNEL  322 (382)
T ss_dssp             GSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------TTC---------CCCCCSSCCHHH
T ss_pred             eeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---------CCCCCccCCHHH
Confidence            999999998899999999999999999999 999998766544332221       111         111222345678


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhccCCCCCCC
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIP  278 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~~~~  278 (313)
                      .+|+..||+.||.+|||++|++++|+.........
T Consensus       323 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          323 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            89999999999999999999999999886444333

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=265.33  Aligned_cols=208  Identities=22%  Similarity=0.331  Sum_probs=169.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|++++++.+++.. ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..++
T Consensus        62 ~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i  135 (326)
T 2y0a_A           62 EREVSILKEIQHPNVITLHEVYEN-KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQI  135 (326)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            457778899999999999999876 67899999999999999999763  46999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCC----cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          120 LHRDIKPANVLLDADL----NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +|+||||+||+++.++    .++|+|||++.......  ......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       136 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  213 (326)
T 2y0a_A          136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  213 (326)
T ss_dssp             ECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             EcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHC
Confidence            9999999999998877    79999999997654322  22345689999999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..||.+....+....+...      .       ...........+..+.+||.+||+.||.+|||+.|+++|-
T Consensus       214 ~~pf~~~~~~~~~~~~~~~------~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          214 ASPFLGDTKQETLANVSAV------N-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             CCSSCCSSHHHHHHHHHHT------C-------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             cCCCCCCCHHHHHHHHHhc------C-------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            9999876655433322110      0       0011111123346788999999999999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-35  Score=269.67  Aligned_cols=225  Identities=25%  Similarity=0.415  Sum_probs=168.2

Q ss_pred             cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           27 VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        27 ~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ...+++|.+...        ...|...+++++|++++++.+++.. ++..++||||+++++|.++++.. ...+++..++
T Consensus        73 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~  150 (373)
T 2qol_A           73 EISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLV  150 (373)
T ss_dssp             BCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHH
T ss_pred             ceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHH
Confidence            345677766432        2245667788899999999999876 56899999999999999999865 4469999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      .++.||+.||.|||   ..+++||||||+||+++.++.++|+|||++.........  ......++..|+|||.+.+..+
T Consensus       151 ~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  227 (373)
T 2qol_A          151 GMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF  227 (373)
T ss_dssp             HHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCc
Confidence            99999999999999   589999999999999999999999999998765432211  1112234678999999998899


Q ss_pred             CcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCC
Q 048068          177 STSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP  255 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P  255 (313)
                      +.++||||||+++|++++ |..||......+....+.       .+         .....+...+..+.++|..||+.||
T Consensus       228 ~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-------~~---------~~~~~~~~~~~~l~~li~~cl~~dp  291 (373)
T 2qol_A          228 TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-------EG---------YRLPPPMDCPAALYQLMLDCWQKDR  291 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-------TT---------EECCCCTTCBHHHHHHHHHHTCSSG
T ss_pred             CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cC---------CCCCCCccccHHHHHHHHHHhCcCh
Confidence            999999999999999998 999998766544332221       11         0111223345678999999999999


Q ss_pred             CCCCCHHHHHHHHhccC
Q 048068          256 EARPNMRQVMQYLDGNA  272 (313)
Q Consensus       256 ~~Rpt~~ell~~L~~~~  272 (313)
                      .+|||+.++++.|+...
T Consensus       292 ~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          292 NNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             GGSCCHHHHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHHHHH
Confidence            99999999999998764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-35  Score=259.25  Aligned_cols=231  Identities=16%  Similarity=0.138  Sum_probs=178.0

Q ss_pred             ceEEEcccC-----CChhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 048068           28 NQFIYHGFN-----EDPQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII  101 (313)
Q Consensus        28 ~~~~~~~~~-----~~~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  101 (313)
                      ..++.|.+.     .....+...++.+ .|++++++..+... +...++||||+ +++|.+++... ...+++..++.++
T Consensus        36 ~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~  112 (298)
T 1csn_A           36 QQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAA  112 (298)
T ss_dssp             EEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHH
T ss_pred             cEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHH
Confidence            345555442     3344566777777 78999998888765 67899999999 99999999875 3469999999999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc-----EEEeecccccccCCCCCC------cccccccccccccccc
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN-----GKLGDFGLARLYDHDTIP------QTTKLVGTFGYMAPEL  170 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~-----~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~  170 (313)
                      .||+.||.|||   ..+++|+||||+||+++.++.     ++|+|||++.........      ......|++.|+|||.
T Consensus       113 ~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  189 (298)
T 1csn_A          113 KQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT  189 (298)
T ss_dssp             HHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchh
Confidence            99999999999   689999999999999987765     999999999765443221      2334568999999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHc
Q 048068          171 MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       171 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  250 (313)
                      +.+..++.++||||||+++|+|++|+.||.+............+.......         .........++.+.+++..|
T Consensus       190 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~  260 (298)
T 1csn_A          190 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---------PLRELCAGFPEEFYKYMHYA  260 (298)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---------CHHHHTTTSCHHHHHHHHHH
T ss_pred             hcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc---------cHHHHHhhCcHHHHHHHHHH
Confidence            998889999999999999999999999998765443333222221111100         00001123456789999999


Q ss_pred             CCCCCCCCCCHHHHHHHHhccCC
Q 048068          251 SHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      |+.||.+|||++++++.|++...
T Consensus       261 l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          261 RNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hcCCcccCCCHHHHHHHHHHHHH
Confidence            99999999999999999988753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-35  Score=262.71  Aligned_cols=234  Identities=22%  Similarity=0.256  Sum_probs=174.4

Q ss_pred             cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           27 VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        27 ~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ...++.|.+..         ....|.+.++.++|+++++..+++.+ ++..++||||++ ++|.+++... ...+++..+
T Consensus        45 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~  121 (311)
T 3niz_A           45 GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLVFEFME-KDLKKVLDEN-KTGLQDSQI  121 (311)
T ss_dssp             SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEEEECCS-EEHHHHHHTC-TTCCCHHHH
T ss_pred             CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEEEcCCC-CCHHHHHHhc-cCCCCHHHH
Confidence            34566666542         22356778888999999999999876 668999999996 5888888765 446999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKA  176 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  176 (313)
                      +.++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+ ..+
T Consensus       122 ~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~  197 (311)
T 3niz_A          122 KIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKY  197 (311)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSC
T ss_pred             HHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCC
Confidence            999999999999999   58999999999999999999999999999976543321 2334567999999999876 567


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccc-------------cccccccccCCccHHHHHHH
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI-------------LDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l  243 (313)
                      +.++|||||||++|+|++|+.||.+....+....+............             ................+..+
T Consensus       198 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (311)
T 3niz_A          198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEG  277 (311)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHH
T ss_pred             CchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHH
Confidence            99999999999999999999999887766554433221111000000             00000000011112234578


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+||.+||+.||++|||++|+++|
T Consensus       278 ~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          278 IDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcC
Confidence            899999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=274.56  Aligned_cols=225  Identities=23%  Similarity=0.343  Sum_probs=176.6

Q ss_pred             eEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----CCCCCHH
Q 048068           29 QFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----KPSLSWY   95 (313)
Q Consensus        29 ~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----~~~~~~~   95 (313)
                      .+++|.+...        ...+...++.++|+++++..+++.. ++..++||||+++|+|.+++....     ...+++.
T Consensus       103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~  181 (367)
T 3l9p_A          103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML  181 (367)
T ss_dssp             EEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHH
T ss_pred             eEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHH
Confidence            5677776431        2245566778899999999999876 567899999999999999997632     2459999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC---cEEEeecccccccCCC-CCCccccccccccccccccc
Q 048068           96 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLGDFGLARLYDHD-TIPQTTKLVGTFGYMAPELM  171 (313)
Q Consensus        96 ~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~---~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~  171 (313)
                      .++.++.||+.||.|||   ..+|+||||||+||+++.++   .++|+|||++...... .........+++.|+|||.+
T Consensus       182 ~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  258 (367)
T 3l9p_A          182 DLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF  258 (367)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHh
Confidence            99999999999999999   58999999999999999555   4999999998644211 11223345678899999999


Q ss_pred             cCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHc
Q 048068          172 RTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       172 ~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  250 (313)
                      .+..++.++|||||||++|+|++ |..||......+....+.       .+.         ....+...+..+.+||..|
T Consensus       259 ~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~~  322 (367)
T 3l9p_A          259 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-------SGG---------RMDPPKNCPGPVYRIMTQC  322 (367)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHH
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---------CCCCCccCCHHHHHHHHHH
Confidence            88889999999999999999998 999998776554433321       111         0112233456788999999


Q ss_pred             CCCCCCCCCCHHHHHHHHhccCC
Q 048068          251 SHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      |+.||.+|||+.+++++|+....
T Consensus       323 l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          323 WQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHHHHHhh
Confidence            99999999999999999987753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-35  Score=262.27  Aligned_cols=200  Identities=25%  Similarity=0.308  Sum_probs=168.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++.++.+.+ .+.+++||||++||+|.+++...  ..+++..++.++.||+.||.|||   ..+|+
T Consensus        55 ~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~iv  128 (318)
T 1fot_A           55 DERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDII  128 (318)
T ss_dssp             HHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEE
T ss_pred             HHHHHHhhCCCCCCceEeEEEEe-CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            46677888999999999999886 67899999999999999999874  35999999999999999999999   69999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.+|.++|+|||++......    .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       129 HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  204 (318)
T 1fot_A          129 YRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  204 (318)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccCCChheEEEcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999764332    234578999999999998899999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ..+.......+.      .. .          ...+...+..+.++|.+||..||.+||     +++++++|
T Consensus       205 ~~~~~~~~~~i~------~~-~----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          205 DSNTMKTYEKIL------NA-E----------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CSSHHHHHHHHH------HC-C----------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCHHHHHHHHH------hC-C----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            766544433221      10 0          012233456788999999999999999     99999976

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3e-36  Score=273.08  Aligned_cols=239  Identities=18%  Similarity=0.196  Sum_probs=170.4

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      .++.|.+..+++.++   ...+++|.+..      ....+...++.++|++++++.+++.. ++.+++||||+++++|.+
T Consensus        27 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~  105 (361)
T 3uc3_A           27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIMEYASGGELYE  105 (361)
T ss_dssp             EESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHH
T ss_pred             EeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEEeCCCCCHHH
Confidence            444555555555544   33566665542      23466677888999999999999986 678999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc--EEEeecccccccCCCCCCcccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--GKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      ++...  +.+++..++.++.||+.||.|||   ..+++||||||+||+++.++.  ++|+|||++.......  ......
T Consensus       106 ~l~~~--~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~  178 (361)
T 3uc3_A          106 RICNA--GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV  178 (361)
T ss_dssp             HHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------
T ss_pred             HHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CCCCCc
Confidence            99763  35999999999999999999999   589999999999999987765  9999999986432221  223456


Q ss_pred             ccccccccccccCCCCCcc-hhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          161 GTFGYMAPELMRTGKASTS-TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       161 ~~~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      ||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+...........  ........       ..+  .....
T Consensus       179 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~~~-------~~~--~~~~~  247 (361)
T 3uc3_A          179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI--QRILSVKY-------SIP--DDIRI  247 (361)
T ss_dssp             --CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH--HHHHTTCC-------CCC--TTSCC
T ss_pred             CCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH--HHHhcCCC-------CCC--CcCCC
Confidence            8999999999987777655 899999999999999999998765543322111  11111100       000  11123


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +..+.+||.+||+.||.+|||+.|+++|-.
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            467889999999999999999999999743

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.4e-36  Score=270.95  Aligned_cols=236  Identities=21%  Similarity=0.272  Sum_probs=181.2

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      .++.|.+..++...+   ...++.|.+..       ....|.+.++.++|++++++.+++.. ++.+++||||+++++|.
T Consensus        96 ~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             ECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCEEH
T ss_pred             EEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCcHH
Confidence            356677776666543   34666666543       22356677888899999999999887 66899999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE--cCCCcEEEeecccccccCCCCCCccccc
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL--DADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv--~~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      +++... ...+++..++.++.||+.||.|||   ..+|+|+||||+||++  +.++.++|+|||++.......  .....
T Consensus       175 ~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~  248 (373)
T 2x4f_A          175 DRIIDE-SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN  248 (373)
T ss_dssp             HHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence            998764 345999999999999999999999   5899999999999999  566789999999997654332  22334


Q ss_pred             cccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      .|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.  ...|.           .........
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~-----------~~~~~~~~~  315 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--ACRWD-----------LEDEEFQDI  315 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCC-----------SCSGGGTTS
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCC-----------CChhhhccC
Confidence            68999999999998889999999999999999999999998776554433221  11110           011111234


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ++.+.+||.+||+.||.+|||+.|+++|
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            5678999999999999999999999995

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-35  Score=262.40  Aligned_cols=224  Identities=23%  Similarity=0.355  Sum_probs=178.2

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC----------
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK----------   89 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~----------   89 (313)
                      ..+++|.+...        ...+...++.++|++++++++++.. ++..++||||+++++|.+++.....          
T Consensus        54 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  132 (314)
T 2ivs_A           54 TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG  132 (314)
T ss_dssp             EEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----
T ss_pred             ceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CCceEEEEeecCCCCHHHHHHHHhhccCCcccccc
Confidence            45666666432        2246667788899999999999876 6689999999999999999986432          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccc
Q 048068           90 ------------PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQT  156 (313)
Q Consensus        90 ------------~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~  156 (313)
                                  ..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........ ...
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  209 (314)
T 2ivs_A          133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR  209 (314)
T ss_dssp             ------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECS
T ss_pred             cccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceec
Confidence                        34899999999999999999999   58999999999999999999999999999875543221 112


Q ss_pred             ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCc
Q 048068          157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY  235 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (313)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.       .+.         ....
T Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~  273 (314)
T 2ivs_A          210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK-------TGH---------RMER  273 (314)
T ss_dssp             SCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TTC---------CCCC
T ss_pred             cCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhh-------cCC---------cCCC
Confidence            23456788999999988889999999999999999999 999998776654433221       110         1112


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +...++.+.+++.+||+.||.+|||+.+++++|+..
T Consensus       274 ~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          274 PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            334456789999999999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.1e-37  Score=272.56  Aligned_cols=243  Identities=20%  Similarity=0.252  Sum_probs=179.4

Q ss_pred             ccceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           26 DVNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        26 ~~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ....+++|.+...       ...|.+.++.++|++++++.++.. ..+...++||||+++++|.+++... ...+++..+
T Consensus        51 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~  129 (327)
T 3lxl_A           51 TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRL  129 (327)
T ss_dssp             CSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH-GGGCCHHHH
T ss_pred             cceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc-ccCCCHHHH
Confidence            3446677766532       345667778889999999999876 3467899999999999999999864 235999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGK  175 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~  175 (313)
                      +.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++.........  ......++..|+|||.+.+..
T Consensus       130 ~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  206 (327)
T 3lxl_A          130 LLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI  206 (327)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCC
Confidence            999999999999999   589999999999999999999999999999765433221  122345778899999998888


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCC
Q 048068          176 ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP  255 (313)
Q Consensus       176 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P  255 (313)
                      ++.++||||||+++|+|++|..||............. ......................+...++.+.+|+..||+.||
T Consensus       207 ~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  285 (327)
T 3lxl_A          207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSP  285 (327)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCCh
Confidence            8999999999999999999999987543321110000 000000000000000111112234456778999999999999


Q ss_pred             CCCCCHHHHHHHHhccCC
Q 048068          256 EARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       256 ~~Rpt~~ell~~L~~~~~  273 (313)
                      .+|||+++++++|+....
T Consensus       286 ~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          286 QDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             GGSCCHHHHHHHHHHC--
T ss_pred             hhCcCHHHHHHHHHHHHh
Confidence            999999999999998864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.6e-36  Score=279.28  Aligned_cols=226  Identities=22%  Similarity=0.406  Sum_probs=179.3

Q ss_pred             ceEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 048068           28 NQFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII  101 (313)
Q Consensus        28 ~~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  101 (313)
                      ..+++|.+...      ...|...++.++|+++++..+++.  ++..++||||+++|+|.++++......+++..++.++
T Consensus       213 ~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  290 (454)
T 1qcf_A          213 TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS  290 (454)
T ss_dssp             EEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHH
T ss_pred             cEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHH
Confidence            35666666532      235667788889999999999876  4578999999999999999985433458999999999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchh
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD  181 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  181 (313)
                      .||+.||.|||   ..+++||||||+||+++.++.+||+|||++...............++..|+|||.+....++.++|
T Consensus       291 ~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  367 (454)
T 1qcf_A          291 AQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD  367 (454)
T ss_dssp             HHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHH
Confidence            99999999999   489999999999999999999999999999765332111122234567899999998888999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          182 VYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       182 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      |||||+++|+|++ |+.||.+....+....+.       .+..         ...+..+++.+.+||.+||+.||++|||
T Consensus       368 vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt  431 (454)
T 1qcf_A          368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYR---------MPRPENCPEELYNIMMRCWKNRPEERPT  431 (454)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------HTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC---------CCCCCCCCHHHHHHHHHHccCChhHCcC
Confidence            9999999999999 999998776554433221       1110         0122344567899999999999999999


Q ss_pred             HHHHHHHHhccCCC
Q 048068          261 MRQVMQYLDGNATL  274 (313)
Q Consensus       261 ~~ell~~L~~~~~~  274 (313)
                      ++++++.|++....
T Consensus       432 ~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          432 FEYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHHHHHHHTSSSS
T ss_pred             HHHHHHHHHHHHhc
Confidence            99999999988643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.5e-36  Score=272.00  Aligned_cols=224  Identities=21%  Similarity=0.318  Sum_probs=177.0

Q ss_pred             cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           27 VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        27 ~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ...+++|.+..        ....|.+.++.++|+++++.++++.. ++..++||||+++|+|.++++.. ...+++..++
T Consensus       139 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~  216 (377)
T 3cbl_A          139 NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLL  216 (377)
T ss_dssp             CCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHH
T ss_pred             CeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHH
Confidence            44567776543        23356778888999999999999876 56899999999999999999864 3459999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc-cccccccccccccccccCCCCC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFGYMAPELMRTGKAS  177 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  177 (313)
                      .++.||+.||.|||   ..+++||||||+||+++.++.+||+|||++.......... .....++..|+|||.+.+..++
T Consensus       217 ~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  293 (377)
T 3cbl_A          217 QMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS  293 (377)
T ss_dssp             HHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCC
Confidence            99999999999999   5899999999999999999999999999987543221111 1122346779999999888899


Q ss_pred             cchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      .++||||||+++||+++ |..||.+.........+.       .+..         ...+...++.+.+||..||+.||+
T Consensus       294 ~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~l~~li~~cl~~dP~  357 (377)
T 3cbl_A          294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGR---------LPCPELCPDAVFRLMEQCWAYEPG  357 (377)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTCC---------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC---------CCCCCCCCHHHHHHHHHHcCCCch
Confidence            99999999999999998 999998766544332221       1110         112233456788999999999999


Q ss_pred             CCCCHHHHHHHHhcc
Q 048068          257 ARPNMRQVMQYLDGN  271 (313)
Q Consensus       257 ~Rpt~~ell~~L~~~  271 (313)
                      +|||++++++.|++.
T Consensus       358 ~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          358 QRPSFSTIYQELQSI  372 (377)
T ss_dssp             GSCCHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHH
Confidence            999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-36  Score=264.51  Aligned_cols=207  Identities=23%  Similarity=0.332  Sum_probs=164.9

Q ss_pred             hhhHHhhhhhccccceeeeeeEEec-cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ...|.+.++.++|+++++..+++.. .++.+++||||+++++|.+++..   ..+++..++.++.||+.||.|||   ..
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~  156 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQ  156 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence            3467788899999999999999885 35789999999999999886543   46999999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC---CCcchhhHHHHHHHHHHHh
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK---ASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~  194 (313)
                      +++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+..   .+.++|||||||++|+|++
T Consensus       157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             CeeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            999999999999999999999999999976543321 223457899999999997654   3788999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |+.||...........+.       ....        ........++.+.+||.+||+.||++|||+.|+++|
T Consensus       236 g~~pf~~~~~~~~~~~~~-------~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          236 GQCPFMDERIMCLHSKIK-------SQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCSSCCSSHHHHHHHHH-------HCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCCCCccHHHHHHHHh-------cccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            999998655433222111       1100        000112234678899999999999999999999886

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-35  Score=264.65  Aligned_cols=251  Identities=20%  Similarity=0.279  Sum_probs=179.1

Q ss_pred             hhhHHHHHHHHhhccc---cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           11 CVLLCVSFILSALAQD---VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      ..++.|.+..++...+   ...++.|.+..        ....|...++.++|+++++.++++.. ++..++||||++ ++
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~~   88 (317)
T 2pmi_A           11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVFEFMD-ND   88 (317)
T ss_dssp             --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEEECCC-CB
T ss_pred             eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEEEecC-CC
Confidence            3455565555555543   34566665532        22356778899999999999999886 678999999996 59


Q ss_pred             HHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc
Q 048068           80 LDKILHTN----IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ  155 (313)
Q Consensus        80 L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~  155 (313)
                      |.+++...    ....+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........ .
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~  164 (317)
T 2pmi_A           89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-T  164 (317)
T ss_dssp             HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-C
T ss_pred             HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-c
Confidence            99998653    1246999999999999999999999   58999999999999999999999999999976543221 2


Q ss_pred             cccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhcccccccc-
Q 048068          156 TTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKGAILDASD-  228 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-  228 (313)
                      .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+....+......     |.......... 
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T 2pmi_A          165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP  244 (317)
T ss_dssp             CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred             CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence            234567999999999876 46799999999999999999999999887766544433221111     11000000000 


Q ss_pred             ---cc--------ccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          229 ---SR--------LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       229 ---~~--------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                         ..        .........+..+.+||.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence               00        0001111234578999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4e-35  Score=259.35  Aligned_cols=224  Identities=33%  Similarity=0.550  Sum_probs=175.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN-IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...++.++|+++++..++... ++..++||||+++++|.+++... ....+++..++.++.||+.||.|||   ..++
T Consensus        79 ~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i  154 (307)
T 2nru_A           79 QEIKVMAKCQHENLVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHH  154 (307)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHhcCCCCeEEEEEEEec-CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCe
Confidence            56677888899999999999876 56899999999999999999743 2456999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||+|+||+++.++.++|+|||++......... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..|
T Consensus       155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence            99999999999999999999999998765432211 1233568999999998874 578899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhc-cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKG-AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      |...........+..  ...... ......+... ...+...+..+.+++..||+.||.+|||+++++++|++..
T Consensus       234 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          234 VDEHREPQLLLDIKE--EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             BCTTBSSSBTTHHHH--HHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             cccCcchHHHHHHHH--Hhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            987655443322211  111110 1111111112 2345677889999999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-35  Score=263.29  Aligned_cols=213  Identities=22%  Similarity=0.279  Sum_probs=169.8

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ....+...++.++|+++++++++... ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..
T Consensus        51 ~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~  124 (323)
T 3tki_A           51 NIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GI  124 (323)
T ss_dssp             CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence            34567788899999999999999886 67899999999999999999764  45999999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCC-CCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHhC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g  195 (313)
                      +++|+||||+||+++.++.++|+|||++....... ........|++.|+|||.+.+..+ +.++|||||||++|+|++|
T Consensus       125 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  204 (323)
T 3tki_A          125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (323)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence            99999999999999999999999999997543222 112334578999999999987665 7789999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ..||............      +....        .........+..+.+|+.+||+.||.+|||++|+++|-.=
T Consensus       205 ~~pf~~~~~~~~~~~~------~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          205 ELPWDQPSDSCQEYSD------WKEKK--------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             SCSCSSSCTTSHHHHH------HHTTC--------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             CCCCCCCchHHHHHHH------Hhccc--------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            9999876544322111      11100        0000112344667899999999999999999999997643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.8e-35  Score=258.80  Aligned_cols=245  Identities=14%  Similarity=0.150  Sum_probs=184.9

Q ss_pred             ceEEEcccC-----CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           28 NQFIYHGFN-----EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        28 ~~~~~~~~~-----~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      ..++.|.+.     .....+...++.+.|++.+.....+...++..++||||+ +++|.+++... ...+++..++.++.
T Consensus        35 ~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~  112 (296)
T 3uzp_A           35 EEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLAD  112 (296)
T ss_dssp             EEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHH
T ss_pred             cEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHH
Confidence            355555432     344567788899999998888777776688999999999 99999999854 34699999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEE---cCCCcEEEeecccccccCCCCC------CccccccccccccccccccC
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMAPELMRT  173 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~  173 (313)
                      ||+.||.|||   ..+++|+||||+||++   +.++.++|+|||++........      .......+++.|+|||.+.+
T Consensus       113 qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  189 (296)
T 3uzp_A          113 QMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG  189 (296)
T ss_dssp             HHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC
Confidence            9999999999   5899999999999999   4788999999999976544322      11234578999999999998


Q ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCC
Q 048068          174 GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHP  253 (313)
Q Consensus       174 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  253 (313)
                      ..++.++||||||+++|+|++|+.||..............+......         ..........++.+.+++..||+.
T Consensus       190 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~  260 (296)
T 3uzp_A          190 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---------TPIEVLCKGYPSEFATYLNFCRSL  260 (296)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH---------SCHHHHTTTSCHHHHHHHHHHHTS
T ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC---------CchHHHHhhCCHHHHHHHHHHHhc
Confidence            88999999999999999999999999875443322222111111000         000001122346789999999999


Q ss_pred             CCCCCCCHHHHHHHHhccCCCCCCCCCCccccc
Q 048068          254 KPEARPNMRQVMQYLDGNATLPDIPRDSTLIAP  286 (313)
Q Consensus       254 ~P~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~  286 (313)
                      ||.+|||++++++.|+....-...+.+..++|.
T Consensus       261 dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          261 RFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             CTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             CcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence            999999999999999887654444444444443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-36  Score=271.22  Aligned_cols=203  Identities=24%  Similarity=0.355  Sum_probs=166.5

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...+..+ +|+++++.++.+.+ ++.+|+||||++||+|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        66 ~E~~il~~~~~hp~iv~l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~i  139 (345)
T 1xjd_A           66 VEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGI  139 (345)
T ss_dssp             HHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHhcCCCCCCCcEEEEEEe-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            344555555 89999999999887 66899999999999999999863  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.+|.++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       140 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  218 (345)
T 1xjd_A          140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF  218 (345)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EeCCCChhhEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999999987543221 1234567899999999999889999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR-QVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~  267 (313)
                      .+.+.......+..       +.          ...+...+..+.+||.+||..||.+||++. ++++|
T Consensus       219 ~~~~~~~~~~~i~~-------~~----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          219 HGQDEEELFHSIRM-------DN----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             CCSSHHHHHHHHHH-------CC----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CCCCHHHHHHHHHh-------CC----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            87765544433311       00          112223456788999999999999999998 77764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-35  Score=268.28  Aligned_cols=245  Identities=20%  Similarity=0.237  Sum_probs=180.9

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCCC------hhhHHhhhhhcc-----ccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNED------PQLQRDGLASVH-----SNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~l~~~~-----~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      +.|.+..+|...+   ...+++|.+...      ...+...++.+.     |+++++..+.+.. .+..++||||+ +++
T Consensus        44 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-~~~~~lv~e~~-~~~  121 (360)
T 3llt_A           44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-YDHMCLIFEPL-GPS  121 (360)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-TTEEEEEECCC-CCB
T ss_pred             cccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-CCeeEEEEcCC-CCC
Confidence            3444444444443   346677766532      234556677775     9999999998886 57899999999 999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-------------------------C
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------------------------D  134 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-------------------------~  134 (313)
                      |.+++.......+++..++.++.||+.||.|||   ..+|+||||||+||+++.                         +
T Consensus       122 L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (360)
T 3llt_A          122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS  198 (360)
T ss_dssp             HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESC
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcccccccccccccCC
Confidence            999998876567999999999999999999999   589999999999999975                         7


Q ss_pred             CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHH
Q 048068          135 LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWV  214 (313)
Q Consensus       135 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  214 (313)
                      +.++|+|||++......    .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus       199 ~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  274 (360)
T 3llt_A          199 TGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI  274 (360)
T ss_dssp             CCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence            88999999999754332    23456899999999999989999999999999999999999999887665544433221


Q ss_pred             HHhhhhcc--------cc-----ccccccccCC----------------ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          215 SDCWKKGA--------IL-----DASDSRLEGI----------------YEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       215 ~~~~~~~~--------~~-----~~~~~~~~~~----------------~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      ........        ..     .......+..                ......+.+.+||.+||+.||.+|||++|++
T Consensus       275 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL  354 (360)
T 3llt_A          275 IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL  354 (360)
T ss_dssp             TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            11000000        00     0000000000                0011126688999999999999999999999


Q ss_pred             HH
Q 048068          266 QY  267 (313)
Q Consensus       266 ~~  267 (313)
                      +|
T Consensus       355 ~h  356 (360)
T 3llt_A          355 KH  356 (360)
T ss_dssp             TS
T ss_pred             cC
Confidence            86

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-35  Score=258.74  Aligned_cols=222  Identities=21%  Similarity=0.316  Sum_probs=173.4

Q ss_pred             eEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHH
Q 048068           29 QFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI  100 (313)
Q Consensus        29 ~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i  100 (313)
                      .+++|.+...        ...+...++.++|+++++..+++.+  +..++||||+++++|.+++... ...+++..++.+
T Consensus        42 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~  118 (281)
T 3cc6_A           42 NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLY  118 (281)
T ss_dssp             EEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHH
T ss_pred             eEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHH
Confidence            3566665432        2245667788899999999998764  4568999999999999999765 346999999999


Q ss_pred             HHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcch
Q 048068          101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST  180 (313)
Q Consensus       101 ~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  180 (313)
                      +.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+..++.++
T Consensus       119 ~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  195 (281)
T 3cc6_A          119 SLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTAS  195 (281)
T ss_dssp             HHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchh
Confidence            999999999999   58999999999999999999999999999876544332233344567889999999888899999


Q ss_pred             hhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          181 DVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       181 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      ||||||+++|+|++ |..||...........+.       .+..         ...+...++.+.+++..||+.||.+||
T Consensus       196 Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rp  259 (281)
T 3cc6_A          196 DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------KGDR---------LPKPDLCPPVLYTLMTRCWDYDPSDRP  259 (281)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-------HTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             ccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-------cCCC---------CCCCCCCCHHHHHHHHHHccCCchhCc
Confidence            99999999999998 999998766554433221       1100         011223456789999999999999999


Q ss_pred             CHHHHHHHHhccC
Q 048068          260 NMRQVMQYLDGNA  272 (313)
Q Consensus       260 t~~ell~~L~~~~  272 (313)
                      |+.+++++|++..
T Consensus       260 s~~ell~~L~~~~  272 (281)
T 3cc6_A          260 RFTELVCSLSDVY  272 (281)
T ss_dssp             CHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHH
Confidence            9999999998753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-35  Score=258.76  Aligned_cols=237  Identities=22%  Similarity=0.289  Sum_probs=172.9

Q ss_pred             cceEEEcccCCChh----hHHhhhhh--ccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           27 VNQFIYHGFNEDPQ----LQRDGLAS--VHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        27 ~~~~~~~~~~~~~~----~~~~~l~~--~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ...+++|.+.....    .+.+.+..  ++|+|++++.+....   .....++||||+++|+|.++++..   .+++..+
T Consensus        31 ~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~  107 (301)
T 3q4u_A           31 GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSC  107 (301)
T ss_dssp             TEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHH
T ss_pred             CEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHH
Confidence            34566666643222    24444444  799999999887652   245789999999999999999653   5999999


Q ss_pred             HHHHHHHHHHHHHhhhcC-----CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccccc
Q 048068           98 FRIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPE  169 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~-----~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE  169 (313)
                      +.++.||+.||.|||+..     +.+++||||||+||+++.++.++|+|||++.........   ......||+.|+|||
T Consensus       108 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  187 (301)
T 3q4u_A          108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE  187 (301)
T ss_dssp             HHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChh
Confidence            999999999999999211     279999999999999999999999999998655433211   122347899999999


Q ss_pred             cccCC------CCCcchhhHHHHHHHHHHHhC----------CCCCccCCchhhhhHHHHHHHhhhhccccccccccccC
Q 048068          170 LMRTG------KASTSTDVYAFGVFMLEVASG----------RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG  233 (313)
Q Consensus       170 ~~~~~------~~~~~~DiwslG~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (313)
                      .+.+.      .++.++|||||||++|+|++|          ..||............  ........   .........
T Consensus       188 ~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~  262 (301)
T 3q4u_A          188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED--MRKVVCVD---QQRPNIPNR  262 (301)
T ss_dssp             HHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH--HHHHHTTS---CCCCCCCGG
T ss_pred             hhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh--hhHHHhcc---CCCCCCChh
Confidence            99866      345799999999999999999          8888654332211111  00000000   011111122


Q ss_pred             CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       234 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ..+...+..+.+|+..||+.||.+|||+.++++.|+..
T Consensus       263 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            23456788999999999999999999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-36  Score=273.39  Aligned_cols=254  Identities=22%  Similarity=0.278  Sum_probs=176.9

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC---------hhhHHhhhhhcc-ccceeeeeeEEec-cCCeEEEEEecCCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED---------PQLQRDGLASVH-SNGLLQLTNTVNS-RKGEFLLVYDYMPN   77 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~l~~~~-~~~~l~~~~~~~~-~~~~~~lV~e~~~~   77 (313)
                      .++.|.+..++.+.+   ...++.|.+...         ...+...++.+. |+++++..+++.. ....+|+||||++ 
T Consensus        16 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-   94 (388)
T 3oz6_A           16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-   94 (388)
T ss_dssp             C-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-
T ss_pred             EeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-
Confidence            455666666666543   446677765321         123455666676 9999999999874 3457999999996 


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-----
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-----  152 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-----  152 (313)
                      ++|..+++..   .+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.++|+|||++.......     
T Consensus        95 ~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  168 (388)
T 3oz6_A           95 TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN  168 (388)
T ss_dssp             EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred             cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccc
Confidence            6999999864   5999999999999999999999   4899999999999999999999999999997543211     


Q ss_pred             ---------------CCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHH
Q 048068          153 ---------------IPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD  216 (313)
Q Consensus       153 ---------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  216 (313)
                                     ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  248 (388)
T 3oz6_A          169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID  248 (388)
T ss_dssp             GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence                           111233578999999999876 5789999999999999999999999998776655544421111


Q ss_pred             hhhhccccccc------------------cccccCCc------------cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          217 CWKKGAILDAS------------------DSRLEGIY------------EEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       217 ~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      ...........                  .......+            ....++.+.+|+.+||..||++|||++|+++
T Consensus       249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence            10000000000                  00000000            0123457889999999999999999999999


Q ss_pred             H--HhccC
Q 048068          267 Y--LDGNA  272 (313)
Q Consensus       267 ~--L~~~~  272 (313)
                      |  +....
T Consensus       329 Hp~~~~~~  336 (388)
T 3oz6_A          329 HPFVSIFH  336 (388)
T ss_dssp             STTTTTTC
T ss_pred             CHHHHHhc
Confidence            8  44443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-35  Score=271.26  Aligned_cols=243  Identities=19%  Similarity=0.240  Sum_probs=174.4

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCChhh--HHhh-hhhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNEDPQL--QRDG-LASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~--~~~~-l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~   82 (313)
                      .++.|.+..++...+   ...+++|.+......  +... .+..+|+|++++.+++..   .++++|+||||++||+|.+
T Consensus        69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~  148 (400)
T 1nxk_A           69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS  148 (400)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHH
T ss_pred             eeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHH
Confidence            345555555555543   346777777544332  2233 355689999999988763   3567899999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---CCcEEEeecccccccCCCCCCccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      ++.......+++..++.++.||+.||.|||   ..+|+||||||+||+++.   ++.+||+|||++.......  .....
T Consensus       149 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~  223 (400)
T 1nxk_A          149 RIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTP  223 (400)
T ss_dssp             HHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----------
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC--ccccC
Confidence            998765557999999999999999999999   589999999999999987   7889999999997554322  23345


Q ss_pred             cccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhh-HHHHHHHhhhhccccccccccccCCccHH
Q 048068          160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN-LVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      .+|+.|+|||++.+..++.++|||||||++|+|++|..||.+........ ....+.    .+..      ..+......
T Consensus       224 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~------~~~~~~~~~  293 (400)
T 1nxk_A          224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY------EFPNPEWSE  293 (400)
T ss_dssp             ---CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC------CCCTTTTTT
T ss_pred             CCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc------cCCCccccc
Confidence            78999999999998899999999999999999999999998655433211 111000    0000      001111123


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      .+..+.+||..||+.||.+|||+.|+++|-.
T Consensus       294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            4567899999999999999999999999753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.8e-35  Score=260.48  Aligned_cols=234  Identities=21%  Similarity=0.266  Sum_probs=180.8

Q ss_pred             HHHHHHHHhhcc---ccceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           14 LCVSFILSALAQ---DVNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        14 ~~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      +.|.+..++.+.   ....+++|.+..       ....+...++.++|+++++..+++.. ++..++||||+++++|.++
T Consensus        54 g~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~  132 (321)
T 2c30_A           54 GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLMEFLQGGALTDI  132 (321)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEECCCCSCBHHHH
T ss_pred             ccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEecCCCCCHHHH
Confidence            334444444443   344666666532       12356677888899999999998886 5689999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTF  163 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  163 (313)
                      +...   .+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++....... .......|++
T Consensus       133 l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~  205 (321)
T 2c30_A          133 VSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTP  205 (321)
T ss_dssp             HTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCG
T ss_pred             HHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccccccCCc
Confidence            8753   5999999999999999999999   5899999999999999999999999999987654322 1233457899


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       164 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      .|+|||.+.+..++.++||||||+++|+|++|..||...........+.       ....     +  ........+..+
T Consensus       206 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~-------~~~~-----~--~~~~~~~~~~~l  271 (321)
T 2c30_A          206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-------DSPP-----P--KLKNSHKVSPVL  271 (321)
T ss_dssp             GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HSSC-----C--CCTTGGGSCHHH
T ss_pred             cccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCC-----C--CcCccccCCHHH
Confidence            9999999998889999999999999999999999998765443322221       1000     0  001122345678


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      .+++.+||+.||++|||++++++|-.
T Consensus       272 ~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          272 RDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHccCChhhCcCHHHHhcChh
Confidence            89999999999999999999999753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.4e-35  Score=259.11  Aligned_cols=223  Identities=15%  Similarity=0.184  Sum_probs=176.7

Q ss_pred             CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           37 EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        37 ~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      .....+...++.+.|++.+.....+...++..++||||+ +++|.+++... ...+++..++.++.||+.||.|||   .
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~  123 (296)
T 4hgt_A           49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---S  123 (296)
T ss_dssp             CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred             hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence            455677888899999999888888877688999999999 99999999864 346999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEE---cCCCcEEEeecccccccCCCCC------CccccccccccccccccccCCCCCcchhhHHHHH
Q 048068          117 QVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGV  187 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  187 (313)
                      .+++|+||||+||++   +.++.++|+|||++........      .......+++.|+|||.+.+..++.++|||||||
T Consensus       124 ~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  203 (296)
T 4hgt_A          124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY  203 (296)
T ss_dssp             TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence            899999999999999   7889999999999976544322      1223457899999999999889999999999999


Q ss_pred             HHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          188 FMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       188 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ++|+|++|+.||.+....................         .........++.+.+++..||+.||++|||++++++.
T Consensus       204 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  274 (296)
T 4hgt_A          204 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             HHHHHhcCCCCCcccchhhhhhhhhhhhcccccc---------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence            9999999999998765543333222111111000         0000111234678999999999999999999999999


Q ss_pred             HhccCC
Q 048068          268 LDGNAT  273 (313)
Q Consensus       268 L~~~~~  273 (313)
                      |++...
T Consensus       275 l~~~~~  280 (296)
T 4hgt_A          275 FRNLFH  280 (296)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            988753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.1e-35  Score=266.52  Aligned_cols=207  Identities=21%  Similarity=0.299  Sum_probs=168.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++.++|++++++++++.+ ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+|+
T Consensus        77 ~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~iv  150 (362)
T 2bdw_A           77 REARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIV  150 (362)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCB
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            46677888999999999999887 67899999999999999999764  46999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCC---CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||||+||+++.+   +.++|+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       151 H~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  228 (362)
T 2bdw_A          151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  228 (362)
T ss_dssp             CCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eccCchHHEEEecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence            99999999999865   459999999997654332  2234578999999999998889999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ||.+.+.......+.       .+..      ..+.......+..+.+||.+||+.||.+|||+.|+++|-
T Consensus       229 Pf~~~~~~~~~~~i~-------~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          229 PFWDEDQHRLYAQIK-------AGAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             SSCCSSHHHHHHHHH-------HTCC------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             CCCCCCHHHHHHHHH-------hCCC------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            998766544333221       1100      001111123456788999999999999999999999873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3e-35  Score=274.04  Aligned_cols=221  Identities=25%  Similarity=0.352  Sum_probs=178.8

Q ss_pred             eEEEcccCCC-----hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Q 048068           29 QFIYHGFNED-----PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG  103 (313)
Q Consensus        29 ~~~~~~~~~~-----~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~q  103 (313)
                      .+++|.+...     ...|...++.++|+++++.++++...++..++||||+++|+|.++++......+++..++.++.|
T Consensus       218 ~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~q  297 (450)
T 1k9a_A          218 KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD  297 (450)
T ss_dssp             EEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHH
T ss_pred             eEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHH
Confidence            5666666532     33567788899999999999998876668999999999999999998764455899999999999


Q ss_pred             HHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhH
Q 048068          104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY  183 (313)
Q Consensus       104 i~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  183 (313)
                      |+.||.|||   ..+++||||||+||+++.++.+||+|||++.......    ....++..|+|||.+.+..++.++|||
T Consensus       298 i~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvw  370 (450)
T 1k9a_A          298 VCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVW  370 (450)
T ss_dssp             HHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHH
T ss_pred             HHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----cCCCCCcceeCHHHhcCCCCCcHHHHH
Confidence            999999999   5899999999999999999999999999987543221    223567889999999988999999999


Q ss_pred             HHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 048068          184 AFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR  262 (313)
Q Consensus       184 slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  262 (313)
                      |||+++|+|++ |..||.+....+....+.       .+.         ....+..++..+.+||..||+.||.+|||+.
T Consensus       371 slG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~---------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~  434 (450)
T 1k9a_A          371 SFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGY---------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFL  434 (450)
T ss_dssp             HHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            99999999998 999998776555433221       111         1112334567889999999999999999999


Q ss_pred             HHHHHHhccC
Q 048068          263 QVMQYLDGNA  272 (313)
Q Consensus       263 ell~~L~~~~  272 (313)
                      ++++.|+...
T Consensus       435 ~l~~~L~~i~  444 (450)
T 1k9a_A          435 QLREQLEHIR  444 (450)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998753

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=271.73  Aligned_cols=248  Identities=14%  Similarity=0.069  Sum_probs=182.2

Q ss_pred             ceEEEcccC--CChhhHHhhhhhccccceee---------------eeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCC
Q 048068           28 NQFIYHGFN--EDPQLQRDGLASVHSNGLLQ---------------LTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKP   90 (313)
Q Consensus        28 ~~~~~~~~~--~~~~~~~~~l~~~~~~~~l~---------------~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~   90 (313)
                      ..++.|.+.  +....|..+++.++|+++++               ..++....++..++||||+ +++|.+++......
T Consensus        76 ~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~  154 (352)
T 2jii_A           76 QKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH  154 (352)
T ss_dssp             -CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG
T ss_pred             ceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC
Confidence            455666554  34667888999999999887               3444444578999999999 99999999875445


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC--cEEEeecccccccCCCCC------Ccccccccc
Q 048068           91 SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL--NGKLGDFGLARLYDHDTI------PQTTKLVGT  162 (313)
Q Consensus        91 ~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~--~~~l~dfg~~~~~~~~~~------~~~~~~~~~  162 (313)
                      .+++..++.++.||+.||.|||   ..+++|+||||+||+++.++  .++|+|||++........      .......++
T Consensus       155 ~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt  231 (352)
T 2jii_A          155 VLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD  231 (352)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCC
Confidence            7999999999999999999999   48999999999999999988  899999999975532211      112334789


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      +.|+|||.+.+..++.++||||||+++|+|++|+.||......... .... ...+... .......   .......+..
T Consensus       232 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~-~~~~~~~-~~~~~~~---~~~~~~~~~~  305 (352)
T 2jii_A          232 LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED-IMKQ-KQKFVDK-PGPFVGP---CGHWIRPSET  305 (352)
T ss_dssp             TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-HHHH-HHHHHHS-CCCEECT---TSCEECCCHH
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH-HHHH-HHhccCC-hhhhhhh---ccccCCCcHH
Confidence            9999999999889999999999999999999999999876422111 1111 1111110 0000000   0011123467


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCcccc
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIA  285 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~  285 (313)
                      +.+|+..||+.||.+|||++++++.|+....-...+.+..+.+
T Consensus       306 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw  348 (352)
T 2jii_A          306 LQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGL  348 (352)
T ss_dssp             HHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred             HHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccC
Confidence            8999999999999999999999999988764444443333333

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.3e-35  Score=256.55  Aligned_cols=221  Identities=21%  Similarity=0.322  Sum_probs=165.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.++.++|+++++..+++.. ++..++||||+++ +|.+++... ...+++..++.++.||+.||.|||   ..+++
T Consensus        49 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~  122 (288)
T 1ob3_A           49 REISILKELKHSNIVKLYDVIHT-KKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVL  122 (288)
T ss_dssp             HHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            57788899999999999999886 5689999999965 999998765 356999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus       123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  201 (288)
T 1ob3_A          123 HRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF  201 (288)
T ss_dssp             CSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876543221 2233467999999999875 45899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHh-----hhhccccc-------cccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDC-----WKKGAILD-------ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+....+....+......     |.......       ...+..........+..+.+||.+||+.||++|||++|+++|
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            877655443332211100     11000000       000000111122345678899999999999999999999986


Q ss_pred             H
Q 048068          268 L  268 (313)
Q Consensus       268 L  268 (313)
                      -
T Consensus       282 p  282 (288)
T 1ob3_A          282 A  282 (288)
T ss_dssp             G
T ss_pred             c
Confidence            3

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-35  Score=256.93  Aligned_cols=223  Identities=25%  Similarity=0.376  Sum_probs=176.8

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .++.|.+...      ...+.+.++.++|+++++..++... ++..++||||+++++|.+++... ...+++..++.++.
T Consensus        34 ~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~  111 (267)
T 3t9t_A           34 KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCL  111 (267)
T ss_dssp             EEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHH
T ss_pred             eEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHH
Confidence            4566665432      2356677788899999999999876 56899999999999999999875 34699999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...............++..|.|||.+.+..++.++|+
T Consensus       112 ~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  188 (267)
T 3t9t_A          112 DVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV  188 (267)
T ss_dssp             HHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhch
Confidence            9999999999   5899999999999999999999999999987553322112223456778999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|+|++ |..||...........+.       .+.         ....+...+..+.+++.+||+.||.+|||+
T Consensus       189 ~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  252 (267)
T 3t9t_A          189 WSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TGF---------RLYKPRLASTHVYQIMNHCWRERPEDRPAF  252 (267)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-------cCC---------cCCCCccCcHHHHHHHHHHccCChhhCcCH
Confidence            999999999999 899998765443322221       110         011122345678899999999999999999


Q ss_pred             HHHHHHHhccC
Q 048068          262 RQVMQYLDGNA  272 (313)
Q Consensus       262 ~ell~~L~~~~  272 (313)
                      ++++++|++..
T Consensus       253 ~~ll~~L~~l~  263 (267)
T 3t9t_A          253 SRLLRQLAEIA  263 (267)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-35  Score=257.04  Aligned_cols=206  Identities=25%  Similarity=0.437  Sum_probs=161.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV-  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~-  118 (313)
                      ..+...++.++|+++++..+++.. ++..++||||+++++|.+++..   ..+++..++.++.|++.||.|||+   .+ 
T Consensus        54 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~  126 (271)
T 3dtc_A           54 RQEAKLFAMLKHPNIIALRGVCLK-EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAI  126 (271)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECC-C--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSS
T ss_pred             HHHHHHHHhcCCCCEeeEEEEEec-CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCC
Confidence            356677888999999999999876 5678999999999999999964   359999999999999999999995   66 


Q ss_pred             --ceecCcCCCcEEEcC--------CCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHH
Q 048068          119 --VLHRDIKPANVLLDA--------DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVF  188 (313)
Q Consensus       119 --i~H~dl~~~nIlv~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i  188 (313)
                        ++|+||||+||+++.        ++.++|+|||++.......   .....+++.|+|||.+.+..++.++||||||++
T Consensus       127 ~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  203 (271)
T 3dtc_A          127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVL  203 (271)
T ss_dssp             SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHH
T ss_pred             CceeecCCchHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHH
Confidence              999999999999986        6789999999987544322   223468899999999998889999999999999


Q ss_pred             HHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          189 MLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       189 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +|++++|+.||.+...........      ..         ......+...++.+.+++.+||+.||.+|||+.|++++|
T Consensus       204 l~~l~~g~~p~~~~~~~~~~~~~~------~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L  268 (271)
T 3dtc_A          204 LWELLTGEVPFRGIDGLAVAYGVA------MN---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL  268 (271)
T ss_dssp             HHHHHHCCCTTTTSCHHHHHHHHH------TS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCHHHHHHhhh------cC---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            999999999998766544332221      00         111112334456789999999999999999999999999


Q ss_pred             hc
Q 048068          269 DG  270 (313)
Q Consensus       269 ~~  270 (313)
                      ++
T Consensus       269 ~~  270 (271)
T 3dtc_A          269 TT  270 (271)
T ss_dssp             HC
T ss_pred             hc
Confidence            75

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-35  Score=267.37  Aligned_cols=221  Identities=20%  Similarity=0.292  Sum_probs=175.4

Q ss_pred             ceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHH
Q 048068           28 NQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI  100 (313)
Q Consensus        28 ~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i  100 (313)
                      ..++.|.+..       ....|...++.++|++++++.+++.+ ++.+++||||+++++|.+++... ...+++..++.+
T Consensus        77 ~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i  154 (387)
T 1kob_A           77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINY  154 (387)
T ss_dssp             CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHH
T ss_pred             CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHH
Confidence            3455555532       23356778888999999999999886 67899999999999999999764 346999999999


Q ss_pred             HHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC--CCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCc
Q 048068          101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST  178 (313)
Q Consensus       101 ~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  178 (313)
                      +.||+.||.|||   ..+++|+||||+||+++.  .+.++|+|||++.......  ......+|+.|+|||++.+..++.
T Consensus       155 ~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  229 (387)
T 1kob_A          155 MRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF  229 (387)
T ss_dssp             HHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCH
T ss_pred             HHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc--ceeeeccCCCccCchhccCCCCCC
Confidence            999999999999   589999999999999974  4679999999997654332  233457899999999999888999


Q ss_pred             chhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCC
Q 048068          179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR  258 (313)
Q Consensus       179 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  258 (313)
                      ++|||||||++|+|++|..||.+.........+.       ....      ..........+..+.+||.+||+.||.+|
T Consensus       230 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~-------~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R  296 (387)
T 1kob_A          230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-------RCDW------EFDEDAFSSVSPEAKDFIKNLLQKEPRKR  296 (387)
T ss_dssp             HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------HCCC------CCCSSTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred             cccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC------CCCccccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999999998766544332221       0000      01111222345678899999999999999


Q ss_pred             CCHHHHHHHH
Q 048068          259 PNMRQVMQYL  268 (313)
Q Consensus       259 pt~~ell~~L  268 (313)
                      ||+.|+++|-
T Consensus       297 pt~~ell~hp  306 (387)
T 1kob_A          297 LTVHDALEHP  306 (387)
T ss_dssp             CCHHHHHTST
T ss_pred             cCHHHHhhCc
Confidence            9999999974

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4e-35  Score=262.20  Aligned_cols=205  Identities=21%  Similarity=0.304  Sum_probs=164.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+++.. ++.+++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        69 ~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i  142 (327)
T 3a62_A           69 KAERNILEEVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLH---QKGI  142 (327)
T ss_dssp             --HHHHHHHCCCTTBCCEEEEEEC-SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhCCCCCccceeEEEEc-CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence            357778899999999999999887 67899999999999999999864  35899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       143 vH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  221 (327)
T 3a62_A          143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF  221 (327)
T ss_dssp             CCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             EcccCCHHHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999986433221 1223456899999999999888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      .+.........+.      ..           ....+...+..+.++|.+||+.||.+||     ++.++++|-
T Consensus       222 ~~~~~~~~~~~i~------~~-----------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          222 TGENRKKTIDKIL------KC-----------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             CCSSHHHHHHHHH------HT-----------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             CCCCHHHHHHHHH------hC-----------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence            8766544332221      10           0012233456788999999999999999     889999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-36  Score=266.92  Aligned_cols=211  Identities=25%  Similarity=0.455  Sum_probs=165.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..+++.. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||   ..+++
T Consensus        95 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~iv  169 (333)
T 1mqb_A           95 GEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYV  169 (333)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCCCcEEEEEec-CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            45567788899999999999876 66899999999999999999865 356999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||||+||+++.++.++|+|||++.........  ......++..|+|||.+.+..++.++||||||+++|++++ |..
T Consensus       170 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  249 (333)
T 1mqb_A          170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  249 (333)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999998765432211  1122345778999999998889999999999999999999 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||......+....+.       .+.         ....+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus       250 pf~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          250 PYWELSNHEVMKAIN-------DGF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             TTTTCCHHHHHHHHH-------TTC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CcccCCHHHHHHHHH-------CCC---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            998765544332221       110         00112234567899999999999999999999999998765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.3e-35  Score=254.06  Aligned_cols=208  Identities=20%  Similarity=0.324  Sum_probs=168.1

Q ss_pred             hHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV-  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~-  118 (313)
                      .|...++.++|+++++..+++... ++..++||||+++++|.+++.......+++..++.++.||+.||.|||   ..+ 
T Consensus        56 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~  132 (271)
T 3kmu_A           56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEP  132 (271)
T ss_dssp             HHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSS
T ss_pred             HHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCC
Confidence            456677778999999999998753 368899999999999999998765556999999999999999999999   578 


Q ss_pred             -ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCc---chhhHHHHHHHHHHHh
Q 048068          119 -VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKAST---STDVYAFGVFMLEVAS  194 (313)
Q Consensus       119 -i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~~ll~  194 (313)
                       ++|+||||+||+++.++.++++||++.....      .....+++.|+|||.+.+..++.   ++||||||+++|+|++
T Consensus       133 ~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  206 (271)
T 3kmu_A          133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT  206 (271)
T ss_dssp             CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred             ceecCCCccceEEEcCCcceeEEeccceeeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence             9999999999999999999999988765322      22346789999999998765444   7999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      |+.||.............      ..+         .....+...+..+.+++..||+.||++|||++++++.|+...
T Consensus       207 g~~p~~~~~~~~~~~~~~------~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          207 REVPFADLSNMEIGMKVA------LEG---------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CSCTTTTSCHHHHHHHHH------HSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCccccChHHHHHHHH------hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            999998766544332221      111         111123344567899999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.2e-35  Score=266.41  Aligned_cols=210  Identities=22%  Similarity=0.268  Sum_probs=165.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ..|...++.++|+|++++++++.. ++.+++||||++|++|.+.+...  ....+++..++.++.||+.||.|||   ..
T Consensus        74 ~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~  149 (351)
T 3c0i_A           74 KREASICHMLKHPHIVELLETYSS-DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DN  149 (351)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence            466778889999999999999887 67899999999999999888643  2345899999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCCc---EEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh
Q 048068          118 VVLHRDIKPANVLLDADLN---GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  194 (313)
                      +|+|+||||+||+++.++.   ++|+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  228 (351)
T 3c0i_A          150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS  228 (351)
T ss_dssp             TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred             CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH
Confidence            9999999999999986654   9999999997654432 12334578999999999998889999999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |..||.+.... ....+      ... ...  ..+.    .....+..+.+||.+||+.||++|||+.|+++|-
T Consensus       229 g~~pf~~~~~~-~~~~i------~~~-~~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          229 GCLPFYGTKER-LFEGI------IKG-KYK--MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             SSCSSCSSHHH-HHHHH------HHT-CCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CCCCCCCcHHH-HHHHH------HcC-CCC--CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence            99999864321 11111      011 000  0000    0112346788999999999999999999999853

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.6e-35  Score=269.55  Aligned_cols=211  Identities=23%  Similarity=0.308  Sum_probs=164.5

Q ss_pred             hhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..+...+.++ +|+++++..+.+.. ++.+++||||++||+|..++.+.  ..+++..++.++.||+.||.|||   ..+
T Consensus       100 ~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~g  173 (396)
T 4dc2_A          100 QTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERG  173 (396)
T ss_dssp             HHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHhcCCCCCcCeeEEEEEE-CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            3455566555 89999999999887 67899999999999999999874  35999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      |+||||||+||+++.++.++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.|
T Consensus       174 ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~P  252 (396)
T 4dc2_A          174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  252 (396)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEeccCCHHHEEECCCCCEEEeecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999997532221 234456789999999999999999999999999999999999999


Q ss_pred             CccCCchhhh--hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 048068          199 IEQQGSMEMV--NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM------RQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~------~ell~~  267 (313)
                      |......+..  .............          ....+...+..+.+||.+||+.||.+||++      +|+++|
T Consensus       253 f~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          253 FDIVGSSDNPDQNTEDYLFQVILEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             STTTTC------CCHHHHHHHHHHC----------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             CcccccccccchhhHHHHHHHHhcc----------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            9754322110  0001111111111          111233445678899999999999999985      788875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.4e-35  Score=265.01  Aligned_cols=201  Identities=20%  Similarity=0.250  Sum_probs=169.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|++++++.+.+.+ ++.+++||||++|++|.+++...  +.+++..++.++.||+.||.|||   ..+|+
T Consensus        90 ~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~iv  163 (350)
T 1rdq_E           90 NEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLI  163 (350)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            46677888999999999999887 67899999999999999999874  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      ||||||+||+++.++.++|+|||++......    .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       164 HrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  239 (350)
T 1rdq_E          164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence            9999999999999999999999999765332    234578999999999998899999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~L  268 (313)
                      +.........+.       .+.          ...+...+..+.++|.+||+.||.+||+     ++++++|-
T Consensus       240 ~~~~~~~~~~i~-------~~~----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          240 ADQPIQIYEKIV-------SGK----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             CSSHHHHHHHHH-------HCC----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CCCHHHHHHHHH-------cCC----------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            766554433321       111          0122334567889999999999999998     99999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.2e-35  Score=257.02  Aligned_cols=221  Identities=20%  Similarity=0.224  Sum_probs=164.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.+ ++.+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||   ..+++
T Consensus        50 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~iv  123 (292)
T 3o0g_A           50 REICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVL  123 (292)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            56677888999999999999886 6789999999965 666666554 346999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||||+||+++.++.++|+|||++........ ......+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||
T Consensus       124 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCCHHHEEEcCCCCEEEeecccceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999976543322 233456799999999997765 799999999999999999888875


Q ss_pred             c-cCCchhhhhHHHHHHHhhhhccccccc------------cccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          200 E-QQGSMEMVNLVDWVSDCWKKGAILDAS------------DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       200 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      . +....+....+................            ............+..+.+|+.+||+.||++|||++|+++
T Consensus       203 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            4 433333222221111100000000000            000011122345567889999999999999999999998


Q ss_pred             HH
Q 048068          267 YL  268 (313)
Q Consensus       267 ~L  268 (313)
                      |-
T Consensus       283 hp  284 (292)
T 3o0g_A          283 HP  284 (292)
T ss_dssp             SG
T ss_pred             Cc
Confidence            63

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-34  Score=253.11  Aligned_cols=207  Identities=21%  Similarity=0.418  Sum_probs=165.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV-  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~-  118 (313)
                      ..+...++.++|+++++.+++..+..   ++||||+++++|.+.+... ...+++..++.++.|++.||.|||   ..+ 
T Consensus        71 ~~E~~~l~~l~h~~i~~~~~~~~~~~---~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~  143 (287)
T 4f0f_A           71 QREVFIMSNLNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ---NQNP  143 (287)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEETTTT---EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---TSSS
T ss_pred             HHHHHHHHhCCCCCchhhheeecCCC---eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH---hCCC
Confidence            35667788899999999999886532   7999999999999998765 456999999999999999999999   578 


Q ss_pred             -ceecCcCCCcEEEcCCCc-----EEEeecccccccCCCCCCcccccccccccccccccc--CCCCCcchhhHHHHHHHH
Q 048068          119 -VLHRDIKPANVLLDADLN-----GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR--TGKASTSTDVYAFGVFML  190 (313)
Q Consensus       119 -i~H~dl~~~nIlv~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~  190 (313)
                       ++|+||||+||+++.++.     ++|+|||++.....    ......+++.|+|||.+.  ...++.++||||||+++|
T Consensus       144 ~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~  219 (287)
T 4f0f_A          144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY  219 (287)
T ss_dssp             CCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHH
T ss_pred             CeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHH
Confidence             999999999999988776     99999999874332    233457899999999984  455789999999999999


Q ss_pred             HHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          191 EVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      +|++|..||...............    ..         ......+...++.+.++|..||+.||.+|||++++++.|++
T Consensus       220 ~l~~g~~pf~~~~~~~~~~~~~~~----~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          220 TILTGEGPFDEYSYGKIKFINMIR----EE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHSSCTTTTCCCCHHHHHHHHH----HS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHcCCCCCccccccHHHHHHHHh----cc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            999999999876554432211111    01         11112333445778999999999999999999999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-35  Score=266.50  Aligned_cols=233  Identities=20%  Similarity=0.263  Sum_probs=180.5

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      ++.|.+..++++.+   ...++.|.+..          ....|...++.++|+++++.++++.. ++..++||||+ +|+
T Consensus        17 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~-~g~   94 (336)
T 3h4j_B           17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVMVIEYA-GGE   94 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCC-CEE
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEECC-CCc
Confidence            34444444454443   33566665421          23456778899999999999999887 66899999999 789


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      |.+++...  +.+++..++.++.||+.||.|||   ..+++||||||+||+++.++.++|+|||++.......  .....
T Consensus        95 l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~~~~  167 (336)
T 3h4j_B           95 LFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTS  167 (336)
T ss_dssp             HHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TTCCC
T ss_pred             HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--ccccc
Confidence            99988764  35999999999999999999999   4899999999999999999999999999987654332  23345


Q ss_pred             cccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          160 VGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      .|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.........+            .     ......+..
T Consensus       168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------~-----~~~~~~p~~  230 (336)
T 3h4j_B          168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------N-----SCVYVMPDF  230 (336)
T ss_dssp             TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC------------C-----SSCCCCCTT
T ss_pred             cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH------------H-----cCCCCCccc
Confidence            78999999999987766 78999999999999999999999865543322111            0     001112333


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+..+.+||.+||+.||.+|||++|+++|-.=.
T Consensus       231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            456788999999999999999999999976533

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-35  Score=265.72  Aligned_cols=210  Identities=23%  Similarity=0.302  Sum_probs=163.5

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...++.+ +|++++++.+.+.. ++.+++||||++||+|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        58 ~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~i  131 (345)
T 3a8x_A           58 TEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGI  131 (345)
T ss_dssp             HHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHhcCCCCccCeEEEEEEe-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            455566666 89999999999887 67899999999999999999864  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.++.++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       132 vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  210 (345)
T 3a8x_A          132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF  210 (345)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecCCCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCc
Confidence            999999999999999999999999987532221 2234567899999999999889999999999999999999999999


Q ss_pred             ccCCchhhh--hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Q 048068          200 EQQGSMEMV--NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM------RQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~------~ell~~  267 (313)
                      .........  ..............          ...+...+..+.+||.+||+.||.+||++      +++++|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          211 DIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             TTTTC-------CHHHHHHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             CCcccccccccccHHHHHHHHHcCC----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            753221110  00000111111110          11233345678899999999999999995      788876

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-35  Score=267.16  Aligned_cols=255  Identities=19%  Similarity=0.246  Sum_probs=182.6

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccC-----CeEEEEEec
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDY   74 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~   74 (313)
                      .++.|.+..++.+.+   ...++.|.+..         ....+...++.++|+|++++.+++...+     ..+|+||||
T Consensus        32 ~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~  111 (367)
T 1cm8_A           32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF  111 (367)
T ss_dssp             EC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred             EeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEec
Confidence            455666666666643   45677777632         1235667788889999999999987532     457999999


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~  154 (313)
                      + +++|.++++..   .+++..+..++.||+.||.|||   ..+++||||||+||+++.++.++|+|||++......   
T Consensus       112 ~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---  181 (367)
T 1cm8_A          112 M-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---  181 (367)
T ss_dssp             C-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred             C-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccccc---
Confidence            9 88999999863   5999999999999999999999   489999999999999999999999999999764332   


Q ss_pred             ccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcc-----------
Q 048068          155 QTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA-----------  222 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------  222 (313)
                       .....+|..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+...........           
T Consensus       182 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          182 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             -cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence             234567999999999876 6789999999999999999999999998776655443322111100000           


Q ss_pred             ----ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCCCCCCC
Q 048068          223 ----ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATLPDIP  278 (313)
Q Consensus       223 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~~~~~~  278 (313)
                          ...... ..........+..+.+|+.+||..||.+|||++|+++|  +.+.......|
T Consensus       261 ~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  321 (367)
T 1cm8_A          261 YMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP  321 (367)
T ss_dssp             HHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred             HHHhCCCCCC-CCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCC
Confidence                000000 00011222345678999999999999999999999996  45554444433

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-35  Score=257.61  Aligned_cols=223  Identities=23%  Similarity=0.424  Sum_probs=177.1

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .++.|.+...      ...+.+.++.++|+++++.++++..  +..++||||+++++|.+++.......+++..++.++.
T Consensus        39 ~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~  116 (279)
T 1qpc_A           39 KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA  116 (279)
T ss_dssp             EEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHH
T ss_pred             EEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHH
Confidence            4566655432      2356678888999999999998763  4689999999999999999754333699999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.||.|||   ..+++|+||+|+||+++.++.++|+|||++...............++..|+|||.+.+..++.++||
T Consensus       117 qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  193 (279)
T 1qpc_A          117 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV  193 (279)
T ss_dssp             HHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhh
Confidence            9999999999   5899999999999999999999999999997665433222333456778999999988888999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|+|++ |..||.+....+....+.       .+.         ....+...+..+.+++..||+.||++|||+
T Consensus       194 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  257 (279)
T 1qpc_A          194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGY---------RMVRPDNCPEELYQLMRLCWKERPEDRPTF  257 (279)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-------ccc---------CCCCcccccHHHHHHHHHHhccChhhCCCH
Confidence            999999999999 999998766544332221       110         011222345678999999999999999999


Q ss_pred             HHHHHHHhccC
Q 048068          262 RQVMQYLDGNA  272 (313)
Q Consensus       262 ~ell~~L~~~~  272 (313)
                      +++++.|++..
T Consensus       258 ~~l~~~l~~~~  268 (279)
T 1qpc_A          258 DYLRSVLEDFF  268 (279)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-35  Score=263.78  Aligned_cols=212  Identities=23%  Similarity=0.316  Sum_probs=170.3

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+|+++.+++..  ++..++||||+++++|.+++... ...+++..++.++.||+.||.|||   ..++
T Consensus        63 ~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i  136 (325)
T 3kex_A           63 TDHMLAIGSLDHAHIVRLLGLCP--GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGM  136 (325)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEC--BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHhcCCCCCcCeEEEEEc--CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCC
Confidence            45667788889999999999876  45789999999999999999765 346999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      +||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..
T Consensus       137 vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  216 (325)
T 3kex_A          137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE  216 (325)
T ss_dssp             CCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCC
Confidence            99999999999999999999999999866443222 2234456779999999998889999999999999999999 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      ||.+.........+.       .+.         ....+...+..+.+++.+||+.||.+|||+.+++++|+....
T Consensus       217 p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          217 PYAGLRLAEVPDLLE-------KGE---------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTTTSCTTHHHHHHH-------TTC---------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CccccCHHHHHHHHH-------cCC---------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            998776555433331       110         001112233457789999999999999999999999988754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.5e-35  Score=262.47  Aligned_cols=210  Identities=21%  Similarity=0.332  Sum_probs=165.7

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...++.+ .|++++++.+++.. ++..++||||+++++|.+++.......+++..++.++.||+.||.|||   ..++
T Consensus        77 ~e~~~l~~l~~~~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~gi  152 (327)
T 3lm5_A           77 HEIAVLELAKSCPRVINLHEVYEN-TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNI  152 (327)
T ss_dssp             HHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHhccCCCCEEEEEEEEEe-CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            344455555 56999999999876 678999999999999999997665667999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcC---CCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +|+||||+||+++.   ++.++|+|||++.......  ......+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  230 (327)
T 3lm5_A          153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT  230 (327)
T ss_dssp             ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999987   7899999999997654332  223457899999999999889999999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      .||...........+....             ...........+..+.+||.+||+.||.+|||++++++|-.
T Consensus       231 ~pf~~~~~~~~~~~i~~~~-------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          231 SPFVGEDNQETYLNISQVN-------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             CSSCCSSHHHHHHHHHHTC-------------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             CCCCCCCchHHHHHHHhcc-------------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence            9998776655443332110             01111122334567889999999999999999999999753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-35  Score=264.30  Aligned_cols=243  Identities=22%  Similarity=0.248  Sum_probs=160.2

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC----ChhhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHh
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE----DPQLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH   85 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~   85 (313)
                      +.|.+..++...+   ...+++|.+..    ....+...++.+. |+++++.++++.+ ++..++||||+++++|.+++.
T Consensus        20 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   98 (325)
T 3kn6_A           20 GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGGELFERIK   98 (325)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHH
T ss_pred             ccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCCcHHHHHH
Confidence            3344444444333   34566666543    3335566677776 9999999999986 678999999999999999998


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC---cEEEeecccccccCCCCCCcccccccc
Q 048068           86 TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        86 ~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ..  ..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++   .++|+|||++....... .......++
T Consensus        99 ~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t  172 (325)
T 3kn6_A           99 KK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFT  172 (325)
T ss_dssp             HC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCCC
Confidence            74  46999999999999999999999   58999999999999998765   79999999997554322 123345679


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      +.|+|||.+.+..++.++||||||+++|+|++|..||.....................+..      ..........++.
T Consensus       173 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~s~~  246 (325)
T 3kn6_A          173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHHHTSCHH
T ss_pred             cCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccccCCCHH
Confidence            9999999999889999999999999999999999999865442211111111111111110      1111111234567


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +.+||..||+.||.+|||++|+++|-.
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             HHHHHHHHCCCChhHCCCHHHHhcChh
Confidence            899999999999999999999998743

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.9e-35  Score=255.41  Aligned_cols=204  Identities=24%  Similarity=0.361  Sum_probs=167.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.+.|+++++..+++.+ ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..++
T Consensus        57 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i  130 (279)
T 3fdn_A           57 RREVEIQSHLRHPNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRV  130 (279)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTC
T ss_pred             HHHHHHHHcCCCCCCcchhheEec-CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence            356677888899999999999886 67899999999999999999864  35999999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++.......   .....++..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus       131 ~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  207 (279)
T 3fdn_A          131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF  207 (279)
T ss_dssp             EECCCCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecccCChHhEEEcCCCCEEEEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999885443222   23456899999999999888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ...........+..                 .....+...+..+.+||..||+.||.+|||++|+++|-.
T Consensus       208 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          208 EANTYQETYKRISR-----------------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             CCSSHHHHHHHHHH-----------------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             CCCcHHHHHHHHHh-----------------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            87665544333211                 011122334567889999999999999999999999753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.9e-35  Score=266.23  Aligned_cols=205  Identities=25%  Similarity=0.362  Sum_probs=167.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++.++.+.+ .+.+++||||+.||+|.+++...  ..+++..++.++.||+.||.|||   ..||+
T Consensus        64 ~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giv  137 (384)
T 4fr4_A           64 KELQIMQGLEHPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRII  137 (384)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCce
Confidence            56778889999999999999887 66899999999999999999874  46999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT---GKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      ||||||+||+++.+|.++|+|||++.......  ......||+.|+|||++.+   ..++.++|+|||||++|+|++|+.
T Consensus       138 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~  215 (384)
T 4fr4_A          138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR  215 (384)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             eccCcHHHeEECCCCCEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence            99999999999999999999999997654332  3345678999999999863   458899999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-MRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ell~~  267 (313)
                      ||.................              ....++...+..+.+||.+||+.||.+||+ ++++++|
T Consensus       216 Pf~~~~~~~~~~~~~~~~~--------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          216 PYHIRSSTSSKEIVHTFET--------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             SSCCCTTSCHHHHHHHHHH--------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             CCCCCCCccHHHHHHHHhh--------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            9986544433322211110              111133344577899999999999999998 8888763

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.9e-35  Score=257.69  Aligned_cols=212  Identities=25%  Similarity=0.367  Sum_probs=169.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...+++++|+++++..++....++..++||||+++++|.+++... ...+++..++.++.|++.||.|||   ..+++
T Consensus        75 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~  150 (298)
T 3f66_A           75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFV  150 (298)
T ss_dssp             HHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            45667788899999999998776677899999999999999999764 456899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC---CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI---PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GR  196 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  196 (313)
                      |+||||+||+++.++.++|+|||++........   .......+++.|+|||.+.+..++.++|+||||+++|++++ +.
T Consensus       151 H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~  230 (298)
T 3f66_A          151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA  230 (298)
T ss_dssp             CSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999975533221   11223456778999999988889999999999999999999 66


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +||......+......       .+.         ....+...++.+.+++.+||+.||.+|||++++++.|+...
T Consensus       231 ~~~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          231 PPYPDVNTFDITVYLL-------QGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             CSSTTSCTTTHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHh-------cCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            6776655544332221       000         01112223467899999999999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-36  Score=266.27  Aligned_cols=233  Identities=20%  Similarity=0.306  Sum_probs=176.3

Q ss_pred             ccceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHH
Q 048068           26 DVNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ   96 (313)
Q Consensus        26 ~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~   96 (313)
                      ....+++|.+..        ....+...++.++|+++++..+++... ...+++||||+++++|.+++... ...+++..
T Consensus        49 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~  127 (302)
T 4e5w_A           49 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQ  127 (302)
T ss_dssp             CSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHH
T ss_pred             cCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHH
Confidence            344666666642        234567788899999999999998853 35789999999999999999654 34699999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCC
Q 048068           97 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTG  174 (313)
Q Consensus        97 ~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  174 (313)
                      ++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++........  .......++..|+|||.+.+.
T Consensus       128 ~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  204 (302)
T 4e5w_A          128 QLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS  204 (302)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC
Confidence            9999999999999999   58999999999999999999999999999976544322  122344677889999999888


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCccCCchhh--------hhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHH
Q 048068          175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM--------VNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKL  246 (313)
Q Consensus       175 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (313)
                      .++.++||||||+++|+|++|..|+........        .............+         .....+...++.+.+|
T Consensus       205 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~l  275 (302)
T 4e5w_A          205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG---------KRLPCPPNCPDEVYQL  275 (302)
T ss_dssp             EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT---------CCCCCCTTCCHHHHHH
T ss_pred             CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc---------CCCCCCCCCCHHHHHH
Confidence            889999999999999999999998653221100        00000001111111         1111233455778999


Q ss_pred             HHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          247 GLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       247 i~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      |.+||+.||.+|||++++++.|+..
T Consensus       276 i~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          276 MRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            9999999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.3e-35  Score=261.32  Aligned_cols=212  Identities=22%  Similarity=0.302  Sum_probs=171.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|+++++++++...  +..++|++++.+|+|.+++... ...+++..++.++.||+.||.|||   ..++
T Consensus        65 ~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~i  138 (327)
T 3poz_A           65 LDEAYVMASVDNPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRL  138 (327)
T ss_dssp             HHHHHHHHHCCBTTBCCEEEEEES--SSEEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCe
Confidence            346677888999999999999885  3478999999999999999875 356999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      +||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       139 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  218 (327)
T 3poz_A          139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK  218 (327)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCC
Confidence            99999999999999999999999999765433221 2223456778999999998899999999999999999999 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      ||.+.........+.       .+.         ....+...+..+.+++.+||+.||.+|||+.+++++|+....
T Consensus       219 p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          219 PYDGIPASEISSILE-------KGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTTTCCGGGHHHHHH-------TTC---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CccCCCHHHHHHHHH-------cCC---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            998776655433331       110         111223345678899999999999999999999999987643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-35  Score=273.32  Aligned_cols=232  Identities=23%  Similarity=0.255  Sum_probs=176.8

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      +.|.+..+++..+   ...+++|.+..          ....+...++.++|++++++.+.+.. ++.+++||||+++++|
T Consensus       157 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e~~~~~~L  235 (446)
T 4ejn_A          157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANGGEL  235 (446)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEEEEECCCSSCBH
T ss_pred             eeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEEEEEeeCCCCcH
Confidence            3444444444332   33566665531          12245567788899999999999886 6689999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      .+++...  ..+++..+..++.||+.||.|||+  ..+|+||||||+||+++.++.++|+|||++....... .......
T Consensus       236 ~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~  310 (446)
T 4ejn_A          236 FFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFC  310 (446)
T ss_dssp             HHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCSS
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-ccccccc
Confidence            9999764  369999999999999999999994  2799999999999999999999999999987533222 1234467


Q ss_pred             ccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHH
Q 048068          161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM  240 (313)
Q Consensus       161 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (313)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..      .           ....+...+
T Consensus       311 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~-----------~~~~p~~~~  373 (446)
T 4ejn_A          311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------E-----------EIRFPRTLG  373 (446)
T ss_dssp             SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C-----------CCCCCTTSC
T ss_pred             CCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------C-----------CCCCCccCC
Confidence            89999999999988999999999999999999999999987765544433311      0           001223345


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----CHHHHHHHH
Q 048068          241 ELVLKLGLFCSHPKPEARP-----NMRQVMQYL  268 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rp-----t~~ell~~L  268 (313)
                      +.+.+||..||+.||.+||     |++|+++|-
T Consensus       374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence            6788999999999999999     999999853

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-35  Score=260.08  Aligned_cols=210  Identities=20%  Similarity=0.330  Sum_probs=163.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++.+++... ++..++||||+++++|.+++... ...+++..++.++.||+.||.|||   ..+++
T Consensus        61 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~iv  135 (289)
T 4fvq_A           61 EAASMMSKLSHKHLVLNYGVCVC-GDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---ENTLI  135 (289)
T ss_dssp             HHHHHHHTSCCTTBCCEEEEECC-TTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCEeEEEEEEEe-CCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeE
Confidence            45667888899999999999886 56789999999999999999875 334999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCc--------EEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHH
Q 048068          121 HRDIKPANVLLDADLN--------GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~  191 (313)
                      |+||||+||+++.++.        ++|+|||++.....     .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus       136 H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e  210 (289)
T 4fvq_A          136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE  210 (289)
T ss_dssp             CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHH
T ss_pred             CCCcCcceEEEecCCcccccccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHH
Confidence            9999999999998877        99999999854321     233457889999999987 678999999999999999


Q ss_pred             HHhCCC-CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          192 VASGRR-PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       192 ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      |++|.. ||............       ...       ..    .+...+..+.+|+..||+.||.+|||+++++++|++
T Consensus       211 l~~g~~~~~~~~~~~~~~~~~-------~~~-------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  272 (289)
T 4fvq_A          211 ICSGGDKPLSALDSQRKLQFY-------EDR-------HQ----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS  272 (289)
T ss_dssp             HHTTTCCTTTTSCHHHHHHHH-------HTT-------CC----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred             HHcCCCCCccccchHHHHHHh-------hcc-------CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            999554 45443332221111       000       00    111123457899999999999999999999999999


Q ss_pred             cCCCCCCC
Q 048068          271 NATLPDIP  278 (313)
Q Consensus       271 ~~~~~~~~  278 (313)
                      ..++..++
T Consensus       273 l~~p~~~~  280 (289)
T 4fvq_A          273 LFTPDLVP  280 (289)
T ss_dssp             CC------
T ss_pred             hcCCCCCC
Confidence            98655544

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.7e-35  Score=263.28  Aligned_cols=203  Identities=23%  Similarity=0.335  Sum_probs=166.4

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...+..+ .|++++++...+.. .+.+|+||||++||+|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        69 ~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~gi  142 (353)
T 2i0e_A           69 VEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGI  142 (353)
T ss_dssp             HHHHHHTCTTCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHhcCCCCEEeeEEEEEEc-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCE
Confidence            345556655 79999999999887 67899999999999999999864  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.+|.++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||
T Consensus       143 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf  221 (353)
T 2i0e_A          143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF  221 (353)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EeccCCHHHEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCC
Confidence            999999999999999999999999987533221 1234567899999999999889999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      .+.+..+....+.       ...          ..++...+..+.+||.+||..||.+||+     ++++++|
T Consensus       222 ~~~~~~~~~~~i~-------~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          222 EGEDEDELFQSIM-------EHN----------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CCSSHHHHHHHHH-------HCC----------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CCCCHHHHHHHHH-------hCC----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            8766554443331       100          1122344567889999999999999994     6899886

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=263.98  Aligned_cols=213  Identities=22%  Similarity=0.284  Sum_probs=167.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|+++++.+++...  +..++|++++.+++|.+++... ...+++..++.++.||+.||.|||   ..++
T Consensus        65 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i  138 (327)
T 3lzb_A           65 LDEAYVMASVDNPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRL  138 (327)
T ss_dssp             HHHHHHHTTCCBTTBCCCCEEEES--SSEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhCCCCCeeEEEEEEec--CCceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCC
Confidence            356677888999999999999885  3488999999999999999875 446999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      +|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       139 vH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~  218 (327)
T 3lzb_A          139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK  218 (327)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999999976543221 12223456778999999998899999999999999999999 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      ||.+.........+.       .+.         ....+...+..+.++|..||+.||.+|||+.|+++.|+.....
T Consensus       219 p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          219 PYDGIPASEISSILE-------KGE---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTTTCCGGGHHHHHH-------TTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCCCHHHHHHHHH-------cCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            998876655443331       110         1112233455788999999999999999999999999987643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-35  Score=267.19  Aligned_cols=212  Identities=24%  Similarity=0.366  Sum_probs=162.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++.++|+++++.+++....++..++||||+++++|.++++.. ...+++..++.++.||+.||.|||   ..+++
T Consensus       139 ~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~iv  214 (373)
T 3c1x_A          139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFV  214 (373)
T ss_dssp             HHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            45566778899999999998776567889999999999999999865 446899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GR  196 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  196 (313)
                      ||||||+||+++.++.+||+|||++.........   ......++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus       215 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~  294 (373)
T 3c1x_A          215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA  294 (373)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcC
Confidence            9999999999999999999999998754322111   1223456778999999998899999999999999999999 78


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +||......+....+.       .+.         ....+...+..+.++|.+||+.||++|||+++++++|+...
T Consensus       295 ~p~~~~~~~~~~~~~~-------~~~---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          295 PPYPDVNTFDITVYLL-------QGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CSCTTSCSSCHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHH-------cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            8887665544332221       110         00112234567899999999999999999999999998875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-35  Score=256.08  Aligned_cols=223  Identities=22%  Similarity=0.310  Sum_probs=178.1

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ..+++|.+...        ...+.+.++.++|+++++..++..  .+..++||||+++++|.+++... ...+++..++.
T Consensus        38 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~  114 (287)
T 1u59_A           38 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAE  114 (287)
T ss_dssp             EEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHH
T ss_pred             ceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHH
Confidence            34666666432        224667778889999999999984  45699999999999999999754 45699999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCCC
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKAS  177 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~  177 (313)
                      ++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++.........  ......+++.|+|||.+.+..++
T Consensus       115 ~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  191 (287)
T 1u59_A          115 LLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS  191 (287)
T ss_dssp             HHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCC
Confidence            9999999999999   589999999999999999999999999999765433211  12233457889999999888899


Q ss_pred             cchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      .++|+||||+++|+|++ |..||......+....+.       .+.         ....+...+..+.++|..||+.||.
T Consensus       192 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~  255 (287)
T 1u59_A          192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGK---------RMECPPECPPELYALMSDCWIYKWE  255 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred             chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-------cCC---------cCCCCCCcCHHHHHHHHHHcCCChh
Confidence            99999999999999998 999998766554433221       110         1112334557889999999999999


Q ss_pred             CCCCHHHHHHHHhccC
Q 048068          257 ARPNMRQVMQYLDGNA  272 (313)
Q Consensus       257 ~Rpt~~ell~~L~~~~  272 (313)
                      +|||+.+++++|+...
T Consensus       256 ~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          256 DRPDFLTVEQRMRACY  271 (287)
T ss_dssp             GSCCHHHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.9e-35  Score=258.72  Aligned_cols=226  Identities=21%  Similarity=0.303  Sum_probs=176.5

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC---------
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK---------   89 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------   89 (313)
                      ..+++|.+...        ...+...++.+ +|+++++..+++.. ++..++||||+++++|.+++.....         
T Consensus        54 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  132 (313)
T 1t46_A           54 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP  132 (313)
T ss_dssp             EEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHHTTTTC-------
T ss_pred             hhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccc
Confidence            35666665432        22455666777 89999999999876 5688999999999999999986532         


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccc
Q 048068           90 -------PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVG  161 (313)
Q Consensus        90 -------~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~  161 (313)
                             ..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++......... ......+
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  209 (313)
T 1t46_A          133 AIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL  209 (313)
T ss_dssp             -------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEE
T ss_pred             cccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCC
Confidence                   24899999999999999999999   589999999999999999999999999998765443221 1223456


Q ss_pred             cccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHH
Q 048068          162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM  240 (313)
Q Consensus       162 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (313)
                      ++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..........  ..    ..         .....+...+
T Consensus       210 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--~~----~~---------~~~~~~~~~~  274 (313)
T 1t46_A          210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM--IK----EG---------FRMLSPEHAP  274 (313)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH--HH----HT---------CCCCCCTTSC
T ss_pred             cceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH--hc----cC---------CCCCCcccCC
Confidence            778999999988889999999999999999999 99999876544322211  11    11         0111122345


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          241 ELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ..+.+++.+||+.||.+|||+.+++++|++..
T Consensus       275 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          275 AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            67899999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-35  Score=264.98  Aligned_cols=213  Identities=23%  Similarity=0.313  Sum_probs=163.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCC-----eEEEEEecCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKG-----EFLLVYDYMPNGSLDKILHTNI----KPSLSWYQRFRIIRGVASGLLYL  111 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~l  111 (313)
                      .|.+.++.++|+++++.+++....+.     ..++||||+++++|.+++....    ...+++..++.++.||+.||.||
T Consensus        74 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L  153 (323)
T 3qup_A           74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL  153 (323)
T ss_dssp             HHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH
Confidence            56677788899999999999875332     2489999999999999996431    22599999999999999999999


Q ss_pred             hhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHH
Q 048068          112 HEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML  190 (313)
Q Consensus       112 hs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  190 (313)
                      |   ..+++|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|
T Consensus       154 H---~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  230 (323)
T 3qup_A          154 S---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW  230 (323)
T ss_dssp             H---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             H---cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHH
Confidence            9   589999999999999999999999999999755332211 122345677899999999888999999999999999


Q ss_pred             HHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          191 EVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       191 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +|++ |..||.+....+....+.       .+.         ....+...+..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       231 ell~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          231 EIMTRGQTPYAGIENAEIYNYLI-------GGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             HHHTTSCCTTTTCCGGGHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhCCCCCccccChHHHHHHHh-------cCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            9999 999998776655443321       000         11122334567899999999999999999999999998


Q ss_pred             ccC
Q 048068          270 GNA  272 (313)
Q Consensus       270 ~~~  272 (313)
                      +..
T Consensus       295 ~~l  297 (323)
T 3qup_A          295 NIL  297 (323)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            775

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-35  Score=281.14  Aligned_cols=228  Identities=25%  Similarity=0.384  Sum_probs=180.9

Q ss_pred             eEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .+++|.+...      ...|.+.++.++|++++++++++.+  +..++||||+++|+|.++++......+++..++.++.
T Consensus       293 ~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  370 (535)
T 2h8h_A          293 RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA  370 (535)
T ss_dssp             EEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred             eEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence            4666666532      3456778888999999999998865  5789999999999999999864345699999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      ||+.||.|||   ..+|+||||||+|||++.++.+||+|||++...............++..|+|||.+.+..++.++||
T Consensus       371 qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv  447 (535)
T 2h8h_A          371 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV  447 (535)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhH
Confidence            9999999999   5899999999999999999999999999997543221111122345678999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|+|++ |..||.+....+....+.       .+..         ...+..++..+.+||.+||+.||++|||+
T Consensus       448 wSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~  511 (535)
T 2h8h_A          448 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYR---------MPCPPECPESLHDLMCQCWRKEPEERPTF  511 (535)
T ss_dssp             HHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-------TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence            999999999999 999998776554333221       1110         11223445678999999999999999999


Q ss_pred             HHHHHHHhccCCCCCC
Q 048068          262 RQVMQYLDGNATLPDI  277 (313)
Q Consensus       262 ~ell~~L~~~~~~~~~  277 (313)
                      ++|++.|++......+
T Consensus       512 ~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          512 EYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHHHHHHTSSCCCSC
T ss_pred             HHHHHHHHHHhhccCc
Confidence            9999999998754443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-35  Score=260.65  Aligned_cols=236  Identities=22%  Similarity=0.277  Sum_probs=170.2

Q ss_pred             ceEEEcccCCChh----hHHhhhhh--ccccceeeeeeEEeccC---CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           28 NQFIYHGFNEDPQ----LQRDGLAS--VHSNGLLQLTNTVNSRK---GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        28 ~~~~~~~~~~~~~----~~~~~l~~--~~~~~~l~~~~~~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ..+++|.+.....    .+.+.+..  +.|++++++.++.....   ..+++||||+++++|.++++..   .+++..++
T Consensus        61 ~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~  137 (337)
T 3mdy_A           61 EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSML  137 (337)
T ss_dssp             EEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHH
T ss_pred             ceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHH
Confidence            3556665533221    23333333  48999999999887532   6899999999999999999764   59999999


Q ss_pred             HHHHHHHHHHHHhhhcCCC--------CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---ccccccccccccc
Q 048068           99 RIIRGVASGLLYLHEDWEQ--------VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMA  167 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~--------~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~a  167 (313)
                      .++.|++.||.|||   ..        +++|+||||+||+++.++.++|+|||++.........   ......||+.|+|
T Consensus       138 ~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  214 (337)
T 3mdy_A          138 KLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP  214 (337)
T ss_dssp             HHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCC
T ss_pred             HHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeC
Confidence            99999999999999   46        9999999999999999999999999998655432211   1224578999999


Q ss_pred             cccccCCCCCcc------hhhHHHHHHHHHHHhC----------CCCCccCCchhhhhHHHHHHHhhhhccccccccccc
Q 048068          168 PELMRTGKASTS------TDVYAFGVFMLEVASG----------RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL  231 (313)
Q Consensus       168 PE~~~~~~~~~~------~DiwslG~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (313)
                      ||.+.+......      +|||||||++|+|++|          +.||............  .........   ......
T Consensus       215 PE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~  289 (337)
T 3mdy_A          215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED--MREIVCIKK---LRPSFP  289 (337)
T ss_dssp             HHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH--HHHHHTTSC---CCCCCC
T ss_pred             hhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh--hHHHHhhhc---cCcccc
Confidence            999987665554      9999999999999999          6666543322211111  000000000   011111


Q ss_pred             cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCC
Q 048068          232 EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       232 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      .......+++.+.+||.+||+.||.+|||+.+++++|+.....
T Consensus       290 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            1112346788899999999999999999999999999887543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-34  Score=254.23  Aligned_cols=212  Identities=22%  Similarity=0.317  Sum_probs=169.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.+.++..++||||+.+++|.+++... ...+++..++.++.|++.||.|||   ..+++
T Consensus        71 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~  146 (298)
T 3pls_A           71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFV  146 (298)
T ss_dssp             HHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            45667788899999999999987666779999999999999999864 456899999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCC---CCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDT---IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||||+||+++.++.++|+|||++.......   ........++..|.|||.+.+..++.++||||||+++|+|++|..
T Consensus       147 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  226 (298)
T 3pls_A          147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA  226 (298)
T ss_dssp             CSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             cCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCC
Confidence            99999999999999999999999987543221   112233466889999999998899999999999999999999555


Q ss_pred             C-CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 P-IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      | |......+....+.       .+.         ....+...++.+.+++..||+.||.+|||++++++.|+...
T Consensus       227 ~~~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          227 PPYRHIDPFDLTHFLA-------QGR---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             CTTTTSCGGGHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHhh-------cCC---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4 55444433322221       000         01122234567899999999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.7e-35  Score=262.29  Aligned_cols=228  Identities=23%  Similarity=0.352  Sum_probs=178.6

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC---------
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK---------   89 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------   89 (313)
                      ..+++|.+...        ...+...++.+ +|++++++.+++.. ++..++||||+++++|.+++.....         
T Consensus        68 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  146 (334)
T 2pvf_A           68 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI  146 (334)
T ss_dssp             CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--
T ss_pred             eEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-CCceEEEEECCCCCcHHHHHHHhccccccccccc
Confidence            35667766532        22455666777 89999999998876 5689999999999999999986431         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccc
Q 048068           90 -----PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTF  163 (313)
Q Consensus        90 -----~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~  163 (313)
                           ..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++......... ......+++
T Consensus       147 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  223 (334)
T 2pvf_A          147 NRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV  223 (334)
T ss_dssp             ------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCG
T ss_pred             cccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCccc
Confidence                 24899999999999999999999   589999999999999999999999999998765433211 122345678


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          164 GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       164 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      .|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.       .+.         ....+...+..
T Consensus       224 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~  287 (334)
T 2pvf_A          224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-------EGH---------RMDKPANCTNE  287 (334)
T ss_dssp             GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------HTC---------CCCCCTTCCHH
T ss_pred             ceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh-------cCC---------CCCCCccCCHH
Confidence            8999999988889999999999999999999 999998765544332221       111         01122334567


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCC
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYLDGNATLP  275 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~  275 (313)
                      +.+++..||+.||.+|||+.+++++|+......
T Consensus       288 l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            899999999999999999999999999886443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-35  Score=262.76  Aligned_cols=215  Identities=20%  Similarity=0.292  Sum_probs=171.6

Q ss_pred             hhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC---------------------CCCCHHHH
Q 048068           40 QLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK---------------------PSLSWYQR   97 (313)
Q Consensus        40 ~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~   97 (313)
                      ..+...++.+ .|++++++.+++.. ++..++||||+++++|.+++.....                     ..+++..+
T Consensus        96 ~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  174 (344)
T 1rjb_A           96 MSELKMMTQLGSHENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL  174 (344)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred             HHHHHHHHhhcCCCCeeeEEEEEee-CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHH
Confidence            3566777888 89999999999886 6689999999999999999986432                     23799999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      +.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..+
T Consensus       175 ~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  251 (344)
T 1rjb_A          175 LCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY  251 (344)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence            999999999999999   589999999999999999999999999999755432211 2233456788999999988889


Q ss_pred             CcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCC
Q 048068          177 STSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP  255 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P  255 (313)
                      +.++||||||+++|+|++ |..||.+..........  .    ..+         .....+...++.+.+|+..||+.||
T Consensus       252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~--~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp  316 (344)
T 1rjb_A          252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL--I----QNG---------FKMDQPFYATEEIYIIMQSCWAFDS  316 (344)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH--H----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHH--H----hcC---------CCCCCCCCCCHHHHHHHHHHcCCCc
Confidence            999999999999999998 99999876544322211  0    111         0111223345678999999999999


Q ss_pred             CCCCCHHHHHHHHhccCC
Q 048068          256 EARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       256 ~~Rpt~~ell~~L~~~~~  273 (313)
                      .+|||+.+++++|+....
T Consensus       317 ~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          317 RKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             GGSCCHHHHHHHHHHHC-
T ss_pred             hhCcCHHHHHHHHHHHHH
Confidence            999999999999998753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.1e-35  Score=275.98  Aligned_cols=246  Identities=19%  Similarity=0.174  Sum_probs=174.5

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYM   75 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~   75 (313)
                      ++.|.+..++...+   ...++.|.+..         ....|...++.++|+|++++.+++...     ...+|+||||+
T Consensus        70 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~  149 (464)
T 3ttj_A           70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM  149 (464)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECC
T ss_pred             eecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCC
Confidence            34444444444433   33566666642         122455677888999999999998743     25789999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc
Q 048068           76 PNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ  155 (313)
Q Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~  155 (313)
                      ++ +|.+.+..    .+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||++.......  .
T Consensus       150 ~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~  219 (464)
T 3ttj_A          150 DA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--M  219 (464)
T ss_dssp             SE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC--C
T ss_pred             CC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--c
Confidence            65 67777754    3999999999999999999999   4899999999999999999999999999997654322  2


Q ss_pred             cccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhc---------
Q 048068          156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKG---------  221 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~---------  221 (313)
                      .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......     +...         
T Consensus       220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~  299 (464)
T 3ttj_A          220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE  299 (464)
T ss_dssp             C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHT
T ss_pred             cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhh
Confidence            34467899999999999999999999999999999999999999987766554433211100     0000         


Q ss_pred             cc---c-----cccccc---ccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          222 AI---L-----DASDSR---LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       222 ~~---~-----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..   .     ......   ............+.+||.+||..||++|||++|+++|-
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             cccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence            00   0     000000   00011122367799999999999999999999999974

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-35  Score=266.76  Aligned_cols=230  Identities=18%  Similarity=0.154  Sum_probs=172.1

Q ss_pred             hhhccccceeeeeeEEecc---CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           46 LASVHSNGLLQLTNTVNSR---KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~~---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      ++.+.|+++++++++....   ....++||||+ +++|.+++... ...+++..++.++.||+.||.|||   ..+|+||
T Consensus       102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHr  176 (364)
T 3op5_A          102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHG  176 (364)
T ss_dssp             HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred             HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEe
Confidence            3456799999999987742   35689999999 99999999875 456999999999999999999999   4899999


Q ss_pred             CcCCCcEEEc--CCCcEEEeecccccccCCCCC------CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh
Q 048068          123 DIKPANVLLD--ADLNGKLGDFGLARLYDHDTI------PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       123 dl~~~nIlv~--~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  194 (313)
                      ||||+||+++  .++.++|+|||++........      .......||+.|+|||.+.+..++.++|||||||++|+|++
T Consensus       177 Dlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  256 (364)
T 3op5_A          177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT  256 (364)
T ss_dssp             CCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999  889999999999975532211      11233458999999999998889999999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCC
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      |+.||.+...........  ...+.. ......+....   ....+..+.+++..||+.||.+|||++++++.|++...-
T Consensus       257 g~~Pf~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          257 GHLPWEDNLKDPKYVRDS--KIRYRE-NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             SCCTTGGGTTCHHHHHHH--HHHHHH-CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCccccccCHHHHHHH--HHHhhh-hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            999998643332221111  100000 00111111110   112346788999999999999999999999999887755


Q ss_pred             CCCCCCCccccc
Q 048068          275 PDIPRDSTLIAP  286 (313)
Q Consensus       275 ~~~~~~~~~~~~  286 (313)
                      ...+.+...++.
T Consensus       331 ~~~~~~~~~dw~  342 (364)
T 3op5_A          331 IGSKDDGKLDLS  342 (364)
T ss_dssp             TTCCCCCCCCC-
T ss_pred             cCCCcCCccceE
Confidence            555555554444

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-34  Score=271.31  Aligned_cols=204  Identities=23%  Similarity=0.391  Sum_probs=168.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|+++++.++++.. ++.+++||||+++++|.+++...  +.+++..++.++.||+.||.|||   ..++
T Consensus        64 ~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~gi  137 (476)
T 2y94_A           64 RREIQNLKLFRHPHIIKLYQVIST-PSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMV  137 (476)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTE
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence            356677888999999999999887 57899999999999999999763  46999999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +||||||+||+++.++.++|+|||++.......  ......|++.|+|||.+.+..+ +.++|||||||++|+|++|..|
T Consensus       138 vHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P  215 (476)
T 2y94_A          138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP  215 (476)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccccHHHEEEecCCCeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence            999999999999999999999999997654332  2344578999999999987765 6899999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |.+.........+.       .+.          ...+...+..+.+||.+||+.||.+|||++|+++|-
T Consensus       216 f~~~~~~~~~~~i~-------~~~----------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          216 FDDDHVPTLFKKIC-------DGI----------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             SCCSSSHHHHHHHH-------TTC----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             CCCCCHHHHHHHHh-------cCC----------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence            98766554333221       110          011222345688999999999999999999999963

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.8e-35  Score=270.56  Aligned_cols=210  Identities=21%  Similarity=0.286  Sum_probs=171.3

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...+...++.++|+++++.++.+.+ ++.+|+||||++||+|.++++..   .+++..++.++.||+.||.|||   ..+
T Consensus       116 ~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~g  188 (410)
T 3v8s_A          116 FWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMG  188 (410)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            3467788899999999999999987 67899999999999999999864   4999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC----CCcchhhHHHHHHHHHHHh
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK----ASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~  194 (313)
                      |+||||||+||+++.++.++|+|||++...............||+.|+|||++.+..    ++.++|+|||||++|+|++
T Consensus       189 ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~  268 (410)
T 3v8s_A          189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  268 (410)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred             eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence            999999999999999999999999999765543322334567999999999997654    7889999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA--RPNMRQVMQYL  268 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~L  268 (313)
                      |+.||.+.+.......+.......           ..+  .....+..+.+||..||..+|.+  ||+++|+++|-
T Consensus       269 G~~Pf~~~~~~~~~~~i~~~~~~~-----------~~p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          269 GDTPFYADSLVGTYSKIMNHKNSL-----------TFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             SSCTTCCSSHHHHHHHHHTHHHHC-----------CCC--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             CCCCCCCCChhhHHHHHHhccccc-----------cCC--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            999998776655444332100000           000  11123467889999999999998  99999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=272.11  Aligned_cols=212  Identities=24%  Similarity=0.274  Sum_probs=169.3

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...+...+..++|+++++..+.+.+ ++.+|+||||++||+|.+++.+. ...+++..++.++.||+.||.|||   +.+
T Consensus       108 ~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~g  182 (412)
T 2vd5_A          108 FREERDVLVNGDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH---RLG  182 (412)
T ss_dssp             HHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            3467777888999999999999887 67899999999999999999864 236999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-------CCCCCcchhhHHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-------TGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~~  191 (313)
                      |+||||||+||+++.++.+||+|||++...............||+.|+|||++.       +..++.++|+|||||++|+
T Consensus       183 iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilye  262 (412)
T 2vd5_A          183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE  262 (412)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHH
T ss_pred             eeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHH
Confidence            999999999999999999999999999765443322233457899999999986       3568999999999999999


Q ss_pred             HHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHH
Q 048068          192 VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEAR---PNMRQVMQYL  268 (313)
Q Consensus       192 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt~~ell~~L  268 (313)
                      |++|+.||.+.+..+....+........           .+ ......+..+.+||.+||. +|.+|   |+++|+++|-
T Consensus       263 lltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          263 MFYGQTPFYADSTAETYGKIVHYKEHLS-----------LP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HHHSSCTTCCSSHHHHHHHHHTHHHHCC-----------CC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             HHhCCCCCCCCCHHHHHHHHHhcccCcC-----------CC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            9999999988766554433321100000           00 0112345678999999999 99998   6999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.9e-35  Score=261.06  Aligned_cols=224  Identities=21%  Similarity=0.318  Sum_probs=164.1

Q ss_pred             cceEEEcccCCC----------hhhHHhhhhhccccceeeeeeEEeccC---CeEEEEEecCCCCCHHHHHhhCCCCCCC
Q 048068           27 VNQFIYHGFNED----------PQLQRDGLASVHSNGLLQLTNTVNSRK---GEFLLVYDYMPNGSLDKILHTNIKPSLS   93 (313)
Q Consensus        27 ~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~l~~~~~~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~   93 (313)
                      ...+++|.+...          ...+...++.++|+++++.+++.....   ...|+||||+++++|.+++...  ..++
T Consensus        37 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~  114 (311)
T 3ork_A           37 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMT  114 (311)
T ss_dssp             TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH--CSCC
T ss_pred             CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc--CCCC
Confidence            345666666432          234556677789999999998877422   2469999999999999999864  3599


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--Cccccccccccccccccc
Q 048068           94 WYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELM  171 (313)
Q Consensus        94 ~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~  171 (313)
                      +..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........  .......|++.|+|||.+
T Consensus       115 ~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  191 (311)
T 3ork_A          115 PKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA  191 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHh
Confidence            9999999999999999999   58999999999999999999999999999875543221  122335689999999999


Q ss_pred             cCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcC
Q 048068          172 RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCS  251 (313)
Q Consensus       172 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  251 (313)
                      .+..++.++||||||+++|+|++|+.||.+...........      ....       ..........+..+.+||.+||
T Consensus       192 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~------~~~~-------~~~~~~~~~~~~~l~~li~~~l  258 (311)
T 3ork_A          192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------REDP-------IPPSARHEGLSADLDAVVLKAL  258 (311)
T ss_dssp             HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HCCC-------CCHHHHSTTCCHHHHHHHHHHT
T ss_pred             cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------cCCC-------CCcccccCCCCHHHHHHHHHHH
Confidence            98899999999999999999999999998766544332221      0100       0000011224567889999999


Q ss_pred             CCCCCCCCCHHHHHHHH
Q 048068          252 HPKPEARPNMRQVMQYL  268 (313)
Q Consensus       252 ~~~P~~Rpt~~ell~~L  268 (313)
                      +.||.+||++.+++++-
T Consensus       259 ~~dP~~R~~~~~~l~~~  275 (311)
T 3ork_A          259 AKNPENRYQTAAEMRAD  275 (311)
T ss_dssp             CSSGGGSCSSHHHHHHH
T ss_pred             hcCHhhChhhHHHHHHH
Confidence            99999999766666543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.7e-35  Score=255.69  Aligned_cols=225  Identities=20%  Similarity=0.352  Sum_probs=176.3

Q ss_pred             cceEEEcccC---CChhhHHhhhhhccccceeeeeeEEec---------------cCCeEEEEEecCCCCCHHHHHhhCC
Q 048068           27 VNQFIYHGFN---EDPQLQRDGLASVHSNGLLQLTNTVNS---------------RKGEFLLVYDYMPNGSLDKILHTNI   88 (313)
Q Consensus        27 ~~~~~~~~~~---~~~~~~~~~l~~~~~~~~l~~~~~~~~---------------~~~~~~lV~e~~~~g~L~~~l~~~~   88 (313)
                      ...++.|.+.   +....+.+.++.++|+++++..+++..               ....+++||||+++++|.+++....
T Consensus        36 ~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  115 (284)
T 2a19_B           36 GKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR  115 (284)
T ss_dssp             CCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG
T ss_pred             CeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc
Confidence            3455666553   345567788899999999999887752               2456899999999999999998654


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccc
Q 048068           89 KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAP  168 (313)
Q Consensus        89 ~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aP  168 (313)
                      ...+++..++.++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++.......  ......+++.|+||
T Consensus       116 ~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aP  190 (284)
T 2a19_B          116 GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSP  190 (284)
T ss_dssp             GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc--cccccCCcccccCh
Confidence            567999999999999999999999   5899999999999999999999999999987654432  22345689999999


Q ss_pred             ccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHH
Q 048068          169 ELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGL  248 (313)
Q Consensus       169 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (313)
                      |.+.+..++.++||||||+++|+|++|..|+.....     ...    ....+        .    .+...+..+.++|.
T Consensus       191 E~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~----~~~~~--------~----~~~~~~~~~~~li~  249 (284)
T 2a19_B          191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFT----DLRDG--------I----ISDIFDKKEKTLLQ  249 (284)
T ss_dssp             HHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHH----HHHTT--------C----CCTTSCHHHHHHHH
T ss_pred             hhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHH----Hhhcc--------c----ccccCCHHHHHHHH
Confidence            999988899999999999999999999988753210     000    00111        1    11223456789999


Q ss_pred             HcCCCCCCCCCCHHHHHHHHhccCCCCCC
Q 048068          249 FCSHPKPEARPNMRQVMQYLDGNATLPDI  277 (313)
Q Consensus       249 ~cl~~~P~~Rpt~~ell~~L~~~~~~~~~  277 (313)
                      +||+.||.+|||+.|++++|+.....+..
T Consensus       250 ~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          250 KLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             HHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            99999999999999999999988655443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-35  Score=261.72  Aligned_cols=220  Identities=21%  Similarity=0.258  Sum_probs=164.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.. ++..++||||+++++|.+++...  ..+++..++.++.|++.||.|||   ..+++
T Consensus        51 ~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~iv  124 (311)
T 4agu_A           51 REIRMLKQLKHPNLVNLLEVFRR-KRRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCI  124 (311)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCccchhheeec-CCeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence            46677888899999999999886 67899999999999999988764  45999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus       125 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  203 (311)
T 4agu_A          125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW  203 (311)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976543221 2234567899999999876 56799999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHH--------Hhhhhcccc-ccccccccCC-----ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          200 EQQGSMEMVNLVDWVS--------DCWKKGAIL-DASDSRLEGI-----YEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      .+....+....+....        ..+...... ....+.....     .....+..+.+|+.+||+.||.+|||++|++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  283 (311)
T 4agu_A          204 PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL  283 (311)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence            8877665544332110        001100000 0000000000     0123455688999999999999999999999


Q ss_pred             HH
Q 048068          266 QY  267 (313)
Q Consensus       266 ~~  267 (313)
                      +|
T Consensus       284 ~h  285 (311)
T 4agu_A          284 HH  285 (311)
T ss_dssp             TS
T ss_pred             cC
Confidence            87

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.7e-35  Score=258.18  Aligned_cols=216  Identities=21%  Similarity=0.252  Sum_probs=161.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..++... ++..++||||+++++|.+++...  ..+++..++.++.|++.||.|||   ..+++
T Consensus        83 ~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~  156 (309)
T 2h34_A           83 REARTAGRLQEPHVVPIHDFGEI-DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGAT  156 (309)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHhhcCCCCeeEEEEEEee-CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCC
Confidence            46667788899999999999876 67899999999999999999864  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++...............++..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus       157 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (309)
T 2h34_A          157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ  236 (309)
T ss_dssp             CSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999999987654433233344568899999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhccCCCCC
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-NMRQVMQYLDGNATLPD  276 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ell~~L~~~~~~~~  276 (313)
                      ..........+       ... .      ......+...+..+.++|.+||+.||++|| |++++++.|+.......
T Consensus       237 ~~~~~~~~~~~-------~~~-~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          237 GDQLSVMGAHI-------NQA-I------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             SCHHHHHHHHH-------HSC-C------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CchHHHHHHHh-------ccC-C------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            65433211111       010 0      001112334456788999999999999999 99999999998864443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.7e-35  Score=262.28  Aligned_cols=220  Identities=20%  Similarity=0.282  Sum_probs=162.7

Q ss_pred             eEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Q 048068           29 QFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG  103 (313)
Q Consensus        29 ~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~q  103 (313)
                      .+++|.+..     ....|...++.+.|+++++..+++.. ++..++||||+++++|.+++...  ..+++..++.++.|
T Consensus        80 ~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~q  156 (349)
T 2w4o_A           80 PYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQ  156 (349)
T ss_dssp             EEEEEEEEC----------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHH
T ss_pred             EEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHH
Confidence            456665542     23356778889999999999999886 67899999999999999999764  45999999999999


Q ss_pred             HHHHHHHhhhcCCCCceecCcCCCcEEEcC---CCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcch
Q 048068          104 VASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST  180 (313)
Q Consensus       104 i~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  180 (313)
                      |+.||.|||   ..+++|+||||+||+++.   ++.++|+|||++.......  ......|++.|+|||.+.+..++.++
T Consensus       157 i~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~  231 (349)
T 2w4o_A          157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEV  231 (349)
T ss_dssp             HHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTTCCCCTHH
T ss_pred             HHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCccc
Confidence            999999999   589999999999999975   7899999999987554322  22345689999999999988899999


Q ss_pred             hhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       181 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      |||||||++|+|++|..||............     .. ....      ..........+..+.+||.+||+.||++|||
T Consensus       232 DiwslG~il~ell~g~~pf~~~~~~~~~~~~-----i~-~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  299 (349)
T 2w4o_A          232 DMWSVGIITYILLCGFEPFYDERGDQFMFRR-----IL-NCEY------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLT  299 (349)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-----HH-TTCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             chHHHHHHHHHHHhCCCCCCCCcccHHHHHH-----HH-hCCC------ccCCchhhhCCHHHHHHHHHHccCChhhCcC
Confidence            9999999999999999999765544321111     00 1000      0011112234567889999999999999999


Q ss_pred             HHHHHHHH
Q 048068          261 MRQVMQYL  268 (313)
Q Consensus       261 ~~ell~~L  268 (313)
                      +.|+++|-
T Consensus       300 ~~e~l~hp  307 (349)
T 2w4o_A          300 TFQALQHP  307 (349)
T ss_dssp             HHHHHHST
T ss_pred             HHHHhcCc
Confidence            99999963

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-34  Score=257.73  Aligned_cols=208  Identities=21%  Similarity=0.311  Sum_probs=169.3

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.+.|+++++..+++.. ++.+++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..++
T Consensus        63 ~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~i  136 (321)
T 2a2a_A           63 EREVSILRQVLHHNVITLHDVYEN-RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKI  136 (321)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCcceEEEEEec-CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            456778889999999999999876 67899999999999999999863  46999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCC----cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          120 LHRDIKPANVLLDADL----NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +|+||+|+||+++.++    .++|+|||++.......  ......+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       137 vH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  214 (321)
T 2a2a_A          137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  214 (321)
T ss_dssp             ECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ecCCCChHHEEEecCCCCcCCEEEccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHC
Confidence            9999999999999887    79999999997654432  22345689999999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..||.+....+....+.       ...      ...+.......+..+.+||.+||+.||++|||+.|+++|-
T Consensus       215 ~~pf~~~~~~~~~~~i~-------~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          215 ASPFLGDTKQETLANIT-------SVS------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             CCSSCCSSHHHHHHHHH-------TTC------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred             CCCCCCCCHHHHHHHHH-------hcc------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            99998766544332221       000      0000011122346789999999999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.4e-35  Score=262.42  Aligned_cols=224  Identities=20%  Similarity=0.296  Sum_probs=171.1

Q ss_pred             ceEEEcccC---CChhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Q 048068           28 NQFIYHGFN---EDPQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRG  103 (313)
Q Consensus        28 ~~~~~~~~~---~~~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~q  103 (313)
                      ..++.|.+.   .....+.+.+..+ .|++++++++++.+ ++.+|+||||++||+|.+++...  +.+++..++.++.|
T Consensus        48 ~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~q  124 (342)
T 2qr7_A           48 MEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFT  124 (342)
T ss_dssp             EEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHH
T ss_pred             CEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHH
Confidence            345555553   2334555666666 79999999999876 67899999999999999999864  46999999999999


Q ss_pred             HHHHHHHhhhcCCCCceecCcCCCcEEEcCC----CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcc
Q 048068          104 VASGLLYLHEDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTS  179 (313)
Q Consensus       104 i~~al~~lhs~~~~~i~H~dl~~~nIlv~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  179 (313)
                      |+.||.|||   ..+|+||||||+||++...    +.++|+|||++....... .......+|+.|+|||++.+..++.+
T Consensus       125 i~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~  200 (342)
T 2qr7_A          125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLERQGYDAA  200 (342)
T ss_dssp             HHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-CceeccCCCccccCHHHhcCCCCCCc
Confidence            999999999   5899999999999998543    359999999997654332 12334578999999999987778899


Q ss_pred             hhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          180 TDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       180 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      +|+|||||++|+|++|..||..............+.    .+..      ..........++.+.+||.+||..||++||
T Consensus       201 ~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  270 (342)
T 2qr7_A          201 CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRL  270 (342)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             cCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCc------ccCccccccCCHHHHHHHHHHCCCChhHCc
Confidence            999999999999999999998643332222221111    1110      111112234456788999999999999999


Q ss_pred             CHHHHHHHH
Q 048068          260 NMRQVMQYL  268 (313)
Q Consensus       260 t~~ell~~L  268 (313)
                      |+.++++|-
T Consensus       271 t~~~il~hp  279 (342)
T 2qr7_A          271 TAALVLRHP  279 (342)
T ss_dssp             CHHHHTTSH
T ss_pred             CHHHHhcCC
Confidence            999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.3e-35  Score=261.10  Aligned_cols=221  Identities=24%  Similarity=0.349  Sum_probs=173.4

Q ss_pred             hhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHH
Q 048068           40 QLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGV  104 (313)
Q Consensus        40 ~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi  104 (313)
                      ..+...++.+ .|+++++..+++.. ++..++||||+++++|.+++....              ...+++..++.++.||
T Consensus        73 ~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  151 (327)
T 1fvr_A           73 AGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV  151 (327)
T ss_dssp             HHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCchhhhceeeee-CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHH
Confidence            3466778888 89999999999876 678999999999999999997642              2469999999999999


Q ss_pred             HHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHH
Q 048068          105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA  184 (313)
Q Consensus       105 ~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  184 (313)
                      +.||.|||   ..+++|+||||+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++||||
T Consensus       152 ~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  226 (327)
T 1fvr_A          152 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWS  226 (327)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHHHH---hCCccCCCCccceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchH
Confidence            99999999   5899999999999999999999999999986432211  122335678899999998888899999999


Q ss_pred             HHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          185 FGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       185 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      ||+++|+|++ |..||.+.........+       ..+.         ....+...+..+.+|+.+||+.||.+|||+++
T Consensus       227 lG~il~ellt~g~~pf~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  290 (327)
T 1fvr_A          227 YGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  290 (327)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCHHHHHHHG-------GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHcCCCCCCCCCcHHHHHHHh-------hcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999998 99999876544332211       1110         11122234567899999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCc
Q 048068          264 VMQYLDGNATLPDIPRDST  282 (313)
Q Consensus       264 ll~~L~~~~~~~~~~~~~~  282 (313)
                      ++++|+....-........
T Consensus       291 ll~~L~~~~~~~~~~~~~~  309 (327)
T 1fvr_A          291 ILVSLNRMLEERKTYVNTT  309 (327)
T ss_dssp             HHHHHHHHHHSSSCSBCCB
T ss_pred             HHHHHHHHHHhhcCccccc
Confidence            9999988764444333333

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-34  Score=260.05  Aligned_cols=208  Identities=24%  Similarity=0.346  Sum_probs=169.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|++++++++++.+ ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+++
T Consensus        90 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  163 (335)
T 2owb_A           90 MEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVI  163 (335)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCE
Confidence            45667788899999999999887 67899999999999999998764  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus       164 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  242 (335)
T 2owb_A          164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE  242 (335)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ecCCCchhEEEcCCCCEEEeeccCceecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence            99999999999999999999999997654322 12334568999999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccC
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNA  272 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~  272 (313)
                      .....+....+.       ...      ..    .+......+.+||.+||+.||++|||++|+++|  +.+..
T Consensus       243 ~~~~~~~~~~~~-------~~~------~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          243 TSCLKETYLRIK-------KNE------YS----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             CSSHHHHHHHHH-------HTC------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             CCCHHHHHHHHh-------cCC------CC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            765544332221       000      01    122334568899999999999999999999985  44443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.7e-35  Score=271.11  Aligned_cols=213  Identities=22%  Similarity=0.272  Sum_probs=171.9

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...+...+..++|+++++..+.+.+ ++.+|+||||++||+|.+++.+. ...+++..++.++.||+.||.|||   ..+
T Consensus       121 ~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~g  195 (437)
T 4aw2_A          121 FREERDVLVNGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLH  195 (437)
T ss_dssp             HHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEee-CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            4567778889999999999999887 67899999999999999999864 346999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc-----CCCCCcchhhHHHHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll  193 (313)
                      |+||||||+||+++.++.+||+|||++...............||+.|+|||++.     ...++.++|+|||||++|+|+
T Consensus       196 iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell  275 (437)
T 4aw2_A          196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML  275 (437)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred             eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence            999999999999999999999999999765443333334467999999999986     456899999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEA--RPNMRQVMQYL  268 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~L  268 (313)
                      +|+.||.+.+..+....+.......           ..+. .....++.+.+||.+||..+|++  ||+++|+++|-
T Consensus       276 tG~~Pf~~~~~~~~~~~i~~~~~~~-----------~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          276 YGETPFYAESLVETYGKIMNHKERF-----------QFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTHHHHC-----------CCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             hCCCCCCCCChhHHHHhhhhccccc-----------cCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            9999998876655544332100000           0010 11124566889999999988888  99999999973

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=258.38  Aligned_cols=221  Identities=21%  Similarity=0.238  Sum_probs=164.6

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++.++|+++++..+++.. ++..++||||++ ++|.+++... ...+++..++.++.||+.||.|||   ..+++
T Consensus        49 ~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~iv  122 (324)
T 3mtl_A           49 REVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH---RQKVL  122 (324)
T ss_dssp             CCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhcCCCCCCeeeeEEee-CCEEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            46778889999999999999886 668999999996 5999998875 446999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus       123 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  201 (324)
T 3mtl_A          123 HRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF  201 (324)
T ss_dssp             ESSCCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCcCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987544322 12233467999999999876 56799999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccc---------cc----cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDS---------RL----EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      .+....+....+..................         ..    ........+..+.+||.+||+.||.+|||++|+++
T Consensus       202 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            887766554443222111111100000000         00    00011223467889999999999999999999999


Q ss_pred             HH
Q 048068          267 YL  268 (313)
Q Consensus       267 ~L  268 (313)
                      |-
T Consensus       282 hp  283 (324)
T 3mtl_A          282 HP  283 (324)
T ss_dssp             SG
T ss_pred             Ch
Confidence            53

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.7e-35  Score=257.68  Aligned_cols=213  Identities=20%  Similarity=0.298  Sum_probs=164.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCC----eEEEEEecCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKG----EFLLVYDYMPNGSLDKILHTN----IKPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~----~~~lV~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      .+...++.++|++++++++++...+.    ..++||||+++++|.+++...    ....+++..++.++.||+.||.|||
T Consensus        85 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  164 (313)
T 3brb_A           85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS  164 (313)
T ss_dssp             HHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH
Confidence            45667788899999999999875332    569999999999999999532    2456999999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  191 (313)
                         ..+++|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+
T Consensus       165 ---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  241 (313)
T 3brb_A          165 ---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE  241 (313)
T ss_dssp             ---TTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHH
T ss_pred             ---hCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHH
Confidence               689999999999999999999999999998755432211 1223456778999999998889999999999999999


Q ss_pred             HHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          192 VAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       192 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      |++ |..||.............       .+.         ....+...+..+.+++..||+.||.+|||+.+++++|+.
T Consensus       242 l~~~g~~p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          242 IATRGMTPYPGVQNHEMYDYLL-------HGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             HHTTSCCSSTTCCGGGHHHHHH-------TTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhcCCCCCccCCHHHHHHHHH-------cCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            999 999998766554433221       110         111223345678999999999999999999999999987


Q ss_pred             cC
Q 048068          271 NA  272 (313)
Q Consensus       271 ~~  272 (313)
                      ..
T Consensus       306 l~  307 (313)
T 3brb_A          306 LL  307 (313)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.3e-34  Score=254.43  Aligned_cols=209  Identities=24%  Similarity=0.345  Sum_probs=169.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..++..  .+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+++
T Consensus        67 ~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~  139 (291)
T 1xbb_A           67 AEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFV  139 (291)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEE--SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCEEEEEEEEC--CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeE
Confidence            4667778889999999999984  56789999999999999999874  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc--cccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ--TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++..........  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.
T Consensus       140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~  219 (291)
T 1xbb_A          140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK  219 (291)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999987654332211  122345678999999988888999999999999999999 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||...........+.       .+.         ....+...+..+.+++..||+.||.+|||+.++++.|++..
T Consensus       220 p~~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          220 PYRGMKGSEVTAMLE-------KGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             SSTTCCHHHHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHH-------cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            998766544332221       111         11123345567899999999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.1e-35  Score=255.78  Aligned_cols=221  Identities=26%  Similarity=0.361  Sum_probs=170.6

Q ss_pred             ceEEEcccCCC-----hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           28 NQFIYHGFNED-----PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        28 ~~~~~~~~~~~-----~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      ..+++|.+...     ...+...++.++|+++++..++....++..++||||+++++|.+++.......+++..++.++.
T Consensus        45 ~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  124 (278)
T 1byg_A           45 NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL  124 (278)
T ss_dssp             EEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             CEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHH
Confidence            35566665432     2346677888899999999998776567899999999999999999865333489999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      |++.||.|||   ..+++|+||+|+||+++.++.++|+|||++......    .....++..|+|||.+.+..++.++|+
T Consensus       125 ~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di  197 (278)
T 1byg_A          125 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDV  197 (278)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCCCCCCchhcH
Confidence            9999999999   589999999999999999999999999998654322    123356788999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      ||||+++|+|++ |..||......+....+.       .+         .....+...+..+.++|..||+.||.+|||+
T Consensus       198 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  261 (278)
T 1byg_A          198 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KG---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF  261 (278)
T ss_dssp             HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cC---------CCCCCcccCCHHHHHHHHHHhcCChhhCCCH
Confidence            999999999998 999998765544332221       11         0111233445678999999999999999999


Q ss_pred             HHHHHHHhcc
Q 048068          262 RQVMQYLDGN  271 (313)
Q Consensus       262 ~ell~~L~~~  271 (313)
                      .++++.|+..
T Consensus       262 ~~l~~~L~~i  271 (278)
T 1byg_A          262 LQLREQLEHI  271 (278)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=262.68  Aligned_cols=215  Identities=20%  Similarity=0.284  Sum_probs=164.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..++... ++..++||||+++++|.+++... ...+++..++.++.||+.||.|||   ..++
T Consensus        77 ~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i  151 (319)
T 2y4i_B           77 KREVMAYRQTRHENVVLFMGACMS-PPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGI  151 (319)
T ss_dssp             CTTGGGGTTCCCTTBCCCCEEEEC-SSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHhcCCCCCEeEEEEEEec-CCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            456778888999999999999886 56799999999999999999865 346999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCC----CCCccccccccccccccccccC---------CCCCcchhhHHHH
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHD----TIPQTTKLVGTFGYMAPELMRT---------GKASTSTDVYAFG  186 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG  186 (313)
                      +|+||+|+||+++ ++.++|+|||++......    .........++..|+|||.+.+         ..++.++||||||
T Consensus       152 ~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG  230 (319)
T 2y4i_B          152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG  230 (319)
T ss_dssp             CCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH
T ss_pred             cccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH
Confidence            9999999999998 679999999987654321    1112233457899999999864         3468899999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      +++|+|++|..||.............       .+....        ......+..+.+++..||+.||.+|||+.++++
T Consensus       231 ~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          231 TIWYELHAREWPFKTQPAEAIIWQMG-------TGMKPN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHHHHHSSCSSSSCCHHHHHHHHH-------TTCCCC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHhc-------cCCCCC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999998766544332221       111000        011123345889999999999999999999999


Q ss_pred             HHhccCCCC
Q 048068          267 YLDGNATLP  275 (313)
Q Consensus       267 ~L~~~~~~~  275 (313)
                      .|+....-.
T Consensus       296 ~l~~l~~~~  304 (319)
T 2y4i_B          296 MLEKLPKRN  304 (319)
T ss_dssp             HHTTC----
T ss_pred             HHHHHHHhh
Confidence            999987543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.2e-35  Score=260.90  Aligned_cols=239  Identities=21%  Similarity=0.270  Sum_probs=177.2

Q ss_pred             cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           27 VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        27 ~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ...+++|.+...        ...|...++.++|+++++..+++.+. ...+++||||+++++|.+++...   .+++..+
T Consensus        60 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~  136 (318)
T 3lxp_A           60 GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQL  136 (318)
T ss_dssp             CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHH
T ss_pred             CcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHH
Confidence            345666666532        23566778889999999999998854 46889999999999999999865   3999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGK  175 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~  175 (313)
                      +.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++.........  ......++..|+|||.+.+..
T Consensus       137 ~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  213 (318)
T 3lxp_A          137 LLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK  213 (318)
T ss_dssp             HHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC
Confidence            999999999999999   589999999999999999999999999999766543221  123345678899999999888


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCC
Q 048068          176 ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKP  255 (313)
Q Consensus       176 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P  255 (313)
                      ++.++||||||+++|+|++|..||......... ..........................+...+..+.+||.+||+.||
T Consensus       214 ~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  292 (318)
T 3lxp_A          214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEA  292 (318)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCc
Confidence            899999999999999999999998754322110 0000000000000000000111112233455778999999999999


Q ss_pred             CCCCCHHHHHHHHhccC
Q 048068          256 EARPNMRQVMQYLDGNA  272 (313)
Q Consensus       256 ~~Rpt~~ell~~L~~~~  272 (313)
                      .+|||++++++.|+...
T Consensus       293 ~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          293 SFRPTFENLIPILKTVH  309 (318)
T ss_dssp             GGSCCHHHHHHHHHHHH
T ss_pred             ccCcCHHHHHHHHHHHH
Confidence            99999999999998753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-34  Score=252.82  Aligned_cols=208  Identities=21%  Similarity=0.321  Sum_probs=170.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+++.+ ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..++
T Consensus        62 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i  135 (284)
T 2vgo_A           62 RREIEIQSHLRHPNILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH---ERKV  135 (284)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTE
T ss_pred             HHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            356677888899999999999886 67899999999999999999864  35999999999999999999999   6899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++.......   .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       136 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  212 (284)
T 2vgo_A          136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF  212 (284)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecCCCHHHEEEcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999986544322   23456889999999999888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCC
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNAT  273 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~  273 (313)
                      ...........+.       ..          ....+...+..+.++|.+||+.||.+|||++++++|  +.....
T Consensus       213 ~~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          213 DSPSHTETHRRIV-------NV----------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             CCSSHHHHHHHHH-------TT----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             CCCCHhHHHHHHh-------cc----------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            8765544332221       00          011223345678899999999999999999999984  444443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-35  Score=262.22  Aligned_cols=217  Identities=18%  Similarity=0.159  Sum_probs=165.0

Q ss_pred             hhhhhccccceeeeeeEEecc---CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           44 DGLASVHSNGLLQLTNTVNSR---KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        44 ~~l~~~~~~~~l~~~~~~~~~---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      ..++.+.|+++++.+++....   +...++||||+ +++|.+++....  .+++..++.++.||+.||.|||   ..+++
T Consensus       100 ~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~iv  173 (345)
T 2v62_A          100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYV  173 (345)
T ss_dssp             HHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            344566899999999988752   56899999999 999999998643  6999999999999999999999   48999


Q ss_pred             ecCcCCCcEEEcCCC--cEEEeecccccccCCCC------CCccccccccccccccccccCCCCCcchhhHHHHHHHHHH
Q 048068          121 HRDIKPANVLLDADL--NGKLGDFGLARLYDHDT------IPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       121 H~dl~~~nIlv~~~~--~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  192 (313)
                      |+||||+||+++.++  .++|+|||++.......      ........++..|+|||.+.+..++.++|||||||++|+|
T Consensus       174 H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  253 (345)
T 2v62_A          174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW  253 (345)
T ss_dssp             CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence            999999999999877  99999999997553211      1112345789999999999988899999999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ++|+.||............  ........ .........   .....+..+.++|..||+.||++|||++++++.|++..
T Consensus       254 l~g~~pf~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          254 LCGKLPWEQNLKDPVAVQT--AKTNLLDE-LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHSSCTTGGGTTCHHHHHH--HHHHHHHT-TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HhCCCCccccccccHHHHH--HHHhhccc-ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            9999999653322211111  00100000 000000000   00134457899999999999999999999999998865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.5e-35  Score=259.23  Aligned_cols=227  Identities=22%  Similarity=0.290  Sum_probs=175.4

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC---------
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK---------   89 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------   89 (313)
                      ..+++|.+...        ...+...++.+ +|++++++.+++...++.+++||||+++++|.+++.....         
T Consensus        58 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  137 (316)
T 2xir_A           58 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP  137 (316)
T ss_dssp             EEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC----
T ss_pred             eEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccc
Confidence            35566665432        12344555666 6899999999988767779999999999999999986532         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Cccccccccc
Q 048068           90 -----PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTF  163 (313)
Q Consensus        90 -----~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~  163 (313)
                           ..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........ .......+++
T Consensus       138 ~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~  214 (316)
T 2xir_A          138 EDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  214 (316)
T ss_dssp             ---CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred             hhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcce
Confidence                 12899999999999999999999   58999999999999999999999999999975543221 1223445688


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          164 GYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       164 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      .|+|||.+.+..++.++||||||+++|+|++ |..||.+..........      ...+.         ....+...+..
T Consensus       215 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~------~~~~~---------~~~~~~~~~~~  279 (316)
T 2xir_A          215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------LKEGT---------RMRAPDYTTPE  279 (316)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH------HHHTC---------CCCCCTTCCHH
T ss_pred             eecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH------hccCc---------cCCCCCCCCHH
Confidence            8999999988889999999999999999998 99999876543322111      01111         01122234567


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +.+++..||+.||.+|||+.+++++|+...
T Consensus       280 l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          280 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            889999999999999999999999998753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.8e-35  Score=263.40  Aligned_cols=249  Identities=21%  Similarity=0.297  Sum_probs=179.3

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      .++.|.+..++...+   ...++.|.+...         ...+...++.++|+++++..+++.. ++..++||||+++++
T Consensus        32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~  110 (331)
T 4aaa_A           32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLVFEFVDHTI  110 (331)
T ss_dssp             EGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCSEEH
T ss_pred             EEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEEEecCCcch
Confidence            445566655665544   345666665321         1246677888999999999999886 678999999999988


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      |.+++...  ..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........ .....
T Consensus       111 l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  184 (331)
T 4aaa_A          111 LDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDE  184 (331)
T ss_dssp             HHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------C
T ss_pred             HHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccCCC
Confidence            88887653  35999999999999999999999   58999999999999999999999999999875443221 22345


Q ss_pred             cccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHH--------Hhhhhc------ccc
Q 048068          160 VGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS--------DCWKKG------AIL  224 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~------~~~  224 (313)
                      .++..|+|||.+.+. .++.++|||||||++|+|++|..||.+....+....+....        ..+...      ...
T Consensus       185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (331)
T 4aaa_A          185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP  264 (331)
T ss_dssp             CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCC
T ss_pred             cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCc
Confidence            678999999999865 67999999999999999999999998877655443332110        001110      000


Q ss_pred             ccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...............++.+.+||.+||+.||.+|||+.|+++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0011111111112345779999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-34  Score=261.75  Aligned_cols=251  Identities=20%  Similarity=0.224  Sum_probs=180.1

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEecc-------CCeEEEEEec
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSR-------KGEFLLVYDY   74 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~-------~~~~~lV~e~   74 (313)
                      +.|.+..++...+   ...++.|.+..         ....+...++.++|+++++..+++...       ++.+++||||
T Consensus        26 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~  105 (351)
T 3mi9_A           26 GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF  105 (351)
T ss_dssp             SSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEEC
T ss_pred             ecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEec
Confidence            3344444444433   34666665522         122577888999999999999988743       4578999999


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-  153 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-  153 (313)
                      ++ ++|.+.+... ...+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........ 
T Consensus       106 ~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  180 (351)
T 3mi9_A          106 CE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS  180 (351)
T ss_dssp             CS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSS
T ss_pred             cC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccc
Confidence            96 4888887654 346999999999999999999999   58999999999999999999999999999976542211 


Q ss_pred             --CccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccccc--
Q 048068          154 --PQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD--  228 (313)
Q Consensus       154 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  228 (313)
                        .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.................  
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (351)
T 3mi9_A          181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE  260 (351)
T ss_dssp             SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred             cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence              12234567999999999876 4579999999999999999999999998776655544432211111110000000  


Q ss_pred             ------c--cccCCccHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          229 ------S--RLEGIYEEE-----QMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       229 ------~--~~~~~~~~~-----~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                            .  .........     ..+.+.+||.+||+.||++|||++|+++|-.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence                  0  000000001     1356889999999999999999999999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.4e-35  Score=267.86  Aligned_cols=248  Identities=19%  Similarity=0.188  Sum_probs=176.5

Q ss_pred             HHHHHHHHhhcccc--ceEEEcccC---CChhhHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHH
Q 048068           14 LCVSFILSALAQDV--NQFIYHGFN---EDPQLQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        14 ~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~   83 (313)
                      +.|.+..++.+++.  ..++.+++.   .....|.+.++.++|+|++++.+++...     ...+++||||+++ ++...
T Consensus        49 G~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~  127 (394)
T 4e7w_A           49 GNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRA  127 (394)
T ss_dssp             EEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHH
T ss_pred             eeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHH
Confidence            34444444444432  234444442   2334688899999999999999988632     2247899999976 44444


Q ss_pred             Hhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc-CCCcEEEeecccccccCCCCCCcccccc
Q 048068           84 LHT--NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        84 l~~--~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      +..  .....+++..++.++.||+.||.|||   ..+|+||||||+||+++ .++.++|+|||++.......  ......
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~--~~~~~~  202 (394)
T 4e7w_A          128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYI  202 (394)
T ss_dssp             HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSSC
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--CCcccc
Confidence            331  22457999999999999999999999   58999999999999999 78999999999997653332  233457


Q ss_pred             ccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhh------------hhccccccc
Q 048068          161 GTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCW------------KKGAILDAS  227 (313)
Q Consensus       161 ~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~  227 (313)
                      +++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+....+....+.......            .........
T Consensus       203 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~  282 (394)
T 4e7w_A          203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIR  282 (394)
T ss_dssp             SCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCC
T ss_pred             cCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhcccccc
Confidence            79999999998764 58999999999999999999999999877665444332211100            000000001


Q ss_pred             cccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          228 DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       228 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ........+...++.+.+||.+||+.||.+|||+.|+++|
T Consensus       283 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          283 PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            1111111222345688999999999999999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.2e-35  Score=253.44  Aligned_cols=206  Identities=23%  Similarity=0.353  Sum_probs=147.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++..+++.+ ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||   ..++
T Consensus        59 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i  133 (278)
T 3cok_A           59 QNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGI  133 (278)
T ss_dssp             HHHHHHHTTBCCTTBCCEEEEEEC-SSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCeEeEEEEEcc-CCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            356677888899999999999887 67899999999999999999865 356999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||
T Consensus       134 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  212 (278)
T 3cok_A          134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF  212 (278)
T ss_dssp             ECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSS
T ss_pred             ecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999876543221 122356789999999998888899999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ............          ..   ...    ..+...+..+.++|.+||+.||++|||++++++|-
T Consensus       213 ~~~~~~~~~~~~----------~~---~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          213 DTDTVKNTLNKV----------VL---ADY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             CCCSCC-----C----------CS---SCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             CChhHHHHHHHH----------hh---ccc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence            865543321110          00   000    12223456788999999999999999999999863

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-34  Score=276.89  Aligned_cols=238  Identities=22%  Similarity=0.290  Sum_probs=182.7

Q ss_pred             hHHHHHHHHhhccc-----cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           13 LLCVSFILSALAQD-----VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        13 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      ++.|.+..++.+..     ...+++|.+...        ...|.+.++.++|++++++++++..  +.+++||||+++|+
T Consensus       344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTCB
T ss_pred             EecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCCc
Confidence            44555555554322     234666666431        2356678888999999999999875  46999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTT  157 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~  157 (313)
                      |.+++... ...+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||++.........  ...
T Consensus       422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            99999765 456999999999999999999999   589999999999999999999999999999765432211  112


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCcc
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE  236 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (313)
                      ...++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.       .+.         ....+
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~---------~~~~p  561 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGK---------RMECP  561 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------TTC---------CCCCC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC---------CCCCC
Confidence            2334678999999998899999999999999999998 999999877665443331       111         11123


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       237 ~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ..++..+.+||..||+.||++|||+.++++.|++..
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            345678899999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.8e-35  Score=260.48  Aligned_cols=212  Identities=22%  Similarity=0.330  Sum_probs=168.5

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHH
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI------------KPSLSWYQRFRIIRGVASG  107 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~a  107 (313)
                      .+...++.+ .|++++++.+++.. ++..++||||+++|+|.+++....            ...+++..++.++.||+.|
T Consensus        98 ~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  176 (333)
T 2i1m_A           98 SELKIMSHLGQHENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG  176 (333)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCeeeEEEEEec-CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHH
Confidence            556677777 89999999999876 568999999999999999997531            2458999999999999999


Q ss_pred             HHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHH
Q 048068          108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFG  186 (313)
Q Consensus       108 l~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  186 (313)
                      |.|||   ..+++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||
T Consensus       177 l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  253 (333)
T 2i1m_A          177 MAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG  253 (333)
T ss_dssp             HHHHH---HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHh---cCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHH
Confidence            99999   48999999999999999999999999999875433221 112334567789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          187 VFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       187 ~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      +++|+|++ |..||.+..........  ..    .+.         ....+...+..+.+++..||+.||.+|||+.+++
T Consensus       254 ~il~el~t~g~~p~~~~~~~~~~~~~--~~----~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  318 (333)
T 2i1m_A          254 ILLWEIFSLGLNPYPGILVNSKFYKL--VK----DGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC  318 (333)
T ss_dssp             HHHHHHTTTSCCSSTTCCSSHHHHHH--HH----HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHcCCCCCCcccchhHHHHHH--Hh----cCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            99999998 99999876544322211  11    110         0111222346788999999999999999999999


Q ss_pred             HHHhcc
Q 048068          266 QYLDGN  271 (313)
Q Consensus       266 ~~L~~~  271 (313)
                      ++|++.
T Consensus       319 ~~L~~~  324 (333)
T 2i1m_A          319 SFLQEQ  324 (333)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999865

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-34  Score=263.59  Aligned_cols=198  Identities=23%  Similarity=0.282  Sum_probs=163.2

Q ss_pred             hhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcC
Q 048068           46 LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~  125 (313)
                      ++.++|++++++++.+.. .+.+|+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||   ..+|+|||||
T Consensus        93 l~~~~hp~Iv~l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlk  166 (373)
T 2r5t_A           93 LKNVKHPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLK  166 (373)
T ss_dssp             BCCCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred             HHhCCCCCCCCEEEEEEe-CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCC
Confidence            567899999999999887 67999999999999999999864  35999999999999999999999   5899999999


Q ss_pred             CCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCch
Q 048068          126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM  205 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  205 (313)
                      |+||+++.+|.++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..
T Consensus       167 p~NIll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~  245 (373)
T 2r5t_A          167 PENILLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA  245 (373)
T ss_dssp             GGGEEECTTSCEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH
T ss_pred             HHHEEECCCCCEEEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence            999999999999999999987533222 2334567899999999999889999999999999999999999999876655


Q ss_pred             hhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Q 048068          206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM----RQVMQY  267 (313)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~----~ell~~  267 (313)
                      +....+.      ..           ....+...+..+.+||.+||+.||.+||++    .++++|
T Consensus       246 ~~~~~i~------~~-----------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          246 EMYDNIL------NK-----------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             HHHHHHH------HS-----------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             HHHHHHH------hc-----------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            4443331      00           001222345678899999999999999987    466654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4e-34  Score=249.24  Aligned_cols=207  Identities=22%  Similarity=0.278  Sum_probs=167.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|.+.++.++|+++++..+++.. ++..++||||+++++|.+++...  ..+++..++.++.|++.||.|||   ..++
T Consensus        54 ~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i  127 (277)
T 3f3z_A           54 KQEIEIMKSLDHPNIIRLYETFED-NTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH---KLNV  127 (277)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            357778889999999999999886 67899999999999999998764  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEE---cCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +|+||+|+||++   +.++.++|+|||++.......  ......+++.|+|||.+.+ .++.++||||||+++|+|++|.
T Consensus       128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~  204 (277)
T 3f3z_A          128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGY  204 (277)
T ss_dssp             ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCC
Confidence            999999999999   778899999999987654332  2334568999999999875 4899999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .||......+....+.       .+..      ..+.......++.+.+++..||+.||.+|||+.++++|-
T Consensus       205 ~p~~~~~~~~~~~~~~-------~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  263 (277)
T 3f3z_A          205 PPFSAPTDSEVMLKIR-------EGTF------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE  263 (277)
T ss_dssp             CSSCCSSHHHHHHHHH-------HCCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             CCCCCCCHHHHHHHHH-------hCCC------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            9998766554333221       1100      000000112356789999999999999999999999853

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=254.02  Aligned_cols=224  Identities=23%  Similarity=0.366  Sum_probs=167.1

Q ss_pred             ceEEEcccCCC-----hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC-CCCCHHHHHHHH
Q 048068           28 NQFIYHGFNED-----PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK-PSLSWYQRFRII  101 (313)
Q Consensus        28 ~~~~~~~~~~~-----~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~  101 (313)
                      ..+++|.+...     ...+...++.++|+|+++++++..+   ..++||||+++++|.+++..... ..++...++.++
T Consensus        32 ~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  108 (307)
T 2eva_A           32 KDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC  108 (307)
T ss_dssp             EEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHH
T ss_pred             eeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHH
Confidence            34566666432     2245667788899999999887753   47999999999999999986532 347899999999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc-EEEeecccccccCCCCCCccccccccccccccccccCCCCCcch
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN-GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTST  180 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  180 (313)
                      .|++.||.|||+....+++|+||||+||+++.++. ++|+|||++......    .....+++.|+|||.+.+..++.++
T Consensus       109 ~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~  184 (307)
T 2eva_A          109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKC  184 (307)
T ss_dssp             HHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHH
T ss_pred             HHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHH
Confidence            99999999999422279999999999999998876 799999998654322    2234689999999999988999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       181 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      ||||||+++|+|++|+.||.............    . ..+.         ........+..+.+++.+||+.||.+|||
T Consensus       185 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps  250 (307)
T 2eva_A          185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----V-HNGT---------RPPLIKNLPKPIESLMTRCWSKDPSQRPS  250 (307)
T ss_dssp             HHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH----H-HTTC---------CCCCBTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHHHHHCCCCchhhCccHHHHHHH----H-hcCC---------CCCcccccCHHHHHHHHHHhcCChhhCcC
Confidence            99999999999999999997654332111110    0 0110         01122234567889999999999999999


Q ss_pred             HHHHHHHHhccC
Q 048068          261 MRQVMQYLDGNA  272 (313)
Q Consensus       261 ~~ell~~L~~~~  272 (313)
                      +++++++|+...
T Consensus       251 ~~ell~~L~~~~  262 (307)
T 2eva_A          251 MEEIVKIMTHLM  262 (307)
T ss_dssp             HHHHHHHHHHHG
T ss_pred             HHHHHHHHHHHH
Confidence            999999998765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=255.65  Aligned_cols=235  Identities=21%  Similarity=0.265  Sum_probs=179.1

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHh
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH   85 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~   85 (313)
                      +.|.+..++...+   ...++.|.+..     ....+...++.+.|++++++++++.. ++..++||||+++++|.+++.
T Consensus        38 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~  116 (314)
T 3com_A           38 GEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIIR  116 (314)
T ss_dssp             C----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEHHHHHH
T ss_pred             ccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEeecCCCCCHHHHHH
Confidence            3344444444332   34566665532     23456778888999999999998876 678999999999999999997


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccc
Q 048068           86 TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY  165 (313)
Q Consensus        86 ~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y  165 (313)
                      .. ...+++..++.++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++....... .......++..|
T Consensus       117 ~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y  191 (314)
T 3com_A          117 LR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFW  191 (314)
T ss_dssp             HH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCCCSCGGG
T ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCccCCCCCc
Confidence            43 346999999999999999999999   5899999999999999999999999999987654332 123345688999


Q ss_pred             cccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHH
Q 048068          166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLK  245 (313)
Q Consensus       166 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  245 (313)
                      +|||.+.+..++.++||||||+++|+|++|..||.............       ....       .....+...+..+.+
T Consensus       192 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~~~~l~~  257 (314)
T 3com_A          192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-------TNPP-------PTFRKPELWSDNFTD  257 (314)
T ss_dssp             CCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HSCC-------CCCSSGGGSCHHHHH
T ss_pred             cChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-------cCCC-------cccCCcccCCHHHHH
Confidence            99999998889999999999999999999999998665443222111       0000       001122234567899


Q ss_pred             HHHHcCCCCCCCCCCHHHHHHHH
Q 048068          246 LGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       246 li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +|.+||+.||.+|||+.++++|-
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             HHHHHccCChhhCcCHHHHHhCH
Confidence            99999999999999999999854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-34  Score=257.44  Aligned_cols=221  Identities=20%  Similarity=0.265  Sum_probs=162.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|++++++.+++.. ++.+++||||++ ++|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        81 ~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH---~~~i  153 (329)
T 3gbz_A           81 IREVSLLKELQHRNIIELKSVIHH-NHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCH---SRRC  153 (329)
T ss_dssp             HHHHHHGGGCCCTTBCCEEEEEEE-TTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHHcCCCCcceEEEEEec-CCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence            357788899999999999999886 678999999996 5999999875  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEc-----CCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHH
Q 048068          120 LHRDIKPANVLLD-----ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       120 ~H~dl~~~nIlv~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll  193 (313)
                      +|+||||+||+++     .++.++|+|||++........ ......++..|+|||.+.+. .++.++|||||||++|+|+
T Consensus       154 vH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  232 (329)
T 3gbz_A          154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML  232 (329)
T ss_dssp             CCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999994     455699999999976543321 22344679999999999864 4799999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccc-------------cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAI-------------LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      +|..||.+....+....+............             ................++.+.+||.+||+.||.+|||
T Consensus       233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  312 (329)
T 3gbz_A          233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS  312 (329)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence            999999887665544333211111000000             0000000011111124467889999999999999999


Q ss_pred             HHHHHHHH
Q 048068          261 MRQVMQYL  268 (313)
Q Consensus       261 ~~ell~~L  268 (313)
                      ++|+++|-
T Consensus       313 ~~e~l~hp  320 (329)
T 3gbz_A          313 AKNALEHP  320 (329)
T ss_dssp             HHHHHTSG
T ss_pred             HHHHhCCc
Confidence            99999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5e-34  Score=250.42  Aligned_cols=205  Identities=24%  Similarity=0.380  Sum_probs=163.1

Q ss_pred             hHHhhhhhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      .+...++.++|+++++.++++..   .+..+++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..
T Consensus        74 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~  148 (290)
T 1t4h_A           74 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TR  148 (290)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TS
T ss_pred             HHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cC
Confidence            46677888899999999988763   356789999999999999999863  35999999999999999999999   57


Q ss_pred             C--ceecCcCCCcEEEc-CCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh
Q 048068          118 V--VLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       118 ~--i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  194 (313)
                      +  ++|+||+|+||+++ .++.++|+|||++......   ......+++.|+|||.+. +.++.++||||||+++|+|++
T Consensus       149 ~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~  224 (290)
T 1t4h_A          149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT  224 (290)
T ss_dssp             SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHh
Confidence            7  99999999999997 7889999999998654332   233456899999999887 458999999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |..||............      ...+.        .+...+...++.+.++|..||+.||.+|||++++++|-
T Consensus       225 g~~pf~~~~~~~~~~~~------~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  284 (290)
T 1t4h_A          225 SEYPYSECQNAAQIYRR------VTSGV--------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             SSCTTTTCSSHHHHHHH------HTTTC--------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCCCcCcHHHHHHH------HhccC--------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence            99999875543322111      01110        01111222335689999999999999999999999863

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-34  Score=249.95  Aligned_cols=207  Identities=21%  Similarity=0.301  Sum_probs=167.4

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.. ++..++||||+++++|.+.+...  ..+++..++.++.|++.||.|||   ..+++
T Consensus        54 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  127 (284)
T 3kk8_A           54 REARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIV  127 (284)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHHcCCCCcCeEEEEEEc-CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcC
Confidence            46677888899999999999876 67889999999999999988764  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCc---EEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDADLN---GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.++.   ++|+|||++.......  ......+++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus       128 H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  205 (284)
T 3kk8_A          128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  205 (284)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCC
Confidence            9999999999986655   9999999997654332  2234578999999999998889999999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ||.+.........+.       .+..      ..+.......++.+.+++..||+.||++|||++|+++|-
T Consensus       206 pf~~~~~~~~~~~~~-------~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          206 PFWDEDQHRLYAQIK-------AGAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  263 (284)
T ss_dssp             SSCCSSHHHHHHHHH-------HTCC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred             CCCCCchhHHHHHHH-------hccc------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence            998766554433221       1100      001111123346788999999999999999999999963

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-34  Score=271.24  Aligned_cols=231  Identities=16%  Similarity=0.170  Sum_probs=177.8

Q ss_pred             cceEEEccc-----CCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 048068           27 VNQFIYHGF-----NEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII  101 (313)
Q Consensus        27 ~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  101 (313)
                      ...+++|..     ......|...++.+.|.+.+.....+...++..++||||+ +++|.+++... ...+++..++.++
T Consensus        32 ~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~  109 (483)
T 3sv0_A           32 NEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLA  109 (483)
T ss_dssp             CCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHH
T ss_pred             CcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHH
Confidence            345555533     2345567788888888777766666666678999999999 99999999864 3469999999999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEE---cCCCcEEEeecccccccCCCCCC------cccccccccccccccccc
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIP------QTTKLVGTFGYMAPELMR  172 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv---~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~  172 (313)
                      .||+.||.|||   ..+|+|+||||+|||+   +.++.++|+|||++.........      ......|+..|++||.+.
T Consensus       110 ~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  186 (483)
T 3sv0_A          110 DQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL  186 (483)
T ss_dssp             HHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc
Confidence            99999999999   5899999999999999   58889999999999765443211      122567899999999999


Q ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCC
Q 048068          173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSH  252 (313)
Q Consensus       173 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  252 (313)
                      +..++.++|||||||++|+|++|+.||.+............+.........         ......++..+.+||..||+
T Consensus       187 ~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~---------~~l~~~~p~~l~~li~~cl~  257 (483)
T 3sv0_A          187 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI---------EALCRGYPTEFASYFHYCRS  257 (483)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH---------HHHHTTSCHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH---------HHHhcCCcHHHHHHHHHHhc
Confidence            999999999999999999999999999886654433333222111111000         00112234678999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcc
Q 048068          253 PKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       253 ~~P~~Rpt~~ell~~L~~~  271 (313)
                      .||++||++++|++.|++.
T Consensus       258 ~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          258 LRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CCTTCCCCHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999988765

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-34  Score=251.30  Aligned_cols=207  Identities=24%  Similarity=0.341  Sum_probs=160.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ..|.+.++.++|+++++..+++.. .+..++||||+++++|.+++...  ....+++..++.++.||+.||.|||   ..
T Consensus        68 ~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~  143 (285)
T 3is5_A           68 EAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQ  143 (285)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             HHHHHHHHhCCCchHHhHHHheec-CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            456778899999999999999886 67899999999999999998642  2356999999999999999999999   58


Q ss_pred             CceecCcCCCcEEE---cCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh
Q 048068          118 VVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       118 ~i~H~dl~~~nIlv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  194 (313)
                      +++|+||||+||++   +.++.++|+|||++.......  ......+++.|+|||.+. ..++.++||||||+++|+|++
T Consensus       144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~  220 (285)
T 3is5_A          144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT  220 (285)
T ss_dssp             TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh
Confidence            99999999999999   445789999999997554322  233456899999999886 568899999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |+.||.+............      ....       ... .....++.+.+|+.+||+.||++|||+.|+++|
T Consensus       221 g~~pf~~~~~~~~~~~~~~------~~~~-------~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          221 GCLPFTGTSLEEVQQKATY------KEPN-------YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             SSCSSCCSSHHHHHHHHHH------CCCC-------CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCHHHHHhhhcc------CCcc-------ccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999987665443322211      0000       000 001134567899999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-34  Score=268.30  Aligned_cols=252  Identities=19%  Similarity=0.201  Sum_probs=169.0

Q ss_pred             hhhHHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEec----cCCeEEEEEec
Q 048068           11 CVLLCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNS----RKGEFLLVYDY   74 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~----~~~~~~lV~e~   74 (313)
                      .+++.|.+..++...+   ...+++|.+..         ....|...++.++|++++++++++..    ....+|+||||
T Consensus        59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  138 (458)
T 3rp9_A           59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI  138 (458)
T ss_dssp             CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred             eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence            4566777777776644   34667776543         12246677888899999999999863    23579999999


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-  153 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-  153 (313)
                      + +++|.+++...  ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||++........ 
T Consensus       139 ~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  212 (458)
T 3rp9_A          139 A-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG  212 (458)
T ss_dssp             C-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTC
T ss_pred             c-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccCcccc
Confidence            8 67999999764  46999999999999999999999   48999999999999999999999999999976532211 


Q ss_pred             -------------------------Cccccccccccccccccc-cCCCCCcchhhHHHHHHHHHHHh-----------CC
Q 048068          154 -------------------------PQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGVFMLEVAS-----------GR  196 (313)
Q Consensus       154 -------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~-----------g~  196 (313)
                                               .......||+.|+|||++ .+..++.++|||||||++|||++           |.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~  292 (458)
T 3rp9_A          213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG  292 (458)
T ss_dssp             CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCC
T ss_pred             ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccc
Confidence                                     112345679999999986 45678999999999999999998           66


Q ss_pred             CCCccCCch--------------------hhhhHHHHHHHhhhhc--------------cccccccccccCCccHHHHHH
Q 048068          197 RPIEQQGSM--------------------EMVNLVDWVSDCWKKG--------------AILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       197 ~pf~~~~~~--------------------~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      ++|.+....                    +....+..+.......              ..................+..
T Consensus       293 p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  372 (458)
T 3rp9_A          293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD  372 (458)
T ss_dssp             CSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHH
T ss_pred             ccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHH
Confidence            777554310                    1111110000000000              000000000001111233567


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +.+||.+||..||++|||++|+++|-
T Consensus       373 ~~dLl~~mL~~dP~~R~t~~e~L~Hp  398 (458)
T 3rp9_A          373 AIHLLKRMLVFNPNKRITINECLAHP  398 (458)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHHHHHhccCccccCCHHHHhcCH
Confidence            88999999999999999999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-34  Score=257.17  Aligned_cols=226  Identities=20%  Similarity=0.373  Sum_probs=177.1

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------CCC
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------KPS   91 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------~~~   91 (313)
                      ..++.|.+...        ...+...++.+.|+++++..+++.. ++..++||||+++++|.+++....        ...
T Consensus        56 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  134 (322)
T 1p4o_A           56 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP  134 (322)
T ss_dssp             EEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCC
T ss_pred             eEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCC
Confidence            34566665432        2246677888899999999999876 568899999999999999997521        145


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccccccccccc
Q 048068           92 LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPEL  170 (313)
Q Consensus        92 ~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~  170 (313)
                      +++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.
T Consensus       135 ~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          135 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            799999999999999999999   58999999999999999999999999999865432211 11223356788999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHH
Q 048068          171 MRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF  249 (313)
Q Consensus       171 ~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  249 (313)
                      +.+..++.++||||||+++|+|++ |..||.+.........+.       .+..         ...+...+..+.+++..
T Consensus       212 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~l~~li~~  275 (322)
T 1p4o_A          212 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------EGGL---------LDKPDNCPDMLFELMRM  275 (322)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-------TTCC---------CCCCTTCCHHHHHHHHH
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-------cCCc---------CCCCCCCCHHHHHHHHH
Confidence            988889999999999999999999 899998765544332221       1110         01223345678899999


Q ss_pred             cCCCCCCCCCCHHHHHHHHhccCC
Q 048068          250 CSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       250 cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      ||+.||.+|||+.+++++|+....
T Consensus       276 ~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          276 CWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HcCCCcccCcCHHHHHHHHHHhhc
Confidence            999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=258.73  Aligned_cols=199  Identities=22%  Similarity=0.284  Sum_probs=165.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG-SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..+...++.++|+++++..+++.. ++.+++||||+.+| +|.+++...  ..+++..++.++.||+.||.|||   ..+
T Consensus        77 ~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~  150 (335)
T 3dls_A           77 TLEIAILSRVEHANIIKVLDIFEN-QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLR---LKD  150 (335)
T ss_dssp             EHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEee-CCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            347788899999999999999876 67899999999666 999999874  35999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~  197 (313)
                      ++|+||||+||+++.++.++|+|||++.......  ......|++.|+|||.+.+..+ +.++|||||||++|+|++|..
T Consensus       151 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  228 (335)
T 3dls_A          151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN  228 (335)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred             eEEeccCHHHEEEcCCCcEEEeecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence            9999999999999999999999999997654432  2334568999999999987776 789999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ||........            .           ....+...+..+.+||..||+.||++|||++++++|-.
T Consensus       229 pf~~~~~~~~------------~-----------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          229 PFCELEETVE------------A-----------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             SCSSGGGGTT------------T-----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             chhhHHHHHh------------h-----------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            9975322110            0           00011123456889999999999999999999999854

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-34  Score=267.26  Aligned_cols=260  Identities=15%  Similarity=0.173  Sum_probs=182.7

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCChh------hHHhhhhhc------cccceeeeeeEEeccCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNEDPQ------LQRDGLASV------HSNGLLQLTNTVNSRKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~l~~~------~~~~~l~~~~~~~~~~~~~~lV~e~~~   76 (313)
                      +++.|.+..++...+   ...+++|.+.....      .+...++.+      .|+++++..+.+.. .+++++||||+ 
T Consensus       104 ~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e~~-  181 (429)
T 3kvw_A          104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RNHICMTFELL-  181 (429)
T ss_dssp             EEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TTEEEEEECCC-
T ss_pred             EcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CCeEEEEEecc-
Confidence            344555555555533   34677777765432      344455555      56688888888776 67899999999 


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc--EEEeecccccccCCCCCC
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN--GKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~--~~l~dfg~~~~~~~~~~~  154 (313)
                      +++|.+++.......+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.  ++|+|||++......   
T Consensus       182 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~---  255 (429)
T 3kvw_A          182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---  255 (429)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC---
T ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc---
Confidence            469999998775567999999999999999999999   489999999999999999887  999999998654332   


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhhc-----ccc
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKKG-----AIL  224 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~-----~~~  224 (313)
                       .....+++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+......     +...     ...
T Consensus       256 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~  334 (429)
T 3kvw_A          256 -VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS  334 (429)
T ss_dssp             -CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBC
T ss_pred             -ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccC
Confidence             23457899999999999888999999999999999999999999887766544433211100     0000     000


Q ss_pred             c----------------------------cccccccC----CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          225 D----------------------------ASDSRLEG----IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       225 ~----------------------------~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .                            ...+....    .........+.+||.+||+.||++|||++|+++|-.=..
T Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~  414 (429)
T 3kvw_A          335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR  414 (429)
T ss_dssp             TTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred             CCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhcc
Confidence            0                            00000000    001112466889999999999999999999999866555


Q ss_pred             CCCCCCCC
Q 048068          273 TLPDIPRD  280 (313)
Q Consensus       273 ~~~~~~~~  280 (313)
                      ..+.+|..
T Consensus       415 ~~~~~~~~  422 (429)
T 3kvw_A          415 RLPKPPTG  422 (429)
T ss_dssp             --------
T ss_pred             CCCCCCcc
Confidence            45555443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-35  Score=264.17  Aligned_cols=238  Identities=21%  Similarity=0.272  Sum_probs=158.6

Q ss_pred             HHHHHHHhhccc---cceEEEcccCC-C------hhhHHhhhhhcc-ccceeeeeeEEe-------ccCCeEEEEEecCC
Q 048068           15 CVSFILSALAQD---VNQFIYHGFNE-D------PQLQRDGLASVH-SNGLLQLTNTVN-------SRKGEFLLVYDYMP   76 (313)
Q Consensus        15 ~~~~~~~~~~~~---~~~~~~~~~~~-~------~~~~~~~l~~~~-~~~~l~~~~~~~-------~~~~~~~lV~e~~~   76 (313)
                      .|.+..+|..++   ...+++|.+.. .      ...+...++.+. |++++++++++.       .....+++||||+ 
T Consensus        38 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-  116 (337)
T 3ll6_A           38 EGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-  116 (337)
T ss_dssp             CCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-
T ss_pred             cCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-
Confidence            344444444443   34567766522 1      223445566664 999999998884       3355789999999 


Q ss_pred             CCCHHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--ceecCcCCCcEEEcCCCcEEEeecccccccCCCCC
Q 048068           77 NGSLDKILHT-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI  153 (313)
Q Consensus        77 ~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~--i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~  153 (313)
                      +|+|.+++.. .....+++..++.++.||+.||.|||   ..+  ++|+||||+||+++.++.++|+|||++........
T Consensus       117 ~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  193 (337)
T 3ll6_A          117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD  193 (337)
T ss_dssp             SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-
T ss_pred             CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCc
Confidence            4799998865 22456999999999999999999999   578  99999999999999999999999999976543221


Q ss_pred             C-----------ccccccccccccccccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhh
Q 048068          154 P-----------QTTKLVGTFGYMAPELM---RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK  219 (313)
Q Consensus       154 ~-----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  219 (313)
                      .           ......+++.|+|||.+   .+..++.++||||||+++|+|++|+.||..........      ... 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~~~-  266 (337)
T 3ll6_A          194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN------GKY-  266 (337)
T ss_dssp             ------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------C-
T ss_pred             ccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc------Ccc-
Confidence            1           11134588999999998   45678899999999999999999999997544322110      000 


Q ss_pred             hccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCCC
Q 048068          220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLP  275 (313)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~~  275 (313)
                              ...    ........+.+||..||+.||.+|||+.|++++|+......
T Consensus       267 --------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          267 --------SIP----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             --------CCC----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --------cCC----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                    000    11112234788999999999999999999999998876433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.2e-35  Score=269.16  Aligned_cols=249  Identities=19%  Similarity=0.177  Sum_probs=177.7

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC---ChhhHHhhhhhccccceeeeeeEEec-----cCCeEEEEEecCCCCCHHH
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE---DPQLQRDGLASVHSNGLLQLTNTVNS-----RKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~~~~~~~l~~~~~~~~-----~~~~~~lV~e~~~~g~L~~   82 (313)
                      +.|.+..++...+   ...+++|.+..   ....|.+.++.++|+|++++.+++..     ....+++||||+++ +|.+
T Consensus        63 G~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  141 (420)
T 1j1b_A           63 GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYR  141 (420)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHH
T ss_pred             eeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHH
Confidence            3444444444443   34566666543   33468889999999999999888752     12346799999965 7777


Q ss_pred             HHhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-CcEEEeecccccccCCCCCCccccc
Q 048068           83 ILHT--NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        83 ~l~~--~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      .+..  .....+++..++.++.||+.||.|||   ..+|+||||||+||+++.+ +.+||+|||++.......  .....
T Consensus       142 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~  216 (420)
T 1j1b_A          142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSY  216 (420)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSC
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC--Cceee
Confidence            6653  22457999999999999999999999   6999999999999999955 678999999997654322  23345


Q ss_pred             cccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHH-----hhhhc--cccccccccc
Q 048068          160 VGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSD-----CWKKG--AILDASDSRL  231 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~  231 (313)
                      .+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.....     .+...  .......+..
T Consensus       217 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~  296 (420)
T 1j1b_A          217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI  296 (420)
T ss_dssp             CSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCC
T ss_pred             eeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCcc
Confidence            789999999998764 789999999999999999999999998766554433322110     01100  0000000000


Q ss_pred             -----cCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          232 -----EGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       232 -----~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                           ...++...+..+.+||.+||..||.+|||+.|+++|-
T Consensus       297 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence                 0012223456789999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.4e-34  Score=273.27  Aligned_cols=209  Identities=25%  Similarity=0.322  Sum_probs=171.1

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|.+.++.++|+++++..+.+.+ ++.+|+||||++||+|.+++.......+++..++.++.||+.||.|||   ..+|
T Consensus       232 ~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gI  307 (576)
T 2acx_A          232 LNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERI  307 (576)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHHcCCCCEeeEEEEEee-CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCE
Confidence            356778889999999999998887 678999999999999999998765556999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.+|.++|+|||++.......  ......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       308 vHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF  385 (576)
T 2acx_A          308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF  385 (576)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eccCCchheEEEeCCCCeEEEecccceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999997654332  233457899999999999888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ...........+..  .. ..          .+..++...+..+.+||.+||+.||.+||     +++|+++|
T Consensus       386 ~~~~~~~~~~~i~~--~i-~~----------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          386 QQRKKKIKREEVER--LV-KE----------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             SCSSSCCCHHHHHH--HH-HH----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             cccccchhHHHHHH--Hh-hc----------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            87654322111110  00 00          11122334456789999999999999999     89999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-34  Score=259.89  Aligned_cols=223  Identities=23%  Similarity=0.238  Sum_probs=169.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|++++++.+++.. ++..++||||+++ +|.+++... ...+++..++.++.|++.||.|||   ..++
T Consensus        60 ~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i  133 (346)
T 1ua2_A           60 LREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWI  133 (346)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHhhCCCCCCCeEEEEEee-CCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCE
Confidence            356778889999999999999876 6689999999965 899988765 346899999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      +|+||||+||+++.++.++|+|||++........ ......+|+.|+|||.+.+. .++.++|||||||++|+|++|.+|
T Consensus       134 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~  212 (346)
T 1ua2_A          134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  212 (346)
T ss_dssp             CCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ECCCCCHHHEEEcCCCCEEEEecccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999999999999999999999976543321 23345689999999998754 578999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhcccccccc------c-ccc----CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASD------S-RLE----GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |.+....+....+.................      . ..+    .......+..+.+||.+||..||.+|||++|+++|
T Consensus       213 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          213 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            988766554433321111100000000000      0 000    00112345778999999999999999999999997


Q ss_pred             Hh
Q 048068          268 LD  269 (313)
Q Consensus       268 L~  269 (313)
                      -.
T Consensus       293 ~~  294 (346)
T 1ua2_A          293 KY  294 (346)
T ss_dssp             GG
T ss_pred             hh
Confidence            64

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.3e-34  Score=271.20  Aligned_cols=233  Identities=23%  Similarity=0.310  Sum_probs=177.4

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      ++.|.+..+|+..+   ...++.|.+..         ....|...++.++|+|+++.++++.. ++.+++||||+++|+|
T Consensus        45 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~g~L  123 (494)
T 3lij_A           45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVMECYKGGEL  123 (494)
T ss_dssp             EECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBH
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecCCCCcH
Confidence            34455555555443   23455554432         22357788899999999999999986 6789999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC---CcEEEeecccccccCCCCCCccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~---~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      .+.+...  ..+++..++.++.||+.||.|||   ..+|+||||||+||+++..   +.++|+|||++.......  ...
T Consensus       124 ~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~~~  196 (494)
T 3lij_A          124 FDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMK  196 (494)
T ss_dssp             HHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--CBC
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--ccc
Confidence            9988764  35999999999999999999999   5899999999999999764   459999999987654332  233


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ...||+.|+|||++. ..++.++|||||||++|+|++|.+||.+....+....+..       +...      .......
T Consensus       197 ~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------~~~~------~~~~~~~  262 (494)
T 3lij_A          197 ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK-------GKYT------FDSPEWK  262 (494)
T ss_dssp             CCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCCC------CCSGGGT
T ss_pred             ccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC------CCchhcc
Confidence            457899999999986 5689999999999999999999999988776554433321       1000      0000112


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+..+.+||.+||+.||.+|||+.|+++|
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            334678899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1e-34  Score=282.44  Aligned_cols=231  Identities=23%  Similarity=0.309  Sum_probs=180.7

Q ss_pred             hHHHHHHHHhhcccc---ceEEEcccCCC----------hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           13 LLCVSFILSALAQDV---NQFIYHGFNED----------PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        13 ~~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      ++.|.+..+++..+.   ..+++|.+...          ...+...+..+ .|++++++...+.. .+.+|+||||++||
T Consensus       349 LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~~lV~E~~~gg  427 (674)
T 3pfq_A          349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGG  427 (674)
T ss_dssp             SSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEEEEEEECCCSC
T ss_pred             EccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEEEEEEeCcCCC
Confidence            445555555555442   34677665421          12344455554 68899988888876 67899999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      +|.+++...  ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.++|+|||++....... .....
T Consensus       428 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~  501 (674)
T 3pfq_A          428 DLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKT  501 (674)
T ss_dssp             BHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CCBCC
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-ccccc
Confidence            999999874  35999999999999999999999   5899999999999999999999999999997543222 23445


Q ss_pred             ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                      ..||+.|+|||++.+..++.++|+||||+++|||++|+.||.+.+..+....+.      ..           ...++..
T Consensus       502 ~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~-----------~~~~p~~  564 (674)
T 3pfq_A          502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EH-----------NVAYPKS  564 (674)
T ss_dssp             CCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------SS-----------CCCCCTT
T ss_pred             ccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH------hC-----------CCCCCcc
Confidence            679999999999999999999999999999999999999998876655444331      10           1113334


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048068          239 QMELVLKLGLFCSHPKPEARPNM-----RQVMQY  267 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~  267 (313)
                      .+..+.+||..||+.||.+||++     +|+++|
T Consensus       565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            55678999999999999999997     888875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=258.86  Aligned_cols=207  Identities=21%  Similarity=0.293  Sum_probs=156.5

Q ss_pred             hHHhhhhhccc--cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHS--NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~--~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .|...++.+.|  +++++.+++... ++.+++|||+ .+++|.+++...  ..+++..++.++.||+.||.|||   ..+
T Consensus        56 ~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~  128 (343)
T 3dbq_A           56 NEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHG  128 (343)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHhhhhcCCceEEEeeeEee-CCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            46667777776  899999998886 6789999995 488999999874  46999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccC-----------CCCCcchhhHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRT-----------GKASTSTDVYAFG  186 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG  186 (313)
                      |+||||||+||+++ ++.++|+|||++......... ......||+.|+|||++.+           ..++.++||||||
T Consensus       129 iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG  207 (343)
T 3dbq_A          129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG  207 (343)
T ss_dssp             CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHH
T ss_pred             eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHH
Confidence            99999999999996 678999999999765433211 2234578999999999854           5678999999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |++|+|++|+.||.......... ...    ..         +......+...+..+.+||..||+.||.+|||+.|+++
T Consensus       208 ~il~ell~g~~pf~~~~~~~~~~-~~~----~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          208 CILYYMTYGKTPFQQIINQISKL-HAI----ID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHHHHHHSSCTTTTCCSHHHHH-HHH----HC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhCCCcchhhhhHHHHH-HHH----hc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            99999999999997644321111 100    00         01111122223456889999999999999999999999


Q ss_pred             HHh
Q 048068          267 YLD  269 (313)
Q Consensus       267 ~L~  269 (313)
                      |..
T Consensus       274 hp~  276 (343)
T 3dbq_A          274 HPY  276 (343)
T ss_dssp             SHH
T ss_pred             Ccc
Confidence            754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=255.89  Aligned_cols=229  Identities=22%  Similarity=0.251  Sum_probs=169.7

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC---ChhhHHhhh-------hhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE---DPQLQRDGL-------ASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~l-------~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      ++.|.+..+|...+   ...+++|.+..   ........+       +...|+++++..+++.+ ++..++||||+ +++
T Consensus        65 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv~e~~-~~~  142 (311)
T 3p1a_A           65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQTELC-GPS  142 (311)
T ss_dssp             EEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC-CCB
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEEEecc-CCC
Confidence            44555555555443   44677776542   122222222       22389999999999876 67899999999 779


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      |.+++... ...+++..++.++.||+.||.|||   ..+|+|+||||+||+++.++.++|+|||++.......  .....
T Consensus       143 L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~  216 (311)
T 3p1a_A          143 LQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQ  216 (311)
T ss_dssp             HHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CC
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CCccc
Confidence            99998765 346999999999999999999999   4899999999999999999999999999987654332  23345


Q ss_pred             cccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..|+.......   .+       ..+        ..+...+...
T Consensus       217 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~-------~~~--------~~~~~~~~~~  277 (311)
T 3p1a_A          217 EGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QL-------RQG--------YLPPEFTAGL  277 (311)
T ss_dssp             CCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HH-------TTT--------CCCHHHHTTS
T ss_pred             CCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HH-------hcc--------CCCcccccCC
Confidence            68999999999875 78999999999999999999977665422111   01       010        0111122234


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +..+.+||.+||+.||++|||++|+++|-
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence            56789999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-34  Score=278.36  Aligned_cols=236  Identities=23%  Similarity=0.310  Sum_probs=181.3

Q ss_pred             hHHHHHHHHhhc-----cccceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           13 LLCVSFILSALA-----QDVNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        13 ~~~~~~~~~~~~-----~~~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      ++.|.+..+|.+     +....+++|.+..         ....|.+.++.++|++++++++++..  +..++||||+++|
T Consensus       377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~~g  454 (635)
T 4fl3_A          377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAELG  454 (635)
T ss_dssp             EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTE
T ss_pred             eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccCCC
Confidence            445555555544     1223566666543         22346677888899999999998864  4589999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--Ccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQT  156 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~  156 (313)
                      +|.+++...  ..+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||++........  ...
T Consensus       455 ~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          455 PLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            999999864  46999999999999999999999   58999999999999999999999999999976543321  112


Q ss_pred             ccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCc
Q 048068          157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY  235 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (313)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+.       .+.         ....
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~---------~~~~  593 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGE---------RMGC  593 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC---------CCCC
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---------CCCC
Confidence            22345778999999998899999999999999999998 999998877655443331       111         1112


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +..++..+.+||..||+.||++|||+.++++.|++.
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            334557789999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=266.45  Aligned_cols=255  Identities=20%  Similarity=0.217  Sum_probs=170.0

Q ss_pred             hhhHHHHHHHHhhccc-----cceEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCC
Q 048068           11 CVLLCVSFILSALAQD-----VNQFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~   79 (313)
                      ++++.|.+..+|....     ...+++|.+..     ....|...++.++|++++++.+++. ..+..+++||||+. ++
T Consensus        27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~  105 (405)
T 3rgf_A           27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD  105 (405)
T ss_dssp             CCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EE
T ss_pred             cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CC
Confidence            3566777777777652     34677776653     2346778899999999999999886 34678999999995 58


Q ss_pred             HHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE----cCCCcEEEeeccccccc
Q 048068           80 LDKILHTN-------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARLY  148 (313)
Q Consensus        80 L~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv----~~~~~~~l~dfg~~~~~  148 (313)
                      |.+++...       ....+++..++.++.||+.||.|||   ..+|+||||||+||++    +.++.++|+|||++...
T Consensus       106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  182 (405)
T 3rgf_A          106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  182 (405)
T ss_dssp             HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred             HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence            88887532       1234999999999999999999999   5899999999999999    67789999999999765


Q ss_pred             CCCCC--CccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCch---------hhhhHHHHHHH
Q 048068          149 DHDTI--PQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSM---------EMVNLVDWVSD  216 (313)
Q Consensus       149 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~~~~~~  216 (313)
                      .....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....         +....+.....
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g  262 (405)
T 3rgf_A          183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  262 (405)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHC
T ss_pred             CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhC
Confidence            43211  22334578999999999987 45899999999999999999999999765432         11111100000


Q ss_pred             hhhhcccccc-------------ccccccC--------CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          217 CWKKGAILDA-------------SDSRLEG--------IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       217 ~~~~~~~~~~-------------~~~~~~~--------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ..........             .......        .........+.+||.+||+.||.+|||++|+++|-.
T Consensus       263 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             CCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            0000000000             0000000        000011356789999999999999999999999754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2e-34  Score=257.11  Aligned_cols=220  Identities=19%  Similarity=0.267  Sum_probs=166.3

Q ss_pred             cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccC---------------------------------
Q 048068           27 VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRK---------------------------------   65 (313)
Q Consensus        27 ~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~---------------------------------   65 (313)
                      ...+++|.+..        ....|...++.++|+|+++.++.+.+.+                                 
T Consensus        31 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  110 (332)
T 3qd2_B           31 DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV  110 (332)
T ss_dssp             CCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----------------------
T ss_pred             CcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccccc
Confidence            34566666531        2235667788889999999998875322                                 


Q ss_pred             -----------------------CeEEEEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           66 -----------------------GEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        66 -----------------------~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                                             ...++||||+++++|.+++.... ....++..++.++.||+.||.|||   ..+++|
T Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH  187 (332)
T 3qd2_B          111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMH  187 (332)
T ss_dssp             ---------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             ceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH---hCCeee
Confidence                                   24899999999999999998753 234677789999999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCC-----------CccccccccccccccccccCCCCCcchhhHHHHHHHH
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTI-----------PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML  190 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  190 (313)
                      +||||+||+++.++.++|+|||++........           .......||+.|+|||.+.+..++.++||||||+++|
T Consensus       188 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  267 (332)
T 3qd2_B          188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF  267 (332)
T ss_dssp             CCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHH
T ss_pred             cCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHH
Confidence            99999999999999999999999976544321           1223356899999999999889999999999999999


Q ss_pred             HHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          191 EVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +|++|..|+....     ......    ...         ............+.++|.+||+.||++|||++|+++|
T Consensus       268 el~~~~~~~~~~~-----~~~~~~----~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          268 ELLYSFSTQMERV-----RIITDV----RNL---------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHSCCCCHHHHH-----HHHHHH----HTT---------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHcCCChhHHH-----HHHHHh----hcc---------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            9999877653211     111000    000         0011223445677899999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-34  Score=259.41  Aligned_cols=212  Identities=25%  Similarity=0.364  Sum_probs=166.9

Q ss_pred             hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           39 PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        39 ~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ...+.+.++.+ .|++++++.+.+.. ++.+++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..
T Consensus       105 ~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~  178 (355)
T 1vzo_A          105 TRTERQVLEHIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KL  178 (355)
T ss_dssp             CCCHHHHHHHHHTCTTBCCEEEEEEE-TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             HHHHHHHHHHccCCCceeEEEEEEee-CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence            34566777888 59999999988876 66899999999999999999864  35999999999999999999999   58


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC--CCCcchhhHHHHHHHHHHHhC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g  195 (313)
                      +|+|+||||+||+++.++.++|+|||++...............||+.|+|||.+.+.  .++.++|||||||++|+|++|
T Consensus       179 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g  258 (355)
T 1vzo_A          179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG  258 (355)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999999999999999999875543222233345789999999999853  468899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHh
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQYLD  269 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~L~  269 (313)
                      ..||...........+.  ......           ....+...+..+.+||.+||..||.+||     |++++++|..
T Consensus       259 ~~pf~~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          259 ASPFTVDGEKNSQAEIS--RRILKS-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             SCTTSCTTSCCCHHHHH--HHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             CCCCccCCccchHHHHH--HHHhcc-----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence            99997654433221111  111110           1112334456788999999999999999     9999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-34  Score=255.92  Aligned_cols=216  Identities=24%  Similarity=0.371  Sum_probs=159.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT------NIKPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~------~~~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      .+...++.++|+++++.++++.. ++..++||||+++++|.+++..      .....+++..++.++.||+.||.|||  
T Consensus        62 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--  138 (303)
T 2vwi_A           62 KEIQAMSQCHHPNIVSYYTSFVV-KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--  138 (303)
T ss_dssp             ----CCCCCCCTTBCCEEEEEES-SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHhhcCCCCEeeEEEEEee-cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            45567778899999999998887 5679999999999999999974      12456999999999999999999999  


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC----CccccccccccccccccccC-CCCCcchhhHHHHHHH
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI----PQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFM  189 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il  189 (313)
                       ..+++|+||+|+||+++.++.++|+|||++........    .......+++.|+|||.+.+ ..++.++||||||+++
T Consensus       139 -~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il  217 (303)
T 2vwi_A          139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA  217 (303)
T ss_dssp             -HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHH
T ss_pred             -hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHH
Confidence             58999999999999999999999999999875543211    11234568999999999865 4678999999999999


Q ss_pred             HHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          190 LEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       190 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |+|++|..||.............      .. ..................+..+.+++.+||+.||.+|||+.++++|
T Consensus       218 ~~l~~g~~pf~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          218 IELATGAAPYHKYPPMKVLMLTL------QN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHHHHSSCTTTTSCGGGHHHHHH------TS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCCCCCccCchhhHHHHHh------cc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            99999999998766544322110      00 0000000000111122334578899999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-34  Score=258.23  Aligned_cols=212  Identities=23%  Similarity=0.240  Sum_probs=162.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--------------------------------
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--------------------------------   87 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--------------------------------   87 (313)
                      ..|...++.++|++++++++++.+ ++..++||||+++++|.+++...                                
T Consensus        76 ~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (345)
T 3hko_A           76 KTEVRLMKKLHHPNIARLYEVYED-EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI  154 (345)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC
T ss_pred             HHHHHHHHhCCCCCcceeehhhcc-CCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccc
Confidence            346677888999999999999876 67899999999999999998521                                


Q ss_pred             ------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC--cEEEeecccccccCCC---CCCcc
Q 048068           88 ------IKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL--NGKLGDFGLARLYDHD---TIPQT  156 (313)
Q Consensus        88 ------~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~--~~~l~dfg~~~~~~~~---~~~~~  156 (313)
                            ....+++..++.++.||+.||.|||   ..+++|+||||+||+++.++  .++|+|||++......   .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  231 (345)
T 3hko_A          155 HGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM  231 (345)
T ss_dssp             --CEEECCHHHHHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----
T ss_pred             ccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccc
Confidence                  0112467889999999999999999   58999999999999998766  8999999998754321   11123


Q ss_pred             ccccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          157 TKLVGTFGYMAPELMRT--GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                      ....+++.|+|||.+.+  ..++.++||||||+++|+|++|+.||.+....+....+.      ....       .....
T Consensus       232 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~------~~~~-------~~~~~  298 (345)
T 3hko_A          232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL------NKKL-------CFENP  298 (345)
T ss_dssp             ---CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCC-------CTTSG
T ss_pred             cccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH------hccc-------ccCCc
Confidence            44578999999999865  567899999999999999999999998776654433221      1100       00111


Q ss_pred             ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          235 YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       235 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+..+.+||..||+.||.+|||+.++++|-
T Consensus       299 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          299 NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP  332 (345)
T ss_dssp             GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence            1123456788999999999999999999999964

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.1e-34  Score=249.24  Aligned_cols=207  Identities=21%  Similarity=0.335  Sum_probs=165.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|++++++.+++.. ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..++
T Consensus        56 ~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i  129 (283)
T 3bhy_A           56 EREVNILREIRHPNIITLHDIFEN-KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRI  129 (283)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCeeehhheecC-CCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            456678889999999999999886 67899999999999999999763  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCC----cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          120 LHRDIKPANVLLDADL----NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +|+||+|+||+++.++    .++|+|||++.......  ......+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       130 ~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  207 (283)
T 3bhy_A          130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  207 (283)
T ss_dssp             ECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCCChHHEEEecCCCCCCceEEEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHC
Confidence            9999999999998876    79999999987654322  22334688999999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..||.+.........+.       ...      ...........+..+.+++.+||+.||.+|||+.++++|
T Consensus       208 ~~p~~~~~~~~~~~~~~-------~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          208 ASPFLGETKQETLTNIS-------AVN------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             SCTTCCSSHHHHHHHHH-------TTC------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             CCCCCCcchHHHHHHhH-------hcc------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            99998766544332221       000      000111112334678999999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.1e-34  Score=251.61  Aligned_cols=224  Identities=21%  Similarity=0.352  Sum_probs=175.7

Q ss_pred             cceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHH
Q 048068           27 VNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFR   99 (313)
Q Consensus        27 ~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~   99 (313)
                      ...++.|.+..       ....+...++.++|+++++..+++.. ++..++||||+++++|.+++...  +.+++..++.
T Consensus        34 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~  110 (304)
T 2jam_A           34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQLVSGGELFDRILER--GVYTEKDASL  110 (304)
T ss_dssp             CCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHH
T ss_pred             CCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHH
Confidence            34555555532       23456778899999999999998876 67899999999999999999764  3599999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCceecCcCCCcEEE---cCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC
Q 048068          100 IIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus       100 i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      ++.|++.||.|||   ..+++|+||+|+||++   +.++.++|+|||++......   ......+++.|+|||.+.+..+
T Consensus       111 ~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~  184 (304)
T 2jam_A          111 VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPY  184 (304)
T ss_dssp             HHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSC
T ss_pred             HHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhccCCC
Confidence            9999999999999   5899999999999999   67889999999998643322   2233468999999999998889


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      +.++||||||+++|+|++|..||...........+.       .+..      ..........+..+.++|.+||+.||+
T Consensus       185 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~  251 (304)
T 2jam_A          185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK-------EGYY------EFESPFWDDISESAKDFICHLLEKDPN  251 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HCCC------CCCTTTTTTSCHHHHHHHHHHHCSSTT
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCC------CCCccccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999999999998765544332221       1110      011112233456789999999999999


Q ss_pred             CCCCHHHHHHH--HhccC
Q 048068          257 ARPNMRQVMQY--LDGNA  272 (313)
Q Consensus       257 ~Rpt~~ell~~--L~~~~  272 (313)
                      +|||++|+++|  +.+..
T Consensus       252 ~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          252 ERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             TSCCHHHHHTSHHHHSSC
T ss_pred             HCcCHHHHhcCccccCCC
Confidence            99999999985  44443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.9e-34  Score=258.81  Aligned_cols=232  Identities=23%  Similarity=0.305  Sum_probs=176.9

Q ss_pred             HHHHHHHHhhcc---ccceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           14 LCVSFILSALAQ---DVNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        14 ~~~~~~~~~~~~---~~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      +.|.+..++.+.   ....+++|.+..          ....|...++.++|++++++.+++.. ++..++||||+. |+|
T Consensus        63 G~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~-g~l  140 (348)
T 1u5q_A           63 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCL-GSA  140 (348)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCS-EEH
T ss_pred             ccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEEEecCC-CCH
Confidence            334444444443   234566666532          12356677788899999999998876 678999999996 688


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      .+++... ...+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++.....     .....
T Consensus       141 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~~~~  211 (348)
T 1u5q_A          141 SDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFV  211 (348)
T ss_dssp             HHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCC
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CCccc
Confidence            8888654 346999999999999999999999   58999999999999999999999999999875432     23457


Q ss_pred             cccccccccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          161 GTFGYMAPELMR---TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       161 ~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      |++.|+|||++.   ...++.++|||||||++|+|++|..||...........+.      ...         .+...+.
T Consensus       212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~------~~~---------~~~~~~~  276 (348)
T 1u5q_A          212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNE---------SPALQSG  276 (348)
T ss_dssp             SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC---------CCCCCCT
T ss_pred             CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------hcC---------CCCCCCC
Confidence            899999999984   4678999999999999999999999998765543322221      110         0011122


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ..+..+.+||..||+.||.+|||++++++|..-.
T Consensus       277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence            3356788999999999999999999999976543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-33  Score=255.62  Aligned_cols=207  Identities=27%  Similarity=0.420  Sum_probs=164.4

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|..+++++ .|+++++..+++.. .+..++||||++|++|.+++...  ..+++..++.++.||+.||.|||   ..|+
T Consensus       148 ~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi  221 (365)
T 2y7j_A          148 RETHILRQVAGHPHIITLIDSYES-SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNI  221 (365)
T ss_dssp             HHHHHHHHHTTCTTBCCEEEEEEB-SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhcCCCCEeEEEEEEee-CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            455667777 79999999998876 67899999999999999999863  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC------CCCCcchhhHHHHHHHHHHH
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT------GKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll  193 (313)
                      +|+||+|+||+++.++.++|+|||++.......  ......|++.|+|||++.+      ..++.++|||||||++|+|+
T Consensus       222 ~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell  299 (365)
T 2y7j_A          222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL  299 (365)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH
Confidence            999999999999999999999999987654332  2334678999999998853      35788999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +|..||...........+.       .+... ...+     .....+..+.++|.+||+.||++|||+.++++|-
T Consensus       300 ~g~~pf~~~~~~~~~~~i~-------~~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          300 AGSPPFWHRRQILMLRMIM-------EGQYQ-FSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             HSSCSSCCSSHHHHHHHHH-------HTCCC-CCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HCCCCCCCCCHHHHHHHHH-------hCCCC-CCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            9999998765443322221       00000 0000     0012245688999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-34  Score=252.70  Aligned_cols=212  Identities=25%  Similarity=0.361  Sum_probs=168.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++.+++....  ..++||||+++++|.+++... ...+++..++.++.||+.||.|||   ..+++
T Consensus        70 ~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  143 (291)
T 1u46_A           70 REVNAMHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFI  143 (291)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEECSS--SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCcccEEEEEccC--CceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            455667788999999999998853  488999999999999999764 345999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      |+||+|+||+++.++.++|+|||++.........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       144 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~  223 (291)
T 1u46_A          144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE  223 (291)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998765433211  1223456778999999988888999999999999999999 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                      ||......+....+.      ....         ....+...+..+.+++..||+.||.+|||+.+++++|++..+
T Consensus       224 p~~~~~~~~~~~~~~------~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          224 PWIGLNGSQILHKID------KEGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             TTTTCCHHHHHHHHH------TSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CcccCCHHHHHHHHH------ccCC---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            998766544332221      1100         011222345678999999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=263.67  Aligned_cols=232  Identities=19%  Similarity=0.298  Sum_probs=174.0

Q ss_pred             cceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           27 VNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        27 ~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ...+++|.+...       ...|...++.++|+++++..+++... ...+++||||+++++|.+++... ...+++..++
T Consensus        70 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~  148 (326)
T 2w1i_A           70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLL  148 (326)
T ss_dssp             CEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHH
T ss_pred             ceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHH
Confidence            445666666432       23566777888999999999987743 34789999999999999999875 3469999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      .++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++.........  ......++..|+|||.+.+..+
T Consensus       149 ~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  225 (326)
T 2w1i_A          149 QYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF  225 (326)
T ss_dssp             HHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCC
Confidence            99999999999999   589999999999999999999999999999765443221  1122346677999999988888


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhh---------hHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHH
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMV---------NLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLG  247 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  247 (313)
                      +.++||||||+++|+|++|..||.........         ............+.         ....+...+..+.++|
T Consensus       226 ~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li  296 (326)
T 2w1i_A          226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG---------RLPRPDGCPDEIYMIM  296 (326)
T ss_dssp             EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC---------CCCCCTTCCHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC---------CCCCCCcccHHHHHHH
Confidence            99999999999999999999998643211100         00000001111110         0112334457789999


Q ss_pred             HHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          248 LFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       248 ~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+||+.||.+|||+.++++.|+..
T Consensus       297 ~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          297 TECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.5e-34  Score=254.06  Aligned_cols=225  Identities=23%  Similarity=0.344  Sum_probs=174.0

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCC-----CCCCH
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK-----PSLSW   94 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-----~~~~~   94 (313)
                      ..+++|.+...        ...+...++.+.|++++++.++... ++..++||||+++++|.+++.....     ..+++
T Consensus        61 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  139 (327)
T 2yfx_A           61 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM  139 (327)
T ss_dssp             CEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCH
T ss_pred             ceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CCCcEEEEecCCCCcHHHHHHhhcccccccccccH
Confidence            35677766421        2235556677899999999999886 5678999999999999999986532     45899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---CCcEEEeecccccccCCCCC-Ccccccccccccccccc
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPEL  170 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~  170 (313)
                      ..++.++.||+.||.|||   ..+++|+||+|+||+++.   +..++|+|||++........ .......+++.|+|||.
T Consensus       140 ~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          140 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhH
Confidence            999999999999999999   589999999999999984   44599999999865432221 12234567889999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHH
Q 048068          171 MRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF  249 (313)
Q Consensus       171 ~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  249 (313)
                      +.+..++.++||||||+++|+|++ |..||...........+.       .+..         ...+...+..+.++|..
T Consensus       217 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~l~~li~~  280 (327)
T 2yfx_A          217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-------SGGR---------MDPPKNCPGPVYRIMTQ  280 (327)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------TTCC---------CCCCTTCCHHHHHHHHH
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-------cCCC---------CCCCCCCCHHHHHHHHH
Confidence            988889999999999999999998 999998765544332221       1100         11222345678899999


Q ss_pred             cCCCCCCCCCCHHHHHHHHhccC
Q 048068          250 CSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       250 cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||+.||.+|||+.+++++|+...
T Consensus       281 ~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          281 CWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999998765

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-33  Score=247.89  Aligned_cols=208  Identities=21%  Similarity=0.298  Sum_probs=164.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..|.+.++.++|+++++..+++. ..++..++||||++++ |.+++.......+++..++.++.||+.||.|||   ..+
T Consensus        54 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~  129 (305)
T 2wtk_C           54 KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQG  129 (305)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            35667788889999999999885 3456899999999765 888887765667999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCC-CCccccccccccccccccccCCC--CCcchhhHHHHHHHHHHHhC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKLVGTFGYMAPELMRTGK--ASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g  195 (313)
                      ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+..  ++.++||||||+++|+|++|
T Consensus       130 i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (305)
T 2wtk_C          130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG  209 (305)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999987654322 11223456899999999987644  37899999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..||.+.........+.       .+.          ...+...+..+.++|.+||+.||.+|||++|+++|-
T Consensus       210 ~~p~~~~~~~~~~~~i~-------~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          210 LYPFEGDNIYKLFENIG-------KGS----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             SCSCCCSSHHHHHHHHH-------HCC----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             CCCCCCchHHHHHHHHh-------cCC----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            99998765443332221       110          012223456788999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-34  Score=260.23  Aligned_cols=254  Identities=20%  Similarity=0.225  Sum_probs=184.8

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEecc-CCeEEEEEecCCCCCHH
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~   81 (313)
                      +.|.+..+|...+   ...+++|.+..        ....+.+.++.++|+++++.+++.... ....++||||+++++|.
T Consensus        18 G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~   97 (396)
T 4eut_A           18 GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLY   97 (396)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHH
T ss_pred             EcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHH
Confidence            3344444444333   34566666542        122566788999999999999988753 34789999999999999


Q ss_pred             HHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE----cCCCcEEEeecccccccCCCCCCcc
Q 048068           82 KILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL----DADLNGKLGDFGLARLYDHDTIPQT  156 (313)
Q Consensus        82 ~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv----~~~~~~~l~dfg~~~~~~~~~~~~~  156 (313)
                      +++.... ...+++..++.++.||+.||.|||   ..+|+||||||+||++    +.++.++|+|||++.......  ..
T Consensus        98 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--~~  172 (396)
T 4eut_A           98 TVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QF  172 (396)
T ss_dssp             HHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--GS
T ss_pred             HHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC--cc
Confidence            9998642 334999999999999999999999   5899999999999999    777789999999997654322  22


Q ss_pred             ccccccccccccccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhh-hHHHHHHHhhhhccc----
Q 048068          157 TKLVGTFGYMAPELMRT--------GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV-NLVDWVSDCWKKGAI----  223 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~----  223 (313)
                      ....|+..|+|||.+.+        ..++.++|||||||++|+|++|+.||......... .....+........+    
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  252 (396)
T 4eut_A          173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ  252 (396)
T ss_dssp             SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEE
T ss_pred             ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhhe
Confidence            34568999999998864        45678999999999999999999999754433211 111111110000000    


Q ss_pred             -------cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          224 -------LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       224 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                             .-..........+......+.+++..||+.||++|||++|+++.+++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             CSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             eccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence                   0000111122355778899999999999999999999999999987764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.2e-35  Score=253.77  Aligned_cols=212  Identities=24%  Similarity=0.364  Sum_probs=168.2

Q ss_pred             hHHhhhhhccccceeeeeeEEe-ccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVN-SRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      .+...++.++|++++++.+++. ..++..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+   .
T Consensus        54 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~  130 (279)
T 2w5a_A           54 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---R  130 (279)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             HHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---c
Confidence            4566778889999999999765 4467899999999999999999753  23459999999999999999999995   6


Q ss_pred             C-----ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHH
Q 048068          118 V-----VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       118 ~-----i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  192 (313)
                      +     ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|
T Consensus       131 ~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  209 (279)
T 2w5a_A          131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL  209 (279)
T ss_dssp             C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHH
T ss_pred             cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHH
Confidence            6     9999999999999999999999999987654322 112234678999999999988899999999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ++|..||......+....+.       .+..         ...+...+..+.++|.+||+.||.+|||++|+++++....
T Consensus       210 ~~g~~p~~~~~~~~~~~~i~-------~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          210 CALMPPFTAFSQKELAGKIR-------EGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             HHSSCSSCCSSHHHHHHHHH-------HTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             HHCCCCCcccCHHHHHHHHh-------hccc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            99999998765443322221       1111         0122234567899999999999999999999999887654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.6e-34  Score=250.45  Aligned_cols=206  Identities=26%  Similarity=0.392  Sum_probs=168.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.+.|+++++.++++.. ++..++||||+++++|.+++...   .+++..++.++.|++.||.|||   ..++
T Consensus        68 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i  140 (303)
T 3a7i_A           68 QQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKK  140 (303)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence            355667788899999999998876 66899999999999999999753   5999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       141 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  219 (303)
T 3a7i_A          141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH  219 (303)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCCChheEEECCCCCEEEeecccceecCccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCC
Confidence            999999999999999999999999987654332 1233456889999999999888999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ...........+.       ...         ....+...+..+.+|+..||+.||.+|||+.++++|..
T Consensus       220 ~~~~~~~~~~~~~-------~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          220 SELHPMKVLFLIP-------KNN---------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             TTSCHHHHHHHHH-------HSC---------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             CCcCHHHHHHHhh-------cCC---------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            8765443322221       000         11122233466889999999999999999999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-34  Score=263.12  Aligned_cols=245  Identities=20%  Similarity=0.224  Sum_probs=165.6

Q ss_pred             hHHHHHHHHhhcc---ccceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEecc-----CCeEEEEEecC
Q 048068           13 LLCVSFILSALAQ---DVNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDYM   75 (313)
Q Consensus        13 ~~~~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~~   75 (313)
                      ++.|.+..++.+.   ....++.|.+...         ...+...++.++|+|+++..+++...     ...+++|||++
T Consensus        37 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~  116 (367)
T 2fst_X           37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  116 (367)
T ss_dssp             CC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc
Confidence            3445555555553   2446777776431         12466778888999999999998742     35789999999


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc
Q 048068           76 PNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ  155 (313)
Q Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~  155 (313)
                       +++|.++++.   ..+++..++.++.||+.||.|||   ..+++||||||+||+++.++.++|+|||++......    
T Consensus       117 -~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----  185 (367)
T 2fst_X          117 -GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----  185 (367)
T ss_dssp             -CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------------
T ss_pred             -CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccccc----
Confidence             7899999875   35999999999999999999999   489999999999999999999999999998754322    


Q ss_pred             cccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccccc------
Q 048068          156 TTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASD------  228 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  228 (313)
                      .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.................      
T Consensus       186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  265 (367)
T 2fst_X          186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  265 (367)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHH
T ss_pred             CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence            234578999999999876 6789999999999999999999999988776555443322111100000000000      


Q ss_pred             ----ccccC----CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          229 ----SRLEG----IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       229 ----~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                          +..+.    ......+..+.+||.+||..||.+|||+.|+++|-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence                00000    01112346789999999999999999999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-33  Score=248.23  Aligned_cols=204  Identities=24%  Similarity=0.338  Sum_probs=167.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..+++.. ++..++||||+++++|.+++...  ..+++..++.++.|++.||.|||   ..+++
T Consensus        64 ~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~  137 (294)
T 2rku_A           64 MEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVI  137 (294)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCEeeeeeeecc-CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            45667788899999999999876 67899999999999999998764  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      |+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.
T Consensus       138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  216 (294)
T 2rku_A          138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE  216 (294)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999876543221 2234568899999999998889999999999999999999999998


Q ss_pred             cCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          201 QQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .....+....+.       ...          ...+...+..+.+++.+||+.||++|||++++++|-
T Consensus       217 ~~~~~~~~~~~~-------~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          217 TSCLKETYLRIK-------KNE----------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             CSSHHHHHHHHH-------TTC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             CCCHHHHHHHHh-------hcc----------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            766544322221       100          011223345788999999999999999999999964

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-33  Score=265.67  Aligned_cols=207  Identities=24%  Similarity=0.367  Sum_probs=166.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|||++++++++.. ++.+++||||+++++|.+.+...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        69 ~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i  142 (486)
T 3mwu_A           69 LREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNI  142 (486)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            357778899999999999999887 67899999999999999998764  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEc---CCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLD---ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +||||||+||+++   .++.++|+|||++.......  ......||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus       143 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~  219 (486)
T 3mwu_A          143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT  219 (486)
T ss_dssp             CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999995   45679999999997654332  2334578999999999875 5899999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +||.+....+....+.       .+...      .........++.+.+||.+||+.||.+|||+.|+++|-
T Consensus       220 ~pf~~~~~~~~~~~i~-------~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          220 PPFYGKNEYDILKRVE-------TGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             CSSCCSSHHHHHHHHH-------HTCCC------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             CCCCCCCHHHHHHHHH-------hCCCC------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence            9998876655443331       11000      00011223456788999999999999999999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.6e-34  Score=247.27  Aligned_cols=203  Identities=22%  Similarity=0.397  Sum_probs=158.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+++++..+++.. ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+++
T Consensus        60 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~  133 (276)
T 2h6d_A           60 REIQNLKLFRHPHIIKLYQVIST-PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCH---RHMVV  133 (276)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHCSS
T ss_pred             HHHHHHhcCCCCCEeEEEEEEec-CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence            46667788899999999999876 67899999999999999999864  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||
T Consensus       134 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCChhhEEECCCCCEEEeecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987654322  2234467899999999987665 68999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ...........+.       .+.          ...+...+..+.+++.+||+.||.+|||+.++++|-
T Consensus       212 ~~~~~~~~~~~~~-------~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~  263 (276)
T 2h6d_A          212 DDEHVPTLFKKIR-------GGV----------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE  263 (276)
T ss_dssp             CCSSHHHHHHHHH-------HCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             CCCcHHHHHHHhh-------cCc----------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence            8765443322221       110          011223346688999999999999999999999973

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-34  Score=262.93  Aligned_cols=251  Identities=22%  Similarity=0.242  Sum_probs=180.4

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEecc----CCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSR----KGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~----~~~~~lV~e~~~   76 (313)
                      .++.|.+..++...+   ...++.|.+..        ....|...++.++|+++++..+++...    ....++||||++
T Consensus        34 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~  113 (364)
T 3qyz_A           34 YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME  113 (364)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS
T ss_pred             EeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC
Confidence            344444444454433   33566666642        122566778888999999999998743    257899999995


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC--C
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--P  154 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~  154 (313)
                       ++|.++++..   .+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++........  .
T Consensus       114 -~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  186 (364)
T 3qyz_A          114 -TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG  186 (364)
T ss_dssp             -EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred             -cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccc
Confidence             6999999864   4999999999999999999999   58999999999999999999999999999975543211  1


Q ss_pred             ccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccc----------
Q 048068          155 QTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI----------  223 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------  223 (313)
                      ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+............          
T Consensus       187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  266 (364)
T 3qyz_A          187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN  266 (364)
T ss_dssp             TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred             cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence            1234578999999998754 45899999999999999999999999887766655443211100000000          


Q ss_pred             --cccc--cccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          224 --LDAS--DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       224 --~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                        ....  ............+..+.+||.+||+.||++|||+.|+++|-.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence              0000  000000011223467889999999999999999999999753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2e-33  Score=251.21  Aligned_cols=232  Identities=18%  Similarity=0.223  Sum_probs=174.5

Q ss_pred             cceEEEcccCCC------hhhHHhhhhhccccc------eeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCH
Q 048068           27 VNQFIYHGFNED------PQLQRDGLASVHSNG------LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSW   94 (313)
Q Consensus        27 ~~~~~~~~~~~~------~~~~~~~l~~~~~~~------~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~   94 (313)
                      ...+++|.+...      ...+.+.++.+.|++      +++..+++.. ++..++||||+ +++|.+++.......+++
T Consensus        40 ~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~  117 (339)
T 1z57_A           40 GRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HGHICIVFELL-GLSTYDFIKENGFLPFRL  117 (339)
T ss_dssp             TEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTTTCCCCH
T ss_pred             CcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CCcEEEEEcCC-CCCHHHHHHhcCCCCCcH
Confidence            345677766543      234556667777765      7777777765 67999999999 889999998765567999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-------------------CCcEEEeecccccccCCCCCCc
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-------------------DLNGKLGDFGLARLYDHDTIPQ  155 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-------------------~~~~~l~dfg~~~~~~~~~~~~  155 (313)
                      ..++.++.||+.||.|||   ..+++|+||||+||+++.                   ++.++|+|||++......    
T Consensus       118 ~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----  190 (339)
T 1z57_A          118 DHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----  190 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----
Confidence            999999999999999999   589999999999999987                   667999999998754332    


Q ss_pred             cccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhh-----hhccccc-----
Q 048068          156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCW-----KKGAILD-----  225 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~-----  225 (313)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.......     .......     
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  270 (339)
T 1z57_A          191 HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHD  270 (339)
T ss_dssp             CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETT
T ss_pred             cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhc
Confidence            234568999999999998889999999999999999999999998876655443332211100     0000000     


Q ss_pred             ----------------c-ccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          226 ----------------A-SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       226 ----------------~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                                      . .............++.+.+||.+||+.||.+|||+.|+++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          271 RLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             EECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence                            0 00000011234567889999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-34  Score=257.24  Aligned_cols=232  Identities=18%  Similarity=0.218  Sum_probs=171.0

Q ss_pred             cceEEEcccCC----ChhhHHhhhhhcc-ccceeeeeeEEecc-CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHH
Q 048068           27 VNQFIYHGFNE----DPQLQRDGLASVH-SNGLLQLTNTVNSR-KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI  100 (313)
Q Consensus        27 ~~~~~~~~~~~----~~~~~~~~l~~~~-~~~~l~~~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i  100 (313)
                      ...+++|.+..    ....|...++.+. |++++++.+++... ....++||||+++++|.++++.     +++..++.+
T Consensus        61 ~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~  135 (330)
T 3nsz_A           61 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFY  135 (330)
T ss_dssp             CCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHH
T ss_pred             CcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHH
Confidence            34666666643    2345667778886 99999999998853 5678999999999999999864     899999999


Q ss_pred             HHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC-cEEEeecccccccCCCCCCccccccccccccccccccC-CCCCc
Q 048068          101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKAST  178 (313)
Q Consensus       101 ~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  178 (313)
                      +.||+.||.|||   ..+++|+||||+||+++.++ .++|+|||++.......  ......++..|+|||.+.+ ..++.
T Consensus       136 ~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  210 (330)
T 3nsz_A          136 MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDY  210 (330)
T ss_dssp             HHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCT
T ss_pred             HHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--ccccccccccccChhhhcCCCcCCc
Confidence            999999999999   58999999999999999776 89999999997654332  2334567889999999876 66899


Q ss_pred             chhhHHHHHHHHHHHhCCCCCccCCch-hhhhHHHHHH------Hhhhhcc--------------ccccccccccCCccH
Q 048068          179 STDVYAFGVFMLEVASGRRPIEQQGSM-EMVNLVDWVS------DCWKKGA--------------ILDASDSRLEGIYEE  237 (313)
Q Consensus       179 ~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~------~~~~~~~--------------~~~~~~~~~~~~~~~  237 (313)
                      ++|||||||++|+|++|..||...... +....+....      .......              ...............
T Consensus       211 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (330)
T 3nsz_A          211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH  290 (330)
T ss_dssp             HHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGG
T ss_pred             hhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccc
Confidence            999999999999999999999543332 2111111000      0000000              000000011111222


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..+..+.+||.+||+.||.+|||++|+++|-
T Consensus       291 ~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp  321 (330)
T 3nsz_A          291 LVSPEALDFLDKLLRYDHQSRLTAREAMEHP  321 (330)
T ss_dssp             GCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence            3467789999999999999999999999963

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.2e-34  Score=267.52  Aligned_cols=234  Identities=25%  Similarity=0.321  Sum_probs=180.8

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      +.|.+..++...+   ...+++|.+..          ....+...+++++|+|++++++++.. ++.+++||||+.+++|
T Consensus        35 g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L  113 (484)
T 3nyv_A           35 GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYLVGEVYTGGEL  113 (484)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBH
T ss_pred             ecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEecCCCCCH
Confidence            3444444444433   34566665421          13356778899999999999999887 6789999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE---cCCCcEEEeecccccccCCCCCCccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv---~~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      .+.+...  ..+++..++.++.||+.||.|||   ..+|+||||||+||++   +.++.++|+|||++.......  ...
T Consensus       114 ~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  186 (484)
T 3nyv_A          114 FDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK  186 (484)
T ss_dssp             HHHHHTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC--SHH
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc--ccc
Confidence            9999764  46999999999999999999999   5899999999999999   467889999999997654432  234


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+....+.       .+...      .......
T Consensus       187 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-------~~~~~------~~~~~~~  252 (484)
T 3nyv_A          187 DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-------KGKYT------FELPQWK  252 (484)
T ss_dssp             HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCC------CCSGGGG
T ss_pred             cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCCC------CCCcccc
Confidence            4578999999999875 68999999999999999999999998876655443331       11100      0011122


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ..++.+.+||.+||+.||.+|||+.|+++|-.
T Consensus       253 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          253 KVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence            34567889999999999999999999998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-33  Score=257.19  Aligned_cols=247  Identities=20%  Similarity=0.206  Sum_probs=177.9

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCCChh------hHHhhhhhcc--------ccceeeeeeEEe---ccCCeEEEEEe
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNEDPQ------LQRDGLASVH--------SNGLLQLTNTVN---SRKGEFLLVYD   73 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~l~~~~--------~~~~l~~~~~~~---~~~~~~~lV~e   73 (313)
                      +.|.+..+|...+   ...+++|.+.....      .|...++.+.        |+++++..+.+.   ..+.++++|||
T Consensus        46 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e  125 (397)
T 1wak_A           46 GWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE  125 (397)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             eecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEe
Confidence            3444444455433   34677777764433      3445556664        778999988877   24568999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CceecCcCCCcEEEcCCC-----------------
Q 048068           74 YMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ-VVLHRDIKPANVLLDADL-----------------  135 (313)
Q Consensus        74 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~-~i~H~dl~~~nIlv~~~~-----------------  135 (313)
                      |+ +++|.+.+.......+++..++.++.||+.||.|||+   + +|+||||||+||+++.++                 
T Consensus       126 ~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~  201 (397)
T 1wak_A          126 VL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG  201 (397)
T ss_dssp             CC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHHHC------
T ss_pred             cc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcC
Confidence            99 6677777766545679999999999999999999995   6 999999999999998775                 


Q ss_pred             --------------------------------cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhH
Q 048068          136 --------------------------------NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY  183 (313)
Q Consensus       136 --------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  183 (313)
                                                      .++|+|||++......    .....+|..|+|||++.+..++.++|||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Diw  277 (397)
T 1wak_A          202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTPADIW  277 (397)
T ss_dssp             ---------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCTHHHHH
T ss_pred             CCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCCcHHHHH
Confidence                                            7999999999765432    2334689999999999988899999999


Q ss_pred             HHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----------hhhcc-----------cccccccc---------cc
Q 048068          184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----------WKKGA-----------ILDASDSR---------LE  232 (313)
Q Consensus       184 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----------~~~~~-----------~~~~~~~~---------~~  232 (313)
                      ||||++|+|++|..||..................           +..+.           ........         ..
T Consensus       278 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (397)
T 1wak_A          278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK  357 (397)
T ss_dssp             HHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHT
T ss_pred             HHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhh
Confidence            9999999999999999865543321111111000           00000           00000000         01


Q ss_pred             CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          233 GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       233 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ...+......+.+||.+||+.||++|||++|+++|-
T Consensus       358 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  393 (397)
T 1wak_A          358 YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP  393 (397)
T ss_dssp             SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred             cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence            123566778899999999999999999999999863

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=253.02  Aligned_cols=217  Identities=23%  Similarity=0.347  Sum_probs=158.9

Q ss_pred             hhhccccceeeeeeEEe----ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC----
Q 048068           46 LASVHSNGLLQLTNTVN----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ----  117 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~----~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~----  117 (313)
                      +..+.|++++++.....    .....+++||||+++|+|.+++...   ..++..++.++.||+.||.|||   ..    
T Consensus        61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~~~~  134 (336)
T 3g2f_A           61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLH---TELPRG  134 (336)
T ss_dssp             STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---CCBCCG
T ss_pred             HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHH---hhhccc
Confidence            34579999999886443    3344789999999999999999865   3689999999999999999999   46    


Q ss_pred             -----CceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-------CccccccccccccccccccC-------CCCCc
Q 048068          118 -----VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-------PQTTKLVGTFGYMAPELMRT-------GKAST  178 (313)
Q Consensus       118 -----~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~  178 (313)
                           +++|+||||+||+++.++.++|+|||++........       .......||+.|+|||.+.+       ..++.
T Consensus       135 ~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  214 (336)
T 3g2f_A          135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK  214 (336)
T ss_dssp             GGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred             cccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence                 999999999999999999999999999976543211       11223468999999999976       34567


Q ss_pred             chhhHHHHHHHHHHHhCCCCCccCCchhhhh-HHH----------HHHHhhhhccccccccccccC--CccHHHHHHHHH
Q 048068          179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVN-LVD----------WVSDCWKKGAILDASDSRLEG--IYEEEQMELVLK  245 (313)
Q Consensus       179 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~----------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~  245 (313)
                      ++|||||||++|+|++|..||.......... ...          ..........    ..+..+.  ......+..+.+
T Consensus       215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~  290 (336)
T 3g2f_A          215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKE  290 (336)
T ss_dssp             HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHH
T ss_pred             ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHH
Confidence            8999999999999999977764332211110 000          0000000000    0111111  112346778999


Q ss_pred             HHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          246 LGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       246 li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||.+||+.||++|||++|+++.|+...
T Consensus       291 li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          291 TIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            999999999999999999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-33  Score=258.30  Aligned_cols=248  Identities=20%  Similarity=0.222  Sum_probs=179.7

Q ss_pred             HHHHHHHHhhcc---ccceEEEcccCC---ChhhHHhhhhhccccceeeeeeEEec------------------------
Q 048068           14 LCVSFILSALAQ---DVNQFIYHGFNE---DPQLQRDGLASVHSNGLLQLTNTVNS------------------------   63 (313)
Q Consensus        14 ~~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~l~~~~~~~~l~~~~~~~~------------------------   63 (313)
                      +.|.+..++.+.   ....++.|.+..   ....|.+.++.++|+|+++..+++..                        
T Consensus        16 G~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (383)
T 3eb0_A           16 GTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG   95 (383)
T ss_dssp             ECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------
T ss_pred             EeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccc
Confidence            334444444443   234566665532   34468889999999999999988742                        


Q ss_pred             -------------cCCeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCc
Q 048068           64 -------------RKGEFLLVYDYMPNGSLDKILHT--NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPAN  128 (313)
Q Consensus        64 -------------~~~~~~lV~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~n  128 (313)
                                   .+..+++||||++ ++|.+.+..  .....+++..++.++.||+.||.|||   ..+|+||||||+|
T Consensus        96 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~N  171 (383)
T 3eb0_A           96 VNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQN  171 (383)
T ss_dssp             --------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGG
T ss_pred             cccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHH
Confidence                         2345899999996 588888764  22457999999999999999999999   6999999999999


Q ss_pred             EEEc-CCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchh
Q 048068          129 VLLD-ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSME  206 (313)
Q Consensus       129 Ilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  206 (313)
                      |+++ .++.++|+|||++.......  ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+....+
T Consensus       172 il~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  249 (383)
T 3eb0_A          172 LLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID  249 (383)
T ss_dssp             EEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH
Confidence            9997 68899999999997654322  23345678999999998764 48999999999999999999999999877665


Q ss_pred             hhhHHHHHHHhhhhc------------cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          207 MVNLVDWVSDCWKKG------------AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       207 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ....+..........            ..............+...+..+.+||.+||+.||.+|||+.|+++|
T Consensus       250 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          250 QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            544432211110000            0000001111111233345678999999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.1e-34  Score=262.88  Aligned_cols=209  Identities=22%  Similarity=0.304  Sum_probs=158.0

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...|...++.++|++++++.+++.  .+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+
T Consensus       187 ~~~E~~~l~~l~hpniv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~  259 (419)
T 3i6u_A          187 VETEIEILKKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENG  259 (419)
T ss_dssp             HHHHHHHHHHCCCTTBCCCCEEEE--SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEe--cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            346788899999999999999876  35689999999999999988764  46999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCC---cEEEeecccccccCCCCCCccccccccccccccccccC---CCCCcchhhHHHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT---GKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l  192 (313)
                      ++||||||+||+++.++   .++|+|||++.......  ......|++.|+|||++.+   ..++.++|||||||++|+|
T Consensus       260 ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~l  337 (419)
T 3i6u_A          260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC  337 (419)
T ss_dssp             CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred             ccccCCChHhEEEecCCCcceEEEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHH
Confidence            99999999999997554   49999999997654322  2334578999999999853   5678899999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ++|..||............  +    ..+...      .........++.+.+||.+||+.||.+|||++|+++|-
T Consensus       338 ltg~~pf~~~~~~~~~~~~--i----~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          338 LSGYPPFSEHRTQVSLKDQ--I----TSGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HHSSCSSCCCSSSCCHHHH--H----HTTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHCCCCCCCCcchHHHHHH--H----hcCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            9999999865443322111  0    010000      00001122356789999999999999999999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-33  Score=246.20  Aligned_cols=209  Identities=22%  Similarity=0.306  Sum_probs=165.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|+++++.+++..+ ++..++||||+++++|.+++...  ..+++..++.++.|++.||.|||   ..++
T Consensus        53 ~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i  126 (276)
T 2yex_A           53 KKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGI  126 (276)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            356677788899999999998876 67899999999999999998753  45999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHhCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~  197 (313)
                      +|+||+|+||+++.++.++|+|||++........ .......++..|.|||.+.+..+ +.++|+||||+++|+|++|..
T Consensus       127 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  206 (276)
T 2yex_A          127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL  206 (276)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             eccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999875432211 12234568899999999987665 779999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ||............      +......        .......+..+.+++.+||+.||.+|||++|+++|-
T Consensus       207 p~~~~~~~~~~~~~------~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (276)
T 2yex_A          207 PWDQPSDSCQEYSD------WKEKKTY--------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (276)
T ss_dssp             CCSCSCTTSHHHHH------HHTTCTT--------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             CCCCCchHHHHHHH------hhhcccc--------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence            99876543221111      1111000        001123456788999999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-34  Score=257.86  Aligned_cols=221  Identities=24%  Similarity=0.334  Sum_probs=166.2

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..+...++.++|++++++++++.. ++..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+  ..++
T Consensus        79 ~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~~i  153 (360)
T 3eqc_A           79 IRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKI  153 (360)
T ss_dssp             HHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCC
T ss_pred             HHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCE
Confidence            356677888899999999998886 67899999999999999999874  359999999999999999999995  2389


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +|+||||+||+++.++.++|+|||++......   ......+++.|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus       154 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  230 (360)
T 3eqc_A          154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI  230 (360)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred             EcCCccHHHEEECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998644221   123356899999999999889999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHH-Hh--------hhhcc--------------c----cccccccccCCccHHHHHHHHHHHHHcCC
Q 048068          200 EQQGSMEMVNLVDWVS-DC--------WKKGA--------------I----LDASDSRLEGIYEEEQMELVLKLGLFCSH  252 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~-~~--------~~~~~--------------~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~  252 (313)
                      ................ ..        +..+.              .    ........+.......+..+.+||.+||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  310 (360)
T 3eqc_A          231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI  310 (360)
T ss_dssp             SCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHC
T ss_pred             CCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhh
Confidence            8765544322210000 00        00000              0    00000000111112235678999999999


Q ss_pred             CCCCCCCCHHHHHHHH
Q 048068          253 PKPEARPNMRQVMQYL  268 (313)
Q Consensus       253 ~~P~~Rpt~~ell~~L  268 (313)
                      .||.+|||++|+++|-
T Consensus       311 ~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          311 KNPAERADLKQLMVHA  326 (360)
T ss_dssp             SSTTTSCCHHHHHTSH
T ss_pred             cChhhCCCHHHHhhCh
Confidence            9999999999999964

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.8e-33  Score=251.03  Aligned_cols=236  Identities=21%  Similarity=0.262  Sum_probs=173.5

Q ss_pred             ceEEEcccCCCh----hhHHhhhhh--ccccceeeeeeEEeccC---CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           28 NQFIYHGFNEDP----QLQRDGLAS--VHSNGLLQLTNTVNSRK---GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        28 ~~~~~~~~~~~~----~~~~~~l~~--~~~~~~l~~~~~~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ..++.|.+....    ..+.+.++.  +.|++++++.++....+   ...++||||+++++|.+++...   .+++..++
T Consensus        66 ~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~  142 (342)
T 1b6c_B           66 EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMI  142 (342)
T ss_dssp             EEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHH
T ss_pred             ccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHH
Confidence            355666664322    234455555  78999999999988644   3799999999999999999864   59999999


Q ss_pred             HHHHHHHHHHHHhhhcC-----CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---cccccccccccccccc
Q 048068           99 RIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---QTTKLVGTFGYMAPEL  170 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~-----~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~  170 (313)
                      .++.|++.||.|||+..     ..+++|+||||+||+++.++.++|+|||++.........   ......+++.|+|||.
T Consensus       143 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  222 (342)
T 1b6c_B          143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  222 (342)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhh
Confidence            99999999999999210     279999999999999999999999999998765443211   1234568999999999


Q ss_pred             ccCCC------CCcchhhHHHHHHHHHHHhC----------CCCCccCCchhhhhHHHHHHHhhhhcccccccccccc-C
Q 048068          171 MRTGK------ASTSTDVYAFGVFMLEVASG----------RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE-G  233 (313)
Q Consensus       171 ~~~~~------~~~~~DiwslG~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  233 (313)
                      +.+..      ++.++||||||+++|+|++|          ..||............  ........    ...+..+ .
T Consensus       223 ~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~  296 (342)
T 1b6c_B          223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE--MRKVVCEQ----KLRPNIPNR  296 (342)
T ss_dssp             HTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH--HHHHHTTS----CCCCCCCGG
T ss_pred             hcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHH--HHHHHHHH----HhCCCCccc
Confidence            87652      33689999999999999999          7788654332211000  00111111    0111111 1


Q ss_pred             CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       234 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .......+.+.+||.+||+.||++|||+++++++|+...
T Consensus       297 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          297 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            123467788999999999999999999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-33  Score=267.51  Aligned_cols=209  Identities=26%  Similarity=0.348  Sum_probs=168.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .|...++.++|+++++....+.. ++.+|+||||++||+|.+++....  ...+++..++.++.||+.||.|||   ..+
T Consensus       234 ~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~g  309 (543)
T 3c4z_A          234 VEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRN  309 (543)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHhcCCCCEeeEEEEEee-CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcC
Confidence            46778889999999999998876 678999999999999999997643  456999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      |+||||||+||+++.+|.++|+|||++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|+.|
T Consensus       310 IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~P  388 (543)
T 3c4z_A          310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP  388 (543)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCC
Confidence            99999999999999999999999999976543321 23345789999999999998999999999999999999999999


Q ss_pred             CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Q 048068          199 IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM-----RQVMQY  267 (313)
Q Consensus       199 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~  267 (313)
                      |...........+  .......           ...++...+..+.+||.+||+.||.+||++     +++++|
T Consensus       389 F~~~~~~~~~~~~--~~~i~~~-----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          389 FRARGEKVENKEL--KQRVLEQ-----------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             SCCTTCCCCHHHH--HHHHHHC-----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             CCCCccchhHHHH--HHHHhhc-----------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            9875432211111  0111110           011233445678899999999999999964     788874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-34  Score=254.06  Aligned_cols=222  Identities=22%  Similarity=0.320  Sum_probs=165.4

Q ss_pred             cceEEEcccCC------ChhhHHhhhhhc-cccceeeeeeEEecc-----CCeEEEEEecCCCCCHHHHHhhCCCCCCCH
Q 048068           27 VNQFIYHGFNE------DPQLQRDGLASV-HSNGLLQLTNTVNSR-----KGEFLLVYDYMPNGSLDKILHTNIKPSLSW   94 (313)
Q Consensus        27 ~~~~~~~~~~~------~~~~~~~~l~~~-~~~~~l~~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~   94 (313)
                      ...+++|.+..      ....+...++.+ .|++++++++++...     .+..++||||+++++|.+++.......+++
T Consensus        49 ~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  128 (326)
T 2x7f_A           49 GQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE  128 (326)
T ss_dssp             CCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCH
T ss_pred             CCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCH
Confidence            34556665532      223455566676 799999999998753     468999999999999999998754457999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc--
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR--  172 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--  172 (313)
                      ..++.++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.  
T Consensus       129 ~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~  204 (326)
T 2x7f_A          129 EWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACD  204 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccc
Confidence            999999999999999999   5899999999999999999999999999987543221 1223456899999999986  


Q ss_pred             ---CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHH
Q 048068          173 ---TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF  249 (313)
Q Consensus       173 ---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  249 (313)
                         +..++.++|||||||++|+|++|..||...........+.      .. .        .+.......+..+.+||.+
T Consensus       205 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~-~--------~~~~~~~~~~~~l~~li~~  269 (326)
T 2x7f_A          205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP------RN-P--------APRLKSKKWSKKFQSFIES  269 (326)
T ss_dssp             ------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HS-C--------CCCCSCSCSCHHHHHHHHH
T ss_pred             cccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh------cC-c--------cccCCccccCHHHHHHHHH
Confidence               4567899999999999999999999997665443322211      00 0        0111122334678899999


Q ss_pred             cCCCCCCCCCCHHHHHHH
Q 048068          250 CSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       250 cl~~~P~~Rpt~~ell~~  267 (313)
                      ||..||.+|||+.++++|
T Consensus       270 ~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          270 CLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HCCSSGGGSCCHHHHHTS
T ss_pred             HhccChhhCCCHHHHhhC
Confidence            999999999999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.7e-34  Score=267.82  Aligned_cols=208  Identities=24%  Similarity=0.356  Sum_probs=168.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++||++++.++++.+ ++.+++||||+++|+|.+++...  ..+++..++.++.||+.||.|||   ..+|
T Consensus        94 ~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i  167 (504)
T 3q5i_A           94 YNEISLLKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNI  167 (504)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            356778889999999999999986 67899999999999999999764  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCC---cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          120 LHRDIKPANVLLDADL---NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      +||||||+||+++.++   .++|+|||++.......  ......|++.|+|||++. ..++.++|||||||++|+|++|.
T Consensus       168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~  244 (504)
T 3q5i_A          168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY  244 (504)
T ss_dssp             ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCC
Confidence            9999999999998776   59999999997654432  234457899999999987 46899999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +||.+....+....+..       +...      .........+..+.+||.+||..||.+|||++|+++|-.
T Consensus       245 ~pf~~~~~~~~~~~i~~-------~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~  304 (504)
T 3q5i_A          245 PPFGGQNDQDIIKKVEK-------GKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW  304 (504)
T ss_dssp             CSSCCSSHHHHHHHHHH-------CCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             CCCCCCCHHHHHHHHHc-------CCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence            99998776554433321       1000      000001123467899999999999999999999999753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.2e-34  Score=253.29  Aligned_cols=231  Identities=20%  Similarity=0.206  Sum_probs=172.5

Q ss_pred             cceEEEcccC-------CChhhHHhhhhhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHHHhhC--CCCCCCH
Q 048068           27 VNQFIYHGFN-------EDPQLQRDGLASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKILHTN--IKPSLSW   94 (313)
Q Consensus        27 ~~~~~~~~~~-------~~~~~~~~~l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~   94 (313)
                      ...++.|.+.       +....+...++.++|+++++..+++..   .....++||||+++++|.+++...  ....+++
T Consensus        54 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  133 (317)
T 2buj_A           54 GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE  133 (317)
T ss_dssp             CCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCH
T ss_pred             CcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCH
Confidence            3456666542       123356677788899999999998862   345889999999999999999752  2457999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--------cccccccccccc
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--------QTTKLVGTFGYM  166 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~y~  166 (313)
                      ..++.++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++.........        ......+++.|+
T Consensus       134 ~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  210 (317)
T 2buj_A          134 DQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR  210 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccC
Confidence            999999999999999999   589999999999999999999999999987643221100        011234688999


Q ss_pred             ccccccCCC---CCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          167 APELMRTGK---ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       167 aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      |||.+.+..   ++.++||||||+++|+|++|+.||............ ..    ...         .........+..+
T Consensus       211 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~----~~~---------~~~~~~~~~~~~l  276 (317)
T 2buj_A          211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-AV----QNQ---------LSIPQSPRHSSAL  276 (317)
T ss_dssp             CGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-HH----HCC-----------CCCCTTSCHHH
T ss_pred             CHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-Hh----hcc---------CCCCccccCCHHH
Confidence            999987554   688999999999999999999999642211110000 00    000         0001122345678


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhccCCC
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      .++|..||+.||.+|||+++++++|+...+.
T Consensus       277 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          277 WQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             HHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            9999999999999999999999999987643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.9e-34  Score=248.86  Aligned_cols=214  Identities=17%  Similarity=0.277  Sum_probs=162.5

Q ss_pred             cceEEEcccCC---ChhhHHhhhhhc-------cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--CCCCCH
Q 048068           27 VNQFIYHGFNE---DPQLQRDGLASV-------HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--KPSLSW   94 (313)
Q Consensus        27 ~~~~~~~~~~~---~~~~~~~~l~~~-------~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~   94 (313)
                      ...++.|.+..   ....+..+++++       .|+++++.++++.+ ++..++||||+++++|.+++....  ...+++
T Consensus        36 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  114 (289)
T 1x8b_A           36 GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKE  114 (289)
T ss_dssp             CCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCH
T ss_pred             CceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEEEEecCCCcHHHHHHhhcccccCCCH
Confidence            34566665542   222334444444       89999999999876 678999999999999999997632  256999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-------------------CcEEEeecccccccCCCCCCc
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-------------------LNGKLGDFGLARLYDHDTIPQ  155 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-------------------~~~~l~dfg~~~~~~~~~~~~  155 (313)
                      ..++.++.||+.||.|||   ..+++|+||||+||+++.+                   ..++|+|||.+.......   
T Consensus       115 ~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---  188 (289)
T 1x8b_A          115 AELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---  188 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---
Confidence            999999999999999999   5899999999999999844                   478999999987654322   


Q ss_pred             cccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          156 TTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                        ...++..|+|||.+.+. .++.++||||||+++|++++|.+++.....   ...+       ..+..     +    .
T Consensus       189 --~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~-------~~~~~-----~----~  247 (289)
T 1x8b_A          189 --VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI-------RQGRL-----P----R  247 (289)
T ss_dssp             --CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH-------HTTCC-----C----C
T ss_pred             --ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH-------HcCCC-----C----C
Confidence              23588999999999865 556899999999999999999987654321   1111       01110     1    1


Q ss_pred             ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          235 YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       235 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .+...+..+.+++.+||+.||.+|||+.++++|-
T Consensus       248 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          248 IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            2223456789999999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.3e-34  Score=255.49  Aligned_cols=244  Identities=19%  Similarity=0.222  Sum_probs=170.4

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCC-------hhhHHhhhhh-ccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNED-------PQLQRDGLAS-VHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~l~~-~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      ++.|.+..++...+   ...+++|.+...       ...+.+.+.+ ..|+++++..+++.. ++.+++||||+++++|.
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~   99 (316)
T 2ac3_A           21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLVFEKMRGGSIL   99 (316)
T ss_dssp             CCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTCBHH
T ss_pred             ecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEEcCCCCcHH
Confidence            34444444444432   346666665321       2234455555 479999999999886 67899999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc---EEEeecccccccCCCCC-----
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGLARLYDHDTI-----  153 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~---~~l~dfg~~~~~~~~~~-----  153 (313)
                      +++...  ..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.   ++|+|||++........     
T Consensus       100 ~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (316)
T 2ac3_A          100 SHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS  174 (316)
T ss_dssp             HHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence            999864  35999999999999999999999   589999999999999988766   99999999865432111     


Q ss_pred             -CccccccccccccccccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhH--------HHHHHHhhh
Q 048068          154 -PQTTKLVGTFGYMAPELMRT-----GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL--------VDWVSDCWK  219 (313)
Q Consensus       154 -~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------~~~~~~~~~  219 (313)
                       .......|++.|+|||.+.+     ..++.++|||||||++|+|++|+.||.+....+....        .........
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  254 (316)
T 2ac3_A          175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ  254 (316)
T ss_dssp             -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred             ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence             11223458999999999864     4578899999999999999999999987543321000        000001111


Q ss_pred             hccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          220 KGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .+..      ..+.......+..+.+||.+||+.||.+|||+.|+++|-
T Consensus       255 ~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          255 EGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             HCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             ccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            1100      000000112346789999999999999999999999964

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.2e-34  Score=256.04  Aligned_cols=222  Identities=19%  Similarity=0.292  Sum_probs=168.3

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH------HhhCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI------LHTNIKPSLSWYQRFRIIRGVASGLLYLH  112 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~~~~~~i~~qi~~al~~lh  112 (313)
                      ...+...++.++|+++++..+++.. ++..++||||+++++|.++      +.......+++..++.++.||+.||.|||
T Consensus        90 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  168 (348)
T 2pml_X           90 FKNELQIITDIKNEYCLTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH  168 (348)
T ss_dssp             HHHHHHHHTTCCCTTBCCCSEEEES-SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh
Confidence            3466788889999999999999887 5789999999999999999      66544567999999999999999999999


Q ss_pred             hcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCc-chhhHHHHHHHH
Q 048068          113 EDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KAST-STDVYAFGVFML  190 (313)
Q Consensus       113 s~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~  190 (313)
                      +  ..+++|+||+|+||+++.++.++|+|||++......   ......++..|+|||.+.+. .++. ++||||||+++|
T Consensus       169 ~--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  243 (348)
T 2pml_X          169 N--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY  243 (348)
T ss_dssp             H--TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred             c--cCCEeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence            4  289999999999999999999999999998765432   23345688999999999876 5555 999999999999


Q ss_pred             HHHhCCCCCccCCc-hhhhhHHHHHHHhhhhc----cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 048068          191 EVASGRRPIEQQGS-MEMVNLVDWVSDCWKKG----AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM  265 (313)
Q Consensus       191 ~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell  265 (313)
                      +|++|..||..... .+....+.  .......    ..................+..+.+|+.+||+.||.+|||+.|++
T Consensus       244 ~l~~g~~pf~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l  321 (348)
T 2pml_X          244 VMFYNVVPFSLKISLVELFNNIR--TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL  321 (348)
T ss_dssp             HHHHSSCSSCCSSCSHHHHHHHT--SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             HHHhCCCCCCCCCcHHHHHHHHh--ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            99999999987665 22221110  0000000    00000000000001133456789999999999999999999999


Q ss_pred             HHH
Q 048068          266 QYL  268 (313)
Q Consensus       266 ~~L  268 (313)
                      +|-
T Consensus       322 ~hp  324 (348)
T 2pml_X          322 KHE  324 (348)
T ss_dssp             TSG
T ss_pred             cCc
Confidence            863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.4e-33  Score=249.85  Aligned_cols=221  Identities=22%  Similarity=0.335  Sum_probs=168.7

Q ss_pred             hHHhhhhhc---cccceeeeeeEEe----ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           41 LQRDGLASV---HSNGLLQLTNTVN----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        41 ~~~~~l~~~---~~~~~l~~~~~~~----~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      .+...++.+   .|+++++.++++.    ......++||||++ ++|.+++.......+++..++.++.||+.||.||| 
T Consensus        60 ~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH-  137 (326)
T 1blx_A           60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH-  137 (326)
T ss_dssp             HHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            445555555   8999999999876    24668999999996 69999998765566999999999999999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                        ..|++|+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.+..++.++||||||+++|+|+
T Consensus       138 --~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  213 (326)
T 1blx_A          138 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF  213 (326)
T ss_dssp             --HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             --HCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence              5899999999999999999999999999986543221  233456789999999999888999999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHH-----hhhhccc-----cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSD-----CWKKGAI-----LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      +|+.||.+....+....+.....     .|.....     ................+..+.+||.+||+.||.+|||+.+
T Consensus       214 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  293 (326)
T 1blx_A          214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  293 (326)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            99999988766554433321110     1111000     0000001111122345567889999999999999999999


Q ss_pred             HHHH
Q 048068          264 VMQY  267 (313)
Q Consensus       264 ll~~  267 (313)
                      +++|
T Consensus       294 ~l~h  297 (326)
T 1blx_A          294 ALSH  297 (326)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9976

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-35  Score=269.50  Aligned_cols=226  Identities=18%  Similarity=0.118  Sum_probs=163.8

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC----Ch------hhHH---hhhhhccccceeeee-------eEEeccCC--
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE----DP------QLQR---DGLASVHSNGLLQLT-------NTVNSRKG--   66 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~----~~------~~~~---~~l~~~~~~~~l~~~-------~~~~~~~~--   66 (313)
                      .++.|.+..++.+.+   ...+++|.+..    ..      ..|.   +.++.+.|+++++.+       +++...+.  
T Consensus        80 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~  159 (377)
T 3byv_A           80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK  159 (377)
T ss_dssp             EEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCS
T ss_pred             eeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcc
Confidence            344555555555543   44677777631    11      1333   445556899999887       55554322  


Q ss_pred             --------------eEEEEEecCCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCC
Q 048068           67 --------------EFLLVYDYMPNGSLDKILHTNIK-----PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPA  127 (313)
Q Consensus        67 --------------~~~lV~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~  127 (313)
                                    ..++||||+ +|+|.+++.....     ..+++..++.++.||+.||.|||   ..+|+||||||+
T Consensus       160 ~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~  235 (377)
T 3byv_A          160 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPV  235 (377)
T ss_dssp             EEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred             ccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence                          388999999 6899999986311     12334888899999999999999   489999999999


Q ss_pred             cEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-----------CCCcchhhHHHHHHHHHHHhCC
Q 048068          128 NVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-----------KASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       128 nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~ll~g~  196 (313)
                      ||+++.++.+||+|||++.....    ......| +.|+|||++.+.           .++.++|||||||++|+|++|+
T Consensus       236 NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~  310 (377)
T 3byv_A          236 DIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD  310 (377)
T ss_dssp             GEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             HEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence            99999999999999999975332    2234456 899999999877           7899999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .||.+.........+                ..     .....++.+.+||.+||+.||.+|||+.|+++|
T Consensus       311 ~Pf~~~~~~~~~~~~----------------~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          311 LPITKDAALGGSEWI----------------FR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             CCC------CCSGGG----------------GS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             CCCcccccccchhhh----------------hh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999765543322111                00     011234678899999999999999999999974

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.7e-34  Score=250.90  Aligned_cols=230  Identities=23%  Similarity=0.334  Sum_probs=167.7

Q ss_pred             cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--CCCCCCH
Q 048068           27 VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--IKPSLSW   94 (313)
Q Consensus        27 ~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~   94 (313)
                      ...++.|.+..          ....+...++.++|+++++.++++.. ++..++||||+++++|.+++...  ....+++
T Consensus        57 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  135 (310)
T 2wqm_A           57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPE  135 (310)
T ss_dssp             CCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCH
T ss_pred             CceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEEEEecCCCCCHHHHHHHhcccccCCCH
Confidence            45666665542          12245667788899999999999886 66899999999999999999742  2456999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG  174 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  174 (313)
                      ..++.++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+.
T Consensus       136 ~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~  211 (310)
T 2wqm_A          136 RTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHEN  211 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCCC
Confidence            999999999999999999   58999999999999999999999999999875443221 22335678999999999988


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCC
Q 048068          175 KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPK  254 (313)
Q Consensus       175 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  254 (313)
                      .++.++||||||+++|+|++|..||.+..... ......+    .....        +.......+..+.+++.+||+.|
T Consensus       212 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~~--------~~~~~~~~~~~l~~li~~~l~~d  278 (310)
T 2wqm_A          212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI----EQCDY--------PPLPSDHYSEELRQLVNMCINPD  278 (310)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHH----HTTCS--------CCCCTTTSCHHHHHHHHHHTCSS
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHh----hcccC--------CCCcccccCHHHHHHHHHHcCCC
Confidence            89999999999999999999999997643221 1111111    11110        01111234567889999999999


Q ss_pred             CCCCCCHHHHHHHHhccCCC
Q 048068          255 PEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       255 P~~Rpt~~ell~~L~~~~~~  274 (313)
                      |.+|||+++++++|+...+.
T Consensus       279 p~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          279 PEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             GGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHHHHHHh
Confidence            99999999999999887633

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.2e-33  Score=274.31  Aligned_cols=209  Identities=22%  Similarity=0.349  Sum_probs=167.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.++|+|+++.++++.  ++..++||||+++|+|.++++.. ...+++..++.++.||+.||.|||   ..+++
T Consensus       440 ~E~~~l~~l~HpnIv~l~~~~~--~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~giv  513 (656)
T 2j0j_A          440 QEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFV  513 (656)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEC--SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCCCeEEEEEe--cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            4556777889999999999885  45689999999999999999865 346999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      ||||||+||+++.++.++|+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       514 HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  593 (656)
T 2j0j_A          514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  593 (656)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999997654433222333456788999999988889999999999999999997 99999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+....+....+.       .+.         ....+...+..+.++|.+||+.||.+|||+.++++.|++.
T Consensus       594 ~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          594 QGVKNNDVIGRIE-------NGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             TTCCHHHHHHHHH-------HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHH-------cCC---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            8766554433221       111         0112334456789999999999999999999999999865

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8e-34  Score=263.10  Aligned_cols=180  Identities=27%  Similarity=0.307  Sum_probs=138.5

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccC----CeEEEEEecCCC
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRK----GEFLLVYDYMPN   77 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~----~~~~lV~e~~~~   77 (313)
                      +.|.+..++.+.+   ...++.|.+..         ....|...++.++|++++++++++....    ..+|+||||++ 
T Consensus        35 G~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-  113 (432)
T 3n9x_A           35 GRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-  113 (432)
T ss_dssp             EEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-
T ss_pred             eecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-
Confidence            3444444444433   34567776643         2235667788889999999999987543    67999999995 


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC----
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI----  153 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~----  153 (313)
                      ++|.++++..  ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++........    
T Consensus       114 ~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  188 (432)
T 3n9x_A          114 SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV  188 (432)
T ss_dssp             EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC---------
T ss_pred             cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccc
Confidence            6999999863  469999999999999999999994   8999999999999999999999999999976543211    


Q ss_pred             -----------------Cccccccccccccccccc-cCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          154 -----------------PQTTKLVGTFGYMAPELM-RTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       154 -----------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                                       .......+|+.|+|||++ ....++.++|||||||++|+|++|..||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence                             112456789999999986 4566899999999999999999854443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.1e-34  Score=255.45  Aligned_cols=242  Identities=19%  Similarity=0.205  Sum_probs=157.6

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCChhhH---HhhhhhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNEDPQLQ---RDGLASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~---~~~l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..++...+   ...+++|.+.......   ...++.+.|++++++.+++..   .+..+++||||+++++|.++
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~  116 (336)
T 3fhr_A           37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR  116 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHH
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHH
Confidence            34444444444433   4467777775544333   344566789999999998873   24568999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---CCcEEEeecccccccCCCCCCcccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      +.......+++..++.++.||+.||.|||   ..+++|+||||+||+++.   ++.++|+|||++.......   .....
T Consensus       117 l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~  190 (336)
T 3fhr_A          117 IQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC  190 (336)
T ss_dssp             HHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc---cccCC
Confidence            98765567999999999999999999999   589999999999999976   4559999999987544322   23456


Q ss_pred             ccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHH
Q 048068          161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM  240 (313)
Q Consensus       161 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (313)
                      +++.|+|||.+.+..++.++||||||+++|+|++|..||..............   ....      .....+.......+
T Consensus       191 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~  261 (336)
T 3fhr_A          191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRL------GQYGFPNPEWSEVS  261 (336)
T ss_dssp             -------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CCCTTTSTTCC
T ss_pred             CCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhc------cccccCchhhccCC
Confidence            78999999999888889999999999999999999999976554332111100   0000      00001111122345


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          241 ELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      ..+.+||..||+.||.+|||++|+++|-.
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          262 EDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            67889999999999999999999999553

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=247.22  Aligned_cols=210  Identities=22%  Similarity=0.365  Sum_probs=165.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ..+...++.+.|++++++.+++.. ++..++||||+++++|.+++.... ...+++..++.++.||+.||.|||   ..+
T Consensus        67 ~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~  142 (295)
T 2clq_A           67 HEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ  142 (295)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCC
Confidence            356678888999999999999876 668999999999999999998652 345789999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCccccccccccccccccccCC--CCCcchhhHHHHHHHHHHHhC
Q 048068          119 VLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       119 i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g  195 (313)
                      ++|+||+|+||+++. ++.++|+|||++....... .......++..|+|||.+.+.  .++.++|+||||+++|+|++|
T Consensus       143 i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  221 (295)
T 2clq_A          143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG  221 (295)
T ss_dssp             EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred             EEccCCChhhEEEECCCCCEEEeecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            999999999999987 8899999999987654322 122345688999999998754  378999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..||.............   ...           ......+...+..+.++|.+||+.||++|||+.++++|-
T Consensus       222 ~~pf~~~~~~~~~~~~~---~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~  280 (295)
T 2clq_A          222 KPPFYELGEPQAAMFKV---GMF-----------KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE  280 (295)
T ss_dssp             SCTTGGGSSHHHHHHHH---HHH-----------CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred             CCCccCCCchhHHHHhh---ccc-----------cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            99997654433211110   000           011112334456788999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-33  Score=253.61  Aligned_cols=253  Identities=20%  Similarity=0.183  Sum_probs=172.5

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC------hhhHHhhhhhccccceeeeeeEEecc------CCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSR------KGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~------~~~~~lV~e~~~   76 (313)
                      .++.|.+..++...+   ...+++|.+...      ...+.+.++.++|+|++++.+++...      ...+++||||++
T Consensus        30 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~  109 (360)
T 3e3p_A           30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP  109 (360)
T ss_dssp             ---------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCS
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccc
Confidence            456666666666654   346677765332      22333445667999999999988632      223789999996


Q ss_pred             CCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-CCcEEEeecccccccCCCCC
Q 048068           77 NGSLDKILHT--NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTI  153 (313)
Q Consensus        77 ~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~  153 (313)
                      + +|...+..  .....+++..++.++.|++.||.|||.. ..+|+|+||||+||+++. ++.++|+|||++....... 
T Consensus       110 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-  186 (360)
T 3e3p_A          110 D-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-  186 (360)
T ss_dssp             C-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-
T ss_pred             c-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-
Confidence            5 65555442  2255799999999999999999999921 289999999999999996 8999999999997654332 


Q ss_pred             CccccccccccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh-----hhh----ccc
Q 048068          154 PQTTKLVGTFGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC-----WKK----GAI  223 (313)
Q Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~----~~~  223 (313)
                       ......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.........+......     +..    ...
T Consensus       187 -~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3e3p_A          187 -PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD  265 (360)
T ss_dssp             -CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCC
T ss_pred             -CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhh
Confidence             233456799999999986554 799999999999999999999999987765544433211100     000    000


Q ss_pred             cccc------cccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          224 LDAS------DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       224 ~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ....      ............+..+.+||.+||+.||.+|||+.|+++|-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            0000      00000112223567899999999999999999999999973

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-32  Score=249.02  Aligned_cols=249  Identities=17%  Similarity=0.162  Sum_probs=178.2

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCChh------hHHhhhhhcccc------ceeeeeeEEeccCCeEEEEEecCCC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNEDPQ------LQRDGLASVHSN------GLLQLTNTVNSRKGEFLLVYDYMPN   77 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~l~~~~~~------~~l~~~~~~~~~~~~~~lV~e~~~~   77 (313)
                      ++.|.+..++...+   ...+++|.+.....      .+...++.+.+.      ++++..+.+.. ++..|+||||+. 
T Consensus        62 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e~~~-  139 (382)
T 2vx3_A           62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCLVFEMLS-  139 (382)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-TTEEEEEEECCC-
T ss_pred             EeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-CCceEEEEecCC-
Confidence            34445555555533   34577777754432      344555555433      37777777765 579999999995 


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc--CCCcEEEeecccccccCCCCCCc
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD--ADLNGKLGDFGLARLYDHDTIPQ  155 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~--~~~~~~l~dfg~~~~~~~~~~~~  155 (313)
                      ++|.+++.......+++..++.++.||+.||.|||+. ..+|+||||||+||+++  .++.++|+|||++......    
T Consensus       140 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~----  214 (382)
T 2vx3_A          140 YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----  214 (382)
T ss_dssp             CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC----
T ss_pred             CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc----
Confidence            5999999876556799999999999999999999942 36899999999999995  4778999999999765432    


Q ss_pred             cccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhh-----hc-----cccc
Q 048068          156 TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK-----KG-----AILD  225 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~-----~~~~  225 (313)
                      .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+........     ..     ....
T Consensus       215 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  294 (382)
T 2vx3_A          215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEK  294 (382)
T ss_dssp             CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEE
T ss_pred             cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHh
Confidence            2345788999999999988999999999999999999999999998776654443322111000     00     0000


Q ss_pred             ccc-----------------c--------------------cccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          226 ASD-----------------S--------------------RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       226 ~~~-----------------~--------------------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..+                 +                    ...........+.+.+||.+||+.||++|||++|+++|-
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp  374 (382)
T 2vx3_A          295 LPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS  374 (382)
T ss_dssp             CTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCc
Confidence            000                 0                    000011223456889999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.2e-33  Score=245.98  Aligned_cols=207  Identities=27%  Similarity=0.405  Sum_probs=165.1

Q ss_pred             hHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .+...++.+. |+++++..++... ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..++
T Consensus        72 ~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i  145 (298)
T 1phk_A           72 KEVDILRKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNI  145 (298)
T ss_dssp             HHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhcCCCCEeeeeeeecc-CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            4455666774 9999999999876 67899999999999999999864  35999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc------CCCCCcchhhHHHHHHHHHHH
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR------TGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll  193 (313)
                      +|+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+.      ...++.++||||||+++|+|+
T Consensus       146 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~  223 (298)
T 1phk_A          146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL  223 (298)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred             ccCCCCcceEEEcCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHH
Confidence            999999999999999999999999987654322  233456889999999884      456788999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      +|..||...........+.       .+..      ..........+..+.+++.+||+.||.+|||+.|+++|-
T Consensus       224 ~g~~p~~~~~~~~~~~~~~-------~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (298)
T 1phk_A          224 AGSPPFWHRKQMLMLRMIM-------SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  285 (298)
T ss_dssp             HSSCSSCCSSHHHHHHHHH-------HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             HCCCCCcCccHHHHHHHHh-------cCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence            9999998765443332221       1000      011111223456789999999999999999999999853

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.2e-33  Score=253.25  Aligned_cols=218  Identities=19%  Similarity=0.214  Sum_probs=157.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccC-----CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.++|++++++.+++...+     ...++||||++ ++|.+.+..    .+++..+..++.||+.||.|||   
T Consensus        73 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---  144 (371)
T 2xrw_A           73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---  144 (371)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---
T ss_pred             HHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---
Confidence            4567778889999999999987533     37899999996 588888863    3899999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      ..+++|+||||+||+++.++.++|+|||++.......  ......+++.|+|||.+.+..++.++|||||||++|+|++|
T Consensus       145 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  222 (371)
T 2xrw_A          145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG  222 (371)
T ss_dssp             HTTCCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             HCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence            5899999999999999999999999999987544321  22345789999999999988899999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHH-----Hhh-----------hhcccc------ccccc---cccCCccHHHHHHHHHHHHHc
Q 048068          196 RRPIEQQGSMEMVNLVDWVS-----DCW-----------KKGAIL------DASDS---RLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~-----~~~-----------~~~~~~------~~~~~---~~~~~~~~~~~~~l~~li~~c  250 (313)
                      ..||.+.+..+....+....     ..+           ......      .....   ..........+..+.+||.+|
T Consensus       223 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m  302 (371)
T 2xrw_A          223 GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM  302 (371)
T ss_dssp             SCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHH
Confidence            99998876554433221000     000           000000      00000   000011223467899999999


Q ss_pred             CCCCCCCCCCHHHHHHHH
Q 048068          251 SHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~L  268 (313)
                      |..||.+|||++|+++|-
T Consensus       303 L~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          303 LVIDASKRISVDEALQHP  320 (371)
T ss_dssp             SCSSGGGSCCHHHHHHSH
T ss_pred             CcCChhhCCCHHHHhCCc
Confidence            999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-33  Score=255.26  Aligned_cols=222  Identities=23%  Similarity=0.223  Sum_probs=160.6

Q ss_pred             hhHHhhhhhccccceeeeeeEEec----cCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNS----RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      ..+...++.++|+++++..+++..    ....+++||||++ ++|.+.+... ...+++..++.++.||+.||.|||   
T Consensus        77 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---  151 (362)
T 3pg1_A           77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---  151 (362)
T ss_dssp             HHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred             HHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---
Confidence            457778888999999999998852    2447899999996 6888888754 456999999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHh
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~  194 (313)
                      ..+++|+||||+||+++.++.++|+|||++.......  ......+++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus       152 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  229 (362)
T 3pg1_A          152 EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN  229 (362)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred             HCcCEecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh
Confidence            5899999999999999999999999999997443322  2234567889999999876 678999999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhh------------c---cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKK------------G---AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP  259 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~------------~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  259 (313)
                      |+.||.+....+....+.........            .   ..................+..+.+||.+||+.||.+||
T Consensus       230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  309 (362)
T 3pg1_A          230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI  309 (362)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC
Confidence            99999877655444333111000000            0   00000000011111223356789999999999999999


Q ss_pred             CHHHHHHHH
Q 048068          260 NMRQVMQYL  268 (313)
Q Consensus       260 t~~ell~~L  268 (313)
                      |+.|+++|-
T Consensus       310 t~~ell~hp  318 (362)
T 3pg1_A          310 STEQALRHP  318 (362)
T ss_dssp             CHHHHHTSG
T ss_pred             CHHHHHcCc
Confidence            999999974

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.2e-33  Score=255.77  Aligned_cols=207  Identities=22%  Similarity=0.303  Sum_probs=156.1

Q ss_pred             hHHhhhhhcc--ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVH--SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~--~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .|...++.+.  |+++++++++... ++.+++|||+ .+++|.+++...  ..+++..++.++.||+.||.|||   ..+
T Consensus       103 ~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~  175 (390)
T 2zmd_A          103 NEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHG  175 (390)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---TTT
T ss_pred             HHHHHHHHcccCCCeEEEEEEEEec-CCEEEEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            4555666775  5999999998876 5689999995 588999999874  36899999999999999999999   689


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccC-----------CCCCcchhhHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRT-----------GKASTSTDVYAFG  186 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG  186 (313)
                      |+||||||+||+++ ++.+||+|||++......... ......||+.|+|||++.+           ..++.++||||||
T Consensus       176 ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG  254 (390)
T 2zmd_A          176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG  254 (390)
T ss_dssp             CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred             eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence            99999999999995 578999999999765432211 2234578999999999864           3678999999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      |++|+|++|+.||......... ..    .....         ......+...+..+.+||.+||+.||.+|||+.|+++
T Consensus       255 vil~ell~G~~Pf~~~~~~~~~-~~----~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          255 CILYYMTYGKTPFQQIINQISK-LH----AIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHHHHHSSCTTTTCCCHHHH-HH----HHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHCCCcchhhhHHHHH-HH----HHhCc---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            9999999999999765432111 11    11110         0011111122456889999999999999999999999


Q ss_pred             HHh
Q 048068          267 YLD  269 (313)
Q Consensus       267 ~L~  269 (313)
                      |-.
T Consensus       321 hp~  323 (390)
T 2zmd_A          321 HPY  323 (390)
T ss_dssp             SHH
T ss_pred             CcC
Confidence            753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-33  Score=250.50  Aligned_cols=208  Identities=23%  Similarity=0.321  Sum_probs=162.5

Q ss_pred             hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           39 PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      ...+.+.++.++|++++++.+++...  ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+
T Consensus        62 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~  134 (322)
T 2ycf_A           62 VETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENG  134 (322)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEESS--SEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHHHhCCCCCCceEeeEEcCC--ceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            34677888999999999999998753  489999999999999999763  46999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCc---EEEeecccccccCCCCCCcccccccccccccccccc---CCCCCcchhhHHHHHHHHHH
Q 048068          119 VLHRDIKPANVLLDADLN---GKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR---TGKASTSTDVYAFGVFMLEV  192 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l  192 (313)
                      ++|+||||+||+++.++.   ++|+|||++.......  ......+++.|+|||.+.   ...++.++|||||||++|+|
T Consensus       135 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l  212 (322)
T 2ycf_A          135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC  212 (322)
T ss_dssp             EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHH
Confidence            999999999999987654   9999999987654321  223456899999999873   45678999999999999999


Q ss_pred             HhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          193 ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       193 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ++|..||............  +    ..+...      .........+..+.+|+.+||+.||++|||+.++++|
T Consensus       213 ~~g~~pf~~~~~~~~~~~~--~----~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          213 LSGYPPFSEHRTQVSLKDQ--I----TSGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHSSCSSCSTTCSSCHHHH--H----HHTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhCCCCCcccchHHHHHHH--H----HhCccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            9999999865543222111  0    011000      0000112235678899999999999999999999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.6e-32  Score=248.98  Aligned_cols=248  Identities=19%  Similarity=0.251  Sum_probs=174.1

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCCCh------hhHHhhhhhcc-----------ccceeeeeeEEecc---CCeEEE
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNEDP------QLQRDGLASVH-----------SNGLLQLTNTVNSR---KGEFLL   70 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~l~~~~-----------~~~~l~~~~~~~~~---~~~~~l   70 (313)
                      +.|.+..++...+   ...+++|.+....      ..+...++.+.           |+++++..+++...   ...+++
T Consensus        28 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  107 (373)
T 1q8y_A           28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM  107 (373)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEE
T ss_pred             eecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEE
Confidence            3344444444442   3466777765432      23444555554           78999999888742   337899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CceecCcCCCcEEEcC------CCcEEEeecc
Q 048068           71 VYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ-VVLHRDIKPANVLLDA------DLNGKLGDFG  143 (313)
Q Consensus        71 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~-~i~H~dl~~~nIlv~~------~~~~~l~dfg  143 (313)
                      |||++ +++|.+++.......+++..++.++.||+.||.|||+   . +|+|+||||+||+++.      .+.++|+|||
T Consensus       108 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg  183 (373)
T 1q8y_A          108 VFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG  183 (373)
T ss_dssp             EECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCT
T ss_pred             EEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcceEEEcccc
Confidence            99999 8999999987655679999999999999999999995   6 9999999999999953      3479999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhh----
Q 048068          144 LARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK----  219 (313)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----  219 (313)
                      ++......    .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||....................    
T Consensus       184 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (373)
T 1q8y_A          184 NACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE  259 (373)
T ss_dssp             TCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred             cccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCC
Confidence            98765432    2234679999999999988899999999999999999999999986543221111110000000    


Q ss_pred             -------hc-----------ccccccc---------ccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          220 -------KG-----------AILDASD---------SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       220 -------~~-----------~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                             ..           .......         .......+...+..+.+||.+||+.||.+|||++|+++|-.
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  336 (373)
T 1q8y_A          260 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW  336 (373)
T ss_dssp             CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred             CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChh
Confidence                   00           0000000         00111345677889999999999999999999999999643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.2e-34  Score=259.79  Aligned_cols=185  Identities=13%  Similarity=0.071  Sum_probs=139.1

Q ss_pred             CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEE
Q 048068           66 GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR------FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL  139 (313)
Q Consensus        66 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~------~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l  139 (313)
                      ..+|+||||++ ++|.+++... ...+++...      +.++.||+.||.|||   ..+|+||||||+||+++.++.+||
T Consensus       161 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL  235 (371)
T 3q60_A          161 ANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLML  235 (371)
T ss_dssp             EEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEEE
T ss_pred             eeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEEE
Confidence            45899999997 8999999864 223455555      677799999999999   589999999999999999999999


Q ss_pred             eecccccccCCCCCCccccccccccccccccccC--CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh
Q 048068          140 GDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT--GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC  217 (313)
Q Consensus       140 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  217 (313)
                      +|||++......    .....+++.|+|||.+.+  ..++.++|||||||++|+|++|+.||.+.......        .
T Consensus       236 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--------~  303 (371)
T 3q60_A          236 GDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG--------S  303 (371)
T ss_dssp             CCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT--------C
T ss_pred             EecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc--------c
Confidence            999999755321    213456799999999987  67899999999999999999999999876432211        0


Q ss_pred             hhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          218 WKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +.....................+..+.+||.+||+.||++|||+.++++|
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000001111111122446788999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.3e-33  Score=245.79  Aligned_cols=202  Identities=23%  Similarity=0.310  Sum_probs=149.7

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-Ccee
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT--NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ-VVLH  121 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~-~i~H  121 (313)
                      .++.+.|+++++..+++.+ ++..++||||++ ++|.+++..  .....+++..++.++.||+.||.|||+   . +++|
T Consensus        59 ~~~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H  133 (290)
T 3fme_A           59 SMRTVDCPFTVTFYGALFR-EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIH  133 (290)
T ss_dssp             HHTTCCCTTBCCEEEEEEC-SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCC
T ss_pred             HHHhCCCCeEEEEeeeeec-cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeec
Confidence            3677899999999999886 668999999996 588888764  124579999999999999999999995   6 9999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccc----cCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM----RTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      +||||+||+++.++.++|+|||++.......  ......+++.|+|||.+    .+..++.++||||||+++|+|++|..
T Consensus       134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  211 (290)
T 3fme_A          134 RDVKPSNVLINALGQVKMCDFGISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF  211 (290)
T ss_dssp             CCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSC
T ss_pred             CCCCHHHEEECCCCCEEEeecCCcccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCC
Confidence            9999999999999999999999987554332  22334688999999996    45678899999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||............     .....         .........+..+.+++.+||+.||++|||+.|+++|
T Consensus       212 p~~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          212 PYDSWGTPFQQLKQ-----VVEEP---------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             SSCCCSCHHHHHHH-----HHHSC---------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CccccCchHHHHHH-----HhccC---------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            99764433211111     11110         0111112345678999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-32  Score=247.36  Aligned_cols=232  Identities=16%  Similarity=0.212  Sum_probs=171.5

Q ss_pred             ceEEEcccCCC------hhhHHhhhhhccccc------eeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHH
Q 048068           28 NQFIYHGFNED------PQLQRDGLASVHSNG------LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWY   95 (313)
Q Consensus        28 ~~~~~~~~~~~------~~~~~~~l~~~~~~~------~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~   95 (313)
                      ..+++|.+...      ...+...++.+.|++      ++...+++.. .++.++||||+ +++|.+.+.......+++.
T Consensus        46 ~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~  123 (355)
T 2eu9_A           46 SQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-HGHMCIAFELL-GKNTFEFLKENNFQPYPLP  123 (355)
T ss_dssp             EEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTTTCCCCHH
T ss_pred             eEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-CCeEEEEEecc-CCChHHHHHhccCCCCCHH
Confidence            35677766543      234556677777766      6666666655 67899999999 6788888876655679999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEE-------------------cCCCcEEEeecccccccCCCCCCcc
Q 048068           96 QRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL-------------------DADLNGKLGDFGLARLYDHDTIPQT  156 (313)
Q Consensus        96 ~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv-------------------~~~~~~~l~dfg~~~~~~~~~~~~~  156 (313)
                      .++.++.||+.||.|||   ..+|+|+||||+||++                   +.++.++|+|||++......    .
T Consensus       124 ~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~  196 (355)
T 2eu9_A          124 HVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----H  196 (355)
T ss_dssp             HHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----C
T ss_pred             HHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc----c
Confidence            99999999999999999   6899999999999999                   56788999999999754332    2


Q ss_pred             ccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhh-----hcccccc-----
Q 048068          157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWK-----KGAILDA-----  226 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-----  226 (313)
                      ....+++.|+|||.+.+..++.++|||||||++|+|++|..||......+....+........     .......     
T Consensus       197 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  276 (355)
T 2eu9_A          197 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGG  276 (355)
T ss_dssp             CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTE
T ss_pred             cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccc
Confidence            345689999999999988999999999999999999999999988766554433322111000     0000000     


Q ss_pred             ----------------ccc-cccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          227 ----------------SDS-RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       227 ----------------~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                                      ..+ .............+.+||.+||+.||.+|||+.|+++|-
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp  335 (355)
T 2eu9_A          277 LVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP  335 (355)
T ss_dssp             ECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSG
T ss_pred             cccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                            000 000112234567899999999999999999999999763

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-33  Score=249.04  Aligned_cols=208  Identities=21%  Similarity=0.338  Sum_probs=162.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+...++.+.|+++++..+++.. ++..++||||+++++|.+++... ...+++..++.++.||+.||.|||   ..+++
T Consensus        65 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  139 (302)
T 2j7t_A           65 VEIEILATCDHPYIVKLLGAYYH-DGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH---SKRII  139 (302)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHhcCCCCCEeeeeeeeee-CCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh---cCCcc
Confidence            45667788899999999999887 56899999999999999998764 346999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccc-----cCCCCCcchhhHHHHHHHHHHHhC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM-----RTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      |+||+|+||+++.++.++|+|||++....... .......++..|+|||.+     .+..++.++||||||+++|+|++|
T Consensus       140 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  218 (302)
T 2j7t_A          140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  218 (302)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence            99999999999999999999999875321110 012234678999999988     356788999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..||.............       ....       .....+...+..+.++|..||+.||.+|||+.++++|-
T Consensus       219 ~~p~~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  277 (302)
T 2j7t_A          219 EPPHHELNPMRVLLKIA-------KSDP-------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP  277 (302)
T ss_dssp             SCTTTTSCHHHHHHHHH-------HSCC-------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred             CCCCccCCHHHHHHHHh-------ccCC-------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            99998765543322111       1000       00112233456789999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-32  Score=249.52  Aligned_cols=221  Identities=12%  Similarity=0.067  Sum_probs=169.7

Q ss_pred             cceEEEcccCCCh----hhHHhhhhhcc---ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC---CCCCCCHHH
Q 048068           27 VNQFIYHGFNEDP----QLQRDGLASVH---SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN---IKPSLSWYQ   96 (313)
Q Consensus        27 ~~~~~~~~~~~~~----~~~~~~l~~~~---~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~---~~~~~~~~~   96 (313)
                      ...+++|.+....    ..+.+.++.+.   |+++++.++.... ++..++||||+++|+|.+++...   ....+++..
T Consensus        95 ~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~  173 (365)
T 3e7e_A           95 KQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL  173 (365)
T ss_dssp             CCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHH
T ss_pred             CcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHH
Confidence            3456666665432    23344444454   8999999998887 56889999999999999999742   245699999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-----------CCcEEEeecccccccCC-CCCCcccccccccc
Q 048068           97 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-----------DLNGKLGDFGLARLYDH-DTIPQTTKLVGTFG  164 (313)
Q Consensus        97 ~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-----------~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~  164 (313)
                      ++.++.||+.||.|||   ..+|+||||||+||+++.           ++.++|+|||++..... ..........||+.
T Consensus       174 ~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~  250 (365)
T 3e7e_A          174 VISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG  250 (365)
T ss_dssp             HHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTS
T ss_pred             HHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCC
Confidence            9999999999999999   689999999999999988           89999999999965432 11122344578999


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHH
Q 048068          165 YMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL  244 (313)
Q Consensus       165 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (313)
                      |+|||++.+..++.++|||||||++|+|++|+.||.........              ..    ..... .  ...+.+.
T Consensus       251 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------------~~----~~~~~-~--~~~~~~~  309 (365)
T 3e7e_A          251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--------------PE----GLFRR-L--PHLDMWN  309 (365)
T ss_dssp             CCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--------------EC----SCCTT-C--SSHHHHH
T ss_pred             CCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--------------ec----hhccc-c--CcHHHHH
Confidence            99999999988999999999999999999999999754332110              00    00000 1  1245677


Q ss_pred             HHHHHcCCCCCCCC-CCHHHHHHHHhccC
Q 048068          245 KLGLFCSHPKPEAR-PNMRQVMQYLDGNA  272 (313)
Q Consensus       245 ~li~~cl~~~P~~R-pt~~ell~~L~~~~  272 (313)
                      +++..||+.+|.+| |+++++.+.|++..
T Consensus       310 ~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          310 EFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             HHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            89999999999999 58888888877653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=249.15  Aligned_cols=249  Identities=20%  Similarity=0.243  Sum_probs=172.4

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEec-------------cCCeE
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNS-------------RKGEF   68 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~-------------~~~~~   68 (313)
                      .++.|.+..++...+   ...++.|.+...       ...+...++.++|+++++.++++..             ..+..
T Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~   97 (320)
T 2i6l_A           18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSV   97 (320)
T ss_dssp             ECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEE
T ss_pred             EeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCce
Confidence            344455555555543   345666655321       2346677788899999999988742             34688


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc-CCCcEEEeecccccc
Q 048068           69 LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD-ADLNGKLGDFGLARL  147 (313)
Q Consensus        69 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~  147 (313)
                      ++||||++ ++|.+++..   +.+++..++.++.||+.||.|||   ..+++|+||||+||+++ .++.++|+|||++..
T Consensus        98 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~  170 (320)
T 2i6l_A           98 YIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARI  170 (320)
T ss_dssp             EEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred             eEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence            99999996 699999975   35999999999999999999999   58999999999999997 567899999999875


Q ss_pred             cCCCC--CCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcc--
Q 048068          148 YDHDT--IPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA--  222 (313)
Q Consensus       148 ~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  222 (313)
                      .....  ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+...........  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (320)
T 2i6l_A          171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ  250 (320)
T ss_dssp             C--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHH
T ss_pred             cCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhh
Confidence            53221  112233456889999998865 6789999999999999999999999987765544332211100000000  


Q ss_pred             -----cc-----ccccc-cccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          223 -----IL-----DASDS-RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       223 -----~~-----~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                           ..     ....+ ..........+..+.+||.+||+.||.+|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          251 ELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                 00     00000 00000112345678999999999999999999999996

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.8e-33  Score=243.53  Aligned_cols=223  Identities=22%  Similarity=0.380  Sum_probs=162.2

Q ss_pred             cceEEEcccCCC------hhhHHhhhhhccccceeeeeeEEec------------cCCeEEEEEecCCCCCHHHHHhhCC
Q 048068           27 VNQFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNS------------RKGEFLLVYDYMPNGSLDKILHTNI   88 (313)
Q Consensus        27 ~~~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~------------~~~~~~lV~e~~~~g~L~~~l~~~~   88 (313)
                      ...++.|.+...      ...+...++.++|+++++.++.+.+            ..+..++||||+++++|.+++... 
T Consensus        31 ~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-  109 (303)
T 1zy4_A           31 SRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-  109 (303)
T ss_dssp             CCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-
T ss_pred             CeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-
Confidence            445666665432      2346667788899999999887653            246789999999999999999865 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-------------CCc
Q 048068           89 KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-------------IPQ  155 (313)
Q Consensus        89 ~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-------------~~~  155 (313)
                      ...+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.......             ...
T Consensus       110 ~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  186 (303)
T 1zy4_A          110 NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN  186 (303)
T ss_dssp             CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------------------
T ss_pred             ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccc
Confidence            345889999999999999999999   5899999999999999999999999999987543211             112


Q ss_pred             cccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          156 TTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       156 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++   ||.......  ......    ...      ....+..
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--~~~~~~----~~~------~~~~~~~  251 (303)
T 1zy4_A          187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--NILKKL----RSV------SIEFPPD  251 (303)
T ss_dssp             -------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHHHHH----HST------TCCCCTT
T ss_pred             cccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--HHHHhc----ccc------ccccCcc
Confidence            2345688999999999764 68999999999999999998   443221111  111110    110      1112222


Q ss_pred             ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          235 YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       235 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      .+...+..+.+++..||+.||.+|||++++++|-
T Consensus       252 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            3445556789999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-32  Score=239.71  Aligned_cols=205  Identities=24%  Similarity=0.373  Sum_probs=163.2

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .+.+.++.++|+++++..+++.. ++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||   ..+++
T Consensus        70 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~  143 (287)
T 2wei_A           70 REVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIV  143 (287)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhccCCCccEEEEEEeC-CCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            56677888899999999999876 67899999999999999998764  35999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCC---CcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          121 HRDIKPANVLLDAD---LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      |+||+|+||+++.+   +.++|+|||++.......  ......++..|+|||.+.+ .++.++|+||||+++|+|++|..
T Consensus       144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~  220 (287)
T 2wei_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP  220 (287)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCChhhEEEecCCCcccEEEeccCcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCC
Confidence            99999999999754   469999999987654332  2233457889999999875 48899999999999999999999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ||.+....+....+.       .+...      .........+..+.++|.+||+.||.+|||+.++++|
T Consensus       221 p~~~~~~~~~~~~~~-------~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          221 PFYGKNEYDILKRVE-------TGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             SSCCSSHHHHHHHHH-------HCCCC------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCHHHHHHHHH-------cCCCC------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            998766544332221       11100      0000112335678899999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-32  Score=246.65  Aligned_cols=235  Identities=20%  Similarity=0.193  Sum_probs=170.8

Q ss_pred             cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEecc----CCeEEEEEecCCCCCHHHHHhhCCCCCCCH
Q 048068           27 VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSR----KGEFLLVYDYMPNGSLDKILHTNIKPSLSW   94 (313)
Q Consensus        27 ~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~   94 (313)
                      ...+++|.+...        ...+...++.++|+++++..++....    ....++||||+. ++|.+++...   .+++
T Consensus        36 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~  111 (353)
T 2b9h_A           36 GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSD  111 (353)
T ss_dssp             TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCH
T ss_pred             CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCH
Confidence            345666665421        12566778888999999999887642    368999999995 6999999864   5999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC---------ccccccccccc
Q 048068           95 YQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP---------QTTKLVGTFGY  165 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y  165 (313)
                      ..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++.........         ......|++.|
T Consensus       112 ~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  188 (353)
T 2b9h_A          112 DHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY  188 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence            999999999999999999   589999999999999999999999999998765432111         11234679999


Q ss_pred             cccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccc-------------cc--ccc
Q 048068          166 MAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAIL-------------DA--SDS  229 (313)
Q Consensus       166 ~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~--~~~  229 (313)
                      +|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.............             ..  ...
T Consensus       189 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
T 2b9h_A          189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA  268 (353)
T ss_dssp             CCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCC
T ss_pred             cCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCC
Confidence            99998764 678999999999999999999999998876554433322111100000000             00  000


Q ss_pred             cccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       230 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ..........+..+.+||.+||+.||++|||++|+++|-
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            000001123456788999999999999999999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-32  Score=253.27  Aligned_cols=221  Identities=18%  Similarity=0.252  Sum_probs=162.0

Q ss_pred             cceEEEcccCC----ChhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 048068           27 VNQFIYHGFNE----DPQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII  101 (313)
Q Consensus        27 ~~~~~~~~~~~----~~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  101 (313)
                      ...+++|.+..    ....|.+.++++ .|+|++++++...+ +...++||||+. |+|.+++.... ....+..++.++
T Consensus        48 ~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~  124 (432)
T 3p23_A           48 NRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLL  124 (432)
T ss_dssp             SSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHH
T ss_pred             CeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHH
Confidence            45667776643    345677888888 79999999988876 678999999995 69999998653 345555678999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---C--CcEEEeecccccccCCCCC--Ccccccccccccccccccc--
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---D--LNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMR--  172 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~--~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~--  172 (313)
                      .||+.||.|||   ..+|+||||||+||+++.   +  ..++|+|||++........  .......||+.|+|||++.  
T Consensus       125 ~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~  201 (432)
T 3p23_A          125 QQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED  201 (432)
T ss_dssp             HHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC
T ss_pred             HHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc
Confidence            99999999999   489999999999999953   2  3578999999976543221  1233457899999999997  


Q ss_pred             -CCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHc
Q 048068          173 -TGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFC  250 (313)
Q Consensus       173 -~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  250 (313)
                       ...++.++|||||||++|+|++ |..||............        .....      ............+.+||.+|
T Consensus       202 ~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--------~~~~~------~~~~~~~~~~~~~~~li~~~  267 (432)
T 3p23_A          202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--------GACSL------DCLHPEKHEDVIARELIEKM  267 (432)
T ss_dssp             ---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--------TCCCC------TTSCTTCHHHHHHHHHHHHH
T ss_pred             cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--------ccCCc------cccCccccccHHHHHHHHHH
Confidence             3566789999999999999999 99999654433221110        00000      00111234556788999999


Q ss_pred             CCCCCCCCCCHHHHHHH
Q 048068          251 SHPKPEARPNMRQVMQY  267 (313)
Q Consensus       251 l~~~P~~Rpt~~ell~~  267 (313)
                      |+.||.+|||++++++|
T Consensus       268 L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          268 IAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             SCSSGGGSCCHHHHHTS
T ss_pred             HhCCHhhCCCHHHHHhC
Confidence            99999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-32  Score=253.85  Aligned_cols=224  Identities=20%  Similarity=0.331  Sum_probs=160.5

Q ss_pred             cceEEEcccCCC----hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCC-----CCHHH
Q 048068           27 VNQFIYHGFNED----PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPS-----LSWYQ   96 (313)
Q Consensus        27 ~~~~~~~~~~~~----~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~-----~~~~~   96 (313)
                      ...+++|.+...    ...|...++++ +|+|++++++.... ++..++||||++ |+|.+++.......     .++..
T Consensus        39 g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~  116 (434)
T 2rio_A           39 GRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN  116 (434)
T ss_dssp             SSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCS-EEHHHHHHTC------------CC
T ss_pred             CeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchh
Confidence            456677765432    23566667665 89999999988876 678999999995 69999998643211     13334


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC-------------CcEEEeecccccccCCCCCC---cccccc
Q 048068           97 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD-------------LNGKLGDFGLARLYDHDTIP---QTTKLV  160 (313)
Q Consensus        97 ~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~-------------~~~~l~dfg~~~~~~~~~~~---~~~~~~  160 (313)
                      ++.++.||+.||.|||   ..+|+||||||+||+++.+             +.++|+|||++.........   ......
T Consensus       117 ~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~  193 (434)
T 2rio_A          117 PISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS  193 (434)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-------------
T ss_pred             HHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCC
Confidence            6789999999999999   4899999999999999754             47999999999865443211   123457


Q ss_pred             ccccccccccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhcccccccccccc
Q 048068          161 GTFGYMAPELMRT-------GKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE  232 (313)
Q Consensus       161 ~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (313)
                      ||+.|+|||++.+       ..++.++|||||||++|+|++ |..||........ ..   ......        .+...
T Consensus       194 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~i---~~~~~~--------~~~~~  261 (434)
T 2rio_A          194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NI---IRGIFS--------LDEMK  261 (434)
T ss_dssp             -CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-HH---HHTCCC--------CCCCT
T ss_pred             CCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-HH---hcCCCC--------ccccc
Confidence            8999999999865       567899999999999999999 9999976543321 11   111000        01111


Q ss_pred             CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          233 GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       233 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .......+..+.+||.+||+.||.+|||+.++++|
T Consensus       262 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          262 CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            22345677889999999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.98  E-value=1.2e-32  Score=250.16  Aligned_cols=243  Identities=20%  Similarity=0.222  Sum_probs=172.4

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCC-----eEEEEEecCC
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKG-----EFLLVYDYMP   76 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~-----~~~lV~e~~~   76 (313)
                      +.|.+..++...+   ...+++|.+..         ....+...++.++|+++++..+++...+.     .+++||||+.
T Consensus        51 G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~  130 (371)
T 4exu_A           51 GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ  130 (371)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc
Confidence            3444444444432   34666676643         12245667788899999999999885332     2499999995


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcc
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQT  156 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~  156 (313)
                       ++|.+++..    .+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++......    .
T Consensus       131 -~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~  198 (371)
T 4exu_A          131 -TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----M  198 (371)
T ss_dssp             -EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----------
T ss_pred             -ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC----c
Confidence             688888743    4999999999999999999999   589999999999999999999999999998754332    2


Q ss_pred             ccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccc----------
Q 048068          157 TKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD----------  225 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------  225 (313)
                      ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+....+..............          
T Consensus       199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  278 (371)
T 4exu_A          199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI  278 (371)
T ss_dssp             -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHH
T ss_pred             CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhh
Confidence            34567999999999886 6789999999999999999999999988765554433321110000000000          


Q ss_pred             -cccccccC---CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          226 -ASDSRLEG---IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       226 -~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                       ........   ......+..+.+||.+||+.||.+|||++|+++|-
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence             00000000   01123356789999999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.98  E-value=1.6e-32  Score=247.55  Aligned_cols=229  Identities=20%  Similarity=0.240  Sum_probs=167.3

Q ss_pred             cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEeccCC-----eEEEEEecCCCCCHHHHHhhCCCCCC
Q 048068           27 VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSRKG-----EFLLVYDYMPNGSLDKILHTNIKPSL   92 (313)
Q Consensus        27 ~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~   92 (313)
                      ...++.|.+...         ...+...++.++|+++++..+++...+.     .+++||||+. ++|.+++..    .+
T Consensus        49 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~  123 (353)
T 3coi_A           49 GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KF  123 (353)
T ss_dssp             TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CC
T ss_pred             CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC----CC
Confidence            446667665321         2245667788899999999999885332     4699999996 688877743    49


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc
Q 048068           93 SWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR  172 (313)
Q Consensus        93 ~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  172 (313)
                      ++..++.++.||+.||.|||   ..+++|+||||+||+++.++.++|+|||++......    .....+++.|+|||.+.
T Consensus       124 ~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~  196 (353)
T 3coi_A          124 SEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVIL  196 (353)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHS
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHh
Confidence            99999999999999999999   589999999999999999999999999998754322    23356789999999987


Q ss_pred             C-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhc---------------cccccccccccCCcc
Q 048068          173 T-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKG---------------AILDASDSRLEGIYE  236 (313)
Q Consensus       173 ~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~  236 (313)
                      + ..++.++||||||+++|+|++|..||.+.+..+....+..........               ........ ......
T Consensus       197 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  275 (353)
T 3coi_A          197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK-DFTQLF  275 (353)
T ss_dssp             CCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSC-CTTTTC
T ss_pred             CcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCc-cHHHhc
Confidence            6 678999999999999999999999998876554433321110000000               00000000 001122


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       237 ~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ...+..+.+||.+||+.||.+|||+.|+++|-
T Consensus       276 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          276 PRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             CCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence            34567889999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.98  E-value=1.9e-32  Score=243.09  Aligned_cols=236  Identities=19%  Similarity=0.211  Sum_probs=160.9

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCCh--h-------hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNEDP--Q-------LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~--~-------~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      ++.|.+...+...+   ...++.|.+....  .       .+...++.+.|++++++.+++.. ++..++||||+ ++.+
T Consensus        33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~~  110 (318)
T 2dyl_A           33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIAMELM-GTCA  110 (318)
T ss_dssp             C------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCC-SEEH
T ss_pred             eeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEEEecc-CCcH
Confidence            44555555555543   4566777664321  1       22234567799999999999887 56899999999 6677


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      ..+.... ...+++..++.++.||+.||.|||+  ..+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus       111 ~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~  185 (318)
T 2dyl_A          111 EKLKKRM-QGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AKDRSA  185 (318)
T ss_dssp             HHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC---------------
T ss_pred             HHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--cccccC
Confidence            6666543 3469999999999999999999994  1399999999999999999999999999986543322  223346


Q ss_pred             cccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCc
Q 048068          161 GTFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY  235 (313)
Q Consensus       161 ~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (313)
                      +++.|+|||.+.     ...++.++||||||+++|+|++|+.||.........  ..   ...... .     +..+  .
T Consensus       186 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~---~~~~~~-~-----~~~~--~  252 (318)
T 2dyl_A          186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV--LT---KVLQEE-P-----PLLP--G  252 (318)
T ss_dssp             -CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HH---HHHHSC-C-----CCCC--S
T ss_pred             CCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH--HH---HHhccC-C-----CCCC--c
Confidence            889999999984     456788999999999999999999999864332211  11   111110 0     0011  1


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      ....+..+.++|..||+.||.+|||++++++|-
T Consensus       253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence            112346688999999999999999999999853

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.98  E-value=2.3e-32  Score=243.86  Aligned_cols=205  Identities=24%  Similarity=0.355  Sum_probs=140.6

Q ss_pred             hhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-Cce
Q 048068           45 GLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHT---NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ-VVL  120 (313)
Q Consensus        45 ~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~-~i~  120 (313)
                      .++.+.|++++++.+++.. ++..++||||+++ +|.+++..   .....+++..++.++.|++.||.|||+   . +++
T Consensus        74 ~~~~~~h~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~iv  148 (327)
T 3aln_A           74 VMRSSDCPYIVQFYGALFR-EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKII  148 (327)
T ss_dssp             HHSSCCCTTBCCEEEEEEC-SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCC
T ss_pred             HHHcCCCCcEeeeeeEEEe-CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEe
Confidence            5566789999999999887 5689999999964 88888763   224579999999999999999999995   6 999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccc----cCCCCCcchhhHHHHHHHHHHHhCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELM----RTGKASTSTDVYAFGVFMLEVASGR  196 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~  196 (313)
                      |+||+|+||+++.++.++|+|||++.......  ......++..|+|||.+    .+..++.++||||||+++|+|++|+
T Consensus       149 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  226 (327)
T 3aln_A          149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR  226 (327)
T ss_dssp             CSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSC
T ss_pred             ECCCCHHHEEEcCCCCEEEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCC
Confidence            99999999999999999999999987554322  12234688999999998    4566889999999999999999999


Q ss_pred             CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          197 RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       197 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .||.........  .   .      .......+..........+..+.+|+.+||+.||.+|||+.++++|
T Consensus       227 ~pf~~~~~~~~~--~---~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          227 FPYPKWNSVFDQ--L---T------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCSSCC------------C------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCcchHHHH--H---H------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            999764322100  0   0      0011111111111222345678999999999999999999999884

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.9e-32  Score=242.75  Aligned_cols=197  Identities=24%  Similarity=0.355  Sum_probs=156.6

Q ss_pred             hHHhhhhhc----cccceeeeeeEEeccCCeEEEEEec-CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           41 LQRDGLASV----HSNGLLQLTNTVNSRKGEFLLVYDY-MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        41 ~~~~~l~~~----~~~~~l~~~~~~~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      .+...++.+    .|+++++..+++.. ++..++|||+ +.+++|.+++...  ..+++..++.++.||+.||.|||   
T Consensus        83 ~e~~~l~~l~~~~~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---  156 (312)
T 2iwi_A           83 LEVALLWKVGAGGGHPGVIRLLDWFET-QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCH---  156 (312)
T ss_dssp             HHHHHHHHHHSSCCCSSBCCEEEEC------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred             HHHHHHHhhcccCCCCCeeeEEEEEec-CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---
Confidence            355666677    89999999998876 5678999999 7899999999874  35999999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEc-CCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHH
Q 048068          116 EQVVLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVA  193 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll  193 (313)
                      ..+++|+||+|+||+++ .++.++|+|||++.......   .....++..|+|||.+.+..+ +.++||||||+++|+++
T Consensus       157 ~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  233 (312)
T 2iwi_A          157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV  233 (312)
T ss_dssp             HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence            48999999999999999 78999999999987654322   334568899999999876665 45899999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD  269 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~  269 (313)
                      +|+.||......     .       ..           ....+...+..+.++|.+||+.||++|||++|+++|-.
T Consensus       234 ~g~~pf~~~~~~-----~-------~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          234 CGDIPFERDQEI-----L-------EA-----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             HSSCSCCSHHHH-----H-------HT-----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             HCCCCCCChHHH-----h-------hh-----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            999999743210     0       00           00122334567889999999999999999999999654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=1.1e-32  Score=245.55  Aligned_cols=197  Identities=23%  Similarity=0.358  Sum_probs=160.2

Q ss_pred             hhHHhhhhhcc--ccceeeeeeEEeccCCeEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           40 QLQRDGLASVH--SNGLLQLTNTVNSRKGEFLLVYDYMPN-GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        40 ~~~~~~l~~~~--~~~~l~~~~~~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ..+...++.+.  |+++++..+++.. ++..++|||++.+ ++|.+++...  ..+++..++.++.||+.||.|||   .
T Consensus        94 ~~E~~~l~~l~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~  167 (320)
T 3a99_A           94 PMEVVLLKKVSSGFSGVIRLLDWFER-PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---N  167 (320)
T ss_dssp             EHHHHHHHHHCSSSCSBCCEEEEEEC-SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred             HHHHHHHHhhccCCCCceEEEEEEec-CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---H
Confidence            34677788886  5999999999886 6789999999976 8999999864  35999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEc-CCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHh
Q 048068          117 QVVLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  194 (313)
                      .+++|+||||+||+++ .++.++|+|||++.......   .....+++.|+|||.+.+..+ +.++||||||+++|+|++
T Consensus       168 ~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~  244 (320)
T 3a99_A          168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  244 (320)
T ss_dssp             TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH
Confidence            8999999999999999 77899999999987654322   234568999999999876655 678999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                      |+.||......     .        ....          ..+...+..+.+||.+||+.||.+|||++++++|-
T Consensus       245 g~~pf~~~~~~-----~--------~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          245 GDIPFEHDEEI-----I--------RGQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             SSCSCCSHHHH-----H--------HCCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCCChhhh-----h--------cccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            99999653210     0        0000          01122346788999999999999999999999964

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.3e-31  Score=237.69  Aligned_cols=207  Identities=21%  Similarity=0.295  Sum_probs=154.4

Q ss_pred             hHHhhhhhccc--cceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048068           41 LQRDGLASVHS--NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV  118 (313)
Q Consensus        41 ~~~~~l~~~~~--~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~  118 (313)
                      .+.+.++.+.|  +++++..++... ++..++|||+ .+++|.+++...  ..+++..++.++.||+.||.|||   ..+
T Consensus        75 ~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~  147 (313)
T 3cek_A           75 NEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHG  147 (313)
T ss_dssp             HHHHHHHHHGGGCTTBCCEEEEEEC-SSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             HHHHHHHhccccCCceEEEEEEeec-CCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            45566677764  999999998876 6689999995 588999999874  36999999999999999999999   589


Q ss_pred             ceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccC-----------CCCCcchhhHHHH
Q 048068          119 VLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRT-----------GKASTSTDVYAFG  186 (313)
Q Consensus       119 i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG  186 (313)
                      ++|+||||+||++++ +.++|+|||++......... ......+++.|+|||.+.+           ..++.++||||||
T Consensus       148 ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG  226 (313)
T 3cek_A          148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG  226 (313)
T ss_dssp             CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred             ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence            999999999999964 89999999998755432211 1234468999999999865           4678899999999


Q ss_pred             HHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          187 VFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       187 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                      +++|+|++|..||......... ..    .....         ......+...+..+.++|.+||+.||.+|||+.++++
T Consensus       227 ~il~el~~g~~pf~~~~~~~~~-~~----~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          227 CILYYMTYGKTPFQQIINQISK-LH----AIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHHHHSSCTTTTCCSHHHH-HH----HHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhCCCchhhHHHHHHH-HH----HHHhc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            9999999999999765432211 11    00010         0011112222457889999999999999999999999


Q ss_pred             HHh
Q 048068          267 YLD  269 (313)
Q Consensus       267 ~L~  269 (313)
                      |-.
T Consensus       293 h~~  295 (313)
T 3cek_A          293 HPY  295 (313)
T ss_dssp             SHH
T ss_pred             Ccc
Confidence            754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=2.2e-32  Score=262.73  Aligned_cols=245  Identities=21%  Similarity=0.206  Sum_probs=175.1

Q ss_pred             HHHHHHHhhccc---cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEec-----cCCeEEEEEecCCCC
Q 048068           15 CVSFILSALAQD---VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNS-----RKGEFLLVYDYMPNG   78 (313)
Q Consensus        15 ~~~~~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~-----~~~~~~lV~e~~~~g   78 (313)
                      .|.+..+|...+   ...+++|.+...        ...|...++.++|+|+++..++...     .++..++||||++|+
T Consensus        24 ~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~gg  103 (676)
T 3qa8_A           24 TGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGG  103 (676)
T ss_dssp             BCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSC
T ss_pred             eCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCC
Confidence            344444444333   446777766532        2346677888899999999888653     266789999999999


Q ss_pred             CHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc---EEEeecccccccCCCCCC
Q 048068           79 SLDKILHTNI-KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN---GKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        79 ~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~---~~l~dfg~~~~~~~~~~~  154 (313)
                      +|.+++.... ...+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.   ++|+|||++.......  
T Consensus       104 sL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~--  178 (676)
T 3qa8_A          104 DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--  178 (676)
T ss_dssp             BHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC--
T ss_pred             CHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc--
Confidence            9999998642 346999999999999999999999   589999999999999997664   8999999997654433  


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHH--HHHHh-h----hhccccccc
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVD--WVSDC-W----KKGAILDAS  227 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~-~----~~~~~~~~~  227 (313)
                      ......++..|+|||.+.+..++.++||||||+++|++++|..||........+....  ..... .    ..+......
T Consensus       179 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~  258 (676)
T 3qa8_A          179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSS  258 (676)
T ss_dssp             CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCS
T ss_pred             ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccccc
Confidence            2234578999999999998899999999999999999999999997643322110000  00000 0    000000001


Q ss_pred             cccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 048068          228 DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV  264 (313)
Q Consensus       228 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  264 (313)
                      ....+.......+..+.++|..||..||.+|||+.++
T Consensus       259 ~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          259 VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            1112233455678899999999999999999999774

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=7.3e-31  Score=231.43  Aligned_cols=231  Identities=18%  Similarity=0.244  Sum_probs=163.5

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCChh--hHHhhh-hhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNEDPQ--LQRDGL-ASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~l-~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..++...+   ...++.|.+.....  .+...+ +...|++++++.+++..   .+..+++||||+++++|.++
T Consensus        26 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (299)
T 3m2w_A           26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR  105 (299)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHH
T ss_pred             cccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHH
Confidence            34444444444433   44677777754333  333333 66799999999988763   35678999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---CCcEEEeecccccccCCCCCCcccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      +.......+++..++.++.||+.||.|||   ..+++|+||||+||+++.   ++.++|+|||++....           
T Consensus       106 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------  171 (299)
T 3m2w_A          106 IQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------  171 (299)
T ss_dssp             HHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------
Confidence            98865567999999999999999999999   589999999999999998   7889999999885322           


Q ss_pred             ccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHH
Q 048068          161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM  240 (313)
Q Consensus       161 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (313)
                                  +..++.++|||||||++|+|++|..||............        . ..........+.......+
T Consensus       172 ------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~  230 (299)
T 3m2w_A          172 ------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------K-TRIRMGQYEFPNPEWSEVS  230 (299)
T ss_dssp             ------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--------C-CSSCTTCCSSCHHHHTTSC
T ss_pred             ------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--------H-HHHhhccccCCchhcccCC
Confidence                        234678999999999999999999999765443211000        0 0000000000000112345


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCCCCCCC
Q 048068          241 ELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATLPDIP  278 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~~~~~~  278 (313)
                      ..+.+|+.+||+.||.+|||+.|+++|  +.+....+.+|
T Consensus       231 ~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~  270 (299)
T 3m2w_A          231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  270 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence            678999999999999999999999996  44444444444

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=3.9e-31  Score=231.97  Aligned_cols=216  Identities=14%  Similarity=0.116  Sum_probs=158.2

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC----------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCC
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED----------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNG   78 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g   78 (313)
                      .++.|.+..+|...+   ...++.|.+...          ...+...++.+.|+|+++.+++... ++..|+||||++|+
T Consensus        38 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~g~  116 (286)
T 3uqc_A           38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLVVAEWIRGG  116 (286)
T ss_dssp             EEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCCEE
T ss_pred             EEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEEEEEecCCC
Confidence            334455545555544   346677766432          2344556678899999999999886 57899999999999


Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccc
Q 048068           79 SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK  158 (313)
Q Consensus        79 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~  158 (313)
                      +|.++++..    .....+..++.||+.||.|||   ..||+|+||||+||+++.++.++|++++               
T Consensus       117 ~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------------  174 (286)
T 3uqc_A          117 SLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------------  174 (286)
T ss_dssp             EHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------------
T ss_pred             CHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------------
Confidence            999999643    466678899999999999999   5899999999999999999999987433               


Q ss_pred             ccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHH
Q 048068          159 LVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE  238 (313)
Q Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (313)
                            |.+       .++.++|||||||++|+|++|+.||.+...........        ....  ............
T Consensus       175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTA--GQPIEPADIDRD  231 (286)
T ss_dssp             ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------BCTT--SCBCCHHHHCTT
T ss_pred             ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------HHhc--cCCCChhhcccC
Confidence                  222       36789999999999999999999998765533110000        0000  000001112233


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCCC
Q 048068          239 QMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       239 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      .++.+.+||.+||+.||++| |+.|+++.|+.....
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            45678999999999999999 999999999887644

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=5e-30  Score=250.35  Aligned_cols=220  Identities=23%  Similarity=0.264  Sum_probs=165.1

Q ss_pred             HHHHHHHHhhccc----cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCe----EEEEEecCCC
Q 048068           14 LCVSFILSALAQD----VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGE----FLLVYDYMPN   77 (313)
Q Consensus        14 ~~~~~~~~~~~~~----~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~----~~lV~e~~~~   77 (313)
                      +.|.+..+|...+    ...+++|.+...        ...|..++++++|++++++++++...+..    .|+||||++|
T Consensus        89 g~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g  168 (681)
T 2pzi_A           89 AHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG  168 (681)
T ss_dssp             EEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCC
T ss_pred             eeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCC
Confidence            3444444555543    345677766422        23567788999999999999998853332    7999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      ++|.+++..    .+++..++.++.||+.||.|||   ..+|+||||||+||+++.+ .++|+|||++......     .
T Consensus       169 ~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~  235 (681)
T 2pzi_A          169 QSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----G  235 (681)
T ss_dssp             EECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----S
T ss_pred             CcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC-----C
Confidence            999987754    5999999999999999999999   5899999999999999875 8999999998765432     3


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ...||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......                       .......
T Consensus       236 ~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------------~~~~~~~  291 (681)
T 2pzi_A          236 YLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------------PEDDPVL  291 (681)
T ss_dssp             CCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------------CTTCHHH
T ss_pred             ccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------------------ccccccc
Confidence            45689999999998754 48899999999999999999998865321110                       0011122


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhc
Q 048068          238 EQMELVLKLGLFCSHPKPEARPN-MRQVMQYLDG  270 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt-~~ell~~L~~  270 (313)
                      ...+.+.+||.+||+.||.+||+ ++++...|..
T Consensus       292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            33467899999999999999995 5556555544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.5e-30  Score=239.75  Aligned_cols=170  Identities=17%  Similarity=0.169  Sum_probs=134.0

Q ss_pred             eEEEEEecCCCCCHHHHHh-----hCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEee
Q 048068           67 EFLLVYDYMPNGSLDKILH-----TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGD  141 (313)
Q Consensus        67 ~~~lV~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~d  141 (313)
                      .++++|+++ +++|.++++     ......+++..++.++.||+.||.|||   ..+|+||||||+||+++.++.+||+|
T Consensus       179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~D  254 (413)
T 3dzo_A          179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG  254 (413)
T ss_dssp             SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred             ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEe
Confidence            467888877 789999995     222445788899999999999999999   58999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccc----------cCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHH
Q 048068          142 FGLARLYDHDTIPQTTKLVGTFGYMAPELM----------RTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV  211 (313)
Q Consensus       142 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  211 (313)
                      ||++......    .....| +.|+|||++          .+..++.++|||||||++|+|++|+.||...........+
T Consensus       255 FG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~  329 (413)
T 3dzo_A          255 FEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI  329 (413)
T ss_dssp             GGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG
T ss_pred             ccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH
Confidence            9998754322    333456 899999998          5556788999999999999999999999765543322111


Q ss_pred             HHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 048068          212 DWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ  266 (313)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  266 (313)
                                         ..  .....++.+.+||.+||+.||++|||+.++++
T Consensus       330 -------------------~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          330 -------------------FR--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             -------------------GS--SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------------------Hh--hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                               00  00122367899999999999999999777654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=1.1e-29  Score=227.58  Aligned_cols=176  Identities=15%  Similarity=0.091  Sum_probs=133.4

Q ss_pred             CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCceecCcCCCcEEEcCCC--------
Q 048068           65 KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLH-EDWEQVVLHRDIKPANVLLDADL--------  135 (313)
Q Consensus        65 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lh-s~~~~~i~H~dl~~~nIlv~~~~--------  135 (313)
                      ++.+|+||||+++|++.+.+.+   ..+++..++.++.||+.||.||| +   .+|+||||||+|||++.++        
T Consensus       134 ~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~  207 (336)
T 2vuw_A          134 DDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTL  207 (336)
T ss_dssp             TTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEE
T ss_pred             cCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeec
Confidence            6789999999999976666643   35899999999999999999999 6   7999999999999999887        


Q ss_pred             ------------cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHH-HHHHHhCCCCCccC
Q 048068          136 ------------NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVF-MLEVASGRRPIEQQ  202 (313)
Q Consensus       136 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~  202 (313)
                                  .+||+|||++......      ...||+.|+|||++.+.. +.++||||++++ .++++.|..||...
T Consensus       208 ~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~  280 (336)
T 2vuw_A          208 NGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV  280 (336)
T ss_dssp             TTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred             cCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch
Confidence                        8999999999765432      347899999999998766 889999998776 77788899998532


Q ss_pred             CchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH
Q 048068          203 GSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM-QY  267 (313)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell-~~  267 (313)
                      ....  ....   .......    .............++.+.+||.+||+.|     |++|++ +|
T Consensus       281 ~~~~--~~~~---~~~~~~~----~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          281 LWLH--YLTD---KMLKQMT----FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHH--HHHH---HHHHTCC----CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhh--HHHH---hhhhhhc----cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            1000  0010   0000000    0111122234567889999999999977     999999 76

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=2.7e-26  Score=219.01  Aligned_cols=150  Identities=20%  Similarity=0.181  Sum_probs=109.8

Q ss_pred             hhhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           39 PQLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        39 ~~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ...|.++++++ .|++++++.++..+ ++.+||||||++|++|.++|.+.  ++++..   .++.||+.||.|+|   ++
T Consensus       288 ~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH---~~  358 (569)
T 4azs_A          288 LHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALE---KQ  358 (569)
T ss_dssp             HHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHH---HT
T ss_pred             HHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHH---HC
Confidence            44567788888 79999999999887 67999999999999999999874  356665   47899999999999   59


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRR  197 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  197 (313)
                      ||+||||||+|||++.+|.+||+|||+++...... .......||+.|++||++.+ .+..++|+|++|++++++.++..
T Consensus       359 GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          359 GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             TCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            99999999999999999999999999997654332 23345679999999999975 45678999999999888766554


Q ss_pred             CC
Q 048068          198 PI  199 (313)
Q Consensus       198 pf  199 (313)
                      ++
T Consensus       437 ~~  438 (569)
T 4azs_A          437 NW  438 (569)
T ss_dssp             HH
T ss_pred             hh
Confidence            43

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.77  E-value=5.2e-20  Score=174.61  Aligned_cols=144  Identities=15%  Similarity=0.163  Sum_probs=116.4

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|.+.++.++|+|+++...+... .+..|+||||++|++|.+++..          +..++.|++.||.|||   +.+|
T Consensus       387 ~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gI  452 (540)
T 3en9_A          387 AREARYLALVKDFGIPAPYIFDVD-LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDV  452 (540)
T ss_dssp             HHHHHHHHHGGGGTCCCCCEEEEE-TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhcCCCCcCceEEEEEe-CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcC
Confidence            466778888999999944333333 4567999999999999999875          5689999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCc------cccccccccccccccccC--CCCCcchhhHHHHHHHHH
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ------TTKLVGTFGYMAPELMRT--GKASTSTDVYAFGVFMLE  191 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~  191 (313)
                      +||||||+||+++.  .+||+|||++..........      .....||+.|+|||++..  ..|+..+|+|+..+-..+
T Consensus       453 iHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~  530 (540)
T 3en9_A          453 IHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMK  530 (540)
T ss_dssp             ECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHH
T ss_pred             ccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHH
Confidence            99999999999998  99999999998664422111      134678999999999976  567888999999888888


Q ss_pred             HHhCCCCC
Q 048068          192 VASGRRPI  199 (313)
Q Consensus       192 ll~g~~pf  199 (313)
                      -+.++.+|
T Consensus       531 ~v~~r~rY  538 (540)
T 3en9_A          531 DVERRARY  538 (540)
T ss_dssp             HHHTCSCC
T ss_pred             HHHhcccc
Confidence            77766655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.52  E-value=3.4e-15  Score=130.14  Aligned_cols=89  Identities=12%  Similarity=0.151  Sum_probs=72.0

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.+.  + ++.+.++..  +..++||||++|++|.+ +..        .....++.|++.|+.|||   ..++
T Consensus       152 ~~E~~~l~~l~--~-~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~gi  214 (282)
T 1zar_A          152 RNEFRALQKLQ--G-LAVPKVYAW--EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGI  214 (282)
T ss_dssp             HHHHHHHHHTT--T-SSSCCEEEE--ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhcc--C-CCcCeEEec--cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCC
Confidence            35666667776  4 666665543  45699999999999988 432        124479999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      +|+||||+||+++ ++.++|+|||++.
T Consensus       215 iHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          215 VHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             ECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             EeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            9999999999999 9999999999886

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.23  E-value=9.1e-12  Score=106.90  Aligned_cols=97  Identities=15%  Similarity=0.187  Sum_probs=71.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCC-C----CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPN-G----SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      ..|...++.+.|+++ .++..+..  +..++||||+.+ |    +|.+....     .++..+..++.|++.++.|||. 
T Consensus       118 ~~E~~~l~~l~~~~i-~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~-  188 (258)
T 1zth_A          118 EKEFRNLERAKEAGV-SVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ-  188 (258)
T ss_dssp             HHHHHHHHHHHHTTC-CCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHhCCC-CCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH-
Confidence            345566777777764 33333332  356899999932 3    77766543     2345678899999999999993 


Q ss_pred             CCCCceecCcCCCcEEEcCCCcEEEeeccccccc
Q 048068          115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY  148 (313)
Q Consensus       115 ~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~  148 (313)
                       ..+++||||||.||+++.  .++|+|||++...
T Consensus       189 -~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          189 -EAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             -TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             -HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence             279999999999999988  8999999998643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.90  E-value=9.1e-10  Score=99.19  Aligned_cols=69  Identities=12%  Similarity=0.144  Sum_probs=56.1

Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC----------cEE
Q 048068           69 LLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL----------NGK  138 (313)
Q Consensus        69 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~----------~~~  138 (313)
                      +|||||++|++|..+...        ..+..++.||+.++.+||   ..|++||||||.|||+++++          .+.
T Consensus       187 ~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~  255 (397)
T 4gyi_A          187 TIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSITLTPI  255 (397)
T ss_dssp             EEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred             eEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcccccccccceE
Confidence            799999999888654321        124567899999999999   58999999999999998776          388


Q ss_pred             Eeeccccccc
Q 048068          139 LGDFGLARLY  148 (313)
Q Consensus       139 l~dfg~~~~~  148 (313)
                      |+||+-+...
T Consensus       256 iID~~Q~V~~  265 (397)
T 4gyi_A          256 IIXFPQMVSM  265 (397)
T ss_dssp             ECCCTTCEET
T ss_pred             EEEeCCcccC
Confidence            9999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.39  E-value=4.7e-07  Score=77.18  Aligned_cols=101  Identities=15%  Similarity=0.071  Sum_probs=70.5

Q ss_pred             ChhhHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc--
Q 048068           38 DPQLQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED--  114 (313)
Q Consensus        38 ~~~~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~--  114 (313)
                      ....|...++.+. +..+.+....... .+..++|||+++|.+|.+.+..       ......++.++..++..||+-  
T Consensus        55 ~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~  126 (263)
T 3tm0_A           55 DVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDI  126 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCc
Confidence            3456666776664 3444455555444 6789999999999999876421       112346778888889999960  


Q ss_pred             ------------------------------------------------------CCCCceecCcCCCcEEEcCCCcEEEe
Q 048068          115 ------------------------------------------------------WEQVVLHRDIKPANVLLDADLNGKLG  140 (313)
Q Consensus       115 ------------------------------------------------------~~~~i~H~dl~~~nIlv~~~~~~~l~  140 (313)
                                                                            ...+++|+|+++.||++++.+...|+
T Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lI  206 (263)
T 3tm0_A          127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI  206 (263)
T ss_dssp             TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEEC
T ss_pred             ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEE
Confidence                                                                  01458999999999999875556799


Q ss_pred             eccccc
Q 048068          141 DFGLAR  146 (313)
Q Consensus       141 dfg~~~  146 (313)
                      ||+.+.
T Consensus       207 Dwe~a~  212 (263)
T 3tm0_A          207 DLGRSG  212 (263)
T ss_dssp             CCTTCE
T ss_pred             Echhcc
Confidence            998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.26  E-value=4.7e-07  Score=79.15  Aligned_cols=155  Identities=16%  Similarity=0.150  Sum_probs=90.3

Q ss_pred             hhHHhhhhhccccceeeeeeEEe---ccC--CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVN---SRK--GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED  114 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~---~~~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~  114 (313)
                      ..|...++.+.....+..+.++.   ..+  ...|+||++++|.+|......    .++......++.+++..+..||+.
T Consensus        58 ~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~  133 (304)
T 3sg8_A           58 FNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSI  133 (304)
T ss_dssp             HHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcC
Confidence            45556666653322232333332   111  245889999999888754332    266777777777777777777740


Q ss_pred             -------------------------------------------------------CCCCceecCcCCCcEEEcC--CCcE
Q 048068          115 -------------------------------------------------------WEQVVLHRDIKPANVLLDA--DLNG  137 (313)
Q Consensus       115 -------------------------------------------------------~~~~i~H~dl~~~nIlv~~--~~~~  137 (313)
                                                                             ....++|+|+++.||+++.  .+.+
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~  213 (304)
T 3sg8_A          134 NISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTIC  213 (304)
T ss_dssp             CCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEE
T ss_pred             CCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEE
Confidence                                                                   0135799999999999998  4567


Q ss_pred             EEeecccccccCCCCCCcccccccccccccccccc------CC--------CCCcchhhHHHHHHHHHHHhCCCCCc
Q 048068          138 KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR------TG--------KASTSTDVYAFGVFMLEVASGRRPIE  200 (313)
Q Consensus       138 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~--------~~~~~~DiwslG~il~~ll~g~~pf~  200 (313)
                      .++||+.+..... . ...........-..|+...      +.        ......+.|+++.++|.+.+|..+|.
T Consensus       214 ~~iD~~~~~~~~~-~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          214 GIIDFGDAAISDP-D-NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             EECCCTTCEEECT-T-HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             EEEeCCCCccCCh-H-HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            8999998753211 0 0000000000001222110      00        01123589999999999999988764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.20  E-value=2e-06  Score=72.79  Aligned_cols=97  Identities=20%  Similarity=0.164  Sum_probs=64.1

Q ss_pred             hhhHHhhhhhccccce--eeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-
Q 048068           39 PQLQRDGLASVHSNGL--LQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDW-  115 (313)
Q Consensus        39 ~~~~~~~l~~~~~~~~--l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~-  115 (313)
                      ...|...++.+.+.++  .+....... ++..++||||++|.+|.  ...     .+.   ..++.+++..+..||+.. 
T Consensus        60 ~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~  128 (264)
T 1nd4_A           60 LQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDP  128 (264)
T ss_dssp             HHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCG
T ss_pred             hhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCC
Confidence            4466677777755433  234444333 56789999999998884  221     121   245666777777777410 


Q ss_pred             ------------------------------------------------------CCCceecCcCCCcEEEcCCCcEEEee
Q 048068          116 ------------------------------------------------------EQVVLHRDIKPANVLLDADLNGKLGD  141 (313)
Q Consensus       116 ------------------------------------------------------~~~i~H~dl~~~nIlv~~~~~~~l~d  141 (313)
                                                                            ..+++|+|++|.||++++++.+.|+|
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD  208 (264)
T 1nd4_A          129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFID  208 (264)
T ss_dssp             GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECC
T ss_pred             CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEc
Confidence                                                                  12399999999999998766667999


Q ss_pred             ccccc
Q 048068          142 FGLAR  146 (313)
Q Consensus       142 fg~~~  146 (313)
                      |+.+.
T Consensus       209 ~~~a~  213 (264)
T 1nd4_A          209 CGRLG  213 (264)
T ss_dssp             CTTCE
T ss_pred             chhcc
Confidence            99764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.18  E-value=3e-06  Score=75.76  Aligned_cols=105  Identities=11%  Similarity=0.130  Sum_probs=74.2

Q ss_pred             ChhhHHhhhhhccc--cceeeeeeEEeccC--CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           38 DPQLQRDGLASVHS--NGLLQLTNTVNSRK--GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        38 ~~~~~~~~l~~~~~--~~~l~~~~~~~~~~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      ....|..+++.+..  .++.+.+....+..  +..++|||+++|..+.+..    -..++......++.+++..|..||+
T Consensus        82 ~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A           82 AIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhC
Confidence            34456667777763  33444444443321  4589999999988774421    1237788888899999999999996


Q ss_pred             cC-------------------------------------------------------CCCceecCcCCCcEEEcCCCc--
Q 048068          114 DW-------------------------------------------------------EQVVLHRDIKPANVLLDADLN--  136 (313)
Q Consensus       114 ~~-------------------------------------------------------~~~i~H~dl~~~nIlv~~~~~--  136 (313)
                      ..                                                       ...++|+|+++.||+++.++.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v  237 (359)
T 3dxp_A          158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRV  237 (359)
T ss_dssp             SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCE
T ss_pred             CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcE
Confidence            10                                                       257999999999999987653  


Q ss_pred             EEEeeccccc
Q 048068          137 GKLGDFGLAR  146 (313)
Q Consensus       137 ~~l~dfg~~~  146 (313)
                      +.|+||+.+.
T Consensus       238 ~~viDwe~a~  247 (359)
T 3dxp_A          238 LAVLDWELST  247 (359)
T ss_dssp             EEECCCTTCE
T ss_pred             EEEECccccc
Confidence            6899999875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.94  E-value=0.00011  Score=60.15  Aligned_cols=145  Identities=16%  Similarity=0.074  Sum_probs=92.3

Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccc
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      -+|.++|... +.++++.++|+++.|.+.+|.-+-.  +..-..+-+.|..|++..+|.+-+.+ ..+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            4899999865 5689999999999999999877621  11222344556899999999887653 1110           


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                        .....+.+||... ...+.+.=|||||+++|..+--..|-.                                  .+.
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~----------------------------------eE~  140 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN----------------------------------EER  140 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT----------------------------------EEE
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc----------------------------------cch
Confidence              1123455777653 345678889999999999987433311                                  122


Q ss_pred             HHHHHHHHHHHHcCCC-------------------------CCCCCCCHHHHHHHHhccCCC
Q 048068          238 EQMELVLKLGLFCSHP-------------------------KPEARPNMRQVMQYLDGNATL  274 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~-------------------------~P~~Rpt~~ell~~L~~~~~~  274 (313)
                      ..++.+.+||..|.+.                         .+..|+|++++++.=++..+-
T Consensus       141 eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~  202 (229)
T 2yle_A          141 ELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPT  202 (229)
T ss_dssp             CCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSSS
T ss_pred             hhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccC
Confidence            2334455555556543                         457899999999988877543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.36  E-value=0.00066  Score=59.10  Aligned_cols=103  Identities=17%  Similarity=0.100  Sum_probs=61.6

Q ss_pred             hhHHhhhhhccccc---eeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc--
Q 048068           40 QLQRDGLASVHSNG---LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED--  114 (313)
Q Consensus        40 ~~~~~~l~~~~~~~---~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~--  114 (313)
                      ..|...++.+.+..   +.+...+.....+..++|||+++|.+|....-.    .++......++.++...|..||+.  
T Consensus        57 ~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~  132 (306)
T 3tdw_A           57 NKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPV  132 (306)
T ss_dssp             HHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCH
T ss_pred             HHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence            45666666665422   222222222335668899999999888763211    133444444444444444444420  


Q ss_pred             -------------------------------------------------------CCCCceecCcCCCcEEEcC---CCc
Q 048068          115 -------------------------------------------------------WEQVVLHRDIKPANVLLDA---DLN  136 (313)
Q Consensus       115 -------------------------------------------------------~~~~i~H~dl~~~nIlv~~---~~~  136 (313)
                                                                             ....++|+|+++.||+++.   ++.
T Consensus       133 ~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~  212 (306)
T 3tdw_A          133 ETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP  212 (306)
T ss_dssp             HHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC
T ss_pred             ccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc
Confidence                                                                   1346799999999999987   355


Q ss_pred             -EEEeeccccc
Q 048068          137 -GKLGDFGLAR  146 (313)
Q Consensus       137 -~~l~dfg~~~  146 (313)
                       ..|+||+.+.
T Consensus       213 ~~~~iD~~~a~  223 (306)
T 3tdw_A          213 LTGIIDFGDAA  223 (306)
T ss_dssp             EEEECCCTTCE
T ss_pred             eEEEEehhhcC
Confidence             4799998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.13  E-value=0.0011  Score=56.19  Aligned_cols=76  Identities=21%  Similarity=0.151  Sum_probs=53.0

Q ss_pred             CCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------
Q 048068           65 KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHED------------------------------  114 (313)
Q Consensus        65 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~------------------------------  114 (313)
                      ++..++|||+++|.++.+......      .....+..++...+..||+.                              
T Consensus        92 ~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (272)
T 4gkh_A           92 PDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDAS  165 (272)
T ss_dssp             TTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGG
T ss_pred             CCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhh
Confidence            578899999999988887765421      11234455555666666620                              


Q ss_pred             -------------------------CCCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          115 -------------------------WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       115 -------------------------~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                                               ....++|+|+.+.||+++..+..-|+||+.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          166 DFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                     01237899999999999887767799998664

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.61  E-value=0.0053  Score=54.28  Aligned_cols=31  Identities=26%  Similarity=0.251  Sum_probs=25.8

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...++|+|+.+.||++++.+.+.|+||+.+.
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            3679999999999999864457899998774

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.72  E-value=0.08  Score=45.46  Aligned_cols=30  Identities=20%  Similarity=0.093  Sum_probs=24.9

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...++|+|+.+.||+ ..++.+.++||..+.
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            456899999999999 556678999998764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=94.31  E-value=0.055  Score=47.04  Aligned_cols=31  Identities=19%  Similarity=0.172  Sum_probs=27.5

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5789999999999999877889999999663

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=92.55  E-value=0.12  Score=46.65  Aligned_cols=31  Identities=19%  Similarity=0.325  Sum_probs=27.3

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARL  147 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~  147 (313)
                      ...++|||+++.||+++.++ +.++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            58899999999999998776 99999987753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.23  E-value=0.94  Score=36.92  Aligned_cols=82  Identities=12%  Similarity=0.090  Sum_probs=58.8

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCceecCcCCC
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPN-GSLDKILHTNIKPSLSWYQRFRIIRGVASGLL-YLHEDWEQVVLHRDIKPA  127 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~-~lhs~~~~~i~H~dl~~~  127 (313)
                      .++.+  ...+. ..++.+.+.++.-++ .++. .++     ..+....++++.+|+.... +++     .-+|--++|+
T Consensus        48 ~~~~f--~~~I~-~~eD~~~i~y~~~~~~~~f~-~i~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDID-VSEDEVKVVIKPPSSFLTFA-AIR-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEE-ECSSEEEEEEECCTTCEEHH-HHH-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEE-EeCCEEEEEEEcCcccCcHH-HHH-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            44555  44444 446788888887533 3444 333     3788899999999888766 454     4678899999


Q ss_pred             cEEEcCCCcEEEeecccc
Q 048068          128 NVLLDADLNGKLGDFGLA  145 (313)
Q Consensus       128 nIlv~~~~~~~l~dfg~~  145 (313)
                      ||+++.++.+++.-.|+-
T Consensus       114 NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GEEECTTCCEEESCCEET
T ss_pred             eEEEeCCCcEEEEEcCCc
Confidence            999999999999866643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=89.24  E-value=0.46  Score=41.18  Aligned_cols=32  Identities=31%  Similarity=0.416  Sum_probs=27.3

Q ss_pred             CCCceecCcCCCcEEEcCC----CcEEEeecccccc
Q 048068          116 EQVVLHRDIKPANVLLDAD----LNGKLGDFGLARL  147 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~----~~~~l~dfg~~~~  147 (313)
                      ...++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4689999999999999874    6789999997753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.01  E-value=0.46  Score=43.55  Aligned_cols=17  Identities=24%  Similarity=0.368  Sum_probs=15.3

Q ss_pred             CCCceecCcCCCcEEEc
Q 048068          116 EQVVLHRDIKPANVLLD  132 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~  132 (313)
                      ...++|+|+.+.||+++
T Consensus       289 ~~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          289 PIVLCHCDLLSSNIINT  305 (458)
T ss_dssp             CEEEECSCCCGGGEEEC
T ss_pred             CeeEEecCCCCCcEEee
Confidence            45789999999999998

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=87.98  E-value=0.17  Score=43.65  Aligned_cols=31  Identities=32%  Similarity=0.288  Sum_probs=25.7

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+++.||+++.++...++||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3578999999999999876556799998663

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=86.44  E-value=0.7  Score=39.80  Aligned_cols=29  Identities=31%  Similarity=0.378  Sum_probs=24.8

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...++|+|+++.||+++ + .+.++||+.+.
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            46789999999999998 4 78999998664

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=85.06  E-value=0.42  Score=43.35  Aligned_cols=19  Identities=26%  Similarity=0.447  Sum_probs=16.0

Q ss_pred             CCCceecCcCCCcEEEcCC
Q 048068          116 EQVVLHRDIKPANVLLDAD  134 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~  134 (313)
                      ...++|+|+.+.||+++.+
T Consensus       248 ~~v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          248 PVTFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             CEEEECSCCCGGGEEEEC-
T ss_pred             CeEEEeCCCCCCeEEeeCC
Confidence            4578999999999999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=84.98  E-value=0.41  Score=41.84  Aligned_cols=31  Identities=26%  Similarity=0.309  Sum_probs=27.0

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...++|+|+.+.||+++.++.+.++||+.+.
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            3679999999999999887889999997664

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=84.35  E-value=1.2  Score=39.13  Aligned_cols=30  Identities=23%  Similarity=0.320  Sum_probs=24.4

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.||+++.++ +.++||..+.
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            45789999999999997654 8899998664

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=83.93  E-value=0.73  Score=41.03  Aligned_cols=31  Identities=32%  Similarity=0.375  Sum_probs=26.7

Q ss_pred             CCCceecCcCCCcEEEcCC----CcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDAD----LNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~----~~~~l~dfg~~~  146 (313)
                      ...++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            4578999999999999876    688999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=83.79  E-value=1.1  Score=39.93  Aligned_cols=30  Identities=17%  Similarity=0.305  Sum_probs=25.5

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...++|||+.+.||+++.+ .+.++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            5789999999999999875 48899997664

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.01  E-value=6.1  Score=32.00  Aligned_cols=118  Identities=12%  Similarity=0.176  Sum_probs=77.4

Q ss_pred             hccccceeeeeeEEeccCCeEEEEEecCC-CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCC
Q 048068           48 SVHSNGLLQLTNTVNSRKGEFLLVYDYMP-NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP  126 (313)
Q Consensus        48 ~~~~~~~l~~~~~~~~~~~~~~lV~e~~~-~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~  126 (313)
                      +-.+++++.. .+... .+.+.+.++.-+ +.++.. ++     ..+....++++.+|+....+++     .-+|--++|
T Consensus        41 ~~~~~~Fl~~-~I~e~-eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P  107 (215)
T 4ann_A           41 EQHSPYFIDA-ELTEL-RDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAP  107 (215)
T ss_dssp             GSCCTTBCCE-EEEEC-SSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSG
T ss_pred             hccCCcccce-EEEEc-ccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEec
Confidence            3356777755 34444 557777777654 334443 33     3788899999999988775555     357889999


Q ss_pred             CcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       127 ~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      +||+++.++.+++.-.|+-..                  ++|.     ..++..=.-.+=|++..+++++..|..
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             ceEEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999999886664321                  1221     112222233456888889999888764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	313
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-41
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-40
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-40
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-39
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-38
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-38
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-37
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-36
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-34
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-34
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-33
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-33
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-27
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-26
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-26
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-25
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-24
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-24
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-21
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-20
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-19
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-16
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-11
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	3e-06
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	8e-06
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	3e-05
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	3e-05
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	5e-05
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	5e-05
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	7e-05
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	1e-04
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	2e-04
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	2e-04
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	3e-04
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	4e-04
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	4e-04
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	5e-04
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	5e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (415), Expect = 2e-49
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
             +  +V  +    SL   LH  I+      +   I R  A G+ YLH    + ++HRD+
Sbjct: 75  APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDL 130

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRT---GKASTST 180
           K  N+ L  DL  K+GDFGLA +    +   Q  +L G+  +MAPE++R       S  +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190

Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM 240
           DVYAFG+ + E+ +G+ P     + + +  +            L    S++     +   
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFM-------VGRGYLSPDLSKVRSNCPKAMK 243

Query: 241 ELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            L+ +    C   K + RP   Q++  ++
Sbjct: 244 RLMAE----CLKKKRDERPLFPQILASIE 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 6e-46
 Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 24/241 (9%)

Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G +   N  N    +  LV DY  +GSL   L+   + +++     ++    ASG
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASG 112

Query: 108 LLYLHED-----WEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD---TIPQTTKL 159
           L +LH +      +  + HRD+K  N+L+  +    + D GLA  +D             
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172

Query: 160 VGTFGYMAPELMRT------GKASTSTDVYAFGVFMLEVASGRRPI----EQQGSMEMVN 209
           VGT  YMAPE++         ++    D+YA G+   E+A          + Q     + 
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEE-EQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
             D   +  +K          +   ++  E + ++ K+   C +    AR    ++ + L
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

Query: 269 D 269
            
Sbjct: 293 S 293

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 6e-46
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 21/221 (9%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIK--PSLSWYQRFRIIRGVASG 107
           H N +      ++       +V +Y   G L  ++    K    L      R++  +   
Sbjct: 62  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 108 LLYLHE--DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           L   H   D    VLHRD+KPANV LD   N KLGDFGLAR+ +HDT       VGT  Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYY 180

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           M+PE M     +  +D+++ G  + E+ +   P       E+               I +
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIRE 228

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
               R+   Y +E  E++ +      + K   RP++ ++++
Sbjct: 229 GKFRRIPYRYSDELNEIITR----MLNLKDYHRPSVEEILE 265

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-44
 Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 20/224 (8%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L++L   V   +    ++ +YM NGSL   L T     L+  +   +   +A
Sbjct: 62  MKQLQHQRLVRLYAVVT--QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            G+ ++ E      +HRD++ AN+L+   L+ K+ DFGLARL + +             +
Sbjct: 120 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
            APE +  G  +  +DV++FG+ + E+ +  R      +                  ++ 
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---------------EVIQ 221

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +     +  +   E + +L   C   +PE RP    +   L+
Sbjct: 222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-42
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 24/225 (10%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +  + L+QL   +   KG   +V +YM  GSL   L +  +  L      +    V 
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             + YL  +     +HRD+   NVL+  D   K+ DFGL +                  +
Sbjct: 114 EAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKW 166

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
            APE +R  K ST +DV++FG+ + E+ S GR P  +    ++V  V       +KG  +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYKM 219

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           DA D     +YE         +   C H     RP+  Q+ + L+
Sbjct: 220 DAPDGCPPAVYE---------VMKNCWHLDAAMRPSFLQLREQLE 255

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-42
 Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 22/214 (10%)

Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
                 +    K   +LV + M +G+L   L       +         R +  GL +LH 
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT 130

Query: 114 DWEQVVLHRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR 172
               ++ HRD+K  N+ +       K+GD GLA L           ++GT  +MAPE+  
Sbjct: 131 RTPPII-HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE 186

Query: 173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE 232
             K   S DVYAFG+ MLE+A+   P           +   V+   K         +  +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVK--------PASFD 235

Query: 233 GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
            +   E  E++      C     + R +++ ++ 
Sbjct: 236 KVAIPEVKEIIEG----CIRQNKDERYSIKDLLN 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-42
 Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 20/233 (8%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL   V+  +    +V +YM  GSL   L       L   Q   +   +A
Sbjct: 66  MKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           SG+ Y+        +HRD++ AN+L+  +L  K+ DFGLARL + +             +
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
            APE    G+ +  +DV++FG+ + E+ +  R                         +LD
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLD 225

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIP 278
             +         E  E +  L   C   +PE RP    +  +L+   T  +  
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 9e-42
 Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 43/252 (17%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L   +S  ++       S  GE  +  ++M  GSLD++L    +  +      ++   V 
Sbjct: 58  LHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVI 114

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            GL YL E  +  ++HRD+KP+N+L+++    KL DFG++              VGT  Y
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSY 169

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM------------------ 207
           M+PE ++    S  +D+++ G+ ++E+A GR PI    + E+                  
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229

Query: 208 -----VNLVDWVSDCWKKGAILDASDSRL--------EGIYEEEQMELVLKLGLFCSHPK 254
                  L  +  D     AI +  D  +         G++  E  + V K    C    
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK----CLIKN 285

Query: 255 PEARPNMRQVMQ 266
           P  R +++Q+M 
Sbjct: 286 PAERADLKQLMV 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (361), Expect = 3e-41
 Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 26/229 (11%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +       ++ L   V       +++ ++M NGSLD  L  N     +  Q   ++RG+A
Sbjct: 81  MGQFDHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIA 138

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTK----LVG 161
           +G+ YL +      +HRD+   N+L++++L  K+ DFGL+R  + DT   T         
Sbjct: 139 AGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLE-VASGRRPIEQQGSMEMVNLVDWVSDCWKK 220
              + APE ++  K ++++DV+++G+ M E ++ G RP     + +++N ++        
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-------- 247

Query: 221 GAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  D RL      +    + +L L C       RP   Q++  LD
Sbjct: 248 ------QDYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-40
 Identities = 53/250 (21%), Positives = 94/250 (37%), Gaps = 32/250 (12%)

Query: 31  IYHGFNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILH 85
           ++    E   ++      V     L+  N +             L+ +Y P G++ + L 
Sbjct: 39  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 98

Query: 86  TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLA 145
              K      +    I  +A+ L Y H    + V+HRDIKP N+LL +    K+ DFG +
Sbjct: 99  KLSK--FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 153

Query: 146 RLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM 205
                    + T L GT  Y+ PE++         D+++ GV   E   G+ P E     
Sbjct: 154 VHAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210

Query: 206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVM 265
           E    +  V             +        E   +L+ +         P  RP +R+V+
Sbjct: 211 ETYKRISRV-------------EFTFPDFVTEGARDLISR----LLKHNPSQRPMLREVL 253

Query: 266 Q--YLDGNAT 273
           +  ++  N++
Sbjct: 254 EHPWITANSS 263

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 8e-40
 Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 22/224 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + ++    L+QL     +++    ++ +YM NG L   L           Q   + + V 
Sbjct: 53  MMNLSHEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVC 110

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             + YL        LHRD+   N L++     K+ DFGL+R    D    +        +
Sbjct: 111 EAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
             PE++   K S+ +D++AFGV M E+ S G+ P E+  + E    +             
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------- 214

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
                 L         E V  +   C H K + RP  + ++  +
Sbjct: 215 ---AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-39
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 23/205 (11%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
             +LV +    G L K L    +  +       ++  V+ G+ YL E   +  +HRD+  
Sbjct: 82  ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAA 137

Query: 127 ANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
            NVLL      K+ DFGL++    D       +       + APE +   K S+ +DV++
Sbjct: 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 197

Query: 185 FGVFMLEV-ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
           +GV M E  + G++P ++    E++  +       ++G  ++        +Y      L+
Sbjct: 198 YGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRMECPPECPPELY-----ALM 245

Query: 244 LKLGLFCSHPKPEARPNMRQVMQYL 268
                 C   K E RP+   V Q +
Sbjct: 246 SD----CWIYKWEDRPDFLTVEQRM 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-39
 Identities = 49/240 (20%), Positives = 88/240 (36%), Gaps = 24/240 (10%)

Query: 35  FNEDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLDKILHTNIK 89
             E    + D +        L     V        +    LV+++M +G L   L T   
Sbjct: 37  IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG 96

Query: 90  PSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYD 149
              +      +   V  G+       E  V+HRD+   N L+  +   K+ DFG+ R   
Sbjct: 97  LF-AAETLLGMCLDVCEGM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152

Query: 150 HDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVN 209
            D    +T       + +PE+    + S+ +DV++FGV M EV S  +   +  S     
Sbjct: 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--E 210

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +V+ +S  ++                       V ++   C   +PE RP   ++++ L 
Sbjct: 211 VVEDISTGFRL-------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-39
 Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 21/214 (9%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
               +++ +YM NG+LDK          S  Q   ++RG+A+G+ YL        +HRD+
Sbjct: 81  YKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDL 136

Query: 125 KPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
              N+L++++L  K+ DFGL+R+   D +    T+       + APE +   K ++++DV
Sbjct: 137 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 196

Query: 183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           ++FG+ M EV +       + S                  ++ A +         +    
Sbjct: 197 WSFGIVMWEVMTYGERPYWELSNH---------------EVMKAINDGFRLPTPMDCPSA 241

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPD 276
           + +L + C   +   RP    ++  LD     PD
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 8e-39
 Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 41/232 (17%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTN----------------------IKPSLSWYQRF 98
           V +      L+++YM  G L++ L +                         P LS  ++ 
Sbjct: 84  VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 143

Query: 99  RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTT 157
            I R VA+G+ YL E      +HRD+   N L+  ++  K+ DFGL+R +Y  D      
Sbjct: 144 CIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 200

Query: 158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC 217
                  +M PE +   + +T +DV+A+GV + E+ S         + E       V   
Sbjct: 201 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE------EVIYY 254

Query: 218 WKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            + G IL   ++    +Y          L   C    P  RP+   + + L 
Sbjct: 255 VRDGNILACPENCPLELYN---------LMRLCWSKLPADRPSFCSIHRILQ 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (343), Expect = 1e-38
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 19/224 (8%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +    L+QL     +R+  F ++ ++M  G+L   L    +  +S      +   ++
Sbjct: 67  MKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S + YL +   +  +HRD+   N L+  +   K+ DFGL+RL   DT            +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
            APE +   K S  +DV+AFGV + E+A+          +                 + +
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYE 227

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
             +        E   E V +L   C    P  RP+  ++ Q  +
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-38
 Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 34/241 (14%)

Query: 65  KGEFLLVYDYMPNGSLDKILH--------------TNIKPSLSWYQRFRIIRGVASGLLY 110
           +G   L  +Y P+G+L   L                +   +LS  Q       VA G+ Y
Sbjct: 83  RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142

Query: 111 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL 170
           L    ++  +HRD+   N+L+  +   K+ DFGL+R  +     + T       +MA E 
Sbjct: 143 L---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIES 197

Query: 171 MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSR 230
           +     +T++DV+++GV + E+ S          M    L + +   ++    L+  D  
Sbjct: 198 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEKLPQGYRLEKPLNCDDE- 254

Query: 231 LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTLIAPFSAS 290
                       V  L   C   KP  RP+  Q++  L+          ++TL   F+ +
Sbjct: 255 ------------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302

Query: 291 N 291
            
Sbjct: 303 G 303

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 1e-38
 Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 29/224 (12%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  +     +Q       R+    LV +Y    + D +     K  L   +   +  G  
Sbjct: 69  LQKLRHPNTIQYRGCY-LREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGAL 125

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            GL YLH      ++HRD+K  N+LL      KLGDFG A +            VGT  +
Sbjct: 126 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYW 177

Query: 166 MAPEL---MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA 222
           MAPE+   M  G+     DV++ G+  +E+A  + P+    +M  +  +           
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----------- 226

Query: 223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
             + S +   G + E     V      C    P+ RP    +++
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDS----CLQKIPQDRPTSEVLLK 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-38
 Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 22/227 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +       +L L       +G  L+V  YM +G L   +      + +          VA
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVA 140

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY---DHDTIPQTTKLVGT 162
            G+        +  +HRD+   N +LD     K+ DFGLAR     + D++   T     
Sbjct: 141 KGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA 222
             +MA E ++T K +T +DV++FGV + E+ +   P         VN  D      +   
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFDITVYLLQGRR 252

Query: 223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
           +L            E   + + ++ L C HPK E RP+  +++  + 
Sbjct: 253 LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 7e-38
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 24/206 (11%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
             ++LV +    G L+K L  N    +       ++  V+ G+ YL E      +HRD+ 
Sbjct: 80  ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN---FVHRDLA 134

Query: 126 PANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
             NVLL      K+ DFGL++    D +     T       + APE +   K S+ +DV+
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194

Query: 184 AFGVFMLE-VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           +FGV M E  + G++P       E+  ++       +KG  +             E  +L
Sbjct: 195 SFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGCPAG-----CPREMYDL 242

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQYL 268
           +      C     E RP    V   L
Sbjct: 243 MNL----CWTYDVENRPGFAAVELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-38
 Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 22/223 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
              ++   +++             L  +Y   G L   +  +I   +      R    + 
Sbjct: 57  NKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLM 113

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQ-TTKLVGTFG 164
           +G++YLH      + HRDIKP N+LLD   N K+ DFGLA ++ ++   +   K+ GT  
Sbjct: 114 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170

Query: 165 YMAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
           Y+APEL++  +  +   DV++ G+ +  + +G      Q S       DW          
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
                           + L+ K         P AR  +  + +
Sbjct: 230 KKID---------SAPLALLHK----ILVENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-37
 Identities = 41/223 (18%), Positives = 73/223 (32%), Gaps = 34/223 (15%)

Query: 65  KGEFLLVYDYMPNGSLDKILH----------------TNIKPSLSWYQRFRIIRGVASGL 108
            G  L++ +Y   G L   L                  + + +L           VA G+
Sbjct: 99  GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158

Query: 109 LYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMA 167
            +L        +HRD+   N+LL      K+ DFGLAR + +               +MA
Sbjct: 159 AFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 215

Query: 168 PELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDAS 227
           PE +     +  +DV+++G+F+ E+ S                                 
Sbjct: 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYPGMPVDSKFYKMI 261

Query: 228 DSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG 270
                 +  E     +  +   C    P  RP  +Q++Q ++ 
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-37
 Identities = 48/228 (21%), Positives = 95/228 (41%), Gaps = 29/228 (12%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           LAS     +++L +     +    ++ ++   G++D ++    +P L+  Q   + +   
Sbjct: 63  LASCDHPNIVKLLDAFYY-ENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTL 120

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             L YLH+     ++HRD+K  N+L   D + KL DFG++      TI +    +GT  +
Sbjct: 121 DALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYW 176

Query: 166 MAPELMRTGKA-----STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKK 220
           MAPE++    +         DV++ G+ ++E+A    P  +   M ++            
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL----------- 225

Query: 221 GAILDASDSRLE--GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
             I  +    L     +     + + K    C     +AR    Q++Q
Sbjct: 226 -KIAKSEPPTLAQPSRWSSNFKDFLKK----CLEKNVDARWTTSQLLQ 268

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-36
 Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 32/239 (13%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--------------IKPS 91
           +   H   ++ L        G  +++ ++   G+L   L +                K  
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 92  LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDH 150
           L+          VA G+ +L     +  +HRD+   N+LL      K+ DFGLAR +Y  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 151 DTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL 210
               +         +MAPE +     +  +DV++FGV + E+ S             V +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKI 242

Query: 211 VDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            +      K+G  + A D     +Y+           L C H +P  RP   +++++L 
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLG 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-36
 Identities = 51/263 (19%), Positives = 97/263 (36%), Gaps = 24/263 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +ASV +  + +L            L+   MP G L   +  + K ++           +A
Sbjct: 65  MASVDNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIA 121

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFG 164
            G+ YL    ++ ++HRD+   NVL+    + K+ DFGLA+ L   +             
Sbjct: 122 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 165 YMAPELMRTGKASTSTDVYAFGVFMLE-VASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
           +MA E +     +  +DV+++GV + E +  G +P +   + E+ ++++           
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------- 227

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNATLPDIPRDSTL 283
                 RL           V  + + C     ++RP  R+++      A  P        
Sbjct: 228 ---KGERLP--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 284 IAPFSASNDAFSGNSSATMSTID 306
                  +   S    A M   D
Sbjct: 283 DERMHLPSPTDSNFYRALMDEED 305

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  130 bits (327), Expect = 7e-36
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 21/204 (10%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
             E +++Y++M  G L + +       +S  +    +R V  GL ++HE      +H D+
Sbjct: 95  DNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDL 150

Query: 125 KPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV 182
           KP N++     +   KL DFGL    D     + T   GT  + APE+         TD+
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDM 208

Query: 183 YAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL 242
           ++ GV    + SG  P   +   E +  V        K    +  DS   GI E+ + + 
Sbjct: 209 WSVGVLSYILLSGLSPFGGENDDETLRNV--------KSCDWNMDDSAFSGISEDGK-DF 259

Query: 243 VLKLGLFCSHPKPEARPNMRQVMQ 266
           + K         P  R  + Q ++
Sbjct: 260 IRK----LLLADPNTRMTIHQALE 279

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 9e-36
 Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 24/226 (10%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           + S+    L++L   V +      +V +  P GSL   L  + +         R    VA
Sbjct: 65  MHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVA 121

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARL--YDHDTIPQTTKLVGTF 163
            G+ YL        +HRD+   N+LL      K+GDFGL R    + D           F
Sbjct: 122 EGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLE-VASGRRPIEQQGSMEMVNLVDWVSDCWKKGA 222
            + APE ++T   S ++D + FGV + E    G+ P       ++++ +           
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------- 227

Query: 223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL 268
             D    RL     E+  + +  + + C   KPE RP    +  +L
Sbjct: 228 --DKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-35
 Identities = 41/228 (17%), Positives = 73/228 (32%), Gaps = 41/228 (17%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKP---------------------SLSWYQRFRIIRG 103
            G   L+++Y   G L   L +  +                       L++         
Sbjct: 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172

Query: 104 VASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGT 162
           VA G+ +L     +  +HRD+   NVL+      K+ DFGLAR +               
Sbjct: 173 VAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKG 221
             +MAPE +  G  +  +DV+++G+ + E+ S G  P                       
Sbjct: 230 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-------------- 275

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  +  +        E +  +   C       RP+   +  +L 
Sbjct: 276 -FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 7e-35
 Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 21/206 (10%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           +    ++ +    G L   L       L           +++ L YL     +  +HRDI
Sbjct: 79  ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KRFVHRDI 134

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
              NVL+ ++   KLGDFGL+R  +  T  + +K      +MAPE +   + ++++DV+ 
Sbjct: 135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194

Query: 185 FGVFMLEV-ASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV 243
           FGV M E+   G +P +   + +++              I +     +          L+
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIG------------RIENGERLPMPPNCPPTLYSLM 242

Query: 244 LKLGLFCSHPKPEARPNMRQVMQYLD 269
            K    C    P  RP   ++   L 
Sbjct: 243 TK----CWAYDPSRRPRFTELKAQLS 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-34
 Identities = 43/202 (21%), Positives = 82/202 (40%), Gaps = 21/202 (10%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
             E  +V +Y+  GSL  ++    +  +   Q   + R     L +LH      V+HRDI
Sbjct: 89  GDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           K  N+LL  D + KL DFG       +   + + +VGT  +MAPE++         D+++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
            G+  +E+  G  P   +  +  + L+             +  +            + + 
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPELQNPE---KLSAIFRDFLN 251

Query: 245 KLGLFCSHPKPEARPNMRQVMQ 266
           +    C     E R + ++++Q
Sbjct: 252 R----CLDMDVEKRGSAKELLQ 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-34
 Identities = 51/220 (23%), Positives = 82/220 (37%), Gaps = 33/220 (15%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPS--------------LSWYQRFRIIRGVASGLLY 110
            G   ++ +Y   G+L + L     P               LS          VA G+ Y
Sbjct: 91  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150

Query: 111 LHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV-GTFGYMAPE 169
           L     +  +HRD+   NVL+  D   K+ DFGLAR   H    + T        +MAPE
Sbjct: 151 LAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207

Query: 170 LMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDS 229
            +     +  +DV++FGV + E+ +          +E       +    K+G  +D    
Sbjct: 208 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELFKLLKEGHRMD---- 257

Query: 230 RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                        +  +   C H  P  RP  +Q+++ LD
Sbjct: 258 -----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-34
 Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 24/225 (10%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           ++ +     ++L  T      +      Y  NG L K +      S            + 
Sbjct: 62  MSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIV 118

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHD-TIPQTTKLVGTFG 164
           S L YLH      ++HRD+KP N+LL+ D++ ++ DFG A++   +    +    VGT  
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 165 YMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAIL 224
           Y++PEL+    A  S+D++A G  + ++ +G  P        +               I+
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------------KII 223

Query: 225 DASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
                  E  + + + +LV K            R    ++  Y  
Sbjct: 224 KLEYDFPEKFFPKAR-DLVEK----LLVLDATKRLGCEEMEGYGP 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-34
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 27/217 (12%)

Query: 63  SRKGEFLLVYDYMPNGSLDKILHTN--------IKPSLSWYQRFRIIRGVASGLLYLHED 114
           S+    L++ + M  G L   L +         +    S  +  ++   +A G+ YL   
Sbjct: 93  SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL--- 149

Query: 115 WEQVVLHRDIKPANVLLDADLNGKLGDFGLAR-LYDHDTIPQTTKLVGTFGYMAPELMRT 173
                +HRD+   N ++  D   K+GDFG+ R +Y+ D   +  K +    +M+PE ++ 
Sbjct: 150 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209

Query: 174 GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG 233
           G  +T +DV++FGV + E+A+      Q  S E       V     +G +LD  D+  + 
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVMEGGLLDKPDNCPDM 263

Query: 234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG 270
           ++E         L   C    P+ RP+  +++  +  
Sbjct: 264 LFE---------LMRMCWQYNPKMRPSFLEIISSIKE 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  123 bits (309), Expect = 5e-34
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 26/206 (12%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
            F LV+D M  G L   L   +   LS  +  +I+R +   +  LH+     ++HRD+KP
Sbjct: 84  FFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHK---LNIVHRDLKP 138

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA------STST 180
            N+LLD D+N KL DFG +   D     +  ++ GT  Y+APE++               
Sbjct: 139 ENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196

Query: 181 DVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM 240
           D+++ GV M  + +G  P   +  M M+ ++   +  +      D SD            
Sbjct: 197 DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD---------TVK 247

Query: 241 ELVLKLGLFCSHPKPEARPNMRQVMQ 266
           +LV +        +P+ R    + + 
Sbjct: 248 DLVSR----FLVVQPQKRYTAEEALA 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  123 bits (309), Expect = 3e-33
 Identities = 50/230 (21%), Positives = 92/230 (40%), Gaps = 24/230 (10%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           +  +H   L+ L +     K E +L+ +++  G L   +       +S  +    +R   
Sbjct: 80  MNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQAC 137

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTF 163
            GL ++HE     ++H DIKP N++ +       K+ DFGLA   + D I + T    T 
Sbjct: 138 EGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATA 192

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            + APE++        TD++A GV    + SG  P   +  +E +  V      + + A 
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ--YLDGN 271
              S          E  + +          +P  R  +   ++  +L G+
Sbjct: 253 SSVS---------PEAKDFIKN----LLQKEPRKRLTVHDALEHPWLKGD 289

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-33
 Identities = 43/243 (17%), Positives = 91/243 (37%), Gaps = 19/243 (7%)

Query: 54  LLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE 113
           ++ +   + + +   L+V + +  G L   +      + +  +   I++ +   + YLH 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 128

Query: 114 DWEQVVLHRDIKPANVLLDADLNG---KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPEL 170
                + HRD+KP N+L  +       KL DFG A+         T     T  Y+APE+
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEV 184

Query: 171 MRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSR 230
           +   K   S D+++ GV M  +  G  P      + +   +        +    +  +  
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYEFPNPE 240

Query: 231 LEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ--YLDGNATLPDIPRDSTLIAPFS 288
              + EE +  L+          +P  R  + + M   ++  +  +P  P  ++ +    
Sbjct: 241 WSEVSEEVK-MLIRN----LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295

Query: 289 ASN 291
              
Sbjct: 296 KER 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 40/223 (17%), Positives = 90/223 (40%), Gaps = 22/223 (9%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L       +L L  +  S   E +++++++    + + ++T+    L+  +    +  V 
Sbjct: 55  LNIARHRNILHLHESFES-MEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVC 112

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNG--KLGDFGLARLYDHDTIPQTTKLVGTF 163
             L +LH      + H DI+P N++     +   K+ +FG AR        +        
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAP 167

Query: 164 GYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI 223
            Y APE+ +    ST+TD+++ G  +  + SG  P   + + +++  +      + + A 
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227

Query: 224 LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
            + S          E M+ V +        + ++R    + +Q
Sbjct: 228 KEIS---------IEAMDFVDR----LLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 5e-31
 Identities = 50/235 (21%), Positives = 91/235 (38%), Gaps = 26/235 (11%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  +    ++ L +   S  G   L+   +  G L   +    K   +     R+I  V 
Sbjct: 61  LHKIKHPNIVALDDIYES-GGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVL 117

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLL---DADLNGKLGDFGLARLYDHDTIPQTTKLVGT 162
             + YLH+     ++HRD+KP N+L    D D    + DFGL+++ D  ++   +   GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGT 172

Query: 163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA 222
            GY+APE++     S + D ++ GV    +  G  P   +   ++   +      +    
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232

Query: 223 ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ--YLDGNATLP 275
             D S         +   + +           PE R    Q +Q  ++ G+  L 
Sbjct: 233 WDDIS---------DSAKDFIRH----LMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-30
 Identities = 45/213 (21%), Positives = 84/213 (39%), Gaps = 16/213 (7%)

Query: 64  RKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRD 123
           R+ +  LV++++       +     +P +       ++  +  GL +LH      V+HRD
Sbjct: 86  RETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRD 141

Query: 124 IKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVY 183
           +KP N+L+ +    KL DFGLAR+Y       +   V T  Y APE++     +T  D++
Sbjct: 142 LKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VVTLWYRAPEVLLQSSYATPVDLW 199

Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLV----------DWVSDCWKKGAILDASDSRLEG 233
           + G    E+   +        ++ +  +          DW  D         +  ++   
Sbjct: 200 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 259

Query: 234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
            +  +  EL   L L C    P  R +    + 
Sbjct: 260 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  107 bits (269), Expect = 4e-28
 Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 23/224 (10%)

Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H     +               +V +Y+   +L  I+HT     ++  +   +I      
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGY 165
           L +     +  ++HRD+KPAN+++ A    K+ DFG+AR      +++ QT  ++GT  Y
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILD 225
           ++PE  R       +DVY+ G  + EV +G  P      + +           ++  I  
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VREDPIP- 233

Query: 226 ASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-NMRQVMQYL 268
              S        +   +VLK         PE R     ++   L
Sbjct: 234 --PSARHEGLSADLDAVVLK----ALAKNPENRYQTAAEMRADL 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 6e-28
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 23/199 (11%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
           K     V +Y+  G L   + +  K      +       +  GL +L     + +++RD+
Sbjct: 75  KENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL---HSKGIVYRDL 129

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA 184
           K  N+LLD D + K+ DFG+ +          T   GT  Y+APE++   K + S D ++
Sbjct: 130 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWS 188

Query: 185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
           FGV + E+  G+ P   Q   E+ + +   +  + +               E+E  +L++
Sbjct: 189 FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-------------LEKEAKDLLV 235

Query: 245 KLGLFCSHPKPEARPNMRQ 263
           K        +PE R  +R 
Sbjct: 236 K----LFVREPEKRLGVRG 250

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (263), Expect = 4e-27
 Identities = 42/245 (17%), Positives = 78/245 (31%), Gaps = 25/245 (10%)

Query: 36  NEDPQLQRDG--LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLS 93
            + PQL  +      +     +       +     ++V + +     D  L        S
Sbjct: 44  TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFS 101

Query: 94  WYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKL---GDFGLARLYDH 150
                 +   + S + Y+H    +  +HRD+KP N L+     G L    DFGLA+ Y  
Sbjct: 102 LKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158

Query: 151 DTIPQ------TTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS 204
               Q         L GT  Y +       + S   D+ + G  ++    G  P +   +
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218

Query: 205 MEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQV 264
                  + +S+       +      L   Y  E    +      C   + + +P+   +
Sbjct: 219 ATKRQKYERISEKK-----MSTPIEVLCKGYPSEFATYLNF----CRSLRFDDKPDYSYL 269

Query: 265 MQYLD 269
            Q   
Sbjct: 270 RQLFR 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  104 bits (261), Expect = 2e-26
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 9/150 (6%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
             +   + D M  G L   L  +   S            +  GL ++H  +   V++RD+
Sbjct: 79  PDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHMHNRF---VVYRDL 133

Query: 125 KPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVY 183
           KPAN+LLD   + ++ D GLA  +      +    VGT GYMAPE+++ G A  +S D +
Sbjct: 134 KPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWF 190

Query: 184 AFGVFMLEVASGRRPIEQQGSMEMVNLVDW 213
           + G  + ++  G  P  Q  + +   +   
Sbjct: 191 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  103 bits (257), Expect = 2e-26
 Identities = 36/216 (16%), Positives = 72/216 (33%), Gaps = 25/216 (11%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
               +LV D +     D  L        S        + + + +  +HE   + +++RDI
Sbjct: 73  GLHNVLVIDLLGPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDI 127

Query: 125 KPANVLLDADLNG-----KLGDFGLARLYD------HDTIPQTTKLVGTFGYMAPELMRT 173
           KP N L+    +       + DFG+ + Y       H    +   L GT  YM+      
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187

Query: 174 GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG 233
            + S   D+ A G   +    G  P +   +       + + +  +   + +     L  
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----LCA 242

Query: 234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLD 269
            + EE  + +        +   +A P+   +     
Sbjct: 243 GFPEEFYKYMHY----ARNLAFDATPDYDYLQGLFS 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 5e-26
 Identities = 46/225 (20%), Positives = 88/225 (39%), Gaps = 25/225 (11%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  +    ++ L   V   K + +L+ + +  G L   L    K SL+  +    ++ + 
Sbjct: 67  LKEIQHPNVITLHE-VYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQIL 123

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDAD----LNGKLGDFGLARLYDHDTIPQTTKLVG 161
           +G+ YLH      + H D+KP N++L          K+ DFGLA   D     +   + G
Sbjct: 124 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFG 178

Query: 162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKG 221
           T  ++APE++         D+++ GV    + SG  P       E +  V  V+  ++  
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238

Query: 222 AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
              + S             + + +         P+ R  ++  +Q
Sbjct: 239 YFSNTS---------ALAKDFIRR----LLVKDPKKRMTIQDSLQ 270

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 6e-26
 Identities = 64/267 (23%), Positives = 100/267 (37%), Gaps = 28/267 (10%)

Query: 50  HSN--GLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASG 107
           H N  G+  +       + + + +  ++    L K+L T     LS       +  +  G
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRG 121

Query: 108 LLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLY--DHDTIPQTTKLVGTFGY 165
           L Y+H      VLHRD+KP+N+LL+   + K+ DFGLAR+   DHD     T+ V T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 166 MAPELMRTGKAST-STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV----------DWV 214
            APE+M   K  T S D+++ G  + E+ S R     +  ++ +N +          D  
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 215 SDCWKKGAILDASDSRLEGIYEEEQM----ELVLKLGLFCSHPKPEARPNMRQVMQ--YL 268
                K      S      +             L L        P  R  + Q +   YL
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

Query: 269 DGNATLPDIPRDSTLIAPFSASNDAFS 295
           +      D P  +     F    D   
Sbjct: 299 EQYYDPSDEPI-AEAPFKFDMELDDLP 324

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 7e-26
 Identities = 41/208 (19%), Positives = 66/208 (31%), Gaps = 32/208 (15%)

Query: 61  VNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL 120
              R   F+L+ +            T  + +L           V   + +        VL
Sbjct: 77  WFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC---HNCGVL 132

Query: 121 HRDIKPANVLLDADLNG-KLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-ST 178
           HRDIK  N+L+D +    KL DFG   L         T   GT  Y  PE +R  +    
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGR 189

Query: 179 STDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEE 238
           S  V++ G+ + ++  G  P E     E++    +                         
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQVFFRQRVSSECQ--------------- 232

Query: 239 QMELVLKLGLFCSHPKPEARPNMRQVMQ 266
              L+      C   +P  RP   ++  
Sbjct: 233 --HLIRW----CLALRPSDRPTFEEIQN 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 8e-26
 Identities = 50/237 (21%), Positives = 86/237 (36%), Gaps = 26/237 (10%)

Query: 68  FLLVYDYMPNGSLDKILH-TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
             LV DY+P        H +  K +L        +  +   L Y+H      + HRDIKP
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150

Query: 127 ANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAP-ELMRTGKASTSTDVYA 184
            N+LLD D    KL DFG A+         +   + +  Y AP  +      ++S DV++
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPELIFGATDYTSSIDVWS 208

Query: 185 FGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL 244
            G  + E+  G+        ++ +  +  V     +  I + + +  E  + + +     
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 268

Query: 245 KLGLFCSHPK------------PEARPNMRQVMQ------YLDGNATLPDIPRDSTL 283
           K+    + P+            P AR    +           D N  LP+      L
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPAL 325

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-25
 Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 32/228 (14%)

Query: 62  NSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH 121
           N  KG   LV+D+  +      L +N+    +  +  R+++ + +GL Y+H +    +LH
Sbjct: 86  NRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILH 140

Query: 122 RDIKPANVLLDADLNGKLGDFGLARLYD---HDTIPQTTKLVGTFGYMAPELMRTGKA-S 177
           RD+K ANVL+  D   KL DFGLAR +    +    + T  V T  Y  PEL+   +   
Sbjct: 141 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 200

Query: 178 TSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV-------------------DWVSDCW 218
              D++  G  M E+ +    ++       + L+                    +     
Sbjct: 201 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 260

Query: 219 KKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
            KG      D     + +   ++L+ K         P  R +    + 
Sbjct: 261 VKGQKRKVKDRLKAYVRDPYALDLIDK----LLVLDPAQRIDSDDALN 304

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 3e-25
 Identities = 49/238 (20%), Positives = 92/238 (38%), Gaps = 27/238 (11%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  ++   +++L   V   + +  LV++++ +  L K +  +    +        +  + 
Sbjct: 55  LKELNHPNIVKL-LDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            GL +        VLHRD+KP N+L++ +   KL DFGLAR +       T + V T  Y
Sbjct: 113 QGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE-VVTLWY 168

Query: 166 MAPE-LMRTGKASTSTDVYAFGVFMLEVASGRRP-------------IEQQGSMEMVNLV 211
            APE L+     ST+ D+++ G    E+ + R                   G+ + V   
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228

Query: 212 DWVSDCWKKGAILDASDSRLEGIYE---EEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
              S    K +    +      +     E+   L+ +      H  P  R + +  + 
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ----MLHYDPNKRISAKAALA 282

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 1e-24
 Identities = 52/237 (21%), Positives = 88/237 (37%), Gaps = 27/237 (11%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  +    ++ L +     K    LV+D+M       I        L+       +    
Sbjct: 54  LQELSHPNIIGLLD-AFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTL 110

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
            GL YLH+ W   +LHRD+KP N+LLD +   KL DFGLA+ +       T + V T  Y
Sbjct: 111 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWY 166

Query: 166 MAPELMRTGKA-STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV----------DWV 214
            APEL+   +      D++A G  + E+      +     ++ +  +           W 
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226

Query: 215 SDCWKKGAILDASD-----SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
             C     +   S        +     ++ ++L+           P AR    Q ++
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG----LFLFNPCARITATQALK 279

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 97.3 bits (241), Expect = 3e-24
 Identities = 44/233 (18%), Positives = 96/233 (41%), Gaps = 18/233 (7%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L  +  + +++L + ++++K   +LV++++       +     +  L        +  + 
Sbjct: 54  LKELKHSNIVKLYDVIHTKK-RLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLL 110

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           +G+ Y H+     VLHRD+KP N+L++ +   K+ DFGLAR +       T ++V  +  
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV----------DW-- 213
               LM + K ST+ D+++ G    E+ +G          + +  +          +W  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 214 VSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ 266
           V++  K        +      + +   E  + L        P  R   +Q ++
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.9 bits (243), Expect = 3e-24
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 10/166 (6%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L+ V    ++++  T      +  ++ DY+  G L  +L  + +              V 
Sbjct: 58  LSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVC 114

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
             L YLH    + +++RD+KP N+LLD + + K+ DFG A+         T  L GT  Y
Sbjct: 115 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDY 167

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           +APE++ T   + S D ++FG+ + E+ +G  P     +M+    +
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 1e-22
 Identities = 41/166 (24%), Positives = 62/166 (37%), Gaps = 7/166 (4%)

Query: 46  LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVA 105
           L +     L  L             V +Y   G L   L        +  +       + 
Sbjct: 59  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIV 115

Query: 106 SGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY 165
           S L        + V++RDIK  N++LD D + K+ DFGL +    D         GT  Y
Sbjct: 116 SAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEY 171

Query: 166 MAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           +APE++       + D +  GV M E+  GR P   Q    +  L+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 1e-21
 Identities = 49/238 (20%), Positives = 92/238 (38%), Gaps = 28/238 (11%)

Query: 67  EFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKP 126
           +F LV  +M       + H      L   +   ++  +  GL Y+H        HRD+KP
Sbjct: 97  DFYLVMPFMGTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKP 149

Query: 127 ANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE-LMRTGKASTSTDVYAF 185
            N+ ++ D   K+ DFGLAR  D     + T  V T  Y APE ++   + + + D+++ 
Sbjct: 150 GNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLVDWV----SDCWKKGAILDASDSRLEGIYEEEQME 241
           G  M E+ +G+   +    ++ +  +  V       + +    D + + ++G+ E E+ +
Sbjct: 206 GCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD 265

Query: 242 LVLKLGLF----------CSHPKPEARPNMRQVMQ--YLDGNATLPDIPRDSTLIAPF 287
               L                   E R    + +   Y +      D P+       F
Sbjct: 266 FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.4 bits (223), Expect = 1e-21
 Identities = 35/186 (18%), Positives = 69/186 (37%), Gaps = 13/186 (6%)

Query: 94  WYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI 153
                 +   +   L  L     + VLHRD+KP N+L++ +   KL +FGLAR +     
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156

Query: 154 PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGS----MEMVN 209
             + ++V  +      L      STS D+++ G    E+A+  RP+         ++ + 
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216

Query: 210 LVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF---------CSHPKPEARPN 260
            +       +  ++    D +   +Y      + +   L               P  R +
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276

Query: 261 MRQVMQ 266
             + +Q
Sbjct: 277 AEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 87.2 bits (215), Expect = 4e-20
 Identities = 34/143 (23%), Positives = 63/143 (44%), Gaps = 9/143 (6%)

Query: 71  VYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVL 130
           V +Y+  G +   L    +   S          +     YLH      +++RD+KP N+L
Sbjct: 119 VMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLL 173

Query: 131 LDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFML 190
           +D     ++ DFG A+        +T  L GT   +APE++ +   + + D +A GV + 
Sbjct: 174 IDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229

Query: 191 EVASGRRPIEQQGSMEMVNLVDW 213
           E+A+G  P      +++   +  
Sbjct: 230 EMAAGYPPFFADQPIQIYEKIVS 252

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 86.4 bits (213), Expect = 6e-20
 Identities = 43/225 (19%), Positives = 85/225 (37%), Gaps = 33/225 (14%)

Query: 65  KGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDI 124
                LV++++ N    ++  T     L+ Y     +  +   L Y H      ++HRD+
Sbjct: 104 SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS---MGIMHRDV 155

Query: 125 KPANVLLDAD-LNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDV 182
           KP NV++D +    +L D+GLA  Y      +    V +  +  PEL+   +    S D+
Sbjct: 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDM 213

Query: 183 YAFGVFMLEVASGRRP-------IEQQGSMEMVNLVDWVSDCWKKGAI-LDASDSRLEGI 234
           ++ G  +  +   + P        +Q   +  V   + + D   K  I LD   + + G 
Sbjct: 214 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 273

Query: 235 YEEEQMELVLKLGLF-------------CSHPKPEARPNMRQVMQ 266
           +  ++ E  +                        ++R   R+ M+
Sbjct: 274 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.8 bits (211), Expect = 1e-19
 Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 15/171 (8%)

Query: 46  LASVHSNGLLQLTNTVNSRK-----GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRI 100
           +  V+   ++ L N    +K      +  LV + M       I            +   +
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYL 124

Query: 101 IRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLV 160
           +  +  G+ +LH      ++HRD+KP+N+++ +D   K+ DFGLAR          T  V
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 179

Query: 161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
            T  Y APE++       + D+++ G  M E+   +     +  ++  N V
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (207), Expect = 4e-19
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 8/164 (4%)

Query: 50  HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLL 109
            S  L+ L     + + +  L+ DY+  G L   L    + +    Q +     V   +L
Sbjct: 87  QSPFLVTLHYAFQT-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVL 140

Query: 110 YLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPE 169
            L    +  +++RDIK  N+LLD++ +  L DFGL++ +  D   +     GT  YMAP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 170 LMRTGKA--STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLV 211
           ++R G +    + D ++ GV M E+ +G  P    G       +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 77.0 bits (188), Expect = 1e-16
 Identities = 35/191 (18%), Positives = 69/191 (36%), Gaps = 5/191 (2%)

Query: 31  IYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKP 90
           +    N+    + D + + H   LL   N         ++V++ +    L  I     + 
Sbjct: 62  LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121

Query: 91  SLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYD 149
                   +I + +  GL Y+H      ++H DIKP NVL++  D    L    +A L +
Sbjct: 122 I-PLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178

Query: 150 HDTIPQTTKLV-GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMV 208
                +       T  Y +PE++         D+++    + E+ +G    E        
Sbjct: 179 ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238

Query: 209 NLVDWVSDCWK 219
              D ++   +
Sbjct: 239 KDDDHIAQIIE 249

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 2e-16
 Identities = 45/247 (18%), Positives = 92/247 (37%), Gaps = 37/247 (14%)

Query: 66  GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK 125
              + +  ++    L+ I+       L+      +I  +  GL Y+H      ++HRD+K
Sbjct: 95  FNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLK 148

Query: 126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAF 185
           P+N+ ++ D   K+ DFGLAR  D      T  +   +      ++     + + D+++ 
Sbjct: 149 PSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205

Query: 186 GVFMLEVASGRRPIEQQGSMEMVNLV-----DWVSDCWKKGAILDASD------------ 228
           G  M E+ +GR        ++ + L+        ++  KK +   A +            
Sbjct: 206 GCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN 265

Query: 229 -SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQ--YLDGNATLPDIPRDSTLIA 285
            + +        ++L+ K          + R    Q +   Y    A   D P D  +  
Sbjct: 266 FANVFIGANPLAVDLLEK----MLVLDSDKRITAAQALAHAYF---AQYHD-PDDEPVAD 317

Query: 286 PFSASND 292
           P+  S +
Sbjct: 318 PYDQSFE 324

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 59.0 bits (142), Expect = 4e-11
 Identities = 10/79 (12%), Positives = 27/79 (34%), Gaps = 4/79 (5%)

Query: 72  YDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLL 131
           Y +  N  L +++       +       ++  +   +   +      ++H D+   NVL+
Sbjct: 80  YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 136

Query: 132 DADLNGKLGDFGLARLYDH 150
             +    + DF  +     
Sbjct: 137 S-EEGIWIIDFPQSVEVGE 154

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 14/39 (35%), Positives = 17/39 (43%), Gaps = 1/39 (2%)

Query: 28 NQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
            FI   FN+   L   G A+V SNG LQL+        
Sbjct: 4  TSFIIDAFNK-TNLILQGDATVSSNGNLQLSYNSYDSMS 41

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score = 44.0 bits (103), Expect = 8e-06
 Identities = 13/43 (30%), Positives = 21/43 (48%), Gaps = 1/43 (2%)

Query: 24 AQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          A +   F +  F+ D +L   G A++ S G LQLT   ++   
Sbjct: 1  ATET-SFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELP 42

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 42.0 bits (98), Expect = 3e-05
 Identities = 15/43 (34%), Positives = 22/43 (51%), Gaps = 2/43 (4%)

Query: 24 AQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          + D+  F +  FNE   L     ASV S+G L+LTN   + + 
Sbjct: 1  SNDI-YFNFQRFNE-TNLILQRDASVSSSGQLRLTNLNGNGEP 41

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score = 42.0 bits (98), Expect = 3e-05
 Identities = 14/42 (33%), Positives = 20/42 (47%), Gaps = 1/42 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKGEFL 69
           F  + F  +   L   G ASV S G+LQLT   N +  ++ 
Sbjct: 5  SFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYS 46

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 12/42 (28%), Positives = 20/42 (47%), Gaps = 1/42 (2%)

Query: 26 DVNQFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          +   F +  F E+  +L     AS+ SNG+L+LT    +   
Sbjct: 1  ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVP 42

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score = 41.3 bits (96), Expect = 5e-05
 Identities = 15/44 (34%), Positives = 24/44 (54%), Gaps = 2/44 (4%)

Query: 24 AQDVNQFIYHGFNE-DPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          A+ V+ F ++ F+E +P +   G  +V SNG +QLTN       
Sbjct: 1  AETVS-FNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSV 43

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 40.9 bits (95), Expect = 7e-05
 Identities = 14/43 (32%), Positives = 19/43 (44%), Gaps = 2/43 (4%)

Query: 24 AQDVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          + D   F    FN+   L   G A+V S G L LTN   + + 
Sbjct: 1  SNDA-SFNVETFNK-TNLILQGDATVSSEGHLLLTNVKGNEED 41

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 40.5 bits (94), Expect = 1e-04
 Identities = 13/44 (29%), Positives = 20/44 (45%), Gaps = 2/44 (4%)

Query: 24 AQDVNQFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          A+ V+ F ++ F    P +   G A V S+G LQL     +   
Sbjct: 1  AETVS-FSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTP 43

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 12/34 (35%), Positives = 21/34 (61%), Gaps = 1/34 (2%)

Query: 30 FIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVN 62
          F ++ F+++  QL+    A + SN +L+LT  VN
Sbjct: 5  FNFNQFHQNEEQLKLQRDARISSNSVLELTKVVN 38

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score = 39.7 bits (92), Expect = 2e-04
 Identities = 10/38 (26%), Positives = 15/38 (39%), Gaps = 1/38 (2%)

Query: 30 FIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          F +  F      L   G A +  +G+LQLT    +   
Sbjct: 6  FSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMP 43

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score = 39.4 bits (91), Expect = 3e-04
 Identities = 16/40 (40%), Positives = 19/40 (47%), Gaps = 1/40 (2%)

Query: 30 FIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNSRKGEF 68
          F +  F  + P L   G A V S G+LQLTN VN      
Sbjct: 6  FSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSK 45

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 12/35 (34%), Positives = 17/35 (48%), Gaps = 1/35 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVN 62
           F +  F+++   L   G ASV   G+LQL    N
Sbjct: 5  SFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGN 39

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 11/36 (30%), Positives = 15/36 (41%), Gaps = 1/36 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNS 63
           F +  FN +   L     A V+S G L+LT     
Sbjct: 5  SFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAG 40

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score = 38.5 bits (89), Expect = 5e-04
 Identities = 10/36 (27%), Positives = 16/36 (44%), Gaps = 1/36 (2%)

Query: 29 QFIYHGFNED-PQLQRDGLASVHSNGLLQLTNTVNS 63
           F +  F  +   +   G ASV + G+LQ+T     
Sbjct: 5  SFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKP 40

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score = 38.6 bits (89), Expect = 5e-04
 Identities = 11/41 (26%), Positives = 17/41 (41%), Gaps = 2/41 (4%)

Query: 26 DVNQFIYHGFNEDPQLQRDGLASVHSNGLLQLTNTVNSRKG 66
          D+  F +  FN        G A+V S+  L+LT    +   
Sbjct: 2  DIQSFSFKNFNS-SSFILQGDATV-SSSKLRLTKVKGNGLP 40

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	313
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.46
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.92
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.03
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.27
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	80.78

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-44  Score=306.39  Aligned_cols=202  Identities=24%  Similarity=0.378  Sum_probs=170.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|.+.++.++|||+++.++++.+ ++.+++||||+++|+|.+++...  ..+++..++.++.||+.||.|||   +++|
T Consensus        54 ~~E~~il~~l~hpnIv~~~~~~~~-~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH---~~~i  127 (263)
T d2j4za1          54 RREVEIQSHLRHPNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRV  127 (263)
T ss_dssp             HHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            356678889999999999999987 67899999999999999999864  35999999999999999999999   4899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.++.+||+|||++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       128 vHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf  204 (263)
T d2j4za1         128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF  204 (263)
T ss_dssp             CCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             eeeeeccccceecCCCCEeecccceeeecCCC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCC
Confidence            99999999999999999999999999755432   234467899999999999988999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+.+..+....+.       ..          ....+...++.+.+||.+||+.||++|||++|+++|
T Consensus       205 ~~~~~~~~~~~i~-------~~----------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         205 EANTYQETYKRIS-------RV----------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             CCSSHHHHHHHHH-------TT----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCCHHHHHHHHH-------cC----------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            8766554443321       10          111233345678899999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-44  Score=312.42  Aligned_cols=234  Identities=21%  Similarity=0.282  Sum_probs=185.4

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      +++.|.+..++...+   +..+++|.+..       ....|...++.++|||+++.++++.+ ++.+|+||||++||+|.
T Consensus        27 ~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy~~gg~L~  105 (293)
T d1yhwa1          27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLT  105 (293)
T ss_dssp             ECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTCBHH
T ss_pred             EEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEEecCCCcHH
Confidence            344555555555533   34566665531       12357788899999999999999987 66899999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccc
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG  161 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  161 (313)
                      +++.+.   .+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....... .......|
T Consensus       106 ~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~g  178 (293)
T d1yhwa1         106 DVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVG  178 (293)
T ss_dssp             HHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCS
T ss_pred             HHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cccccccc
Confidence            988764   5999999999999999999999   4899999999999999999999999999998654332 23345679


Q ss_pred             cccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          162 TFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       162 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.      ...        ......+...++
T Consensus       179 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------~~~--------~~~~~~~~~~s~  244 (293)
T d1yhwa1         179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNG--------TPELQNPEKLSA  244 (293)
T ss_dssp             CGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HHC--------SCCCSSGGGSCH
T ss_pred             CCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH------hCC--------CCCCCCcccCCH
Confidence            999999999999889999999999999999999999998766554333221      110        011112334567


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      .+.+||.+||+.||++|||++|+++|
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            78999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=311.94  Aligned_cols=243  Identities=24%  Similarity=0.322  Sum_probs=181.8

Q ss_pred             hHHHHHHHHhhccccceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQDVNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..+|.++....+++|.+..         ....|...++.++|+|+++++++..  ++.+++||||+++|+|.++
T Consensus        16 lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~--~~~~~lv~Ey~~~g~L~~~   93 (276)
T d1uwha_          16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEGSSLYHH   93 (276)
T ss_dssp             EEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEECCCEEEHHHH
T ss_pred             EeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe--ccEEEEEEecCCCCCHHHH
Confidence            3444455555555555667776632         1224667778889999999998865  3568999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT  162 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~  162 (313)
                      +... ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++........ .......||
T Consensus        94 l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  169 (276)
T d1uwha_          94 LHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS  169 (276)
T ss_dssp             HHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCC
T ss_pred             Hhhc-cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccC
Confidence            9765 3469999999999999999999994   8999999999999999999999999999976543221 223456789


Q ss_pred             ccccccccccCC---CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          163 FGYMAPELMRTG---KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       163 ~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      +.|+|||++.+.   .++.++|||||||++|||++|+.||.+...........      ..+...    + .....+...
T Consensus       170 ~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~----p-~~~~~~~~~  238 (276)
T d1uwha_         170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------GRGYLS----P-DLSKVRSNC  238 (276)
T ss_dssp             GGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH------HHTSCC----C-CGGGSCTTC
T ss_pred             cccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH------hcCCCC----C-cchhccccc
Confidence            999999998643   47899999999999999999999998766554332221      111110    0 011233345


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ++.+.+||.+||+.||++|||++|++++|+...
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            578899999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-44  Score=307.98  Aligned_cols=223  Identities=24%  Similarity=0.392  Sum_probs=168.8

Q ss_pred             ceEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHH
Q 048068           28 NQFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRII  101 (313)
Q Consensus        28 ~~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  101 (313)
                      ..+++|.+....      ..|.+.++.++|+|++++++++.. ++.+++||||+++|+|.+++... ...+++..++.++
T Consensus        30 ~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~  107 (263)
T d1sm2a_          30 DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMC  107 (263)
T ss_dssp             EEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHH
T ss_pred             CEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHH
Confidence            457777775433      345667778899999999999886 56899999999999999998765 4569999999999


Q ss_pred             HHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchh
Q 048068          102 RGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTD  181 (313)
Q Consensus       102 ~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  181 (313)
                      .||+.||.|||   ..+|+||||||+||+++.++.+||+|||++...............||..|+|||.+.+..++.++|
T Consensus       108 ~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~D  184 (263)
T d1sm2a_         108 LDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD  184 (263)
T ss_dssp             HHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHH
T ss_pred             HHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhh
Confidence            99999999999   589999999999999999999999999999766544333344457889999999999999999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC
Q 048068          182 VYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN  260 (313)
Q Consensus       182 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  260 (313)
                      ||||||++|||++ |.+||......+....+.   .    +.         ....+...++.+.+||..||+.||++|||
T Consensus       185 VwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~---~----~~---------~~~~p~~~~~~l~~li~~cl~~~p~~Rps  248 (263)
T d1sm2a_         185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---T----GF---------RLYKPRLASTHVYQIMNHCWKERPEDRPA  248 (263)
T ss_dssp             HHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH---H----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH---h----cC---------CCCCccccCHHHHHHHHHHccCCHhHCcC
Confidence            9999999999999 566666554443333221   1    10         11122334567899999999999999999


Q ss_pred             HHHHHHHHhcc
Q 048068          261 MRQVMQYLDGN  271 (313)
Q Consensus       261 ~~ell~~L~~~  271 (313)
                      ++|++++|++.
T Consensus       249 ~~~il~~L~~i  259 (263)
T d1sm2a_         249 FSRLLRQLAEI  259 (263)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=309.29  Aligned_cols=210  Identities=21%  Similarity=0.260  Sum_probs=169.4

Q ss_pred             ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 048068           38 DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQ  117 (313)
Q Consensus        38 ~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~  117 (313)
                      ....|.+.++.++|||+++.++++.+ ++.+|+||||++||+|.+++..+  +.+++..++.++.||+.||.|||   +.
T Consensus        49 ~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~  122 (271)
T d1nvra_          49 NIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GI  122 (271)
T ss_dssp             CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             HHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---Hc
Confidence            34567788899999999999999987 67899999999999999999763  46999999999999999999999   48


Q ss_pred             CceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHhC
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g  195 (313)
                      +|+||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus       123 ~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence            999999999999999999999999999976543221 22344679999999999987776 5789999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ++||..............      ...        .........++.+.+|+.+||+.||++|||++|+++|
T Consensus       203 ~~pf~~~~~~~~~~~~~~------~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         203 ELPWDQPSDSCQEYSDWK------EKK--------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             SCSCSSSSTTSHHHHHHH------TTC--------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCChHHHHHHHHh------cCC--------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            999987654433221110      000        0001122334677899999999999999999999886

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-43  Score=309.01  Aligned_cols=241  Identities=22%  Similarity=0.257  Sum_probs=189.4

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      +++.|.+..++.+.+   ...+++|.+..+.      ..|.+.++.++|||++++++++.+ ++.+++||||+++|+|.+
T Consensus        24 ~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~~~g~l~~  102 (287)
T d1opja_          24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLD  102 (287)
T ss_dssp             ETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHH
T ss_pred             EEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-CCeeEEEeecccCcchHH
Confidence            455666666666544   3356777765332      345677788899999999999876 678999999999999999


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ++.......+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++...............++
T Consensus       103 ~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~  179 (287)
T d1opja_         103 YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP  179 (287)
T ss_dssp             HHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEEC
T ss_pred             HhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeecccccc
Confidence            998766678999999999999999999999   58999999999999999999999999999986654443333445678


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCcc-CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQ-QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      +.|+|||++.+..++.++|||||||++|||++|..||.. .+.......+.       .+         .....+...++
T Consensus       180 ~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-------~~---------~~~~~~~~~~~  243 (287)
T d1opja_         180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KD---------YRMERPEGCPE  243 (287)
T ss_dssp             GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------TT---------CCCCCCTTCCH
T ss_pred             ccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-------cC---------CCCCCCccchH
Confidence            899999999989999999999999999999997666543 33332222221       11         11112334556


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .+.+||..||+.||++|||++|+++.|+...
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            7899999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=309.84  Aligned_cols=236  Identities=21%  Similarity=0.259  Sum_probs=183.5

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC-------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE-------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      .++.|.+..++...+   ...++.|.+..       ....|.+.+++++|||++++++++.+ ++.+++||||+++|+|.
T Consensus        19 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy~~~g~L~   97 (288)
T d2jfla1          19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCAGGAVD   97 (288)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEHH
T ss_pred             EEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEEecCCCCcHH
Confidence            345555555555544   33566666532       23356778888999999999999887 67899999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccc
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVG  161 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  161 (313)
                      +++.+. ..++++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++....... .......|
T Consensus        98 ~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~G  172 (288)
T d2jfla1          98 AVMLEL-ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIG  172 (288)
T ss_dssp             HHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCS
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccccc
Confidence            998754 346999999999999999999999   5899999999999999999999999999986443211 12234678


Q ss_pred             ccccccccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCcc
Q 048068          162 TFGYMAPELMR-----TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE  236 (313)
Q Consensus       162 ~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (313)
                      |+.|+|||++.     +..++.++|||||||++|+|++|+.||.+....+....+.       .+..       .....+
T Consensus       173 t~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-------~~~~-------~~~~~~  238 (288)
T d2jfla1         173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------KSEP-------PTLAQP  238 (288)
T ss_dssp             CCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-------HSCC-------CCCSSG
T ss_pred             ccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCC-------CCCCcc
Confidence            99999999984     4557899999999999999999999998876655443331       1110       111123


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       237 ~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...++.+.+||.+||+.||++|||++|+++|
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            3456778999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-43  Score=307.84  Aligned_cols=240  Identities=22%  Similarity=0.326  Sum_probs=176.5

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      .++.|.+..++...+   ...+++|.+..        ....|...++.++|||++++++++.+ ++.+|+||||++||+|
T Consensus        16 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvmE~~~gg~L   94 (307)
T d1a06a_          16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIMQLVSGGEL   94 (307)
T ss_dssp             ESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBH
T ss_pred             EEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeccCCCcH
Confidence            345566666666544   34566666531        22357788899999999999999987 6789999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc---CCCcEEEeecccccccCCCCCCccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD---ADLNGKLGDFGLARLYDHDTIPQTT  157 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~---~~~~~~l~dfg~~~~~~~~~~~~~~  157 (313)
                      .+++...  +.+++..+..++.||+.||.|||   +.+|+||||||+||++.   .++.+||+|||++.......  ...
T Consensus        95 ~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~~  167 (307)
T d1a06a_          95 FDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLS  167 (307)
T ss_dssp             HHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------
T ss_pred             HHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--eee
Confidence            9999763  46999999999999999999999   58999999999999995   47889999999997554332  233


Q ss_pred             cccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccH
Q 048068          158 KLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEE  237 (313)
Q Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (313)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.      .. .      ...+.....
T Consensus       168 ~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~-~------~~~~~~~~~  234 (307)
T d1a06a_         168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------KA-E------YEFDSPYWD  234 (307)
T ss_dssp             -----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------TT-C------CCCCTTTTT
T ss_pred             eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh------cc-C------CCCCCcccc
Confidence            4679999999999999999999999999999999999999998766554433321      11 0      011111223


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccC
Q 048068          238 EQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNA  272 (313)
Q Consensus       238 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~  272 (313)
                      ..++.+.+||.+||+.||++|||++|+++|  +.+..
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            445678999999999999999999999997  54443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=303.62  Aligned_cols=224  Identities=23%  Similarity=0.363  Sum_probs=164.8

Q ss_pred             cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEec-cCCeEEEEEecCCCCCHHHHHhhC--CCCCCCH
Q 048068           27 VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKILHTN--IKPSLSW   94 (313)
Q Consensus        27 ~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~   94 (313)
                      +..++.|.+...         ...|.+.+++++|||++++++++.+ .++.+|+||||+++|+|.+++.+.  ....+++
T Consensus        29 ~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e  108 (269)
T d2java1          29 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE  108 (269)
T ss_dssp             CCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCH
T ss_pred             CCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCH
Confidence            346677765321         1235567788899999999998764 356789999999999999999642  2457999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcC--CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccccccccccc
Q 048068           95 YQRFRIIRGVASGLLYLHEDW--EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMR  172 (313)
Q Consensus        95 ~~~~~i~~qi~~al~~lhs~~--~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  172 (313)
                      ..++.++.||+.||.|||+..  ..+|+||||||+||+++.++.+||+|||++....... .......||+.|+|||++.
T Consensus       109 ~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~  187 (269)
T d2java1         109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMN  187 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC-CccccCCCCcccCCHHHHc
Confidence            999999999999999999621  1349999999999999999999999999998654332 1234567899999999999


Q ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCC
Q 048068          173 TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSH  252 (313)
Q Consensus       173 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  252 (313)
                      +..++.++|||||||++|+|++|+.||.+.+..+....+.       .+..         ...+...++.+.+||.+||+
T Consensus       188 ~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-------~~~~---------~~~~~~~s~~l~~li~~~L~  251 (269)
T d2java1         188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKF---------RRIPYRYSDELNEIITRMLN  251 (269)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCC---------CCCCTTSCHHHHHHHHHHTC
T ss_pred             CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCC---------CCCCcccCHHHHHHHHHHcC
Confidence            8899999999999999999999999998766554433221       1111         11223345678999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048068          253 PKPEARPNMRQVMQY  267 (313)
Q Consensus       253 ~~P~~Rpt~~ell~~  267 (313)
                      .||++|||++|+++|
T Consensus       252 ~dp~~Rps~~ell~h  266 (269)
T d2java1         252 LKDYHRPSVEEILEN  266 (269)
T ss_dssp             SSGGGSCCHHHHHTS
T ss_pred             CChhHCcCHHHHHhC
Confidence            999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-43  Score=302.01  Aligned_cols=233  Identities=23%  Similarity=0.344  Sum_probs=177.2

Q ss_pred             hhHHHHHHHHhhcccc---ceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEec---cCCeEEEEEecCC
Q 048068           12 VLLCVSFILSALAQDV---NQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNS---RKGEFLLVYDYMP   76 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~   76 (313)
                      +++.|.+..++.+.+.   ..++.|.+...         ...|.+.+++++|||++++++++..   .+..+++||||++
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~   95 (270)
T d1t4ha_          16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT   95 (270)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred             EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence            4555555555555442   34566654321         2356677888999999999998763   3457899999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--ceecCcCCCcEEEc-CCCcEEEeecccccccCCCCC
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQV--VLHRDIKPANVLLD-ADLNGKLGDFGLARLYDHDTI  153 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~--i~H~dl~~~nIlv~-~~~~~~l~dfg~~~~~~~~~~  153 (313)
                      +|+|.+++.+.  ..+++..++.++.||+.||.|||   .++  |+||||||+|||++ .++.+||+|||++......  
T Consensus        96 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--  168 (270)
T d1t4ha_          96 SGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--  168 (270)
T ss_dssp             SCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred             CCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence            99999999864  36999999999999999999999   466  99999999999996 5789999999999754332  


Q ss_pred             CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccC
Q 048068          154 PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEG  233 (313)
Q Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (313)
                       ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........  +    ..+.        .+.
T Consensus       169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--i----~~~~--------~~~  232 (270)
T d1t4ha_         169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--V----TSGV--------KPA  232 (270)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--H----TTTC--------CCG
T ss_pred             -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH--H----HcCC--------CCc
Confidence             2345679999999999875 5899999999999999999999999765443322111  1    1110        011


Q ss_pred             CccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          234 IYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       234 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ..+...++.+.+||.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            1222234568899999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-43  Score=301.22  Aligned_cols=237  Identities=22%  Similarity=0.325  Sum_probs=187.2

Q ss_pred             hHHHHHHHHhhccc--cceEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHH
Q 048068           13 LLCVSFILSALAQD--VNQFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL   84 (313)
Q Consensus        13 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l   84 (313)
                      ++.|.+..++..+.  ...+++|.+....      ..|...++.++|+|+++.++++.+ ++.+++||||+++|+|.+++
T Consensus        12 iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~~~g~l~~~~   90 (258)
T d1k2pa_          12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYL   90 (258)
T ss_dssp             CCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECCTTEEHHHHH
T ss_pred             EecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEccCCCcHHHhh
Confidence            34444444444443  3356667665433      245566677799999999998876 57899999999999999998


Q ss_pred             hhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccccc
Q 048068           85 HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFG  164 (313)
Q Consensus        85 ~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  164 (313)
                      ... ...+++..++.++.|+++||.|||   ..+|+||||||+||+++.++.+||+|||++...............+|..
T Consensus        91 ~~~-~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~  166 (258)
T d1k2pa_          91 REM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR  166 (258)
T ss_dssp             HSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGG
T ss_pred             hcc-ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCC
Confidence            765 346899999999999999999999   5899999999999999999999999999997655443333444678899


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          165 YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       165 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      |+|||.+.+..++.++|||||||++|||+| |+.||.+....+....+.       .+.         ....+...+..+
T Consensus       167 y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~~---------~~~~p~~~~~~l  230 (258)
T d1k2pa_         167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGL---------RLYRPHLASEKV  230 (258)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTC---------CCCCCTTCCHHH
T ss_pred             cCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-------hCC---------CCCCcccccHHH
Confidence            999999998999999999999999999998 899998877665443331       110         111223344678


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      .+||.+||+.||++|||+++++++|.+
T Consensus       231 ~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         231 YTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-43  Score=303.39  Aligned_cols=210  Identities=24%  Similarity=0.340  Sum_probs=172.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.+++++|||++++++++..  +.+++||||+++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+
T Consensus        58 ~E~~il~~l~HpnIv~l~g~~~~--~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~---~~ii  131 (285)
T d1u59a_          58 REAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFV  131 (285)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             HHHHHHHhCCCCCEeeEeeeecc--CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence            35566778899999999998864  4689999999999999998654 3469999999999999999999994   8999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      ||||||+||+++.++.+||+|||++........  .......+|+.|+|||++.++.++.++|||||||++|||++ |+.
T Consensus       132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~  211 (285)
T d1u59a_         132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK  211 (285)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence            999999999999999999999999986644322  12233467889999999998899999999999999999998 999


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||.+....+....+.       .+..         ...+...++.+.+||.+||+.||++|||+.++++.|+...
T Consensus       212 Pf~~~~~~~~~~~i~-------~~~~---------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         212 PYKKMKGPEVMAFIE-------QGKR---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TTTTCCTHHHHHHHH-------TTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHH-------cCCC---------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            998876655443331       1111         1123345567899999999999999999999999987653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=312.26  Aligned_cols=220  Identities=24%  Similarity=0.331  Sum_probs=166.8

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...+++++|||+++.++++.+ ++++|+||||++||+|.+++.+.  +.+++..++.++.||+.||.|||+  +.+|
T Consensus        52 ~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~--~~~I  126 (322)
T d1s9ja_          52 IRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKI  126 (322)
T ss_dssp             HHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCE
Confidence            356778899999999999999987 67899999999999999999864  359999999999999999999995  2489


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+|||++.++.+||+|||++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       127 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf  203 (322)
T d1s9ja_         127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI  203 (322)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCS
T ss_pred             EccccCHHHeeECCCCCEEEeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999999755322   123468999999999999999999999999999999999999999


Q ss_pred             ccCCchhhhhHH-HHHHHhhhh-----------------ccc-----c----ccccccccCCccHHHHHHHHHHHHHcCC
Q 048068          200 EQQGSMEMVNLV-DWVSDCWKK-----------------GAI-----L----DASDSRLEGIYEEEQMELVLKLGLFCSH  252 (313)
Q Consensus       200 ~~~~~~~~~~~~-~~~~~~~~~-----------------~~~-----~----~~~~~~~~~~~~~~~~~~l~~li~~cl~  252 (313)
                      .+.+........ .........                 ...     .    .......+.......+..+.+||.+||.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~  283 (322)
T d1s9ja_         204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI  283 (322)
T ss_dssp             SCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcC
Confidence            875544321111 000000000                 000     0    0000000001111234578899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 048068          253 PKPEARPNMRQVMQY  267 (313)
Q Consensus       253 ~~P~~Rpt~~ell~~  267 (313)
                      .||++|||++|+++|
T Consensus       284 ~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         284 KNPAERADLKQLMVH  298 (322)
T ss_dssp             SSTTTSCCHHHHHTS
T ss_pred             CChhHCcCHHHHhhC
Confidence            999999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.2e-43  Score=311.84  Aligned_cols=240  Identities=21%  Similarity=0.280  Sum_probs=190.9

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC-------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED-------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      .++.|.+..+|++.+   ...++.|.+...       ...|...++.++|||++++++++.+ ++.+|+||||++||+|.
T Consensus        36 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~L~  114 (352)
T d1koba_          36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELF  114 (352)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCCBHH
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCChHH
Confidence            455666666666654   346777766432       2346678889999999999999986 67899999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEc--CCCcEEEeecccccccCCCCCCccccc
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLD--ADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~--~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      +.+... ..++++..++.++.||+.||.|||   +.||+||||||+|||++  .++.+||+|||++.......  .....
T Consensus       115 ~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~~~~~  188 (352)
T d1koba_         115 DRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVT  188 (352)
T ss_dssp             HHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEE
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--ceeec
Confidence            988754 446999999999999999999999   58999999999999997  56899999999998765432  23456


Q ss_pred             cccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      .+++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..       +      ....+.......
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-------~------~~~~~~~~~~~~  255 (352)
T d1koba_         189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-------C------DWEFDEDAFSSV  255 (352)
T ss_dssp             CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-------C------CCCCCSSTTTTS
T ss_pred             cCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------C------CCCCCcccccCC
Confidence            789999999999999999999999999999999999999988776654433321       0      011122223345


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHH--Hhcc
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQY--LDGN  271 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~  271 (313)
                      ++.+.+||.+||+.||.+|||++|+++|  +.+.
T Consensus       256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            5678999999999999999999999997  5544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-42  Score=309.77  Aligned_cols=236  Identities=20%  Similarity=0.257  Sum_probs=186.6

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCCh-------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNEDP-------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~   81 (313)
                      .++.|.+..++...+   +..+++|.+....       ..|...++.++|+|+++.++++.+ ++.+|+||||++||+|.
T Consensus        33 ~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~L~  111 (350)
T d1koaa2          33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGELF  111 (350)
T ss_dssp             EEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEECCCCSCBHH
T ss_pred             EEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCCCHH
Confidence            345555555665544   3466777664322       246677888899999999999887 67999999999999999


Q ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC--CCcEEEeecccccccCCCCCCccccc
Q 048068           82 KILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA--DLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        82 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~--~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      +++... ...+++..++.++.||+.||.|||   +.+|+||||||+||+++.  ++.+||+|||++.......  .....
T Consensus       112 ~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~  185 (350)
T d1koaa2         112 EKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVT  185 (350)
T ss_dssp             HHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--CEEEE
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--cccee
Confidence            999654 346999999999999999999999   589999999999999964  5789999999998654433  33456


Q ss_pred             cccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..      ..       ...+.......
T Consensus       186 ~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------~~-------~~~~~~~~~~~  252 (350)
T d1koaa2         186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS------CD-------WNMDDSAFSGI  252 (350)
T ss_dssp             CSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TC-------CCSCCGGGGGC
T ss_pred             cCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh------CC-------CCCCcccccCC
Confidence            789999999999999999999999999999999999999987766554433311      00       01111122334


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ++.+.+||.+||+.||++|||++|+++|
T Consensus       253 s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         253 SEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            5678999999999999999999999997

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-42  Score=301.85  Aligned_cols=211  Identities=26%  Similarity=0.441  Sum_probs=164.0

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.+++++|||++++++++.. ++.+++||||+++|+|.+++... .+.+++..+..++.||+.||.|||   ..+++
T Consensus        76 ~E~~~l~~l~HpnIv~l~g~~~~-~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH---~~~ii  150 (299)
T d1jpaa_          76 SEASIMGQFDHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA---DMNYV  150 (299)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCCccEEEEEee-CCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCCc
Confidence            45567788899999999999876 67899999999999999998865 446999999999999999999999   48999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC----ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-C
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP----QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-G  195 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g  195 (313)
                      ||||||+|||++.++.+||+|||++.........    ......+++.|+|||.+.++.++.++|||||||++|||+| |
T Consensus       151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g  230 (299)
T d1jpaa_         151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG  230 (299)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCC
Confidence            9999999999999999999999999765432211    1122457889999999998999999999999999999998 8


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      +.||.+....+....+.       .+.         ....+...+..+.+||.+||+.||++|||+.|++++|+...
T Consensus       231 ~~Pf~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         231 ERPYWDMTNQDVINAIE-------QDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             CCTTTTCCHHHHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHH-------cCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            99998776654433321       111         11123345567899999999999999999999999998753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=307.69  Aligned_cols=252  Identities=19%  Similarity=0.242  Sum_probs=188.6

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCChhh--HHhh-hhhccccceeeeeeEEec---cCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNEDPQL--QRDG-LASVHSNGLLQLTNTVNS---RKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~--~~~~-l~~~~~~~~l~~~~~~~~---~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..++++.+   ...++.|.+......  |... ++..+|+|++++++++.+   .+.++|+|||||+||+|.++
T Consensus        20 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~   99 (335)
T d2ozaa1          20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR   99 (335)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred             eeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHH
Confidence            45555555666544   347778877654443  3334 345689999999998863   35679999999999999999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---CCcEEEeecccccccCCCCCCcccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTIPQTTKLV  160 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~  160 (313)
                      +.+.....+++..++.++.||+.||.|||   ..+|+||||||+||+++.   .+.+||+|||++.......  ......
T Consensus       100 i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~  174 (335)
T d2ozaa1         100 IQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPC  174 (335)
T ss_dssp             HHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC--CCCCCS
T ss_pred             HHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCC--cccccc
Confidence            98765567999999999999999999999   589999999999999985   4579999999997655433  234567


Q ss_pred             ccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHH
Q 048068          161 GTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQM  240 (313)
Q Consensus       161 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (313)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..         .........+.......+
T Consensus       175 gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---------~i~~~~~~~~~~~~~~~s  245 (335)
T d2ozaa1         175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---------RIRMGQYEFPNPEWSEVS  245 (335)
T ss_dssp             CCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CCCSCSSSCCTTHHHHSC
T ss_pred             CCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---------HHhcCCCCCCCcccccCC
Confidence            99999999999988999999999999999999999999987665443222110         000001111112223456


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCCCCCCC
Q 048068          241 ELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATLPDIP  278 (313)
Q Consensus       241 ~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~~~~~~  278 (313)
                      +.+.+||.+||+.||++|||+.|+++|  +......+.+|
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~  285 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  285 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence            789999999999999999999999996  55554444443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=298.97  Aligned_cols=237  Identities=22%  Similarity=0.372  Sum_probs=182.1

Q ss_pred             HHHHHHHHhhccc--cceEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHh
Q 048068           14 LCVSFILSALAQD--VNQFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILH   85 (313)
Q Consensus        14 ~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~   85 (313)
                      +.|.+..++.+..  ...+++|.+....      ..|.+.+++++|+|+++++++..+  +..++||||+++|+|.+++.
T Consensus        22 G~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey~~~g~L~~~~~   99 (272)
T d1qpca_          22 GAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLK   99 (272)
T ss_dssp             EEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHTT
T ss_pred             ecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEeCCCCcHHHHHh
Confidence            3344444444433  2356777775432      356677788899999999998754  46799999999999999887


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccc
Q 048068           86 TNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGY  165 (313)
Q Consensus        86 ~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y  165 (313)
                      ......+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||++...............+++.|
T Consensus       100 ~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y  176 (272)
T d1qpca_         100 TPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW  176 (272)
T ss_dssp             SHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTT
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccc
Confidence            554456999999999999999999999   58999999999999999999999999999987654433334455788999


Q ss_pred             cccccccCCCCCcchhhHHHHHHHHHHHhCC-CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHH
Q 048068          166 MAPELMRTGKASTSTDVYAFGVFMLEVASGR-RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVL  244 (313)
Q Consensus       166 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (313)
                      +|||++.++.++.++|||||||++|||+||. +|+......+....+.       .+         .....+...++.+.
T Consensus       177 ~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-------~~---------~~~~~p~~~~~~l~  240 (272)
T d1qpca_         177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RG---------YRMVRPDNCPEELY  240 (272)
T ss_dssp             SCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TT---------CCCCCCTTCCHHHH
T ss_pred             cChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hc---------CCCCCcccChHHHH
Confidence            9999999888999999999999999999955 4555544433332221       11         01112234456789


Q ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          245 KLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       245 ~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +||.+||+.||++|||++++++.|++.
T Consensus       241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         241 QLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=300.82  Aligned_cols=231  Identities=22%  Similarity=0.309  Sum_probs=179.0

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCH
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSL   80 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L   80 (313)
                      +.|.+..++.+.+   ...+++|.+..          ....|.+.++.++|||+++.++++.+ ++.+|+||||++||+|
T Consensus        17 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ivmEy~~gg~L   95 (288)
T d1uu3a_          17 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGEL   95 (288)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEEECCCTTEEH
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEEEEccCCCCH
Confidence            3344444444433   34566665421          23356677888999999999999887 6789999999999999


Q ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-CCccccc
Q 048068           81 DKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQTTKL  159 (313)
Q Consensus        81 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  159 (313)
                      .+++...  +.+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++....... .......
T Consensus        96 ~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~  170 (288)
T d1uu3a_          96 LKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF  170 (288)
T ss_dssp             HHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------C
T ss_pred             HHhhhcc--CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcccccccc
Confidence            9998864  36999999999999999999999   5899999999999999999999999999998654322 2223446


Q ss_pred             cccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.       .+.          ...+...
T Consensus       171 ~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-------~~~----------~~~p~~~  233 (288)
T d1uu3a_         171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-------KLE----------YDFPEKF  233 (288)
T ss_dssp             CCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------TTC----------CCCCTTC
T ss_pred             cCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-------cCC----------CCCCccC
Confidence            79999999999999999999999999999999999999998776555443331       110          0122234


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          240 MELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ++.+.+||.+||+.||++|||++|++++
T Consensus       234 s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         234 FPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            5678899999999999999999987543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-42  Score=303.23  Aligned_cols=210  Identities=21%  Similarity=0.292  Sum_probs=169.7

Q ss_pred             hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC---------------------CCCCCHHHHH
Q 048068           41 LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI---------------------KPSLSWYQRF   98 (313)
Q Consensus        41 ~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~   98 (313)
                      .|...+.++ +|+|+++.++++.+ .+.+++||||+++|+|.++++...                     ...+++..++
T Consensus        89 ~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  167 (325)
T d1rjba_          89 SELKMMTQLGSHENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL  167 (325)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHH
T ss_pred             HHHHHHHHhcCCCcEeEEEEEEee-CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHH
Confidence            455666777 89999999999987 568999999999999999997542                     1358999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCC
Q 048068           99 RIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKAS  177 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  177 (313)
                      .++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.++.++
T Consensus       168 ~i~~qi~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  244 (325)
T d1rjba_         168 CFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT  244 (325)
T ss_dssp             HHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence            99999999999999   489999999999999999999999999999765433221 23345679999999999989999


Q ss_pred             cchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          178 TSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       178 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      .++|||||||++|||++ |.+||.+.........+  +    ..+.         ....+...++.+.+||.+||+.||+
T Consensus       245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~--~----~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~  309 (325)
T d1rjba_         245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL--I----QNGF---------KMDQPFYATEEIYIIMQSCWAFDSR  309 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH--H----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHH--H----hcCC---------CCCCCCcCCHHHHHHHHHHcCCChh
Confidence            99999999999999998 89999876654433222  1    1111         1112334456789999999999999


Q ss_pred             CCCCHHHHHHHHh
Q 048068          257 ARPNMRQVMQYLD  269 (313)
Q Consensus       257 ~Rpt~~ell~~L~  269 (313)
                      +|||++||+++|.
T Consensus       310 ~RPt~~ei~~~L~  322 (325)
T d1rjba_         310 KRPSFPNLTSFLG  322 (325)
T ss_dssp             GSCCHHHHHHHHH
T ss_pred             HCcCHHHHHHHHh
Confidence            9999999999995

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=302.16  Aligned_cols=207  Identities=22%  Similarity=0.324  Sum_probs=170.7

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...+++++|||+++.++++.+ ++.+|+||||++||+|.+++...  +.+++..++.++.||+.||.|||   +.+|
T Consensus        61 ~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH---~~~i  134 (293)
T d1jksa_          61 EREVSILKEIQHPNVITLHEVYEN-KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQI  134 (293)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhh---hcce
Confidence            356778899999999999999987 67999999999999999999864  36999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCC----cEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhC
Q 048068          120 LHRDIKPANVLLDADL----NGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASG  195 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  195 (313)
                      +||||||+||+++.++    .+|++|||++.......  ......+++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       135 vHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g  212 (293)
T d1jksa_         135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  212 (293)
T ss_dssp             ECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             eecccccceEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcC
Confidence            9999999999998776    49999999997654433  23345789999999999988999999999999999999999


Q ss_pred             CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          196 RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       196 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +.||.+.+..+....+..       ..      ...+...+...+..+.+||.+||+.||++|||++|+++|
T Consensus       213 ~~Pf~~~~~~~~~~~i~~-------~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         213 ASPFLGDTKQETLANVSA-------VN------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             SCSSCCSSHHHHHHHHHT-------TC------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCCCHHHHHHHHHh-------cC------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999988766554433310       00      011111222345678899999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-42  Score=303.95  Aligned_cols=229  Identities=22%  Similarity=0.302  Sum_probs=177.7

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCCC----------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNED----------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~~----------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      ++.|.+..++.+.+   ...+++|.+...          ...|...+++++|||++++++++.+ ++.+|+|||||++|+
T Consensus        23 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~~~g~  101 (309)
T d1u5ra_          23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYCLGSA  101 (309)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCSEEH
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEEEEecCCCc
Confidence            34444444444432   335666665321          2246677888999999999999886 678999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      |..++...  +++++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.....     ....
T Consensus       102 l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~  171 (309)
T d1u5ra_         102 SDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSF  171 (309)
T ss_dssp             HHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCC
T ss_pred             hHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CCcc
Confidence            98776653  46999999999999999999999   58999999999999999999999999999975432     2345


Q ss_pred             cccccccccccccC---CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCcc
Q 048068          160 VGTFGYMAPELMRT---GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYE  236 (313)
Q Consensus       160 ~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (313)
                      .||+.|+|||++.+   +.++.++|||||||++|+|++|..||.+....+....+.      ...         .+...+
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~------~~~---------~~~~~~  236 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNE---------SPALQS  236 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC---------CCCCSC
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCC---------CCCCCC
Confidence            79999999999864   457899999999999999999999998766544332221      110         111112


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          237 EEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       237 ~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...++.+.+||.+||+.||.+|||++|+++|
T Consensus       237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            2345678999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=300.35  Aligned_cols=231  Identities=24%  Similarity=0.363  Sum_probs=175.6

Q ss_pred             eEEEcccCCCh------hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           29 QFIYHGFNEDP------QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        29 ~~~~~~~~~~~------~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      .+++|.+....      ..|...++.++|+|+++.++++.+  +.+++||||+++|+|..++.......+++..++.++.
T Consensus        43 ~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~  120 (285)
T d1fmka3          43 RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA  120 (285)
T ss_dssp             EEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred             EEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHH
Confidence            56777765333      345566677799999999998754  4578999999999999999765445699999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      ||+.||.|||   ..+++||||||+||+++.++.+||+|||++...............+++.|+|||++.++.++.++||
T Consensus       121 ~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI  197 (285)
T d1fmka3         121 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV  197 (285)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhh
Confidence            9999999999   5899999999999999999999999999997654443333444678999999999998999999999


Q ss_pred             HHHHHHHHHHHhCCCC-CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVASGRRP-IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      |||||++|||++|..| +......+....+.       .+.         ....+...++.+.+||.+||+.||++|||+
T Consensus       198 ~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-------~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  261 (285)
T d1fmka3         198 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGY---------RMPCPPECPESLHDLMCQCWRKEPEERPTF  261 (285)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hcC---------CCCCCcccCHHHHHHHHHHcccCHhHCcCH
Confidence            9999999999996555 44444433332221       111         111233445678999999999999999999


Q ss_pred             HHHHHHHhccCCCCCCCCC
Q 048068          262 RQVMQYLDGNATLPDIPRD  280 (313)
Q Consensus       262 ~ell~~L~~~~~~~~~~~~  280 (313)
                      +++++.|++......|+..
T Consensus       262 ~~i~~~L~~~~~~~~p~~~  280 (285)
T d1fmka3         262 EYLQAFLEDYFTSTEPQYQ  280 (285)
T ss_dssp             HHHHHHHHTTTSCSCCCCC
T ss_pred             HHHHHHHhhhhcCCCCCCC
Confidence            9999999998766655443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=293.99  Aligned_cols=207  Identities=25%  Similarity=0.359  Sum_probs=168.8

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.+++++|||+++.++++..  +..++||||+++|+|.++++..  ..+++..+..++.||+.||.|||   +.+|+
T Consensus        57 ~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH---~~~ii  129 (277)
T d1xbba_          57 AEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFV  129 (277)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH---hCCcc
Confidence            45677788899999999998864  4578999999999999999874  46999999999999999999999   48999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      ||||||+||+++.++.++|+|||++.........  ......||+.|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus       130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~  209 (277)
T d1xbba_         130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK  209 (277)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCC
Confidence            9999999999999999999999999765433221  1223468899999999998889999999999999999998 899


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDG  270 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~  270 (313)
                      ||.+....+....+.       .+.         ....+...++.+.+||.+||+.||++|||++++++.|+.
T Consensus       210 Pf~~~~~~~~~~~i~-------~~~---------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         210 PYRGMKGSEVTAMLE-------KGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             SSTTCCHHHHHHHHH-------TTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHH-------cCC---------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            998876554433331       111         111233455778999999999999999999999988865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=296.20  Aligned_cols=204  Identities=24%  Similarity=0.284  Sum_probs=171.5

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++||++++.++.+.+ ++.+|+||||++||+|.+++...  ..+++..++.++.||+.||.|||   .++|
T Consensus        53 ~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH---~~~i  126 (337)
T d1o6la_          53 VTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDV  126 (337)
T ss_dssp             HHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             HHHHHHHHhCCCCCEEEEEeeecc-ccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhh---hcCc
Confidence            356677888999999999999987 67899999999999999999874  36999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      +||||||+||+++.+|.+||+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|++||
T Consensus       127 iHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf  205 (337)
T d1o6la_         127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccCHHHeEecCCCCEEEeecccccccccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCC
Confidence            999999999999999999999999997654322 2334567999999999999999999999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      .+.+.......+.       .+.          ...+...+..+.+||.+||+.||.+|+     +++|+++|
T Consensus       206 ~~~~~~~~~~~i~-------~~~----------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         206 YNQDHERLFELIL-------MEE----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCSSHHHHHHHHH-------HCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCcCHHHHHHHHh-------cCC----------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            9877655443331       111          112333456788999999999999999     48999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-41  Score=291.49  Aligned_cols=209  Identities=22%  Similarity=0.345  Sum_probs=162.7

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...+++++|||++++++++.  ++.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||   +.+++
T Consensus        57 ~E~~~l~~l~HpnIv~l~~~~~--~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~ii  130 (273)
T d1mp8a_          57 QEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV  130 (273)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCEeeEEEEEe--cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc---ccCee
Confidence            4566678889999999999885  45789999999999999988765 456999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  199 (313)
                      ||||||+||+++.++.+||+|||++...............+|+.|+|||.+.+..++.++|||||||++|||++ |.+||
T Consensus       131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~  210 (273)
T d1mp8a_         131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  210 (273)
T ss_dssp             CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence            99999999999999999999999997655443333445567899999999998899999999999999999998 89999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+....+....+.       .+..         ...+...++.+.+||.+||+.||++|||++|++++|+..
T Consensus       211 ~~~~~~~~~~~i~-------~~~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         211 QGVKNNDVIGRIE-------NGER---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             TTCCGGGHHHHHH-------TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHH-------cCCC---------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            8877665543331       1111         112334557799999999999999999999999999764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=291.80  Aligned_cols=221  Identities=25%  Similarity=0.354  Sum_probs=172.6

Q ss_pred             ceEEEcccCC-----ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Q 048068           28 NQFIYHGFNE-----DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIR  102 (313)
Q Consensus        28 ~~~~~~~~~~-----~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  102 (313)
                      ..+++|.+..     ....|...++.++|+|+++.+++..+.++.+++||||+++|+|.+++.......+++..++.++.
T Consensus        31 ~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~  110 (262)
T d1byga_          31 NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL  110 (262)
T ss_dssp             EEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             eEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence            3456666643     23456778888899999999998876567789999999999999999764344589999999999


Q ss_pred             HHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhh
Q 048068          103 GVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDV  182 (313)
Q Consensus       103 qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  182 (313)
                      ||+.||.|||   ..+++||||+|+||+++.++.++++|||++......    .....++..|+|||.+.++.++.++||
T Consensus       111 ~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDI  183 (262)
T d1byga_         111 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDV  183 (262)
T ss_dssp             HHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHH
T ss_pred             HHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhCCCCChHHHH
Confidence            9999999999   489999999999999999999999999999754332    223456889999999988899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCH
Q 048068          183 YAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNM  261 (313)
Q Consensus       183 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  261 (313)
                      |||||++|||++ |.+||......+....+.       .+         .....+...++.+.+||.+||+.||++|||+
T Consensus       184 wSfG~il~el~t~~~~p~~~~~~~~~~~~i~-------~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  247 (262)
T d1byga_         184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KG---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF  247 (262)
T ss_dssp             HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cC---------CCCCCCccCCHHHHHHHHHHcccCHhHCcCH
Confidence            999999999998 788888776655443331       11         1111333445678999999999999999999


Q ss_pred             HHHHHHHhcc
Q 048068          262 RQVMQYLDGN  271 (313)
Q Consensus       262 ~ell~~L~~~  271 (313)
                      .+++++|+..
T Consensus       248 ~~l~~~L~~i  257 (262)
T d1byga_         248 LQLREQLEHI  257 (262)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-41  Score=293.93  Aligned_cols=224  Identities=22%  Similarity=0.221  Sum_probs=170.3

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...+++++|+|+++.++++.. ++++|+||||+.++++..+...  ...+++..+..++.||+.||+|||   .++|+
T Consensus        49 ~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~ii  122 (299)
T d1ua2a_          49 REIKLLQELSHPNIIGLLDAFGH-KSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWIL  122 (299)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhCCCCCEeEEEeeecc-CCceeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---cccee
Confidence            57778899999999999999987 6689999999988776655543  456999999999999999999999   58999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPI  199 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  199 (313)
                      ||||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus       123 HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf  201 (299)
T d1ua2a_         123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL  201 (299)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCCcceEEecCCCccccccCccccccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC
Confidence            999999999999999999999999976544322 23345789999999998654 5799999999999999999999999


Q ss_pred             ccCCchhhhhHHHHHHHhhhhcccccccc-------cccc----CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Q 048068          200 EQQGSMEMVNLVDWVSDCWKKGAILDASD-------SRLE----GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY-  267 (313)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~-  267 (313)
                      .+..+.+....+.................       ...+    .......++.+.+||.+||+.||++|||++|+++| 
T Consensus       202 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp  281 (299)
T d1ua2a_         202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  281 (299)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             CCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence            88776665544422211111100000000       0000    00111234678999999999999999999999996 


Q ss_pred             -Hhcc
Q 048068          268 -LDGN  271 (313)
Q Consensus       268 -L~~~  271 (313)
                       +.+.
T Consensus       282 ~f~~~  286 (299)
T d1ua2a_         282 YFSNR  286 (299)
T ss_dssp             GGTSS
T ss_pred             hhCCC
Confidence             5543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=296.76  Aligned_cols=234  Identities=16%  Similarity=0.210  Sum_probs=182.0

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCCC------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHH
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNED------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKIL   84 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l   84 (313)
                      +.|.|..++...+   ...++.|.+...      ...|.+.++.++|+|+++.++++.+ ++++|+|||||+||+|.+++
T Consensus        14 G~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE~~~gg~L~~~i   92 (321)
T d1tkia_          14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFEFISGLDIFERI   92 (321)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEECCCCCCBHHHHH
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEecCCCCcHHHHH
Confidence            3444444444332   335666666432      2256677889999999999999987 67899999999999999999


Q ss_pred             hhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCC--CcEEEeecccccccCCCCCCcccccccc
Q 048068           85 HTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDAD--LNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        85 ~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ... +..+++..++.++.||+.||.|||   +.+|+||||||+||+++.+  ..++|+|||++.......  ......++
T Consensus        93 ~~~-~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~~~~~~t  166 (321)
T d1tkia_          93 NTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTA  166 (321)
T ss_dssp             TSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESC
T ss_pred             Hhc-CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC--cccccccc
Confidence            765 346999999999999999999999   5899999999999999854  479999999997654332  23445789


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMEL  242 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (313)
                      +.|++||...+..++.++|||||||++|+|++|..||.+.+..+....+..      . .      ...+.......++.
T Consensus       167 ~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~------~-~------~~~~~~~~~~~s~~  233 (321)
T d1tkia_         167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN------A-E------YTFDEEAFKEISIE  233 (321)
T ss_dssp             GGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------T-C------CCCCHHHHTTSCHH
T ss_pred             cccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------C-C------CCCChhhccCCCHH
Confidence            999999999999999999999999999999999999988776554443321      0 0      00111111123566


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          243 VLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       243 l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +.+||.+||..||++|||++|+++|
T Consensus       234 ~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         234 AMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            8899999999999999999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.2e-40  Score=284.18  Aligned_cols=206  Identities=27%  Similarity=0.411  Sum_probs=169.1

Q ss_pred             hHHhhhhhcc-ccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           41 LQRDGLASVH-SNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        41 ~~~~~l~~~~-~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      .|...++.+. |+|+++.++++.+ ++++|+||||++||+|.++++.+  +++++..++.++.||+.||.|||   .++|
T Consensus        58 ~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~i  131 (277)
T d1phka_          58 KEVDILRKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNI  131 (277)
T ss_dssp             HHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHHHHHHHhcCCCCeEEEEeeccc-CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HcCC
Confidence            4556667776 9999999999987 67999999999999999999864  36999999999999999999999   5899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC------CCCCcchhhHHHHHHHHHHH
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT------GKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll  193 (313)
                      +||||||+||+++.++.+||+|||++.......  ......||+.|.+||.+.+      ..++.++||||+||++|+|+
T Consensus       132 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml  209 (277)
T d1phka_         132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL  209 (277)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred             cccccccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence            999999999999999999999999998765433  2344678999999998852      34688999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +|+.||.+.........+.       .+..      ..+.......++.+.+|+.+||+.||.+|||++|+++|
T Consensus       210 ~g~~Pf~~~~~~~~~~~i~-------~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         210 AGSPPFWHRKQMLMLRMIM-------SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HSSCSSCCSSHHHHHHHHH-------HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cCCCCCCCCCHHHHHHHHH-------hCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            9999999876655443331       1110      11111233455778999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-40  Score=287.97  Aligned_cols=212  Identities=24%  Similarity=0.406  Sum_probs=163.5

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|.+.+++++|+|+++++++..+ ++..++||||+.+++|.+++... ...+++..+..++.||+.|+.|||   +.+|+
T Consensus        58 ~E~~il~~l~H~nIv~~~g~~~~-~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH---~~~ii  132 (283)
T d1mqba_          58 GEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYV  132 (283)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             HHHHHHHhcCCCCEeeeeEEEec-CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc---ccccc
Confidence            45567777899999999999876 56889999999999999988765 456999999999999999999999   48999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCC--CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTI--PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRP  198 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (313)
                      ||||||+|||++.++.+||+|||++........  .......||+.|+|||++.++.++.++|||||||++|||+++..|
T Consensus       133 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence            999999999999999999999999976533221  112234678999999999999999999999999999999996555


Q ss_pred             -CccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccCC
Q 048068          199 -IEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNAT  273 (313)
Q Consensus       199 -f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~~  273 (313)
                       +......+....+       ..+.         ....+...+..+.+||.+||+.||++|||+.|+++.|+....
T Consensus       213 ~~~~~~~~~~~~~i-------~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         213 PYWELSNHEVMKAI-------NDGF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             TTTTCCHHHHHHHH-------HTTC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ccccCCHHHHHHHH-------hccC---------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence             4444433322222       1111         111233445678999999999999999999999999987653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=297.56  Aligned_cols=198  Identities=24%  Similarity=0.353  Sum_probs=166.1

Q ss_pred             hhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcC
Q 048068           46 LASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIK  125 (313)
Q Consensus        46 l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~  125 (313)
                      .+.++||+++++++++.+ ++.+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||   +++++|||||
T Consensus        57 ~~~~~hp~Iv~~~~~~~~-~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDik  130 (320)
T d1xjda_          57 SLAWEHPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLK  130 (320)
T ss_dssp             HHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCC
T ss_pred             HHhCCCCcEEEEEEEEcc-CCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            357899999999999987 67899999999999999999864  35999999999999999999999   4899999999


Q ss_pred             CCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCch
Q 048068          126 PANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSM  205 (313)
Q Consensus       126 ~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  205 (313)
                      |+|||++.++.++|+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus       131 p~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~  209 (320)
T d1xjda_         131 LDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE  209 (320)
T ss_dssp             GGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccceeecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999999997554332 2334467899999999999999999999999999999999999999987766


Q ss_pred             hhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q 048068          206 EMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMR-QVMQY  267 (313)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~  267 (313)
                      .....+.       .+      .+    ..+...+..+.+||.+||..||.+|||+. ++++|
T Consensus       210 ~~~~~i~-------~~------~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         210 ELFHSIR-------MD------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             HHHHHHH-------HC------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHHHHHH-------cC------CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence            5443331       11      01    12233456789999999999999999996 78764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.6e-40  Score=288.85  Aligned_cols=214  Identities=23%  Similarity=0.298  Sum_probs=176.7

Q ss_pred             cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHH
Q 048068           27 VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQ   96 (313)
Q Consensus        27 ~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~   96 (313)
                      +..+++|.+..          ....|...++.++|||+++.++++.+ ++.+|+||||++||+|..++...  ..+++..
T Consensus        29 g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~  105 (316)
T d1fota_          29 GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKS--QRFPNPV  105 (316)
T ss_dssp             CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHT--SSCCHHH
T ss_pred             CCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeEeeecCCcccccccccc--ccccccH
Confidence            44666666532          22356778889999999999999987 67999999999999999999874  4589999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCC
Q 048068           97 RFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA  176 (313)
Q Consensus        97 ~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  176 (313)
                      ++.++.||+.||.|||   +++|+||||||+||+++.+|.+||+|||++......    .....||+.|+|||++.+..+
T Consensus       106 ~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y  178 (316)
T d1fota_         106 AKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPY  178 (316)
T ss_dssp             HHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCB
T ss_pred             HHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc----cccccCcccccCHHHHcCCCC
Confidence            9999999999999999   699999999999999999999999999999765432    234679999999999999899


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCC
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPE  256 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  256 (313)
                      +.++|||||||++|+|++|+.||.+.+..+....+.       .+          ....+...++.+.+++.+||..||.
T Consensus       179 ~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-------~~----------~~~~p~~~s~~~~~li~~~L~~dp~  241 (316)
T d1fota_         179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-------NA----------ELRFPPFFNEDVKDLLSRLITRDLS  241 (316)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------HC----------CCCCCTTSCHHHHHHHHHHTCSCTT
T ss_pred             CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH-------cC----------CCCCCCCCCHHHHHHHHHHhhhCHH
Confidence            999999999999999999999998766555443331       11          0112233456688999999999999


Q ss_pred             CCC-----CHHHHHHH
Q 048068          257 ARP-----NMRQVMQY  267 (313)
Q Consensus       257 ~Rp-----t~~ell~~  267 (313)
                      +|+     |++++++|
T Consensus       242 ~R~~~~r~t~~~il~H  257 (316)
T d1fota_         242 QRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             TCTTSSTTTTHHHHTS
T ss_pred             hccccchhhHHHHHcC
Confidence            996     99999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-40  Score=297.85  Aligned_cols=228  Identities=20%  Similarity=0.237  Sum_probs=182.3

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC----------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE----------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGS   79 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~   79 (313)
                      ++.|.+..++...+   +..+++|.+..          ....|...++.++||++++.++++.. ...+++||||+.+|+
T Consensus        49 lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v~e~~~~g~  127 (350)
T d1rdqe_          49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGE  127 (350)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCB
T ss_pred             eecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccccccccccc
Confidence            34445555555443   44667776531          12356678899999999999999887 678999999999999


Q ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccc
Q 048068           80 LDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        80 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      |..++.+.  +.+++..++.++.||+.||.|||   +.+|+||||||+|||++.+|.+||+|||++......    ....
T Consensus       128 l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~~  198 (350)
T d1rdqe_         128 MFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTL  198 (350)
T ss_dssp             HHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCC
T ss_pred             hhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----cccc
Confidence            99999874  35999999999999999999999   589999999999999999999999999999865432    2346


Q ss_pred             cccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHH
Q 048068          160 VGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQ  239 (313)
Q Consensus       160 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (313)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.       .+.          ...+...
T Consensus       199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-------~~~----------~~~p~~~  261 (350)
T d1rdqe_         199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-------SGK----------VRFPSHF  261 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC----------CCCCTTC
T ss_pred             cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh-------cCC----------CCCCccC
Confidence            78999999999999999999999999999999999999998766544433331       110          0122334


Q ss_pred             HHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          240 MELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       240 ~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ++.+.+||.+||+.||.+|+     |++++++|
T Consensus       262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            56788999999999999994     99999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.6e-40  Score=294.62  Aligned_cols=202  Identities=20%  Similarity=0.281  Sum_probs=165.3

Q ss_pred             HhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceec
Q 048068           43 RDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHR  122 (313)
Q Consensus        43 ~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~  122 (313)
                      .+.++.++||++++.++++.. ++.+|+||||++||+|.+++...  ..+++..++.++.||+.||.|||   ..+|+||
T Consensus        58 ~~~l~~~~hpnIv~l~~~~~~-~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHr  131 (364)
T d1omwa3          58 LSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYR  131 (364)
T ss_dssp             HHHHSSSCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred             HHHHhcCCCCcEEEEEEEEEE-CCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH---HCCccce
Confidence            345566789999999999887 67899999999999999999874  36899999999999999999999   5999999


Q ss_pred             CcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 048068          123 DIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQ  201 (313)
Q Consensus       123 dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (313)
                      ||||+|||++.+|.+||+|||++.......   .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+
T Consensus       132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  208 (364)
T d1omwa3         132 DLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ  208 (364)
T ss_dssp             CCSGGGEEECSSSCEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             eeccceeEEcCCCcEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998654332   344579999999999864 5689999999999999999999999987


Q ss_pred             CCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 048068          202 QGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPN-----MRQVMQY  267 (313)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  267 (313)
                      ....+........   .           ......+...++.+.+||.+||+.||++|||     ++|+++|
T Consensus       209 ~~~~~~~~~~~~~---~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         209 HKTKDKHEIDRMT---L-----------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SCSSCHHHHHHHS---S-----------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCHHHHHHHHHhc---c-----------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            6655433222110   0           0111122334567899999999999999999     7999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-40  Score=288.42  Aligned_cols=204  Identities=24%  Similarity=0.308  Sum_probs=158.4

Q ss_pred             cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 048068           50 HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI--------------KPSLSWYQRFRIIRGVASGLLYLHEDW  115 (313)
Q Consensus        50 ~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lhs~~  115 (313)
                      +|++++...+.....+..+++||||+++|+|.++++...              ...+++..+..++.||+.||.|||   
T Consensus        75 ~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---  151 (299)
T d1ywna1          75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---  151 (299)
T ss_dssp             CCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---
T ss_pred             CCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---
Confidence            688999988888876778999999999999999997532              235889999999999999999999   


Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  194 (313)
                      +++|+||||||+|||++.++.+||+|||++........ .......||+.|+|||.+.++.++.++|||||||++|||++
T Consensus       152 ~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt  231 (299)
T d1ywna1         152 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  231 (299)
T ss_dssp             HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence            48999999999999999999999999999975543322 22344678999999999999999999999999999999998


Q ss_pred             C-CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          195 G-RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       195 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      | .+||.+..........      ...+..         ...+...++.+.+||.+||+.||++|||++|+++||++.
T Consensus       232 ~~~~p~~~~~~~~~~~~~------~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         232 LGASPYPGVKIDEEFCRR------LKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             TSCCSSTTCCCSHHHHHH------HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHH------HhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            6 5678765544322211      111111         112233456789999999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=292.02  Aligned_cols=211  Identities=22%  Similarity=0.303  Sum_probs=170.9

Q ss_pred             hhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCc
Q 048068           40 QLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVV  119 (313)
Q Consensus        40 ~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i  119 (313)
                      ..|...++.++|||++++++++.+  +..+++|+++.+++|.+.+... ...+++..++.++.||+.||.|||+   ++|
T Consensus        59 ~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~i  132 (317)
T d1xkka_          59 LDEAYVMASVDNPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRL  132 (317)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             HHHHHHHHhCCCCCEeeEEEEEec--CCeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCc
Confidence            356677888899999999999875  4578889999999999998876 4569999999999999999999994   899


Q ss_pred             eecCcCCCcEEEcCCCcEEEeecccccccCCCCCC-ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          120 LHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP-QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       120 ~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      +||||||+||+++.++.+||+|||++......... ......||+.|+|||.+.++.++.++|||||||++|||+| |.+
T Consensus       133 iHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~  212 (317)
T d1xkka_         133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK  212 (317)
T ss_dssp             CCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCC
Confidence            99999999999999999999999999866443222 2233467999999999998899999999999999999998 899


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||.+....+....+.       .+.         ....+...++.+.+||.+||+.||.+|||+.|++++|+...
T Consensus       213 p~~~~~~~~~~~~i~-------~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         213 PYDGIPASEISSILE-------KGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             TTTTSCGGGHHHHHH-------HTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHH-------cCC---------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            998776655443332       111         11123345567899999999999999999999999987653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-40  Score=287.66  Aligned_cols=240  Identities=19%  Similarity=0.250  Sum_probs=177.9

Q ss_pred             cceEEEcccC---------CChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           27 VNQFIYHGFN---------EDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        27 ~~~~~~~~~~---------~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ...++.|.+.         +....|.+.+++++|++++++++.+.+ ++++|+||||+. +++.+++.....+.+++..+
T Consensus        27 ~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~  104 (298)
T d1gz8a_          27 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEFLH-QDLKKFMDASALTGIPLPLI  104 (298)
T ss_dssp             CCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHH
T ss_pred             CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEEeecC-CchhhhhhhhcccCCCHHHH
Confidence            3456666652         223357788899999999999999987 679999999995 56666665554667999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCC-C
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGK-A  176 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~  176 (313)
                      +.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++....... .......|++.|+|||.+.... +
T Consensus       105 ~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~  180 (298)
T d1gz8a_         105 KSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYY  180 (298)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccCC
Confidence            999999999999999   5899999999999999999999999999997664432 2334457899999999877655 5


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccc-----ccccccccc----C---CccHHHHHHHH
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAI-----LDASDSRLE----G---IYEEEQMELVL  244 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~----~---~~~~~~~~~l~  244 (313)
                      +.++|+|||||++|+|++|+.||.+.+..+....+............     ........+    .   ......+..+.
T Consensus       181 ~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  260 (298)
T d1gz8a_         181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR  260 (298)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHH
T ss_pred             CccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHH
Confidence            78999999999999999999999877665544333211111000000     000000000    0   01112346788


Q ss_pred             HHHHHcCCCCCCCCCCHHHHHHH--HhccC
Q 048068          245 KLGLFCSHPKPEARPNMRQVMQY--LDGNA  272 (313)
Q Consensus       245 ~li~~cl~~~P~~Rpt~~ell~~--L~~~~  272 (313)
                      +|+.+||+.||++|||++|+++|  +++..
T Consensus       261 dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         261 SLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            99999999999999999999998  65553

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=286.08  Aligned_cols=224  Identities=25%  Similarity=0.367  Sum_probs=176.1

Q ss_pred             eEEEcccCCCh--h------hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           29 QFIYHGFNEDP--Q------LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        29 ~~~~~~~~~~~--~------~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      .+++|.+..+.  .      .+...+..+ +|+|++++++++.+ ++..++||||+++|+|.+++....           
T Consensus        47 ~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~  125 (299)
T d1fgka_          47 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS  125 (299)
T ss_dssp             EEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEECCCTTCBHHHHHHTTSCC---------
T ss_pred             EEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-CCeEEEEEEccCCCcHHHHHHhhcCCccccccccc
Confidence            46677664322  1      233334444 79999999999987 668999999999999999997542           


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccccc
Q 048068           89 ---KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFG  164 (313)
Q Consensus        89 ---~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~  164 (313)
                         ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++........ .......+++.
T Consensus       126 ~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  202 (299)
T d1fgka_         126 HNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK  202 (299)
T ss_dssp             ---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGG
T ss_pred             cCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChh
Confidence               245899999999999999999999   58999999999999999999999999999976543322 22344568889


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHH
Q 048068          165 YMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELV  243 (313)
Q Consensus       165 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (313)
                      |+|||.+.++.++.++||||||+++|||++ |.+||.+.........+       ..+..         ...+...++.+
T Consensus       203 y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i-------~~~~~---------~~~p~~~~~~l  266 (299)
T d1fgka_         203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------KEGHR---------MDKPSNCTNEL  266 (299)
T ss_dssp             GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------HTTCC---------CCCCSSCCHHH
T ss_pred             hhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH-------HcCCC---------CCCCccchHHH
Confidence            999999998999999999999999999998 78899876655433222       11111         11222345678


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          244 LKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       244 ~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .+||.+||+.||.+|||+.|+++.|+...
T Consensus       267 ~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         267 YMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            99999999999999999999999998753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-40  Score=290.21  Aligned_cols=212  Identities=25%  Similarity=0.355  Sum_probs=170.5

Q ss_pred             hhHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--------------CCCCCCHHHHHHHHHHH
Q 048068           40 QLQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--------------IKPSLSWYQRFRIIRGV  104 (313)
Q Consensus        40 ~~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~qi  104 (313)
                      ..|...++.+ +|+|++++++++.+ ++.+++||||+++|+|.++++..              ....+++..+..++.||
T Consensus        58 ~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  136 (309)
T d1fvra_          58 AGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV  136 (309)
T ss_dssp             HHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCCEeeEEEEEec-CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHH
Confidence            4567777887 79999999999886 67899999999999999999753              23579999999999999


Q ss_pred             HHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHH
Q 048068          105 ASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYA  184 (313)
Q Consensus       105 ~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  184 (313)
                      +.|+.|+|   ..+++||||||+|||++.++.+||+|||++.......  ......+|..|+|||.+.+..++.++||||
T Consensus       137 a~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwS  211 (309)
T d1fvra_         137 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWS  211 (309)
T ss_dssp             HHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHhhh---cCCccccccccceEEEcCCCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeeh
Confidence            99999999   4899999999999999999999999999987543322  122346789999999999889999999999


Q ss_pred             HHHHHHHHHhCC-CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          185 FGVFMLEVASGR-RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       185 lG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      |||++|||++|. +||.+.+..+....+   .    .+.         ....+...++.+.+||.+||+.||++|||++|
T Consensus       212 fGvil~ell~~~~~p~~~~~~~~~~~~i---~----~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  275 (309)
T d1fvra_         212 YGVLLWEIVSLGGTPYCGMTCAELYEKL---P----QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  275 (309)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCHHHHHHHG---G----GTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hHHHHHHHHhcCCCCCCCCCHHHHHHHH---H----hcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            999999999965 567766544433222   1    110         11123344567999999999999999999999


Q ss_pred             HHHHHhccCC
Q 048068          264 VMQYLDGNAT  273 (313)
Q Consensus       264 ll~~L~~~~~  273 (313)
                      ++++|+....
T Consensus       276 il~~L~~i~~  285 (309)
T d1fvra_         276 ILVSLNRMLE  285 (309)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHh
Confidence            9999988753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-40  Score=288.86  Aligned_cols=242  Identities=22%  Similarity=0.278  Sum_probs=181.3

Q ss_pred             hhHHHHHHHHhhcccc------ceEEEcccCC--C------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCC
Q 048068           12 VLLCVSFILSALAQDV------NQFIYHGFNE--D------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPN   77 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~~------~~~~~~~~~~--~------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~   77 (313)
                      +++.|.|..+|.+...      ..+++|.+..  +      ...|.+.+++++|+|+++++++..+.++..++||||+++
T Consensus        34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~  113 (311)
T d1r0pa_          34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  113 (311)
T ss_dssp             EEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTT
T ss_pred             EEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeec
Confidence            3455555555544321      1355666642  2      234445666779999999999887667789999999999


Q ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC---C
Q 048068           78 GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI---P  154 (313)
Q Consensus        78 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~---~  154 (313)
                      |+|.+++... ....++..+..++.|++.||.|+|   ..+|+||||||+|||++.++.+||+|||++........   .
T Consensus       114 g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         114 GDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             Cchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            9999998865 446888999999999999999999   58999999999999999999999999999976543221   1


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                      ......||..|+|||.+.+..++.++||||||+++|||++|..||........  ....+.    .+..         ..
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i~----~g~~---------~~  254 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL----QGRR---------LL  254 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCC---------CC
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHHH----cCCC---------CC
Confidence            22335678999999999988999999999999999999998877764332211  111111    1110         01


Q ss_pred             ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          235 YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       235 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .+...++.+.+||.+||+.||++|||+.|++++|++..
T Consensus       255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            22234567899999999999999999999999998875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=286.65  Aligned_cols=221  Identities=21%  Similarity=0.322  Sum_probs=167.1

Q ss_pred             hHHhhhhhc---cccceeeeeeEEe----ccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 048068           41 LQRDGLASV---HSNGLLQLTNTVN----SRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHE  113 (313)
Q Consensus        41 ~~~~~l~~~---~~~~~l~~~~~~~----~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs  113 (313)
                      .|...++.+   +|||++++++++.    ....+.+++||+++++.+...... ....+++..++.++.||+.||+||| 
T Consensus        56 ~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH-  133 (305)
T d1blxa_          56 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH-  133 (305)
T ss_dssp             HHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            344555554   7999999998875    345688999999977666544443 3567999999999999999999999 


Q ss_pred             cCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHH
Q 048068          114 DWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVA  193 (313)
Q Consensus       114 ~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  193 (313)
                        ..+|+||||||+|||++.++.++|+|||++.......  ......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus       134 --~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell  209 (305)
T d1blxa_         134 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF  209 (305)
T ss_dssp             --HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             --hCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHH
Confidence              5899999999999999999999999999986543222  334567899999999999999999999999999999999


Q ss_pred             hCCCCCccCCchhhhhHHHHHHHh-----hhhcc-----ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 048068          194 SGRRPIEQQGSMEMVNLVDWVSDC-----WKKGA-----ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQ  263 (313)
Q Consensus       194 ~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  263 (313)
                      +|++||.+.+..+....+......     |....     .................++.+.+||.+||+.||++|||++|
T Consensus       210 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e  289 (305)
T d1blxa_         210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  289 (305)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            999999987766555444222111     11100     00000111111122334567889999999999999999999


Q ss_pred             HHHH
Q 048068          264 VMQY  267 (313)
Q Consensus       264 ll~~  267 (313)
                      +++|
T Consensus       290 ~L~H  293 (305)
T d1blxa_         290 ALSH  293 (305)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.5e-39  Score=278.65  Aligned_cols=241  Identities=22%  Similarity=0.307  Sum_probs=176.5

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC----C------hhhHHhhhhhccccceeeeeeEEeccC---CeEEEEEecCC
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE----D------PQLQRDGLASVHSNGLLQLTNTVNSRK---GEFLLVYDYMP   76 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~----~------~~~~~~~l~~~~~~~~l~~~~~~~~~~---~~~~lV~e~~~   76 (313)
                      ++.|.+..+|.+.+   ...++.|.+..    +      ...|.+.++.++|||+++.+++....+   ..+|+||||++
T Consensus        15 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~   94 (277)
T d1o6ya_          15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD   94 (277)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCC
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCC
Confidence            34444444555543   34667776532    1      224566677789999999999887432   35899999999


Q ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC--CC
Q 048068           77 NGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT--IP  154 (313)
Q Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~--~~  154 (313)
                      |++|.+++...  +.+++..++.++.||+.||.|||   +.+|+||||||+||+++.++..+++|||.+.......  ..
T Consensus        95 g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~  169 (277)
T d1o6ya_          95 GVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT  169 (277)
T ss_dssp             EEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-------
T ss_pred             CCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhcccccccc
Confidence            99999998764  36999999999999999999999   5899999999999999999999999999886543222  12


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+....+......      ....       ..+..
T Consensus       170 ~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~------~~~~-------~~~~~  236 (277)
T d1o6ya_         170 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------REDP-------IPPSA  236 (277)
T ss_dssp             ---------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HCCC-------CCGGG
T ss_pred             ccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH------hcCC-------CCCch
Confidence            2344578999999999998899999999999999999999999998766554332221      1111       11111


Q ss_pred             ccHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcc
Q 048068          235 YEEEQMELVLKLGLFCSHPKPEARP-NMRQVMQYLDGN  271 (313)
Q Consensus       235 ~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ell~~L~~~  271 (313)
                      .....++.+.+||.+||+.||.+|| |++++++.|...
T Consensus       237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            2233456788999999999999999 899998887643

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-39  Score=280.42  Aligned_cols=210  Identities=25%  Similarity=0.363  Sum_probs=168.1

Q ss_pred             hHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCce
Q 048068           41 LQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVL  120 (313)
Q Consensus        41 ~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~  120 (313)
                      .|...++.++|+|+++.++++.+  ...++||||+++|+|.+++..+ .+.+++..+..++.||+.||.|||   +++|+
T Consensus        60 ~Ei~~l~~l~H~nIv~~~g~~~~--~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~ii  133 (273)
T d1u46a_          60 REVNAMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFI  133 (273)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HHHHHHHhCCCCCEEEEEEEEee--cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhh---hCCEe
Confidence            44556778899999999999864  4678999999999999988765 345999999999999999999999   48999


Q ss_pred             ecCcCCCcEEEcCCCcEEEeecccccccCCCCCC--ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHh-CCC
Q 048068          121 HRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP--QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRR  197 (313)
Q Consensus       121 H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  197 (313)
                      ||||||+||+++.++.+||+|||++.........  ......++..|+|||.+.+..++.++||||||+++|||++ |..
T Consensus       134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~  213 (273)
T d1u46a_         134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE  213 (273)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence            9999999999999999999999999866443221  1223456788999999998889999999999999999998 899


Q ss_pred             CCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          198 PIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       198 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      ||.+.+..+....+.      +.+.         ....+...+..+.+||.+||+.||++|||++++++.|.+.
T Consensus       214 Pf~~~~~~~~~~~i~------~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         214 PWIGLNGSQILHKID------KEGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TTTTCCHHHHHHHHH------TSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcCHHHHHHHHH------hCCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            998776665443321      1111         1112233456789999999999999999999999999764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-38  Score=279.96  Aligned_cols=224  Identities=25%  Similarity=0.373  Sum_probs=176.5

Q ss_pred             ceEEEcccCC--------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           28 NQFIYHGFNE--------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        28 ~~~~~~~~~~--------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      ..+++|.+..        ....|.+.++.++|+|++++++.+.. ++..++||||+++|+|.+++....           
T Consensus        44 ~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~  122 (301)
T d1lufa_          44 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD  122 (301)
T ss_dssp             EEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHTCC----------
T ss_pred             eEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-CCceEEEEEecCCCcHHHHHHhcCccccccccccc
Confidence            3567777643        23455677788899999999999886 678999999999999999996421           


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC-CCcc
Q 048068           89 -----------KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT-IPQT  156 (313)
Q Consensus        89 -----------~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~-~~~~  156 (313)
                                 ...+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+|||++....... ....
T Consensus       123 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~  199 (301)
T d1lufa_         123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD  199 (301)
T ss_dssp             ------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC--
T ss_pred             cchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCcccccc
Confidence                       234889999999999999999999   5899999999999999999999999999997543322 1223


Q ss_pred             ccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCC-CCCccCCchhhhhHHHHHHHhhhhccccccccccccCCc
Q 048068          157 TKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGR-RPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIY  235 (313)
Q Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (313)
                      ....+++.|+|||.+.+..++.++|||||||++|||++|. +||.+....+....+.       .+..     +    ..
T Consensus       200 ~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~-------~~~~-----~----~~  263 (301)
T d1lufa_         200 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-------DGNI-----L----AC  263 (301)
T ss_dssp             --CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TTCC-----C----CC
T ss_pred             CCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHH-------cCCC-----C----CC
Confidence            3456788999999999999999999999999999999985 6788776665443321       1111     1    12


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +...+..+.+||..||+.||++|||+.||+++|+..
T Consensus       264 p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         264 PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            233445788999999999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-40  Score=283.80  Aligned_cols=196  Identities=23%  Similarity=0.352  Sum_probs=159.3

Q ss_pred             hhHHhhhhhcc--ccceeeeeeEEeccCCeEEEEEecCCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 048068           40 QLQRDGLASVH--SNGLLQLTNTVNSRKGEFLLVYDYMPN-GSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWE  116 (313)
Q Consensus        40 ~~~~~~l~~~~--~~~~l~~~~~~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~  116 (313)
                      ..|...+++++  |+|+++.++++.+ ++..++||||+.+ +++.+++...  ..+++..++.++.||+.||.|||   +
T Consensus        55 ~~E~~il~~l~~~h~nIv~~~~~~~~-~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~  128 (273)
T d1xwsa_          55 PMEVVLLKKVSSGFSGVIRLLDWFER-PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---N  128 (273)
T ss_dssp             EHHHHHHHHHCSSSCSBCCEEEEEEC-SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred             HHHHHHHHHhccCCCCccEEEEEEee-CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---H
Confidence            35677788886  8999999999887 6789999999976 6888888763  36999999999999999999999   5


Q ss_pred             CCceecCcCCCcEEEcC-CCcEEEeecccccccCCCCCCccccccccccccccccccCCCC-CcchhhHHHHHHHHHHHh
Q 048068          117 QVVLHRDIKPANVLLDA-DLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKA-STSTDVYAFGVFMLEVAS  194 (313)
Q Consensus       117 ~~i~H~dl~~~nIlv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  194 (313)
                      .+|+||||||+||+++. ++.++|+|||++......   ......||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       129 ~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~  205 (273)
T d1xwsa_         129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  205 (273)
T ss_dssp             TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCccccCcccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence            89999999999999985 478999999999765432   2345678999999999876655 677999999999999999


Q ss_pred             CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          195 GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       195 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      |+.||......     .        .+..      .    .+...++.+.+||.+||+.||++|||++|+++|
T Consensus       206 g~~Pf~~~~~i-----~--------~~~~------~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         206 GDIPFEHDEEI-----I--------RGQV------F----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             SSCSCCSHHHH-----H--------HCCC------C----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCchHH-----h--------hccc------C----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            99999753210     0        0000      1    122234678899999999999999999999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-38  Score=284.16  Aligned_cols=254  Identities=19%  Similarity=0.165  Sum_probs=183.1

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccC---CChhhHHhhhhhccccceeeeeeEEe-----ccCCeEEEEEecCCCCCHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFN---EDPQLQRDGLASVHSNGLLQLTNTVN-----SRKGEFLLVYDYMPNGSLD   81 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~~~~~~~l~~~~~~~-----~~~~~~~lV~e~~~~g~L~   81 (313)
                      ++.|.+..+|++++   ...+++|.+.   .....|.+.+++++|+|+++.++++.     ....++++||||++++.+.
T Consensus        28 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~  107 (350)
T d1q5ka_          28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR  107 (350)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHH
T ss_pred             EeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHH
Confidence            45566666666555   3456666653   34456888999999999999999885     2344689999999665433


Q ss_pred             HHHhh-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC-cEEEeecccccccCCCCCCccccc
Q 048068           82 KILHT-NIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIPQTTKL  159 (313)
Q Consensus        82 ~~l~~-~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  159 (313)
                      .+... .....+++..++.++.||+.||+|||   +.||+||||||+|||++.++ .+||+|||++.......  .....
T Consensus       108 ~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~  182 (350)
T d1q5ka_         108 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSY  182 (350)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS--CCCSC
T ss_pred             HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc--ccccc
Confidence            33321 22457999999999999999999999   69999999999999999775 89999999987654332  23345


Q ss_pred             cccccccccccccC-CCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHH-----Hhhhh-------cccccc
Q 048068          160 VGTFGYMAPELMRT-GKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS-----DCWKK-------GAILDA  226 (313)
Q Consensus       160 ~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----~~~~~-------~~~~~~  226 (313)
                      .|+..|.|||.+.+ ..++.++||||+||++|||++|+.||......+....+....     ..+..       ......
T Consensus       183 ~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  262 (350)
T d1q5ka_         183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI  262 (350)
T ss_dssp             CSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCC
T ss_pred             cccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcccccc
Confidence            78999999998765 468999999999999999999999998877665544332111     01110       000111


Q ss_pred             ccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--Hhcc
Q 048068          227 SDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGN  271 (313)
Q Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~  271 (313)
                      .............++.+.+|+.+||..||++|||++|+++|  +++.
T Consensus       263 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            11111111223345678899999999999999999999986  4443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-38  Score=280.17  Aligned_cols=237  Identities=21%  Similarity=0.249  Sum_probs=170.9

Q ss_pred             ceEEEcccCCChhh----H--HhhhhhccccceeeeeeEEeccC---CeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHH
Q 048068           28 NQFIYHGFNEDPQL----Q--RDGLASVHSNGLLQLTNTVNSRK---GEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRF   98 (313)
Q Consensus        28 ~~~~~~~~~~~~~~----~--~~~l~~~~~~~~l~~~~~~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~   98 (313)
                      ..+++|.+..+...    +  ...+.+++|+|+++++++....+   ..+|+||||+++|+|.+++++.   ++++..++
T Consensus        27 ~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~  103 (303)
T d1vjya_          27 EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMI  103 (303)
T ss_dssp             EEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHH
T ss_pred             EEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHH
Confidence            35666666432222    2  22334678999999999988433   3689999999999999999875   49999999


Q ss_pred             HHHHHHHHHHHHhhhcC-----CCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC---Ccccccccccccccccc
Q 048068           99 RIIRGVASGLLYLHEDW-----EQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI---PQTTKLVGTFGYMAPEL  170 (313)
Q Consensus        99 ~i~~qi~~al~~lhs~~-----~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~  170 (313)
                      .++.|++.|+.|+|+.+     .++|+||||||+||+++.++.+||+|||++........   .......||+.|+|||+
T Consensus       104 ~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  183 (303)
T d1vjya_         104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhh
Confidence            99999999999999521     36999999999999999999999999999976543221   12234678999999999


Q ss_pred             ccCCC------CCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhH--------HHHHHHhhhhcccccccccccc-CCc
Q 048068          171 MRTGK------ASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNL--------VDWVSDCWKKGAILDASDSRLE-GIY  235 (313)
Q Consensus       171 ~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~-~~~  235 (313)
                      +.+..      ++.++|||||||++|||++|..||...........        .........    .....+..+ ...
T Consensus       184 ~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~p~~~~~~~  259 (303)
T d1vjya_         184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC----EQKLRPNIPNRWQ  259 (303)
T ss_dssp             HTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGG
T ss_pred             ccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHh----ccccCCCCCcccC
Confidence            87543      46789999999999999999988754332211100        000111111    111111111 122


Q ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          236 EEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       236 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      +......+.+|+.+||+.||++|||+.|++++|+..
T Consensus       260 ~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            445667799999999999999999999999999764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-38  Score=277.75  Aligned_cols=234  Identities=18%  Similarity=0.249  Sum_probs=172.1

Q ss_pred             cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHH
Q 048068           27 VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQR   97 (313)
Q Consensus        27 ~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~   97 (313)
                      ...+++|.+..         ....|...++.++|+|+++.++.+.. +++.+++||++.++.+..+...  .+.+++..+
T Consensus        26 ~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~  102 (286)
T d1ob3a_          26 GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFEHLDQDLKKLLDVC--EGGLESVTA  102 (286)
T ss_dssp             SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEECCSEEHHHHHHTS--TTCCCHHHH
T ss_pred             CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEEEeehhhhHHHHHhh--cCCcchhhh
Confidence            34667776632         23356778899999999999999987 6689999999977666655554  356999999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccccccccCC-CC
Q 048068           98 FRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMAPELMRTG-KA  176 (313)
Q Consensus        98 ~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~  176 (313)
                      ..++.||+.||.|||   +.+|+||||||+||+++.++.+|++|||.+........ ......+++.|.+||.+.+. .+
T Consensus       103 ~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~  178 (286)
T d1ob3a_         103 KSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKY  178 (286)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSC
T ss_pred             HHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccceecccchhhhHHHHhCCCCC
Confidence            999999999999999   58999999999999999999999999999976654322 23344678999999998754 56


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcc------------ccccccccccCCccHHHHHHHH
Q 048068          177 STSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA------------ILDASDSRLEGIYEEEQMELVL  244 (313)
Q Consensus       177 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~  244 (313)
                      +.++|||||||++|+|++|+.||.+....+....+...........            ......+..........+..+.
T Consensus       179 ~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  258 (286)
T d1ob3a_         179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI  258 (286)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHH
T ss_pred             CcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHH
Confidence            8999999999999999999999987766555443322111110000            0000111111122233456788


Q ss_pred             HHHHHcCCCCCCCCCCHHHHHHH
Q 048068          245 KLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       245 ~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      +||.+||+.||++|||++|+++|
T Consensus       259 dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         259 DLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHccCChhHCcCHHHHhcC
Confidence            99999999999999999999976

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-38  Score=278.56  Aligned_cols=225  Identities=20%  Similarity=0.375  Sum_probs=179.0

Q ss_pred             ceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhC--------CCCC
Q 048068           28 NQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTN--------IKPS   91 (313)
Q Consensus        28 ~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~--------~~~~   91 (313)
                      ..+++|.+...        ...|.+.+++++|+|++++.+++.. ++..++||||+++|+|.+++...        ....
T Consensus        51 ~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~  129 (308)
T d1p4oa_          51 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP  129 (308)
T ss_dssp             EEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCC
T ss_pred             cEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCceeEEEeecCCCCHHHHHHhcccccccccccCC
Confidence            45677766531        2356677788899999999999876 66899999999999999998642        1235


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccccccccccc
Q 048068           92 LSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGTFGYMAPEL  170 (313)
Q Consensus        92 ~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~  170 (313)
                      +++..+..++.|++.||.|||   .++|+||||||+|||++.++.+||+|||++........ .......+++.|++||.
T Consensus       130 ~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHH
Confidence            789999999999999999999   58999999999999999999999999999975543222 12334468899999999


Q ss_pred             ccCCCCCcchhhHHHHHHHHHHHhC-CCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHHHHHHHHHH
Q 048068          171 MRTGKASTSTDVYAFGVFMLEVASG-RRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQMELVLKLGLF  249 (313)
Q Consensus       171 ~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  249 (313)
                      +.+..++.++||||||+++|||++| .+||.+....+....+.       .+..         ...+...+..+.++|.+
T Consensus       207 l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-------~~~~---------~~~p~~~~~~l~~li~~  270 (308)
T d1p4oa_         207 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------EGGL---------LDKPDNCPDMLFELMRM  270 (308)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-------TTCC---------CCCCTTCCHHHHHHHHH
T ss_pred             HccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hCCC---------CCCcccchHHHHHHHHH
Confidence            9999999999999999999999998 57787766555443331       1111         11223345679999999


Q ss_pred             cCCCCCCCCCCHHHHHHHHhccC
Q 048068          250 CSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       250 cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      ||+.||++|||+++++++|++..
T Consensus       271 cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         271 CWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HcCCChhHCcCHHHHHHHHHHhc
Confidence            99999999999999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-38  Score=279.68  Aligned_cols=256  Identities=20%  Similarity=0.239  Sum_probs=182.8

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEecc-----CCeEEEEEec
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSR-----KGEFLLVYDY   74 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~-----~~~~~lV~e~   74 (313)
                      +++.|.+..++.+.+   ...+++|.+...         ...|.+.+++++|++++++++++...     ..++|+||||
T Consensus        25 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~  104 (346)
T d1cm8a_          25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF  104 (346)
T ss_dssp             EC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred             EEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEec
Confidence            456777777777654   446778877521         22466778899999999999998743     2368999999


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~  154 (313)
                      + +.+|..+++..   .+++..++.++.||+.||.|||   +.||+||||||+||+++.++.++++|||++......   
T Consensus       105 ~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~---  174 (346)
T d1cm8a_         105 M-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---  174 (346)
T ss_dssp             C-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred             c-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCCc---
Confidence            9 77888888754   5999999999999999999999   589999999999999999999999999999765432   


Q ss_pred             ccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhh-----hhc-------
Q 048068          155 QTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCW-----KKG-------  221 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~-------  221 (313)
                       .....+++.|+|||.+.+. .++.++||||+||++|+|++|++||.+.+...............     ...       
T Consensus       175 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             -cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence             2345789999999998764 56899999999999999999999998876655443332211100     000       


Q ss_pred             --cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCCCCCCC
Q 048068          222 --AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATLPDIP  278 (313)
Q Consensus       222 --~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~~~~~~  278 (313)
                        ..................++.+.+||.+||..||++|||++|+++|  +++.....+.|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~  314 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP  314 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred             hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence              0000000000111222345667899999999999999999999997  66655444443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-38  Score=275.81  Aligned_cols=224  Identities=21%  Similarity=0.309  Sum_probs=174.3

Q ss_pred             eEEEcccCCC--hh------hHHhhhhhc-cccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCC-----------
Q 048068           29 QFIYHGFNED--PQ------LQRDGLASV-HSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNI-----------   88 (313)
Q Consensus        29 ~~~~~~~~~~--~~------~~~~~l~~~-~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------   88 (313)
                      .+++|.+...  ..      .|...++.+ +|+|+++++++..+ +..+++||||+++|+|.++++...           
T Consensus        55 ~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~  133 (311)
T d1t46a_          55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA  133 (311)
T ss_dssp             EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHHTTTTC--------
T ss_pred             EEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-CCEEEEEEEcCCCCCHHHHHHhccccccccccccc
Confidence            5677776432  22      233344445 69999999999986 567999999999999999997542           


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC-Ccccccccc
Q 048068           89 -----KPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI-PQTTKLVGT  162 (313)
Q Consensus        89 -----~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~  162 (313)
                           ...+++..+..++.||+.|+.|||   .++++||||||+||+++.++.++++|||.+........ .......+|
T Consensus       134 ~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt  210 (311)
T d1t46a_         134 IMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP  210 (311)
T ss_dssp             ------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred             cccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccC
Confidence                 235899999999999999999999   58999999999999999999999999999976544322 223345789


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHh-CCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCCccHHHHH
Q 048068          163 FGYMAPELMRTGKASTSTDVYAFGVFMLEVAS-GRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGIYEEEQME  241 (313)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (313)
                      +.|+|||.+.+..++.++|||||||++|||++ |.+||...........+.      ..+         .....+...+.
T Consensus       211 ~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i------~~~---------~~~~~~~~~~~  275 (311)
T d1t46a_         211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI------KEG---------FRMLSPEHAPA  275 (311)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH------HHT---------CCCCCCTTSCH
T ss_pred             hHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH------hcC---------CCCCCcccccH
Confidence            99999999998899999999999999999998 666676655543322221      111         11112333456


Q ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          242 LVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       242 ~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .+.+||.+||+.||++|||++|+++.|++.
T Consensus       276 ~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         276 EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            789999999999999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=274.89  Aligned_cols=250  Identities=19%  Similarity=0.203  Sum_probs=175.4

Q ss_pred             HHHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEec-------cCCeEEEEEec
Q 048068           14 LCVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNS-------RKGEFLLVYDY   74 (313)
Q Consensus        14 ~~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~-------~~~~~~lV~e~   74 (313)
                      +.|.+..+|.+.+   +..+++|.+..         ....|..+++.++|+++++..+++..       .+++.++||||
T Consensus        19 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~   98 (318)
T d3blha1          19 GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF   98 (318)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEEC
T ss_pred             ecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEec
Confidence            3344444444433   34677776521         12367788999999999999988763       24578999999


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC--
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT--  152 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~--  152 (313)
                      +.++.+......  ...+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.++++|||++.......  
T Consensus        99 ~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~  173 (318)
T d3blha1          99 CEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS  173 (318)
T ss_dssp             CCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC----
T ss_pred             cCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeeccccccc
Confidence            977655544333  456999999999999999999999   5899999999999999999999999999997654322  


Q ss_pred             -CCccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccc----
Q 048068          153 -IPQTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDA----  226 (313)
Q Consensus       153 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  226 (313)
                       ........||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+..+......+...............    
T Consensus       174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  253 (318)
T d3blha1         174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE  253 (318)
T ss_dssp             -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred             ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence             1122335689999999998754 6789999999999999999999999887665555444322211111000000    


Q ss_pred             ----cc--ccccCCcc-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          227 ----SD--SRLEGIYE-----EEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       227 ----~~--~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                          ..  ........     ......+.+||.+||+.||++|||++|+++|=
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence                00  00000000     11234667899999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=278.29  Aligned_cols=257  Identities=22%  Similarity=0.229  Sum_probs=181.0

Q ss_pred             hhhHHHHHHHHhhccc---cceEEEcccCCC--------hhhHHhhhhhccccceeeeeeEEecc----CCeEEEEEecC
Q 048068           11 CVLLCVSFILSALAQD---VNQFIYHGFNED--------PQLQRDGLASVHSNGLLQLTNTVNSR----KGEFLLVYDYM   75 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~l~~~~~~~~l~~~~~~~~~----~~~~~lV~e~~   75 (313)
                      .+++.|.+..++...+   ...+++|.+...        ...|.+.+++++|+++++.++++...    ...+++||+ +
T Consensus        14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~-~   92 (345)
T d1pmea_          14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH-L   92 (345)
T ss_dssp             EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE-C
T ss_pred             EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe-e
Confidence            4555666666666543   446777776422        22567888899999999999998742    234566555 5


Q ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCC--C
Q 048068           76 PNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDT--I  153 (313)
Q Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~--~  153 (313)
                      .+|+|.+++...   .+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++.......  .
T Consensus        93 ~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~  166 (345)
T d1pmea_          93 MGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  166 (345)
T ss_dssp             CCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             cCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence            599999999764   5999999999999999999999   5899999999999999999999999999987543221  1


Q ss_pred             Ccccccccccccccccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcc----------
Q 048068          154 PQTTKLVGTFGYMAPELMR-TGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGA----------  222 (313)
Q Consensus       154 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  222 (313)
                      .......|++.|+|||.+. +..++.++||||+||++|+|++|+.||.+....+................          
T Consensus       167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T d1pmea_         167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR  246 (345)
T ss_dssp             CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred             eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence            1234467899999999985 45678899999999999999999999987765554433322111100000          


Q ss_pred             ----ccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCCC
Q 048068          223 ----ILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATL  274 (313)
Q Consensus       223 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~~  274 (313)
                          .................+..+.+|+.+||+.||.+|||++|+++|  |+.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                000000000000111233568899999999999999999999998  5554433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-37  Score=271.68  Aligned_cols=246  Identities=15%  Similarity=0.158  Sum_probs=179.2

Q ss_pred             hhHHHHHHHHhhccc---cceEEEccc-----CCChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGF-----NEDPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      .++.|.+..++.+.+   ...+++|..     ......|.+.++.+.|++++.........++..++||||+ +++|...
T Consensus        14 ~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~   92 (299)
T d1ckia_          14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDL   92 (299)
T ss_dssp             EEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             EEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhh
Confidence            445555555555543   235566643     2355568888999998888877766666688999999999 6677777


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC---CCcEEEeecccccccCCCCC------C
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA---DLNGKLGDFGLARLYDHDTI------P  154 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~---~~~~~l~dfg~~~~~~~~~~------~  154 (313)
                      +... ...+++..+..++.|++.||.|||   +++|+||||||+||+++.   +..++++|||++........      .
T Consensus        93 ~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~  168 (299)
T d1ckia_          93 FNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR  168 (299)
T ss_dssp             HHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCC
T ss_pred             hhhc-cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceecc
Confidence            7654 456999999999999999999999   589999999999999864   45699999999986643221      1


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccccCC
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLEGI  234 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (313)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................         .....
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  239 (299)
T d1ckia_         169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---------TPIEV  239 (299)
T ss_dssp             BCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---------SCHHH
T ss_pred             ccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---------CChhH
Confidence            233457999999999999989999999999999999999999999876555443332211111000         00001


Q ss_pred             ccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcc
Q 048068          235 YEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGN  271 (313)
Q Consensus       235 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~  271 (313)
                      .....++.+.+||..||+.||++||+++++.+.|++.
T Consensus       240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1223446788999999999999999999887777654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=274.98  Aligned_cols=237  Identities=23%  Similarity=0.325  Sum_probs=183.1

Q ss_pred             hhHHHHHHHHhhccc------cceEEEcccC-----------CChhhHHhhhhhccc-cceeeeeeEEeccCCeEEEEEe
Q 048068           12 VLLCVSFILSALAQD------VNQFIYHGFN-----------EDPQLQRDGLASVHS-NGLLQLTNTVNSRKGEFLLVYD   73 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~------~~~~~~~~~~-----------~~~~~~~~~l~~~~~-~~~l~~~~~~~~~~~~~~lV~e   73 (313)
                      +++.|.+..+++..+      +..+++|.+.           +....|.+.++.++| +++++..+++.+ +..+++|||
T Consensus        31 ~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~~~~~v~e  109 (322)
T d1vzoa_          31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKLHLILD  109 (322)
T ss_dssp             EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             EEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CCceeeeee
Confidence            345566655555432      3356666542           233467788899977 789999888877 668999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCC
Q 048068           74 YMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTI  153 (313)
Q Consensus        74 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~  153 (313)
                      |+.+|+|.+++...  +.+++..++.++.||+.||.|+|   +.+++||||||+||+++.++.++|+|||++........
T Consensus       110 ~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~  184 (322)
T d1vzoa_         110 YINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET  184 (322)
T ss_dssp             CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG
T ss_pred             cccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhccccc
Confidence            99999999999874  35889999999999999999999   58999999999999999999999999999976654443


Q ss_pred             CccccccccccccccccccCC--CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhccccccccccc
Q 048068          154 PQTTKLVGTFGYMAPELMRTG--KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRL  231 (313)
Q Consensus       154 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (313)
                      .......+++.|.+||.+.+.  .++.++|||||||++|+|++|+.||.+....+....+..  ..+.           .
T Consensus       185 ~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~--~~~~-----------~  251 (322)
T d1vzoa_         185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILK-----------S  251 (322)
T ss_dssp             GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHH-----------C
T ss_pred             ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hccc-----------C
Confidence            344556789999999998754  468899999999999999999999987766554433321  1111           1


Q ss_pred             cCCccHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 048068          232 EGIYEEEQMELVLKLGLFCSHPKPEARP-----NMRQVMQY  267 (313)
Q Consensus       232 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~  267 (313)
                      ....+...+..+.+||.+||+.||++||     |++|+++|
T Consensus       252 ~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            1113334567889999999999999999     58999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.7e-36  Score=262.72  Aligned_cols=245  Identities=16%  Similarity=0.117  Sum_probs=180.2

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccC-----CChhhHHhhhhhccc-cceeeeeeEEeccCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFN-----EDPQLQRDGLASVHS-NGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~l~~~~~-~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..+|.+.+   ...+++|.+.     .....+.+.++.+.| ++++.+..+... +...++||||+ +++|.++
T Consensus        13 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~~-~~~l~~~   90 (293)
T d1csna_          13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GPSLEDL   90 (293)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEEec-CCCHHHH
Confidence            34444444555433   2355665542     233456677777766 677777777665 77899999999 7899999


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcC-----CCcEEEeecccccccCCCCC-----
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDA-----DLNGKLGDFGLARLYDHDTI-----  153 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~-----~~~~~l~dfg~~~~~~~~~~-----  153 (313)
                      +... ...++...+..++.|++.||.|||   +.||+||||||+||+++.     .+.++|+|||++........     
T Consensus        91 ~~~~-~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~  166 (293)
T d1csna_          91 LDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP  166 (293)
T ss_dssp             HHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCC
T ss_pred             HHhh-ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccccee
Confidence            8765 456999999999999999999999   699999999999999964     57799999999986543211     


Q ss_pred             -CccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhcccccccccccc
Q 048068          154 -PQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKGAILDASDSRLE  232 (313)
Q Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (313)
                       .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+............+.......         ..
T Consensus       167 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~---------~~  237 (293)
T d1csna_         167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---------PL  237 (293)
T ss_dssp             CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---------CH
T ss_pred             ecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC---------Ch
Confidence             12334579999999999999999999999999999999999999998765554433222221111110         00


Q ss_pred             CCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhccC
Q 048068          233 GIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYLDGNA  272 (313)
Q Consensus       233 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L~~~~  272 (313)
                      .......++.+.+++..|++.+|++||+++.+.+.|++..
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            0111223456889999999999999999999988887653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-36  Score=270.92  Aligned_cols=247  Identities=19%  Similarity=0.171  Sum_probs=173.9

Q ss_pred             hhHHHHHHHHhhccc---cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEec-----cCCeEEEEEec
Q 048068           12 VLLCVSFILSALAQD---VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNS-----RKGEFLLVYDY   74 (313)
Q Consensus        12 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~-----~~~~~~lV~e~   74 (313)
                      +++.|.+..+|++.+   +..+++|.+...         ...|...+++++|++++++++++..     ...++|+||||
T Consensus        24 ~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey  103 (355)
T d2b1pa1          24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL  103 (355)
T ss_dssp             ECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred             EeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEec
Confidence            556667666777654   346677776421         2356677788999999999999873     34789999999


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~  154 (313)
                      +.+ ++.+.+..    .+++..++.++.||+.||.|||   ..||+||||||+||+++.++.++++|||++.......  
T Consensus       104 ~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--  173 (355)
T d2b1pa1         104 MDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--  173 (355)
T ss_dssp             CSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             cch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcccccc--
Confidence            965 55555533    4899999999999999999999   5899999999999999999999999999987654432  


Q ss_pred             ccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHH-----Hhhhh---------
Q 048068          155 QTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVS-----DCWKK---------  220 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----~~~~~---------  220 (313)
                      ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+....     ..|..         
T Consensus       174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  253 (355)
T d2b1pa1         174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV  253 (355)
T ss_dssp             -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence            2344578999999999999999999999999999999999999998776554433221100     00100         


Q ss_pred             -ccc-------ccccc---ccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 048068          221 -GAI-------LDASD---SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQYL  268 (313)
Q Consensus       221 -~~~-------~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~L  268 (313)
                       ...       .....   ...........+..+.+||.+||..||++|||++|+|+|=
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp  312 (355)
T d2b1pa1         254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  312 (355)
T ss_dssp             HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence             000       00000   0011112334567889999999999999999999999973

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.1e-36  Score=266.61  Aligned_cols=245  Identities=17%  Similarity=0.180  Sum_probs=176.6

Q ss_pred             hHHHHHHHHhhccc---cceEEEcccCC----ChhhHHhhhhhcc-ccceeeeeeEEec-cCCeEEEEEecCCCCCHHHH
Q 048068           13 LLCVSFILSALAQD---VNQFIYHGFNE----DPQLQRDGLASVH-SNGLLQLTNTVNS-RKGEFLLVYDYMPNGSLDKI   83 (313)
Q Consensus        13 ~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~l~~~~-~~~~l~~~~~~~~-~~~~~~lV~e~~~~g~L~~~   83 (313)
                      ++.|.+..+|++.+   ...++.|.+..    ....|.+.++++. |++++++.+++.. ....+++||||+++++|..+
T Consensus        43 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~  122 (328)
T d3bqca1          43 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL  122 (328)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH
Confidence            44555556666544   34567776543    3335677888885 9999999999873 35679999999999998765


Q ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCC-cEEEeecccccccCCCCCCcccccccc
Q 048068           84 LHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADL-NGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        84 l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      .     +.+++..++.++.||+.||.|||   +.||+||||||+|||++.++ .++|+|||++.......  ......+|
T Consensus       123 ~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~t  192 (328)
T d3bqca1         123 Y-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVAS  192 (328)
T ss_dssp             T-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSCCSC
T ss_pred             h-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC--cccccccC
Confidence            3     35999999999999999999999   58999999999999998654 68999999997654432  23445789


Q ss_pred             ccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhh-hhHHHHHHH------hhhhccc-----------
Q 048068          163 FGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEM-VNLVDWVSD------CWKKGAI-----------  223 (313)
Q Consensus       163 ~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~------~~~~~~~-----------  223 (313)
                      +.|+|||.+.+. .++.++|+||+||++|++++|..||....+... ...+.....      .+.....           
T Consensus       193 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  272 (328)
T d3bqca1         193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG  272 (328)
T ss_dssp             GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCC
T ss_pred             ccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcc
Confidence            999999998765 479999999999999999999999976544322 111111000      0000000           


Q ss_pred             ---cccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          224 ---LDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       224 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                         ................++.+.+||.+||..||++|||++|+++|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00000011111222345678899999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-36  Score=260.84  Aligned_cols=246  Identities=18%  Similarity=0.168  Sum_probs=176.9

Q ss_pred             HHHHHHHhhccc---cceEEEcccCC---------ChhhHHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHH
Q 048068           15 CVSFILSALAQD---VNQFIYHGFNE---------DPQLQRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDK   82 (313)
Q Consensus        15 ~~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~   82 (313)
                      .|.+..+++..+   ...+++|.+..         ....|...++.++|+|++++..++.. ....++||+++.+++|..
T Consensus        12 ~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~~~~~~~~l~~   90 (292)
T d1unla_          12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQDLKKY   90 (292)
T ss_dssp             ECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCSEEHHHH
T ss_pred             cCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEeeecccccccc
Confidence            333334444433   34567776521         22366777889999999999998887 678999999999988888


Q ss_pred             HHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCCcccccccc
Q 048068           83 ILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGT  162 (313)
Q Consensus        83 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  162 (313)
                      ++..  .+.+++..++.++.|++.||+|||   ..+|+||||||+||+++.++.++|+|||.+........ ......++
T Consensus        91 ~~~~--~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~  164 (292)
T d1unla_          91 FDSC--NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVT  164 (292)
T ss_dssp             HHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCSCCSC
T ss_pred             cccc--ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-cceeeccc
Confidence            8765  356999999999999999999999   58999999999999999999999999999986654332 22334567


Q ss_pred             ccccccccccCCC-CCcchhhHHHHHHHHHHHhCCCCCccCCch-hhhhHHHHHHHhhhhccc-----------cc-ccc
Q 048068          163 FGYMAPELMRTGK-ASTSTDVYAFGVFMLEVASGRRPIEQQGSM-EMVNLVDWVSDCWKKGAI-----------LD-ASD  228 (313)
Q Consensus       163 ~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~-----------~~-~~~  228 (313)
                      ..|.+||.+.+.. ++.++|||||||++|+|++|..||....+. +....+............           .. ...
T Consensus       165 ~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T d1unla_         165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA  244 (292)
T ss_dssp             GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCT
T ss_pred             cchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccc
Confidence            8899999887654 689999999999999999999986543333 322222111110000000           00 000


Q ss_pred             ccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 048068          229 SRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY  267 (313)
Q Consensus       229 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  267 (313)
                      ...........+..+.+|+.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            011112223445678899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-36  Score=268.42  Aligned_cols=257  Identities=19%  Similarity=0.209  Sum_probs=182.3

Q ss_pred             hhhHHHHHHHHhhccc---cceEEEcccCCC---------hhhHHhhhhhccccceeeeeeEEecc----CCeEEEEEec
Q 048068           11 CVLLCVSFILSALAQD---VNQFIYHGFNED---------PQLQRDGLASVHSNGLLQLTNTVNSR----KGEFLLVYDY   74 (313)
Q Consensus        11 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~l~~~~~~~~l~~~~~~~~~----~~~~~lV~e~   74 (313)
                      .+++.|.+..++++.+   +..+++|.+...         ...|.+.++.++|++++++++++...    +...++||++
T Consensus        24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~  103 (348)
T d2gfsa1          24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH  103 (348)
T ss_dssp             EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence            4567777777777754   346788876432         23567788899999999999988621    2334455666


Q ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCcEEEeecccccccCCCCCC
Q 048068           75 MPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLNGKLGDFGLARLYDHDTIP  154 (313)
Q Consensus        75 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~  154 (313)
                      +.+|+|.+++..+   ++++..++.++.||+.||.|||   ++||+||||||+||+++.++.++++|||++.....    
T Consensus       104 ~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----  173 (348)
T d2gfsa1         104 LMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----  173 (348)
T ss_dssp             CCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG----
T ss_pred             ecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc----
Confidence            7799999999753   5999999999999999999999   58999999999999999999999999999864332    


Q ss_pred             ccccccccccccccccccCC-CCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHhhhhc------------
Q 048068          155 QTTKLVGTFGYMAPELMRTG-KASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDCWKKG------------  221 (313)
Q Consensus       155 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  221 (313)
                      ......|+..|+|||...+. .++.++|||||||++|+|++|++||.+.+.......+..........            
T Consensus       174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (348)
T d2gfsa1         174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  253 (348)
T ss_dssp             GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred             ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence            23445788999999987765 45889999999999999999999998877665544432111110000            


Q ss_pred             ---cccccccccccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HhccCCCCCCC
Q 048068          222 ---AILDASDSRLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--LDGNATLPDIP  278 (313)
Q Consensus       222 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L~~~~~~~~~~  278 (313)
                         .......... .......+..+.+||.+||..||.+|||++|+++|  +.........|
T Consensus       254 ~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~  314 (348)
T d2gfsa1         254 YIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  314 (348)
T ss_dssp             HHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred             hhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence               0000000000 00011234568899999999999999999999996  55544444333

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1.7e-31  Score=239.65  Aligned_cols=257  Identities=19%  Similarity=0.228  Sum_probs=173.7

Q ss_pred             hhhhHHHHHHHHhhccc---cceEEEcccCCCh------hhHHhhhhhcc-----------ccceeeeeeEEec-cCCeE
Q 048068           10 FCVLLCVSFILSALAQD---VNQFIYHGFNEDP------QLQRDGLASVH-----------SNGLLQLTNTVNS-RKGEF   68 (313)
Q Consensus        10 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~l~~~~-----------~~~~l~~~~~~~~-~~~~~   68 (313)
                      ..+++.|.+..+|.+++   +..+++|.+....      ..|.+.++++.           |+++++..++... .....
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~   97 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV   97 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence            34556677777777754   3467888776543      33445555554           5678877777652 34556


Q ss_pred             EEEEecCCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCceecCcCCCcEEEcCCCc------EEEee
Q 048068           69 LLVYDYMPNG-SLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLHRDIKPANVLLDADLN------GKLGD  141 (313)
Q Consensus        69 ~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H~dl~~~nIlv~~~~~------~~l~d  141 (313)
                      +++|.++..+ .............+++..++.++.||+.|+.|||+  ..||+||||||+||+++.++.      ++++|
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~d  175 (362)
T d1q8ya_          98 HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIAD  175 (362)
T ss_dssp             EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEECC
T ss_pred             eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEee
Confidence            6666666444 33344444445679999999999999999999996  489999999999999986543      89999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCCcchhhHHHHHHHHHHHhCCCCCccCCchhhhhHHHHHHHh----
Q 048068          142 FGLARLYDHDTIPQTTKLVGTFGYMAPELMRTGKASTSTDVYAFGVFMLEVASGRRPIEQQGSMEMVNLVDWVSDC----  217 (313)
Q Consensus       142 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----  217 (313)
                      ||.+......    .....+++.|+|||++.+..++.++|+||+||++++|++|+.||..................    
T Consensus       176 fg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~l  251 (362)
T d1q8ya_         176 LGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL  251 (362)
T ss_dssp             CTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred             cccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHh
Confidence            9998754332    23457899999999999889999999999999999999999999754432211111000000    


Q ss_pred             -------hhh----------ccccccccc----------cccCCccHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--H
Q 048068          218 -------WKK----------GAILDASDS----------RLEGIYEEEQMELVLKLGLFCSHPKPEARPNMRQVMQY--L  268 (313)
Q Consensus       218 -------~~~----------~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~--L  268 (313)
                             +..          .........          ..........+..+.+|+.+||+.||.+|||++|+|+|  +
T Consensus       252 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f  331 (362)
T d1q8ya_         252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL  331 (362)
T ss_dssp             CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGG
T ss_pred             CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence                   000          000000000          01123445677889999999999999999999999997  6


Q ss_pred             hccC
Q 048068          269 DGNA  272 (313)
Q Consensus       269 ~~~~  272 (313)
                      .+..
T Consensus       332 ~~~~  335 (362)
T d1q8ya_         332 KDTL  335 (362)
T ss_dssp             TTCT
T ss_pred             CCCC
Confidence            5554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.46  E-value=1.4e-14  Score=116.94  Aligned_cols=119  Identities=9%  Similarity=0.038  Sum_probs=82.1

Q ss_pred             HHhhhhhccccceeeeeeEEeccCCeEEEEEecCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 048068           42 QRDGLASVHSNGLLQLTNTVNSRKGEFLLVYDYMPNGSLDKILHTNIKPSLSWYQRFRIIRGVASGLLYLHEDWEQVVLH  121 (313)
Q Consensus        42 ~~~~l~~~~~~~~l~~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lhs~~~~~i~H  121 (313)
                      +...+..+.++++...++..     ..+++|||+++..+..         ++...+..++.|++.++.|||   ..+|+|
T Consensus        64 e~~~l~~l~~~~v~~~~~~~-----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiH  126 (191)
T d1zara2          64 EFRALQKLQGLAVPKVYAWE-----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVH  126 (191)
T ss_dssp             HHHHHHHTTTSSSCCEEEEE-----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             HHHHHHHccCCCcceEEEec-----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEE
Confidence            34556667777776655442     1379999998755432         444556788999999999999   589999


Q ss_pred             cCcCCCcEEEcCCCcEEEeecccccccCCCCCCccccccccccccc------cccccCCCCCcchhhHHHHHH
Q 048068          122 RDIKPANVLLDADLNGKLGDFGLARLYDHDTIPQTTKLVGTFGYMA------PELMRTGKASTSTDVYAFGVF  188 (313)
Q Consensus       122 ~dl~~~nIlv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~DiwslG~i  188 (313)
                      |||||+||+++++ .++|+|||.+.....+...         .|..      .+. ..+.++.++|+||+.--
T Consensus       127 rDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         127 GDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             SCCSTTSEEEETT-EEEECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred             ccCChhheeeeCC-CEEEEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence            9999999999865 5889999988654432210         1111      011 13567788999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.92  E-value=0.00086  Score=54.53  Aligned_cols=29  Identities=21%  Similarity=0.322  Sum_probs=24.2

Q ss_pred             CceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      .++|+|+.+.||++++++...|+||+.+.
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhcc
Confidence            37899999999999877666799998663

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.03  E-value=0.0039  Score=50.12  Aligned_cols=29  Identities=24%  Similarity=0.245  Sum_probs=24.5

Q ss_pred             CceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          118 VVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       118 ~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      .++|+|+.+.||+++.++...|+||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            47999999999999887667799998663

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.32  E-value=0.029  Score=48.28  Aligned_cols=30  Identities=17%  Similarity=0.264  Sum_probs=25.2

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ...++|||+.+.||++++++ ++|+||..+.
T Consensus       222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             CCEEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             CcceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            35789999999999998764 8899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.27  E-value=0.019  Score=47.61  Aligned_cols=31  Identities=32%  Similarity=0.288  Sum_probs=27.3

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..|++|+|+.++||+++.+...-+.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5789999999999999988777899999774

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=80.78  E-value=0.91  Score=37.19  Aligned_cols=29  Identities=28%  Similarity=0.266  Sum_probs=23.4

Q ss_pred             CCCceecCcCCCcEEEcCCCcEEEeeccccc
Q 048068          116 EQVVLHRDIKPANVLLDADLNGKLGDFGLAR  146 (313)
Q Consensus       116 ~~~i~H~dl~~~nIlv~~~~~~~l~dfg~~~  146 (313)
                      ..+++|+|+.+.||++++ + ..++||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            467899999999999964 3 4578998765